BRCA1	O
is	O
secreted	O
and	O
exhibits	O
properties	O
of	O
a	O
granin	O
.	O
<EOS> B-X
Localization B-X
of B-X
BRCA1 B-X
and B-X
a B-X
splice B-X
variant B-X
identifies B-X
the B-X
nuclear B-X
localization B-X
signal B-X
. B-X
Germline B-X
mutations B-X
in B-X
BRCA1 B-X
are B-X
responsible B-X
for B-X
most B-X
cases B-X
of B-X
inherited B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
However B-X
, B-X
the B-X
function B-X
of B-X
the B-X
BRCA1 B-X
protein B-X
has B-X
remained B-X
elusive B-X
. B-X
We B-X
now B-X
Mitochondrial B-X
localization B-X
, B-X
ELK-1 B-X
transcriptional B-X
regulation B-X
and B-X
Growth B-X
inhibitory B-X
functions B-X
of B-X
BRCA1 B-X
, B-X
BRCA1a B-X
and B-X
BRCA1b B-X
proteins B-X
Germline B-X
mutations B-X
in B-X
BRCA1 B-X
are B-X
responsible B-X
for B-X
most B-X
cases B-X
of B-X
inherited B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
However B-X
, B-X
the B-X
function B-X
of B-X
the B-X
BRCA1 B-X
protein B-X
has B-X
remained B-X
elusive B-X
. B-X
We B-X
now B-X
BRCA1 B-X
alterations B-X
are B-X
associated B-X
with B-X
endometriosis B-X
, B-X
but B-X
BRCA2 B-X
alterations B-X
show B-X
no B-X
detectable B-X
endometriosis B-X
risk B-X
: B-X
a B-X
study B-X
in B-X
Indian B-X
population B-X
Moderate B-X
frequency B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
germ-line B-X
mutations B-X
in B-X
Scandinavian B-X
familial B-X
breast B-X
cancer B-X
. B-X
Mutations B-X
of B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
and B-X
the B-X
possibilities B-X
for B-X
predictive B-X
testing B-X
- B-X
ScienceDirect B-X

Germline	O
mutations	O
in	O
BRCA1	O
are	O
responsible	O
for	O
most	O
cases	O
of	O
inherited	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
.	O
<EOS> B-X
Contribution B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Germline B-X
Mutations B-X
to B-X
Early B-X
Algerian B-X
Breast B-X
Cancer B-X

However	O
,	O
the	O
function	O
of	O
the	O
BRCA1	O
protein	O
has	O
remained	O
elusive	O
.	O
<EOS> B-X
BRCA1 B-X
can B-X
stimulate B-X
gene B-X
transcription B-X
by B-X
a B-X
unique B-X
mechanism B-X
Our B-X
findings B-X
support B-X
our B-X
hypothesis B-X
that B-X
common B-X
genetic B-X
variants B-X
can B-X
be B-X
evolutionarily B-X
selected B-X
in B-X
BRCA1 B-X
mutation B-X
carrier B-X
population B-X
to B-X
counterpart B-X
the B-X
oncogenic B-X
effects B-X
imposed B-X
by B-X
mutation B-X
predisposition B-X
in B-X
BRCA1 B-X
, B-X
BRCA1 B-X
: B-X
linking B-X
HOX B-X
to B-X
breast B-X
cancer B-X
suppression B-X
Function B-X
of B-X
BRCA1 B-X
in B-X
the B-X
DNA B-X
Damage B-X
Response B-X
Is B-X
Mediated B-X
by B-X
ADP-Ribosylation B-X
- B-X
ScienceDirect B-X
Homeobox B-X
( B-X
HOX B-X
) B-X
genes B-X
play B-X
key B-X
roles B-X
in B-X
embryogenesis B-X
and B-X
tissue B-X
differentiation B-X
. B-X
Recently B-X
, B-X
a B-X
number B-X
of B-X
groups B-X
have B-X
reported B-X
altered B-X
HOX B-X
gene B-X
expression B-X
in B-X
breast B-X
cancer B-X
. B-X
Abstract B-X
. B-X
Sustaining B-X
genomic B-X
integrity B-X
is B-X
essential B-X
for B-X
preventing B-X
onset B-X
of B-X
cancers B-X
. B-X
Therefore B-X
, B-X
human B-X
cells B-X
evolve B-X
to B-X
have B-X
refined B-X
biological B-X
pathways B-X
to B-X
defend B-X
Inherited B-X
germline B-X
mutations B-X
in B-X
the B-X
tumor B-X
suppressor B-X
gene B-X
BRCA1 B-X
predispose B-X
individuals B-X
to B-X
early B-X
onset B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
BRCA1 B-X
together B-X
with B-X
its B-X
structurally B-X
related B-X
partner B-X
BARD1 B-X
is B-X
required B-X
for B-X

We	O
now	O
show	O
that	O
BRCA1	O
encodes	O
a	O
190	O
-	O
kD	O
protein	O
with	O
sequence	O
homology	O
and	O
biochemical	O
analogy	O
to	O
the	O
granin	O
protein	O
family	O
.	O
<EOS> B-X
Genetic B-X
analysis B-X
of B-X
familial B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
indicates B-X
that B-X
BRCA1 B-X
is B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
. B-X
The B-X
BRCA1 B-X
gene B-X
encodes B-X
a B-X
190 B-X
kDa B-X
protein B-X
with B-X
sequence B-X
homology B-X
and B-X
biochemical B-X
BRCA1 B-X
is B-X
secreted B-X
and B-X
exhibits B-X
properties B-X
of B-X
a B-X
granin B-X
. B-X
Abstract B-X
. B-X
The B-X
breast B-X
cancer B-X
susceptibility B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
was B-X
isolated B-X
in B-X
1994 B-X
. B-X
Recent B-X
investigations B-X
into B-X
the B-X
genetic B-X
epidemiology B-X
of B-X
BRCA1 B-X
have B-X
revealed B-X
an B-X
unex B-X
In B-X
the B-X
present B-X
study B-X
, B-X
we B-X
investigated B-X
the B-X
frequency B-X
of B-X
BRCA1 B-X
gene B-X
mutations B-X
in B-X
30 B-X
breast B-X
cancer B-X
( B-X
BC B-X
) B-X
patients B-X
of B-X
independent B-X
family B-X
history B-X
and B-X
30 B-X
healthy B-X
PDF B-X
| B-X
BRCA1 B-X
acts B-X
as B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
and B-X
germ-line B-X
mutations B-X
in B-X
this B-X
gene B-X
are B-X
found B-X
in B-X
a B-X
large B-X
proportion B-X
of B-X
families B-X
with B-X
breast B-X
and B-X
ovarian B-X
... B-X
| B-X
PDF B-X
| B-X
BRCA1 B-X
is B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
and B-X
germ B-X
line B-X
mutations B-X
account B-X
for B-X
the B-X
majority B-X
of B-X
familial B-X
cases B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
There B-X
is B-X
... B-X
| B-X
Find B-X
BRCA1 B-X
BRCA1 B-X
DNA B-X
repair B-X
associated B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X

Interestingly	O
,	O
BRCA2	O
also	O
includes	O
a	O
motif	O
similar	O
to	O
the	O
granin	O
consensus	O
at	O
the	O
C	O
terminus	O
of	O
the	O
protein	O
.	O
<EOS> B-X
Know B-X
comprehensive B-X
BRCA1 B-X
protein B-X
information B-X
including B-X
protein B-X
sequence B-X
, B-X
molecular B-X
weight B-X
, B-X
theoretical B-X
pI B-X
, B-X
structure B-X
, B-X
function B-X
and B-X
protein B-X
interaction B-X
. B-X
PDF B-X
| B-X
On B-X
Jun B-X
1 B-X
, B-X
1996 B-X
, B-X
Peer B-X
Bork B-X
and B-X
others B-X
published B-X
Internal B-X
repeats B-X
in B-X
BRCA2 B-X
protein B-X
sequence B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
Abstract B-X
. B-X
Five B-X
to B-X
ten B-X
percent B-X
of B-X
breast B-X
cancer B-X
in B-X
the B-X
western B-X
world B-X
may B-X
be B-X
attributed B-X
to B-X
the B-X
inheritance B-X
of B-X
highly B-X
penetrant B-X
mutations B-X
in B-X
the B-X
breast B-X
and B-X
ovarian B-X
Request B-X
PDF B-X
| B-X
Insights B-X
into B-X
the B-X
functions B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
| B-X
Since B-X
BRCA1 B-X
and B-X
BRCA2 B-X
were B-X
cloned B-X
five B-X
years B-X
ago B-X
, B-X
unraveling B-X
their B-X
normal B-X
functions B-X
has B-X
posed B-X
fascinating B-X
problems B-X
PDF B-X
| B-X
Inherited B-X
BRCA2 B-X
mutations B-X
confer B-X
profound B-X
susceptibility B-X
to B-X
human B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
The B-X
rat B-X
and B-X
mouse B-X
Brca2 B-X
homologues B-X
share B-X
58 B-X
% B-X
and B-X
59 B-X
% B-X
... B-X
| B-X
Find B-X
PDF B-X
| B-X
Germ-line B-X
mutations B-X
in B-X
BRCA1 B-X
predispose B-X
individuals B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
We B-X
observed B-X
a B-X
novel B-X
endogenous B-X
association B-X
of B-X
BRCA1 B-X
with B-X
Nmi B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Homologs B-X
of B-X
Breast B-X
Cancer B-X
Genes B-X
in B-X
Plants B-X

Both	O
BRCA1	O
and	O
the	O
granins	O
localize	O
to	O
secretory	O
vesicles	O
,	O
are	O
secreted	O
by	O
a	O
regulated	O
pathway	O
,	O
are	O
post	O
-	O
translationally	O
glycosylated	O
and	O
are	O
responsive	O
to	O
hormones	O
.	O
<EOS> B-X
Secretory B-X
Protein B-X
Biogenesis B-X
and B-X
Traffic B-X
in B-X
the B-X
Early B-X
Secretory B-X
Pathway B-X
Request B-X
PDF B-X
| B-X
BRCA2 B-X
protein B-X
expression B-X
in B-X
sporadic B-X
breast B-X
carcinoma B-X
with B-X
or B-X
without B-X
allelic B-X
loss B-X
of B-X
BRCA2 B-X
| B-X
To B-X
elucidate B-X
the B-X
cellular B-X
role B-X
of B-X
BRCA2 B-X
in B-X
sporadic B-X
breast B-X
tumors B-X
, B-X
Intracellular B-X
trafficking B-X
of B-X
prohormones B-X
and B-X
proneuropeptides B-X
: B-X
cell B-X
type‚Äêspecific B-X
sorting B-X
and B-X
targeting B-X
- B-X
Perone B-X
- B-X
1997 B-X
- B-X
Experimental B-X
Physiology B-X
- B-X
Wiley B-X
Online B-X
Library B-X

As	O
a	O
regulated	O
secretory	O
protein	O
,	O
BRCA1	O
appears	O
to	O
function	O
by	O
a	O
mechanism	O
not	O
previously	O
described	O
for	O
tumour	B-Disease
suppressor	O
gene	O
products	O
.	O
.	O
<EOS> B-X
Germline B-X
mutations B-X
in B-X
BRCA1 B-X
are B-X
responsible B-X
for B-X
most B-X
cases B-X
of B-X
inherited B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
However B-X
, B-X
the B-X
function B-X
of B-X
the B-X
BRCA1 B-X
protein B-X
has B-X
remained B-X
elusive B-X
. B-X
We B-X
now B-X
A B-X
role B-X
for B-X
BRCA1 B-X
in B-X
sporadic B-X
breast B-X
cancer B-X
Loss-of-function B-X
mutations B-X
of B-X
the B-X
breast B-X
cancer B-X
type B-X
1 B-X
susceptibility B-X
protein B-X
( B-X
BRCA1 B-X
) B-X
are B-X
associated B-X
with B-X
breast B-X
( B-X
BC B-X
) B-X
and B-X
ovarian B-X
cancer B-X
( B-X
OC B-X
) B-X
. B-X
To B-X
identify B-X
gene B-X

Ovarian	B-Disease
cancer	I-Disease
risk	O
in	O
BRCA1	O
carriers	O
is	O
modified	O
by	O
the	O
HRAS1	O
variable	O
number	O
of	O
tandem	O
repeat	O
(	O
VNTR	O
)	O
locus	O
.	O
<EOS> B-X
Ovarian B-X
Cancer B-X
Risk B-X
in B-X
BRCA1 B-X
Carriers B-X
is B-X
Modified B-X
by B-X
the B-X
HRAS1 B-X
Variable B-X
Number B-X
of B-X
Tandem B-X
Repeat B-X
( B-X
VNTR B-X
) B-X
Locus B-X
Mutations B-X
of B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
in B-X
patients B-X
with B-X
bilateral B-X
breast B-X
cancer B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
status B-X
and B-X
cancer B-X
family B-X
history B-X
of B-X
Danish B-X
women B-X
affected B-X
with B-X
multifocal B-X
or B-X
bilateral B-X
breast B-X
cancer B-X
at B-X
a B-X
young B-X
age B-X
Modification B-X
of B-X
Ovarian B-X
Cancer B-X
Risk B-X
by B-X
BRCA1/2-Interacting B-X
Genes B-X
in B-X
a B-X
Multicenter B-X
Cohort B-X
of B-X
BRCA1/2 B-X
Mutation B-X
Carriers B-X
| B-X
Cancer B-X
Research B-X
BRCA1 B-X
Wild-Type B-X
Allele B-X
Modifies B-X
Risk B-X
of B-X
Ovarian B-X
Cancer B-X
in B-X
Carriers B-X
of B-X
BRCA1 B-X
Germ-Line B-X
Mutations B-X
| B-X
Cancer B-X
Epidemiology B-X
, B-X
Biomarkers B-X
& B-X
Prevention B-X
HRAS1 B-X
variable B-X
number B-X
of B-X
tandem B-X
repeats B-X
polymorphism B-X
and B-X
risk B-X
of B-X
bladder B-X
cancer B-X
- B-X
van B-X
Gils B-X
- B-X
2002 B-X
- B-X
International B-X
Journal B-X
of B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Molecular B-X
Genetics B-X
of B-X
Cancer B-X
, B-X
Second B-X
Edition B-X
provides B-X
an B-X
authoritative B-X
and B-X
up B-X
to B-X
date B-X
review B-X
of B-X
the B-X
key B-X
genes B-X
known B-X
to B-X
be B-X
critical B-X
in B-X
the B-X
development B-X
or B-X
progression B-X
of B-X
cancer B-X

Women	O
who	O
carry	O
a	O
mutation	O
in	O
the	O
BRCA1	O
gene	O
(	O
on	O
chromosome	O
17q21	O
)	O
,	O
have	O
an	O
80	O
%	O
risk	O
of	O
breast	B-Disease
cancer	I-Disease
and	O
a	O
40	O
%	O
risk	O
of	O
ovarian	B-Disease
cancer	I-Disease
by	O
the	O
age	O
of	O
70	O
(	O
ref	O
.	O
1	O
)	O
.	O
<EOS> B-X
Molecular B-X
analyses B-X
allow B-X
one B-X
to B-X
determine B-X
genetic B-X
lesions B-X
occurring B-X
early B-X
in B-X
the B-X
development B-X
of B-X
tumors B-X
. B-X
With B-X
positional B-X
cloning B-X
approaches B-X
we B-X
are B-X
searching B-X
for B-X
a B-X
gene B-X
involved B-X
in B-X
the B-X
development B-X
Prophylactic B-X
oophorectomy B-X
: B-X
Preventing B-X
cancer B-X
by B-X
surgically B-X
removing B-X
your B-X
ovaries B-X
- B-X
Mayo B-X
Clinic B-X
Your B-X
Total B-X
Solution B-X
for B-X
Math B-X
Grade B-X
1 B-X
will B-X
delight B-X
young B-X
children B-X
with B-X
activities B-X
that B-X
teach B-X
addition B-X
and B-X
subtraction B-X
, B-X
place B-X
value B-X
, B-X
counting B-X
by B-X
fives B-X
and B-X
tens B-X
, B-X
measurement B-X
, B-X
Pioneering B-X
geneticist B-X
Mary-Claire B-X
King B-X
receives B-X
the B-X
2014 B-X
Lasker~Koshland B-X
Special B-X
Achievement B-X
Award B-X
in B-X
Medical B-X
Science B-X
Official B-X
lyric B-X
video B-X
by B-X
Taylor B-X
Swift B-X
performing B-X
‚Äú B-X
the B-X
1 B-X
‚Äù B-X
‚Äì B-X
off B-X
her B-X
album B-X
‚Äò B-X
folklore. B-X
‚Äô B-X
Album B-X
available B-X
here B-X
: B-X
https B-X
: B-X
//store.taylorswift.com B-X
‚ñ∫Subscribe B-X
to B-X
Taylor B-X
... B-X
Another B-X
weighty B-X
regimental B-X
history B-X
, B-X
two B-X
volumes B-X
, B-X
820 B-X
pages B-X
in B-X
all B-X
covering B-X
the B-X
record B-X
of B-X
twenty-two B-X
battalions B-X
in B-X
France B-X
, B-X
Flanders B-X
, B-X
Italy B-X
and B-X
Gallipoli B-X
( B-X
all B-X
of B-X
them B-X
Amazon B-X
Prime B-X
Video B-X
presentsCoolie B-X
No B-X
. B-X
1 B-X
Official B-X
Trailer B-X
A B-X
Pooja B-X
Entertainment B-X
FranchiseDirected B-X
by B-X
David B-X
DhawanStarring B-X
Varun B-X
Dhawan B-X
, B-X
Sara B-X
Ali B-X
Khan B-X
, B-X
Paresh B-X
... B-X

The	O
variable	O
penetrance	O
of	O
BRCA1	O
suggests	O
that	O
other	O
genetic	O
and	O
non	O
-	O
genetic	O
factors	O
play	O
a	O
role	O
in	O
tumourigenesis	O
in	O
these	O
individuals	O
.	O
<EOS> B-X
Through B-X
many B-X
years B-X
of B-X
fundamental B-X
research B-X
, B-X
we B-X
have B-X
begun B-X
to B-X
have B-X
a B-X
better B-X
understanding B-X
of B-X
cancer B-X
. B-X
Research B-X
underlying B-X
the B-X
basic B-X
phenomenon B-X
has B-X
been B-X
hampered B-X
by B-X
the B-X
fact B-X
that B-X

The	O
HRAS1	O
variable	O
number	O
of	O
tandem	O
repeats	O
(	O
VNTR	O
)	O
polymorphism	O
,	O
located	O
1	O
kilobase	O
(	O
kb	O
)	O
downstream	O
of	O
the	O
HRAS1	O
proto	O
-	O
oncogene	O
(	O
chromosome	O
11p15	O
.	O
5	O
)	O
is	O
one	O
possible	O
genetic	O
modifier	O
of	O
cancer	B-Disease
penetrance	O
.	O
<EOS> B-X
The B-X
HRAS1 B-X
variable B-X
number B-X
of B-X
tandem B-X
repeats B-X
( B-X
VNTR B-X
) B-X
polymorphism B-X
, B-X
1 B-X
kb B-X
downstream B-X
from B-X
the B-X
HRAS1 B-X
gene B-X
, B-X
has B-X
been B-X
reported B-X
to B-X
be B-X
associated B-X
with B-X
risk B-X
of B-X
various B-X
Rare B-X
alleles B-X
at B-X
the B-X
HRAS1 B-X
variable B-X
number B-X
of B-X
tandem B-X
repeats B-X
( B-X
VNTRs B-X
) B-X
locus B-X
have B-X
been B-X
implicated B-X
in B-X
breast B-X
cancer B-X
risk B-X
. B-X
We B-X
assessed B-X
the B-X
association B-X
of B-X
rare B-X
HRAS1 B-X
alleles B-X
Request B-X
PDF B-X
| B-X
VNTR B-X
sequence B-X
on B-X
human B-X
chromosome B-X
11p15 B-X
that B-X
affects B-X
transcriptional B-X
activity B-X
| B-X
We B-X
found B-X
a B-X
variable B-X
number B-X
of B-X
tandem B-X
repeat B-X
( B-X
VNTR B-X
) B-X
sequence B-X
with B-X
38-bp B-X
repetitive B-X
units B-X
An B-X
allele B-X
of B-X
HRAS1 B-X
3‚Ä≤variable B-X
number B-X
of B-X
tandem B-X
repeats B-X
is B-X
a B-X
frailty B-X
allele B-X
: B-X
implication B-X
for B-X
an B-X
evolutionarily-conserved B-X
pathway B-X
involved B-X
in B-X
longevity B-X
- B-X
ScienceDirect B-X
The B-X
HRAS1 B-X
Variable B-X
Number B-X
of B-X
Tandem B-X
Repeats B-X
and B-X
Risk B-X
of B-X
Breast B-X
Cancer B-X
| B-X
Cancer B-X
Epidemiology B-X
, B-X
Biomarkers B-X
& B-X
Prevention B-X
HRAS1 B-X
variable B-X
number B-X
of B-X
tandem B-X
repeats B-X
polymorphism B-X
and B-X
risk B-X
of B-X
bladder B-X
cancer B-X
- B-X
van B-X
Gils B-X
- B-X
2002 B-X
- B-X
International B-X
Journal B-X
of B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Women B-X
with B-X
germline B-X
mutations B-X
in B-X
BRCA1 B-X
have B-X
a B-X
greatly B-X
elevated B-X
risk B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
However B-X
, B-X
considerable B-X
variation B-X
in B-X
the B-X
degree B-X
of B-X
breast B-X
cancer B-X
risk B-X
associated B-X
with B-X

Individuals	O
who	O
have	O
rare	O
alleles	O
of	O
the	O
VNTR	O
have	O
an	O
increased	O
risk	O
of	O
certain	O
types	O
of	O
cancers	B-Disease
,	O
including	O
breast	B-Disease
cancer	I-Disease
(	O
2	O
-	O
4	O
)	O
.	O
<EOS> B-X
The B-X
influence B-X
of B-X
an B-X
IL-4 B-X
variable B-X
number B-X
tandem B-X
repeat B-X
( B-X
VNTR B-X
) B-X
polymorphism B-X
on B-X
breast B-X
cancer B-X
susceptibility B-X
Rare B-X
HRAS1 B-X
alleles B-X
are B-X
a B-X
risk B-X
factor B-X
for B-X
the B-X
development B-X
of B-X
brain B-X
tumors B-X
- B-X
Vega B-X
- B-X
2001 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Rare B-X
HRAS1 B-X
alleles B-X
are B-X
a B-X
risk B-X
factor B-X
for B-X
the B-X
development B-X
of B-X
brain B-X
tumors B-X
- B-X
Vega B-X
- B-X
2001 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Over B-X
the B-X
last B-X
several B-X
years B-X
, B-X
evidence B-X
has B-X
accumulated B-X
to B-X
support B-X
the B-X
idea B-X
that B-X
rare B-X
Ha-ras B-X
polymorphisms B-X
are B-X
associated B-X
with B-X
inherited B-X
susceptibility B-X
to B-X
ce B-X
The B-X
hTERT B-X
( B-X
human B-X
telomerase B-X
reverse B-X
transcriptase B-X
) B-X
gene B-X
contains B-X
five B-X
variable B-X
number B-X
tandem B-X
repeats B-X
( B-X
VNTR B-X
) B-X
and B-X
previous B-X
studies B-X
have B-X
described B-X
polymorphisms B-X
for B-X
hTERT-VNTR2-2nd B-X
. B-X
We B-X
investigated B-X
how B-X
Much B-X
of B-X
the B-X
familial B-X
aggregation B-X
of B-X
common B-X
cancer B-X
results B-X
from B-X
inherited B-X
susceptibility B-X
, B-X
but B-X
highly B-X
penetrant B-X
mutations B-X
in B-X
known B-X
genes B-X
can B-X
not B-X
account B-X
for B-X
most B-X
of B-X
the B-X
excess B-X
. B-X
Some B-X
BackgroundMucins B-X
are B-X
the B-X
major B-X
components B-X
of B-X
mucus B-X
and B-X
their B-X
genes B-X
share B-X
a B-X
common B-X
, B-X
centrally-located B-X
region B-X
of B-X
sequence B-X
that B-X
encodes B-X
tandem B-X
repeats B-X
. B-X
Mucins B-X
are B-X
well B-X
known B-X
genes B-X
with B-X
respect B-X

To	O
investigate	O
whether	O
the	O
presence	O
of	O
rare	O
HRAS1	O
alleles	O
increases	O
susceptibility	O
to	O
hereditary	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
,	O
we	O
have	O
typed	O
a	O
panel	O
of	O
307	O
female	O
BRCA1	O
carriers	O
at	O
this	O
locus	O
using	O
a	O
PCR	O
-	O
based	O
technique	O
.	O
<EOS> B-X
Women B-X
who B-X
carry B-X
a B-X
mutation B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
( B-X
on B-X
chromosome B-X
17q21 B-X
) B-X
, B-X
have B-X
an B-X
80 B-X
% B-X
risk B-X
of B-X
breast B-X
cancer B-X
and B-X
a B-X
40 B-X
% B-X
risk B-X
of B-X
ovarian B-X
Women B-X
who B-X
carry B-X
a B-X
mutation B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
( B-X
on B-X
chromosome B-X
17q21 B-X
) B-X
, B-X
have B-X
an B-X
80 B-X
% B-X
risk B-X
of B-X
breast B-X
cancer B-X
and B-X
a B-X
40 B-X
% B-X
risk B-X
of B-X
ovarian B-X
Request B-X
PDF B-X
| B-X
Progesterone B-X
receptor B-X
variant B-X
increases B-X
ovarian B-X
cancer B-X
risk B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
carriers B-X
who B-X
were B-X
never B-X
exposed B-X
to B-X
oral B-X
contraceptives B-X
| B-X
Oral B-X
contraceptives B-X
have B-X
been B-X
shown B-X
to B-X
Request B-X
PDF B-X
| B-X
RareHRAS1 B-X
alleles B-X
are B-X
a B-X
risk B-X
factor B-X
for B-X
the B-X
development B-X
of B-X
brain B-X
tumors B-X
| B-X
The B-X
highly B-X
polymorphic B-X
HRAS1 B-X
minisatellite B-X
locus B-X
, B-X
located B-X
1 B-X
kilobase B-X
downstream B-X
from B-X
the B-X
H-ras1 B-X
Familial B-X
breast B-X
cancer B-X
is B-X
characterized B-X
by B-X
young B-X
age B-X
at B-X
diagnosis B-X
, B-X
an B-X
increased B-X
risk B-X
of B-X
bilateral B-X
breast B-X
cancer B-X
, B-X
an B-X
increasing B-X
risk B-X
in B-X
conjunction B-X
with B-X
increasing B-X
numbers B-X
of B-X
affected B-X
family B-X
Pathogenic B-X
BRCA1/2 B-X
germline B-X
mutations B-X
confer B-X
high B-X
risks B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
to B-X
women B-X
of B-X
European B-X
ancestry B-X
. B-X
Characterization B-X
of B-X
BRCA1/2 B-X
mutations B-X
in B-X
other B-X
ethnic B-X
groups B-X
is B-X
also B-X
medically B-X
important B-X
Pathogenic B-X
BRCA1/2 B-X
germline B-X
mutations B-X
confer B-X
high B-X
risks B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
to B-X
women B-X
of B-X
European B-X
ancestry B-X
. B-X
Characterization B-X
of B-X
BRCA1/2 B-X
mutations B-X
in B-X
other B-X
ethnic B-X
groups B-X
is B-X
also B-X
medically B-X
important B-X

The	O
risk	O
for	O
ovarian	B-Disease
cancer	I-Disease
was	O
2	O
.	O
<EOS> B-X
A B-X
list B-X
of B-X
things B-X
that B-X
could B-X
raise B-X
your B-X
risk B-X
for B-X
ovarian B-X
cancer B-X
. B-X
Risk B-X
factors B-X
for B-X
ovarian B-X
cancer B-X
include B-X
having B-X
a B-X
family B-X
history B-X
of B-X
ovarian B-X
cancer B-X
and B-X
BRCA B-X
gene B-X
mutations B-X
. B-X
Learn B-X
about B-X
ovarian B-X
cancer B-X
risk B-X
. B-X
Family B-X
history B-X
plays B-X
an B-X
important B-X
role B-X
in B-X
the B-X
risk B-X
of B-X
developing B-X
ovarian B-X
cancer B-X
. B-X
The B-X
lifetime B-X
risk B-X
for B-X
developing B-X
ovarian B-X
cancer B-X
is B-X
1.6 B-X
% B-X
in B-X
the B-X
general B-X
population B-X
. B-X
This B-X
If B-X
you B-X
have B-X
a B-X
strong B-X
family B-X
history B-X
of B-X
breast B-X
or B-X
ovarian B-X
cancer B-X
, B-X
you B-X
may B-X
also B-X
be B-X
at B-X
an B-X
increased B-X
risk B-X
for B-X
ovarian B-X
cancer B-X
. B-X
Learn B-X
about B-X
ovarian B-X
cancer B-X
risk B-X
The B-X
high B-X
incidence B-X
of B-X
ovarian B-X
cancer B-X
suggests B-X
that B-X
oophorectomy B-X
should B-X
be B-X
recommended B-X
in B-X
female B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
carriers B-X
with B-X
a B-X
diagnosis B-X
of B-X
breast B-X
cancer B-X
, B-X
especially B-X
those B-X
with B-X
stage B-X
Ovarian B-X
cancer B-X
is B-X
the B-X
10th B-X
most B-X
common B-X
type B-X
of B-X
cancer B-X
among B-X
females B-X
in B-X
the B-X
United B-X
States B-X
. B-X
This B-X
cancer B-X
can B-X
be B-X
difficult B-X
to B-X
detect B-X
, B-X
but B-X
as B-X
with B-X
other B-X
cancers B-X
Every B-X
year B-X
, B-X
25,000 B-X
women B-X
in B-X
the B-X
United B-X
States B-X
( B-X
about B-X
one B-X
in B-X
3,000 B-X
women B-X
older B-X
than B-X
40 B-X
years B-X
) B-X
receive B-X
ovarian B-X
cancer B-X
diagnoses B-X
, B-X
and B-X
14,000 B-X
die B-X
of B-X
the B-X

11	O
times	O
greater	O
for	O
BRCA1	O
carriers	O
harbouring	O
one	O
or	O
two	O
rare	O
HRAS1	O
alleles	O
,	O
compared	O
to	O
carriers	O
with	O
only	O
common	O
alleles	O
(	O
P	O
=	O
0	O
.	O
015	O
)	O
.	O
<EOS> B-X
Haplotype B-X
analysis B-X
of B-X
TP53 B-X
polymorphisms B-X
, B-X
Arg72Pro B-X
and B-X
Ins16 B-X
, B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
carriers B-X
of B-X
French B-X
Canadian B-X
descent B-X
The B-X
genotype-phenotype B-X
correlations B-X
of B-X
the B-X
specific B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
multi-ethnic B-X
populations B-X
in B-X
USA B-X
have B-X
not B-X
yet B-X
been B-X
fully B-X
investigated B-X
. B-X
This B-X
study B-X
was B-X
designed B-X
to B-X
evaluate B-X
the B-X
effects B-X
PDF B-X
| B-X
Women B-X
with B-X
germline B-X
mutations B-X
in B-X
BRCA1 B-X
have B-X
a B-X
greatly B-X
elevated B-X
risk B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
However B-X
, B-X
considerable B-X
variation B-X
in B-X
the B-X
degree B-X
of B-X
... B-X
| B-X
Find B-X
PDF B-X
| B-X
A B-X
recent B-X
meta-analysis B-X
of B-X
23 B-X
studies B-X
supported B-X
the B-X
empirically B-X
derived B-X
hypothesis B-X
that B-X
women B-X
who B-X
lack B-X
one B-X
of B-X
the B-X
four B-X
common B-X
minisatellite B-X
alleles B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
This B-X
WHO B-X
classification B-X
covers B-X
the B-X
female B-X
and B-X
male B-X
breast B-X
, B-X
ovaries B-X
, B-X
fallopian B-X
tumors B-X
, B-X
uterine B-X
cervix B-X
, B-X
uterine B-X
corpus B-X
, B-X
vulva B-X
, B-X
vagina B-X
and B-X
inherited B-X
tumor B-X
syndromes B-X
. B-X
It B-X

The	O
magnitude	O
of	O
the	O
relative	O
risk	O
associated	O
with	O
a	O
rare	O
HRAS1	O
allele	O
was	O
not	O
altered	O
by	O
adjusting	O
for	O
the	O
other	O
known	O
risk	O
factors	O
for	O
hereditary	B-Disease
ovarian	I-Disease
cancer	I-Disease
(	O
5	O
)	O
.	O
<EOS> B-X
PDF B-X
| B-X
Approximately B-X
10 B-X
% B-X
of B-X
ovarian B-X
cancers B-X
are B-X
due B-X
to B-X
mutations B-X
in B-X
highly B-X
penetrant B-X
inherited B-X
cancer B-X
susceptibility B-X
genes B-X
. B-X
The B-X
highly B-X
polymorphic B-X
HRAS1 B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

Susceptibility	O
to	O
breast	B-Disease
cancer	I-Disease
did	O
not	O
appear	O
to	O
be	O
affected	O
by	O
the	O
presence	O
of	O
rare	O
HRAS1	O
alleles	O
.	O
<EOS> B-X
Abstract B-X
. B-X
DNA B-X
sequence B-X
analysis B-X
of B-X
130 B-X
alleles B-X
of B-X
the B-X
HfRAS1 B-X
minisatellite B-X
has B-X
demonstrated B-X
that B-X
breast B-X
cancer-associated B-X
variants B-X
arise B-X
as B-X
a B-X
consequence B-X
of B-X
bot B-X
Over B-X
the B-X
last B-X
several B-X
years B-X
, B-X
evidence B-X
has B-X
accumulated B-X
to B-X
support B-X
the B-X
idea B-X
that B-X
rare B-X
Ha-ras B-X
polymorphisms B-X
are B-X
associated B-X
with B-X
inherited B-X
susceptibility B-X
to B-X
ce B-X
HRAS1 B-X
minisatellite B-X
alleles B-X
and B-X
breast B-X
cancer B-X
in B-X
Spanish B-X
women B-X
under B-X
age B-X
forty B-X
years B-X
| B-X
Breast B-X
Cancer B-X
Research B-X
| B-X
Full B-X
Text B-X

This	O
study	O
is	O
the	O
first	O
to	O
show	O
the	O
effect	O
of	O
a	O
modifying	O
gene	O
on	O
the	O
penetrance	O
of	O
an	O
inherited	B-Disease
cancer	I-Disease
syndrome	I-Disease
<EOS> B-X
Gene B-X
mutations B-X
can B-X
sometimes B-X
lead B-X
to B-X
cancer B-X
. B-X
Learn B-X
more B-X
about B-X
changes B-X
in B-X
genes B-X
here B-X
. B-X
Cancer B-X
Genetics B-X
: B-X
Risks B-X
and B-X
Mechanisms B-X
of B-X
Cancer B-X
in B-X
Women B-X
with B-X
Inherited B-X
Susceptibility B-X
to B-X
Epithelial B-X
Ovarian B-X
Cancer B-X
Hereditary B-X
Cancer B-X
Syndromes B-X
and B-X
Risk B-X
Assessment B-X
| B-X
ACOG B-X
It B-X
is B-X
important B-X
to B-X
have B-X
accurate B-X
knowledge B-X
of B-X
the B-X
range B-X
of B-X
cancers B-X
associated B-X
with B-X
various B-X
CHEK2 B-X
mutations B-X
, B-X
and B-X
of B-X
the B-X
lifetime B-X
risks B-X
of B-X
cancer B-X
associated B-X
with B-X
each B-X
. B-X
We B-X
THE B-X
GORDON B-X
WILSON B-X
LECTURE B-X
: B-X
CANCER B-X
GENE B-X
VARIANT B-X
( B-X
RE B-X
) B-X
CLASSIFICATION B-X
: B-X
FROM B-X
TRUTHINESS B-X
TO B-X
TRUTH B-X

A	O
novel	O
homeodomain	O
-	O
encoding	O
gene	O
is	O
associated	O
with	O
a	O
large	O
CpG	O
island	O
interrupted	O
by	O
the	O
myotonic	B-Disease
dystrophy	I-Disease
unstable	O
(	O
CTG	O
)	O
n	O
repeat	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3‚Ä≤-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
gene B-X
, B-X
DM B-X
Abstract B-X
. B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3‚Ä≤-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
gene B-X
, B-X
DM B-X
Abstract B-X
. B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3‚Ä≤-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
gene B-X
, B-X
DM B-X
Abstract B-X
. B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3‚Ä≤-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
gene B-X
, B-X
DM B-X
PDF B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3'-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
... B-X
| B-X
Find B-X
, B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3'-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
gene B-X
, B-X
DMPK B-X
, B-X
which B-X
maps B-X
Myotonic B-X
dystrophy B-X
: B-X
molecular B-X
windows B-X
on B-X
a B-X
complex B-X
etiology B-X
. B-X

Myotonic	B-Disease
dystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
associated	O
with	O
a	O
(	O
CTG	O
)	O
n	O
trinucleotide	O
repeat	O
expansion	O
in	O
the	O
3	O
-	O
untranslated	O
region	O
of	O
a	O
protein	O
kinase	O
-	O
encoding	O
gene	O
,	O
DMPK	O
,	O
which	O
maps	O
to	O
chromosome	O
19q13	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
an B-X
expansion B-X
of B-X
an B-X
unstable B-X
( B-X
CTG B-X
) B-X
n B-X
repeat B-X
in B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X
of B-X
the B-X
DM B-X
protein B-X
kinase B-X
( B-X
One B-X
form B-X
of B-X
myotonic B-X
dystrophy B-X
, B-X
dystrophia B-X
myotonica B-X
1 B-X
( B-X
DM1 B-X
) B-X
, B-X
is B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
( B-X
CTG B-X
) B-X
( B-X
n B-X
) B-X
repeat B-X
within B-X
the B-X
dystrophia B-X
The B-X
mutation B-X
underlying B-X
myotonic B-X
dystrophy B-X
is B-X
the B-X
expansion B-X
of B-X
polymorphic B-X
CTG B-X
repeat B-X
in B-X
the B-X
3'-noncoding B-X
region B-X
of B-X
the B-X
myotonin B-X
protein B-X
kinase B-X
( B-X
MtPK B-X
) B-X
gene B-X
mapping B-X
to B-X
chromosome B-X
19q13.3 B-X
. B-X
The B-X
mutation B-X
underlying B-X
myotonic B-X
dystrophy B-X
is B-X
the B-X
expansion B-X
of B-X
polymorphic B-X
CTG B-X
repeat B-X
in B-X
the B-X
3'-noncoding B-X
region B-X
of B-X
the B-X
myotonin B-X
protein B-X
kinase B-X
( B-X
MtPK B-X
) B-X
gene B-X
mapping B-X
to B-X
chromosome B-X
19q13.3 B-X
. B-X
Does B-X
( B-X
CUG B-X
) B-X
n B-X
repeat B-X
in B-X
DMPK B-X
mRNA B-X
‚Äò B-X
paint B-X
‚Äô B-X
chromosome B-X
19 B-X
to B-X
suppress B-X
distant B-X
genes B-X
to B-X
create B-X
the B-X
diverse B-X
phenotype B-X
of B-X
myotonic B-X
dystrophy B-X
? B-X
: B-X
| B-X
SpringerLink B-X
Myotonic B-X
Dystrophy B-X
Protein B-X
Kinase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Infantile B-X
bilateral B-X
striatal B-X
necrosis B-X
maps B-X
to B-X
chromosome B-X
19q B-X
| B-X
Neurology B-X

3	O
.	O
<EOS> B-X
Wind B-X
Tre B-X
Wind B-X
Tre B-X
Wind B-X
Tre B-X
Wind B-X
Tre B-X
3 B-X
( B-X
telefonia B-X
mobile B-X
) B-X
- B-X
Wikipedia B-X
3 B-X
( B-X
telefonia B-X
mobile B-X
) B-X
- B-X
Wikipedia B-X
3 B-X
( B-X
telefonia B-X
mobile B-X
) B-X
- B-X
Wikipedia B-X

Characterisation	O
of	O
the	O
expression	O
of	O
this	O
gene	O
in	O
patient	O
tissues	O
has	O
thus	O
far	O
generated	O
conflicting	O
data	O
on	O
alterations	O
in	O
the	O
steady	O
state	O
levels	O
of	O
DMPK	O
mRNA	O
,	O
and	O
on	O
the	O
final	O
DMPK	O
protein	O
levels	O
in	O
the	O
presence	O
of	O
the	O
expansion	O
.	O
<EOS> B-X
In B-X
vivo B-X
co-localisation B-X
of B-X
MBNL B-X
protein B-X
with B-X
DMPK B-X
expanded-repeat B-X
transcripts B-X
Sense B-X
and B-X
Antisense B-X
DMPK B-X
RNA B-X
Foci B-X
Accumulate B-X
in B-X
DM1 B-X
Tissues B-X
during B-X
Development B-X
The B-X
myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
mutation B-X
has B-X
been B-X
identified B-X
as B-X
an B-X
unstable B-X
, B-X
expanded B-X
( B-X
CTG B-X
) B-X
n B-X
repeat B-X
in B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X
of B-X
a B-X
gene B-X
designated B-X
Myotonic B-X
dystrophy B-X
is B-X
an B-X
autosomally B-X
dominant B-X
inherited B-X
disease B-X
in B-X
which B-X
system-wide B-X
abnormalities B-X
are B-X
caused B-X
by B-X
a B-X
triplet B-X
repeat B-X
expansion B-X
within B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X
of B-X
the B-X
myotonic B-X
dystrophy B-X
protein B-X
AON-induced B-X
splice-switching B-X
and B-X
DMPK B-X
pre-mRNA B-X
degradation B-X
as B-X
potential B-X
therapeutic B-X
approaches B-X
for B-X
Myotonic B-X
Dystrophy B-X
type B-X
1 B-X
Request B-X
PDF B-X
| B-X
Effect B-X
of B-X
the B-X
[ B-X
CCTG B-X
] B-X
n B-X
repeat B-X
expansion B-X
on B-X
ZNF9 B-X
expression B-X
in B-X
myotonic B-X
dystrophy B-X
type B-X
II B-X
( B-X
DM2 B-X
) B-X
| B-X
Myotonic B-X
dystrophy B-X
is B-X
caused B-X
by B-X
two B-X
A B-X
low B-X
absolute B-X
number B-X
of B-X
expanded B-X
transcripts B-X
is B-X
involved B-X
in B-X
myotonic B-X
dystrophy B-X
type B-X
1 B-X
manifestation B-X
in B-X
muscle B-X

The	O
DM	B-Disease
region	O
of	O
chromosome	O
19	O
is	O
gene	O
rich	O
,	O
and	O
it	O
is	O
possible	O
that	O
the	O
repeat	O
expansion	O
may	O
lead	O
to	O
dysfunction	O
of	O
a	O
number	O
of	O
transcription	O
units	O
in	O
the	O
vicinity	O
,	O
perhaps	O
as	O
a	O
consequence	O
of	O
chromatin	O
disruption	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
3‚Ä≤-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase-encoding B-X
gene B-X
, B-X
DMPK B-X
, B-X
which B-X
maps B-X
Abstract B-X
. B-X
Chromatin B-X
disruption B-X
and B-X
modification B-X
are B-X
associated B-X
with B-X
transcriptional B-X
regulation B-X
by B-X
diverse B-X
coactivators B-X
and B-X
corepressors B-X
. B-X
Here B-X
we B-X
discuss B-X
the B-X
pos B-X
Abstract B-X
. B-X
FACT B-X
( B-X
FAcilitates B-X
Chromatin B-X
Transcription B-X
) B-X
has B-X
long B-X
been B-X
considered B-X
to B-X
be B-X
a B-X
transcription B-X
elongation B-X
factor B-X
whose B-X
ability B-X
to B-X
destabilize B-X
nucleosomes B-X
p B-X
The B-X
role B-X
of B-X
FACT B-X
in B-X
managing B-X
chromatin B-X
: B-X
disruption B-X
, B-X
assembly B-X
, B-X
or B-X
repair B-X
? B-X
The B-X
role B-X
of B-X
fork B-X
stalling B-X
and B-X
DNA B-X
structures B-X
in B-X
causing B-X
chromosome B-X
fragility B-X
Polymerase B-X
accessibility B-X
to B-X
chromatin B-X
is B-X
a B-X
limiting B-X
step B-X
in B-X
both B-X
RNA B-X
and B-X
DNA B-X
synthesis B-X
. B-X
Unwinding B-X
DNA B-X
and B-X
nucleosomes B-X
during B-X
polymerase B-X
complex B-X
binding B-X
and B-X
processing B-X
likely B-X
requires B-X
priming B-X
by B-X
chromatin B-X
Histone B-X
exchange B-X
and B-X
histone B-X
modifications B-X
during B-X
transcription B-X
and B-X
aging B-X

We	O
have	O
searched	O
for	O
genes	O
associated	O
with	O
a	O
CpG	O
island	O
at	O
the	O
3	O
end	O
of	O
DMPK	O
.	O
<EOS> B-X
CpG B-X
islands B-X
of B-X
the B-X
X B-X
chromosome B-X
are B-X
gene B-X
associated B-X
. B-X
Hypermethylation B-X
of B-X
the B-X
CpG B-X
Island B-X
Near B-X
the B-X
G4C2 B-X
Repeat B-X
in B-X
ALS B-X
with B-X
a B-X
C9orf72 B-X
Expansion B-X
Abstract B-X
. B-X
CpG B-X
island B-X
hypermethylation B-X
is B-X
known B-X
to B-X
be B-X
associated B-X
with B-X
gene B-X
silencing B-X
in B-X
cancer B-X
. B-X
This B-X
epigenetic B-X
event B-X
is B-X
generally B-X
accepted B-X
as B-X
a B-X
stochastic B-X
proce B-X
Abstract B-X
. B-X
We B-X
examined B-X
the B-X
expression B-X
of B-X
the B-X
murine B-X
homologue B-X
of B-X
myotonic B-X
dystrophy B-X
associated B-X
homeodomain B-X
protein B-X
( B-X
mDMAHP B-X
) B-X
using B-X
two B-X
different B-X
strategies B-X
. B-X
The B-X
f B-X
DNA B-X
methylation B-X
is B-X
an B-X
epigenetic B-X
mark B-X
that B-X
plays B-X
an B-X
essential B-X
role B-X
to B-X
regulate B-X
gene B-X
expression B-X
. B-X
However B-X
, B-X
little B-X
is B-X
known B-X
about B-X
gene B-X
expression B-X
levels B-X
associated B-X
with B-X
DNA B-X
methylation B-X
in B-X
More B-X
than B-X
50 B-X
% B-X
of B-X
human B-X
genes B-X
initiate B-X
transcription B-X
from B-X
CpG B-X
dinucleotide-rich B-X
regions B-X
referred B-X
to B-X
as B-X
CpG B-X
islands B-X
. B-X
These B-X
genes B-X
show B-X
differences B-X
in B-X
their B-X
patterns B-X
of B-X
transcription B-X
initiation B-X
, B-X
text B-X
processing B-X
- B-X
Extracting B-X
information B-X
between B-X
tags B-X
- B-X
Unix B-X
& B-X
Linux B-X
Stack B-X
Exchange B-X

Sequencing	O
of	O
this	O
region	O
shows	O
that	O
the	O
island	O
extends	O
over	O
3	O
.	O
<EOS> B-X
Sequence B-X
and B-X
expression B-X
analysis B-X
of B-X
gaps B-X
in B-X
human B-X
chromosome B-X
20 B-X
The B-X
clustered B-X
organization B-X
of B-X
most B-X
imprinted B-X
genes B-X
in B-X
mammals B-X
suggests B-X
coordinated B-X
genetic B-X
and B-X
epigenetic B-X
control B-X
mechanisms B-X
. B-X
Comparisons B-X
between B-X
human B-X
and B-X
mous B-X
Islands B-X
of B-X
euchromatin-like B-X
sequence B-X
and B-X
expressed B-X
polymorphic B-X
sequences B-X
within B-X
the B-X
short B-X
arm B-X
of B-X
human B-X
chromosome B-X
21 B-X
Selection B-X
and B-X
gene B-X
flow B-X
shape B-X
genomic B-X
islands B-X
that B-X
control B-X
floral B-X
guides B-X
Genomic B-X
sequence B-X
of B-X
the B-X
class B-X
II B-X
region B-X
of B-X
the B-X
canine B-X
MHC B-X
: B-X
comparison B-X
with B-X
the B-X
MHC B-X
of B-X
other B-X
mammalian B-X
species B-X
- B-X
ScienceDirect B-X
Computational B-X
Finishing B-X
of B-X
Large B-X
Sequence B-X
Contigs B-X
Reveals B-X
Interspersed B-X
Nested B-X
Repeats B-X
and B-X
Gene B-X
Islands B-X
in B-X
the B-X
rf1-Associated B-X
Region B-X
of B-X
Maize B-X
| B-X
Plant B-X
Physiology B-X
Sequence B-X
and B-X
structure B-X
of B-X
the B-X
nucleolin B-X
promoter B-X
in B-X
rodents B-X
: B-X
characterization B-X
of B-X
a B-X
strikingly B-X
conserved B-X
CpG B-X
island B-X
- B-X
ScienceDirect B-X

5	O
kb	O
and	O
is	O
interrupted	O
by	O
the	O
(	O
CTG	O
)	O
n	O
repeat	O
.	O
<EOS> B-X
CTG B-X
repeat B-X
instability B-X
and B-X
size B-X
variation B-X
timing B-X
in B-X
DNA B-X
repair-deficient B-X
mice B-X
CTG B-X
Repeats B-X
Show B-X
Bimodal B-X
Amplification B-X
in B-X
E. B-X
coli B-X
: B-X
Cell B-X
Myotonic B-X
dystrophy B-X
type B-X
1 B-X
is B-X
a B-X
multisystemic B-X
autosomal B-X
dominant B-X
disorder B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
( B-X
CTG B-X
) B-X
n B-X
triplets B-X
in B-X
the B-X
3'UTR B-X
of B-X
the B-X
DMPK B-X
gene B-X
, B-X
on B-X
chromosome B-X
Stabilizing B-X
Effects B-X
of B-X
Interruptions B-X
on B-X
Trinucleotide B-X
Repeat B-X
Expansions B-X
in B-X
Saccharomyces B-X
cerevisiae B-X

Comparison	O
of	O
genomic	O
sequences	O
downstream	O
(	O
centromeric	O
)	O
of	O
the	O
repeat	O
in	O
human	O
and	O
mouse	O
identified	O
regions	O
of	O
significant	O
homology	O
.	O
<EOS> B-X
Sequence B-X
Comparison B-X
of B-X
Human B-X
and B-X
Mouse B-X
Genes B-X
Reveals B-X
a B-X
Homologous B-X
Block B-X
Structure B-X
in B-X
the B-X
Promoter B-X
Regions B-X
Spatial B-X
inter-centromeric B-X
interactions B-X
facilitated B-X
the B-X
emergence B-X
of B-X
evolutionary B-X
new B-X
centromeres B-X
Comparative B-X
genomic B-X
sequence B-X
analysis B-X
of B-X
the B-X
human B-X
and B-X
mouse B-X
cystic B-X
fibrosis B-X
transmembrane B-X
conductance B-X
regulator B-X
genes B-X
Comparative B-X
Genomics B-X
of B-X
the B-X
Human B-X
and B-X
Mouse B-X
T B-X
Cell B-X
Receptor B-X
Loci B-X
- B-X
ScienceDirect B-X
Human-specific B-X
tandem B-X
repeat B-X
expansion B-X
and B-X
differential B-X
gene B-X
expression B-X
during B-X
primate B-X
evolution B-X
| B-X
PNAS B-X
Comparative B-X
Genomics B-X
and B-X
Molecular B-X
Dynamics B-X
of B-X
DNA B-X
Repeats B-X
in B-X
Eukaryotes B-X
Discovery B-X
of B-X
a B-X
Novel B-X
, B-X
Paternally B-X
Expressed B-X
Ubiquitin-specific B-X
Processing B-X
Protease B-X
Gene B-X
through B-X
Comparative B-X
Analysis B-X
of B-X
an B-X
Imprinted B-X
Region B-X
of B-X
Mouse B-X
Chromosome B-X
7 B-X
and B-X
Human B-X
Chromosome B-X
19q13.4 B-X

These	O
correspond	O
to	O
exons	O
of	O
a	O
gene	O
predicted	O
to	O
encode	O
a	O
homeodomain	O
protein	O
.	O
<EOS> B-X
Distinct B-X
functions B-X
of B-X
homeodomain-containing B-X
and B-X
homeodomain-less B-X
isoforms B-X
encoded B-X
by B-X
homothorax B-X
Classification B-X
and B-X
nomenclature B-X
of B-X
all B-X
human B-X
homeobox B-X
genes B-X
Nobox B-X
is B-X
a B-X
homeobox-encoding B-X
gene B-X
preferentially B-X
expressed B-X
in B-X
primordial B-X
and B-X
growing B-X
oocytes B-X
- B-X
ScienceDirect B-X
Controlled B-X
expression B-X
of B-X
Drosophila B-X
homeobox B-X
loci B-X
using B-X
the B-X
Hostile B-X
takeover B-X
system B-X
Homeodomain B-X
Leucine B-X
Zipper B-X
Class B-X
I B-X
Genes B-X
in B-X
Arabidopsis B-X
. B-X
Expression B-X
Patterns B-X
and B-X
Phylogenetic B-X
Relationships B-X
Hmx B-X
: B-X
an B-X
evolutionary B-X
conserved B-X
homeobox B-X
gene B-X
family B-X
expressed B-X
in B-X
the B-X
developing B-X
nervous B-X
system B-X
in B-X
mice B-X
and B-X
Drosophila B-X
- B-X
ScienceDirect B-X
AceView B-X
: B-X
Gene B-X
: B-X
IRX2 B-X
, B-X
a B-X
comprehensive B-X
annotation B-X
of B-X
human B-X
, B-X
mouse B-X
and B-X
worm B-X
genes B-X
with B-X
mRNAs B-X
or B-X
ESTsAceView B-X
. B-X

RT	O
-	O
PCR	O
analysis	O
shows	O
that	O
this	O
gene	O
,	O
which	O
we	O
have	O
called	O
DM	B-Disease
locus	O
-	O
associated	O
homeodomain	O
protein	O
(	O
DMAHP	O
)	O
,	O
is	O
expressed	O
in	O
a	O
number	O
of	O
human	O
tissues	O
,	O
including	O
skeletal	O
muscle	O
,	O
heart	O
and	O
brain	O
.	O
<EOS> B-X
Transcriptional B-X
profiling B-X
reveals B-X
extraordinary B-X
diversity B-X
among B-X
skeletal B-X
muscle B-X
tissues B-X
The B-X
human B-X
proteome B-X
in B-X
skeletal B-X
muscle B-X
- B-X
The B-X
Human B-X
Protein B-X
Atlas B-X
The B-X
human B-X
proteome B-X
in B-X
skeletal B-X
muscle B-X
- B-X
The B-X
Human B-X
Protein B-X
Atlas B-X
There B-X
is B-X
no B-X
such B-X
thing B-X
as B-X
a B-X
representative B-X
skeletal B-X
muscle B-X
tissue B-X
, B-X
as B-X
each B-X
member B-X
of B-X
this B-X
family B-X
of B-X
tissues B-X
expresses B-X
a B-X
specialized B-X
mRNA B-X
program B-X
. B-X
The B-X
human B-X
proteome B-X
in B-X
smooth B-X
muscle B-X
- B-X
The B-X
Human B-X
Protein B-X
Atlas B-X
We B-X
conclude B-X
that B-X
the B-X
prevalence B-X
of B-X
bimodal B-X
gene B-X
expression B-X
is B-X
quite B-X
rare B-X
in B-X
healthy B-X
muscle B-X
tissue B-X
( B-X
< B-X
0.2 B-X
% B-X
) B-X
, B-X
and B-X
is B-X
much B-X
lower B-X
than B-X
limited B-X
reports B-X
from B-X
A B-X
new B-X
study B-X
in B-X
twins B-X
finds B-X
that B-X
modifiable B-X
factors B-X
, B-X
such B-X
as B-X
early B-X
family B-X
life B-X
, B-X
may B-X
be B-X
more B-X
important B-X
than B-X
genes B-X
in B-X
driving B-X
heart B-X
and B-X
brain B-X
health B-X
outcomes B-X
. B-X

Germline	O
mutations	O
in	O
the	O
RB1	O
gene	O
in	O
patients	O
with	O
hereditary	B-Disease
retinoblastoma	I-Disease
.	O
<EOS> B-X
Hereditary B-X
predisposition B-X
to B-X
retinoblastoma B-X
is B-X
caused B-X
by B-X
germline B-X
mutations B-X
in B-X
the B-X
RB1 B-X
gene B-X
. B-X
Mutation B-X
analysis B-X
in B-X
this B-X
gene B-X
is B-X
important B-X
because B-X
knowledge B-X
of B-X
the B-X
causative B-X
mutation B-X
is B-X
often B-X
required B-X
This B-X
study B-X
provides B-X
a B-X
data B-X
set B-X
of B-X
an B-X
< B-X
i B-X
> B-X
RB1 B-X
< B-X
/i B-X
> B-X
genotypic B-X
spectrum B-X
of B-X
germline B-X
mutations B-X
and B-X
clinical B-X
phenotypes B-X
and B-X
reports B-X
the B-X
distribution B-X
of B-X
disease-associated B-X
germline B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

We	O
have	O
analyzed	O
the	O
27	O
exons	O
and	O
the	O
promoter	O
region	O
of	O
the	O
RB1	O
gene	O
in	O
familial	B-Disease
or	I-Disease
sporadic	I-Disease
bilateral	I-Disease
retinoblastoma	I-Disease
by	O
using	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
analysis	O
.	O
<EOS> B-X
Identification B-X
of B-X
three B-X
new B-X
mutations B-X
in B-X
the B-X
RB1 B-X
gene B-X
in B-X
patients B-X
with B-X
sporadic B-X
retinoblastoma B-X
in B-X
Colombia B-X
Request B-X
PDF B-X
| B-X
Mutational B-X
Screening B-X
of B-X
the B-X
RB1 B-X
Gene B-X
in B-X
Indian B-X
Patients B-X
with B-X
Retinoblastoma B-X
Reveals B-X
Eight B-X
Novel B-X
and B-X
Several B-X
Recurrent B-X
Mutations B-X
( B-X
vol B-X
22 B-X
, B-X
pg B-X
339 B-X
, B-X
2003 B-X
) B-X
PDF B-X
| B-X
To B-X
carry B-X
out B-X
a B-X
retrospective B-X
study B-X
, B-X
screening B-X
for B-X
mutations B-X
of B-X
the B-X
entire B-X
coding B-X
region B-X
of B-X
RB1 B-X
and B-X
adjacent B-X
intronic B-X
regions B-X
in B-X
patients B-X
with B-X
... B-X
| B-X
Find B-X
, B-X
PDF B-X
| B-X
Introducci√≥n B-X
. B-X
El B-X
retinoblastoma B-X
es B-X
un B-X
c√°ncer B-X
pedi√°trico B-X
de B-X
la B-X
retina B-X
originado B-X
por B-X
la B-X
expresi√≥n B-X
alterada B-X
o B-X
ausente B-X
de B-X
la B-X
prote√≠na B-X
del B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

For	O
improvement	O
over	O
previous	O
studies	O
,	O
a	O
new	O
set	O
of	O
primers	O
has	O
been	O
designed	O
,	O
which	O
allow	O
for	O
amplification	O
of	O
the	O
coding	O
and	O
splicing	O
sequences	O
only	O
.	O
<EOS> B-X
High-throughput B-X
quantification B-X
of B-X
splicing B-X
isoforms B-X
Novel B-X
computational B-X
methods B-X
for B-X
increasing B-X
PCR B-X
primer B-X
design B-X
effectiveness B-X
in B-X
directed B-X
sequencing B-X
PDF B-X
| B-X
Primers B-X
design B-X
is B-X
bases B-X
for B-X
most B-X
of B-X
the B-X
molecular B-X
biology B-X
experiments B-X
. B-X
It B-X
may B-X
require B-X
fetching B-X
similar B-X
sequence B-X
from B-X
biological B-X
databases B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Targeted B-X
RNA B-X
sequencing B-X
( B-X
RNA-seq B-X
) B-X
aims B-X
to B-X
focus B-X
coverage B-X
on B-X
areas B-X
of B-X
interest B-X
that B-X
are B-X
inadequately B-X
sampled B-X
in B-X
standard B-X
RNA-seq B-X
experiments B-X
. B-X
Here B-X
we B-X
present B-X
multiplexed B-X
primer B-X
extension B-X
sequencing B-X
Request B-X
PDF B-X
| B-X
Divergent B-X
primer B-X
design B-X
and B-X
detection B-X
of B-X
circular B-X
RNAs B-X
by B-X
RT-PCR B-X
| B-X
Gene B-X
expression B-X
in B-X
eukaryotic B-X
cells B-X
is B-X
tightly B-X
regulated B-X
at B-X
the B-X
transcriptional B-X
and B-X
posttranscriptional B-X
levels B-X
. B-X
Posttranscriptional B-X
Rapid B-X
Assembly B-X
of B-X
Multiple-Exon B-X
cDNA B-X
Directly B-X
from B-X
Genomic B-X
DNA B-X
Read B-X
12 B-X
answers B-X
by B-X
scientists B-X
to B-X
the B-X
question B-X
asked B-X
by B-X
Adron B-X
Ung B-X
on B-X
Dec B-X
29 B-X
, B-X
2017 B-X

The	O
positioning	O
of	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
primers	O
was	O
such	O
that	O
the	O
resulting	O
PCR	O
products	O
were	O
of	O
different	O
sizes	O
,	O
which	O
enabled	O
us	O
to	O
analyze	O
two	O
different	O
exons	O
simultaneously	O
and	O
still	O
distinguish	O
between	O
the	O
banding	O
profiles	O
for	O
both	O
(	O
biplex	O
analysis	O
)	O
.	O
<EOS> B-X
We B-X
have B-X
analyzed B-X
the B-X
27 B-X
exons B-X
and B-X
the B-X
promoter B-X
region B-X
of B-X
the B-X
RB1 B-X
gene B-X
in B-X
familial B-X
or B-X
sporadic B-X
bilateral B-X
retinoblastoma B-X
by B-X
using B-X
single-strand B-X
conformation B-X
polymorphism B-X
analysis B-X
. B-X
For B-X
improvement B-X
over B-X
Predicting B-X
failure B-X
rate B-X
of B-X
PCR B-X
in B-X
large B-X
genomes B-X
Bias B-X
in B-X
Template-to-Product B-X
Ratios B-X
in B-X
Multitemplate B-X
PCR B-X
Academia.edu B-X
is B-X
a B-X
place B-X
to B-X
share B-X
and B-X
follow B-X
research B-X
. B-X
PDF B-X
| B-X
In B-X
an B-X
analysis B-X
of B-X
mutations B-X
in B-X
the B-X
RB1 B-X
gene B-X
in B-X
three B-X
patients B-X
, B-X
selected B-X
at B-X
random B-X
, B-X
who B-X
had B-X
a B-X
positive B-X
family B-X
history B-X
of B-X
tumours B-X
, B-X
we B-X
identified B-X
Polymerase B-X
Chain B-X
Reaction B-X
: B-X
Basic B-X
Protocol B-X
Plus B-X
Troubleshooting B-X
and B-X
Optimization B-X
Strategies B-X
PDF B-X
| B-X
In B-X
an B-X
earlier B-X
study B-X
of B-X
37 B-X
candidate B-X
genes B-X
for B-X
polycystic B-X
ovary B-X
syndrome B-X
( B-X
PCOS B-X
) B-X
, B-X
the B-X
strongest B-X
evidence B-X
for B-X
genetic B-X
linkage B-X
was B-X
found B-X
with B-X
the B-X
... B-X
| B-X

By	O
using	O
this	O
approach	O
,	O
we	O
were	O
able	O
to	O
identify	O
mutation	O
in	O
22	O
new	O
patients	O
,	O
but	O
the	O
overall	O
efficiency	O
of	O
the	O
procedure	O
when	O
we	O
used	O
a	O
single	O
-	O
pass	O
regimen	O
was	O
only	O
48	O
%	O
.	O
<EOS> B-X
Next-generation B-X
sequencing-based B-X
method B-X
shows B-X
increased B-X
mutation B-X
detection B-X
sensitivity B-X
in B-X
an B-X
Indian B-X
retinoblastoma B-X
cohort B-X
Best B-X
Management B-X
Practice B-X
# B-X
9 B-X
: B-X
Single-Pass B-X
Cooling B-X
Equipment B-X
| B-X
Department B-X
of B-X
Energy B-X
A B-X
Highly B-X
Sensitive B-X
Genetic B-X
Protocol B-X
to B-X
Detect B-X
NF1 B-X
Mutations B-X
Gene B-X
copy B-X
number B-X
provides B-X
more B-X
prognostic B-X
information B-X
than B-X
gene B-X
mutation B-X
status B-X
in B-X
cancer B-X
. B-X
Despite B-X
decades B-X
of B-X
research B-X
, B-X
effective B-X
treatments B-X
for B-X
most B-X
cancers B-X
remain B-X
elusive B-X
. B-X
One B-X
reason B-X
is B-X
that B-X
different B-X
instances B-X
of B-X
cancer B-X
result B-X
from B-X
different B-X
combinations B-X
of B-X
multiple B-X
genetic B-X
mutations B-X
( B-X
A B-X
Next-Generation B-X
Sequencing B-X
Approach B-X
to B-X
Identify B-X
Gene B-X
Mutations B-X
in B-X
Early- B-X
and B-X
Late-Onset B-X
Hypertrophic B-X
Cardiomyopathy B-X
Patients B-X
of B-X
an B-X
Italian B-X
Cohort B-X
We B-X
have B-X
new B-X
data B-X
on B-X
hydroxychloroquine B-X
therapy B-X
to B-X
discuss B-X
. B-X
The B-X
numbers B-X
will B-X
not B-X
clear B-X
anything B-X
up B-X
. B-X
First B-X
off B-X
is B-X
an B-X
abstract B-X
from B-X
the B-X
Marseilles B-X
IHU B-X
group B-X
of B-X
Dr B-X

The	O
mutations	O
were	O
small	O
insertions	O
and	O
deletions	O
and	O
point	O
mutations	O
in	O
roughly	O
equal	O
proportions	O
.	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Studies B-X
of B-X
protein B-X
evolution B-X
have B-X
focused B-X
on B-X
amino B-X
acid B-X
substitutions B-X
with B-X
much B-X
less B-X
systematic B-X
analysis B-X
on B-X
insertion B-X
and B-X
deletions B-X
( B-X
indels B-X
) B-X
in B-X
protei B-X
Patterns B-X
of B-X
nucleotide B-X
substitution B-X
, B-X
insertion B-X
and B-X
deletion B-X
in B-X
the B-X
human B-X
genome B-X
inferred B-X
from B-X
pseudogenes B-X
The B-X
Genomic B-X
Landscape B-X
of B-X
Short B-X
Insertion B-X
and B-X
Deletion B-X
Polymorphisms B-X
in B-X
the B-X
Chicken B-X
( B-X
Gallus B-X
gallus B-X
) B-X
Genome B-X
: B-X
A B-X
High B-X
Frequency B-X
of B-X
Deletions B-X
in B-X
Tandem B-X
Duplicates B-X
Mutation B-X
Rates B-X
in B-X
Humans B-X
. B-X
II B-X
. B-X
Sporadic B-X
Mutation-Specific B-X
Rates B-X
and B-X
Rate B-X
of B-X
Detrimental B-X
Human B-X
Mutations B-X
Inferred B-X
from B-X
Hemophilia B-X
B B-X
A B-X
Model B-X
for B-X
Genome B-X
Size B-X
Evolution B-X
Mutation B-X
Rate B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Rates B-X
and B-X
Genomic B-X
Consequences B-X
of B-X
Spontaneous B-X
Mutational B-X
Events B-X
in B-X
Drosophila B-X
melanogaster B-X

Type	B-Disease
II	I-Disease
human	I-Disease
complement	I-Disease
C2	I-Disease
deficiency	I-Disease
.	O

Allele	O
-	O
specific	O
amino	O
acid	O
substitutions	O
(	O
Ser189	O
-	O
-	O
>	O
Phe	O
;	O
Gly444	O
-	O
-	O
>	O
Arg	O
)	O
cause	O
impaired	O
C2	O
secretion	O
.	O
<EOS> B-X
Clinical B-X
studies B-X
led B-X
to B-X
the B-X
discovery B-X
of B-X
complement B-X
deficient B-X
states B-X
several B-X
decades B-X
ago B-X
. B-X
With B-X
the B-X
advent B-X
of B-X
molecular B-X
biology B-X
the B-X
genetic B-X
basis B-X
of B-X
the B-X
deficient B-X
states B-X
has B-X
been B-X
revealed B-X
GlyGen B-X
is B-X
a B-X
data B-X
integration B-X
and B-X
dissemination B-X
project B-X
for B-X
carbohydrate B-X
and B-X
glycoconjugate B-X
related B-X
data B-X
. B-X
VCV000012128.1 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Type	B-Disease
II	I-Disease
complement	I-Disease
protein	I-Disease
C2	I-Disease
deficiency	I-Disease
is	O
characterized	O
by	O
a	O
selective	O
block	O
in	O
C2	O
secretion	O
.	O
<EOS> B-X
Molecular B-X
heterogeneity B-X
in B-X
deficiency B-X
of B-X
complement B-X
protein B-X
C2 B-X
type B-X
I B-X
- B-X
WANG B-X
- B-X
1998 B-X
- B-X
Immunology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
H B-X
Akama B-X
's B-X
4 B-X
research B-X
works B-X
with B-X
285 B-X
citations B-X
and B-X
86 B-X
reads B-X
, B-X
including B-X
: B-X
Type B-X
II B-X
human B-X
complement B-X
C2 B-X
deficiency B-X
: B-X
Allele-specific B-X
amino B-X
acid B-X
substitutions B-X
( B-X
Ser189 B-X
‚Üí B-X
Phe B-X
{ B-X
{ B-X
nm.description B-X
} B-X
} B-X
613927 B-X
- B-X
COMPLEMENT B-X
COMPONENT B-X
2 B-X
; B-X
C2 B-X
- B-X
C2 B-X

The	O
Type	O
II	O
C2	O
null	O
allele	O
(	O
C2Q0	O
)	O
is	O
linked	O
to	O
two	O
major	O
histocompatibility	O
haplotypes	O
(	O
MHC	O
)	O
that	O
differ	O
from	O
the	O
MHC	O
of	O
the	O
more	O
common	O
Type	B-Disease
I	I-Disease
C2	I-Disease
deficiency	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
HLA‚ÄêCw B-X
alleles B-X
associated B-X
with B-X
HLA B-X
extended B-X
haplotypes B-X
and B-X
C2 B-X
deficiency B-X
| B-X
There B-X
are B-X
four B-X
MHC-linked B-X
complement B-X
genes B-X
, B-X
BF B-X
, B-X
C2 B-X
, B-X
C4A B-X
and B-X
C4B B-X
, B-X
that B-X
J B-X
Kulics B-X
's B-X
4 B-X
research B-X
works B-X
with B-X
116 B-X
citations B-X
and B-X
38 B-X
reads B-X
, B-X
including B-X
: B-X
Type B-X
II B-X
human B-X
complement B-X
C2 B-X
deficiency B-X
: B-X
Allele-specific B-X
amino B-X
acid B-X
substitutions B-X
( B-X
Ser189 B-X
‚Üí B-X
Phe B-X
In B-X
1982 B-X
we B-X
reported B-X
that B-X
among B-X
Caucasians B-X
with B-X
systemic B-X
lupus B-X
erythematosus B-X
( B-X
SLE B-X
) B-X
there B-X
is B-X
an B-X
increased B-X
frequency B-X
of B-X
C4A B-X
null B-X
. B-X
As B-X
this B-X
allele B-X
occurs B-X
on B-X
the B-X
HLA-A1 B-X
As B-X
a B-X
phylogenetically B-X
old B-X
system B-X
complement B-X
is B-X
now B-X
regarded B-X
as B-X
a B-X
part B-X
of B-X
innate B-X
immunity B-X
. B-X
But B-X
it B-X
is B-X
much B-X
more B-X
than B-X
that B-X
. B-X
It B-X
bridges B-X
innate B-X
and B-X
adapted B-X
immunity B-X

To	O
determine	O
the	O
molecular	O
basis	O
of	O
Type	B-Disease
II	I-Disease
deficiency	I-Disease
the	O
two	O
Type	O
II	O
C2Q0	O
genes	O
were	O
isolated	O
and	O
transfected	O
separately	O
into	O
L	O
-	O
cells	O
.	O
<EOS> B-X
Mouse B-X
F9 B-X
teratocarcinoma B-X
stem B-X
cells B-X
expressing B-X
the B-X
stably B-X
transfected B-X
homeobox B-X
gene B-X
Hox B-X
1.6 B-X
exhibit B-X
an B-X
altered B-X
morphology B-X
Microarray B-X
Analysis B-X
of B-X
Gene B-X
Expression B-X
Profiles B-X
in B-X
Cells B-X
Transfected B-X
With B-X
Nonviral B-X
Vectors B-X
Cell-Type-Specific B-X
Gene B-X
Transfer B-X
into B-X
Human B-X
Cells B-X
with B-X
Retroviral B-X
Vectors B-X
That B-X
Display B-X
Single-Chain B-X
Antibodies B-X
Nonhomologous B-X
End-Joining B-X
Ligation B-X
Transfers B-X
DNA B-X
Regulatory B-X
Elements B-X
between B-X
Cointroduced B-X
Plasmids B-X

Subsequent	O
molecular	O
biology	O
,	O
biosynthetic	O
,	O
and	O
immunofluorescence	O
studies	O
demonstrated	O
that	O
C2	O
secretion	O
is	O
impaired	O
in	O
Type	B-Disease
II	I-Disease
C2	I-Disease
deficiency	I-Disease
because	O
of	O
different	O
missense	O
mutations	O
at	O
highly	O
conserved	O
residues	O
in	O
each	O
of	O
the	O
C2Q0	O
alleles	O
.	O
<EOS> B-X
Deficiency B-X
of B-X
liver B-X
glycogen B-X
phosphorylase B-X
in B-X
glycogen B-X
storage B-X
disease B-X
( B-X
GSD B-X
) B-X
type B-X
VI B-X
results B-X
in B-X
a B-X
reduced B-X
ability B-X
to B-X
mobilize B-X
glucose B-X
from B-X
glycogen B-X
. B-X
Six B-X
mutations B-X
of B-X
the B-X
PYGL B-X
PDF B-X
| B-X
Genetically B-X
determined B-X
C2 B-X
deficiency B-X
predisposes B-X
an B-X
individual B-X
to B-X
recurrent B-X
and B-X
invasive B-X
bacterial B-X
infections B-X
as B-X
well B-X
as B-X
a B-X
variety B-X
of B-X
rheumatic B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Request B-X
PDF B-X
| B-X
Genetic B-X
association B-X
of B-X
complement B-X
component B-X
2 B-X
polymorphism B-X
with B-X
systemic B-X
lupus B-X
erythematosus B-X
| B-X
Complement B-X
component B-X
2 B-X
( B-X
C2 B-X
) B-X
, B-X
an B-X
early B-X
member B-X
of B-X
the B-X
classical B-X
pathway B-X
, B-X
Request B-X
PDF B-X
| B-X
Frequency B-X
in B-X
Spanish B-X
Population B-X
of B-X
Familial B-X
Complement B-X
Factor B-X
2 B-X
Type B-X
I B-X
Deficits B-X
and B-X
Associated B-X
HLA B-X
Haplotypes B-X
| B-X
We B-X
present B-X
two B-X
familial B-X
cases B-X
of B-X
complement B-X
factor B-X
2 B-X
( B-X
Download B-X
Citation B-X
| B-X
Classical B-X
pathway B-X
deficiencies B-X
‚Äì B-X
A B-X
short B-X
analytical B-X
review B-X
| B-X
Deficiencies B-X
in B-X
the B-X
classical B-X
pathway B-X
of B-X
complement B-X
activation B-X
have B-X
some B-X
common B-X
features B-X
but B-X
show B-X
also B-X
great B-X
differences B-X
. B-X
Download B-X
Citation B-X
| B-X
The B-X
genetic B-X
and B-X
molecular B-X
bases B-X
of B-X
monogenic B-X
disorders B-X
affecting B-X
proteolytic B-X
systems B-X
| B-X
Complete B-X
and B-X
limited B-X
proteolysis B-X
represents B-X
key B-X
events B-X
that B-X
regulate B-X
many B-X
biological B-X
processes B-X
. B-X
At B-X
least B-X
Request B-X
PDF B-X
| B-X
Complement B-X
: B-X
A B-X
critical B-X
test B-X
of B-X
its B-X
biological B-X
importance B-X
| B-X
The B-X
biological B-X
activities B-X
of B-X
the B-X
more B-X
than B-X
30 B-X
proteins B-X
that B-X
comprise B-X
the B-X
complement B-X
system B-X
have B-X
been B-X
elucidated B-X

One	O
is	O
in	O
exon	O
5	O
(	O
nucleotide	O
C566	O
-	O
-	O
>	O
T	O
;	O
Ser189	O
-	O
-	O
>	O
Phe	O
)	O
of	O
the	O
C2Q0	O
gene	O
linked	O
to	O
the	O
MHC	O
haplotype	O
A11	O
,	O
B35	O
,	O
DRw1	O
,	O
BFS	O
,	O
C4A0B1	O
.	O
<EOS> B-X
The B-X
MHC B-X
haplotype B-X
project B-X
: B-X
a B-X
resource B-X
for B-X
HLA-linked B-X
association B-X
studies B-X
Nucleotide B-X
variations B-X
of B-X
TP53 B-X
exon B-X
4 B-X
found B-X
in B-X
intracranial B-X
meningioma B-X
and B-X
in B-X
silico B-X
prediction B-X
of B-X
their B-X
significance B-X
HLA-DRB1 B-X
major B-X
histocompatibility B-X
complex B-X
, B-X
class B-X
II B-X
, B-X
DR B-X
beta B-X
1 B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Gross B-X
deletions B-X
in B-X
TCOF1 B-X
are B-X
a B-X
cause B-X
of B-X
Treacher‚ÄìCollins‚ÄìFranceschetti B-X
syndrome B-X
We B-X
report B-X
the B-X
characterization B-X
of B-X
eight B-X
HLA B-X
class B-X
I B-X
homologous B-X
sequences B-X
isolated B-X
from B-X
cosmid B-X
and B-X
lambda B-X
libraries B-X
made B-X
from B-X
lymphoblastiod B-X
cell B-X
line B-X
721 B-X
DNA B-X
. B-X
Four B-X
of B-X
these B-X
sequences B-X
, B-X
The B-X
future B-X
systematic B-X
mapping B-X
of B-X
variants B-X
that B-X
confer B-X
susceptibility B-X
to B-X
common B-X
diseases B-X
requires B-X
the B-X
construction B-X
of B-X
a B-X
fully B-X
informative B-X
polymorphism B-X
map B-X
. B-X
Ideally B-X
, B-X
every B-X
base B-X
pair B-X
of B-X
the B-X
genome B-X
The B-X
mutations B-X
in B-X
one-third B-X
of B-X
Duchenne B-X
and B-X
Becker B-X
muscular B-X
dystrophy B-X
patients B-X
remain B-X
unknown B-X
, B-X
as B-X
they B-X
do B-X
not B-X
involve B-X
gross B-X
rearrangements B-X
of B-X
the B-X
dystrophin B-X
gene B-X
. B-X
We B-X
now B-X
report B-X
a B-X

The	O
other	O
is	O
in	O
exon	O
11	O
(	O
G1930	O
-	O
-	O
>	O
A	O
;	O
Gly444	O
-	O
-	O
>	O
Arg	O
)	O
of	O
the	O
C2Q0	O
gene	O
linked	O
to	O
the	O
MHC	O
haplotype	O
A2	O
,	O
B5	O
,	O
DRw4	O
,	O
BFS	O
,	O
C4A3B1	O
.	O
<EOS> B-X
Subtypes B-X
of B-X
HLA-DR4 B-X
are B-X
associated B-X
with B-X
susceptibility B-X
or B-X
protection B-X
against B-X
type B-X
1 B-X
diabetes B-X
( B-X
T1DM B-X
) B-X
. B-X
We B-X
addressed B-X
whether B-X
this B-X
reflects B-X
linkage B-X
disequilibrium B-X
with B-X
the B-X
true B-X
susceptibility B-X
locus B-X
by B-X
Clinically B-X
, B-X
the B-X
prognosis B-X
was B-X
worse B-X
for B-X
the B-X
patients B-X
with B-X
mutation-positive B-X
gastrointestinal B-X
mesenchymal B-X
tumors B-X
than B-X
for B-X
those B-X
with B-X
mutation-negative B-X
tumors B-X
. B-X
We B-X
therefore B-X
conclude B-X
that B-X
the B-X
gain-of-function B-X
mutation B-X
in B-X
exon B-X
Clinical B-X
characteristics B-X
and B-X
the B-X
identification B-X
of B-X
novel B-X
mutations B-X
of B-X
COL1A1 B-X
and B-X
COL1A2 B-X
in B-X
61 B-X
Chinese B-X
patients B-X
with B-X
osteogenesis B-X
imperfecta B-X
Defective B-X
expression B-X
of B-X
HLA B-X
class B-X
I B-X
molecules B-X
is B-X
common B-X
in B-X
tumor B-X
cells B-X
and B-X
may B-X
allow B-X
escape B-X
from B-X
CTL-mediated B-X
immunity B-X
. B-X
We B-X
here B-X
investigate B-X
alterations B-X
in B-X
expression B-X
of B-X
HLA B-X
class B-X
I B-X
The B-X
major B-X
histocompatibility B-X
complex B-X
( B-X
MHC B-X
) B-X
is B-X
recognised B-X
as B-X
one B-X
of B-X
the B-X
most B-X
important B-X
genetic B-X
regions B-X
in B-X
relation B-X
to B-X
common B-X
human B-X
disease B-X
. B-X
Advancement B-X
in B-X
identification B-X
of B-X
MHC B-X
genes B-X
Abstract B-X
. B-X
Objective B-X
: B-X
The B-X
GNAS B-X
gene B-X
encodes B-X
the B-X
Œ±-subunit B-X
of B-X
stimulatory B-X
G B-X
proteins B-X
, B-X
which B-X
play B-X
a B-X
crucial B-X
role B-X
in B-X
intracellular B-X
signal B-X
transduction B-X
of B-X
peptide B-X
an B-X
Interplay B-X
of B-X
primary B-X
sequence B-X
, B-X
position B-X
and B-X
secondary B-X
RNA B-X
structure B-X
determines B-X
alternative B-X
splicing B-X
of B-X
LMNA B-X
in B-X
a B-X
pre-mature B-X
aging B-X
syndrome B-X

Each	O
mutant	O
C2	O
gene	O
product	O
is	O
retained	O
early	O
in	O
the	O
secretory	O
pathway	O
.	O
<EOS> B-X
Identification B-X
of B-X
a B-X
gene B-X
required B-X
for B-X
membrane B-X
protein B-X
retention B-X
in B-X
the B-X
early B-X
secretory B-X
pathway B-X
. B-X
The B-X
complete B-X
general B-X
secretory B-X
pathway B-X
in B-X
gram-negative B-X
bacteria B-X
. B-X
Charting B-X
the B-X
Secretory B-X
Pathway B-X
in B-X
a B-X
Simple B-X
Eukaryote B-X
Sec2p B-X
Mediates B-X
Nucleotide B-X
Exchange B-X
on B-X
Sec4p B-X
and B-X
Is B-X
Involved B-X
in B-X
Polarized B-X
Delivery B-X
of B-X
Post-Golgi B-X
Vesicles B-X
| B-X
Journal B-X
of B-X
Cell B-X
Biology B-X
| B-X
Rockefeller B-X
University B-X
Press B-X
Sls1p B-X
Stimulates B-X
Sec63p-Mediated B-X
Activation B-X
of B-X
Kar2p B-X
in B-X
a B-X
Conformation-Dependent B-X
Manner B-X
in B-X
the B-X
Yeast B-X
Endoplasmic B-X
Reticulum B-X
PDF B-X
| B-X
The B-X
murine B-X
cytomegalovirus B-X
immunoevasin B-X
m152/gp40 B-X
binds B-X
major B-X
histocompatibility B-X
complex B-X
( B-X
MHC B-X
) B-X
class B-X
I B-X
molecules B-X
and B-X
retains B-X
them B-X
in B-X
the B-X
early B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
613927 B-X
- B-X
COMPLEMENT B-X
COMPONENT B-X
2 B-X
; B-X
C2 B-X
- B-X
C2 B-X

These	O
mutants	O
provide	O
models	O
for	O
elucidating	O
the	O
C2	O
secretory	O
pathway	O
.	O
.	O
<EOS> B-X
Yeast B-X
Models B-X
for B-X
the B-X
Study B-X
of B-X
Amyloid-Associated B-X
Disorders B-X
and B-X
Development B-X
of B-X
Future B-X
Therapy B-X
Biology B-X
and B-X
therapy B-X
of B-X
inherited B-X
retinal B-X
degenerative B-X
disease B-X
: B-X
insights B-X
from B-X
mouse B-X
models B-X
Anniversary B-X
of B-X
the B-X
discovery B-X
of B-X
sec B-X
mutants B-X
by B-X
Novick B-X
and B-X
Schekman B-X
HID-1 B-X
, B-X
a B-X
New B-X
Component B-X
of B-X
the B-X
Peptidergic B-X
Signaling B-X
Pathway B-X
Dimer B-X
recognition B-X
and B-X
secretion B-X
by B-X
the B-X
ESX B-X
secretion B-X
system B-X
in B-X
Bacillus B-X
subtilis B-X
| B-X
PNAS B-X
Hi B-X
, B-X
I B-X
have B-X
a B-X
corpus B-X
of B-X
medical B-X
text B-X
in B-X
the B-X
following B-X
format B-X
. B-X
Can B-X
we B-X
use B-X
this B-X
to B-X
identify B-X
NER B-X
? B-X
8621452 B-X
< B-X
category= B-X
'' B-X
SpecificDisease B-X
'' B-X
> B-X
Type B-X
{ B-X
{ B-X
nm.description B-X
} B-X
} B-X

Defective	O
dimerization	O
of	O
von	B-Disease
Willebrand	I-Disease
factor	O
subunits	O
due	O
to	O
a	O
Cys	O
-	O
>	O
Arg	O
mutation	O
in	O
type	B-Disease
IID	I-Disease
von	I-Disease
Willebrand	I-Disease
disease	I-Disease
.	O
<EOS> B-X
Aberrant B-X
dimerization B-X
of B-X
von B-X
Willebrand B-X
factor B-X
as B-X
the B-X
result B-X
of B-X
mutations B-X
in B-X
the B-X
carboxy-terminal B-X
region B-X
: B-X
identification B-X
of B-X
3 B-X
mutations B-X
in B-X
members B-X
of B-X
3 B-X
different B-X
families B-X
with B-X
type B-X
2A B-X
( B-X
The B-X
same B-X
heterozygous B-X
T B-X
- B-X
> B-X
C B-X
transition B-X
at B-X
nt B-X
8567 B-X
of B-X
the B-X
von B-X
Willebrand B-X
factor B-X
( B-X
vWF B-X
) B-X
transcript B-X
was B-X
found B-X
in B-X
two B-X
unrelated B-X
patients B-X
with B-X
type B-X
III B-X
) B-X
Type B-X
2 B-X
von B-X
Willebrand B-X
disease B-X
causing B-X
defective B-X
von B-X
Willebrand B-X
factor-dependent B-X
platelet B-X
function B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
The B-X
3‚Ä≤ B-X
end B-X
of B-X
the B-X
VWF B-X
gene B-X
was B-X
screened B-X
in B-X
the B-X
affected B-X
members B-X
of B-X
3 B-X
different B-X
families B-X
with B-X
type B-X
2A B-X
( B-X
phenotype B-X
IID B-X
) B-X
von B-X
Willebrand B-X
disease B-X
( B-X
The B-X
same B-X
heterozygous B-X
T B-X
- B-X
> B-X
C B-X
transition B-X
at B-X
nt B-X
8567 B-X
of B-X
the B-X
von B-X
Willebrand B-X
factor B-X
( B-X
vWF B-X
) B-X
transcript B-X
was B-X
found B-X
in B-X
two B-X
unrelated B-X
patients B-X
with B-X
type B-X
III B-X
) B-X
PDF B-X
| B-X
The B-X
same B-X
heterozygous B-X
T B-X
- B-X
> B-X
C B-X
transition B-X
at B-X
nt B-X
8567 B-X
of B-X
the B-X
von B-X
Willebrand B-X
factor B-X
( B-X
vWF B-X
) B-X
transcript B-X
was B-X
found B-X
in B-X
two B-X
unrelated B-X
patients B-X
with B-X
type B-X
Key B-X
Points B-X
. B-X
The B-X
protein B-X
disulfide B-X
isomerase B-X
is B-X
involved B-X
in B-X
VWF B-X
dimerization B-X
by B-X
initiating B-X
disulfide B-X
bond B-X
formation B-X
at B-X
cysteines B-X
2771 B-X
and B-X
2773.von B-X
Willebrand B-X
dis B-X

The	O
same	O
heterozygous	O
T	O
-	O
>	O
C	O
transition	O
at	O
nt	O
8567	O
of	O
the	O
von	B-Disease
Willebrand	I-Disease
factor	O
(	O
vWF	O
)	O
transcript	O
was	O
found	O
in	O
two	O
unrelated	O
patients	O
with	O
type	B-Disease
IID	I-Disease
von	I-Disease
Willebrand	I-Disease
disease	I-Disease
,	O
with	O
no	O
other	O
apparent	O
abnormality	O
.	O
<EOS> B-X
In B-X
this B-X
manuscript B-X
, B-X
we B-X
describe B-X
a B-X
case B-X
of B-X
type B-X
2A B-X
von B-X
Willebrand B-X
disease B-X
( B-X
VWD B-X
) B-X
caused B-X
by B-X
the B-X
novel B-X
heterozygous B-X
G B-X
> B-X
A B-X
transition B-X
at B-X
nucleotide B-X
3538 B-X
, B-X
Longitudinal B-X
MRI B-X
shows B-X
no B-X
cerebral B-X
abnormality B-X
in B-X
chronic B-X
fatigue B-X
syndrome B-X
von B-X
Willebrand B-X
Factor B-X
Variant B-X
p.Arg924Gln B-X
Marks B-X
an B-X
Allele B-X
Associated B-X
with B-X
Reduced B-X
von B-X
Willebrand B-X
Factor B-X
and B-X
Factor B-X
VIII B-X
Levels B-X
Ultrasonography B-X
shows B-X
no B-X
abnormality B-X
of B-X
pelvic B-X
structures B-X
in B-X
women B-X
with B-X
severe B-X
idiopathic B-X
constipation B-X
. B-X
WHO B-X
fact B-X
sheet B-X
on B-X
congenital B-X
anomalies B-X
, B-X
an B-X
important B-X
cause B-X
of B-X
childhood B-X
death B-X
, B-X
chronic B-X
illness B-X
, B-X
and B-X
disability B-X
in B-X
many B-X
countries B-X
. B-X
No B-X
Obvious B-X
Abnormality B-X
in B-X
Mice B-X
Deficient B-X
in B-X
Receptor B-X
Protein B-X
Tyrosine B-X
Phosphatase B-X
Œ≤ B-X
Congenital B-X
anomalies B-X
of B-X
kidney B-X
and B-X
urinary B-X
tract B-X
( B-X
CAKUT B-X
) B-X
is B-X
a B-X
group B-X
of B-X
abnormalities B-X
affecting B-X
the B-X
kidneys B-X
or B-X
other B-X
structures B-X
of B-X
the B-X
urinary B-X
tract B-X
. B-X
Explore B-X
symptoms B-X
, B-X
inheritance B-X

In	O
one	O
family	O
,	O
both	O
alleles	O
were	O
normal	O
in	O
the	O
parents	O
and	O
one	O
sister	O
;	O
thus	O
,	O
the	O
mutation	O
originated	O
de	O
novo	O
in	O
the	O
proposita	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Unbalanced B-X
X-chromosome B-X
inactivation B-X
with B-X
a B-X
novel B-X
FVIII B-X
gene B-X
mutation B-X
resulting B-X
in B-X
severe B-X
hemophilia B-X
A B-X
in B-X
a B-X
female B-X
| B-X
This B-X
report B-X
is B-X
of B-X
a B-X
14-month-old B-X
girl B-X
affected B-X
with B-X
Germline B-X
and B-X
somatic B-X
mosaicism B-X
for B-X
FGFR2 B-X
mutation B-X
in B-X
the B-X
mother B-X
of B-X
a B-X
child B-X
with B-X
Crouzon B-X
syndrome B-X
: B-X
Implications B-X
for B-X
genetic B-X
testing B-X
in B-X
‚Äú B-X
paternal B-X
age-effect B-X
‚Äù B-X
syndromes B-X
Download B-X
Citation B-X
| B-X
Female B-X
hemophilia B-X
A B-X
heterozygous B-X
for B-X
a B-X
de B-X
novo B-X
frameshift B-X
and B-X
a B-X
novel B-X
missense B-X
mutation B-X
of B-X
factor B-X
VIII B-X
| B-X
Hemophilia B-X
A B-X
( B-X
HA B-X
) B-X
is B-X
an B-X
X-chromosome-linked B-X
recessive B-X
Request B-X
PDF B-X
| B-X
Clinical B-X
and B-X
genetic B-X
findings B-X
in B-X
five B-X
female B-X
patients B-X
with B-X
haemophilia B-X
A B-X
: B-X
Identification B-X
of B-X
a B-X
novel B-X
missense B-X
mutation B-X
, B-X
p.Phe2127Ser B-X
| B-X
Severe B-X
manifestations B-X
of B-X
X-linked B-X
recessive B-X
disorders B-X
Mutations B-X
in B-X
Multiple B-X
PKD B-X
Genes B-X
May B-X
Explain B-X
Early B-X
and B-X
Severe B-X
Polycystic B-X
Kidney B-X
Disease B-X
Molecular B-X
mechanisms B-X
underlying B-X
hemophilia B-X
A B-X
phenotype B-X
in B-X
seven B-X
females B-X
- B-X
PAVLOVA B-X
- B-X
2009 B-X
- B-X
Journal B-X
of B-X
Thrombosis B-X
and B-X
Haemostasis B-X
- B-X
Wiley B-X
Online B-X
Library B-X
613160 B-X
- B-X
VON B-X
WILLEBRAND B-X
FACTOR B-X
; B-X
VWF B-X
- B-X
FACTOR B-X
VIII-VON B-X
WILLEBRAND B-X
FACTOR B-X
; B-X
F8VWF B-X
- B-X
VWF B-X

The	O
second	O
patient	O
also	O
had	O
asymptomatic	O
parents	O
who	O
,	O
however	O
,	O
were	O
not	O
available	O
for	O
study	O
.	O
<EOS> B-X
A B-X
study B-X
on B-X
infectivity B-X
of B-X
asymptomatic B-X
SARS-CoV-2 B-X
carriers B-X
CT B-X
scans B-X
reveal B-X
lung B-X
damage B-X
in B-X
people B-X
with B-X
no B-X
symptoms B-X
. B-X
The B-X
WHO B-X
's B-X
head B-X
of B-X
emerging B-X
diseases B-X
said B-X
evidence B-X
from B-X
'two B-X
or B-X
three B-X
' B-X
studies B-X
suggested B-X
people B-X
with B-X
symptoms B-X
should B-X
be B-X
the B-X
main B-X
focus B-X
. B-X
A B-X
traveler B-X
to B-X
Germany B-X
from B-X
China B-X
who B-X
infected B-X
another B-X
person B-X
did B-X
feel B-X
ill B-X
, B-X
contradicting B-X
New B-X
England B-X
Journal B-X
of B-X
Medicine B-X
report B-X
Scientists B-X
have B-X
discovered B-X
more B-X
evidence B-X
about B-X
a B-X
strange B-X
and B-X
worrying B-X
feature B-X
of B-X
the B-X
coronavirus B-X
. B-X
The B-X
role B-X
of B-X
children B-X
in B-X
transmission B-X
of B-X
SARS-CoV-2 B-X
: B-X
A B-X
rapid B-X
review B-X
Asymptomatic B-X
and B-X
presymptomatic B-X
transmission B-X
of B-X
SARS-CoV-2 B-X
: B-X
A B-X
systematic B-X
review B-X

The	O
structural	O
consequences	O
of	O
the	O
identified	O
mutation	O
,	O
resulting	O
in	O
the	O
CyS2010	O
-	O
>	O
Arg	O
substitution	O
,	O
were	O
evaluated	O
by	O
expression	O
of	O
the	O
vWF	O
carboxyl	O
-	O
terminal	O
domain	O
containing	O
residues	O
1366	O
-	O
2050	O
.	O
<EOS> B-X
Conformational B-X
Changes B-X
in B-X
the B-X
A3 B-X
Domain B-X
of B-X
von B-X
Willebrand B-X
Factor B-X
Modulate B-X
the B-X
Interaction B-X
of B-X
the B-X
A1 B-X
Domain B-X
With B-X
Platelet B-X
Glycoprotein B-X
Ib B-X
- B-X
ScienceDirect B-X
Isolation B-X
and B-X
characterization B-X
of B-X
two B-X
domains B-X
of B-X
human B-X
von B-X
Willebrand B-X
factor B-X
that B-X
interact B-X
with B-X
fibrillar B-X
collagen B-X
types B-X
I B-X
and B-X
III B-X
. B-X
- B-X
ScienceDirect B-X
Request B-X
PDF B-X
| B-X
Dimerization B-X
and B-X
multimerization B-X
defects B-X
of B-X
von B-X
Willebrand B-X
factor B-X
due B-X
to B-X
mutated B-X
cysteine B-X
residues B-X
| B-X
In B-X
patients B-X
classified B-X
with B-X
type B-X
1 B-X
and B-X
type B-X
3 B-X
von B-X
Willebrand B-X
disease B-X
missense B-X
The B-X
metallo-beta-lactamases B-X
require B-X
divalent B-X
cations B-X
such B-X
as B-X
zinc B-X
or B-X
cadmium B-X
for B-X
hydrolyzing B-X
the B-X
amide B-X
bond B-X
of B-X
beta-lactam B-X
antibiotics B-X
. B-X
The B-X
crystal B-X
structure B-X
of B-X
the B-X
Zn2+ B-X
-bound B-X
enzyme B-X
from B-X
Bacteroides B-X
fragilis B-X
The B-X
Binding B-X
Domain B-X
of B-X
von B-X
Willebrand B-X
Factor B-X
to B-X
Sulfatides B-X
Is B-X
Distinct B-X
From B-X
Those B-X
Interacting B-X
With B-X
Glycoprotein B-X
lb B-X
, B-X
Heparin B-X
, B-X
and B-X
Collagen B-X
and B-X
Resides B-X
Between B-X
Amino B-X
Acid B-X
Residues B-X
Leu B-X
512 B-X
Localization B-X
of B-X
a B-X
Collagen-Interactive B-X
Domain B-X
of B-X
Human B-X
von B-X
Willebrand B-X
Factor B-X
Between B-X
Amino B-X
Acid B-X
Residues B-X
Gly B-X
911 B-X
and B-X
Glu B-X
1,365 B-X
- B-X
ScienceDirect B-X
NCBI B-X
Disease B-X
Corpus B-X
- B-X
Development B-X
set B-X
- B-X
in B-X
BioC B-X

Insect	O
cells	O
infected	O
with	O
recombinant	O
baculovirus	O
expressing	O
normal	O
vWF	O
sequence	O
secreted	O
a	O
disulfide	O
linked	O
dimeric	O
molecule	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
150	O
kDa	O
before	O
reduction	O
,	O
yielding	O
a	O
single	O
band	O
of	O
80	O
kDa	O
after	O
disulfide	O
bond	O
reduction	O
.	O
<EOS> B-X
Glycoprotein B-X
hormones B-X
LH B-X
, B-X
FSH B-X
, B-X
TSH B-X
and B-X
chorionic B-X
gonadotrophin B-X
are B-X
heterodimers B-X
composed B-X
of B-X
two B-X
non-covalently B-X
associated B-X
subunits B-X
, B-X
a B-X
common B-X
alpha- B-X
and B-X
a B-X
specific B-X
beta-subunit B-X
. B-X
A B-X
recombinant B-X
baculovirus B-X
Effects B-X
of B-X
antibody B-X
disulfide B-X
bond B-X
reduction B-X
on B-X
purification B-X
process B-X
performance B-X
and B-X
final B-X
drug B-X
substance B-X
stability B-X
- B-X
Chung B-X
- B-X
2017 B-X
- B-X
Biotechnology B-X
and B-X
Bioengineering B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Direct B-X
Radiation B-X
Damage B-X
Is B-X
Confined B-X
to B-X
a B-X
Single B-X
Polypeptide B-X
in B-X
Rabbit B-X
Immunoglobulin B-X
G B-X
Homogeneous B-X
Bispecifics B-X
by B-X
Disulfide B-X
Bridging B-X
Request B-X
PDF B-X
| B-X
Differential B-X
effects B-X
of B-X
the B-X
loss B-X
of B-X
intrachain-versus B-X
interchain-disulfide B-X
bonds B-X
in B-X
the B-X
cystine-knot B-X
domain B-X
of B-X
von B-X
Willebrand B-X
factor B-X
on B-X
the B-X
clinical B-X
phenotype B-X
of B-X
von B-X
Willebrand B-X
disease B-X
| B-X
Von B-X
Enhancing B-X
Protein B-X
Disulfide B-X
Bond B-X
Cleavage B-X
by B-X
UV B-X
Excitation B-X
and B-X
Electron B-X
Capture B-X
Dissociation B-X
for B-X
Top-Down B-X
Mass B-X
Spectrometry B-X
Download B-X
Citation B-X
| B-X
Recombinant B-X
expression B-X
of B-X
mutations B-X
causing B-X
von B-X
Willebrand B-X
disease B-X
type B-X
Normandy B-X
: B-X
Characterization B-X
of B-X
a B-X
combined B-X
defect B-X
of B-X
factor B-X
VIII B-X
binding B-X
and B-X
multimerization B-X
| B-X
Von B-X
Willebrand B-X
disease B-X
type B-X

In	O
contrast	O
,	O
cells	O
expressing	O
the	O
mutant	O
fragment	O
secreted	O
a	O
monomeric	O
molecule	O
of	O
apparent	O
molecular	O
mass	O
of	O
80	O
kDa	O
,	O
which	O
remained	O
unchanged	O
after	O
reduction	O
.	O
<EOS> B-X
The B-X
same B-X
heterozygous B-X
T B-X
- B-X
& B-X
gt B-X
; B-X
C B-X
transition B-X
at B-X
nt B-X
8567 B-X
of B-X
the B-X
von B-X
Willebrand B-X
factor B-X
( B-X
vWF B-X
) B-X
transcript B-X
was B-X
found B-X
in B-X
two B-X
unrelated B-X
patients B-X
with B-X
type B-X
The B-X
16-kDa B-X
fragment B-X
of B-X
prolactin B-X
( B-X
16-kDa B-X
PRL B-X
) B-X
, B-X
derived B-X
from B-X
proteolytic B-X
cleavage B-X
of B-X
23-kDa B-X
PRL B-X
, B-X
was B-X
shown B-X
to B-X
have B-X
antiangiogenic B-X
activity B-X
. B-X
Previous B-X
studies B-X
have B-X
shown B-X
that B-X
Defective B-X
dimerization B-X
of B-X
von B-X
Willebrand B-X
factor B-X
subunits B-X
due B-X
to B-X
a B-X
Cys- B-X
> B-X
Arg B-X
mutation B-X
in B-X
type B-X
IID B-X
von B-X
Willebrand B-X
disease B-X
. B-X
Cysteine B-X
Residues B-X
in B-X
CUB-1 B-X
Domain B-X
are B-X
Critical B-X
for B-X
Adamts-13 B-X
Secretion B-X
and B-X
Stability B-X
Request B-X
PDF B-X
| B-X
Impaired B-X
dimerization B-X
of B-X
von B-X
Willebrand B-X
factor B-X
subunit B-X
due B-X
to B-X
mutation B-X
A280ID B-X
in B-X
the B-X
CK B-X
domain B-X
results B-X
in B-X
a B-X
recessive B-X
type B-X
2A B-X
subtype B-X
IID B-X
von B-X
Willebrand B-X
disease B-X
| B-X
Defective B-X
dimerization B-X
of B-X
von B-X
Willebrand B-X
factor B-X
subunits B-X
due B-X
to B-X
a B-X
Cys- B-X
> B-X
Arg B-X
mutation B-X
in B-X
type B-X
IID B-X
von B-X
Willebrand B-X
disease B-X
| B-X
PNAS B-X
Download B-X
Citation B-X
| B-X
Impact B-X
of B-X
mutations B-X
in B-X
the B-X
von B-X
Willebrand B-X
factor B-X
A2 B-X
domain B-X
on B-X
ADAMTS13-dependent B-X
proteolysis B-X
| B-X
Classical B-X
von B-X
Willebrand B-X
disease B-X
( B-X
VWD B-X
) B-X
type B-X
2A B-X
, B-X
the B-X
most B-X
common B-X

We	O
conclude	O
that	O
CyS2010	O
is	O
essential	O
for	O
normal	O
dimerization	O
of	O
vWF	O
subunits	O
through	O
disulfide	O
bonding	O
of	O
carboxyl	O
-	O
terminal	O
domains	O
and	O
that	O
a	O
heterozygous	O
mutation	O
in	O
the	O
corresponding	O
codon	O
is	O
responsible	O
for	O
defective	O
multimer	O
formation	O
in	O
type	B-Disease
IID	I-Disease
von	I-Disease
Willebrand	I-Disease
disease	I-Disease
.	O
.	O
<EOS> B-X
Dimerization B-X
defects B-X
of B-X
von B-X
Willebrand B-X
factor B-X
( B-X
vWF B-X
) B-X
protomers B-X
underlie B-X
von B-X
Willebrand B-X
disease B-X
( B-X
vWD B-X
) B-X
type B-X
2A B-X
, B-X
subtype B-X
IID B-X
( B-X
vWD B-X
2A/IID B-X
) B-X
, B-X
and B-X
corresponding B-X
mutations B-X
Request B-X
PDF B-X
| B-X
Aberrant B-X
dimerization B-X
of B-X
von B-X
Willebrand B-X
factor B-X
as B-X
the B-X
result B-X
of B-X
mutations B-X
in B-X
the B-X
carboxy-terminal B-X
region B-X
: B-X
Identification B-X
of B-X
3 B-X
mutations B-X
in B-X
members B-X
of B-X
3 B-X
different B-X
families B-X
with B-X
PDF B-X
| B-X
Dimerization B-X
defects B-X
of B-X
von B-X
Willebrand B-X
factor B-X
( B-X
vWF B-X
) B-X
protomers B-X
underlie B-X
von B-X
Willebrand B-X
disease B-X
( B-X
vWD B-X
) B-X
type B-X
2A B-X
, B-X
subtype B-X
IID B-X
( B-X
vWD B-X
2A/IID B-X
) B-X
, B-X
and B-X
Request B-X
PDF B-X
| B-X
Homozygous B-X
C2362F B-X
von B-X
Willebrand B-X
factor B-X
induces B-X
intracellular B-X
retention B-X
of B-X
mutant B-X
von B-X
Willebrand B-X
factor B-X
resulting B-X
in B-X
autosomal B-X
recessive B-X
severe B-X
von B-X
Willebrand B-X
disease B-X
| B-X
The B-X
missense B-X
mutation B-X
of B-X
cysteine B-X
Request B-X
PDF B-X
| B-X
Von B-X
Willebrand B-X
‚Äô B-X
s B-X
Disease B-X
caused B-X
by B-X
Compound B-X
Heterozygosity B-X
for B-X
a B-X
Substitution B-X
Mutation B-X
( B-X
T1156M B-X
) B-X
in B-X
the B-X
D3 B-X
Domain B-X
of B-X
the B-X
Von B-X
Willebrand B-X
Factor B-X
and B-X
a B-X
Request B-X
PDF B-X
| B-X
Sequence B-X
and B-X
structure B-X
relationships B-X
within B-X
von B-X
Willebrand B-X
factor B-X
| B-X
In B-X
the B-X
present B-X
study B-X
, B-X
we B-X
re-annotated B-X
von B-X
Willebrand B-X
factor B-X
( B-X
VWF B-X
) B-X
, B-X
assigned B-X
its B-X
entire B-X
sequence B-X

Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
protein	O
,	O
a	O
novel	O
effector	O
for	O
the	O
GTPase	O
CDC42Hs	O
,	O
is	O
implicated	O
in	O
actin	O
polymerization	O
.	O
<EOS> B-X
Wiskott‚ÄìAldrich B-X
Syndrome B-X
Protein B-X
, B-X
a B-X
Novel B-X
Effector B-X
for B-X
the B-X
GTPase B-X
CDC42Hs B-X
, B-X
Is B-X
Implicated B-X
in B-X
Actin B-X
Polymerization B-X
: B-X
Cell B-X
Wiskott‚ÄìAldrich B-X
Syndrome B-X
Protein B-X
, B-X
a B-X
Novel B-X
Effector B-X
for B-X
the B-X
GTPase B-X
CDC42Hs B-X
, B-X
Is B-X
Implicated B-X
in B-X
Actin B-X
Polymerization B-X
- B-X
ScienceDirect B-X
Direct B-X
interaction B-X
of B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
with B-X
the B-X
GTPase B-X
Cdc42 B-X
. B-X
PAK4 B-X
, B-X
a B-X
novel B-X
effector B-X
for B-X
Cdc42Hs B-X
, B-X
is B-X
implicated B-X
in B-X
the B-X
reorganization B-X
of B-X
the B-X
actin B-X
cytoskeleton B-X
and B-X
in B-X
the B-X
formation B-X
of B-X
filopodia B-X
. B-X
Wiskott‚ÄìAldrich B-X
syndrome B-X
protein B-X
( B-X
WASp B-X
) B-X
is B-X
a B-X
binding B-X
partner B-X
for B-X
c-Src B-X
family B-X
protein-tyrosine B-X
kinases B-X
: B-X
Current B-X
Biology B-X
The B-X
Rho B-X
family B-X
of B-X
GTPases B-X
control B-X
diverse B-X
biological B-X
processes B-X
, B-X
including B-X
cell B-X
morphology B-X
and B-X
mitogenesis B-X
. B-X
We B-X
have B-X
identified B-X
WASP B-X
, B-X
the B-X
protein B-X
that B-X
is B-X
defective B-X
in B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
The B-X
Rho B-X
family B-X
of B-X
GTPases B-X
control B-X
diverse B-X
biological B-X
processes B-X
, B-X
including B-X
cell B-X
morphology B-X
and B-X
mitogenesis B-X
. B-X
We B-X
have B-X
identified B-X
WASP B-X
, B-X
the B-X
protein B-X
that B-X
is B-X
defective B-X
in B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X

The	O
Rho	O
family	O
of	O
GTPases	O
control	O
diverse	O
biological	O
processes	O
,	O
including	O
cell	O
morphology	O
and	O
mitogenesis	O
.	O
<EOS> B-X
Rho B-X
GTPases B-X
Control B-X
Polarity B-X
, B-X
Protrusion B-X
, B-X
and B-X
Adhesion B-X
during B-X
Cell B-X
Movement B-X
The B-X
Rho B-X
family B-X
of B-X
small B-X
GTPases B-X
orchestrates B-X
fundamental B-X
biological B-X
processes B-X
such B-X
as B-X
cell B-X
cycle B-X
progression B-X
, B-X
cell B-X
migration B-X
, B-X
and B-X
actin B-X
cytoskeleton B-X
dynamics B-X
, B-X
and B-X
their B-X
aberrant B-X
signaling B-X
is B-X
linked B-X
Rho B-X
GTPases B-X
are B-X
small B-X
proteins B-X
that B-X
act B-X
as B-X
binary B-X
molecular B-X
switches B-X
in B-X
a B-X
wide B-X
range B-X
of B-X
signalling B-X
pathways B-X
upon B-X
stimulation B-X
of B-X
cell B-X
surface B-X
receptors B-X
. B-X
Thr B-X
Rho B-X
GTPases B-X
as B-X
therapeutic B-X
targets B-X
in B-X
cancer B-X
( B-X
Review B-X
) B-X
Multifaceted B-X
Rho B-X
GTPase B-X
Signaling B-X
at B-X
the B-X
Endomembranes B-X
Cells B-X
, B-X
an B-X
international B-X
, B-X
peer-reviewed B-X
Open B-X
Access B-X
journal B-X
. B-X

We	O
have	O
identified	O
WASP	O
,	O
the	O
protein	O
that	O
is	O
defective	O
in	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
(	O
WAS	B-Disease
)	O
,	O
as	O
a	O
novel	O
effector	O
for	O
CDC42Hs	O
,	O
but	O
not	O
for	O
the	O
other	O
Rho	O
family	O
members	O
,	O
Rac	O
and	O
Rho	O
.	O
<EOS> B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
, B-X
a B-X
novel B-X
effector B-X
for B-X
the B-X
GTPase B-X
CDC42Hs B-X
, B-X
is B-X
implicated B-X
in B-X
actin B-X
polymerization B-X
. B-X
There B-X
is B-X
now B-X
considerable B-X
evidence B-X
for B-X
the B-X
involvement B-X
of B-X
aberrant B-X
Rho B-X
GTPase B-X
activation B-X
in B-X
breast B-X
cancer B-X
development B-X
. B-X
Like B-X
Ras B-X
, B-X
Rho B-X
GTPases B-X
function B-X
as B-X
si B-X
Wiskott-Aldrich B-X
Syndrome B-X
protein B-X
is B-X
required B-X
for B-X
homeostasis B-X
and B-X
function B-X
of B-X
invariant B-X
NKT B-X
cells B-X
Wiskott-Aldrich B-X
Syndrome B-X
Protein B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
PAK B-X
and B-X
other B-X
Rho-associated B-X
kinases B-X
‚Äì B-X
effectors B-X
with B-X
surprisingly B-X
diverse B-X
mechanisms B-X
of B-X
regulation B-X
Wiskott B-X
Aldrich B-X
Syndrome B-X
Protein B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Wiskott-Aldrich B-X
Syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
a B-X
severe B-X
X-linked B-X
disorder B-X
characterised B-X
by B-X
immune B-X
deficiency B-X
, B-X
thrombocytopenia B-X
and B-X
eczema B-X
, B-X
resulting B-X
from B-X
abnormalities B-X
in B-X
a B-X
range B-X
of B-X
haematopoietic B-X
cell B-X
types B-X
. B-X

This	O
interaction	O
is	O
dependent	O
on	O
the	O
presence	O
of	O
the	O
G	O
protein	O
-	O
binding	O
domain	O
.	O

Cellular	O
expression	O
of	O
epitope	O
-	O
tagged	O
WASP	O
produces	O
clusters	O
of	O
WASP	O
that	O
are	O
highly	O
enriched	O
in	O
polymerized	O
actin	O
.	O
<EOS> B-X
Processive B-X
acceleration B-X
of B-X
actin B-X
barbed-end B-X
assembly B-X
by B-X
N-WASP B-X
PDF B-X
| B-X
The B-X
role B-X
of B-X
WASP-interacting B-X
protein B-X
( B-X
WIP B-X
) B-X
in B-X
the B-X
process B-X
of B-X
F-actin B-X
assembly B-X
during B-X
chemotaxis B-X
of B-X
Dictyostelium B-X
was B-X
examined B-X
. B-X
Mutations B-X
of B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
Download B-X
Citation B-X
| B-X
WASP B-X
and B-X
WAVE B-X
family B-X
proteins B-X
: B-X
Key B-X
molecules B-X
for B-X
rapid B-X
rearrangement B-X
of B-X
cortical B-X
actin B-X
filaments B-X
and B-X
cell B-X
movement B-X
| B-X
Reorganization B-X
of B-X
cortical B-X
actin B-X
filaments B-X
plays B-X
critical B-X
roles B-X
Request B-X
PDF B-X
| B-X
WASP-interacting B-X
protein B-X
( B-X
WIP B-X
) B-X
: B-X
working B-X
in B-X
polymerisation B-X
and B-X
much B-X
more B-X
| B-X
The B-X
migration B-X
of B-X
cells B-X
and B-X
the B-X
movement B-X
of B-X
some B-X
intracellular B-X
pathogens B-X
, B-X
such B-X
as B-X
Request B-X
PDF B-X
| B-X
Recent B-X
advances B-X
in B-X
the B-X
biology B-X
of B-X
WASP B-X
and B-X
WIP B-X
| B-X
WASP B-X
, B-X
the B-X
product B-X
of B-X
the B-X
gene B-X
mutated B-X
in B-X
Wiskott-Aldrich B-X
syndrome B-X
, B-X
is B-X
expressed B-X
only B-X
in B-X
hematopoietic B-X
PDF B-X
| B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
an B-X
X-linked B-X
immunodeficiency B-X
characterized B-X
by B-X
microthrombocytopenia B-X
, B-X
eczema B-X
, B-X
recurrent B-X
infections B-X
, B-X
autoimmune B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X

This	O
clustering	O
is	O
not	O
observed	O
with	O
a	O
C	O
-	O
terminally	O
deleted	O
WASP	O
and	O
is	O
inhibited	O
by	O
coexpression	O
with	O
dominant	O
negative	O
CDC42Hs	O
-	O
N17	O
,	O
but	O
not	O
with	O
dominant	O
negative	O
forms	O
of	O
Rac	O
or	O
Rho	O
.	O
<EOS> B-X
The B-X
Rho B-X
family B-X
GTP-binding B-X
proteins B-X
play B-X
a B-X
critical B-X
role B-X
in B-X
a B-X
variety B-X
of B-X
cytoskeleton-dependent B-X
cell B-X
functions B-X
. B-X
In B-X
this B-X
study B-X
, B-X
we B-X
examined B-X
the B-X
role B-X
of B-X
Rho B-X
family B-X
G B-X
proteins B-X
Endothelial B-X
permeability B-X
induced B-X
by B-X
thrombin B-X
and B-X
histamine B-X
is B-X
accompanied B-X
by B-X
actin B-X
stress B-X
fibre B-X
assembly B-X
and B-X
intercellular B-X
gap B-X
formation B-X
. B-X
Here B-X
, B-X
we B-X
investigate B-X
the B-X
roles B-X
of B-X
the B-X
Rho B-X
family B-X
GTPases B-X
Dominant-Negative B-X
Rho B-X
, B-X
Rac B-X
, B-X
and B-X
Cdc42 B-X
Facilitate B-X
the B-X
Invasion B-X
Process B-X
of B-X
Vibrio B-X
parahaemolyticus B-X
into B-X
Caco-2 B-X
Cells B-X
Signals B-X
from B-X
the B-X
Ras B-X
, B-X
Rac B-X
, B-X
and B-X
Rho B-X
GTPases B-X
Converge B-X
on B-X
the B-X
Pak B-X
Protein B-X
Kinase B-X
in B-X
Rat-1 B-X
Fibroblasts B-X
Note B-X
: B-X
Agents B-X
That B-X
Inhibit B-X
Rho B-X
, B-X
Rac B-X
, B-X
and B-X
Cdc42 B-X
Do B-X
Not B-X
Block B-X
Formation B-X
of B-X
Actin B-X
Pedestals B-X
in B-X
HeLa B-X
Cells B-X
Infected B-X
with B-X
Enteropathogenic B-X
Escherichia B-X
coli B-X
Signals B-X
from B-X
the B-X
Ras B-X
, B-X
Rac B-X
, B-X
and B-X
Rho B-X
GTPases B-X
Converge B-X
on B-X
the B-X
Pak B-X
Protein B-X
Kinase B-X
in B-X
Rat-1 B-X
Fibroblasts B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
Dominant-Negative B-X
Rho B-X
, B-X
Rac B-X
, B-X
and B-X
Cdc42 B-X
Facilitate B-X
the B-X
Invasion B-X
Process B-X
of B-X
Vibrio B-X
parahaemolyticus B-X
into B-X
Caco-2 B-X
Cells B-X
| B-X
Infection B-X
and B-X
Immunity B-X

Thus	O
,	O
WASP	O
provides	O
a	O
novel	O
link	O
between	O
CDC42Hs	O
and	O
the	O
actin	O
cytoskeleton	O
,	O
which	O
suggests	O
a	O
molecular	O
mechanism	O
for	O
many	O
of	O
the	O
cellular	O
abnormalities	O
in	O
WAS	B-Disease
.	O
<EOS> B-X
The B-X
Interaction B-X
between B-X
N-WASP B-X
and B-X
the B-X
Arp2/3 B-X
Complex B-X
Links B-X
Cdc42-Dependent B-X
Signals B-X
to B-X
Actin B-X
Assembly B-X
: B-X
Cell B-X
The B-X
Interaction B-X
between B-X
N-WASP B-X
and B-X
the B-X
Arp2/3 B-X
Complex B-X
Links B-X
Cdc42-Dependent B-X
Signals B-X
to B-X
Actin B-X
Assembly B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
In B-X
studies B-X
aimed B-X
at B-X
further B-X
characterizing B-X
the B-X
cellular B-X
immunodeficiency B-X
of B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
, B-X
we B-X
found B-X
that B-X
T B-X
lymphocytes B-X
from B-X
WAS B-X
p B-X
The B-X
Intersectin B-X
2 B-X
Adaptor B-X
Links B-X
Wiskott B-X
Aldrich B-X
Syndrome B-X
Protein B-X
( B-X
WASp B-X
) B-X
-mediated B-X
Actin B-X
Polymerization B-X
to B-X
T B-X
Cell B-X
Antigen B-X
Receptor B-X
Endocytosis B-X
WASP-interacting B-X
Protein B-X
Is B-X
Important B-X
for B-X
Actin B-X
Filament B-X
Elongation B-X
and B-X
Prompt B-X
Pseudopod B-X
Formation B-X
in B-X
Response B-X
to B-X
a B-X
Dynamic B-X
Chemoattractant B-X
Gradient B-X
Disease B-X
mechanism B-X
: B-X
Unravelling B-X
Wiskott‚ÄìAldrich B-X
syndrome B-X
: B-X
Current B-X
Biology B-X

The	O
WASP	O
sequence	O
contains	O
two	O
novel	O
domains	O
that	O
are	O
homologous	O
to	O
other	O
proteins	O
involved	O
in	O
action	O
organization	O
.	O
.	O
<EOS> B-X
The B-X
WASP B-X
Homologue B-X
Las17 B-X
Activates B-X
the B-X
Novel B-X
Actin-regulatory B-X
Activity B-X
of B-X
Ysc84 B-X
to B-X
Promote B-X
Endocytosis B-X
in B-X
Yeast B-X
WASP B-X
Family B-X
Proteins B-X
: B-X
Their B-X
Evolution B-X
and B-X
Its B-X
Physiological B-X
Implications B-X
Evolution B-X
of B-X
the B-X
eukaryotic B-X
ARP2/3 B-X
activators B-X
of B-X
the B-X
WASP B-X
family B-X
: B-X
WASP B-X
, B-X
WAVE B-X
, B-X
WASH B-X
, B-X
and B-X
WHAMM B-X
, B-X
and B-X
the B-X
proposed B-X
new B-X
family B-X
members B-X
WAWH B-X
and B-X
WAML B-X
Under B-X
lock B-X
and B-X
key B-X
: B-X
Spatiotemporal B-X
regulation B-X
of B-X
WASP B-X
family B-X
proteins B-X
coordinates B-X
separate B-X
dynamic B-X
cellular B-X
processes B-X
SMART B-X
: B-X
WH1 B-X
domain B-X
annotation B-X
Request B-X
PDF B-X
| B-X
The B-X
WASP-Binding B-X
Protein B-X
WIRE B-X
Has B-X
a B-X
Role B-X
in B-X
the B-X
Regulation B-X
of B-X
the B-X
Actin B-X
Filament B-X
System B-X
Downstream B-X
of B-X
the B-X
Platelet-Derived B-X
Growth B-X
Factor B-X
Receptor B-X
| B-X
Activation B-X
of B-X
growth B-X
factor B-X
All B-X
eukaryotic B-X
cells B-X
need B-X
to B-X
reorganize B-X
their B-X
actin B-X
cytoskeleton B-X
to B-X
change B-X
shape B-X
, B-X
divide B-X
, B-X
move B-X
, B-X
and B-X
take B-X
up B-X
nutrients B-X
for B-X
survival B-X
. B-X
The B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
( B-X
WASP B-X

X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystrophy	I-Disease
is	O
a	O
frequent	O
cause	O
of	O
idiopathic	O
Addison	B-Disease
'	I-Disease
s	I-Disease
disease	I-Disease
in	O
young	O
adult	O
male	O
patients	O
.	O
<EOS> B-X
The B-X
importance B-X
of B-X
testing B-X
for B-X
adrenoleucodystrophy B-X
in B-X
males B-X
with B-X
idiopathic B-X
Addison B-X
's B-X
disease B-X
The B-X
importance B-X
of B-X
testing B-X
for B-X
adrenoleucodystrophy B-X
in B-X
males B-X
with B-X
idiopathic B-X
Addison B-X
's B-X
disease B-X
| B-X
Archives B-X
of B-X
Disease B-X
in B-X
Childhood B-X
Reminder B-X
of B-X
important B-X
clinical B-X
lesson B-X
: B-X
Adrenoleukodystrophy B-X
: B-X
a B-X
forgotten B-X
diagnosis B-X
in B-X
children B-X
with B-X
primary B-X
Addison B-X
's B-X
disease B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
) B-X
: B-X
clinical B-X
presentation B-X
and B-X
guidelines B-X
for B-X
diagnosis B-X
, B-X
follow-up B-X
and B-X
management B-X
Abstract B-X
. B-X
X-Linked B-X
adrenoleukodystrophy B-X
( B-X
ALD B-X
) B-X
is B-X
a B-X
genetic B-X
disease B-X
associated B-X
with B-X
demyelination B-X
of B-X
the B-X
central B-X
nervous B-X
system B-X
, B-X
adrenal B-X
insufficiency B-X
, B-X
and B-X
accum B-X
Childhood B-X
adrenoleukodystrophy B-X
‚Äì B-X
Classic B-X
and B-X
variant B-X
‚Äì B-X
Review B-X
of B-X
clinical B-X
manifestations B-X
and B-X
magnetic B-X
resonance B-X
imaging B-X
X B-X
linked B-X
adrenoleukodystrophy B-X
: B-X
clinical B-X
presentation B-X
, B-X
diagnosis B-X
, B-X
and B-X
therapy B-X
| B-X
Journal B-X
of B-X
Neurology B-X
, B-X
Neurosurgery B-X
& B-X
Psychiatry B-X

X	B-Disease
-	I-Disease
Linked	I-Disease
adrenoleukodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
is	O
a	O
genetic	B-Disease
disease	I-Disease
associated	O
with	O
demyelination	B-Disease
of	I-Disease
the	I-Disease
central	I-Disease
nervous	I-Disease
system	I-Disease
,	O
adrenal	B-Disease
insufficiency	I-Disease
,	O
and	O
accumulation	O
of	O
very	O
long	O
chain	O
fatty	O
acids	O
in	O
tissue	O
and	O
body	O
fluids	O
.	O
<EOS> B-X
Adrenoleukodystrophy B-X
( B-X
ALD B-X
) B-X
is B-X
a B-X
genetic B-X
disease B-X
associated B-X
with B-X
demyelination B-X
of B-X
the B-X
central B-X
nervous B-X
system B-X
, B-X
adrenal B-X
insufficiency B-X
, B-X
and B-X
accumulation B-X
of B-X
very B-X
long-chain B-X
fatty B-X
acids B-X
in B-X
tissue B-X
and B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
) B-X
is B-X
the B-X
most B-X
frequent B-X
peroxisomal B-X
disorder B-X
that B-X
is B-X
characterized B-X
by B-X
progressive B-X
demyelination B-X
of B-X
the B-X
white B-X
matter B-X
, B-X
adrenal B-X
insufficiency B-X
, B-X
and B-X
accumulation B-X
of B-X
very B-X
long-chain B-X
X-linked B-X
adrenoleukodystrophy B-X
in B-X
8 B-X
patients B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
) B-X
is B-X
a B-X
hereditary B-X
disorder B-X
of B-X
peroxisomal B-X
metabolism B-X
biochemically B-X
characterized B-X
by B-X
the B-X
accumulation B-X
of B-X
very B-X
long B-X
chain B-X
fatty B-X
acids B-X
( B-X
VLCFA B-X
) B-X
, B-X
particularly B-X
hexacosanoic B-X
acid B-X
Adrenoleukodystrophy B-X
disease B-X
: B-X
Malacards B-X
- B-X
Research B-X
Articles B-X
, B-X
Drugs B-X
, B-X
Genes B-X
, B-X
Clinical B-X
Trials B-X

ALD	B-Disease
is	O
due	O
to	O
mutation	O
of	O
a	O
gene	O
located	O
in	O
Xq28	O
that	O
encodes	O
a	O
peroxisomal	O
transporter	O
protein	O
of	O
unknown	O
function	O
.	O

The	O
most	O
common	O
phenotype	O
of	O
ALD	B-Disease
is	O
the	O
cerebral	O
form	O
(	O
45	O
%	O
)	O
that	O
develops	O
in	O
boys	O
between	O
5	O
-	O
12	O
yr	O
.	O
<EOS> B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
) B-X
affects B-X
the B-X
nervous B-X
system B-X
white B-X
matter B-X
and B-X
the B-X
adrenal B-X
cortex B-X
. B-X
Three B-X
main B-X
phenotypes B-X
are B-X
seen B-X
in B-X
affected B-X
males B-X
: B-X
Adrenoleukodystrophy B-X
( B-X
ALD B-X
) B-X
is B-X
a B-X
genetic B-X
disease B-X
that B-X
affects B-X
1 B-X
in B-X
17,000 B-X
people B-X
. B-X
The B-X
LCN B-X
can B-X
help B-X
ensure B-X
the B-X
proper B-X
treatment B-X
is B-X
in B-X
place B-X
. B-X
Learn B-X
more B-X
here B-X
Download B-X
Citation B-X
| B-X
On B-X
Oct B-X
1 B-X
, B-X
2008 B-X
, B-X
W B-X
Furushima B-X
published B-X
Behavioral B-X
abnormality B-X
in B-X
a B-X
10-years-old B-X
boy B-X
with B-X
Addison B-X
disease B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
MRI B-X
brain B-X
lesions B-X
in B-X
asymptomatic B-X
boys B-X
with B-X
X-linked B-X
adrenoleukodystrophy B-X
A B-X
Novel B-X
Variant B-X
in B-X
ABCD1 B-X
Gene B-X
Presenting B-X
as B-X
Adolescent-Onset B-X
Atypical B-X
Adrenomyeloneuropathy B-X
With B-X
Spastic B-X
Ataxia B-X
The B-X
child B-X
is B-X
neither B-X
an B-X
adult B-X
miniature B-X
nor B-X
an B-X
immature B-X
human B-X
being B-X
: B-X
at B-X
each B-X
age B-X
, B-X
it B-X
expresses B-X
specific B-X
abilities B-X
that B-X
optimize B-X
adaptation B-X
to B-X
its B-X
environment B-X
and B-X
development B-X
of B-X
Neurocognitive B-X
Trajectory B-X
of B-X
Boys B-X
Who B-X
Received B-X
a B-X
Hematopoietic B-X
Stem B-X
Cell B-X
Transplant B-X
at B-X
an B-X
Early B-X
Stage B-X
of B-X
Childhood B-X
Cerebral B-X
Adrenoleukodystrophy B-X

Adrenomyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
involves	O
the	O
spinal	O
cord	O
and	O
peripheral	O
nerves	O
in	O
young	O
adults	O
(	O
35	O
%	O
)	O
.	O
<EOS> B-X
Adrenomyeloneuropathy B-X
( B-X
AMN B-X
) B-X
is B-X
a B-X
phenotype B-X
variant B-X
of B-X
X-linked B-X
adrenoleukodystrophy B-X
. B-X
We B-X
present B-X
two B-X
patients B-X
with B-X
adult-onset B-X
AMN B-X
who B-X
were B-X
initially B-X
suspec B-X
PDF B-X
| B-X
Adrenomyeloneuropathy B-X
is B-X
a B-X
varient B-X
of B-X
adrenoleukodystrophy B-X
, B-X
both B-X
of B-X
which B-X
are B-X
rare B-X
inherited B-X
disorders B-X
of B-X
peroxisomes B-X
characterized B-X
by B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
Rare B-X
variability B-X
in B-X
adrenoleukodystrophy B-X
: B-X
a B-X
case B-X
report B-X
The B-X
portal B-X
for B-X
rare B-X
diseases B-X
and B-X
orphan B-X
drugs B-X
Adrenoleukodystrophy B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Adrenoleukodystrophy B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Adrenal	B-Disease
insufficiency	I-Disease
(	O
Addisons	B-Disease
disease	I-Disease
)	O
is	O
frequently	O
associated	O
with	O
AMN	B-Disease
or	O
cerebral	B-Disease
ALD	I-Disease
and	O
may	O
remain	O
the	O
only	O
clinical	O
expression	O
of	O
ALD	B-Disease
(	O
8	O
%	O
of	O
cases	O
)	O
.	O
<EOS> B-X
Adrenomyeloneuropathy B-X
Presenting B-X
With B-X
Adrenal B-X
Insufficiency B-X

The	O
prevalence	O
of	O
ALD	B-Disease
among	O
adults	O
with	O
Addisons	B-Disease
disease	I-Disease
remains	O
unknown	O
.	O
<EOS> B-X
The B-X
risk B-X
for B-X
adrenal B-X
insufficiency B-X
in B-X
male B-X
patients B-X
with B-X
X-linked B-X
ALD B-X
is B-X
time-dependent B-X
and B-X
highest B-X
in B-X
early B-X
childhood B-X
. B-X
Age-dependent B-X
follow-up B-X
of B-X
the B-X
adrenal B-X
f B-X
The B-X
portal B-X
for B-X
rare B-X
diseases B-X
and B-X
orphan B-X
drugs B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
ALD B-X
) B-X
is B-X
a B-X
severe B-X
neurodegenerative B-X
disorder B-X
. B-X
ALD B-X
is B-X
characterized B-X
by B-X
progressive B-X
demyelination B-X
within B-X
the B-X
central B-X
and B-X
peripheral B-X
nervous B-X
system B-X
, B-X
adrenal B-X
insufficiency B-X
( B-X
Addison B-X
's B-X
Late B-X
onset B-X
adrenoleukodystrophy B-X
: B-X
A B-X
review B-X
related B-X
clinical B-X
case B-X
report B-X
- B-X
ScienceDirect B-X

To	O
evaluate	O
this	O
prevalence	O
,	O
we	O
performed	O
biochemical	O
analysis	O
of	O
very	O
long	O
chain	O
fatty	O
acids	O
in	O
14	O
male	O
patients	O
(	O
age	O
ranging	O
from	O
12	O
-	O
45	O
yr	O
at	O
diagnosis	O
)	O
previously	O
diagnosed	O
as	O
having	O
primary	O
idiopathic	O
adrenocortical	B-Disease
insufficiency	I-Disease
.	O
<EOS> B-X
We B-X
detected B-X
a B-X
high B-X
prevalence B-X
of B-X
unrecognized B-X
adrenocortical B-X
insufficiency B-X
in B-X
asymptomatic B-X
boys B-X
with B-X
X-ALD B-X
. B-X
It B-X
is B-X
known B-X
to B-X
be B-X
a B-X
frequent B-X
cause B-X
of B-X
morbidity B-X
and B-X
can B-X
be B-X
prevented B-X
by B-X
Approximately B-X
70‚Äì80 B-X
% B-X
of B-X
cases B-X
of B-X
primary B-X
adrenal B-X
insufficiency B-X
are B-X
classified B-X
as B-X
idiopathic B-X
. B-X
An B-X
effective B-X
protocol B-X
for B-X
the B-X
etiological B-X
diagnosis B-X
of B-X
primary B-X
adre B-X
Context B-X
: B-X
. B-X
Primary B-X
adrenal B-X
insufficiency B-X
is B-X
usually B-X
diagnosed B-X
in B-X
infancy B-X
or B-X
adulthood B-X
, B-X
and B-X
cases B-X
presenting B-X
in B-X
childhood B-X
have B-X
not B-X
been B-X
systematically B-X
reviewed.Ob B-X
Clinical B-X
Practice B-X
Guideline B-X
: B-X
Diagnosis B-X
and B-X
Treatment B-X
of B-X
Primary B-X
Adrenal B-X
Insufficiency B-X
: B-X
An B-X
Endocrine B-X
Society B-X
Clinical B-X
Practice B-X
Guideline B-X
Primary B-X
adrenal B-X
insufficiency B-X
( B-X
PAI B-X
) B-X
in B-X
the B-X
pediatric B-X
population B-X
( B-X
0‚Äì18 B-X
yr B-X
) B-X
is B-X
most B-X
commonly B-X
attributed B-X
to B-X
congenital B-X
adrenal B-X
hyperplasia B-X
( B-X
CAH B-X
) B-X
, B-X
which B-X
occurs B-X
in B-X
a B-X
Primary B-X
adrenal B-X
insufficiency B-X
( B-X
PAI B-X
) B-X
in B-X
the B-X
pediatric B-X
population B-X
( B-X
0‚Äì18 B-X
yr B-X
) B-X
is B-X
most B-X
commonly B-X
attributed B-X
to B-X
congenital B-X
adrenal B-X
hyperplasia B-X
( B-X
CAH B-X
) B-X
, B-X
which B-X
occurs B-X
in B-X
a B-X
X-Linked B-X
adrenoleukodystrophy B-X
( B-X
ALD B-X
) B-X
is B-X
a B-X
genetic B-X
disease B-X
associated B-X
with B-X
demyelination B-X
of B-X
the B-X
central B-X
nervous B-X
system B-X
, B-X
adrenal B-X
insufficiency B-X
, B-X
and B-X
accumulation B-X
of B-X
very B-X
long B-X
chain B-X
fatty B-X
acids B-X
in B-X

In	O
5	O
of	O
14	O
patients	O
(	O
35	O
%	O
)	O
,	O
elevated	O
plasma	O
concentrations	O
of	O
very	O
long	O
chain	O
fatty	O
acids	O
were	O
detected	O
.	O
<EOS> B-X
Lorenzo B-X
's B-X
oil B-X
inhibits B-X
ELOVL1 B-X
and B-X
lowers B-X
the B-X
level B-X
of B-X
sphingomyelin B-X
with B-X
a B-X
saturated B-X
very B-X
long-chain B-X
fatty B-X
acid B-X
Comparison B-X
of B-X
the B-X
Diagnostic B-X
Performance B-X
of B-X
C26:0-Lysophosphatidylcholine B-X
and B-X
Very B-X
Long-Chain B-X
Fatty B-X
Acids B-X
Analysis B-X
for B-X
Peroxisomal B-X
Disorders B-X
Brain B-X
Lipotoxicity B-X
of B-X
Phytanic B-X
Acid B-X
and B-X
Very B-X
Long-chain B-X
Fatty B-X
Acids B-X
. B-X
Harmful B-X
Cellular/Mitochondrial B-X
Activities B-X
in B-X
Refsum B-X
Disease B-X
and B-X
X-Linked B-X
Adrenoleukodystrophy B-X
Abstract B-X
. B-X
Saturated B-X
very B-X
long B-X
chain B-X
fatty B-X
acids B-X
( B-X
VLCFAs B-X
; B-X
‚â•C22:0 B-X
) B-X
accumulate B-X
in B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
, B-X
OMIM B-X
300100 B-X
) B-X
, B-X
a B-X
severe B-X
hereditary B-X
neurodege B-X
Anorexia B-X
nervosa B-X
( B-X
AN B-X
) B-X
is B-X
a B-X
disease B-X
resulting B-X
in B-X
extreme B-X
weight B-X
loss B-X
. B-X
It B-X
is B-X
caused B-X
by B-X
multiple B-X
factors B-X
, B-X
including B-X
psychosocial B-X
, B-X
environmental B-X
, B-X
and B-X
genetic B-X
factors B-X
. B-X
Fatty B-X
acid B-X
oxidation B-X
disorders B-X
Abstract B-X
. B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
) B-X
is B-X
a B-X
fatal B-X
neurodegenerative B-X
disease B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
ABCD1 B-X
gene B-X
, B-X
encoding B-X
a B-X
member B-X
of B-X
the B-X
peroxisomal B-X

None	O
of	O
these	O
patients	O
had	O
adrenocortical	O
antibodies	O
.	O
<EOS> B-X
Detection B-X
of B-X
adrenocortical B-X
autoantibodies B-X
in B-X
Addison B-X
's B-X
disease B-X
with B-X
a B-X
peroxidase-labelled B-X
protein B-X
A B-X
technique B-X
The B-X
incidence B-X
of B-X
adrenal B-X
and B-X
other B-X
antibodies B-X
in B-X
the B-X
sera B-X
of B-X
patients B-X
with B-X
idiopathic B-X
adrenal B-X
insufficiency B-X
( B-X
Addison B-X
's B-X
disease B-X
) B-X
Little B-X
is B-X
known B-X
about B-X
the B-X
factors B-X
that B-X
cause B-X
exacerbations B-X
of B-X
autoimmune B-X
thyroid B-X
dysfunction B-X
. B-X
One B-X
possibility B-X
is B-X
an B-X
alteration B-X
in B-X
adrenocortical B-X
function B-X
, B-X
since B-X
glucocorticoids B-X
are B-X
known B-X
to B-X
alter B-X
both B-X
Context B-X
: B-X
Patients B-X
with B-X
adrenal B-X
cortex B-X
autoantibodies B-X
( B-X
ACA B-X
) B-X
without B-X
overt B-X
autoimmune B-X
Addison B-X
‚Äô B-X
s B-X
disease B-X
( B-X
AAD B-X
) B-X
are B-X
at B-X
risk B-X
of B-X
adrenal B-X
failure.Design B-X
: B-X
To B-X
assess B-X
the B-X
Abstract B-X
. B-X
BACKGROUND B-X
: B-X
Auto-immune B-X
adrenal B-X
insufficiency B-X
is B-X
a B-X
potentially B-X
fatal B-X
disorder B-X
. B-X
Young B-X
women B-X
with B-X
spontaneous B-X
premature B-X
ovarian B-X
failure B-X
( B-X
POF B-X
) B-X
are B-X
at B-X
inc B-X
In B-X
idiopathic B-X
Addison B-X
's B-X
disease B-X
, B-X
auto-antibodies B-X
against B-X
21-hydroxylase B-X
are B-X
found B-X
in B-X
a B-X
majority B-X
of B-X
cases B-X
and B-X
this B-X
represents B-X
an B-X
important B-X
diagnostic B-X
tool B-X
. B-X
The B-X
enzyme B-X
17 B-X
alpha-hydroxylase B-X
does B-X
not B-X
Original B-X
Article B-X
from B-X
The B-X
New B-X
England B-X
Journal B-X
of B-X
Medicine B-X
‚Äî B-X
Autoimmune B-X
Addison B-X
's B-X
Disease B-X
‚Äî B-X
Report B-X
of B-X
a B-X
Possible B-X
Case B-X

By	O
electrophysiological	O
tests	O
and	O
magnetic	O
resonance	O
imaging	O
it	O
was	O
determined	O
that	O
two	O
patients	O
had	O
cerebral	B-Disease
ALD	I-Disease
,	O
one	O
had	O
adrenomyeloneuropathy	B-Disease
with	O
cerebral	O
involvement	O
,	O
and	O
two	O
had	O
preclinical	O
AMN	B-Disease
.	O
<EOS> B-X
Lorenzo B-X
's B-X
oil B-X
for B-X
adrenoleukodystrophy B-X
and B-X
adrenomyeloneuropathy B-X
Our B-X
objective B-X
was B-X
to B-X
study B-X
the B-X
phenotype B-X
evolution B-X
of B-X
X-linked B-X
adrenoleukodystrophy B-X
( B-X
X-ALD B-X
) B-X
and B-X
the B-X
relation B-X
between B-X
axonal B-X
degeneration B-X
and B-X
cerebral B-X
demyelination B-X
. B-X
Although B-X
different B-X
X-ALD B-X
phenotypes B-X
are B-X
recognized B-X
PDF B-X
| B-X
Adrenomyeloneuropathy B-X
( B-X
AMN B-X
) B-X
is B-X
a B-X
phenotype B-X
variant B-X
of B-X
X-linked B-X
adrenoleukodystrophy B-X
. B-X
We B-X
present B-X
two B-X
patients B-X
with B-X
adult-onset B-X
AMN B-X
who B-X
were B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Full B-X
article B-X
: B-X
Childhood B-X
leukodystrophies B-X
: B-X
a B-X
clinical B-X
perspective B-X

Our	O
data	O
support	O
the	O
hypothesis	O
that	O
ALD	B-Disease
is	O
a	O
frequent	O
cause	O
of	O
idiopathic	O
Addisons	B-Disease
disease	I-Disease
in	O
children	O
and	O
adults	O
.	O
.	O
<EOS> B-X
The B-X
risk B-X
for B-X
adrenal B-X
insufficiency B-X
in B-X
male B-X
patients B-X
with B-X
X-linked B-X
ALD B-X
is B-X
time-dependent B-X
and B-X
highest B-X
in B-X
early B-X
childhood B-X
. B-X
Age-dependent B-X
follow-up B-X
of B-X
the B-X
adrenal B-X
f B-X
Addison B-X
's B-X
disease B-X
in B-X
children B-X
requires B-X
customized B-X
, B-X
dedicated B-X
and B-X
emergent B-X
management B-X
. B-X
This B-X
article B-X
envisages B-X
elaborating B-X
the B-X
basics B-X
about B-X
Addison B-X
's B-X
disease B-X
in B-X
children B-X
, B-X
such B-X
as B-X
clinical B-X
presentation B-X
Whereas B-X
it B-X
is B-X
now B-X
more B-X
than B-X
150 B-X
yr B-X
since B-X
T. B-X
Addison B-X
first B-X
described B-X
the B-X
clinical B-X
and B-X
pathological B-X
features B-X
of B-X
adrenal B-X
failure B-X
( B-X
1 B-X
) B-X
, B-X
the B-X
disease B-X
remains B-X
underdia B-X
X-linked B-X
adrenoleukodystrophy B-X
: B-X
clinical B-X
and B-X
laboratory B-X
findings B-X
in B-X
15 B-X
Brazilian B-X
patients B-X
Download B-X
Citation B-X
| B-X
On B-X
May B-X
30 B-X
, B-X
2005 B-X
, B-X
N B-X
Mehta B-X
and B-X
others B-X
published B-X
X-linked B-X
adrenoleukodystrophy B-X
presenting B-X
as B-X
Addison B-X
disease B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
PDF B-X
| B-X
Approximately B-X
one B-X
third B-X
of B-X
boys B-X
with B-X
X-linked B-X
adrenoleukodystophy B-X
( B-X
X-ALD B-X
) B-X
develop B-X
an B-X
acute B-X
, B-X
progressive B-X
inflammatory B-X
process B-X
of B-X
the B-X
central B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Addison B-X
‚Äô B-X
s B-X
disease B-X
is B-X
another B-X
name B-X
for B-X
primary B-X
chronic B-X
adrenal B-X
insufficiency B-X
. B-X
It B-X
is B-X
a B-X
condition B-X
where B-X
the B-X
adrenal B-X
cortex B-X
( B-X
the B-X
outer B-X
layer B-X
of B-X
the B-X
adrenal B-X
gland B-X
that B-X

Tumor	B-Disease
suppression	O
and	O
apoptosis	O
of	O
human	O
prostate	B-Disease
carcinoma	I-Disease
mediated	O
by	O
a	O
genetic	O
locus	O
within	O
human	O
chromosome	O
10pter	O
-	O
q11	O
.	O
<EOS> B-X
Tumor B-X
suppression B-X
and B-X
apoptosis B-X
of B-X
human B-X
prostate B-X
carcinoma B-X
mediated B-X
by B-X
a B-X
genetic B-X
locus B-X
within B-X
human B-X
chromosome B-X
10pter-q11 B-X
. B-X
‚Äî B-X
Early B-X
Detection B-X
Research B-X
Network B-X
Definition B-X
of B-X
a B-X
tumor B-X
suppressor B-X
locus B-X
within B-X
human B-X
chromosome B-X
3p21-p22 B-X
| B-X
PNAS B-X
Molecular B-X
Biology B-X
of B-X
Prostate B-X
Cancer B-X
- B-X
Google B-X
Âõæ‰π¶ B-X
PDF B-X
| B-X
Prostate B-X
cancer B-X
is B-X
the B-X
second B-X
leading B-X
cause B-X
of B-X
male B-X
cancer B-X
deaths B-X
in B-X
the B-X
United B-X
States B-X
. B-X
Yet B-X
, B-X
despite B-X
a B-X
large B-X
international B-X
effort B-X
, B-X
little B-X
is B-X
known B-X
... B-X
Webpathology.com B-X
: B-X
A B-X
Collection B-X
of B-X
Surgical B-X
Pathology B-X
Images B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Prostate	B-Disease
cancer	I-Disease
is	O
the	O
second	O
leading	O
cause	O
of	O
male	O
cancer	B-Disease
deaths	O
in	O
the	O
United	O
States	O
.	O
<EOS> B-X
Prostate B-X
cancer B-X
is B-X
on B-X
of B-X
the B-X
most B-X
common B-X
cancer B-X
in B-X
American B-X
men B-X
. B-X
The B-X
American B-X
Cancer B-X
Society B-X
's B-X
most B-X
recent B-X
estimates B-X
for B-X
prostate B-X
cancer B-X
are B-X
located B-X
here B-X
. B-X
This B-X
report B-X
describes B-X
incidence B-X
of B-X
prostate B-X
cancer B-X
in B-X
the B-X
United B-X
States B-X
. B-X
The B-X
most B-X
common B-X
type B-X
of B-X
cancer B-X
in B-X
the B-X
United B-X
States B-X
in B-X
men B-X
and B-X
women B-X
depends B-X
on B-X
whether B-X
you B-X
are B-X
talking B-X
about B-X
diagnoses B-X
or B-X
deaths B-X
. B-X
Let B-X
's B-X
look B-X
at B-X
numbers B-X
The B-X
latest B-X
federal B-X
data B-X
on B-X
prostate B-X
cancer B-X
cases B-X
and B-X
deaths B-X
. B-X
PROSTATE B-X
CANCER B-X
: B-X
THE B-X
SECOND B-X
LEADING B-X
CAUSE B-X
OF B-X
CANCER B-X
DEATH B-X
IN B-X
MEN B-X
The B-X
death B-X
rate B-X
from B-X
cancer B-X
in B-X
the B-X
US B-X
has B-X
declined B-X
steadily B-X
over B-X
the B-X
past B-X
25 B-X
years B-X
, B-X
according B-X
to B-X
annual B-X
statistics B-X
reporting B-X
from B-X
the B-X
American B-X
Cancer B-X
Society B-X
. B-X
Cancer B-X
death B-X
rates B-X
in B-X
the B-X
U.S. B-X
dropped B-X
26 B-X
% B-X
over B-X
20 B-X
years B-X
. B-X

Yet	O
,	O
despite	O
a	O
large	O
international	O
effort	O
,	O
little	O
is	O
known	O
about	O
the	O
molecular	O
mechanisms	O
that	O
underlie	O
this	O
devastating	O
disease	O
.	O
<EOS> B-X
The B-X
ASAP B-X
initiative B-X
will B-X
incentivize B-X
collaboration B-X
between B-X
researchers B-X
and B-X
encourage B-X
open-science B-X
practices B-X
to B-X
improve B-X
our B-X
understanding B-X
of B-X
the B-X
biology B-X
underlying B-X
Parkinson B-X
's B-X
disease B-X
. B-X
Understanding B-X
the B-X
Cellular B-X
and B-X
Molecular B-X
Mechanisms B-X
of B-X
Physical B-X
Activity-Induced B-X
Health B-X
Benefits B-X
- B-X
ScienceDirect B-X
Parkinson B-X
‚Äô B-X
s B-X
Disease B-X
Molecular B-X
and B-X
cellular B-X
mechanisms B-X
underlying B-X
mood B-X
stabilization B-X
in B-X
bipolar B-X
disorder B-X
: B-X
implications B-X
for B-X
the B-X
development B-X
of B-X
improved B-X
therapeutics B-X
| B-X
Molecular B-X
Psychiatry B-X
Grey B-X
mould B-X
of B-X
strawberry B-X
, B-X
a B-X
devastating B-X
disease B-X
caused B-X
by B-X
the B-X
ubiquitous B-X
necrotrophic B-X
fungal B-X
pathogen B-X
Botrytis B-X
cinerea B-X
Experiences B-X
, B-X
whether B-X
they B-X
be B-X
learning B-X
in B-X
a B-X
classroom B-X
, B-X
a B-X
stressful B-X
event B-X
, B-X
or B-X
ingestion B-X
of B-X
a B-X
psychoactive B-X
substance B-X
, B-X
impact B-X
the B-X
brain B-X
by B-X
modifying B-X
the B-X
activity B-X
and B-X
organization B-X
To B-X
have B-X
a B-X
rare B-X
disease B-X
is B-X
often B-X
to B-X
have B-X
a B-X
condition B-X
that B-X
goes B-X
undiagnosed B-X
for B-X
years B-X
while B-X
concerned B-X
physicians B-X
who B-X
have B-X
never B-X
seen B-X
the B-X
condition B-X
before B-X
may B-X
offer B-X
one B-X
diagnosis B-X

Prostate	O
secretory	O
epithelial	O
cells	O
and	O
androgen	O
-	O
dependent	O
prostate	B-Disease
carcinomas	I-Disease
undergo	O
apoptosis	O
in	O
response	O
to	O
androgen	O
deprivation	O
and	O
,	O
furthermore	O
,	O
most	O
prostate	B-Disease
carcinomas	I-Disease
become	O
androgen	O
independent	O
and	O
refractory	O
to	O
further	O
therapeutic	O
manipulations	O
during	O
disease	O
progression	O
.	O
<EOS> B-X
Prostate B-X
cancer B-X
is B-X
the B-X
second B-X
leading B-X
cause B-X
of B-X
male B-X
cancer B-X
deaths B-X
in B-X
the B-X
United B-X
States B-X
. B-X
Yet B-X
, B-X
despite B-X
a B-X
large B-X
international B-X
effort B-X
, B-X
little B-X
is B-X
known B-X
about B-X
the B-X
molecular B-X
Prostate B-X
cancer B-X
progression B-X
after B-X
androgen B-X
deprivation B-X
therapy B-X
: B-X
mechanisms B-X
of B-X
castrate-resistance B-X
and B-X
novel B-X
therapeutic B-X
approaches B-X
Prostate B-X
cancer B-X
is B-X
the B-X
second B-X
leading B-X
cause B-X
of B-X
male B-X
cancer B-X
deaths B-X
in B-X
the B-X
United B-X
States B-X
. B-X
Yet B-X
, B-X
despite B-X
a B-X
large B-X
international B-X
effort B-X
, B-X
little B-X
is B-X
known B-X
about B-X
the B-X
molecular B-X
Mechanisms B-X
involved B-X
in B-X
the B-X
progression B-X
of B-X
androgen-independent B-X
prostate B-X
cancers B-X
: B-X
it B-X
is B-X
not B-X
only B-X
the B-X
cancer B-X
cell B-X
‚Äô B-X
s B-X
fault B-X
Characterisation B-X
of B-X
human B-X
prostate B-X
epithelial B-X
progenitor B-X
differentiation B-X
in B-X
response B-X
to B-X
androgens B-X
Pathogenesis B-X
of B-X
prostate B-X
cancer B-X
and B-X
hormone B-X
refractory B-X
prostate B-X
cancer B-X
Prostate B-X
cancer B-X
represents B-X
a B-X
major B-X
health B-X
problem B-X
in B-X
men B-X
worldwide B-X
. B-X
Androgens B-X
are B-X
required B-X
for B-X
the B-X
growth B-X
and B-X
maintenance B-X
of B-X
the B-X
prostate B-X
. B-X
Androgens B-X
act B-X
by B-X

Definition	O
of	O
the	O
genetic	O
events	O
that	O
trigger	O
apoptosis	O
in	O
the	O
prostate	O
could	O
provide	O
important	O
insights	O
into	O
critical	O
pathways	O
in	O
normal	O
development	O
as	O
well	O
as	O
elucidate	O
the	O
perturbations	O
of	O
those	O
key	O
pathways	O
in	O
neoplastic	O
transformation	O
.	O
<EOS> B-X
Broad B-X
targeting B-X
of B-X
resistance B-X
to B-X
apoptosis B-X
in B-X
cancer B-X
- B-X
ScienceDirect B-X
The B-X
BCL-2 B-X
family B-X
: B-X
key B-X
mediators B-X
of B-X
the B-X
apoptotic B-X
response B-X
to B-X
targeted B-X
anti-cancer B-X
therapeutics B-X
The B-X
molecular B-X
and B-X
cellular B-X
origin B-X
of B-X
human B-X
prostate B-X
cancer B-X
- B-X
ScienceDirect B-X
Oncogenes B-X
in B-X
Cell B-X
Survival B-X
and B-X
Cell B-X
Death B-X
Over B-X
the B-X
past B-X
decade B-X
, B-X
the B-X
Nomenclature B-X
Committee B-X
on B-X
Cell B-X
Death B-X
( B-X
NCCD B-X
) B-X
has B-X
formulated B-X
guidelines B-X
for B-X
the B-X
definition B-X
and B-X
interpretation B-X
of B-X
cell B-X
death B-X
from B-X
morphological B-X
, B-X
biochemical B-X
, B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

We	O
report	O
the	O
functional	O
definition	O
of	O
a	O
novel	O
genetic	O
locus	O
within	O
human	O
chromosome	O
10pter	O
-	O
q11	O
that	O
mediates	O
both	O
in	O
vivo	O
tumor	O
suppression	O
and	O
in	O
vitro	O
apoptosis	O
of	O
prostatic	B-Disease
adenocarcinoma	I-Disease
cells	O
.	O
<EOS> B-X
Download B-X
Citation B-X
| B-X
Definitive B-X
functional B-X
evidence B-X
for B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
on B-X
human B-X
chromosome B-X
7q31.1 B-X
neighboring B-X
the B-X
Fra7G B-X
site B-X
| B-X
We B-X
have B-X
previously B-X
shown B-X
that B-X
loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
Request B-X
PDF B-X
| B-X
Functional B-X
evidence B-X
for B-X
the B-X
presence B-X
of B-X
tumor B-X
suppressor B-X
gene B-X
on B-X
chromosome B-X
10p15 B-X
in B-X
human B-X
prostate B-X
cancers B-X
| B-X
Loss B-X
of B-X
heterozygosity B-X
on B-X
chromosome B-X
10p B-X
was B-X
observed B-X
frequently B-X
in B-X
Download B-X
Citation B-X
| B-X
Identification B-X
of B-X
a B-X
Gene B-X
on B-X
Chromosome B-X
18q21 B-X
Involved B-X
in B-X
Suppressing B-X
Metastatic B-X
Prostate B-X
Cancer B-X
| B-X
In B-X
metastatic B-X
prostate B-X
cancer B-X
there B-X
is B-X
increased B-X
frequency B-X
of B-X
loss B-X
of B-X
genetic B-X
material B-X
ÂåÖÂê´ËÆ∏Â§öÁøªËØëÁ§∫‰æãÊåâÊ¥ªÂä®ÂàÜÁ±ª B-X
‚Äú B-X
locus B-X
‚Äù B-X
‚Äì B-X
Ëã±ËØ≠-‰∏≠Êñá B-X
Â≠óÂÖ∏ÂíåÊô∫ËÉΩÁøªËØëÂä©Êâã„ÄÇ B-X

A	O
defined	O
fragment	O
of	O
human	O
chromosome	O
10	O
was	O
transferred	O
via	O
microcell	O
fusion	O
into	O
a	O
prostate	B-Disease
adenocarcinoma	I-Disease
cell	O
line	O
.	O
<EOS> B-X
PDF B-X
| B-X
On B-X
Feb B-X
3 B-X
, B-X
2012 B-X
, B-X
Hong B-X
Lok B-X
Lung B-X
and B-X
others B-X
published B-X
Identification B-X
of B-X
Tumor B-X
Suppressor B-X
Genes B-X
via B-X
Cell B-X
Fusion B-X
and B-X
Chromosomal B-X
Transfer B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
PDF B-X
| B-X
Microcell-mediated B-X
chromosome B-X
transfer B-X
( B-X
MMCT B-X
) B-X
was B-X
a B-X
technique B-X
originally B-X
developed B-X
in B-X
the B-X
1970s B-X
to B-X
transfer B-X
exogenous B-X
chromosome B-X
material B-X
into B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X

Microcell	O
hybrids	O
containing	O
only	O
the	O
region	O
10pter	O
-	O
q11	O
were	O
suppressed	O
for	O
tumorigenicity	O
following	O
injection	O
of	O
microcell	O
hybrids	O
into	O
nude	O
mice	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
The B-X
human B-X
Y B-X
chromosome B-X
suppresses B-X
the B-X
tumorigenicity B-X
of B-X
PC-3 B-X
, B-X
a B-X
human B-X
prostate B-X
cancer B-X
cell B-X
line B-X
, B-X
in B-X
athymic B-X
nude B-X
mice B-X
| B-X
The B-X
loss B-X
of B-X
the B-X
Y B-X
Loss B-X
of B-X
heterozygosity B-X
on B-X
chromosome B-X
10p B-X
was B-X
observed B-X
frequently B-X
in B-X
human B-X
prostate B-X
cancers B-X
. B-X
Studies B-X
have B-X
demonstrated B-X
that B-X
the B-X
introduction B-X
of B-X
the B-X
short B-X
arm B-X
of B-X
human B-X
chromosome B-X
10 B-X
into B-X
a B-X
Loss B-X
of B-X
heterozygosity B-X
on B-X
chromosome B-X
10p B-X
was B-X
observed B-X
frequently B-X
in B-X
human B-X
prostate B-X
cancers B-X
. B-X
Studies B-X
have B-X
demonstrated B-X
that B-X
the B-X
introduction B-X
of B-X
the B-X
short B-X
arm B-X
of B-X
human B-X
chromosome B-X
10 B-X
into B-X
a B-X
Request B-X
PDF B-X
| B-X
Construction B-X
of B-X
human-rodent B-X
hybrid B-X
cells B-X
containing B-X
single B-X
transferable B-X
fragments B-X
of B-X
human B-X
chromosome B-X
10p B-X
| B-X
The B-X
introduction B-X
of B-X
chromosome B-X
10p B-X
into B-X
human B-X
glioblastoma B-X
or B-X
prostate B-X
cancer B-X
cells B-X
has B-X
The B-X
Chromosome B-X
10 B-X
Monosomy B-X
Common B-X
in B-X
Human B-X
Melanomas B-X
Results B-X
from B-X
the B-X
Loss B-X
of B-X
Two B-X
Separate B-X
Tumor B-X
Suppressor B-X
Loci B-X
| B-X
Cancer B-X
Research B-X

Furthermore	O
,	O
the	O
complemented	O
hybrids	O
undergo	O
programmed	O
cell	O
death	O
in	O
vitro	O
via	O
a	O
mechanism	O
that	O
does	O
not	O
require	O
nuclear	O
localization	O
of	O
p53	O
.	O
<EOS> B-X
PDF B-X
| B-X
The B-X
p53 B-X
tumor B-X
suppressor B-X
protein B-X
plays B-X
a B-X
central B-X
role B-X
in B-X
maintaining B-X
genomic B-X
integrity B-X
. B-X
It B-X
does B-X
so B-X
by B-X
occupying B-X
a B-X
nodal B-X
point B-X
in B-X
the B-X
DNA B-X
damage B-X
... B-X
| B-X
The B-X
Roles B-X
of B-X
p53 B-X
in B-X
Mitochondrial B-X
Dynamics B-X
and B-X
Cancer B-X
Metabolism B-X
: B-X
The B-X
Pendulum B-X
between B-X
Survival B-X
and B-X
Death B-X
in B-X
Breast B-X
Cancer B-X
? B-X
Request B-X
PDF B-X
| B-X
The B-X
cell B-X
death B-X
machinery B-X
governed B-X
by B-X
the B-X
p53 B-X
tumor B-X
suppressor B-X
in B-X
response B-X
to B-X
DNA B-X
damage B-X
| B-X
The B-X
cellular B-X
response B-X
to B-X
genotoxic B-X
stress B-X
that B-X
damages B-X
DNA B-X
includes B-X
cell B-X
Neuronal B-X
Cell B-X
Death B-X
Request B-X
PDF B-X
| B-X
Oren B-X
, B-X
M. B-X
Decision B-X
making B-X
by B-X
p53 B-X
: B-X
life B-X
, B-X
death B-X
and B-X
cancer B-X
. B-X
Cell B-X
Death B-X
Differ B-X
. B-X
4 B-X
, B-X
431-442 B-X
| B-X
The B-X
p53 B-X
tumor-suppressor B-X
plays B-X
a B-X
Viruses B-X
and B-X
apoptosis B-X
p53 B-X

These	O
data	O
functionally	O
define	O
a	O
novel	O
genetic	O
locus	O
,	O
designated	O
PAC1	O
,	O
for	O
prostate	O
adenocarcinoma	O
1	O
,	O
involved	O
in	O
tumor	O
suppression	O
of	O
human	O
prostate	B-Disease
carcinoma	I-Disease
and	O
furthermore	O
strongly	O
suggest	O
that	O
the	O
cell	O
death	O
pathway	O
can	O
be	O
functionally	O
restored	O
in	O
prostatic	B-Disease
adenocarcinoma	I-Disease
.	O
.	O
<EOS> B-X
Novel B-X
genetic B-X
loci B-X
affecting B-X
facial B-X
shape B-X
variation B-X
in B-X
humans B-X
Molecular B-X
genetics B-X
of B-X
prostate B-X
cancer B-X
: B-X
new B-X
prospects B-X
for B-X
old B-X
challenges B-X
Tumor B-X
associated B-X
macrophages B-X
( B-X
TAM B-X
) B-X
influence B-X
diverse B-X
processes B-X
such B-X
as B-X
angiogenesis B-X
, B-X
tumor B-X
cell B-X
proliferation B-X
, B-X
and B-X
metastasis B-X
during B-X
tumor B-X
progression B-X
. B-X
In B-X
a B-X
variety B-X
of B-X
tumor B-X
types B-X
, B-X
Apoptosis B-X
Evasion B-X
: B-X
The B-X
Role B-X
of B-X
Survival B-X
Pathways B-X
in B-X
Prostate B-X
Cancer B-X
Progression B-X
and B-X
Therapeutic B-X
Resistance B-X
Genetics B-X
and B-X
biology B-X
of B-X
prostate B-X
cancer B-X
Proceedings B-X
of B-X
International B-X
Conference B-X
on B-X
Cell B-X
Death B-X
in B-X
Cancer B-X
and B-X
Toxicology B-X
Prostate B-X
cancer B-X
is B-X
the B-X
most B-X
common B-X
cancer B-X
in B-X
men B-X
and B-X
the B-X
second B-X
most B-X
common B-X
cause B-X
of B-X
cancer-related B-X
deaths B-X
in B-X
men B-X
. B-X
Although B-X
, B-X
various B-X
drugs B-X
targeting B-X
the B-X
androgen B-X
receptor B-X
are B-X

Low	O
incidence	O
of	O
BRCA2	O
mutations	O
in	O
breast	B-Disease
carcinoma	I-Disease
and	O
other	O
cancers	B-Disease
.	O
<EOS> B-X
Low B-X
incidence B-X
of B-X
BRCA2 B-X
mutations B-X
in B-X
breast B-X
carcinoma B-X
and B-X
other B-X
cancers B-X
| B-X
Amplicon B-X
Express B-X
A B-X
systematic B-X
review B-X
of B-X
the B-X
international B-X
prevalence B-X
of B-X
BRCA B-X
mutation B-X
in B-X
breast B-X
cancer B-X
Prevalance B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
familial B-X
breast B-X
cancer B-X
patients B-X
in B-X
Lebanon B-X
Prevalence B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
non-familial B-X
breast B-X
cancer B-X
patients B-X
with B-X
high B-X
risks B-X
in B-X
Korea B-X
: B-X
The B-X
Korean B-X
Hereditary B-X
Breast B-X
Cancer B-X
( B-X
KOHBRA B-X
) B-X
Study B-X
Cancers B-X
Associated B-X
with B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Mutations B-X
other B-X
than B-X
Breast B-X
and B-X
Ovarian B-X
The B-X
true B-X
prevalence B-X
of B-X
BRCA1/BRCA2 B-X
( B-X
BRCAs B-X
) B-X
germline B-X
mutations B-X
in B-X
sporadic B-X
breast B-X
or B-X
ovarian B-X
cancer B-X
( B-X
SBC/SOC B-X
) B-X
in B-X
Caucasian B-X
population B-X
is B-X
not B-X
well B-X
established B-X
. B-X
The B-X
aim B-X
of B-X
PDF B-X
| B-X
Inherited B-X
mutant B-X
alleles B-X
of B-X
familial B-X
tumour B-X
suppressor B-X
genes B-X
predispose B-X
individuals B-X
to B-X
particular B-X
types B-X
of B-X
cancer B-X
. B-X
In B-X
addition B-X
to B-X
an B-X
involvement B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X

Inherited	O
mutant	O
alleles	O
of	O
familial	O
tumour	B-Disease
suppressor	O
genes	O
predispose	O
individuals	O
to	O
particular	O
types	O
of	O
cancer	B-Disease
.	O
<EOS> B-X
This B-X
post B-X
describes B-X
how B-X
mutations B-X
in B-X
proto-oncogenes B-X
and B-X
tumor B-X
suppressor B-X
genes B-X
account B-X
for B-X
tumorigenesis B-X
. B-X
Inherited B-X
predisposition B-X
to B-X
cancer B-X
- B-X
ScienceDirect B-X
Realising B-X
the B-X
Promise B-X
of B-X
Cancer B-X
Predisposition B-X
Genes B-X

In	O
addition	O
to	O
an	O
involvement	O
in	O
inherited	O
susceptibility	O
to	O
cancer	B-Disease
,	O
these	O
tumour	B-Disease
suppressor	O
genes	O
are	O
targets	O
for	O
somatic	O
mutations	O
in	O
sporadic	B-Disease
cancers	I-Disease
of	O
the	O
same	O
type	O
found	O
in	O
the	O
familial	O
forms	O
.	O
<EOS> B-X
Tumor-suppressor B-X
genes B-X
: B-X
cardinal B-X
factors B-X
in B-X
inherited B-X
predisposition B-X
to B-X
human B-X
cancers B-X
. B-X
Genetic B-X
Susceptibility B-X
to B-X
Cancer B-X
: B-X
the B-X
Role B-X
of B-X
Polymorphisms B-X
in B-X
Candidate B-X
Genes B-X
It B-X
seems B-X
that B-X
strong B-X
and B-X
novel B-X
genetic B-X
causes B-X
of B-X
hereditary B-X
colorectal B-X
cancer B-X
are B-X
responsible B-X
for B-X
a B-X
high B-X
proportion B-X
of B-X
colorectal B-X
cancer B-X
in B-X
this B-X
population B-X
. B-X
Conditions B-X
are B-X
suitable B-X
for B-X
the B-X
Cancerarises B-X
as B-X
the B-X
result B-X
of B-X
an B-X
accumulation B-X
of B-X
inherited B-X
and B-X
somatic B-X
mutations B-X
in B-X
cancer‚Äêcritical B-X
genes B-X
. B-X
These B-X
genes B-X
can B-X
be B-X
divided B-X
in B-X
two B-X
broad B-X
classes B-X
, B-X
depending B-X
on B-X
whether B-X
the B-X
Mutations B-X
in B-X
the B-X
recognized B-X
breast B-X
cancer B-X
susceptibility B-X
genes B-X
BRCA1 B-X
, B-X
BRCA2 B-X
, B-X
TP53 B-X
, B-X
ATM B-X
, B-X
and B-X
CHEK2 B-X
account B-X
for B-X
approximately B-X
20 B-X
% B-X
of B-X
hereditary B-X
breast B-X
cancer B-X
. B-X
This B-X
raises B-X
Lung B-X
cancer B-X
is B-X
the B-X
leading B-X
cause B-X
of B-X
cancer B-X
death B-X
worldwide B-X
, B-X
and B-X
cigarette B-X
smoking B-X
is B-X
the B-X
major B-X
environmental B-X
factor B-X
for B-X
its B-X
development B-X
. B-X
To B-X
elucidate B-X
the B-X
genetic B-X
differences B-X
in B-X
the B-X
Genetic B-X
Susceptibility B-X
to B-X
Triple B-X
Negative B-X
Breast B-X
Cancer B-X

An	O
exception	O
is	O
BRCA1	O
,	O
which	O
contributes	O
to	O
a	O
significant	O
fraction	O
of	O
familial	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
,	O
but	O
undergoes	O
mutation	O
at	O
very	O
low	O
rates	O
in	O
sporadic	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancers	I-Disease
.	O
<EOS> B-X
Molecular B-X
classification B-X
of B-X
familial B-X
non-BRCA1/BRCA2 B-X
breast B-X
cancer B-X
| B-X
PNAS B-X
Advances B-X
in B-X
Breast B-X
Cancer B-X
: B-X
Pathways B-X
to B-X
Personalized B-X
Medicine B-X
Impact B-X
of B-X
Prophylactic B-X
Mastectomy B-X
in B-X
BRCA1/2 B-X
Mutation B-X
Carriers B-X
Ovarian B-X
Cancer B-X
: B-X
The B-X
Fallopian B-X
Tube B-X
as B-X
the B-X
Site B-X
of B-X
Origin B-X
and B-X
Opportunities B-X
for B-X
Prevention B-X

This	O
finding	O
suggests	O
that	O
other	O
genes	O
may	O
be	O
the	O
principal	O
targets	O
for	O
somatic	O
mutation	O
in	O
breast	B-Disease
carcinoma	I-Disease
.	O
<EOS> B-X
Somatic B-X
mutations B-X
and B-X
copy B-X
number B-X
changes B-X
in B-X
cancer B-X
: B-X
finding B-X
the B-X
right B-X
targets B-X
The B-X
somatic B-X
mutation B-X
profiles B-X
of B-X
2,433 B-X
breast B-X
cancers B-X
refines B-X
their B-X
genomic B-X
and B-X
transcriptomic B-X
landscapes B-X
Targeted B-X
next B-X
generation B-X
sequencing B-X
identifies B-X
somatic B-X
mutations B-X
in B-X
a B-X
cohort B-X
of B-X
Egyptian B-X
breast B-X
cancer B-X
patients B-X
- B-X
ScienceDirect B-X
Integrating B-X
Germline B-X
and B-X
Somatic B-X
Mutation B-X
Information B-X
for B-X
the B-X
Discovery B-X
of B-X
Biomarkers B-X
in B-X
Triple-Negative B-X
Breast B-X
Cancer B-X
The B-X
Genomic B-X
Landscape B-X
of B-X
Breast B-X
Cancer B-X
as B-X
a B-X
Therapeutic B-X
Roadmap B-X
It B-X
is B-X
particularly B-X
important B-X
to B-X
provide B-X
precise B-X
therapies B-X
and B-X
understand B-X
tumor B-X
heterogeneity B-X
based B-X
on B-X
the B-X
molecular B-X
typing B-X
of B-X
mutational B-X
landscape B-X
. B-X
However B-X
, B-X
the B-X
landscape B-X
of B-X
somatic B-X
mutations B-X
in B-X
different B-X
The B-X
cancer B-X
genome B-X

A	O
second	O
,	O
recently	O
identified	O
familial	B-Disease
breast	I-Disease
cancer	I-Disease
gene	O
,	O
BRCA2	O
(	O
refs	O
5	O
-	O
8	O
)	O
,	O
accounts	O
for	O
a	O
proportion	O
of	O
breast	B-Disease
cancer	I-Disease
roughly	O
equal	O
to	O
BRCA1	O
.	O
<EOS> B-X
Prevalence B-X
and B-X
impact B-X
of B-X
founder B-X
mutations B-X
in B-X
hereditary B-X
breast B-X
cancer B-X
in B-X
Latin B-X
America B-X
BRCA2 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Germline B-X
BRCA B-X
mutation B-X
and B-X
outcome B-X
in B-X
young-onset B-X
breast B-X
cancer B-X
( B-X
POSH B-X
) B-X
: B-X
a B-X
prospective B-X
cohort B-X
study B-X
- B-X
The B-X
Lancet B-X
Oncology B-X

Like	O
BRCA1	O
,	O
BRCA2	O
behaves	O
as	O
a	O
dominantly	O
inherited	O
tumour	B-Disease
suppressor	O
gene	O
.	O
<EOS> B-X
The B-X
breast B-X
cancer B-X
susceptibility B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
are B-X
classic B-X
tumor B-X
suppressor B-X
genes B-X
that B-X
exhibit B-X
an B-X
autosomal B-X
dominant B-X
pattern B-X
of B-X
inheritance B-X
with B-X
high B-X
penetrance B-X
. B-X
BRCA B-X
carriers B-X
inherit B-X
one B-X
mutant B-X
Low B-X
incidence B-X
of B-X
BRCA2 B-X
mutations B-X
in B-X
breast B-X
carcinoma B-X
and B-X
other B-X
cancers B-X
. B-X
Low B-X
incidence B-X
of B-X
BRCA2 B-X
mutations B-X
in B-X
breast B-X
carcinoma B-X
and B-X
other B-X
cancers B-X
. B-X
Targeting B-X
Tumor B-X
Suppressor B-X
Networks B-X
for B-X
Cancer B-X
Therapeutics B-X

Individuals	O
who	O
inherit	O
one	O
mutant	O
allele	O
are	O
at	O
increased	O
risk	O
for	O
breast	B-Disease
cancer	I-Disease
,	O
and	O
the	O
tumours	B-Disease
they	O
develop	O
lose	O
the	O
wild	O
-	O
type	O
allele	O
by	O
heterozygous	O
deletion	O
.	O
<EOS> B-X
We B-X
reaffirm B-X
that B-X
p53 B-X
function B-X
is B-X
not B-X
required B-X
for B-X
normal B-X
mouse B-X
development B-X
and B-X
conclude B-X
that B-X
p53 B-X
status B-X
can B-X
strongly B-X
influence B-X
tumor B-X
latency B-X
and B-X
tissue B-X
distribution B-X
. B-X
Accelerated B-X
geroncogenesis B-X
in B-X
hereditary B-X
breast-ovarian B-X
cancer B-X
syndrome B-X
Brain B-X
Tumor B-X
Susceptibility B-X
: B-X
the B-X
Role B-X
of B-X
Genetic B-X
Factors B-X
and B-X
Uses B-X
of B-X
Mouse B-X
Models B-X
to B-X
Unravel B-X
Risk B-X
X-linked B-X
Tumor B-X
Suppressors B-X
: B-X
Perplexing B-X
Inheritance B-X
, B-X
a B-X
unique B-X
Therapeutic B-X
Opportunity B-X
Haploinsufficiency B-X
for B-X
Tumor B-X
Suppression B-X

The	O
BRCA2	O
coding	O
sequence	O
is	O
huge	O
,	O
composed	O
of	O
26	O
exons	O
that	O
span	O
10	O
,	O
443	O
bp	O
.	O
<EOS> B-X
Functional B-X
Classification B-X
of B-X
BRCA2 B-X
DNA B-X
Variants B-X
by B-X
Splicing B-X
Assays B-X
in B-X
a B-X
Large B-X
Minigene B-X
with B-X
9 B-X
Exons B-X
protein-coding B-X
exon B-X
ii B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
BRCA1 B-X
Gene B-X
Mutations B-X
in B-X
Breast B-X
Cancer B-X
Patients B-X
from B-X
Kerman B-X
Province B-X
, B-X
Iran B-X
This B-X
executive B-X
summary B-X
reviews B-X
the B-X
topics B-X
covered B-X
in B-X
the B-X
PDQ B-X
summary B-X
on B-X
the B-X
genetics B-X
of B-X
colorectal B-X
cancer B-X
( B-X
CRC B-X
) B-X
, B-X
with B-X
hyperlinks B-X
to B-X
detailed B-X
sections B-X
below B-X
that B-X
describe B-X
the B-X

Here	O
we	O
investigate	O
the	O
rate	O
of	O
BRCA2	O
mutation	O
in	O
sporadic	B-Disease
breast	I-Disease
cancers	I-Disease
and	O
in	O
a	O
set	O
of	O
cell	O
lines	O
that	O
represent	O
twelve	O
other	O
tumour	B-Disease
types	O
.	O
<EOS> B-X
Genomic B-X
and B-X
phenotypic B-X
analysis B-X
of B-X
BRCA2 B-X
mutated B-X
breast B-X
cancers B-X
reveals B-X
co-occurring B-X
changes B-X
linked B-X
to B-X
progression B-X
Targeting B-X
BRCA B-X
Deficiency B-X
in B-X
Breast B-X
Cancer B-X
: B-X
What B-X
are B-X
the B-X
Clinical B-X
Evidences B-X
and B-X
the B-X
Next B-X
Perspectives B-X
? B-X

Surprisingly	O
,	O
mutations	O
in	O
BRCA2	O
are	O
infrequent	O
in	O
cancers	B-Disease
including	O
breast	B-Disease
carcinoma	I-Disease
.	O
<EOS> B-X
An B-X
immune-centric B-X
exploration B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
germline B-X
mutation B-X
related B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
Minor B-X
role B-X
of B-X
BRCA2 B-X
mutation B-X
( B-X
Exon2 B-X
and B-X
Exon11 B-X
) B-X
in B-X
patients B-X
with B-X
early-onset B-X
breast B-X
cancer B-X
amongst B-X
Iranian B-X
Azeri-Turkish B-X
women B-X
Infrequent B-X
Mutation B-X
in B-X
the B-X
BRCA2 B-X
Gene B-X
in B-X
Esophageal B-X
Squamous B-X
Cell B-X
Carcinoma B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Immunohistochemical B-X
Characteristics B-X
Defined B-X
by B-X
Tissue B-X
Microarray B-X
of B-X
Hereditary B-X
Breast B-X
Cancer B-X
Not B-X
Attributable B-X
to B-X
BRCA1 B-X
or B-X
BRCA2 B-X
Mutations B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Inherited B-X
mutant B-X
alleles B-X
of B-X
familial B-X
tumour B-X
suppressor B-X
genes B-X
predispose B-X
individuals B-X
to B-X
particular B-X
types B-X
of B-X
cancer B-X
. B-X
In B-X
addition B-X
to B-X
an B-X
involvement B-X
in B-X
inherited B-X
susceptibility B-X
to B-X
cancer B-X
, B-X
these B-X
tumour B-X
suppressor B-X
Our B-X
findings B-X
, B-X
using B-X
the B-X
largest B-X
gene B-X
panel B-X
for B-X
MBC B-X
patients B-X
so B-X
far B-X
, B-X
indicate B-X
that B-X
BRCA B-X
testing B-X
should B-X
be B-X
the B-X
primary B-X
concern B-X
for B-X
MBC B-X
patients B-X
. B-X
Until B-X
sufficient B-X
evidence B-X
Inherited B-X
mutant B-X
alleles B-X
of B-X
familial B-X
tumour B-X
suppressor B-X
genes B-X
predispose B-X
individuals B-X
to B-X
particular B-X
types B-X
of B-X
cancer B-X
. B-X
In B-X
addition B-X
to B-X
an B-X
involvement B-X
in B-X
inherited B-X
susceptibility B-X
to B-X
cancer B-X
, B-X
these B-X
tumour B-X
suppressor B-X

However	O
,	O
a	O
probable	O
germline	O
mutation	O
in	O
a	O
pancreatic	B-Disease
tumour	I-Disease
cell	O
line	O
suggests	O
a	O
role	O
for	O
BRCA2	O
in	O
susceptibility	O
to	O
pancreatic	B-Disease
cancer	I-Disease
.	O
.	O
<EOS> B-X
Absence B-X
of B-X
germline B-X
BRCA1 B-X
mutations B-X
in B-X
Familial B-X
Pancreatic B-X
Cancer B-X
Patients B-X
The B-X
Role B-X
of B-X
BRCA2 B-X
Mutation B-X
Status B-X
as B-X
Diagnostic B-X
, B-X
Predictive B-X
, B-X
and B-X
Prognosis B-X
Biomarker B-X
for B-X
Pancreatic B-X
Cancer B-X
Inherited B-X
Predisposition B-X
to B-X
Pancreatic B-X
Adenocarcinoma B-X
: B-X
Role B-X
of B-X
Family B-X
History B-X
and B-X
Germ-Line B-X
p16 B-X
, B-X
BRCA1 B-X
, B-X
and B-X
BRCA2 B-X
Mutations B-X
| B-X
Cancer B-X
Research B-X
Genetic B-X
determinants B-X
and B-X
potential B-X
therapeutic B-X
targets B-X
for B-X
pancreatic B-X
adenocarcinoma B-X
Germline B-X
Variants B-X
and B-X
Risk B-X
for B-X
Pancreatic B-X
Cancer B-X
: B-X
A B-X
Systematic B-X
Review B-X
and B-X
Emerging B-X
Concepts B-X
Pancreatic B-X
ductal B-X
adenocarcinoma B-X
in B-X
BRCA2 B-X
mutation B-X
carriers B-X
in B-X
: B-X
Endocrine-Related B-X
Cancer B-X
Volume B-X
23 B-X
Issue B-X
10 B-X
( B-X
2016 B-X
) B-X
Mutations B-X
in B-X
genes B-X
of B-X
the B-X
breast B-X
cancer B-X
susceptibility B-X
gene B-X
( B-X
BRCA B-X
) B-X
pathway B-X
, B-X
namely B-X
, B-X
BRCA1 B-X
, B-X
BRCA2 B-X
, B-X
and B-X
PALB2 B-X
, B-X
can B-X
provide B-X
useful B-X
information B-X
for B-X
the B-X
efficacy B-X

Founding	O
BRCA1	O
mutations	O
in	O
hereditary	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
in	O
southern	O
Sweden	O
.	O
<EOS> B-X
Founding B-X
BRCA1 B-X
Mutations B-X
in B-X
Hereditary B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
in B-X
Southern B-X
Sweden B-X
- B-X
Lund B-X
University B-X
Founding B-X
BRCA1 B-X
Mutations B-X
in B-X
Hereditary B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
in B-X
Southern B-X
Sweden B-X
- B-X
Research B-X
Outputs B-X
- B-X
Lund B-X
University B-X
The B-X
most B-X
recurrent B-X
BRCA1/BRCA2 B-X
mutation B-X
in B-X
Sweden B-X
is B-X
the B-X
BRCA1 B-X
mutation B-X
3171ins5 B-X
. B-X
In B-X
the B-X
western B-X
part B-X
of B-X
Sweden B-X
this B-X
mutation B-X
accounts B-X
for B-X
as B-X
much B-X
as B-X
77 B-X
% B-X
of B-X
identified B-X

Nine	O
different	O
germ	O
-	O
line	O
mutations	O
in	O
the	O
BRCA1	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
susceptibility	O
gene	O
were	O
identified	O
in	O
15	O
of	O
47	O
kindreds	O
from	O
southern	O
Sweden	O
,	O
by	O
use	O
of	O
SSCP	O
and	O
heteroduplex	O
analysis	O
of	O
all	O
exons	O
and	O
flanking	O
intron	O
region	O
and	O
by	O
a	O
protein	O
-	O
truncation	O
test	O
for	O
exon	O
11	O
,	O
followed	O
by	O
direct	O
sequencing	O
.	O
<EOS> B-X
Nine B-X
different B-X
germ-line B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
were B-X
identified B-X
in B-X
15 B-X
of B-X
47 B-X
kindreds B-X
from B-X
southern B-X
Sweden B-X
, B-X
by B-X
use B-X
of B-X
SSCP B-X
and B-X
heteroduplex B-X
Founding B-X
BRCA1 B-X
Mutations B-X
in B-X
Hereditary B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
in B-X
Southern B-X
Sweden B-X
- B-X
Lund B-X
University B-X
Abstract B-X
. B-X
The B-X
recent B-X
identification B-X
of B-X
major B-X
genomic B-X
rearrangements B-X
in B-X
breast B-X
and B-X
breast/ovarian B-X
cancer B-X
families B-X
has B-X
widened B-X
the B-X
mutational B-X
spectrum B-X
of B-X
the B-X
BRCA B-X
Abstract B-X
. B-X
Germ-line B-X
mutations B-X
of B-X
the B-X
TSC2 B-X
tumour B-X
suppressor B-X
gene B-X
have B-X
been B-X
identified B-X
in B-X
humans B-X
with B-X
tuberous B-X
sclerosis B-X
and B-X
in B-X
the B-X
Eker B-X
rat B-X
. B-X
Tuberin B-X
, B-X
the B-X
human B-X
A B-X
variety B-X
of B-X
reasons B-X
related B-X
to B-X
the B-X
HLA B-X
class B-X
I B-X
system B-X
has B-X
complicated B-X
the B-X
application B-X
of B-X
molecular B-X
approaches B-X
to B-X
HLA B-X
class B-X
I B-X
typing B-X
. B-X
Here B-X
we B-X
present B-X
a B-X
PCR-based B-X
HLA-A B-X
A B-X
comparison B-X
of B-X
Direct B-X
sequencing B-X
, B-X
Pyrosequencing B-X
, B-X
High B-X
resolution B-X
melting B-X
analysis B-X
, B-X
TheraScreen B-X
DxS B-X
, B-X
and B-X
the B-X
K-ras B-X
StripAssay B-X
for B-X
detecting B-X
KRAS B-X
mutations B-X
in B-X
non B-X
small B-X
cell B-X
lung B-X
carcinomas B-X
Due B-X
to B-X
the B-X
enormous B-X
allelic B-X
diversity B-X
of B-X
the B-X
HLA-B B-X
locus B-X
, B-X
it B-X
has B-X
been B-X
difficult B-X
to B-X
design B-X
an B-X
unambiguous B-X
molecular B-X
typing B-X
method B-X
for B-X
the B-X
alleles B-X
at B-X
this B-X
locus B-X
. B-X
Here B-X

All	O
but	O
one	O
of	O
the	O
mutations	O
are	O
predicted	O
to	O
give	O
rise	O
to	O
premature	O
translation	O
termination	O
and	O
include	O
seven	O
frameshift	O
insertions	O
or	O
deletions	O
,	O
a	O
nonsense	O
mutation	O
,	O
and	O
a	O
splice	O
acceptor	O
site	O
mutation	O
.	O
<EOS> B-X
Splice-acceptor B-X
site B-X
mutation B-X
in B-X
p53 B-X
gene B-X
of B-X
hu888 B-X
zebrafish B-X
line B-X
Autosomal B-X
dominant B-X
polycystic B-X
kidney B-X
disease B-X
( B-X
ADPKD B-X
) B-X
occurs B-X
mainly B-X
from B-X
mutations B-X
of B-X
polycystic B-X
kidney B-X
disease B-X
1 B-X
( B-X
PKD1 B-X
) B-X
gene B-X
. B-X
A B-X
novel B-X
mutation B-X
of B-X
the B-X
PKD1 B-X
gene B-X
due B-X
Birt-Hogg-Dub√© B-X
syndrome B-X
( B-X
BHD B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
caused B-X
by B-X
germline B-X
mutations B-X
in B-X
the B-X
folliculin B-X
gene B-X
( B-X
FLCN B-X
) B-X
. B-X
Nearly B-X
150 B-X
pathogenic B-X
mutations B-X
have B-X
been B-X
identified B-X
in B-X
PDF B-X
| B-X
Mutations B-X
in B-X
OPA1 B-X
are B-X
the B-X
most B-X
frequent B-X
cause B-X
underlying B-X
autosomal B-X
dominant B-X
optic B-X
atrophy B-X
( B-X
adOA B-X
) B-X
. B-X
Until B-X
now B-X
only B-X
few B-X
putative B-X
splicing B-X
mutations B-X
... B-X
| B-X
Find B-X
, B-X
Direct B-X
DNA B-X
sequencing B-X
of B-X
the B-X
steroid B-X
21-hydroxylase B-X
gene B-X
( B-X
CYP21 B-X
) B-X
revealed B-X
two B-X
novel B-X
mutations B-X
in B-X
two B-X
patients B-X
with B-X
severe B-X
congenital B-X
adrenal B-X
hyperplasia B-X
. B-X
The B-X
nonsense B-X
mutation B-X
Trp23Stop B-X
( B-X
TGG B-X
Nonsense B-X
mutation-associated B-X
Becker B-X
muscular B-X
dystrophy B-X
: B-X
interplay B-X
between B-X
exon B-X
definition B-X
and B-X
splicing B-X
regulatory B-X
elements B-X
within B-X
the B-X
DMD B-X
gene B-X

The	O
remaining	O
mutation	O
is	O
a	O
missense	O
mutation	O
(	O
Cys61Gly	O
)	O
in	O
the	O
zinc	O
-	O
binding	O
motif	O
.	O
<EOS> B-X
CTCF B-X
is B-X
a B-X
widely B-X
expressed B-X
11-zinc B-X
finger B-X
( B-X
ZF B-X
) B-X
transcription B-X
factor B-X
that B-X
is B-X
involved B-X
in B-X
different B-X
aspects B-X
of B-X
gene B-X
regulation B-X
including B-X
promoter B-X
activation B-X
or B-X
repression B-X
, B-X
hormone-responsive B-X
gene B-X
silencing B-X
Duchenne B-X
muscular B-X
dystrophy B-X
( B-X
DMD B-X
) B-X
is B-X
associated B-X
with B-X
the B-X
loss B-X
of B-X
dystrophin B-X
, B-X
which B-X
plays B-X
an B-X
important B-X
role B-X
in B-X
myofiber B-X
integrity B-X
via B-X
interactions B-X
with B-X
Œ≤-dystroglycan B-X
and B-X
other B-X
members B-X
of B-X
Many B-X
studies B-X
have B-X
shown B-X
that B-X
missense B-X
mutations B-X
might B-X
play B-X
an B-X
important B-X
role B-X
in B-X
carcinogenesis B-X
. B-X
However B-X
, B-X
the B-X
extent B-X
to B-X
which B-X
cancer B-X
mutations B-X
might B-X
affect B-X
biomolecular B-X
interactions B-X
remains B-X
unclear B-X
. B-X
bioRxiv B-X
- B-X
the B-X
preprint B-X
server B-X
for B-X
biology B-X
, B-X
operated B-X
by B-X
Cold B-X
Spring B-X
Harbor B-X
Laboratory B-X
, B-X
a B-X
research B-X
and B-X
educational B-X
institution B-X

Four	O
novel	O
Swedish	O
founding	O
mutations	O
were	O
identified	O
the	O
nucleotide	O
2595	O
deletion	O
A	O
was	O
found	O
in	O
five	O
families	O
,	O
the	O
C	O
1806	O
T	O
nonsense	O
mutation	O
in	O
three	O
families	O
,	O
the	O
3166	O
insertion	O
TGAGA	O
in	O
three	O
families	O
,	O
and	O
the	O
nucleotide	O
1201	O
deletion	O
11	O
in	O
two	O
families	O
.	O
<EOS> B-X
We B-X
have B-X
identified B-X
androgen B-X
receptor B-X
( B-X
AR B-X
) B-X
gene B-X
mutations B-X
in B-X
eight B-X
Australian B-X
subjects B-X
with B-X
complete B-X
androgen B-X
insensitivity B-X
syndrome B-X
( B-X
AIS B-X
) B-X
. B-X
Four B-X
individuals B-X
, B-X
from B-X
three B-X
families B-X
, B-X
Abstract B-X
. B-X
Folate-sensitive B-X
fragile B-X
sites B-X
are B-X
associated B-X
with B-X
the B-X
expansion B-X
and B-X
hypermethylation B-X
of B-X
CCG-repeats B-X
. B-X
The B-X
fragile B-X
site B-X
in B-X
11q23.3 B-X
, B-X
FRA11B B-X
, B-X
has B-X
been B-X
sh B-X
Founding B-X
BRCA1 B-X
mutations B-X
in B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
in B-X
southern B-X
Sweden B-X
. B-X
PDF B-X
| B-X
Various B-X
studies B-X
have B-X
been B-X
published B-X
in B-X
Italy B-X
regarding B-X
the B-X
different B-X
BRCA1 B-X
mutations B-X
, B-X
but B-X
only B-X
the B-X
BRCA1-5083del19 B-X
mutation B-X
is B-X
recurrent B-X
and B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Whole B-X
genome B-X
sequencing B-X
and B-X
integrative B-X
genomic B-X
analysis B-X
approach B-X
on B-X
two B-X
22q11.2 B-X
deletion B-X
syndrome B-X
family B-X
trios B-X
for B-X
genotype B-X
to B-X
phenotype B-X
correlations B-X
We B-X
describe B-X
a B-X
family B-X
with B-X
recurrent B-X
11q23-qter B-X
deletion B-X
Jacobsen B-X
syndrome B-X
in B-X
two B-X
affected B-X
brothers B-X
, B-X
with B-X
unique B-X
mosaic B-X
deletion B-X
'rescue B-X
' B-X
through B-X
development B-X
of B-X
uniparental B-X
disomy B-X
( B-X
UPD B-X
) B-X
in B-X
Founding B-X
BRCA1 B-X
Mutations B-X
in B-X
Hereditary B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
in B-X
Southern B-X
Sweden B-X

Analysis	O
of	O
the	O
intragenic	O
polymorphism	O
D17S855	O
supports	O
common	O
origins	O
of	O
the	O
mutations	O
.	O
<EOS> B-X
Uncertainty B-X
exists B-X
whether B-X
the B-X
4154delA B-X
mutation B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
detected B-X
in B-X
unrelated B-X
individuals B-X
from B-X
Latvia B-X
, B-X
Poland B-X
and B-X
Russia B-X
is B-X
a B-X
founder B-X
mutation B-X
with B-X
a B-X
common B-X
ancestral B-X
origin B-X
. B-X
Uncertainty B-X
exists B-X
whether B-X
the B-X
4154delA B-X
mutation B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
detected B-X
in B-X
unrelated B-X
individuals B-X
from B-X
Latvia B-X
, B-X
Poland B-X
and B-X
Russia B-X
is B-X
a B-X
founder B-X
mutation B-X
w B-X
A B-X
Novel B-X
Mutation-BRCA1 B-X
Associated B-X
Hereditary B-X
Haplotype B-X
of B-X
Intragenic B-X
Markers B-X
of B-X
BRCA1 B-X
Gene B-X
in B-X
a B-X
Family B-X
with B-X
History B-X
of B-X
Breast B-X
Cancer B-X
PDF B-X
| B-X
Background B-X
: B-X
Breast B-X
cancer B-X
molecular B-X
analysis B-X
by B-X
linkage B-X
analysis B-X
has B-X
the B-X
advantage B-X
of B-X
facilitating B-X
early B-X
diagnosis B-X
in B-X
asymptomatic B-X
genetic B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
PDF B-X
| B-X
Background B-X
: B-X
Breast B-X
cancer B-X
is B-X
the B-X
most B-X
common B-X
cancer B-X
diagnosed B-X
among B-X
women B-X
, B-X
Tumor B-X
suppressor B-X
genes B-X
such B-X
as B-X
BRCA1 B-X
involved B-X
in B-X
cell B-X
cycle B-X
control B-X
and B-X
... B-X
| B-X
Find B-X

Eleven	O
of	O
the	O
15	O
kindreds	O
manifesting	O
BRCA1	O
mutations	O
were	O
breast	B-Disease
-	I-Disease
ovarian	I-Disease
cancer	I-Disease
families	O
,	O
several	O
of	O
them	O
with	O
a	O
predominant	O
ovarian	B-Disease
cancer	I-Disease
phenotype	O
.	O

The	O
set	O
of	O
32	O
families	O
in	O
which	O
no	O
BRCA1	O
alterations	O
were	O
detected	O
included	O
1	O
breast	B-Disease
-	I-Disease
ovarian	I-Disease
cancer	I-Disease
kindred	O
manifesting	O
clear	O
linkage	O
to	O
the	O
BRCA1	O
region	O
and	O
loss	O
of	O
the	O
wild	O
-	O
type	O
chromosome	O
in	O
associated	O
tumors	B-Disease
.	O
<EOS> B-X
Steroid B-X
receptors B-X
in B-X
hereditary B-X
breast B-X
carcinomas B-X
associated B-X
with B-X
BRCA1 B-X
or B-X
BRCA2 B-X
mutations B-X
or B-X
unknown B-X
susceptibility B-X
genes B-X
- B-X
Loman B-X
- B-X
1998 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Tumor B-X
Characteristics B-X
as B-X
an B-X
Analytic B-X
Tool B-X
for B-X
Classifying B-X
Genetic B-X
Variants B-X
of B-X
Uncertain B-X
Clinical B-X
Significance B-X
The B-X
Pacific B-X
Symposium B-X
on B-X
Biocomputing B-X
( B-X
PSB B-X
) B-X
2015 B-X
is B-X
an B-X
international B-X
, B-X
multidisciplinary B-X
conference B-X
for B-X
the B-X
presentation B-X
and B-X
discussion B-X
of B-X
current B-X
research B-X
in B-X
the B-X
theory B-X
and B-X
application B-X
of B-X
computational B-X
The B-X
Pacific B-X
Symposium B-X
on B-X
Biocomputing B-X
( B-X
PSB B-X
) B-X
2015 B-X
is B-X
an B-X
international B-X
, B-X
multidisciplinary B-X
conference B-X
for B-X
the B-X
presentation B-X
and B-X
discussion B-X
of B-X
current B-X
research B-X
in B-X
the B-X
theory B-X
and B-X
application B-X
of B-X
computational B-X
604370 B-X
- B-X
BREAST-OVARIAN B-X
CANCER B-X
, B-X
FAMILIAL B-X
, B-X
SUSCEPTIBILITY B-X
TO B-X
, B-X
1 B-X
; B-X
BROVCA1 B-X
- B-X
BREAST B-X
CANCER B-X
, B-X
FAMILIAL B-X
, B-X
SUSCEPTIBILITY B-X
TO B-X
, B-X
1 B-X
, B-X
INCLUDED B-X
; B-X
; B-X
OVARIAN B-X
CANCER B-X
, B-X

Other	O
tumor	B-Disease
types	O
found	O
in	O
BRCA1	O
mutation	O
/	O
haplotype	O
carriers	O
included	O
prostatic	B-Disease
,	I-Disease
pancreas	I-Disease
,	I-Disease
skin	I-Disease
,	I-Disease
and	I-Disease
lung	I-Disease
cancer	I-Disease
,	O
a	O
malignant	B-Disease
melanoma	I-Disease
,	O
an	O
oligodendroglioma	B-Disease
,	O
and	O
a	O
carcinosarcoma	B-Disease
.	O
<EOS> B-X
Clinical B-X
management B-X
of B-X
grade B-X
III B-X
oligodendroglioma B-X
Learn B-X
about B-X
the B-X
outlook B-X
for B-X
oligodendroglioma B-X
, B-X
including B-X
causes B-X
and B-X
treatment B-X
options B-X
. B-X
Increased B-X
prevalence B-X
of B-X
lung B-X
, B-X
breast B-X
and B-X
pancreatic B-X
cancers B-X
in B-X
addition B-X
to B-X
melanoma B-X
risk B-X
in B-X
families B-X
bearing B-X
the B-X
CDKN2A B-X
mutation B-X
: B-X
Implications B-X
for B-X
genetic B-X
counseling B-X
Survey B-X
of B-X
treatment B-X
recommendations B-X
for B-X
anaplastic B-X
oligodendroglioma B-X
Oligodendroglioma B-X
: B-X
pathology B-X
, B-X
molecular B-X
mechanisms B-X
and B-X
markers B-X
Oligodendroglioma B-X
is B-X
a B-X
rare B-X
type B-X
of B-X
brain B-X
tumour B-X
. B-X
It B-X
starts B-X
in B-X
glial B-X
cells B-X
called B-X
oligodendrocytes B-X
. B-X
Oligodendroglioma B-X
is B-X
a B-X
rare B-X
tumor B-X
that B-X
usually B-X
develops B-X
in B-X
either B-X
the B-X
frontal B-X
or B-X
temporal B-X
lobes B-X
of B-X
the B-X
brain B-X
, B-X
but B-X
in B-X
rare B-X
cases B-X
, B-X
can B-X
form B-X
in B-X
the B-X
spinal B-X
cord B-X

In	O
all	O
,	O
12	O
of	O
16	O
kindreds	O
manifesting	O
BRCA1	O
mutation	O
or	O
linkage	O
contained	O
ovarian	B-Disease
cancer	I-Disease
,	O
as	O
compared	O
with	O
only	O
6	O
of	O
the	O
remaining	O
31	O
families	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O
<EOS> B-X
The B-X
Social B-X
Determinants B-X
of B-X
Health B-X
: B-X
It B-X
's B-X
Time B-X
to B-X
Consider B-X
the B-X
Causes B-X
of B-X
the B-X
Causes B-X
Public B-X
policies B-X
can B-X
either B-X
fuel B-X
or B-X
ease B-X
racial B-X
disparities B-X
in B-X
wealth B-X
. B-X
This B-X
report B-X
is B-X
the B-X
first-ever B-X
systematic B-X
analysis B-X
of B-X
the B-X
impact B-X
of B-X
policies B-X
on B-X
the B-X
racial B-X
wealth B-X
gap B-X
. B-X
The B-X
median B-X
wealth B-X
of B-X
white B-X
households B-X
is B-X
20 B-X
times B-X
that B-X
of B-X
black B-X
households B-X
and B-X
18 B-X
times B-X
that B-X
of B-X
Hispanic B-X
households B-X
, B-X
according B-X
to B-X
a B-X
Pew B-X
Research B-X
Center B-X
analysis B-X
of B-X
newly B-X
Temporary B-X
Assistance B-X
for B-X
Needy B-X
Families B-X
, B-X
the B-X
primary B-X
cash B-X
assistance B-X
program B-X
for B-X
families B-X
with B-X
the B-X
lowest B-X
incomes B-X
, B-X
is B-X
at B-X
its B-X
weakest B-X
point B-X
in B-X
the B-X
program B-X
‚Äô B-X
s B-X
history B-X
in B-X
Executive B-X
Summary B-X
The B-X
situation B-X
of B-X
induced B-X
abortion B-X
has B-X
changed B-X
markedly B-X
over B-X
the B-X
past B-X
few B-X
decades B-X
. B-X
This B-X
report B-X
provides B-X
updated B-X
information B-X
on B-X
the B-X
incidence B-X
of B-X
abortion B-X
worldwide B-X
, B-X
the B-X
laws B-X
FAQs B-X
| B-X
001 B-X
Taxis B-X
Read B-X
the B-X
latest B-X
messages B-X
for B-X
families B-X
on B-X
remote B-X
learning B-X
and B-X
NYCDOE B-X
school B-X
closures B-X
. B-X

The	O
present	O
study	O
confirms	O
the	O
involvement	O
of	O
BRCA1	O
in	O
disease	O
predisposition	O
for	O
a	O
subset	O
of	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
families	O
often	O
characterized	O
by	O
ovarian	B-Disease
cancers	I-Disease
.	O
<EOS> B-X
The B-X
cancer B-X
susceptibility B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
appear B-X
to B-X
be B-X
responsible B-X
for B-X
virtually B-X
all B-X
hereditary B-X
breast B-X
ovarian B-X
families B-X
, B-X
and B-X
a B-X
smaller B-X
subset B-X
of B-X
hereditary B-X
site-specific B-X
breast B-X
cancer B-X
families B-X
. B-X
BRCA1 B-X
and B-X
BRCA2mutations B-X
in B-X
breast B-X
cancer B-X
patients B-X
from B-X
Venezuela B-X
Hereditary B-X
breast B-X
cancer B-X
runs B-X
in B-X
families B-X
where B-X
several B-X
members B-X
in B-X
different B-X
generations B-X
are B-X
affected B-X
. B-X
Most B-X
of B-X
these B-X
breast B-X
cancers B-X
are B-X
caused B-X
by B-X
mutations B-X

Rapid	O
detection	O
of	O
regionally	O
clustered	O
germ	O
-	O
line	O
BRCA1	O
mutations	O
by	O
multiplex	O
heteroduplex	O
analysis	O
.	O
<EOS> B-X
Frequently B-X
occurring B-X
germ-line B-X
mutations B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
in B-X
ovarian B-X
cancer B-X
families B-X
from B-X
Russia B-X
. B-X
Germ-line B-X
mutations B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
are B-X
responsible B-X
for B-X
a B-X
substantial B-X
proportion B-X
of B-X
families B-X
with B-X
multiple B-X
cases B-X
of B-X
early-onset B-X
breast B-X
and/or B-X
ovarian B-X
cancer B-X
. B-X
Since B-X
the B-X
isolation B-X
of B-X
BRCA1 B-X
last B-X
Ten B-X
variants B-X
different B-X
from B-X
the B-X
canonical B-X
nucleotide B-X
sequence B-X
( B-X
GenBank B-X
, B-X
U14680 B-X
) B-X
has B-X
been B-X
identified B-X
when B-X
studying B-X
the B-X
mutation B-X
spectrum B-X
in B-X
gene B-X
BRCA1 B-X
. B-X
Six B-X
The B-X
discovery B-X
of B-X
theBRCA1 B-X
gene B-X
involved B-X
in B-X
the B-X
development B-X
of B-X
human B-X
hereditary B-X
breast B-X
cancer B-X
led B-X
to B-X
extensive B-X
international B-X
efforts B-X
to B-X
identify B-X
the B-X
mutatio B-X

UKCCCR	O
Familial	O
Ovarian	B-Disease
Cancer	I-Disease
Study	O
Group	O
.	O
<EOS> B-X
PubMed B-X
journal B-X
article B-X
: B-X
Rapid B-X
detection B-X
of B-X
regionally B-X
clustered B-X
germ-line B-X
BRCA1 B-X
mutations B-X
by B-X
multiplex B-X
heteroduplex B-X
analysis B-X
. B-X
UKCCCR B-X
Familial B-X
Ovarian B-X
Cancer B-X
Study B-X
Group B-X
. B-X
Download B-X
Prime B-X
PubMed B-X
App B-X
to B-X
iPhone B-X
Improved B-X
survival B-X
in B-X
BRCA2 B-X
carriers B-X
with B-X
ovarian B-X
cancer B-X
Survival B-X
in B-X
Familial B-X
, B-X
BRCA1-associated B-X
, B-X
and B-X
BRCA2-associated B-X
EpithelialOvarian B-X
Cancer B-X
| B-X
Cancer B-X
Research B-X
Analysis B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
Hungarian B-X
families B-X
with B-X
breast B-X
or B-X
breast-ovarian B-X
cancer B-X
. B-X
Our B-X
data B-X
suggest B-X
that B-X
many B-X
of B-X
the B-X
histologic B-X
`` B-X
abnormalities B-X
'' B-X
described B-X
in B-X
`` B-X
normal B-X
'' B-X
ovaries B-X
are B-X
, B-X
in B-X
fact B-X
, B-X
variations B-X
of B-X
the B-X
normal B-X
and B-X
are B-X
not B-X
associated B-X
Ovarian B-X
and B-X
breast B-X
cancer B-X
risks B-X
to B-X
women B-X
in B-X
families B-X
with B-X
two B-X
or B-X
more B-X
cases B-X
of B-X
ovarian B-X
cancer B-X
- B-X
Sutcliffe B-X
- B-X
2000 B-X
- B-X
International B-X
Journal B-X
of B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
The B-X
natural B-X
history B-X
of B-X
hereditary B-X
and B-X
BRCA1- B-X
and B-X
BRCA2-associated B-X
epithelial B-X
ovarian B-X
cancer B-X
may B-X
differ B-X
from B-X
that B-X
of B-X
sporadic B-X
disease B-X
. B-X
The B-X
purpose B-X
of B-X
this B-X
study B-X
was B-X
to B-X
compare B-X
the B-X
clinical B-X

Germ	O
-	O
line	O
mutations	O
of	O
the	O
BRCA1	O
gene	O
are	O
responsible	O
for	O
a	O
substantial	O
proportion	O
of	O
families	O
with	O
multiple	O
cases	O
of	O
early	O
-	O
onset	O
breast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
.	O
<EOS> B-X
Germline B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
highly B-X
predispose B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
and B-X
are B-X
responsible B-X
for B-X
a B-X
substantial B-X
proportion B-X
of B-X
familial B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
No B-X
Among B-X
Asian B-X
countries B-X
, B-X
Pakistan B-X
has B-X
the B-X
highest B-X
rates B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
To B-X
assess B-X
the B-X
contribution B-X
of B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
germ B-X
line B-X
mutations B-X
to B-X
these B-X
high B-X
Breast B-X
cancer B-X
is B-X
the B-X
most B-X
common B-X
cancer B-X
in B-X
Iranian B-X
women B-X
( B-X
Mousavi B-X
et B-X
al B-X
in B-X
Asian B-X
Pac B-X
J B-X
Cancer B-X
Prev B-X
9 B-X
( B-X
2 B-X
) B-X
:275‚Äì278 B-X
, B-X
2008 B-X
) B-X
. B-X
Genetic B-X

Since	O
the	O
isolation	O
of	O
BRCA1	O
last	O
year	O
,	O
>	O
65	O
distinct	O
mutations	O
scattered	O
throughout	O
the	O
coding	O
region	O
have	O
been	O
detected	O
,	O
making	O
analysis	O
of	O
the	O
gene	O
time	O
consuming	O
and	O
technically	O
challenging	O
.	O
<EOS> B-X
Germ-line B-X
mutations B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
are B-X
responsible B-X
for B-X
a B-X
substantial B-X
proportion B-X
of B-X
families B-X
with B-X
multiple B-X
cases B-X
of B-X
early-onset B-X
breast B-X
and/or B-X
ovarian B-X
cancer B-X
. B-X
Since B-X
the B-X
isolation B-X
of B-X
BRCA1 B-X
last B-X
Case B-X
report B-X
: B-X
Analysis B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
gene B-X
mutations B-X
in B-X
a B-X
hereditary B-X
ovarian B-X
cancer B-X
family B-X
BRCA1 B-X
and B-X
BRCA2 B-X
germline B-X
mutation B-X
analysis B-X
in B-X
the B-X
Indonesian B-X
population B-X
PDF B-X
| B-X
Germline B-X
mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
predispose B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
A B-X
multitude B-X
of B-X
mutations B-X
have B-X
been B-X
described B-X
and B-X
are B-X
found B-X
to B-X
be B-X
... B-X
| B-X
Find B-X
Rapid B-X
detection B-X
of B-X
regionally B-X
clustered B-X
germ-line B-X
BRCA1 B-X
mutations B-X
by B-X
multiplex B-X
heteroduplex B-X
analysis B-X
. B-X
UKCCCR B-X
Familial B-X
Ovarian B-X
Cancer B-X
Study B-X
Group B-X
. B-X
Germline B-X
BRCA1 B-X
and B-X
BRCA2 B-X
deleterious B-X
mutations B-X
and B-X
variants B-X
of B-X
unknown B-X
clinical B-X
significance B-X
associated B-X
with B-X
breast/ovarian B-X
cancer B-X
: B-X
a B-X
report B-X
from B-X
North B-X
India B-X
Genomic B-X
analysis B-X
in B-X
the B-X
clinic B-X
: B-X
benefits B-X
and B-X
challenges B-X
for B-X
health B-X
care B-X
professionals B-X
and B-X
patients B-X
in B-X
Brazil B-X

We	O
have	O
developed	O
a	O
multiplex	O
heteroduplex	O
analysis	O
that	O
is	O
designed	O
to	O
analyze	O
one	O
-	O
quarter	O
of	O
the	O
coding	O
sequence	O
in	O
a	O
single	O
-	O
step	O
screening	O
procedure	O
and	O
that	O
will	O
detect	O
approximately	O
50	O
%	O
of	O
all	O
BRCA1	O
mutations	O
so	O
far	O
reported	O
in	O
breast	B-Disease
/	I-Disease
ovarian	I-Disease
cancer	I-Disease
families	O
.	O
<EOS> B-X
We B-X
have B-X
developed B-X
a B-X
2-stage B-X
protocol B-X
for B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
screening B-X
from B-X
blood B-X
spot B-X
paper B-X
. B-X
Stage B-X
1 B-X
screening B-X
was B-X
aimed B-X
to B-X
analyze B-X
patients B-X
at B-X
highest B-X
risk B-X
for B-X
the B-X
New B-X
challenges B-X
for B-X
BRCA B-X
testing B-X
: B-X
a B-X
view B-X
from B-X
the B-X
diagnostic B-X
laboratory B-X
WikiGenes B-X
- B-X
Heteroduplex B-X
Analysis B-X
Next-Generation B-X
Sequencing B-X
in B-X
Oncology B-X
: B-X
Genetic B-X
Diagnosis B-X
, B-X
Risk B-X
Prediction B-X
and B-X
Cancer B-X
Classification B-X
The B-X
main B-X
risk B-X
factor B-X
for B-X
familial B-X
breast B-X
cancer B-X
is B-X
the B-X
presence B-X
of B-X
mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
. B-X
The B-X
prevalence B-X
of B-X
mutations B-X
in B-X
these B-X
genes B-X
is B-X
heterogeneous B-X
and B-X
varies B-X

We	O
have	O
used	O
this	O
technique	O
to	O
analyze	O
BRCA1	O
in	O
162	O
families	O
with	O
a	O
history	O
of	O
breast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
and	O
identified	O
12	O
distinct	O
mutations	O
in	O
35	O
families	O
.	O
.	O

A	O
previously	O
undescribed	O
mutation	O
within	O
the	O
tetramerisation	O
domain	O
of	O
TP53	O
in	O
a	O
family	O
with	O
Li	B-Disease
-	I-Disease
Fraumeni	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
We B-X
report B-X
details B-X
of B-X
a B-X
family B-X
with B-X
classic B-X
Li-Fraumeni B-X
syndrome B-X
in B-X
which B-X
there B-X
is B-X
a B-X
mutation B-X
in B-X
codon B-X
344 B-X
of B-X
the B-X
tumour B-X
suppressor B-X
gene B-X
TP53 B-X
. B-X
Codon B-X
344 B-X
is B-X
a B-X
Chromosome B-X
instability B-X
is B-X
a B-X
predominant B-X
trait B-X
of B-X
fibroblasts B-X
from B-X
Li-Fraumeni B-X
families B-X
. B-X
Li-Fraumeni B-X
syndrome B-X
disease B-X
model B-X
: B-X
A B-X
platform B-X
to B-X
develop B-X
precision B-X
cancer B-X
therapy B-X
targeting B-X
oncogenic B-X
p53 B-X
P53 B-X
germline B-X
mutations B-X
in B-X
childhood B-X
cancers B-X
and B-X
cancer B-X
risk B-X
for B-X
carrier B-X
individuals B-X
Li-Fraumeni B-X
syndrome B-X
( B-X
LFS B-X
) B-X
is B-X
a B-X
rare B-X
genetic B-X
disease B-X
with B-X
a B-X
highly B-X
significant B-X
predisposition B-X
to B-X
multiple B-X
early-onset B-X
neoplasms B-X
. B-X
These B-X
neoplasms B-X
include B-X
adrenocortical B-X
carcinoma B-X
, B-X
sarcoma B-X
, B-X
leukemia B-X
and B-X
Over B-X
the B-X
last B-X
20 B-X
years B-X
it B-X
has B-X
become B-X
increasingly B-X
apparent B-X
that B-X
the B-X
occurrence B-X
of B-X
many B-X
cancers B-X
can B-X
have B-X
an B-X
inherited B-X
basis B-X
. B-X
This B-X
book B-X
examines B-X
the B-X
principles B-X
underlying B-X
genetic B-X
predisposition B-X

We	O
report	O
details	O
of	O
a	O
family	O
with	O
classic	O
Li	B-Disease
-	I-Disease
Fraumeni	I-Disease
syndrome	I-Disease
in	O
which	O
there	O
is	O
a	O
mutation	O
in	O
codon	O
344	O
of	O
the	O
tumour	B-Disease
suppressor	O
gene	O
TP53	O
.	O
<EOS> B-X
Gastric B-X
Cancer B-X
in B-X
Individuals B-X
with B-X
Li-Fraumeni B-X
Syndrome B-X
Li-Fraumeni B-X
syndrome B-X
: B-X
report B-X
of B-X
a B-X
clinical B-X
research B-X
workshop B-X
and B-X
creation B-X
of B-X
a B-X
research B-X
consortium B-X

Codon	O
344	O
is	O
a	O
key	O
residue	O
within	O
the	O
tetramerisation	O
domain	O
,	O
and	O
the	O
amino	O
acid	O
substitution	O
of	O
a	O
proline	O
for	O
a	O
leucine	O
is	O
predicted	O
to	O
have	O
profound	O
implications	O
for	O
tetramerisation	O
and	O
potentially	O
DNA	O
binding	O
.	O
<EOS> B-X
We B-X
report B-X
details B-X
of B-X
a B-X
family B-X
with B-X
classic B-X
Li-Fraumeni B-X
syndrome B-X
in B-X
which B-X
there B-X
is B-X
a B-X
mutation B-X
in B-X
codon B-X
344 B-X
of B-X
the B-X
tumour B-X
suppressor B-X
gene B-X
TP53 B-X
. B-X
Codon B-X
344 B-X
is B-X
a B-X
Lysines B-X
in B-X
the B-X
tetramerization B-X
domain B-X
of B-X
p53 B-X
selectively B-X
modulate B-X
G1 B-X
arrest B-X
Explore B-X
the B-X
17 B-X
papers B-X
that B-X
mention B-X
a B-X
possible B-X
interaction B-X
between B-X
Leucine B-X
and B-X
Proline B-X
. B-X
Yeast B-X
Whi2 B-X
is B-X
required B-X
to B-X
suppress B-X
cell B-X
death B-X
and B-X
cell B-X
growth B-X
in B-X
response B-X
to B-X
specific B-X
amino B-X
acids B-X
. B-X
Whi2 B-X
signals B-X
low B-X
leucine B-X
availability B-X
to B-X
halt B-X
yeast B-X
growth B-X
and B-X
cell B-X
death B-X
A B-X
previously B-X
undescribed B-X
mutation B-X
within B-X
the B-X
tetramerisation B-X
domain B-X
of B-X
TP53 B-X
in B-X
a B-X
family B-X
with B-X
Li-Fraumeni B-X
syndrome B-X
. B-X
A B-X
previously B-X
undescribed B-X
mutation B-X
within B-X
the B-X
tetramerisation B-X
domain B-X
of B-X
TP53 B-X
in B-X
a B-X
family B-X
with B-X
Li-Fraumeni B-X
syndrome B-X
. B-X

This	O
is	O
the	O
first	O
report	O
of	O
a	O
mutation	O
at	O
this	O
residue	O
in	O
either	O
sporadic	B-Disease
tumours	I-Disease
or	O
in	O
the	O
germline	O
and	O
the	O
first	O
report	O
of	O
a	O
germline	O
mutation	O
within	O
the	O
tetramerisation	O
domain	O
.	O
<EOS> B-X
A B-X
42‚Äëyear‚Äëold B-X
woman B-X
presented B-X
with B-X
~30 B-X
adenomatous B-X
polyps B-X
of B-X
the B-X
left B-X
sided‚Äëcolon B-X
with B-X
early B-X
rectosigmoid B-X
cancer B-X
. B-X
The B-X
patient B-X
had B-X
no B-X
previous B-X
medical B-X
history B-X
and B-X
no B-X
familial B-X
history B-X
of B-X
inherited B-X

The	O
family	O
does	O
not	O
appear	O
to	O
be	O
remarkable	O
in	O
the	O
spectrum	O
of	O
tumours	B-Disease
,	O
and	O
there	O
is	O
loss	O
of	O
the	O
wild	O
-	O
type	O
allele	O
in	O
a	O
leiomyosarcoma	B-Disease
from	O
the	O
proband	O
.	O
<EOS> B-X
Among B-X
mesenchymal B-X
tumors B-X
of B-X
the B-X
uterus B-X
, B-X
smooth B-X
muscle B-X
neoplasms B-X
are B-X
most B-X
common B-X
. B-X
The B-X
wide B-X
morphologic B-X
spectrum B-X
, B-X
especially B-X
within B-X
the B-X
category B-X
of B-X
leiomyomas B-X
, B-X
is B-X
responsible B-X
for B-X
diagnostic B-X
Genetic B-X
predisposition B-X
to B-X
neural B-X
crest-derived B-X
tumors B-X
: B-X
revisiting B-X
the B-X
role B-X
of B-X
KIF1B B-X
Among B-X
mesenchymal B-X
tumors B-X
of B-X
the B-X
uterus B-X
, B-X
smooth B-X
muscle B-X
neoplasms B-X
are B-X
most B-X
common B-X
. B-X
The B-X
wide B-X
morphologic B-X
spectrum B-X
, B-X
especially B-X
within B-X
the B-X
category B-X
of B-X
leiomyomas B-X
, B-X
is B-X
responsible B-X
for B-X
diagnostic B-X
Among B-X
mesenchymal B-X
tumors B-X
of B-X
the B-X
uterus B-X
, B-X
smooth B-X
muscle B-X
neoplasms B-X
are B-X
most B-X
common B-X
. B-X
The B-X
wide B-X
morphologic B-X
spectrum B-X
, B-X
especially B-X
within B-X
the B-X
category B-X
of B-X
leiomyomas B-X
, B-X
is B-X
responsible B-X
for B-X
diagnostic B-X
TAMeless B-X
traitors B-X
: B-X
macrophages B-X
in B-X
cancer B-X
progression B-X
and B-X
metastasis B-X
Genetic B-X
predisposition B-X
to B-X
neural B-X
crest-derived B-X
tumors B-X
: B-X
revisiting B-X
the B-X
role B-X
of B-X
KIF1B B-X
in B-X
: B-X
Endocrine B-X
Connections B-X
Volume B-X
9 B-X
Issue B-X
10 B-X
( B-X
2020 B-X
) B-X
Abstract B-X
. B-X
Germline B-X
mutations B-X
of B-X
the B-X
fumarate B-X
hydratase B-X
( B-X
FH B-X
, B-X
fumarase B-X
) B-X
gene B-X
are B-X
found B-X
in B-X
the B-X
recessive B-X
FH B-X
deficiency B-X
syndrome B-X
and B-X
in B-X
dominantly B-X
inherited B-X
suscept B-X

A	O
cell	O
line	O
has	O
been	O
established	O
from	O
the	O
tumour	B-Disease
of	O
the	O
proband	O
and	O
cytogenetic	O
and	O
molecular	O
studies	O
carried	O
out	O
,	O
providing	O
an	O
extensive	O
analysis	O
in	O
this	O
family	O
.	O
.	O
<EOS> B-X
The B-X
extensive B-X
chromosome B-X
rearrangements B-X
of B-X
breast B-X
carcinomas B-X
must B-X
contribute B-X
to B-X
tumour B-X
development B-X
, B-X
but B-X
have B-X
been B-X
largely B-X
intractable B-X
to B-X
classical B-X
cytogenetic B-X
banding B-X
. B-X
We B-X
report B-X
here B-X
the B-X
analysis B-X
by B-X
24-colour B-X
The B-X
FBI B-X
is B-X
the B-X
lead B-X
federal B-X
agency B-X
for B-X
investigating B-X
cyber B-X
attacks B-X
by B-X
criminals B-X
, B-X
overseas B-X
adversaries B-X
, B-X
and B-X
terrorists B-X
. B-X
The B-X
threat B-X
is B-X
incredibly B-X
serious‚Äîand B-X
growing B-X
. B-X
Identification B-X
of B-X
a B-X
Novel B-X
Tumor B-X
Suppressor B-X
Gene B-X
p34 B-X
on B-X
Human B-X
Chromosome B-X
6q25.1 B-X
Conventional B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
CRCC B-X
) B-X
may B-X
appear B-X
in B-X
families B-X
with B-X
germline B-X
translocations B-X
involving B-X
chromosome B-X
3 B-X
, B-X
although B-X
a B-X
recurrent B-X
responsible B-X
gene B-X
has B-X
not B-X
been B-X
found B-X
. B-X
We B-X
recently B-X
Conventional B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
CRCC B-X
) B-X
may B-X
appear B-X
in B-X
families B-X
with B-X
germline B-X
translocations B-X
involving B-X
chromosome B-X
3 B-X
, B-X
although B-X
a B-X
recurrent B-X
responsible B-X
gene B-X
has B-X
not B-X
been B-X
found B-X
. B-X
We B-X
recently B-X
Ewing B-X
's B-X
sarcoma/primitive B-X
neuroectodermal B-X
tumor/Askin B-X
's B-X
tumor B-X
( B-X
Ewing B-X
` B-X
s B-X
sarcoma B-X
family B-X
of B-X
tumors B-X
: B-X
ESFT B-X
) B-X
is B-X
the B-X
most B-X
common B-X
type B-X
of B-X
malignant B-X
tumor B-X
of B-X
bone B-X
and B-X
soft B-X
Familial B-X
risk B-X
for B-X
lung B-X
cancer B-X

The	O
spectrum	O
of	O
RB1	O
germ	O
-	O
line	O
mutations	O
in	O
hereditary	B-Disease
retinoblastoma	I-Disease
.	O
<EOS> B-X
Spectrum B-X
of B-X
germline B-X
RB1 B-X
mutations B-X
and B-X
clinical B-X
manifestations B-X
in B-X
retinoblastoma B-X
patients B-X
from B-X
Thailand B-X
Spectrum B-X
of B-X
RB1 B-X
Germline B-X
Mutations B-X
and B-X
Clinical B-X
Features B-X
in B-X
Unrelated B-X
Chinese B-X
Patients B-X
With B-X
Retinoblastoma B-X

We	O
have	O
searched	O
for	O
germ	O
-	O
line	O
RB1	O
mutations	O
in	O
119	O
patients	O
with	O
hereditary	B-Disease
retinoblastoma	I-Disease
.	O
<EOS> B-X
RB1 B-X
mutations B-X
and B-X
second B-X
primary B-X
malignancies B-X
after B-X
hereditary B-X
retinoblastoma B-X
RB1 B-X
gene B-X
mutations B-X
in B-X
retinoblastoma B-X
and B-X
its B-X
clinical B-X
correlation B-X

Previous	O
investigations	O
by	O
Southern	O
blot	O
hybridization	O
and	O
PCR	O
fragment	O
-	O
length	O
analysis	O
had	O
revealed	O
mutations	O
in	O
48	O
patients	O
.	O
<EOS> B-X
Automated B-X
design B-X
of B-X
genomic B-X
Southern B-X
blot B-X
probes B-X
Comprehensive B-X
Mutation B-X
Analysis B-X
of B-X
the B-X
CYP21A2 B-X
Gene B-X
Simultaneous B-X
Detection B-X
and B-X
Quantification B-X
of B-X
Mitochondrial B-X
DNA B-X
Deletion B-X
( B-X
s B-X
) B-X
, B-X
Depletion B-X
, B-X
and B-X
Over-Replication B-X
in B-X
Patients B-X
with B-X
Mitochondrial B-X
Disease B-X
Clinical B-X
spectrum B-X
of B-X
the B-X
pentanucleotide B-X
repeat B-X
expansion B-X
in B-X
the B-X
RFC1 B-X
gene B-X
in B-X
ataxia B-X
syndromes B-X
| B-X
Neurology B-X
BackgroundDefects B-X
in B-X
the B-X
oxidative B-X
phosphorylation B-X
system B-X
can B-X
cause B-X
a B-X
broad B-X
spectrum B-X
of B-X
clinical B-X
symptoms B-X
ranging B-X
from B-X
an B-X
isolated B-X
myopathy B-X
to B-X
a B-X
multisystemic B-X
d B-X
A B-X
de B-X
Novo B-X
Deletion B-X
in B-X
the B-X
C1 B-X
Inhibitor B-X
Gene B-X
in B-X
a B-X
Case B-X
of B-X
Sporadic B-X
Hereditary B-X
Angioneurotic B-X
Edema B-X
- B-X
ScienceDirect B-X
Duchenne B-X
muscular B-X
dystrophy B-X
( B-X
DMD B-X
) B-X
and B-X
Becker B-X
muscular B-X
dystrophy B-X
( B-X
BMD B-X
) B-X
are B-X
common B-X
X-chromosomal B-X
recessive B-X
disorders B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
dystrophin B-X
ge B-X

Here	O
we	O
report	O
on	O
the	O
analysis	O
of	O
the	O
remaining	O
71	O
patients	O
.	O
<EOS> B-X
Clinical B-X
impact B-X
of B-X
COVID-19 B-X
on B-X
patients B-X
with B-X
cancer B-X
( B-X
CCC19 B-X
) B-X
: B-X
a B-X
cohort B-X
study B-X
- B-X
The B-X
Lancet B-X
Artificial B-X
intelligence B-X
provides B-X
the B-X
opportunity B-X
to B-X
reveal B-X
important B-X
information B-X
buried B-X
in B-X
large B-X
amounts B-X
of B-X
complex B-X
data B-X
. B-X
Electronic B-X
health B-X
records B-X
( B-X
eHRs B-X
) B-X
are B-X
a B-X
source B-X
of B-X
such B-X
big B-X
data B-X
Author B-X
summary B-X
Viruses B-X
must B-X
overcome B-X
various B-X
setbacks B-X
in B-X
a B-X
variety B-X
of B-X
tissues B-X
and B-X
cells B-X
during B-X
transmission B-X
from B-X
the B-X
initial B-X
replication B-X
site B-X
to B-X
the B-X
final B-X
target B-X
site B-X
. B-X
To B-X
achieve B-X
this B-X
A B-X
diagnosis B-X
of B-X
motor B-X
Parkinson B-X
‚Äô B-X
s B-X
disease B-X
( B-X
PD B-X
) B-X
is B-X
preceded B-X
by B-X
a B-X
prolonged B-X
premotor B-X
phase B-X
with B-X
accumulating B-X
neuronal B-X
damage B-X
. B-X
Here B-X
we B-X
examined B-X
the B-X
temporal B-X
relation B-X
between B-X
The B-X
immune B-X
system B-X
of B-X
patients B-X
infected B-X
by B-X
SARS-CoV-2 B-X
is B-X
severely B-X
impaired B-X
. B-X
Detailed B-X
investigation B-X
of B-X
T B-X
cells B-X
and B-X
cytokine B-X
production B-X
in B-X
patients B-X
affected B-X
by B-X
COVID-19 B-X
pneumonia B-X
are B-X
urgently B-X
required B-X
. B-X
Enterovirus B-X
71 B-X
( B-X
EV71 B-X
) B-X
is B-X
a B-X
neurotropic B-X
enterovirus B-X
without B-X
antivirals B-X
or B-X
vaccine B-X
, B-X
and B-X
its B-X
host-pathogen B-X
interactions B-X
remain B-X
poorly B-X
understood B-X
. B-X
Here B-X
we B-X
use B-X
a B-X
human B-X
genome-wide B-X
RNAi B-X
screen B-X
Anecdotal B-X
evidence B-X
suggests B-X
that B-X
Coronavirus B-X
disease B-X
2019 B-X
( B-X
COVID-19 B-X
) B-X
, B-X
caused B-X
by B-X
the B-X
coronavirus B-X
SARS-CoV-2 B-X
, B-X
exhibits B-X
differences B-X
in B-X
morbidity B-X
and B-X
mortality B-X
between B-X
sexes B-X
. B-X
Here B-X
, B-X
we B-X
present B-X

By	O
applying	O
heteroduplex	O
analysis	O
,	O
nonisotopic	O
SSCP	O
,	O
and	O
direct	O
sequencing	O
,	O
we	O
detected	O
germ	O
-	O
line	O
mutations	O
resulting	O
in	O
premature	O
termination	O
codons	O
or	O
disruption	O
of	O
splice	O
signals	O
in	O
51	O
(	O
72	O
%	O
)	O
of	O
the	O
71	O
patients	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Cryptic B-X
splice B-X
sites B-X
are B-X
used B-X
only B-X
when B-X
use B-X
of B-X
a B-X
natural B-X
splice B-X
site B-X
is B-X
disrupted B-X
by B-X
mutation B-X
. B-X
To B-X
determine B-X
the B-X
features B-X
that B-X
distinguish B-X
authentic B-X
fr B-X
PDF B-X
| B-X
Single-strand B-X
conformation B-X
( B-X
SSCP B-X
) B-X
and B-X
heteroduplex B-X
analysis B-X
are B-X
separate B-X
mutation B-X
scanning B-X
methods B-X
in B-X
their B-X
own B-X
right B-X
. B-X
They B-X
are B-X
, B-X
however B-X
, B-X
unusual B-X
... B-X
| B-X
Find B-X
, B-X
Characterization B-X
of B-X
cryptic B-X
splicing B-X
in B-X
germline B-X
PTEN B-X
intronic B-X
variants B-X
in B-X
Cowden B-X
syndrome B-X
PDF B-X
| B-X
We B-X
have B-X
developed B-X
a B-X
procedure B-X
for B-X
nonradioactive B-X
single B-X
strand B-X
conformation B-X
polymorphism B-X
analysis B-X
and B-X
applied B-X
it B-X
to B-X
the B-X
detection B-X
of B-X
point B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Request B-X
PDF B-X
| B-X
A B-X
comparison B-X
of B-X
fluorescent B-X
SSCP B-X
and B-X
denaturing B-X
HPLC B-X
for B-X
high B-X
throughput B-X
mutation B-X
scanning B-X
| B-X
We B-X
examined B-X
67 B-X
different B-X
mutations B-X
in B-X
16 B-X
different B-X
amplicons B-X
in B-X
a B-X
comparison B-X
of B-X
Request B-X
PDF B-X
| B-X
The B-X
position B-X
of B-X
premature B-X
termination B-X
codons B-X
in B-X
the B-X
hepatocyte B-X
nuclear B-X
factor-1 B-X
? B-X
? B-X
gene B-X
determines B-X
susceptibility B-X
to B-X
nonsense-mediated B-X
decay B-X
| B-X
The B-X
nonsense-mediated B-X
decay B-X
( B-X
NMD B-X
) B-X
pathway B-X
Analysis B-X
of B-X
GNAS1 B-X
and B-X
Overlapping B-X
Transcripts B-X
Identifies B-X
the B-X
Parental B-X
Origin B-X
of B-X
Mutations B-X
in B-X
Patients B-X
with B-X
Sporadic B-X
Albright B-X
Hereditary B-X
Osteodystrophy B-X
and B-X
Reveals B-X
a B-X
Model B-X
System B-X
in B-X
Which B-X
to B-X
Observe B-X
the B-X
Effects B-X

Four	O
patients	O
also	O
showed	O
rare	O
sequence	O
variants	O
.	O
<EOS> B-X
Five B-X
major B-X
sequence B-X
variants B-X
and B-X
copy B-X
number B-X
variants B-X
in B-X
the B-X
EYS B-X
gene B-X
account B-X
for B-X
one-third B-X
of B-X
Japanese B-X
patients B-X
with B-X
autosomal B-X
recessive B-X
and B-X
simplex B-X
retinitis B-X
pigmentosa B-X
Multiple B-X
rare B-X
variants B-X
in B-X
high-risk B-X
pancreatic B-X
cancer B-X
related B-X
genes B-X
may B-X
increase B-X
risk B-X
for B-X
pancreatic B-X
cancer B-X
in B-X
a B-X
subset B-X
of B-X
patients B-X
with B-X
and B-X
without B-X
germline B-X
CDKN2A B-X
mutations B-X
Prioritization B-X
and B-X
burden B-X
analysis B-X
of B-X
rare B-X
variants B-X
in B-X
208 B-X
candidate B-X
genes B-X
suggest B-X
they B-X
do B-X
not B-X
play B-X
a B-X
major B-X
role B-X
in B-X
CAKUT B-X
- B-X
ScienceDirect B-X
Inherited B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
are B-X
known B-X
to B-X
confer B-X
a B-X
predisposition B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
We B-X
have B-X
first B-X
characterized B-X
19 B-X
sequence B-X
variants B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
during B-X
Rare B-X
Variants B-X
in B-X
Neurodegeneration B-X
Associated B-X
Genes B-X
Revealed B-X
by B-X
Targeted B-X
Panel B-X
Sequencing B-X
in B-X
a B-X
German B-X
ALS B-X
Cohort B-X
Excess B-X
of B-X
Rare B-X
Variants B-X
in B-X
Genes B-X
that B-X
are B-X
Key B-X
Epigenetic B-X
Regulators B-X
of B-X
Spermatogenesis B-X
in B-X
the B-X
Patients B-X
with B-X
Non-Obstructive B-X
Azoospermia B-X
Next-generation B-X
sequencing B-X
( B-X
NGS B-X
) B-X
technology B-X
has B-X
improved B-X
enough B-X
to B-X
discover B-X
mutations B-X
associated B-X
with B-X
genetic B-X
diseases B-X
. B-X
Our B-X
study B-X
evaluated B-X
the B-X
feasibility B-X
of B-X
targeted B-X
NGS B-X
as B-X
a B-X
primary B-X
screening B-X
tool B-X

No	O
region	O
of	O
the	O
RB1	O
gene	O
was	O
preferentially	O
involved	O
in	O
single	O
base	O
substitutions	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Conservation B-X
of B-X
the B-X
RB1 B-X
gene B-X
in B-X
human B-X
and B-X
primates B-X
| B-X
Mutations B-X
in B-X
the B-X
RB1 B-X
gene B-X
are B-X
associated B-X
with B-X
retinoblastoma B-X
, B-X
which B-X
has B-X
served B-X
as B-X
an B-X
important B-X
model B-X
Origin B-X
of B-X
mutations B-X
in B-X
genes B-X
associated B-X
with B-X
human B-X
glioblastoma B-X
multiform B-X
cancer B-X
: B-X
random B-X
polymerase B-X
errors B-X
versus B-X
deamination B-X
Security B-X
validation B-X
- B-X
VarSome B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Example B-X
of B-X
RT-PCR B-X
analysis B-X
of B-X
the B-X
region B-X
from B-X
exon B-X
6 B-X
to B-X
exon B-X
21. B-X
cDNAs B-X
derived B-X
from B-X
skin B-X
fibroblasts B-X
( B-X
RB188 B-X
, B-X
RB210 B-X
, B-X
RB219 B-X
, B-X
RB229 B-X

Recurrent	O
transitions	O
were	O
observed	O
at	O
most	O
of	O
the	O
14	O
codons	O
within	O
the	O
RB1	O
.	O
<EOS> B-X
We B-X
have B-X
searched B-X
for B-X
germ-line B-X
RB1 B-X
mutations B-X
in B-X
119 B-X
patients B-X
with B-X
hereditary B-X
retinoblastoma B-X
. B-X
Previous B-X
investigations B-X
by B-X
Southern B-X
blot B-X
hybridization B-X
and B-X
PCR B-X
fragment-length B-X
analysis B-X
had B-X
revealed B-X
mutations B-X
in B-X
48 B-X
patients B-X
Alterations B-X
in B-X
the B-X
RB1 B-X
gene B-X
in B-X
Pakistani B-X
patients B-X
with B-X
retinoblastoma B-X
using B-X
direct B-X
sequencing B-X
analysis B-X
RB1 B-X
gene B-X
mutation B-X
up-date B-X
, B-X
a B-X
meta-analysis B-X
based B-X
on B-X
932 B-X
reported B-X
mutations B-X
available B-X
in B-X
a B-X
searchable B-X
database B-X
PDF B-X
| B-X
Objectives B-X
: B-X
To B-X
detect B-X
mutations B-X
and B-X
single B-X
nucleotide B-X
polymorphisms B-X
( B-X
SNPs B-X
) B-X
in B-X
N-and B-X
C-termini B-X
of B-X
RB1 B-X
and B-X
to B-X
determine B-X
the B-X
association B-X
of B-X
these B-X
... B-X
| B-X
Find B-X
, B-X
Spectrum B-X
of B-X
germ-line B-X
RB1 B-X
gene B-X
mutations B-X
in B-X
Malaysian B-X
patients B-X
with B-X
retinoblastoma B-X
We B-X
have B-X
shown B-X
previously B-X
that B-X
the B-X
most B-X
common B-X
point B-X
mutation B-X
in B-X
the B-X
RBI B-X
gene B-X
in B-X
retinoblastoma B-X
tumours B-X
is B-X
a B-X
C‚ÜíT B-X
transition B-X
and B-X
that B-X
the B-X
majority B-X
of B-X
these B-X
occur B-X
in B-X
CGAarg B-X
Request B-X
PDF B-X
| B-X
Genetic B-X
screening B-X
in B-X
Iranian B-X
patients B-X
with B-X
retinoblastoma B-X
| B-X
PurposeThe B-X
most B-X
common B-X
intraocular B-X
tumor B-X
in B-X
childhood B-X
, B-X
retinoblastoma B-X
, B-X
is B-X
largely B-X
associated B-X
with B-X
mutations B-X
in B-X
the B-X
RB1 B-X
gene B-X

No	O
mutation	O
was	O
observed	O
in	O
exons	O
25	O
-	O
27	O
,	O
although	O
this	O
region	O
contains	O
two	O
CGA	O
codons	O
.	O
<EOS> B-X
Minor B-X
Lesion B-X
Mutational B-X
Spectrum B-X
of B-X
the B-X
Entire B-X
NF1 B-X
Gene B-X
Does B-X
Not B-X
Explain B-X
Its B-X
High B-X
Mutability B-X
but B-X
Points B-X
to B-X
a B-X
Functional B-X
Domain B-X
Upstream B-X
of B-X
the B-X
GAP-Related B-X
Domain B-X
Prognostic B-X
Significance B-X
of B-X
p53 B-X
Codon B-X
72 B-X
Polymorphism B-X
Differs B-X
with B-X
Race B-X
in B-X
Colorectal B-X
Adenocarcinoma B-X

This	O
suggests	O
that	O
mutations	O
within	O
the	O
3	O
-	O
terminal	O
region	O
of	O
the	O
RB1	O
gene	O
may	O
not	O
be	O
oncogenic	O
.	O

When	O
these	O
data	O
were	O
combined	O
with	O
the	O
results	O
of	O
our	O
previous	O
investigations	O
,	O
mutations	O
were	O
identified	O
in	O
a	O
total	O
of	O
99	O
(	O
83	O
%	O
)	O
of	O
119	O
patients	O
.	O
<EOS> B-X
The B-X
spectrum B-X
of B-X
RB1 B-X
germ-line B-X
mutations B-X
in B-X
hereditary B-X
retinoblastoma B-X
. B-X
Hypomyelinating B-X
disorders B-X
in B-X
China B-X
: B-X
The B-X
clinical B-X
and B-X
genetic B-X
heterogeneity B-X
in B-X
119 B-X
patients B-X
Specific B-X
gyrA B-X
gene B-X
mutations B-X
predict B-X
poor B-X
treatment B-X
outcome B-X
in B-X
MDR-TB B-X
Novel B-X
transglutaminase-1 B-X
mutations B-X
and B-X
genotype‚Äìphenotype B-X
investigations B-X
of B-X
104 B-X
patients B-X
with B-X
autosomal B-X
recessive B-X
congenital B-X
ichthyosis B-X
in B-X
the B-X
USA B-X
Request B-X
PDF B-X
| B-X
Novel B-X
RB1 B-X
gene B-X
constitutional B-X
mutations B-X
found B-X
in B-X
Polish B-X
patients B-X
with B-X
familial B-X
and/or B-X
bilateral B-X
retinoblastoma B-X
| B-X
Retinoblastoma B-X
is B-X
the B-X
most B-X
common B-X
intraocular B-X
malignancy B-X
in B-X
children B-X
. B-X
It B-X
is B-X
Missense B-X
mutations B-X
in B-X
the B-X
TP53 B-X
DNA-binding B-X
domain B-X
predict B-X
outcomes B-X
in B-X
patients B-X
with B-X
advanced B-X
oral B-X
cavity B-X
squamous B-X
cell B-X
carcinoma B-X
The B-X
promising B-X
expectations B-X
about B-X
personalized B-X
medicine B-X
have B-X
opened B-X
the B-X
path B-X
to B-X
routine B-X
large-scale B-X
sequencing B-X
and B-X
increased B-X
the B-X
importance B-X
of B-X
genetic B-X
counseling B-X
for B-X
hereditary B-X
cancers B-X
, B-X
among B-X
which B-X
hereditary B-X
breast B-X
and B-X

The	O
spectrum	O
comprises	O
15	O
%	O
large	O
deletions	O
,	O
26	O
%	O
small	O
length	O
alterations	O
,	O
and	O
42	O
%	O
base	O
substitutions	O
.	O
<EOS> B-X
A B-X
genome-wide B-X
view B-X
of B-X
the B-X
spectrum B-X
of B-X
spontaneous B-X
mutations B-X
in B-X
yeast B-X
| B-X
PNAS B-X
Old B-X
Trade B-X
, B-X
New B-X
Tricks B-X
: B-X
Insights B-X
into B-X
the B-X
Spontaneous B-X
Mutation B-X
Process B-X
from B-X
the B-X
Partnering B-X
of B-X
Classical B-X
Mutation B-X
Accumulation B-X
Experiments B-X
with B-X
High-Throughput B-X
Genomic B-X
Approaches B-X
Prophage-Driven B-X
Genomic B-X
Structural B-X
Changes B-X
Promote B-X
Bartonella B-X
Vertical B-X
Evolution B-X
The B-X
diversity B-X
of B-X
somatic B-X
mutations B-X
in B-X
human B-X
cancers B-X
can B-X
be B-X
decomposed B-X
into B-X
individual B-X
mutational B-X
signatures B-X
, B-X
patterns B-X
of B-X
mutagenesis B-X
that B-X
arise B-X
because B-X
of B-X
DNA B-X
damage B-X
and B-X
DNA B-X
repair B-X
processes B-X
that B-X

No	O
correlation	O
between	O
the	O
location	O
of	O
frameshift	O
or	O
nonsense	O
mutations	O
and	O
phenotypic	O
features	O
,	O
including	O
age	O
at	O
diagnosis	O
,	O
the	O
number	O
of	O
tumor	B-Disease
foci	O
,	O
and	O
manifestation	O
of	O
nonocular	B-Disease
tumors	I-Disease
was	O
observed	O
.	O
.	O
<EOS> B-X
Antibiotic B-X
resistance B-X
by B-X
high-level B-X
intrinsic B-X
suppression B-X
of B-X
a B-X
frameshift B-X
mutation B-X
in B-X
an B-X
essential B-X
gene B-X
| B-X
PNAS B-X
A B-X
review B-X
of B-X
693 B-X
patients B-X
with B-X
bilateral B-X
retinoblastoma B-X
and B-X
18 B-X
patients B-X
with B-X
unilateral/germinal B-X
retinoblastoma B-X
was B-X
carried B-X
out B-X
to B-X
find B-X
the B-X
incidence B-X
, B-X
time B-X
, B-X
course B-X
and B-X
pattern B-X
of B-X
second B-X
nonocular B-X
Guidelines B-X
on B-X
the B-X
diagnosis B-X
and B-X
treatment B-X
of B-X
breast B-X
cancer B-X
( B-X
2011 B-X
edition B-X
) B-X
Visual B-X
disturbances B-X
in B-X
advanced B-X
cancer B-X
patients B-X
are B-X
very B-X
rarely B-X
signaled B-X
, B-X
evaluated B-X
, B-X
or B-X
adequately B-X
treated B-X
. B-X
The B-X
main B-X
causes B-X
of B-X
sight B-X
disturbances B-X
are B-X
primary B-X
eye B-X
tumors B-X
, B-X
ocular B-X
metastases B-X
In B-X
this B-X
report B-X
, B-X
we B-X
assessed B-X
how B-X
the B-X
incidence B-X
of B-X
metastatic B-X
prostate B-X
cancer B-X
has B-X
changed B-X
over B-X
recent B-X
years B-X
, B-X
and B-X
forecast B-X
future B-X
incidence B-X
trends B-X
and B-X
the B-X
number B-X
of B-X
new B-X
cases B-X
Single B-X
Foci B-X
Prostate B-X
Cancer B-X
: B-X
Current B-X
Diagnosis B-X
and B-X
Management B-X
Effect B-X
of B-X
Mutation B-X
Type B-X
and B-X
Location B-X
on B-X
Clinical B-X
Outcome B-X
in B-X
1,013 B-X
Probands B-X
with B-X
Marfan B-X
Syndrome B-X
or B-X
Related B-X
Phenotypes B-X
and B-X
FBN1 B-X
Mutations B-X
: B-X
An B-X
International B-X
Study B-X
- B-X
ScienceDirect B-X

Phenotypic	O
characterization	O
of	O
individuals	O
with	O
30	O
-	O
40	O
CAG	O
repeats	O
in	O
the	O
Huntington	B-Disease
disease	I-Disease
(	O
HD	B-Disease
)	O
gene	O
reveals	O
HD	B-Disease
cases	O
with	O
36	O
repeats	O
and	O
apparently	O
normal	O
elderly	O
individuals	O
with	O
36	O
-	O
39	O
repeats	O
.	O

Abnormal	O
CAG	O
expansions	O
in	O
the	O
IT	O
-	O
15	O
gene	O
are	O
associated	O
with	O
Huntington	B-Disease
disease	I-Disease
(	O
HD	B-Disease
)	O
.	O
<EOS> B-X
Identification B-X
of B-X
an B-X
expanded B-X
CAG B-X
repeat B-X
in B-X
the B-X
Huntington B-X
's B-X
disease B-X
gene B-X
( B-X
IT15 B-X
) B-X
in B-X
a B-X
family B-X
reported B-X
to B-X
have B-X
benign B-X
hereditary B-X
chorea B-X
. B-X
The B-X
abnormal B-X
expansion B-X
of B-X
a B-X
‚â•36 B-X
CAG B-X
unit B-X
tract B-X
in B-X
the B-X
Huntingtin B-X
gene B-X
( B-X
HTT B-X
) B-X
leads B-X
to B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
, B-X
but B-X
has B-X
also B-X
been B-X
associated B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
an B-X
inherited B-X
neurodegenerative B-X
disorder B-X
associated B-X
with B-X
expansion B-X
of B-X
a B-X
CAG B-X
repeat B-X
in B-X
the B-X
IT15 B-X
gene B-X
. B-X
The B-X
IT15 B-X
gene B-X
is B-X
translated B-X
to B-X
a B-X
Characterization B-X
of B-X
the B-X
Huntington B-X
intermediate B-X
CAG B-X
repeat B-X
expansion B-X
phenotype B-X
in B-X
PHAROS B-X
A B-X
trinucleotide B-X
repeat B-X
( B-X
CAG B-X
) B-X
expansion B-X
in B-X
the B-X
huntingtin B-X
gene B-X
causes B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
. B-X
In B-X
brain B-X
tissue B-X
from B-X
HD B-X
heterozygotes B-X
with B-X
adult B-X
onset B-X
and B-X
more B-X
Expansion B-X
of B-X
polyglutamine B-X
repeat B-X
in B-X
huntingtin B-X
leads B-X
to B-X
abnormal B-X
protein B-X
interactions B-X
involving B-X
calmodulin B-X
. B-X

In	O
the	O
diagnostic	O
setting	O
it	O
is	O
necessary	O
to	O
define	O
the	O
limits	O
of	O
the	O
CAG	O
size	O
ranges	O
on	O
normal	O
and	O
HD	B-Disease
-	O
associated	O
chromosomes	O
.	O
<EOS> B-X
CAG-Repeat B-X
Length B-X
and B-X
the B-X
Age B-X
of B-X
Onset B-X
in B-X
Huntington B-X
Disease B-X
( B-X
HD B-X
) B-X
: B-X
A B-X
Review B-X
and B-X
Validation B-X
Study B-X
of B-X
Statistical B-X
Approaches B-X
CAG B-X
repeat B-X
expansions B-X
with B-X
loss B-X
of B-X
CAT B-X
interruptions B-X
in B-X
the B-X
coding B-X
region B-X
of B-X
the B-X
ataxin-1 B-X
gene B-X
are B-X
associated B-X
with B-X
spinocerebellar B-X
ataxia B-X
type B-X
1 B-X
( B-X
SCA1 B-X
) B-X
. B-X
For B-X
molecular B-X
genetic B-X
One B-X
mission B-X
of B-X
the B-X
ACMG B-X
Laboratory B-X
Quality B-X
Assurance B-X
( B-X
QA B-X
) B-X
Committee B-X
is B-X
to B-X
develop B-X
standards B-X
and B-X
guidelines B-X
for B-X
clinical B-X
genetics B-X
laboratories B-X
, B-X
including B-X
cytogenetics B-X
, B-X
biochemical B-X
, B-X
and B-X
molecular B-X
Huntington B-X
disease B-X
is B-X
an B-X
autosomal-dominant B-X
neurodegenerative B-X
disease B-X
of B-X
mid-life B-X
onset B-X
caused B-X
by B-X
expansion B-X
of B-X
a B-X
polymorphic B-X
trinucleotide B-X
( B-X
CAG B-X
) B-X
repeat B-X
. B-X
Variable B-X
penetrance B-X
for B-X
alleles B-X
carrying B-X
36‚Äì39 B-X
repeats B-X
has B-X
Triplet B-X
Repeat B-X
Primed B-X
PCR B-X
Simplifies B-X
Testing B-X
for B-X
Huntington B-X
Disease B-X
- B-X
ScienceDirect B-X
Despite B-X
the B-X
progress B-X
in B-X
the B-X
knowledge B-X
of B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
in B-X
recent B-X
years B-X
, B-X
the B-X
epidemiology B-X
continues B-X
uncertain B-X
, B-X
so B-X
the B-X
study B-X
of B-X
incidence B-X
becomes B-X
relevant B-X
. B-X
This B-X

Most	O
large	O
analyses	O
that	O
defined	O
the	O
limits	O
of	O
the	O
normal	O
and	O
pathological	O
size	O
ranges	O
employed	O
PCR	O
assays	O
,	O
which	O
included	O
the	O
CAG	O
repeats	O
and	O
a	O
CCG	O
repeat	O
tract	O
that	O
was	O
thought	O
to	O
be	O
invariant	O
.	O
<EOS> B-X
An B-X
overview B-X
of B-X
technical B-X
considerations B-X
when B-X
using B-X
quantitative B-X
real-time B-X
PCR B-X
analysis B-X
of B-X
gene B-X
expression B-X
in B-X
human B-X
exercise B-X
research B-X
Methods B-X
to B-X
determine B-X
limit B-X
of B-X
detection B-X
and B-X
limit B-X
of B-X
quantification B-X
in B-X
quantitative B-X
real-time B-X
PCR B-X
( B-X
qPCR B-X
) B-X
Real-Time B-X
PCR B-X
in B-X
Clinical B-X
Microbiology B-X
: B-X
Applications B-X
for B-X
Routine B-X
Laboratory B-X
Testing B-X
cag B-X
repeat B-X
tracts B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
Request B-X
PDF B-X
| B-X
Mosaicism B-X
of B-X
the B-X
CAG B-X
repeat B-X
sequence B-X
in B-X
the B-X
Huntington B-X
disease B-X
gene B-X
in B-X
a B-X
pair B-X
of B-X
monozygotic B-X
twins B-X
| B-X
We B-X
report B-X
on B-X
a B-X
pair B-X
of B-X
monozygotic B-X
twins B-X
belonging B-X
The B-X
College B-X
of B-X
American B-X
Pathologists B-X
offers B-X
biannual B-X
proficiency B-X
testing B-X
for B-X
molecular B-X
analysis B-X
of B-X
fragile B-X
X B-X
syndrome B-X
. B-X
The B-X
purpose B-X
of B-X
this B-X
study B-X
was B-X
to B-X
analyze B-X
laboratory B-X
performance B-X
on B-X
the B-X
fragile B-X
Phenotypic B-X
Characterization B-X
of B-X
Individuals B-X
with B-X
30‚Äì40 B-X
CAG B-X
Repeats B-X
in B-X
the B-X
Huntington B-X
Disease B-X
( B-X
HD B-X
) B-X
Gene B-X
Reveals B-X
HD B-X
Cases B-X
with B-X
36 B-X
Repeats B-X
and B-X
Apparently B-X
Normal B-X
Elderly B-X
Individuals B-X
with B-X
36‚Äì39 B-X
Repeats B-X

Many	O
of	O
these	O
experiments	O
found	O
an	O
overlap	O
between	O
the	O
normal	O
and	O
disease	O
size	O
ranges	O
.	O
<EOS> B-X
Learn B-X
how B-X
to B-X
choose B-X
the B-X
right B-X
read B-X
length B-X
for B-X
your B-X
next-generation B-X
sequencing B-X
run B-X
. B-X
Analysis B-X
of B-X
the B-X
RNA B-X
content B-X
of B-X
the B-X
exosomes B-X
derived B-X
from B-X
blood B-X
serum B-X
and B-X
urine B-X
and B-X
its B-X
potential B-X
as B-X
biomarkers B-X
Sequencing B-X
coverage B-X
requirements B-X
vary B-X
by B-X
application B-X
. B-X
Find B-X
out B-X
how B-X
to B-X
estimate B-X
and B-X
achieve B-X
your B-X
desired B-X
NGS B-X
coverage B-X
level B-X
. B-X
Five B-X
Years B-X
of B-X
GWAS B-X
Discovery B-X
RNA-Seq B-X
: B-X
a B-X
revolutionary B-X
tool B-X
for B-X
transcriptomics B-X
The B-X
UK B-X
Biobank B-X
project B-X
is B-X
a B-X
prospective B-X
cohort B-X
study B-X
with B-X
deep B-X
genetic B-X
and B-X
phenotypic B-X
data B-X
collected B-X
on B-X
approximately B-X
500,000 B-X
individuals B-X
from B-X
across B-X
the B-X
United B-X
Kingdom B-X
, B-X
aged B-X
between B-X
40 B-X
and B-X
The B-X
majority B-X
of B-X
cellular B-X
processes B-X
are B-X
carried B-X
out B-X
by B-X
protein B-X
complexes B-X
. B-X
Various B-X
size B-X
fractionation B-X
methods B-X
have B-X
previously B-X
been B-X
combined B-X
with B-X
mass B-X
spectrometry B-X
to B-X
identify B-X
protein B-X
complexes B-X
. B-X
However B-X
, B-X

Subsequent	O
findings	O
that	O
the	O
CCG	O
repeats	O
vary	O
by	O
8	O
trinucleotide	O
lengths	O
suggested	O
that	O
the	O
limits	O
of	O
the	O
normal	O
and	O
disease	O
size	O
ranges	O
should	O
be	O
reevaluated	O
with	O
assays	O
that	O
exclude	O
the	O
CCG	O
polymorphism	O
.	O

Since	O
patients	O
with	O
between	O
30	O
and	O
40	O
repeats	O
are	O
rare	O
,	O
a	O
consortium	O
was	O
assembled	O
to	O
collect	O
such	O
individuals	O
.	O
<EOS> B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Author B-X
summary B-X
The B-X
Y B-X
chromosome B-X
is B-X
extraordinary B-X
in B-X
many B-X
respects B-X
; B-X
it B-X
is B-X
non-recombining B-X
along B-X
most B-X
of B-X
its B-X
length B-X
, B-X
it B-X
carries B-X
many B-X
testis-expressed B-X
genes B-X
that B-X
are B-X
often B-X
found B-X
in B-X
In B-X
some B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
patients B-X
, B-X
the B-X
‚Äú B-X
loss B-X
of B-X
interruption B-X
‚Äù B-X
( B-X
LOI B-X
) B-X
variant B-X
eliminates B-X
an B-X
interrupting B-X
codon B-X
in B-X
the B-X
HTT B-X
CAG-repeat B-X
tract B-X
, B-X
which B-X
In B-X
some B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
patients B-X
, B-X
the B-X
‚Äú B-X
loss B-X
of B-X
interruption B-X
‚Äù B-X
( B-X
LOI B-X
) B-X
variant B-X
eliminates B-X
an B-X
interrupting B-X
codon B-X
in B-X
the B-X
HTT B-X
CAG-repeat B-X
tract B-X
, B-X
which B-X
Human B-X
Genome B-X
Sequencing B-X
in B-X
Health B-X
and B-X
Disease B-X
Publisher B-X
of B-X
over B-X
50 B-X
scientific B-X
journals B-X
across B-X
the B-X
life B-X
, B-X
physical B-X
, B-X
earth B-X
, B-X
and B-X
health B-X
sciences B-X
, B-X
both B-X
independently B-X
and B-X
in B-X
partnership B-X
with B-X
scientific B-X
societies B-X
including B-X
Cell B-X
, B-X
Neuron B-X

All	O
178	O
samples	O
were	O
reanalyzed	O
in	O
Cambridge	O
by	O
using	O
assays	O
specific	O
for	O
the	O
CAG	O
repeats	O
.	O
<EOS> B-X
We B-X
have B-X
developed B-X
a B-X
sequence-specific B-X
internal B-X
DNA B-X
size B-X
standard B-X
for B-X
the B-X
accurate B-X
determination B-X
of B-X
the B-X
number B-X
of B-X
CAG B-X
repeats B-X
in B-X
the B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
gene B-X
by B-X
cloning B-X
key B-X
A B-X
genetic B-X
association B-X
study B-X
of B-X
glutamine-encoding B-X
DNA B-X
sequence B-X
structures B-X
, B-X
somatic B-X
CAG B-X
expansion B-X
, B-X
and B-X
DNA B-X
repair B-X
gene B-X
variants B-X
, B-X
with B-X
Huntington B-X
disease B-X
clinical B-X
outcomes B-X
CAG B-X
Repeat B-X
Not B-X
Polyglutamine B-X
Length B-X
Determines B-X
Timing B-X
of B-X
Huntington B-X
‚Äô B-X
s B-X
Disease B-X
Onset B-X
Genotypes B-X
at B-X
the B-X
GluR6 B-X
kainate B-X
receptor B-X
locus B-X
are B-X
associated B-X
with B-X
variation B-X
in B-X
the B-X
age B-X
of B-X
onset B-X
of B-X
Huntington B-X
disease B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X

We	O
have	O
optimized	O
methods	O
for	O
reliable	O
sizing	O
of	O
CAG	O
repeats	O
and	O
show	O
cases	O
that	O
demonstrate	O
the	O
dangers	O
of	O
using	O
PCR	O
assays	O
that	O
include	O
both	O
the	O
CAG	O
and	O
CCG	O
polymorphisms	O
.	O
<EOS> B-X
Detailed B-X
analysis B-X
of B-X
HTT B-X
repeat B-X
elements B-X
in B-X
human B-X
blood B-X
using B-X
targeted B-X
amplification‚Äêfree B-X
long‚Äêread B-X
sequencing B-X
Robust B-X
Preimplantation B-X
Genetic B-X
Testing B-X
of B-X
Huntington B-X
Disease B-X
by B-X
Combined B-X
Triplet-Primed B-X
PCR B-X
Analysis B-X
of B-X
the B-X
HTT B-X
CAG B-X
Repeat B-X
and B-X
Multi-Microsatellite B-X
Haplotyping B-X
Phenotypic B-X
characterization B-X
of B-X
individuals B-X
with B-X
30-40 B-X
CAG B-X
repeats B-X
in B-X
the B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
gene B-X
reveals B-X
HD B-X
cases B-X
with B-X
36 B-X
repeats B-X
and B-X
apparently B-X
normal B-X
elderly B-X
individuals B-X
with B-X
36-39 B-X
repeats B-X

Seven	O
HD	B-Disease
patients	O
had	O
36	O
repeats	O
,	O
which	O
confirms	O
that	O
this	O
allele	O
is	O
associated	O
with	O
disease	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Controversy B-X
persists B-X
concerning B-X
the B-X
significance B-X
of B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
alleles B-X
in B-X
the B-X
36‚Äì39 B-X
repeat B-X
range B-X
. B-X
Although B-X
some B-X
clinically B-X
affected B-X
perso B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Pedigree B-X
of B-X
family B-X
2 B-X
and B-X
autoradiograph B-X
of B-X
a B-X
gel B-X
showing B-X
the B-X
number B-X
of B-X
from B-X
publication B-X
: B-X
Study B-X
of B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
gene B-X
CAG B-X
The B-X
gene B-X
for B-X
spinocerebellar B-X
ataxia B-X
type B-X
2 B-X
( B-X
SCA2 B-X
) B-X
has B-X
been B-X
mapped B-X
to B-X
12q24.1 B-X
. B-X
A1.1‚Äìmegabase B-X
contig B-X
in B-X
the B-X
candidate B-X
region B-X
was B-X
assembled B-X
in B-X
P1 B-X
artificial B-X
chromosome B-X
and B-X
bacterial B-X
Despite B-X
the B-X
progress B-X
in B-X
the B-X
knowledge B-X
of B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
in B-X
recent B-X
years B-X
, B-X
the B-X
epidemiology B-X
continues B-X
uncertain B-X
, B-X
so B-X
the B-X
study B-X
of B-X
incidence B-X
becomes B-X
relevant B-X
. B-X
This B-X

Individuals	O
without	O
apparent	O
symptoms	O
or	O
signs	O
of	O
HD	B-Disease
were	O
found	O
at	O
36	O
repeats	O
(	O
aged	O
74	O
,	O
78	O
,	O
79	O
,	O
and	O
87	O
years	O
)	O
,	O
37	O
repeats	O
(	O
aged	O
69	O
years	O
)	O
,	O
38	O
repeats	O
(	O
aged	O
69	O
and	O
90	O
years	O
)	O
,	O
and	O
39	O
repeats	O
(	O
aged	O
67	O
,	O
90	O
,	O
and	O
95	O
years	O
)	O
.	O
<EOS> B-X
Annual B-X
mid-year B-X
population B-X
estimates B-X
for B-X
people B-X
aged B-X
90 B-X
years B-X
and B-X
over B-X
by B-X
sex B-X
and B-X
single B-X
year B-X
of B-X
age B-X
( B-X
90 B-X
to B-X
104 B-X
) B-X
and B-X
105 B-X
years B-X
and B-X
over B-X
, B-X
and B-X
Outcomes B-X
of B-X
surgery B-X
in B-X
patients B-X
aged B-X
‚â•90 B-X
years B-X
in B-X
the B-X
general B-X
surgical B-X
setting B-X
Phenotypic B-X
characterization B-X
of B-X
individuals B-X
with B-X
30-40 B-X
CAG B-X
repeats B-X
in B-X
the B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
gene B-X
reveals B-X
HD B-X
cases B-X
with B-X
36 B-X
repeats B-X
and B-X
apparently B-X
normal B-X
elderly B-X
individuals B-X
with B-X
36-39 B-X
repeats B-X
Predictive B-X
testing B-X
for B-X
Huntington B-X
disease B-X
over B-X
24 B-X
years B-X
: B-X
Evolution B-X
of B-X
the B-X
profile B-X
of B-X
the B-X
participants B-X
and B-X
analysis B-X
of B-X
symptoms B-X
Want B-X
to B-X
live B-X
to B-X
90 B-X
years B-X
old B-X
? B-X
A B-X
new B-X
report B-X
reveals B-X
how B-X
you B-X
can B-X
. B-X
This B-X
study B-X
was B-X
done B-X
to B-X
review B-X
the B-X
reliability B-X
, B-X
durability B-X
, B-X
and B-X
safety B-X
of B-X
primary B-X
and B-X
revision B-X
total B-X
knee B-X
arthroplasty B-X
for B-X
patients B-X
90 B-X
years B-X
of B-X
age B-X
and B-X
older B-X
. B-X
Because B-X
Sleep B-X
and B-X
aging B-X
: B-X
1 B-X
. B-X
Sleep B-X
disorders B-X
commonly B-X
found B-X
in B-X
older B-X
people B-X

The	O
detailed	O
case	O
histories	O
of	O
an	O
exceptional	O
case	O
from	O
this	O
series	O
will	O
be	O
presented	O
a	O
95	O
-	O
year	O
-	O
old	O
man	O
with	O
39	O
repeats	O
who	O
did	O
not	O
have	O
classical	O
features	O
of	O
HD	B-Disease
.	O
<EOS> B-X
A B-X
Case B-X
of B-X
Previously B-X
Unsuspected B-X
Huntington B-X
Disease B-X
Diagnosed B-X
at B-X
Autopsy B-X
Request B-X
PDF B-X
| B-X
On B-X
Apr B-X
30 B-X
, B-X
2009 B-X
, B-X
Qi B-X
Zheng B-X
and B-X
others B-X
published B-X
Hunting B-X
for B-X
the B-X
function B-X
of B-X
Huntingtin B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
NEUROPATHOLOGICAL B-X
COMPARISON B-X
OF B-X
ADULT B-X
ONSET B-X
AND B-X
JUVENILE B-X
HUNTINGTON B-X
‚Äô B-X
S B-X
DISEASE B-X
WITH B-X
CEREBELLAR B-X
ATROPHY B-X
: B-X
A B-X
REPORT B-X
OF B-X
A B-X
FATHER B-X
AND B-X
SON B-X

The	O
apparently	O
healthy	O
survival	O
into	O
old	O
age	O
of	O
some	O
individuals	O
with	O
36	O
-	O
39	O
repeats	O
suggests	O
that	O
the	O
HD	B-Disease
mutation	O
may	O
not	O
always	O
be	O
fully	O
penetrant	O
.	O
.	O
<EOS> B-X
Phenotypic B-X
characterization B-X
of B-X
individuals B-X
with B-X
30-40 B-X
CAG B-X
repeats B-X
in B-X
the B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
gene B-X
reveals B-X
HD B-X
cases B-X
with B-X
36 B-X
repeats B-X
and B-X
apparently B-X
normal B-X
elderly B-X
individuals B-X
with B-X
36-39 B-X
repeats B-X
Huntington B-X
disease B-X
reduced B-X
penetrance B-X
alleles B-X
occur B-X
at B-X
high B-X
frequency B-X
in B-X
the B-X
general B-X
population B-X
PDF B-X
| B-X
To B-X
obtain B-X
penetrance B-X
data B-X
for B-X
Huntington B-X
's B-X
disease B-X
when B-X
DNA B-X
results B-X
are B-X
in B-X
the B-X
range B-X
of B-X
36-39 B-X
CAG B-X
repeats B-X
and B-X
assess B-X
the B-X
consistency B-X
of B-X
reporting B-X
... B-X
| B-X
Find B-X
Abnormal B-X
CAG B-X
expansions B-X
in B-X
the B-X
IT-15 B-X
gene B-X
are B-X
associated B-X
with B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
. B-X
In B-X
the B-X
diagnostic B-X
setting B-X
it B-X
is B-X
necessary B-X
to B-X
define B-X
the B-X
limits B-X
of B-X
the B-X
CAG B-X
Download B-X
Citation B-X
| B-X
Evidence-Based B-X
Genetic B-X
Counselling B-X
Implications B-X
for B-X
Huntington B-X
Disease B-X
Intermediate B-X
Allele B-X
Predictive B-X
Test B-X
Results B-X
. B-X
| B-X
Intermediate B-X
alleles B-X
( B-X
IA B-X
) B-X
for B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
contain B-X
27-35 B-X
Request B-X
PDF B-X
| B-X
International B-X
Huntington B-X
's B-X
Disease B-X
Collaborative B-X
Group B-X
. B-X
A B-X
new B-X
model B-X
for B-X
prediction B-X
of B-X
the B-X
age B-X
of B-X
onset B-X
and B-X
penetrance B-X
for B-X
Huntington B-X
's B-X
disease B-X
based B-X
on B-X
CAG B-X
length B-X
Request B-X
PDF B-X
| B-X
High B-X
Frequency B-X
of B-X
Intermediate B-X
Alleles B-X
on B-X
Huntington B-X
Disease-Associated B-X
Haplotypes B-X
in B-X
British B-X
Columbia B-X
's B-X
General B-X
Population B-X
| B-X
Intermediate B-X
alleles B-X
( B-X
27-35 B-X
CAG B-X
, B-X
IAs B-X
) B-X
for B-X
Huntington B-X
disease B-X

Identification	O
and	O
expression	O
of	O
eight	O
novel	O
mutations	O
among	O
non	O
-	O
Jewish	O
patients	O
with	O
Canavan	B-Disease
disease	I-Disease
.	O
<EOS> B-X
Canavan B-X
disease B-X
, B-X
an B-X
inherited B-X
leukodystrophy B-X
, B-X
is B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
aspartoacylase B-X
( B-X
ASPA B-X
) B-X
gene B-X
. B-X
It B-X
is B-X
most B-X
common B-X
among B-X
children B-X
of B-X
Ashkenazi B-X
Jewish B-X
descent B-X
but B-X
Canavan B-X
disease B-X
is B-X
inherited B-X
as B-X
an B-X
autosomal B-X
recessive B-X
trait B-X
that B-X
is B-X
caused B-X
by B-X
the B-X
deficiency B-X
of B-X
aspartoacylase B-X
( B-X
ASPA B-X
) B-X
. B-X
The B-X
majority B-X
of B-X
patients B-X
with B-X
Canavan B-X
disease B-X
are B-X
from B-X
Canavan B-X
disease B-X
, B-X
an B-X
inherited B-X
leukodystrophy B-X
, B-X
is B-X
caused B-X
by B-X
mutationsin B-X
the B-X
aspartoacylase B-X
( B-X
ASPA B-X
) B-X
gene B-X
. B-X
It B-X
is B-X
most B-X
common B-X
among B-X
children B-X
of B-X
Ashkenazi B-X
Jewish B-X
descent B-X
but B-X
has B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Canavan	B-Disease
disease	I-Disease
is	O
inherited	O
as	O
an	O
autosomal	O
recessive	O
trait	O
that	O
is	O
caused	O
by	O
the	O
deficiency	B-Disease
of	I-Disease
aspartoacylase	I-Disease
(	O
ASPA	O
)	O
.	O
<EOS> B-X
Canavan B-X
disease B-X
: B-X
mutations B-X
among B-X
Jewish B-X
and B-X
non-jewish B-X
patients B-X
. B-X
Canavan B-X
disease B-X
, B-X
also B-X
called B-X
Canavan-Van B-X
Bogaert-Bertrand B-X
disease B-X
, B-X
is B-X
a B-X
rare B-X
, B-X
progressive B-X
, B-X
and B-X
fatal B-X
neurological B-X
hereditary B-X
disorder B-X
that B-X
begins B-X
in B-X
infancy B-X
. B-X
It B-X
is B-X
part B-X
of B-X
a B-X
Aspartoacylase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Canavan B-X
Disease B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Canavan B-X
Disease B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
KEGG B-X
DISEASE B-X
: B-X
Canavan B-X
disease B-X

The	O
majority	O
of	O
patients	O
with	O
Canavan	B-Disease
disease	I-Disease
are	O
from	O
an	O
Ashkenazi	O
Jewish	O
background	O
.	O
<EOS> B-X
The B-X
Clinical B-X
Features B-X
and B-X
Diagnosis B-X
of B-X
Canavan B-X
‚Äô B-X
s B-X
Disease B-X
: B-X
A B-X
Case B-X
Series B-X
of B-X
Iranian B-X
Patients B-X
Canavan B-X
disease B-X
is B-X
a B-X
hereditary B-X
condition B-X
that B-X
's B-X
present B-X
at B-X
birth B-X
. B-X
Learn B-X
why B-X
it B-X
develops B-X
, B-X
its B-X
symptoms B-X
, B-X
and B-X
more B-X
. B-X
Canavan B-X
disease B-X
is B-X
inherited B-X
in B-X
an B-X
autosomal B-X
recessive B-X
manner B-X
. B-X
Each B-X
pregnancy B-X
of B-X
a B-X
couple B-X
in B-X
which B-X
both B-X
partners B-X
are B-X
heterozygous B-X
for B-X
a B-X
pathogenic B-X
variant B-X
in B-X
< B-X
i B-X
> B-X
ASPA B-X
Top B-X
of B-X
the B-X
page B-X

Mutations	O
in	O
ASPA	O
that	O
lead	O
to	O
loss	O
of	O
enzymatic	O
activity	O
have	O
been	O
identified	O
,	O
and	O
E285A	O
and	O
Y231X	O
are	O
the	O
two	O
predominant	O
mutations	O
that	O
account	O
for	O
97	O
%	O
of	O
the	O
mutant	O
chromosomes	O
in	O
Ashkenazi	O
Jewish	O
patients	O
.	O
<EOS> B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Effect B-X
of B-X
Mutation B-X
on B-X
ASPA B-X
Activity B-X
Observed B-X
in B-X
Vitro B-X
in B-X
Transient-Expression B-X
System B-X
from B-X
publication B-X
: B-X
Identification B-X
and B-X
expression B-X
of B-X
eight B-X
novel B-X
mutations B-X
among B-X
non-Jewish B-X
patients B-X
with B-X
PDF B-X
| B-X
Canavan B-X
disease B-X
( B-X
CD B-X
) B-X
is B-X
a B-X
fatal B-X
neurological B-X
disorder B-X
caused B-X
by B-X
defects B-X
in B-X
the B-X
gene B-X
that B-X
encodes B-X
for B-X
a B-X
critical B-X
metabolic B-X
enzyme B-X
. B-X
The B-X
enzyme B-X
... B-X
| B-X
Mutational B-X
Analysis B-X
of B-X
Aspartoacylase B-X
: B-X
Implications B-X
for B-X
Canavan B-X
Disease B-X
Clinically B-X
Distinct B-X
Phenotypes B-X
of B-X
Canavan B-X
Disease B-X
Correlate B-X
with B-X
Residual B-X
Aspartoacylase B-X
Enzyme B-X
Activity B-X
Canavan B-X
disease B-X
( B-X
CD B-X
) B-X
is B-X
a B-X
neurodegenerative B-X
disorder B-X
usually B-X
presenting B-X
in B-X
the B-X
first B-X
six B-X
months B-X
of B-X
life B-X
. B-X
CD B-X
patients B-X
can B-X
be B-X
identified B-X
via B-X
elevated B-X
levels B-X
of B-X
N-acetyl-l-aspartate B-X
in B-X
ASPA B-X
aspartoacylase B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Aspartoacylase B-X
- B-X
Wikipedia B-X

The	O
current	O
study	O
was	O
aimed	O
at	O
finding	O
the	O
molecular	O
basis	O
of	O
Canavan	B-Disease
disease	I-Disease
in	O
25	O
independent	O
patients	O
of	O
non	O
-	O
Jewish	O
background	O
.	O
<EOS> B-X
Identification B-X
and B-X
expression B-X
of B-X
eight B-X
novel B-X
mutations B-X
among B-X
non-Jewish B-X
patients B-X
with B-X
Canavan B-X
disease B-X
. B-X
PubMed B-X
journal B-X
article B-X
: B-X
Identification B-X
and B-X
expression B-X
of B-X
eight B-X
novel B-X
mutations B-X
among B-X
non-Jewish B-X
patients B-X
with B-X
Canavan B-X
disease B-X
. B-X
Download B-X
Prime B-X
PubMed B-X
App B-X
to B-X
iPhone B-X
, B-X
iPad B-X
, B-X
or B-X
Android B-X
Long-Term B-X
Follow-Up B-X
After B-X
Gene B-X
Therapy B-X
for B-X
Canavan B-X
Disease B-X
Canavan B-X
disease B-X
is B-X
an B-X
infantile B-X
neurodegenerative B-X
disease B-X
that B-X
is B-X
due B-X
to B-X
aspartoacylase B-X
deficiency B-X
. B-X
The B-X
disease B-X
has B-X
been B-X
reported B-X
mainly B-X
in B-X
Ashkenazi B-X
Jews B-X
but B-X
also B-X
occurs B-X
in B-X
other B-X
ethnic B-X
groups B-X
Download B-X
Citation B-X
| B-X
Canavan B-X
disease B-X
: B-X
Clinical B-X
features B-X
and B-X
recent B-X
advances B-X
in B-X
research B-X
| B-X
Canavan B-X
disease B-X
( B-X
CD B-X
) B-X
is B-X
a B-X
genetic B-X
neurodegenerative B-X
leukodystrophy B-X
that B-X
results B-X
in B-X
the B-X
spongy B-X
degeneration B-X
PDF B-X
| B-X
Canavan B-X
disease B-X
is B-X
characterized B-X
by B-X
macrocephaly B-X
, B-X
lack B-X
of B-X
head B-X
control B-X
, B-X
developmental B-X
delay B-X
, B-X
severe B-X
hypotonia B-X
‚Äì- B-X
> B-X
spasticity B-X
at B-X
later B-X
stages B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
Canavan B-X
Disease B-X
- B-X
NORD B-X
( B-X
National B-X
Organization B-X
for B-X
Rare B-X
Disorders B-X
) B-X

Eight	O
novel	O
and	O
three	O
previously	O
characterized	O
mutations	O
accounted	O
for	O
80	O
%	O
(	O
40	O
/	O
50	O
)	O
of	O
mutant	O
chromosomes	O
.	O
<EOS> B-X
Comprehensive B-X
Characterization B-X
of B-X
Cancer B-X
Driver B-X
Genes B-X
and B-X
Mutations B-X
Abstract B-X
. B-X
Rett B-X
syndrome B-X
( B-X
RTT B-X
) B-X
is B-X
a B-X
severe B-X
progressive B-X
neurological B-X
disorder B-X
that B-X
affects B-X
almost B-X
exclusively B-X
females B-X
, B-X
with B-X
an B-X
estimated B-X
prevalence B-X
of B-X
approximate B-X
Identification B-X
of B-X
Gene B-X
Mutations B-X
in B-X
Autosomal B-X
Dominant B-X
Polycystic B-X
Kidney B-X
Disease B-X
through B-X
Targeted B-X
Resequencing B-X
Purpose B-X
: B-X
Approximately B-X
20 B-X
% B-X
of B-X
patients B-X
with B-X
congenital B-X
absence B-X
of B-X
the B-X
vas B-X
deferens B-X
remain B-X
without B-X
two B-X
mutations B-X
identified B-X
. B-X
We B-X
applied B-X
a B-X
strategy B-X
of B-X
serial B-X
screening B-X
steps B-X
to B-X
45 B-X

The	O
A305E	O
missense	O
mutation	O
accounted	O
for	O
48	O
%	O
(	O
24	O
/	O
50	O
)	O
of	O
mutant	O
chromosomes	O
in	O
patients	O
of	O
western	O
European	O
descent	O
,	O
while	O
the	O
two	O
predominant	O
Jewish	O
mutations	O
each	O
accounted	O
for	O
a	O
single	O
mutant	O
chromosome	O
.	O
<EOS> B-X
Identification B-X
and B-X
expression B-X
of B-X
eight B-X
novel B-X
mutations B-X
among B-X
non-Jewish B-X
patients B-X
with B-X
Canavan B-X
disease B-X
. B-X
A B-X
founder B-X
mutation B-X
in B-X
the B-X
Ashkenazi B-X
Jewish B-X
population B-X
affecting B-X
mRNA B-X
splicing B-X
of B-X
the B-X
CCM2 B-X
gene B-X
is B-X
associated B-X
with B-X
Cerebral B-X
Cavernous B-X
Malformations B-X
Characterization B-X
of B-X
two B-X
Ashkenazi B-X
Jewish B-X
founder B-X
mutations B-X
in B-X
MSH6 B-X
gene B-X
causing B-X
Lynch B-X
syndrome B-X
A B-X
team B-X
led B-X
by B-X
researchers B-X
in B-X
the B-X
Basser B-X
Center B-X
for B-X
BRCA B-X
at B-X
the B-X
Abramson B-X
Cancer B-X
Center B-X
of B-X
the B-X
University B-X
of B-X
Pennsylvania B-X
detail B-X
the B-X
potential B-X
implications B-X
of B-X
a B-X
lower B-X
risk B-X
TP53 B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Niemann-Pick B-X
Disease B-X
( B-X
NPD B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
lysosomal B-X
storage B-X
disorder B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
acid B-X
sphingomyelinase B-X
( B-X
ASM B-X
) B-X
. B-X
NPD B-X
occurs B-X
in B-X
two B-X
forms B-X
, B-X
neuronopathic B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

The	O
eight	O
novel	O
mutations	O
identified	O
included	O
1	O
-	O
and	O
4	O
-	O
bp	O
deletions	O
(	O
32	O
deltaT	O
and	O
876	O
deltaAGAA	O
,	O
respectively	O
)	O
and	O
I16T	O
,	O
G27R	O
,	O
D114E	O
,	O
G123E	O
,	O
C152Y	O
,	O
and	O
R168C	O
missense	O
mutations	O
.	O
<EOS> B-X
We B-X
have B-X
identified B-X
a B-X
family B-X
segregating B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
with B-X
a B-X
previously B-X
unreported B-X
T547A B-X
mutation B-X
in B-X
exon B-X
1 B-X
of B-X
the B-X
VHL B-X
gene B-X
that B-X
causes B-X
a B-X
Tyr112 B-X
to B-X
These B-X
findings B-X
have B-X
important B-X
implications B-X
for B-X
in B-X
vitro B-X
functional B-X
studies B-X
, B-X
suggesting B-X
that B-X
the B-X
majority B-X
of B-X
missense B-X
mutations B-X
inactivate B-X
Madh4 B-X
by B-X
protein B-X
degradation B-X
in B-X
contrast B-X
to B-X
those B-X
that B-X
occur B-X
within B-X
Identification B-X
and B-X
expression B-X
of B-X
eight B-X
novel B-X
mutations B-X
among B-X
non-Jewish B-X
patients B-X
with B-X
Canavan B-X
disease B-X
. B-X
Genetic B-X
defects B-X
in B-X
distinct B-X
domains B-X
of B-X
the B-X
nuclear-envelope B-X
proteins B-X
lamin B-X
A B-X
and B-X
lamin B-X
C B-X
selectively B-X
cause B-X
dilated B-X
cardiomyopathy B-X
with B-X
conduction-system B-X
disease B-X
or B-X
autosomal B-X
dominant B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
. B-X
Missense B-X
mutations B-X
Canavan B-X
disease B-X
is B-X
inherited B-X
as B-X
an B-X
autosomal B-X
recessive B-X
trait B-X
that B-X
is B-X
caused B-X
by B-X
the B-X
deficiency B-X
of B-X
aspartoacylase B-X
( B-X
ASPA B-X
) B-X
. B-X
The B-X
majority B-X
of B-X
patients B-X
with B-X
Canavan B-X
disease B-X
are B-X
from B-X
Single-point B-X
mutation B-X
in B-X
genome B-X
, B-X
for B-X
example B-X
, B-X
single-nucleotide B-X
polymorphism B-X
( B-X
SNP B-X
) B-X
or B-X
rare B-X
genetic B-X
mutation B-X
, B-X
is B-X
the B-X
change B-X
of B-X
a B-X
single B-X
nucleotide B-X
for B-X
another B-X
in B-X
the B-X
genome B-X
PDF B-X
| B-X
In B-X
this B-X
work B-X
, B-X
the B-X
most B-X
detrimental B-X
missense B-X
mutations B-X
of B-X
aspartoacylase B-X
that B-X
cause B-X
Canavan B-X
's B-X
disease B-X
were B-X
identified B-X
computationally B-X
and B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X

The	O
homozygous	O
32	O
deltaT	O
deletion	O
was	O
identified	O
in	O
the	O
only	O
known	O
patient	O
of	O
African	O
-	O
American	O
origin	O
with	O
Canavan	B-Disease
disease	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Mutation B-X
Analysis B-X
of B-X
the B-X
Aspartoacylase B-X
Gene B-X
in B-X
Non-Jewish B-X
Patients B-X
with B-X
Canavan B-X
Disease B-X
| B-X
Whereas B-X
two B-X
mutations B-X
in B-X
the B-X
ASPA B-X
gene B-X
account B-X
for B-X
more B-X
than B-X
98 B-X
% B-X
of B-X
Request B-X
PDF B-X
| B-X
Rapid B-X
detection B-X
of B-X
three B-X
large B-X
novel B-X
deletions B-X
of B-X
the B-X
aspartoacylase B-X
gene B-X
in B-X
non-Jewish B-X
patients B-X
with B-X
Canavan B-X
disease B-X
| B-X
Canavan B-X
disease B-X
( B-X
CD B-X
) B-X
, B-X
an B-X
autosomal B-X
recessive B-X

The	O
heterozygosity	O
for	O
876	O
deltaAGAA	O
mutation	O
was	O
identified	O
in	O
three	O
independent	O
patients	O
from	O
England	O
.	O

Six	O
single	O
-	O
base	O
changes	O
leading	O
to	O
missense	O
mutations	O
were	O
identified	O
in	O
patients	O
from	O
Turkey	O
(	O
D114E	O
,	O
R168C	O
)	O
,	O
The	O
Netherlands	O
(	O
I16T	O
)	O
,	O
Germany	O
(	O
G27R	O
)	O
,	O
Ireland	O
(	O
C152Y	O
)	O
,	O
and	O
Canada	O
(	O
G123E	O
)	O
.	O
<EOS> B-X
The B-X
Netherlands B-X
began B-X
transferring B-X
COVID-19 B-X
patients B-X
to B-X
Germany B-X
again B-X
on B-X
Friday B-X
, B-X
as B-X
hospitals B-X
come B-X
under B-X
increasing B-X
strain B-X
from B-X
a B-X
second B-X
wave B-X
of B-X
infections B-X
. B-X
The B-X
Netherlands B-X
began B-X
transferring B-X
COVID-19 B-X
patients B-X
to B-X
Germany B-X
again B-X
on B-X
Friday B-X
, B-X
as B-X
hospitals B-X
come B-X
under B-X
increasing B-X
strain B-X
from B-X
a B-X
second B-X
wave B-X
of B-X
infections B-X
. B-X
The B-X
Netherlands B-X
began B-X
transferring B-X
COVID-19 B-X
patients B-X
to B-X
Germany B-X
again B-X
on B-X
Friday B-X
, B-X
as B-X
hospitals B-X
come B-X
under B-X
increasing B-X
strain B-X
from B-X
a B-X
second B-X
wave B-X
of B-X
infections B-X
. B-X
We B-X
have B-X
completely B-X
sequenced B-X
the B-X
adenine B-X
phosphoribosyltransferase B-X
( B-X
APRT B-X
) B-X
gene B-X
from B-X
each B-X
of B-X
six B-X
patients B-X
-- B-X
five B-X
( B-X
I-V B-X
) B-X
from B-X
Iceland B-X
and B-X
one B-X
( B-X
VI B-X
) B-X
from B-X
Britain B-X
We B-X
have B-X
studied B-X
the B-X
molecular B-X
basis B-X
of B-X
protein B-X
C B-X
deficiency B-X
in B-X
three B-X
families B-X
with B-X
a B-X
history B-X
of B-X
thromboembolic B-X
disease B-X
. B-X
An B-X
approximately B-X
50 B-X
% B-X
reduction B-X
in B-X
both B-X
functional B-X
and B-X
immunologic B-X
Novel B-X
splicing B-X
, B-X
missense B-X
, B-X
and B-X
deletion B-X
mutations B-X
in B-X
seven B-X
adenosine B-X
deaminase-deficient B-X
patients B-X
with B-X
late/delayed B-X
onset B-X
of B-X
combined B-X
immunodeficiency B-X
disease B-X
. B-X
Contribution B-X
of B-X
genotype B-X
to B-X
phenotype B-X
. B-X
Mutations B-X
of B-X
the B-X
p53 B-X
gene B-X
on B-X
chromosome B-X
17p B-X
are B-X
a B-X
common B-X
genetic B-X
change B-X
in B-X
the B-X
malignant B-X
progression B-X
of B-X
many B-X
cancers B-X
. B-X
We B-X
have B-X
analyzed B-X
38 B-X
malignant B-X
tumors B-X
of B-X
ovarian B-X
or B-X

A	O
PCR	O
-	O
based	O
protocol	O
is	O
described	O
that	O
was	O
used	O
to	O
introduce	O
mutations	O
in	O
wild	O
-	O
type	O
cDNA	O
.	O
<EOS> B-X
An B-X
improved B-X
PCR-based B-X
method B-X
for B-X
site B-X
directed B-X
mutagenesis B-X
using B-X
megaprimers B-X
- B-X
ScienceDirect B-X
Two-round B-X
COLD-PCR-based B-X
Sanger B-X
sequencing B-X
identifies B-X
a B-X
novel B-X
spectrum B-X
of B-X
low-level B-X
mutations B-X
in B-X
lung B-X
adenocarcinoma B-X
Background B-X
Molecular B-X
tests B-X
for B-X
diagnosis B-X
of B-X
disease B-X
, B-X
particularly B-X
cancer B-X
, B-X
are B-X
gaining B-X
increased B-X
acceptance B-X
by B-X
physicians B-X
and B-X
their B-X
patients B-X
for B-X
disease B-X
prognosis B-X
and B-X
selection B-X
of B-X
treatment B-X
options B-X
. B-X
Gene B-X
TAMS B-X
technology B-X
for B-X
simple B-X
and B-X
efficient B-X
in B-X
vitro B-X
site-directed B-X
mutagenesis B-X
and B-X
mutant B-X
screening B-X
We B-X
previously B-X
developed B-X
oligoribonucleotide B-X
( B-X
ORN B-X
) B-X
interference-PCR B-X
( B-X
ORNi-PCR B-X
) B-X
, B-X
in B-X
which B-X
an B-X
ORN B-X
hybridises B-X
with B-X
a B-X
complementary B-X
DNA B-X
sequence B-X
and B-X
inhibits B-X
PCR B-X
amplification B-X
across B-X
the B-X
sequence B-X
in B-X
Genome B-X
editing B-X
techniques B-X
such B-X
as B-X
the B-X
zinc-finger B-X
nucleases B-X
( B-X
ZFNs B-X
) B-X
, B-X
transcription B-X
activator-like B-X
effecter B-X
nucleases B-X
( B-X
TALENs B-X
) B-X
and B-X
clustered B-X
regularly B-X
interspaced B-X
short B-X
palindromic B-X
repeats B-X
( B-X
CRISPR B-X
) B-X
/CRISPR-associated B-X

In	O
vitro	O
expression	O
of	O
mutant	O
cDNA	O
clones	O
demonstrated	O
that	O
all	O
of	O
these	O
mutations	O
led	O
to	O
a	O
deficiency	B-Disease
of	I-Disease
ASPA	I-Disease
and	O
should	O
therefore	O
result	O
in	O
Canavan	B-Disease
disease	I-Disease
.	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
ASPA B-X
- B-X
aspartoacylase B-X

Identification	O
and	O
chromosomal	O
localization	O
of	O
Atm	O
,	O
the	O
mouse	O
homolog	O
of	O
the	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
gene	O
.	O
<EOS> B-X
Identification B-X
and B-X
Chromosomal B-X
Localization B-X
of B-X
Atm B-X
, B-X
the B-X
Mouse B-X
Homolog B-X
of B-X
the B-X
Ataxia‚ÄìTelangiectasia B-X
Gene B-X
- B-X
ScienceDirect B-X

Atm	O
,	O
the	O
mouse	O
homolog	O
of	O
the	O
human	O
ATM	O
gene	O
defective	O
in	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
has	O
been	O
identified	O
.	O
<EOS> B-X
Identification B-X
and B-X
chromosomal B-X
localization B-X
of B-X
Atm B-X
, B-X
the B-X
mouse B-X
homolog B-X
of B-X
the B-X
ataxia-telangiectasia B-X
gene B-X
. B-X
Identification B-X
and B-X
chromosomal B-X
localization B-X
of B-X
Atm B-X
, B-X
the B-X
mouse B-X
homolog B-X
of B-X
the B-X
ataxia-telangiectasia B-X
gene B-X
‚Äî B-X
Houston B-X
Methodist B-X
Scholars B-X
Atm B-X
ataxia B-X
telangiectasia B-X
mutated B-X
[ B-X
Mus B-X
musculus B-X
( B-X
house B-X
mouse B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
primarily B-X
characterized B-X
by B-X
cerebellar B-X
degeneration B-X
, B-X
telangiectasia B-X
, B-X
immunodeficiency B-X
, B-X
cancer B-X
susceptibility B-X
and B-X
radiation B-X
sensitivity B-X
. B-X
A-T B-X
is B-X
often B-X
referred B-X
ATM B-X
serine/threonine B-X
kinase B-X
- B-X
Wikipedia B-X

The	O
entire	O
coding	O
sequence	O
of	O
the	O
Atm	O
transcript	O
was	O
cloned	O
and	O
found	O
to	O
contain	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
3066	O
amino	O
acids	O
with	O
84	O
%	O
overall	O
identity	O
and	O
91	O
%	O
similarity	O
to	O
the	O
human	O
ATM	O
protein	O
.	O
<EOS> B-X
Atm B-X
, B-X
the B-X
mouse B-X
homolog B-X
of B-X
the B-X
human B-X
ATM B-X
gene B-X
defective B-X
in B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
has B-X
been B-X
identified B-X
. B-X
The B-X
entire B-X
coding B-X
sequence B-X
of B-X
the B-X
Atm B-X
transcript B-X
was B-X
In B-X
an B-X
earlier B-X
report B-X
we B-X
showed B-X
that B-X
the B-X
5 B-X
' B-X
end B-X
of B-X
the B-X
gene B-X
for B-X
ataxia B-X
telangiectasia B-X
ATM B-X
is B-X
within B-X
700 B-X
bp B-X
of B-X
the B-X
5 B-X
' B-X
end B-X
of B-X
a B-X
novel B-X
R B-X
Harnik B-X
's B-X
8 B-X
research B-X
works B-X
with B-X
2,886 B-X
citations B-X
and B-X
1,095 B-X
reads B-X
, B-X
including B-X
: B-X
Identification B-X
of B-X
ATM B-X
mutations B-X
using B-X
extended B-X
RT‚ÄêPCR B-X
and B-X
restriction B-X
endonuclease B-X
fingerprinting B-X
, B-X
and B-X
elucidation B-X
of B-X
A B-X
purified B-X
and B-X
isolated B-X
gene B-X
, B-X
designated B-X
ATM B-X
, B-X
mutations B-X
of B-X
which B-X
cause B-X
ataxia-telangiectasia B-X
. B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
cloning B-X
and B-X
functional B-X
characterization B-X
of B-X
murine B-X
Transmembrane B-X
Activator B-X
and B-X
CAML B-X
Interactor B-X
( B-X
TACI B-X
) B-X
with B-X
chromosomal B-X
localization B-X
in B-X
human B-X
and B-X
mouse B-X
| B-X
The B-X
human B-X
Taci B-X
gene B-X
Novel B-X
mutations B-X
and B-X
defective B-X
protein B-X
kinase B-X
C B-X
activation B-X
of B-X
T-lymphocytes B-X
in B-X
ataxia B-X
telangiectasia B-X
a-t B-X
mutated B-X
atm B-X
: B-X
Topics B-X
by B-X
Science.gov B-X

Variable	O
levels	O
of	O
expression	O
of	O
Atm	O
were	O
observed	O
in	O
different	O
tissues	O
.	O
<EOS> B-X
Expression B-X
patterns B-X
of B-X
the B-X
ATM B-X
gene B-X
in B-X
mammary B-X
tissues B-X
and B-X
their B-X
associations B-X
with B-X
breast B-X
cancer B-X
survival B-X
- B-X
Ye B-X
- B-X
2007 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Variation B-X
of B-X
ATM B-X
Gene B-X
Expression B-X
in B-X
Peripheral B-X
Blood B-X
Cells B-X
of B-X
Sporadic B-X
Breast B-X
Carcinomas B-X
in B-X
Iranian B-X
Patients B-X
Low B-X
expression B-X
levels B-X
of B-X
ATM B-X
may B-X
substitute B-X
for B-X
CHEK2 B-X
/TP53 B-X
mutations B-X
predicting B-X
resistance B-X
towards B-X
anthracycline B-X
and B-X
mitomycin B-X
chemotherapy B-X
in B-X
breast B-X
cancer B-X
DNA B-X
Repair B-X
Gene B-X
Expression B-X
Levels B-X
as B-X
Indicators B-X
of B-X
Breast B-X
Cancer B-X
in B-X
the B-X
Breast B-X
Cancer B-X
Family B-X
Registry B-X
CHK1 B-X
gene B-X
encodes B-X
for B-X
a B-X
serine/threonine B-X
kinase B-X
involved B-X
in B-X
the B-X
regulation B-X
of B-X
cell B-X
cycle B-X
progression B-X
and B-X
DNA B-X
damage B-X
checkpoints B-X
. B-X
To B-X
determine B-X
the B-X
role B-X
of B-X
CHK1 B-X
in B-X
the B-X
pathogenesis B-X
of B-X
Methylation B-X
of B-X
the B-X
ataxia B-X
telangiectasia B-X
mutated B-X
gene B-X
( B-X
ATM B-X
) B-X
promoter B-X
as B-X
a B-X
radiotherapy B-X
outcome B-X
biomarker B-X
in B-X
patients B-X
with B-X
hepatocellular B-X
carcinoma B-X
ATM B-X
ATM B-X
serine/threonine B-X
kinase B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X

Fluorescence	O
in	O
situ	O
hybridization	O
and	O
linkage	O
analysis	O
located	O
the	O
Atm	O
gene	O
on	O
mouse	O
chromosome	O
9	O
,	O
band	O
9C	O
,	O
in	O
a	O
region	O
homologous	O
to	O
the	O
ATM	O
region	O
on	O
human	O
chromosome	O
11q22	O
-	O
q23	O
.	O
.	O
<EOS> B-X
Fluorescence B-X
in B-X
situ B-X
hybridization B-X
( B-X
FISH B-X
) B-X
is B-X
an B-X
effective B-X
technique B-X
for B-X
localizing B-X
cloned B-X
DNA B-X
probes B-X
directly B-X
onto B-X
metaphase B-X
chromosomes B-X
. B-X
Human B-X
genome B-X
mapping B-X
using B-X
FISH B-X
has B-X
been B-X
significantly B-X
enhanced B-X
The B-X
defect B-X
in B-X
the B-X
AT-like B-X
hamster B-X
cell B-X
mutants B-X
is B-X
complemented B-X
by B-X
mouse B-X
chromosome B-X
9 B-X
but B-X
not B-X
by B-X
any B-X
of B-X
the B-X
human B-X
chromosomes B-X
- B-X
ScienceDirect B-X
Mantle B-X
cell B-X
lymphoma B-X
is B-X
characterized B-X
by B-X
inactivation B-X
of B-X
the B-X
ATM B-X
gene B-X
A B-X
purified B-X
and B-X
isolated B-X
gene B-X
, B-X
designated B-X
ATM B-X
, B-X
mutations B-X
of B-X
which B-X
cause B-X
ataxia-telangiectasia B-X
. B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
cloning B-X
and B-X
characterization B-X
of B-X
the B-X
catalytic B-X
domain B-X
of B-X
zebrafish B-X
homologue B-X
of B-X
the B-X
ataxia-telangiectasia B-X
mutated B-X
gene B-X
| B-X
Inherited B-X
biallelic B-X
mutations B-X
of B-X
the B-X
ATM B-X
( B-X
ataxia-telangiectasia B-X
mutated B-X
) B-X
There B-X
is B-X
provided B-X
a B-X
purified B-X
amino B-X
acid B-X
sequence B-X
selected B-X
from B-X
the B-X
group B-X
of B-X
Sequence B-X
ID B-X
No B-X
. B-X
: B-X
3 B-X
and B-X
analogs B-X
thereof B-X
and B-X
mutations B-X
of B-X
Sequence B-X
ID B-X
No B-X
. B-X
: B-X
Request B-X
PDF B-X
| B-X
Abnormal B-X
rearrangement B-X
within B-X
the B-X
Œ±/Œ¥ B-X
T-cell B-X
receptor B-X
locus B-X
in B-X
lymphomas B-X
from B-X
Atm-deficient B-X
mice B-X
| B-X
Atm-deficient B-X
mice B-X
( B-X
Atm‚àí/‚àí B-X
) B-X
recapitulate B-X
many B-X
aspects B-X
of B-X
the B-X
ataxia B-X
telangiectasia B-X
( B-X

The	O
mouse	O
homolog	O
of	O
the	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
protein	O
(	O
WASP	O
)	O
gene	O
is	O
highly	O
conserved	O
and	O
maps	O
near	O
the	O
scurfy	O
(	O
sf	O
)	O
mutation	O
on	O
the	O
X	O
chromosome	O
.	O
<EOS> B-X
The B-X
Mouse B-X
Homolog B-X
of B-X
the B-X
Wiskott‚ÄìAldrich B-X
Syndrome B-X
Protein B-X
( B-X
WASP B-X
) B-X
Gene B-X
Is B-X
Highly B-X
Conserved B-X
and B-X
Maps B-X
near B-X
the B-X
Scurfy B-X
( B-X
sf B-X
) B-X
Mutation B-X
on B-X
the B-X
X B-X
Chromosome B-X
- B-X
ScienceDirect B-X
Characterization B-X
of B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
and B-X
its B-X
role B-X
in B-X
the B-X
disease B-X
- B-X
ScienceDirect B-X
WikiGenes B-X
- B-X
Was B-X
- B-X
Wiskott-Aldrich B-X
syndrome B-X
homolog B-X
( B-X
human B-X
) B-X
Request B-X
PDF B-X
| B-X
On B-X
Feb B-X
1 B-X
, B-X
2001 B-X
, B-X
S B-X
Cirera B-X
and B-X
others B-X
published B-X
Isolation B-X
and B-X
mapping B-X
of B-X
the B-X
pig B-X
homolog B-X
of B-X
the B-X
Wiskott-Aldrich B-X
Syndrome B-X
gene B-X
( B-X
WAS B-X
) B-X
| B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
and B-X
X-linked B-X
thrombocytopenia B-X
( B-X
XLT B-X
) B-X
are B-X
rare B-X
X-linked B-X
genetic B-X
disorders B-X
caused B-X
by B-X
mutations B-X
of B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
( B-X
WASP B-X
) B-X
gene B-X
. B-X
Both B-X
Wiskott-Aldrich B-X
Syndrome B-X
Protein-Deficient B-X
Mice B-X
Reveal B-X
a B-X
Role B-X
for B-X
WASP B-X
in B-X
T B-X
but B-X
Not B-X
B B-X
Cell B-X
Activation B-X
- B-X
ScienceDirect B-X
Wiskott-Aldrich B-X
Syndrome B-X
Protein-Deficient B-X
Mice B-X
Reveal B-X
a B-X
Role B-X
for B-X
WASP B-X
in B-X
T B-X
but B-X
Not B-X
B B-X
Cell B-X
Activation B-X
: B-X
Immunity B-X

The	O
mouse	O
WASP	O
gene	O
,	O
the	O
homolog	O
of	O
the	O
gene	O
mutated	O
in	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
,	O
has	O
been	O
isolated	O
and	O
sequenced	O
.	O
the	O
predicted	O
amino	O
acid	O
sequence	O
is	O
86	O
%	O
identical	O
to	O
the	O
human	O
WASP	O
sequence	O
.	O
<EOS> B-X
The B-X
mouse B-X
WASP B-X
gene B-X
, B-X
the B-X
homolog B-X
of B-X
the B-X
gene B-X
mutated B-X
in B-X
Wiskott-Aldrich B-X
syndrome B-X
, B-X
has B-X
been B-X
isolated B-X
and B-X
sequenced B-X
. B-X
the B-X
predicted B-X
amino B-X
acid B-X
sequence B-X
is B-X
86 B-X
% B-X
identical B-X
WAS B-X
( B-X
Wiskott-Aldrich B-X
syndrome B-X
) B-X
Second-site B-X
mutation B-X
in B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
protein B-X
gene B-X
causes B-X
somatic B-X
mosaicism B-X
in B-X
two B-X
WAS B-X
siblings B-X
The B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
an B-X
X-linked B-X
primary B-X
immunodeficiency B-X
that B-X
is B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
recently B-X
identified B-X
WASP B-X
gene B-X
. B-X
WASP B-X
plays B-X
an B-X
important B-X
role B-X
in B-X
T-cell B-X
Wasp B-X
, B-X
the B-X
Drosophila B-X
Wiskott-Aldrich B-X
Syndrome B-X
Gene B-X
Homologue B-X
, B-X
Is B-X
Required B-X
for B-X
Cell B-X
Fate B-X
Decisions B-X
Mediated B-X
by B-X
Notch B-X
Signaling B-X
Mutations B-X
That B-X
Cause B-X
the B-X
Wiskott-Aldrich B-X
Syndrome B-X
Impair B-X
the B-X
Interaction B-X
of B-X
Wiskott-Aldrich B-X
Syndrome B-X
Protein B-X
( B-X
WASP B-X
) B-X
with B-X
WASP B-X
Interacting B-X
Protein B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
The B-X
Rat B-X
Homologue B-X
of B-X
Wiskott-Aldrich B-X
Syndrome B-X
Protein B-X
( B-X
WASP B-X
) B-X
-interacting B-X
Protein B-X
( B-X
WIP B-X
) B-X
Associates B-X
with B-X
Actin B-X
Filaments B-X
, B-X
Recruits B-X
N-WASP B-X
from B-X
the B-X
Nucleus B-X
, B-X
and B-X
Mediates B-X
Mobilization B-X
of B-X

A	O
distinct	O
feature	O
of	O
the	O
mouse	O
gene	O
is	O
an	O
expanded	O
polymorphic	O
GGA	O
trinucleotide	O
repeat	O
that	O
codes	O
for	O
polyglycine	O
and	O
varies	O
from	O
15	O
to	O
17	O
triplets	O
in	O
different	O
Mus	O
musculus	O
strains	O
.	O
<EOS> B-X
Download B-X
Citation B-X
| B-X
Housekeeping B-X
and B-X
tissue-specific B-X
genes B-X
differ B-X
in B-X
simple B-X
sequence B-X
repeats B-X
in B-X
the B-X
5‚Ä≤-UTR B-X
region B-X
| B-X
SSRs B-X
( B-X
simple B-X
sequence B-X
repeats B-X
) B-X
have B-X
been B-X
shown B-X
to B-X
have B-X
a B-X
variety B-X
It B-X
has B-X
become B-X
evident B-X
over B-X
the B-X
last B-X
years B-X
that B-X
abnormalities B-X
in B-X
RNA B-X
processing B-X
play B-X
a B-X
fundamental B-X
part B-X
in B-X
the B-X
pathogenesis B-X
of B-X
neurodegenerative B-X
diseases B-X
. B-X
Cellular B-X
viability B-X
depends B-X
on B-X
proper B-X
regulatio B-X
The B-X
aim B-X
of B-X
this B-X
study B-X
was B-X
to B-X
develop B-X
a B-X
method B-X
to B-X
generate B-X
identical B-X
twins B-X
and B-X
triplets B-X
with B-X
predicted B-X
gender B-X
. B-X
As B-X
a B-X
first B-X
step B-X
toward B-X
that B-X
aim B-X
, B-X
single B-X
blastomeres B-X
Download B-X
Citation B-X
| B-X
Intramolecular B-X
higher B-X
order B-X
packing B-X
of B-X
parallel B-X
quadruplexes B-X
comprising B-X
a B-X
G B-X
: B-X
G B-X
: B-X
G B-X
: B-X
G B-X
tetrad B-X
and B-X
a B-X
G B-X
( B-X
: B-X
A B-X
) B-X
: B-X
G B-X
( B-X
Request B-X
PDF B-X
| B-X
An B-X
X-encoded B-X
alloantigenicity B-X
between B-X
BALB/c B-X
and B-X
C57BL/6 B-X
strains B-X
of B-X
mice B-X
| B-X
To B-X
detect B-X
minor B-X
barriers B-X
to B-X
histocompatibility B-X
that B-X
might B-X
be B-X
encoded B-X
on B-X
the B-X
X B-X
chromosome B-X
in B-X
mice B-X
PDF B-X
| B-X
Androgen B-X
effects B-X
mediated B-X
by B-X
the B-X
androgen B-X
receptor B-X
( B-X
AR B-X
) B-X
are B-X
essential B-X
for B-X
male B-X
reproductive B-X
development B-X
and B-X
virilization B-X
. B-X
Comparison B-X
of B-X
AR B-X
DNA B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
A B-X
Transcript B-X
Map B-X
of B-X
a B-X
2-Mb B-X
BAC B-X
Contig B-X
in B-X
the B-X
Proximal B-X
Portion B-X
of B-X
the B-X
Mouse B-X
X B-X
Chromosome B-X
and B-X
Regional B-X
Mapping B-X
of B-X
the B-X
scurfy B-X
Mutation B-X
| B-X
A B-X
physical B-X

The	O
genomic	O
structure	O
of	O
the	O
mouse	O
WASP	O
gene	O
is	O
expressed	O
as	O
an	O
approximately	O
2	O
.	O
<EOS> B-X
Human B-X
Subtelomeric B-X
WASH B-X
Genes B-X
Encode B-X
a B-X
New B-X
Subclass B-X
of B-X
the B-X
WASP B-X
Family B-X
N-WASp B-X
is B-X
required B-X
for B-X
Schwann B-X
cell B-X
cytoskeletal B-X
dynamics B-X
, B-X
normal B-X
myelin B-X
gene B-X
expression B-X
and B-X
peripheral B-X
nerve B-X
myelination B-X
WASF2 B-X
WASP B-X
family B-X
member B-X
2 B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
WAS B-X
Promoter-Driven B-X
Lentiviral B-X
Vectors B-X
Mimic B-X
Closely B-X
the B-X
Lopsided B-X
WASP B-X
Expression B-X
during B-X
Megakaryocytic B-X
Differentiation B-X
: B-X
Molecular B-X
Therapy B-X
- B-X
Methods B-X
& B-X
Clinical B-X
Development B-X
Regulates B-X
actin B-X
polymerization B-X
by B-X
stimulating B-X
the B-X
actin-nucleating B-X
activity B-X
of B-X
the B-X
Arp2/3 B-X
complex B-X
. B-X
Involved B-X
in B-X
various B-X
processes B-X
, B-X
such B-X
as B-X
mitosis B-X
and B-X
cytokinesis B-X
, B-X
via B-X
its B-X
role B-X
in B-X
the B-X
regulation B-X
Was B-X
Wiskott-Aldrich B-X
syndrome B-X
[ B-X
Mus B-X
musculus B-X
( B-X
house B-X
mouse B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Was B-X
Wiskott-Aldrich B-X
syndrome B-X
[ B-X
Mus B-X
musculus B-X
( B-X
house B-X
mouse B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X

4	O
-	O
kb	O
mRNA	O
in	O
thymus	O
and	O
spleen	O
.	O
<EOS> B-X
A B-X
genomic B-X
DNA B-X
probe B-X
derived B-X
from B-X
the B-X
region B-X
immediately B-X
3 B-X
' B-X
of B-X
the B-X
clusters B-X
of B-X
integrated B-X
proviruses B-X
in B-X
the B-X
Mlvi-4 B-X
locus B-X
detects B-X
a B-X
5.5-kb B-X
mRNA B-X
transcript B-X
which B-X
is B-X
specifically B-X
expressed B-X
Expression B-X
of B-X
mRNA B-X
encoding B-X
neurotrophins B-X
and B-X
neurotrophin B-X
receptors B-X
in B-X
rat B-X
thymus B-X
, B-X
spleen B-X
tissue B-X
and B-X
immunocompetent B-X
cells B-X
- B-X
LAURENZI B-X
- B-X
1994 B-X
- B-X
European B-X
Journal B-X
of B-X
Biochemistry B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Increasing B-X
lines B-X
of B-X
evidence B-X
indicate B-X
that B-X
arsenic B-X
may B-X
be B-X
associated B-X
with B-X
immune B-X
related B-X
problems B-X
, B-X
but B-X
its B-X
detailed B-X
effects B-X
on B-X
immune B-X
organs B-X
are B-X
poorly B-X
understood B-X
. B-X
The B-X
objective B-X
of B-X
this B-X
Cannabinoid B-X
receptor B-X
( B-X
CB B-X
) B-X
expression B-X
was B-X
characterized B-X
in B-X
immunological B-X
cell B-X
and B-X
tissue B-X
preparations B-X
. B-X
Northern B-X
analysis B-X
revealed B-X
approximately B-X
6-kb B-X
transcripts B-X
for B-X
CB1 B-X
( B-X
brain-type B-X
) B-X
in B-X
mouse B-X
spleen B-X
and B-X
We B-X
have B-X
made B-X
use B-X
of B-X
RNA.RNA B-X
in B-X
situ B-X
hybridization B-X
to B-X
study B-X
the B-X
presence B-X
of B-X
cells B-X
producing B-X
mRNA B-X
for B-X
interleukin B-X
4 B-X
( B-X
IL-4 B-X
) B-X
in B-X
the B-X
developing B-X
thymus B-X
, B-X
spleen B-X
, B-X
Down-regulation B-X
of B-X
T B-X
cell B-X
receptors B-X
on B-X
self-reactive B-X
T B-X
cells B-X
as B-X
a B-X
novel B-X
mechanism B-X
for B-X
extrathymic B-X
tolerance B-X
induction B-X
- B-X
ScienceDirect B-X
Differential B-X
up-regulation B-X
of B-X
ceruloplasmin B-X
gene B-X
expression B-X
in B-X
rat B-X
immune B-X
tissues B-X
during B-X
experimental B-X
inflammation B-X
- B-X
ScienceDirect B-X

Chromosomal	O
mapping	O
in	O
an	O
interspecific	O
M	O
.	O
<EOS> B-X
An B-X
interspecific B-X
backcross B-X
linkage B-X
map B-X
of B-X
the B-X
proximal B-X
half B-X
of B-X
mouse B-X
chromosome B-X
14 B-X
- B-X
ScienceDirect B-X
Gene B-X
mapping B-X
on B-X
mouse B-X
chromosome B-X
8 B-X
by B-X
interspecific B-X
crosses B-X
: B-X
New B-X
data B-X
on B-X
a B-X
linkage B-X
group B-X
conserved B-X
on B-X
human B-X
chromosome B-X
16q B-X
- B-X
ScienceDirect B-X
Saturated B-X
Molecular B-X
Map B-X
of B-X
the B-X
Rice B-X
Genome B-X
Based B-X
on B-X
an B-X
Interspecific B-X
Backcross B-X
Population B-X
9.3 B-X
INTERSPECIFIC B-X
MAPPING B-X
PANELS B-X
One B-X
hundred B-X
fourteen B-X
progeny B-X
from B-X
an B-X
interspecific B-X
backcross B-X
between B-X
laboratory B-X
mice B-X
and B-X
M. B-X
spretus B-X
were B-X
typed B-X
for B-X
six B-X
markers B-X
spanning B-X
most B-X
of B-X
mouse B-X
Chromosome B-X
( B-X
Chr B-X
) B-X
16 B-X
. B-X
Additional B-X
We B-X
have B-X
constructed B-X
RAPD-based B-X
linkage B-X
maps B-X
for B-X
an B-X
interspecific B-X
cross B-X
between B-X
two B-X
species B-X
of B-X
the B-X
genus B-X
Populus B-X
( B-X
P. B-X
adenopoda B-X
and B-X
P. B-X
alba B-X
) B-X
, B-X
based B-X
on B-X
a B-X
double B-X
pseudo-test-cross B-X
An B-X
AFLP-Based B-X
Interspecific B-X
Linkage B-X
Map B-X
of B-X
Sympatric B-X
, B-X
Hybridizing B-X
Colias B-X
Butterflies B-X

Musculus	O
/	O
M	O
.	O
spretus	O
backcross	O
placed	O
the	O
Wasp	O
locus	O
near	O
the	O
centromere	O
of	O
the	O
mouse	O
X	O
chromosome	O
,	O
inseparable	O
from	O
Gata1	O
,	O
Tcfe3	O
,	O
and	O
scurfy	O
(	O
sf	O
)	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
Gata1 B-X
- B-X
GATA B-X
binding B-X
protein B-X
1 B-X
To B-X
study B-X
oncogenesis B-X
in B-X
the B-X
erythroid B-X
lineage B-X
, B-X
we B-X
have B-X
generated B-X
transgenic B-X
mice B-X
carrying B-X
the B-X
human B-X
c-MYC B-X
proto-oncogene B-X
under B-X
the B-X
control B-X
of B-X
mouse B-X
GATA-1 B-X
regulatory B-X
sequences B-X
. B-X
Six B-X
transgenic B-X
lines B-X
PDF B-X
| B-X
We B-X
found B-X
a B-X
new B-X
X-linked B-X
dominant B-X
mouse B-X
mutation B-X
. B-X
This B-X
mouse B-X
has B-X
the B-X
same B-X
phenotype B-X
as B-X
Td B-X
, B-X
which B-X
exhibits B-X
hyperkeratotic B-X
skin B-X
, B-X
reduced B-X
viability B-X
in B-X
... B-X
| B-X
The B-X
zinc-finger B-X
transcription B-X
factor B-X
GATA-1 B-X
( B-X
previously B-X
known B-X
as B-X
GF-1 B-X
, B-X
NF-E1 B-X
or B-X
Eryf B-X
1 B-X
binds B-X
to B-X
GATA B-X
consensus B-X
elements B-X
in B-X
regulatory B-X
regions B-X
of B-X
the B-X
alpha- B-X
and B-X
beta-globin B-X
gene B-X
clusters B-X
Disruption B-X
of B-X
Genetic B-X
Interaction B-X
Between B-X
Two B-X
Autosomal B-X
Regions B-X
and B-X
the B-X
X B-X
Chromosome B-X
Causes B-X
Reproductive B-X
Isolation B-X
Between B-X
Mouse B-X
Strains B-X
Derived B-X
From B-X
Different B-X
Subspecies B-X
Two B-X
libraries B-X
enriched B-X
in B-X
murine B-X
X B-X
chromosome B-X
material B-X
have B-X
been B-X
constructed B-X
in B-X
the B-X
lambda B-X
vector B-X
NM B-X
1149 B-X
from B-X
flow-sorted B-X
chromosomes B-X
. B-X
Inserts B-X
of B-X
unique B-X
genomic B-X
sequence B-X
DNA B-X
were B-X
purified B-X
and B-X
Transcriptional B-X
activator B-X
or B-X
repressor B-X
which B-X
probably B-X
serves B-X
as B-X
a B-X
general B-X
switch B-X
factor B-X
for B-X
erythroid B-X
development B-X
. B-X
It B-X
binds B-X
to B-X
DNA B-X
sites B-X
with B-X
the B-X
consensus B-X
sequence B-X
5'- B-X
[ B-X
AT B-X
] B-X
GATA B-X

This	O
localization	O
makes	O
Wasp	O
a	O
candidate	O
for	O
involvement	O
in	O
scurfy	O
,	O
a	O
T	O
cell	O
-	O
mediated	O
fatal	B-Disease
lymphoreticular	I-Disease
disease	I-Disease
of	O
mice	O
that	O
has	O
previously	O
been	O
proposed	O
as	O
a	O
mouse	O
homolog	O
of	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Cdc42 B-X
, B-X
Rac1 B-X
, B-X
and B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
are B-X
involved B-X
in B-X
the B-X
cytoskeletal B-X
Regulation B-X
of B-X
B B-X
lymphocytes B-X
| B-X
Patients B-X
with B-X
the B-X
immunodeficiency B-X
disorder B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
Request B-X
PDF B-X
| B-X
Scurfin B-X
( B-X
FOXP3 B-X
) B-X
Acts B-X
as B-X
a B-X
Repressor B-X
of B-X
Transcription B-X
and B-X
Regulates B-X
T B-X
Cell B-X
Activation B-X
| B-X
We B-X
have B-X
recently B-X
identified B-X
and B-X
clonedFoxp3 B-X
, B-X
the B-X
gene B-X
defective B-X
in B-X
The B-X
ability B-X
to B-X
rapidly B-X
and B-X
efficiently B-X
recognize B-X
and B-X
eliminate B-X
pathogens B-X
while B-X
sparing B-X
normal B-X
self B-X
tissue B-X
is B-X
a B-X
hallmark B-X
of B-X
the B-X
mammalian B-X
immune B-X
system B-X
. B-X
When B-X
it B-X
fails B-X
, B-X
however B-X
, B-X
Regulatory B-X
T B-X
Cell B-X
and B-X
Forkhead B-X
Box B-X
Protein B-X
3 B-X
as B-X
Modulators B-X
of B-X
Immune B-X
Homeostasis B-X
The B-X
Wiskott‚ÄìAldrich B-X
syndrome B-X
- B-X
Thrasher B-X
- B-X
2000 B-X
- B-X
Clinical B-X
& B-X
amp B-X
; B-X
Experimental B-X
Immunology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
A B-X
Transcript B-X
Map B-X
of B-X
a B-X
2-Mb B-X
BAC B-X
Contig B-X
in B-X
the B-X
Proximal B-X
Portion B-X
of B-X
the B-X
Mouse B-X
X B-X
Chromosome B-X
and B-X
Regional B-X
Mapping B-X
of B-X
the B-X
scurfy B-X
Mutation B-X
- B-X
ScienceDirect B-X
X-Linked B-X
Syndrome B-X
of B-X
Polyendocrinopathy B-X
, B-X
Immune B-X
Dysfunction B-X
, B-X
and B-X
Diarrhea B-X
Maps B-X
to B-X
Xp11.23-Xq13.3 B-X

Northern	O
analysis	O
of	O
sf	O
tissue	O
samples	O
indicated	O
the	O
presence	O
of	O
WASP	O
mRNA	O
in	O
liver	O
and	O
skin	O
,	O
presumably	O
as	O
a	O
consequence	O
of	O
lymphocytic	O
infiltration	O
,	O
but	O
non	O
abnormalities	O
in	O
the	O
amount	O
or	O
size	O
of	O
mRNA	O
present	O
.	O
<EOS> B-X
Overexpression B-X
of B-X
CTGF B-X
in B-X
liver B-X
cirrhosis B-X
, B-X
especially B-X
in B-X
fibroblasts/myofibroblasts B-X
and B-X
stellate B-X
cells B-X
, B-X
suggests B-X
that B-X
this B-X
novel B-X
factor B-X
may B-X
play B-X
an B-X
important B-X
role B-X
in B-X
hepatic B-X
fibrosis B-X
. B-X
3‚Ä≤ B-X
end B-X
mRNA B-X
processing B-X
: B-X
molecular B-X
mechanisms B-X
and B-X
implications B-X
for B-X
health B-X
and B-X
disease B-X
Protective B-X
and B-X
Regenerative B-X
Roles B-X
of B-X
T B-X
Cells B-X
in B-X
Central B-X
Nervous B-X
System B-X
Disorders B-X
Sepsis B-X
: B-X
Multiple B-X
Abnormalities B-X
, B-X
Heterogeneous B-X
Responses B-X
, B-X
and B-X
Evolving B-X
Understanding B-X
Update B-X
on B-X
Pathogenesis B-X
of B-X
Sj√∂gren B-X
‚Äô B-X
s B-X
syndrome B-X
Ribosomal B-X
Proteins B-X
and B-X
Human B-X
Diseases B-X
: B-X
Pathogenesis B-X
, B-X
Molecular B-X
Mechanisms B-X
, B-X
and B-X
Therapeutic B-X
Implications B-X
Vaccines B-X
are B-X
urgently B-X
needed B-X
to B-X
control B-X
the B-X
coronavirus B-X
disease B-X
2019 B-X
( B-X
COVID-19 B-X
) B-X
pandemic B-X
and B-X
to B-X
help B-X
the B-X
return B-X
to B-X
pre-pandemic B-X
normalcy B-X
. B-X
A B-X
great B-X
many B-X
vaccine B-X
candidates B-X
are B-X
being B-X

Colchicine	O
in	O
breast	O
milk	O
of	O
patients	O
with	O
familial	B-Disease
Mediterranean	I-Disease
fever	I-Disease
.	O

OBJECTIVE	O
.	O
<EOS> B-X
Definition B-X
of B-X
OBJECTIVE B-X
( B-X
noun B-X
) B-X
: B-X
something B-X
you B-X
plan B-X
to B-X
achieve B-X
Objective B-X
definition B-X
: B-X
Your B-X
objective B-X
is B-X
what B-X
you B-X
are B-X
trying B-X
to B-X
achieve B-X
. B-X
| B-X
Meaning B-X
, B-X
pronunciation B-X
, B-X
translations B-X
and B-X
examples B-X
Objective B-X
vs B-X
Subjective B-X
- B-X
BSMimpact B-X
What B-X
does B-X
objective B-X
mean B-X
? B-X
Objective B-X
is B-X
defined B-X
as B-X
someone B-X
or B-X
something B-X
that B-X
is B-X
real B-X
or B-X
not B-X
imagined B-X
. B-X
( B-X
adjective B-X
) B-X
An B-X
e B-X
... B-X
objective B-X
- B-X
WordReference B-X
English B-X
dictionary B-X
, B-X
questions B-X
, B-X
discussion B-X
and B-X
forums B-X
. B-X
All B-X
Free B-X
. B-X
An B-X
objective B-X
is B-X
something B-X
you B-X
plan B-X
to B-X
achieve B-X
. B-X
A B-X
military B-X
objective B-X
is B-X
the B-X
overall B-X
plan B-X
for B-X
a B-X
mission B-X
. B-X
The B-X
objective B-X
for B-X
a B-X
bake B-X
sale B-X
is B-X
to B-X
raise B-X
money B-X
What B-X
is B-X
the B-X
definition B-X
of B-X
objective B-X
? B-X
What B-X
is B-X
the B-X
meaning B-X
of B-X
objective B-X
? B-X
How B-X
do B-X
you B-X
use B-X
objective B-X
in B-X
a B-X
sentence B-X
? B-X
What B-X
are B-X
synonyms B-X
for B-X
objective B-X
? B-X

To	O
clarify	O
whether	O
colchicine	O
is	O
excreted	O
in	O
breast	O
milk	O
,	O
and	O
to	O
compare	O
its	O
concentrations	O
in	O
the	O
serum	O
and	O
breast	O
milk	O
of	O
lactating	O
women	O
who	O
have	O
familial	B-Disease
Mediterranean	I-Disease
fever	I-Disease
(	O
FMF	B-Disease
)	O
.	O
<EOS> B-X
PDF B-X
| B-X
Familial B-X
Mediterranean B-X
fever B-X
( B-X
FMF B-X
) B-X
, B-X
amyloidosis B-X
, B-X
and B-X
colchicine B-X
may B-X
affect B-X
the B-X
reproductive B-X
system B-X
of B-X
male B-X
and B-X
female B-X
patients B-X
. B-X
Colchicine B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
Colchicine B-X
poisoning B-X
: B-X
The B-X
dark B-X
side B-X
of B-X
an B-X
ancient B-X
drug B-X
| B-X
Colchicine B-X
is B-X
used B-X
mainly B-X
for B-X
the B-X
treatment B-X
and B-X
prevention B-X
of B-X
gout B-X
and B-X
for B-X
familial B-X
Mediterranean B-X
fever B-X
Request B-X
PDF B-X
| B-X
Pregnancy B-X
outcome B-X
in B-X
women B-X
with B-X
familial B-X
Mediterranean B-X
fever B-X
| B-X
This B-X
study B-X
comprised B-X
74 B-X
infertile B-X
patients B-X
with B-X
familial B-X
Mediterranean B-X
fever B-X
( B-X
FMF B-X
) B-X
, B-X
among B-X
which B-X
26 B-X
women B-X
Request B-X
PDF B-X
| B-X
The B-X
Impact B-X
of B-X
Familial B-X
Mediterranean B-X
Fever B-X
on B-X
Women B-X
's B-X
Health B-X
| B-X
Familial B-X
Mediterranean B-X
fever B-X
( B-X
FMF B-X
) B-X
is B-X
the B-X
most B-X
common B-X
hereditary B-X
recurrent B-X
febrile B-X
disorder B-X
, B-X
characterized B-X
Request B-X
PDF B-X
| B-X
On B-X
Nov B-X
1 B-X
, B-X
2003 B-X
, B-X
Riva B-X
Brik B-X
and B-X
others B-X
published B-X
Infantile B-X
familial B-X
Mediterranean B-X
fever B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
on B-X

METHODS	O
.	O
<EOS> B-X
JavaScript B-X
Methods B-X
JavaScript B-X
Methods B-X
JavaScript B-X
Methods B-X
Java B-X
Methods B-X
Java B-X
Methods B-X
Java B-X
Methods B-X
960 B-X
methods B-X
‚Ä¢ B-X
53651 B-X
papers B-X
with B-X
code B-X
. B-X

Using	O
a	O
specific	O
radioimmunoassay	O
,	O
we	O
determined	O
colchicine	O
concentrations	O
in	O
the	O
serum	O
and	O
breast	O
milk	O
of	O
4	O
patients	O
at	O
various	O
time	O
points	O
,	O
following	O
oral	O
administration	O
of	O
the	O
drug	O
.	O
<EOS> B-X
ObjectiveTo B-X
clarify B-X
whether B-X
colchicine B-X
is B-X
excreted B-X
in B-X
breast B-X
milk B-X
, B-X
and B-X
to B-X
compare B-X
its B-X
concentrations B-X
in B-X
the B-X
serum B-X
and B-X
breast B-X
milk B-X
of B-X
lactating B-X
women B-X
who B-X
have B-X
familial B-X
Mediterranean B-X
fever B-X
( B-X
OBJECTIVE B-X
To B-X
clarify B-X
whether B-X
colchicine B-X
is B-X
excreted B-X
in B-X
breast B-X
milk B-X
, B-X
and B-X
to B-X
compare B-X
its B-X
concentrations B-X
in B-X
the B-X
serum B-X
and B-X
breast B-X
milk B-X
of B-X
lactating B-X
women B-X
who B-X
have B-X
familial B-X
Mediterranean B-X
fever B-X
Colchicine B-X
Download B-X
Citation B-X
| B-X
The B-X
pharmacologic B-X
basis B-X
of B-X
treatment B-X
with B-X
colchicine B-X
in B-X
children B-X
with B-X
familial B-X
Mediterranean B-X
fever B-X
| B-X
Familial B-X
Mediterranean B-X
fever B-X
( B-X
FMF B-X
) B-X
is B-X
the B-X
prototype B-X
of B-X
auto-inflammatory B-X
disorders B-X
and B-X
Download B-X
Citation B-X
| B-X
Colchicine B-X
today B-X
| B-X
Colchicine B-X
is B-X
used B-X
chiefly B-X
in B-X
the B-X
treatment B-X
of B-X
gout B-X
but B-X
is B-X
also B-X
valuable B-X
in B-X
other B-X
inflammatory B-X
diseases B-X
such B-X
as B-X
familial B-X
Mediterranean B-X
fever B-X
... B-X
| B-X
Colchicine B-X
is B-X
an B-X
alkaloid B-X
which B-X
was B-X
originally B-X
extracted B-X
from B-X
bulbs B-X
of B-X
a B-X
plant B-X
called B-X
Colchicum B-X
autumnale B-X
( B-X
meadow B-X
saffron B-X
) B-X
. B-X
Its B-X
active B-X
pharmacological B-X
component B-X
was B-X
isolated B-X
in B-X
1820 B-X
and B-X

The	O
study	O
evaluated	O
4	O
patients	O
with	O
FMF	B-Disease
who	O
had	O
been	O
taking	O
colchicine	O
on	O
a	O
long	O
-	O
term	O
basis	O
.	O
<EOS> B-X
Update B-X
on B-X
the B-X
management B-X
of B-X
colchicine B-X
resistant B-X
Familial B-X
Mediterranean B-X
Fever B-X
( B-X
FMF B-X
) B-X
Familial B-X
Mediterranean B-X
fever B-X
( B-X
FMF B-X
) B-X
is B-X
the B-X
most B-X
common B-X
autoinflammatory B-X
disease B-X
worldwide B-X
. B-X
Approximately B-X
5-10 B-X
% B-X
of B-X
patients B-X
are B-X
unresponsive B-X
to B-X
colchicine B-X
. B-X
Aim B-X
of B-X
this B-X
study B-X
was B-X
to B-X
PDF B-X
| B-X
Familial B-X
Mediterranean B-X
fever B-X
( B-X
FMF B-X
) B-X
is B-X
the B-X
most B-X
common B-X
autoinflammatory B-X
disease B-X
worldwide B-X
. B-X
Approximately B-X
5-10 B-X
% B-X
of B-X
patients B-X
are B-X
unresponsive B-X
to B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

RESULTS	O
.	O
<EOS> B-X
RESULTS B-X
UK B-X
RESULTS B-X
UK B-X
RESULTS B-X
UK B-X
RESULTS B-X
UK B-X
RESULTS B-X
UK B-X
All B-X
results B-X
| B-X
Football B-X
| B-X
The B-X
Guardian B-X
All B-X
results B-X
| B-X
Football B-X
| B-X
The B-X
Guardian B-X

Colchicine	O
was	O
found	O
to	O
be	O
excreted	O
in	O
breast	O
milk	O
.	O
<EOS> B-X
The B-X
extensive B-X
peripheral B-X
tissue B-X
binding B-X
and B-X
relatively B-X
low B-X
concentration B-X
of B-X
colchicine B-X
in B-X
breast B-X
milk B-X
suggests B-X
that B-X
the B-X
amount B-X
ingested B-X
by B-X
the B-X
infant B-X
is B-X
small B-X
. B-X
Furthermore B-X
, B-X
based B-X
on B-X
our B-X
Advice B-X
for B-X
mothers B-X
using B-X
Colchicine B-X
while B-X
breastfeeding B-X
. B-X
Includes B-X
possible B-X
effects B-X
on B-X
breastfed B-X
infants B-X
and B-X
lactation B-X
. B-X
No B-X
increase B-X
in B-X
adverse B-X
long-term B-X
outcomes B-X
was B-X
found B-X
in B-X
colchicine-exposed B-X
breastfed B-X
infants B-X
. B-X
Our B-X
data B-X
support B-X
continuation B-X
of B-X
breastfeeding B-X
in B-X
women B-X
treated B-X
with B-X
colchicine B-X
. B-X
Colchicine B-X
has B-X
FDA B-X
approval B-X
for B-X
gout B-X
prophylaxis B-X
and B-X
treatment B-X
of B-X
acute B-X
gouty B-X
flares B-X
. B-X
It B-X
also B-X
has B-X
approval B-X
for B-X
the B-X
treatment B-X
of B-X
familial B-X
Mediterranean B-X
fever B-X
. B-X
[ B-X
1 B-X
] B-X
[ B-X
Colchicine B-X
( B-X
Colchicine B-X
) B-X
: B-X
Uses B-X
, B-X
Dosage B-X
, B-X
Side B-X
Effects B-X
, B-X
Interactions B-X
, B-X
Warning B-X
Colchicine B-X
in B-X
breast B-X
milk B-X
of B-X
patients B-X
with B-X
familial B-X
mediterranean B-X
fever B-X
- B-X
Ben‚ÄêChetrit B-X
- B-X
1996 B-X
- B-X
Arthritis B-X
& B-X
amp B-X
; B-X
Rheumatism B-X
- B-X
Wiley B-X
Online B-X
Library B-X
PDF B-X
| B-X
Objective B-X
: B-X
This B-X
study B-X
evaluated B-X
the B-X
outcome B-X
of B-X
infants B-X
exposed B-X
to B-X
colchicine B-X
during B-X
lactation B-X
. B-X
Subjects B-X
and B-X
methods B-X
: B-X
A B-X
prospective B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X

Its	O
levels	O
ranged	O
between	O
1	O
.	O
<EOS> B-X
The B-X
correlation B-X
coefficient B-X
: B-X
Its B-X
values B-X
range B-X
between B-X
+1/‚àí1 B-X
, B-X
or B-X
do B-X
they B-X
? B-X
| B-X
SpringerLink B-X
Dynamic B-X
range B-X
- B-X
Wikipedia B-X
Ranged B-X
in B-X
the B-X
free-to-play B-X
worlds B-X
, B-X
while B-X
having B-X
less B-X
equipment B-X
and B-X
features B-X
than B-X
the B-X
member B-X
's B-X
worlds B-X
, B-X
provides B-X
some B-X
fun B-X
with B-X
the B-X
ability B-X
to B-X
battle B-X
monsters B-X
and B-X
players B-X
who B-X
A B-X
Combat B-X
pure B-X
is B-X
a B-X
character B-X
whose B-X
combat B-X
stats B-X
are B-X
specifically B-X
trained B-X
in B-X
order B-X
to B-X
optimise B-X
performance B-X
in B-X
player-versus-player B-X
scenarios B-X
( B-X
Wilderness B-X
, B-X
Duel B-X
Arena B-X
, B-X
etc B-X
. B-X
) B-X
, B-X
Ranged B-X
level B-X
up B-X
music B-X
Ranged B-X
is B-X
a B-X
combat B-X
skill B-X
that B-X
involves B-X
the B-X
use B-X
of B-X
bows B-X
, B-X
crossbows B-X
, B-X
and B-X
thrown B-X
weapons B-X
to B-X
take B-X
down B-X
opponents B-X
, B-X
and B-X
wearing B-X
armour B-X
based B-X
40 B-X
votes B-X
, B-X
46 B-X
comments B-X
. B-X
Other B-X
than B-X
some B-X
bullshit B-X
August B-X
spewed B-X
that B-X
people B-X
with B-X
less B-X
than B-X
two B-X
braincells B-X
will B-X
believe B-X
in B-X
? B-X
A B-X
full B-X
and B-X
complete B-X
level B-X
1 B-X
to B-X
99 B-X
ranged B-X
training B-X
guide B-X
for B-X
Oldschool B-X
Runescape B-X
! B-X
If B-X
you B-X
have B-X
any B-X
questions B-X
, B-X
leave B-X
a B-X
comment B-X
! B-X
CheersüíÄNEW B-X
MERCH B-X
DESIGNSüíÄ B-X
- B-X
ht B-X

9	O
and	O
8	O
.	O
<EOS> B-X
The B-X
9-8 B-X
- B-X
Wikipedia B-X
9 B-X
- B-X
Wikipedia B-X
Type B-X
Eight B-X
‚Äî B-X
The B-X
Enneagram B-X
Institute B-X
Type B-X
Nine B-X
‚Äî B-X
The B-X
Enneagram B-X
Institute B-X
Why B-X
Tiger B-X
Woods B-X
was B-X
actually B-X
upset B-X
he B-X
beat B-X
Stephen B-X
Ames B-X
9 B-X
and B-X
8 B-X
. B-X
What B-X
is B-X
the B-X
sum B-X
of B-X
9 B-X
and B-X
8 B-X
? B-X
Here B-X
we B-X
will B-X
calculate B-X
the B-X
sum B-X
of B-X
9 B-X
and B-X
8 B-X
and B-X
display B-X
the B-X
answer B-X
. B-X
Relationship B-X
Type B-X
8 B-X
with B-X
Type B-X
9 B-X
‚Äî B-X
The B-X
Enneagram B-X
Institute B-X

6	O
ng	O
/	O
ml	O
,	O
which	O
were	O
similar	O
to	O
those	O
found	O
in	O
the	O
serum	O
(	O
parallel	O
concentration	O
time	O
curves	O
)	O
.	O
<EOS> B-X
Plasma B-X
Concentration-Time B-X
Curve B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
The B-X
pharmacokinetic B-X
modelling B-X
of B-X
GI198745 B-X
( B-X
dutasteride B-X
) B-X
, B-X
a B-X
compound B-X
with B-X
parallel B-X
linear B-X
and B-X
nonlinear B-X
elimination B-X
Pharmacokinetics B-X
and B-X
Concentration-Effect B-X
Relationship B-X
of B-X
Oral B-X
LSD B-X
in B-X
Humans B-X
The B-X
concentration B-X
of B-X
oxazepam B-X
and B-X
oxazepam B-X
glucuronide B-X
in B-X
oral B-X
fluid B-X
, B-X
blood B-X
and B-X
serum B-X
after B-X
controlled B-X
administration B-X
of B-X
15 B-X
and B-X
30 B-X
mg B-X
oxazepam B-X
Many B-X
studies B-X
have B-X
focused B-X
on B-X
the B-X
challenges B-X
of B-X
small B-X
molecule B-X
uptake B-X
across B-X
the B-X
blood‚Äìbrain B-X
barrier B-X
, B-X
whereas B-X
few B-X
in-depth B-X
studies B-X
have B-X
assessed B-X
the B-X
challenges B-X
with B-X
the B-X
uptake B-X
of B-X
antibodies B-X
into B-X
The B-X
effect B-X
of B-X
dosing B-X
regimen B-X
on B-X
the B-X
pharmacokinetics B-X
of B-X
risedronate B-X
The B-X
pharmacokinetics B-X
and B-X
associated B-X
pharmacodynamics B-X
of B-X
nifedipine B-X
were B-X
studied B-X
at B-X
steady B-X
state B-X
in B-X
12 B-X
patients B-X
with B-X
angina B-X
pectoris B-X
who B-X
were B-X
receiving B-X
nifedipine B-X
10-40 B-X
mg B-X
tid B-X
. B-X
After B-X
dosing B-X
, B-X
serum B-X

However	O
,	O
there	O
appeared	O
to	O
be	O
a	O
considerable	O
variation	O
in	O
colchicine	O
milk	O
concentration	O
among	O
the	O
different	O
patients	O
,	O
which	O
might	O
be	O
related	O
to	O
individual	O
breast	O
milk	O
composition	O
and	O
,	O
possibly	O
,	O
to	O
other	O
nutritional	O
or	O
metabolic	O
factors	O
.	O
<EOS> B-X
ABSTRACT B-X
. B-X
Background B-X
: B-X
It B-X
is B-X
widely B-X
reported B-X
that B-X
maternal B-X
diet B-X
influences B-X
the B-X
nutritional B-X
composition B-X
of B-X
breast B-X
milk B-X
. B-X
The B-X
amount B-X
of B-X
variability B-X
in B-X
human B-X
milk B-X
at B-X
Did B-X
you B-X
know B-X
that B-X
breast B-X
milk B-X
composition B-X
varies B-X
over B-X
time B-X
? B-X
Find B-X
out B-X
what B-X
‚Äô B-X
s B-X
in B-X
your B-X
breast B-X
milk B-X
and B-X
how B-X
it B-X
changes B-X
to B-X
meet B-X
your B-X
growing B-X
baby B-X
‚Äô B-X
Breast B-X
milk B-X
composition B-X
changes B-X
over B-X
time B-X
to B-X
meet B-X
your B-X
growing B-X
baby B-X
's B-X
nutrition B-X
requirements B-X
. B-X
Learn B-X
more B-X
about B-X
breast B-X
milk B-X
composition B-X
change B-X
Breastmilk B-X
is B-X
uniquely B-X
superior B-X
for B-X
infant B-X
feeding B-X
. B-X
It B-X
is B-X
the B-X
normal B-X
food B-X
for B-X
infants B-X
from B-X
birth.Breastmilk B-X
contains B-X
all B-X
of B-X
the B-X
essential B-X
nutrients B-X
, B-X
antibodies B-X
and B-X
other B-X
factors B-X
important B-X
for B-X
Cells B-X
of B-X
human B-X
breast B-X
milk B-X
Breastfeeding B-X
is B-X
the B-X
biologically B-X
normal B-X
way B-X
to B-X
feed B-X
babies B-X
. B-X
Hence B-X
, B-X
the B-X
composition B-X
of B-X
breastmilk B-X
is B-X
the B-X
biological B-X
norm B-X
for B-X
human B-X
babies B-X
. B-X
Breastmilk B-X
contains B-X
many B-X
factors B-X
which B-X
help B-X
The B-X
Relationship B-X
between B-X
Dietary B-X
Patterns B-X
and B-X
Metabolic B-X
Health B-X
in B-X
a B-X
Representative B-X
Sample B-X
of B-X
Adult B-X
Australians B-X

CONCLUSION	O
.	O
<EOS> B-X
How B-X
to B-X
Write B-X
a B-X
Strong B-X
Conclusion B-X
for B-X
Your B-X
Essay B-X
Writer B-X
's B-X
Web B-X
: B-X
Writing B-X
Effective B-X
Conclusions B-X
A B-X
conclusion B-X
is B-X
the B-X
last B-X
part B-X
of B-X
something B-X
, B-X
its B-X
end B-X
or B-X
result B-X
. B-X
When B-X
you B-X
write B-X
a B-X
paper B-X
, B-X
you B-X
always B-X
end B-X
by B-X
summing B-X
up B-X
your B-X
arguments B-X
and B-X
drawing B-X
So B-X
much B-X
is B-X
at B-X
stake B-X
in B-X
writing B-X
a B-X
conclusion B-X
. B-X
This B-X
is B-X
, B-X
after B-X
all B-X
, B-X
your B-X
last B-X
chance B-X
to B-X
persuade B-X
your B-X
readers B-X
to B-X
your B-X
point B-X
of B-X
view B-X
, B-X
to B-X
< B-X
p B-X
> B-X
Some B-X
might B-X
argue B-X
a B-X
conclusion B-X
is B-X
one B-X
of B-X
the B-X
most B-X
important B-X
components B-X
of B-X
any B-X
research B-X
paper B-X
or B-X
article B-X
. B-X
It B-X
's B-X
your B-X
last B-X
opportunity B-X
to B-X
make B-X
a B-X
Conclusion B-X
definition B-X
, B-X
the B-X
end B-X
or B-X
close B-X
; B-X
final B-X
part B-X
. B-X
See B-X
more B-X
. B-X

The	O
extensive	O
peripheral	O
tissue	O
binding	O
and	O
relatively	O
low	O
concentration	O
of	O
colchicine	O
in	O
breast	O
milk	O
suggests	O
that	O
the	O
amount	O
ingested	O
by	O
the	O
infant	O
is	O
small	O
.	O

Furthermore	O
,	O
based	O
on	O
our	O
clinical	O
experience	O
,	O
nursing	O
appears	O
to	O
be	O
safe	O
for	O
lactating	O
women	O
with	O
FMF	B-Disease
who	O
continue	O
to	O
take	O
colchicine	O
.	O

Abnormal	O
myotonic	B-Disease
dystrophy	I-Disease
protein	O
kinase	O
levels	O
produce	O
only	O
mild	O
myopathy	B-Disease
in	O
mice	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
is B-X
involved B-X
in B-X
the B-X
modulation B-X
of B-X
the B-X
Ca2+ B-X
homeostasis B-X
in B-X
skeletal B-X
muscle B-X
cells B-X
. B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
commonly B-X
associated B-X
with B-X
CTG B-X
repeat B-X
expansions B-X
within B-X
the B-X
gene B-X
for B-X
DM-protein B-X
kinase B-X
( B-X
DMPK B-X
) B-X
. B-X
The B-X
effect B-X
of B-X
altered B-X
expression B-X
levels B-X
of B-X
DMPK B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
commonly B-X
associated B-X
with B-X
CTG B-X
repeat B-X
expansions B-X
within B-X
the B-X
gene B-X
for B-X
DM‚Äìprotein B-X
kinase B-X
( B-X
DMPK B-X
) B-X
. B-X
The B-X
effect B-X
of B-X
altered B-X
expression B-X
levels B-X
of B-X
DMPK B-X
MYOBASE B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
scientific B-X
article B-X
published B-X
in B-X
July B-X
1996 B-X

Myotonic	B-Disease
dystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
commonly	O
associated	O
with	O
CTG	O
repeat	O
expansions	O
within	O
the	O
gene	O
for	O
DM	O
-	O
protein	O
kinase	O
(	O
DMPK	O
)	O
.	O

The	O
effect	O
of	O
altered	O
expression	O
levels	O
of	O
DMPK	O
,	O
which	O
is	O
ubiquitously	O
expressed	O
in	O
all	O
muscle	O
cell	O
lineages	O
during	O
development	O
,	O
was	O
examined	O
by	O
disrupting	O
the	O
endogenous	O
Dmpk	O
gene	O
and	O
overexpressing	O
a	O
normal	O
human	O
DMPK	O
transgene	O
in	O
mice	O
.	O
<EOS> B-X
Abnormal B-X
expression B-X
of B-X
human B-X
myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
( B-X
hDMPK B-X
) B-X
gene B-X
products B-X
has B-X
been B-X
implicated B-X
in B-X
myotonic B-X
dystrophy B-X
type B-X
1 B-X
( B-X
DM1 B-X
) B-X
, B-X
yet B-X
the B-X
impact B-X
of B-X
distress B-X
PDF B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
commonly B-X
associated B-X
with B-X
CTG B-X
repeat B-X
expansions B-X
within B-X
the B-X
gene B-X
for B-X
DM-protein B-X
kinase B-X
( B-X
DMPK B-X
) B-X
. B-X
The B-X
effect B-X
of B-X
altered B-X
... B-X
| B-X
Alternative B-X
Splicing B-X
of B-X
Transcription B-X
Factors B-X
Genes B-X
in B-X
Muscle B-X
Physiology B-X
and B-X
Pathology B-X
Request B-X
PDF B-X
| B-X
Abnormal B-X
actomyosin B-X
assembly B-X
in B-X
proliferating B-X
and B-X
differentiating B-X
myoblasts B-X
upon B-X
expression B-X
of B-X
a B-X
cytosolic B-X
DMPK B-X
isoform B-X
| B-X
DMPK B-X
, B-X
the B-X
product B-X
of B-X
the B-X
mutated B-X
gene B-X
in B-X
myotonic B-X
dystrophy B-X
RNA-binding B-X
proteins B-X
and B-X
gene B-X
regulation B-X
in B-X
myogenesis B-X
Abstract B-X
. B-X
Myotonic B-X
dystrophy B-X
( B-X
DM1 B-X
) B-X
is B-X
a B-X
multisystemic B-X
disorder B-X
caused B-X
by B-X
a B-X
CTG B-X
repeat B-X
expansion B-X
within B-X
the B-X
3‚Ä≤-UTR B-X
of B-X
the B-X
DMPK B-X
gene B-X
. B-X
DM1 B-X
is B-X
characterized B-X
by B-X
dela B-X
Myotonic B-X
dystrophy B-X
type B-X
1 B-X
( B-X
DM1 B-X
) B-X
is B-X
a B-X
neuromuscular B-X
disorder B-X
caused B-X
by B-X
an B-X
unstable B-X
( B-X
CTG B-X
. B-X
CAG B-X
) B-X
n B-X
segment B-X
in B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X
of B-X
the B-X

Nullizygous	O
(	O
-	O
/	O
-	O
)	O
mice	O
showed	O
only	O
inconsistent	O
and	O
minor	O
size	O
changes	O
in	O
head	O
and	O
neck	O
muscle	O
fibres	O
at	O
older	O
age	O
,	O
animals	O
with	O
the	O
highest	O
DMPK	O
transgene	O
expression	O
showed	O
hypertrophic	B-Disease
cardiomyopathy	I-Disease
and	O
enhanced	O
neonatal	O
mortality	O
.	O
<EOS> B-X
Small B-X
mammalian B-X
animal B-X
models B-X
of B-X
heart B-X
disease B-X
WikiGenes B-X
- B-X
Infant B-X
Mortality B-X
Neck B-X
Muscle B-X
Changes B-X
Following B-X
Long-Duration B-X
Spaceflight B-X
Request B-X
PDF B-X
| B-X
Age-dependent B-X
chloride B-X
channel B-X
expression B-X
in B-X
skeletal B-X
muscle B-X
fibres B-X
of B-X
normal B-X
and B-X
HSA B-X
( B-X
LR B-X
) B-X
myotonic B-X
mice B-X
| B-X
We B-X
combine B-X
electrophysiological B-X
and B-X
optical B-X
techniques B-X
to B-X
investigate B-X
the B-X
Dropped B-X
head B-X
syndrome B-X
due B-X
to B-X
neuromuscular B-X
disorders B-X
: B-X
Clinical B-X
manifestation B-X
and B-X
evaluation B-X
Neck B-X
pain B-X
is B-X
common B-X
but B-X
it B-X
‚Äô B-X
s B-X
not B-X
usually B-X
a B-X
sign B-X
of B-X
arthritis B-X
or B-X
medical B-X
condition B-X
. B-X
Learn B-X
about B-X
the B-X
causes B-X
, B-X
exercises B-X
, B-X
treatment B-X
and B-X
how B-X
the B-X
neck B-X
Association B-X
Between B-X
Forward B-X
Head B-X
, B-X
Rounded B-X
Shoulders B-X
, B-X
and B-X
Increased B-X
Thoracic B-X
Kyphosis B-X
: B-X
A B-X
Review B-X
of B-X
the B-X
Literature B-X

However	O
,	O
both	O
models	O
lack	O
other	O
frequent	O
DM	B-Disease
symptoms	O
including	O
the	O
fibre	O
-	O
type	O
dependent	O
atrophy	B-Disease
,	O
myotonia	B-Disease
,	O
cataract	B-Disease
and	O
male	B-Disease
-	I-Disease
infertility	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Differential B-X
susceptibility B-X
of B-X
muscles B-X
to B-X
myotonia B-X
and B-X
force B-X
impairment B-X
in B-X
a B-X
mouse B-X
model B-X
of B-X
Myotonic B-X
dystrophy B-X
| B-X
Myotonic B-X
dystrophy B-X
, B-X
or B-X
dystrophia B-X
myotonica B-X
( B-X
DM B-X
) B-X
, B-X
Abnormal B-X
myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
levels B-X
produce B-X
only B-X
mild B-X
myopathy B-X
in B-X
mice B-X
| B-X
Read B-X
by B-X
QxMD B-X

These	O
results	O
strengthen	O
the	O
contention	O
that	O
simple	O
loss	O
-	O
or	O
gain	O
-	O
of	O
-	O
expression	O
of	O
DMPK	O
is	O
not	O
the	O
only	O
crucial	O
requirement	O
for	O
development	O
of	O
the	O
disease	O
.	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Myotonic B-X
dystrophy B-X
1 B-X
in B-X
the B-X
nervous B-X
system B-X
: B-X
From B-X
the B-X
clinic B-X
to B-X
molecular B-X
mechanisms B-X
| B-X
Myotonic B-X
dystrophy B-X
type B-X
1 B-X
( B-X
DM1 B-X
) B-X
is B-X
a B-X
dominant B-X
neuromuscular B-X
disorder B-X

Mice	O
lacking	O
the	O
myotonic	B-Disease
dystrophy	I-Disease
protein	O
kinase	O
develop	O
a	O
late	O
onset	O
progressive	O
myopathy	B-Disease
.	O
<EOS> B-X
Altered B-X
Œ≤-adrenergic B-X
response B-X
in B-X
mice B-X
lacking B-X
myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
( B-X
DMPK B-X
) B-X
Muscle B-X
wasting B-X
in B-X
myotonic B-X
dystrophies B-X
: B-X
a B-X
model B-X
of B-X
premature B-X
aging B-X
PubMed B-X
journal B-X
article B-X
: B-X
Myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
( B-X
DMPK B-X
) B-X
and B-X
its B-X
role B-X
in B-X
the B-X
pathogenesis B-X
of B-X
myotonic B-X
dystrophy B-X
1 B-X
. B-X
Download B-X
Prime B-X
PubMed B-X
App B-X
to B-X
iPhone B-X
, B-X
iPad B-X

Myotonic	B-Disease
dystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
an	O
autosomal	B-Disease
dominant	I-Disease
disorder	I-Disease
resulting	O
from	O
the	O
expansion	O
of	O
a	O
CTG	O
repeat	O
in	O
the	O
3	O
untranslated	O
region	O
of	O
a	O
putative	O
protein	O
kinase	O
(	O
DMPK	O
)	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
type B-X
1 B-X
( B-X
DM1 B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disease B-X
caused B-X
by B-X
a B-X
trinucleotide B-X
repeat-expansion B-X
, B-X
cytosine-thymine-guanine B-X
( B-X
CTG B-X
) B-X
n B-X
, B-X
in B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X

To	O
elucidate	O
the	O
role	O
of	O
DMPK	O
in	O
DM	B-Disease
pathogenesis	O
we	O
have	O
developed	O
Dmpk	B-Disease
deficient	I-Disease
(	O
Dmpk	O
-	O
/	O
-	O
)	O
mice	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
1 B-X
( B-X
DM1 B-X
) B-X
is B-X
caused B-X
by B-X
a B-X
CTG B-X
expansion B-X
in B-X
the B-X
3‚Ä≤-unstranslated B-X
region B-X
of B-X
the B-X
DMPK B-X
gene B-X
, B-X
which B-X
encodes B-X
a B-X
serine/threonine B-X
protein B-X
kinase B-X
. B-X
One B-X
of B-X
Role B-X
of B-X
Myotonic B-X
Dystrophy B-X
Protein B-X
Kinase B-X
( B-X
DMPK B-X
) B-X
in B-X
Glucose B-X
Homeostasis B-X
and B-X
Muscle B-X
Insulin B-X
Action B-X
Myotonic B-X
dystrophy B-X
1 B-X
( B-X
DM1 B-X
) B-X
is B-X
caused B-X
by B-X
a B-X
CTG B-X
expansion B-X
in B-X
the B-X
3'-unstranslated B-X
region B-X
of B-X
the B-X
DMPK B-X
gene B-X
, B-X
which B-X
encodes B-X
a B-X
serine/threonine B-X
protein B-X
kinase B-X
. B-X
One B-X
of B-X
Of B-X
Mice B-X
and B-X
Men B-X
: B-X
Advances B-X
in B-X
the B-X
Understanding B-X
of B-X
Neuromuscular B-X
Aspects B-X
of B-X
Myotonic B-X
Dystrophy B-X

Dmpk	O
-	O
/	O
-	O
mice	O
develop	O
a	O
late	O
-	O
onset	O
,	O
progressive	B-Disease
skeletal	I-Disease
myopathy	I-Disease
that	O
shares	O
some	O
pathological	O
features	O
with	O
DM	B-Disease
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
resulting B-X
from B-X
the B-X
expansion B-X
of B-X
a B-X
CTG B-X
repeat B-X
in B-X
the B-X
3‚Ä≤ B-X
untranslated B-X
region B-X
of B-X
a B-X
putative B-X
protein B-X
kinase B-X
( B-X
DMPK B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
resulting B-X
from B-X
the B-X
expansion B-X
of B-X
a B-X
CTG B-X
repeat B-X
in B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X
of B-X
a B-X
putative B-X
protein B-X
kinase B-X
( B-X
Download B-X
Citation B-X
| B-X
Skeletal B-X
myopathy B-X
in B-X
mice B-X
over-expressing B-X
the B-X
human B-X
myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
( B-X
DMPK B-X
) B-X
gene B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
Effect B-X
of B-X
the B-X
[ B-X
CCTG B-X
] B-X
n B-X
repeat B-X
expansion B-X
on B-X
ZNF9 B-X
expression B-X
in B-X
myotonic B-X
dystrophy B-X
type B-X
II B-X
( B-X
DM2 B-X
) B-X
- B-X
ScienceDirect B-X
Changes B-X
in B-X
Myotonic B-X
Dystrophy B-X
Protein B-X
Kinase B-X
Levels B-X
and B-X
Muscle B-X
Development B-X
in B-X
Congenital B-X
Myotonic B-X
Dystrophy B-X

Muscles	O
from	O
mature	O
mice	O
show	O
variation	O
in	O
fibre	O
size	O
,	O
increased	O
fibre	B-Disease
degeneration	I-Disease
and	O
fibrosis	B-Disease
.	O
<EOS> B-X
Age-related B-X
changes B-X
in B-X
skeletal B-X
muscle B-X
: B-X
changes B-X
to B-X
life-style B-X
as B-X
a B-X
therapy B-X
Morphometric B-X
analysis B-X
of B-X
mdx B-X
diaphragm B-X
muscle B-X
fibres B-X
. B-X
Comparison B-X
with B-X
hindlimb B-X
muscles B-X
- B-X
ScienceDirect B-X
Request B-X
PDF B-X
| B-X
T B-X
and B-X
B B-X
lymphocyte B-X
depletion B-X
has B-X
a B-X
marked B-X
effect B-X
on B-X
the B-X
fibrosis B-X
of B-X
dystrophic B-X
skeletal B-X
muscles B-X
in B-X
the B-X
SCID/mdx B-X
mouse B-X
| B-X
Abnormal B-X
connective B-X
tissue B-X
proliferation B-X
following B-X
muscle B-X
Aging B-X
leads B-X
to B-X
decreased B-X
skeletal B-X
muscle B-X
function B-X
in B-X
mammals B-X
and B-X
is B-X
associated B-X
with B-X
a B-X
progressive B-X
loss B-X
of B-X
muscle B-X
mass B-X
, B-X
quality B-X
and B-X
strength B-X
. B-X
Age-related B-X
muscle B-X
loss B-X
( B-X
sarcopenia B-X
) B-X
Muscle B-X
Weakness B-X
and B-X
Fibrosis B-X
Due B-X
to B-X
Cell B-X
Autonomous B-X
and B-X
Non-cell B-X
Autonomous B-X
Events B-X
in B-X
Collagen B-X
VI B-X
Deficient B-X
Congenital B-X
Muscular B-X
Dystrophy B-X
- B-X
ScienceDirect B-X
Mice B-X
lacking B-X
the B-X
sarcolemmal B-X
protein B-X
dystrophin B-X
, B-X
designated B-X
mdx B-X
, B-X
have B-X
been B-X
widely B-X
used B-X
as B-X
a B-X
model B-X
of B-X
Duchenne B-X
muscular B-X
dystrophy B-X
. B-X
Dystrophic B-X
mdx B-X
mice B-X
as B-X
they B-X
mature B-X
develop B-X
notable B-X

Adult	O
Dmpk	O
-	O
/	O
-	O
mice	O
show	O
ultrastructural	O
changes	O
in	O
muscle	O
and	O
a	O
50	O
%	O
decrease	O
in	O
force	O
generation	O
compared	O
to	O
young	O
mice	O
.	O
<EOS> B-X
Dmpk B-X
gene B-X
deletion B-X
or B-X
antisense B-X
knockdown B-X
does B-X
not B-X
compromise B-X
cardiac B-X
or B-X
skeletal B-X
muscle B-X
function B-X
in B-X
mice B-X
Functional B-X
and B-X
histopathological B-X
identification B-X
of B-X
the B-X
respiratory B-X
failure B-X
in B-X
a B-X
DMSXL B-X
transgenic B-X
mouse B-X
model B-X
of B-X
myotonic B-X
dystrophy B-X
Mice B-X
lacking B-X
the B-X
myotonic B-X
dystrophy B-X
protein B-X
kinase B-X
develop B-X
a B-X
late B-X
onset B-X
progressive B-X
myopathy B-X
. B-X
PDF B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
the B-X
most B-X
common B-X
form B-X
of B-X
muscular B-X
dystrophy B-X
and B-X
is B-X
caused B-X
by B-X
expansion B-X
of B-X
a B-X
CTG B-X
trinucleotide B-X
repeat B-X
on B-X
human B-X
chromosome B-X
... B-X
| B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
University B-X
of B-X
Southern B-X
California B-X

Our	O
results	O
indicate	O
that	O
DMPK	O
may	O
be	O
necessary	O
for	O
the	O
maintenance	O
of	O
skeletal	O
muscle	O
structure	O
and	O
function	O
and	O
suggest	O
that	O
a	O
decrease	O
in	O
DMPK	O
levels	O
may	O
contribute	O
to	O
DM	B-Disease
pathology	O
.	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
the B-X
most B-X
common B-X
inherited B-X
adult B-X
neuromuscular B-X
disorder B-X
. B-X
DM B-X
is B-X
caused B-X
by B-X
a B-X
CTG B-X
expansion B-X
in B-X
the B-X
3'-untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase B-X
gene B-X
Request B-X
PDF B-X
| B-X
Changes B-X
in B-X
Myotonic B-X
Dystrophy B-X
Protein B-X
Kinase B-X
Levels B-X
and B-X
Muscle B-X
Development B-X
in B-X
Congenital B-X
Myotonic B-X
Dystrophy B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM1 B-X
) B-X
is B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X

The	O
tumor	B-Disease
suppressor	O
gene	O
Brca1	O
is	O
required	O
for	O
embryonic	O
cellular	O
proliferation	O
in	O
the	O
mouse	O
.	O
<EOS> B-X
Tumour B-X
suppressor B-X
gene B-X
mutations B-X
in B-X
humans B-X
and B-X
mice B-X
: B-X
parallels B-X
and B-X
contrasts B-X
. B-X
Mutations B-X
of B-X
the B-X
BRCA1 B-X
gone B-X
in B-X
humans B-X
are B-X
associated B-X
with B-X
predisposition B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
We B-X
show B-X
here B-X
that B-X
Brca1+/- B-X
mice B-X
are B-X
normal B-X
and B-X
fertile B-X
and B-X
lack B-X
tumors B-X
Breast B-X
cancer B-X
is B-X
a B-X
chief B-X
cause B-X
of B-X
cancer-related B-X
mortality B-X
that B-X
affects B-X
women B-X
worldwide B-X
. B-X
About B-X
8 B-X
% B-X
of B-X
cases B-X
are B-X
hereditary B-X
, B-X
and B-X
approximately B-X
half B-X
of B-X
these B-X
are B-X
associated B-X
with B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

Mutations	O
of	O
the	O
BRCA1	O
gone	O
in	O
humans	O
are	O
associated	O
with	O
predisposition	O
to	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancers	I-Disease
.	O

We	O
show	O
here	O
that	O
Brca1	O
+	O
/	O
-	O
mice	O
are	O
normal	O
and	O
fertile	O
and	O
lack	O
tumors	B-Disease
by	O
age	O
eleven	O
months	O
.	O
<EOS> B-X
Download B-X
Citation B-X
| B-X
The B-X
cancer B-X
connection B-X
: B-X
BRCA1 B-X
and B-X
BRCA2 B-X
tumor B-X
suppression B-X
in B-X
mice B-X
and B-X
humans B-X
| B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
are B-X
estimated B-X
to B-X
be B-X
responsible B-X
for B-X
the B-X
great B-X
majority B-X
Cre-mediated B-X
deletion B-X
of B-X
exons B-X
3 B-X
and B-X
4 B-X
of B-X
the B-X
mouse B-X
Brca2 B-X
gene B-X
occurring B-X
specifically B-X
in B-X
mammary B-X
epithelial B-X
cells B-X
of B-X
conditional B-X
female B-X
mutants B-X
carrying B-X
a B-X
combination B-X
of B-X
loxP-modified B-X
and B-X
null B-X
Brca2 B-X
Author B-X
Summary B-X
Women B-X
with B-X
one B-X
strong B-X
BRCA2 B-X
( B-X
FANCD1 B-X
) B-X
mutation B-X
have B-X
high B-X
risks B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
People B-X
with B-X
two B-X
mild B-X
BRCA2 B-X
( B-X
FANCD1 B-X
) B-X
mutations B-X
develop B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
are B-X
estimated B-X
to B-X
be B-X
responsible B-X
for B-X
the B-X
great B-X
majority B-X
of B-X
familial B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
Much B-X
progress B-X
has B-X
been B-X
made B-X
toward B-X
the B-X
understanding B-X
of B-X
the B-X
Brca1 B-X

Homozygous	O
Brca1	O
(	O
5	O
-	O
6	O
)	O
mutant	O
mice	O
die	O
before	O
day	O
7	O
.	O
<EOS> B-X
Mutations B-X
of B-X
the B-X
tumor B-X
suppressor B-X
gene B-X
BRCA2 B-X
are B-X
associated B-X
with B-X
predisposition B-X
to B-X
breast B-X
and B-X
other B-X
cancers B-X
. B-X
Homozygous B-X
mutant B-X
mice B-X
in B-X
which B-X
exons B-X
10 B-X
and B-X
11 B-X
of B-X
the B-X
Brca2 B-X
gene B-X
Tumorigenesis B-X
in B-X
mice B-X
carrying B-X
a B-X
truncating B-X
Brca1 B-X
mutation B-X
Preclinical B-X
mouse B-X
models B-X
for B-X
BRCA1-associated B-X
breast B-X
cancer B-X
BRCA1 B-X
and B-X
homologous B-X
recombination B-X
: B-X
implications B-X
from B-X
mouse B-X
embryonic B-X
development B-X
The B-X
Tumor B-X
Suppressor B-X
Gene B-X
Brca1 B-X
Is B-X
Required B-X
for B-X
Embryonic B-X
Cellular B-X
Proliferation B-X
in B-X
the B-X
Mouse B-X
: B-X
Cell B-X
Increased B-X
cell B-X
survival B-X
by B-X
inhibition B-X
of B-X
BRCA1 B-X
using B-X
an B-X
antisense B-X
approach B-X
in B-X
an B-X
estrogen B-X
responsive B-X
ovarian B-X
carcinoma B-X
cell B-X
line B-X
Disruption B-X
of B-X
muREC2/RAD51L1 B-X
in B-X
Mice B-X
Results B-X
in B-X
Early B-X
Embryonic B-X
Lethality B-X
Which B-X
Can B-X
Be B-X
Partially B-X
Rescued B-X
in B-X
a B-X
p53‚àí/‚àí B-X
Background B-X

5	O
of	O
embryogenesis	O
.	O
<EOS> B-X
Timeline B-X
of B-X
human B-X
prenatal B-X
development B-X
- B-X
Wikipedia B-X
Timeline B-X
of B-X
human B-X
prenatal B-X
development B-X
- B-X
Wikipedia B-X
Human B-X
embryogenesis B-X
( B-X
article B-X
) B-X
| B-X
Embryology B-X
| B-X
Khan B-X
Academy B-X
Human B-X
embryogenesis B-X
( B-X
article B-X
) B-X
| B-X
Embryology B-X
| B-X
Khan B-X
Academy B-X
Timeline B-X
human B-X
development B-X
- B-X
Embryology B-X
Timeline B-X
human B-X
development B-X
- B-X
Embryology B-X
Mammalian B-X
embryogenesis B-X
- B-X
Wikipedia B-X

Mutant	O
embryos	O
are	O
poorly	O
developed	O
,	O
with	O
no	O
evidence	O
of	O
mesoderm	O
formation	O
.	O
<EOS> B-X
Distinct B-X
mesoderm B-X
migration B-X
phenotypes B-X
in B-X
extra-embryonic B-X
and B-X
embryonic B-X
regions B-X
of B-X
the B-X
early B-X
mouse B-X
embryo B-X
Cdx2 B-X
is B-X
essential B-X
for B-X
axial B-X
elongation B-X
in B-X
mouse B-X
development B-X
Cripto B-X
is B-X
required B-X
for B-X
mesoderm B-X
and B-X
endoderm B-X
cell B-X
allocation B-X
during B-X
mouse B-X
gastrulation B-X
BMP B-X
signaling B-X
in B-X
the B-X
epiblast B-X
is B-X
required B-X
for B-X
proper B-X
recruitment B-X
of B-X
the B-X
prospective B-X
paraxial B-X
mesoderm B-X
and B-X
development B-X
of B-X
the B-X
somites B-X
| B-X
Development B-X
At B-X
gastrulation B-X
, B-X
mesoderm B-X
arises B-X
as B-X
a B-X
migratory B-X
germ B-X
layer B-X
that B-X
will B-X
participate B-X
to B-X
both B-X
foetal B-X
and B-X
placental B-X
development B-X
through B-X
region-dependant B-X
adaptation B-X
of B-X
cytoskeleton B-X
composition B-X
, B-X
cell B-X
shape B-X
and B-X
migration B-X
Targeted B-X
disruption B-X
of B-X
Fgf8 B-X
causes B-X
failure B-X
of B-X
cell B-X
migration B-X
in B-X
the B-X
gastrulating B-X
mouse B-X
embryo B-X
T-box B-X
Genes B-X
in B-X
Early B-X
Embryogenesis B-X

The	O
extraembryonic	O
region	O
is	O
abnormal	O
,	O
but	O
aggregation	O
with	O
wild	O
-	O
type	O
tetraploid	O
embryos	O
does	O
not	O
rescue	O
the	O
lethality	O
.	O
<EOS> B-X
Aggregation B-X
Chimeras B-X
: B-X
Combining B-X
ES B-X
Cells B-X
, B-X
Diploid B-X
, B-X
and B-X
Tetraploid B-X
Embryos B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Rescue B-X
of B-X
embryonic B-X
lethality B-X
by B-X
tetraploid B-X
aggregation B-X
. B-X
Diploid B-X
8-cell B-X
embryos B-X
from B-X
matings B-X
of B-X
heterozygous B-X
knockout B-X
mice B-X
are B-X
aggregated B-X
with B-X
tetraploid B-X
4-cell B-X
embryos B-X
, B-X
generated B-X
by B-X
The B-X
Tumor B-X
Suppressor B-X
Gene B-X
Brca1 B-X
Is B-X
Required B-X
for B-X
Embryonic B-X
Cellular B-X
Proliferation B-X
in B-X
the B-X
Mouse B-X
- B-X
ScienceDirect B-X
Genetic B-X
and B-X
molecular B-X
evidence B-X
indicates B-X
that B-X
visceral B-X
endoderm B-X
, B-X
an B-X
extraembryonic B-X
cell B-X
lineage B-X
, B-X
is B-X
required B-X
for B-X
gastrulation B-X
, B-X
early B-X
anterior B-X
neural B-X
patterning B-X
, B-X
cell B-X
death B-X
and B-X
specification B-X
of B-X
posterior B-X
Request B-X
PDF B-X
| B-X
Aggregation B-X
Chimeras B-X
: B-X
Combining B-X
ES B-X
Cells B-X
, B-X
Diploid B-X
and B-X
Tetraploid B-X
Embryos B-X
| B-X
In B-X
recent B-X
years B-X
, B-X
chimeras B-X
have B-X
been B-X
providing B-X
a B-X
powerful B-X
way B-X
to B-X
study B-X
mouse B-X
development B-X
PDF B-X
| B-X
Mouse B-X
embryos B-X
with B-X
an B-X
additional B-X
maternally B-X
inherited B-X
X B-X
chromosome B-X
, B-X
i.e. B-X
, B-X
disomic B-X
for B-X
XM B-X
( B-X
DsXM B-X
) B-X
, B-X
cease B-X
to B-X
grow B-X
early B-X
in B-X
development B-X
and B-X
have B-X
a B-X
Tetraploid B-X
development B-X
in B-X
the B-X
mouse B-X
- B-X
Eakin B-X
- B-X
2003 B-X
- B-X
Developmental B-X
Dynamics B-X
- B-X
Wiley B-X
Online B-X
Library B-X

In	O
vivo	O
,	O
mutant	O
embryos	O
do	O
not	O
exhibit	O
increased	O
apoptosis	O
but	O
show	O
reduced	O
cell	O
proliferation	O
accompanied	O
by	O
decreased	O
expression	O
of	O
cyclin	O
E	O
and	O
mdm	O
-	O
2	O
,	O
a	O
regulator	O
of	O
p53	O
activity	O
.	O
<EOS> B-X
Nuclear B-X
FAK B-X
promotes B-X
cell B-X
proliferation B-X
and B-X
survival B-X
through B-X
FERM-enhanced B-X
p53 B-X
degradation B-X
Mdmx B-X
as B-X
an B-X
essential B-X
regulator B-X
of B-X
p53 B-X
activity B-X
- B-X
ScienceDirect B-X
Regulation B-X
of B-X
p53 B-X
protein B-X
activity B-X
is B-X
required B-X
for B-X
normal B-X
embryogenesis B-X
, B-X
tumor B-X
suppression B-X
, B-X
and B-X
cellular B-X
response B-X
to B-X
DNA B-X
damage B-X
. B-X
Here B-X
we B-X
report B-X
that B-X
loss B-X
of B-X
mdmx B-X
, B-X
a B-X
Control B-X
of B-X
cell B-X
cycle B-X
progression B-X
by B-X
c-Jun B-X
is B-X
p53 B-X
dependent B-X
The B-X
Mdm B-X
network B-X
and B-X
its B-X
regulation B-X
of B-X
p53 B-X
activities B-X
: B-X
a B-X
rheostat B-X
of B-X
cancer B-X
risk B-X
The B-X
tumor B-X
suppressor B-X
p53 B-X
regulates B-X
cell B-X
cycle B-X
progression B-X
and B-X
apoptosis B-X
in B-X
response B-X
to B-X
various B-X
types B-X
of B-X
stress B-X
, B-X
whereas B-X
excess B-X
p53 B-X
activity B-X
creates B-X
unwanted B-X
effects B-X
. B-X
Tight B-X
regulation B-X
of B-X
p53 B-X
The B-X
p53 B-X
tumor B-X
suppressor B-X
is B-X
a B-X
universal B-X
sensor B-X
of B-X
genotoxic B-X
stress B-X
that B-X
regulates B-X
the B-X
transcription B-X
of B-X
genes B-X
required B-X
for B-X
cell-cycle B-X
arrest B-X
and B-X
apoptosis B-X
. B-X
In B-X
response B-X
to B-X
DNA B-X
damage B-X
, B-X

The	O
expression	O
of	O
cyclin	O
-	O
dependent	O
kinase	O
inhibitor	O
p21	O
is	O
dramatically	O
increased	O
in	O
the	O
mutant	O
embryos	O
.	O
<EOS> B-X
Cyclin-dependent B-X
kinase B-X
inhibitor B-X
p20 B-X
controls B-X
circadian B-X
cell-cycle B-X
timing B-X
Expression B-X
of B-X
the B-X
cyclin-dependent B-X
kinase B-X
inhibitor B-X
Dacapo B-X
is B-X
regulated B-X
by B-X
Cyclin B-X
E B-X
- B-X
ScienceDirect B-X
The B-X
Cyclin-Dependent B-X
Kinase B-X
Inhibitor B-X
p21 B-X
Is B-X
a B-X
Crucial B-X
Target B-X
for B-X
Histone B-X
Deacetylase B-X
1 B-X
as B-X
a B-X
Regulator B-X
of B-X
Cellular B-X
Proliferation B-X
Inhibition B-X
of B-X
cyclin-dependent B-X
kinase B-X
2 B-X
by B-X
p21 B-X
is B-X
necessary B-X
for B-X
retinoblastoma B-X
protein-mediated B-X
G1 B-X
arrest B-X
after B-X
Œ≥-irradiation B-X
| B-X
PNAS B-X
Tbx2 B-X
Directly B-X
Represses B-X
the B-X
Expression B-X
of B-X
the B-X
p21WAF1 B-X
Cyclin-Dependent B-X
Kinase B-X
Inhibitor B-X
| B-X
Cancer B-X
Research B-X
The B-X
Cyclin-Dependent B-X
Kinase B-X
Inhibitor B-X
p21 B-X
Is B-X
a B-X
Crucial B-X
Target B-X
for B-X
Histone B-X
Deacetylase B-X
1 B-X
as B-X
a B-X
Regulator B-X
of B-X
Cellular B-X
Proliferation B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
CDKN1A B-X
cyclin B-X
dependent B-X
kinase B-X
inhibitor B-X
1A B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X

Buttressing	O
these	O
in	O
vivo	O
observations	O
is	O
the	O
fact	O
that	O
mutant	O
blastocyst	O
growth	O
is	O
grossly	O
impaired	O
in	O
vitro	O
.	O
<EOS> B-X
Culture B-X
medium B-X
composition B-X
affects B-X
the B-X
gene B-X
expression B-X
pattern B-X
and B-X
in B-X
vitro B-X
development B-X
potential B-X
of B-X
bovine B-X
somatic B-X
cell B-X
nuclear B-X
transfer B-X
( B-X
SCNT B-X
) B-X
embryos B-X
In B-X
vitro B-X
production B-X
of B-X
ruminant B-X
embryos B-X
has B-X
become B-X
routine B-X
and B-X
is B-X
increasingly B-X
available B-X
as B-X
a B-X
commercial B-X
service B-X
to B-X
dairy B-X
, B-X
meat B-X
and B-X
wool B-X
producers B-X
. B-X
However B-X
, B-X
the B-X
efficiency B-X
of B-X
In B-X
vitro B-X
fertilization B-X
( B-X
IVF B-X
) B-X
in B-X
mammals B-X
: B-X
epigenetic B-X
and B-X
developmental B-X
alterations B-X
. B-X
Scientific B-X
and B-X
bioethical B-X
implications B-X
for B-X
IVF B-X
in B-X
humans B-X
Download B-X
Citation B-X
| B-X
On B-X
Jul B-X
1 B-X
, B-X
2000 B-X
, B-X
Daniel B-X
Haber B-X
published B-X
BRCA1 B-X
: B-X
an B-X
emerging B-X
role B-X
in B-X
the B-X
cellular B-X
response B-X
to B-X
DNA B-X
damage B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Download B-X
Citation B-X
| B-X
The B-X
short B-X
estrous B-X
cycle B-X
of B-X
mice B-X
may B-X
influence B-X
the B-X
effect B-X
of B-X
BRCA1 B-X
mutations B-X
| B-X
Breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
1 B-X
( B-X
BRCA1 B-X
) B-X
was B-X
identified B-X
from B-X
Request B-X
PDF B-X
| B-X
Improvement B-X
of B-X
implantation B-X
potential B-X
in B-X
mouse B-X
blastocysts B-X
derived B-X
from B-X
IVF B-X
by B-X
combined B-X
treatment B-X
with B-X
prolactin B-X
, B-X
epidermal B-X
growth B-X
factor B-X
and B-X
4-hydroxyestradiol B-X
| B-X
STUDY B-X
QUESTION B-X
Can B-X
supplementation B-X
of B-X
Request B-X
PDF B-X
| B-X
Heyer B-X
BS B-X
, B-X
MacAuley B-X
A B-X
, B-X
Behrendtsen B-X
O B-X
, B-X
Werb B-X
Z B-X
.. B-X
Hypersensitivity B-X
to B-X
DNA B-X
damage B-X
leads B-X
to B-X
increased B-X
apoptosis B-X
during B-X
early B-X
mouse B-X
development B-X
. B-X
Genes B-X
Dev B-X

Thus	O
,	O
the	O
death	O
of	O
Brca1	O
(	O
5	O
-	O
6	O
)	O
mutant	O
embryos	O
prior	O
to	O
gastrulation	O
may	O
be	O
due	O
to	O
a	O
failure	O
of	O
the	O
proliferative	O
burst	O
required	O
for	O
the	O
development	O
of	O
the	O
different	O
germ	O
layers	O
.	O
<EOS> B-X
The B-X
tumor B-X
suppressor B-X
gene B-X
Brca1 B-X
is B-X
required B-X
for B-X
embryonic B-X
cellular B-X
proliferation B-X
in B-X
the B-X
mouse B-X
| B-X
Meta B-X
The B-X
Dynamics B-X
of B-X
Morphogenesis B-X
in B-X
the B-X
Early B-X
Mouse B-X
Embryo B-X

Increased	O
coronary	B-Disease
heart	I-Disease
disease	I-Disease
in	O
Japanese	O
-	O
American	O
men	O
with	O
mutation	O
in	O
the	O
cholesteryl	O
ester	O
transfer	O
protein	O
gene	O
despite	O
increased	O
HDL	O
levels	O
.	O
<EOS> B-X
JCI B-X
- B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
Relationship B-X
of B-X
HDL B-X
and B-X
coronary B-X
heart B-X
disease B-X
to B-X
a B-X
common B-X
amino B-X
acid B-X
polymorphism B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
in B-X
men B-X
with B-X
and B-X
without B-X
hypertriglyceridemia B-X
- B-X
ScienceDirect B-X
Elevated B-X
HDL B-X
Cholesterol B-X
Is B-X
a B-X
Risk B-X
Factor B-X
for B-X
Ischemic B-X
Heart B-X
Disease B-X
in B-X
White B-X
Women B-X
When B-X
Caused B-X
by B-X
a B-X
Common B-X
Mutation B-X
in B-X
the B-X
Cholesteryl B-X
Ester B-X
Transfer B-X
Protein B-X
Gene B-X
| B-X
Circulation B-X
A B-X
Low B-X
Prevalence B-X
of B-X
Coronary B-X
Heart B-X
Disease B-X
among B-X
Subjects B-X
with B-X
Increased B-X
High-Density B-X
Lipoprotein B-X
Cholesterol B-X
Levels B-X
, B-X
Including B-X
Those B-X
with B-X
Plasma B-X
Cholesteryl B-X
Ester B-X
Transfer B-X
Protein B-X
Deficiency B-X
- B-X
ScienceDirect B-X

Plasma	O
high	O
density	O
lipoprotein	O
(	O
HDL	O
)	O
levels	O
are	O
strongly	O
genetically	O
determined	O
and	O
show	O
a	O
general	O
inverse	O
relationship	O
with	O
coronary	B-Disease
heart	I-Disease
disease	I-Disease
(	O
CHD	B-Disease
)	O
.	O
<EOS> B-X
High-density B-X
lipoprotein B-X
( B-X
HDL B-X
) B-X
functionality B-X
and B-X
its B-X
relevance B-X
to B-X
atherosclerotic B-X
cardiovascular B-X
disease B-X
High B-X
density B-X
lipoprotein B-X
cholesterol B-X
: B-X
an B-X
evolving B-X
target B-X
of B-X
therapy B-X
in B-X
the B-X
management B-X
of B-X
cardiovascular B-X
disease B-X
High-Density B-X
Lipoprotein B-X
and B-X
Coronary B-X
Heart B-X
Disease B-X
: B-X
Current B-X
and B-X
Future B-X
Therapies B-X
- B-X
ScienceDirect B-X
Lipoprotein B-X
( B-X
a B-X
) B-X
Concentration B-X
and B-X
the B-X
Risk B-X
of B-X
Coronary B-X
Heart B-X
Disease B-X
, B-X
Stroke B-X
, B-X
and B-X
Nonvascular B-X
Mortality B-X
From B-X
HDL B-X
cholesterol B-X
to B-X
measurements B-X
of B-X
function B-X
: B-X
Prospects B-X
for B-X
the B-X
development B-X
of B-X
tests B-X
for B-X
HDL B-X
functionality B-X
in B-X
CVD B-X
Cardiovascular B-X
disease B-X
risk B-X
reduction B-X
by B-X
raising B-X
HDL B-X
cholesterol B-X
‚Äì B-X
current B-X
therapies B-X
and B-X
future B-X
opportunities B-X

The	O
cholesteryl	O
ester	O
transfer	O
protein	O
(	O
CETP	O
)	O
mediates	O
the	O
transfer	O
of	O
cholesteryl	O
esters	O
from	O
HDL	O
to	O
other	O
lipoproteins	O
and	O
is	O
a	O
key	O
participant	O
in	O
the	O
reverse	O
transport	O
of	O
cholesterol	O
from	O
the	O
periphery	O
to	O
the	O
liver	O
.	O
<EOS> B-X
Cholesteryl B-X
ester B-X
transfer B-X
protein B-X
( B-X
CETP B-X
) B-X
and B-X
apolipoprotein B-X
E B-X
( B-X
apo B-X
E B-X
) B-X
play B-X
important B-X
roles B-X
in B-X
reverse B-X
cholesterol B-X
transport B-X
in B-X
humans B-X
. B-X
CETP B-X
transfers B-X
cholesteryl B-X
ester B-X
( B-X
CE B-X
Cholesteryl B-X
ester B-X
transfer B-X
protein B-X
( B-X
CETP B-X
) B-X
and B-X
phospholipid B-X
transfer B-X
protein B-X
( B-X
PLTP B-X
) B-X
are B-X
members B-X
of B-X
the B-X
lipid B-X
transfer/lipopolysaccharide B-X
binding B-X
protein B-X
gene B-X
family B-X
. B-X
Recently B-X
, B-X
the B-X
crystal B-X
structure B-X
Role B-X
of B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
in B-X
reverse B-X
cholesterol B-X
transport B-X
- B-X
Mcpherson B-X
- B-X
1991 B-X
- B-X
Clinical B-X
Cardiology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
TaqI B-X
B1/B2 B-X
and B-X
-629A/C B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
( B-X
CETP B-X
) B-X
gene B-X
polymorphisms B-X
and B-X
their B-X
association B-X
with B-X
CETP B-X
activity B-X
and B-X
high-density B-X
lipoprotein B-X
cholesterol B-X
levels B-X
in B-X
a B-X
Tehranian B-X
population B-X
. B-X
Part B-X
TaqI B-X
B1/B2 B-X
and B-X
-629A/C B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
( B-X
CETP B-X
) B-X
gene B-X
polymorphisms B-X
and B-X
their B-X
association B-X
with B-X
CETP B-X
activity B-X
and B-X
high-density B-X
lipoprotein B-X
cholesterol B-X
levels B-X
in B-X
a B-X
Tehranian B-X
population B-X
. B-X
Part B-X
Reverse B-X
cholesterol B-X
transport B-X
: B-X
From B-X
classical B-X
view B-X
to B-X
new B-X
insights B-X
Reverse B-X
Cholesterol B-X
Transport B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

A	O
high	O
prevalence	O
of	O
two	O
different	O
CETP	O
gene	O
mutations	O
(	O
D442G	O
,	O
5	O
.	O
1	O
%	O
;	O
intron	O
14G	O
A	O
,	O
0	O
.	O
5	O
%	O
)	O
,	O
was	O
found	O
in	O
3	O
,	O
469	O
men	O
of	O
Japanese	O
ancestry	O
in	O
the	O
Honolulu	O
Heart	O
Program	O
and	O
mutations	O
were	O
associated	O
with	O
decreased	O
CETP	O
(	O
-	O
35	O
%	O
)	O
and	O
increased	O
HDL	O
chol	O
levels	O
(	O
+	O
10	O
%	O
for	O
D442G	O
)	O
.	O
<EOS> B-X
Four B-X
different B-X
CETP B-X
gene B-X
mutations B-X
have B-X
been B-X
reported B-X
to B-X
be B-X
causes B-X
of B-X
increased B-X
levels B-X
of B-X
HDL B-X
cholesterol B-X
by B-X
us B-X
and B-X
other B-X
investigators B-X
; B-X
two B-X
splice B-X
donor B-X
site B-X
mutations B-X
involving B-X
intron B-X
Natural B-X
genetic B-X
variation B-X
as B-X
a B-X
tool B-X
in B-X
understanding B-X
the B-X
role B-X
of B-X
CETP B-X
in B-X
lipid B-X
levels B-X
and B-X
disease B-X
- B-X
ScienceDirect B-X
Unique B-X
Features B-X
of B-X
High-Density B-X
Lipoproteins B-X
in B-X
the B-X
Japanese B-X
: B-X
In B-X
Population B-X
and B-X
in B-X
Genetic B-X
Factors B-X
Genetic B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
deficiency B-X
caused B-X
by B-X
two B-X
prevalent B-X
mutations B-X
as B-X
a B-X
major B-X
determinant B-X
of B-X
increased B-X
levels B-X
of B-X
high B-X
density B-X
lipoprotein B-X
cholesterol B-X
. B-X
Genetic B-X
variants B-X
of B-X
proteins B-X
involved B-X
in B-X
lipid B-X
metabolism B-X
may B-X
play B-X
an B-X
important B-X
role B-X
in B-X
determining B-X
the B-X
susceptibility B-X
for B-X
complications B-X
associated B-X
with B-X
type B-X
II B-X
diabetes B-X
mellitus B-X
( B-X
T2DM B-X
) B-X
. B-X
Goal B-X
Genetic B-X
variants B-X
of B-X
proteins B-X
involved B-X
in B-X
lipid B-X
metabolism B-X
may B-X
play B-X
an B-X
important B-X
role B-X
in B-X
determining B-X
the B-X
susceptibility B-X
for B-X
complications B-X
associated B-X
with B-X
type B-X
II B-X
diabetes B-X
mellitus B-X
( B-X
T2DM B-X
) B-X
. B-X
Goal B-X
A B-X
common B-X
mutation B-X
of B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
in B-X
dialysis B-X
patients B-X
- B-X
ScienceDirect B-X

However	O
,	O
the	O
overall	O
prevalence	O
of	O
definite	O
CHD	B-Disease
was	O
21	O
%	O
in	O
men	O
with	O
mutations	O
and	O
16	O
%	O
in	O
men	O
without	O
mutations	O
.	O
<EOS> B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
Familial B-X
hypercholesterolaemia B-X
is B-X
underdiagnosed B-X
and B-X
undertreated B-X
in B-X
the B-X
general B-X
population B-X
: B-X
guidance B-X
for B-X
clinicians B-X
to B-X
prevent B-X
coronary B-X
heart B-X
disease B-X
Request B-X
PDF B-X
| B-X
A B-X
prospective B-X
study B-X
of B-X
HDL-C B-X
and B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
mutations B-X
and B-X
the B-X
risk B-X
of B-X
coronary B-X
heart B-X
disease B-X
in B-X
the B-X
elderly B-X
| B-X
High B-X
density B-X
lipoprotein B-X
cholesterol B-X
Research B-X
Publications B-X
Research B-X
Publications B-X
Research B-X
Publications B-X
Request B-X
PDF B-X
| B-X
Common B-X
Cholesteryl B-X
Ester B-X
Transfer B-X
Protein B-X
Mutations B-X
, B-X
Decreased B-X
HDL B-X
Cholesterol B-X
, B-X
and B-X
Possible B-X
Decreased B-X
Risk B-X
of B-X
Ischemic B-X
Heart B-X
Disease B-X
The B-X
Copenhagen B-X
City B-X
Heart B-X
Study B-X
| B-X
Cholesteryl B-X
ester B-X

The	O
relative	O
risk	O
(	O
RR	O
)	O
of	O
CHD	B-Disease
was	O
1	O
.	O
<EOS> B-X
Risk B-X
Ratios B-X
and B-X
Rate B-X
Ratios B-X
( B-X
Relative B-X
Risk B-X
) B-X
Risk B-X
Ratios B-X
and B-X
Rate B-X
Ratios B-X
( B-X
Relative B-X
Risk B-X
) B-X
Relative B-X
Risk B-X
, B-X
Risk B-X
Difference B-X
, B-X
Attributable B-X
Risk B-X
- B-X
StatsDirect B-X
Download B-X
Table B-X
| B-X
Relative B-X
risk B-X
( B-X
RR B-X
) B-X
of B-X
coronary B-X
heart B-X
disease B-X
( B-X
CHD B-X
) B-X
a B-X
by B-X
job B-X
strain B-X
from B-X
publication B-X
: B-X
A B-X
prospective B-X
study B-X
of B-X
job B-X
strain B-X
and B-X
coronary B-X
Raised B-X
total B-X
cholesterol B-X
is B-X
a B-X
strong B-X
risk B-X
factor B-X
for B-X
CHD B-X
, B-X
with B-X
evidence B-X
of B-X
a B-X
small B-X
, B-X
but B-X
significantly B-X
stronger B-X
, B-X
effect B-X
in B-X
men B-X
compared B-X
to B-X
women B-X
. B-X
Raised B-X
total B-X
Explaining B-X
the B-X
social B-X
gradient B-X
in B-X
coronary B-X
heart B-X
disease B-X
: B-X
comparing B-X
relative B-X
and B-X
absolute B-X
risk B-X
approaches B-X
Cardiovascular B-X
risk B-X
assessment B-X
in B-X
patients B-X
with B-X
diabetes B-X

43	O
in	O
men	O
with	O
mutations	O
(	O
P	O
<	O
.	O
05	O
)	O
;	O
after	O
adjustment	O
for	O
CHD	B-Disease
risk	O
factors	O
,	O
the	O
RR	O
was	O
1	O
.	O
<EOS> B-X
These B-X
findings B-X
suggest B-X
that B-X
consumption B-X
of B-X
up B-X
to B-X
1 B-X
egg B-X
per B-X
day B-X
is B-X
unlikely B-X
to B-X
have B-X
substantial B-X
overall B-X
impact B-X
on B-X
the B-X
risk B-X
of B-X
CHD B-X
or B-X
stroke B-X
among B-X
healthy B-X
men B-X
and B-X
Stroke B-X
Risk B-X
Factors B-X
, B-X
Genetics B-X
, B-X
and B-X
Prevention B-X
Abstract B-X
. B-X
Context B-X
: B-X
Metabolic B-X
changes B-X
and B-X
smoking B-X
are B-X
common B-X
among B-X
HIV B-X
patients B-X
and B-X
may B-X
confer B-X
increased B-X
cardiovascular B-X
risk.Objective B-X
: B-X
The B-X
aim B-X
of B-X
the B-X
study B-X
was B-X
Genetic B-X
Research B-X
and B-X
Women B-X
‚Äô B-X
s B-X
Heart B-X
Disease B-X
: B-X
a B-X
Primer B-X
Final B-X
Draft B-X
Status B-X
of B-X
the B-X
Epidemiology B-X
of B-X
Atrial B-X
Fibrillation B-X
Iron B-X
: B-X
Protector B-X
or B-X
Risk B-X
Factor B-X
for B-X
Cardiovascular B-X
Disease B-X
? B-X
Still B-X
Controversial B-X
Cardiovascular B-X
Disease B-X
in B-X
Women B-X
| B-X
Circulation B-X

55	O
(	O
P	O
=	O
.	O
02	O
)	O
;	O
after	O
additional	O
adjustment	O
for	O
HDL	O
levels	O
,	O
the	O
RR	O
was	O
1	O
.	O
<EOS> B-X
Increases B-X
in B-X
Dietary B-X
Cholesterol B-X
Are B-X
Associated B-X
With B-X
Modest B-X
Increases B-X
in B-X
Both B-X
LDL B-X
and B-X
HDL B-X
Cholesterol B-X
in B-X
Healthy B-X
Young B-X
Women B-X
Efficacy B-X
and B-X
safety B-X
of B-X
more B-X
intensive B-X
lowering B-X
of B-X
LDL B-X
cholesterol B-X
: B-X
a B-X
meta-analysis B-X
of B-X
data B-X
from B-X
170 B-X
000 B-X
participants B-X
in B-X
26 B-X
randomised B-X
trials B-X
Cholesterol B-X
and B-X
the B-X
Risk B-X
of B-X
Renal B-X
Dysfunction B-X
in B-X
Apparently B-X
Healthy B-X
Men B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X
Objectives.‚ÄîTo B-X
examine B-X
the B-X
relationship B-X
of B-X
total B-X
cholesterol B-X
and B-X
high-density B-X
lipoprotein B-X
cholesterol B-X
( B-X
HDL-C B-X
) B-X
with B-X
coronary B-X
heart B-X
disease B-X
( B-X
CHD B-X
) B-X
mortality B-X
and B-X
wi B-X
Efficacy B-X
and B-X
safety B-X
of B-X
more B-X
intensive B-X
lowering B-X
of B-X
LDL B-X
cholesterol B-X
: B-X
a B-X
meta-analysis B-X
of B-X
data B-X
from B-X
170 B-X
000 B-X
participants B-X
in B-X
26 B-X
randomised B-X
trials B-X
- B-X
The B-X
Lancet B-X
Increases B-X
in B-X
Dietary B-X
Cholesterol B-X
Are B-X
Associated B-X
With B-X
Modest B-X
Increases B-X
in B-X
Both B-X
LDL B-X
and B-X
HDL B-X
Cholesterol B-X
in B-X
Healthy B-X
Young B-X
Women B-X
| B-X
Arteriosclerosis B-X
, B-X
Thrombosis B-X
, B-X
and B-X
Vascular B-X
Biology B-X
Increases B-X
in B-X
Dietary B-X
Cholesterol B-X
Are B-X
Associated B-X
With B-X
Modest B-X
Increases B-X
in B-X
Both B-X
LDL B-X
and B-X
HDL B-X
Cholesterol B-X
in B-X
Healthy B-X
Young B-X
Women B-X
| B-X
Arteriosclerosis B-X
, B-X
Thrombosis B-X
, B-X
and B-X
Vascular B-X
Biology B-X

68	O
(	O
P	O
=	O
.	O
008	O
)	O
.	O
<EOS> B-X
Pads B-X
Brembo B-X
P B-X
68 B-X
048 B-X
for B-X
RENAULT B-X
Pads B-X
Brembo B-X
P B-X
68 B-X
048 B-X
for B-X
RENAULT B-X
The B-X
purpose B-X
of B-X
this B-X
study B-X
was B-X
to B-X
determine B-X
the B-X
feasibility B-X
of B-X
implementing B-X
a B-X
multiple-behavior B-X
self-monitoring B-X
intervention B-X
within B-X
a B-X
diabetes B-X
education B-X
program B-X
. B-X
This B-X
study B-X
was B-X
a B-X
3-month B-X
pre- B-X
post-design B-X
, B-X
Pads B-X
Brembo B-X
P B-X
68 B-X
008 B-X
for B-X
PEUGEOT B-X
, B-X
RENAULT B-X
Report B-X
of B-X
the B-X
Chief B-X
of B-X
Engineers B-X
- B-X
United B-X
States B-X
. B-X
Army B-X
. B-X
Corps B-X
of B-X
Engineers B-X
- B-X
Google B-X
Âõæ‰π¶ B-X
ClinicalTrials.gov B-X
identifier B-X
NCT00063206 B-X
. B-X
Index B-X
to B-X
the B-X
Reports B-X
of B-X
the B-X
Chief B-X
of B-X
Engineers B-X
, B-X
U.S. B-X
Army B-X
( B-X
including B-X
the B-X
... B-X
- B-X
United B-X
States B-X
. B-X
Army B-X
. B-X
Corps B-X
of B-X
Engineers B-X
, B-X
George B-X
Arthur B-X
Zinn B-X
- B-X

Similar	O
RR	O
values	O
were	O
obtained	O
for	O
the	O
D442G	O
mutation	O
alone	O
.	O
<EOS> B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
Research B-X
Publications B-X
Research B-X
Publications B-X
Increased B-X
Coronary B-X
Heart B-X
Disease B-X
in B-X
Japanese-American B-X
Men B-X
with B-X
Mutation B-X
in B-X
the B-X
Cholesteryl B-X
Ester B-X
Transfer B-X
Protein B-X
Gene B-X
Despite B-X
Increased B-X
HDL B-X
Levels B-X
.. B-X
Shaobin B-X
Zhong B-X
, B-X
* B-X
Dan B-X
JCI B-X
- B-X
Welcome B-X

Increased	O
CHD	B-Disease
in	O
men	O
with	O
mutations	O
was	O
primarily	O
observed	O
for	O
HDL	O
chol	O
41	O
-	O
60	O
mg	O
/	O
dl	O
;	O
for	O
HDL	O
chol	O
>	O
60	O
mg	O
/	O
dl	O
men	O
with	O
and	O
without	O
mutations	O
had	O
low	O
CHD	B-Disease
prevalence	O
.	O
<EOS> B-X
Subjects B-X
with B-X
very B-X
high B-X
HDL B-X
levels B-X
( B-X
HDL B-X
cholesterol B-X
> B-X
/=80 B-X
mg/dl B-X
) B-X
as B-X
well B-X
as B-X
mild-to-moderate B-X
HDL B-X
elevations B-X
( B-X
60-79 B-X
mg/dl B-X
) B-X
appear B-X
to B-X
be B-X
protected B-X
against B-X
CHD B-X
, B-X
Genetic B-X
and B-X
secondary B-X
causes B-X
of B-X
severe B-X
HDL B-X
deficiency B-X
and B-X
cardiovascular B-X
disease B-X
Abstract B-X
. B-X
Epidemiological B-X
studies B-X
have B-X
associated B-X
low B-X
HDL-cholesterol B-X
with B-X
an B-X
increased B-X
risk B-X
of B-X
morbid B-X
coronary B-X
events B-X
. B-X
Accordingly B-X
, B-X
intervention B-X
to B-X
correct B-X
low B-X
Elevated B-X
High-Density B-X
Lipoprotein B-X
( B-X
HDL B-X
) B-X
Levels B-X
due B-X
to B-X
Hepatic B-X
Lipase B-X
Mutations B-X
Do B-X
Not B-X
Reduce B-X
Cardiovascular B-X
Disease B-X
Risk B-X
: B-X
Another B-X
Strike B-X
against B-X
the B-X
HDL B-X
Dogma B-X
A B-X
prospective B-X
study B-X
of B-X
HDL-C B-X
and B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
mutations B-X
and B-X
the B-X
risk B-X
of B-X
coronary B-X
heart B-X
disease B-X
in B-X
the B-X
elderly B-X
- B-X
ScienceDirect B-X
High B-X
density B-X
lipoprotein B-X
cholesterol B-X
( B-X
HDL-C B-X
) B-X
levels B-X
are B-X
inversely B-X
associated B-X
with B-X
the B-X
incidence B-X
of B-X
coronary B-X
heart B-X
disease B-X
( B-X
CHD B-X
) B-X
in B-X
middle-aged B-X
individuals B-X
; B-X
in B-X
the B-X
elderly B-X
, B-X
the B-X
Management B-X
of B-X
Low B-X
Levels B-X
of B-X
High-Density B-X
Lipoprotein-Cholesterol B-X

Thus	O
,	O
genetic	O
CETP	B-Disease
deficiency	I-Disease
appears	O
to	O
be	O
an	O
independent	O
risk	O
factor	O
for	O
CHD	B-Disease
,	O
primarily	O
due	O
to	O
increased	O
CHD	B-Disease
prevalence	O
in	O
men	O
with	O
the	O
D442G	O
mutation	O
and	O
HDL	O
cholesterol	O
between	O
41	O
and	O
60	O
mg	O
/	O
dl	O
.	O
<EOS> B-X
The B-X
impact B-X
of B-X
common B-X
polymorphisms B-X
in B-X
CETP B-X
and B-X
ABCA1 B-X
genes B-X
with B-X
the B-X
risk B-X
of B-X
coronary B-X
artery B-X
disease B-X
in B-X
Saudi B-X
Arabians B-X
JCI B-X
- B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
JCI B-X
- B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
Increased B-X
coronary B-X
heart B-X
disease B-X
in B-X
Japanese-American B-X
men B-X
with B-X
mutation B-X
in B-X
the B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
gene B-X
despite B-X
increased B-X
HDL B-X
levels B-X
. B-X
Monogenic B-X
causes B-X
of B-X
elevated B-X
HDL B-X
cholesterol B-X
and B-X
implications B-X
for B-X
development B-X
of B-X
new B-X
therapeutics B-X
Association B-X
of B-X
circulating B-X
cholesteryl B-X
ester B-X
transfer B-X
protein B-X
activity B-X
with B-X
incidence B-X
of B-X
cardiovascular B-X
disease B-X
in B-X
the B-X
community B-X
Is B-X
good B-X
cholesterol B-X
always B-X
good B-X
? B-X

The	O
findings	O
suggest	O
that	O
both	O
HDL	O
concentration	O
and	O
the	O
dynamics	O
of	O
cholesterol	O
transport	O
through	O
HDL	O
(	O
i	O
.	O
e	O
.	O
,	O
reverse	O
cholesterol	O
transport	O
)	O
determine	O
the	O
anti	O
-	O
atherogenicity	O
of	O
the	O
HDL	O
fraction	O
.	O
<EOS> B-X
The B-X
metabolism B-X
and B-X
anti-atherogenic B-X
properties B-X
of B-X
HDL B-X
Reverse B-X
Cholesterol B-X
Transport B-X
: B-X
Molecular B-X
Mechanisms B-X
and B-X
the B-X
Non-medical B-X
Approach B-X
to B-X
Enhance B-X
HDL B-X
Cholesterol B-X
Cholesterol B-X
efflux B-X
and B-X
atheroprotection B-X
: B-X
Advancing B-X
the B-X
concept B-X
of B-X
reverse B-X
cholesterol B-X
transport B-X
High-density B-X
lipoprotein B-X
heterogeneity B-X
and B-X
function B-X
in B-X
reverse B-X
cholesterol B-X
transport B-X
High B-X
density B-X
lipoprotein B-X
( B-X
HDL B-X
) B-X
possesses B-X
important B-X
anti-atherogenic B-X
properties B-X
and B-X
this B-X
review B-X
addresses B-X
the B-X
molecular B-X
mechanisms B-X
underlying B-X
these B-X
functions B-X
. B-X
The B-X
structures B-X
and B-X
cholesterol B-X
transport B-X
abilities B-X
of B-X
HDL B-X
particles B-X
Abstract B-X
. B-X
Reverse B-X
cholesterol B-X
transport B-X
( B-X
RCT B-X
) B-X
is B-X
a B-X
pathway B-X
by B-X
which B-X
accumulated B-X
cholesterol B-X
is B-X
transported B-X
from B-X
the B-X
vessel B-X
wall B-X
to B-X
the B-X
liver B-X
for B-X
excretion B-X
, B-X
thus B-X
Recently B-X
, B-X
there B-X
have B-X
been B-X
some B-X
reports B-X
that B-X
changes B-X
in B-X
serum B-X
lipid B-X
composition B-X
may B-X
be B-X
related B-X
to B-X
suicide B-X
, B-X
major B-X
depression B-X
and B-X
immune-inflammatory B-X
responses B-X
. B-X
Findings B-X
from B-X
our B-X
laboratory B-X
suggest B-X

Mapping	O
the	O
homolog	O
of	O
the	O
human	O
Rb1	O
gene	O
to	O
chromosome	O
14	O
of	O
higher	O
primates	O
.	O

The	O
Rb1	O
gene	O
has	O
been	O
implicated	O
with	O
retinoblastoma	B-Disease
and	O
is	O
located	O
on	O
human	O
Chromosome	O
(	O
Chr	O
)	O
13q14	O
.	O
<EOS> B-X
Loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
) B-X
on B-X
the B-X
long B-X
arm B-X
of B-X
chromosome B-X
13 B-X
is B-X
common B-X
in B-X
human B-X
breast B-X
tumors B-X
, B-X
pointing B-X
to B-X
the B-X
existence B-X
of B-X
several B-X
suppressor B-X
genes B-X
in B-X
this B-X
Retinoblastoma B-X
protein B-X
- B-X
Wikipedia B-X
Retinoblastoma B-X
Molecular B-X
Karyotype B-X
of B-X
Sporadic B-X
Unilateral B-X
Retinoblastoma B-X
Tumors B-X
Forty-four B-X
malignant B-X
fibrous B-X
histiocytomas B-X
( B-X
MFHs B-X
) B-X
were B-X
studied B-X
by B-X
comparative B-X
genomic B-X
hybridization B-X
. B-X
Among B-X
the B-X
observed B-X
imbalances B-X
, B-X
losses B-X
of B-X
the B-X
13q14-q21 B-X
region B-X
were B-X
observed B-X
in B-X
almost B-X
all B-X
tumors B-X
The B-X
RB1 B-X
gene B-X
provides B-X
instructions B-X
for B-X
making B-X
a B-X
protein B-X
called B-X
pRB B-X
. B-X
This B-X
protein B-X
acts B-X
as B-X
a B-X
tumor B-X
suppressor B-X
, B-X
which B-X
means B-X
that B-X
it B-X
regulates B-X
cell B-X
growth B-X
and B-X
keeps B-X
cells B-X
Epigenetic B-X
Upregulation B-X
of B-X
lncRNAs B-X
at B-X
13q14.3 B-X
in B-X
Leukemia B-X
Is B-X
Linked B-X
to B-X
the B-X
In B-X
Cis B-X
Downregulation B-X
of B-X
a B-X
Gene B-X
Cluster B-X
That B-X
Targets B-X
NF-kB B-X

2	O
2	O
.	O
<EOS> B-X
2+2 B-X
- B-X
Wikipedia B-X
2+2 B-X
- B-X
Wikipedia B-X
Square B-X
root B-X
of B-X
2 B-X
- B-X
Wikipedia B-X
Square B-X
root B-X
of B-X
2 B-X
- B-X
Wikipedia B-X
Poker B-X
Strategy B-X
- B-X
Two B-X
Plus B-X
Two B-X
Poker B-X
& B-X
Gaming B-X
Strategy B-X
Poker B-X
Strategy B-X
- B-X
Two B-X
Plus B-X
Two B-X
Poker B-X
& B-X
Gaming B-X
Strategy B-X
2 B-X
+ B-X
2 B-X
= B-X
? B-X
- B-X
Wikipedia B-X

A	O
unique	O
sequence	O
human	O
Rb1	O
cosmid	O
DNA	O
probe	O
has	O
been	O
used	O
to	O
localize	O
this	O
region	O
on	O
apes	O
Chr	O
14	O
by	O
the	O
FISH	O
technique	O
.	O
<EOS> B-X
The B-X
Rb1 B-X
gene B-X
has B-X
been B-X
implicated B-X
with B-X
retinoblastoma B-X
and B-X
is B-X
located B-X
on B-X
human B-X
Chromosome B-X
( B-X
Chr B-X
) B-X
13q14.2 B-X
. B-X
A B-X
unique B-X
sequence B-X
human B-X
Rb1 B-X
cosmid B-X
DNA B-X
probe B-X
has B-X
been B-X
used B-X
The B-X
Rb1 B-X
gene B-X
has B-X
been B-X
implicated B-X
with B-X
retinoblastoma B-X
and B-X
is B-X
located B-X
on B-X
human B-X
Chromosome B-X
( B-X
Chr B-X
) B-X
13ql4.2 B-X
. B-X
A B-X
unique B-X
sequence B-X
human B-X
Rb1 B-X
cosmid B-X
DNA B-X
probe B-X
has B-X
bee B-X
The B-X
Rb1 B-X
gene B-X
has B-X
been B-X
implicated B-X
with B-X
retinoblastoma B-X
and B-X
is B-X
located B-X
on B-X
human B-X
Chromosome B-X
( B-X
Chr B-X
) B-X
13ql4.2 B-X
. B-X
A B-X
unique B-X
sequence B-X
human B-X
Rb1 B-X
cosmid B-X
DNA B-X
probe B-X
has B-X
bee B-X
We B-X
have B-X
used B-X
the B-X
proximity B-X
of B-X
probe B-X
hybridization B-X
sites B-X
in B-X
interphase B-X
chromatin B-X
to B-X
derive B-X
the B-X
order B-X
of B-X
DNA B-X
sequences B-X
in B-X
a B-X
2-3-Mbp B-X
region B-X
of B-X
human B-X
chromosome B-X
Xq28 B-X
. B-X
The B-X
map B-X
Rapid B-X
and B-X
Efficient B-X
FISH B-X
using B-X
Pre-Labeled B-X
Oligomer B-X
Probes B-X
Sequence-Based B-X
Design B-X
of B-X
Single-Copy B-X
Genomic B-X
DNA B-X
Probes B-X
for B-X
Fluorescence B-X
In B-X
Situ B-X
Hybridization B-X
COMBO-FISH B-X
Enables B-X
High B-X
Precision B-X
Localization B-X
Microscopy B-X
as B-X
a B-X
Prerequisite B-X
for B-X
Nanostructure B-X
Analysis B-X
of B-X
Genome B-X
Loci B-X

The	O
conservation	O
of	O
the	O
Rb1	O
gene	O
in	O
higher	O
primates	O
at	O
the	O
corresponding	O
equivalent	O
chromosome	O
locus	O
(	O
14q14	O
)	O
of	O
the	O
human	O
may	O
serve	O
as	O
a	O
phylogenetic	O
marker	O
to	O
further	O
trace	O
the	O
evolutionary	O
pathway	O
of	O
human	O
descent	O
.	O
<EOS> B-X
Genetics B-X
of B-X
the B-X
Pig B-X
Tapeworm B-X
in B-X
Madagascar B-X
Reveal B-X
a B-X
History B-X
of B-X
Human B-X
Dispersal B-X
and B-X
Colonization B-X
The B-X
taeniasis/cysticercosis B-X
complex B-X
is B-X
included B-X
in B-X
the B-X
list B-X
of B-X
neglected B-X
zoonotic B-X
diseases B-X
by B-X
the B-X
World B-X
Health B-X
Organization B-X
due B-X
to B-X
its B-X
significant B-X
impact B-X
on B-X
public B-X
health B-X
in B-X
tropical B-X
areas B-X
. B-X
Cysticercosis B-X
Human B-X
evolution B-X
- B-X
Wikipedia B-X
Download B-X
Citation B-X
| B-X
Super B-X
selective B-X
ophthalmic B-X
artery B-X
delivery B-X
of B-X
chemotherapy B-X
for B-X
intraocular B-X
retinoblastoma B-X
: B-X
'chemosurgery B-X
' B-X
The B-X
first B-X
Stallard B-X
lecture B-X
| B-X
Although B-X
success B-X
in B-X
treating B-X
intraocular B-X
retinoblastoma B-X
with B-X
radiation B-X
was B-X
taenia B-X
solium B-X
evolutionary B-X
: B-X
Topics B-X
by B-X
Science.gov B-X

Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
:	O
no	O
strict	O
genotype	O
-	O
phenotype	O
correlations	O
but	O
clustering	O
of	O
missense	O
mutations	O
in	O
the	O
amino	O
-	O
terminal	O
part	O
of	O
the	O
WASP	O
gene	O
product	O
.	O
<EOS> B-X
Wiskott‚ÄêAldrich B-X
syndrome B-X
in B-X
Argentina B-X
: B-X
17 B-X
unique B-X
, B-X
including B-X
nine B-X
novel B-X
, B-X
mutations B-X
- B-X
El‚ÄêHakeh B-X
- B-X
2002 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X
VCV000528222.3 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X

The	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
protein	O
(	O
WASP	O
)	O
gene	O
was	O
found	O
to	O
be	O
mutated	O
in	O
patients	O
presenting	O
with	O
WAS	B-Disease
and	O
in	O
patients	O
showing	O
X	B-Disease
-	I-Disease
linked	I-Disease
thrombocytopenia	I-Disease
.	O
<EOS> B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
an B-X
X-linked B-X
recessive B-X
disorder B-X
characterized B-X
by B-X
immunodeficiency B-X
, B-X
thrombocytopenia B-X
and B-X
eczema B-X
. B-X
A B-X
broad B-X
spectrum B-X
of B-X
mutations B-X
in B-X
the B-X
WASP B-X
gene B-X
has B-X
been B-X
identified B-X

Mutation	O
analysis	O
in	O
19	O
families	O
of	O
German	O
,	O
Swiss	O
and	O
Turkish	O
descent	O
by	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
and	O
sequencing	O
resulted	O
in	O
the	O
detection	O
of	O
seven	O
novel	O
and	O
10	O
known	O
mutations	O
.	O
<EOS> B-X
Single-strand B-X
conformation B-X
polymorphism B-X
( B-X
SSCP B-X
) B-X
analysis B-X
followed B-X
by B-X
direct B-X
sequencing B-X
of B-X
exons B-X
containing B-X
ATP-binding B-X
domains B-X
of B-X
the B-X
cystic B-X
fibrosis B-X
transmembrane B-X
conductance B-X
regulator B-X
( B-X
CFTR B-X
) B-X
gene B-X
was B-X
performed B-X
on B-X
To B-X
date B-X
, B-X
only B-X
one B-X
CRYAB B-X
mutation B-X
has B-X
been B-X
associated B-X
with B-X
congenital B-X
isolated B-X
cataract B-X
. B-X
This B-X
study B-X
identified B-X
a B-X
second B-X
novel B-X
mutation B-X
in B-X
CRYAB B-X
in B-X
a B-X
large B-X
Chinese B-X
cataract B-X
family B-X
Identifying B-X
the B-X
genes B-X
causing B-X
male B-X
infertility B-X
is B-X
important B-X
to B-X
increase B-X
our B-X
biological B-X
understanding B-X
as B-X
well B-X
as B-X
the B-X
diagnostic B-X
yield B-X
and B-X
clinical B-X
relevance B-X
Request B-X
PDF B-X
| B-X
Linkage B-X
analysis B-X
and B-X
a B-X
novel B-X
COL4A5 B-X
mutation B-X
in B-X
a B-X
large B-X
Turkish B-X
family B-X
with B-X
Alport B-X
syndrome B-X
| B-X
Alport B-X
syndrome B-X
( B-X
AS B-X
) B-X
is B-X
a B-X
renal B-X
disease B-X
that B-X
is B-X
PDF B-X
| B-X
We B-X
have B-X
analyzed B-X
97 B-X
CF B-X
unrelated B-X
Mexican B-X
families B-X
for B-X
mutations B-X
in B-X
the B-X
cystic B-X
fibrosis B-X
transmembrane B-X
conductance B-X
regulator B-X
( B-X
CFTR B-X
) B-X
gene B-X
. B-X
Our B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Molecular B-X
defects B-X
underlying B-X
Wolman B-X
disease B-X
appear B-X
to B-X
be B-X
more B-X
heterogeneous B-X
than B-X
those B-X
resulting B-X
in B-X
cholesteryl B-X
ester B-X
storage B-X
disease B-X
- B-X
ScienceDirect B-X
A B-X
Meindl B-X
's B-X
154 B-X
research B-X
works B-X
with B-X
5,508 B-X
citations B-X
and B-X
6,284 B-X
reads B-X
, B-X
including B-X
: B-X
Genetic B-X
principles B-X
of B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X

A	O
striking	O
clustering	O
of	O
missense	O
mutations	O
in	O
the	O
first	O
four	O
exons	O
contrasted	O
with	O
a	O
random	O
distribution	O
of	O
nonsense	O
mutations	O
.	O
<EOS> B-X
Some B-X
250 B-X
different B-X
mutations B-X
have B-X
so B-X
far B-X
been B-X
screened B-X
in B-X
the B-X
cystic B-X
fibrosis B-X
( B-X
CF B-X
) B-X
gene B-X
. B-X
The B-X
50 B-X
nonsense B-X
, B-X
33 B-X
splicing B-X
and B-X
60 B-X
frameshift B-X
mutations B-X
are B-X
randomly B-X
TP53 B-X
exon-6 B-X
truncating B-X
mutations B-X
produce B-X
separation B-X
of B-X
function B-X
isoforms B-X
with B-X
pro-tumorigenic B-X
functions B-X
The B-X
FBI B-X
is B-X
the B-X
lead B-X
federal B-X
agency B-X
for B-X
investigating B-X
cyber B-X
attacks B-X
by B-X
criminals B-X
, B-X
overseas B-X
adversaries B-X
, B-X
and B-X
terrorists B-X
. B-X
The B-X
threat B-X
is B-X
incredibly B-X
serious‚Äîand B-X
growing B-X
. B-X

More	O
than	O
85	O
%	O
of	O
all	O
known	O
missense	O
mutations	O
were	O
localized	O
in	O
the	O
amino	O
-	O
terminal	O
stretch	O
of	O
the	O
WASP	O
gene	O
product	O
;	O
this	O
region	O
contained	O
a	O
mutational	O
hot	O
spot	O
at	O
codon	O
86	O
.	O
<EOS> B-X
An B-X
analysis B-X
of B-X
mutational B-X
signatures B-X
of B-X
synonymous B-X
mutations B-X
across B-X
15 B-X
cancer B-X
types B-X
Exome-scale B-X
discovery B-X
of B-X
hotspot B-X
mutation B-X
regions B-X
in B-X
human B-X
cancer B-X
using B-X
3D B-X
protein B-X
structure B-X
Abstract B-X
. B-X
We B-X
developed B-X
a B-X
rapid B-X
, B-X
simple B-X
method B-X
to B-X
detect B-X
Aflatoxin B-X
B1 B-X
induces B-X
the B-X
transversion B-X
of B-X
G B-X
-- B-X
> B-X
T B-X
in B-X
codon B-X
249 B-X
of B-X
the B-X
p53 B-X
tumor B-X
suppressor B-X
gene B-X
in B-X
human B-X
hepatocytes B-X
. B-X
Synonymous B-X
mutations B-X
have B-X
been B-X
identified B-X
to B-X
play B-X
important B-X
roles B-X
in B-X
cancer B-X
development B-X
, B-X
although B-X
they B-X
do B-X
not B-X
modify B-X
the B-X
protein B-X
sequences B-X
. B-X
However B-X
, B-X
relatively B-X
little B-X
research B-X
has B-X
specifically B-X
delineated B-X
Synonymous B-X
mutations B-X
have B-X
been B-X
identified B-X
to B-X
play B-X
important B-X
roles B-X
in B-X
cancer B-X
development B-X
, B-X
although B-X
they B-X
do B-X
not B-X
modify B-X
the B-X
protein B-X
sequences B-X
. B-X
However B-X
, B-X
relatively B-X
little B-X
research B-X
has B-X
specifically B-X
delineated B-X
Mutation B-X
of B-X
the B-X
p53 B-X
tumor B-X
suppressor B-X
gene B-X
frequently B-X
occurs B-X
in B-X
a B-X
variety B-X
of B-X
tumors B-X
including B-X
lung B-X
, B-X
breast B-X
, B-X
gastrointestinal B-X
, B-X
and B-X
brain B-X
, B-X
as B-X
well B-X
as B-X
lymphomas-leukemias B-X
. B-X
Neuroblastoma B-X

No	O
genotype	O
-	O
phenotype	O
correlation	O
emerged	O
after	O
a	O
comparison	O
of	O
the	O
identified	O
mutations	O
with	O
the	O
resulting	O
clinical	O
picture	O
for	O
a	O
classical	O
WAS	B-Disease
phenotype	O
.	O
<EOS> B-X
Protein B-X
ensembles B-X
link B-X
genotype B-X
to B-X
phenotype B-X
Wiskott-Aldrich B-X
syndrome B-X
: B-X
no B-X
strict B-X
genotype-phenotype B-X
correlations B-X
but B-X
clustering B-X
of B-X
missense B-X
mutations B-X
in B-X
the B-X
amino-terminal B-X
part B-X
of B-X
the B-X
WASP B-X
gene B-X
product B-X
. B-X
Genotype‚ÄìPhenotype B-X
Correlation B-X
in B-X
Children B-X
: B-X
The B-X
Impact B-X
of B-X
FBN1 B-X
Variants B-X
on B-X
Pediatric B-X
Marfan B-X
Care B-X
Genotype‚Äìphenotype B-X
correlation B-X
study B-X
in B-X
364 B-X
osteogenesis B-X
imperfecta B-X
Italian B-X
patients B-X
Patterns B-X
of B-X
Novel B-X
Alleles B-X
and B-X
Genotype/Phenotype B-X
Correlations B-X
Resulting B-X
from B-X
the B-X
Analysis B-X
of B-X
108 B-X
Previously B-X
Undetected B-X
Mutations B-X
in B-X
Patients B-X
Affected B-X
by B-X
Neurofibromatosis B-X
Type B-X
I B-X
Classically B-X
, B-X
phenotype B-X
is B-X
what B-X
is B-X
observed B-X
, B-X
and B-X
genotype B-X
is B-X
the B-X
genetic B-X
makeup B-X
. B-X
Statistical B-X
studies B-X
aim B-X
to B-X
project B-X
phenotypic B-X
likelihoods B-X
of B-X
genotypic B-X
patterns B-X
. B-X
The B-X
traditional B-X
genotype-to-phenotype B-X
theory B-X
Genotype-Phenotype B-X
Correlation B-X
in B-X
NF1 B-X
: B-X
Evidence B-X
for B-X
a B-X
More B-X
Severe B-X
Phenotype B-X
Associated B-X
with B-X
Missense B-X
Mutations B-X
Affecting B-X
NF1 B-X
Codons B-X
844‚Äì848 B-X

A	O
substitution	O
at	O
codon	O
86	O
resulted	O
in	O
an	O
extremely	O
variable	O
expression	O
of	O
the	O
disease	O
in	O
a	O
large	O
Swiss	O
family	O
.	O
<EOS> B-X
PDF B-X
| B-X
We B-X
have B-X
identified B-X
a B-X
hitherto B-X
unrecognized B-X
mutation B-X
of B-X
the B-X
lipoprotein B-X
lipase B-X
gene B-X
( B-X
LPL B-X
) B-X
in B-X
a B-X
Finnish B-X
family B-X
with B-X
Russian B-X
and B-X
Swiss B-X
ancestors B-X
. B-X
A B-X
... B-X
| B-X
Request B-X
PDF B-X
| B-X
Wiskott-Aldrich B-X
syndrome B-X
mutation B-X
in B-X
two B-X
Turkish B-X
siblings B-X
with B-X
X-linked B-X
thrombocytopenia B-X
| B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
a B-X
clinical B-X
condition B-X
characterized B-X
by B-X
thrombocytopenia B-X
, B-X
eczema B-X
, B-X
and B-X
Characterization B-X
of B-X
Coding B-X
Synonymous B-X
and B-X
Non-Synonymous B-X
Variants B-X
in B-X
ADAMTS13 B-X
Using B-X
Ex B-X
Vivo B-X
and B-X
In B-X
Silico B-X
Approaches B-X
Systematic B-X
Analysis B-X
of B-X
Molecular B-X
Defects B-X
in B-X
the B-X
Ferrochelatase B-X
Gene B-X
from B-X
Patients B-X
with B-X
Erythropoietic B-X
Protoporphyria B-X
- B-X
ScienceDirect B-X
Download B-X
Citation B-X
| B-X
First B-X
Turkish B-X
case B-X
of B-X
Bernard-Soulier B-X
syndrome B-X
associated B-X
with B-X
GPIX B-X
N45S B-X
| B-X
Bernard-Soulier B-X
syndrome B-X
( B-X
BSS B-X
) B-X
is B-X
a B-X
rare B-X
bleeding B-X
disorder B-X
characterized B-X
by B-X
giant B-X
platelets B-X
, B-X
thrombocytopenia B-X
Catalogo B-X
Articoli B-X

An	O
extended	O
homology	O
search	O
revealed	O
a	O
distant	O
relationship	O
of	O
this	O
stretch	O
to	O
the	O
vasodilator	O
-	O
stimulated	O
phosphoprotein	O
(	O
VASP	O
)	O
,	O
which	O
is	O
involved	O
in	O
the	O
maintenance	O
of	O
cyto	O
-	O
architecture	O
by	O
interacting	O
with	O
actin	O
-	O
like	O
filaments	O
.	O
.	O
<EOS> B-X
Vasodilator-stimulated B-X
phosphoprotein B-X
( B-X
VASP B-X
) B-X
is B-X
a B-X
member B-X
of B-X
the B-X
Ena/VASP B-X
family B-X
of B-X
proteins B-X
that B-X
are B-X
implicated B-X
in B-X
regulation B-X
of B-X
the B-X
actin B-X
cytoskeleton B-X
. B-X
All B-X
family B-X
members B-X
share B-X
a B-X
tripartite B-X
PDF B-X
| B-X
The B-X
vasodilator-stimulated B-X
phosphoprotein B-X
( B-X
VASP B-X
) B-X
, B-X
a B-X
substrate B-X
for B-X
cAMP- B-X
and B-X
cGMP-dependent B-X
protein B-X
kinases B-X
in B-X
vitro B-X
and B-X
in B-X
intact B-X
cells B-X
, B-X
is B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Drosophila B-X
Enabled B-X
( B-X
Ena B-X
) B-X
was B-X
initially B-X
identified B-X
as B-X
a B-X
dominant B-X
genetic B-X
suppressor B-X
of B-X
mutations B-X
in B-X
the B-X
Abelson B-X
tyrosine B-X
kinase B-X
and B-X
, B-X
more B-X
recently B-X
, B-X
as B-X
a B-X
member B-X
of B-X
the B-X
The B-X
roles B-X
and B-X
regulation B-X
of B-X
the B-X
actin B-X
cytoskeleton B-X
, B-X
intermediate B-X
filaments B-X
and B-X
microtubules B-X
in B-X
smooth B-X
muscle B-X
cell B-X
migration B-X
Ena/VASP B-X
processive B-X
elongation B-X
is B-X
modulated B-X
by B-X
avidity B-X
on B-X
actin B-X
filaments B-X
bundled B-X
by B-X
the B-X
filopodia B-X
cross-linker B-X
fascin B-X
Actin B-X
cytoskeleton B-X
and B-X
small B-X
heat B-X
shock B-X
proteins B-X
: B-X
how B-X
do B-X
they B-X
interact B-X
? B-X
Actin B-X
based B-X
processes B-X
that B-X
could B-X
determine B-X
the B-X
cytoplasmic B-X
architecture B-X
of B-X
plant B-X
cells B-X
- B-X
ScienceDirect B-X

Influence	O
of	O
PAX6	O
gene	O
dosage	O
on	O
development	O
:	O
overexpression	O
causes	O
severe	O
eye	B-Disease
abnormalities	I-Disease
.	O
<EOS> B-X
Controlled B-X
overexpression B-X
of B-X
Pax6 B-X
in B-X
vivo B-X
negatively B-X
autoregulates B-X
the B-X
Pax6 B-X
locus B-X
, B-X
causing B-X
cell-autonomous B-X
defects B-X
of B-X
late B-X
cortical B-X
progenitor B-X
proliferation B-X
with B-X
little B-X
effect B-X
on B-X
cortical B-X
arealization B-X
PAX6 B-X
Dosage B-X
Effects B-X
on B-X
Corneal B-X
Development B-X
, B-X
Growth B-X
, B-X
and B-X
Wound B-X
Healing B-X
Aniridia B-X
in B-X
man B-X
and B-X
Small B-X
eye B-X
in B-X
mice B-X
are B-X
semidominant B-X
developmental B-X
disorders B-X
caused B-X
by B-X
mutations B-X
within B-X
the B-X
paired B-X
box B-X
gene B-X
PAX6 B-X
. B-X
Whereas B-X
heterozygotes B-X
suffer B-X
from B-X
iris B-X
hypoplasia B-X
, B-X
homozygous B-X
Transcription B-X
Factors B-X
Pax6 B-X
and B-X
AP-2Œ± B-X
Interact B-X
To B-X
Coordinate B-X
Corneal B-X
Epithelial B-X
Repair B-X
by B-X
Controlling B-X
Expression B-X
of B-X
Matrix B-X
Metalloproteinase B-X
Gelatinase B-X
B B-X
The B-X
transcription B-X
factor B-X
Pax6 B-X
is B-X
expressed B-X
by B-X
many B-X
cell B-X
types B-X
in B-X
the B-X
developing B-X
eye B-X
. B-X
Eyes B-X
do B-X
not B-X
form B-X
in B-X
homozygous B-X
loss-of-function B-X
mouse B-X
mutants B-X
( B-X
Pax6Sey/Sey B-X
) B-X
and B-X
are B-X
abnormally B-X
Background B-X
Altered B-X
dosage B-X
of B-X
the B-X
transcription B-X
factor B-X
PAX6 B-X
causes B-X
multiple B-X
human B-X
eye B-X
pathophysiologies B-X
. B-X
PAX6+/‚àí B-X
heterozygotes B-X
suffer B-X
from B-X
aniridia B-X
and B-X
aniridia-related B-X
keratopathy B-X
( B-X
ARK B-X
) B-X
, B-X
a B-X
corneal B-X
deterioration B-X
that B-X

Aniridia	B-Disease
in	O
man	O
and	O
Small	O
eye	O
in	O
mice	O
are	O
semidominant	B-Disease
developmental	I-Disease
disorders	I-Disease
caused	O
by	O
mutations	O
within	O
the	O
paired	O
box	O
gene	O
PAX6	O
.	O
<EOS> B-X
Cloning B-X
and B-X
characterization B-X
of B-X
canine B-X
PAX6 B-X
and B-X
evaluation B-X
as B-X
a B-X
candidate B-X
gene B-X
in B-X
a B-X
canine B-X
model B-X
of B-X
aniridia B-X
The B-X
genetic B-X
architecture B-X
of B-X
aniridia B-X
and B-X
Gillespie B-X
syndrome B-X
Postnatal B-X
manipulation B-X
of B-X
Pax6 B-X
dosage B-X
reverses B-X
congenital B-X
tissue B-X
malformation B-X
defects B-X
The B-X
Spectrum B-X
of B-X
PAX6 B-X
Mutations B-X
and B-X
Genotype-Phenotype B-X
Correlations B-X
in B-X
the B-X
Eye B-X
Abstract B-X
. B-X
We B-X
review B-X
the B-X
current B-X
knowledge B-X
of B-X
transcription B-X
factors B-X
in B-X
mammalian B-X
eye B-X
development B-X
. B-X
The B-X
14 B-X
transcription B-X
factors B-X
presently B-X
known B-X
to B-X
be B-X
required B-X
for B-X
Transcription B-X
Factor B-X
PAX6 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Whereas	O
heterozygotes	O
suffer	O
from	O
iris	B-Disease
hypoplasia	I-Disease
,	O
homozygous	O
mice	O
lack	O
eyes	O
and	O
nasal	O
cavities	O
and	O
exhibit	O
brain	B-Disease
abnormalities	I-Disease
.	O
<EOS> B-X
Issue B-X
: B-X
Cell B-X

To	O
investigate	O
the	O
role	O
of	O
gene	O
dosage	O
in	O
more	O
detail	O
,	O
we	O
have	O
generated	O
yeast	O
artificial	O
chromosome	O
transgenic	O
mice	O
carrying	O
the	O
human	O
PAX6	O
locus	O
.	O
<EOS> B-X
Transgenic B-X
mice B-X
generated B-X
by B-X
pronuclear B-X
injection B-X
of B-X
a B-X
yeast B-X
artificial B-X
chromosome B-X
. B-X
The B-X
Pax6 B-X
transcription B-X
factor B-X
is B-X
expressed B-X
during B-X
development B-X
in B-X
the B-X
eyes B-X
and B-X
in B-X
specific B-X
CNS B-X
regions B-X
, B-X
where B-X
it B-X
is B-X
essential B-X
for B-X
normal B-X
cell B-X
proliferation B-X
and B-X
differentiation B-X
. B-X
Mice B-X
lacking B-X
Download B-X
Citation B-X
| B-X
Production B-X
of B-X
Transgenic B-X
Mice B-X
with B-X
Yeast B-X
Artificial B-X
Chromosomes B-X
| B-X
The B-X
stable B-X
introduction B-X
of B-X
recombinant B-X
DNA B-X
into B-X
the B-X
germline B-X
of B-X
mammals B-X
is B-X
one B-X
of B-X
the B-X
major B-X
technological B-X
advances B-X
Effects B-X
of B-X
Elevated B-X
Pax6 B-X
Expression B-X
and B-X
Genetic B-X
Background B-X
on B-X
Mouse B-X
Eye B-X
Development B-X
| B-X
IOVS B-X
| B-X
ARVO B-X
Journals B-X
Overexpression B-X
of B-X
pairedless B-X
Pax6 B-X
in B-X
the B-X
retina B-X
disrupts B-X
corneal B-X
development B-X
and B-X
affects B-X
lens B-X
cell B-X
survival B-X
- B-X
ScienceDirect B-X
Understanding B-X
brain B-X
development B-X
remains B-X
a B-X
major B-X
challenge B-X
at B-X
the B-X
heart B-X
of B-X
understanding B-X
what B-X
makes B-X
us B-X
human B-X
. B-X
The B-X
neocortex B-X
, B-X
in B-X
evolutionary B-X
terms B-X
the B-X
newest B-X
part B-X
of B-X
the B-X
cerebral B-X
cortex B-X
Mice B-X
with B-X
an B-X
Increased B-X
Glucocorticoid B-X
Receptor B-X
Gene B-X
Dosage B-X
Show B-X
Enhanced B-X
Resistance B-X
to B-X
Stress B-X
and B-X
Endotoxic B-X
Shock B-X

When	O
crossed	O
onto	O
the	O
Small	O
eye	O
background	O
,	O
the	O
transgene	O
rescues	O
the	O
mutant	O
phenotype	O
.	O
<EOS> B-X
Analysis B-X
of B-X
an B-X
even-skipped B-X
rescue B-X
transgene B-X
reveals B-X
both B-X
composite B-X
and B-X
discrete B-X
neuronal B-X
and B-X
early B-X
blastoderm B-X
enhancers B-X
, B-X
and B-X
multi-stripe B-X
positioning B-X
by B-X
gap B-X
gene B-X
repressor B-X
gradients B-X
Two B-X
Pax B-X
genes B-X
, B-X
eye B-X
gone B-X
and B-X
eyeless B-X
, B-X
act B-X
cooperatively B-X
in B-X
promoting B-X
Drosophila B-X
eye B-X
development B-X
| B-X
Development B-X
Mutational B-X
analysis B-X
of B-X
the B-X
eyeless B-X
gene B-X
and B-X
phenotypic B-X
rescue B-X
reveal B-X
that B-X
an B-X
intact B-X
Eyeless B-X
protein B-X
is B-X
necessary B-X
for B-X
normal B-X
eye B-X
and B-X
brain B-X
development B-X
in B-X
Drosophila B-X
- B-X
ScienceDirect B-X
Identification B-X
of B-X
genes B-X
required B-X
for B-X
Drosophila B-X
eye B-X
development B-X
using B-X
a B-X
phenotypic B-X
enhancer-trap B-X
Drosophila B-X
Nemo B-X
Promotes B-X
Eye B-X
Specification B-X
Directed B-X
by B-X
the B-X
Retinal B-X
Determination B-X
Gene B-X
Network B-X
Aniridia B-X
in B-X
man B-X
and B-X
Small B-X
eye B-X
in B-X
mice B-X
are B-X
semidominant B-X
developmental B-X
disorders B-X
caused B-X
by B-X
mutations B-X
within B-X
the B-X
paired B-X
box B-X
gene B-X
PAX6 B-X
. B-X
Whereas B-X
heterozygotes B-X
suffer B-X
from B-X
iris B-X
hypoplasia B-X
, B-X
homozygous B-X
Functional B-X
divergence B-X
between B-X
eyeless B-X
and B-X
twin B-X
of B-X
eyeless B-X
in B-X
Drosophila B-X
melanogaster B-X
| B-X
Development B-X

Strikingly	O
,	O
mice	O
carrying	O
multiple	O
copies	O
on	O
a	O
wild	O
-	O
type	O
background	O
show	O
specific	O
developmental	B-Disease
abnormalities	I-Disease
of	I-Disease
the	I-Disease
eye	I-Disease
,	O
but	O
not	O
of	O
other	O
tissues	O
expressing	O
the	O
gene	O
.	O
<EOS> B-X
Effects B-X
of B-X
Elevated B-X
Pax6 B-X
Expression B-X
and B-X
Genetic B-X
Background B-X
on B-X
Mouse B-X
Eye B-X
Development B-X
Effects B-X
of B-X
Aberrant B-X
Pax6 B-X
Gene B-X
Dosage B-X
on B-X
Mouse B-X
Corneal B-X
Pathophysiology B-X
and B-X
Corneal B-X
Epithelial B-X
Homeostasis B-X
De B-X
novo B-X
heterozygous B-X
missense B-X
mutations B-X
in B-X
the B-X
gene B-X
encoding B-X
translation B-X
elongation B-X
factor B-X
eEF1A2 B-X
have B-X
recently B-X
been B-X
found B-X
to B-X
give B-X
rise B-X
to B-X
neurodevelopmental B-X
disorders B-X
. B-X
Children B-X
with B-X
mutations B-X
in B-X
this B-X
gene B-X
Congenital B-X
hydrocephalus B-X
is B-X
an B-X
etiologically B-X
diverse B-X
, B-X
poorly B-X
understood B-X
, B-X
but B-X
relatively B-X
common B-X
birth B-X
defect B-X
. B-X
Most B-X
human B-X
cases B-X
are B-X
sporadic B-X
with B-X
familial B-X
forms B-X
s B-X
Re-imagining B-X
discovery B-X
and B-X
access B-X
to B-X
research B-X
: B-X
grants B-X
, B-X
datasets B-X
, B-X
publications B-X
, B-X
citations B-X
, B-X
clinical B-X
trials B-X
, B-X
patents B-X
and B-X
policy B-X
documents B-X
in B-X
one B-X
place B-X
. B-X
Abstract B-X
. B-X
Townes‚ÄìBrocks B-X
syndrome B-X
( B-X
TBS B-X
, B-X
OMIM B-X
# B-X
107480 B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
that B-X
causes B-X
multiple B-X
birth B-X
defects B-X
including B-X
renal B-X
, B-X
ear B-X
, B-X
anal B-X
and B-X
limb B-X
ma B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Thus	O
,	O
at	O
least	O
five	O
different	O
eye	O
phenotypes	O
are	O
associated	O
with	O
changes	O
in	O
PAX6	O
expression	O
.	O
<EOS> B-X
Influence B-X
of B-X
PAX6 B-X
Gene B-X
Dosage B-X
on B-X
Development B-X
: B-X
Overexpression B-X
Causes B-X
Severe B-X
Eye B-X
Abnormalities B-X
- B-X
ScienceDirect B-X

We	O
provide	O
evidence	O
that	O
not	O
only	O
reduced	O
,	O
but	O
also	O
increased	O
levels	O
of	O
transcriptional	O
regulators	O
can	O
cause	O
developmental	B-Disease
defects	I-Disease
.	O
.	O
<EOS> B-X
Transcriptional B-X
regulation B-X
of B-X
metabolism B-X
in B-X
disease B-X
: B-X
From B-X
transcription B-X
factors B-X
to B-X
epigenetics B-X
The B-X
interplay B-X
between B-X
transcription B-X
factors B-X
and B-X
microRNAs B-X
in B-X
genome-scale B-X
regulatory B-X
networks B-X
Transcriptional B-X
Regulation B-X
and B-X
its B-X
Misregulation B-X
in B-X
Disease B-X
Undercover B-X
: B-X
gene B-X
control B-X
by B-X
metabolites B-X
and B-X
metabolic B-X
enzymes B-X
E-proteins B-X
and B-X
ID-proteins B-X
: B-X
Helix-loop-helix B-X
partners B-X
in B-X
development B-X
and B-X
disease B-X
Transcription B-X
factor B-X
haploinsufficiency B-X
: B-X
when B-X
half B-X
a B-X
loaf B-X
is B-X
not B-X
enough B-X

Heterodimer	O
formation	O
and	O
activity	O
in	O
the	O
human	O
enzyme	O
galactose	O
-	O
1	O
-	O
phosphate	O
uridylyltransferase	O
.	O
<EOS> B-X
FIG B-X
. B-X
3 B-X
. B-X
Schematic B-X
of B-X
the B-X
GALT B-X
coprecipitation B-X
procedure B-X
. B-X
Open B-X
squares B-X
represent B-X
12CA5-tagged B-X
subunits B-X
of B-X
human B-X
GALT B-X
; B-X
solid B-X
circles B-X
represent B-X
HIS6-tagged B-X
subunits B-X
of B-X
human B-X
GALT B-X
. B-X
- B-X
One B-X
of B-X
the B-X
fundamental B-X
questions B-X
concerning B-X
expression B-X
and B-X
function B-X
of B-X
dimeric B-X
enzymes B-X
involves B-X
the B-X
impact B-X
of B-X
naturally B-X
occurring B-X
mutations B-X
on B-X
subunit B-X
assembly B-X
and B-X
heterodimer B-X
activity B-X
. B-X
This B-X
question B-X
is B-X
of B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
IUBMB B-X
Life B-X
is B-X
the B-X
flagship B-X
journal B-X
of B-X
the B-X
International B-X
Union B-X
of B-X
Biochemistry B-X
and B-X
Molecular B-X
Biology B-X
and B-X
is B-X
devoted B-X
to B-X
the B-X
rapid B-X
publication B-X
of B-X
the B-X
most B-X
novel B-X
and B-X
significant B-X
short B-X
articles B-X

One	O
of	O
the	O
fundamental	O
questions	O
concerning	O
expression	O
and	O
function	O
of	O
dimeric	O
enzymes	O
involves	O
the	O
impact	O
of	O
naturally	O
occurring	O
mutations	O
on	O
subunit	O
assembly	O
and	O
heterodimer	O
activity	O
.	O
<EOS> B-X
A B-X
longstanding B-X
goal B-X
in B-X
the B-X
fields B-X
of B-X
molecular B-X
genetics B-X
and B-X
biochemistry B-X
has B-X
been B-X
to B-X
explain B-X
how B-X
naturally B-X
occurring B-X
mutations B-X
associated B-X
with B-X
human B-X
metabolic B-X
disease B-X
impair B-X
activity B-X
of B-X
the B-X
enzymes B-X
involved B-X
One B-X
of B-X
the B-X
fundamental B-X
questions B-X
concerning B-X
expression B-X
and B-X
function B-X
of B-X
dimeric B-X
enzymes B-X
involves B-X
the B-X
impact B-X
of B-X
naturally B-X
occurring B-X
mutations B-X
on B-X
subunit B-X
assembly B-X
and B-X
heterodimer B-X
activity B-X
. B-X
This B-X
question B-X
is B-X
of B-X
Experimental B-X
Approaches B-X
for B-X
Evaluating B-X
the B-X
Contributions B-X
of B-X
Protein-Coding B-X
Mutations B-X
to B-X
Phenotypic B-X
Evolution B-X
Heterodimer B-X
formation B-X
and B-X
activity B-X
in B-X
the B-X
human B-X
enzyme B-X
galactose-1-phosphate B-X
uridylyltransferase B-X
. B-X
Glutathione B-X
catalysis B-X
and B-X
the B-X
reaction B-X
mechanisms B-X
of B-X
glutathione-dependent B-X
enzymes B-X
- B-X
ScienceDirect B-X
Heterodimer B-X
formation B-X
and B-X
activity B-X
in B-X
the B-X
human B-X
enzyme B-X
galactose-1-phosphate B-X
uridylyltransferase B-X
| B-X
PNAS B-X
Heterodimer B-X
formation B-X
and B-X
activity B-X
in B-X
the B-X
human B-X
enzyme B-X
galactose-1-phosphate B-X
uridylyltransferase B-X
| B-X
PNAS B-X

This	O
question	O
is	O
of	O
particular	O
interest	O
for	O
the	O
human	O
enzyme	O
galactose	O
-	O
l	O
-	O
phosphate	O
uridylyl	O
-	O
transferase	O
(	O
GALT	O
)	O
,	O
impairment	O
of	O
which	O
results	O
in	O
the	O
inherited	B-Disease
metabolic	I-Disease
disorder	I-Disease
galactosemia	B-Disease
,	O
because	O
many	O
if	O
not	O
most	O
patients	O
studied	O
to	O
date	O
are	O
compound	O
heterozygotes	O
rather	O
than	O
true	O
molecular	O
homozygotes	O
.	O
<EOS> B-X
Three B-X
inborn B-X
errors B-X
of B-X
galactose B-X
metabolism B-X
are B-X
known B-X
. B-X
The B-X
most B-X
important B-X
is B-X
classic B-X
galactosemia B-X
due B-X
to B-X
galactose-1-phosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
deficiency B-X
. B-X
A B-X
complete B-X
or B-X
near-complete B-X
... B-X
Alpha-D-galactose B-X
is B-X
metabolized B-X
in B-X
species B-X
ranging B-X
from B-X
E. B-X
coli B-X
to B-X
mammals B-X
predominantly B-X
via B-X
a B-X
series B-X
of B-X
sequential B-X
reactions B-X
collectively B-X
known B-X
as B-X
the B-X
Leloir B-X
pathway B-X
. B-X
Deficiency B-X
of B-X
any B-X
one B-X
of B-X
WebMD B-X
explains B-X
some B-X
common B-X
inherited B-X
metabolic B-X
disorders B-X
and B-X
their B-X
symptoms B-X
, B-X
causes B-X
, B-X
and B-X
treatments B-X
. B-X
Metabolic B-X
disorders B-X
, B-X
also B-X
known B-X
as B-X
inborn B-X
errors B-X
of B-X
metabolism B-X
, B-X
are B-X
a B-X
group B-X
of B-X
inherited B-X
genetic B-X
disorders B-X
due B-X
to B-X
enzymatic B-X
deficiency B-X
caused B-X
by B-X
some B-X
defective B-X
genes B-X
. B-X
There B-X
are B-X
PDF B-X
| B-X
Background B-X
and B-X
aims B-X
: B-X
Homozygous B-X
familial B-X
hypercholesterolemia B-X
( B-X
HoFH B-X
) B-X
is B-X
a B-X
rare B-X
genetic B-X
disorder B-X
characterized B-X
by B-X
extremely B-X
elevated B-X
plasma B-X
levels B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Mutations B-X
in B-X
GBA1 B-X
, B-X
the B-X
gene B-X
encoding B-X
the B-X
lysosomal B-X
enzyme B-X
glucocerebrosidase B-X
, B-X
are B-X
among B-X
the B-X
most B-X
common B-X
known B-X
genetic B-X
risk B-X
factors B-X
for B-X
the B-X
development B-X
of B-X
Parkinson B-X
disease B-X
and B-X
related B-X
synucleinopathies B-X
Homozygous B-X
Familial B-X
Hypercholesterolemia B-X
in B-X
Spain B-X
| B-X
Circulation B-X
: B-X
Cardiovascular B-X
Genetics B-X

Furthermore	O
,	O
the	O
broad	O
range	O
of	O
phenotypic	O
severity	O
observed	O
in	O
these	O
patients	O
raises	O
the	O
possibility	O
that	O
allelic	O
combination	O
,	O
not	O
just	O
allelic	O
constitution	O
,	O
may	O
play	O
some	O
role	O
in	O
determining	O
outcome	O
.	O
<EOS> B-X
Genetic B-X
gateways B-X
to B-X
COVID‚Äê19 B-X
infection B-X
: B-X
Implications B-X
for B-X
risk B-X
, B-X
severity B-X
, B-X
and B-X
outcomes B-X
Read B-X
chapter B-X
SUMMARY B-X
: B-X
Matching B-X
DNA B-X
samples B-X
from B-X
crime B-X
scenes B-X
and B-X
suspects B-X
is B-X
rapidly B-X
becoming B-X
a B-X
key B-X
source B-X
of B-X
evidence B-X
for B-X
use B-X
in B-X
our B-X
justice B-X
system B-X
. B-X
DNA B-X
... B-X
Modifier B-X
genes B-X
in B-X
Mendelian B-X
disorders B-X
: B-X
the B-X
example B-X
of B-X
cystic B-X
fibrosis B-X
Drug‚ÄìGene B-X
Interactions B-X
: B-X
Inherent B-X
Variability B-X
In B-X
Drug B-X
Maintenance B-X
Dose B-X
Requirements B-X
mediator B-X
of B-X
paramutation1 B-X
Is B-X
Required B-X
for B-X
Establishment B-X
and B-X
Maintenance B-X
of B-X
Paramutation B-X
at B-X
Multiple B-X
Maize B-X
Loci B-X
Born B-X
to B-X
lead B-X
? B-X
A B-X
twin B-X
design B-X
and B-X
genetic B-X
association B-X
study B-X
of B-X
leadership B-X
role B-X
occupancy B-X
- B-X
ScienceDirect B-X
Grapevine B-X
( B-X
Vitis B-X
vinifera B-X
) B-X
is B-X
one B-X
of B-X
the B-X
most B-X
important B-X
perennial B-X
crop B-X
plants B-X
in B-X
worldwide B-X
. B-X
Understanding B-X
of B-X
developmental B-X
processes B-X
like B-X
flowering B-X
, B-X
which B-X
impact B-X
quality B-X
and B-X
quantity B-X
of B-X

In	O
the	O
work	O
described	O
herein	O
,	O
we	O
have	O
selected	O
two	O
distinct	O
naturally	O
occurring	O
null	O
mutations	O
of	O
GALT	O
,	O
Q188R	O
and	O
R333W	O
,	O
and	O
asked	O
the	O
questions	O
(	O
i	O
)	O
what	O
are	O
the	O
impacts	O
of	O
these	O
mutations	O
on	O
subunit	O
assembly	O
,	O
and	O
(	O
ii	O
)	O
if	O
heterodimers	O
do	O
form	O
,	O
are	O
they	O
active	O
?	O
<EOS> B-X
Impairment B-X
of B-X
the B-X
human B-X
enzyme B-X
galactose-1-P B-X
uridylyltransferase B-X
( B-X
hGALT B-X
) B-X
results B-X
in B-X
the B-X
potentially B-X
lethal B-X
disorder B-X
, B-X
galactosemia B-X
. B-X
One B-X
of B-X
the B-X
fundamental B-X
questions B-X
with B-X
regard B-X
to B-X
this B-X
dimeric B-X
enzyme B-X
Human B-X
Nuclear B-X
Receptor B-X
Heterodimers B-X
: B-X
Opportunities B-X
for B-X
Detecting B-X
Targets B-X
of B-X
Transcriptional B-X
Regulation B-X
Using B-X
Yeast B-X
MsGC-Œ≤3 B-X
forms B-X
active B-X
homodimers B-X
and B-X
inactive B-X
heterodimers B-X
with B-X
NO-sensitive B-X
soluble B-X
guanylyl B-X
cyclase B-X
subunits B-X
| B-X
Journal B-X
of B-X
Experimental B-X
Biology B-X
Abstract B-X
. B-X
sno B-X
is B-X
a B-X
member B-X
of B-X
the B-X
ski B-X
oncogene B-X
family B-X
and B-X
shares B-X
ski B-X
's B-X
ability B-X
to B-X
transform B-X
avian B-X
fibroblasts B-X
and B-X
induce B-X
muscle B-X
differentiation B-X
. B-X
Ski B-X
and B-X
SnoN B-X
are B-X
A B-X
New B-X
Method B-X
to B-X
Study B-X
Heterodimerization B-X
of B-X
Membrane B-X
Proteins B-X
and B-X
Its B-X
Application B-X
to B-X
Fibroblast B-X
Growth B-X
Factor B-X
Receptors B-X
Homo- B-X
and B-X
Heterodimerization B-X
of B-X
Proteins B-X
in B-X
Cell B-X
Signaling B-X
: B-X
Inhibition B-X
and B-X
Drug B-X
Design B-X
In B-X
recent B-X
years B-X
, B-X
antisense B-X
therapy B-X
has B-X
emerged B-X
as B-X
an B-X
increasingly B-X
important B-X
therapeutic B-X
approach B-X
to B-X
tackle B-X
several B-X
genetic B-X
disorders B-X
, B-X
including B-X
inborn B-X
errors B-X
of B-X
metabolism B-X
. B-X
Intronic B-X
mutations B-X
activating B-X
cryptic B-X

To	O
answer	O
these	O
questions	O
,	O
we	O
have	O
established	O
a	O
yeast	O
system	O
for	O
the	O
coexpression	O
of	O
epitope	O
-	O
tagged	O
alleles	O
of	O
human	O
GALT	O
and	O
investigated	O
both	O
the	O
extent	O
of	O
specific	O
GALT	O
subunit	O
interactions	O
and	O
the	O
activity	O
of	O
defined	O
heterodimer	O
pools	O
.	O
<EOS> B-X
One B-X
of B-X
the B-X
fundamental B-X
questions B-X
concerning B-X
expression B-X
and B-X
function B-X
of B-X
dimeric B-X
enzymes B-X
involves B-X
the B-X
impact B-X
of B-X
naturally B-X
occurring B-X
mutations B-X
on B-X
subunit B-X
assembly B-X
... B-X

We	O
have	O
found	O
that	O
both	O
homodimers	O
and	O
heterodimers	O
do	O
form	O
involving	O
each	O
of	O
the	O
mutant	O
subunits	O
tested	O
and	O
that	O
both	O
heterodimer	O
pools	O
retain	O
substantial	O
enzymatic	O
activity	O
.	O
<EOS> B-X
Inter-monomer B-X
electron B-X
transfer B-X
is B-X
too B-X
slow B-X
to B-X
compete B-X
with B-X
monomeric B-X
turnover B-X
in B-X
bc1 B-X
complex B-X
One B-X
of B-X
the B-X
fundamental B-X
questions B-X
concerning B-X
expression B-X
and B-X
function B-X
of B-X
dimeric B-X
enzymes B-X
involves B-X
the B-X
impact B-X
of B-X
naturally B-X
occurring B-X
mutations B-X
on B-X
subunit B-X
assembly B-X
and B-X
heterodimer B-X
activity B-X
. B-X
This B-X
question B-X
is B-X
of B-X
Lack B-X
of B-X
evidence B-X
for B-X
substrate B-X
channeling B-X
or B-X
flux B-X
between B-X
wildtype B-X
and B-X
mutant B-X
isocitrate B-X
dehydrogenase B-X
to B-X
produce B-X
the B-X
oncometabolite B-X
2-hydroxyglutarate B-X
- B-X
ScienceDirect B-X
Download B-X
Citation B-X
| B-X
Studies B-X
of B-X
the B-X
V94M-substituted B-X
human B-X
UDPgalactose-4-epimerase B-X
enzyme B-X
associated B-X
with B-X
generalized B-X
epimerase-deficiency B-X
galactosaemia B-X
| B-X
Impairment B-X
of B-X
the B-X
human B-X
enzyme B-X
UDPgalactose B-X
4-epimerase B-X
( B-X
hGALE B-X
) B-X
results B-X
in B-X
epimerase-deficiency B-X
galactosaemia B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

These	O
results	O
are	O
significant	O
not	O
only	O
in	O
terms	O
of	O
their	O
implications	O
for	O
furthering	O
our	O
understanding	O
of	O
galactosemia	B-Disease
and	O
GALT	O
holoenzyme	O
structure	O
-	O
function	O
relationships	O
but	O
also	O
because	O
the	O
system	O
described	O
may	O
serve	O
as	O
a	O
model	O
for	O
similar	O
studies	O
of	O
other	O
complexes	O
composed	O
of	O
multiple	O
subunits	O
.	O
.	O
<EOS> B-X
PDF B-X
| B-X
One B-X
of B-X
the B-X
fundamental B-X
questions B-X
concerning B-X
expression B-X
and B-X
function B-X
of B-X
dimeric B-X
enzymes B-X
involves B-X
the B-X
impact B-X
of B-X
naturally B-X
occurring B-X
mutations B-X
on B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X

Cleavage	O
of	O
huntingtin	O
by	O
apopain	O
,	O
a	O
proapoptotic	O
cysteine	O
protease	O
,	O
is	O
modulated	O
by	O
the	O
polyglutamine	O
tract	O
.	O
<EOS> B-X
Apoptosis B-X
has B-X
recently B-X
been B-X
recognized B-X
as B-X
a B-X
mode B-X
of B-X
cell B-X
death B-X
in B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
. B-X
Apopain B-X
, B-X
a B-X
human B-X
counterpart B-X
of B-X
the B-X
nematode B-X
cysteine B-X
protease B-X
death‚Äìgene B-X
product B-X
Wild-Type B-X
Huntingtin B-X
Protects B-X
from B-X
Apoptosis B-X
Upstream B-X
of B-X
Caspase-3 B-X
Wild-Type B-X
Huntingtin B-X
Protects B-X
from B-X
Apoptosis B-X
Upstream B-X
of B-X
Caspase-3 B-X
| B-X
Journal B-X
of B-X
Neuroscience B-X
WikiGenes B-X
- B-X
CASP3 B-X
- B-X
caspase B-X
3 B-X
, B-X
apoptosis-related B-X
cysteine B-X
... B-X
Huntington B-X
Disease B-X
( B-X
HD B-X
) B-X
results B-X
from B-X
polyglutamine B-X
expansion B-X
within B-X
the B-X
N-terminus B-X
of B-X
huntingtin B-X
. B-X
We B-X
have B-X
produced B-X
yeast B-X
artificial B-X
chromosome B-X
( B-X
YAC B-X
) B-X
transgenic B-X
mice B-X
expressing B-X
normal B-X
( B-X
YAC18 B-X
Does B-X
apoptosis B-X
have B-X
a B-X
role B-X
in B-X
neurodegeneration B-X
? B-X
Caspase B-X
Cleavage B-X
of B-X
Mutant B-X
Huntingtin B-X
Precedes B-X
Neurodegeneration B-X
in B-X
Huntington B-X
's B-X
Disease B-X
| B-X
Journal B-X
of B-X
Neuroscience B-X

Apoptosis	O
has	O
recently	O
been	O
recognized	O
as	O
a	O
mode	O
of	O
cell	O
death	O
in	O
Huntington	B-Disease
disease	I-Disease
(	O
HD	B-Disease
)	O
.	O
<EOS> B-X
Curcumin B-X
modulates B-X
cell B-X
death B-X
and B-X
is B-X
protective B-X
in B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
model B-X
Many B-X
neurodegenerative B-X
diseases B-X
are B-X
characterized B-X
by B-X
impairment B-X
of B-X
protein B-X
quality B-X
control B-X
mechanisms B-X
in B-X
neuronal B-X
cells B-X
. B-X
Ineffective B-X
clearance B-X
of B-X
misfolded B-X
proteins B-X
by B-X
the B-X
proteasome B-X
, B-X
autophagy B-X
pathways B-X
and B-X
exocytosis B-X
leads B-X
Mutated B-X
huntingtin B-X
( B-X
htt B-X
) B-X
is B-X
ubiquitously B-X
expressed B-X
in B-X
tissues B-X
of B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
patients B-X
. B-X
In B-X
the B-X
brain B-X
, B-X
the B-X
mutated B-X
protein B-X
leads B-X
to B-X
neuronal B-X
cell B-X
Mechanisms B-X
of B-X
tissue B-X
damage B-X
in B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
involve B-X
excitotoxicity B-X
, B-X
mitochondrial B-X
damage B-X
, B-X
and B-X
neuroinflammation B-X
, B-X
including B-X
microglia B-X
activation B-X
. B-X
In B-X
the B-X
present B-X
study B-X
, B-X
we B-X
investigate B-X
the B-X
Huntington B-X
's B-X
Disease B-X
: B-X
Cell B-X
Huntington B-X
's B-X
disease B-X
| B-X
Molecular B-X
Pathology B-X

Apopain	O
,	O
a	O
human	O
counterpart	O
of	O
the	O
nematode	O
cysteine	O
protease	O
death	O
-	O
gene	O
product	O
,	O
CED	O
-	O
3	O
,	O
has	O
a	O
key	O
role	O
in	O
proteolytic	O
events	O
leading	O
to	O
apoptosis	O
.	O
<EOS> B-X
Apoptosis B-X
has B-X
recently B-X
been B-X
recognized B-X
as B-X
a B-X
mode B-X
of B-X
cell B-X
death B-X
in B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
. B-X
Apopain B-X
, B-X
a B-X
human B-X
counterpart B-X
of B-X
the B-X
nematode B-X
cysteine B-X
protease B-X
death‚Äìgene B-X
product B-X
The B-X
role B-X
of B-X
the B-X
Caspase B-X
family B-X
of B-X
cysteine B-X
proteases B-X
in B-X
apoptosis B-X
- B-X
ScienceDirect B-X
The B-X
Role B-X
of B-X
CED-3-Related B-X
Cysteine B-X
Proteases B-X
in B-X
Apoptosis B-X
of B-X
Cerebellar B-X
Granule B-X
Cells B-X
The B-X
Role B-X
of B-X
CED-3-Related B-X
Cysteine B-X
Proteases B-X
in B-X
Apoptosis B-X
of B-X
Cerebellar B-X
Granule B-X
Cells B-X
| B-X
Journal B-X
of B-X
Neuroscience B-X
The B-X
Role B-X
of B-X
Caspases B-X
in B-X
Development B-X
, B-X
Immunity B-X
, B-X
and B-X
Apoptotic B-X
Signal B-X
Transduction B-X
: B-X
Immunity B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

Here	O
we	O
show	O
that	O
apoptotic	O
extracts	O
and	O
apopain	O
itself	O
specifically	O
cleave	O
the	O
HD	B-Disease
gene	O
product	O
,	O
huntingtin	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
HTT B-X
- B-X
huntingtin B-X
Request B-X
PDF B-X
| B-X
Huntington B-X
disease B-X
: B-X
New B-X
insights B-X
on B-X
the B-X
role B-X
of B-X
huntingtin B-X
cleavage B-X
| B-X
Huntington B-X
Disease B-X
( B-X
HD B-X
) B-X
results B-X
from B-X
polyglutamine B-X
expansion B-X
within B-X
the B-X
N-terminus B-X
of B-X
huntingtin B-X
. B-X
H. B-X
Brook B-X
Koide B-X
's B-X
5 B-X
research B-X
works B-X
with B-X
1,419 B-X
citations B-X
and B-X
183 B-X
reads B-X
, B-X
including B-X
: B-X
HIP1 B-X
, B-X
a B-X
human B-X
homologue B-X
of B-X
S-cerevisiae B-X
Sla2p B-X
, B-X
interacts B-X
with B-X
membrane-associated B-X
huntingtin B-X
in B-X
Michael B-X
A. B-X
Kalchman B-X
's B-X
12 B-X
research B-X
works B-X
with B-X
2,932 B-X
citations B-X
and B-X
880 B-X
reads B-X
, B-X
including B-X
: B-X
Forskolin B-X
and B-X
dopamine B-X
D1 B-X
receptor B-X
activation B-X
increase B-X
Huntingtin B-X
's B-X
association B-X
with B-X
endosomes B-X
in B-X
immortalized B-X
Dentatorubral B-X
Pallidoluysian B-X
Atrophy B-X
( B-X
DRPLA B-X
) B-X
Protein B-X
Is B-X
Cleaved B-X
by B-X
Caspase-3 B-X
during B-X
Apoptosis B-X
- B-X
ScienceDirect B-X
Dita B-X
M. B-X
Rasper B-X
's B-X
27 B-X
research B-X
works B-X
with B-X
5,264 B-X
citations B-X
and B-X
1,664 B-X
reads B-X
, B-X
including B-X
: B-X
Solid-phase B-X
analogue B-X
synthesis B-X
of B-X
caspase-3 B-X
inhibitors B-X
via B-X
palladium-catalyzed B-X
amination B-X
of B-X
3-bromopyrazinones B-X
PDF B-X
| B-X
The B-X
neurodegenerative B-X
diseases B-X
Huntington B-X
disease B-X
, B-X
dentatorubropallidoluysian B-X
atrophy B-X
, B-X
spinocerebellar B-X
atrophy B-X
type B-X
3 B-X
, B-X
and B-X
spinal B-X
bulbar B-X
muscular B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X

The	O
rate	O
of	O
cleavage	O
increases	O
with	O
the	O
length	O
of	O
the	O
huntingtin	O
polyglutamine	O
tract	O
,	O
providing	O
an	O
explanation	O
for	O
the	O
gain	O
-	O
of	O
-	O
function	O
associated	O
with	O
CAG	O
expansion	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Expansion B-X
of B-X
CAG B-X
trinucleotide B-X
repeats B-X
coding B-X
for B-X
polyglutamine B-X
in B-X
unrelated B-X
proteins B-X
causes B-X
at B-X
least B-X
nine B-X
late-onset B-X
progressive B-X
neurodegenerative B-X
di B-X
Polyglutamine B-X
Tract B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Novel B-X
DNA B-X
Aptamers B-X
that B-X
Bind B-X
to B-X
Mutant B-X
Huntingtin B-X
and B-X
Modify B-X
Its B-X
Activity B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
a B-X
devastating B-X
neurodegenerative B-X
disorder B-X
whose B-X
main B-X
hallmark B-X
is B-X
brain B-X
atrophy B-X
. B-X
However B-X
, B-X
several B-X
peripheral B-X
organs B-X
are B-X
considerably B-X
affected B-X
and B-X
their B-X
symptoms B-X
CAG B-X
Repeat B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Htt B-X
huntingtin B-X
[ B-X
Mus B-X
musculus B-X
( B-X
house B-X
mouse B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X

Our	O
results	O
show	O
that	O
huntingtin	O
is	O
cleaved	O
by	O
cysteine	O
proteases	O
and	O
suggest	O
that	O
HD	B-Disease
might	O
be	O
a	O
disorder	B-Disease
of	I-Disease
inappropriate	I-Disease
apoptosis	I-Disease
.	O
.	O
<EOS> B-X
Cleavage B-X
of B-X
huntingtin B-X
by B-X
apopain B-X
, B-X
a B-X
proapoptotic B-X
cysteine B-X
protease B-X
, B-X
is B-X
modulated B-X
by B-X
the B-X
polyglutamine B-X
tract B-X
. B-X
Caspases B-X
are B-X
a B-X
family B-X
of B-X
cysteine B-X
proteases B-X
that B-X
play B-X
important B-X
roles B-X
in B-X
regulating B-X
apoptosis B-X
. B-X
A B-X
decade B-X
of B-X
research B-X
has B-X
generated B-X
a B-X
wealth B-X
of B-X
information B-X
on B-X
the B-X
signal B-X
transduction B-X
pathways B-X
Caspases B-X
are B-X
a B-X
family B-X
of B-X
cysteine B-X
proteases B-X
that B-X
play B-X
important B-X
roles B-X
in B-X
regulating B-X
apoptosis B-X
. B-X
A B-X
decade B-X
of B-X
research B-X
has B-X
generated B-X
a B-X
wealth B-X
of B-X
information B-X
on B-X
the B-X
signal B-X
transduction B-X
pathways B-X
Apoptosis B-X
has B-X
recently B-X
been B-X
recognized B-X
as B-X
a B-X
mode B-X
of B-X
cell B-X
death B-X
in B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
. B-X
Apopain B-X
, B-X
a B-X
human B-X
counterpart B-X
of B-X
the B-X
nematode B-X
cysteine B-X
protease B-X
death-gene B-X
product B-X
Role B-X
of B-X
Apoptosis B-X
in B-X
disease B-X
Huntingtin B-X
Acts B-X
in B-X
the B-X
Nucleus B-X
to B-X
Induce B-X
Apoptosis B-X
but B-X
Death B-X
Does B-X
Not B-X
Correlate B-X
with B-X
the B-X
Formation B-X
of B-X
Intranuclear B-X
Inclusions B-X
: B-X
Cell B-X
Abstract B-X
. B-X
The B-X
mutation B-X
underlying B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
CAG B-X
expansion B-X
beyond B-X
35 B-X
repeats B-X
within B-X
a B-X
novel B-X
gene B-X
. B-X
Recently B-X
, B-X
new B-X
insights B-X
into B-X
the B-X
role B-X
of B-X
the B-X

The	O
5	O
'	O
end	O
of	O
the	O
BRCA1	O
gene	O
lies	O
within	O
a	O
duplicated	O
region	O
of	O
human	O
chromosome	O
17q21	O
.	O
<EOS> B-X
The B-X
5 B-X
' B-X
end B-X
of B-X
the B-X
breast B-X
and B-X
ovarian B-X
cancer-susceptibility B-X
gene B-X
BRCA1 B-X
has B-X
previously B-X
been B-X
shown B-X
to B-X
lie B-X
within B-X
a B-X
duplicated B-X
region B-X
of B-X
chromosome B-X
band B-X
17q21 B-X
. B-X
The B-X
duplicated B-X
region B-X
Evidence B-X
for B-X
effective B-X
suppression B-X
of B-X
recombination B-X
in B-X
the B-X
chromosome B-X
17q21 B-X
segment B-X
spanning B-X
RNU2-BRCA1 B-X
. B-X
To B-X
begin B-X
to B-X
address B-X
the B-X
hypothesis B-X
that B-X
abnormal B-X
regulation B-X
of B-X
the B-X
breast/ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
BRCA1 B-X
is B-X
a B-X
critical B-X
step B-X
in B-X
sporadic B-X
breast/ovarian B-X
tumorigenesis B-X
, B-X
we B-X
have B-X
determined B-X
the B-X
detailed B-X
Distinct B-X
BRCA1 B-X
Rearrangements B-X
Involving B-X
the B-X
BRCA1 B-X
Pseudogene B-X
Suggest B-X
the B-X
Existence B-X
of B-X
a B-X
Recombination B-X
Hot B-X
Spot B-X
- B-X
ScienceDirect B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
On B-X
the B-X
basis B-X
of B-X
the B-X
agreement B-X
signed B-X
between B-X
UNESCO B-X
and B-X
the B-X
Government B-X
of B-X
the B-X
Republic B-X
of B-X
Poland B-X
the B-X
International B-X
Institute B-X
for B-X
Cell B-X
and B-X
Molecular B-X
Biology B-X
of B-X
UNESCO B-X
was B-X
officially B-X
inaugurated B-X
scientific B-X
article B-X

To	O
begin	O
to	O
address	O
the	O
hypothesis	O
that	O
abnormal	O
regulation	O
of	O
the	O
breast	B-Disease
/	I-Disease
ovarian	I-Disease
cancer	I-Disease
susceptibility	O
gene	O
BRCA1	O
is	O
a	O
critical	O
step	O
in	O
sporadic	O
breast	O
/	O
ovarian	O
tumorigenesis	O
,	O
we	O
have	O
determined	O
the	O
detailed	O
structure	O
of	O
the	O
BRCA1	O
genomic	O
region	O
.	O
<EOS> B-X
Germline B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
predispose B-X
carriers B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
, B-X
and B-X
there B-X
remains B-X
a B-X
need B-X
to B-X
identify B-X
the B-X
specific B-X
genomic B-X
mechanisms B-X
by B-X
which B-X
cancer B-X
‚Äú B-X
DNA B-X
Binding B-X
Region B-X
‚Äù B-X
of B-X
BRCA1 B-X
Affects B-X
Genetic B-X
Stability B-X
through B-X
modulating B-X
the B-X
Intra-S-Phase B-X
Checkpoint B-X
‚Äú B-X
DNA B-X
Binding B-X
Region B-X
‚Äù B-X
of B-X
BRCA1 B-X
Affects B-X
Genetic B-X
Stability B-X
through B-X
modulating B-X
the B-X
Intra-S-Phase B-X
Checkpoint B-X
The B-X
molecular B-X
genetics B-X
of B-X
breast B-X
cancer B-X
and B-X
targeted B-X
therapy B-X
BRCA2 B-X
Protein B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
STRUCTURE-FUNCTION B-X
OF B-X
THE B-X
TUMOR B-X
SUPPRESSOR B-X
BRCA1 B-X
- B-X
ScienceDirect B-X

We	O
show	O
that	O
this	O
region	O
of	O
the	O
genome	O
contains	O
a	O
tandem	O
duplication	O
of	O
approximately	O
30	O
kilobases	O
,	O
which	O
results	O
in	O
two	O
copies	O
of	O
BRCA1	O
exons	O
1	O
and	O
2	O
,	O
of	O
exons	O
1	O
and	O
3	O
of	O
the	O
adjacent	O
1A1	O
-	O
3B	O
gene	O
and	O
of	O
the	O
previously	O
reported	O
295	O
base	O
pair	O
intergenic	O
region	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
NBR1 B-X
- B-X
neighbor B-X
of B-X
BRCA1 B-X
gene B-X
1 B-X
Rapid B-X
detection B-X
of B-X
copy B-X
number B-X
variations B-X
and B-X
point B-X
mutations B-X
in B-X
BRCA1/2 B-X
genes B-X
using B-X
a B-X
single B-X
workflow B-X
by B-X
ion B-X
semiconductor B-X
sequencing B-X
pipeline B-X
Genomic B-X
rearrangements B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
: B-X
A B-X
literature B-X
review B-X
Clinical B-X
significance B-X
of B-X
large B-X
rearrangements B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Complex B-X
Characterization B-X
of B-X
Germline B-X
Large B-X
Genomic B-X
Rearrangements B-X
of B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Genes B-X
in B-X
High-Risk B-X
Breast B-X
Cancer B-X
Patients‚ÄîNovel B-X
Variants B-X
from B-X
a B-X
Large B-X
National B-X
Center B-X
A B-X
small B-X
intergenic B-X
region B-X
drives B-X
exclusive B-X
tissue-specific B-X
expression B-X
of B-X
the B-X
adjacent B-X
genes B-X
in B-X
Arabidopsis B-X
thaliana B-X
Request B-X
PDF B-X
| B-X
Expression B-X
profiles B-X
and B-X
intergenic B-X
structure B-X
of B-X
head-to-head B-X
oriented B-X
Brca1 B-X
and B-X
Nbr1 B-X
genes B-X
| B-X
Mouse B-X
and B-X
human B-X
Brca1/BRCA1 B-X
and B-X
Nbr1/NBR2 B-X
genes B-X
lie B-X
head-to-head B-X
, B-X
being B-X
transcribed B-X
from B-X
the B-X

Sequence	O
analysis	O
of	O
the	O
duplicated	O
exons	O
of	O
BRCA1	O
and	O
1A1	O
-	O
3B	O
and	O
flanking	O
genomic	O
DNA	O
reveals	O
maintenance	O
of	O
the	O
intron	O
-	O
exon	O
structure	O
and	O
a	O
high	O
degree	O
of	O
nucleotide	O
sequence	O
identity	O
,	O
suggesting	O
that	O
these	O
are	O
non	O
-	O
processed	O
pseudogenes	O
and	O
that	O
the	O
duplication	O
is	O
a	O
recent	O
event	O
in	O
evolutionary	O
terms	O
.	O
<EOS> B-X
The B-X
copy B-X
number B-X
variation B-X
initially B-X
recognized B-X
as B-X
duplication B-X
of B-X
exon B-X
1-19 B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
by B-X
MLPA B-X
analysis B-X
is B-X
a B-X
structural B-X
variation B-X
with B-X
breakpoints B-X
in B-X
the B-X
BRCA1 B-X
and B-X
DHX8 B-X
genes B-X
Request B-X
PDF B-X
| B-X
Identification B-X
of B-X
two B-X
evolutionarily B-X
conserved B-X
and B-X
functional B-X
regulatory B-X
elements B-X
in B-X
intron B-X
2 B-X
of B-X
the B-X
human B-X
BRCA1 B-X
gene B-X
| B-X
Cross-species B-X
comparative B-X
genomics B-X
is B-X
a B-X
powerful B-X
strategy B-X
for B-X
identifying B-X
Comparative B-X
analysis B-X
of B-X
pseudogenes B-X
across B-X
three B-X
phyla B-X
Millions B-X
of B-X
Years B-X
of B-X
Evolution B-X
Preserved B-X
: B-X
A B-X
Comprehensive B-X
Catalog B-X
of B-X
the B-X
Processed B-X
Pseudogenes B-X
in B-X
the B-X
Human B-X
Genome B-X
Pseudogenes B-X
in B-X
the B-X
ENCODE B-X
regions B-X
: B-X
Consensus B-X
annotation B-X
, B-X
analysis B-X
of B-X
transcription B-X
, B-X
and B-X
evolution B-X
Request B-X
PDF B-X
| B-X
Characterisation B-X
of B-X
a B-X
161 B-X
kb B-X
deletion B-X
extending B-X
from B-X
the B-X
NBR1 B-X
to B-X
the B-X
BRCA1 B-X
genes B-X
in B-X
a B-X
French B-X
breast-ovarian B-X
cancer B-X
family B-X
| B-X
A B-X
large B-X
germline B-X
deletion B-X
removing B-X
exons B-X
New B-X
gene B-X
origination B-X
is B-X
a B-X
driving B-X
force B-X
of B-X
evolutionary B-X
innovation B-X
in B-X
all B-X
organisms B-X
. B-X
Although B-X
most B-X
studies B-X
of B-X
new B-X
genes B-X
focus B-X
on B-X
protein-coding B-X
genes B-X
, B-X
researchers B-X
now B-X
have B-X
evidence B-X
of B-X

We	O
also	O
show	O
that	O
a	O
processed	O
pseudogene	O
of	O
the	O
acidic	O
ribosomal	O
phosphoprotein	O
P1	O
(	O
ARPP1	O
)	O
is	O
inserted	O
directly	O
upstream	O
of	O
pseudo	O
-	O
BRCA1	O
exon	O
1A	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
BRCA1P1 B-X
- B-X
BRCA1 B-X
pseudogene B-X
1 B-X
PDF B-X
| B-X
The B-X
5 B-X
' B-X
region B-X
of B-X
BRCA1 B-X
contains B-X
multiple B-X
regulatory B-X
sequences B-X
flanking B-X
the B-X
two B-X
alternative B-X
promoters B-X
alpha B-X
and B-X
beta B-X
and B-X
two B-X
alternative B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
PDF B-X
| B-X
The B-X
85-kb B-X
breast B-X
cancer-associated B-X
gene B-X
BRCA1 B-X
is B-X
an B-X
established B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
but B-X
its B-X
regulation B-X
is B-X
poorly B-X
understood B-X
. B-X
We B-X
demonstrate B-X
by B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
GermlineBRCA1 B-X
promoter B-X
deletions B-X
in B-X
UK B-X
and B-X
Australian B-X
familial B-X
breast B-X
cancer B-X
patients B-X
: B-X
Identification B-X
of B-X
a B-X
novel B-X
deletion B-X
consistent B-X
withBRCA1 B-X
: B-X
? B-X
BRCA1 B-X
recombination B-X
| B-X
Inherited B-X
susceptibility B-X
to B-X
PDF B-X
| B-X
On B-X
May B-X
1 B-X
, B-X
2005 B-X
, B-X
Anders B-X
Kvist B-X
and B-X
others B-X
published B-X
Promoter B-X
usage B-X
of B-X
BRCA1-IRIS B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
on B-X
ResearchGate B-X
Request B-X
PDF B-X
| B-X
On B-X
Oct B-X
23 B-X
, B-X
2018 B-X
, B-X
Tae-Dong B-X
Jeong B-X
and B-X
others B-X
published B-X
Significant B-X
allelic B-X
dropout B-X
phenomenon B-X
of B-X
Oncomine B-X
BRCA B-X
Research B-X
Assay B-X
on B-X
Ion B-X
Torrent B-X
S5 B-X
| B-X
Find B-X
, B-X

We	O
believe	O
that	O
these	O
findings	O
could	O
not	O
only	O
confound	O
BRCA1	O
mutation	O
analysis	O
,	O
but	O
could	O
have	O
implications	O
for	O
the	O
normal	O
and	O
abnormal	O
regulation	O
of	O
BRCA1	O
transcription	O
,	O
translation	O
and	O
function	O
.	O
.	O
<EOS> B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
and B-X
female B-X
fertility B-X
To B-X
begin B-X
to B-X
address B-X
the B-X
hypothesis B-X
that B-X
abnormal B-X
regulation B-X
of B-X
the B-X
breast/ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
BRCA1 B-X
is B-X
a B-X
critical B-X
step B-X
in B-X
sporadic B-X
breast/ovarian B-X
tumorigenesis B-X
, B-X
we B-X
have B-X
determined B-X
the B-X
detailed B-X
BRCA1-Dependent B-X
Transcriptional B-X
Regulation B-X
: B-X
Implication B-X
in B-X
Tissue-Specific B-X
Tumor B-X
Suppression B-X
Germ-line B-X
mutations B-X
in B-X
breast B-X
cancer B-X
susceptibility B-X
gene B-X
1 B-X
( B-X
BRCA1 B-X
) B-X
predominantly B-X
predispose B-X
women B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
BRCA1 B-X
is B-X
best B-X
known B-X
for B-X
its B-X
functions B-X
in B-X
maintenance B-X
of B-X
DNA B-X
Damage B-X
Response B-X
Mediated B-X
through B-X
BRCA1 B-X
Contralateral B-X
mastectomy B-X
and B-X
survival B-X
after B-X
breast B-X
cancer B-X
in B-X
carriers B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
: B-X
retrospective B-X
analysis B-X
| B-X
The B-X
BMJ B-X
Function B-X
translations B-X
, B-X
introduced B-X
using B-X
both B-X
a B-X
visual B-X
and B-X
an B-X
algebraic B-X
approach B-X
. B-X

Deletion	O
of	O
small	O
nuclear	O
ribonucleoprotein	O
polypeptide	O
N	O
(	O
SNRPN	O
)	O
in	O
Prader	B-Disease
-	I-Disease
Willi	I-Disease
syndrome	I-Disease
detected	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
:	O
two	O
sibs	O
with	O
the	O
typical	O
phenotype	O
without	O
a	O
cytogenetic	O
deletion	O
in	O
chromosome	O
15q	O
.	O
<EOS> B-X
Deletion B-X
of B-X
chromosome B-X
15 B-X
was B-X
investigated B-X
in B-X
6 B-X
patients B-X
with B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
using B-X
chromosome B-X
and B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
( B-X
FISH B-X
) B-X
analysis B-X
. B-X
Although B-X
chromosome B-X
analysis B-X
Small B-X
nuclear B-X
ribonucleoprotein B-X
polypeptide B-X
N B-X
- B-X
Wikipedia B-X
Prader-Willi B-X
syndrome B-X
: B-X
Methylation B-X
study B-X
or B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
first B-X
? B-X
Six B-X
patients B-X
, B-X
including B-X
two B-X
sibs B-X
, B-X
with B-X
Angelman B-X
syndrome B-X
( B-X
AS B-X
; B-X
three B-X
females B-X
and B-X
three B-X
males B-X
, B-X
aged B-X
11 B-X
to B-X
18 B-X
years B-X
) B-X
were B-X
studied B-X
cytogenetically B-X
. B-X
Molecular B-X
Angelman B-X
syndrome B-X
: B-X
three B-X
molecular B-X
classes B-X
identified B-X
with B-X
chromosome B-X
15q11q13-specific B-X
DNA B-X
markers B-X
. B-X
Maternal B-X
uniparental B-X
disomy B-X
( B-X
UPD B-X
) B-X
for B-X
chromosome B-X
15 B-X
is B-X
responsible B-X
for B-X
an B-X
estimated B-X
30 B-X
% B-X
of B-X
cases B-X
of B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
. B-X
We B-X
report B-X
on B-X
an B-X
unusual B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
is B-X
neurogenetic B-X
disorder B-X
involving B-X
the B-X
imprinting B-X
mechanism B-X
at B-X
15q11-13 B-X
region B-X
. B-X
We B-X
report B-X
a B-X
4-year-old B-X
girl B-X
who B-X
was B-X
referred B-X
to B-X
our B-X
laboratory B-X
to B-X
be B-X
investigated B-X

The	O
small	O
nuclear	O
ribonucleoprotein	O
polypeptide	O
N	O
(	O
SNRPN	O
)	O
gene	O
is	O
regarded	O
as	O
one	O
of	O
the	O
candidates	O
for	O
Prader	B-Disease
-	I-Disease
Willi	I-Disease
syndrome	I-Disease
(	O
PWS	B-Disease
)	O
.	O
<EOS> B-X
The B-X
SNRPN-expression B-X
test B-X
is B-X
rapid B-X
and B-X
reliable B-X
in B-X
the B-X
molecular B-X
diagnosis B-X
of B-X
Prader-Willi B-X
syndrome B-X
. B-X
Quantitative B-X
and B-X
Qualitative B-X
Analyses B-X
of B-X
the B-X
SNRPN B-X
Gene B-X
Using B-X
Real-Time B-X
PCR B-X
with B-X
Melting B-X
Curve B-X
Analysis B-X
182279 B-X
- B-X
SMALL B-X
NUCLEAR B-X
RIBONUCLEOPROTEIN B-X
POLYPEPTIDE B-X
N B-X
; B-X
SNRPN B-X
- B-X
SMN B-X
- B-X
SNRPN B-X
UPSTREAM B-X
READING B-X
FRAME B-X
, B-X
INCLUDED B-X
; B-X
SNURF B-X
, B-X
INCLUDED B-X
- B-X
SNRPN B-X

We	O
describe	O
two	O
sibs	O
with	O
typical	O
PWS	B-Disease
presenting	O
deletion	O
of	O
SNRPN	O
detected	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O
<EOS> B-X
The B-X
small B-X
nuclear B-X
ribonucleoprotein B-X
polypeptide B-X
N B-X
( B-X
SNRPN B-X
) B-X
gene B-X
is B-X
regarded B-X
as B-X
one B-X
of B-X
the B-X
candidates B-X
for B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
. B-X
We B-X
describe B-X
two B-X
sibs B-X
with B-X
typical B-X
We B-X
have B-X
evaluated B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
( B-X
FISH B-X
) B-X
analysis B-X
for B-X
the B-X
clinical B-X
laboratory B-X
detection B-X
of B-X
the B-X
15q11-q13 B-X
deletion B-X
seen B-X
in B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
and B-X
Angelman B-X
syndrome B-X
Deletion B-X
of B-X
small B-X
nuclear B-X
ribonucleoprotein B-X
polypeptide B-X
N B-X
( B-X
SNRPN B-X
) B-X
in B-X
Prader‚ÄêWilli B-X
syndrome B-X
detected B-X
by B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
: B-X
Two B-X
sibs B-X
with B-X
the B-X
typical B-X
phenotype B-X
without B-X
a B-X
cytogenetic B-X
deletion B-X
Three B-X
siblings B-X
with B-X
Prader-Willi B-X
syndrome B-X
caused B-X
by B-X
imprinting B-X
center B-X
microdeletions B-X
and B-X
review B-X
Request B-X
PDF B-X
| B-X
Use B-X
of B-X
two B-X
FISH B-X
probes B-X
provides B-X
a B-X
cost-effective B-X
, B-X
simple B-X
protocol B-X
to B-X
exclude B-X
an B-X
imprinting B-X
centre B-X
defect B-X
in B-X
routine B-X
laboratory B-X
testing B-X
for B-X
suspected B-X
Prader-Willi B-X
and B-X
Angelman B-X
syndrome B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
markers B-X
for B-X
diagnosis B-X
of B-X
Prader-Willi B-X
syndrome B-X
in B-X
thai B-X
patients B-X
by B-X
fish B-X
| B-X
Paternal B-X
microdeletion B-X
of B-X
chromosome B-X
15 B-X
at B-X
q11-q13 B-X
has B-X
been B-X
reported B-X
in B-X
75 B-X
% B-X
of B-X
Imprinting B-X
centre B-X
deletions B-X
in B-X
two B-X
PWS B-X
families B-X
: B-X
implications B-X
for B-X
diagnostic B-X
testing B-X
and B-X
genetic B-X
counselling B-X
- B-X
Buiting B-X
- B-X
2000 B-X
- B-X
Clinical B-X
Genetics B-X
- B-X
Wiley B-X
Online B-X
Library B-X

Neither	O
a	O
cytogenetically	O
detectable	O
15q12	O
deletion	O
nor	O
a	O
deletion	O
for	O
the	O
D15S11	O
,	O
D15S10	O
,	O
and	O
GABRB3	O
cosmid	O
probes	O
were	O
found	O
in	O
either	O
patient	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
FISH-mapping B-X
of B-X
a B-X
100-Kb B-X
terminal B-X
22q13 B-X
deletion B-X
| B-X
Both B-X
cytogenetically B-X
visible B-X
and B-X
cryptic B-X
deletions B-X
of B-X
the B-X
terminal B-X
region B-X
of B-X
chromosome B-X
22q B-X
are B-X
associated B-X
with B-X
a B-X
clinical B-X
phenotype B-X
Localization B-X
of B-X
the B-X
gene B-X
encoding B-X
the B-X
GABAA B-X
receptor B-X
Œ≤3 B-X
subunit B-X
to B-X
the B-X
Angelman/Prader-Willi B-X
region B-X
of B-X
human B-X
chromosome B-X
15 B-X
Deletion B-X
of B-X
small B-X
nuclear B-X
ribonucleoprotein B-X
polypeptide B-X
N B-X
( B-X
SNRPN B-X
) B-X
in B-X
Prader-Willi B-X
syndrome B-X
detected B-X
by B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
: B-X
two B-X
sibs B-X
with B-X
the B-X
typical B-X
phenotype B-X
without B-X
a B-X
cytogenetic B-X
deletion B-X
PDF B-X
| B-X
A B-X
clinical B-X
, B-X
cytogenetic B-X
, B-X
and B-X
molecular B-X
study B-X
has B-X
been B-X
carried B-X
out B-X
on B-X
40 B-X
adults B-X
with B-X
a B-X
firm B-X
diagnosis B-X
of B-X
Prader-Willi B-X
syndrome B-X
. B-X
A B-X
cytogenetically B-X
... B-X
| B-X
Find B-X
Request B-X
PDF B-X
| B-X
Fluorescence B-X
in B-X
situ B-X
hybridization B-X
detectable B-X
mosaicism B-X
for B-X
Angelman B-X
syndrome B-X
with B-X
biparental B-X
methylation B-X
| B-X
We B-X
present B-X
a B-X
child B-X
with B-X
mild B-X
to B-X
moderate B-X
global B-X
developmental B-X
delay B-X
including B-X
severe B-X
speech B-X

This	O
implies	O
a	O
smaller	O
deletion	O
limited	O
to	O
the	O
PWS	B-Disease
critical	O
region	O
.	O
<EOS> B-X
DECIPHER B-X
helps B-X
the B-X
clinical B-X
community B-X
share B-X
and B-X
compare B-X
human B-X
genome B-X
variants B-X
and B-X
phenotypes B-X
in B-X
a B-X
database B-X
of B-X
tens B-X
of B-X
thousands B-X
of B-X
patients B-X
worldwide B-X
Analysis B-X
of B-X
the B-X
Prader-Willi B-X
Syndrome B-X
Chromosome B-X
Region B-X
Using B-X
Quantitative B-X
Microsphere B-X
Hybridization B-X
( B-X
QMH B-X
) B-X
Array B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
is B-X
associated B-X
with B-X
paternally B-X
derived B-X
chromosomal B-X
deletions B-X
in B-X
region B-X
15q11-13 B-X
or B-X
with B-X
maternal B-X
disomy B-X
for B-X
chromosome B-X
15 B-X
. B-X
Therefore B-X
, B-X
loss B-X
of B-X
the B-X
expressed B-X
paternal B-X
Most B-X
patients B-X
with B-X
an B-X
interstitial B-X
deletion B-X
of B-X
6q16 B-X
have B-X
Prader‚ÄìWilli-like B-X
phenotype B-X
, B-X
featuring B-X
obesity B-X
, B-X
hypotonia B-X
, B-X
short B-X
hands B-X
and B-X
feet B-X
, B-X
and B-X
developmental B-X
delay B-X
. B-X
In B-X
all B-X
reported B-X
studies B-X
The B-X
Prader‚ÄìWilli B-X
syndrome B-X
( B-X
PWS B-X
) B-X
is B-X
caused B-X
by B-X
a B-X
5‚Äì6 B-X
Mbp B-X
de B-X
novo B-X
deletion B-X
on B-X
the B-X
paternal B-X
chromosome B-X
15 B-X
, B-X
maternal B-X
uniparental B-X
disomy B-X
15 B-X
or B-X
an B-X
imprinting B-X
defect B-X
. B-X

FISH	O
with	O
a	O
SNRPN	O
probe	O
will	O
permit	O
analysis	O
of	O
PWS	B-Disease
patients	O
with	O
limited	O
deletions	O
not	O
detectable	O
with	O
other	O
probes	O
.	O
.	O
<EOS> B-X
Paternal B-X
microdeletion B-X
of B-X
chromosome B-X
15 B-X
at B-X
q11-q13 B-X
has B-X
been B-X
reported B-X
in B-X
75 B-X
% B-X
of B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
patients B-X
in B-X
western B-X
countries B-X
. B-X
Diagnosis B-X
of B-X
PWS B-X
in B-X
Thailand B-X
is B-X
Prader-Willi B-X
syndrome B-X
( B-X
PWS B-X
) B-X
and B-X
Angelman B-X
syndrome B-X
( B-X
AS B-X
) B-X
are B-X
clinically B-X
distinct B-X
neurodevelopmental B-X
genetic B-X
disorders B-X
that B-X
map B-X
to B-X
15q11-q13 B-X
. B-X
The B-X
primary B-X
phenotypes B-X
are B-X
attributable B-X
to B-X
loss B-X
of B-X

Expression	O
of	O
the	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
disease	I-Disease
tumour	I-Disease
suppressor	O
gene	O
during	O
human	O
embryogenesis	O
.	O
<EOS> B-X
Expression B-X
of B-X
the B-X
Von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
VHL B-X
, B-X
in B-X
human B-X
fetal B-X
kidney B-X
and B-X
during B-X
mouse B-X
embryogenesis B-X
. B-X
Genetic B-X
and B-X
functional B-X
analysis B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumour B-X
suppressor B-X
gene B-X
promoter B-X
The B-X
VHL B-X
gatekeeper B-X
tumour B-X
suppressor B-X
gene B-X
is B-X
inactivated B-X
in B-X
the B-X
familial B-X
cancer B-X
syndrome B-X
von B-X
Hippel-Lindau B-X
disease B-X
and B-X
in B-X
most B-X
sporadic B-X
clear B-X
cell B-X
renal B-X
cell B-X
carcinomas B-X
. B-X
Recently B-X
the B-X
VHL B-X
gene B-X
Mutations B-X
in B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
cause B-X
tissue-specific B-X
tumors B-X
, B-X
with B-X
a B-X
striking B-X
genotype-phenotype B-X
correlation B-X
. B-X
Loss B-X
of B-X
VHL B-X
expression B-X
predisposes B-X
to B-X
hemangioblastoma B-X
and B-X
clear B-X
In B-X
human B-X
fetal B-X
kidney B-X
, B-X
the B-X
enhanced B-X
epithelial B-X
expression B-X
of B-X
the B-X
VHL B-X
gene B-X
is B-X
consistent B-X
with B-X
the B-X
role B-X
of B-X
this B-X
gene B-X
in B-X
RCC B-X
. B-X
There B-X
is B-X
widespread B-X
expression B-X
of B-X
the B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
is B-X
a B-X
familial B-X
cancer B-X
syndrome B-X
that B-X
has B-X
a B-X
dominant B-X
inherited B-X
pattern B-X
which B-X
predisposes B-X
affected B-X
individuals B-X
to B-X
a B-X
variety B-X
of B-X
tumors B-X
. B-X
The B-X
most B-X
frequent B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

The	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
disease	I-Disease
product	O
is	O
thought	O
to	O
down	O
-	O
regulate	O
transcription	O
by	O
antagonizing	O
elongin	O
-	O
enhanced	O
transcriptional	O
elongation	O
.	O
<EOS> B-X
The B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
product B-X
is B-X
thought B-X
to B-X
down-regulate B-X
transcription B-X
by B-X
antagonizing B-X
elongin-enhanced B-X
transcriptional B-X
elongation B-X
. B-X
Germline B-X
VHL B-X
gene B-X
mutations B-X
predispose B-X
to B-X
the B-X
development B-X
of B-X
retinal B-X
, B-X
Role B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Protein B-X
during B-X
Neuronal B-X
Differentiation B-X
| B-X
Cancer B-X
Research B-X
Request B-X
PDF B-X
| B-X
The B-X
von B-X
Hippel‚ÄìLindau B-X
tumor B-X
suppressor B-X
protein B-X
| B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
protein B-X
( B-X
pVHL B-X
) B-X
has B-X
been B-X
shown B-X
to B-X
bind B-X
directly B-X
to B-X
the B-X
alpha B-X
subunits B-X
of B-X
Download B-X
Citation B-X
| B-X
The B-X
von B-X
Hippel-Lindau B-X
Gene B-X
, B-X
Kidney B-X
Cancer B-X
, B-X
and B-X
Oxygen B-X
Sensing B-X
| B-X
Recent B-X
studies B-X
of B-X
a B-X
relatively B-X
rare B-X
hereditary B-X
cancer B-X
syndrome B-X
, B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
Download B-X
Citation B-X
| B-X
Von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Protein B-X
and B-X
Hypoxia-Inducible B-X
Factor B-X
in B-X
Kidney B-X
Cancer B-X
| B-X
The B-X
development B-X
of B-X
hereditary B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
and B-X
the B-X
majority B-X
of B-X
sporadic B-X
Germline B-X
mutations B-X
in B-X
the B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
VHL B-X
) B-X
predispose B-X
individuals B-X
to B-X
a B-X
variety B-X
of B-X
tumors B-X
, B-X
including B-X
renal B-X
carcinoma B-X
, B-X
hemangioblastoma B-X
of B-X
the B-X
central B-X
nervous B-X
system B-X
Request B-X
PDF B-X
| B-X
The B-X
von B-X
Hippel-Lindau B-X
tumour B-X
suppressor B-X
: B-X
A B-X
multi-faceted B-X
inhibitor B-X
of B-X
tumourigenesis B-X
| B-X
The B-X
proteolytic B-X
degradation B-X
of B-X
hypoxia B-X
inducible B-X
factor B-X
( B-X
HIF B-X
) B-X
Œ± B-X
by B-X
the B-X
von B-X
Hippel-Lindau B-X

Germline	O
VHL	B-Disease
gene	O
mutations	O
predispose	O
to	O
the	O
development	O
of	O
retinal	B-Disease
,	I-Disease
cerebellar	I-Disease
and	I-Disease
spinal	I-Disease
haemangioblastomas	I-Disease
,	O
renal	B-Disease
cell	I-Disease
carcinoma	I-Disease
and	O
phaeochromocytoma	B-Disease
.	O
<EOS> B-X
Von B-X
Hippel-Lindau B-X
disease B-X
is B-X
an B-X
autosomal B-X
dominantly B-X
inherited B-X
familial B-X
cancer B-X
syndrome B-X
predisposing B-X
to B-X
retinal B-X
and B-X
central B-X
nervous B-X
system B-X
haemangioblastomas B-X
, B-X
renal B-X
cell B-X
carcinoma B-X
, B-X
and B-X
phaeochromocytoma B-X
. B-X
VHL B-X
disease B-X
shows B-X
A B-X
germline B-X
mutation B-X
in B-X
the B-X
Von-Hippel B-X
Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
predisposes B-X
carriers B-X
to B-X
development B-X
of B-X
abundantly B-X
vascularised B-X
tumours B-X
in B-X
the B-X
retina B-X
, B-X
cerebellum B-X
, B-X
spine B-X
, B-X
kidney B-X
, B-X
adrenal B-X
Three B-X
novel B-X
germ-line B-X
VHL B-X
mutations B-X
in B-X
Hungarian B-X
von B-X
Hippel-Lindau B-X
patients B-X
, B-X
including B-X
a B-X
nonsense B-X
mutation B-X
in B-X
a B-X
fifteen-year-old B-X
boy B-X
with B-X
renal B-X
cell B-X
carcinoma B-X
Comorbid B-X
VHL B-X
and B-X
SCA2 B-X
mutations B-X
in B-X
a B-X
large B-X
kindred B-X
: B-X
confounding B-X
diagnosis B-X
of B-X
neurological B-X
dysfunction B-X
caused B-X
by B-X
CNS B-X
VHL B-X
vascular B-X
tumours B-X
versus B-X
SCA2 B-X
atrophic B-X
neurodegeneration B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Abstract B-X
. B-X
The B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
product B-X
is B-X
thought B-X
to B-X
down-regulate B-X
transcription B-X
by B-X
antagonizing B-X
elongin-enhanced B-X
transcriptional B-X
elongation B-X
. B-X
Ger B-X

In	O
addition	O
,	O
somatic	O
Inactivation	O
of	O
the	O
VHL	B-Disease
gene	O
is	O
frequent	O
in	O
sporadic	B-Disease
renal	I-Disease
cell	I-Disease
carcinoma	I-Disease
and	O
haemangioblastoma	B-Disease
.	O
<EOS> B-X
Reconsideration B-X
of B-X
biallelic B-X
inactivation B-X
of B-X
theVHL B-X
tumour B-X
suppressor B-X
gene B-X
in B-X
hemangioblastomas B-X
of B-X
the B-X
central B-X
nervous B-X
system B-X
| B-X
Journal B-X
of B-X
Neurology B-X
, B-X
Neurosurgery B-X
& B-X
Psychiatry B-X
A B-X
germline B-X
mutation B-X
in B-X
the B-X
Von-Hippel B-X
Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
predisposes B-X
carriers B-X
to B-X
development B-X
of B-X
abundantly B-X
vascularised B-X
tumours B-X
in B-X
the B-X
retina B-X
, B-X
cerebellum B-X
, B-X
spine B-X
, B-X
kidney B-X
, B-X
adrenal B-X
Hemangioblastomas B-X
consist B-X
of B-X
10-20 B-X
% B-X
neoplastic B-X
‚Äú B-X
stromal B-X
‚Äù B-X
cells B-X
within B-X
a B-X
vascular B-X
tumor B-X
cell B-X
mass B-X
of B-X
reactive B-X
pericytes B-X
, B-X
endothelium B-X
and B-X
lymphocytes B-X
. B-X
Familial B-X
cases B-X
of B-X
central B-X
nervous B-X
system B-X
Hemangioblastomas B-X
consist B-X
of B-X
10-20 B-X
% B-X
neoplastic B-X
‚Äú B-X
stromal B-X
‚Äù B-X
cells B-X
within B-X
a B-X
vascular B-X
tumor B-X
cell B-X
mass B-X
of B-X
reactive B-X
pericytes B-X
, B-X
endothelium B-X
and B-X
lymphocytes B-X
. B-X
Familial B-X
cases B-X
of B-X
central B-X
nervous B-X
system B-X

Regulation	O
of	O
transcript	O
elongation	O
is	O
an	O
important	O
control	O
mechanism	O
for	O
gene	O
expression	O
and	O
the	O
VHL	B-Disease
gene	O
might	O
modify	O
the	O
expression	O
of	O
proto	O
-	O
oncogenes	O
and	O
growth	O
suppressor	O
genes	O
during	O
embryogenesis	O
.	O
<EOS> B-X
Post-transcriptional B-X
regulation B-X
of B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
mRNA B-X
by B-X
the B-X
product B-X
of B-X
the B-X
VHL B-X
tumor B-X
suppressor B-X
gene B-X
. B-X
Many B-X
oncogenes B-X
induce B-X
expression B-X
of B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
( B-X
VEGF B-X
) B-X
, B-X
a B-X
key B-X
factor B-X
in B-X
tumor B-X
angiogenesis B-X
. B-X
Phosphatidylinositol B-X
3'-kinase B-X
( B-X
PI3K B-X
) B-X
/Akt B-X
is B-X
a B-X
common B-X
signaling B-X
The B-X
untold B-X
stories B-X
of B-X
the B-X
speech B-X
gene B-X
, B-X
the B-X
FOXP2 B-X
cancer B-X
gene B-X
The B-X
transcription B-X
factor B-X
MYC B-X
upregulates B-X
and B-X
downregulates B-X
distinct B-X
sets B-X
of B-X
target B-X
genes B-X
, B-X
promoting B-X
cell B-X
growth B-X
and B-X
proliferation B-X
, B-X
increased B-X
metabolic B-X
rate B-X
and B-X
RNA B-X
biogenesis B-X
. B-X
This B-X
Review B-X
discusses B-X
MYC-mediated B-X
MYC B-X
on B-X
the B-X
Path B-X
to B-X
Cancer B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X
This B-X
third B-X
edition B-X
is B-X
a B-X
comprehensive B-X
guide B-X
to B-X
Neurosurgery B-X
. B-X
Divided B-X
into B-X
three B-X
volumes B-X
, B-X
the B-X
textbook B-X
has B-X
been B-X
fully B-X
updated B-X
and B-X
includes B-X
100 B-X
additional B-X
chapters B-X
covering B-X
recent B-X
advances B-X
in B-X

We	O
therefore	O
investigated	O
the	O
expression	O
of	O
VHL	B-Disease
mRNA	O
during	O
human	O
embryogenesis	O
by	O
in	O
situ	O
hybridization	O
studies	O
at	O
4	O
,	O
6	O
and	O
10	O
weeks	O
post	O
conception	O
.	O
<EOS> B-X
We B-X
studied B-X
the B-X
spatial B-X
and B-X
temporal B-X
expression B-X
of B-X
the B-X
homeobox B-X
genes B-X
PAX6 B-X
, B-X
OTX2 B-X
, B-X
and B-X
OTX1 B-X
using B-X
a B-X
developmental B-X
series B-X
of B-X
human B-X
fetal B-X
eyes B-X
aged B-X
from B-X
6 B-X
to B-X
10 B-X
Dynamic B-X
changes B-X
in B-X
gene B-X
expression B-X
during B-X
human B-X
early B-X
embryo B-X
development B-X
: B-X
from B-X
fundamental B-X
aspects B-X
to B-X
clinical B-X
applications B-X
Abstract B-X
. B-X
We B-X
have B-X
generated B-X
2 B-X
zebrafish B-X
lines B-X
carrying B-X
inactivating B-X
germline B-X
mutations B-X
in B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
ortholog B-X
vhl B-X
. B-X
Mutant B-X
Study B-X
on B-X
the B-X
Expressions B-X
of B-X
PHD B-X
and B-X
HIF B-X
in B-X
Placentas B-X
from B-X
Normal B-X
Pregnant B-X
Women B-X
and B-X
Patients B-X
with B-X
Preeclampsia B-X
Hypoxia-inducible B-X
factor-1 B-X
mediates B-X
the B-X
biological B-X
effects B-X
of B-X
oxygen B-X
on B-X
human B-X
trophoblast B-X
differentiation B-X
through B-X
TGFŒ≤3 B-X
PDF B-X
| B-X
Cone B-X
-- B-X
rod B-X
homeobox B-X
( B-X
CRX B-X
) B-X
, B-X
a B-X
paired-like B-X
homeobox B-X
transcription B-X
factor B-X
, B-X
plays B-X
a B-X
major B-X
role B-X
in B-X
photoreceptor B-X
development B-X
and B-X
maintenance B-X
of B-X
the B-X
... B-X
| B-X
Find B-X
Deletion B-X
of B-X
von B-X
Hippel‚ÄìLindau B-X
Protein B-X
Converts B-X
Renin-Producing B-X
Cells B-X
into B-X
Erythropoietin-Producing B-X
Cells B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X

Although	O
VHL	B-Disease
mRNA	O
was	O
expressed	O
in	O
all	O
three	O
germ	O
layers	O
,	O
strong	O
expression	O
was	O
noted	O
in	O
the	O
central	O
nervous	O
system	O
,	O
kidneys	O
,	O
testis	O
and	O
lung	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Von B-X
Hippel-Lindau B-X
gene B-X
expression B-X
on B-X
the B-X
human B-X
fallopian B-X
tube B-X
epithelium B-X
during B-X
the B-X
menstrual B-X
cycle B-X
| B-X
The B-X
Von B-X
Hippel-Lindau B-X
gene B-X
( B-X
VHL B-X
) B-X
is B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
A B-X
germline B-X
mutation B-X
in B-X
the B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
predisposes B-X
carriers B-X
to B-X
development B-X
of B-X
predominantly B-X
abundant B-X
vascularized B-X
tumors B-X
in B-X
multiple B-X
organs B-X
. B-X
Th B-X
PDF B-X
| B-X
The B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumour B-X
suppressorgene B-X
product B-X
is B-X
believed B-X
to B-X
be B-X
involved B-X
in B-X
the B-X
down-regulation B-X
of B-X
transcriptional B-X
elongation B-X
by B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
A B-X
patient B-X
with B-X
bilateral B-X
pheochromocytoma B-X
as B-X
part B-X
of B-X
a B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
syndrome B-X
type B-X
2C B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
is B-X
an B-X
autosomal B-X
dominant B-X
inherited B-X
disease B-X
. B-X
It B-X
is B-X
relatively B-X
recent B-X
that B-X
type B-X
2C B-X
was B-X
identified B-X
as B-X
a B-X
separate B-X
group B-X
solely B-X
presenting B-X
with B-X
pheochromocytomas B-X

Within	O
the	O
kidney	O
,	O
VHL	B-Disease
mRNA	O
was	O
differentially	O
expressed	O
within	O
renal	O
tubules	O
suggesting	O
that	O
the	O
VHL	B-Disease
gene	O
product	O
may	O
have	O
a	O
specific	O
role	O
in	O
kidney	O
development	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Role B-X
of B-X
VHL B-X
gene B-X
mutation B-X
in B-X
human B-X
renal B-X
cell B-X
carcinoma B-X
| B-X
The B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
is B-X
an B-X
inherited B-X
neoplasia B-X
syndrome B-X
caused B-X
by B-X
the B-X
inactivation B-X
of B-X
Renal B-X
Cyst B-X
Development B-X
in B-X
Mice B-X
with B-X
Conditional B-X
Inactivation B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
< B-X
b B-X
> B-X
< B-X
i B-X
> B-X
Background B-X
: B-X
< B-X
/i B-X
> B-X
< B-X
/b B-X
> B-X
< B-X
i B-X
> B-X
von B-X
Hippel-Lindau B-X
< B-X
/i B-X
> B-X
( B-X
< B-X
i B-X
> B-X
VHL B-X
< B-X
/i B-X
> B-X
< B-X
b B-X
> B-X
< B-X
i B-X
> B-X
Background B-X
: B-X
< B-X
/i B-X
> B-X
< B-X
/b B-X
> B-X
< B-X
i B-X
> B-X
von B-X
Hippel-Lindau B-X
< B-X
/i B-X
> B-X
( B-X
< B-X
i B-X
> B-X
VHL B-X
< B-X
/i B-X
> B-X

Two	O
alternatively	O
spliced	O
VHL	B-Disease
mRNAs	O
characterized	O
by	O
inclusion	O
(	O
isoform	O
I	O
)	O
or	O
exclusion	O
(	O
isoform	O
II	O
)	O
of	O
exon	O
2	O
are	O
transcribed	O
in	O
adult	O
tissues	O
.	O
<EOS> B-X
Distinct B-X
functions B-X
of B-X
alternatively B-X
spliced B-X
isoforms B-X
encoded B-X
by B-X
zebrafish B-X
mef2ca B-X
and B-X
mef2cb B-X
Alternative B-X
splicing B-X
as B-X
a B-X
regulator B-X
of B-X
development B-X
and B-X
tissue B-X
identity B-X
New B-X
insights B-X
into B-X
form B-X
and B-X
function B-X
of B-X
Fibronectin B-X
Splice B-X
Variants B-X
Alternative B-X
Splicing B-X
of B-X
Type B-X
II B-X
Procollagen B-X
: B-X
IIB B-X
or B-X
not B-X
IIB B-X
? B-X
factor B-X
i-b2 B-X
isoform B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
isoform B-X
lacking B-X
exon B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
Hypoxia-induced B-X
alternative B-X
splicing B-X
: B-X
the B-X
11th B-X
Hallmark B-X
of B-X
Cancer B-X

To	O
investigate	O
if	O
the	O
two	O
isoforms	O
are	O
differentially	O
expressed	O
during	O
embryogenesis	O
,	O
VHL	B-Disease
mRNA	O
was	O
reverse	O
transcribed	O
from	O
13	O
fetal	O
tissues	O
(	O
8	O
-	O
10	O
weeks	O
gestation	O
)	O
.	O
<EOS> B-X
The B-X
pVHL172 B-X
isoform B-X
is B-X
not B-X
a B-X
tumor B-X
suppressor B-X
and B-X
up-regulates B-X
a B-X
subset B-X
of B-X
pro-tumorigenic B-X
genes B-X
including B-X
TGFB1 B-X
and B-X
MMP13 B-X
The B-X
von B-X
Hippel‚ÄìLindau B-X
tumour B-X
suppressor B-X
gene B-X
: B-X
uncovering B-X
the B-X
expression B-X
of B-X
the B-X
pVHL172 B-X
isoform B-X
Enhanced B-X
HIF2Œ± B-X
expression B-X
during B-X
human B-X
trophoblast B-X
differentiation B-X
into B-X
syncytiotrophoblast B-X
suppresses B-X
transcription B-X
of B-X
placental B-X
growth B-X
factor B-X
Request B-X
PDF B-X
| B-X
Role B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
protein B-X
during B-X
neuronal B-X
differentiation B-X
| B-X
The B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
protein B-X
down-regulates B-X
transcription B-X
by B-X
transcriptional B-X
elongation B-X
enhanced B-X
Increased B-X
Activity B-X
of B-X
Hypoxia-Inducible B-X
Factor B-X
1 B-X
Is B-X
Associated B-X
with B-X
Early B-X
Embryonic B-X
Lethality B-X
in B-X
Commd1 B-X
Null B-X
Mice B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
Placental B-X
growth B-X
factor B-X
( B-X
PlGF B-X
) B-X
, B-X
abundantly B-X
produced B-X
from B-X
trophoblasts B-X
is B-X
involved B-X
in B-X
placental B-X
angiogenesis B-X
. B-X
The B-X
regulatory B-X
mechanism B-X
of B-X
its B-X
expression B-X
is B-X
poorly B-X
understood B-X
. B-X
Hypoxia B-X
inducible B-X
factors B-X
Soluble B-X
Fms-like B-X
tyrosine B-X
kinase-1 B-X
( B-X
sFLT1 B-X
) B-X
as B-X
an B-X
anti-angiogenic B-X
factor B-X
is B-X
abundantly B-X
expressed B-X
in B-X
placental B-X
trophoblasts B-X
. B-X
Choriocarcinoma B-X
, B-X
a B-X
malignant B-X
tumor B-X
derived B-X
from B-X
trophoblasts B-X
, B-X
is B-X
known B-X
to B-X

The	O
quantitative	O
distribution	O
of	O
VHL	B-Disease
mRNA	O
within	O
fetal	O
tissues	O
reflected	O
that	O
seen	O
by	O
in	O
situ	O
hybridization	O
and	O
the	O
ratio	O
of	O
the	O
two	O
VHL	B-Disease
isoforms	O
was	O
similar	O
between	O
tissues	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
A B-X
novel B-X
glutaminase B-X
isoform B-X
in B-X
mammalian B-X
tissues B-X
| B-X
The B-X
synthesis B-X
of B-X
neurotransmitter B-X
glutamate B-X
in B-X
brain B-X
is B-X
mainly B-X
carried B-X
out B-X
by B-X
glutaminase B-X
enzymes B-X
. B-X
This B-X
synthesis B-X
must B-X
be B-X
PDF B-X
| B-X
Activation B-X
of B-X
the B-X
hypoxia-inducible B-X
transcription B-X
factors B-X
HIF-1 B-X
and B-X
HIF-2 B-X
and B-X
a B-X
HIF-independent B-X
defect B-X
in B-X
developmental B-X
apoptosis B-X
have B-X
been B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
PDF B-X
| B-X
Inactivation B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
and B-X
activation B-X
of B-X
the B-X
hypoxia-inducible B-X
factor B-X
( B-X
HIF B-X
) B-X
in B-X
susceptible B-X
cells B-X
precedes B-X
formation B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
Progression B-X
of B-X
Epididymal B-X
Maldevelopment B-X
Into B-X
Hamartoma-like B-X
Neoplasia B-X
in B-X
VHL B-X
Disease B-X

Although	O
the	O
genes	O
regulated	O
by	O
the	O
VHL	B-Disease
gene	O
product	O
have	O
not	O
yet	O
been	O
identified	O
,	O
our	O
findings	O
are	O
compatible	O
with	O
the	O
hypothesis	O
that	O
VHL	B-Disease
-	O
mediated	O
control	O
of	O
transcriptional	O
elongation	O
may	O
have	O
a	O
role	O
in	O
normal	O
human	O
development	O
.	O
.	O
<EOS> B-X
Abstract B-X
. B-X
The B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
product B-X
is B-X
thought B-X
to B-X
down-regulate B-X
transcription B-X
by B-X
antagonizing B-X
elongin-enhanced B-X
transcriptional B-X
elongation B-X
. B-X
Ger B-X
Genetic B-X
and B-X
functional B-X
analysis B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumour B-X
suppressor B-X
gene B-X
promoter B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Role B-X
of B-X
chromosome B-X
3p12‚Äìp21 B-X
tumour B-X
suppressor B-X
genes B-X
in B-X
clear B-X
cell B-X
renal B-X
cell B-X
carcinoma B-X
: B-X
analysis B-X
of B-X
VHL B-X
dependent B-X
and B-X
VHL B-X
independent B-X
pathways B-X
of B-X
tumorigenesis B-X
Download B-X
Citation B-X
| B-X
Role B-X
of B-X
VHL B-X
Gene B-X
Mutation B-X
in B-X
Human B-X
Cancer B-X
| B-X
Germline B-X
inactivation B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
causes B-X
the B-X
von B-X
Hippel-Lindau B-X
hereditary B-X
cancer B-X
The B-X
identification B-X
in B-X
1993 B-X
of B-X
inherited B-X
mutations B-X
in B-X
the B-X
von B-X
Hippel‚ÄìLindau B-X
( B-X
VHL B-X
) B-X
gene B-X
in B-X
families B-X
with B-X
VHL B-X
disease B-X
was B-X
a B-X
seminal B-X
finding B-X
. B-X
This B-X
and B-X
subsequent B-X
discoveries B-X
have B-X
Mutations B-X
in B-X
VHL B-X
underlie B-X
von B-X
Hippel‚ÄìLindau B-X
( B-X
VHL B-X
) B-X
disease B-X
, B-X
a B-X
hereditary B-X
cancer B-X
syndrome B-X
with B-X
several B-X
subtypes B-X
depending B-X
on B-X
the B-X
risk B-X
of B-X
developing B-X
certain B-X
combination B-X
of B-X
classic B-X
features B-X
, B-X
Factors B-X
regulating B-X
the B-X
transcriptional B-X
elongation B-X
activity B-X
of B-X
RNA B-X
polymerase B-X
II B-X
- B-X
Shilatifard B-X
- B-X
1998 B-X
- B-X
The B-X
FASEB B-X
Journal B-X
- B-X
Wiley B-X
Online B-X
Library B-X

Genetic	O
heterogeneity	O
in	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
:	O
role	O
of	O
BRCA1	O
and	O
BRCA2	O
.	O
<EOS> B-X
Role B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
pancreatic B-X
cancer B-X
A B-X
role B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
germline B-X
mutations B-X
in B-X
breast B-X
cancer B-X
susceptibility B-X
within B-X
Sardinian B-X
population B-X
Genes B-X
other B-X
than B-X
BRCA1 B-X
and B-X
BRCA2 B-X
involved B-X
in B-X
breast B-X
cancer B-X
susceptibility B-X
A B-X
probability B-X
model B-X
for B-X
predicting B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
breast B-X
and B-X
breast-ovarian B-X
cancer B-X
families B-X
Stemming B-X
the B-X
Tide B-X
of B-X
Cancer B-X
for B-X
BRCA1/2 B-X
Mutation B-X
Carriers B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

The	O
common	O
hereditary	O
forms	O
of	O
breast	B-Disease
cancer	I-Disease
have	O
been	O
largely	O
attributed	O
to	O
the	O
inheritance	O
of	O
mutations	O
in	O
the	O
BRCA1	O
or	O
BRCA2	O
genes	O
.	O

However	O
,	O
it	O
is	O
not	O
yet	O
clear	O
what	O
proportion	O
of	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
is	O
explained	O
by	O
BRCA1	O
and	O
BRCA2	O
or	O
by	O
some	O
other	O
unidentified	O
susceptibility	O
gene	O
(	O
s	O
)	O
.	O
<EOS> B-X
Molecular B-X
classification B-X
of B-X
familial B-X
non-BRCA1/BRCA2 B-X
breast B-X
cancer B-X
Tumor B-X
suppressor B-X
genes B-X
that B-X
perform B-X
apparently B-X
generic B-X
cellular B-X
functions B-X
nonetheless B-X
cause B-X
tissue-specific B-X
syndromes B-X
in B-X
the B-X
human B-X
population B-X
when B-X
they B-X
are B-X
mutated B-X
in B-X
the B-X
germline B-X
. B-X
The B-X
two B-X
major B-X
hereditary B-X
breast/ovarian B-X
Sensitivity B-X
of B-X
BRCA1/2 B-X
testing B-X
in B-X
high-risk B-X
breast/ovarian/male B-X
breast B-X
cancer B-X
families B-X
: B-X
little B-X
contribution B-X
of B-X
comprehensive B-X
RNA/NGS B-X
panel B-X
testing B-X
The B-X
pathology B-X
of B-X
familial B-X
breast B-X
cancer B-X
: B-X
Clinical B-X
and B-X
genetic B-X
counselling B-X
implications B-X
of B-X
breast B-X
cancer B-X
pathology B-X

We	O
describe	O
the	O
proportion	O
of	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
explained	O
by	O
BRCA1	O
or	O
BRCA2	O
in	O
a	O
sample	O
of	O
North	O
American	O
hereditary	B-Disease
breast	I-Disease
cancers	I-Disease
and	O
assess	O
the	O
evidence	O
for	O
additional	O
susceptibility	O
genes	O
that	O
may	O
confer	O
hereditary	B-Disease
breast	I-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
risk	O
.	O
<EOS> B-X
Genetic B-X
heterogeneity B-X
in B-X
hereditary B-X
breast B-X
cancer B-X
: B-X
role B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
. B-X

Twenty	O
-	O
three	O
families	O
were	O
identified	O
through	O
two	O
high	O
-	O
risk	O
breast	B-Disease
cancer	I-Disease
research	O
programs	O
.	O
<EOS> B-X
Cancer B-X
risk B-X
awareness B-X
and B-X
concern B-X
among B-X
women B-X
with B-X
a B-X
family B-X
history B-X
of B-X
breast B-X
or B-X
ovarian B-X
cancer B-X
Find B-X
out B-X
who B-X
‚Äô B-X
s B-X
at B-X
higher B-X
risk B-X
of B-X
developing B-X
breast B-X
cancer B-X
and B-X
learn B-X
about B-X
special B-X
breast B-X
cancer B-X
screening B-X
recommendations B-X
for B-X
women B-X
at B-X
higher B-X
risk B-X
. B-X
Genome-wide B-X
association B-X
study B-X
identifies B-X
novel B-X
breast B-X
cancer B-X
susceptibility B-X
loci B-X
This B-X
factsheet B-X
discusses B-X
breast B-X
cancer B-X
screening B-X
and B-X
prevention B-X
services B-X
, B-X
and B-X
reviews B-X
the B-X
scope B-X
of B-X
private B-X
and B-X
public B-X
insurance B-X
coverage B-X
, B-X
as B-X
well B-X
as B-X
access B-X
to B-X
those B-X
services B-X
for B-X
women B-X
PDF B-X
| B-X
It B-X
is B-X
well B-X
established B-X
that B-X
mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
significantly B-X
increase B-X
the B-X
risk B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
We B-X
here B-X
report B-X
23 B-X
... B-X
| B-X
Find B-X
The B-X
National B-X
Institute B-X
for B-X
Health B-X
Research B-X
Programme B-X
Grants B-X
for B-X
Applied B-X
Research B-X
programme B-X
. B-X
The B-X
DNA B-X
saliva B-X
collection B-X
for B-X
SNP B-X
analysis B-X
for B-X
PROCAS B-X
was B-X
funded B-X
by B-X
the B-X
Genesis B-X
Breast B-X
Cancer B-X
Prevention B-X
Most B-X
mammography B-X
screening B-X
programs B-X
are B-X
not B-X
individualized B-X
. B-X
To B-X
efficiently B-X
screen B-X
for B-X
breast B-X
cancer B-X
, B-X
the B-X
individual B-X
risk B-X
of B-X
the B-X
disease B-X
should B-X
be B-X
determined B-X
. B-X
We B-X
describe B-X
a B-X
model B-X
that B-X

Genetic	O
analysis	O
was	O
undertaken	O
to	O
establish	O
linkage	O
between	O
the	O
breast	B-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
cases	O
and	O
markers	O
on	O
chromosomes	O
17q	O
(	O
BRCA1	O
)	O
and	O
13q	O
(	O
BRCA2	O
)	O
.	O
<EOS> B-X
Molecular B-X
evidence B-X
for B-X
putative B-X
tumour B-X
suppressor B-X
genes B-X
on B-X
chromosome B-X
13q B-X
specific B-X
to B-X
BRCA1 B-X
related B-X
ovarian B-X
and B-X
fallopian B-X
tube B-X
cancer B-X
To B-X
study B-X
genetic B-X
changes B-X
associated B-X
with B-X
the B-X
development B-X
of B-X
breast B-X
cancer B-X
and B-X
the B-X
extent B-X
of B-X
its B-X
hereditary B-X
predisposition B-X
, B-X
paraffin-embedded B-X
tissue B-X
samples B-X
were B-X
PDF B-X
| B-X
Breast B-X
carcinoma B-X
is B-X
the B-X
most B-X
common B-X
malignancy B-X
among B-X
women B-X
in B-X
developed B-X
countries B-X
. B-X
Because B-X
family B-X
history B-X
remains B-X
the B-X
strongest B-X
single B-X
predictor B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Myriad B-X
Genetics B-X
: B-X
In B-X
the B-X
eye B-X
of B-X
the B-X
policy B-X
storm B-X

Mutation	O
analysis	O
in	O
the	O
BRCA1	O
and	O
BRCA2	O
genes	O
was	O
also	O
undertaken	O
in	O
all	O
families	O
.	O
<EOS> B-X
Phenocopies B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
families B-X
: B-X
evidence B-X
for B-X
modifier B-X
genes B-X
and B-X
implications B-X
for B-X
screening B-X
Since B-X
the B-X
identification B-X
of B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
breast-ovarian B-X
cancer B-X
susceptibility B-X
genes B-X
, B-X
mutation B-X
analyses B-X
have B-X
been B-X
carried B-X
out B-X
in B-X
different B-X
populations B-X
. B-X
Here B-X
we B-X
screened B-X
15 B-X
Turkish B-X
breast B-X
and B-X
A B-X
number B-X
of B-X
molecular B-X
epidemiological B-X
studies B-X
have B-X
been B-X
conducted B-X
the B-X
screening B-X
for B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
breast B-X
cancer B-X
patients B-X
with B-X
a B-X
positive B-X
family B-X
history B-X
of B-X
breast B-X
and/or B-X
ovarian B-X
cancer B-X
Discovery B-X
of B-X
mutations B-X
in B-X
the B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
can B-X
have B-X
emotional B-X
consequences B-X
for B-X
both B-X
the B-X
tested B-X
individual B-X
and B-X
his B-X
or B-X
her B-X
relatives B-X
. B-X
This B-X
Since B-X
the B-X
identification B-X
of B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
( B-X
MIM B-X
# B-X
s B-X
113705 B-X
and B-X
600185 B-X
) B-X
, B-X
more B-X
than B-X
hundred B-X
different B-X
mutations B-X
throughout B-X
both B-X
genes B-X
have B-X
been B-X
reported B-X
. B-X
Hereditary B-X
breast B-X
cancer B-X
accounts B-X
for B-X
5-10 B-X
% B-X
of B-X
all B-X
cases B-X
of B-X
breast B-X
cancer B-X
and B-X
10-15 B-X
% B-X
of B-X
ovarian B-X
cancer B-X
and B-X
is B-X
characterised B-X
by B-X
dominant B-X
inheritance B-X
, B-X
early B-X
onset B-X
, B-X
the B-X
PDF B-X
| B-X
Hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
syndromes B-X
can B-X
be B-X
caused B-X
by B-X
loss-of-function B-X
germline B-X
mutations B-X
in B-X
one B-X
of B-X
the B-X
tumour B-X
suppressor B-X
genes B-X
BRCA1 B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X

The	O
pattern	O
of	O
hereditary	B-Disease
cancer	I-Disease
in	O
14	O
(	O
61	O
%	O
)	O
of	O
the	O
23	O
families	O
studied	O
was	O
attributed	O
to	O
BRCA1	O
by	O
a	O
combination	O
of	O
linkage	O
and	O
mutation	O
analyses	O
.	O

No	O
families	O
were	O
attributed	O
to	O
BRCA2	O
.	O
<EOS> B-X
Questions B-X
About B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Gene B-X
Study B-X
and B-X
Breast B-X
Cancer B-X
In B-X
this B-X
retrospective B-X
analysis B-X
, B-X
heterozygous B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
were B-X
not B-X
a B-X
risk B-X
factor B-X
for B-X
childhood B-X
cancer B-X
in B-X
hereditary B-X
breast B-X
cancer B-X
families B-X
. B-X
These B-X
data B-X
support B-X
the B-X
current B-X
practice B-X
Talking B-X
about B-X
your B-X
BRCA1 B-X
or B-X
BRCA2 B-X
mutation B-X
to B-X
your B-X
family B-X
members B-X
. B-X
Why B-X
talk B-X
to B-X
them B-X
, B-X
how B-X
to B-X
talk B-X
to B-X
them B-X
. B-X
Should B-X
you B-X
talk B-X
to B-X
your B-X
children B-X
about B-X
Risk B-X
assessment B-X
using B-X
familial B-X
risk B-X
models B-X
to B-X
guide B-X
referrals B-X
is B-X
accurate B-X
. B-X
Genetic B-X
counseling B-X
reduces B-X
distress B-X
, B-X
improves B-X
risk B-X
perception B-X
, B-X
and B-X
reduces B-X
intention B-X
for B-X
testing B-X
. B-X
Genetic B-X
testing B-X
provides B-X

Five	O
families	O
(	O
22	O
%	O
)	O
provided	O
evidence	O
against	O
linkage	O
to	O
both	O
BRCA1	O
and	O
BRCA2	O
.	O

No	O
BRCA1	O
or	O
BRCA2	O
mutations	O
were	O
detected	O
in	O
these	O
five	O
families	O
.	O
<EOS> B-X
The B-X
two B-X
major B-X
hereditary B-X
breast/ovarian B-X
cancer B-X
predisposition B-X
tumor B-X
suppressor B-X
genes B-X
, B-X
BRCA1 B-X
and B-X
BRCA2 B-X
that B-X
perform B-X
apparently B-X
generic B-X
cellular B-X
functions B-X
nonetheless B-X
cause B-X
tissue-specific B-X
syndromes B-X
in B-X
the B-X
human B-X
population B-X
when B-X
they B-X
BRCA B-X
mutations B-X
in B-X
Italian B-X
breast/ovarian B-X
cancer B-X
families B-X
| B-X
European B-X
Journal B-X
of B-X
Human B-X
Genetics B-X

The	O
BRCA1	O
or	O
BRCA2	O
status	O
of	O
four	O
families	O
(	O
17	O
%	O
)	O
could	O
not	O
be	O
determined	O
.	O
<EOS> B-X
Mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
account B-X
for B-X
a B-X
significant B-X
proportion B-X
of B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
cases B-X
. B-X
In B-X
this B-X
study B-X
, B-X
we B-X
sought B-X
to B-X
determine B-X
the B-X
frequency B-X
of B-X
BRCA1- B-X
The B-X
common B-X
hereditary B-X
forms B-X
of B-X
breast B-X
cancer B-X
have B-X
been B-X
largely B-X
attributed B-X
to B-X
the B-X
inheritance B-X
of B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
or B-X
BRCA2 B-X
genes B-X
. B-X
However B-X
, B-X
it B-X
is B-X
not B-X
yet B-X
clear B-X
Predicting B-X
BRCA1 B-X
and B-X
BRCA2 B-X
gene B-X
mutation B-X
carriers B-X
: B-X
comparison B-X
of B-X
LAMBDA B-X
, B-X
BRCAPRO B-X
, B-X
Myriad B-X
II B-X
, B-X
and B-X
modified B-X
Couch B-X
models B-X
Haplotype B-X
and B-X
cancer B-X
risk B-X
analysis B-X
of B-X
two B-X
common B-X
mutations B-X
, B-X
BRCA1 B-X
4184del4 B-X
and B-X
BRCA2 B-X
2157delG B-X
, B-X
in B-X
high B-X
risk B-X
northwest B-X
England B-X
breast/ovarian B-X
families B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
BRCA1 B-X
, B-X
BRCA2 B-X
, B-X
PALB2 B-X
, B-X
and B-X
CDKN2A B-X
Mutations B-X
in B-X
Familial B-X
Pancreatic B-X
Cancer B-X
( B-X
FPC B-X
) B-X
: B-X
A B-X
PACGENE B-X
Study B-X

BRCA1	O
and	O
BRCA2	O
probably	O
explain	O
the	O
majority	O
of	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
that	O
exists	O
in	O
the	O
North	O
American	O
population	O
.	O

However	O
,	O
one	O
or	O
more	O
additional	O
genes	O
may	O
yet	O
be	O
found	O
that	O
explain	O
some	O
proportion	O
of	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
.	O
.	O
<EOS> B-X
What B-X
gene B-X
mutations B-X
other B-X
than B-X
BRCA B-X
raise B-X
breast B-X
cancer B-X
risk B-X
? B-X
Learn B-X
about B-X
the B-X
genetics B-X
of B-X
familial B-X
breast B-X
cancer B-X
such B-X
as B-X
ATM B-X
, B-X
PALB2 B-X
, B-X
CHEK2 B-X
, B-X
and B-X
more B-X
. B-X
Breast B-X
cancer B-X
results B-X
from B-X
genetic B-X
and B-X
environmental B-X
factors B-X
leading B-X
to B-X
the B-X
accumulation B-X
of B-X
mutations B-X
in B-X
essential B-X
genes B-X
. B-X
Genetic B-X
predisposition B-X
may B-X
have B-X
a B-X
strong B-X
, B-X
almost B-X
singular B-X
effect B-X
, B-X
as B-X
ON B-X
THIS B-X
PAGE B-X
: B-X
You B-X
will B-X
find B-X
out B-X
more B-X
about B-X
the B-X
factors B-X
that B-X
increase B-X
the B-X
chance B-X
of B-X
developing B-X
breast B-X
cancer B-X
. B-X
Use B-X
the B-X
menu B-X
to B-X
see B-X
other B-X
pages.A B-X
risk B-X
factor B-X

An	O
intronic	O
mutation	O
in	O
a	O
lariat	O
branchpoint	O
sequence	O
is	O
a	O
direct	O
cause	O
of	O
an	O
inherited	B-Disease
human	I-Disease
disorder	I-Disease
(	O
fish	B-Disease
-	I-Disease
eye	I-Disease
disease	I-Disease
)	O
.	O
<EOS> B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
- B-X
Research B-X
database B-X
- B-X
University B-X
of B-X
Groningen B-X
JCI B-X
- B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
JCI B-X
- B-X
Usage B-X
information B-X
: B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
A B-X
point B-X
mutation B-X
in B-X
an B-X
intronic B-X
branch B-X
site B-X
results B-X
in B-X
aberrant B-X
splicing B-X
of B-X
COL5A1 B-X
and B-X
in B-X
Ehlers-Danlos B-X
syndrome B-X
type B-X
II B-X
in B-X
two B-X
British B-X
families B-X
. B-X
Human B-X
branch B-X
point B-X
consensus B-X
sequence B-X
is B-X
yUnAy B-X

The	O
first	O
step	O
in	O
the	O
splicing	O
of	O
an	O
intron	O
from	O
nuclear	O
precursors	O
of	O
mRNA	O
results	O
in	O
the	O
formation	O
of	O
a	O
lariat	O
structure	O
.	O
<EOS> B-X
Requirement B-X
of B-X
ATP B-X
in B-X
the B-X
second B-X
step B-X
of B-X
the B-X
pre-mRNA B-X
splicing B-X
reaction B-X
. B-X
Pre-mRNA B-X
splicing B-X
during B-X
transcription B-X
in B-X
the B-X
mammalian B-X
system B-X
Crystal B-X
structure B-X
of B-X
a B-X
eukaryotic B-X
group B-X
II B-X
intron B-X
lariat B-X
Regulation B-X
of B-X
pre-mRNA B-X
splicing B-X
in B-X
Xenopus B-X
oocytes B-X
by B-X
targeted B-X
2‚Ä≤-O-methylation B-X
Lariat B-X
formation B-X
and B-X
a B-X
hydrolytic B-X
pathway B-X
in B-X
plant B-X
chloroplast B-X
group B-X
II B-X
intron B-X
splicing B-X
Origin B-X
of B-X
Spliceosomal B-X
Introns B-X
and B-X
Alternative B-X
Splicing B-X
The B-X
occurrence B-X
of B-X
spliceosomal B-X
introns B-X
in B-X
eukaryotic B-X
genomes B-X
is B-X
highly B-X
diverse B-X
and B-X
ranges B-X
from B-X
few B-X
introns B-X
in B-X
an B-X
organism B-X
to B-X
multiple B-X
introns B-X
per B-X
gene B-X
. B-X
Int B-X

A	O
distinct	O
intronic	O
nucleotide	O
sequence	O
,	O
known	O
as	O
the	O
branchpoint	O
region	O
,	O
plays	O
a	O
central	O
role	O
in	O
this	O
process	O
.	O
<EOS> B-X
Most B-X
human B-X
introns B-X
are B-X
recognized B-X
via B-X
multiple B-X
and B-X
tissue-specific B-X
branchpoints B-X
Genome-wide B-X
discovery B-X
of B-X
human B-X
splicing B-X
branchpoints B-X
Introns B-X
and B-X
Splicing B-X
Elements B-X
of B-X
Five B-X
Diverse B-X
Fungi B-X

We	O
here	O
describe	O
a	O
point	O
mutation	O
in	O
such	O
a	O
sequence	O
.	O
<EOS> B-X
Using B-X
an B-X
amino B-X
acid B-X
translation B-X
table B-X
to B-X
understand B-X
the B-X
impact B-X
of B-X
point B-X
and B-X
frameshift B-X
mutations B-X
. B-X
Tyrosine B-X
hydroxylase B-X
( B-X
TH B-X
) B-X
catalyzes B-X
the B-X
conversion B-X
of B-X
L-tyrosine B-X
to B-X
L-dihydroxyphenylalanine B-X
( B-X
L-DOPA B-X
) B-X
, B-X
the B-X
rate-limiting B-X
step B-X
in B-X
the B-X
biosynthesis B-X
of B-X
dopamine B-X
. B-X
Recently B-X
, B-X
we B-X
described B-X
a B-X

Three	O
sisters	O
were	O
shown	O
to	O
suffer	O
from	O
fish	B-Disease
-	I-Disease
eye	I-Disease
disease	I-Disease
(	O
FED	B-Disease
)	O
,	O
a	O
disorder	O
which	O
is	O
caused	O
by	O
mutations	O
in	O
the	O
gene	O
coding	O
for	O
lecithin	O
cholesterol	O
acyltransferase	O
(	O
LCAT	O
)	O
.	O
<EOS> B-X
The B-X
two B-X
familial B-X
forms B-X
of B-X
lecithin-cholesterol B-X
acyltransferase B-X
( B-X
LCAT B-X
) B-X
deficiency B-X
are B-X
termed B-X
familial B-X
LCAT B-X
deficiency B-X
( B-X
complete B-X
LCAT B-X
deficiency B-X
) B-X
and B-X
fish B-X
eye B-X
disease B-X
( B-X
partial B-X
LCAT B-X
deficiency B-X
) B-X
Familial B-X
lecithin-cholesterol B-X
acyltransferase B-X
( B-X
LCAT B-X
) B-X
deficiency B-X
( B-X
FLD B-X
) B-X
is B-X
a B-X
rare B-X
genetic B-X
disease B-X
characterized B-X
by B-X
corneal B-X
opacities B-X
, B-X
normocytic B-X
anemia B-X
, B-X
dyslipidemia B-X
, B-X
and B-X
proteinuria B-X
progressing B-X
to B-X
chronic B-X
Request B-X
PDF B-X
| B-X
Lecithin-cholesterol B-X
acyltransferase B-X
( B-X
LCAT B-X
) B-X
deficiency B-X
without B-X
mutations B-X
in B-X
the B-X
coding B-X
sequence B-X
: B-X
A B-X
case B-X
report B-X
and B-X
literature B-X
review B-X
| B-X
Familial B-X
lecithin-cholesterol B-X
acyltransferase B-X
( B-X
LCAT B-X
) B-X
deficiency B-X
A B-X
case B-X
of B-X
acquired B-X
lecithin B-X
: B-X
cholesterol B-X
acyltransferase B-X
deficiency B-X
with B-X
sarcoidosis B-X
that B-X
remitted B-X
spontaneously B-X
Familial B-X
LCAT B-X
deficiency B-X
and B-X
fish B-X
eye B-X
disease B-X
are B-X
both B-X
autosomal B-X
recessive B-X
disorders B-X
caused B-X
by B-X
mutations B-X
of B-X
the B-X
LCAT B-X
gene B-X
. B-X
{ B-X
ref1 B-X
} B-X
Only B-X
one B-X
LCAT B-X
gene B-X
has B-X
been B-X
discovered B-X
Lecithin-cholesterol B-X
acyltransferase B-X
( B-X
LCAT B-X
) B-X
is B-X
a B-X
lipoprotein-associated B-X
enzyme B-X
which B-X
plays B-X
a B-X
large B-X
role B-X
in B-X
the B-X
esterification B-X
of B-X
free B-X
cholesterol B-X
, B-X
the B-X
maturation B-X
of B-X
high B-X
density-lipoprotein B-X
( B-X
HDL B-X
) B-X
part B-X
LCAT B-X
lecithin-cholesterol B-X
acyltransferase B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X

Sequencing	O
of	O
the	O
LCAT	O
gene	O
of	O
all	O
three	O
probands	O
revealed	O
compound	O
heterozygosity	O
for	O
a	O
missense	O
mutation	O
in	O
exon	O
4	O
which	O
is	O
reported	O
to	O
underlie	O
the	O
FED	B-Disease
phenotype	O
,	O
and	O
a	O
point	O
mutation	O
located	O
in	O
intron	O
4	O
(	O
IVS4	O
T	O
-	O
22C	O
)	O
.	O
<EOS> B-X
We B-X
have B-X
previously B-X
identified B-X
a B-X
point B-X
mutation B-X
( B-X
intervening B-X
sequence B-X
( B-X
IVS B-X
) B-X
4 B-X
: B-X
T B-X
-- B-X
> B-X
C B-X
) B-X
in B-X
the B-X
branchpoint B-X
consensus B-X
sequence B-X
of B-X
intron B-X
4 B-X
of B-X
the B-X
PDF B-X
| B-X
We B-X
have B-X
previously B-X
identified B-X
a B-X
point B-X
mutation B-X
( B-X
intervening B-X
sequence B-X
( B-X
IVS B-X
) B-X
4 B-X
: B-X
T B-X
‚Üí B-X
C B-X
) B-X
in B-X
the B-X
branchpoint B-X
consensus B-X
sequence B-X
of B-X
intron B-X
4 B-X
of B-X
JCI B-X
- B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
A B-X
Point B-X
Mutation B-X
in B-X
an B-X
Intronic B-X
Branch B-X
Site B-X
Results B-X
in B-X
Aberrant B-X
Splicing B-X
of B-X
COL5A1 B-X
and B-X
in B-X
Ehlers-Danlos B-X
Syndrome B-X
Type B-X
II B-X
in B-X
Two B-X
British B-X
Families B-X
- B-X
ScienceDirect B-X
The B-X
first B-X
step B-X
in B-X
the B-X
splicing B-X
of B-X
an B-X
intron B-X
from B-X
nuclear B-X
precursors B-X
of B-X
mRNA B-X
results B-X
in B-X
the B-X
formation B-X
of B-X
a B-X
lariat B-X
structure B-X
. B-X
A B-X
distinct B-X
intronic B-X
nucleotide B-X
sequence B-X
, B-X
known B-X
Download B-X
scientific B-X
diagram B-X
| B-X
LCAT B-X
minigenes B-X
, B-X
stable B-X
transfection B-X
and B-X
in B-X
vivo B-X
labeling B-X
. B-X
( B-X
A B-X
) B-X
A B-X
schematic B-X
representation B-X
of B-X
the B-X
LCAT B-X
minigene B-X
constructs B-X
which B-X
were B-X
used B-X
for B-X
stable B-X
Download B-X
scientific B-X
diagram B-X
| B-X
The B-X
effect B-X
of B-X
the B-X
introduction B-X
of B-X
a B-X
normal B-X
branch B-X
site B-X
into B-X
the B-X
intron B-X
sequences B-X
on B-X
the B-X
splicing B-X
of B-X
the B-X
LCAT B-X
mRNA B-X
precursors B-X
containing B-X
the B-X
natural B-X
( B-X

By	O
performing	O
in	O
vitro	O
expression	O
of	O
LCAT	O
minigenes	O
and	O
reverse	O
transcriptase	O
PCR	O
on	O
mRNA	O
isolated	O
from	O
leukocytes	O
of	O
the	O
patient	O
,	O
this	O
gene	O
defect	O
was	O
shown	O
to	O
cause	O
a	O
null	O
allele	O
as	O
the	O
result	O
of	O
complete	O
intron	O
retention	O
.	O
<EOS> B-X
Download B-X
scientific B-X
diagram B-X
| B-X
RT-PCR B-X
. B-X
( B-X
A B-X
) B-X
Schematic B-X
representation B-X
of B-X
the B-X
RT-PCR B-X
strategy B-X
. B-X
The B-X
use B-X
of B-X
primers B-X
A B-X
and B-X
B B-X
in B-X
the B-X
PCR B-X
reaction B-X
results B-X
in B-X
the B-X
Eunjung B-X
Lee B-X
, B-X
Peter B-X
Park B-X
, B-X
Dongwan B-X
Hong B-X
and B-X
colleagues B-X
report B-X
an B-X
analysis B-X
of B-X
cancer B-X
RNA B-X
sequencing B-X
data B-X
identifying B-X
approximately B-X
900 B-X
somatic B-X
coding B-X
variants B-X
that B-X
cause B-X
disrupted B-X
splicing B-X
in B-X
cancer B-X
Syndromic B-X
immune B-X
disorder B-X
caused B-X
by B-X
a B-X
viable B-X
hypomorphic B-X
allele B-X
of B-X
spliceosome B-X
component B-X
Snrnp40 B-X
Severe B-X
alpha-1 B-X
antitrypsin B-X
deficiency B-X
in B-X
composite B-X
heterozygotes B-X
inheriting B-X
a B-X
new B-X
splicing B-X
mutation B-X
QOMadrid B-X
Intron B-X
Retention B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

In	O
conclusion	O
,	O
we	O
demonstrated	O
that	O
a	O
point	O
mutation	O
in	O
a	O
lariat	O
branchpoint	O
consensus	O
sequence	O
causes	O
a	O
null	O
allele	O
in	O
a	O
patient	O
with	O
FED	B-Disease
.	O
<EOS> B-X
JCI B-X
- B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
PDF B-X
| B-X
The B-X
first B-X
step B-X
in B-X
the B-X
splicing B-X
of B-X
an B-X
intron B-X
from B-X
nuclear B-X
precursors B-X
of B-X
mRNA B-X
results B-X
in B-X
the B-X
formation B-X
of B-X
a B-X
lariat B-X
structure B-X
. B-X
A B-X
distinct B-X
intronic B-X
... B-X
| B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

In	O
addition	O
,	O
our	O
finding	O
illustrates	O
the	O
importance	O
of	O
this	O
sequence	O
for	O
normal	O
human	O
mRNA	O
processing	O
.	O
<EOS> B-X
Coupling B-X
mRNA B-X
processing B-X
with B-X
transcription B-X
in B-X
time B-X
and B-X
space B-X
Processing B-X
and B-X
transcriptome B-X
expansion B-X
at B-X
the B-X
mRNA B-X
3‚Ä≤ B-X
end B-X
in B-X
health B-X
and B-X
disease B-X
: B-X
finding B-X
the B-X
right B-X
end B-X
When B-X
you B-X
have B-X
read B-X
Chapter B-X
10 B-X
, B-X
you B-X
should B-X
be B-X
able B-X
to B-X
: B-X
The B-X
multifaceted B-X
control B-X
of B-X
gene B-X
expression B-X
requires B-X
tight B-X
coordination B-X
of B-X
regulatory B-X
mechanisms B-X
at B-X
transcriptional B-X
and B-X
post-transcriptional B-X
level B-X
. B-X
Here B-X
, B-X
we B-X
studied B-X
the B-X
interdependence B-X
of B-X
transcription B-X
initiation B-X
, B-X
splicing B-X
and B-X
Regulation B-X
of B-X
mRNA B-X
Splicing B-X
by B-X
Signal B-X
Transduction B-X
| B-X
Learn B-X
Science B-X
at B-X
Scitable B-X
RNA B-X
Processing B-X
and B-X
Export B-X
RNA B-X
Processing B-X
in B-X
Eukaryotes B-X
| B-X
OpenStax B-X
Biology B-X
2e B-X

Finally	O
,	O
this	O
report	O
provides	O
a	O
widely	O
applicable	O
strategy	O
which	O
ensures	O
fast	O
and	O
effective	O
screening	O
for	O
intronic	O
defects	O
that	O
underlie	O
differential	O
gene	O
expression	O
.	O
.	O
<EOS> B-X
Yanagi B-X
: B-X
Fast B-X
and B-X
interpretable B-X
segment-based B-X
alternative B-X
splicing B-X
and B-X
gene B-X
expression B-X
analysis B-X
JCI B-X
- B-X
Citations B-X
to B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X
JCI B-X
- B-X
Citations B-X
to B-X
An B-X
intronic B-X
mutation B-X
in B-X
a B-X
lariat B-X
branchpoint B-X
sequence B-X
is B-X
a B-X
direct B-X
cause B-X
of B-X
an B-X
inherited B-X
human B-X
disorder B-X
( B-X
fish-eye B-X
disease B-X
) B-X
. B-X

Mutations	O
associated	O
with	O
variant	O
phenotypes	O
in	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
.	O

We	O
have	O
identified	O
14	O
families	O
with	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
in	O
which	O
mutation	O
of	O
the	O
ATM	O
gene	O
is	O
associated	O
with	O
a	O
less	O
severe	O
clinical	O
and	O
cellular	O
phenotype	O
(	O
approximately	O
10	O
%	O
-	O
15	O
%	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
families	O
identified	O
in	O
the	O
United	O
Kingdom	O
)	O
.	O

In	O
10	O
of	O
these	O
families	O
,	O
all	O
the	O
homozygotes	O
have	O
a	O
137	O
-	O
bp	O
insertion	O
in	O
their	O
cDNA	O
caused	O
by	O
a	O
point	O
mutation	O
in	O
a	O
sequence	O
resembling	O
a	O
splice	O
-	O
donor	O
site	O
.	O
<EOS> B-X
We B-X
have B-X
identified B-X
14 B-X
families B-X
with B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
in B-X
which B-X
mutation B-X
of B-X
the B-X
ATM B-X
gene B-X
is B-X
associated B-X
with B-X
a B-X
less B-X
severe B-X
clinical B-X
and B-X
cellular B-X
phenotype B-X
( B-X
approximately B-X
10 B-X
Request B-X
PDF B-X
| B-X
Functional B-X
significance B-X
of B-X
deep B-X
intronic B-X
mutation B-X
in B-X
the B-X
ATM B-X
gene B-X
and B-X
evidence B-X
for B-X
an B-X
alternative B-X
Exon B-X
28a B-X
| B-X
Screening B-X
for B-X
ATM B-X
mutations B-X
is B-X
usually B-X
performed B-X
using B-X
genomic B-X
Request B-X
PDF B-X
| B-X
Adult-onset B-X
ataxia B-X
telangiectasia B-X
due B-X
to B-X
ATM B-X
5762ins137 B-X
mutation B-X
homozygosity B-X
| B-X
Ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
neurodegenerative B-X
disorder B-X
that B-X
arises B-X
because B-X
of B-X
mutations B-X
in B-X
Request B-X
PDF B-X
| B-X
Genotype B-X
, B-X
extrapyramidal B-X
features B-X
and B-X
severity B-X
of B-X
variant B-X
Ataxia‚ÄêTelangiectasia B-X
| B-X
Objective B-X
Variant B-X
Ataxia‚ÄêTelangiectasia B-X
is B-X
caused B-X
by B-X
mutations B-X
that B-X
allow B-X
some B-X
retained B-X
ATM B-X
kinase B-X
activity B-X
. B-X
Here B-X
, B-X
ClinVar B-X
archives B-X
and B-X
aggregates B-X
information B-X
about B-X
relationships B-X
among B-X
variation B-X
and B-X
human B-X
health B-X
. B-X
ClinVar B-X
archives B-X
and B-X
aggregates B-X
information B-X
about B-X
relationships B-X
among B-X
variation B-X
and B-X
human B-X
health B-X
. B-X
ClinVar B-X
archives B-X
and B-X
aggregates B-X
information B-X
about B-X
relationships B-X
among B-X
variation B-X
and B-X
human B-X
health B-X
. B-X

The	O
second	O
A	B-Disease
-	I-Disease
T	I-Disease
allele	O
has	O
a	O
different	O
mutation	O
in	O
each	O
patient	O
.	O
<EOS> B-X
On B-X
the B-X
probability B-X
that B-X
a B-X
novel B-X
variant B-X
is B-X
a B-X
disease-causing B-X
mutation B-X
The B-X
first B-X
case B-X
report B-X
of B-X
double B-X
homozygous B-X
of B-X
2 B-X
different B-X
mutations B-X
in B-X
the B-X
CFTR B-X
gene B-X
in B-X
Saudi B-X
Arabia B-X
The B-X
first B-X
case B-X
report B-X
of B-X
double B-X
homozygous B-X
of B-X
2 B-X
different B-X
mutations B-X
in B-X
the B-X
CFTR B-X
gene B-X
in B-X
Saudi B-X
Arabia B-X
- B-X
ScienceDirect B-X
Genotype-phenotype B-X
correlation B-X
in B-X
cystic B-X
fibrosis B-X
patients B-X
bearing B-X
[ B-X
H939R B-X
; B-X
H949L B-X
] B-X
allele B-X
Alleles B-X
with B-X
more B-X
than B-X
one B-X
mutation B-X
can B-X
complicate B-X
genotype/phenotype B-X
studies B-X
in B-X
Mendelian B-X
disorders B-X
: B-X
Lessons B-X
from B-X
Gaucher B-X
disease B-X
Allele B-X
specific B-X
repair B-X
of B-X
splicing B-X
mutations B-X
in B-X
cystic B-X
fibrosis B-X
through B-X
AsCas12a B-X
genome B-X
editing B-X
Guidelines B-X
for B-X
genetic B-X
studies B-X
in B-X
single B-X
patients B-X
: B-X
lessons B-X
from B-X
primary B-X
immunodeficiencies B-X

We	O
show	O
that	O
the	O
less	O
severe	O
phenotype	O
in	O
these	O
patients	O
is	O
caused	O
by	O
some	O
degree	O
of	O
normal	O
splicing	O
,	O
which	O
occurs	O
as	O
an	O
alternative	O
product	O
from	O
the	O
insertion	O
-	O
containing	O
allele	O
.	O
<EOS> B-X
The B-X
neurogenetics B-X
of B-X
alternative B-X
splicing B-X
The B-X
impact B-X
of B-X
alternative B-X
splicing B-X
in B-X
vivo B-X
: B-X
Mouse B-X
models B-X
show B-X
the B-X
way B-X
Lect B-X
. B-X
8 B-X
. B-X
Intro B-X
. B-X
to B-X
microsatellites B-X
Differences B-X
in B-X
RNA B-X
processing B-X
underlie B-X
the B-X
tissue B-X
specific B-X
phenotype B-X
of B-X
ISCU B-X
myopathy B-X
- B-X
ScienceDirect B-X
Alternative B-X
Ac/Ds B-X
transposition B-X
induces B-X
major B-X
chromosomal B-X
rearrangements B-X
in B-X
maize B-X
Targeted B-X
Exon B-X
Skipping B-X
to B-X
Address B-X
‚Äú B-X
Leaky B-X
‚Äù B-X
Mutations B-X
in B-X
the B-X
Dystrophin B-X
Gene B-X
MGI B-X
provides B-X
access B-X
to B-X
integrated B-X
data B-X
on B-X
mouse B-X
genes B-X
and B-X
genome B-X
features B-X
, B-X
from B-X
sequences B-X
and B-X
genomic B-X
maps B-X
to B-X
gene B-X
expression B-X
and B-X
disease B-X
models B-X
. B-X

The	O
level	O
of	O
the	O
137	O
-	O
bp	O
PCR	O
product	O
containing	O
the	O
insertion	O
was	O
lowest	O
in	O
two	O
patients	O
who	O
showed	O
a	O
later	O
onset	O
of	O
cerebellar	B-Disease
ataxia	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Clinical B-X
spectrum B-X
of B-X
ataxia-telangiectasia B-X
in B-X
adulthood B-X
| B-X
To B-X
describe B-X
the B-X
phenotype B-X
of B-X
adult B-X
patients B-X
with B-X
variant B-X
and B-X
classic B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
to B-X
raise B-X
the B-X
degree B-X
Severe B-X
reaction B-X
to B-X
radiotherapy B-X
provoked B-X
by B-X
hypomorphic B-X
germline B-X
mutations B-X
in B-X
ATM B-X
( B-X
ataxia‚Äìtelangiectasia B-X
mutated B-X
gene B-X
) B-X
REPAIRtoire B-X
- B-X
a B-X
database B-X
of B-X
DNA B-X
repair B-X
pathways B-X

A	O
further	O
four	O
families	O
who	O
do	O
not	O
have	O
this	O
insertion	O
have	O
been	O
identified	O
.	O
<EOS> B-X
An B-X
analysis B-X
of B-X
the B-X
IS6/IS26 B-X
family B-X
of B-X
insertion B-X
sequences B-X
: B-X
is B-X
it B-X
a B-X
single B-X
family B-X
? B-X
Physical B-X
therapist B-X
insertion B-X
in B-X
the B-X
Family B-X
Health B-X
Strategy B-X
team B-X
: B-X
the B-X
users B-X
‚Äô B-X
view B-X
Physical B-X
therapist B-X
insertion B-X
in B-X
the B-X
Family B-X
Health B-X
Strategy B-X
team B-X
: B-X
the B-X
users B-X
‚Äô B-X
view B-X
The B-X
Diversity B-X
of B-X
Prokaryotic B-X
DDE B-X
Transposases B-X
of B-X
the B-X
Mutator B-X
Superfamily B-X
, B-X
Insertion B-X
Specificity B-X
, B-X
and B-X
Association B-X
with B-X
Conjugation B-X
Machineries B-X
Insertion B-X
sequence-caused B-X
large-scale B-X
rearrangements B-X
in B-X
the B-X
genome B-X
of B-X
Escherichia B-X
coli B-X
Insertion B-X
Preference B-X
of B-X
Maize B-X
and B-X
Rice B-X
Miniature B-X
Inverted B-X
Repeat B-X
Transposable B-X
Elements B-X
as B-X
Revealed B-X
by B-X
the B-X
Analysis B-X
of B-X
Nested B-X
Elements B-X
Insertion B-X
Sequences B-X

Mutations	O
detected	O
in	O
two	O
of	O
four	O
of	O
these	O
are	O
missense	O
mutations	O
,	O
normally	O
rare	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
patients	O
.	O
<EOS> B-X
Two B-X
rare B-X
missense B-X
mutations B-X
in B-X
the B-X
fibrillin-1 B-X
gene B-X
associated B-X
with B-X
atypical B-X
cardiovascular B-X
manifestations B-X
in B-X
a B-X
Chinese B-X
patient B-X
affected B-X
by B-X
Marfan B-X
syndrome B-X
Congenital B-X
Leptin B-X
Deficiency B-X
and B-X
Leptin B-X
Gene B-X
Missense B-X
Mutation B-X
Found B-X
in B-X
Two B-X
Colombian B-X
Sisters B-X
with B-X
Severe B-X
Obesity B-X
Novel B-X
Missense B-X
Mutations B-X
in B-X
BEST1 B-X
Are B-X
Associated B-X
with B-X
Bestrophinopathies B-X
in B-X
Lebanese B-X
Patients B-X
Germline B-X
loss-of-function B-X
mutations B-X
in B-X
BRCA1 B-X
interacting B-X
protein B-X
C-terminal B-X
helicase B-X
1 B-X
( B-X
BRIP1 B-X
) B-X
are B-X
associated B-X
with B-X
ovarian B-X
carcinoma B-X
and B-X
may B-X
also B-X
contribute B-X
to B-X
breast B-X
cancer B-X
risk B-X
, B-X
particularly B-X
among B-X
patients B-X

The	O
demonstration	O
of	O
mutations	O
giving	O
rise	O
to	O
a	O
slightly	O
milder	O
phenotype	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
raises	O
the	O
interesting	O
question	O
of	O
what	O
range	O
of	O
phenotypes	O
might	O
occur	O
in	O
individuals	O
in	O
whom	O
both	O
mutations	O
are	O
milder	O
.	O
<EOS> B-X
Deep B-X
phenotyping B-X
of B-X
89 B-X
xeroderma B-X
pigmentosum B-X
patients B-X
reveals B-X
unexpected B-X
heterogeneity B-X
dependent B-X
on B-X
the B-X
precise B-X
molecular B-X
defect B-X
| B-X
PNAS B-X

One	O
possibility	O
might	O
be	O
that	O
individuals	O
who	O
are	O
compound	O
heterozygotes	O
for	O
ATM	O
mutations	O
are	O
more	O
common	O
than	O
we	O
realize	O
.	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Background B-X
: B-X
Homozygous B-X
or B-X
compound B-X
heterozygous B-X
mutations B-X
in B-X
the B-X
ATM B-X
gene B-X
are B-X
the B-X
principal B-X
cause B-X
of B-X
ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
. B-X
Several B-X
studies B-X
have B-X
Atm B-X
heterozygous B-X
mice B-X
are B-X
more B-X
sensitive B-X
to B-X
radiation-induced B-X
cataracts B-X
than B-X
are B-X
their B-X
wild-type B-X
counterparts B-X
The B-X
ATM B-X
missense B-X
mutation B-X
Ser49Cys B-X
and B-X
risk B-X
of B-X
breast B-X
cancer B-X
Variants B-X
in B-X
the B-X
ATM B-X
gene B-X
associated B-X
with B-X
a B-X
reduced B-X
risk B-X
of B-X
contralateral B-X
breast B-X
cancer B-X
The B-X
ataxia B-X
telangiectasia B-X
mutated B-X
( B-X
ATM B-X
) B-X
gene B-X
is B-X
a B-X
moderate-risk B-X
breast B-X
cancer B-X
susceptibility B-X
gene B-X
; B-X
germline B-X
loss-of-function B-X
variants B-X
are B-X
found B-X
in B-X
up B-X
to B-X
3 B-X
% B-X
of B-X
hereditary B-X
breast B-X
and B-X
People B-X
with B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
display B-X
phenotypic B-X
variability B-X
with B-X
regard B-X
to B-X
progression B-X
of B-X
immunodeficiency B-X
, B-X
sino-pulmonary B-X
disease B-X
, B-X
and B-X
neurologic B-X
decline B-X
. B-X
To B-X
determine B-X
the B-X
association B-X
between B-X
differential B-X
gene B-X

Mutation	O
of	O
the	O
VHL	O
gene	O
is	O
associated	O
exclusively	O
with	O
the	O
development	O
of	O
non	B-Disease
-	I-Disease
papillary	I-Disease
renal	I-Disease
cell	I-Disease
carcinomas	I-Disease
.	O
<EOS> B-X
Analysis B-X
of B-X
VHL B-X
gene B-X
alterations B-X
and B-X
their B-X
relationship B-X
to B-X
clinical B-X
parameters B-X
in B-X
sporadic B-X
conventional B-X
renal B-X
cell B-X
carcinoma B-X
To B-X
define B-X
the B-X
possible B-X
role B-X
of B-X
the B-X
VHL B-X
gene B-X
in B-X
the B-X
development B-X
of B-X
sporadic B-X
renal B-X
cell B-X
carcinomas B-X
, B-X
91 B-X
different B-X
parenchymal B-X
tumours B-X
of B-X
the B-X
kidney B-X
have B-X
been B-X
investigated B-X
for B-X
mutation B-X
To B-X
define B-X
the B-X
possible B-X
role B-X
of B-X
the B-X
VHL B-X
gene B-X
in B-X
the B-X
development B-X
of B-X
sporadic B-X
renal B-X
cell B-X
carcinomas B-X
, B-X
91 B-X
different B-X
parenchymal B-X
tumours B-X
of B-X
the B-X
kidney B-X
have B-X
been B-X
investigated B-X
for B-X
mutation B-X
MUTATION B-X
OF B-X
THE B-X
VHL B-X
GENE B-X
IS B-X
ASSOCIATED B-X
EXCLUSIVELY B-X
WITH B-X
THE B-X
DEVELOPMENT B-X
OF B-X
NON‚ÄêPAPILLARY B-X
RENAL B-X
CELL B-X
CARCINOMAS B-X
- B-X
KENCK B-X
- B-X
1996 B-X
- B-X
The B-X
Journal B-X
of B-X
Pathology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
VHL B-X
Alterations B-X
in B-X
Human B-X
Clear B-X
Cell B-X
Renal B-X
Cell B-X
Carcinoma B-X
: B-X
Association B-X
with B-X
Advanced B-X
Tumor B-X
Stage B-X
and B-X
a B-X
Novel B-X
Hot B-X
Spot B-X
Mutation B-X
| B-X
Cancer B-X
Research B-X
Relevance B-X
of B-X
Nuclear B-X
and B-X
Cytoplasmic B-X
von B-X
Hippel B-X
Lindau B-X
Protein B-X
Expression B-X
for B-X
Renal B-X
Carcinoma B-X
Progression B-X
The B-X
treatment B-X
of B-X
kidney B-X
cancer B-X
has B-X
been B-X
re-energised B-X
by B-X
the B-X
introduction B-X
of B-X
novel B-X
therapeutics B-X
and B-X
innovative B-X
surgical B-X
advances B-X
. B-X
Edited B-X
and B-X
written B-X
by B-X
medical B-X
oncologists B-X
and B-X
surgeons B-X
, B-X
this B-X
new B-X

To	O
define	O
the	O
possible	O
role	O
of	O
the	O
VHL	B-Disease
gene	O
in	O
the	O
development	O
of	O
sporadic	B-Disease
renal	I-Disease
cell	I-Disease
carcinomas	I-Disease
,	O
91	O
different	O
parenchymal	B-Disease
tumours	I-Disease
of	I-Disease
the	I-Disease
kidney	I-Disease
have	O
been	O
investigated	O
for	O
mutation	O
of	O
the	O
VHL	B-Disease
gene	O
by	O
single	O
strand	O
conformation	O
polymorphism	O
(	O
SSCP	O
)	O
and	O
/	O
or	O
heteroduplex	O
(	O
HD	O
)	O
techniques	O
.	O
<EOS> B-X
To B-X
compare B-X
the B-X
sensitivity B-X
of B-X
the B-X
mutation B-X
detection B-X
techniques B-X
single-strand B-X
conformation B-X
polymorphism B-X
analysis B-X
( B-X
SSCP B-X
) B-X
and B-X
heteroduplex B-X
analysis B-X
( B-X
HA B-X
) B-X
, B-X
we B-X
analyzed B-X
a B-X
cohort B-X
of B-X
73 B-X
patients B-X
The B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
is B-X
an B-X
inherited B-X
neoplasia B-X
syndrome B-X
caused B-X
by B-X
the B-X
inactivation B-X
of B-X
VHL B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
and B-X
somatic B-X
mutation B-X
of B-X
this B-X
gene B-X
has B-X
been B-X
related B-X
Request B-X
PDF B-X
| B-X
VHL B-X
tumor B-X
suppressor B-X
gene B-X
: B-X
Its B-X
mutation B-X
and B-X
protein B-X
level B-X
in B-X
renal B-X
cell B-X
carcinoma B-X
| B-X
In B-X
this B-X
study B-X
, B-X
we B-X
identified B-X
mutations B-X
in B-X
the B-X
von B-X
Hippel-Lindau B-X
gene B-X
Request B-X
PDF B-X
| B-X
Expression B-X
of B-X
HGF/SF B-X
and B-X
Met B-X
protein B-X
is B-X
associated B-X
with B-X
genetic B-X
alterations B-X
of B-X
VHL B-X
gene B-X
in B-X
primary B-X
renal B-X
cell B-X
carcinomas B-X
| B-X
We B-X
analyzed B-X
the B-X
genetic B-X
alterations B-X
of B-X
VHL B-X
Request B-X
PDF B-X
| B-X
VHL B-X
Alterations B-X
in B-X
Human B-X
Clear B-X
Cell B-X
Renal B-X
Cell B-X
Carcinoma B-X
: B-X
Association B-X
with B-X
Advanced B-X
Tumor B-X
Stage B-X
and B-X
a B-X
Novel B-X
Hot B-X
Spot B-X
Mutation B-X
| B-X
To B-X
elucidate B-X
the B-X
role B-X
of B-X
PDF B-X
| B-X
Mutations B-X
in B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
are B-X
common B-X
in B-X
human B-X
clear B-X
cell B-X
kidney B-X
cancers B-X
. B-X
Carcinogens B-X
in B-X
cigarette B-X
smoke B-X
, B-X
especially B-X
... B-X
| B-X
Find B-X
, B-X

Chromosome	O
3p	O
deletion	O
was	O
detected	O
in	O
98	O
per	O
cent	O
of	O
non	B-Disease
-	I-Disease
papillary	I-Disease
renal	I-Disease
cell	I-Disease
carcinomas	I-Disease
and	O
in	O
25	O
per	O
cent	O
of	O
chromophobe	O
renal	B-Disease
cell	I-Disease
carcinomas	I-Disease
.	O
<EOS> B-X
Chromosomal B-X
Imbalances B-X
in B-X
Papillary B-X
Renal B-X
Cell B-X
Carcinoma B-X
Clear-cell B-X
and B-X
papillary B-X
renal B-X
cell B-X
carcinomas B-X
( B-X
RCCs B-X
) B-X
have B-X
specific B-X
genetic B-X
changes B-X
that B-X
allow B-X
them B-X
to B-X
be B-X
classified B-X
on B-X
the B-X
basis B-X
of B-X
histopathology B-X
and B-X
on B-X
the B-X
basis B-X
of B-X
cytogenetic B-X
The B-X
diagnosis B-X
of B-X
benign B-X
renal B-X
oncocytomas B-X
( B-X
RO B-X
) B-X
and B-X
chromophobe B-X
renal B-X
cell B-X
carcinomas B-X
( B-X
RCC B-X
) B-X
based B-X
on B-X
their B-X
morphology B-X
remains B-X
uncertain B-X
in B-X
several B-X
cases B-X
. B-X
We B-X
have B-X
applied B-X
The B-X
Epigenetics B-X
of B-X
Kidney B-X
Cancer B-X
and B-X
Bladder B-X
Cancer B-X
Systemic B-X
Therapy B-X
for B-X
Metastatic B-X
Non-Clear B-X
Cell B-X
Renal B-X
Cell B-X
Carcinoma B-X
: B-X
Recent B-X
Progress B-X
and B-X
Future B-X
Directions B-X
von B-X
Hippel-Lindau B-X
disease B-X
( B-X
VHL B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
inherited B-X
disease B-X
, B-X
frequently B-X
accompanied B-X
by B-X
occurrences B-X
of B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
RCC B-X
) B-X
. B-X
Both B-X
the B-X
VHL B-X
gene B-X
and B-X
Intratumor B-X
heterogeneity B-X
( B-X
ITH B-X
) B-X
and B-X
tumor B-X
evolution B-X
have B-X
been B-X
well B-X
described B-X
for B-X
clear B-X
cell B-X
renal B-X
cell B-X
carcinomas B-X
( B-X
ccRCC B-X
) B-X
, B-X
but B-X
they B-X
are B-X
less B-X
studied B-X
for B-X
other B-X
kidney B-X

In	O
22	O
of	O
the	O
43	O
non	B-Disease
-	I-Disease
papillary	I-Disease
renal	I-Disease
cell	I-Disease
carcinomas	I-Disease
,	O
abnormally	O
migrating	O
DNA	O
bands	O
were	O
detected	O
by	O
SSCP	O
and	O
/	O
or	O
HD	O
analysis	O
.	O
<EOS> B-X
PDF B-X
| B-X
The B-X
aim B-X
of B-X
the B-X
study B-X
was B-X
to B-X
investigate B-X
differences B-X
in B-X
microvessels B-X
between B-X
renal B-X
tumors B-X
. B-X
The B-X
material B-X
consisted B-X
of B-X
97 B-X
clear B-X
cell B-X
carcinomas B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
PDF B-X
| B-X
Urothelial B-X
carcinoma B-X
of B-X
the B-X
renal B-X
pelvis B-X
is B-X
a B-X
deadly B-X
disease B-X
with B-X
an B-X
unclear B-X
tumorigenic B-X
mechanism B-X
. B-X
We B-X
conducted B-X
gene B-X
expression B-X
profiling B-X
on B-X
a B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Abstract B-X
. B-X
A B-X
mechanism B-X
decreasing B-X
oxidative B-X
metabolism B-X
during B-X
normal B-X
cell B-X
division B-X
and B-X
growth B-X
is B-X
expected B-X
to B-X
direct B-X
substrates B-X
toward B-X
biosyntheses B-X
rather B-X
than B-X
to B-X
Author B-X
summary B-X
Renal B-X
cell B-X
carcinoma B-X
accounts B-X
for B-X
more B-X
than B-X
90 B-X
% B-X
of B-X
kidney B-X
cancers B-X
. B-X
Papillary B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
pRCC B-X
) B-X
is B-X
the B-X
second B-X
most B-X
common B-X
subtype B-X
of B-X
renal B-X
Request B-X
PDF B-X
| B-X
Understanding B-X
the B-X
molecular B-X
genetics B-X
of B-X
renal B-X
cell B-X
neoplasia B-X
: B-X
Implications B-X
for B-X
diagnosis B-X
, B-X
prognosis B-X
and B-X
therapy B-X
| B-X
Renal B-X
neoplasms B-X
exhibit B-X
a B-X
wide B-X
spectrum B-X
of B-X
molecular B-X
characteristics B-X
that B-X
beta-Catenin B-X
acts B-X
as B-X
a B-X
downstream B-X
transcriptional B-X
activator B-X
of B-X
the B-X
Wingless-Wnt B-X
signaling B-X
pathway B-X
. B-X
The B-X
beta-catenin-Tcf B-X
complex B-X
transactivates B-X
the B-X
downstream B-X
genes B-X
that B-X
regulate B-X
cell B-X
proliferation B-X
or B-X
inhibit B-X
apoptosis B-X
. B-X
The B-X
activation B-X
Aberrant B-X
DNA B-X
methylation B-X
patterns B-X
are B-X
involved B-X
in B-X
the B-X
pathogenesis B-X
of B-X
papillary B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
pRCC B-X
) B-X
. B-X
This B-X
study B-X
aimed B-X
to B-X
investigate B-X
the B-X
potential B-X
of B-X
methylation-driven B-X
genes B-X
as B-X
biomarkers B-X

No	O
mobility	O
shift	O
was	O
seen	O
in	O
any	O
of	O
the	O
23	O
chromophobe	O
renal	B-Disease
cell	I-Disease
carcinomas	I-Disease
.	O
<EOS> B-X
This B-X
paper B-X
reports B-X
on B-X
32 B-X
chromophobe B-X
cell B-X
renal B-X
carcinomas B-X
observed B-X
in B-X
697 B-X
renal B-X
cell B-X
cancers B-X
( B-X
RCC B-X
) B-X
of B-X
adults B-X
( B-X
peak B-X
in B-X
the B-X
sixth B-X
decade B-X
of B-X
life B-X
) B-X
. B-X
In B-X
renal B-X
cell B-X
carcinomas B-X
( B-X
RCC B-X
) B-X
, B-X
NF-Œ∫B B-X
blockade B-X
is B-X
required B-X
for B-X
maximal B-X
bortezomib-induced B-X
apoptosis B-X
, B-X
and B-X
expression B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
protein B-X
downregulates B-X
Clear B-X
cell B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
ccRCC B-X
) B-X
is B-X
the B-X
third B-X
most B-X
common B-X
urological B-X
cancer B-X
, B-X
and B-X
it B-X
has B-X
the B-X
highest B-X
mortality B-X
rate B-X
. B-X
The B-X
increasing B-X
drug B-X
resistance B-X
of B-X
metastatic B-X

In	O
addition	O
,	O
15	O
papillary	B-Disease
renal	I-Disease
cell	I-Disease
tumours	I-Disease
and	O
ten	O
renal	B-Disease
oncocytomas	I-Disease
,	O
which	O
are	O
characterized	O
by	O
genetic	O
changes	O
other	O
than	O
loss	O
of	O
chromosome	O
3p	O
sequences	O
,	O
were	O
analysed	O
for	O
mutation	O
of	O
the	O
VHL	B-Disease
gene	O
.	O
<EOS> B-X
Software B-X
and B-X
database B-X
for B-X
the B-X
analysis B-X
of B-X
mutations B-X
in B-X
the B-X
VHL B-X
gene B-X
. B-X
Papillary B-X
renal B-X
cell B-X
carcinoma B-X
within B-X
a B-X
renal B-X
oncocytoma B-X
: B-X
case B-X
report B-X
of B-X
an B-X
incidental B-X
finding B-X
of B-X
a B-X
tumour B-X
within B-X
a B-X
tumour B-X
Multiple B-X
, B-X
bilateral B-X
renal B-X
carcinomas B-X
are B-X
a B-X
frequent B-X
occurrence B-X
in B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
. B-X
To B-X
elucidate B-X
the B-X
aetiological B-X
role B-X
of B-X
the B-X
VHL B-X
gene B-X
in B-X
human B-X
kidney B-X
tumorigenesis B-X
Kidney B-X
: B-X
Papillary B-X
renal B-X
cell B-X
carcinoma B-X
Molecular B-X
analysis B-X
of B-X
the B-X
Von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
in B-X
a B-X
family B-X
with B-X
non-syndromic B-X
pheochromocytoma B-X
: B-X
the B-X
importance B-X
of B-X
genetic B-X
testing B-X
Computational B-X
models B-X
for B-X
predicting B-X
the B-X
impact B-X
of B-X
missense B-X
VHL B-X
gene B-X
mutations B-X
may B-X
be B-X
used B-X
as B-X
a B-X
prognostic B-X
factor B-X
in B-X
patients B-X
with B-X
PNETs B-X
in B-X
the B-X
context B-X
of B-X
vHL B-X
disease B-X
. B-X
VHL B-X
is B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
localized B-X
on B-X
chromosome B-X
3p25-26 B-X
. B-X
Mutations B-X
of B-X
the B-X
VHL B-X
gene B-X
were B-X
described B-X
at B-X
first B-X
in B-X
the B-X
heritable B-X
von B-X
Hippel-Lindau B-X
disease B-X
and B-X
in B-X
the B-X
sporadic B-X

None	O
of	O
these	O
tumours	B-Disease
showed	O
abnormal	O
migration	O
patterns	O
.	O
<EOS> B-X
Cell B-X
motility B-X
in B-X
cancer B-X
invasion B-X
and B-X
metastasis B-X
: B-X
insights B-X
from B-X
simple B-X
model B-X
organisms B-X
Inflammation B-X
and B-X
cancer B-X
Cancer B-X
is B-X
an B-X
umbrella B-X
term B-X
for B-X
a B-X
large B-X
group B-X
of B-X
diseases B-X
caused B-X
when B-X
abnormal B-X
cells B-X
divide B-X
rapidly B-X
, B-X
and B-X
spread B-X
to B-X
other B-X
tissue B-X
and B-X
organs B-X
. B-X
Hallmarks B-X
of B-X
Cancer B-X
: B-X
The B-X
Next B-X
Generation B-X
: B-X
Cell B-X
Benign B-X
tumor B-X
- B-X
Wikipedia B-X
Cell B-X
migration B-X
, B-X
an B-X
essential B-X
process B-X
for B-X
normal B-X
cell B-X
development B-X
and B-X
cancer B-X
metastasis B-X
, B-X
differs B-X
from B-X
a B-X
simple B-X
random B-X
walk B-X
: B-X
the B-X
mean-square B-X
displacement B-X
( B-X
„Äà B-X
( B-X
Œîr B-X
) B-X
2 B-X
Intratumoral B-X
genetic B-X
heterogeneity B-X
is B-X
a B-X
widely B-X
accepted B-X
characteristic B-X
of B-X
human B-X
cancer B-X
, B-X
including B-X
the B-X
most B-X
common B-X
primary B-X
malignant B-X
brain B-X
tumor B-X
, B-X
glioblastoma B-X
. B-X
However B-X
, B-X
the B-X
variability B-X
in B-X
biological B-X
behaviors B-X

The	O
results	O
indicate	O
that	O
mutation	O
of	O
the	O
VHL	B-Disease
gene	O
is	O
associated	O
exclusively	O
with	O
the	O
development	O
of	O
non	B-Disease
-	I-Disease
papillary	I-Disease
renal	I-Disease
cell	I-Disease
carcinoma	I-Disease
.	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Background B-X
: B-X
Mutations B-X
in B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
are B-X
common B-X
in B-X
human B-X
clear B-X
cell B-X
kidney B-X
cancers B-X
. B-X
Carcinogens B-X
in B-X
cigarette B-X
smoke B-X
, B-X
especially B-X
ni B-X
In B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
RCC B-X
) B-X
, B-X
mostly B-X
occurring B-X
as B-X
sporadic B-X
cases B-X
, B-X
the B-X
short B-X
arm B-X
of B-X
chromosome B-X
3 B-X
is B-X
a B-X
frequent B-X
target B-X
of B-X
deletion B-X
events B-X
. B-X
Taking B-X
into B-X

The	O
Emery	B-Disease
-	I-Disease
Dreifuss	I-Disease
muscular	I-Disease
dystrophy	I-Disease
protein	O
,	O
emerin	O
,	O
is	O
a	O
nuclear	O
membrane	O
protein	O
.	O
<EOS> B-X
The B-X
product B-X
of B-X
the B-X
X-linked B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
gene B-X
is B-X
a B-X
single-membrane-spanning B-X
protein B-X
called B-X
emerin B-X
, B-X
which B-X
is B-X
localized B-X
to B-X
the B-X
inner B-X
nuclear B-X
membrane B-X
of B-X
all B-X
tissues B-X
studied B-X
. B-X
To B-X
Emerin B-X
is B-X
an B-X
integral B-X
protein B-X
of B-X
the B-X
inner B-X
nuclear B-X
membrane B-X
that B-X
is B-X
mutated B-X
or B-X
not B-X
expressed B-X
in B-X
patients B-X
with B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
. B-X
Confocal B-X
immunofluorescence B-X
microscopy B-X
studies B-X
of B-X
the B-X
intracellular B-X
The B-X
X-linked B-X
form B-X
of B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
( B-X
X-EDMD B-X
) B-X
is B-X
caused B-X
by B-X
absence B-X
, B-X
or B-X
greatly B-X
reduced B-X
amounts B-X
, B-X
of B-X
the B-X
inner B-X
nuclear-membrane B-X
protein B-X
, B-X
emerin B-X
. B-X
The B-X
autosomal B-X
Emerin B-X
is B-X
a B-X
nuclear B-X
membrane B-X
protein B-X
that B-X
interacts B-X
with B-X
lamin B-X
A/C B-X
at B-X
the B-X
nuclear B-X
envelope B-X
. B-X
Mutations B-X
in B-X
either B-X
emerin B-X
or B-X
lamin B-X
A/C B-X
cause B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
( B-X
EDMD B-X
) B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
( B-X
EDMD B-X
) B-X
is B-X
an B-X
inherited B-X
disorder B-X
characterized B-X
by B-X
the B-X
clinical B-X
triad B-X
of B-X
life-threatening B-X
progressive B-X
cardiomyopathy B-X
with B-X
conduction B-X
defect B-X
, B-X
early B-X
onset B-X
joint B-X
contractures B-X
and B-X
slow B-X
progressive B-X
Alteration B-X
of B-X
the B-X
nuclear B-X
Ca B-X
< B-X
sup B-X
> B-X
2+ B-X
< B-X
/sup B-X
> B-X
transient B-X
is B-X
an B-X
early B-X
event B-X
in B-X
cardiac B-X
remodeling B-X
. B-X
Regulation B-X
of B-X
the B-X
nuclear B-X
Ca B-X
< B-X
sup B-X
> B-X
2+ B-X

A	O
large	O
fragment	O
of	O
emerin	O
cDNA	O
was	O
prepared	O
by	O
PCR	O
and	O
expressed	O
as	O
a	O
recombinant	O
protein	O
in	O
Escherichia	O
coli	O
.	O
<EOS> B-X
Distinct B-X
functional B-X
domains B-X
in B-X
emerin B-X
bind B-X
lamin B-X
A B-X
and B-X
DNA-bridging B-X
protein B-X
BAF B-X
| B-X
Journal B-X
of B-X
Cell B-X
Science B-X
Nesprin-1Œ± B-X
self-associates B-X
and B-X
binds B-X
directly B-X
to B-X
emerin B-X
and B-X
lamin B-X
A B-X
in B-X
vitro B-X
- B-X
ScienceDirect B-X
PDF B-X
| B-X
Seventeen B-X
families B-X
with B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
( B-X
EDMD B-X
) B-X
have B-X
been B-X
studied B-X
both B-X
by B-X
DNA B-X
sequencing B-X
and B-X
by B-X
emerin B-X
protein B-X
expression B-X
.... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Download B-X
Citation B-X
| B-X
Coexistence B-X
of B-X
X-linked B-X
recessive B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
with B-X
inclusion B-X
body B-X
myositis-like B-X
morphology B-X
| B-X
We B-X
reported B-X
three B-X
cases B-X
( B-X
two B-X
familial B-X
and B-X
one B-X
sporadic B-X
) B-X
of B-X
X-linked B-X
Emery-Dreifuss B-X
PDF B-X
| B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
( B-X
EMD B-X
) B-X
is B-X
an B-X
X-linked B-X
recessive B-X
disorder B-X
associated B-X
with B-X
muscle B-X
wasting B-X
, B-X
contractures B-X
, B-X
and B-X
cardiomyopathy B-X
. B-X
The B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
PCR B-X
Search B-X
Results B-X
- B-X
Chile B-X
300384 B-X
- B-X
EMERIN B-X
; B-X
EMD B-X
- B-X
STA B-X
- B-X
EMD B-X

Using	O
this	O
as	O
immunogen	O
,	O
we	O
prepared	O
a	O
panel	O
of	O
12	O
monoclonal	O
antibodies	O
which	O
recognise	O
at	O
least	O
four	O
different	O
epitopes	O
on	O
emerin	O
in	O
order	O
to	O
ensure	O
that	O
emerin	O
can	O
be	O
distinguished	O
from	O
non	O
-	O
specific	O
cross	O
-	O
reacting	O
proteins	O
.	O
<EOS> B-X
A B-X
large B-X
fragment B-X
of B-X
emerin B-X
cDNA B-X
was B-X
prepared B-X
by B-X
PCR B-X
and B-X
expressed B-X
as B-X
a B-X
recombinant B-X
protein B-X
in B-X
Escherichia B-X
coli B-X
. B-X
Using B-X
this B-X
as B-X
immunogen B-X
, B-X
we B-X
prepared B-X
a B-X
panel B-X
of B-X
Abstract B-X
. B-X
A B-X
large B-X
fragment B-X
of B-X
emerin B-X
cDNA B-X
was B-X
prepared B-X
by B-X
PCR B-X
and B-X
expressed B-X
as B-X
a B-X
recombinant B-X
protein B-X
in B-X
Escherichia B-X
coli B-X
. B-X
Using B-X
this B-X
as B-X
immunogen B-X
, B-X
we B-X
prepared B-X
a B-X
Abstract B-X
. B-X
A B-X
large B-X
fragment B-X
of B-X
emerin B-X
cDNA B-X
was B-X
prepared B-X
by B-X
PCR B-X
and B-X
expressed B-X
as B-X
a B-X
recombinant B-X
protein B-X
in B-X
Escherichia B-X
coli B-X
. B-X
Using B-X
this B-X
as B-X
immunogen B-X
, B-X
we B-X
prepared B-X
a B-X
G B-X
E B-X
Morris B-X
's B-X
84 B-X
research B-X
works B-X
with B-X
4,911 B-X
citations B-X
and B-X
3,063 B-X
reads B-X
, B-X
including B-X
: B-X
G.P.27 B-X
: B-X
Latest B-X
updates B-X
to B-X
the B-X
MDA B-X
monoclonal B-X
antibody B-X
resource B-X
for B-X
neuromuscular B-X
disorders B-X
Nesprins B-X
, B-X
but B-X
not B-X
Sun B-X
proteins B-X
, B-X
switch B-X
isoforms B-X
at B-X
the B-X
nuclear B-X
envelope B-X
during B-X
muscle B-X
development B-X
S B-X
Manilal B-X
's B-X
19 B-X
research B-X
works B-X
with B-X
1,389 B-X
citations B-X
and B-X
500 B-X
reads B-X
, B-X
including B-X
: B-X
The B-X
Distribution B-X
of B-X
Emerin B-X
and B-X
Lamins B-X
in B-X
X-Linked B-X
Emery-Dreifuss B-X
Muscular B-X
Dystrophy B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

All	O
the	O
mAbs	O
recognised	O
a	O
34	O
kDa	O
protein	O
in	O
all	O
tissues	O
tested	O
,	O
though	O
minor	O
emerin	O
-	O
related	O
bands	O
were	O
also	O
detected	O
in	O
some	O
tissues	O
.	O
<EOS> B-X
PDF B-X
| B-X
The B-X
nuclear B-X
lamina B-X
is B-X
a B-X
protein B-X
meshwork B-X
lining B-X
the B-X
nucleoplasmic B-X
face B-X
of B-X
the B-X
inner B-X
nuclear B-X
membrane B-X
and B-X
represents B-X
an B-X
important B-X
determinant B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Nesprin-1-giant B-X
and B-X
nesprin-2-giant B-X
regulate B-X
nuclear B-X
positioning B-X
by B-X
the B-X
interaction B-X
of B-X
their B-X
C-terminal B-X
KASH B-X
domains B-X
with B-X
nuclear B-X
membrane B-X
SUN B-X
proteins B-X
and B-X
their B-X
N-terminal B-X
calponin-homology B-X
domains B-X
with B-X
cytoskeletal B-X
actin B-X
. B-X
A B-X
number B-X
Request B-X
PDF B-X
| B-X
Emerin-Lacking B-X
Mice B-X
Show B-X
Minimal B-X
Motor B-X
and B-X
Cardiac B-X
Dysfunctions B-X
with B-X
Nuclear-Associated B-X
Vacuoles B-X
| B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
is B-X
an B-X
inherited B-X
muscular B-X
disorder B-X
clinically B-X
characterized B-X
by B-X
slowly B-X
progressive B-X
weakness B-X
affecting B-X

Immunofluorescence	O
microscopy	O
showed	O
that	O
emerin	O
is	O
located	O
at	O
the	O
nuclear	O
rim	O
in	O
all	O
tissues	O
examined	O
.	O
<EOS> B-X
Distribution B-X
of B-X
emerin B-X
during B-X
the B-X
cell B-X
cycle B-X
- B-X
ScienceDirect B-X
Human B-X
emerin B-X
is B-X
a B-X
nuclear B-X
membrane B-X
protein B-X
that B-X
is B-X
lost B-X
or B-X
altered B-X
in B-X
patients B-X
with B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
( B-X
EMD B-X
) B-X
. B-X
While B-X
the B-X
protein B-X
is B-X
expressed B-X
in B-X
the B-X
majority B-X
Lamina-associated B-X
Polypeptide B-X
1 B-X
: B-X
Protein B-X
Interactions B-X
and B-X
Tissue-selective B-X
Functions B-X
Lamina-associated B-X
Polypeptide-1 B-X
Interacts B-X
with B-X
the B-X
Muscular B-X
Dystrophy B-X
Protein B-X
Emerin B-X
and B-X
is B-X
Essential B-X
for B-X
Skeletal B-X
Muscle B-X
Maintenance B-X
Mutations B-X
in B-X
LMNA B-X
, B-X
the B-X
gene B-X
that B-X
encodes B-X
nuclear B-X
lamins B-X
A B-X
and B-X
C B-X
, B-X
cause B-X
up B-X
to B-X
eight B-X
different B-X
diseases B-X
collectively B-X
referred B-X
to B-X
as B-X
`` B-X
laminopathies B-X
. B-X
'' B-X
These B-X
diseases B-X

A	O
muscle	O
biopsy	O
from	O
an	O
Emery	B-Disease
-	I-Disease
Dreifuss	I-Disease
muscular	I-Disease
dystrophy	I-Disease
(	O
EMDM	B-Disease
)	O
patient	O
showed	O
complete	O
absence	O
of	O
emerin	O
by	O
both	O
Western	O
blotting	O
and	O
immunohistochemistry	O
,	O
suggesting	O
a	O
simple	O
diagnostic	O
antibody	O
test	O
for	O
EDMD	B-Disease
families	O
.	O
<EOS> B-X
In B-X
diagnosing B-X
any B-X
form B-X
of B-X
muscular B-X
dystrophy B-X
, B-X
a B-X
doctor B-X
usually B-X
begins B-X
by B-X
taking B-X
a B-X
patient B-X
and B-X
family B-X
history B-X
and B-X
performing B-X
a B-X
physical B-X
examination B-X
. B-X
Much B-X
can B-X
be B-X
learned B-X
from B-X
NTD B-X
Genetics B-X
| B-X
About B-X
NTD B-X
Genetics B-X

Biochemical	O
fractionation	O
of	O
brain	O
and	O
liver	O
tissues	O
showed	O
that	O
emerin	O
was	O
present	O
in	O
nuclei	O
purified	O
by	O
centrifugation	O
through	O
65	O
%	O
sucrose	O
and	O
was	O
absent	O
from	O
soluble	O
fractions	O
(	O
post	O
-	O
100	O
,	O
000	O
g	O
)	O
.	O
<EOS> B-X
Cell B-X
fractionation B-X
of B-X
parasitic B-X
protozoa B-X
: B-X
a B-X
review B-X
G B-X
Force B-X
calculator B-X
for B-X
fast B-X
RCF B-X
to B-X
RPM B-X
conversions B-X
. B-X
Find B-X
centrifugal B-X
force B-X
from B-X
revolutions B-X
per B-X
minute B-X
, B-X
or B-X
g B-X
force B-X
given B-X
RPMs B-X
and B-X
centrifuge B-X
radius B-X
. B-X
Designed B-X
for B-X
scientists B-X
PDF B-X
| B-X
We B-X
report B-X
a B-X
role B-X
for B-X
HA95 B-X
, B-X
a B-X
nuclear B-X
protein B-X
with B-X
high B-X
homology B-X
to B-X
the B-X
nuclear B-X
A-kinase B-X
anchoring B-X
protein B-X
AKAP95 B-X
, B-X
in B-X
the B-X
regulation B-X
of B-X
nuclear B-X
... B-X
| B-X
Request B-X
PDF B-X
| B-X
Direct B-X
Interaction B-X
between B-X
Emerin B-X
and B-X
Lamin B-X
A B-X
| B-X
Emerin B-X
is B-X
the B-X
protein B-X
of B-X
the B-X
inner B-X
nuclear B-X
membrane B-X
that B-X
is B-X
affected B-X
by B-X
mutation B-X
in B-X
X-linked B-X
Emery-Dreifuss B-X
muscular B-X
dystrophy B-X
Isolation B-X
of B-X
Endoplasmic B-X
Reticulum B-X
, B-X
Mitochondria B-X
, B-X
and B-X
Mitochondria-Associated B-X
Membrane B-X
and B-X
Detergent B-X
Resistant B-X
Membrane B-X
Fractions B-X
from B-X
Transfected B-X
Cells B-X
and B-X
from B-X
Human B-X
Cytomegalovirus-Infected B-X
Primary B-X
Fibroblasts B-X
Mercedes-Benz B-X
G B-X
63 B-X
AMG B-X
–∫—Ä–æ—Å—Å–æ–≤–µ—Ä B-X
5 B-X
–¥–≤ B-X
2020 B-X
–≥–æ–¥–∞ B-X
Mercedes-Benz B-X
: B-X
—Ñ–æ—Ç–æ–≥—Ä–∞—Ñ–∏–∏ B-X
, B-X
–≤–∏–¥–µ–æ B-X
, B-X
–∫–æ–º–ø–ª–µ–∫—Ç–∞—Ü–∏–∏ B-X
, B-X
—Ü–µ–Ω—ã B-X
, B-X
–æ—Ç–∑—ã–≤—ã B-X
, B-X
–ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è B-X
–æ—Ç B-X
–∞–≤—Ç–æ—Å–∞–ª–æ–Ω–æ–≤ B-X
–ê–≤—Ç–æ.—Ä—É B-X
: B-X
–∫—É–ø–∏—Ç—å B-X
, B-X
–ø—Ä–æ–¥–∞—Ç—å B-X
–∏ B-X
–æ–±–º–µ–Ω—è—Ç—å B-X
–º–∞—à–∏–Ω—É B-X

From	O
these	O
results	O
,	O
together	O
with	O
sequence	O
and	O
structural	O
homologies	O
between	O
emerin	O
,	O
thymopoietins	O
and	O
the	O
nuclear	O
lamina	O
-	O
associated	O
protein	O
,	O
LAP2	O
,	O
we	O
suggest	O
that	O
emerin	O
will	O
prove	O
to	O
be	O
one	O
member	O
of	O
a	O
family	O
of	O
inner	O
nuclear	O
membrane	O
proteins	O
.	O
.	O
<EOS> B-X
May B-X
help B-X
direct B-X
the B-X
assembly B-X
of B-X
the B-X
nuclear B-X
lamina B-X
and B-X
thereby B-X
help B-X
maintain B-X
the B-X
structural B-X
organization B-X
of B-X
the B-X
nuclear B-X
envelope B-X
. B-X
Possible B-X
receptor B-X
for B-X
attachment B-X
of B-X
lamin B-X
filaments B-X
to B-X
the B-X
PDF B-X
| B-X
Emerin B-X
is B-X
a B-X
type B-X
II B-X
inner B-X
nuclear B-X
membrane B-X
( B-X
INM B-X
) B-X
protein B-X
of B-X
unknown B-X
function B-X
. B-X
Emerin B-X
function B-X
is B-X
likely B-X
to B-X
be B-X
important B-X
because B-X
, B-X
when B-X
it B-X
is B-X
LUMA B-X
interacts B-X
with B-X
emerin B-X
and B-X
influences B-X
its B-X
distribution B-X
at B-X
the B-X
inner B-X
nuclear B-X
membrane B-X
| B-X
Journal B-X
of B-X
Cell B-X
Science B-X
Complete B-X
information B-X
for B-X
TMPO B-X
gene B-X
( B-X
Protein B-X
Coding B-X
) B-X
, B-X
Thymopoietin B-X
, B-X
including B-X
: B-X
function B-X
, B-X
proteins B-X
, B-X
disorders B-X
, B-X
pathways B-X
, B-X
orthologs B-X
, B-X
and B-X
expression B-X
. B-X
GeneCards B-X
- B-X
The B-X
Lamina-associated B-X
polypeptide B-X
( B-X
LAP B-X
) B-X
2Œ± B-X
and B-X
other B-X
LEM B-X
proteins B-X
in B-X
cancer B-X
biology B-X
Inner B-X
nuclear B-X
membrane B-X
protein B-X
- B-X
Wikipedia B-X
Thymopoietin B-X
or B-X
TMPO B-X
( B-X
indicated B-X
by B-X
its B-X
alternative B-X
gene B-X
symbol B-X
, B-X
LAP2 B-X
, B-X
in B-X
this B-X
work B-X
) B-X
has B-X
been B-X
proposed B-X
as B-X
a B-X
candidate B-X
disease B-X
gene B-X
for B-X
dilated B-X
cardiomyopathy B-X
( B-X
DCM B-X

Mutation	O
of	O
MSH3	O
in	O
endometrial	B-Disease
cancer	I-Disease
and	O
evidence	O
for	O
its	O
functional	O
role	O
in	O
heteroduplex	O
repair	O
.	O
<EOS> B-X
Mismatch B-X
repair B-X
gene B-X
MSH3 B-X
polymorphism B-X
is B-X
associated B-X
with B-X
the B-X
risk B-X
of B-X
sporadic B-X
prostate B-X
cancer B-X
To B-X
clarify B-X
the B-X
origin B-X
of B-X
defective B-X
mismatch B-X
repair B-X
( B-X
MMR B-X
) B-X
in B-X
sporadic B-X
endometrial B-X
cancers B-X
with B-X
microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
, B-X
a B-X
thorough B-X
mutation B-X
analysi B-X
Genetic B-X
Instability B-X
Caused B-X
by B-X
Loss B-X
of B-X
MutS B-X
Homologue B-X
3 B-X
in B-X
Human B-X
Colorectal B-X
Cancer B-X
| B-X
Cancer B-X
Research B-X
Complete B-X
information B-X
for B-X
MSH3 B-X
gene B-X
( B-X
Protein B-X
Coding B-X
) B-X
, B-X
MutS B-X
Homolog B-X
3 B-X
, B-X
including B-X
: B-X
function B-X
, B-X
proteins B-X
, B-X
disorders B-X
, B-X
pathways B-X
, B-X
orthologs B-X
, B-X
and B-X
expression B-X
. B-X
GeneCards B-X
Many B-X
human B-X
tumours B-X
have B-X
length B-X
alterations B-X
in B-X
repetitive B-X
sequence B-X
elements1 B-X
. B-X
Although B-X
this B-X
microsatellite B-X
instability B-X
has B-X
been B-X
attributed B-X
to B-X
mutations B-X
in B-X
four B-X
DNA B-X
mismatch B-X
repair B-X
genes B-X
in B-X
hereditary B-X
nonpolyposis B-X
colorectal B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
VCV000008738.5 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X

Many	O
human	O
tumours	B-Disease
have	O
length	O
alterations	O
in	O
repetitive	O
sequence	O
elements	O
.	O
<EOS> B-X
Systematic B-X
analysis B-X
of B-X
telomere B-X
length B-X
and B-X
somatic B-X
alterations B-X
in B-X
31 B-X
cancer B-X
types B-X
Repetitive B-X
Elements B-X
May B-X
Comprise B-X
Over B-X
Two-Thirds B-X
of B-X
the B-X
Human B-X
Genome B-X
Short-Sequence B-X
DNA B-X
Repeats B-X
in B-X
Prokaryotic B-X
Genomes B-X
Revisiting B-X
Telomere B-X
Shortening B-X
in B-X
Cancer B-X
Chromosome B-X
Evolution B-X
in B-X
Connection B-X
with B-X
Repetitive B-X
Sequences B-X
and B-X
Epigenetics B-X
in B-X
Plants B-X
SVA B-X
retrotransposons B-X
as B-X
potential B-X
modulators B-X
of B-X
neuropeptide B-X
gene B-X
expression B-X
Numerous B-X
mutations B-X
have B-X
been B-X
related B-X
to B-X
various B-X
types B-X
of B-X
cancer B-X
. B-X
Short B-X
tandem B-X
repeats B-X
( B-X
STRs B-X
) B-X
are B-X
repetitive B-X
DNA B-X
elements B-X
that B-X
are B-X
often B-X
polymorphic B-X
in B-X
normal B-X
populations B-X
. B-X
Triplet B-X

Although	O
this	O
microsatellite	B-Disease
instability	I-Disease
has	O
been	O
attributed	O
to	O
mutations	O
in	O
four	O
DNA	O
mismatch	O
repair	O
genes	O
in	O
hereditary	B-Disease
nonpolyposis	I-Disease
colorectal	I-Disease
cancer	I-Disease
(	O
HNPCC	B-Disease
)	O
kindreds	O
,	O
many	O
sporadic	B-Disease
tumours	I-Disease
exhibit	O
instability	O
but	O
no	O
detectable	O
mutations	O
in	O
these	O
genes	O
.	O
<EOS> B-X
DNA B-X
microsatellite B-X
instability B-X
and B-X
mismatch B-X
repair B-X
protein B-X
loss B-X
in B-X
adenomas B-X
presenting B-X
in B-X
hereditary B-X
non-polyposis B-X
colorectal B-X
cancer B-X
| B-X
Gut B-X
Alterations B-X
of B-X
the B-X
length B-X
of B-X
simple B-X
repetitive B-X
genomic B-X
sequences B-X
( B-X
microsatellite B-X
instability B-X
, B-X
MSI B-X
) B-X
characterize B-X
a B-X
distinct B-X
mechanism B-X
of B-X
colorectal B-X
carcinogenesis B-X
. B-X
Such B-X
MSI B-X
has B-X
been B-X
found B-X
to B-X
be B-X
Download B-X
Citation B-X
| B-X
Methylation B-X
of B-X
thehMLH1 B-X
promoter B-X
but B-X
nohMLH1 B-X
mutations B-X
in B-X
sporadic B-X
gastric B-X
carcinomas B-X
with B-X
high-level B-X
microsatellite B-X
instability B-X
| B-X
Microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
in B-X
tumors B-X
from B-X
patients B-X
with B-X
hereditary B-X
Microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
has B-X
been B-X
identified B-X
in B-X
various B-X
human B-X
cancers B-X
, B-X
particularly B-X
those B-X
associated B-X
with B-X
the B-X
hereditary B-X
nonpolyposis B-X
colorectal B-X
cancer B-X
syndrome B-X
. B-X
Although B-X
gliomas B-X
have B-X
been B-X
reported B-X
in B-X
Hereditary B-X
non‚Äìpolyposis B-X
colorectal B-X
cancer B-X
( B-X
HNPCC B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
characterized B-X
by B-X
the B-X
early B-X
onset B-X
of B-X
colorectal B-X
cancer B-X
and B-X
linked B-X
to B-X
germline B-X
defects B-X
in B-X
at B-X
least B-X
four B-X
mismatch B-X
Two B-X
modes B-X
of B-X
microsatellite B-X
instability B-X
in B-X
human B-X
cancer B-X
: B-X
differential B-X
connection B-X
of B-X
defective B-X
DNA B-X
mismatch B-X
repair B-X
to B-X
dinucleotide B-X
repeat B-X
instability B-X
DNA B-X
mismatch B-X
repair B-X
genes B-X
and B-X
colorectal B-X
cancer B-X
| B-X
Gut B-X

It	O
is	O
therefore	O
of	O
interest	O
to	O
identify	O
other	O
genes	O
that	O
contribute	O
to	O
this	O
instability	O
.	O
<EOS> B-X
PNAS B-X
Plus B-X
: B-X
Bioinformatic B-X
identification B-X
of B-X
genes B-X
suppressing B-X
genome B-X
instability B-X
Bioinformatic B-X
identification B-X
of B-X
genes B-X
suppressing B-X
genome B-X
instability B-X
| B-X
PNAS B-X
The B-X
identification B-X
of B-X
cancer-promoting B-X
genetic B-X
alterations B-X
is B-X
challenging B-X
particularly B-X
in B-X
highly B-X
unstable B-X
and B-X
heterogeneous B-X
cancers B-X
, B-X
such B-X
as B-X
esophageal B-X
adenocarcinoma B-X
( B-X
EAC B-X
) B-X
. B-X
Here B-X
we B-X
describe B-X
a B-X
machine B-X
learning B-X
Enhancers B-X
: B-X
five B-X
essential B-X
questions B-X

In	O
yeast	O
,	O
mutations	O
in	O
several	O
genes	O
,	O
including	O
RTH	O
and	O
MSH3	O
,	O
cause	O
microsatellite	O
instability	O
.	O
<EOS> B-X
Microsatellite B-X
instability B-X
in B-X
yeast B-X
: B-X
dependence B-X
on B-X
repeat B-X
unit B-X
size B-X
and B-X
DNA B-X
mismatch B-X
repair B-X
genes B-X
. B-X
Eukaryotic B-X
genomes B-X
contain B-X
tracts B-X
of B-X
DNA B-X
in B-X
which B-X
a B-X
single B-X
base B-X
or B-X
a B-X
small B-X
number B-X
of B-X
bases B-X
are B-X
repeated B-X
( B-X
microsatellites B-X
) B-X
. B-X
Mutations B-X
in B-X
the B-X
yeast B-X
DNA B-X
mismatch B-X
repair B-X
Mononucleotide B-X
microsatellite B-X
instability B-X
and B-X
germline B-X
MSH6 B-X
mutation B-X
analysis B-X
in B-X
early B-X
onset B-X
colorectal B-X
cancer B-X
Mutations B-X
in B-X
the B-X
MSH3 B-X
gene B-X
preferentially B-X
lead B-X
to B-X
deletions B-X
within B-X
tracts B-X
of B-X
simple B-X
repetitive B-X
DNA B-X
in B-X
Saccharomyces B-X
cerevisiae B-X
. B-X
Isolation B-X
and B-X
Characterization B-X
of B-X
Point B-X
Mutations B-X
in B-X
Mismatch B-X
Repair B-X
Genes B-X
That B-X
Destabilize B-X
Microsatellites B-X
in B-X
Yeast B-X
Novel B-X
Implications B-X
in B-X
Molecular B-X
Diagnosis B-X
of B-X
Lynch B-X
Syndrome B-X
DNA B-X
mismatch B-X
repair B-X
( B-X
MMR B-X
) B-X
function B-X
is B-X
critical B-X
for B-X
correcting B-X
errors B-X
coincident B-X
with B-X
polymerase-driven B-X
DNA B-X
replication B-X
, B-X
and B-X
its B-X
proteins B-X
are B-X
frequent B-X
targets B-X
for B-X
inactivation B-X
( B-X
germline B-X
or B-X
somatic B-X

Thus	O
,	O
we	O
screened	O
16	O
endometrial	B-Disease
carcinomas	I-Disease
with	O
microsatellite	O
instability	O
for	O
alterations	O
in	O
FEN1	O
(	O
the	O
human	O
homolog	O
of	O
RTH	O
)	O
and	O
in	O
MSH3	O
(	O
refs	O
12	O
-	O
14	O
)	O
.	O
<EOS> B-X
Endometrial B-X
cancer B-X
is B-X
associated B-X
with B-X
numeric B-X
and B-X
structural B-X
chromosomal B-X
abnormalities B-X
, B-X
microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
, B-X
and B-X
alterations B-X
that B-X
activate B-X
oncogenes B-X
and B-X
inactivate B-X
tumor B-X
suppressor B-X
genes B-X
. B-X
The B-X
aim B-X
Request B-X
PDF B-X
| B-X
Microsatellite B-X
instability B-X
and B-X
hMLH1/hMSH2 B-X
expression B-X
in B-X
young B-X
endometrial B-X
carcinoma B-X
patients B-X
: B-X
Associations B-X
with B-X
family B-X
history B-X
and B-X
histopathology B-X
| B-X
Endometrial B-X
cancer B-X
is B-X
the B-X
second B-X
most B-X
common B-X
malignancy B-X
in B-X
Download B-X
Citation B-X
| B-X
Microsatellite B-X
instability B-X
is B-X
associated B-X
with B-X
genetic B-X
alteration B-X
but B-X
not B-X
with B-X
low B-X
levels B-X
of B-X
expression B-X
of B-X
the B-X
human B-X
mismatch B-X
repair B-X
proteins B-X
hMSH2 B-X
and B-X
hMLH1 B-X
| B-X
Mutational B-X
inactivation B-X
of B-X
WikiGenes B-X
- B-X
Endometrial B-X
Neoplasms B-X
Request B-X
PDF B-X
| B-X
Absence B-X
of B-X
PTEN B-X
Repeat B-X
Tract B-X
Mutation B-X
in B-X
Endometrial B-X
Cancers B-X
with B-X
Microsatellite B-X
Instability B-X
| B-X
Objective B-X
: B-X
PTEN B-X
, B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
shown B-X
to B-X
be B-X
frequently B-X
mutated B-X
in B-X
Request B-X
PDF B-X
| B-X
HMSH6 B-X
alterations B-X
in B-X
patients B-X
with B-X
microsatellite B-X
instability-low B-X
colorectal B-X
cancer B-X
| B-X
Two B-X
microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
phenotypes B-X
have B-X
been B-X
described B-X
in B-X
colorectal B-X
cancer B-X
( B-X
CRC B-X
) B-X
: B-X
Endometrial B-X
cancer B-X
is B-X
the B-X
most B-X
common B-X
cancer B-X
in B-X
women B-X
with B-X
Lynch B-X
syndrome B-X
. B-X
The B-X
identification B-X
of B-X
individuals B-X
with B-X
Lynch B-X
syndrome B-X
is B-X
desirable B-X
because B-X
they B-X
can B-X
benefit B-X
from B-X
increased B-X
cancer B-X
surveillance B-X

Although	O
we	O
found	O
no	O
FEN1	O
mutations	O
,	O
a	O
frameshift	O
mutation	O
in	O
MSH3	O
was	O
observed	O
in	O
an	O
endometrial	B-Disease
carcinoma	I-Disease
and	O
in	O
an	O
endometrial	B-Disease
carcinoma	I-Disease
cell	O
line	O
.	O
<EOS> B-X
Although B-X
the B-X
delta B-X
A B-X
mutation B-X
is B-X
a B-X
frequent B-X
event B-X
in B-X
sporadic B-X
MSI-positive B-X
endometrial B-X
cancers B-X
, B-X
it B-X
may B-X
not B-X
be B-X
causally B-X
associated B-X
with B-X
defective B-X
DNA B-X
MMR B-X
. B-X
Germ-line B-X
msh6 B-X
Mutations B-X
in B-X
Colorectal B-X
Cancer B-X
Families B-X
| B-X
Cancer B-X
Research B-X
Request B-X
PDF B-X
| B-X
Inactivation B-X
of B-X
the B-X
hMSH3 B-X
mismatch B-X
repair B-X
gene B-X
in B-X
bladder B-X
cancer B-X
| B-X
Deficiency B-X
in B-X
the B-X
DNA B-X
mismatch B-X
repair B-X
( B-X
MMR B-X
) B-X
is B-X
frequently B-X
involved B-X
in B-X
various B-X
cancers B-X
. B-X
Request B-X
PDF B-X
| B-X
Genetic B-X
Analysis B-X
of B-X
Mouse B-X
Embryonic B-X
Stem B-X
Cells B-X
Bearing B-X
Msh3 B-X
and B-X
Msh2 B-X
Single B-X
and B-X
Compound B-X
Mutations B-X
| B-X
We B-X
have B-X
previously B-X
described B-X
the B-X
use B-X
of B-X
homologous B-X
recombination B-X
and B-X
CRE-loxP-mediated B-X
PDF B-X
| B-X
Disruption B-X
of B-X
the B-X
DNA B-X
mismatch B-X
repair B-X
system B-X
, B-X
characterized B-X
by B-X
microsatellite B-X
instability B-X
( B-X
MI B-X
) B-X
, B-X
plays B-X
an B-X
important B-X
role B-X
in B-X
the B-X
course B-X
of B-X
human B-X
... B-X
| B-X
Find B-X

Extracts	O
of	O
the	O
cell	O
line	O
were	O
deficient	O
in	O
repair	O
of	O
DNA	O
substrates	O
containing	O
mismatches	O
or	O
extra	O
nucleotides	O
.	O
<EOS> B-X
Mutation B-X
in B-X
the B-X
Mismatch B-X
Repair B-X
Gene B-X
Msh6 B-X
Causes B-X
Cancer B-X
Susceptibility B-X
: B-X
Cell B-X
The B-X
DNA B-X
Mismatch B-X
Repair B-X
Genes B-X
Msh3 B-X
and B-X
Msh6 B-X
Cooperate B-X
in B-X
Intestinal B-X
Tumor B-X
Suppression B-X
| B-X
Cancer B-X
Research B-X
An B-X
Msh2 B-X
Point B-X
Mutation B-X
Uncouples B-X
DNA B-X
Mismatch B-X
Repair B-X
and B-X
Apoptosis B-X
| B-X
Cancer B-X
Research B-X
Mutation B-X
in B-X
the B-X
Mismatch B-X
Repair B-X
Gene B-X
Msh6 B-X
Causes B-X
Cancer B-X
Susceptibility B-X
- B-X
ScienceDirect B-X

Introducing	O
chromosome	O
5	O
,	O
encoding	O
the	O
MSH3	O
gene	O
,	O
into	O
the	O
mutant	O
cell	O
line	O
increased	O
the	O
stability	O
of	O
some	O
but	O
not	O
all	O
microsatellites	O
.	O
<EOS> B-X
Functional B-X
Overlap B-X
in B-X
Mismatch B-X
Repair B-X
by B-X
Human B-X
MSH3 B-X
and B-X
MSH6 B-X
| B-X
Genetics B-X
Inflammation-Associated B-X
Microsatellite B-X
Alterations B-X
Caused B-X
by B-X
MSH3 B-X
Dysfunction B-X
Are B-X
Prevalent B-X
in B-X
Ulcerative B-X
Colitis B-X
and B-X
Increase B-X
With B-X
Neoplastic B-X
Advancement B-X
An B-X
MSI B-X
Tumor B-X
Specific B-X
Frameshift B-X
Mutation B-X
in B-X
a B-X
Coding B-X
Microsatellite B-X
of B-X
MSH3 B-X
Encodes B-X
for B-X
HLA-A0201-Restricted B-X
CD8+ B-X
Cytotoxic B-X
T B-X
Cell B-X
Epitopes B-X
Inactivating B-X
mutations B-X
affecting B-X
key B-X
mismatch B-X
repair B-X
( B-X
MMR B-X
) B-X
components B-X
lead B-X
to B-X
microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
and B-X
cancer B-X
. B-X
However B-X
, B-X
a B-X
number B-X
of B-X
patients B-X
with B-X
MSI-tumors B-X
do B-X
not B-X
Microsatellite B-X
Instability B-X
Pathway B-X
and B-X
EMAST B-X
in B-X
Colorectal B-X
Cancer B-X
MSH3 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
MSH3 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Extracts	O
of	O
these	O
cells	O
repaired	O
certain	O
substrates	O
containing	O
extra	O
nucleotides	O
,	O
but	O
were	O
deficient	O
in	O
repair	O
of	O
those	O
containing	O
mismatches	O
or	O
other	O
extra	O
nucleotides	O
.	O
<EOS> B-X
PDF B-X
| B-X
Repair B-X
of B-X
mismatches B-X
in B-X
DNA B-X
in B-X
mammalian B-X
cells B-X
is B-X
mediated B-X
by B-X
a B-X
complex B-X
of B-X
proteins B-X
that B-X
are B-X
members B-X
of B-X
two B-X
highly B-X
conserved B-X
families B-X
of B-X
genes B-X
... B-X
| B-X
Find B-X
Isolation B-X
of B-X
MutSŒ≤ B-X
from B-X
Human B-X
Cells B-X
and B-X
Comparison B-X
of B-X
the B-X
Mismatch B-X
Repair B-X
Specificities B-X
of B-X
MutSŒ≤ B-X
and B-X
MutSŒ± B-X
- B-X
ScienceDirect B-X
Interconverting B-X
Conformations B-X
of B-X
Slipped-DNA B-X
Junctions B-X
Formed B-X
by B-X
Trinucleotide B-X
Repeats B-X
Affect B-X
Repair B-X
Outcome B-X
The B-X
DNA B-X
Mismatch B-X
Repair B-X
Genes B-X
Msh3 B-X
and B-X
Msh6 B-X
Cooperate B-X
in B-X
Intestinal B-X
Tumor B-X
Suppression B-X
| B-X
Cancer B-X
Research B-X

A	O
subsequent	O
search	O
revealed	O
a	O
second	O
gene	O
mutation	O
in	O
HHUA	O
cells	O
,	O
a	O
missense	O
mutation	O
in	O
the	O
MSH6	O
gene	O
.	O
<EOS> B-X
A B-X
Hereditable B-X
Mutation B-X
of B-X
MSH2 B-X
Gene B-X
Associated B-X
with B-X
Lynch B-X
Syndrome B-X
in B-X
a B-X
Five B-X
Generation B-X
Chinese B-X
Family B-X
Mutation B-X
of B-X
MSH3 B-X
in B-X
endometrial B-X
cancer B-X
and B-X
evidence B-X
for B-X
its B-X
functional B-X
role B-X
in B-X
heteroduplex B-X
repair B-X
. B-X
Detection B-X
of B-X
hMSH2 B-X
and B-X
hMLH1 B-X
mutations B-X
in B-X
Chinese B-X
hereditary B-X
non-polyposis B-X
colorectal B-X
cancer B-X
kindreds B-X
WikiGenes B-X
- B-X
MSH6 B-X
- B-X
mutS B-X
homolog B-X
6 B-X
Next B-X
generation B-X
sequencing B-X
in B-X
synovial B-X
sarcoma B-X
reveals B-X
novel B-X
gene B-X
mutations B-X
Request B-X
PDF B-X
| B-X
Dominant B-X
effects B-X
of B-X
an B-X
Msh6 B-X
missense B-X
mutation B-X
on B-X
DNA B-X
repair B-X
and B-X
cancer B-X
susceptibility B-X
| B-X
Mutations B-X
in B-X
DNA B-X
mismatch B-X
repair B-X
( B-X
MMR B-X
) B-X
genes B-X
cause B-X
hereditary B-X
nonpolyposis B-X
colorectal B-X
Identification B-X
of B-X
novel B-X
mutations B-X
in B-X
endometrial B-X
cancer B-X
patients B-X
by B-X
whole-exome B-X
sequencing B-X

Together	O
the	O
data	O
suggest	O
that	O
the	O
MSH3	O
gene	O
encodes	O
a	O
product	O
that	O
functions	O
in	O
repair	O
of	O
some	O
but	O
not	O
all	O
pre	O
-	O
mutational	O
intermediates	O
,	O
its	O
mutation	O
in	O
tumours	B-Disease
can	O
result	O
in	O
genomic	O
instability	O
and	O
,	O
as	O
in	O
yeast	O
,	O
MSH3	O
and	O
MSH6	O
are	O
partially	O
redundant	O
for	O
mismatch	O
repair	O
.	O
.	O
<EOS> B-X
Functional B-X
overlap B-X
in B-X
mismatch B-X
repair B-X
by B-X
human B-X
MSH3 B-X
and B-X
MSH6 B-X
. B-X
Three B-X
human B-X
genes B-X
, B-X
hMSH2 B-X
, B-X
hMSH3 B-X
, B-X
and B-X
hMSH6 B-X
, B-X
are B-X
homologues B-X
of B-X
the B-X
bacterial B-X
MutS B-X
gene B-X
whose B-X
products B-X
bind B-X
DNA B-X
mismatches B-X
to B-X
initiate B-X
strand-specific B-X
repair B-X
of B-X
DNA B-X
replication B-X
The B-X
properties B-X
of B-X
Msh2‚ÄìMsh6 B-X
ATP B-X
binding B-X
mutants B-X
suggest B-X
a B-X
signal B-X
amplification B-X
mechanism B-X
in B-X
DNA B-X
mismatch B-X
repair B-X
New B-X
insights B-X
into B-X
the B-X
mechanism B-X
of B-X
DNA B-X
mismatch B-X
repair B-X
Understanding B-X
how B-X
mismatch B-X
repair B-X
proteins B-X
participate B-X
in B-X
the B-X
repair/anti-recombination B-X
decision B-X
Saccharomyces B-X
cerevisiae B-X
MSH2-MSH3 B-X
and B-X
MSH2-MSH6 B-X
complexes B-X
display B-X
distinct B-X
requirements B-X
for B-X
DNA B-X
binding B-X
Domain B-X
I B-X
in B-X
mismatch B-X
recognition B-X
. B-X
The B-X
authors B-X
review B-X
studies B-X
, B-X
primarily B-X
in B-X
baker B-X
's B-X
yeast B-X
, B-X
which B-X
support B-X
how B-X
specific B-X
factors B-X
can B-X
regulate B-X
the B-X
MMR/anti-recombination B-X
decision B-X
. B-X

Comparative	O
genome	O
mapping	O
of	O
the	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
region	O
in	O
mouse	O
,	O
rat	O
,	O
and	O
Syrian	O
hamster	O
.	O
<EOS> B-X
Comparative B-X
Genome B-X
Mapping B-X
of B-X
the B-X
Ataxia‚ÄìTelangiectasia B-X
Region B-X
in B-X
Mouse B-X
, B-X
Rat B-X
, B-X
and B-X
Syrian B-X
Hamster B-X
- B-X
ScienceDirect B-X
Article B-X
‚Äú B-X
Comparative B-X
Genome B-X
Mapping B-X
of B-X
the B-X
Ataxia-Telangiectasia B-X
Region B-X
in B-X
Mouse B-X
, B-X
Rat B-X
, B-X
and B-X
Syrian B-X
Hamster. B-X
‚Äù B-X
Detailed B-X
information B-X
of B-X
the B-X
J-GLOBAL B-X
is B-X
a B-X
service B-X
based B-X
on B-X
the B-X
concept B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Abstract B-X
. B-X
By B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
( B-X
FISH B-X
) B-X
using B-X
mouse B-X
probes B-X
, B-X
we B-X
assigned B-X
homologues B-X
for B-X
cathepsin B-X
E B-X
( B-X
< B-X
i B-X
> B-X
Ctse B-X
< B-X
/i B-X
> B-X
) B-X
, B-X
Principal B-X
InvestigatorÔºöMATSUDA B-X
Yoichi B-X
, B-X
Project B-X
Period B-X
( B-X
FY B-X
) B-X
Ôºö1995 B-X
‚Äì B-X
1996 B-X
, B-X
Research B-X
CategoryÔºöGrant-in-Aid B-X
for B-X
Scientific B-X
Research B-X
( B-X
C B-X
) B-X
, B-X
SectionÔºö‰∏ÄËà¨ B-X
, B-X
Research B-X
FieldÔºöLaboratory B-X
animal B-X
science B-X

Chromosomal	O
locations	O
of	O
the	O
Atm	O
(	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
(	O
AT	B-Disease
)	O
-	O
mutated	O
)	O
and	O
Acat1	O
(	O
mitochondrial	O
acetoacetyl	O
-	O
CoA	O
thiolase	O
)	O
genes	O
in	O
mouse	O
,	O
rat	O
,	O
and	O
Syrian	O
hamster	O
were	O
determined	O
by	O
direct	O
R	O
-	O
banding	O
FISH	O
.	O
<EOS> B-X
Chromosomal B-X
locations B-X
of B-X
the B-X
Atm B-X
( B-X
ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
-mutated B-X
) B-X
and B-X
Acat1 B-X
( B-X
mitochondrial B-X
acetoacetyl-CoA B-X
thiolase B-X
) B-X
genes B-X
in B-X
mouse B-X
, B-X
rat B-X
, B-X
and B-X
Syrian B-X
hamster B-X
were B-X
determined B-X
Comparative B-X
Gene B-X
Mapping B-X
of B-X
the B-X
Human B-X
and B-X
Mouse B-X
TEP1 B-X
Genes B-X
, B-X
Which B-X
Encode B-X
One B-X
Protein B-X
Component B-X
of B-X
Telomerases B-X
- B-X
ScienceDirect B-X
Using B-X
direct B-X
R-banding B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
, B-X
we B-X
assigned B-X
five B-X
functional B-X
genes‚Äîgrowth B-X
hormone B-X
receptor B-X
( B-X
GHR B-X
) B-X
, B-X
prolactin B-X
receptor B-X
( B-X
PRLR B-X
) B-X
, B-X
spleen B-X
tyrosine B-X
kinase B-X
( B-X
SYK B-X
Request B-X
PDF B-X
| B-X
Conservation B-X
of B-X
the B-X
rat B-X
X B-X
chromosome B-X
gene B-X
order B-X
in B-X
rodent B-X
species B-X
| B-X
We B-X
constructed B-X
the B-X
comparative B-X
cytogenetic B-X
maps B-X
of B-X
X B-X
chromosomes B-X
in B-X
three B-X
rodent B-X
species B-X
, B-X
Indian B-X
Request B-X
PDF B-X
| B-X
Construction B-X
of B-X
comparative B-X
cytogenetic B-X
maps B-X
of B-X
the B-X
Chinese B-X
hamster B-X
to B-X
mouse B-X
, B-X
rat B-X
and B-X
human B-X
| B-X
We B-X
constructed B-X
comparative B-X
cytogenetic B-X
maps B-X
of B-X
the B-X
Chinese B-X
hamster B-X
to B-X
mouse B-X
In B-X
order B-X
to B-X
construct B-X
a B-X
chicken B-X
< B-X
i B-X
> B-X
( B-X
Gallus B-X
gallus B-X
) B-X
< B-X
/i B-X
> B-X
cytogenetic B-X
map B-X
, B-X
we B-X
isolated B-X
134 B-X
genomic B-X
DNA B-X
clones B-X
as B-X
new B-X
cytogenetic B-X
markers B-X
from B-X
During B-X
the B-X
last B-X
few B-X
decades B-X
, B-X
Cytogenetic B-X
and B-X
Genome B-X
Research B-X
has B-X
been B-X
the B-X
leading B-X
forum B-X
for B-X
original B-X
reports B-X
and B-X
reviews B-X
in B-X
human B-X
, B-X
animal B-X
, B-X
insect B-X
, B-X
and B-X
plant B-X
cytogenetics B-X

Both	O
genes	O
were	O
colocalized	O
to	O
the	O
C	O
-	O
D	O
band	O
of	O
mouse	O
chromosome	O
9	O
,	O
the	O
proximal	O
end	O
of	O
q24	O
.	O
<EOS> B-X
A B-X
position B-X
effect B-X
on B-X
TRPS1 B-X
is B-X
associated B-X
with B-X
Ambras B-X
syndrome B-X
in B-X
humans B-X
and B-X
the B-X
Koala B-X
phenotype B-X
in B-X
mice B-X
FXY2/MID2 B-X
, B-X
a B-X
Gene B-X
Related B-X
to B-X
the B-X
X-Linked B-X
Opitz B-X
Syndrome B-X
Gene B-X
FXY/MID1 B-X
, B-X
Maps B-X
to B-X
Xq22 B-X
and B-X
Encodes B-X
a B-X
FNIII B-X
Domain-Containing B-X
Protein B-X
That B-X
Associates B-X
with B-X
Microtubules B-X
- B-X
ScienceDirect B-X

1	O
of	O
rat	O
chromosome	O
8	O
,	O
and	O
qa4	O
-	O
qa5	O
of	O
Syrian	O
hamster	O
chromosome	O
12	O
.	O
<EOS> B-X
Comparative B-X
genome B-X
mapping B-X
of B-X
the B-X
ataxia-telangiectasia B-X
region B-X
in B-X
mouse B-X
, B-X
rat B-X
, B-X
and B-X
Syrian B-X
hamster B-X
. B-X
Chromosomal B-X
locations B-X
of B-X
the B-X
Atm B-X
( B-X
ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
-mutated B-X
) B-X
and B-X
Acat1 B-X
( B-X
mitochondrial B-X
acetoacetyl-CoA B-X
thiolase B-X
) B-X
genes B-X
in B-X
mouse B-X
, B-X
rat B-X
, B-X
and B-X
Syrian B-X
hamster B-X
were B-X
determined B-X
AbstractChromosomal B-X
locations B-X
of B-X
theAtm B-X
( B-X
ataxia‚Äìtelangiectasia B-X
( B-X
AT B-X
) B-X
-mutated B-X
) B-X
andAcat1 B-X
( B-X
mitochondrial B-X
acetoacetyl-CoA B-X
thiolase B-X
) B-X
genes B-X
in B-X
mouse B-X
, B-X
rat B-X
, B-X
and B-X
Syrian B-X
hamster B-X
were B-X
determined B-X
by B-X
direct B-X
This B-X
study B-X
was B-X
performed B-X
( B-X
1 B-X
) B-X
to B-X
provide B-X
a B-X
comparison B-X
of B-X
the B-X
genotoxic B-X
effects B-X
of B-X
inhaled B-X
radon B-X
and B-X
radon B-X
progeny B-X
, B-X
referred B-X
to B-X
as B-X
radon B-X
in B-X
this B-X
paper B-X
, B-X
WikiGenes B-X
- B-X
The B-X
BIO14.6 B-X
hamster B-X
is B-X
a B-X
widely B-X
used B-X
model B-X
for B-X
autosomal B-X
recessive B-X
cardiomyopathy B-X
. B-X
These B-X
animals B-X
die B-X
prematurely B-X
from B-X
progressive B-X
myocardial B-X
necrosis B-X
and B-X
heart B-X
failure B-X
. B-X
The B-X
primary B-X
genetic B-X
defect B-X
leading B-X
Tadahiro B-X
Shiomi B-X
's B-X
65 B-X
research B-X
works B-X
with B-X
1,512 B-X
citations B-X
and B-X
2,208 B-X
reads B-X
, B-X
including B-X
: B-X
Deoxyinosine B-X
triphosphate B-X
induces B-X
MLH1/PMS2-and B-X
p53-dependent B-X
cell B-X
growth B-X
arrest B-X
and B-X
DNA B-X
instability B-X
in B-X
mammalian B-X
cells B-X
OPEN B-X

The	O
regions	O
in	O
the	O
mouse	O
and	O
rat	O
were	O
homologous	O
to	O
human	O
chromosome	O
11q	O
.	O
<EOS> B-X
The B-X
DNA B-X
sequence B-X
of B-X
the B-X
human B-X
X B-X
chromosome B-X
Abstract B-X
. B-X
The B-X
Œî B-X
Sxr B-X
b B-X
deletion B-X
interval B-X
of B-X
the B-X
mouse B-X
Y B-X
chromosome B-X
contains B-X
Spy B-X
, B-X
a B-X
spermatogenesis B-X
factor B-X
gene B-X
( B-X
s B-X
) B-X
whose B-X
expression B-X
is B-X
essential B-X
for B-X
the B-X
postnata B-X
Characterization B-X
of B-X
the B-X
Genomic B-X
Xist B-X
Locus B-X
in B-X
Rodents B-X
Reveals B-X
Conservation B-X
of B-X
Overall B-X
Gene B-X
Structure B-X
and B-X
Tandem B-X
Repeats B-X
but B-X
Rapid B-X
Evolution B-X
of B-X
Unique B-X
Sequence B-X
Rodent B-X
models B-X
in B-X
Down B-X
syndrome B-X
research B-X
: B-X
impact B-X
and B-X
future B-X
opportunities B-X
Comparative B-X
Maps B-X

Fine	O
genetic	O
linkage	O
mapping	O
of	O
the	O
mouse	O
AT	B-Disease
region	O
was	O
performed	O
using	O
the	O
interspecific	O
backcross	O
mice	O
.	O
<EOS> B-X
An B-X
interspecific B-X
backcross B-X
linkage B-X
map B-X
of B-X
mouse B-X
chromosome B-X
8 B-X
- B-X
ScienceDirect B-X
Technological B-X
advances B-X
have B-X
made B-X
possible B-X
the B-X
development B-X
of B-X
high-resolution B-X
genetic B-X
linkage B-X
maps B-X
for B-X
the B-X
mouse B-X
. B-X
These B-X
maps B-X
in B-X
turn B-X
offer B-X
exciting B-X
prospects B-X
for B-X
... B-X
A B-X
molecular B-X
genetic B-X
linkage B-X
map B-X
of B-X
mouse B-X
chromosome B-X
13 B-X
was B-X
constructed B-X
using B-X
cloned B-X
DNA B-X
markers B-X
and B-X
interspecific B-X
backcross B-X
mice B-X
from B-X
two B-X
independent B-X
crosses B-X
. B-X
The B-X
map B-X
locations B-X
of B-X
Ctla-3 B-X
, B-X
A B-X
multilocus B-X
linkage B-X
map B-X
of B-X
mouse B-X
chromosome B-X
8 B-X
- B-X
ScienceDirect B-X
A B-X
molecular B-X
genetic B-X
linkage B-X
map B-X
of B-X
mouse B-X
chromosome B-X
13 B-X
anchored B-X
by B-X
the B-X
beige B-X
( B-X
bg B-X
) B-X
and B-X
satin B-X
( B-X
sa B-X
) B-X
loci B-X
- B-X
ScienceDirect B-X
Molecular B-X
genetic B-X
markers B-X
spanning B-X
mouse B-X
chromosome B-X
10 B-X
- B-X
ScienceDirect B-X
Genetic B-X
mapping B-X
of B-X
meander B-X
tail B-X
, B-X
a B-X
mouse B-X
mutation B-X
affecting B-X
cerebellar B-X
development B-X
- B-X
ScienceDirect B-X

Atm	O
,	O
Acat1	O
,	O
and	O
Npat	O
,	O
which	O
is	O
a	O
new	O
gene	O
isolated	O
from	O
the	O
AT	O
region	O
,	O
and	O
12	O
flanking	O
microsatellite	O
DNA	O
markers	O
were	O
examined	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
Npat B-X
- B-X
nuclear B-X
protein B-X
in B-X
the B-X
AT B-X
region B-X
Takashi B-X
Imai B-X
's B-X
131 B-X
research B-X
works B-X
with B-X
1,845 B-X
citations B-X
and B-X
3,692 B-X
reads B-X
, B-X
including B-X
: B-X
Radiogenomics B-X
Consortium B-X
Genome-Wide B-X
Association B-X
Study B-X
Meta-Analysis B-X
of B-X
Late B-X
Toxicity B-X
After B-X
Prostate B-X
Cancer B-X
Radiotherapy B-X
Use B-X
of B-X
at B-X
least B-X
one B-X
polynucleotide B-X
fragment B-X
comprising B-X
at B-X
least B-X
18 B-X
consecutive B-X
nucleotides B-X
whose B-X
sequence B-X
corresponds B-X
to B-X
all B-X
or B-X
part B-X
of B-X
a B-X
gene B-X
from B-X
the B-X
human B-X
chromosome B-X
3 B-X
chosen B-X
from B-X
CMS B-X
, B-X
Netcommons B-X
, B-X
Maple B-X
PDF B-X
| B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
involving B-X
cerebellar B-X
degeneration B-X
, B-X
immunodeficiency B-X
, B-X
chromosomal B-X
instability B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
The B-X
invention B-X
concerns B-X
the B-X
use B-X
of B-X
at B-X
least B-X
one B-X
polynucleotide B-X
fragment B-X
comprising B-X
at B-X
least B-X
18 B-X
consecutive B-X
nucleotides B-X
whereof B-X
the B-X
sequence B-X
corresponds B-X
to B-X
all B-X
or B-X
part B-X
of B-X
a B-X
human B-X
chromosome B-X
3 B-X
The B-X
invention B-X
concerns B-X
the B-X
use B-X
of B-X
at B-X
least B-X
one B-X
polynucleotide B-X
fragment B-X
comprising B-X
at B-X
least B-X
18 B-X
consecutive B-X
nucleotides B-X
whereof B-X
the B-X
sequence B-X
corresponds B-X
to B-X
all B-X
or B-X
part B-X
of B-X
a B-X
human B-X
chromosome B-X
3 B-X

No	O
recombinations	O
were	O
found	O
among	O
the	O
Atm	O
,	O
Npat	O
,	O
Acat1	O
,	O
and	O
D9Mit6	O
loci	O
,	O
and	O
these	O
loci	O
were	O
mapped	O
2	O
.	O
<EOS> B-X
Haplotypes B-X
at B-X
ATM B-X
Identify B-X
Coding-Sequence B-X
Variation B-X
and B-X
Indicate B-X
a B-X
Region B-X
of B-X
Extensive B-X
Linkage B-X
Disequilibrium B-X
ATM B-X
orchestrates B-X
the B-X
DNA-damage B-X
response B-X
to B-X
counter B-X
toxic B-X
non-homologous B-X
end-joining B-X
at B-X
broken B-X
replication B-X
forks B-X
Ataxia-telangiectasia B-X
mutated B-X
( B-X
ATM B-X
) B-X
is B-X
needed B-X
for B-X
the B-X
initiation B-X
of B-X
the B-X
double-strand B-X
break B-X
( B-X
DSB B-X
) B-X
repair B-X
by B-X
homologous B-X
recombination B-X
( B-X
HR B-X
) B-X
. B-X
ATM B-X
triggers B-X
DSB B-X
end B-X
resection B-X

0	O
cM	O
distal	O
to	O
D9Mit99	O
and	O
1	O
.	O
<EOS> B-X
Problem B-X
5 B-X
A B-X
cast B-X
venturi B-X
meter B-X
is B-X
to B-X
be B-X
used B-X
to B-X
meter B-X
the B-X
flow B-X
of B-X
15 B-X
C B-X
water B-X
from B-X
AA B-X
1 B-X
Homework B-X
Statement B-X
A B-X
4 B-X
cm B-X
diameter B-X
cylinder B-X
floats B-X
in B-X
the B-X
water B-X
. B-X
How B-X
much B-X
work B-X
must B-X
be B-X
done B-X
to B-X
push B-X
the B-X
cylinder B-X
10 B-X
cm B-X
deeper B-X
into B-X
the B-X
water B-X
... B-X
Introduction B-X
to B-X
the B-X
Metric B-X
System B-X
Body B-X
Lab B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
PDF B-X
| B-X
The B-X
promyelocytic B-X
leukemia B-X
zinc B-X
finger B-X
gene B-X
Plzf B-X
( B-X
also B-X
called B-X
Zbtb16 B-X
, B-X
Zfp145 B-X
or B-X
Green B-X
's B-X
luxoid B-X
) B-X
belongs B-X
to B-X
the B-X
POZ/zinc-finger B-X
family B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
Download B-X
scientific B-X
diagram B-X
| B-X
FIGURE B-X
LEGEND B-X
The B-X
chart B-X
shows B-X
a B-X
current B-X
genetic B-X
map B-X
of B-X
the B-X
mouse B-X
that B-X
provides B-X
a B-X
marker B-X
every B-X
0.6 B-X
centimorgans B-X
( B-X
cM B-X
) B-X
on B-X
average B-X
, B-X
which B-X
Circulatory B-X
System B-X
: B-X
The B-X
speed B-X
S B-X
of B-X
blood B-X
that B-X
is B-X
r B-X
centimeters B-X
from B-X
the B-X
center B-X
of B-X
an B-X
artery B-X
is B-X
S=C B-X
( B-X
R^2 B-X
- B-X
r^2 B-X
) B-X
where B-X
C B-X
is B-X
a B-X
constant B-X

3	O
cM	O
proximal	O
to	O
D9Mit102	O
.	O
<EOS> B-X
The B-X
genetic B-X
component B-X
of B-X
susceptibility B-X
to B-X
malaria B-X
is B-X
complex B-X
, B-X
both B-X
in B-X
humans B-X
and B-X
in B-X
the B-X
mouse B-X
model B-X
of B-X
infection B-X
. B-X
Two B-X
murine B-X
loci B-X
on B-X
chromosomes B-X
8 B-X
( B-X
Pchr/Char2 B-X
) B-X
A B-X
Cutoff B-X
of B-X
2 B-X
cm B-X
Instead B-X
of B-X
3 B-X
cm B-X
Would B-X
Detect B-X
More B-X
Malignant B-X
BD-IPMNs B-X
: B-X
Is B-X
There B-X
a B-X
Reason B-X
to B-X
Be B-X
Wary B-X
of B-X
the B-X
International B-X
Consensus B-X
Guidelines B-X
? B-X
Download B-X
scientific B-X
diagram B-X
| B-X
A B-X
visible B-X
mass B-X
of B-X
3 B-X
cm B-X
in B-X
the B-X
proximal B-X
portion B-X
of B-X
the B-X
umbilical B-X
cord B-X
( B-X
a B-X
) B-X
. B-X
Lateral B-X
view B-X
of B-X
the B-X
same B-X
mass B-X
( B-X
b B-X

Comparison	O
of	O
the	O
linkage	O
map	O
of	O
mouse	O
chromosome	O
9	O
(	O
MMU9	O
)	O
and	O
that	O
of	O
human	O
chromosome	O
11	O
(	O
HSA11	O
)	O
indicates	O
that	O
there	O
is	O
a	O
chromosomal	O
rearrangement	O
due	O
to	O
an	O
inversion	O
between	O
Ets1	O
and	O
Atm	O
-	O
Npat	O
-	O
Acat1	O
and	O
that	O
the	O
inversion	O
of	O
MMU9	O
originated	O
from	O
the	O
chromosomal	O
breakage	O
at	O
the	O
boundary	O
between	O
Gria4	O
and	O
Atm	O
-	O
Npat	O
-	O
Acat1	O
on	O
HSA11	O
.	O
<EOS> B-X
A B-X
42-cM B-X
map B-X
of B-X
proximal B-X
mouse B-X
chromosome B-X
9 B-X
, B-X
including B-X
eight B-X
loci B-X
defined B-X
by B-X
restriction B-X
fragment B-X
length B-X
variants B-X
, B-X
has B-X
been B-X
generated B-X
. B-X
Linkage B-X
was B-X
established B-X
by B-X
haplotype B-X
analyses B-X
of B-X
A B-X
New B-X
Standard B-X
Genetic B-X
Map B-X
for B-X
the B-X
Laboratory B-X
Mouse B-X
Geneticists B-X
are B-X
frequently B-X
interested B-X
in B-X
knowing B-X
where B-X
a B-X
gene B-X
is B-X
located B-X
within B-X
the B-X
genome B-X
. B-X
There B-X
are B-X
many B-X
reasons B-X
for B-X
this B-X
interest B-X
. B-X
For B-X
example B-X
, B-X
in B-X
many B-X
well-studied B-X
genetic B-X
Request B-X
PDF B-X
| B-X
A B-X
comparative B-X
cytogenetic B-X
study B-X
of B-X
chromosome B-X
homology B-X
between B-X
chicken B-X
and B-X
Japanese B-X
quail B-X
| B-X
In B-X
order B-X
to B-X
construct B-X
a B-X
chicken B-X
( B-X
Gallus B-X
gallus B-X
) B-X
cytogenetic B-X
map B-X
, B-X
we B-X
Request B-X
PDF B-X
| B-X
Spatio-temporally B-X
regulated B-X
expression B-X
of B-X
receptor B-X
tyrosine B-X
kinases B-X
, B-X
mRor1 B-X
, B-X
mRor2 B-X
, B-X
during B-X
mouse B-X
development B-X
: B-X
implications B-X
in B-X
development B-X
and B-X
function B-X
of B-X
the B-X
nervous B-X
system B-X
| B-X
BackgroundsDrosophila B-X

This	O
type	O
of	O
inversion	O
appeared	O
to	O
be	O
conserved	O
in	O
the	O
three	O
rodent	O
species	O
,	O
mouse	O
,	O
rat	O
,	O
and	O
Syrian	O
hamster	O
,	O
using	O
additional	O
comparative	O
mapping	O
data	O
with	O
the	O
Rck	O
gene	O
<EOS> B-X
This B-X
Syrian B-X
hamster B-X
transcriptome B-X
dataset B-X
significantly B-X
improves B-X
our B-X
knowledge B-X
of B-X
the B-X
Syrian B-X
hamster B-X
's B-X
transcriptome B-X
, B-X
especially B-X
towards B-X
its B-X
future B-X
use B-X
in B-X
infectious B-X
disease B-X
research B-X
. B-X
Moreover B-X
, B-X
this B-X
library B-X
Human B-X
, B-X
Mouse B-X
, B-X
and B-X
Rat B-X
Genome B-X
Large-Scale B-X
Rearrangements B-X
: B-X
Stability B-X
Versus B-X
Speciation B-X
Multiple B-X
intrasyntenic B-X
rearrangements B-X
and B-X
rapid B-X
speciation B-X
in B-X
voles B-X
Rodentia B-X
is B-X
the B-X
most B-X
species-rich B-X
mammalian B-X
order B-X
and B-X
includes B-X
several B-X
important B-X
laboratory B-X
model B-X
species B-X
. B-X
The B-X
amount B-X
of B-X
new B-X
information B-X
on B-X
karyotypic B-X
and B-X
phylogenetic B-X
relations B-X
within B-X
and B-X
among B-X
rodent B-X
taxa B-X
PDF B-X
| B-X
In B-X
the B-X
agouti B-X
signaling B-X
gene B-X
protein B-X
( B-X
Asip B-X
) B-X
of B-X
the B-X
house B-X
mouse B-X
( B-X
Mus B-X
musculus B-X
) B-X
, B-X
inverted B-X
repeat B-X
( B-X
IR B-X
) B-X
arrays B-X
are B-X
known B-X
to B-X
exist B-X
All B-X
Rodents B-X
Are B-X
Not B-X
the B-X
Same B-X
: B-X
A B-X
Modern B-X
Synthesis B-X
of B-X
Cortical B-X
Organization B-X
PDF B-X
| B-X
By B-X
suppressing B-X
recombination B-X
and B-X
reducing B-X
gene B-X
flow B-X
, B-X
chromosome B-X
inversions B-X
favor B-X
the B-X
capture B-X
and B-X
protection B-X
of B-X
advantageous B-X
allelic B-X
combinations B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X

An	O
animal	O
model	O
for	O
Norrie	B-Disease
disease	I-Disease
(	O
ND	B-Disease
)	O
:	O
gene	O
targeting	O
of	O
the	O
mouse	O
ND	B-Disease
gene	O
.	O
<EOS> B-X
An B-X
animal B-X
model B-X
for B-X
Norrie B-X
disease B-X
( B-X
ND B-X
) B-X
: B-X
gene B-X
targeting B-X
of B-X
the B-X
mouse B-X
ND B-X
gene B-X
Figure B-X
1 B-X
. B-X
Hybridization B-X
of B-X
a B-X
multiple B-X
tissue B-X
Northern B-X
blot B-X
containing B-X
poly B-X
( B-X
A B-X
) B-X
+-RNA B-X
of B-X
indicated B-X
adult B-X
mouse B-X
organs B-X
and B-X
tissues B-X
using B-X
the B-X
mouse B-X
ND B-X
gene B-X
cDNA B-X
pmnc2 B-X
Figure B-X
5 B-X
. B-X
PCR-genotyping B-X
of B-X
mouse B-X
tail B-X
DNA B-X
. B-X
( B-X
a B-X
) B-X
Genotyping B-X
strategy B-X
. B-X
Amplification B-X
of B-X
the B-X
endogenous B-X
wild-type B-X
locus B-X
with B-X
two B-X
intron B-X
primers B-X
results B-X
in B-X
a B-X
fragment B-X
of B-X
View B-X
Ndp B-X
< B-X
tm1Wbrg B-X
> B-X
allele B-X
: B-X
origin B-X
, B-X
molecular B-X
description B-X
and B-X
human B-X
disease B-X
models B-X
, B-X
gene B-X
associations B-X
, B-X
and B-X
references B-X
. B-X
In B-X
order B-X
to B-X
elucidate B-X
the B-X
cellular B-X
and B-X
molecular B-X
processes B-X
which B-X
are B-X
involved B-X
in B-X
Norrie B-X
disease B-X
( B-X
ND B-X
) B-X
, B-X
we B-X
have B-X
used B-X
gene B-X
targeting B-X
technology B-X
to B-X
generate B-X
ND B-X
mutant B-X
mice B-X
The B-X
identification B-X
of B-X
numerous B-X
photoreceptor B-X
cell-specific B-X
transcripts B-X
with B-X
a B-X
reduced B-X
expression B-X
in B-X
2-year-old B-X
, B-X
but B-X
not B-X
in B-X
young B-X
, B-X
Ndp B-X
knockout B-X
mice B-X
indicates B-X
that B-X
normal B-X
gene B-X
expression B-X
in B-X
these B-X
light-sensitive B-X
Figure B-X
3 B-X
. B-X
RNA B-X
in B-X
situ B-X
hybridization B-X
of B-X
a B-X
mND B-X
gene B-X
riboprobe B-X
to B-X
a B-X
transversal B-X
cryosection B-X
of B-X
a B-X
mouse B-X
head B-X
2 B-X
weeks B-X
after B-X
birth B-X
. B-X
Bright B-X
field B-X
( B-X
a B-X
, B-X

In	O
order	O
to	O
elucidate	O
the	O
cellular	O
and	O
molecular	O
processes	O
which	O
are	O
involved	O
in	O
Norrie	B-Disease
disease	I-Disease
(	O
ND	B-Disease
)	O
,	O
we	O
have	O
used	O
gene	O
targeting	O
technology	O
to	O
generate	O
ND	B-Disease
mutant	O
mice	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
analysis B-X
of B-X
the B-X
NDP B-X
gene B-X
in B-X
two B-X
families B-X
with B-X
Norrie B-X
disease B-X
| B-X
To B-X
describe B-X
the B-X
molecular B-X
defects B-X
in B-X
the B-X
Norrie B-X
disease B-X
protein B-X
( B-X
NDP B-X
) B-X
gene B-X
Abstract B-X
. B-X
Norrie B-X
disease B-X
( B-X
ND B-X
) B-X
is B-X
a B-X
congenital B-X
disorder B-X
characterized B-X
by B-X
retinal B-X
hypovascularization B-X
and B-X
cognitive B-X
delay B-X
. B-X
ND B-X
has B-X
been B-X
linked B-X
to B-X
mutations B-X
in B-X
‚Äò B-X
Nor B-X
Norrie B-X
disease B-X
( B-X
ND B-X
) B-X
is B-X
a B-X
severe B-X
form B-X
of B-X
congenital B-X
blindness B-X
accompanied B-X
by B-X
mental B-X
retardation B-X
and/or B-X
deafness B-X
in B-X
at B-X
least B-X
one B-X
third B-X
of B-X
the B-X
patients B-X
. B-X
This B-X
article B-X
summarizes B-X
Learn B-X
about B-X
the B-X
evolution B-X
of B-X
genetic B-X
targeting B-X
techniques B-X
from B-X
ZNFs B-X
and B-X
TALENs B-X
to B-X
today B-X
‚Äô B-X
s B-X
hot B-X
CRISPR/Cas B-X
systems B-X
that B-X
allow B-X
the B-X
one-step B-X
generation B-X
of B-X
mice B-X
carrying B-X
mutations B-X
in B-X
multiple B-X
Genome-editing B-X
Technologies B-X
for B-X
Gene B-X
and B-X
Cell B-X
Therapy B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Gene B-X
targeting B-X
of B-X
the B-X
murine B-X
ND B-X
gene B-X
. B-X
( B-X
a B-X
) B-X
Targeting B-X
strategy B-X
. B-X
A B-X
portion B-X
of B-X
exon B-X
2 B-X
( B-X
black B-X
box B-X
) B-X
was B-X
replaced B-X
by B-X
The B-X
CRISPR/Cas9 B-X
system B-X
is B-X
widely B-X
used B-X
to B-X
generate B-X
gene-edited B-X
animals B-X
. B-X
Here B-X
, B-X
we B-X
developed B-X
an B-X
efficient B-X
system B-X
for B-X
generating B-X
genetically B-X
modified B-X
mice B-X
using B-X
maternal B-X
Cas9 B-X
from B-X
Cas9 B-X
transgenic B-X
mice B-X

The	O
murine	O
homologue	O
of	O
the	O
ND	B-Disease
gene	O
was	O
cloned	O
and	O
shown	O
to	O
encode	O
a	O
polypeptide	O
that	O
shares	O
94	O
%	O
of	O
the	O
amino	O
acid	O
sequence	O
with	O
its	O
human	O
counterpart	O
.	O
<EOS> B-X
Cloning B-X
of B-X
the B-X
Bacillus B-X
thuringiensis B-X
serovar B-X
sotto B-X
chitinase B-X
( B-X
Schi B-X
) B-X
gene B-X
and B-X
characterization B-X
of B-X
its B-X
protein B-X
Isolation B-X
of B-X
human B-X
and B-X
mouse B-X
genes B-X
based B-X
on B-X
homology B-X
to B-X
REC2 B-X
, B-X
a B-X
recombinational B-X
repair B-X
gene B-X
from B-X
the B-X
fungus B-X
Ustilago B-X
maydis B-X
Cloning B-X
of B-X
murine B-X
RNA B-X
polymerase B-X
I-specific B-X
TAF B-X
factors B-X
: B-X
Conserved B-X
interactions B-X
between B-X
the B-X
subunits B-X
of B-X
the B-X
species-specific B-X
transcription B-X
initiation B-X
factor B-X
TIF-IB/SL1 B-X
Identification B-X
and B-X
characterization B-X
of B-X
genes B-X
expressed B-X
in B-X
normal B-X
cells B-X
and B-X
decreased B-X
in B-X
their B-X
malignant B-X
counterparts B-X
is B-X
an B-X
important B-X
method B-X
for B-X
detecting B-X
candidate B-X
tumor B-X
suppressors B-X
. B-X
Using B-X
differential B-X
display B-X
of B-X
mRNAs B-X
The B-X
mitochondrial B-X
genome B-X
: B-X
structure B-X
, B-X
transcription B-X
, B-X
translation B-X
and B-X
replication B-X
- B-X
ScienceDirect B-X
Sequence B-X
analysis B-X
of B-X
the B-X
cDNA B-X
encoding B-X
for B-X
SpCTx B-X
: B-X
a B-X
lethal B-X
factor B-X
from B-X
scorpionfish B-X
venom B-X
( B-X
Scorpaena B-X
plumieri B-X
) B-X
Genomic B-X
Organization B-X
of B-X
the B-X
Dog B-X
Dystroglycan B-X
Gene B-X
DAG1 B-X
Locus B-X
on B-X
Chromosome B-X
20q15.1‚Äìq15.2 B-X

RNA	O
in	O
situ	O
hybridization	O
revealed	O
expression	O
in	O
retina	O
,	O
brain	O
and	O
the	O
olfactory	O
bulb	O
and	O
epithelium	O
of	O
2	O
week	O
old	O
mice	O
.	O
<EOS> B-X
Neurodegeneration B-X
in B-X
the B-X
olfactory B-X
bulb B-X
and B-X
olfactory B-X
deficits B-X
in B-X
the B-X
Ccdc66 B-X
-/- B-X
mouse B-X
model B-X
for B-X
retinal B-X
degeneration B-X
Expression B-X
of B-X
Olfactory B-X
Signaling B-X
Genes B-X
in B-X
the B-X
Eye B-X
Formation B-X
of B-X
Precise B-X
Connections B-X
in B-X
the B-X
Olfactory B-X
Bulb B-X
Occurs B-X
in B-X
the B-X
Absence B-X
of B-X
Odorant-Evoked B-X
Neuronal B-X
Activity B-X
: B-X
Neuron B-X
Non-neuronal B-X
expression B-X
of B-X
SARS-CoV-2 B-X
entry B-X
genes B-X
in B-X
the B-X
olfactory B-X
system B-X
suggests B-X
mechanisms B-X
underlying B-X
COVID-19-associated B-X
anosmia B-X
| B-X
Science B-X
Advances B-X
Non-neuronal B-X
expression B-X
of B-X
SARS-CoV-2 B-X
entry B-X
genes B-X
in B-X
the B-X
olfactory B-X
system B-X
suggests B-X
mechanisms B-X
underlying B-X
COVID-19-associated B-X
anosmia B-X
| B-X
Science B-X
Advances B-X
Non-neuronal B-X
expression B-X
of B-X
SARS-CoV-2 B-X
entry B-X
genes B-X
in B-X
the B-X
olfactory B-X
system B-X
suggests B-X
mechanisms B-X
underlying B-X
COVID-19-associated B-X
anosmia B-X
| B-X
Science B-X
Advances B-X
Purpose B-X
To B-X
advance B-X
our B-X
understanding B-X
how B-X
the B-X
outer B-X
eye B-X
interacts B-X
with B-X
its B-X
environment B-X
, B-X
we B-X
asked B-X
which B-X
cellular B-X
receptors B-X
are B-X
expressed B-X
in B-X
the B-X
cornea B-X
, B-X
focusing B-X
on B-X
G B-X
protein-coupled B-X
receptors B-X

Hemizygous	O
mice	O
carrying	O
a	O
replacement	O
mutation	O
in	O
exon	O
2	O
of	O
the	O
ND	B-Disease
gene	O
developed	O
retrolental	O
structures	O
in	O
the	O
vitreous	O
body	O
and	O
showed	O
an	O
overall	O
disorganization	O
of	O
the	O
retinal	O
ganglion	O
cell	O
layer	O
.	O
<EOS> B-X
Widespread B-X
expression B-X
of B-X
type B-X
II B-X
collagen B-X
mRNAs B-X
in B-X
ocular B-X
structures B-X
suggests B-X
an B-X
important B-X
role B-X
for B-X
type B-X
II B-X
collagen B-X
in B-X
structural B-X
development B-X
of B-X
the B-X
eye B-X
. B-X
As B-X
the B-X
expression B-X
patterns B-X
observed B-X
WikiGenes B-X
- B-X
Retinal B-X
Ganglion B-X
Cells B-X
Request B-X
PDF B-X
| B-X
Reduced B-X
expression B-X
of B-X
the B-X
nob8 B-X
gene B-X
does B-X
not B-X
normalize B-X
the B-X
distribution B-X
or B-X
function B-X
of B-X
mGluR6 B-X
in B-X
the B-X
mouse B-X
retina B-X
| B-X
Purpose B-X
: B-X
The B-X
Grm6nob8 B-X
mouse B-X
carries B-X
a B-X
Pathogenesis B-X
of B-X
Persistent B-X
Hyperplastic B-X
Primary B-X
Vitreous B-X
in B-X
Mice B-X
Lacking B-X
the B-X
Arf B-X
Tumor B-X
Suppressor B-X
Gene B-X
In B-X
order B-X
to B-X
elucidate B-X
the B-X
cellular B-X
and B-X
molecular B-X
processes B-X
which B-X
are B-X
involved B-X
in B-X
Norrie B-X
disease B-X
( B-X
ND B-X
) B-X
, B-X
we B-X
have B-X
used B-X
gene B-X
targeting B-X
technology B-X
to B-X
generate B-X
ND B-X
mutant B-X
mice B-X
Mutations B-X
in B-X
Lama1 B-X
Disrupt B-X
Retinal B-X
Vascular B-X
Development B-X
and B-X
Inner B-X
Limiting B-X
Membrane B-X
Formation B-X
Abstract B-X
. B-X
In B-X
order B-X
to B-X
elucidate B-X
the B-X
cellular B-X
and B-X
molecular B-X
processes B-X
which B-X
are B-X
involved B-X
in B-X
Norrie B-X
disease B-X
( B-X
ND B-X
) B-X
, B-X
we B-X
have B-X
used B-X
gene B-X
targeting B-X
technology B-X
to B-X
genera B-X

The	O
outer	O
plexiform	O
layer	O
disappears	O
occasionally	O
,	O
resulting	O
in	O
a	O
juxtaposed	O
inner	O
and	O
outer	O
nuclear	O
layer	O
.	O
<EOS> B-X
Arrested B-X
Foveal B-X
Development B-X
in B-X
Preterm B-X
Eyes B-X
: B-X
Thickening B-X
of B-X
the B-X
Outer B-X
Nuclear B-X
Layer B-X
and B-X
Structural B-X
Redistribution B-X
Within B-X
the B-X
Fovea B-X
| B-X
IOVS B-X
| B-X
ARVO B-X
Journals B-X
Directional B-X
Optical B-X
Coherence B-X
Tomography B-X
Provides B-X
Accurate B-X
Outer B-X
Nuclear B-X
Layer B-X
and B-X
Henle B-X
Fiber B-X
Layer B-X
Measurements B-X
Immunohistochemical B-X
Analysis B-X
of B-X
the B-X
Developing B-X
Inner B-X
Plexiform B-X
Layer B-X
in B-X
Postnatal B-X
Rat B-X
Retina B-X
| B-X
IOVS B-X
| B-X
ARVO B-X
Journals B-X
Longitudinal B-X
follow-up B-X
of B-X
two B-X
patients B-X
with B-X
isolated B-X
paracentral B-X
acute B-X
middle B-X
maculopathy B-X
The B-X
retina B-X
is B-X
the B-X
innermost B-X
layer B-X
in B-X
the B-X
eye B-X
that B-X
is B-X
responsible B-X
for B-X
the B-X
visual B-X
processing B-X
that B-X
turns B-X
light B-X
energy B-X
from B-X
photons B-X
into B-X
three-dimensional B-X
images B-X
. B-X
[ B-X
1 B-X
] B-X
Located B-X
In B-X
adult B-X
albino B-X
mice B-X
the B-X
effects B-X
of B-X
increased B-X
intraocular B-X
pressure B-X
on B-X
the B-X
outer B-X
retina B-X
and B-X
its B-X
circuitry B-X
was B-X
investigated B-X
at B-X
intervals B-X
ranging B-X
3-14 B-X
weeks B-X
. B-X
Ocular B-X
hypertension B-X
( B-X
OHT B-X
) B-X
Peptides B-X
have B-X
been B-X
found B-X
in B-X
the B-X
retinas B-X
of B-X
all B-X
mammalian B-X
species B-X
studied B-X
to B-X
date B-X
, B-X
but B-X
little B-X
is B-X
known B-X
about B-X
their B-X
localization B-X
and B-X
function B-X
in B-X
the B-X
cat B-X
. B-X
Using B-X
two B-X

At	O
the	O
same	O
regions	O
,	O
the	O
outer	O
segments	O
of	O
the	O
photoreceptor	O
cell	O
layer	O
are	O
no	O
longer	O
present	O
.	O
<EOS> B-X
Spontaneous B-X
Regeneration B-X
of B-X
Human B-X
Photoreceptor B-X
Outer B-X
Segments B-X
Photoreceptor B-X
cell B-X
- B-X
Wikipedia B-X
The B-X
morphological B-X
development B-X
of B-X
parafoveal B-X
retina B-X
( B-X
1-1.5 B-X
mm B-X
from B-X
the B-X
foveal B-X
center B-X
) B-X
and B-X
the B-X
mid-peripheral B-X
( B-X
4 B-X
mm B-X
from B-X
the B-X
foveal B-X
center B-X
) B-X
human B-X
retina B-X
has B-X
been B-X
studied B-X
Photoreceptor B-X
Cells B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Outer B-X
Nuclear B-X
Layer B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Photoreceptors B-X
by B-X
Helga B-X
Kolb B-X
‚Äì B-X
Webvision B-X
THE B-X
BRAIN B-X
FROM B-X
TOP B-X
TO B-X
BOTTOM B-X

These	O
ocular	O
findings	O
are	O
consistent	O
with	O
observations	O
in	O
ND	B-Disease
patients	O
and	O
the	O
generated	O
mouse	O
line	O
provides	O
a	O
faithful	O
model	O
for	O
study	O
of	O
early	O
pathogenic	O
events	O
in	O
this	O
severe	O
X	B-Disease
-	I-Disease
linked	I-Disease
recessive	I-Disease
neurological	I-Disease
disorder	I-Disease
.	O
.	O
<EOS> B-X
mouse B-X
neurological B-X
mutation B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
mutant B-X
mouse B-X
model B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
x-linked B-X
ipex B-X
syndrome B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
recessive B-X
disease B-X
genes B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
target B-X
gene B-X
mutations B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
wilson B-X
disease B-X
gene B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
stargardt B-X
disease B-X
gene B-X
: B-X
Topics B-X
by B-X
Science.gov B-X

The	O
hybrid	O
PAX3	O
-	O
FKHR	O
fusion	O
protein	O
of	O
alveolar	B-Disease
rhabdomyosarcoma	I-Disease
transforms	O
fibroblasts	O
in	O
culture	O
.	O
<EOS> B-X
A B-X
Genetic B-X
Analysis B-X
of B-X
PAX3-FKHR B-X
, B-X
the B-X
Oncogene B-X
of B-X
Alveolar B-X
Rhabdomyosarcoma B-X
-- B-X
Kempf B-X
and B-X
Vogt B-X
10 B-X
( B-X
12 B-X
) B-X
: B-X
813 B-X
-- B-X
Cell B-X
Growth B-X
& B-X
Differentiation B-X
Regulated B-X
expression B-X
of B-X
the B-X
diphtheria B-X
toxin B-X
A B-X
chain B-X
by B-X
a B-X
tumor-specific B-X
chimeric B-X
transcription B-X
factor B-X
results B-X
in B-X
selective B-X
toxicity B-X
for B-X
alveolar B-X
rhabdomyosarcoma B-X
cells B-X
| B-X
PNAS B-X
Pediatric B-X
alveolar B-X
rhabdomyosarcoma B-X
is B-X
characterized B-X
by B-X
a B-X
chromosomal B-X
translocation B-X
that B-X
fuses B-X
parts B-X
of B-X
the B-X
PAX3 B-X
and B-X
FKHR B-X
genes B-X
. B-X
PAX3 B-X
codes B-X
for B-X
a B-X
transcriptional B-X
regulator B-X
that B-X
controls B-X
developmental B-X
programs B-X
, B-X
Embryonic B-X
expression B-X
of B-X
the B-X
tumor-associated B-X
PAX3-FKHR B-X
fusion B-X
protein B-X
interferes B-X
with B-X
the B-X
developmental B-X
functions B-X
of B-X
Pax3 B-X
| B-X
PNAS B-X
Embryonic B-X
expression B-X
of B-X
the B-X
tumor-associated B-X
PAX3-FKHR B-X
fusion B-X
protein B-X
interferes B-X
with B-X
the B-X
developmental B-X
functions B-X
of B-X
Pax3 B-X
| B-X
PNAS B-X
Embryonic B-X
expression B-X
of B-X
the B-X
tumor-associated B-X
PAX3-FKHR B-X
fusion B-X
protein B-X
interferes B-X
with B-X
the B-X
developmental B-X
functions B-X
of B-X
Pax3 B-X
| B-X
PNAS B-X
Comparative B-X
Analysis B-X
of B-X
Paired- B-X
and B-X
Homeodomain-specific B-X
Roles B-X
in B-X
PAX3-FKHR B-X
Oncogenesis B-X

Pediatric	B-Disease
alveolar	I-Disease
rhabdomyosarcoma	I-Disease
is	O
characterized	O
by	O
a	O
chromosomal	O
translocation	O
that	O
fuses	O
parts	O
of	O
the	O
PAX3	O
and	O
FKHR	O
genes	O
.	O
<EOS> B-X
Pediatric B-X
alveolar B-X
rhabdomyosarcoma B-X
is B-X
characterized B-X
by B-X
a B-X
chromosomal B-X
translocation B-X
that B-X
fuses B-X
parts B-X
of B-X
the B-X
PAX3 B-X
and B-X
FKHR B-X
genes B-X
. B-X
PAX3 B-X
codes B-X
for B-X
a B-X
transcriptional B-X
regulator B-X
that B-X
controls B-X
developmental B-X
programs B-X
, B-X
Alveolar B-X
rhabdomyosarcoma B-X
‚Äì B-X
The B-X
molecular B-X
drivers B-X
of B-X
PAX3/7-FOXO1-induced B-X
tumorigenesis B-X
The B-X
PAX3-FKHR B-X
fusion B-X
protein B-X
created B-X
by B-X
the B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
translocation B-X
in B-X
alveolar B-X
rhabdomyosarcomas B-X
is B-X
a B-X
more B-X
potent B-X
transcriptional B-X
activator B-X
than B-X
PAX3 B-X
. B-X
NELL1 B-X
, B-X
whose B-X
high B-X
expression B-X
correlates B-X
with B-X
negative B-X
outcomes B-X
, B-X
has B-X
different B-X
methylation B-X
patterns B-X
in B-X
alveolar B-X
and B-X
embryonal B-X
rhabdomyosarcoma B-X
Recurrent B-X
( B-X
2 B-X
; B-X
2 B-X
) B-X
and B-X
( B-X
2 B-X
; B-X
8 B-X
) B-X
Translocations B-X
in B-X
Rhabdomyosarcoma B-X
without B-X
the B-X
Canonical B-X
PAX-FOXO1 B-X
fuse B-X
PAX3 B-X
to B-X
Members B-X
of B-X
the B-X
Nuclear B-X
Receptor B-X
Transcriptional B-X
Coactivator B-X
( B-X

PAX3	O
codes	O
for	O
a	O
transcriptional	O
regulator	O
that	O
controls	O
developmental	O
programs	O
,	O
and	O
FKHR	O
codes	O
for	O
a	O
forkhead	O
-	O
winged	O
helix	O
protein	O
,	O
also	O
a	O
likely	O
transcription	O
factor	O
.	O

The	O
PAX3	O
-	O
FKHR	O
fusion	O
product	O
retains	O
the	O
DNA	O
binding	O
domains	O
of	O
the	O
PAX3	O
protein	O
and	O
the	O
putative	O
activator	O
domain	O
of	O
the	O
FKHR	O
protein	O
.	O
<EOS> B-X
Alveolar B-X
rhabdomyosarcoma B-X
( B-X
ARMS B-X
) B-X
is B-X
characterized B-X
cytogenetically B-X
by B-X
a B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
chromosomal B-X
translocation B-X
involving B-X
two B-X
transcription B-X
factor B-X
genes B-X
: B-X
PAX3 B-X
The B-X
expression B-X
and B-X
function B-X
of B-X
PAX3 B-X
in B-X
development B-X
and B-X
disease B-X
Tumor-Specific B-X
PAX3-FKHR B-X
Transcription B-X
Factor B-X
, B-X
but B-X
Not B-X
PAX3 B-X
, B-X
Activates B-X
the B-X
Platelet-Derived B-X
Growth B-X
Factor B-X
Alpha B-X
Receptor B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
Genome-wide B-X
Identification B-X
of B-X
PAX3-FKHR B-X
Binding B-X
Sites B-X
in B-X
Rhabdomyosarcoma B-X
Reveals B-X
Candidate B-X
Target B-X
Genes B-X
Important B-X
for B-X
Development B-X
and B-X
Cancer B-X
An B-X
Engineered B-X
PAX3-KRAB B-X
Transcriptional B-X
Repressor B-X
Inhibits B-X
the B-X
Malignant B-X
Phenotype B-X
of B-X
Alveolar B-X
Rhabdomyosarcoma B-X
Cells B-X
Harboring B-X
the B-X
Endogenous B-X
PAX3-FKHR B-X
Oncogene B-X

The	O
PAX3	O
-	O
FKHR	O
protein	O
has	O
been	O
shown	O
to	O
function	O
as	O
a	O
transcriptional	O
activator	O
.	O
<EOS> B-X
The B-X
transcriptional B-X
activator B-X
PAX3-FKHR B-X
rescues B-X
the B-X
defects B-X
of B-X
Pax3 B-X
mutant B-X
mice B-X
but B-X
induces B-X
a B-X
myogenic B-X
gain-of-function B-X
phenotype B-X
with B-X
ligand-independent B-X
activation B-X
of B-X
Met B-X
signaling B-X
in B-X
vivo B-X
Coordinated B-X
oncogenic B-X
transformation B-X
and B-X
inhibition B-X
of B-X
host B-X
immune B-X
responses B-X
by B-X
the B-X
PAX3-FKHR B-X
fusion B-X
oncoprotein B-X
Mechanism B-X
for B-X
transcriptional B-X
gain B-X
of B-X
function B-X
resulting B-X
from B-X
chromosomal B-X
translocation B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
. B-X
PAX3 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
PAX3 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Using	O
the	O
RCAS	O
retroviral	O
vector	O
,	O
we	O
have	O
introduced	O
the	O
PAX3	O
-	O
FKHR	O
gene	O
into	O
chicken	O
embryo	O
fibroblasts	O
.	O
<EOS> B-X
The B-X
hybrid B-X
PAX3-FKHR B-X
fusion B-X
protein B-X
of B-X
alveolar B-X
rhabdomyosarcoma B-X
transforms B-X
fibroblasts B-X
in B-X
culture B-X
| B-X
PNAS B-X
Development B-X
of B-X
Retroviral B-X
Vectors B-X
for B-X
Tissue-Restricted B-X
Expression B-X
in B-X
Chicken B-X
Embryonic B-X
Gonads B-X
Pediatric B-X
alveolar B-X
rhabdomyosarcoma B-X
is B-X
characterized B-X
by B-X
a B-X
chromosomal B-X
translocation B-X
that B-X
fuses B-X
parts B-X
of B-X
the B-X
PAX3 B-X
and B-X
FKHR B-X
genes B-X
. B-X
PAX3 B-X
codes B-X
for B-X
a B-X
transcriptiona B-X
... B-X
Download B-X
Citation B-X
| B-X
Identification B-X
of B-X
a B-X
new B-X
class B-X
of B-X
PAX3-FKHR B-X
target B-X
promoters B-X
: B-X
A B-X
role B-X
of B-X
the B-X
Pax3 B-X
paired B-X
box B-X
DNA B-X
binding B-X
domain B-X
| B-X
Alveolar B-X
rhabdomyosarcoma B-X
( B-X
aRMS B-X
) B-X
, B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
ScienceDirect.com B-X
| B-X
Science B-X
, B-X
health B-X
and B-X
medical B-X
journals B-X
, B-X
full B-X
text B-X
articles B-X
and B-X
books B-X
. B-X
ScienceDirect.com B-X
| B-X
Science B-X
, B-X
health B-X
and B-X
medical B-X
journals B-X
, B-X
full B-X
text B-X
articles B-X
and B-X
books B-X
. B-X

Expression	O
of	O
the	O
PAX3	O
-	O
FKHR	O
protein	O
in	O
these	O
cells	O
leads	O
to	O
transformation	O
the	O
cells	O
become	O
enlarged	O
,	O
grow	O
tightly	O
packed	O
and	O
in	O
multiple	O
layers	O
,	O
and	O
acquire	O
the	O
ability	O
for	O
anchorage	O
-	O
independent	O
growth	O
.	O
<EOS> B-X
Embryonic B-X
expression B-X
of B-X
the B-X
tumor-associated B-X
PAX3-FKHR B-X
fusion B-X
protein B-X
interferes B-X
with B-X
the B-X
developmental B-X
functions B-X
of B-X
Pax3 B-X
Structural B-X
and B-X
Functional B-X
Studies B-X
of B-X
FKHR-PAX3 B-X
, B-X
a B-X
Reciprocal B-X
Fusion B-X
Gene B-X
of B-X
the B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
Chromosomal B-X
Translocation B-X
in B-X
Alveolar B-X
Rhabdomyosarcoma B-X
Paired B-X
Box B-X
Transcription B-X
Factor B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Paired B-X
Box B-X
Transcription B-X
Factor B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

This	O
cellular	O
transformation	O
in	O
vitro	O
will	O
facilitate	O
studies	O
on	O
the	O
mechanism	O
of	O
PAX3	O
-	O
FKHR	O
-	O
induced	O
oncogenesis	O
.	O
.	O
<EOS> B-X
Pax B-X
genes B-X
in B-X
embryogenesis B-X
and B-X
oncogenesis B-X
Genome-Wide B-X
Identification B-X
of B-X
PAX3-FKHR B-X
Binding B-X
Sites B-X
in B-X
Rhabdomyosarcoma B-X
Reveals B-X
Candidate B-X
Target B-X
Genes B-X
Important B-X
for B-X
Development B-X
and B-X
Cancer B-X
| B-X
Cancer B-X
Research B-X
Small B-X
molecule B-X
inhibition B-X
of B-X
PAX3-FOXO1 B-X
through B-X
AKT B-X
activation B-X
suppresses B-X
malignant B-X
phenotypes B-X
of B-X
alveolar B-X
rhabdomyosarcoma B-X
Nephroblastoma B-X
overexpressed B-X
( B-X
NOV/CCN3 B-X
) B-X
gene B-X
: B-X
a B-X
paired-domainspecific B-X
PAX3-FKHR B-X
transcription B-X
target B-X
that B-X
promotes B-X
survival B-X
and B-X
motility B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
cells B-X
The B-X
2 B-X
; B-X
13 B-X
chromosomal B-X
translocation B-X
occurs B-X
in B-X
most B-X
cases B-X
of B-X
the B-X
cancer B-X
alveolar B-X
rhabdomyosarcoma B-X
( B-X
ARMS B-X
) B-X
, B-X
and B-X
juxtaposes B-X
the B-X
genes B-X
encoding B-X
the B-X
PAX3 B-X
and B-X
FKHR B-X
transcription B-X
factors B-X

Somatic	O
-	O
cell	O
selection	O
is	O
a	O
major	O
determinant	O
of	O
the	O
blood	O
-	O
cell	O
phenotype	O
in	O
heterozygotes	O
for	O
glucose	O
-	O
6	O
-	O
phosphate	O
dehydrogenase	O
mutations	O
causing	O
severe	O
enzyme	B-Disease
deficiency	I-Disease
.	O
<EOS> B-X
Noninferiority B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
diagnosis B-X
by B-X
a B-X
point-of-care B-X
rapid B-X
test B-X
vs B-X
the B-X
laboratory B-X
fluorescent B-X
spot B-X
test B-X
demonstrated B-X
by B-X
copper B-X
inhibition B-X
in B-X
normal B-X
human B-X
red B-X
blood B-X
cells B-X
- B-X
ScienceDirect B-X
Noninferiority B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
diagnosis B-X
by B-X
a B-X
point-of-care B-X
rapid B-X
test B-X
vs B-X
the B-X
laboratory B-X
fluorescent B-X
spot B-X
test B-X
demonstrated B-X
by B-X
copper B-X
inhibition B-X
in B-X
normal B-X
human B-X
red B-X
blood B-X
cells B-X
Primaquine-induced B-X
haemolysis B-X
in B-X
females B-X
heterozygous B-X
for B-X
G6PD B-X
deficiency B-X
Is B-X
red B-X
cell B-X
from B-X
an B-X
otherwise B-X
healthy B-X
G6PD-deficient B-X
donor B-X
efficient B-X
for B-X
transfusion B-X
to B-X
fauvism B-X
patients B-X
? B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

X	O
-	O
chromosome	O
inactivation	O
in	O
mammals	O
is	O
regarded	O
as	O
an	O
essentially	O
random	O
process	O
,	O
but	O
the	O
resulting	O
somatic	O
-	O
cell	O
mosaicism	O
creates	O
the	O
opportunity	O
for	O
cell	O
selection	O
.	O
<EOS> B-X
X-Chromosome B-X
inactivation B-X
leads B-X
to B-X
the B-X
formation B-X
of B-X
mosaic B-X
cell B-X
populations B-X
in B-X
the B-X
somatic B-X
cells B-X
of B-X
mammalian B-X
females B-X
. B-X
Cells B-X
have B-X
either B-X
a B-X
maternal B-X
or B-X
paternal B-X
X-chromosome B-X
active B-X
. B-X
If B-X
an B-X
PDF B-X
| B-X
Marsupial B-X
and B-X
eutherian B-X
mammals B-X
inactivate B-X
one B-X
X B-X
chromosome B-X
in B-X
female B-X
somatic B-X
cells B-X
in B-X
what B-X
is B-X
thought B-X
to B-X
be B-X
a B-X
means B-X
of B-X
compensating B-X
for B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
X B-X
Inactivation B-X
, B-X
Female B-X
Mosaicism B-X
, B-X
and B-X
Sex B-X
Differences B-X
in B-X
Renal B-X
Diseases B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X
Cellular B-X
Resolution B-X
Maps B-X
of B-X
X B-X
Chromosome B-X
Inactivation B-X
: B-X
Implications B-X
for B-X
Neural B-X
Development B-X
, B-X
Function B-X
, B-X
and B-X
Disease B-X
- B-X
ScienceDirect B-X
Request B-X
PDF B-X
| B-X
Why B-X
females B-X
are B-X
mosaics B-X
, B-X
X-chromosome B-X
inactivation B-X
, B-X
and B-X
sex B-X
differences B-X
in B-X
disease B-X
| B-X
At B-X
every B-X
age B-X
, B-X
males B-X
have B-X
a B-X
higher B-X
risk B-X
of B-X
mortality B-X
than B-X
do B-X

In	O
most	O
people	O
with	O
red	O
-	O
blood	O
-	O
cell	O
glucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphate	I-Disease
dehydrogenase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deficiency	I-Disease
,	O
the	O
enzyme	O
-	O
deficient	O
phenotype	O
is	O
only	O
moderately	O
expressed	O
in	O
nucleated	O
cells	O
.	O
<EOS> B-X
X-chromosome B-X
inactivation B-X
in B-X
mammals B-X
is B-X
regarded B-X
as B-X
an B-X
essentially B-X
random B-X
process B-X
, B-X
but B-X
the B-X
resulting B-X
somatic-cell B-X
mosaicism B-X
creates B-X
the B-X
opportunity B-X
for B-X
cell B-X
selection B-X
. B-X
In B-X
most B-X
people B-X
with B-X
red-blood-cell B-X
glucose-6-phosphate B-X
Learn B-X
about B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
, B-X
the B-X
most B-X
common B-X
enzyme B-X
deficiency B-X
in B-X
the B-X
world B-X
. B-X
Glucose-6-Phosphate B-X
Dehydrogenase B-X
( B-X
G6PD B-X
) B-X
Deficiency B-X
- B-X
Etiology B-X
, B-X
pathophysiology B-X
, B-X
symptoms B-X
, B-X
signs B-X
, B-X
diagnosis B-X
& B-X
prognosis B-X
from B-X
the B-X
Merck B-X
Manuals B-X
- B-X
Medical B-X
Professional B-X
Version B-X
. B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
| B-X
McMaster B-X
Pathophysiology B-X
Review B-X
Functional B-X
and B-X
structural B-X
analysis B-X
of B-X
double B-X
and B-X
triple B-X
mutants B-X
reveals B-X
the B-X
contribution B-X
of B-X
protein B-X
instability B-X
to B-X
clinical B-X
manifestations B-X
of B-X
G6PD B-X
variants B-X
- B-X
ScienceDirect B-X
Ubc13 B-X
maintains B-X
the B-X
suppressive B-X
function B-X
of B-X
regulatory B-X
T B-X
cells B-X
and B-X
prevents B-X
their B-X
conversion B-X
into B-X
effector-like B-X
T B-X
cells B-X
Identification B-X
and B-X
functional B-X
characterization B-X
of B-X
2 B-X
variant B-X
alleles B-X
of B-X
the B-X
telomerase B-X
RNA B-X
template B-X
gene B-X
( B-X
TERC B-X
) B-X
in B-X
a B-X
patient B-X
with B-X
dyskeratosis B-X
congenita B-X

However	O
,	O
in	O
a	O
small	O
subset	O
of	O
hemizygous	O
males	O
who	O
suffer	O
from	O
chronic	B-Disease
nonspherocytic	I-Disease
hemolytic	I-Disease
anemia	I-Disease
,	O
the	O
underlying	O
mutations	O
(	O
designated	O
class	O
I	O
)	O
cause	O
more	O
-	O
severe	O
G6PD	B-Disease
deficiency	I-Disease
,	O
and	O
this	O
might	O
provide	O
an	O
opportunity	O
for	O
selection	O
in	O
heterozygous	O
females	O
during	O
development	O
.	O
<EOS> B-X
Sexually B-X
antagonistic B-X
selection B-X
promotes B-X
genetic B-X
divergence B-X
between B-X
males B-X
and B-X
females B-X
in B-X
an B-X
ant B-X
Sexually B-X
antagonistic B-X
selection B-X
promotes B-X
genetic B-X
divergence B-X
between B-X
males B-X
and B-X
females B-X
in B-X
an B-X
ant B-X
| B-X
PNAS B-X
Sexual B-X
selection B-X
on B-X
male B-X
body B-X
size B-X
, B-X
genital B-X
length B-X
and B-X
heterozygosity B-X
: B-X
Consistency B-X
across B-X
habitats B-X
and B-X
social B-X
settings B-X
- B-X
Head B-X
- B-X
2017 B-X
- B-X
Journal B-X
of B-X
Animal B-X
Ecology B-X
- B-X
Wiley B-X
Online B-X
Sexual B-X
interactions B-X
play B-X
an B-X
important B-X
role B-X
in B-X
the B-X
evolution B-X
of B-X
reproductive B-X
isolation B-X
, B-X
with B-X
important B-X
consequences B-X
for B-X
speciation B-X
. B-X
Theoretical B-X
studies B-X
have B-X
focused B-X
on B-X
the B-X
evolution B-X
of B-X
mate B-X
preferences B-X
in B-X
Genetic B-X
quality B-X
and B-X
sexual B-X
selection B-X
: B-X
an B-X
integrated B-X
framework B-X
for B-X
good B-X
genes B-X
and B-X
compatible B-X
genes B-X
- B-X
NEFF B-X
- B-X
2005 B-X
- B-X
Molecular B-X
Ecology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Genetic B-X
architecture B-X
and B-X
balancing B-X
selection B-X
: B-X
the B-X
life B-X
and B-X
death B-X
of B-X
differentiated B-X
variants B-X
- B-X
Llaurens B-X
- B-X
2017 B-X
- B-X
Molecular B-X
Ecology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
bioRxiv B-X
- B-X
the B-X
preprint B-X
server B-X
for B-X
biology B-X
, B-X
operated B-X
by B-X
Cold B-X
Spring B-X
Harbor B-X
Laboratory B-X
, B-X
a B-X
research B-X
and B-X
educational B-X
institution B-X

In	O
order	O
to	O
test	O
this	O
possibility	O
we	O
have	O
analyzed	O
four	O
heterozygotes	O
for	O
class	O
I	O
G6PD	O
mutations	O
two	O
with	O
G6PD	O
Portici	O
(	O
1178G	O
-	O
-	O
>	O
A	O
)	O
and	O
two	O
with	O
G6PD	O
Bari	O
(	O
1187C	O
-	O
-	O
>	O
T	O
)	O
.	O

We	O
found	O
that	O
in	O
fractionated	O
blood	O
cell	O
types	O
(	O
including	O
erythroid	O
,	O
myeloid	O
,	O
and	O
lymphoid	O
cell	O
lineages	O
)	O
there	O
was	O
a	O
significant	O
excess	O
of	O
G6PD	O
-	O
normal	O
cells	O
.	O
<EOS> B-X
The B-X
initial B-X
and B-X
rate-limiting B-X
enzyme B-X
of B-X
the B-X
oxidative B-X
pentose B-X
phosphate B-X
shunt B-X
, B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
, B-X
is B-X
inhibited B-X
by B-X
NADPH B-X
and B-X
stimulated B-X
by B-X
NADP B-X
( B-X
+ B-X
) B-X
. B-X
Request B-X
PDF B-X
| B-X
Chronic B-X
nonspherocytic B-X
hemolytic B-X
anemia B-X
due B-X
to B-X
glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
: B-X
Report B-X
of B-X
two B-X
families B-X
with B-X
novel B-X
mutations B-X
causing B-X
G6PD B-X
Bangkok B-X
and B-X
G6PD B-X
Bangkok B-X
Noi B-X
| B-X
Glucose-6-phosphate B-X
dehydrogenase B-X

The	O
significant	O
concordance	O
that	O
we	O
have	O
observed	O
in	O
the	O
degree	O
of	O
imbalance	O
in	O
the	O
different	O
blood	O
-	O
cell	O
lineages	O
indicates	O
that	O
a	O
selective	O
mechanism	O
is	O
likely	O
to	O
operate	O
at	O
the	O
level	O
of	O
pluripotent	O
blood	O
stem	O
cells	O
.	O
<EOS> B-X
Current B-X
understanding B-X
of B-X
the B-X
mechanism B-X
of B-X
benzene-induced B-X
leukemia B-X
in B-X
humans B-X
: B-X
implications B-X
for B-X
risk B-X
assessment B-X
Blood B-X
contains B-X
many B-X
types B-X
of B-X
cells B-X
with B-X
very B-X
different B-X
functions B-X
, B-X
ranging B-X
from B-X
the B-X
transport B-X
of B-X
oxygen B-X
to B-X
the B-X
production B-X
of B-X
antibodies B-X
. B-X
Some B-X
of B-X
these B-X
cells B-X
function B-X
entirely B-X
within B-X
Satellite B-X
Cells B-X
and B-X
the B-X
Muscle B-X
Stem B-X
Cell B-X
Niche B-X
Myeloid B-X
cell B-X
origins B-X
, B-X
differentiation B-X
, B-X
and B-X
clinical B-X
implications B-X
The B-X
chronological B-X
history B-X
of B-X
the B-X
important B-X
discoveries B-X
leading B-X
to B-X
our B-X
present B-X
understanding B-X
of B-X
the B-X
essential B-X
clinical B-X
, B-X
biological B-X
, B-X
biochemical B-X
, B-X
and B-X
molecular B-X
features B-X
of B-X
chronic B-X
myelogenous B-X
leukemia B-X
( B-X
CML B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Thus	O
,	O
it	O
appears	O
that	O
severe	O
G6PD	B-Disease
deficiency	I-Disease
affects	O
adversely	O
the	O
proliferation	O
or	O
the	O
survival	O
of	O
nucleated	O
blood	O
cells	O
and	O
that	O
this	O
phenotypic	O
characteristic	O
is	O
critical	O
during	O
hematopoiesis	O
.	O
.	O
<EOS> B-X
g6pd-deficient B-X
red B-X
blood B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
The B-X
generation B-X
of B-X
reducing B-X
equivalent B-X
NADPH B-X
via B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
is B-X
critical B-X
for B-X
the B-X
maintenance B-X
of B-X
redox B-X
homeostasis B-X
and B-X
reductive B-X
biosynthesis B-X
in B-X
cells B-X
. B-X
NADPH B-X
also B-X
plays B-X
key B-X
g6pd-deficient B-X
red B-X
cells B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
g6pd-deficient B-X
red B-X
blood B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
Pathological B-X
basis B-X
of B-X
symptoms B-X
and B-X
crises B-X
in B-X
sickle B-X
cell B-X
disorder B-X
: B-X
implications B-X
for B-X
counseling B-X
and B-X
psychotherapy B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Analysis	O
of	O
meiotic	O
segregation	O
,	O
using	O
single	O
-	O
sperm	O
typing	O
:	O
meiotic	O
drive	O
at	O
the	O
myotonic	B-Disease
dystrophy	I-Disease
locus	O
.	O
<EOS> B-X
Meiotic B-X
drive B-X
at B-X
the B-X
myotonic B-X
dystrophy B-X
and B-X
the B-X
cone-rod B-X
dystrophy B-X
loci B-X
on B-X
chromosome B-X
19q13.3 B-X
. B-X
Genetic B-X
analysis B-X
of B-X
meiotic B-X
recombination B-X
in B-X
humans B-X
by B-X
use B-X
of B-X
sperm B-X
typing B-X
: B-X
reduced B-X
recombination B-X
within B-X
a B-X
heterozygous B-X
paracentric B-X
inversion B-X
of B-X
chromosome B-X
9q32-q34.3 B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
scientific B-X
article B-X
published B-X
in B-X
October B-X
1996 B-X

Meiotic	O
drive	O
at	O
the	O
myotonic	B-Disease
dystrophy	I-Disease
(	O
DM	B-Disease
)	O
locus	O
has	O
recently	O
been	O
suggested	O
as	O
being	O
responsible	O
for	O
maintaining	O
the	O
frequency	O
,	O
in	O
the	O
human	O
population	O
,	O
of	O
DM	B-Disease
chromosomes	O
capable	O
of	O
expansion	O
to	O
the	O
disease	O
state	O
.	O
<EOS> B-X
Meiotic B-X
drive B-X
at B-X
the B-X
myotonic B-X
dystrophy B-X
locus B-X
. B-X
Recent B-X
Studies B-X
of B-X
the B-X
Human B-X
Chromosome B-X
9p21 B-X
Locus B-X
, B-X
Which B-X
Is B-X
Associated B-X
With B-X
Atherosclerosis B-X
in B-X
Human B-X
Populations B-X
| B-X
Arteriosclerosis B-X
, B-X
Thrombosis B-X
, B-X
and B-X
Vascular B-X
Biology B-X
The B-X
genetics B-X
of B-X
type B-X
2 B-X
diabetes B-X
The B-X
mechanism B-X
of B-X
sex B-X
determination B-X
in B-X
mammals B-X
appears B-X
highly B-X
conserved B-X
: B-X
the B-X
presence B-X
of B-X
a B-X
Y B-X
chromosome B-X
triggers B-X
the B-X
male B-X
developmental B-X
pathway B-X
, B-X
whereas B-X
the B-X
abse B-X
... B-X
Read B-X
chapter B-X
4 B-X
Heritable B-X
Genetic B-X
Effects B-X
of B-X
Radiation B-X
in B-X
Human B-X
Populations B-X
: B-X
This B-X
book B-X
is B-X
the B-X
seventh B-X
in B-X
a B-X
series B-X
of B-X
titles B-X
from B-X
the B-X
National B-X
Research B-X
Coun B-X
... B-X
Cognitive B-X
brain B-X
networks B-X
such B-X
as B-X
the B-X
default-mode B-X
network B-X
( B-X
DMN B-X
) B-X
, B-X
frontoparietal B-X
network B-X
, B-X
and B-X
salience B-X
network B-X
, B-X
are B-X
key B-X
functional B-X
networks B-X
of B-X
the B-X
human B-X
brain B-X
. B-X
Here B-X
we B-X
Transposable B-X
elements B-X
: B-X
genome B-X
innovation B-X
, B-X
chromosome B-X
diversity B-X
, B-X
and B-X
centromere B-X
conflict B-X

In	O
order	O
to	O
test	O
this	O
hypothesis	O
,	O
we	O
have	O
studied	O
samples	O
of	O
single	O
sperm	O
from	O
three	O
individuals	O
heterozygous	O
at	O
the	O
DM	B-Disease
locus	O
,	O
each	O
with	O
one	O
allele	O
larger	O
and	O
one	O
allele	O
smaller	O
than	O
19	O
CTG	O
repeats	O
.	O
<EOS> B-X
The B-X
semen B-X
of B-X
many B-X
primate B-X
species B-X
coagulates B-X
into B-X
a B-X
mating B-X
plug B-X
believed B-X
to B-X
prevent B-X
the B-X
sperm B-X
of B-X
subsequent B-X
mating B-X
events B-X
from B-X
accessing B-X
the B-X
ova B-X
. B-X
The B-X
textu B-X
Genome-Wide B-X
Single-Cell B-X
Analysis B-X
of B-X
Recombination B-X
Activity B-X
and B-X
de B-X
novo B-X
Mutation B-X
Rates B-X
in B-X
Human B-X
Sperm B-X
The B-X
major B-X
waves B-X
of B-X
extinction B-X
that B-X
appear B-X
in B-X
the B-X
fossil B-X
record B-X
of B-X
marine B-X
invertebrates B-X
, B-X
e.g. B-X
, B-X
that B-X
occurring B-X
near B-X
the B-X
Permian-Triassic B-X
boundary B-X
, B-X
affect B-X
shallow- B-X
... B-X
N B-X
Arnheim B-X
's B-X
46 B-X
research B-X
works B-X
with B-X
5,141 B-X
citations B-X
and B-X
1,822 B-X
reads B-X
, B-X
including B-X
: B-X
Evidence B-X
for B-X
the B-X
Lack B-X
of B-X
Mismatch-Repair B-X
Directed B-X
Antirecombination B-X
During B-X
Mouse B-X
Meiosis B-X
Polyploidisation B-X
is B-X
a B-X
key B-X
source B-X
of B-X
diversification B-X
and B-X
speciation B-X
in B-X
plants B-X
. B-X
Most B-X
researchers B-X
consider B-X
sexual B-X
polyploidisation B-X
leading B-X
to B-X
unreduced B-X
gamete B-X
as B-X
its B-X
main B-X
origin B-X
. B-X
Unreduced B-X
gametes B-X
are B-X
useful B-X

To	O
guard	O
against	O
the	O
possible	O
problem	O
of	O
differential	O
PCR	O
amplification	O
rates	O
based	O
on	O
the	O
lengths	O
of	O
the	O
alleles	O
,	O
the	O
sperm	O
were	O
also	O
typed	O
at	O
another	O
closely	O
linked	O
marker	O
whose	O
allele	O
size	O
was	O
unrelated	O
to	O
the	O
allele	O
size	O
at	O
the	O
DM	B-Disease
locus	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Transcript B-X
variation B-X
has B-X
important B-X
implications B-X
for B-X
organismal B-X
function B-X
in B-X
health B-X
and B-X
disease B-X
. B-X
Most B-X
transcriptome B-X
studies B-X
focus B-X
on B-X
assessing B-X
variation B-X
Challenges B-X
in B-X
analysis B-X
and B-X
interpretation B-X
of B-X
microsatellite B-X
data B-X
for B-X
population B-X
genetic B-X
studies B-X
Pooled B-X
Genotyping B-X
of B-X
Microsatellite B-X
Markers B-X
in B-X
Parent‚ÄìOffspring B-X
Trios B-X
An B-X
international B-X
, B-X
peer-reviewed B-X
genome B-X
sciences B-X
journal B-X
featuring B-X
outstanding B-X
original B-X
research B-X
that B-X
offers B-X
novel B-X
insights B-X
into B-X
the B-X
biology B-X
of B-X
all B-X
organisms B-X
Abstract B-X
. B-X
Previous B-X
research B-X
indicates B-X
that B-X
the B-X
scent B-X
of B-X
developmental B-X
stability B-X
( B-X
low B-X
fluctuating B-X
asymmetry B-X
, B-X
FA B-X
) B-X
is B-X
attractive B-X
to B-X
women B-X
who B-X
are B-X
fertile B-X
( B-X
at B-X
high- B-X
Population B-X
genetic B-X
data B-X
underpin B-X
many B-X
studies B-X
of B-X
behavioral B-X
, B-X
ecological B-X
, B-X
and B-X
evolutionary B-X
processes B-X
in B-X
wild B-X
populations B-X
and B-X
contribute B-X
to B-X
effective B-X
conservation B-X
management B-X
. B-X
However B-X
, B-X
collecting B-X
genetic B-X
samples B-X
can B-X
Author B-X
Summary B-X
Individual B-X
recognition B-X
via B-X
scent B-X
is B-X
critical B-X
for B-X
many B-X
aspects B-X
of B-X
behavior B-X
including B-X
parental B-X
care B-X
, B-X
competition B-X
, B-X
cooperation B-X
and B-X
mate B-X
choice B-X
. B-X
While B-X
animal B-X
scents B-X
can B-X
differ B-X
in B-X

Using	O
statistical	O
models	O
specifically	O
designed	O
to	O
study	O
single	O
-	O
sperm	O
segregation	O
data	O
,	O
we	O
find	O
no	O
evidence	O
of	O
meiotic	O
segregation	O
distortion	O
.	O
<EOS> B-X
Bulk B-X
pollen B-X
sequencing B-X
reveals B-X
rapid B-X
evolution B-X
of B-X
segregation B-X
distortion B-X
in B-X
the B-X
male B-X
germline B-X
of B-X
Arabidopsis B-X
hybrids B-X
Evaluating B-X
the B-X
Evidence B-X
for B-X
Transmission B-X
Distortion B-X
in B-X
Human B-X
Pedigrees B-X
Evaluating B-X
the B-X
Evidence B-X
for B-X
Transmission B-X
Distortion B-X
in B-X
Human B-X
Pedigrees B-X
| B-X
Genetics B-X
Female-inherited B-X
supernumerary B-X
chromosomes B-X
that B-X
lack B-X
a B-X
male-inherited B-X
homolog B-X
are B-X
transmitted B-X
to B-X
all B-X
meiotic B-X
products B-X
instead B-X
of B-X
the B-X
expected B-X
half B-X
, B-X
which B-X
indicates B-X
an B-X
additional B-X
amplification B-X
of B-X
unpaired B-X
chromosomes B-X
during B-X
meiosis B-X
PDF B-X
| B-X
As B-X
all B-X
four B-X
meiotic B-X
products B-X
give B-X
rise B-X
to B-X
sperm B-X
in B-X
males B-X
, B-X
female B-X
meiosis B-X
result B-X
in B-X
a B-X
single B-X
egg B-X
in B-X
most B-X
eukaryotes B-X
. B-X
Any B-X
genetic B-X
element B-X
with B-X
the B-X
As B-X
all B-X
four B-X
meiotic B-X
products B-X
give B-X
rise B-X
to B-X
sperm B-X
in B-X
males B-X
, B-X
female B-X
meiosis B-X
result B-X
in B-X
a B-X
single B-X
egg B-X
in B-X
most B-X
eukaryotes B-X
. B-X
Any B-X
genetic B-X
element B-X
with B-X
the B-X
potential B-X
to B-X
Unexpected B-X
patterns B-X
of B-X
segregation B-X
distortion B-X
at B-X
a B-X
selfish B-X
supergene B-X
in B-X
the B-X
fire B-X
ant B-X
Solenopsis B-X
invicta B-X

The	O
upper	O
limit	O
of	O
the	O
two	O
-	O
sided	O
95	O
%	O
confidence	O
interval	O
for	O
the	O
estimate	O
of	O
the	O
common	O
segregation	O
probability	O
for	O
the	O
three	O
donors	O
is	O
at	O
or	O
below	O
.	O
<EOS> B-X
Typically B-X
, B-X
confidence B-X
intervals B-X
are B-X
expressed B-X
as B-X
a B-X
two-sided B-X
range B-X
. B-X
You B-X
might B-X
state B-X
, B-X
for B-X
example B-X
, B-X
with B-X
95 B-X
% B-X
confidence B-X
, B-X
that B-X
the B-X
true B-X
value B-X
of B-X
a B-X
parameter B-X
7.2.4.1 B-X
. B-X
Confidence B-X
intervals B-X
The B-X
FBI B-X
is B-X
the B-X
lead B-X
federal B-X
agency B-X
for B-X
investigating B-X
cyber B-X
attacks B-X
by B-X
criminals B-X
, B-X
overseas B-X
adversaries B-X
, B-X
and B-X
terrorists B-X
. B-X
The B-X
threat B-X
is B-X
incredibly B-X
serious‚Äîand B-X
growing B-X
. B-X
Circulating B-X
Testosterone B-X
as B-X
the B-X
Hormonal B-X
Basis B-X
of B-X
Sex B-X
Differences B-X
in B-X
Athletic B-X
Performance B-X
Perceived B-X
Everyday B-X
Racism B-X
, B-X
Residential B-X
Segregation B-X
, B-X
and B-X
HIV B-X
Testing B-X
Among B-X
Patients B-X
at B-X
a B-X
Sexually B-X
Transmitted B-X
Disease B-X
Clinic B-X
A B-X
Statistical B-X
Approach B-X
to B-X
Genetic B-X
Epidemiology B-X
| B-X
Wiley B-X
Online B-X
Books B-X

515	O
for	O
all	O
models	O
considered	O
,	O
and	O
no	O
statistically	O
significant	O
difference	O
from	O
.	O
<EOS> B-X
Non-significant B-X
p-values B-X
? B-X
Strategies B-X
to B-X
understand B-X
and B-X
better B-X
determine B-X
the B-X
importance B-X
of B-X
effects B-X
and B-X
interactions B-X
in B-X
logistic B-X
regression B-X
How B-X
to B-X
work B-X
with B-X
a B-X
subgroup B-X
analysis B-X
When B-X
the B-X
Test B-X
of B-X
Mediation B-X
is B-X
More B-X
Powerful B-X
than B-X
the B-X
Test B-X
of B-X
the B-X
Total B-X
Effect B-X
The B-X
Misuse B-X
of B-X
‚Äò B-X
No B-X
Significant B-X
Difference B-X
‚Äô B-X
in B-X
British B-X
Orthopaedic B-X
Literature B-X
Modeling B-X
site B-X
effects B-X
in B-X
the B-X
design B-X
and B-X
analysis B-X
of B-X
multisite B-X
trials B-X
Tests B-X
of B-X
Statistical B-X
Significance B-X
A B-X
Primer B-X
on B-X
the B-X
Use B-X
of B-X
Equivalence B-X
Testing B-X
for B-X
Evaluating B-X
Measurement B-X
Agreement B-X

5	O
is	O
detected	O
in	O
any	O
of	O
the	O
models	O
.	O
<EOS> B-X
Download B-X
ready-to-use B-X
models B-X
for B-X
your B-X
computer B-X
vision B-X
projects B-X
. B-X
Format B-X
errors B-X
, B-X
in B-X
the B-X
best-case B-X
scenario B-X
, B-X
can B-X
break B-X
an B-X
automated B-X
data B-X
processing B-X
pipeline B-X
. B-X
In B-X
this B-X
story B-X
, B-X
we B-X
use B-X
n-grams B-X
, B-X
a B-X
language B-X
model B-X
, B-X
to B-X
automate B-X
Detect B-X
, B-X
track B-X
and B-X
classify B-X
objects B-X
with B-X
a B-X
custom B-X
classification B-X
model B-X
on B-X
Android B-X
Part B-X
4 B-X
of B-X
the B-X
‚Äú B-X
Object B-X
Detection B-X
for B-X
Dummies B-X
‚Äù B-X
series B-X
focuses B-X
on B-X
one-stage B-X
models B-X
for B-X
fast B-X
detection B-X
, B-X
including B-X
SSD B-X
, B-X
RetinaNet B-X
, B-X
and B-X
models B-X
in B-X
the B-X
YOLO B-X
family B-X
These B-X
days B-X
, B-X
machine B-X
learning B-X
and B-X
computer B-X
vision B-X
are B-X
all B-X
the B-X
craze B-X
. B-X
We B-X
‚Äô B-X
ve B-X
all B-X
seen B-X
the B-X
news B-X
about B-X
self-driving B-X
cars B-X
and B-X
facial B-X
recognition B-X
and B-X
probably B-X
imagined B-X
how B-X
Since B-X
I B-X
published B-X
the B-X
article B-X
‚Äú B-X
Explain B-X
Your B-X
Model B-X
with B-X
the B-X
SHAP B-X
Values B-X
‚Äù B-X
that B-X
was B-X
built B-X
on B-X
a B-X
random B-X
forest B-X
tree B-X
, B-X
readers B-X
have B-X
been B-X
asking B-X
if B-X
there B-X
is B-X
Anomaly B-X
detection B-X
- B-X
Wikipedia B-X

This	O
suggests	O
that	O
any	O
greater	O
amount	O
of	O
segregation	O
distortion	O
at	O
the	O
myotonic	B-Disease
dystrophy	I-Disease
locus	O
must	O
result	O
from	O
events	O
following	O
sperm	O
ejaculation	O
.	O
<EOS> B-X
Meiotic B-X
drive B-X
at B-X
the B-X
myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
locus B-X
has B-X
recently B-X
been B-X
suggested B-X
as B-X
being B-X
responsible B-X
for B-X
maintaining B-X
the B-X
frequency B-X
, B-X
in B-X
the B-X
human B-X
population B-X
, B-X
of B-X
DM B-X
chromosomes B-X
Analysis B-X
of B-X
meiotic B-X
segregation B-X
, B-X
using B-X
single-sperm B-X
typing B-X
: B-X
Meiotic B-X
drive B-X
at B-X
the B-X
myotonic B-X
dystrophy B-X
locus B-X
‚Ä¢ B-X
GeneConvene B-X
Virtual B-X
Institute B-X
myotonic B-X
dystrophy B-X
locus B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

LPP	O
,	O
the	O
preferred	O
fusion	O
partner	O
gene	O
of	O
HMGIC	O
in	O
lipomas	B-Disease
,	O
is	O
a	O
novel	O
member	O
of	O
the	O
LIM	O
protein	O
gene	O
family	O
.	O
<EOS> B-X
LHFP B-X
, B-X
a B-X
Novel B-X
Translocation B-X
Partner B-X
Gene B-X
ofHMGICin B-X
a B-X
Lipoma B-X
, B-X
Is B-X
a B-X
Member B-X
of B-X
a B-X
New B-X
Family B-X
ofLHFP-like B-X
Genes B-X
- B-X
ScienceDirect B-X
LPP B-X
( B-X
lipoma B-X
preferred B-X
partner B-X
) B-X
LIM B-X
domain B-X
containing B-X
preferred B-X
translocation B-X
partner B-X
in B-X
lipoma B-X
; B-X
LPP B-X
Lipoma-preferred B-X
partner B-X
( B-X
LPP B-X
) B-X
is B-X
a B-X
LIM B-X
domain B-X
protein B-X
that B-X
belongs B-X
to B-X
the B-X
zyxin B-X
family B-X
of B-X
cytoskeletal B-X
adaptor B-X
proteins B-X
A B-X
major B-X
cytogenetic B-X
subgroup B-X
among B-X
human B-X
lipomas B-X
is B-X
characterized B-X
by B-X
translocations B-X
involving B-X
the B-X
HMGIC B-X
gene B-X
at B-X
12q15 B-X
. B-X
In B-X
the B-X
context B-X
of B-X
an B-X
ongoing B-X
research B-X
program B-X
aiming B-X
at B-X
the B-X
elucidation B-X
LIM B-X
domain B-X
containing B-X
preferred B-X
translocation B-X
partner B-X
in B-X
lipoma B-X
; B-X
LPP B-X
Lipoma B-X
preferred B-X
partner B-X
( B-X
LPP B-X
) B-X
is B-X
a B-X
LIM B-X
domain B-X
protein B-X
that B-X
belongs B-X
to B-X
the B-X
zyxinfamily B-X
of B-X
cytoskeletal B-X
adaptor B-X
proteins B-X
Complete B-X
information B-X
for B-X
LPP B-X
gene B-X
( B-X
Protein B-X
Coding B-X
) B-X
, B-X
LIM B-X
Domain B-X
Containing B-X
Preferred B-X
Translocation B-X
Partner B-X
In B-X
Lipoma B-X
, B-X
including B-X
: B-X
function B-X
, B-X
proteins B-X
, B-X
disorders B-X
, B-X
pathways B-X
, B-X
orthologs B-X
LPP B-X
( B-X
gene B-X
) B-X
- B-X
Wikipedia B-X

A	O
major	O
cytogenetic	O
subgroup	O
of	O
lipomas	B-Disease
is	O
characterized	O
by	O
recurrent	O
chromosome	O
aberrations	O
,	O
mainly	O
translocations	O
,	O
that	O
involve	O
chromosome	O
segment	O
12q13	O
-	O
q15	O
.	O
<EOS> B-X
A B-X
major B-X
cytogenetic B-X
subgroup B-X
of B-X
lipomas B-X
is B-X
characterized B-X
by B-X
recurrent B-X
chromosome B-X
aberrations B-X
, B-X
mainly B-X
translocations B-X
, B-X
that B-X
involve B-X
chromosome B-X
segment B-X
12q13-q15 B-X
. B-X
Multiple B-X
chromosomes B-X
have B-X
been B-X
found B-X
as B-X
the B-X
translocation B-X
PDF B-X
| B-X
The B-X
major B-X
cytogenetic B-X
subgroup B-X
of B-X
lipomas B-X
is B-X
characterized B-X
by B-X
aberrations B-X
of B-X
chromosome B-X
segment B-X
12q13-15 B-X
, B-X
which B-X
recombines B-X
with B-X
a B-X
large B-X
number B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Aberrations B-X
of B-X
chromosome B-X
segment B-X
12q13‚Äì15 B-X
characterize B-X
a B-X
subgroup B-X
of B-X
hemangiopericytomas B-X
- B-X
Mandahl B-X
- B-X
1993 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
We B-X
have B-X
investigated B-X
cytogenetically B-X
a B-X
total B-X
of B-X
35 B-X
solitary B-X
lipomas B-X
, B-X
10 B-X
of B-X
which B-X
have B-X
been B-X
reported B-X
previously B-X
. B-X
Of B-X
the B-X
25 B-X
tumours B-X
presented B-X
herein B-X
for B-X
the B-X
first B-X
time B-X
, B-X
PDF B-X
| B-X
Cytogenetic B-X
analysis B-X
of B-X
short-term B-X
cultures B-X
was B-X
carried B-X
out B-X
on B-X
109 B-X
lipomas B-X
from B-X
92 B-X
patients B-X
. B-X
Clonal B-X
chromosomal B-X
abnormalities B-X
were B-X
present B-X
in B-X
50 B-X
% B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
LPP B-X
, B-X
the B-X
preferred B-X
fusion B-X
partner B-X
gene B-X
of B-X
HMGIC B-X
in B-X
lipomas B-X
, B-X
is B-X
a B-X
novel B-X
member B-X
of B-X
the B-X
LIM B-X
protein B-X
gene B-X
family B-X
Cytogenic B-X
and B-X
molecular B-X
analysis B-X
of B-X
an B-X
aggressive B-X
angiomyxoma B-X
. B-X

Multiple	O
chromosomes	O
have	O
been	O
found	O
as	O
the	O
translocation	O
partners	O
of	O
chromosome	O
12	O
but	O
3q27	O
-	O
q28	O
is	O
preferentially	O
involved	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Chromosome B-X
rearrangement B-X
of B-X
14q32.33 B-X
has B-X
recurrently B-X
occurred B-X
with B-X
variable B-X
partner B-X
sites B-X
, B-X
including B-X
11q13.3 B-X
, B-X
8q24.1 B-X
, B-X
18q21.3 B-X
, B-X
and B-X
6p21.1 B-X
in B-X
multiple B-X
Chromosomal B-X
translocations B-X
involving B-X
the B-X
immunoglobulin B-X
heavy B-X
chain B-X
( B-X
IGH B-X
) B-X
locus B-X
at B-X
chromosome B-X
14q32 B-X
represent B-X
a B-X
common B-X
mechanism B-X
of B-X
oncogene B-X
activation B-X
in B-X
lymphoid B-X
malignancies B-X
. B-X
In B-X
multiple B-X
myeloma B-X
( B-X
MM B-X
Translocation B-X
Breakpoints B-X
Preferentially B-X
Occur B-X
in B-X
Euchromatin B-X
and B-X
Acrocentric B-X
Chromosomes B-X
Raf B-X
Mols B-X
's B-X
14 B-X
research B-X
works B-X
with B-X
979 B-X
citations B-X
and B-X
101 B-X
reads B-X
, B-X
including B-X
: B-X
Identification B-X
, B-X
molecular B-X
cloning B-X
, B-X
and B-X
characterization B-X
of B-X
the B-X
chromosome B-X
12 B-X
breakpoint B-X
cluster B-X
region B-X
of B-X
Soft B-X
tissue B-X
tumors B-X
: B-X
an B-X
overview B-X
Molecular B-X
aspects B-X
of B-X
multiple B-X
myeloma B-X

In	O
previous	O
studies	O
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
high	O
mobility	O
group	O
(	O
HMG	O
)	O
protein	O
gene	O
HMGIC	O
at	O
12q15	O
is	O
consistently	O
rearranged	O
as	O
a	O
consequence	O
of	O
these	O
translocations	O
.	O
<EOS> B-X
Download B-X
Citation B-X
| B-X
An B-X
identicalHMGIC-LPP B-X
fusion B-X
transcript B-X
is B-X
consistently B-X
expressed B-X
in B-X
pulmonary B-X
chondroid B-X
hamartomas B-X
with B-X
t B-X
( B-X
3 B-X
; B-X
12 B-X
) B-X
( B-X
q27-28 B-X
; B-X
q14-15 B-X
) B-X
| B-X
The B-X
high B-X
frequency B-X
High B-X
mobility B-X
group B-X
A B-X
( B-X
HMGA B-X
) B-X
proteins B-X
alter B-X
chromatin B-X
structure B-X
and B-X
therefore B-X
affect B-X
the B-X
transcription B-X
of B-X
large B-X
sets B-X
of B-X
genes B-X
. B-X
This B-X
can B-X
contribute B-X
to B-X
both B-X
benign B-X
and B-X
malignant B-X
Cell B-X
Adhesion B-X
and B-X
Transcriptional B-X
Activity B-X
‚Äî B-X
Defining B-X
the B-X
Role B-X
of B-X
the B-X
Novel B-X
Protooncogene B-X
LPP B-X
Uterine B-X
leiomyoma B-X
is B-X
a B-X
common B-X
benign B-X
smooth B-X
muscle B-X
tumor B-X
occurring B-X
in B-X
20 B-X
to B-X
30 B-X
% B-X
of B-X
women B-X
over B-X
30 B-X
years B-X
of B-X
age B-X
. B-X
Cytogenetic B-X
analysis B-X
of B-X
such B-X
tumors B-X
has B-X
revealed B-X

Here	O
,	O
we	O
report	O
the	O
identification	O
and	O
characterization	O
of	O
the	O
chromosome	O
3	O
-	O
derived	O
translocation	O
partner	O
gene	O
,	O
which	O
we	O
have	O
designated	O
LPP	O
(	O
lipoma	B-Disease
preferred	O
partner	O
gene	O
)	O
.	O
<EOS> B-X
The B-X
present B-X
invention B-X
relates B-X
to B-X
the B-X
multi-tumor B-X
Aberrant B-X
Growth B-X
( B-X
MAG B-X
) B-X
gene B-X
having B-X
the B-X
nucleotide B-X
sequence B-X
of B-X
any B-X
one B-X
of B-X
the B-X
strands B-X
of B-X
any B-X
one B-X
of B-X
the B-X
members B-X
of B-X
Download B-X
Citation B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
2008 B-X
, B-X
Marleen B-X
M. B-X
R. B-X
Petit B-X
published B-X
Lipoma B-X
Preferred B-X
Partner B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
on B-X
ResearchGate B-X
May B-X
play B-X
a B-X
structural B-X
role B-X
at B-X
sites B-X
of B-X
cell B-X
adhesion B-X
in B-X
maintaining B-X
cell B-X
shape B-X
and B-X
motility B-X
. B-X
In B-X
addition B-X
to B-X
these B-X
structural B-X
functions B-X
, B-X
it B-X
may B-X
also B-X
be B-X
implicated B-X
in B-X
LPP B-X

Using	O
3	O
-	O
RACE	O
analysis	O
of	O
HMGIC	O
fusion	O
transcripts	O
in	O
lipoma	B-Disease
cell	O
line	O
Li	O
-	O
501	O
/	O
SV40	O
,	O
ectopic	O
genetic	O
sequences	O
were	O
obtained	O
,	O
which	O
by	O
CASH	O
(	O
chromosome	O
assignment	O
using	O
somatic	O
cell	O
hybrids	O
)	O
and	O
FISH	O
(	O
fluorescence	O
in	O
situ	O
hybridization	O
)	O
analysis	O
were	O
found	O
to	O
originate	O
from	O
chromosome	O
segment	O
3q27	O
-	O
q28	O
.	O
<EOS> B-X
PDF B-X
| B-X
Rearrangements B-X
of B-X
chromosome B-X
bands B-X
12q13-15 B-X
are B-X
frequent B-X
in B-X
various B-X
benign B-X
mesenchymal B-X
and B-X
epithelial B-X
tumors B-X
, B-X
and B-X
the B-X
gene B-X
HMGA2 B-X
seems B-X
to B-X
be B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
Chromosomal B-X
rearrangements B-X
leading B-X
to B-X
abnormal B-X
splicing B-X
within B-X
intron B-X
4 B-X
of B-X
HMGIC B-X
? B-X
| B-X
Fusion B-X
of B-X
the B-X
high-mobility B-X
group B-X
protein B-X
gene B-X
HMGIC B-X
to B-X
other B-X
genes B-X
due B-X
to B-X
chromosomal B-X
Application B-X
of B-X
Genomic B-X
In B-X
Situ B-X
Hybridization B-X
in B-X
Horticultural B-X
Science B-X
PDF B-X
| B-X
Uterine B-X
leiomyomata B-X
are B-X
one B-X
of B-X
several B-X
benign B-X
tumors B-X
characterized B-X
by B-X
frequent B-X
chromosomal B-X
rearrangement B-X
involving B-X
12q15 B-X
. B-X
The B-X
12q15 B-X
rearrangement B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
The B-X
serum B-X
amyloid B-X
A B-X
( B-X
SAA B-X
) B-X
superfamily B-X
consists B-X
of B-X
two B-X
acute B-X
phase B-X
genes B-X
, B-X
SAA1 B-X
and B-X
SAA2 B-X
; B-X
a B-X
pseudogene B-X
, B-X
SAA3 B-X
; B-X
and B-X
a B-X
constitutively B-X
expressed B-X
gene B-X
, B-X
Edible B-X
banana B-X
cultivars B-X
are B-X
diploid B-X
, B-X
triploid B-X
, B-X
or B-X
tetraploid B-X
hybrids B-X
, B-X
which B-X
originated B-X
by B-X
natural B-X
cross B-X
hybridization B-X
between B-X
subspecies B-X
of B-X
diploid B-X
Musa B-X
acuminata B-X
, B-X
or B-X
between B-X
M. B-X
acuminata B-X
and B-X
Monochromosomal B-X
Hybrids B-X
and B-X
Chromosome B-X
Transfer B-X
: B-X
A B-X
Functional B-X
Approach B-X
for B-X
Gene B-X
Identification B-X

In	O
Northern	O
blot	O
analysis	O
,	O
an	O
mRNA	O
of	O
over	O
10	O
kb	O
was	O
detected	O
by	O
these	O
ectopic	O
sequences	O
in	O
a	O
variety	O
of	O
human	O
tissues	O
but	O
not	O
in	O
brain	O
and	O
peripheral	O
blood	O
leukocytes	O
.	O
<EOS> B-X
The B-X
Human B-X
SHIP B-X
Gene B-X
Is B-X
Differentially B-X
Expressed B-X
in B-X
Cell B-X
Lineages B-X
of B-X
the B-X
Bone B-X
Marrow B-X
and B-X
Blood B-X
- B-X
ScienceDirect B-X
Mutational B-X
and B-X
functional B-X
analyses B-X
reveal B-X
that B-X
ST7 B-X
is B-X
a B-X
highly B-X
conserved B-X
tumor-suppressor B-X
gene B-X
on B-X
human B-X
chromosome B-X
7q31 B-X
| B-X
Nature B-X
Genetics B-X
Ectopic B-X
overexpression B-X
of B-X
LAPTM5 B-X
results B-X
in B-X
lysosomal B-X
targeting B-X
and B-X
induces B-X
Mcl-1 B-X
down-regulation B-X
, B-X
Bak B-X
activation B-X
, B-X
and B-X
mitochondria-dependent B-X
apoptosis B-X
in B-X
human B-X
HeLa B-X
cells B-X
We B-X
previously B-X
identified B-X
a B-X
novel B-X
p53-induced B-X
mouse B-X
gene B-X
, B-X
wig-1 B-X
, B-X
that B-X
encodes B-X
a B-X
290 B-X
amino B-X
acid B-X
zinc B-X
finger B-X
protein B-X
( B-X
Varmeh-Ziaie B-X
et B-X
al. B-X
, B-X
1997 B-X
) B-X
. B-X
Here B-X
we B-X
Human B-X
Relaxin B-X
Gene B-X
3 B-X
( B-X
H3 B-X
) B-X
and B-X
the B-X
Equivalent B-X
Mouse B-X
Relaxin B-X
( B-X
M3 B-X
) B-X
Gene B-X
A B-X
large B-X
fraction B-X
of B-X
pediatric B-X
pre-B B-X
acute B-X
lymphoblastoid B-X
leukemias B-X
( B-X
ALL B-X
) B-X
consistently B-X
contain B-X
a B-X
t B-X
( B-X
1 B-X
; B-X
19 B-X
) B-X
chromosomal B-X
translocation B-X
. B-X
The B-X
t B-X
( B-X
1 B-X
; B-X
19 B-X
Alternative B-X
splicing B-X
of B-X
mRNAs B-X
is B-X
known B-X
to B-X
involve B-X
a B-X
major B-X
regulation B-X
of B-X
gene B-X
expression B-X
at B-X
RNA B-X
level B-X
in B-X
mammalian B-X
cells B-X
. B-X
The B-X
PTEN B-X
( B-X
Phosphatase B-X
and B-X
TENsin B-X
homologue B-X
deleted B-X
from B-X

Upon	O
partial	O
cDNA	O
cloning	O
,	O
features	O
of	O
the	O
genetic	O
organization	O
of	O
LPP	O
were	O
established	O
.	O
<EOS> B-X
In B-X
an B-X
Arabidopsis B-X
thaliana B-X
T87-C3 B-X
cell-suspension B-X
culture B-X
, B-X
entry B-X
into B-X
the B-X
growth-arrest B-X
phase B-X
is B-X
rapidly B-X
followed B-X
by B-X
a B-X
loss B-X
of B-X
cell B-X
viability B-X
. B-X
Three B-X
cDNA B-X
clones B-X
... B-X
PDF B-X
| B-X
The B-X
magnetic B-X
resonance B-X
( B-X
MR B-X
) B-X
characteristics B-X
of B-X
parosteal B-X
lipomas B-X
with B-X
the B-X
HMGA2-LPP B-X
fusion B-X
transcripts B-X
are B-X
described B-X
. B-X
The B-X
expression B-X
of B-X
HMGA2-LPP B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
We B-X
have B-X
isolated B-X
a B-X
cDNA B-X
clone B-X
for B-X
one B-X
of B-X
the B-X
HLA-B B-X
locus B-X
alloantigens B-X
by B-X
hybridization B-X
with B-X
a B-X
30-nucleotide-long B-X
DNA B-X
probe B-X
. B-X
The B-X
probe B-X
was B-X
isolated B-X
from B-X
a B-X
reverse B-X
transcriptase B-X
( B-X
PDF B-X
| B-X
Although B-X
lipid B-X
phosphate B-X
phosphatases B-X
( B-X
LPPs B-X
) B-X
play B-X
an B-X
important B-X
role B-X
in B-X
cellular B-X
signaling B-X
in B-X
addition B-X
to B-X
lipid B-X
biosynthesis B-X
, B-X
little B-X
is B-X
thus B-X
far B-X
... B-X
| B-X
Find B-X
, B-X
gene B-X
mouse B-X
cdna B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
LPP B-X
, B-X
an B-X
Actin B-X
Cytoskeleton B-X
Protein B-X
Related B-X
to B-X
Zyxin B-X
, B-X
Harbors B-X
a B-X
Nuclear B-X
Export B-X
Signal B-X
and B-X
Transcriptional B-X
Activation B-X
Capacity B-X
At B-X
sites B-X
of B-X
cell B-X
adhesion B-X
, B-X
proteins B-X
exist B-X
that B-X
not B-X
only B-X
perform B-X
structural B-X
tasks B-X
but B-X
also B-X
have B-X
a B-X
signaling B-X
function B-X
. B-X
Previously B-X
, B-X
we B-X
found B-X
that B-X
the B-X
Lipoma B-X
Preferred B-X
Partner B-X

The	O
gene	O
was	O
found	O
to	O
span	O
a	O
genomic	O
region	O
of	O
over	O
400	O
kb	O
.	O
<EOS> B-X
The B-X
human B-X
CD22 B-X
gene B-X
is B-X
expressed B-X
specifically B-X
in B-X
B B-X
lymphocytes B-X
and B-X
likely B-X
has B-X
an B-X
important B-X
function B-X
in B-X
cell-cell B-X
interactions B-X
. B-X
A B-X
nearly B-X
full B-X
length B-X
human B-X
CD22 B-X
cDNA B-X
clone B-X
was B-X
used B-X
GPC3 B-X
, B-X
the B-X
gene B-X
modified B-X
in B-X
the B-X
Simpson-Golabi-Behmel B-X
gigantism/overgrowth B-X
syndrome B-X
( B-X
SGBS B-X
) B-X
, B-X
is B-X
shown B-X
to B-X
span B-X
more B-X
than B-X
500 B-X
kb B-X
of B-X
genomic B-X
sequence B-X
, B-X
with B-X
the B-X
transcript B-X
beginning B-X
Genomic B-X
regulatory B-X
blocks B-X
encompass B-X
multiple B-X
neighboring B-X
genes B-X
and B-X
maintain B-X
conserved B-X
synteny B-X
in B-X
vertebrates B-X
The B-X
genomic B-X
architecture B-X
of B-X
segmental B-X
duplications B-X
and B-X
associated B-X
copy B-X
number B-X
variants B-X
in B-X
dogs B-X
Genome-wide B-X
sequencing B-X
for B-X
the B-X
identification B-X
of B-X
rearrangements B-X
associated B-X
with B-X
Tourette B-X
syndrome B-X
and B-X
obsessive-compulsive B-X
disorder B-X
Analysis B-X
of B-X
exon/intron B-X
structure B-X
and B-X
400 B-X
kb B-X
of B-X
genomic B-X
sequence B-X
surrounding B-X
the B-X
5'-promoter B-X
and B-X
3'-terminal B-X
ends B-X
of B-X
the B-X
human B-X
glypican B-X
3 B-X
( B-X
GPC3 B-X
) B-X
gene B-X
. B-X
When B-X
you B-X
have B-X
read B-X
Chapter B-X
5 B-X
, B-X
you B-X
should B-X
be B-X
able B-X
to B-X
: B-X

Nucleotide	O
sequence	O
analysis	O
of	O
a	O
composite	O
cDNA	O
of	O
LPP	O
revealed	O
an	O
open	O
reading	O
frame	O
of	O
1836	O
nucleotides	O
encoding	O
a	O
proline	O
-	O
rich	O
protein	O
containing	O
a	O
leucine	O
-	O
zipper	O
motif	O
in	O
its	O
amino	O
-	O
terminal	O
region	O
and	O
three	O
LIM	O
domains	O
in	O
its	O
carboxy	O
-	O
terminal	O
region	O
.	O
<EOS> B-X
The B-X
tumor B-X
suppressor B-X
Scrib B-X
interacts B-X
with B-X
the B-X
zyxin-related B-X
protein B-X
LPP B-X
, B-X
which B-X
shuttles B-X
between B-X
cell B-X
adhesion B-X
sites B-X
and B-X
the B-X
nucleus B-X
LPP B-X
LIM B-X
domain B-X
containing B-X
preferred B-X
translocation B-X
partner B-X
in B-X
lipoma B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Request B-X
PDF B-X
| B-X
A B-X
novel B-X
gene B-X
containing B-X
LIM B-X
domains B-X
( B-X
LIMD1 B-X
) B-X
is B-X
located B-X
within B-X
the B-X
common B-X
eliminated B-X
region B-X
1 B-X
( B-X
C3CER1 B-X
) B-X
in B-X
3p21.3 B-X
| B-X
Chromosomal B-X
deletions B-X
on B-X
3p B-X
Request B-X
PDF B-X
| B-X
Characterization B-X
of B-X
the B-X
Felix B-X
domesticus B-X
( B-X
cat B-X
) B-X
glaucoma-associated B-X
protein B-X
myocilin B-X
| B-X
The B-X
domestic B-X
cat B-X
( B-X
Felix B-X
domesticus B-X
) B-X
is B-X
a B-X
useful B-X
model B-X
for B-X
understanding B-X
the B-X
implications B-X
600700 B-X
- B-X
LIM B-X
DOMAIN-CONTAINING B-X
PREFERRED B-X
TRANSLOCATION B-X
PARTNER B-X
IN B-X
LIPOMA B-X
; B-X
LPP B-X
- B-X
LIPOMA-PREFERRED B-X
PARTNER B-X
- B-X
LPP/MLL B-X
FUSION B-X
GENE B-X
, B-X
INCLUDED B-X
; B-X
; B-X
LPP/HMGIC B-X
FUSION B-X
GENE B-X
, B-X
INCLUDED B-X
- B-X
LPP B-X
600700 B-X
- B-X
LIM B-X
DOMAIN-CONTAINING B-X
PREFERRED B-X
TRANSLOCATION B-X
PARTNER B-X
IN B-X
LIPOMA B-X
; B-X
LPP B-X
- B-X
LIPOMA-PREFERRED B-X
PARTNER B-X
- B-X
LPP/MLL B-X
FUSION B-X
GENE B-X
, B-X
INCLUDED B-X
; B-X
; B-X
LPP/HMGIC B-X
FUSION B-X
GENE B-X
, B-X
INCLUDED B-X
- B-X
LPP B-X
600700 B-X
- B-X
LIM B-X
DOMAIN-CONTAINING B-X
PREFERRED B-X
TRANSLOCATION B-X
PARTNER B-X
IN B-X
LIPOMA B-X
; B-X
LPP B-X
- B-X
LIPOMA-PREFERRED B-X
PARTNER B-X
- B-X
LPP/MLL B-X
FUSION B-X
GENE B-X
, B-X
INCLUDED B-X
; B-X
; B-X
LPP/HMGIC B-X
FUSION B-X
GENE B-X
, B-X
INCLUDED B-X
- B-X
LPP B-X

The	O
LPP	O
-	O
encoded	O
protein	O
should	O
be	O
classified	O
as	O
a	O
novel	O
member	O
of	O
the	O
group	O
3	O
proteins	O
of	O
the	O
LIM	O
protein	O
gene	O
family	O
.	O
<EOS> B-X
Providing B-X
an B-X
extensive B-X
range B-X
of B-X
internationally B-X
recognized B-X
polyclonal B-X
antibodies B-X
designed B-X
for B-X
research B-X
use B-X
. B-X
Click B-X
here B-X
to B-X
view B-X
our B-X
high-quality B-X
products B-X
. B-X
Informations B-X
about B-X
Anti-LPP B-X
( B-X
ARP-10-P2040 B-X
) B-X

Using	O
reverse	O
transcriptase	O
combined	O
with	O
polymerase	O
chain	O
reactions	O
in	O
the	O
analysis	O
of	O
a	O
number	O
of	O
lipoma	B-Disease
cell	O
lines	O
and	O
primary	B-Disease
lipomas	I-Disease
,	O
it	O
appeared	O
that	O
LPP	O
is	O
frequently	O
rearranged	O
also	O
in	O
cases	O
without	O
a	O
cytogenetically	O
detectable	O
involvement	O
of	O
3q27	O
-	O
q28	O
.	O
<EOS> B-X
The B-X
major B-X
cytogenetic B-X
subgroup B-X
of B-X
lipomas B-X
is B-X
characterized B-X
by B-X
aberrations B-X
of B-X
chromosome B-X
segment B-X
12q13-15 B-X
, B-X
which B-X
recombines B-X
with B-X
a B-X
large B-X
number B-X
of B-X
other B-X
chromosomal B-X
regions B-X
. B-X
The B-X
gene B-X
HMGA2 B-X
is B-X
Request B-X
PDF B-X
| B-X
Human B-X
LPP B-X
gene B-X
is B-X
fused B-X
to B-X
MLL B-X
in B-X
a B-X
secondary B-X
acute B-X
leukemia B-X
with B-X
a B-X
t B-X
( B-X
3 B-X
; B-X
11 B-X
) B-X
( B-X
q28 B-X
; B-X
q23 B-X
) B-X
| B-X
The B-X
Download B-X
Citation B-X
| B-X
Large B-X
deletion B-X
of B-X
part B-X
of B-X
the B-X
HMGIC B-X
locus B-X
accompanying B-X
a B-X
t B-X
( B-X
3 B-X
; B-X
12 B-X
) B-X
( B-X
q27 B-X
approximately B-X
q28 B-X
; B-X
q14 B-X
approximately B-X
q15 B-X
) B-X
in B-X
a B-X
Download B-X
Citation B-X
| B-X
Expression B-X
of B-X
the B-X
HMGA2-LPP B-X
fusion B-X
transcript B-X
in B-X
only B-X
1 B-X
of B-X
61 B-X
karyotypically B-X
normal B-X
pulmonary B-X
chondroid B-X
hamartomas B-X
| B-X
The B-X
HMGA2 B-X
gene B-X
has B-X
been B-X
found B-X
to B-X
be B-X
rearranged B-X
in B-X
Download B-X
Citation B-X
| B-X
An B-X
identical B-X
HMGICLPP B-X
fusion B-X
transcript B-X
is B-X
consistently B-X
expressed B-X
in B-X
pulmonary B-X
chondroid B-X
hamartomas B-X
with B-X
t B-X
( B-X
3 B-X
; B-X
12 B-X
) B-X
( B-X
q27‚Äì28 B-X
; B-X
q14‚Äì15 B-X
) B-X
| B-X
The B-X
high B-X
PDF B-X
| B-X
LPP B-X
( B-X
Lipoma B-X
Preferred B-X
Partner B-X
) B-X
is B-X
a B-X
zyxin-related B-X
cell B-X
adhesion B-X
protein B-X
that B-X
is B-X
involved B-X
in B-X
the B-X
regulation B-X
of B-X
cell B-X
migration B-X
. B-X
We B-X
generated B-X
mice B-X
... B-X
| B-X
Find B-X

Two	O
alternative	O
HMGIC	O
/	O
LPP	O
hybrid	O
transcripts	O
have	O
been	O
detected	O
;	O
the	O
difference	O
between	O
them	O
is	O
mainly	O
the	O
presence	O
of	O
either	O
two	O
or	O
three	O
LIM	O
domains	O
in	O
the	O
predicted	O
HMGI	O
-	O
C	O
/	O
LPP	O
fusion	O
proteins	O
.	O
.	O

Absence	O
of	O
disease	O
phenotype	O
and	O
intergenerational	O
stability	O
of	O
the	O
CAG	O
repeat	O
in	O
transgenic	O
mice	O
expressing	O
the	O
human	O
Huntington	B-Disease
disease	I-Disease
transcript	O
.	O
<EOS> B-X
Long B-X
CAG/CTG B-X
repeats B-X
in B-X
mice B-X
| B-X
SpringerLink B-X
Request B-X
PDF B-X
| B-X
Intergenerational B-X
and B-X
striatal B-X
CAG B-X
repeat B-X
instability B-X
in B-X
Huntington B-X
's B-X
disease B-X
knock-in B-X
mice B-X
involve B-X
different B-X
DNA B-X
repair B-X
genes B-X
| B-X
Modifying B-X
the B-X
length B-X
of B-X
the B-X
Huntington B-X
's B-X
disease B-X
( B-X
Abstract B-X
. B-X
The B-X
mutation B-X
underlying B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
CAG B-X
expansion B-X
in B-X
the B-X
first B-X
exon B-X
of B-X
the B-X
HD B-X
gene B-X
. B-X
In B-X
order B-X
to B-X
investigate B-X
the B-X
role B-X
of B-X
CAG B-X
Abstract B-X
. B-X
CAG/polyglutamine B-X
expansion B-X
has B-X
been B-X
shown B-X
to B-X
form B-X
the B-X
molecular B-X
basis B-X
of B-X
an B-X
increasing B-X
number B-X
of B-X
inherited B-X
neurodegenerative B-X
diseases B-X
. B-X
The B-X
mutation B-X
i B-X
X-linked B-X
spinal B-X
and B-X
bulbar B-X
muscular B-X
atrophy B-X
( B-X
SBMA B-X
) B-X
is B-X
caused B-X
by B-X
a B-X
CAG B-X
repeat B-X
expansion B-X
in B-X
the B-X
first B-X
exon B-X
of B-X
the B-X
androgen B-X
receptor B-X
( B-X
AR B-X
) B-X
gene B-X
. B-X
Disease-associated B-X
Abstract B-X
. B-X
Spinocerebellar B-X
ataxia B-X
type B-X
7 B-X
( B-X
SCA7 B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
cerebellar B-X
ataxia B-X
caused B-X
by B-X
a B-X
CAG B-X
repeat B-X
expansion B-X
in B-X
the B-X
ataxin-7 B-X
gene B-X
. B-X
In B-X
humans B-X
, B-X
SCA7 B-X
Six B-X
inherited B-X
neurodegenerative B-X
diseases B-X
are B-X
caused B-X
by B-X
a B-X
CAG/polyglutamine B-X
expansion B-X
, B-X
including B-X
spinal B-X
and B-X
bulbar B-X
muscular B-X
atrophy B-X
( B-X
SBMA B-X
) B-X
1 B-X
, B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
2 B-X
, B-X

The	O
mutation	O
underlying	O
Huntington	B-Disease
disease	I-Disease
(	O
HD	B-Disease
)	O
is	O
CAG	O
expansion	O
in	O
the	O
first	O
exon	O
of	O
the	O
HD	B-Disease
gene	O
.	O
<EOS> B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
caused B-X
by B-X
an B-X
expanded B-X
CAG B-X
repeat B-X
in B-X
exon B-X
1 B-X
of B-X
the B-X
gene B-X
coding B-X
for B-X
the B-X
huntingtin B-X
protein B-X
. B-X
The B-X
cellular B-X
pathway B-X
by B-X
which B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
a B-X
dominantly B-X
inherited B-X
neurodegenerative B-X
disorder B-X
whose B-X
characterstics B-X
were B-X
first B-X
described B-X
by B-X
George B-X
Huntington B-X
in B-X
1872 B-X
. B-X
Several B-X
decades B-X
later B-X
, B-X
in B-X
1993 B-X
, B-X
Introducing B-X
an B-X
expanded B-X
CAG B-X
tract B-X
into B-X
the B-X
huntingtin B-X
gene B-X
causes B-X
a B-X
wide B-X
spectrum B-X
of B-X
ultrastructural B-X
defects B-X
in B-X
cultured B-X
human B-X
cells B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
a B-X
progressive B-X
neurodegenerative B-X
disorder B-X
that B-X
generally B-X
begins B-X
in B-X
middle B-X
age B-X
with B-X
abnormalities B-X
of B-X
movement B-X
, B-X
cognition B-X
, B-X
personality B-X
, B-X
and B-X
mood B-X
. B-X
Neuronal B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
: B-X
underlying B-X
molecular B-X
mechanisms B-X
and B-X
emerging B-X
concepts B-X
We B-X
have B-X
previously B-X
shown B-X
that B-X
exon B-X
1 B-X
of B-X
the B-X
huntingtin B-X
gene B-X
does B-X
not B-X
always B-X
splice B-X
to B-X
exon B-X
2 B-X
resulting B-X
in B-X
the B-X
production B-X
of B-X
a B-X
small B-X
polyadenylated B-X
mRNA B-X
( B-X
HTTexon1 B-X
) B-X
In B-X
1872 B-X
, B-X
physician B-X
George B-X
Huntington B-X
reported B-X
a B-X
familial B-X
form B-X
of B-X
chorea B-X
noted B-X
previously B-X
on B-X
Long B-X
Island B-X
by B-X
his B-X
father B-X
and B-X
grandfather B-X
, B-X
also B-X
physicians B-X
. B-X
More B-X
than B-X
a B-X
century B-X

In	O
order	O
to	O
investigate	O
the	O
role	O
of	O
CAG	O
expansion	O
in	O
the	O
pathogenesis	O
of	O
HD	B-Disease
,	O
we	O
have	O
produced	O
transgenic	O
mice	O
containing	O
the	O
full	O
length	O
human	O
HD	B-Disease
cDNA	O
with	O
44	O
CAG	O
repeats	O
.	O
<EOS> B-X
A B-X
genetic B-X
association B-X
study B-X
of B-X
glutamine-encoding B-X
DNA B-X
sequence B-X
structures B-X
, B-X
somatic B-X
CAG B-X
expansion B-X
, B-X
and B-X
DNA B-X
repair B-X
gene B-X
variants B-X
, B-X
with B-X
Huntington B-X
disease B-X
clinical B-X
outcomes B-X
- B-X
ScienceDirect B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
a B-X
progressive B-X
neurodegenerative B-X
disorder B-X
characterized B-X
clinically B-X
by B-X
motor B-X
and B-X
psychiatric B-X
disturbances B-X
and B-X
pathologically B-X
by B-X
neuronal B-X
loss B-X
and B-X
gliosis B-X
( B-X
reactive B-X
astrocytosis B-X
) B-X
particularly B-X
CAG B-X
Repeat B-X
Not B-X
Polyglutamine B-X
Length B-X
Determines B-X
Timing B-X
of B-X
Huntington B-X
‚Äô B-X
s B-X
Disease B-X
Onset B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
Spinal B-X
and B-X
bulbar B-X
muscular B-X
atrophy B-X
( B-X
SBMA B-X
) B-X
is B-X
a B-X
motor B-X
neuron B-X
disease B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
polyglutamine B-X
tract B-X
within B-X
the B-X
androgen B-X
receptor B-X
. B-X
Thi B-X
Ever B-X
since B-X
its B-X
original B-X
description B-X
by B-X
George B-X
Huntington B-X
in B-X
1872 B-X
, B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
( B-X
HD B-X
) B-X
has B-X
been B-X
known B-X
as B-X
one B-X
of B-X
the B-X
most B-X
devastating B-X
inherited B-X
neurodegenerative B-X
disorders B-X
Abstract B-X
. B-X
Dentatorubral-pallidoluysian B-X
atrophy B-X
( B-X
DRPLA B-X
) B-X
is B-X
one B-X
among B-X
an B-X
increasing B-X
number B-X
of B-X
hereditary B-X
neurodegenerative B-X
diseases B-X
determined B-X
as B-X
being B-X
caused B-X
by B-X

By	O
1	O
year	O
,	O
these	O
mice	O
have	O
no	O
behavioral	B-Disease
abnormalities	I-Disease
and	O
morphometric	O
analysis	O
at	O
6	O
(	O
one	O
animal	O
)	O
and	O
9	O
(	O
two	O
animals	O
)	O
months	O
age	O
revealed	O
no	O
changes	O
.	O
<EOS> B-X
Novel B-X
BAC B-X
mouse B-X
model B-X
of B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
with B-X
225 B-X
CAG B-X
repeats B-X
exhibits B-X
an B-X
early B-X
widespread B-X
and B-X
stable B-X
degenerative B-X
phenotype B-X
A B-X
variety B-X
of B-X
mouse B-X
models B-X
have B-X
been B-X
developed B-X
that B-X
express B-X
mutant B-X
huntingtin B-X
( B-X
mHTT B-X
) B-X
leading B-X
to B-X
aggregates B-X
and B-X
inclusions B-X
that B-X
model B-X
the B-X
molecular B-X
pathology B-X
observed B-X
in B-X
Huntington B-X
‚Äô B-X
s B-X
Morphological B-X
analysis B-X
of B-X
the B-X
hippocampal B-X
region B-X
associated B-X
with B-X
an B-X
innate B-X
behaviour B-X
task B-X
in B-X
the B-X
transgenic B-X
mouse B-X
model B-X
( B-X
3xTg-AD B-X
) B-X
for B-X
Alzheimer B-X
disease B-X
| B-X
Neurolog√≠a B-X
( B-X
English B-X
Edition B-X
) B-X
Phenotypic B-X
characterization B-X
of B-X
recessive B-X
gene B-X
knockout B-X
rat B-X
models B-X
of B-X
Parkinson B-X
's B-X
disease B-X
- B-X
ScienceDirect B-X
Developmental B-X
Changes B-X
in B-X
Dendritic B-X
Spine B-X
Morphology B-X
in B-X
the B-X
Striatum B-X
and B-X
Their B-X
Alteration B-X
in B-X
an B-X
A53T B-X
Œ±-Synuclein B-X
Transgenic B-X
Mouse B-X
Model B-X
of B-X
Parkinson B-X
‚Äô B-X
s B-X
Disease B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
CAG B-X
repeat B-X
in B-X
the B-X
huntingtin B-X
( B-X
HTT B-X
) B-X
gene B-X
. B-X
The B-X
R6 B-X
mouse B-X
models B-X
of B-X
HD B-X
Dietary B-X
restriction B-X
regimes B-X
extend B-X
lifespan B-X
in B-X
various B-X
animal B-X
models B-X
. B-X
Here B-X
we B-X
show B-X
that B-X
longevity B-X
in B-X
male B-X
C57BL/6J B-X
mice B-X
subjected B-X
to B-X
every-other-day B-X
feeding B-X
is B-X
associated B-X
with B-X
a B-X
delayed B-X
onset B-X
of B-X

Despite	O
high	O
levels	O
of	O
mRNA	O
expression	O
,	O
there	O
was	O
no	O
evidence	O
of	O
the	O
HD	B-Disease
gene	O
product	O
in	O
any	O
of	O
these	O
transgenic	O
mice	O
.	O
<EOS> B-X
Exon B-X
1 B-X
of B-X
the B-X
HD B-X
Gene B-X
with B-X
an B-X
Expanded B-X
CAG B-X
Repeat B-X
Is B-X
Sufficient B-X
to B-X
Cause B-X
a B-X
Progressive B-X
Neurological B-X
Phenotype B-X
in B-X
Transgenic B-X
Mice B-X
: B-X
Cell B-X
Exon B-X
1 B-X
of B-X
the B-X
HD B-X
Gene B-X
with B-X
an B-X
Expanded B-X
CAG B-X
Repeat B-X
Is B-X
Sufficient B-X
to B-X
Cause B-X
a B-X
Progressive B-X
Neurological B-X
Phenotype B-X
in B-X
Transgenic B-X
Mice B-X
- B-X
ScienceDirect B-X
The B-X
Use B-X
of B-X
the B-X
R6 B-X
Transgenic B-X
Mouse B-X
Models B-X
of B-X
Huntington B-X
's B-X
Disease B-X
in B-X
Attempts B-X
to B-X
Develop B-X
Novel B-X
Therapeutic B-X
Strategies B-X
Abstract B-X
. B-X
To B-X
test B-X
the B-X
hypotheses B-X
that B-X
mutant B-X
huntingtin B-X
protein B-X
length B-X
and B-X
wild-type B-X
huntingtin B-X
dosage B-X
have B-X
important B-X
effects B-X
on B-X
disease-related B-X
transcriptional B-X
Huntington B-X
‚Äô B-X
s B-X
Disease B-X
: B-X
Can B-X
Mice B-X
Lead B-X
the B-X
Way B-X
to B-X
Treatment B-X
? B-X
Transcriptional B-X
Signatures B-X
in B-X
Huntington B-X
's B-X
Disease B-X
The B-X
goal B-X
of B-X
this B-X
chapter B-X
is B-X
to B-X
describe B-X
strategies B-X
for B-X
the B-X
development B-X
of B-X
RNA- B-X
and B-X
DNA-based B-X
therapies B-X
for B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
( B-X
HD B-X
) B-X
. B-X
RNA-based B-X
therapies B-X
use B-X
endogenous B-X

In	O
vitro	O
transfection	O
studies	O
indicated	O
that	O
the	O
inclusion	O
of	O
120	O
bp	O
of	O
the	O
5	O
UTR	O
in	O
the	O
cDNA	O
construct	O
and	O
the	O
presence	O
of	O
a	O
frameshift	O
mutation	O
at	O
nucleotide	O
2349	O
prevented	O
expression	O
of	O
the	O
HD	B-Disease
cDNA	O
.	O
<EOS> B-X
PDF B-X
| B-X
One B-X
of B-X
the B-X
most B-X
successful B-X
chromatic B-X
adaptations B-X
in B-X
vertebrates B-X
is B-X
the B-X
dorsal-ventral B-X
pigment B-X
pattern B-X
in B-X
which B-X
the B-X
dorsal B-X
skin B-X
is B-X
darkly B-X
colored B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
A B-X
cDNA B-X
encoding B-X
minoxidil B-X
sulfotransferase B-X
( B-X
Mx-ST B-X
) B-X
, B-X
a B-X
rat B-X
liver B-X
cytosolic B-X
sulfotransferase B-X
that B-X
catalyzes B-X
the B-X
3'-phosphoadenosine B-X
5'-phosphosulfate-dependent B-X
sulfate B-X
conjugation B-X
of B-X
minoxidil B-X
and B-X
p-nitrophenol B-X
, B-X
has B-X
been B-X
isolated B-X
from B-X

These	O
findings	O
suggest	O
that	O
the	O
pathogenesis	O
of	O
HD	B-Disease
is	O
not	O
mediated	O
through	O
DNA	O
-	O
protein	O
interaction	O
and	O
that	O
presence	O
of	O
the	O
RNA	O
transcript	O
with	O
an	O
expanded	O
CAG	O
repeat	O
is	O
insufficient	O
to	O
cause	O
the	O
disease	O
.	O
<EOS> B-X
A B-X
Novel B-X
Antisense B-X
CAG B-X
Repeat B-X
Transcript B-X
at B-X
JPH3 B-X
Locus B-X
Mediating B-X
Expanded B-X
Polyglutamine B-X
Protein B-X
Toxicity B-X
in B-X
Huntington B-X
‚Äô B-X
s B-X
Disease-Like B-X
2 B-X
( B-X
HDL2 B-X
) B-X
Mice B-X
Huntingtin B-X
Modulates B-X
Transcription B-X
, B-X
Occupies B-X
Gene B-X
Promoters B-X
In B-X
Vivo B-X
, B-X
and B-X
Binds B-X
Directly B-X
to B-X
DNA B-X
in B-X
a B-X
Polyglutamine-Dependent B-X
Manner B-X

Rather	O
,	O
translation	O
of	O
the	O
CAG	O
is	O
crucial	O
for	O
the	O
pathogenesis	O
of	O
HD	B-Disease
.	O
<EOS> B-X
Abstract B-X
. B-X
The B-X
mutation B-X
underlying B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
CAG B-X
expansion B-X
in B-X
the B-X
first B-X
exon B-X
of B-X
the B-X
HD B-X
gene B-X
. B-X
In B-X
order B-X
to B-X
investigate B-X
the B-X
role B-X
of B-X
CAG B-X
Altered B-X
Co-Translational B-X
Processing B-X
Plays B-X
a B-X
Role B-X
in B-X
Huntington B-X
's B-X
Pathogenesis‚ÄîA B-X
Hypothesis B-X
The B-X
mutation B-X
underlying B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
CAG B-X
expansion B-X
in B-X
the B-X
first B-X
exon B-X
of B-X
the B-X
HD B-X
gene B-X
. B-X
In B-X
order B-X
to B-X
investigate B-X
the B-X
role B-X
of B-X
CAG B-X
expansion B-X
in B-X
Absence B-X
of B-X
disease B-X
phenotype B-X
and B-X
intergenerational B-X
stability B-X
of B-X
the B-X
CAG B-X
repeat B-X
in B-X
transgenic B-X
mice B-X
expressing B-X
the B-X
human B-X
Huntington B-X
disease B-X
transcript B-X
‚Äî B-X
Johns B-X
Hopkins B-X
University B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
neurodegenerative B-X
disorder B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
CAG B-X
codon B-X
repeat B-X
region B-X
in B-X
the B-X
HTT B-X
gene B-X
‚Äô B-X
s B-X
first B-X
Huntington B-X
disease B-X
( B-X
HD B-X
) B-X
is B-X
a B-X
neurodegenerative B-X
disease B-X
caused B-X
by B-X
CAG B-X
repeat B-X
expansion B-X
in B-X
the B-X
huntingtin B-X
gene B-X
( B-X
HTT B-X
) B-X
and B-X
involves B-X
a B-X
complex B-X
web B-X
of B-X
pathogenic B-X
mechanisms B-X
. B-X
Expansion B-X
of B-X
CAG B-X
repeats B-X
is B-X
a B-X
common B-X
feature B-X
of B-X
various B-X
neurodegenerative B-X
disorders B-X
, B-X
including B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
. B-X
Here B-X
we B-X
show B-X
that B-X
expanded B-X
CAG B-X
repeats B-X
bind B-X
to B-X
a B-X
translation B-X

In	O
contrast	O
to	O
that	O
seen	O
in	O
humans	O
,	O
the	O
CAG	O
repeat	O
in	O
these	O
mice	O
was	O
remarkably	O
stable	O
in	O
97	O
meioses	O
.	O
<EOS> B-X
Hum B-X
Mol B-X
Genet.1996 B-X
Feb B-X
; B-X
177-85.pii:5w0296. B-X
, B-X
Human B-X
molecular B-X
genetics B-X

This	O
suggests	O
that	O
genomic	O
sequences	O
may	O
play	O
a	O
critical	O
role	O
in	O
influencing	O
repeat	O
instability	O
.	O
.	O
<EOS> B-X
New B-X
insights B-X
into B-X
repeat B-X
instability B-X
R B-X
loops B-X
stimulate B-X
genetic B-X
instability B-X
of B-X
CTG¬∑CAG B-X
repeats B-X
Topoisomerase B-X
I B-X
Plays B-X
a B-X
Critical B-X
Role B-X
in B-X
Suppressing B-X
Genome B-X
Instability B-X
at B-X
a B-X
Highly B-X
Transcribed B-X
G-Quadruplex-Forming B-X
Sequence B-X
R B-X
loops B-X
stimulate B-X
genetic B-X
instability B-X
of B-X
CTG¬∑CAG B-X
repeats B-X
| B-X
PNAS B-X
Bacterial B-X
Genome B-X
Instability B-X
Beyond B-X
Junk-Variable B-X
Tandem B-X
Repeats B-X
as B-X
Facilitators B-X
of B-X
Rapid B-X
Evolution B-X
of B-X
Regulatory B-X
and B-X
Coding B-X
Sequences B-X
Author B-X
Summary B-X
Genome B-X
instability B-X
is B-X
not B-X
evenly B-X
distributed B-X
, B-X
but B-X
rather B-X
is B-X
highly B-X
elevated B-X
at B-X
certain B-X
genomic B-X
loci B-X
containing B-X
DNA B-X
sequences B-X
that B-X
can B-X
fold B-X
into B-X
non-canonical B-X
secondary B-X
structures B-X
. B-X
The B-X

FISH	O
studies	O
in	O
a	O
patient	O
with	O
sporadic	B-Disease
aniridia	I-Disease
and	O
t	O
(	O
7	O
;	O
11	O
)	O
(	O
q31	O
.	O
2	O
;	O
p13	O
)	O
.	O
<EOS> B-X
A B-X
probable B-X
case B-X
of B-X
the B-X
homozygous B-X
condition B-X
of B-X
the B-X
aniridia B-X
gene B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
A B-X
2 B-X
year B-X
old B-X
female B-X
presenting B-X
with B-X
bilateral B-X
sporadic B-X
aniridia B-X
was B-X
found B-X
to B-X
have B-X
an B-X
apparently B-X
balanced B-X
reciprocal B-X
translocation B-X
with B-X
a B-X
chromosome B-X
11 B-X
breakpoint B-X
within B-X
band B-X
p13 B-X
. B-X
Fluorescence B-X
in B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

A	O
2	O
year	O
old	O
female	O
presenting	O
with	O
bilateral	B-Disease
sporadic	I-Disease
aniridia	I-Disease
was	O
found	O
to	O
have	O
an	O
apparently	O
balanced	O
reciprocal	O
translocation	O
with	O
a	O
chromosome	O
11	O
breakpoint	O
within	O
band	O
p13	O
.	O
<EOS> B-X
FISH B-X
studies B-X
in B-X
a B-X
patient B-X
with B-X
sporadic B-X
aniridia B-X
and B-X
t B-X
( B-X
7 B-X
; B-X
11 B-X
) B-X
( B-X
q31.2 B-X
; B-X
p13 B-X
) B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
FISH B-X
studies B-X
in B-X
a B-X
patient B-X
with B-X
sporadic B-X
aniridia B-X
and B-X
t B-X
( B-X
7 B-X
; B-X
11 B-X
) B-X
( B-X
q31.2 B-X
; B-X
p13 B-X
) B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
PDF B-X
| B-X
A B-X
father B-X
and B-X
three B-X
of B-X
his B-X
offspring B-X
had B-X
skeletal B-X
abnormalities B-X
consisting B-X
of B-X
a B-X
short B-X
forearm B-X
, B-X
cubitus B-X
valgus B-X
, B-X
fusion B-X
of B-X
first B-X
and B-X
second B-X
cervical B-X
... B-X
| B-X
Find B-X
Translocations B-X
are B-X
the B-X
most B-X
common B-X
type B-X
of B-X
structural B-X
chromosomal B-X
abnormalities B-X
. B-X
Unbalanced B-X
translocations B-X
are B-X
usually B-X
found B-X
in B-X
children B-X
who B-X
present B-X
with B-X
congenital B-X
abnormalities B-X
, B-X
developmental B-X
delay B-X
, B-X
or B-X
intellectual B-X
disability B-X

Fluorescence	O
in	O
situ	O
hybridisation	O
(	O
FISH	O
)	O
studies	O
with	O
distal	O
11p13	O
specific	O
cosmids	O
showed	O
that	O
the	O
chromosome	O
11	O
breakpoint	O
lay	O
between	O
the	O
aniridia	B-Disease
(	O
PAX6	O
)	O
locus	O
and	O
a	O
region	O
approximately	O
100	O
kb	O
distal	O
to	O
PAX6	O
defined	O
by	O
the	O
cosmid	O
FO2121	O
.	O
<EOS> B-X
Seventy-seven B-X
patients B-X
with B-X
aniridia B-X
, B-X
referred B-X
for B-X
cytogenetic B-X
analysis B-X
predominantly B-X
to B-X
assess B-X
Wilms B-X
tumor B-X
risk B-X
, B-X
were B-X
studied B-X
by B-X
fluorescence B-X
in B-X
situ B-X
hybridization B-X
( B-X
FISH B-X
) B-X
, B-X
through B-X
use B-X
of B-X
FISH B-X
studies B-X
in B-X
a B-X
patient B-X
with B-X
sporadic B-X
aniridia B-X
and B-X
t B-X
( B-X
7 B-X
; B-X
11 B-X
) B-X
( B-X
q31.2 B-X
; B-X
p13 B-X
) B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Request B-X
PDF B-X
| B-X
Congenital B-X
diaphragmatic B-X
hernia B-X
in B-X
WAGR B-X
syndrome B-X
| B-X
Wilms B-X
tumor B-X
, B-X
aniridia B-X
, B-X
genitourinary B-X
anomalies B-X
, B-X
and B-X
mental B-X
retardation B-X
( B-X
WAGR B-X
) B-X
syndrome B-X
is B-X
a B-X
contiguous B-X
gene B-X
deletion B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Although	O
this	O
patient	O
did	O
not	O
have	O
a	O
detectable	O
deletion	O
within	O
PAX6	O
,	O
her	O
aniridia	B-Disease
may	O
have	O
resulted	O
from	O
a	O
disruption	O
of	O
the	O
distal	O
chromatin	O
domain	O
containing	O
either	O
enhancers	O
or	O
regulators	O
for	O
PAX6	O
.	O
<EOS> B-X
Analysis B-X
of B-X
Pax6 B-X
Contiguous B-X
Gene B-X
Deletions B-X
in B-X
the B-X
Mouse B-X
, B-X
Mus B-X
musculus B-X
, B-X
Identifies B-X
Regions B-X
Distinct B-X
from B-X
Pax6 B-X
Responsible B-X
for B-X
Extreme B-X
Small-Eye B-X
and B-X
Belly-Spotting B-X
Phenotypes B-X

This	O
case	O
may	O
therefore	O
be	O
another	O
example	O
of	O
aniridia	B-Disease
caused	O
by	O
a	O
position	O
effect	O
as	O
recently	O
described	O
in	O
two	O
familial	B-Disease
aniridia	I-Disease
patients	O
in	O
which	O
the	O
phenotype	O
cosegregated	O
with	O
chromosome	B-Disease
abnormalities	I-Disease
with	O
11p13	O
breakpoints	O
.	O
.	O
<EOS> B-X
Large B-X
novel B-X
deletions B-X
detected B-X
in B-X
Chinese B-X
families B-X
with B-X
aniridia B-X
: B-X
correlation B-X
between B-X
genotype B-X
and B-X
phenotype B-X
A B-X
2 B-X
year B-X
old B-X
female B-X
presenting B-X
with B-X
bilateral B-X
sporadic B-X
aniridia B-X
was B-X
found B-X
to B-X
have B-X
an B-X
apparently B-X
balanced B-X
reciprocal B-X
translocation B-X
with B-X
a B-X
chromosome B-X
11 B-X
breakpoint B-X
within B-X
band B-X
p13 B-X
. B-X
Fluorescence B-X
in B-X
Frequent B-X
Chromosome B-X
Aberrations B-X
Revealed B-X
by B-X
Molecular B-X
Cytogenetic B-X
Studies B-X
in B-X
Patients B-X
with B-X
Aniridia B-X
PDF B-X
| B-X
Aniridia B-X
is B-X
a B-X
congenital B-X
pan-ocular B-X
, B-X
bilateral B-X
disorder B-X
. B-X
The B-X
term B-X
aniridia B-X
is B-X
a B-X
misleading B-X
misnomer B-X
, B-X
since B-X
at B-X
least B-X
a B-X
rudimentary B-X
iris B-X
is B-X
always B-X
... B-X
| B-X
Find B-X
PDF B-X
| B-X
Aniridia B-X
is B-X
a B-X
congenital B-X
panocular B-X
malformation B-X
defined B-X
as B-X
iris B-X
aplasia B-X
or B-X
hypoplasia B-X
. B-X
It B-X
can B-X
be B-X
either B-X
isolated B-X
or B-X
be B-X
a B-X
part B-X
of B-X
multiple B-X
ocular B-X
... B-X
| B-X
Find B-X
Request B-X
PDF B-X
| B-X
Frequent B-X
Chromosome B-X
Aberrations B-X
Revealed B-X
by B-X
Molecular B-X
Cytogenetic B-X
Studies B-X
in B-X
Patients B-X
with B-X
Aniridia B-X
| B-X
Seventy-seven B-X
patients B-X
with B-X
aniridia B-X
, B-X
referred B-X
for B-X
cytogenetic B-X
analysis B-X
predominantly B-X
to B-X
assess B-X
Wilms B-X
tumor B-X
PDF B-X
| B-X
The B-X
PAX6 B-X
gene B-X
is B-X
a B-X
transcription B-X
factor B-X
expressed B-X
early B-X
in B-X
development B-X
, B-X
predominantly B-X
in B-X
the B-X
eye B-X
, B-X
brain B-X
and B-X
gut B-X
. B-X
It B-X
is B-X
well B-X
known B-X
that B-X
mutations B-X
... B-X

Muscle	O
expression	O
of	O
glucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphate	I-Disease
dehydrogenase	I-Disease
deficiency	I-Disease
in	O
different	O
variants	O
.	O
<EOS> B-X
New B-X
Diagnosis B-X
of B-X
G6PD B-X
Deficiency B-X
Presenting B-X
as B-X
Severe B-X
Rhabdomyolysis B-X

Muscle	O
expression	O
of	O
G6PD	B-Disease
deficiency	I-Disease
has	O
been	O
investigated	O
in	O
Mediterranean	O
,	O
Seattle	O
-	O
like	O
and	O
A	O
-	O
variants	O
.	O
<EOS> B-X
Muscle B-X
expression B-X
of B-X
G6PD B-X
deficiency B-X
has B-X
been B-X
investigated B-X
in B-X
Mediterranean B-X
, B-X
Seattle-like B-X
and B-X
A-variants B-X
. B-X
G6PD B-X
activity B-X
was B-X
detected B-X
in B-X
samples B-X
obtained B-X
from B-X
biopsies B-X
on B-X
the B-X
quadriceps B-X
muscle B-X
of B-X
seven B-X
Muscle B-X
expression B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
in B-X
different B-X
variants B-X
‚Äî B-X
Italian B-X
Ministry B-X
of B-X
Health B-X
Role B-X
of B-X
G6PD B-X
in B-X
the B-X
Clearance B-X
of B-X
Oxidant B-X
Stress B-X
Products B-X
in B-X
Muscle B-X
During B-X
Exercise B-X
PDF B-X
| B-X
BACKGROUND B-X
In B-X
southern B-X
China B-X
, B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
a B-X
significant B-X
health B-X
problem B-X
. B-X
The B-X
aim B-X
of B-X
this B-X
study B-X
was B-X
to B-X
... B-X
| B-X
Find B-X
, B-X
PDF B-X
| B-X
Theoretically B-X
, B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
-deficient B-X
compared B-X
with B-X
nondeficient B-X
individuals B-X
may B-X
be B-X
less B-X
capable B-X
of B-X
performing B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
Clearance B-X
of B-X
Oxidant B-X
Stress B-X

G6PD	O
activity	O
was	O
detected	O
in	O
samples	O
obtained	O
from	O
biopsies	O
on	O
the	O
quadriceps	O
muscle	O
of	O
seven	O
males	O
and	O
one	O
female	O
.	O
<EOS> B-X
Muscle B-X
Expression B-X
of B-X
G6PD B-X
Deficiency B-X
in B-X
Different B-X
Variants B-X
Muscle B-X
Expression B-X
of B-X
G6PD B-X
Deficiency B-X
in B-X
Different B-X
Variants B-X
Case B-X
Report B-X
: B-X
Acute B-X
haemolytic B-X
anaemia B-X
and B-X
myolysis B-X
due B-X
to B-X
G6PD B-X
deficiency B-X
Muscle B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
described B-X
in B-X
four B-X
clinically B-X
heterogeneous B-X
patients B-X
: B-X
an B-X
athlete B-X
who B-X
developed B-X
myoglobinuria B-X
after B-X
physical B-X
exercise B-X
; B-X
a B-X
7-year-old B-X
, B-X
mildly B-X
mentally B-X
retarded B-X
PDF B-X
| B-X
Unaccustomed B-X
exercise B-X
is B-X
followed B-X
by B-X
delayed-onset B-X
muscle B-X
soreness B-X
and B-X
morphological B-X
changes B-X
in B-X
skeletal B-X
muscle B-X
. B-X
Animal B-X
studies B-X
have B-X
demonstrated B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
PDF B-X
| B-X
A B-X
24-year-old B-X
African-American B-X
man B-X
presented B-X
with B-X
malaise B-X
and B-X
low B-X
back B-X
pain B-X
and B-X
was B-X
found B-X
to B-X
have B-X
acute B-X
severe B-X
rhabdomyolysis B-X
followed B-X
by B-X
acute B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
PDF B-X
| B-X
Glucose-6-Phosphate B-X
Dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
an B-X
X-linked B-X
genetic B-X
disorder B-X
associated B-X
with B-X
intravascular B-X
hemolysis B-X
. B-X
Rhabdomyolysis B-X
with B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X

The	O
type	O
of	O
genetic	O
variant	O
was	O
determined	O
by	O
molecular	O
analysis	O
of	O
DNA	O
,	O
extracted	O
from	O
blood	O
samples	O
.	O
<EOS> B-X
The B-X
utility B-X
of B-X
DNA B-X
extracted B-X
from B-X
saliva B-X
for B-X
genome-wide B-X
molecular B-X
research B-X
platforms B-X
A B-X
rapid B-X
and B-X
efficient B-X
DNA B-X
extraction B-X
protocol B-X
from B-X
fresh B-X
and B-X
frozen B-X
human B-X
blood B-X
samples B-X
Impact B-X
of B-X
DNA B-X
source B-X
on B-X
genetic B-X
variant B-X
detection B-X
from B-X
human B-X
whole-genome B-X
sequencing B-X
data B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
A B-X
Simple B-X
Method B-X
of B-X
Genomic B-X
DNA B-X
Extraction B-X
from B-X
Human B-X
Samples B-X
for B-X
PCR-RFLP B-X
Analysis B-X
Systematic B-X
molecular B-X
analysis B-X
of B-X
hemophilia B-X
A B-X
patients B-X
from B-X
Colombia B-X
Standards B-X
and B-X
Guidelines B-X
for B-X
the B-X
Interpretation B-X
and B-X
Reporting B-X
of B-X
Sequence B-X
Variants B-X
in B-X
Cancer B-X
Clinical B-X
Exome B-X
Sequencing B-X
for B-X
Genetic B-X
Identification B-X
of B-X
Rare B-X
Mendelian B-X
Disorders B-X

All	O
variants	O
showed	O
the	O
enzyme	O
defect	O
in	O
muscle	O
.	O
<EOS> B-X
A B-X
New B-X
Muscle B-X
Glycogen B-X
Storage B-X
Disease B-X
Associated B-X
with B-X
Glycogenin-1 B-X
Deficiency B-X
PFKM B-X
gene B-X
defect B-X
and B-X
glycogen B-X
storage B-X
disease B-X
GSDVII B-X
with B-X
misleading B-X
enzyme B-X
histochemistry B-X
Pompe B-X
disease B-X
is B-X
classified B-X
by B-X
age B-X
of B-X
onset B-X
, B-X
organ B-X
involvement B-X
, B-X
severity B-X
, B-X
and B-X
rate B-X
of B-X
progression B-X
. B-X
Muscle B-X
glycogenoses B-X
: B-X
an B-X
overview B-X
Neuromuscular B-X
forms B-X
of B-X
glycogen B-X
branching B-X
enzyme B-X
deficiency B-X
Enzyme B-X
Defect B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Type B-X
IV B-X
glycogenosis B-X
is B-X
due B-X
to B-X
branching B-X
enzyme B-X
deficiency B-X
and B-X
is B-X
usually B-X
manifested B-X
clinically B-X
by B-X
progressive B-X
liver B-X
disease B-X
with B-X
cirrhosis B-X
and B-X
hepatic B-X
failure B-X
between B-X
the B-X
second B-X
and B-X
fourth B-X
years B-X
of B-X

A	O
statistically	O
significant	O
relationship	O
was	O
found	O
in	O
the	O
activity	O
of	O
G6PD	O
between	O
erythrocytes	O
and	O
muscle	O
of	O
the	O
male	O
subjects	O
(	O
r	O
=	O
0	O
.	O
968	O
;	O
p	O
=	O
0	O
.	O
00008	O
)	O
.	O
<EOS> B-X
G6PD B-X
deficiency B-X
may B-X
render B-X
afflicted B-X
individuals B-X
more B-X
susceptible B-X
to B-X
certain B-X
degenerative B-X
diseases B-X
. B-X
To B-X
clarify B-X
the B-X
relationship B-X
between B-X
G6PD B-X
deficiency B-X
and B-X
cataract B-X
, B-X
blood B-X
G6PD B-X
activity B-X
was B-X
determined B-X
in B-X
patients B-X
Prediction B-X
of B-X
mortality B-X
benefit B-X
based B-X
on B-X
periodic B-X
repolarisation B-X
dynamics B-X
in B-X
patients B-X
undergoing B-X
prophylactic B-X
implantation B-X
of B-X
a B-X
defibrillator B-X
: B-X
a B-X
prospective B-X
, B-X
controlled B-X
, B-X
multicentre B-X
cohort B-X
study B-X
- B-X
ScienceDirect B-X
PDF B-X
| B-X
Diabetes B-X
mellitus B-X
is B-X
a B-X
metabolic B-X
affliction B-X
saunter B-X
that B-X
is B-X
characterized B-X
by B-X
a B-X
nobler B-X
than B-X
normal B-X
blood B-X
glucose B-X
poise B-X
. B-X
Glucose-6-phosphate B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Exercise B-X
in B-X
Glucose-6-Phosphate B-X
Dehydrogenase B-X
Deficiency B-X
: B-X
Harmful B-X
or B-X
Harmless B-X
? B-X
A B-X
Narrative B-X
Review B-X
PDF B-X
| B-X
Background B-X
: B-X
A B-X
small B-X
proportion B-X
of B-X
patients B-X
undergoing B-X
primary B-X
prophylactic B-X
implantation B-X
of B-X
implantable B-X
cardioverter B-X
defibrillators B-X
( B-X
ICDs B-X
) B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
Current B-X
Business B-X
Reports B-X
. B-X
Monthly B-X
Retail B-X
Trade B-X
, B-X
Sales B-X
and B-X
Accounts B-X
Receivable B-X
- B-X
Google B-X
Âõæ‰π¶ B-X
The B-X
Astronomical B-X
Almanac B-X
for B-X
the B-X
Year B-X
- B-X
Google B-X
Âõæ‰π¶ B-X

The	O
equation	O
for	O
the	O
best	O
fit	O
line	O
was	O
Y	O
=	O
0	O
.	O
<EOS> B-X
Calculating B-X
the B-X
equation B-X
of B-X
a B-X
least-squares B-X
regression B-X
line B-X
. B-X
Intuition B-X
for B-X
why B-X
this B-X
equation B-X
makes B-X
sense B-X
. B-X
Learn B-X
how B-X
to B-X
approximate B-X
the B-X
line B-X
of B-X
best B-X
fit B-X
and B-X
find B-X
the B-X
equation B-X
of B-X
the B-X
line B-X
. B-X
We B-X
go B-X
through B-X
an B-X
example B-X
in B-X
this B-X
free B-X
math B-X
video B-X
tutorial B-X
by B-X
Mario B-X
A B-X
regression B-X
line B-X
, B-X
or B-X
a B-X
line B-X
of B-X
best B-X
fit B-X
, B-X
can B-X
be B-X
drawn B-X
on B-X
a B-X
scatter B-X
plot B-X
and B-X
used B-X
to B-X
predict B-X
outcomes B-X
for B-X
the B-X
x B-X
and B-X
y B-X
variables B-X
in B-X
The B-X
Least-Square B-X
Regression B-X
Line B-X
and B-X
Equation B-X
How B-X
to B-X
Calculate B-X
a B-X
Regression B-X
Line B-X
- B-X
dummies B-X
Data B-X
rarely B-X
fit B-X
a B-X
straight B-X
line B-X
exactly B-X
. B-X
Usually B-X
, B-X
you B-X
must B-X
be B-X
satisfied B-X
with B-X
rough B-X
predictions B-X
. B-X
Typically B-X
, B-X
you B-X
have B-X
a B-X
set B-X
of B-X
data B-X
with B-X
a B-X
scatter B-X
plot B-X
Build B-X
a B-X
basic B-X
understanding B-X
of B-X
what B-X
a B-X
residual B-X
is B-X
. B-X

390X	O
+	O
0	O
.	O
<EOS> B-X
UserBenchmark B-X
: B-X
AMD B-X
R9 B-X
390X B-X
PassMark B-X
- B-X
Radeon B-X
R9 B-X
390X B-X
- B-X
Price B-X
performance B-X
comparison B-X
R9 B-X
390X B-X
( B-X
8GB B-X
) B-X
VS. B-X
GTX B-X
1060 B-X
( B-X
6GB B-X
) B-X
| B-X
New B-X
Games B-X
BenchmarksIn B-X
this B-X
Video B-X
I B-X
'll B-X
Show B-X
You B-X
Gaming B-X
Benchmarks B-X
of B-X
AMD B-X
R9 B-X
390X B-X
Stock B-X
and B-X
Nvidia B-X
R9 B-X
390X B-X
VS B-X
RX B-X
580 B-X
| B-X
New B-X
Games B-X
BenchmarksIn B-X
this B-X
Video B-X
I B-X
'll B-X
Show B-X
You B-X
Gaming B-X
Benchmarks B-X
of B-X
R9 B-X
390X B-X
8GB B-X
and B-X
RX B-X
580 B-X
8GB B-X
( B-X
Both B-X
Paired B-X
with B-X
Core B-X
Gentoo B-X
Forums B-X
: B-X
: B-X
ÈòÖËØª‰∏ªÈ¢ò B-X
- B-X
amd B-X
r9 B-X
390x B-X
amdgpu B-X
R9 B-X
390X B-X
VS B-X
GTX B-X
980 B-X
| B-X
New B-X
Games B-X
BenchmarksIn B-X
this B-X
Video B-X
I B-X
'll B-X
Show B-X
You B-X
Gaming B-X
Benchmarks B-X
of B-X
AMD B-X
R9 B-X
390X B-X
and B-X
NVIDIA B-X
GeForce B-X
GTX B-X
980 B-X
( B-X
Both B-X
Paired B-X
with B-X
0:00 B-X
Rainbow B-X
Six B-X
Siege B-X
( B-X
Steel B-X
Wave B-X
) B-X
1:07 B-X
Forza B-X
Horizon B-X
42:12 B-X
Assassin B-X
's B-X
Creed B-X
Odyssey3:18 B-X
Battlefield B-X
V4:23 B-X
Fortnite B-X
( B-X
Chapter B-X
2 B-X
Season B-X
3 B-X
) B-X
5:29 B-X
Apex B-X
Legends B-X
( B-X
Se B-X

198	O
198	O
.	O
<EOS> B-X
Radical B-X
198 B-X
- B-X
Wikipedia B-X
A/74/198 B-X
- B-X
F B-X
- B-X
A/74/198 B-X
-Desktop B-X
A/CN.9/WG.II/WP.198 B-X
- B-X
E B-X
- B-X
A/CN.9/WG.II/WP.198 B-X
-Desktop B-X
SCP-198 B-X
- B-X
SCPÂü∫Èáë‰ºö B-X
A/AC.198/2020/2 B-X
- B-X
E B-X
- B-X
A/AC.198/2020/2 B-X
-Desktop B-X
A/RES/74/198 B-X
- B-X
E B-X
- B-X
A/RES/74/198 B-X
-Desktop B-X
S/2019/198 B-X
- B-X
E B-X
- B-X
S/2019/198 B-X
-Desktop B-X

The	O
results	O
suggest	O
that	O
,	O
for	O
a	O
given	O
variant	O
,	O
the	O
extent	O
of	O
the	O
enzyme	O
defect	O
in	O
muscle	O
may	O
be	O
determined	O
,	O
using	O
this	O
equation	O
,	O
from	O
the	O
G6PD	O
activity	O
of	O
erythrocytes	O
<EOS> B-X
The B-X
present B-X
invention B-X
relates B-X
to B-X
a B-X
composition B-X
for B-X
measuring B-X
the B-X
activity B-X
of B-X
G6PD B-X
, B-X
a B-X
kit B-X
containing B-X
the B-X
same B-X
, B-X
and B-X
a B-X
method B-X
for B-X
measuring B-X
the B-X
activity B-X
of B-X
G6PD B-X
. B-X
The B-X
GSH B-X
analysis B-X
has B-X
pointed B-X
to B-X
the B-X
60 B-X
% B-X
G6PD B-X
activity B-X
cut-off B-X
and B-X
this B-X
data B-X
is B-X
supportive B-X
of B-X
the B-X
old B-X
World B-X
Health B-X
Organization B-X
threshold B-X
for B-X
intermediate B-X
upper B-X
limit B-X
of B-X
60 B-X
Methods B-X
for B-X
the B-X
field B-X
evaluation B-X
of B-X
quantitative B-X
G6PD B-X
diagnostics B-X
: B-X
a B-X
review B-X
Daniel B-X
Pfeffer B-X
and B-X
coauthors B-X
report B-X
on B-X
the B-X
assessment B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
activity B-X
, B-X
which B-X
is B-X
required B-X
for B-X
safe B-X
use B-X
of B-X
some B-X
malaria B-X
treatments B-X
. B-X
Genetic B-X
influence B-X
on B-X
athletic B-X
performance B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
the B-X
most B-X
common B-X
enzyme B-X
disorder B-X
in B-X
the B-X
world B-X
. B-X
Its B-X
main B-X
function B-X
is B-X
to B-X
generate B-X
NADPH B-X
that B-X
is B-X
required B-X
for B-X
anti-oxidative B-X
pathway B-X
in B-X
Enzyme B-X
Blood B-X
Level B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Gene	O
therapy	O
for	O
phenylketonuria	B-Disease
.	O
<EOS> B-X
Trends B-X
in B-X
Enzyme B-X
Therapy B-X
for B-X
Phenylketonuria B-X
: B-X
Molecular B-X
Therapy B-X
BioMarin B-X
, B-X
Pioneer B-X
in B-X
Phenylketonuria B-X
, B-X
to B-X
Begin B-X
Clinical B-X
Trial B-X
with B-X
BMN B-X
307 B-X
Gene B-X
Therapy B-X
- B-X
Jan B-X
13 B-X
, B-X
2020 B-X
BioMarin B-X
, B-X
Pioneer B-X
in B-X
Phenylketonuria B-X
( B-X
PKU B-X
) B-X
and B-X
Gene B-X
Therapy B-X
, B-X
Receives B-X
FDA B-X
Fast B-X
Track B-X
Designation B-X
for B-X
PKU B-X
Investigational B-X
Gene B-X
Therapy B-X
, B-X
BMN B-X
307 B-X
- B-X
Oct B-X
2 B-X
, B-X
2020 B-X
AAV B-X
Gene B-X
Therapy B-X
Study B-X
for B-X
Subjects B-X
With B-X
PKU B-X
- B-X
Full B-X
Text B-X
View B-X
- B-X
ClinicalTrials.gov B-X
Gene B-X
therapy B-X
is B-X
the B-X
delivery B-X
of B-X
genetic B-X
material B-X
to B-X
specific B-X
cell B-X
types B-X
of B-X
an B-X
organism B-X
to B-X
alter B-X
its B-X
physiology B-X
or B-X
function B-X
. B-X
This B-X
technology B-X
is B-X
being B-X
explor B-X
BioPharma B-X

Classical	O
phenylketonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
autosomal	B-Disease
recessive	I-Disease
disorder	I-Disease
caused	O
by	O
a	O
deficiency	B-Disease
of	I-Disease
hepatic	I-Disease
phenylalanine	I-Disease
hydroxylase	I-Disease
(	O
PAH	O
)	O
.	O
<EOS> B-X
PAH B-X
phenylalanine B-X
hydroxylase B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Phenylketonuria B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Diseases B-X
and B-X
Disorders B-X
of B-X
the B-X
Metabolism B-X
| B-X
Boundless B-X
Anatomy B-X
and B-X
Physiology B-X

Limitations	O
of	O
the	O
current	O
dietary	O
treatment	O
for	O
PKU	B-Disease
have	O
led	O
to	O
the	O
development	O
of	O
potential	O
treatments	O
based	O
on	O
somatic	O
gene	O
transfer	O
.	O
<EOS> B-X
Somatic B-X
Gene B-X
Therapy B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
The B-X
National B-X
Institutes B-X
of B-X
Health B-X
( B-X
NIH B-X
) B-X
Consensus B-X
Development B-X
Program B-X
: B-X
Phenylketonuria B-X
: B-X
Screening B-X
and B-X
Management B-X
PDF B-X
| B-X
Phenylketonuria B-X
( B-X
PKU B-X
) B-X
due B-X
to B-X
recessively B-X
inherited B-X
phenylalanine B-X
hydroxylase B-X
( B-X
PAH B-X
) B-X
deficiency B-X
is B-X
among B-X
the B-X
most B-X
common B-X
inborn B-X
errors B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

Three	O
different	O
vector	O
systems	O
have	O
been	O
examined	O
.	O
<EOS> B-X
Advances B-X
in B-X
Gene B-X
Delivery B-X
Systems B-X
Characterization B-X
of B-X
Promoter B-X
Function B-X
and B-X
Cell-Type-Specific B-X
Expression B-X
from B-X
Viral B-X
Vectors B-X
in B-X
the B-X
Nervous B-X
System B-X
RNA B-X
Virus B-X
Vectors B-X
: B-X
Molecular B-X
Therapy B-X
Bacteria B-X
as B-X
vectors B-X
for B-X
gene B-X
therapy B-X
of B-X
cancer B-X
RNA B-X
Vectors B-X
: B-X
Molecular B-X
Therapy B-X
Theoretically B-X
, B-X
cystic B-X
fibrosis B-X
transmembrane B-X
conductance B-X
regulator B-X
( B-X
CFTR B-X
) B-X
gene B-X
replacement B-X
during B-X
the B-X
neonatal B-X
period B-X
can B-X
decrease B-X
morbidity B-X
and B-X
mortality B-X
from B-X
cystic B-X
fibrosis B-X
( B-X
CF B-X
) B-X
. B-X
In B-X
vivo B-X
RNA B-X
virus-based B-X
episomal B-X
vector B-X
( B-X
REVec B-X
) B-X
is B-X
an B-X
emerging B-X
viral B-X
vector B-X
system B-X
that B-X
mediates B-X
long-term B-X
stable B-X
gene B-X
expression B-X
in B-X
variety B-X
of B-X
cell B-X
types B-X
in B-X
vitro B-X
. B-X
However B-X
, B-X
little B-X

Vectors	O
derived	O
from	O
a	O
recombinant	O
retrovirus	O
or	O
a	O
DNA	O
/	O
protein	O
complex	O
can	O
efficiently	O
transduce	O
the	O
PAH	O
cDNA	O
into	O
PAH	B-Disease
-	I-Disease
deficient	I-Disease
hepatocytes	O
in	O
vitro	O
,	O
but	O
the	O
application	O
of	O
these	O
vector	O
systems	O
is	O
presently	O
limited	O
by	O
their	O
low	O
transduction	O
efficiency	O
in	O
vivo	O
.	O
<EOS> B-X
Viral B-X
vectors B-X
show B-X
promise B-X
as B-X
a B-X
delivery B-X
mechanism B-X
for B-X
gene B-X
therapy B-X
, B-X
but B-X
which B-X
virus B-X
types B-X
are B-X
commercially B-X
viable B-X
? B-X
Engineering B-X
targeted B-X
viral B-X
vectors B-X
for B-X
gene B-X
therapy B-X
Classical B-X
phenylketonuria B-X
( B-X
PKU B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
hepatic B-X
phenylalanine B-X
hydroxylase B-X
( B-X
PAH B-X
) B-X
. B-X
Three B-X
different B-X
vector B-X
systems B-X
have B-X
been B-X
developed B-X
to B-X
Viral B-X
vectors B-X
: B-X
from B-X
virology B-X
to B-X
transgene B-X
expression B-X
Viral B-X
and B-X
nonviral B-X
delivery B-X
systems B-X
for B-X
gene B-X
delivery B-X
Self-Inactivating B-X
Lentivirus B-X
Vector B-X
for B-X
Safe B-X
and B-X
Efficient B-X
In B-X
Vivo B-X
Gene B-X
Delivery B-X
Vectors B-X
in B-X
Gene B-X
Therapy B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

In	O
contrast	O
,	O
a	O
vector	O
derived	O
from	O
a	O
recombinant	O
adenovirus	O
can	O
restore	O
10	O
%	O
-	O
80	O
%	O
of	O
normal	O
hepatic	O
PAH	O
activity	O
into	O
PAH	B-Disease
-	I-Disease
deficient	I-Disease
mice	O
,	O
which	O
completely	O
normalizes	O
serum	O
phenylalanine	O
levels	O
.	O
<EOS> B-X
Classical B-X
phenylketonuria B-X
( B-X
PKU B-X
) B-X
, B-X
which B-X
predisposes B-X
affected B-X
individuals B-X
to B-X
severe B-X
mental B-X
retardation B-X
, B-X
is B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
hepatic B-X
phenylalanine B-X
hydroxylase B-X
( B-X
PAH B-X
) B-X
. B-X
A B-X
recombinant B-X
Complete B-X
correction B-X
of B-X
hyperphenylalaninemia B-X
following B-X
liver-directed B-X
, B-X
recombinant B-X
AAV2/8 B-X
vector-mediated B-X
gene B-X
therapy B-X
in B-X
murine B-X
phenylketonuria B-X
Actual B-X
dietary B-X
regimens B-X
can B-X
not B-X
completely B-X
normalize B-X
the B-X
carnitine B-X
status B-X
; B-X
therefore B-X
, B-X
carnitine B-X
levels B-X
should B-X
be B-X
given B-X
careful B-X
consideration B-X
in B-X
subjects B-X
with B-X
PKU B-X
. B-X
Classical B-X
phenylketonuria B-X
( B-X
PKU B-X
) B-X
is B-X
a B-X
metabolic B-X
disorder B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
the B-X
hepatic B-X
enzyme B-X
phenylalanine B-X
hydroxylase B-X
( B-X
PAH B-X
) B-X
. B-X
If B-X
untreated B-X
, B-X
accumulation B-X
of B-X
phenylalanine B-X
will B-X
Classical B-X
phenylketonuria B-X
( B-X
PKU B-X
) B-X
is B-X
a B-X
metabolic B-X
disorder B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
the B-X
hepatic B-X
enzyme B-X
phenylalanine B-X
hydroxylase B-X
( B-X
PAH B-X
) B-X
. B-X
If B-X
untreated B-X
, B-X
accumulation B-X
of B-X
phenylalanine B-X
will B-X
Classical B-X
phenylketonuria B-X
( B-X
PKU B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
hepatic B-X
phenylalanine B-X
hydroxylase B-X
( B-X
PAH B-X
) B-X
. B-X
Limitations B-X
of B-X
the B-X
current B-X
dietary B-X
treatment B-X
for B-X
PKU B-X
Correction B-X
of B-X
Murine B-X
PKU B-X
Following B-X
AAV-mediated B-X
Intramuscular B-X
Expression B-X
of B-X
a B-X
Complete B-X
Phenylalanine B-X
Hydroxylating B-X
System B-X

This	O
treatment	O
is	O
transient	O
and	O
cannot	O
be	O
effectively	O
re	O
-	O
administered	O
due	O
to	O
the	O
presence	O
of	O
neutralizing	O
antibodies	O
directed	O
against	O
the	O
recombinant	O
adenoviral	O
vector	O
.	O
<EOS> B-X
Strategies B-X
to B-X
overcome B-X
host B-X
immunity B-X
to B-X
adenovirus B-X
vectors B-X
in B-X
vaccine B-X
development B-X
Effective B-X
repeat B-X
administration B-X
of B-X
adenovirus B-X
vectors B-X
following B-X
intranasal B-X
or B-X
intravenous B-X
delivery B-X
is B-X
hindered B-X
by B-X
a B-X
strong B-X
neutralizing B-X
antibody B-X
response B-X
to B-X
the B-X
vector B-X
. B-X
Intramuscular B-X
administration B-X
of B-X
adenovirus B-X
vectors B-X
elicited B-X
a B-X
Immune B-X
responses B-X
to B-X
AAV B-X
vectors B-X
: B-X
overcoming B-X
barriers B-X
to B-X
successful B-X
gene B-X
therapy B-X
Adenovirus-mediated B-X
gene B-X
delivery B-X
: B-X
Potential B-X
applications B-X
for B-X
gene B-X
and B-X
cell-based B-X
therapies B-X
in B-X
the B-X
new B-X
era B-X
of B-X
personalized B-X
medicine B-X
Adeno-Associated B-X
Virus B-X
( B-X
AAV B-X
) B-X
as B-X
a B-X
Vector B-X
for B-X
Gene B-X
Therapy B-X
Adenoviral B-X
Vector B-X
Immunity B-X
: B-X
Its B-X
Implications B-X
and B-X
circumvention B-X
strategies B-X
Emerging B-X
Issues B-X
in B-X
AAV-Mediated B-X
In B-X
Vivo B-X
Gene B-X
Therapy B-X

However	O
,	O
these	O
findings	O
suggest	O
that	O
PKU	B-Disease
can	O
be	O
completely	O
corrected	O
by	O
somatic	O
gene	O
therapy	O
,	O
and	O
provide	O
some	O
direction	O
for	O
the	O
future	O
development	O
of	O
adenoviral	O
vectors	O
.	O
.	O

Exon	O
-	O
intron	O
structure	O
of	O
the	O
human	O
neuronal	O
nicotinic	O
acetylcholine	O
receptor	O
alpha	O
4	O
subunit	O
(	O
CHRNA4	O
)	O
.	O
<EOS> B-X
Association B-X
study B-X
of B-X
the B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
Œ±4 B-X
subunit B-X
gene B-X
, B-X
CHRNA4 B-X
, B-X
in B-X
attention-deficit B-X
hyperactivity B-X
disorder B-X
PDF B-X
| B-X
The B-X
Œ±4-subunit B-X
gene B-X
( B-X
CHRNA4 B-X
) B-X
of B-X
the B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
( B-X
nAChR B-X
) B-X
subunit B-X
family B-X
has B-X
recently B-X
been B-X
identified B-X
in B-X
two B-X
families B-X
... B-X
| B-X
Find B-X
, B-X
CHRNA4 B-X
cholinergic B-X
receptor B-X
nicotinic B-X
alpha B-X
4 B-X
subunit B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
PDF B-X
| B-X
Genes B-X
coding B-X
for B-X
the B-X
alpha5 B-X
, B-X
alpha3 B-X
, B-X
and B-X
beta4 B-X
subunits B-X
( B-X
CHRNA5 B-X
, B-X
CHRNA3 B-X
, B-X
and B-X
CHRNB4 B-X
) B-X
of B-X
the B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptors B-X
( B-X
nAChRs B-X
) B-X
Neuronal B-X
acetylcholine B-X
receptor B-X
subunit B-X
alpha-4 B-X
| B-X
DrugBank B-X
Online B-X
The B-X
alpha4-subunit B-X
gene B-X
( B-X
CHRNA4 B-X
) B-X
of B-X
the B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
( B-X
nAChR B-X
) B-X
subunit B-X
family B-X
has B-X
recently B-X
been B-X
identified B-X
in B-X
two B-X
families B-X
as B-X
the B-X
gene B-X
responsible B-X
for B-X
autosomal B-X
Genes B-X
coding B-X
for B-X
the B-X
alpha5 B-X
, B-X
alpha3 B-X
, B-X
and B-X
beta4 B-X
subunits B-X
( B-X
CHRNA5 B-X
, B-X
CHRNA3 B-X
, B-X
and B-X
CHRNB4 B-X
) B-X
of B-X
the B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptors B-X
( B-X
nAChRs B-X
) B-X
are B-X
clustered B-X

The	O
human	O
neuronal	O
nicotinic	O
acetylcholine	O
receptor	O
alpha	O
4	O
subunit	O
gene	O
(	O
CHRNA4	O
)	O
is	O
located	O
in	O
the	O
candidate	O
region	O
for	O
three	O
different	O
phenotypes	O
benign	B-Disease
familial	I-Disease
neonatal	I-Disease
convulsions	I-Disease
,	O
autosomal	B-Disease
dominant	I-Disease
nocturnal	I-Disease
frontal	I-Disease
lobe	I-Disease
epilepsy	I-Disease
,	O
and	O
low	O
-	O
voltage	O
EEG	O
.	O
<EOS> B-X
The B-X
human B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
alpha B-X
4 B-X
subunit B-X
gene B-X
( B-X
CHRNA4 B-X
) B-X
is B-X
located B-X
in B-X
the B-X
candidate B-X
region B-X
for B-X
three B-X
different B-X
phenotypes B-X
: B-X
benign B-X
familial B-X
neonatal B-X
convulsions B-X
, B-X
autosomal B-X
The B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
alpha B-X
4 B-X
subunit B-X
contains B-X
a B-X
functionally B-X
relevant B-X
SNP B-X
Haplotype B-X
Request B-X
PDF B-X
| B-X
Mutation B-X
of B-X
CHRNA2 B-X
in B-X
a B-X
family B-X
with B-X
benign B-X
familial B-X
infantile B-X
seizures B-X
: B-X
Potential B-X
role B-X
of B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
in B-X
various B-X
phenotypes B-X
of B-X
epilepsy B-X
| B-X
Nicotinic B-X
acetylcholine B-X
receptor B-X
CHRNA4 B-X
cholinergic B-X
receptor B-X
nicotinic B-X
alpha B-X
4 B-X
subunit B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Possible B-X
association B-X
of B-X
a B-X
silent B-X
polymorphism B-X
in B-X
the B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
subunit B-X
Œ±4 B-X
with B-X
common B-X
idiopathic B-X
generalized B-X
epilepsies B-X
- B-X
Steinlein B-X
- B-X
1997 B-X
- B-X
American B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
- B-X
WikiGenes B-X
- B-X
CHRNA4 B-X
- B-X
cholinergic B-X
receptor B-X
, B-X
nicotinic B-X
, B-X
alpha B-X
4 B-X
... B-X
Complete B-X
information B-X
for B-X
CHRNA4 B-X
gene B-X
( B-X
Protein B-X
Coding B-X
) B-X
, B-X
Cholinergic B-X
Receptor B-X
Nicotinic B-X
Alpha B-X
4 B-X
Subunit B-X
, B-X
including B-X
: B-X
function B-X
, B-X
proteins B-X
, B-X
disorders B-X
, B-X
pathways B-X
, B-X
orthologs B-X
, B-X
and B-X

Recently	O
,	O
a	O
missense	O
mutation	O
in	O
transmembrane	O
domain	O
2	O
of	O
CHRNA4	O
was	O
found	O
to	O
be	O
associated	O
with	O
autosomal	B-Disease
dominant	I-Disease
nocturnal	I-Disease
frontal	I-Disease
lobe	I-Disease
epilepsy	I-Disease
in	O
one	O
extended	O
pedigree	O
.	O
<EOS> B-X
Mutations B-X
in B-X
familial B-X
nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
might B-X
be B-X
associated B-X
with B-X
distinct B-X
neurological B-X
phenotypes B-X
- B-X
ScienceDirect B-X
Request B-X
PDF B-X
| B-X
The B-X
CHRNB2 B-X
mutation B-X
I312M B-X
is B-X
associated B-X
with B-X
epilepsy B-X
and B-X
distinct B-X
memory B-X
deficits B-X
| B-X
Mutations B-X
in B-X
nAChRs B-X
are B-X
found B-X
in B-X
a B-X
rare B-X
form B-X
of B-X
nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
Nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
with B-X
paroxysmal B-X
arousals B-X
due B-X
to B-X
CHRNA2 B-X
loss B-X
of B-X
function B-X
| B-X
Neurology B-X
Request B-X
PDF B-X
| B-X
On B-X
Sep B-X
1 B-X
, B-X
2009 B-X
, B-X
F. B-X
Picard B-X
and B-X
others B-X
published B-X
20 B-X
. B-X
In B-X
vivo B-X
PET B-X
study B-X
of B-X
the B-X
mutated B-X
nicotinic B-X
receptors B-X
using B-X
[ B-X
18F B-X
] B-X
-A-85380 B-X
PDF B-X
| B-X
In B-X
this B-X
review B-X
the B-X
current B-X
literature B-X
regarding B-X
autosomal B-X
dominant B-X
nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
( B-X
ADNFLE B-X
) B-X
is B-X
presented B-X
and B-X
discussed B-X
. B-X
This B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Autosomal B-X
Dominant B-X
Nocturnal B-X
Frontal-Lobe B-X
Epilepsy B-X
: B-X
Genetic B-X
Heterogeneity B-X
and B-X
Evidence B-X
for B-X
a B-X
Second B-X
Locus B-X
at B-X
15q24 B-X
- B-X
ScienceDirect B-X
Epilepsy B-X
affects B-X
at B-X
least B-X
2 B-X
% B-X
of B-X
the B-X
population B-X
at B-X
some B-X
time B-X
in B-X
their B-X
lives B-X
. B-X
The B-X
epilepsies B-X
are B-X
a B-X
heterogeneous B-X
group B-X
of B-X
disorders B-X
, B-X
many B-X
with B-X
an B-X
inherited B-X
component B-X

We	O
have	O
determined	O
the	O
genomic	O
organization	O
of	O
CHRNA4	O
,	O
which	O
consists	O
of	O
six	O
exons	O
distributed	O
over	O
approximately	O
17	O
kb	O
of	O
genomic	O
DNA	O
.	O
<EOS> B-X
NDLI B-X
: B-X
Exon-intron B-X
structure B-X
of B-X
the B-X
human B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
{ B-X
alpha B-X
} B-X
4 B-X
subunit B-X
( B-X
CHRNA4 B-X
) B-X
Rare B-X
nonsynonymous B-X
variants B-X
in B-X
alpha-4 B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
gene B-X
protect B-X
against B-X
nicotine B-X
dependence B-X
Request B-X
PDF B-X
| B-X
Genomic B-X
organization B-X
and B-X
promoter B-X
analysis B-X
of B-X
the B-X
human B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
Œ±6 B-X
subunit B-X
( B-X
CHNRA6 B-X
) B-X
gene B-X
: B-X
Alu B-X
and B-X
other B-X
elements B-X
direct B-X
transcriptional B-X
repression B-X
| B-X
Nicotinic B-X
Exon‚ÄìIntron B-X
Structure B-X
of B-X
the B-X
Human B-X
Neuronal B-X
Nicotinic B-X
Acetylcholine B-X
Receptor B-X
Œ±4 B-X
Subunit B-X
( B-X
CHRNA4 B-X
) B-X
- B-X
ScienceDirect B-X
A B-X
Common B-X
Haplotype B-X
of B-X
the B-X
Nicotine B-X
Acetylcholine B-X
Receptor B-X
Œ±4 B-X
Subunit B-X
Gene B-X
Is B-X
Associated B-X
with B-X
Vulnerability B-X
to B-X
Nicotine B-X
Addiction B-X
in B-X
Men B-X
- B-X
ScienceDirect B-X
Œ±-4 B-X
subunit B-X
of B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
polymorphisms B-X
exhibit B-X
no B-X
association B-X
with B-X
smoking B-X
behavior B-X
among B-X
Malay B-X
Males B-X
in B-X
Kelantan B-X
, B-X
Malaysia B-X
- B-X
ScienceDirect B-X

The	O
nucleotide	O
sequence	O
obtained	O
from	O
the	O
genomic	O
regions	O
adjacent	O
to	O
the	O
exon	O
boundaries	O
enabled	O
us	O
to	O
develop	O
a	O
set	O
of	O
primer	O
pairs	O
for	O
PCR	O
amplification	O
of	O
the	O
complete	O
coding	O
region	O
.	O
<EOS> B-X
Design B-X
PCR B-X
primers B-X
and B-X
check B-X
them B-X
for B-X
specificity B-X
ELXR B-X
( B-X
Exon B-X
Locator B-X
and B-X
Extractor B-X
for B-X
Resequencing B-X
) B-X
streamlines B-X
the B-X
process B-X
of B-X
determining B-X
exon/intron B-X
boundaries B-X
and B-X
designing B-X
PCR B-X
and B-X
sequencing B-X
primers B-X
for B-X
high-throughput B-X
resequencing B-X
of B-X
exons B-X
. B-X
We B-X
have B-X
Nested B-X
Patch B-X
PCR B-X
enables B-X
highly B-X
multiplexed B-X
mutation B-X
discovery B-X
in B-X
candidate B-X
genes B-X
Choosing B-X
appropriate B-X
primers B-X
is B-X
probably B-X
the B-X
single B-X
most B-X
important B-X
factor B-X
affecting B-X
the B-X
polymerase B-X
chain B-X
reaction B-X
( B-X
PCR B-X
) B-X
. B-X
Specific B-X
amplification B-X
of B-X
the B-X
intended B-X
target B-X
requires B-X
that B-X
primers B-X
do B-X
not B-X
Primer B-X
Walking B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
DNA B-X
Sequence B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
BioInformatics B-X
& B-X
BestKeeeper B-X
Software B-X
& B-X
Gene B-X
Quantification B-X
Homepage B-X

The	O
sequence	O
analysis	O
provides	O
the	O
basis	O
for	O
a	O
comprehensive	O
mutation	O
screening	O
of	O
CHRNA4	O
in	O
the	O
above	O
-	O
mentioned	O
phenotypes	O
and	O
possibly	O
in	O
other	O
types	O
of	O
idiopathic	B-Disease
epilepsies	I-Disease
.	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
A B-X
de B-X
novo B-X
mutation B-X
in B-X
sporadic B-X
nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
| B-X
Autosomal B-X
dominant B-X
nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
is B-X
sometimes B-X
due B-X
to B-X
mutations B-X
in B-X
CHRNA4 B-X
. B-X
The B-X
commoner B-X
PDF B-X
| B-X
Autosomal B-X
dominant B-X
nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
is B-X
a B-X
familial B-X
partial B-X
epilepsy B-X
syndrome B-X
and B-X
the B-X
first B-X
human B-X
idiopathic B-X
epilepsy B-X
known B-X
to B-X
be B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Nocturnal B-X
frontal B-X
lobe B-X
epilepsy B-X
with B-X
paroxysmal B-X
arousals B-X
due B-X
to B-X
CHRNA2 B-X
loss B-X
of B-X
function B-X
PDF B-X
| B-X
We B-X
assessed B-X
the B-X
mutation B-X
frequency B-X
in B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
( B-X
nAChR B-X
) B-X
subunits B-X
CHRNA4 B-X
, B-X
CHRNB2 B-X
, B-X
and B-X
CHRNA2 B-X
in B-X
a B-X
cohort B-X
including B-X
autosomal B-X
... B-X
| B-X
Find B-X
, B-X
Request B-X
PDF B-X
| B-X
Evaluation B-X
of B-X
the B-X
positional B-X
candidate B-X
gene B-X
CHRNA7 B-X
at B-X
the B-X
juvenile B-X
myoclonic B-X
epilepsy B-X
locus B-X
( B-X
EJM2 B-X
) B-X
on B-X
chromosome B-X
15q13-14 B-X
| B-X
A B-X
previous B-X
study B-X
of B-X
34 B-X
nuclear B-X
pedigrees B-X
Exon-intron B-X
structure B-X
of B-X
the B-X
human B-X
neuronal B-X
nicotinic B-X
acetylcholine B-X
receptor B-X
alpha B-X
4 B-X
subunit B-X
( B-X
CHRNA4 B-X
) B-X
. B-X
Rats B-X
Harboring B-X
S284L B-X
Chrna4 B-X
Mutation B-X
Show B-X
Attenuation B-X
of B-X
Synaptic B-X
and B-X
Extrasynaptic B-X
GABAergic B-X
Transmission B-X
and B-X
Exhibit B-X
the B-X
Nocturnal B-X
Frontal B-X
Lobe B-X
Epilepsy B-X
Phenotype B-X

Ashkenazi	O
Jewish	O
population	O
frequencies	O
for	O
common	O
mutations	O
in	O
BRCA1	O
and	O
BRCA2	O
.	O
<EOS> B-X
The B-X
prevalence B-X
of B-X
common B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
among B-X
Ashkenazi B-X
Jews B-X
. B-X
Mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
that B-X
predispose B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
are B-X
detected B-X
in B-X
approximately B-X
2.5 B-X
% B-X
of B-X
the B-X
Ashkenazi B-X
Jewish B-X
population B-X
. B-X
To B-X
explore B-X
whether B-X
carriers B-X
of B-X
Ashkenazi B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

BRCA1	O
and	O
BRCA2	O
are	O
the	O
two	O
major	O
identified	O
causes	O
of	O
inherited	B-Disease
breast	I-Disease
cancer	I-Disease
,	O
with	O
mutations	O
in	O
either	O
gene	O
conferring	O
up	O
to	O
80	O
-	O
90	O
%	O
lifetime	O
risk	O
of	O
breast	B-Disease
cancer	I-Disease
in	O
carrier	O
females	O
.	O
<EOS> B-X
Read B-X
about B-X
inherited B-X
gene B-X
mutations B-X
that B-X
increase B-X
breast B-X
cancer B-X
risk B-X
. B-X
Inherited B-X
gene B-X
mutations B-X
account B-X
for B-X
5-10 B-X
percent B-X
of B-X
all B-X
breast B-X
cancers B-X
diagnosed B-X
in B-X
the B-X
U.S B-X
. B-X
Future B-X
possibilities B-X
in B-X
the B-X
prevention B-X
of B-X
breast B-X
cancer B-X
: B-X
Intervention B-X
strategies B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
carriers B-X
Role B-X
of B-X
BRCA B-X
gene B-X
dysfunction B-X
in B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
predisposition B-X
BRCA B-X
mutation B-X
- B-X
Wikipedia B-X
Inherited B-X
and B-X
acquired B-X
alterations B-X
in B-X
development B-X
of B-X
breast B-X
cancer B-X
New B-X
Insights B-X
into B-X
Breast B-X
Cancer B-X
Genetics B-X
and B-X
Impact B-X
on B-X
Patient B-X
Management B-X
Genetics B-X
of B-X
breast B-X
cancer B-X
: B-X
a B-X
topic B-X
in B-X
evolution B-X
- B-X
Annals B-X
of B-X
Oncology B-X

Mutations	O
in	O
BRCA1	O
account	O
for	O
approximately	O
45	O
%	O
of	O
familial	B-Disease
breast	I-Disease
cancer	I-Disease
and	O
90	O
%	O
of	O
inherited	B-Disease
breast	I-Disease
/	I-Disease
ovarian	I-Disease
cancer	I-Disease
,	O
whereas	O
mutations	O
in	O
BRCA2	O
account	O
for	O
a	O
comparable	O
percentage	O
of	O
inherited	B-Disease
breast	I-Disease
cancer	I-Disease
cases	O
.	O
<EOS> B-X
BRCA1 B-X
and B-X
BRCA2 B-X
are B-X
the B-X
two B-X
major B-X
identified B-X
causes B-X
of B-X
inherited B-X
breast B-X
cancer B-X
, B-X
with B-X
mutations B-X
in B-X
either B-X
gene B-X
conferring B-X
up B-X
to B-X
80-90 B-X
% B-X
lifetime B-X
risk B-X
of B-X
breast B-X
cancer B-X
in B-X
One B-X
in B-X
8 B-X
women B-X
( B-X
12.5 B-X
% B-X
) B-X
in B-X
the B-X
United B-X
States B-X
will B-X
develop B-X
breast B-X
cancer B-X
throughout B-X
their B-X
lifetime B-X
. B-X
Certain B-X
populations B-X
are B-X
at B-X
an B-X
increased B-X
risk B-X
of B-X
developing B-X
cancer B-X
The B-X
first B-X
comprehensive B-X
reference B-X
to B-X
focus B-X
on B-X
the B-X
molecular B-X
development B-X
and B-X
treatment B-X
of B-X
the B-X
disease B-X
, B-X
Molecular B-X
Oncology B-X
of B-X
Breast B-X
Cancer B-X
provides B-X
authoritative B-X
information B-X
across B-X
the B-X
spectrum B-X
of B-X
modern B-X
breast B-X

Over	O
85	O
distinct	O
BRCA1	O
mutations	O
and	O
a	O
growing	O
list	O
of	O
BRCA2	O
mutations	O
have	O
been	O
identified	O
,	O
with	O
the	O
majority	O
resulting	O
in	O
protein	O
truncation	O
.	O

A	O
specific	O
BRCA1	O
mutation	O
,	O
185delAG	O
,	O
has	O
a	O
reported	O
increased	O
carrier	O
frequency	O
of	O
approximately	O
0	O
.	O

9	O
%	O
in	O
the	O
Ashkenazi	O
Jewish	O
population	O
,	O
but	O
is	O
also	O
found	O
in	O
rare	O
non	O
-	O
Jewish	O
patients	O
with	O
a	O
different	O
haplotype	O
.	O
<EOS> B-X
Pharmacogenetics B-X
in B-X
Jewish B-X
populations B-X
The B-X
relative B-X
roles B-X
of B-X
natural B-X
selection B-X
and B-X
accentuated B-X
genetic B-X
drift B-X
as B-X
explanations B-X
for B-X
the B-X
high B-X
frequency B-X
of B-X
more B-X
than B-X
20 B-X
Ashkenazi B-X
Jewish B-X
disease B-X
alleles B-X
remain B-X
controversial B-X
. B-X
To B-X
test B-X
for B-X
The B-X
relative B-X
roles B-X
of B-X
natural B-X
selection B-X
and B-X
accentuated B-X
genetic B-X
drift B-X
as B-X
explanations B-X
for B-X
the B-X
high B-X
frequency B-X
of B-X
more B-X
than B-X
20 B-X
Ashkenazi B-X
Jewish B-X
disease B-X
alleles B-X
remain B-X
controversial B-X
. B-X
To B-X
test B-X
for B-X
The B-X
origins B-X
of B-X
Ashkenazi B-X
Jews B-X
remain B-X
highly B-X
controversial B-X
. B-X
Like B-X
Judaism B-X
, B-X
mitochondrial B-X
DNA B-X
is B-X
passed B-X
along B-X
the B-X
maternal B-X
line B-X
. B-X
Its B-X
variation B-X
in B-X
the B-X
Ashkenazim B-X
is B-X
highly B-X
distinctive B-X
, B-X
Chuetas B-X
are B-X
a B-X
group B-X
of B-X
descendants B-X
of B-X
Majorcan B-X
Crypto-Jews B-X
( B-X
Balearic B-X
Islands B-X
, B-X
Spain B-X
) B-X
who B-X
were B-X
socially B-X
stigmatized B-X
and B-X
segregated B-X
by B-X
their B-X
Majorcan B-X
neighbours B-X
until B-X
recently B-X
; B-X
generating B-X
a B-X
Jewish B-X
ethnic B-X
divisions B-X
- B-X
Wikipedia B-X
Genetic B-X
isolates B-X
such B-X
as B-X
the B-X
Ashkenazi B-X
Jews B-X
( B-X
AJ B-X
) B-X
potentially B-X
offer B-X
advantages B-X
in B-X
mapping B-X
novel B-X
loci B-X
in B-X
whole B-X
genome B-X
disease B-X
association B-X
studies B-X
. B-X
To B-X
analyze B-X
patterns B-X
of B-X
genetic B-X
variation B-X

The	O
6174delT	O
mutation	O
in	O
BRCA2	O
was	O
recently	O
identified	O
as	O
a	O
frequent	O
mutation	O
in	O
8	O
out	O
of	O
107	O
Ashkenazi	O
Jewish	O
women	O
diagnosed	O
with	O
breast	B-Disease
cancer	I-Disease
by	O
age	O
50	O
(	O
ref	O
.	O
8	O
)	O
,	O
as	O
well	O
as	O
in	O
three	O
Ashkenazi	O
male	B-Disease
breast	I-Disease
cancer	I-Disease
patients	O
.	O
<EOS> B-X
The B-X
lifetime B-X
risk B-X
of B-X
breast B-X
cancer B-X
may B-X
approach B-X
80-90 B-X
% B-X
in B-X
women B-X
who B-X
have B-X
germline B-X
mutations B-X
of B-X
either B-X
of B-X
two B-X
genes B-X
, B-X
BRCA1 B-X
or B-X
BRCA2 B-X
. B-X
A B-X
single B-X
BRCA1 B-X
mutation B-X
Prevalence B-X
of B-X
HOXB13 B-X
mutation B-X
in B-X
a B-X
population B-X
of B-X
Ashkenazi B-X
Jewish B-X
men B-X
treated B-X
for B-X
prostate B-X
cancer B-X
A B-X
family B-X
history B-X
of B-X
breast B-X
cancer B-X
poses B-X
higher B-X
risks B-X
for B-X
Jewish B-X
versus B-X
non-Jewish B-X
women B-X
, B-X
particularly B-X
for B-X
early-onset B-X
breast B-X
cancer B-X
. B-X
This B-X
appears B-X
to B-X
be B-X
due B-X
in B-X
large B-X
part B-X
to B-X
Abstract B-X
. B-X
BACKGROUND B-X
: B-X
Approximately B-X
2.0 B-X
% B-X
-2.5 B-X
% B-X
of B-X
Ashkenazi B-X
Jewish B-X
women B-X
carry B-X
one B-X
of B-X
three B-X
founding B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
, B-X
and B-X
each B-X
mutation B-X
is B-X
Study B-X
Estimates B-X
Ashkenazi B-X
Jewish B-X
Women B-X
‚Äô B-X
s B-X
Risk B-X
of B-X
Having B-X
Mutations B-X
Other B-X
Than B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Request B-X
PDF B-X
| B-X
Founder B-X
mutations B-X
in B-X
BRCA1/2 B-X
are B-X
not B-X
frequent B-X
in B-X
Canadian B-X
Ashkenazi B-X
Jewish B-X
men B-X
with B-X
prostate B-X
cancer B-X
| B-X
Relatives B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
carriers B-X
have B-X
long B-X
been B-X
proposed B-X
Download B-X
Citation B-X
| B-X
The B-X
lifetime B-X
risks B-X
of B-X
breast B-X
cancer B-X
in B-X
Ashkenazi B-X
Jewish B-X
carriers B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
| B-X
Several B-X
studies B-X
using B-X
families B-X
with B-X
multiple B-X
occurrences B-X
of B-X
breast B-X
cancer B-X
have B-X

We	O
have	O
conducted	O
a	O
large	O
-	O
scale	O
population	O
study	O
to	O
investigate	O
the	O
prevalence	O
of	O
specific	O
BRCA1	O
and	O
BRCA2	O
mutations	O
in	O
Ashkenazi	O
Jewish	O
individuals	O
who	O
were	O
unselected	O
for	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Prevalence B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
breast B-X
cancer B-X
patients B-X
from B-X
Brazil B-X
| B-X
The B-X
contribution B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
to B-X
breast B-X
cancer B-X
incidence B-X
in B-X
Brazil B-X
has B-X
not B-X
The B-X
spectrum B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
alleles B-X
in B-X
Latin B-X
America B-X
and B-X
the B-X
Caribbean B-X
: B-X
a B-X
clinical B-X
perspective B-X
Request B-X
PDF B-X
| B-X
A B-X
high B-X
prevalence B-X
of B-X
BRCA1 B-X
mutations B-X
among B-X
breast B-X
cancer B-X
patients B-X
from B-X
the B-X
Bahamas B-X
| B-X
The B-X
Bahamas B-X
is B-X
a B-X
group B-X
of B-X
islands B-X
in B-X
the B-X
Caribbean B-X
with B-X
a B-X
high B-X
PDF B-X
| B-X
The B-X
purpose B-X
of B-X
our B-X
study B-X
was B-X
to B-X
establish B-X
the B-X
frequency B-X
and B-X
distribution B-X
of B-X
the B-X
four B-X
most B-X
common B-X
BRCA1 B-X
mutations B-X
in B-X
Polish B-X
general B-X
population B-X
and B-X
... B-X
| B-X
Find B-X
, B-X
Pathogenic B-X
variants B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
( B-X
BRCA1/2 B-X
) B-X
lead B-X
to B-X
increased B-X
risk B-X
of B-X
breast B-X
, B-X
ovarian B-X
, B-X
and B-X
other B-X
cancers B-X
, B-X
but B-X
most B-X
variant-positive B-X
individuals B-X
in B-X
the B-X
general B-X
population B-X
PDF B-X
| B-X
Purpose B-X
Over B-X
the B-X
past B-X
three B-X
decades B-X
, B-X
the B-X
incidence B-X
rate B-X
of B-X
breast B-X
cancer B-X
( B-X
BC B-X
) B-X
among B-X
Arab B-X
women B-X
has B-X
continually B-X
increased B-X
. B-X
However B-X
, B-X
data B-X
on B-X
the B-X

BRCA1	O
mutation	O
screening	O
on	O
approximately	O
3	O
,	O
000	O
Ashkenazi	O
Jewish	O
samples	O
determined	O
a	O
carrier	O
frequency	O
of	O
1	O
.	O
<EOS> B-X
AbstractBackground B-X
: B-X
. B-X
Technological B-X
advances B-X
raise B-X
the B-X
possibility B-X
of B-X
systematic B-X
population-based B-X
genetic B-X
testing B-X
for B-X
cancer-predisposing B-X
mutations B-X
, B-X
but B-X
it B-X
is B-X
un B-X

09	O
%	O
for	O
the	O
185delAG	O
mutation	O
and	O
0	O
.	O
<EOS> B-X
A B-X
predominant B-X
mutation B-X
within B-X
the B-X
BRCA1 B-X
predisposition B-X
gene B-X
, B-X
185delAG B-X
, B-X
has B-X
been B-X
detected B-X
in B-X
about B-X
1 B-X
% B-X
of B-X
the B-X
Ashkenazi B-X
population B-X
, B-X
considered B-X
a B-X
high-risk B-X
group B-X
for B-X
breast B-X
and B-X
Prevalence B-X
of B-X
the B-X
BRCA1 B-X
c.68_69delAG B-X
( B-X
BIC B-X
: B-X
185delAG B-X
) B-X
mutation B-X
in B-X
women B-X
with B-X
breast B-X
cancer B-X
from B-X
north-central B-X
Poland B-X
and B-X
a B-X
review B-X
of B-X
the B-X
literature B-X
on B-X
other B-X
regions B-X
of B-X
the B-X
Prevalence B-X
of B-X
185delAG B-X
and B-X
5382insC B-X
mutations B-X
in B-X
BRCA1 B-X
, B-X
and B-X
6174delT B-X
in B-X
BRCA2 B-X
in B-X
women B-X
of B-X
Ashkenazi B-X
Jewish B-X
origin B-X
in B-X
southern B-X
Brazil B-X
Germ-line B-X
BRCA1 B-X
mutations B-X
can B-X
be B-X
present B-X
in B-X
young B-X
women B-X
with B-X
breast B-X
cancer B-X
who B-X
do B-X
not B-X
belong B-X
to B-X
families B-X
with B-X
multiple B-X
affected B-X
members B-X
. B-X
The B-X
specific B-X
BRCA1 B-X
mutation B-X
known B-X
as B-X
185delAG B-X
The B-X
185delAG B-X
mutation B-X
( B-X
c.68_69delAG B-X
; B-X
ter39 B-X
) B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
is B-X
a B-X
founder B-X
Jewish B-X
Ashkenazi B-X
mutation B-X
that B-X
is B-X
carried B-X
by B-X
1 B-X
% B-X
of B-X
this B-X
population B-X
and B-X
has B-X
been B-X
BRAt-mediated B-X
enhanced B-X
chemosensitivity B-X
correlates B-X
clinically B-X
with B-X
enhanced B-X
chemotherapeutic B-X
response B-X
in B-X
BRCA1 B-X
mutation B-X
carriers B-X
. B-X
BRAt-mediated B-X
maspin B-X
expression B-X
also B-X
correlates B-X
with B-X
improved B-X
prognostic B-X
outlook B-X
for B-X
ovarian B-X
tumors B-X
with B-X
high B-X
levels B-X
of B-X
Familial B-X
history B-X
remains B-X
the B-X
strongest B-X
risk B-X
factor B-X
for B-X
developing B-X
ovarian B-X
cancer B-X
( B-X
OC B-X
) B-X
and B-X
is B-X
associated B-X
with B-X
germline B-X
BRCA1 B-X
mutations B-X
, B-X
such B-X
as B-X
the B-X
185delAG B-X
founder B-X
mutation B-X
. B-X
We B-X

13	O
%	O
for	O
the	O
5382insC	O
mutation	O
.	O
<EOS> B-X
The B-X
frequency B-X
of B-X
BRCA1 B-X
founder B-X
mutation B-X
c.5266dupC B-X
( B-X
5382insC B-X
) B-X
in B-X
breast B-X
cancer B-X
patients B-X
from B-X
Ukraine B-X
Contribution B-X
of B-X
BRCA1 B-X
5382insC B-X
mutation B-X
in B-X
triple B-X
negative B-X
breast B-X
cancer B-X
in B-X
Tunisia B-X
BRCA1 B-X
and B-X
BRCA2 B-X
gene B-X
mutations B-X
confer B-X
a B-X
high B-X
lifetime B-X
risk B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
We B-X
have B-X
screened B-X
cancer B-X
patients B-X
from B-X
13 B-X
families B-X
with B-X
at B-X
least B-X
three B-X
breast B-X
and/or B-X
The B-X
mutations B-X
185delAG B-X
, B-X
188del11 B-X
, B-X
and B-X
5382insC B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
and B-X
6174delT B-X
in B-X
the B-X
BRCA2 B-X
gene B-X
were B-X
analyzed B-X
in B-X
199 B-X
Ashkenazi B-X
and B-X
44 B-X
non-Ashkenazi B-X
Jewish B-X
unrelated B-X
patients B-X
with B-X
PDF B-X
| B-X
Germ-line B-X
mutations B-X
in B-X
several B-X
genes B-X
, B-X
such B-X
as B-X
BRCA1 B-X
and B-X
BRCA2 B-X
, B-X
are B-X
known B-X
to B-X
increase B-X
the B-X
risk B-X
of B-X
breast B-X
cancer B-X
. B-X
These B-X
heritable B-X
mutations B-X
are B-X
... B-X
| B-X

BRCA2	O
analysis	O
on	O
3	O
,	O
085	O
individuals	O
from	O
the	O
same	O
population	O
showed	O
a	O
carrier	O
frequency	O
of	O
1	O
.	O
<EOS> B-X
Determining B-X
Carrier B-X
Probabilities B-X
for B-X
Breast B-X
Cancer‚ÄìSusceptibility B-X
Genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
- B-X
ScienceDirect B-X
Hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
syndrome B-X
( B-X
HBOC B-X
) B-X
is B-X
most B-X
frequently B-X
caused B-X
by B-X
mutations B-X
in B-X
BRCA1 B-X
or B-X
BRCA2 B-X
( B-X
in B-X
short B-X
, B-X
BRCA B-X
) B-X
genes B-X
. B-X
The B-X
incidence B-X
of B-X

52	O
%	O
for	O
the	O
6174delT	O
mutation	O
.	O
<EOS> B-X
Breast B-X
and B-X
ovarian B-X
cancer B-X
risks B-X
to B-X
carriers B-X
of B-X
the B-X
BRCA1 B-X
5382insC B-X
and B-X
185delAG B-X
and B-X
BRCA2 B-X
6174delT B-X
mutations B-X
: B-X
a B-X
combined B-X
analysis B-X
of B-X
22 B-X
population B-X
based B-X
studies B-X
| B-X
Journal B-X
of B-X
Medical B-X
Certain B-X
germline B-X
mutations B-X
in B-X
either B-X
BRCA1 B-X
or B-X
BRCA2 B-X
confer B-X
a B-X
lifetime B-X
risk B-X
of B-X
developing B-X
breast B-X
cancer B-X
that B-X
may B-X
approach B-X
90 B-X
% B-X
. B-X
The B-X
BRCA1 B-X
185delAG B-X
mutation B-X
was B-X
found B-X
in B-X
20 B-X
An B-X
evaluation B-X
of B-X
common B-X
breast B-X
cancer B-X
gene B-X
mutations B-X
in B-X
a B-X
population B-X
of B-X
Ashkenazi B-X
Jews B-X
. B-X
PDF B-X
| B-X
A B-X
recent B-X
report B-X
estimated B-X
the B-X
breast B-X
cancer B-X
risks B-X
in B-X
carriers B-X
of B-X
the B-X
three B-X
Ashkenazi B-X
founder B-X
mutations B-X
to B-X
be B-X
higher B-X
than B-X
previously B-X
published B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Founder B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
Ashkenazi B-X
Jews B-X
in B-X
Israel B-X
: B-X
frequency B-X
and B-X
differential B-X
penetrance B-X
in B-X
ovarian B-X
cancer B-X
and B-X
in B-X
breast-ovarian B-X
cancer B-X
families B-X
. B-X
Secondary B-X
BRCA1 B-X
and B-X
BRCA2 B-X
alterations B-X
and B-X
acquired B-X
chemoresistance B-X
Common B-X
Mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Do B-X
Not B-X
Contribute B-X
to B-X
Early B-X
Prostate B-X
Cancer B-X
in B-X
Jewish B-X
Men B-X

This	O
expanded	O
population	O
-	O
based	O
study	O
confirms	O
that	O
the	O
BRCA1	O
185delAG	O
mutation	O
and	O
the	O
BRCA2	O
6174delT	O
mutation	O
constitute	O
the	O
two	O
most	O
frequent	O
mutation	O
alleles	O
predisposing	O
to	O
hereditary	B-Disease
breast	I-Disease
cancer	I-Disease
among	O
the	O
Ashkenazim	O
,	O
and	O
suggests	O
a	O
relatively	O
lower	O
penetrance	O
for	O
the	O
6174delT	O
mutation	O
in	O
BRCA2	O
<EOS> B-X
Prevalence B-X
of B-X
185delAG B-X
and B-X
5382insC B-X
mutations B-X
in B-X
BRCA1 B-X
, B-X
and B-X
6174delT B-X
in B-X
BRCA2 B-X
in B-X
women B-X
of B-X
Ashkenazi B-X
Jewish B-X
origin B-X
in B-X
southern B-X
Brazil B-X
Epidemiological B-X
studies B-X
have B-X
demonstrated B-X
a B-X
clustering B-X
of B-X
breast B-X
and B-X
prostate B-X
cancers B-X
in B-X
some B-X
families B-X
. B-X
Moreover B-X
, B-X
there B-X
is B-X
an B-X
increase B-X
in B-X
the B-X
number B-X
of B-X
cases B-X
of B-X
prostate B-X
cancer B-X
in B-X
Recent B-X
studies B-X
have B-X
identified B-X
mutations B-X
in B-X
the B-X
breast B-X
and B-X
( B-X
ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
2 B-X
( B-X
BRCA2 B-X
) B-X
, B-X
one B-X
which B-X
has B-X
been B-X
found B-X
in B-X
the B-X
germline B-X
of B-X
several B-X
males B-X
PDF B-X
| B-X
BRCA1 B-X
and B-X
BRCA2 B-X
are B-X
the B-X
two B-X
major B-X
identified B-X
causes B-X
of B-X
inherited B-X
breast B-X
cancer B-X
, B-X
with B-X
mutations B-X
in B-X
either B-X
gene B-X
conferring B-X
up B-X
to B-X
80-90 B-X
% B-X
lifetime B-X
... B-X
| B-X
Find B-X
PDF B-X
| B-X
Inherited B-X
mutations B-X
of B-X
the B-X
BRCA2 B-X
gene B-X
give B-X
rise B-X
to B-X
a B-X
multi-site B-X
cancer B-X
phenotype B-X
which B-X
includes B-X
breast B-X
cancer B-X
( B-X
in B-X
female B-X
and B-X
males B-X
) B-X
, B-X
ovarian B-X
, B-X
... B-X
| B-X
Purpose B-X
: B-X
Three B-X
founder B-X
mutations B-X
in B-X
BRCA1 B-X
or B-X
BRCA2 B-X
genes B-X
increase B-X
breast B-X
cancer B-X
risk B-X
among B-X
Ashkenazi B-X
Jewish B-X
women B-X
. B-X
Reported B-X
estimates B-X
of B-X
the B-X
magnitude B-X
of B-X
this B-X
risk B-X
vary B-X
widely B-X
. B-X
BRCA2 B-X
Is B-X
Inactivated B-X
Late B-X
in B-X
the B-X
Development B-X
of B-X
Pancreatic B-X
Intraepithelial B-X
Neoplasia B-X

Dual	O
roles	O
of	O
ATM	O
in	O
the	O
cellular	O
response	O
to	O
radiation	O
and	O
in	O
cell	O
growth	O
control	O
.	O
<EOS> B-X
Involvement B-X
of B-X
p53 B-X
and B-X
p21 B-X
in B-X
Cellular B-X
Defects B-X
and B-X
Tumorigenesis B-X
in B-X
Atm‚àí/‚àí B-X
Mice B-X
Mutations B-X
in B-X
the B-X
ATM B-X
gene B-X
lead B-X
to B-X
the B-X
genetic B-X
disorder B-X
ataxia-telangiectasia B-X
. B-X
ATM B-X
encodes B-X
a B-X
protein B-X
kinase B-X
that B-X
is B-X
mainly B-X
distributed B-X
in B-X
the B-X
nucleus B-X
of B-X
proliferating B-X
cells B-X
. B-X
Recent B-X
studies B-X

The	O
gene	O
mutated	O
in	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
(	O
AT	B-Disease
)	O
patients	O
,	O
denoted	O
ATM	O
,	O
encodes	O
a	O
putative	O
protein	O
or	O
lipid	O
kinase	O
.	O
<EOS> B-X
The B-X
ATM B-X
protein B-X
, B-X
encoded B-X
by B-X
the B-X
gene B-X
responsible B-X
for B-X
the B-X
human B-X
genetic B-X
disorder B-X
ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
regulates B-X
several B-X
cellular B-X
responses B-X
to B-X
DNA B-X
breaks B-X
.... B-X
Ataxia B-X
telangiectasia B-X
( B-X
AT B-X
) B-X
is B-X
a B-X
rare B-X
human B-X
autosomal B-X
recessive B-X
disorder B-X
with B-X
pleiotropic B-X
phenotypes B-X
, B-X
including B-X
neuronal B-X
degeneration B-X
, B-X
immune B-X
dysfunction B-X
, B-X
premature B-X
ageing B-X
and B-X
increased B-X
cancer B-X
risk B-X
. B-X
Mitochondrial B-X
dysfunction B-X
in B-X
ataxia-telangiectasia B-X
A B-X
gene B-X
, B-X
ATM B-X
, B-X
that B-X
is B-X
mutated B-X
in B-X
the B-X
autosomal B-X
recessive B-X
disorder B-X
ataxia B-X
telangiectasia B-X
( B-X
AT B-X
) B-X
was B-X
identified B-X
by B-X
positional B-X
cloning B-X
on B-X
chromosome B-X
11q22-23 B-X
. B-X
AT B-X
is B-X
c B-X
PDF B-X
| B-X
In B-X
mammals B-X
, B-X
the B-X
ATM B-X
( B-X
ataxia-telangiectasia-mutated B-X
) B-X
and B-X
ATR B-X
( B-X
ATM B-X
and B-X
Rad3-related B-X
) B-X
protein B-X
kinases B-X
function B-X
as B-X
critical B-X
regulators B-X
of B-X
the B-X
cellular B-X
... B-X
| B-X
Find B-X
, B-X
Request B-X
PDF B-X
| B-X
Pathogenesis B-X
of B-X
ataxia-telangiectasia B-X
: B-X
The B-X
next B-X
generation B-X
of B-X
ATM B-X
functions B-X
| B-X
Twenty-five B-X
years B-X
ago B-X
, B-X
the B-X
gene B-X
responsible B-X
for B-X
the B-X
autosomal B-X
recessive B-X
disease B-X
ataxia- B-X
telangiectasia B-X
( B-X
A-T B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

To	O
elucidate	O
the	O
functions	O
of	O
ATM	O
,	O
we	O
disrupted	O
the	O
mouse	O
ATM	O
gene	O
through	O
homologous	O
recombination	O
in	O
mice	O
.	O
<EOS> B-X
The B-X
controlling B-X
role B-X
of B-X
ATM B-X
in B-X
homologous B-X
recombinational B-X
repair B-X
of B-X
DNA B-X
damage B-X
Targeted B-X
disruption B-X
of B-X
NBS1 B-X
reveals B-X
its B-X
roles B-X
in B-X
mouse B-X
development B-X
and B-X
DNA B-X
repair B-X
Atm B-X
Deficiency B-X
Causes B-X
an B-X
Increased B-X
Frequency B-X
of B-X
Intrachromosomal B-X
Homologous B-X
Recombination B-X
in B-X
Mice B-X
| B-X
Cancer B-X
Research B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X
References B-X

Consistent	O
with	O
cellular	O
defects	O
of	O
AT	B-Disease
patients	O
,	O
the	O
ATM	O
-	O
/	O
-	O
cells	O
are	O
hypersensitive	O
to	O
gamma	O
-	O
irradiation	O
and	O
defective	O
in	O
cell	O
-	O
cycle	O
arrest	O
following	O
radiation	O
,	O
correlating	O
with	O
a	O
defective	O
up	O
-	O
regulation	O
of	O
p53	O
.	O
<EOS> B-X
Loss B-X
of B-X
p21 B-X
increases B-X
sensitivity B-X
to B-X
ionizing B-X
radiation B-X
and B-X
delays B-X
the B-X
onset B-X
of B-X
lymphoma B-X
in B-X
atm-deficient B-X
mice B-X
| B-X
PNAS B-X
p53 B-X
Upregulation B-X
Is B-X
a B-X
Frequent B-X
Response B-X
to B-X
Deficiency B-X
of B-X
Cell-Essential B-X
Genes B-X
p53 B-X
tumour-suppressor B-X
gene B-X
is B-X
involved B-X
in B-X
cell B-X
growth B-X
control B-X
, B-X
arrest B-X
and B-X
apoptosis B-X
. B-X
Nevertheless B-X
cell B-X
cycle B-X
arrest B-X
and B-X
apoptosis B-X
induction B-X
can B-X
be B-X
observed B-X
in B-X
p53-defective B-X
cells B-X
after B-X
exposure B-X
to B-X
Negative B-X
Regulation B-X
of B-X
the B-X
Tumor B-X
Suppressor B-X
p53 B-X
Gene B-X
by B-X
MicroRNAs B-X
ATM B-X
is B-X
a B-X
member B-X
of B-X
the B-X
large B-X
phosphatidylinositol-3 B-X
kinase B-X
family B-X
and B-X
plays B-X
an B-X
important B-X
role B-X
in B-X
cellular B-X
response B-X
to B-X
DNA B-X
damage B-X
. B-X
To B-X
further B-X
define B-X
the B-X
physiological B-X
roles B-X
of B-X
ATM B-X
p53 B-X
: B-X
a B-X
molecular B-X
marker B-X
for B-X
the B-X
detection B-X
of B-X
cancer B-X
Involvement B-X
of B-X
p53 B-X
and B-X
p21 B-X
in B-X
Cellular B-X
Defects B-X
and B-X
Tumorigenesis B-X
in B-X
Atm‚àí/‚àí B-X
Mice B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X

In	O
addition	O
,	O
ATM	O
-	O
/	O
-	O
mouse	O
thymocytes	O
are	O
more	O
resistant	O
to	O
apoptosis	O
induced	O
by	O
gamma	O
-	O
irradiation	O
than	O
normal	O
thymocytes	O
.	O
<EOS> B-X
Developmental B-X
regulation B-X
of B-X
p53-dependent B-X
radiation-induced B-X
thymocyte B-X
apoptosis B-X
in B-X
mice B-X
Differential B-X
Response B-X
of B-X
Mouse B-X
Thymic B-X
Epithelial B-X
Cell B-X
Types B-X
to B-X
Ionizing B-X
Radiation-Induced B-X
DNA B-X
Damage B-X
Critical B-X
role B-X
for B-X
Atm B-X
in B-X
suppressing B-X
V B-X
( B-X
D B-X
) B-X
J B-X
recombination-driven B-X
thymic B-X
lymphoma B-X
Thymic B-X
epithelial B-X
cells B-X
are B-X
the B-X
main B-X
components B-X
of B-X
the B-X
thymic B-X
stroma B-X
, B-X
which B-X
supports B-X
and B-X
controls B-X
T-cell B-X
development B-X
. B-X
Preparative B-X
regimens B-X
using B-X
DNA B-X
damaging B-X
agents B-X
such B-X
as B-X
total B-X
body B-X
irradiation B-X
Multicellular B-X
organisms B-X
maintain B-X
genomic B-X
integrity B-X
and B-X
resist B-X
tumorigenesis B-X
through B-X
a B-X
tightly B-X
regulated B-X
DNA B-X
damage B-X
response B-X
( B-X
DDR B-X
) B-X
that B-X
prevents B-X
propagation B-X
of B-X
deleterious B-X
mutations B-X
either B-X
through B-X
DNA B-X
repair B-X
or B-X
programmed B-X
Irradiation B-X
Promotes B-X
V B-X
( B-X
D B-X
) B-X
J B-X
Joining B-X
and B-X
RAG-Dependent B-X
Neoplastic B-X
Transformation B-X
in B-X
SCID B-X
T-Cell B-X
Precursors B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

ATM	O
-	O
/	O
-	O
fibroblasts	O
are	O
inefficient	O
in	O
G1	O
to	O
S	O
-	O
phase	O
progression	O
following	O
serum	O
stimulation	O
and	O
senesce	O
after	O
only	O
a	O
few	O
passages	O
in	O
culture	O
.	O
<EOS> B-X
Dual B-X
roles B-X
of B-X
ATM B-X
in B-X
the B-X
cellular B-X
response B-X
to B-X
radiation B-X
and B-X
in B-X
cell B-X
growth B-X
control B-X
- B-X
CaltechAUTHORS B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

They	O
have	O
an	O
increased	O
constitutive	O
level	O
of	O
p21CP1	O
/	O
WAF1	O
.	O
<EOS> B-X
Regulation B-X
of B-X
the B-X
human B-X
p21/WAF1/Cip1 B-X
promoter B-X
in B-X
hepatic B-X
cells B-X
by B-X
functional B-X
interactions B-X
between B-X
Sp1 B-X
and B-X
Smad B-X
family B-X
members B-X
The B-X
WAF1/Cip1 B-X
gene B-X
product B-X
is B-X
an B-X
important B-X
regulator B-X
at B-X
the B-X
G1 B-X
checkpoint B-X
in B-X
the B-X
cell B-X
cycle B-X
. B-X
WAF1/Cip1 B-X
expression B-X
can B-X
be B-X
activated B-X
through B-X
p53-dependent B-X
and B-X
p53-independent B-X
pathways B-X
. B-X
The B-X
WAF1/Cip1 B-X
Protein B-X
p21 B-X
( B-X
Cip1/Waf1 B-X
) B-X
is B-X
a B-X
cyclin-dependent B-X
kinase B-X
inhibitor B-X
, B-X
which B-X
is B-X
important B-X
in B-X
the B-X
response B-X
of B-X
cells B-X
to B-X
genotoxic B-X
stress B-X
and B-X
a B-X
major B-X
transcriptional B-X
target B-X
of B-X
p53 B-X
protein B-X
Request B-X
PDF B-X
| B-X
Constitutive B-X
expression B-X
and B-X
cytoplasmic B-X
compartmentalization B-X
of B-X
ATM B-X
protein B-X
in B-X
differentiated B-X
human B-X
neuron-like B-X
SH-SY5Y B-X
cells B-X
| B-X
Ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
, B-X
recessive B-X
disorder B-X
mainly B-X
Request B-X
PDF B-X
| B-X
Foci B-X
formation B-X
of B-X
P53-binding B-X
protein B-X
1 B-X
in B-X
thyroid B-X
tumors B-X
: B-X
Activation B-X
of B-X
genomic B-X
instability B-X
during B-X
thyroid B-X
carcinogenesis B-X
| B-X
Defective B-X
DNA B-X
damage B-X
response B-X
( B-X
DDR B-X
) B-X
can B-X
result B-X
PDF B-X
| B-X
Inactivating B-X
mutations B-X
within B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
predispose B-X
patients B-X
to B-X
develop B-X
a B-X
variety B-X
of B-X
highly B-X
vascularized B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
PDF B-X
| B-X
Chronic B-X
infection B-X
with B-X
hepatitis B-X
B B-X
virus B-X
( B-X
HBV B-X
) B-X
is B-X
a B-X
major B-X
factor B-X
associated B-X
with B-X
the B-X
development B-X
of B-X
hepatocellular B-X
carcinoma B-X
, B-X
but B-X
the B-X
mechanism B-X
by B-X
... B-X
| B-X
Find B-X

The	O
ATM	O
protein	O
is	O
therefore	O
critical	O
both	O
for	O
cellular	O
responses	O
to	O
ionizing	O
radiation	O
and	O
for	O
normal	O
cell	O
-	O
cycle	O
progression	O
.	O
<EOS> B-X
The B-X
ATM B-X
protein B-X
kinase B-X
is B-X
a B-X
critical B-X
intermediate B-X
in B-X
a B-X
number B-X
of B-X
cellular B-X
responses B-X
to B-X
ionizing B-X
irradiation B-X
( B-X
IR B-X
) B-X
and B-X
possibly B-X
other B-X
stresses B-X
. B-X
ATM B-X
dysfunction B-X
results B-X
in B-X
abnormal B-X

ATM	O
+	O
/	O
-	O
fibroblasts	O
and	O
thymocytes	O
showed	O
intermediately	O
defective	O
responses	O
to	O
irradiation	O
but	O
no	O
growth	O
defect	O
,	O
suggesting	O
that	O
the	O
increased	O
cancer	B-Disease
risk	O
of	O
AT	B-Disease
heterozygotes	O
could	O
be	O
attributable	O
to	O
poor	O
checkpoint	O
function	O
.	O
.	O
<EOS> B-X
Less B-X
Efficient B-X
G2-M B-X
Checkpoint B-X
Is B-X
Associated B-X
with B-X
an B-X
Increased B-X
Risk B-X
of B-X
Lung B-X
Cancer B-X
in B-X
African B-X
Americans B-X

Targeted	O
disruption	O
of	O
ATM	O
leads	O
to	O
growth	B-Disease
retardation	I-Disease
,	O
chromosomal	B-Disease
fragmentation	I-Disease
during	I-Disease
meiosis	I-Disease
,	O
immune	B-Disease
defects	I-Disease
,	O
and	O
thymic	B-Disease
lymphoma	I-Disease
.	O
<EOS> B-X
Complementary B-X
functions B-X
of B-X
ATM B-X
and B-X
H2AX B-X
in B-X
development B-X
and B-X
suppression B-X
of B-X
genomic B-X
instability B-X
ATM B-X
, B-X
the B-X
gene B-X
mutated B-X
in B-X
the B-X
inherited B-X
human B-X
disease B-X
ataxia-telangiectasia B-X
, B-X
is B-X
a B-X
member B-X
of B-X
a B-X
family B-X
of B-X
kinases B-X
involved B-X
in B-X
DNA B-X
metabolism B-X
and B-X
cell-cycle B-X
checkpoint B-X
control B-X
. B-X
To B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X
ATM B-X
is B-X
a B-X
member B-X
of B-X
the B-X
phosphatidylinositol B-X
3-kinase B-X
( B-X
PIK B-X
) B-X
like B-X
kinases B-X
, B-X
some B-X
of B-X
which B-X
are B-X
active B-X
in B-X
regulating B-X
DNA B-X
damage-induced B-X
mitotic B-X
cell-cycle B-X
checkpoints1,2 B-X
. B-X
ATM B-X
also B-X
plays B-X

ATM	O
,	O
the	O
gene	O
mutated	O
in	O
the	O
inherited	B-Disease
human	I-Disease
disease	I-Disease
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
,	O
is	O
a	O
member	O
of	O
a	O
family	O
of	O
kinases	O
involved	O
in	O
DNA	O
metabolism	O
and	O
cell	O
-	O
cycle	O
checkpoint	O
control	O
.	O
<EOS> B-X
Ataxia-telangiectasia B-X
is B-X
a B-X
rare B-X
inherited B-X
disorder B-X
that B-X
affects B-X
the B-X
nervous B-X
system B-X
, B-X
immune B-X
system B-X
, B-X
and B-X
other B-X
body B-X
systems B-X
. B-X
Explore B-X
symptoms B-X
, B-X
inheritance B-X
, B-X
genetics B-X
of B-X
this B-X
condition B-X
. B-X
Ataxia B-X
telangiectasia B-X
( B-X
AT B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disease B-X
characterized B-X
by B-X
neurological B-X
and B-X
immunological B-X
symptoms B-X
, B-X
radiosensitivity B-X
and B-X
cancer B-X
predisposition B-X
. B-X
The B-X
gene B-X
mutated B-X
in B-X
AT B-X
, B-X
designated B-X
the B-X
Blood B-X
relatives B-X
of B-X
patients B-X
with B-X
the B-X
inherited B-X
disease B-X
ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
have B-X
an B-X
increased B-X
susceptibility B-X
for B-X
breast B-X
cancer B-X
. B-X
We B-X
therefore B-X
looked B-X
for B-X
sequence B-X
alterations B-X
of B-X
the B-X
ATM B-X
Inherited B-X
biallelic B-X
mutations B-X
of B-X
the B-X
ATM B-X
( B-X
ataxia-telangiectasia B-X
mutated B-X
) B-X
gene B-X
cause B-X
ataxia-telangiectasia B-X
, B-X
a B-X
rare B-X
autosomal B-X
recessive B-X
disorder B-X
associated B-X
with B-X
a B-X
high B-X
incidence B-X
of B-X
childhood B-X
leukaemias B-X
and B-X
lymphomas B-X
, B-X
Ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
neurodegenerative B-X
disorder B-X
with B-X
immunodeficiency B-X
and B-X
an B-X
increased B-X
risk B-X
of B-X
developing B-X
cancer B-X
, B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
ataxia-telangiectasia B-X
mutated B-X
( B-X
ATM B-X
) B-X
There B-X
are B-X
conflicting B-X
reports B-X
about B-X
the B-X
involvement B-X
of B-X
single B-X
nucleotide B-X
polymorphisms B-X
( B-X
SNPs B-X
) B-X
of B-X
the B-X
ataxia B-X
telangiectasia B-X
mutated B-X
( B-X
ATM B-X
) B-X
gene B-X
with B-X
cancer B-X
, B-X
and B-X
the B-X
consequences B-X
of B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
a B-X
pleiotropic B-X
inherited B-X
disease B-X
characterized B-X
by B-X
neurodegeneration B-X
, B-X
cancer B-X
, B-X
immunodeficiencies B-X
, B-X
radiation B-X
sensitivity B-X
, B-X
and B-X
genetic B-X
instability B-X
. B-X
Although B-X
A-T B-X
homozygotes B-X
are B-X
rare B-X
, B-X

To	O
help	O
clarify	O
the	O
physiological	O
roles	O
of	O
the	O
ATM	O
protein	O
,	O
we	O
disrupted	O
the	O
ATM	O
gene	O
in	O
mice	O
through	O
homologous	O
recombination	O
.	O
<EOS> B-X
ATM B-X
loss B-X
leads B-X
to B-X
synthetic B-X
lethality B-X
in B-X
BRCA1 B-X
BRCT B-X
mutant B-X
mice B-X
associated B-X
with B-X
exacerbated B-X
defects B-X
in B-X
homology-directed B-X
repair B-X
| B-X
PNAS B-X
p53 B-X
Binding B-X
Protein B-X
53BP1 B-X
Is B-X
Required B-X
for B-X
DNA B-X
Damage B-X
Responses B-X
and B-X
Tumor B-X
Suppression B-X
in B-X
Mice B-X
Ataxia B-X
Telangiectasia B-X
Mutated B-X
( B-X
ATM B-X
) B-X
Is B-X
Dispensable B-X
for B-X
Endonuclease B-X
I-SceI-induced B-X
Homologous B-X
Recombination B-X
in B-X
Mouse B-X
Embryonic B-X
Stem B-X
Cells B-X

Initial	O
evaluation	O
of	O
the	O
ATM	O
knockout	O
animals	O
indicates	O
that	O
inactivation	O
of	O
the	O
mouse	O
ATM	O
gene	O
recreates	O
much	O
of	O
the	O
phenotype	O
of	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Ataxia B-X
telangiectasia B-X
mutated B-X
( B-X
Atm B-X
) B-X
knockout B-X
mice B-X
as B-X
a B-X
model B-X
of B-X
osteopenia B-X
due B-X
to B-X
impaired B-X
bone B-X
formation B-X
| B-X
ATM B-X
is B-X
a B-X
member B-X
of B-X
the B-X
PI-3 B-X
kinase B-X
Request B-X
PDF B-X
| B-X
The B-X
neurological B-X
phenotype B-X
of B-X
Ataxia-telangiectasia B-X
: B-X
Solving B-X
a B-X
persistent B-X
puzzle B-X
| B-X
Human B-X
genomic B-X
instability B-X
syndromes B-X
affect B-X
the B-X
nervous B-X
system B-X
to B-X
different B-X
degrees B-X
of B-X
severity B-X
, B-X
attesting B-X
to B-X
Request B-X
PDF B-X
| B-X
Targeted B-X
disruption B-X
of B-X
Ataxia-telangiectasia B-X
mutated B-X
gene B-X
in B-X
miniature B-X
pigs B-X
by B-X
somatic B-X
cell B-X
nuclear B-X
transfer B-X
| B-X
Ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
a B-X
recessive B-X
autosomal B-X
disorder B-X
associated B-X
with B-X
Targeted B-X
disruption B-X
of B-X
ATM B-X
leads B-X
to B-X
growth B-X
retardation B-X
, B-X
chromosomal B-X
fragmentation B-X
during B-X
meiosis B-X
, B-X
immune B-X
defects B-X
, B-X
and B-X
thymic B-X
lymphoma B-X
. B-X
Targeted B-X
disruption B-X
of B-X
ATM B-X
leads B-X
to B-X
growth B-X
retardation B-X
, B-X
chromosomal B-X
fragmentation B-X
during B-X
meiosis B-X
, B-X
immune B-X
defects B-X
, B-X
and B-X
thymic B-X
lymphoma B-X
- B-X
CaltechAUTHORS B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

The	O
homozygous	O
mutant	O
(	O
ATM	O
-	O
/	O
-	O
)	O
mice	O
are	O
viable	O
,	O
growth	O
-	O
retarded	O
,	O
and	O
infertile	O
.	O

The	O
infertility	B-Disease
of	O
ATM	O
-	O
/	O
-	O
mice	O
results	O
from	O
meiotic	O
failure	O
.	O
<EOS> B-X
BRCA2 B-X
deficiency B-X
in B-X
mice B-X
leads B-X
to B-X
meiotic B-X
impairment B-X
and B-X
infertility B-X
| B-X
Development B-X
A B-X
putative B-X
human B-X
infertility B-X
allele B-X
of B-X
the B-X
meiotic B-X
recombinase B-X
DMC1 B-X
does B-X
not B-X
affect B-X
fertility B-X
in B-X
mice B-X
Infertility B-X
is B-X
a B-X
common B-X
feature B-X
of B-X
the B-X
human B-X
disorder B-X
ataxia-telangiectasia B-X
and B-X
Atm-deficient B-X
mice B-X
are B-X
completely B-X
infertile B-X
. B-X
To B-X
gain B-X
further B-X
insight B-X
into B-X
the B-X
role B-X
of B-X
ATM B-X
in B-X
meiosis B-X
, B-X
we B-X
Meiotic B-X
Telomere B-X
Distribution B-X
and B-X
Sertoli B-X
Cell B-X
Nuclear B-X
Architecture B-X
Are B-X
Altered B-X
in B-X
Atm- B-X
and B-X
Atm-p53-Deficient B-X
Mice B-X
RAD51C B-X
deficiency B-X
in B-X
mice B-X
results B-X
in B-X
early B-X
prophase B-X
I B-X
arrest B-X
in B-X
males B-X
and B-X
sister B-X
chromatid B-X
separation B-X
at B-X
metaphase B-X
II B-X
in B-X
females B-X
DNA B-X
MISMATCH B-X
REPAIR B-X
AND B-X
INFERTILITY B-X
The B-X
world B-X
's B-X
population B-X
is B-X
increasing B-X
at B-X
an B-X
alarming B-X
rate B-X
and B-X
is B-X
projected B-X
to B-X
reach B-X
nine B-X
billion B-X
by B-X
2050 B-X
. B-X
Despite B-X
this B-X
, B-X
15 B-X
% B-X
of B-X
couples B-X
world-wide B-X
remain B-X
childless B-X

Meiosis	O
is	O
arrested	O
at	O
the	O
zygotene	O
/	O
pachytene	O
stage	O
of	O
prophase	O
I	O
as	O
a	O
result	O
of	O
abnormal	O
chromosomal	O
synapsis	O
and	O
subsequent	O
chromosome	O
fragmentation	O
.	O
<EOS> B-X
Meiosis B-X
is B-X
a B-X
double-division B-X
process B-X
that B-X
is B-X
preceded B-X
by B-X
only B-X
one B-X
DNA B-X
replication B-X
event B-X
to B-X
produce B-X
haploid B-X
gametes B-X
. B-X
The B-X
defining B-X
event B-X
in B-X
meiosis B-X
is B-X
prophase B-X
I B-X
, B-X
Abstract B-X
. B-X
Oocytes B-X
in B-X
embryonic B-X
ovaries B-X
enter B-X
meiosis B-X
I B-X
and B-X
arrest B-X
in B-X
the B-X
diplonema B-X
stage B-X
. B-X
Perturbations B-X
in B-X
meiosis B-X
I B-X
, B-X
such B-X
as B-X
abnormal B-X
double-strand B-X
break B-X
( B-X
DSB B-X
) B-X
Meiotic B-X
Prophase B-X
Arrest B-X
with B-X
Failure B-X
of B-X
Chromosome B-X
Synapsis B-X
in B-X
Mice B-X
Deficient B-X
for B-X
Dmc1 B-X
, B-X
a B-X
Germline-Specific B-X
RecA B-X
Homolog B-X
- B-X
ScienceDirect B-X
The B-X
AtRAD51C B-X
Gene B-X
Is B-X
Required B-X
for B-X
Normal B-X
Meiotic B-X
Chromosome B-X
Synapsis B-X
and B-X
Double-Stranded B-X
Break B-X
Repair B-X
in B-X
Arabidopsis B-X
Meiosis B-X
Sexual B-X
reproduction B-X
requires B-X
the B-X
production B-X
of B-X
haploid B-X
gametes B-X
( B-X
sperm B-X
and B-X
egg B-X
) B-X
with B-X
only B-X
one B-X
copy B-X
of B-X
each B-X
chromosome B-X
; B-X
fertilization B-X
then B-X
restores B-X
the B-X
diploid B-X
chromosome B-X
content B-X
in B-X
the B-X
MEIOTIC B-X
F-BOX B-X
Is B-X
Essential B-X
for B-X
Male B-X
Meiotic B-X
DNA B-X
Double-Strand B-X
Break B-X
Repair B-X
in B-X
Rice B-X

Immune	B-Disease
defects	I-Disease
also	O
are	O
evident	O
in	O
ATM	O
-	O
/	O
-	O
mice	O
,	O
including	O
reduced	O
numbers	O
of	O
B220	O
+	O
CD43	O
-	O
pre	O
-	O
B	O
cells	O
,	O
thymocytes	O
,	O
and	O
peripheral	O
T	O
cells	O
,	O
as	O
well	O
as	O
functional	O
impairment	O
of	O
T	O
-	O
cell	O
-	O
dependent	O
immune	O
responses	O
.	O
<EOS> B-X
Age-related B-X
changes B-X
in B-X
the B-X
occurrence B-X
and B-X
characteristics B-X
of B-X
thymic B-X
CD4+ B-X
CD25+ B-X
T B-X
cells B-X
in B-X
mice B-X
Thymic B-X
function B-X
in B-X
the B-X
regulation B-X
of B-X
T B-X
cells B-X
, B-X
and B-X
molecular B-X
mechanisms B-X
underlying B-X
the B-X
modulation B-X
of B-X
cytokines B-X
and B-X
stress B-X
signaling B-X
( B-X
Review B-X
) B-X
Thymic B-X
function B-X
in B-X
the B-X
regulation B-X
of B-X
T B-X
cells B-X
, B-X
and B-X
molecular B-X
mechanisms B-X
underlying B-X
the B-X
modulation B-X
of B-X
cytokines B-X
and B-X
stress B-X
signaling B-X
Deviation B-X
of B-X
the B-X
B B-X
Cell B-X
Pathway B-X
in B-X
Senescent B-X
Mice B-X
is B-X
Associated B-X
with B-X
Reduced B-X
Surrogate B-X
Light B-X
Chain B-X
Expression B-X
and B-X
Altered B-X
Immature B-X
B B-X
Cell B-X
Generation B-X
, B-X
Phenotype B-X
, B-X
and B-X
Light B-X
Chain B-X
Expression B-X
CD19 B-X
Function B-X
in B-X
Early B-X
and B-X
Late B-X
B B-X
Cell B-X
Development B-X
. B-X
II B-X
. B-X
CD19 B-X
Facilitates B-X
the B-X
Pro-B/Pre-B B-X
Transition B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
PU.1 B-X
is B-X
not B-X
strictly B-X
required B-X
for B-X
B B-X
cell B-X
development B-X
and B-X
its B-X
absence B-X
induces B-X
a B-X
B-2 B-X
to B-X
B-1 B-X
cell B-X
switch B-X
Positive B-X
and B-X
negative B-X
selection B-X
of B-X
the B-X
T B-X
cell B-X
repertoire B-X
: B-X
what B-X
thymocytes B-X
see B-X
and B-X
do B-X
n't B-X
see B-X

The	O
cerebella	O
of	O
ATM	O
-	O
/	O
-	O
mice	O
appear	O
normal	O
by	O
histologic	O
examination	O
at	O
3	O
to	O
4	O
months	O
and	O
the	O
mice	O
have	O
no	O
gross	O
behavioral	B-Disease
abnormalities	I-Disease
.	O
<EOS> B-X
Inactive B-X
Atm B-X
abrogates B-X
DSB B-X
repair B-X
in B-X
mouse B-X
cerebellum B-X
more B-X
than B-X
does B-X
Atm B-X
loss B-X
, B-X
without B-X
causing B-X
a B-X
neurological B-X
phenotype B-X
- B-X
ScienceDirect B-X
From B-X
the B-X
Cover B-X
: B-X
Abnormal B-X
development B-X
of B-X
Purkinje B-X
cells B-X
and B-X
lymphocytes B-X
in B-X
Atm B-X
mutant B-X
mice B-X
ATM B-X
is B-X
a B-X
cytoplasmic B-X
protein B-X
in B-X
mouse B-X
brain B-X
required B-X
to B-X
prevent B-X
lysosomal B-X
accumulation B-X
Atm B-X
deficiency B-X
in B-X
the B-X
DNA B-X
polymerase B-X
Œ≤ B-X
null B-X
cerebellum B-X
results B-X
in B-X
cerebellar B-X
ataxia B-X
and B-X
Itpr1 B-X
reduction B-X
associated B-X
with B-X
alteration B-X
of B-X
cytosine B-X
methylation B-X

The	O
majority	O
of	O
mutant	O
mice	O
rapidly	O
develop	O
thymic	B-Disease
lymphomas	I-Disease
and	O
die	O
before	O
4	O
months	O
of	O
age	O
.	O
<EOS> B-X
No B-X
Requirement B-X
for B-X
V B-X
( B-X
D B-X
) B-X
J B-X
Recombination B-X
in B-X
p53-Deficient B-X
Thymic B-X
Lymphoma B-X
The B-X
Evolution B-X
of B-X
Tumor B-X
Formation B-X
in B-X
Humans B-X
and B-X
Mice B-X
with B-X
Inherited B-X
Mutations B-X
in B-X
the B-X
p53 B-X
Gene B-X
002526 B-X
- B-X
C.129S2 B-X
( B-X
B6 B-X
) B-X
-Trp53 B-X
< B-X
tm1Tyj B-X
> B-X
/J B-X
002547 B-X
- B-X
C3Ou.129S2 B-X
( B-X
B6 B-X
) B-X
-Trp53 B-X
< B-X
tm1Tyj B-X
> B-X
/J B-X
002080 B-X
- B-X
129-Trp53 B-X
< B-X
tm1Tyj B-X
> B-X
/J B-X

These	O
findings	O
indicate	O
that	O
the	O
ATM	O
gene	O
product	O
plays	O
an	O
essential	O
role	O
in	O
a	O
diverse	O
group	O
of	O
cellular	O
processes	O
,	O
including	O
meiosis	O
,	O
the	O
normal	O
growth	O
of	O
somatic	O
tissues	O
,	O
immune	O
development	O
,	O
and	O
tumor	B-Disease
suppression	O
.	O
.	O
<EOS> B-X
Two B-X
of B-X
the B-X
main B-X
types B-X
of B-X
genes B-X
that B-X
play B-X
a B-X
role B-X
in B-X
cancer B-X
are B-X
oncogenes B-X
and B-X
tumor B-X
suppressor B-X
genes B-X
. B-X
Learn B-X
more B-X
here B-X
. B-X
Cellular B-X
senescence B-X
is B-X
a B-X
permanent B-X
cell B-X
cycle B-X
arrest B-X
and B-X
a B-X
potent B-X
tumor B-X
suppression B-X
mechanism B-X
. B-X
The B-X
p53 B-X
tumor B-X
suppressor B-X
is B-X
a B-X
sequence-specific B-X
transcription B-X
factor B-X
and B-X
acts B-X
as B-X
a B-X
central B-X
hub B-X
Cellular B-X
senescence B-X
has B-X
emerged B-X
as B-X
a B-X
potent B-X
tumor B-X
suppression B-X
mechanism B-X
that B-X
restrains B-X
proliferation B-X
of B-X
cells B-X
at B-X
risk B-X
for B-X
malignant B-X
transformation B-X
. B-X
Although B-X
senescent B-X
cells B-X
have B-X
permanently B-X
exited B-X
the B-X
cell B-X
cycle B-X
Molecular B-X
genetic B-X
studies B-X
of B-X
familial B-X
cancer B-X
syndromes B-X
identified B-X
and B-X
defined B-X
the B-X
recessive B-X
nature B-X
of B-X
tumor B-X
suppressor B-X
genes B-X
and B-X
resolved B-X
the B-X
paradox B-X
of B-X
why B-X
tumors B-X
arising B-X
in B-X
such B-X
families B-X
exhibited B-X
an B-X
The B-X
activation B-X
of B-X
cellular B-X
oncogenes B-X
represents B-X
only B-X
one B-X
of B-X
two B-X
distinct B-X
types B-X
of B-X
genetic B-X
alterations B-X
involved B-X
in B-X
tumor B-X
development B-X
; B-X
the B-X
other B-X
is B-X
inactivation B-X
of B-X
tumor B-X
suppressor B-X
genes B-X
. B-X
Oncogenes B-X
The B-X
ATM B-X
protein B-X
kinase B-X
and B-X
cellular B-X
redox B-X
signaling B-X
: B-X
beyond B-X
the B-X
DNA B-X
damage B-X
response B-X
The B-X
HINT1 B-X
tumor B-X
suppressor B-X
regulates B-X
both B-X
Œ≥-H2AX B-X
and B-X
ATM B-X
in B-X
response B-X
to B-X
DNA B-X
damage B-X

Cloning	O
and	O
characterization	O
of	O
human	O
very	O
-	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
dehydrogenase	O
cDNA	O
,	O
chromosomal	O
assignment	O
of	O
the	O
gene	O
and	O
identification	O
in	O
four	O
patients	O
of	O
nine	O
different	O
mutations	O
within	O
the	O
VLCAD	O
gene	O
.	O
<EOS> B-X
Figure B-X
2 B-X
. B-X
Western B-X
blot B-X
analysis B-X
of B-X
different B-X
human B-X
tissues B-X
using B-X
VLCAD B-X
, B-X
LCAD B-X
or B-X
MCAD B-X
antibodies B-X
. B-X
Experimental B-X
conditions B-X
are B-X
summarized B-X
in B-X
the B-X
text B-X
. B-X
Each B-X
lane B-X
of B-X
the B-X
Characterization B-X
of B-X
the B-X
Human B-X
Very-Long-Chain B-X
Acyl-CoA B-X
Dehydrogenase B-X
Gene B-X
Promoter B-X
Region B-X
: B-X
A B-X
Role B-X
for B-X
Activator B-X
Protein B-X
2 B-X
- B-X
ScienceDirect B-X
Very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
is B-X
one B-X
of B-X
four B-X
straight-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
ACD B-X
) B-X
enzymes B-X
, B-X
which B-X
are B-X
all B-X
nuclear B-X
encoded B-X
mitochondrial B-X
flavoproteins B-X
catalyzing B-X
the B-X
initial B-X
step B-X
in B-X
In B-X
a B-X
field B-X
where B-X
even B-X
experts B-X
may B-X
find B-X
that B-X
years B-X
have B-X
elapsed B-X
since B-X
they B-X
last B-X
encountered B-X
a B-X
child B-X
with B-X
a B-X
given B-X
disorder B-X
, B-X
it B-X
is B-X
essential B-X
for B-X
the B-X
clinician B-X
to B-X
Volume B-X
5 B-X
Issue B-X
4 B-X
| B-X
Human B-X
Molecular B-X
Genetics B-X
| B-X
Oxford B-X
Academic B-X
VCV000203579.5 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Very	O
-	O
long	O
-	O
chain	O
acyl	O
-	O
CoA	O
dehydrogenase	O
(	O
VLCAD	O
)	O
is	O
one	O
of	O
four	O
straight	O
-	O
chain	O
acyl	O
-	O
CoA	O
dehydrogenase	O
(	O
ACD	O
)	O
enzymes	O
,	O
which	O
are	O
all	O
nuclear	O
encoded	O
mitochondrial	O
flavoproteins	O
catalyzing	O
the	O
initial	O
step	O
in	O
fatty	O
acid	O
beta	O
-	O
oxidation	O
.	O
<EOS> B-X
Very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
is B-X
one B-X
of B-X
four B-X
straight-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
ACD B-X
) B-X
enzymes B-X
, B-X
which B-X
are B-X
all B-X
nuclear B-X
encoded B-X
mitochondrial B-X
flavoproteins B-X
catalyzing B-X
the B-X
initial B-X
step B-X
in B-X
PDF B-X
| B-X
Very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
is B-X
one B-X
of B-X
four B-X
straight-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
ACD B-X
) B-X
enzymes B-X
, B-X
which B-X
are B-X
all B-X
nuclear B-X
encoded B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Cloning B-X
and B-X
characterization B-X
of B-X
human B-X
very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
cDNA B-X
, B-X
chromosomal B-X
assignment B-X
of B-X
the B-X
gene B-X
and B-X
identification B-X
in B-X
four B-X
patients B-X
of B-X
nine B-X
different B-X
mutations B-X
within B-X
the B-X
VLCAD B-X
gene B-X
. B-X
Short-Chain B-X
Acyl-CoA B-X
Dehydrogenase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Combined B-X
defects B-X
in B-X
oxidative B-X
phosphorylation B-X
and B-X
fatty B-X
acid B-X
Œ≤-oxidation B-X
in B-X
mitochondrial B-X
disease B-X
Structural B-X
basis B-X
for B-X
the B-X
broad B-X
substrate B-X
specificity B-X
of B-X
two B-X
acyl-CoA B-X
dehydrogenases B-X
FadE5 B-X
from B-X
mycobacteria B-X
| B-X
PNAS B-X
Medium-chain B-X
acyl-Coenzyme B-X
A B-X
dehydrogenase B-X
( B-X
MCAD B-X
) B-X
is B-X
involved B-X
in B-X
the B-X
initial B-X
step B-X
of B-X
mitochondrial B-X
fatty B-X
acid B-X
Œ≤-oxidation B-X
( B-X
FAO B-X
) B-X
. B-X
Loss B-X
of B-X
function B-X
results B-X
in B-X
MCAD B-X
deficiency B-X
, B-X

We	O
have	O
used	O
the	O
very	O
fast	O
,	O
Rapid	O
Amplification	O
of	O
cDNA	O
Ends	O
(	O
RACE	O
)	O
based	O
strategy	O
to	O
obtain	O
the	O
sequence	O
of	O
cDNAs	O
encoding	O
human	O
VLCAD	O
from	O
placenta	O
and	O
fibroblasts	O
.	O
<EOS> B-X
PDF B-X
| B-X
Tandem B-X
mass B-X
spectrometry-based B-X
newborn B-X
screening B-X
correctly B-X
identifies B-X
individuals B-X
with B-X
very B-X
long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
deficiency B-X
( B-X
VLCADD B-X
) B-X
.... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
PDF B-X
| B-X
Very B-X
long B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
deficiency B-X
is B-X
a B-X
genetic B-X
pediatric B-X
disorder B-X
presenting B-X
with B-X
a B-X
spectrum B-X
of B-X
phenotypes B-X
that B-X
remains B-X
for B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
IN B-X
VITRO B-X
STUDY B-X
OF B-X
VERY B-X
LONG B-X
CHAIN B-X
ACYL-COA B-X
DEHYDROGENASE B-X
DEFICIENCY B-X
WITH B-X
MUSCULAR B-X
INVOLVEMENT B-X
| B-X
Introduction B-X
: B-X
In B-X
vitro B-X
studies B-X
for B-X
searching B-X
intermediates B-X
of B-X
mitochondrial B-X
fatty B-X
acid B-X
degradation B-X

Alignment	O
of	O
the	O
predicted	O
amino	O
acid	O
sequence	O
of	O
human	O
VLCAD	O
with	O
those	O
of	O
the	O
other	O
human	O
ACD	O
enzymes	O
revealed	O
extensive	O
sequence	O
homology	O
.	O
<EOS> B-X
cDNA B-X
encoding B-X
the B-X
precursor B-X
of B-X
rat B-X
very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
was B-X
cloned B-X
and B-X
sequenced B-X
. B-X
The B-X
longest B-X
cDNA B-X
insert B-X
had B-X
2117 B-X
bases B-X
. B-X
This B-X
cDNA B-X
encodes B-X
the B-X
entire B-X
PDF B-X
| B-X
The B-X
acyl-CoA B-X
dehydrogenases B-X
( B-X
ACDs B-X
) B-X
are B-X
a B-X
family B-X
of B-X
related B-X
enzymes B-X
that B-X
catalyze B-X
the B-X
alpha B-X
, B-X
beta-dehydrogenation B-X
of B-X
acyl-CoA B-X
esters B-X
. B-X
Two B-X
homologues B-X
... B-X
| B-X
Find B-X
, B-X
PDF B-X
| B-X
Very B-X
long B-X
chain B-X
acyl-CoA B-X
dehydrogenase B-X
deficiency B-X
( B-X
VLCADD B-X
) B-X
is B-X
an B-X
inherited B-X
metabolic B-X
disease B-X
caused B-X
by B-X
deleterious B-X
mutations B-X
in B-X
the B-X
ACADVL B-X
gene B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

Moreover	O
,	O
human	O
VLCAD	O
and	O
human	O
acyl	O
-	O
CoA	O
oxidase	O
showed	O
extensive	O
sequence	O
homology	O
corroborating	O
the	O
notion	O
that	O
these	O
genes	O
are	O
evolutionarily	O
related	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Acyl-CoA B-X
Dehydrogenases B-X
: B-X
Dynamic B-X
History B-X
of B-X
Protein B-X
Family B-X
Evolution B-X
| B-X
The B-X
acyl-CoA B-X
dehydrogenases B-X
( B-X
ACADs B-X
) B-X
are B-X
enzymes B-X
that B-X
catalyze B-X
the B-X
alpha B-X
, B-X
beta-dehydrogenation B-X
of B-X
acyl-CoA B-X
esters B-X
Clear B-X
Correlation B-X
of B-X
Genotype B-X
with B-X
Disease B-X
Phenotype B-X
in B-X
Very‚ÄìLong-Chain B-X
Acyl-CoA B-X
Dehydrogenase B-X
Deficiency B-X
- B-X
ScienceDirect B-X
Very B-X
long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
deficiency B-X
is B-X
a B-X
disorder B-X
of B-X
fatty B-X
acid B-X
beta-oxidation B-X
that B-X
can B-X
present B-X
at B-X
any B-X
age B-X
with B-X
cardiomyopathy B-X
, B-X
rhabdomyolysis B-X
, B-X
hepatic B-X
dysfunction B-X
, B-X
and/or B-X

Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
from	O
hybrid	O
cell	O
lines	O
was	O
used	O
to	O
localize	O
the	O
VLCAD	O
gene	O
to	O
human	O
chromosome	O
17p11	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Characterization B-X
of B-X
the B-X
bidirectional B-X
promoter B-X
region B-X
between B-X
the B-X
human B-X
genes B-X
encoding B-X
VLCAD B-X
and B-X
PSD-95 B-X
| B-X
Bidirectional B-X
promoters B-X
are B-X
widely B-X
known B-X
among B-X
lower B-X
organisms B-X
but B-X
rare B-X
in B-X
mammals B-X
Short/branched B-X
chain B-X
acyl-CoA B-X
dehydrogenase B-X
, B-X
SBCAD B-X
( B-X
gene B-X
symbol B-X
ACADSB B-X
) B-X
, B-X
is B-X
a B-X
member B-X
of B-X
the B-X
acyl-CoA B-X
dehydrogenase B-X
family B-X
of B-X
genes B-X
with B-X
activity B-X
toward B-X
the B-X
short/branched B-X
chain B-X
acyl-CoA B-X
derivatives B-X
WikiGenes B-X
- B-X
ACADVL B-X
- B-X
acyl-CoA B-X
dehydrogenase B-X
, B-X
very B-X
long B-X
chain B-X
Abstract B-X
. B-X
Very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
is B-X
one B-X
of B-X
four B-X
straight-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
ACD B-X
) B-X
enzymes B-X
, B-X
which B-X
are B-X
all B-X
nuclear B-X
encoded B-X
mitoc B-X
Abstract B-X
. B-X
Very-long-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
VLCAD B-X
) B-X
is B-X
one B-X
of B-X
four B-X
straight-chain B-X
acyl-CoA B-X
dehydrogenase B-X
( B-X
ACD B-X
) B-X
enzymes B-X
, B-X
which B-X
are B-X
all B-X
nuclear B-X
encoded B-X
mitoc B-X
Request B-X
PDF B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
2009 B-X
, B-X
Brage B-X
Storstein B-X
Andresen B-X
published B-X
Very-Long-Chain B-X
Acyl-CoA B-X
Dehydrogenase B-X
Deficiency B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
on B-X
ResearchGate B-X

2	O
-	O
p11	O
.	O
<EOS> B-X
613604 B-X
- B-X
CHROMOSOME B-X
16p12.2-p11.2 B-X
DELETION B-X
SYNDROME B-X
, B-X
7.1- B-X
TO B-X
8.7-MB B-X
The B-X
Variant B-X
inv B-X
( B-X
2 B-X
) B-X
( B-X
p11.2q13 B-X
) B-X
Is B-X
a B-X
Genuinely B-X
Recurrent B-X
Rearrangement B-X
but B-X
Displays B-X
Some B-X
Breakpoint B-X
Heterogeneity B-X
16p11.2-p12.2 B-X
microdeletion B-X
syndrome B-X
is B-X
a B-X
recently B-X
described B-X
syndrome B-X
characterized B-X
by B-X
developmental B-X
delay B-X
and B-X
facial B-X
dysmorphism B-X
. B-X
Translocation B-X
t B-X
( B-X
2 B-X
; B-X
7 B-X
) B-X
( B-X
p11.2 B-X
; B-X
q21.2 B-X
) B-X
: B-X
a B-X
rare B-X
genetic B-X
aberration B-X
associated B-X
with B-X
B-cell B-X
lymphoproliferative B-X
disorders B-X
of B-X
marginal-zone B-X
origin B-X
We B-X
report B-X
on B-X
an B-X
Arab B-X
boy B-X
with B-X
Alagille B-X
syndrome B-X
and B-X
a B-X
de B-X
novo B-X
deletion B-X
of B-X
the B-X
short B-X
arm B-X
of B-X
chromosome B-X
20 B-X
with B-X
a B-X
46 B-X
, B-X
XY B-X
, B-X
del B-X
( B-X
20 B-X
Dic B-X
( B-X
17 B-X
; B-X
18 B-X
) B-X
( B-X
p11.2 B-X
; B-X
p11.2 B-X
) B-X
is B-X
a B-X
recurring B-X
abnormality B-X
in B-X
chronic B-X
lymphocytic B-X
leukaemia B-X
associated B-X
with B-X
aggressive B-X
disease B-X
The B-X
case B-X
of B-X
a B-X
young B-X
man B-X
with B-X
del B-X
( B-X
2 B-X
) B-X
( B-X
p11.2p13 B-X
) B-X
is B-X
reported B-X
. B-X
Accounts B-X
of B-X
previous B-X
cases B-X
of B-X
deletion B-X
of B-X
the B-X
short B-X
arm B-X
of B-X
chromosome B-X
2 B-X

13105	O
.	O
<EOS> B-X
L13105 B-X
KEGG B-X
T01002 B-X
: B-X
13105 B-X
NVD B-X
- B-X
CVE-2019-13105 B-X
13105 B-X
Train B-X
Running B-X
Status B-X
or B-X
Live B-X
Train B-X
Status B-X
of B-X
SDAH B-X
BUI B-X
EXPRESS B-X
and B-X
Spot B-X
Your B-X
Train B-X
SDAH B-X
BUI B-X
EXPRESS B-X
accurately B-X
in B-X
Indian B-X
Railways B-X
Plug B-X
PowerTOP¬Æ B-X
Xtra B-X
13105 B-X
| B-X
MENNEKES B-X
Common B-X
Vulnerabilities B-X
and B-X
Exposures B-X
( B-X
CVE¬Æ B-X
) B-X
is B-X
a B-X
list B-X
of B-X
records B-X
‚Äî B-X
each B-X
containing B-X
an B-X
identification B-X
number B-X
, B-X
a B-X
description B-X
, B-X
and B-X
at B-X
least B-X
one B-X
public B-X
reference B-X
‚Äî B-X
for B-X
HomoloGene B-X
is B-X
an B-X
automated B-X
system B-X
for B-X
detecting B-X
homologs B-X
among B-X
eukaryotic B-X
gene B-X
sets B-X
. B-X

Using	O
Northern	O
and	O
Western	O
blot	O
analysis	O
to	O
investigate	O
the	O
tissue	O
specific	O
distribution	O
of	O
VLCAD	O
mRNA	O
and	O
protein	O
in	O
several	O
human	O
tissues	O
we	O
showed	O
that	O
VLCAD	O
is	O
most	O
abundant	O
in	O
heart	O
and	O
skeletal	O
muscle	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Mitochondrial B-X
long B-X
chain B-X
fatty B-X
acid B-X
Œ≤-oxidation B-X
in B-X
man B-X
and B-X
mouse B-X
| B-X
Several B-X
mouse B-X
models B-X
for B-X
mitochondrial B-X
fatty B-X
acid B-X
beta-oxidation B-X
( B-X
FAO B-X
) B-X
defects B-X
have B-X
been B-X
developed B-X
. B-X
Tissue-Specific B-X
Strategies B-X
of B-X
the B-X
Very-Long B-X
Chain B-X
Acyl-CoA B-X
Dehydrogenase-Deficient B-X
( B-X
VLCAD‚àí/‚àí B-X
) B-X
Mouse B-X
to B-X
Compensate B-X
a B-X
Defective B-X
Fatty B-X
Acid B-X
Œ≤-Oxidation B-X

This	O
agrees	O
well	O
with	O
the	O
fact	O
that	O
cardiac	O
and	O
muscle	O
symptoms	O
are	O
characteristic	O
for	O
patients	O
with	O
VLCAD	B-Disease
deficiency	I-Disease
.	O
<EOS> B-X
Mitochondrial B-X
Fatty B-X
Acid B-X
Oxidation B-X
Disorders B-X
: B-X
Laboratory B-X
Diagnosis B-X
, B-X
Pathogenesis B-X
, B-X
and B-X
the B-X
Complicated B-X
Route B-X
to B-X
Treatment B-X

Northern	O
blot	O
analysis	O
and	O
sequencing	O
of	O
cloned	O
PCR	O
amplified	O
VLCAD	O
cDNA	O
from	O
four	O
unrelated	O
patients	O
with	O
VLCAD	B-Disease
deficiency	I-Disease
showed	O
that	O
VLCAD	O
mRNA	O
was	O
undetectable	O
in	O
one	O
patient	O
and	O
that	O
the	O
other	O
three	O
have	O
mutations	O
in	O
both	O
VLCAD	O
alleles	O
.	O

Western	O
blot	O
analysis	O
of	O
patient	O
fibroblasts	O
showed	O
that	O
the	O
identified	O
mutations	O
result	O
in	O
severely	O
reduced	O
amounts	O
of	O
VLCAD	O
protein	O
.	O
<EOS> B-X
Compared B-X
effects B-X
of B-X
missense B-X
mutations B-X
in B-X
Very-Long-Chain B-X
Acyl-CoA B-X
Dehydrogenase B-X
deficiency B-X
: B-X
Combined B-X
analysis B-X
by B-X
structural B-X
, B-X
functional B-X
and B-X
pharmacological B-X
approaches B-X
- B-X
ScienceDirect B-X

Molecular	O
bases	O
of	O
combined	B-Disease
subtotal	I-Disease
deficiencies	I-Disease
of	I-Disease
C6	I-Disease
and	I-Disease
C7	I-Disease
:	O
their	O
effects	O
in	O
combination	O
with	O
other	O
C6	B-Disease
and	I-Disease
C7	I-Disease
deficiencies	I-Disease
.	O
<EOS> B-X
Molecular B-X
bases B-X
of B-X
combined B-X
subtotal B-X
deficiencies B-X
of B-X
C6 B-X
and B-X
C7 B-X
: B-X
their B-X
effects B-X
in B-X
combination B-X
with B-X
other B-X
C6 B-X
and B-X
C7 B-X
deficiencies B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Combined B-X
subtotal B-X
deficiency B-X
of B-X
C6 B-X
and B-X
C7 B-X
, B-X
in B-X
which B-X
both B-X
proteins B-X
are B-X
expressed B-X
at B-X
very B-X
low B-X
levels B-X
, B-X
has B-X
been B-X
observed B-X
in B-X
homozygous B-X
form B-X
in B-X
two B-X
families B-X
. B-X
A B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
article B-X
Cumulated B-X
Index B-X
Medicus B-X
- B-X
Google B-X
Âõæ‰π¶ B-X

Combined	B-Disease
subtotal	I-Disease
deficiency	I-Disease
of	I-Disease
C6	I-Disease
and	I-Disease
C7	I-Disease
,	O
in	O
which	O
both	O
proteins	O
are	O
expressed	O
at	O
very	O
low	O
levels	O
,	O
has	O
been	O
observed	O
in	O
homozygous	O
form	O
in	O
two	O
families	O
.	O
<EOS> B-X
Complement B-X
component B-X
C7 B-X
deficiency B-X
in B-X
a B-X
Spanish B-X
family B-X
Molecular B-X
defects B-X
of B-X
the B-X
C7 B-X
gene B-X
in B-X
two B-X
patients B-X
with B-X
complement B-X
C7 B-X
deficiency B-X
- B-X
Barroso B-X
- B-X
2006 B-X
- B-X
Immunology B-X
- B-X
Wiley B-X
Online B-X
Library B-X

A	O
defect	O
at	O
the	O
5	O
splice	O
donor	O
site	O
of	O
intron	O
15	O
of	O
the	O
C6	O
gene	O
explains	O
the	O
low	O
molecular	O
weight	O
of	O
the	O
C6	O
protein	O
and	O
is	O
probably	O
responsible	O
for	O
its	O
low	O
expressed	O
concentration	O
.	O
<EOS> B-X
C6 B-X
complement B-X
C6 B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
The B-X
Aldo-Keto B-X
Reductase B-X
Superfamily B-X
and B-X
its B-X
Role B-X
in B-X
Drug B-X
Metabolism B-X
and B-X
Detoxification B-X
Reinhard B-X
W√ºrzner B-X
currently B-X
works B-X
at B-X
Medizinische B-X
Universit√§t B-X
Innsbruck B-X
. B-X

The	O
C7	O
defect	O
is	O
more	O
enigmatic	O
the	O
protein	O
is	O
of	O
normal	O
molecular	O
weight	O
,	O
low	O
circulating	O
concentration	O
,	O
and	O
altered	O
isoelectric	O
point	O
.	O
<EOS> B-X
The B-X
objective B-X
of B-X
this B-X
study B-X
was B-X
to B-X
evaluate B-X
the B-X
low B-X
weight B-X
( B-X
10-30 B-X
kDa B-X
) B-X
protein B-X
profile B-X
of B-X
bovine B-X
seminal B-X
plasma B-X
using B-X
two-dimensional B-X
polyacrylamide B-X
gel B-X
electrophoresis B-X
( B-X
2D-PAGE B-X
) B-X
and B-X
Gentamicin B-X
nucleotidyltransferase B-X
, B-X
AAD B-X
2 B-X
'' B-X
, B-X
catalyzes B-X
the B-X
transfer B-X
of B-X
a B-X
nucleotide B-X
to B-X
many B-X
aminoglycoside B-X
antibiotics B-X
, B-X
which B-X
are B-X
the B-X
drugs B-X
of B-X
choice B-X
in B-X
the B-X
treatment B-X
of B-X
gram-negative B-X
bacterial B-X
publicationslist.org B-X
, B-X
gian_marco.ghiggeri B-X
, B-X
online B-X
hosting B-X
of B-X
academic B-X
publications B-X
list B-X
, B-X
improve B-X
impact B-X
factor B-X
and B-X
citations B-X
, B-X
easier B-X
for B-X
people B-X
to B-X
cite B-X
your B-X
work B-X

An	O
Arg	O
>	O
Ser	O
codon	O
substitution	O
in	O
exon	O
11	O
is	O
the	O
only	O
molecular	O
alteration	O
within	O
the	O
mature	O
C7	O
protein	O
.	O

These	O
defects	O
are	O
associated	O
with	O
a	O
characteristic	O
set	O
of	O
polymorphic	O
DNA	O
markers	O
in	O
the	O
C6	O
/	O
C7	O
region	O
,	O
forming	O
a	O
distinct	O
haplotype	O
.	O

The	O
haplotype	O
has	O
been	O
found	O
in	O
combination	O
with	O
a	O
number	O
of	O
other	O
haplotypes	O
containing	O
defective	O
genes	O
that	O
lead	O
either	O
to	O
C6	B-Disease
or	I-Disease
C7	I-Disease
deficiency	I-Disease
,	O
but	O
with	O
different	O
consequences	O
.	O

Where	O
it	O
is	O
combined	O
with	O
a	O
C6	B-Disease
-	I-Disease
deficient	I-Disease
gene	O
,	O
the	O
serum	O
C7	O
levels	O
can	O
be	O
surprisingly	O
high	O
,	O
possibly	O
because	O
there	O
is	O
no	O
C6	O
generating	O
C56	O
to	O
consume	O
the	O
C7	O
.	O
<EOS> B-X
Molecular B-X
bases B-X
of B-X
combined B-X
subtotal B-X
deficiencies B-X
of B-X
C6 B-X
and B-X
C7 B-X
: B-X
their B-X
effects B-X
in B-X
combination B-X
with B-X
other B-X
C6 B-X
and B-X
C7 B-X
deficiencies B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Deficiencies B-X
of B-X
the B-X
complement B-X
MAC B-X
II B-X
gene B-X
cluster B-X
( B-X
C6 B-X
, B-X
C7 B-X
, B-X
C9 B-X
) B-X
: B-X
is B-X
subtotal B-X
C6 B-X
deficiency B-X
of B-X
particular B-X
evolutionary B-X
benefit B-X
? B-X
Complement B-X
component B-X
6 B-X
deficiency B-X
, B-X
C6D B-X
. B-X
C6 B-X
deficiencies B-X
are B-X
very B-X
rare B-X
genetic B-X
defects B-X
( B-X
autosomal B-X
recessive B-X
) B-X
that B-X
lead B-X
to B-X
complete B-X
or B-X
significantly B-X
diminished B-X
hepatic B-X
production B-X
of B-X
complement B-X
component B-X
Request B-X
PDF B-X
| B-X
On B-X
Jan B-X
30 B-X
, B-X
2015 B-X
, B-X
Jamal B-X
Saeedi B-X
and B-X
others B-X
published B-X
c6 B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
on B-X
ResearchGate B-X
{ B-X
{ B-X
nm.description B-X
} B-X
} B-X
217050 B-X
- B-X
COMPLEMENT B-X
COMPONENT B-X
6 B-X
; B-X
C6 B-X
- B-X
C6 B-X

In	O
contrast	O
,	O
where	O
the	O
C7	O
genes	O
are	O
both	O
defective	O
(	O
but	O
still	O
partially	O
functional	O
)	O
,	O
there	O
may	O
be	O
a	O
profound	O
deficit	O
of	O
circulating	O
C7	O
because	O
there	O
is	O
ample	O
C6	O
to	O
produce	O
C56	O
and	O
consume	O
the	O
already	O
small	O
amount	O
of	O
C7	O
.	O
<EOS> B-X
Molecular B-X
bases B-X
of B-X
combined B-X
subtotal B-X
deficiencies B-X
of B-X
C6 B-X
and B-X
C7 B-X
: B-X
their B-X
effects B-X
in B-X
combination B-X
with B-X
other B-X
C6 B-X
and B-X
C7 B-X
deficiencies B-X
. B-X
Download B-X
Citation B-X
| B-X
C7 B-X
| B-X
This B-X
chapter B-X
provides B-X
a B-X
brief B-X
description B-X
of B-X
C7 B-X
, B-X
which B-X
is B-X
synthesized B-X
as B-X
a B-X
single-chain B-X
precursor B-X
of B-X
843 B-X
amino B-X
acids B-X
including B-X
a B-X
leader B-X
peptide B-X
of B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Autoradiograph B-X
showing B-X
gene B-X
fragments B-X
from B-X
publication B-X
: B-X
The B-X
human B-X
genes B-X
for B-X
complement B-X
components B-X
6 B-X
( B-X
C6 B-X
) B-X
and B-X
9 B-X
( B-X
C9 B-X
) B-X
are B-X
closely B-X
linked B-X
on B-X
Complement B-X
component B-X
C7 B-X
deficiency B-X
in B-X
two B-X
Spanish B-X
families B-X
- B-X
Barroso B-X
- B-X
2004 B-X
- B-X
Immunology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Request B-X
PDF B-X
| B-X
The B-X
endothelium B-X
is B-X
an B-X
extrahepatic B-X
site B-X
of B-X
synthesis B-X
of B-X
the B-X
seventh B-X
component B-X
of B-X
the B-X
complement B-X
system B-X
| B-X
The B-X
level B-X
of B-X
the B-X
terminal B-X
complement B-X
components B-X
secreted B-X
by B-X
human B-X

Each	O
molecular	O
defect	O
has	O
also	O
been	O
found	O
in	O
isolation	O
and	O
has	O
the	O
expected	O
effect	O
.	O
.	O
<EOS> B-X
Molecular B-X
pathogenesis B-X
of B-X
Wilson B-X
and B-X
Menkes B-X
disease B-X
: B-X
correlation B-X
of B-X
mutations B-X
with B-X
molecular B-X
defects B-X
and B-X
disease B-X
phenotypes B-X
The B-X
Cystic B-X
Fibrosis B-X
Gene B-X
: B-X
A B-X
Molecular B-X
Genetic B-X
Perspective B-X
Ultimately B-X
, B-X
one B-X
wishes B-X
to B-X
determine B-X
how B-X
genes‚Äîand B-X
the B-X
proteins B-X
they B-X
encode‚Äîfunction B-X
in B-X
the B-X
intact B-X
organism B-X
. B-X
Although B-X
it B-X
may B-X
sound B-X
counterintuitive B-X
, B-X
one B-X
of B-X
the B-X
most B-X
direct B-X
ways B-X
to B-X
Pathogenesis B-X
, B-X
Diagnosis B-X
, B-X
and B-X
Management B-X
of B-X
Primary B-X
Antibody B-X
Deficiencies B-X
and B-X
Infections B-X
Mycobacterium B-X
tuberculosis B-X
Pathogenesis B-X
and B-X
Molecular B-X
Determinants B-X
of B-X
Virulence B-X

Genetic	O
bases	O
of	O
human	O
complement	B-Disease
C7	I-Disease
deficiency	I-Disease
.	O
<EOS> B-X
Genetic B-X
Basis B-X
of B-X
Human B-X
Complement B-X
C8Œ±-Œ≥ B-X
Deficiency B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Different B-X
genetic B-X
mutations B-X
have B-X
been B-X
described B-X
in B-X
complement B-X
component B-X
C7 B-X
deficiency B-X
, B-X
a B-X
molecular B-X
defect B-X
which B-X
is B-X
clinically B-X
associated B-X
with B-X
an B-X
increased B-X
susceptibility B-X
to B-X
neisserial B-X
recurrent B-X
infections B-X
, B-X
although B-X
some B-X
Deficiencies B-X
in B-X
terminal B-X
complement B-X
components B-X
, B-X
including B-X
the B-X
component B-X
C7 B-X
, B-X
are B-X
uncommon B-X
and B-X
associated B-X
with B-X
an B-X
increased B-X
risk B-X
of B-X
recurrent B-X
systemic B-X
neisserial B-X
infection B-X
. B-X
A B-X
total B-X
of B-X
22 B-X
molecular B-X

Complement	B-Disease
C7	I-Disease
deficiency	I-Disease
(	O
C7D	B-Disease
)	O
is	O
associated	O
frequently	O
with	O
recurrent	O
bacterial	B-Disease
infections	I-Disease
,	O
especially	O
meningitis	B-Disease
caused	O
by	O
Neisseria	B-Disease
meningitidis	I-Disease
.	O
<EOS> B-X
610102 B-X
- B-X
COMPLEMENT B-X
COMPONENT B-X
7 B-X
DEFICIENCY B-X
; B-X
C7D B-X
- B-X
C7 B-X
DEFICIENCY B-X
610102 B-X
- B-X
COMPLEMENT B-X
COMPONENT B-X
7 B-X
DEFICIENCY B-X
; B-X
C7D B-X
- B-X
C7 B-X
DEFICIENCY B-X
610102 B-X
- B-X
COMPLEMENT B-X
COMPONENT B-X
7 B-X
DEFICIENCY B-X
; B-X
C7D B-X
- B-X
C7 B-X
DEFICIENCY B-X

We	O
report	O
in	O
this	O
work	O
the	O
molecular	O
bases	O
of	O
C7D	B-Disease
in	O
two	O
unrelated	O
Japanese	O
males	O
.	O
<EOS> B-X
Professor B-X
Takahiko B-X
Horiuchi B-X
is B-X
Director/Professor B-X
and B-X
Chair B-X
of B-X
the B-X
Department B-X
of B-X
Internal B-X
Medicine B-X
at B-X
Kyushu B-X
University B-X
Beppu B-X
Hospital B-X
in B-X
Oita B-X
, B-X
Japan B-X
. B-X
Professor B-X
Horiuchi B-X
obtained B-X
his B-X
MD B-X
and B-X
DMedSc B-X

We	O
used	O
exon	O
-	O
specific	O
PCR	O
/	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
analysis	O
as	O
a	O
screening	O
step	O
for	O
mutations	O
.	O
<EOS> B-X
The B-X
identification B-X
of B-X
the B-X
specific B-X
mutation B-X
causing B-X
an B-X
inherited B-X
disease B-X
in B-X
a B-X
patient B-X
is B-X
the B-X
framework B-X
for B-X
the B-X
development B-X
of B-X
a B-X
rationale B-X
for B-X
therapy B-X
and B-X
of B-X
DNA-based B-X
tests B-X
for B-X
screening B-X
This B-X
protocol B-X
describes B-X
capillary B-X
array B-X
electrophoresis B-X
single-strand B-X
conformation B-X
polymorphism B-X
( B-X
CAE-SSCP B-X
) B-X
, B-X
a B-X
screening B-X
method B-X
for B-X
detection B-X
of B-X
unknown B-X
and B-X
previously B-X
identified B-X
mutations B-X
. B-X
The B-X
method B-X
detects B-X
98 B-X
% B-X

Subsequent	O
direct	O
sequencing	O
of	O
the	O
target	O
exons	O
identified	O
homozygous	O
mutations	O
in	O
exon	O
16	O
of	O
case	O
1	O
and	O
in	O
exon	O
15	O
of	O
case	O
2	O
.	O
<EOS> B-X
Fundoscopy-directed B-X
genetic B-X
testing B-X
to B-X
re-evaluate B-X
negative B-X
whole B-X
exome B-X
sequencing B-X
results B-X
The B-X
Use B-X
of B-X
EGFR B-X
Exon B-X
19 B-X
and B-X
21 B-X
Unlabeled B-X
DNA B-X
Probes B-X
to B-X
Screen B-X
for B-X
Activating B-X
Mutations B-X
in B-X
Non‚ÄìSmall B-X
Cell B-X
Lung B-X
Cancer B-X
Next-Generation B-X
Sequencing B-X
of B-X
Lung B-X
Cancer B-X
EGFR B-X
Exons B-X
18-21 B-X
Allows B-X
Effective B-X
Molecular B-X
Diagnosis B-X
of B-X
Small B-X
Routine B-X
Samples B-X
( B-X
Cytology B-X
and B-X
Biopsy B-X
) B-X
Next-Generation B-X
Sequencing B-X
Reveals B-X
Deep B-X
Intronic B-X
Cryptic B-X
ABCC8 B-X
and B-X
HADH B-X
Splicing B-X
Founder B-X
Mutations B-X
Causing B-X
Hyperinsulinism B-X
by B-X
Pseudoexon B-X
Activation B-X
Genomic B-X
Approaches B-X
For B-X
the B-X
Discovery B-X
of B-X
Genes B-X
Mutated B-X
in B-X
Inherited B-X
Retinal B-X
Degeneration B-X
Genetic B-X
bases B-X
of B-X
human B-X
complement B-X
C7 B-X
deficiency B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Complement B-X
C7 B-X
deficiency B-X
( B-X
C7D B-X
) B-X
is B-X
associated B-X
frequently B-X
with B-X
recurrent B-X
bacterial B-X
infections B-X
, B-X
especially B-X
meningitis B-X
caused B-X
by B-X
Neisseria B-X
meningitidis B-X
. B-X
We B-X
report B-X
in B-X
this B-X
work B-X
the B-X
molecular B-X
bases B-X
of B-X

The	O
mutation	O
of	O
case	O
1	O
was	O
a	O
homozygous	O
T	O
to	O
A	O
transversion	O
at	O
nucleotide	O
2250	O
,	O
the	O
third	O
nucleotide	O
of	O
the	O
codon	O
TGT	O
for	O
Cys728	O
,	O
leading	O
to	O
a	O
stop	O
codon	O
TGA	O
(	O
C728X	O
)	O
.	O
<EOS> B-X
Stop B-X
codons B-X
and B-X
the B-X
+4 B-X
nucleotide B-X
may B-X
influence B-X
the B-X
efficiency B-X
of B-X
G418 B-X
in B-X
rescuing B-X
nonsense B-X
mutations B-X
of B-X
the B-X
HERG B-X
gene B-X
LDLR B-X
promoter B-X
variant B-X
and B-X
exon B-X
14 B-X
mutation B-X
on B-X
the B-X
same B-X
chromosome B-X
are B-X
associated B-X
with B-X
an B-X
unusually B-X
severe B-X
FH B-X
phenotype B-X
and B-X
treatment B-X
resistance B-X
homozygous B-X
lmna B-X
mutation B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
Request B-X
PDF B-X
| B-X
Acetaminophen B-X
administration B-X
in B-X
a B-X
patient B-X
with B-X
Gilbert B-X
's B-X
syndrome B-X
| B-X
The B-X
patient B-X
was B-X
an B-X
8-year-old B-X
Japanese B-X
girl B-X
with B-X
Gilbert B-X
's B-X
syndrome B-X
( B-X
GS B-X
) B-X
. B-X
Based B-X
on B-X
Case B-X
Report B-X
: B-X
The B-X
Role B-X
of B-X
Molecular B-X
Analysis B-X
of B-X
the B-X
MUTYH B-X
Gene B-X
in B-X
Asymptomatic B-X
Individuals B-X
Abstract B-X
. B-X
Mutant B-X
mouse B-X
models B-X
are B-X
indispensable B-X
tools B-X
for B-X
clarifying B-X
the B-X
functions B-X
of B-X
genes B-X
and B-X
for B-X
elucidating B-X
the B-X
underlying B-X
pathogenic B-X
mechanisms B-X
of B-X
human B-X
di B-X
The B-X
mutation B-X
rates B-X
of B-X
EGFR B-X
in B-X
non-small B-X
cell B-X
lung B-X
cancer B-X
and B-X
KRAS B-X
in B-X
colorectal B-X
cancer B-X
of B-X
Chinese B-X
patients B-X
as B-X
detected B-X
by B-X
pyrosequencing B-X
using B-X
a B-X
novel B-X
dispensation B-X
order B-X

In	O
case	O
2	O
,	O
a	O
homozygous	O
2	O
-	O
bp	O
deletion	O
(	O
2137delTG	O
/	O
2138delGT	O
/	O
2139delTG	O
)	O
caused	O
a	O
frameshift	O
,	O
generating	O
a	O
premature	O
termination	O
codon	O
4	O
to	O
6	O
nucleotides	O
downstream	O
.	O
<EOS> B-X
The B-X
role B-X
of B-X
nucleotide B-X
composition B-X
in B-X
premature B-X
termination B-X
codon B-X
recognition B-X
Impact B-X
of B-X
the B-X
six B-X
nucleotides B-X
downstream B-X
of B-X
the B-X
stop B-X
codon B-X
on B-X
translation B-X
termination B-X
A B-X
frameshift B-X
mutation B-X
is B-X
a B-X
type B-X
of B-X
mutation B-X
involving B-X
the B-X
insertion B-X
or B-X
deletion B-X
of B-X
a B-X
nucleotide B-X
in B-X
which B-X
the B-X
number B-X
of B-X
deleted B-X
base B-X
pairs B-X
is B-X
not B-X
divisible B-X
by B-X
three B-X
. B-X
Apparent B-X
Homozygosity B-X
of B-X
a B-X
Novel B-X
Frame B-X
Shift B-X
Mutation B-X
in B-X
the B-X
CFTR B-X
Gene B-X
Because B-X
of B-X
a B-X
Large B-X
Deletion B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Schematic B-X
diagram B-X
of B-X
the B-X
molecular B-X
structure B-X
of B-X
normal B-X
C7 B-X
( B-X
adapted B-X
from B-X
Hobart B-X
et B-X
al B-X
. B-X
1995 B-X
with B-X
permission B-X
) B-X
and B-X
the B-X
position B-X
of B-X
mutations B-X
described B-X
Therapeutic B-X
suppression B-X
of B-X
premature B-X
termination B-X
codons B-X
: B-X
Mechanisms B-X
and B-X
clinical B-X
considerations B-X
( B-X
Review B-X
) B-X
Eukaryotic B-X
translational B-X
termination B-X
efficiency B-X
is B-X
influenced B-X
by B-X
the B-X
3‚Ä≤ B-X
nucleotides B-X
within B-X
the B-X
ribosomal B-X
mRNA B-X
channel B-X

Family	O
study	O
in	O
case	O
1	O
confirmed	O
the	O
genetic	O
nature	O
of	O
the	O
defect	O
.	O
<EOS> B-X
Decades B-X
of B-X
research B-X
show B-X
that B-X
genes B-X
play B-X
an B-X
vital B-X
role B-X
in B-X
the B-X
etiology B-X
of B-X
attention B-X
deficit B-X
hyperactivity B-X
disorder B-X
( B-X
ADHD B-X
) B-X
and B-X
its B-X
comorbidity B-X
with B-X
other B-X
disorders B-X
. B-X
Family B-X
, B-X
Oral B-X
squamous B-X
cell B-X
carcinoma B-X
( B-X
OSCC B-X
) B-X
is B-X
a B-X
common B-X
subtype B-X
of B-X
head B-X
and B-X
neck B-X
squamous B-X
cell B-X
carcinoma B-X
( B-X
HNSCC B-X
) B-X
, B-X
but B-X
the B-X
pathogenesis B-X
underlying B-X
familial B-X
OSCCs B-X
is B-X
unknown B-X
The B-X
etiology B-X
of B-X
congenital B-X
heart B-X
defect B-X
( B-X
CHD B-X
) B-X
combines B-X
environmental B-X
and B-X
genetic B-X
factors B-X
. B-X
So B-X
far B-X
, B-X
there B-X
were B-X
studies B-X
reporting B-X
on B-X
the B-X
screening B-X
of B-X
a B-X
single B-X
gene B-X
on B-X
Understanding B-X
how B-X
human B-X
genetics B-X
influence B-X
infectious B-X
disease B-X
susceptibility B-X
offers B-X
the B-X
opportunity B-X
for B-X
new B-X
insights B-X
into B-X
pathogenesis B-X
, B-X
potential B-X
drug B-X
targets B-X
, B-X
risk B-X
stratification B-X
, B-X
response B-X
to B-X
therapy B-X
and B-X
vaccination B-X
. B-X
Autism B-X
Spectrum B-X
Disorder B-X
( B-X
ASD B-X
) B-X
is B-X
a B-X
complex B-X
neurodevelopmental B-X
disorder B-X
with B-X
a B-X
strong B-X
genetic B-X
component B-X
. B-X
Although B-X
next-generation B-X
sequencing B-X
( B-X
NGS B-X
) B-X
technologies B-X
have B-X
been B-X
successfully B-X
applied B-X
to B-X
gene B-X
Ocular B-X
coloboma B-X
is B-X
a B-X
common B-X
eye B-X
malformation B-X
arising B-X
from B-X
incomplete B-X
closure B-X
of B-X
the B-X
human B-X
optic B-X
fissure B-X
during B-X
development B-X
. B-X
Multiple B-X
genetic B-X
mutations B-X
contribute B-X
to B-X
the B-X
disease B-X
process B-X
, B-X
showing B-X
extensive B-X
Purpose B-X
: B-X
To B-X
assess B-X
usefulness B-X
of B-X
family B-X
history B-X
information B-X
obtained B-X
in B-X
pediatric B-X
practice B-X
, B-X
we B-X
evaluated B-X
maternally B-X
reported B-X
family B-X
history B-X
data B-X
. B-X
Methods B-X
: B-X
We B-X
analyzed B-X
family B-X
history B-X
responses B-X
from B-X

Moreover	O
,	O
we	O
detected	O
a	O
novel	O
polymorphism	O
in	O
intron	O
11	O
that	O
presumably	O
is	O
linked	O
to	O
the	O
mutation	O
responsible	O
for	O
C7D	B-Disease
in	O
case	O
1	O
.	O
<EOS> B-X
A B-X
missense B-X
mutation B-X
in B-X
exon B-X
11 B-X
of B-X
the B-X
WKL1 B-X
gene B-X
on B-X
chromosome B-X
22 B-X
was B-X
found B-X
to B-X
be B-X
associated B-X
with B-X
cases B-X
of B-X
catatonic B-X
schizophrenia B-X
in B-X
a B-X
single B-X
large B-X
pedigree B-X
. B-X
We B-X
Genetic B-X
Bases B-X
of B-X
Human B-X
Complement B-X
C7 B-X
Deficiency B-X
‚Äî B-X
Kyushu B-X
University B-X
Genetic B-X
Bases B-X
of B-X
Human B-X
Complement B-X
C7 B-X
Deficiency B-X
‚Äî B-X
‰πùÂ∑ûÂ§ßÂ≠¶ B-X

Our	O
results	O
indicate	O
that	O
the	O
pathogenesis	O
of	O
C7D	B-Disease
is	O
heterogeneous	O
like	O
most	O
of	O
the	O
other	O
deficiencies	B-Disease
of	I-Disease
complement	I-Disease
components	I-Disease
.	O
.	O
<EOS> B-X
PDF B-X
| B-X
Deficiency B-X
of B-X
the B-X
seventh B-X
component B-X
of B-X
complement B-X
( B-X
C7D B-X
) B-X
is B-X
frequently B-X
associated B-X
with B-X
recurrent B-X
neisserial B-X
infections B-X
. B-X
We B-X
report B-X
in B-X
the B-X
present B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Clinical B-X
and B-X
Genetic B-X
Spectrum B-X
of B-X
a B-X
Large B-X
Cohort B-X
With B-X
Total B-X
and B-X
Sub-total B-X
Complement B-X
Deficiencies B-X
PDF B-X
| B-X
Deficiency B-X
of B-X
the B-X
sixth B-X
component B-X
of B-X
complement B-X
( B-X
C6D B-X
) B-X
is B-X
frequently B-X
associated B-X
with B-X
recurrent B-X
neisserial B-X
infections B-X
, B-X
especially B-X
meningitis B-X
caused B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Request B-X
PDF B-X
| B-X
Complement B-X
component B-X
C7 B-X
deficiency B-X
in B-X
a B-X
Spanish B-X
family B-X
| B-X
Different B-X
genetic B-X
mutations B-X
have B-X
been B-X
described B-X
in B-X
complement B-X
component B-X
C7 B-X
deficiency B-X
, B-X
a B-X
molecular B-X
defect B-X
which B-X
is B-X
clinically B-X
Request B-X
PDF B-X
| B-X
Complement B-X
component B-X
C7 B-X
deficiency B-X
in B-X
two B-X
Spanish B-X
families B-X
| B-X
Different B-X
genetic B-X
mutations B-X
have B-X
been B-X
described B-X
in B-X
complement B-X
component B-X
C7 B-X
deficiency B-X
, B-X
a B-X
molecular B-X
defect B-X
clinically B-X
associated B-X
with B-X

HPRT	B-Disease
-	I-Disease
APRT	I-Disease
-	I-Disease
deficient	I-Disease
mice	O
are	O
not	O
a	O
model	O
for	O
lesch	B-Disease
-	I-Disease
nyhan	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
Complete B-X
hypoxanthine-guanine B-X
phosphoribosyl-transferase B-X
( B-X
HPRT B-X
) B-X
deficiency B-X
in B-X
humans B-X
results B-X
in B-X
the B-X
Lesch-Nyhan B-X
syndrome B-X
which B-X
is B-X
characterized B-X
, B-X
among B-X
other B-X
features B-X
, B-X
by B-X
compulsive B-X
self-injurious B-X
behavior B-X
. B-X
HPRT-deficient B-X
mice B-X
generated B-X
Two B-X
transgenic B-X
strains B-X
of B-X
mutant B-X
mice B-X
lacking B-X
hypoxanthine-guanidine B-X
phosphoribosyltransferase B-X
( B-X
HPRT B-X
) B-X
activity B-X
were B-X
examined B-X
behaviorally B-X
and B-X
neurochemically B-X
for B-X
phenotypic B-X
similarity B-X
to B-X
the B-X
human B-X
Lesch-Nyhan B-X
syndrome B-X
. B-X
In B-X
this B-X
syndrome B-X
Complete B-X
hypoxanthine-guanine B-X
phosphoribosyl-transferase B-X
( B-X
HPRT B-X
) B-X
deficiency B-X
in B-X
humans B-X
results B-X
in B-X
the B-X
Lesch-Nyhan B-X
syndrome B-X
which B-X
is B-X
characterized B-X
, B-X
among B-X
other B-X
features B-X
, B-X
by B-X
compulsive B-X
self-injurious B-X
behavior B-X
. B-X
HPRT-deficient B-X
mice B-X
generated B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Complete	B-Disease
hypoxanthine	I-Disease
-	I-Disease
guanine	I-Disease
phosphoribosyl	I-Disease
-	I-Disease
transferase	I-Disease
(	I-Disease
HPRT	I-Disease
)	I-Disease
deficiency	I-Disease
in	O
humans	O
results	O
in	O
the	O
Lesch	B-Disease
-	I-Disease
Nyhan	I-Disease
syndrome	I-Disease
which	O
is	O
characterized	O
,	O
among	O
other	O
features	O
,	O
by	O
compulsive	O
self	O
-	O
injurious	O
behavior	O
.	O
<EOS> B-X
The B-X
Lesch-Nyhan B-X
syndrome B-X
results B-X
from B-X
a B-X
complete B-X
or B-X
virtually B-X
complete B-X
deficiency B-X
of B-X
the B-X
purine B-X
salvage B-X
enzyme B-X
, B-X
hypoxanthine B-X
guanine B-X
phosphoribosyl B-X
transferase B-X
( B-X
HPRT B-X
) B-X
. B-X
The B-X
disease B-X
is B-X
characterized B-X
by B-X
Lesch-Nyhan B-X
disease B-X
( B-X
LND B-X
) B-X
, B-X
caused B-X
by B-X
complete B-X
deficiency B-X
of B-X
hypoxanthine B-X
guanine B-X
phosphoribosyltransferase B-X
( B-X
HPRT B-X
) B-X
, B-X
is B-X
characterized B-X
by B-X
a B-X
neurological B-X
deficit B-X
, B-X
the B-X
etiology B-X
of B-X
which B-X
is B-X
Researchers B-X
have B-X
argued B-X
that B-X
individuals B-X
who B-X
show B-X
self-restraint B-X
are B-X
more B-X
likely B-X
to B-X
show B-X
self-injurious B-X
behavior B-X
( B-X
SIB B-X
) B-X
that B-X
is B-X
compulsive B-X
. B-X
Self-injurious B-X
behavior B-X
, B-X
self-restraint B-X
, B-X
and B-X
compulsive B-X
behaviors B-X
A B-X
specific B-X
link B-X
between B-X
self-injurious B-X
behavior B-X
and B-X
bulimia B-X
nervosa B-X
has B-X
been B-X
observed B-X
. B-X
In B-X
affective B-X
spectrum B-X
disorders B-X
, B-X
some B-X
authors B-X
propose B-X
a B-X
distinction B-X
between B-X
impulsive B-X
and B-X
compulsive B-X
self-injurious B-X
behavior B-X
. B-X
Self-injurious B-X
behaviors B-X
are B-X
common B-X
among B-X
young B-X
women B-X
. B-X
There B-X
is B-X
a B-X
significant B-X
association B-X
between B-X
SIBs B-X
and B-X
other B-X
forms B-X
of B-X
direct B-X
and B-X
indirect B-X
self-damaging B-X
behaviors B-X
, B-X
including B-X
alcohol B-X
abuse B-X
, B-X
use B-X
Self-injurious B-X
skin B-X
picking B-X
is B-X
a B-X
severe B-X
and B-X
chronic B-X
psychiatric B-X
and B-X
dermatologic B-X
problem B-X
associated B-X
with B-X
high B-X
rates B-X
of B-X
psychiatric B-X
comorbidity B-X
. B-X
It B-X
may B-X
be B-X
conceptualized B-X
as B-X
a B-X
variant B-X
of B-X
OCD B-X
or B-X
Should B-X
Non-Suicidal B-X
Self-Injury B-X
Be B-X
A B-X
Putative B-X
Obsessive-Compulsive B-X
Related B-X
Condition B-X
? B-X
A B-X
Critical B-X
Appraisal B-X

HPRT	B-Disease
-	I-Disease
deficient	I-Disease
mice	O
generated	O
using	O
mouse	O
embryonic	O
stem	O
cells	O
exhibit	O
none	O
of	O
the	O
behavioral	O
symptoms	O
associated	O
with	O
the	O
Lesch	B-Disease
-	I-Disease
Nyhan	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
Rescuing B-X
compounds B-X
for B-X
Lesch-Nyhan B-X
disease B-X
identified B-X
using B-X
stem B-X
cell‚Äìbased B-X
phenotypic B-X
screening B-X
Abstract B-X
. B-X
Complete B-X
hypoxanthine-guanine B-X
phosphoribosyl-transferase B-X
( B-X
HPRT B-X
) B-X
deficiency B-X
in B-X
humans B-X
results B-X
in B-X
the B-X
Lesch-Nyhan B-X
syndrome B-X
which B-X
is B-X
characterized B-X
, B-X
among B-X
We B-X
established B-X
rat B-X
embryonic B-X
stem B-X
( B-X
ES B-X
) B-X
cell B-X
lines B-X
from B-X
a B-X
double B-X
transgenic B-X
rat B-X
line B-X
which B-X
harbours B-X
CAG-GFP B-X
for B-X
ubiquitous B-X
expression B-X
of B-X
GFP B-X
in B-X
somatic B-X
cells B-X
and B-X
Acr3-EGFP B-X
for B-X

Administration	O
of	O
drugs	O
that	O
inhibit	O
adenine	O
phosphoribosyltransferase	O
(	O
APRT	O
)	O
in	O
HPRT	B-Disease
-	I-Disease
deficient	I-Disease
mice	O
has	O
produced	O
the	O
suggestion	O
that	O
deficiency	B-Disease
of	I-Disease
APRT	I-Disease
in	O
combination	O
with	O
HPRT	B-Disease
-	I-Disease
deficiency	I-Disease
in	O
mice	O
may	O
lead	O
to	O
self	O
-	O
mutilation	O
behavior	O
[	O
C	O
.	O
L	O
.	O
Wu	O
and	O
D	O
.	O
W	O
.	O
Melton	O
(	O
1993	O
)	O
Nature	O
Genet	O
.	O
3	O
,	O
235	O
-	O
240	O
]	O
.	O
<EOS> B-X
Hypoxanthine-guanine B-X
phosphoribosyl-transferase B-X
( B-X
HPRT B-X
) B-X
deficiency B-X
is B-X
the B-X
cause B-X
of B-X
Lesch-Nyhan B-X
disease B-X
. B-X
Adenine B-X
phosphoribosyl-transferase B-X
( B-X
APRT B-X
) B-X
deficiency B-X
causes B-X
renal B-X
calculi B-X
. B-X
The B-X
activity B-X
of B-X
each B-X
enzyme B-X
is B-X
readily B-X
Correction B-X
of B-X
liver B-X
dysfunction B-X
in B-X
DNA B-X
repair-deficient B-X
mice B-X
with B-X
an B-X
ERCC1 B-X
transgene B-X
Adenine B-X
Phosphoribosyltransferase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
The B-X
ability B-X
to B-X
reduce B-X
the B-X
expression B-X
of B-X
specific B-X
genes B-X
by B-X
inhibiting B-X
their B-X
expression B-X
directly B-X
or B-X
by B-X
interfering B-X
with B-X
the B-X
gene B-X
product B-X
is B-X
desirable B-X
for B-X
both B-X
therapeutic B-X
and B-X
experimental B-X
reasons B-X
. B-X
How B-X
relevant B-X
are B-X
mouse B-X
models B-X
for B-X
human B-X
diseases B-X
to B-X
somatic B-X
gene B-X
therapy B-X
? B-X
- B-X
ScienceDirect B-X
Transgenic B-X
animals B-X
as B-X
pharmacological B-X
tools B-X
- B-X
ScienceDirect B-X
Four B-X
distinct B-X
DMA B-X
ligase B-X
activities B-X
( B-X
I-IV B-X
) B-X
have B-X
been B-X
identified B-X
within B-X
mammalian B-X
cells1‚Äì3 B-X
. B-X
Evidence B-X
has B-X
indicated B-X
that B-X
DNA B-X
ligase B-X
I B-X
is B-X
central B-X
to B-X
DMA B-X
replication4‚Äì7 B-X
, B-X
as B-X
well B-X

To	O
test	O
this	O
proposition	O
,	O
we	O
bred	O
HPRT	B-Disease
-	I-Disease
APRT	I-Disease
-	I-Disease
deficient	I-Disease
mice	O
.	O

Although	O
the	O
doubly	O
-	O
deficient	O
mice	O
excrete	O
adenine	O
and	O
its	O
highly	O
insoluble	O
derivative	O
,	O
2	O
,	O
8	O
-	O
dihydroxyadenine	O
,	O
which	O
are	O
also	O
associated	O
with	O
human	O
APRT	B-Disease
deficiency	I-Disease
,	O
additional	O
abnormalities	O
or	O
any	O
self	O
-	O
injurious	O
behavior	O
were	O
not	O
detected	O
.	O
<EOS> B-X
HPRT-APRT-deficient B-X
mice B-X
are B-X
not B-X
a B-X
model B-X
for B-X
lesch-nyhan B-X
syndrome B-X
. B-X
Clinical B-X
and B-X
theoretical B-X
issues B-X
in B-X
self-injurious B-X
behavior B-X
2,8-Dihydroxyadenine B-X
( B-X
2,8-DHA B-X
) B-X
urolithiasis B-X
in B-X
people B-X
is B-X
caused B-X
by B-X
autosomal B-X
recessive B-X
mutations B-X
in B-X
the B-X
adenine B-X
phosphoribosyltransferase B-X
gene B-X
( B-X
APRT B-X
) B-X
. B-X
2,8-DHA B-X
urolithiasis B-X
has B-X
recently B-X
been B-X
reported B-X
in B-X
two B-X
Self-injurious B-X
behavior B-X
: B-X
A B-X
clinical B-X
appraisal B-X
We B-X
have B-X
studied B-X
adenine B-X
phosphoribosyltransferase B-X
( B-X
APRT B-X
) B-X
in B-X
the B-X
hemolysates B-X
from B-X
the B-X
families B-X
of B-X
2,8-dihydroxyadenine B-X
urolithiasis B-X
associated B-X
with B-X
partial B-X
deficiency B-X
of B-X
APRT B-X
( B-X
the B-X
Japanese B-X
type B-X
) B-X
and B-X
complete B-X
2,8-Dihydroxyadenine B-X
lithiasis B-X
in B-X
a B-X
Japanese B-X
patient B-X
heterozygous B-X
at B-X
the B-X
adenine B-X
phosphoribosyltransferase B-X
locus B-X
. B-X
The B-X
behavior B-X
of B-X
this B-X
patient B-X
is B-X
nonsuicidal B-X
self-injury B-X
, B-X
defined B-X
as B-X
the B-X
intended B-X
destruction B-X
of B-X
body B-X
tissue B-X
without B-X
suicidal B-X
intent B-X
. B-X
Nonsuicidal B-X
self-injury B-X
is B-X
a B-X
common B-X
biopsychosocial B-X
disorder B-X
observed B-X
in B-X

Thus	O
,	O
APRT	B-Disease
-	I-Disease
HPRT	I-Disease
-	I-Disease
deficient	I-Disease
mice	O
,	O
which	O
are	O
devoid	O
of	O
any	O
purine	O
salvage	O
pathways	O
,	O
show	O
no	O
novel	O
phenotype	O
and	O
are	O
not	O
a	O
model	O
for	O
the	O
behavioral	B-Disease
abnormalities	I-Disease
associated	O
with	O
the	O
Lesch	B-Disease
-	I-Disease
Nyhan	I-Disease
syndrome	I-Disease
as	O
previously	O
suggested	O
<EOS> B-X
NAD B-X
metabolism B-X
in B-X
HPRT-deficient B-X
mice B-X
Consequences B-X
of B-X
Impaired B-X
Purine B-X
Recycling B-X
on B-X
the B-X
Proteome B-X
in B-X
a B-X
Cellular B-X
Model B-X
of B-X
Lesch-Nyhan B-X
Disease B-X
Brain B-X
white B-X
matter B-X
volume B-X
abnormalities B-X
in B-X
Lesch-Nyhan B-X
disease B-X
and B-X
its B-X
variants B-X
The B-X
mTORC1 B-X
signaling B-X
network B-X
senses B-X
changes B-X
in B-X
cellular B-X
purine B-X
nucleotide B-X
levels B-X
Hypoxanthine-guanine B-X
phosphoribosyl B-X
transferase B-X
regulates B-X
early B-X
developmental B-X
programming B-X
of B-X
dopamine B-X
neurons B-X
: B-X
implications B-X
for B-X
Lesch-Nyhan B-X
disease B-X
pathogenesis B-X
WikiGenes B-X
- B-X

Somatic	O
alterations	O
of	O
the	O
DPC4	O
gene	O
in	O
human	O
colorectal	B-Disease
cancers	I-Disease
in	O
vivo	O
.	O
<EOS> B-X
Somatic B-X
alterations B-X
of B-X
the B-X
DPC4 B-X
gene B-X
in B-X
human B-X
colorectal B-X
cancers B-X
in B-X
vivo B-X
- B-X
Gastroenterology B-X
Somatic B-X
alterations B-X
of B-X
the B-X
DPC4 B-X
gene B-X
in B-X
human B-X
colorectal B-X
cancers B-X
in B-X
vivo B-X
- B-X
Gastroenterology B-X
Somatic B-X
alterations B-X
of B-X
the B-X
SMAD-2 B-X
gene B-X
in B-X
human B-X
colorectal B-X
cancers B-X
. B-X
The B-X
DPC4 B-X
and B-X
Madr2 B-X
genes B-X
are B-X
located B-X
at B-X
18q21 B-X
, B-X
and B-X
the B-X
LOH B-X
on B-X
chromosome B-X
18q21 B-X
has B-X
been B-X
shown B-X
to B-X
occur B-X
frequently B-X
in B-X
colorectal B-X
cancers B-X
. B-X
To B-X
investigate B-X
the B-X
role B-X
The B-X
molecular B-X
characteristics B-X
of B-X
colorectal B-X
cancer B-X
: B-X
Implications B-X
for B-X
diagnosis B-X
and B-X
therapy B-X
( B-X
Review B-X
) B-X
The B-X
DPC4 B-X
gene B-X
may B-X
play B-X
a B-X
role B-X
as B-X
a B-X
tumor-suppressor B-X
gene B-X
in B-X
a B-X
fraction B-X
of B-X
colorectal B-X
cancers B-X
; B-X
however B-X
, B-X
while B-X
allelic B-X
loss B-X
at B-X
18q21 B-X
is B-X
very B-X
often B-X
seen B-X
in B-X
BACKGROUND B-X
& B-X
AIMS B-X
The B-X
chromosome B-X
region B-X
18q21 B-X
has B-X
been B-X
shown B-X
to B-X
be B-X
frequently B-X
deleted B-X
in B-X
colorectal B-X
cancers B-X
, B-X
and B-X
such B-X
frequent B-X
allelic B-X
loss B-X
is B-X
a B-X
hallmark B-X
of B-X
the B-X
presence B-X
of B-X

BACKGROUND	O
&	O
AIMS	O
The	O
chromosome	O
region	O
18q21	O
has	O
been	O
shown	O
to	O
be	O
frequently	O
deleted	O
in	O
colorectal	B-Disease
cancers	I-Disease
,	O
and	O
such	O
frequent	O
allelic	O
loss	O
is	O
a	O
hallmark	O
of	O
the	O
presence	O
of	O
a	O
tumor	O
-	O
suppressor	O
gene	O
.	O
<EOS> B-X
Loss B-X
of B-X
heterozygosity B-X
at B-X
particular B-X
chromosomal B-X
loci B-X
in B-X
the B-X
tumor B-X
cell B-X
, B-X
as B-X
evidenced B-X
by B-X
restriction B-X
fragment B-X
length B-X
polymorphism B-X
analysis B-X
, B-X
has B-X
been B-X
taken B-X
as B-X
a B-X
hallmark B-X
of B-X
the B-X
presence B-X
Frequent B-X
allelic B-X
imbalance B-X
suggests B-X
involvement B-X
of B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
at B-X
1p36 B-X
in B-X
the B-X
pathogenesis B-X
of B-X
human B-X
lung B-X
cancers B-X
- B-X
Nomoto B-X
- B-X
2000 B-X
- B-X
Genes B-X
, B-X
Chromosomes B-X
and B-X
Cancer B-X
- B-X
Analysis B-X
of B-X
loss B-X
of B-X
heterozygosity B-X
on B-X
chromosomes B-X
10q B-X
, B-X
11 B-X
, B-X
and B-X
16 B-X
in B-X
medulloblastomas B-X
in B-X
: B-X
Journal B-X
of B-X
Neurosurgery B-X
Volume B-X
94 B-X
Issue B-X
5 B-X
( B-X
2001 B-X
) B-X
CSS B-X
background-position B-X
property B-X
Loss B-X
of B-X
heterozygosity B-X
is B-X
commonly B-X
assumed B-X
to B-X
be B-X
due B-X
to B-X
deletion B-X
of B-X
the B-X
appropriate B-X
genomic B-X
region B-X
in B-X
one B-X
chromosome B-X
within B-X
a B-X
neoplastic B-X
cell B-X
but B-X
may B-X
be B-X
due B-X
to B-X
other B-X
mechanisms B-X
pRB B-X
, B-X
a B-X
Tumor B-X
Suppressor B-X
with B-X
a B-X
Stabilizing B-X
Presence B-X
CSS B-X
Multiple B-X
Backgrounds B-X

The	O
DPC4	O
gene	O
,	O
which	O
is	O
located	O
at	O
18q21	O
,	O
has	O
been	O
identified	O
as	O
a	O
tumor	O
-	O
suppressor	O
gene	O
from	O
examination	O
of	O
pancreatic	B-Disease
cancers	I-Disease
.	O
<EOS> B-X
Loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
) B-X
of B-X
loci B-X
on B-X
chromosome B-X
18q B-X
occurs B-X
in B-X
a B-X
majority B-X
of B-X
colorectal B-X
cancers B-X
. B-X
The B-X
DPC4/SMAD4 B-X
gene B-X
, B-X
lying B-X
in B-X
close B-X
proximity B-X
to B-X
the B-X
DCC B-X
The B-X
18q21 B-X
region B-X
in B-X
colorectal B-X
and B-X
pancreatic B-X
cancer B-X
: B-X
independent B-X
loss B-X
of B-X
DCC B-X
and B-X
DPC4 B-X
expression B-X
- B-X
ScienceDirect B-X
Loss B-X
of B-X
DPC4 B-X
expression B-X
and B-X
its B-X
correlation B-X
with B-X
clinicopathological B-X
parameters B-X
in B-X
pancreatic B-X
carcinoma B-X
SMAD4/DPC4 B-X
and B-X
Pancreatic B-X
Cancer B-X
Survival B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Loss B-X
of B-X
Dpc4 B-X
Expression B-X
in B-X
Colonic B-X
Adenocarcinomas B-X
Correlates B-X
with B-X
the B-X
Presence B-X
of B-X
Metastatic B-X
Disease B-X
Immunohistochemical B-X
Labeling B-X
for B-X
Dpc4 B-X
Mirrors B-X
Genetic B-X
Status B-X
in B-X
Pancreatic B-X
Adenocarcinomas B-X
The B-X
K-ras B-X
oncogene B-X
is B-X
activated B-X
in B-X
approximately B-X
90 B-X
% B-X
of B-X
pancreatic B-X
adenocarcinomas B-X
, B-X
and B-X
the B-X
DPC4 B-X
( B-X
MADH4/SMAD4 B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
is B-X
inactivated B-X
in B-X
approximately B-X
55 B-X
% B-X
of B-X
pancreatic B-X

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
if	O
it	O
might	O
also	O
be	O
altered	O
in	O
colorectal	B-Disease
cancers	I-Disease
.	O
<EOS> B-X
Altered B-X
ARID1A B-X
expression B-X
in B-X
colorectal B-X
cancer B-X
Altered B-X
JS‚Äê2 B-X
expression B-X
in B-X
colorectal B-X
cancers B-X
and B-X
its B-X
clinical B-X
pathological B-X
relevance B-X
Primary B-X
Prevention B-X
of B-X
Colorectal B-X
Cancer B-X
Research B-X
into B-X
causes B-X
, B-X
prevention B-X
and B-X
treatment B-X
of B-X
colorectal B-X
cancer B-X
is B-X
ongoing B-X
in B-X
many B-X
medical B-X
centers B-X
throughout B-X
the B-X
world B-X
. B-X
Find B-X
out B-X
what B-X
's B-X
new B-X
here B-X
. B-X
Some B-X
colorectal B-X
screening B-X
tests B-X
mainly B-X
look B-X
for B-X
cancer B-X
, B-X
while B-X
others B-X
can B-X
find B-X
both B-X
polyps B-X
and B-X
cancer B-X
. B-X
Learn B-X
about B-X
the B-X
different B-X
types B-X
of B-X
screening B-X
tests B-X
here B-X
. B-X
Biomarkers B-X
in B-X
colorectal B-X
cancer B-X
: B-X
Current B-X
clinical B-X
utility B-X
and B-X
future B-X
perspectives B-X
Association B-X
of B-X
adherence B-X
to B-X
lifestyle B-X
recommendations B-X
and B-X
risk B-X
of B-X
colorectal B-X
cancer B-X
: B-X
a B-X
prospective B-X
Danish B-X
cohort B-X
study B-X
| B-X
The B-X
BMJ B-X

METHODS	O
Mutation	O
analyses	O
of	O
the	O
DPC4	O
gene	O
were	O
performed	O
on	O
complementary	O
DNA	O
samples	O
from	O
31	O
primary	O
colorectal	B-Disease
cancer	I-Disease
specimens	O
using	O
a	O
combination	O
of	O
polymerase	O
chain	O
reaction	O
,	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
,	O
and	O
DNA	O
sequencing	O
.	O
<EOS> B-X
Single-stranded B-X
conformation B-X
polymorphism B-X
( B-X
SSCP B-X
) B-X
analysis B-X
is B-X
a B-X
widely B-X
used B-X
screening B-X
method B-X
that B-X
allows B-X
you B-X
to B-X
identify B-X
different B-X
genomic B-X
variants B-X
in B-X
a B-X
large B-X
number B-X
of B-X
samples B-X
and B-X
in B-X
a B-X
Single-strand B-X
conformation B-X
polymorphism B-X
- B-X
Wikipedia B-X
Molecular B-X
genetic B-X
alterations B-X
in B-X
hamartomatous B-X
polyps B-X
and B-X
carcinomas B-X
of B-X
patients B-X
with B-X
Peutz-Jeghers B-X
syndrome B-X
| B-X
Journal B-X
of B-X
Clinical B-X
Pathology B-X

RESULTS	O
Four	O
missense	O
mutations	O
producing	O
amino	O
acid	O
substitutions	O
and	O
a	O
somatic	O
12	O
-	O
base	O
pair	O
deletion	O
in	O
the	O
coding	O
region	O
of	O
the	O
DPC4	O
gene	O
were	O
detected	O
in	O
the	O
31	O
cancers	B-Disease
(	O
16	O
%	O
;	O
5	O
of	O
31	O
)	O
.	O
<EOS> B-X
Somatic B-X
alterations B-X
of B-X
the B-X
DPC4 B-X
gene B-X
in B-X
human B-X
colorectal B-X
cancers B-X
in B-X
vivo B-X
- B-X
ScienceDirect B-X
The B-X
role B-X
of B-X
somatic B-X
mutation B-X
in B-X
cancer B-X
is B-X
well B-X
established B-X
and B-X
several B-X
genes B-X
have B-X
been B-X
identified B-X
that B-X
are B-X
frequent B-X
targets B-X
. B-X
This B-X
has B-X
enabled B-X
large-scale B-X
screening B-X
studies B-X
of B-X
the B-X
spectrum B-X
Request B-X
PDF B-X
| B-X
Status B-X
of B-X
the B-X
DPC4 B-X
tumor B-X
suppressor B-X
gene B-X
in B-X
sporadic B-X
colon B-X
adenocarcinoma B-X
of B-X
Croatian B-X
patients B-X
: B-X
Identification B-X
of B-X
a B-X
novel B-X
somatic B-X
mutation B-X
| B-X
Loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
SMAD4 B-X
Somatic B-X
Mutations B-X
in B-X
Head B-X
and B-X
Neck B-X
Carcinoma B-X
Are B-X
Associated B-X
With B-X
Tumor B-X
Progression B-X
The B-X
present B-X
invention B-X
relates B-X
generally B-X
to B-X
the B-X
field B-X
of B-X
human B-X
genetics B-X
. B-X
Specifically B-X
, B-X
the B-X
present B-X
invention B-X
relates B-X
to B-X
methods B-X
and B-X
materials B-X
used B-X
to B-X
isolate B-X
and B-X
detect B-X
a B-X
human B-X
breast B-X
KRAS B-X
KRAS B-X
proto-oncogene B-X
, B-X
GTPase B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Solution B-X
to B-X
5 B-X
out B-X
of B-X
31 B-X
as B-X
percentage B-X
. B-X
Step-by-step B-X
we B-X
show B-X
work B-X
to B-X
find B-X
5 B-X
out B-X
of B-X
31 B-X
as B-X
percentage B-X
. B-X
What B-X
is B-X
5 B-X
out B-X
of B-X
31 B-X
as B-X
a B-X

CONCLUSIONS	O
The	O
DPC4	O
gene	O
may	O
play	O
a	O
role	O
as	O
a	O
tumor	O
-	O
suppressor	O
gene	O
in	O
a	O
fraction	O
of	O
colorectal	B-Disease
cancers	I-Disease
;	O
however	O
,	O
while	O
allelic	O
loss	O
at	O
18q21	O
is	O
very	O
often	O
seen	O
in	O
colorectal	B-Disease
cancers	I-Disease
,	O
only	O
a	O
minority	O
show	O
DPC4	O
mutations	O
,	O
suggesting	O
that	O
there	O
might	O
be	O
another	O
tumor	O
-	O
suppressor	O
gene	O
in	O
this	O
chromosome	O
region	O
.	O
.	O
<EOS> B-X
Frequent B-X
loss B-X
of B-X
SMAD4/DPC4 B-X
protein B-X
in B-X
colorectal B-X
cancers B-X
SMAD4 B-X
mutations B-X
in B-X
colorectal B-X
cancer B-X
probably B-X
occur B-X
before B-X
chromosomal B-X
instability B-X
, B-X
but B-X
after B-X
divergence B-X
of B-X
the B-X
microsatellite B-X
instability B-X
pathway B-X
Request B-X
PDF B-X
| B-X
Role B-X
of B-X
Smad4 B-X
( B-X
DPC4 B-X
) B-X
inactivation B-X
in B-X
human B-X
cancer B-X
| B-X
The B-X
tumor B-X
suppressor B-X
gene B-X
Smad4 B-X
( B-X
DPC4 B-X
) B-X
at B-X
chromosome B-X
18q21.1 B-X
belongs B-X
to B-X
the B-X
Smad B-X
family B-X
The B-X
molecular B-X
characteristics B-X
of B-X
colorectal B-X
cancer B-X
: B-X
Implications B-X
for B-X
diagnosis B-X
and B-X
therapy B-X
Genetics B-X
, B-X
Cytogenetics B-X
, B-X
and B-X
Epigenetics B-X
of B-X
Colorectal B-X
Cancer B-X
Abstract B-X
. B-X
BACKGROUND B-X
: B-X
Microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
and B-X
allelic B-X
imbalance B-X
involving B-X
chromosome B-X
arms B-X
5q B-X
, B-X
8p B-X
, B-X
17p B-X
, B-X
and B-X
18q B-X
are B-X
genetic B-X
alterations B-X
commonly B-X
fou B-X
Request B-X
PDF B-X
| B-X
ITF-2 B-X
Is B-X
Disrupted B-X
via B-X
Allelic B-X
Loss B-X
of B-X
Chromosome B-X
18q21 B-X
, B-X
and B-X
ITF-2B B-X
Expression B-X
Is B-X
Lost B-X
at B-X
the B-X
Adenoma-Carcinoma B-X
Transition B-X
| B-X
The B-X
ubiquitously B-X
expressed B-X
basic B-X
helix-loop-helix B-X
transcription B-X
factor B-X

Pleiotropic	O
defects	O
in	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
protein	O
-	O
deficient	O
mice	O
.	O
<EOS> B-X
A B-X
murine B-X
model B-X
of B-X
ataxia B-X
telangiectasia B-X
was B-X
created B-X
by B-X
disrupting B-X
the B-X
Atm B-X
locus B-X
via B-X
gene B-X
targeting B-X
. B-X
Mice B-X
homozygous B-X
for B-X
the B-X
disrupted B-X
Atm B-X
allele B-X
displayed B-X
growth B-X
retardation B-X
, B-X
neurologic B-X
dysfunction B-X
We B-X
have B-X
generated B-X
a B-X
mouse B-X
model B-X
for B-X
ataxia-telangiectasia B-X
by B-X
using B-X
gene B-X
targeting B-X
to B-X
generate B-X
mice B-X
that B-X
do B-X
not B-X
express B-X
the B-X
Atm B-X
protein B-X
. B-X
Atm-deficient B-X
mice B-X
are B-X
retarded B-X
in B-X
growth B-X
, B-X
Re-imagining B-X
discovery B-X
and B-X
access B-X
to B-X
research B-X
: B-X
grants B-X
, B-X
datasets B-X
, B-X
publications B-X
, B-X
citations B-X
, B-X
clinical B-X
trials B-X
, B-X
patents B-X
and B-X
policy B-X
documents B-X
in B-X
one B-X
place B-X
. B-X

We	O
have	O
generated	O
a	O
mouse	O
model	O
for	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
by	O
using	O
gene	O
targeting	O
to	O
generate	O
mice	O
that	O
do	O
not	O
express	O
the	O
Atm	O
protein	O
.	O
<EOS> B-X
A B-X
novel B-X
mouse B-X
model B-X
for B-X
ataxia-telangiectasia B-X
with B-X
a B-X
N-terminal B-X
mutation B-X
displays B-X
a B-X
behavioral B-X
defect B-X
and B-X
a B-X
low B-X
incidence B-X
of B-X
lymphoma B-X
but B-X
no B-X
increased B-X
oxidative B-X
burden B-X
Disease B-X
severity B-X
in B-X
a B-X
mouse B-X
model B-X
of B-X
ataxia B-X
telangiectasia B-X
is B-X
modulated B-X
by B-X
the B-X
DNA B-X
damage B-X
checkpoint B-X
gene B-X
Hus1 B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
a B-X
rare B-X
multi-system B-X
disorder B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
ATM B-X
gene B-X
. B-X
Significant B-X
heterogeneity B-X
exists B-X
in B-X
the B-X
underlying B-X
genetic B-X
mutations B-X
and B-X
clinical B-X
phenotypes B-X
. B-X
A B-X
Abstract B-X
. B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
a B-X
rare B-X
multi-system B-X
disorder B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
ATM B-X
gene B-X
. B-X
Significant B-X
heterogeneity B-X
exists B-X
in B-X
the B-X
underlying B-X
ge B-X
PDF B-X
| B-X
Ataxia B-X
Telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
caused B-X
by B-X
null B-X
mutations B-X
in B-X
the B-X
genome B-X
stability B-X
gene B-X
, B-X
ATM B-X
( B-X
A-T B-X
mutated B-X
) B-X
. B-X
In B-X
mice B-X
, B-X
similar B-X
null B-X
mutations B-X
Pleiotropic B-X
defects B-X
in B-X
ataxia-telangiectasia B-X
protein-deficient B-X
mice B-X
| B-X
PNAS B-X
Pleiotropic B-X
defects B-X
in B-X
ataxia-telangiectasia B-X
protein-deficient B-X
mice B-X
| B-X
PNAS B-X

Atm	O
-	O
deficient	O
mice	O
are	O
retarded	O
in	O
growth	O
,	O
do	O
not	O
produce	O
mature	O
sperm	O
,	O
and	O
exhibit	O
severe	O
defects	O
in	O
T	O
cell	O
maturation	O
while	O
going	O
on	O
to	O
develop	O
thymomas	B-Disease
.	O
<EOS> B-X
The B-X
Atm B-X
gene B-X
and B-X
its B-X
possible B-X
relation B-X
to B-X
ageing B-X
in B-X
mice B-X
The B-X
Atm B-X
gene B-X
and B-X
its B-X
possible B-X
relation B-X
to B-X
ageing B-X
in B-X
mice B-X
The B-X
Atm B-X
gene B-X
and B-X
its B-X
possible B-X
relation B-X
to B-X
ageing B-X
in B-X
mice B-X
We B-X
have B-X
generated B-X
a B-X
mouse B-X
model B-X
for B-X
ataxia-telangiectasia B-X
by B-X
using B-X
gene B-X
targeting B-X
to B-X
generate B-X
mice B-X
that B-X
do B-X
not B-X
express B-X
the B-X
Atm B-X
protein B-X
. B-X
Atm-deficient B-X
mice B-X
are B-X
r B-X
... B-X
Pleiotropic B-X
defects B-X
in B-X
ataxia-telangiectasia B-X
protein-deficient B-X
mice B-X
Pleiotropic B-X
defects B-X
in B-X
ataxia-telangiectasia B-X
protein-deficient B-X
mice B-X
| B-X
PNAS B-X
Pleiotropic B-X
defects B-X
in B-X
ataxia-telangiectasia B-X
protein-deficient B-X
mice B-X
| B-X
PNAS B-X

Atm	O
-	O
deficient	O
fibroblasts	O
grow	O
poorly	O
in	O
culture	O
and	O
display	O
a	O
high	O
level	O
of	O
double	O
-	O
stranded	O
chromosome	O
breaks	O
.	O
<EOS> B-X
We B-X
have B-X
generated B-X
a B-X
mouse B-X
model B-X
for B-X
ataxia-telangiectasia B-X
by B-X
using B-X
gene B-X
targeting B-X
to B-X
generate B-X
mice B-X
that B-X
do B-X
not B-X
express B-X
the B-X
Atm B-X
protein B-X
. B-X
Atm-deficient B-X
mice B-X
are B-X
retarded B-X
in B-X
growth B-X
, B-X
ATM B-X
and B-X
Artemis B-X
promote B-X
homologous B-X
recombination B-X
of B-X
radiation-induced B-X
DNA B-X
double-strand B-X
breaks B-X
in B-X
G2 B-X
Do B-X
DNA B-X
double-strand B-X
breaks B-X
drive B-X
aging B-X
? B-X
Endogenously B-X
induced B-X
DNA B-X
double B-X
strand B-X
breaks B-X
arise B-X
in B-X
heterochromatic B-X
DNA B-X
regions B-X
and B-X
require B-X
ataxia B-X
telangiectasia B-X
mutated B-X
and B-X
Artemis B-X
for B-X
their B-X
repair B-X
DNA B-X
double-strand B-X
breaks B-X
( B-X
DSBs B-X
) B-X
are B-X
traditionally B-X
associated B-X
with B-X
cancer B-X
through B-X
their B-X
abilities B-X
to B-X
cause B-X
chromosomal B-X
instabilities B-X
or B-X
gene B-X
mutations B-X
. B-X
Here B-X
we B-X
report B-X
a B-X
new B-X
class B-X
of B-X
self-inflicted B-X

Atm	O
-	O
deficient	O
thymocytes	O
undergo	O
spontaneous	O
apoptosis	O
in	O
vitro	O
significantly	O
more	O
than	O
controls	O
.	O
<EOS> B-X
ATM B-X
deficiency B-X
disrupts B-X
Tcra B-X
locus B-X
integrity B-X
and B-X
the B-X
maturation B-X
of B-X
CD4+CD8+ B-X
thymocytes B-X
- B-X
ScienceDirect B-X
Spontaneous B-X
and B-X
oxidative B-X
stress-induced B-X
programmed B-X
cell B-X
death B-X
in B-X
lymphocytes B-X
from B-X
patients B-X
with B-X
ataxia B-X
telangiectasia B-X
( B-X
AT B-X
) B-X
Prevention B-X
of B-X
Thymic B-X
Lymphoma B-X
Development B-X
in B-X
Atm‚àí/‚àí B-X
Mice B-X
by B-X
Dexamethasone B-X
| B-X
Cancer B-X
Research B-X
Prevention B-X
of B-X
Thymic B-X
Lymphoma B-X
Development B-X
in B-X
Atm‚àí/‚àí B-X
Mice B-X
by B-X
Dexamethasone B-X
| B-X
Cancer B-X
Research B-X
Ataxia B-X
telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disease B-X
in B-X
humans B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
Atm B-X
( B-X
A-T B-X
mutated B-X
) B-X
gene B-X
. B-X
The B-X
disease B-X
involves B-X
multiple B-X
or B-X
PDF B-X
| B-X
Mutations B-X
in B-X
ATM B-X
( B-X
ataxia-telangiectasia B-X
mutated B-X
) B-X
cause B-X
ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
, B-X
a B-X
disease B-X
characterized B-X
by B-X
neurodegeneration B-X
, B-X
sterility B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X

Atm	O
-	O
deficient	O
mice	O
then	O
exhibit	O
many	O
of	O
the	O
same	O
symptoms	O
found	O
in	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
patients	O
and	O
in	O
cells	O
derived	O
from	O
them	O
.	O
<EOS> B-X
We B-X
have B-X
generated B-X
a B-X
mouse B-X
model B-X
for B-X
ataxia-telangiectasia B-X
by B-X
using B-X
gene B-X
targeting B-X
to B-X
generate B-X
mice B-X
that B-X
do B-X
not B-X
express B-X
the B-X
Atm B-X
protein B-X
. B-X
Atm-deficient B-X
mice B-X
are B-X
retarded B-X
in B-X
growth B-X
, B-X
Pleiotropic B-X
defects B-X
in B-X
ataxia-telangiectasia B-X
protein-deficient B-X
mice B-X
| B-X
PNAS B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Furthermore	O
,	O
we	O
demonstrate	O
that	O
the	O
Atm	O
protein	O
exists	O
as	O
two	O
discrete	O
molecular	O
species	O
,	O
and	O
that	O
loss	O
of	O
one	O
or	O
of	O
both	O
of	O
these	O
can	O
lead	O
to	O
the	O
development	O
of	O
the	O
disease	O
.	O
.	O
<EOS> B-X
A B-X
recent B-X
study B-X
has B-X
pinpointed B-X
six B-X
types B-X
of B-X
prediabetes B-X
, B-X
based B-X
on B-X
a B-X
person B-X
‚Äô B-X
s B-X
metabolic B-X
characteristics B-X
and B-X
risk B-X
profile B-X
for B-X
diabetes B-X
and B-X
its B-X
complications B-X
. B-X
Alzheimer B-X
's B-X
disease B-X
is B-X
caused B-X
by B-X
parts B-X
of B-X
the B-X
brain B-X
shrinking B-X
( B-X
atrophy B-X
) B-X
, B-X
which B-X
affects B-X
the B-X
structure B-X
and B-X
function B-X
of B-X
particular B-X
brain B-X
areas B-X
. B-X
A B-X
nutritional B-X
deficiency B-X
occurs B-X
when B-X
the B-X
body B-X
doesn B-X
‚Äô B-X
t B-X
absorb B-X
the B-X
necessary B-X
amount B-X
of B-X
a B-X
nutrient B-X
. B-X
Read B-X
more B-X
about B-X
symptoms B-X
and B-X
treatment B-X
. B-X
How B-X
does B-X
Alzheimer B-X
's B-X
disease B-X
affect B-X
the B-X
brain B-X
? B-X
Read B-X
how B-X
genetics B-X
, B-X
environment B-X
, B-X
and B-X
lifestyle B-X
play B-X
a B-X
role B-X
in B-X
developing B-X
early- B-X
or B-X
late-onset B-X
Alzheimer B-X
‚Äô B-X
s B-X
. B-X
Type B-X
1 B-X
and B-X
type B-X
2 B-X
diabetes B-X
both B-X
relate B-X
to B-X
the B-X
body B-X
‚Äô B-X
s B-X
use B-X
of B-X
insulin B-X
, B-X
but B-X
they B-X
have B-X
different B-X
causes B-X
and B-X
treatment B-X
. B-X
Find B-X
out B-X
here B-X
about B-X
the B-X
The B-X
body B-X
systems B-X
that B-X
control B-X
the B-X
growth B-X
and B-X
maintenance B-X
of B-X
the B-X
skeleton B-X
, B-X
which B-X
are B-X
described B-X
in B-X
Chapter B-X
2 B-X
, B-X
can B-X
be B-X
disrupted B-X
in B-X
different B-X
ways B-X
that B-X
result B-X
in B-X
a B-X
The B-X
consequences B-X
of B-X
human B-X
actions B-X
on B-X
risks B-X
for B-X
infectious B-X
diseases B-X
: B-X
a B-X
review B-X

The	O
DCC	O
protein	O
and	O
prognosis	O
in	O
colorectal	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
The B-X
DCC B-X
protein B-X
and B-X
prognosis B-X
in B-X
colorectal B-X
cancer B-X
. B-X
Original B-X
Article B-X
from B-X
The B-X
New B-X
England B-X
Journal B-X
of B-X
Medicine B-X
‚Äî B-X
The B-X
DCC B-X
Protein B-X
and B-X
Prognosis B-X
in B-X
Colorectal B-X
Cancer B-X
Original B-X
Article B-X
from B-X
The B-X
New B-X
England B-X
Journal B-X
of B-X
Medicine B-X
‚Äî B-X
The B-X
DCC B-X
Protein B-X
and B-X
Prognosis B-X
in B-X
Colorectal B-X
Cancer B-X
Reduced B-X
expression B-X
of B-X
deleted B-X
colorectal B-X
carcinoma B-X
( B-X
DCC B-X
) B-X
protein B-X
in B-X
established B-X
colon B-X
cancers B-X
. B-X
Detection B-X
of B-X
the B-X
DCC B-X
gene B-X
product B-X
in B-X
normal B-X
and B-X
malignant B-X
colorectal B-X
tissues B-X
and B-X
its B-X
relation B-X
to B-X
a B-X
codon B-X
201 B-X
mutation B-X
. B-X
DCC B-X
( B-X
deleted B-X
in B-X
colorectal B-X
carcinoma B-X
) B-X
DCC B-X
( B-X
deleted B-X
in B-X
colorectal B-X
carcinoma B-X
) B-X

BACKGROUND	O
Allelic	O
loss	O
of	O
chromosome	O
18q	O
predicts	O
a	O
poor	O
outcome	O
in	O
patients	O
with	O
stage	B-Disease
II	I-Disease
colorectal	I-Disease
cancer	I-Disease
.	O
<EOS> B-X
Deletion B-X
of B-X
chromosome B-X
4q B-X
predicts B-X
outcome B-X
in B-X
Stage B-X
II B-X
colon B-X
cancer B-X
patients B-X
The B-X
status B-X
of B-X
chromosome B-X
18q B-X
has B-X
strong B-X
prognostic B-X
value B-X
in B-X
patients B-X
with B-X
stage B-X
II B-X
colorectal B-X
cancer B-X
. B-X
The B-X
prognosis B-X
in B-X
patients B-X
with B-X
stage B-X
II B-X
cancer B-X
and B-X
chromosome B-X
18q B-X
allelic B-X
loss B-X
Prognostic B-X
values B-X
of B-X
chromosome B-X
18q B-X
microsatellite B-X
alterations B-X
in B-X
stage B-X
II B-X
colonic B-X
carcinoma B-X
18q B-X
LOH B-X
indicates B-X
an B-X
unfavorable B-X
outcome B-X
in B-X
patients B-X
with B-X
stage B-X
II B-X
CRC B-X
. B-X
Our B-X
results B-X
emphasize B-X
the B-X
importance B-X
of B-X
the B-X
18q21.1 B-X
region B-X
, B-X
where B-X
several B-X
tumor-suppressor B-X
genes B-X
have B-X
been B-X
mapped B-X
Genetic B-X
Classification B-X
of B-X
Colorectal B-X
Cancer B-X
Based B-X
on B-X
Chromosomal B-X
Loss B-X
and B-X
Microsatellite B-X
Instability B-X
Predicts B-X
Survival B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
DNA B-X
copy B-X
number B-X
aberrations B-X
( B-X
CNA B-X
) B-X
are B-X
frequently B-X
observed B-X
in B-X
colorectal B-X
cancers B-X
( B-X
CRC B-X
) B-X
. B-X
There B-X
is B-X
an B-X
urgent B-X
need B-X
for B-X
CNA-based B-X
biomarkers B-X
in B-X
clinics B-X
, B-X
. B-X
n B-X
Home B-X
Page B-X
: B-X
Gastroenterology B-X

Although	O
the	O
specific	O
gene	O
inactivated	O
by	O
this	O
allelic	O
loss	O
has	O
not	O
been	O
elucidated	O
,	O
the	O
DCC	O
(	O
deleted	O
in	O
colorectal	B-Disease
cancer	I-Disease
)	O
gene	O
is	O
a	O
candidate	O
.	O
<EOS> B-X
Frequent B-X
loss B-X
of B-X
SMAD4/DPC4 B-X
protein B-X
in B-X
colorectal B-X
cancers B-X
| B-X
Gut B-X
Refinement B-X
of B-X
heterozygosity B-X
loss B-X
on B-X
chromosome B-X
5p15 B-X
in B-X
sporadic B-X
colorectal B-X
cancer B-X
Deleted B-X
in B-X
Colorectal B-X
Cancer B-X
- B-X
Wikipedia B-X
Mutation B-X
and B-X
Expression B-X
of B-X
the B-X
DCC B-X
Gene B-X
in B-X
Human B-X
Lung B-X
Cancer B-X
- B-X
ScienceDirect B-X
Chromosome B-X
18q B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

We	O
investigated	O
whether	O
the	O
expression	O
of	O
the	O
DCC	O
protein	O
in	O
tumor	B-Disease
cells	O
is	O
a	O
prognostic	O
marker	O
in	O
colorectal	B-Disease
carcinoma	I-Disease
.	O
<EOS> B-X
Inactivation B-X
of B-X
the B-X
UNC5C B-X
netrin-1 B-X
receptor B-X
is B-X
associated B-X
with B-X
tumor B-X
progression B-X
in B-X
colorectal B-X
malignancies B-X
CK1Œ± B-X
overexpression B-X
correlates B-X
with B-X
poor B-X
survival B-X
in B-X
colorectal B-X
cancer B-X
SMAD4 B-X
as B-X
a B-X
Prognostic B-X
Marker B-X
in B-X
Colorectal B-X
Cancer B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Cell B-X
Surface B-X
Markers B-X
in B-X
Colorectal B-X
Cancer B-X
Prognosis B-X
What B-X
we B-X
could B-X
do B-X
now B-X
: B-X
molecular B-X
pathology B-X
of B-X
colorectal B-X
cancer B-X
Overexpression B-X
of B-X
methylation-driven B-X
DCC B-X
suppresses B-X
proliferation B-X
of B-X
lung B-X
cancer B-X
cells B-X
Deleted B-X
in B-X
Colorectal B-X
Cancer B-X
( B-X
DCC B-X
) B-X
Pathfinding B-X
: B-X
Axon B-X
Guidance B-X
Gene B-X
Finally B-X
Turned B-X
Tumor B-X
Suppressor B-X

METHODS	O
The	O
expression	O
of	O
DCC	O
was	O
evaluated	O
immunohistochemically	O
in	O
132	O
paraffin	O
-	O
embedded	O
samples	O
from	O
patients	O
with	O
curatively	O
resected	O
stage	B-Disease
II	I-Disease
and	I-Disease
III	I-Disease
colorectal	I-Disease
carcinomas	I-Disease
.	O
<EOS> B-X
MOLECULAR B-X
PREDICTORS B-X
OF B-X
SURVIVAL B-X
AFTER B-X
ADJUVANT B-X
CHEMOTHERAPY B-X
FOR B-X
COLON B-X
CANCER B-X

The	O
Cox	O
proportional	O
-	O
hazards	O
model	O
was	O
used	O
to	O
adjust	O
for	O
covariates	O
including	O
age	O
,	O
sex	O
,	O
tumor	B-Disease
site	O
,	O
degree	O
of	O
tumor	B-Disease
differentiation	O
,	O
and	O
use	O
of	O
adjuvant	O
therapy	O
.	O
<EOS> B-X
Cox B-X
regression B-X
model B-X
with B-X
randomly B-X
censored B-X
covariates B-X
Benefit B-X
of B-X
Postoperative B-X
Adjuvant B-X
Therapy B-X
for B-X
Pancreatic B-X
Cancer B-X
: B-X
A B-X
Population-Based B-X
Analysis B-X
Restricted B-X
mean B-X
survival B-X
time B-X
: B-X
Does B-X
covariate B-X
adjustment B-X
improve B-X
precision B-X
in B-X
randomized B-X
clinical B-X
trials B-X
? B-X
Moving B-X
beyond B-X
the B-X
Cox B-X
proportional B-X
hazards B-X
model B-X
in B-X
survival B-X
data B-X
analysis B-X
: B-X
a B-X
cervical B-X
cancer B-X
study B-X
| B-X
BMJ B-X
Open B-X
Survival B-X
Benefits B-X
and B-X
Trends B-X
in B-X
Use B-X
of B-X
Adjuvant B-X
Therapy B-X
Among B-X
Elderly B-X
Stage B-X
II B-X
and B-X
III B-X
Rectal B-X
Cancer B-X
Patients B-X
in B-X
the B-X
General B-X
Population B-X
Effect B-X
of B-X
adjuvant B-X
chemotherapy B-X
on B-X
survival B-X
benefit B-X
in B-X
stage B-X
III B-X
colon B-X
cancer B-X
patients B-X
stratified B-X
by B-X
age B-X
: B-X
a B-X
Japanese B-X
real-world B-X
cohort B-X
study B-X
A B-X
reference B-X
relative B-X
time-scale B-X
as B-X
an B-X
alternative B-X
to B-X
chronological B-X
age B-X
for B-X
cohorts B-X
with B-X
long B-X
follow-up B-X

RESULTS	O
The	O
expression	O
of	O
DCC	O
was	O
a	O
strong	O
positive	O
predictive	O
factor	O
for	O
survival	O
in	O
both	O
stage	B-Disease
II	I-Disease
and	I-Disease
stage	I-Disease
III	I-Disease
colorectal	I-Disease
carcinomas	I-Disease
.	O
<EOS> B-X
DCC B-X
is B-X
a B-X
prognostic B-X
factor B-X
for B-X
colorectal B-X
cancer B-X
. B-X
Positive B-X
expression B-X
of B-X
DCC B-X
identifies B-X
a B-X
subgroup B-X
of B-X
patients B-X
who B-X
respond B-X
favorably B-X
to B-X
adjuvant B-X
chemotherapy B-X
, B-X
which B-X
resulted B-X
in B-X
our B-X
cases B-X
Prognostic B-X
and B-X
Predictive B-X
Markers B-X
in B-X
Stage B-X
II B-X
Colon B-X
Cancer B-X
: B-X
Is B-X
There B-X
a B-X
Role B-X
for B-X
Gene B-X
Expression B-X
Profiling B-X
? B-X
PDF B-X
| B-X
Objectives B-X
: B-X
Microsatellite B-X
instability B-X
( B-X
MSI B-X
) B-X
is B-X
an B-X
established B-X
marker B-X
of B-X
good B-X
prognosis B-X
in B-X
colorectal B-X
cancer B-X
( B-X
CRC B-X
) B-X
. B-X
Chromosomal B-X
instability B-X
( B-X
CIN B-X
) B-X
... B-X
| B-X
American B-X
Joint B-X
Committee B-X
on B-X
Cancer B-X
prognostic B-X
factors B-X
consensus B-X
conference B-X
- B-X
Compton B-X
- B-X
2000 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

In	O
patients	O
with	O
stage	O
II	O
disease	O
whose	O
tumors	B-Disease
expressed	O
DCC	O
,	O
the	O
five	O
-	O
year	O
survival	O
rate	O
was	O
94	O
.	O
<EOS> B-X
A B-X
review B-X
of B-X
soft-tissue B-X
sarcomas B-X
: B-X
translation B-X
of B-X
biological B-X
advances B-X
into B-X
treatment B-X
measures B-X
What B-X
we B-X
could B-X
do B-X
now B-X
: B-X
molecular B-X
pathology B-X
of B-X
colorectal B-X
cancer B-X
| B-X
Molecular B-X
Pathology B-X
CA B-X
: B-X
A B-X
Cancer B-X
Journal B-X
for B-X
Clinicians B-X
publishes B-X
information B-X
about B-X
the B-X
prevention B-X
, B-X
early B-X
detection B-X
, B-X
and B-X
treatment B-X
of B-X
cancer B-X
, B-X
as B-X
well B-X
as B-X
nutrition B-X
, B-X
palliative B-X
care B-X
, B-X
survivorship B-X
American B-X
Joint B-X
Committee B-X
on B-X
Cancer B-X
prognostic B-X
factors B-X
consensus B-X
conference B-X
- B-X
Compton B-X
- B-X
2000 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
Library B-X

3	O
percent	O
,	O
whereas	O
in	O
patients	O
with	O
DCC	B-Disease
-	I-Disease
negative	I-Disease
tumors	I-Disease
,	O
the	O
survival	O
rate	O
was	O
61	O
.	O
<EOS> B-X
Triple-negative B-X
breast B-X
cancer B-X
( B-X
TNBC B-X
) B-X
is B-X
characterized B-X
by B-X
aggressive B-X
behavior B-X
and B-X
poor B-X
prognosis B-X
. B-X
While B-X
> B-X
50 B-X
% B-X
of B-X
patients B-X
with B-X
inherited B-X
BRCA1 B-X
mutations B-X
have B-X
TNBC B-X
, B-X
the B-X
prevalence B-X
Triple-negative B-X
breast B-X
cancer B-X
molecular B-X
subtyping B-X
and B-X
treatment B-X
progress B-X
Triple B-X
Negative B-X
Breast B-X
Cancer B-X
: B-X
Role B-X
of B-X
Specific B-X
Chemotherapy B-X
Agents B-X
Prognostic B-X
Factors B-X
in B-X
Node-Negative B-X
Breast B-X
Cancer B-X
Why B-X
are B-X
people B-X
still B-X
dying B-X
of B-X
colorectal B-X
cancer B-X
when B-X
the B-X
data B-X
indicate B-X
we B-X
should B-X
be B-X
able B-X
to B-X
prevent B-X
it B-X
? B-X
- B-X
ScienceDirect B-X
Breast B-X
Cancer B-X
Subtypes B-X
Based B-X
on B-X
ER/PR B-X
and B-X
Her2 B-X
Expression B-X
: B-X
Comparison B-X
of B-X
Clinicopathologic B-X
Features B-X
and B-X
Survival B-X
The B-X
fate B-X
of B-X
chemoresistance B-X
in B-X
triple B-X
negative B-X
breast B-X
cancer B-X
( B-X
TNBC B-X
) B-X

6	O
percent	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O
<EOS> B-X
‚Äú B-X
P B-X
< B-X
0.05 B-X
‚Äù B-X
Might B-X
Not B-X
Mean B-X
What B-X
You B-X
Think B-X
: B-X
American B-X
Statistical B-X
Association B-X
Clarifies B-X
P B-X
Values B-X
A B-X
statistically B-X
significant B-X
finding B-X
means B-X
that B-X
the B-X
differences B-X
observed B-X
in B-X
a B-X
study B-X
are B-X
likely B-X
real B-X
and B-X
not B-X
simply B-X
due B-X
to B-X
chance B-X
. B-X
This B-X
is B-X
a B-X
basic B-X
introduction B-X
to B-X
interpreting B-X
odds B-X
ratios B-X
, B-X
confidence B-X
intervals B-X
and B-X
p B-X
values B-X
only B-X
and B-X
should B-X
help B-X
students B-X
begin B-X
to B-X
grasp B-X
published B-X
research B-X
. B-X
Read B-X
72 B-X
answers B-X
by B-X
scientists B-X
to B-X
the B-X
question B-X
asked B-X
by B-X
Khubaib B-X
A. B-X
Ayoub B-X
on B-X
Aug B-X
17 B-X
, B-X
2015 B-X
P-Value B-X
and B-X
Statistical B-X
Significance B-X
| B-X
Simply B-X
Psychology B-X
P B-X
‚Äì B-X
VALUE B-X
, B-X
A B-X
TRUE B-X
TEST B-X
OF B-X
STATISTICAL B-X
SIGNIFICANCE B-X
? B-X
A B-X
CAUTIONARY B-X
NOTE B-X

In	O
patients	O
with	O
stage	B-Disease
III	I-Disease
disease	I-Disease
,	O
the	O
respective	O
survival	O
rates	O
were	O
59	O
.	O
<EOS> B-X
The B-X
10-year B-X
relative B-X
survival B-X
for B-X
stage B-X
III B-X
is B-X
higher B-X
than B-X
expected B-X
. B-X
This B-X
information B-X
provides B-X
the B-X
physician B-X
and B-X
the B-X
patient B-X
with B-X
more B-X
accurate B-X
prognostic B-X
information B-X
. B-X
Survival B-X
of B-X
patients B-X
with B-X
operable B-X
breast B-X
cancer B-X
( B-X
Stages B-X
I-III B-X
) B-X
at B-X
a B-X
Brazilian B-X
public B-X
hospital B-X
- B-X
a B-X
closer B-X
look B-X
into B-X
cause-specific B-X
mortality B-X
Long-term B-X
survival B-X
from B-X
FAP-CRC B-X
remains B-X
poor B-X
; B-X
therefore B-X
, B-X
early-stage B-X
detection B-X
and B-X
the B-X
choice B-X
of B-X
an B-X
appropriate B-X
surgical B-X
method B-X
can B-X
improve B-X
survival B-X
in B-X
such B-X
patients B-X
. B-X
Outcomes B-X
of B-X
patients B-X
with B-X
unresected B-X
stage B-X
III B-X
and B-X
stage B-X
IV B-X
non-small B-X
cell B-X
lung B-X
cancer B-X
: B-X
A B-X
single B-X
institution B-X
experience B-X
In B-X
the B-X
absence B-X
of B-X
biological B-X
biomarkers B-X
, B-X
clinical B-X
stage B-X
and B-X
LVI B-X
seem B-X
to B-X
be B-X
the B-X
only B-X
significant B-X
prognostic B-X
factors B-X
for B-X
survival B-X
of B-X
TNBC B-X
patients B-X
in B-X
our B-X
study B-X
population B-X
. B-X
Timing B-X
Clinical B-X
and B-X
prognostic B-X
factors B-X
in B-X
98 B-X
patients B-X
with B-X
malignant B-X
melanoma B-X
in B-X
China B-X
New B-X
paradigm B-X
for B-X
stage B-X
III B-X
melanoma B-X
: B-X
from B-X
surgery B-X
to B-X
adjuvant B-X
treatment B-X

3	O
percent	O
and	O
33	O
.	O
<EOS> B-X
Percentage B-X
Calculator B-X
: B-X
33 B-X
is B-X
what B-X
percent B-X
of B-X
133 B-X
? B-X
= B-X
24.81 B-X
3 B-X
% B-X
off B-X
33 B-X
is B-X
32.01 B-X
- B-X
Percent B-X
Off B-X
Calculator B-X
Result B-X
by B-X
Percent-Change.Com B-X
Percentage B-X
Calculator B-X
: B-X
3 B-X
is B-X
what B-X
percent B-X
of B-X
33 B-X
? B-X
= B-X
9.09 B-X
Percentage B-X
Calculator B-X
: B-X
11 B-X
is B-X
what B-X
percent B-X
of B-X
33 B-X
? B-X
= B-X
33.33 B-X
Percentage B-X
Calculator B-X
: B-X
12 B-X
is B-X
what B-X
percent B-X
of B-X
33 B-X
? B-X
= B-X
36.36 B-X
Percentage B-X
Calculator B-X
: B-X
26 B-X
is B-X
what B-X
percent B-X
of B-X
33 B-X
? B-X
= B-X
78.79 B-X
Percentage B-X
Calculator B-X
: B-X
What B-X
is B-X
.3 B-X
percent B-X
of B-X
33 B-X
? B-X
= B-X
0.1 B-X

2	O
percent	O
(	O
P	O
=	O
0	O
.	O
03	O
)	O
.	O
<EOS> B-X
Example B-X
showing B-X
how B-X
to B-X
use B-X
a B-X
standard B-X
normal B-X
table B-X
to B-X
estimate B-X
a B-X
P-value B-X
. B-X
Learn B-X
how B-X
to B-X
use B-X
a B-X
P-value B-X
and B-X
the B-X
significance B-X
level B-X
to B-X
make B-X
a B-X
conclusion B-X
in B-X
a B-X
significance B-X
test B-X
. B-X
Example B-X
of B-X
estimating B-X
a B-X
P-value B-X
based B-X
on B-X
a B-X
simulation B-X
to B-X
approximate B-X
a B-X
sampling B-X
distribution B-X
assuming B-X
the B-X
null B-X
hypothesis B-X
is B-X
true B-X
. B-X
P B-X
values B-X
indicate B-X
whether B-X
hypothesis B-X
tests B-X
are B-X
statistically B-X
significant B-X
but B-X
they B-X
are B-X
frequently B-X
misinterpreted B-X
. B-X
Learn B-X
how B-X
to B-X
correctly B-X
interpret B-X
P B-X
values B-X
. B-X
Get B-X
this B-X
complete B-X
course B-X
at B-X
http B-X
: B-X
//www.MathTutorDVD.comIn B-X
this B-X
lesson B-X
, B-X
we B-X
will B-X
discuss B-X
the B-X
very B-X
important B-X
topic B-X
of B-X
p-values B-X
in B-X
statistics B-X
. B-X
The B-X
p-value B-X
is B-X
a B-X
... B-X
Percent B-X
sign B-X
- B-X
Wikipedia B-X
Deriving B-X
and B-X
using B-X
the B-X
expected B-X
value B-X
( B-X
mean B-X
) B-X
formula B-X
for B-X
binomial B-X
random B-X
variables B-X

CONCLUSIONS	O
DCC	O
is	O
a	O
prognostic	O
marker	O
in	O
patients	O
with	O
stage	B-Disease
II	I-Disease
or	I-Disease
stage	I-Disease
III	I-Disease
colorectal	I-Disease
cancer	I-Disease
.	O
<EOS> B-X
Predictive B-X
and B-X
Prognostic B-X
Markers B-X
in B-X
Colorectal B-X
Cancer B-X
Molecular B-X
Prognostic B-X
and B-X
Predictive B-X
Markers B-X
in B-X
Colorectal B-X
Cancer B-X
: B-X
Current B-X
Status B-X
Systemic B-X
Treatment B-X
of B-X
Colorectal B-X
Cancer B-X
Adjuvant B-X
Therapy B-X
for B-X
Stage B-X
II B-X
and B-X
III B-X
Colon B-X
Cancer B-X
: B-X
Consensus B-X
Report B-X
of B-X
the B-X
International B-X
Society B-X
of B-X
Gastrointestinal B-X
Oncology B-X
Current B-X
Tissue B-X
Molecular B-X
Markers B-X
in B-X
Colorectal B-X
Cancer B-X
: B-X
A B-X
Literature B-X
Review B-X
Adjuvant B-X
Chemotherapy B-X
for B-X
Stage B-X
II B-X
Colon B-X
Cancer B-X
: B-X
The B-X
Role B-X
of B-X
Molecular B-X
Markers B-X
in B-X
Choosing B-X
Therapy B-X
< B-X
i B-X
> B-X
Background B-X
< B-X
/i B-X
> B-X
. B-X
Colorectal B-X
cancer B-X
( B-X
CRC B-X
) B-X
is B-X
one B-X
of B-X
the B-X
most B-X
spread B-X
neoplasia B-X
types B-X
all B-X
around B-X
the B-X
world B-X
, B-X
especially B-X
in B-X
western B-X
areas B-X

In	O
stage	B-Disease
II	I-Disease
colorectal	I-Disease
carcinomas	I-Disease
,	O
the	O
absence	O
of	O
DCC	O
identifies	O
a	O
subgroup	O
of	O
patients	O
with	O
lesions	O
that	O
behave	O
like	O
stage	B-Disease
III	I-Disease
cancers	I-Disease
.	O
<EOS> B-X
Challenges B-X
in B-X
the B-X
management B-X
of B-X
stage B-X
II B-X
colon B-X
cancer B-X
Why B-X
are B-X
people B-X
still B-X
dying B-X
of B-X
colorectal B-X
cancer B-X
when B-X
the B-X
data B-X
indicate B-X
we B-X
should B-X
be B-X
able B-X
to B-X
prevent B-X
it B-X
? B-X
- B-X
Gastroenterology B-X
PDF B-X
| B-X
A B-X
gene B-X
called B-X
deleted B-X
in B-X
colon B-X
cancer B-X
( B-X
DCC B-X
) B-X
has B-X
been B-X
identified B-X
on B-X
a B-X
region B-X
of B-X
chromosome B-X
18 B-X
, B-X
which B-X
is B-X
deleted B-X
in B-X
70 B-X
% B-X
of B-X
colorectal B-X
Prognostic B-X
Value B-X
of B-X
Colorectal B-X
Cancer B-X
Biomarkers B-X
Download B-X
Citation B-X
| B-X
Role B-X
of B-X
the B-X
Dependence B-X
Receptor B-X
DCC B-X
in B-X
Colorectal B-X
Cancer B-X
Pathogenesis B-X
| B-X
More B-X
than B-X
a B-X
decade B-X
ago B-X
, B-X
the B-X
DCC B-X
( B-X
deleted B-X
in B-X
colorectal B-X
cancer B-X
) B-X
gene B-X
was B-X
Request B-X
PDF B-X
| B-X
Identifying B-X
patients B-X
with B-X
T3-T4 B-X
node-negative B-X
colon B-X
cancer B-X
at B-X
high B-X
risk B-X
of B-X
recurrence B-X
| B-X
Adjuvant B-X
chemotherapy B-X
is B-X
effective B-X
for B-X
node-positive B-X
colon B-X
cancer B-X
patients B-X
. B-X
In B-X
node-negative B-X
patients B-X
, B-X
Download B-X
Citation B-X
| B-X
On B-X
Jun B-X
1 B-X
, B-X
2003 B-X
, B-X
Kevin B-X
O'Boyle B-X
published B-X
The B-X
Role B-X
of B-X
the B-X
Deleted B-X
Colon B-X
Cancer B-X
( B-X
DCC B-X
) B-X
Gene B-X
in B-X
Colorectal B-X
and B-X
Gastric B-X
Cancer B-X
| B-X
Find B-X

These	O
findings	O
may	O
thus	O
have	O
therapeutic	O
implications	O
in	O
this	O
group	O
of	O
patients	O
<EOS> B-X
The B-X
impact B-X
of B-X
the B-X
therapeutic B-X
alliance B-X
on B-X
treatment B-X
outcome B-X
in B-X
patients B-X
with B-X
dissociative B-X
disorders B-X
The B-X
challenge B-X
of B-X
patient B-X
adherence B-X
Factors B-X
affecting B-X
therapeutic B-X
compliance B-X
: B-X
A B-X
review B-X
from B-X
the B-X
patient B-X
‚Äô B-X
s B-X
perspective B-X
Treatment-resistant B-X
depression B-X
: B-X
therapeutic B-X
trends B-X
, B-X
challenges B-X
, B-X
and B-X
future B-X
directions B-X
Mindfulness-Based B-X
Cognitive B-X
Therapy B-X
Effectiveness B-X
of B-X
Art B-X
Therapy B-X
With B-X
Adult B-X
Clients B-X
in B-X
2018‚ÄîWhat B-X
Progress B-X
Has B-X
Been B-X
Made B-X
? B-X
Synchrony B-X
in B-X
Psychotherapy B-X
: B-X
A B-X
Review B-X
and B-X
an B-X
Integrative B-X
Framework B-X
for B-X
the B-X
Therapeutic B-X
Alliance B-X

Association	O
of	O
anxiety	B-Disease
-	I-Disease
related	I-Disease
traits	I-Disease
with	O
a	O
polymorphism	O
in	O
the	O
serotonin	O
transporter	O
gene	O
regulatory	O
region	O
.	O
<EOS> B-X
Association B-X
of B-X
Anxiety-Related B-X
Traits B-X
with B-X
a B-X
Polymorphism B-X
in B-X
the B-X
Serotonin B-X
Transporter B-X
Gene B-X
Regulatory B-X
Region B-X
| B-X
Science B-X
Association B-X
of B-X
Anxiety-Related B-X
Traits B-X
with B-X
a B-X
Polymorphism B-X
in B-X
the B-X
Serotonin B-X
Transporter B-X
Gene B-X
Regulatory B-X
Region B-X
| B-X
Science B-X
Gale B-X
OneFile B-X
: B-X
Health B-X
and B-X
Medicine B-X
- B-X
Document B-X
- B-X
Association B-X
of B-X
anxiety-related B-X
traits B-X
with B-X
a B-X
polymorphism B-X
in B-X
the B-X
Serotonin B-X
transporter B-X
gene B-X
regulatory B-X
region B-X
5-HTTLPR B-X
Genotype B-X
and B-X
Anxiety-Related B-X
Personality B-X
Traits B-X
: B-X
A B-X
meta-analysis B-X
and B-X
new B-X
data B-X
We B-X
determined B-X
polymorphism B-X
in B-X
the B-X
serotonin B-X
( B-X
5-HT B-X
) B-X
transporter B-X
gene-linked B-X
polymorphic B-X
region B-X
( B-X
5-HTTLPR B-X
) B-X
in B-X
501 B-X
healthy B-X
Japanese B-X
, B-X
individuals B-X
, B-X
using B-X
the B-X
polymerase B-X
chain B-X
reaction B-X
of B-X
Lesch B-X
A B-X
functional B-X
polymorphism B-X
in B-X
the B-X
regulatory B-X
region B-X
of B-X
the B-X
serotonin B-X
transporter B-X
gene B-X
( B-X
5-HTTLPR B-X
) B-X
has B-X
been B-X
reported B-X
to B-X
be B-X
both B-X
associated B-X
and B-X
linked B-X
to B-X
anxiety-related B-X
personality B-X
measures B-X
, B-X
although B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Transporter	O
-	O
facilitated	O
uptake	O
of	O
serotonin	O
(	O
5	O
-	O
hydroxytryptamine	O
or	O
5	O
-	O
HT	O
)	O
has	O
been	O
implicated	O
in	O
anxiety	B-Disease
in	O
humans	O
and	O
animal	O
models	O
and	O
is	O
the	O
site	O
of	O
action	O
of	O
widely	O
used	O
uptake	O
-	O
inhibiting	O
antidepressant	O
and	O
antianxiety	O
drugs	O
.	O
<EOS> B-X
Skeletal B-X
effects B-X
of B-X
serotonin B-X
( B-X
5-hydroxytryptamine B-X
) B-X
transporter B-X
inhibition B-X
: B-X
evidence B-X
from B-X
in B-X
vitro B-X
and B-X
animal-based B-X
studies B-X
The B-X
role B-X
of B-X
5-HT B-X
receptors B-X
in B-X
depression B-X
The B-X
therapeutic B-X
role B-X
of B-X
5-HT1A B-X
and B-X
5-HT2A B-X
receptors B-X
in B-X
depression B-X
Serotonin B-X
receptors B-X
in B-X
depression B-X
: B-X
from B-X
A B-X
to B-X
B B-X
Ontogeny B-X
and B-X
Regulation B-X
of B-X
the B-X
Serotonin B-X
Transporter B-X
: B-X
Providing B-X
Insights B-X
into B-X
Human B-X
Disorders B-X
Innovative B-X
Approaches B-X
for B-X
the B-X
Development B-X
of B-X
Antidepressant B-X
Drugs B-X
: B-X
Current B-X
and B-X
Future B-X
Strategies B-X
Trends B-X
in B-X
the B-X
Development B-X
of B-X
New B-X
Antidepressants B-X
. B-X
Is B-X
there B-X
a B-X
Light B-X
at B-X
the B-X
End B-X
of B-X
the B-X
Tunnel B-X
? B-X

Human	O
5	O
-	O
HT	O
transporter	O
(	O
5	O
-	O
HTT	O
)	O
gene	O
transcription	O
is	O
modulated	O
by	O
a	O
common	O
polymorphism	O
in	O
its	O
upstream	O
regulatory	O
region	O
.	O
<EOS> B-X
The B-X
serotonin B-X
transporter B-X
( B-X
5-HTT B-X
) B-X
gene B-X
is B-X
a B-X
promising B-X
candidate B-X
for B-X
introducing B-X
the B-X
heritability B-X
of B-X
interindividual B-X
variation B-X
in B-X
personality B-X
and B-X
the B-X
genetic B-X
susceptibility B-X
for B-X
various B-X
psychiatric B-X
diseases B-X
. B-X
Transcription B-X
Transporter-facilitated B-X
uptake B-X
of B-X
serotonin B-X
( B-X
5-hydroxytryptamine B-X
or B-X
5-HT B-X
) B-X
has B-X
been B-X
implicated B-X
in B-X
anxiety B-X
in B-X
humans B-X
and B-X
animal B-X
models B-X
and B-X
is B-X
the B-X
site B-X
of B-X
action B-X
of B-X
widely B-X
used B-X
uptake-inhibiting B-X
antidepressant B-X
Association B-X
of B-X
the B-X
5-HTT B-X
gene-linked B-X
promoter B-X
region B-X
( B-X
5-HTTLPR B-X
) B-X
polymorphism B-X
with B-X
psychiatric B-X
disorders B-X
: B-X
review B-X
of B-X
psychopathology B-X
and B-X
pharmacotherapy B-X
Mood B-X
, B-X
emotion B-X
and B-X
cognition B-X
are B-X
modulated B-X
by B-X
serotonergic B-X
neurotransmission B-X
, B-X
while B-X
the B-X
physiological B-X
function B-X
of B-X
serotonergic B-X
synapses B-X
depends B-X
on B-X
serotonin B-X
reuptake B-X
, B-X
which B-X
is B-X
mediated B-X
by B-X
the B-X
serotonin B-X
transporter B-X
Serotonin B-X
transporter B-X
gene B-X
polymorphism B-X
and B-X
psychiatric B-X
disorders B-X
: B-X
Is B-X
there B-X
a B-X
link B-X
? B-X
PDF B-X
| B-X
The B-X
serotonin B-X
transporter B-X
( B-X
5-HTT B-X
) B-X
gene B-X
is B-X
a B-X
promising B-X
candidate B-X
for B-X
introducing B-X
the B-X
heritability B-X
of B-X
interindividual B-X
variation B-X
in B-X
personality B-X
and B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Polymorphisms B-X
of B-X
the B-X
serotonin B-X
transporter B-X
and B-X
receptor B-X
genes B-X
: B-X
susceptibility B-X
to B-X
substance B-X
abuse B-X

The	O
short	O
variant	O
of	O
the	O
polymorphism	O
reduces	O
the	O
transcriptional	O
efficiency	O
of	O
the	O
5	O
-	O
HTT	O
gene	O
promoter	O
,	O
resulting	O
in	O
decreased	O
5	O
-	O
HTT	O
expression	O
and	O
5	O
-	O
HT	O
uptake	O
in	O
lymphoblasts	O
.	O
<EOS> B-X
The B-X
human B-X
serotonin B-X
transporter B-X
( B-X
5-HTT B-X
) B-X
, B-X
encoded B-X
by B-X
a B-X
single B-X
gene B-X
on B-X
chromosome B-X
17q11.2 B-X
, B-X
is B-X
expressed B-X
in B-X
brain B-X
and B-X
blood B-X
cells B-X
. B-X
5-HTT B-X
is B-X
implicated B-X
in B-X
mood B-X
Modulation B-X
of B-X
Human B-X
Serotonin B-X
Transporter B-X
Expression B-X
by B-X
5-HTTLPR B-X
in B-X
Colon B-X
Cells B-X
Polymorphisms B-X
in B-X
the B-X
5-HTTLPR B-X
Gene B-X
Mediate B-X
Storage B-X
Capacity B-X
of B-X
Visual B-X
Working B-X
Memory B-X
Transporter-facilitated B-X
uptake B-X
of B-X
serotonin B-X
( B-X
5-hydroxytryptamine B-X
or B-X
5-HT B-X
) B-X
has B-X
been B-X
implicated B-X
in B-X
anxiety B-X
in B-X
humans B-X
and B-X
animal B-X
models B-X
and B-X
is B-X
the B-X
site B-X
of B-X
action B-X
of B-X
widely B-X
used B-X
uptake-inhibiting B-X
antidepressant B-X
Association B-X
of B-X
the B-X
Serotonin B-X
Transporter B-X
Gene B-X
Promoter B-X
Region B-X
( B-X
5-HTTLPR B-X
) B-X
Polymorphism B-X
with B-X
Biased B-X
Attention B-X
for B-X
Emotional B-X
Stimuli B-X
Genetic B-X
variation B-X
in B-X
the B-X
serotonin B-X
transporter B-X
gene B-X
( B-X
5-HTTLPR B-X
, B-X
rs25531 B-X
) B-X
influences B-X
the B-X
analgesic B-X
response B-X
to B-X
the B-X
short B-X
acting B-X
opioid B-X
Remifentanil B-X
in B-X
humans B-X
Sleep B-X
Quality B-X
Varies B-X
as B-X
a B-X
Function B-X
of B-X
5-HTTLPR B-X
Genotype B-X
and B-X
Stress B-X

Association	O
studies	O
in	O
two	O
independent	O
samples	O
totaling	O
505	O
individuals	O
revealed	O
that	O
the	O
5	O
-	O
HTT	O
polymorphism	O
accounts	O
for	O
3	O
to	O
4	O
percent	O
of	O
total	O
variation	O
and	O
7	O
to	O
9	O
percent	O
of	O
inherited	O
variance	O
in	O
anxiety	B-Disease
-	I-Disease
related	I-Disease
personality	I-Disease
traits	I-Disease
in	O
individuals	O
as	O
well	O
as	O
sibships	O
.	O
.	O
<EOS> B-X
Gale B-X
Academic B-X
OneFile B-X
- B-X
Document B-X
- B-X
Association B-X
of B-X
anxiety-related B-X
traits B-X
with B-X
a B-X
polymorphism B-X
in B-X
the B-X
Serotonin B-X
transporter B-X
gene B-X
regulatory B-X
region B-X
Request B-X
PDF B-X
| B-X
Association B-X
between B-X
the B-X
serotonin B-X
transporter B-X
promoter B-X
polymorphism B-X
and B-X
personality B-X
traits B-X
in B-X
a B-X
primarily B-X
female B-X
population B-X
sample B-X
| B-X
The B-X
serotonin B-X
transporter B-X
( B-X
5-HTT B-X
) B-X
regulates B-X
serotonergic B-X
neurotransmission B-X
and B-X
Are B-X
there B-X
anxious B-X
genes B-X
? B-X
Request B-X
PDF B-X
| B-X
Functional B-X
polymorphism B-X
( B-X
5-HTTLPR B-X
) B-X
in B-X
the B-X
serotonin B-X
transporter B-X
gene B-X
is B-X
associated B-X
with B-X
subjective B-X
well-being B-X
: B-X
Evidence B-X
from B-X
a B-X
US B-X
nationally B-X
representative B-X
sample B-X
| B-X
Variation B-X
in B-X
the B-X
Transporter-facilitated B-X
uptake B-X
of B-X
serotonin B-X
( B-X
5-hydroxytryptamine B-X
or B-X
5-HT B-X
) B-X
has B-X
been B-X
implicated B-X
in B-X
anxiety B-X
in B-X
humans B-X
and B-X
animal B-X
models B-X
and B-X
is B-X
the B-X
site B-X
of B-X
action B-X
of B-X
widely B-X
used B-X
uptake-inhibiting B-X
antidepressant B-X
Request B-X
PDF B-X
| B-X
Behavioral B-X
inhibition B-X
and B-X
triallelic B-X
genotyping B-X
of B-X
the B-X
serotonin B-X
transporter B-X
promoter B-X
( B-X
5-HTTLPR B-X
) B-X
polymorphism B-X
| B-X
To B-X
examine B-X
the B-X
genetic B-X
bases B-X
of B-X
the B-X
behavioral B-X
inhibition B-X
system B-X
( B-X
BIS B-X
ÌôîÌïôÍ≥µÌïôÏÜåÏû¨Ïó∞Íµ¨Ï†ïÎ≥¥ÏÑºÌÑ∞ B-X
( B-X
CHERIC B-X
) B-X
| B-X
Ïó∞Íµ¨Ï†ïÎ≥¥ B-X
| B-X
Î¨∏ÌóåDB B-X
| B-X
ÌïôÏà†ÏßÄ B-X
Í≤ÄÏÉâ B-X

Phenotypic	O
and	O
genotypic	O
overlap	O
between	O
atelosteogenesis	B-Disease
type	I-Disease
2	I-Disease
and	O
diastrophic	B-Disease
dysplasia	I-Disease
.	O
<EOS> B-X
Abstract B-X
Mutations B-X
in B-X
the B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
gene B-X
DTDST B-X
have B-X
been B-X
associated B-X
with B-X
a B-X
family B-X
of B-X
chondrodysplasias B-X
that B-X
comprises B-X
, B-X
in B-X
order B-X
of B-X
increasing B-X
severity B-X
, B-X
diastrophic B-X
dysplasia B-X
( B-X

Mutations	O
in	O
the	O
diastrophic	B-Disease
dysplasia	I-Disease
sulfate	O
transporter	O
gene	O
DTDST	O
have	O
been	O
associated	O
with	O
a	O
family	O
of	O
chondrodysplasias	B-Disease
that	O
comprises	O
,	O
in	O
order	O
of	O
increasing	O
severity	O
,	O
diastrophic	B-Disease
dysplasia	I-Disease
(	O
DTD	B-Disease
)	O
,	O
atelosteogenesis	B-Disease
type	I-Disease
2	I-Disease
(	O
AO2	B-Disease
)	O
,	O
and	O
achondrogenesis	B-Disease
type	I-Disease
1B	I-Disease
(	O
ACG1B	B-Disease
)	O
.	O
<EOS> B-X
Mutations B-X
in B-X
the B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
( B-X
DTDST B-X
or B-X
SLC26A2 B-X
) B-X
cause B-X
a B-X
family B-X
of B-X
recessively B-X
inherited B-X
chondrodysplasias B-X
including B-X
, B-X
in B-X
order B-X
of B-X
decreasing B-X
severity B-X
, B-X
achondrogenesis B-X
1B B-X
, B-X
Mutated B-X
alleles B-X
of B-X
the B-X
SLC26A2 B-X
( B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
or B-X
DTDST B-X
) B-X
gene B-X
cause B-X
each B-X
of B-X
the B-X
four B-X
recessive B-X
chondrodysplasias B-X
, B-X
i.e. B-X
, B-X
diastrophic B-X
dysplasia B-X
( B-X
DTD B-X
) B-X
, B-X
Diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
( B-X
DTDST B-X
) B-X
is B-X
a B-X
sulfate B-X
transporter B-X
required B-X
for B-X
the B-X
synthesis B-X
of B-X
sulfated B-X
proteoglycans B-X
in B-X
the B-X
cartilage B-X
. B-X
Over B-X
30 B-X
mutations B-X
have B-X
been B-X
described B-X
in B-X
the B-X
Mutations B-X
in B-X
the B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
( B-X
DTDST B-X
) B-X
gene B-X
( B-X
SLC26A2 B-X
) B-X
: B-X
22 B-X
novel B-X
mutations B-X
, B-X
mutation B-X
review B-X
, B-X
associated B-X
skeletal B-X
phenotypes B-X
, B-X
and B-X
diagnostic B-X
relevance B-X
- B-X
Clinical B-X
features B-X
of B-X
achondrogenesis B-X
type B-X
1B B-X
( B-X
ACG1B B-X
) B-X
include B-X
extremely B-X
short B-X
limbs B-X
with B-X
short B-X
fingers B-X
and B-X
toes B-X
, B-X
hypoplasia B-X
of B-X
the B-X
thorax B-X
, B-X
protuberant B-X
abdomen B-X
, B-X
and B-X
hydropic B-X
fetal B-X
Clinical B-X
features B-X
of B-X
atelosteogenesis B-X
type B-X
2 B-X
( B-X
AO2 B-X
) B-X
include B-X
rhizomelic B-X
limb B-X
shortening B-X
with B-X
normal-sized B-X
skull B-X
, B-X
hitchhiker B-X
thumbs B-X
, B-X
small B-X
chest B-X
, B-X
protuberant B-X
abdomen B-X
, B-X
cleft B-X
palate B-X
, B-X
and B-X

To	O
learn	O
more	O
about	O
the	O
molecular	O
basis	O
of	O
DTDST	B-Disease
chondrodysplasias	I-Disease
and	O
about	O
genotype	O
-	O
phenotype	O
correlations	O
,	O
we	O
studied	O
fibroblast	O
cultures	O
of	O
three	O
new	O
patients	O
one	O
with	O
AO	B-Disease
-	I-Disease
2	I-Disease
,	O
one	O
with	O
DTD	B-Disease
,	O
and	O
one	O
with	O
an	O
intermediate	O
phenotype	O
(	O
AO2	B-Disease
/	O
DTD	B-Disease
)	O
.	O
<EOS> B-X
PDF B-X
| B-X
Achondrogenesis B-X
type B-X
1B B-X
( B-X
ACG-1B B-X
) B-X
, B-X
atelosteogenesis B-X
type B-X
2 B-X
( B-X
AO-2 B-X
) B-X
, B-X
and B-X
diastrophic B-X
dysplasia B-X
( B-X
DTD B-X
) B-X
are B-X
recessively B-X
inherited B-X
chondrodysplasias B-X
of B-X
... B-X
| B-X
Find B-X
Interplay B-X
Between B-X
Keratinocytes B-X
and B-X
Fibroblasts B-X
: B-X
A B-X
Systematic B-X
Review B-X
Providing B-X
a B-X
New B-X
Angle B-X
for B-X
Understanding B-X
Skin B-X
Fibrotic B-X
Disorders B-X
Primary B-X
cultured B-X
fibroblasts B-X
derived B-X
from B-X
patients B-X
with B-X
chronic B-X
wounds B-X
: B-X
a B-X
methodology B-X
to B-X
produce B-X
human B-X
cell B-X
lines B-X
and B-X
test B-X
putative B-X
growth B-X
factor B-X
therapy B-X
such B-X
as B-X
GMCSF B-X
Congenital B-X
adrenal B-X
hyperplasia B-X
( B-X
CAH B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
genetic B-X
disorder B-X
due B-X
to B-X
presence B-X
of B-X
mutations B-X
in B-X
the B-X
genes B-X
involved B-X
in B-X
the B-X
metabolism B-X
of B-X
steroid B-X
hormones B-X
in B-X
adrenal B-X
gland B-X
Knowledge B-X
and B-X
research B-X
results B-X
about B-X
hand B-X
osteoarthritis B-X
( B-X
hOA B-X
) B-X
are B-X
limited B-X
due B-X
to B-X
the B-X
lack B-X
of B-X
samples B-X
and B-X
animal B-X
models B-X
of B-X
the B-X
disease B-X
. B-X
Here B-X
, B-X
we B-X
report B-X
the B-X
Abstract B-X
. B-X
The B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
( B-X
DTDST B-X
) B-X
gene B-X
encodes B-X
a B-X
transmembrane B-X
protein B-X
that B-X
transports B-X
sulfate B-X
into B-X
chondrocytes B-X
to B-X
maintain B-X
adequa B-X
Multiple B-X
physiologic B-X
impairments B-X
are B-X
responsible B-X
for B-X
chronic B-X
wounds B-X
. B-X
A B-X
cell B-X
line B-X
grown B-X
which B-X
retains B-X
its B-X
phenotype B-X
from B-X
patient B-X
wounds B-X
would B-X
provide B-X
means B-X
of B-X
testing B-X
new B-X
therapies B-X
. B-X
Clinical B-X
information B-X

Reduced	O
incorporation	O
of	O
inorganic	O
sulfate	O
into	O
macromolecules	O
was	O
found	O
in	O
all	O
three	O
.	O
<EOS> B-X
Microbial B-X
sulfate B-X
reduction B-X
and B-X
organic B-X
sulfur B-X
formation B-X
in B-X
sinking B-X
marine B-X
particles B-X
| B-X
Science B-X
Microbial B-X
sulfate B-X
reduction B-X
and B-X
organic B-X
sulfur B-X
formation B-X
in B-X
sinking B-X
marine B-X
particles B-X
| B-X
Science B-X
The B-X
incorporation B-X
of B-X
[ B-X
35S B-X
] B-X
sulfate B-X
into B-X
heart B-X
proteoglycans B-X
has B-X
been B-X
studied B-X
in B-X
normal B-X
and B-X
alloxan-diabetic B-X
rats B-X
by B-X
perfusion B-X
and B-X
in B-X
vivo B-X
administration B-X
of B-X
Sulfur B-X
assimilation B-X
- B-X
Wikipedia B-X
Autophagy B-X
catabolizes B-X
cellular B-X
constituents B-X
to B-X
promote B-X
survival B-X
during B-X
nutrient B-X
deprivation B-X
. B-X
Yet B-X
, B-X
a B-X
metabolic B-X
comprehension B-X
of B-X
this B-X
recycling B-X
operation B-X
, B-X
despite B-X
its B-X
crucial B-X
importance B-X
, B-X
remains B-X
incomplete B-X
. B-X
Here B-X
Acidic B-X
macromolecules B-X
are B-X
traditionally B-X
considered B-X
key B-X
to B-X
calcium B-X
carbonate B-X
biomineralisation B-X
and B-X
have B-X
long B-X
been B-X
first B-X
choice B-X
in B-X
the B-X
bio-inspired B-X
synthesis B-X
of B-X
crystalline B-X
materials B-X
. B-X
Here B-X
, B-X
we B-X
challenge B-X
this B-X
view B-X
Dimethylsulfoniopropionate B-X
and B-X
Methanethiol B-X
Are B-X
Important B-X
Precursors B-X
of B-X
Methionine B-X
and B-X
Protein-Sulfur B-X
in B-X
Marine B-X
Bacterioplankton B-X

Each	O
of	O
the	O
three	O
patients	O
was	O
found	O
to	O
be	O
heterozygous	O
for	O
a	O
c862t	O
transition	O
predicting	O
a	O
R279W	O
substitution	O
in	O
the	O
third	O
extracellular	O
loop	O
of	O
DTDST	O
.	O
<EOS> B-X
( B-X
PDF B-X
) B-X
Phenotypic B-X
and B-X
genotypic B-X
overlap B-X
between B-X
atelosteogenesis B-X
type B-X
2 B-X
and B-X
diastrophic B-X
dysplasia B-X
| B-X
Wim B-X
Kleijer B-X
- B-X
Academia.edu B-X

In	O
two	O
patients	O
(	O
DTD	B-Disease
and	O
AO2	B-Disease
/	O
DTD	B-Disease
)	O
,	O
no	O
other	O
structural	O
mutation	O
was	O
found	O
,	O
but	O
polymerase	O
chain	O
reaction	O
amplification	O
and	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
analysis	O
of	O
fibroblast	O
cDNA	O
showed	O
reduced	O
mRNA	O
levels	O
of	O
the	O
wild	O
-	O
type	O
DTDST	O
allele	O
these	O
two	O
patients	O
may	O
be	O
compound	O
heterozygotes	O
for	O
the	O
"	O
Finnish	O
"	O
mutation	O
(	O
as	O
yet	O
uncharacterized	O
at	O
the	O
DNA	O
level	O
)	O
,	O
which	O
causes	O
reduced	O
expression	O
of	O
DTDST	O
.	O
<EOS> B-X
A B-X
novel B-X
mutation B-X
in B-X
the B-X
sulfate B-X
transporter B-X
gene B-X
SLC26A2 B-X
( B-X
DTDST B-X
) B-X
specific B-X
to B-X
the B-X
Finnish B-X
population B-X
causes B-X
de B-X
la B-X
Chapelle B-X
dysplasia B-X
Defects B-X
in B-X
sulfate B-X
transport B-X
in B-X
chondrocytes B-X
lead B-X
to B-X
undersulfation B-X
of B-X
the B-X
cartilage B-X
extracellular B-X
matrix B-X
proteoglycans B-X
. B-X
Mutations B-X
in B-X
the B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
( B-X
DTDST B-X
) B-X
gene B-X
have B-X
been B-X
linked B-X
Epigenetic B-X
Silencing B-X
of B-X
the B-X
Sulfate B-X
Transporter B-X
Gene B-X
DTDST B-X
Induces B-X
Sialyl B-X
Lewisx B-X
Expression B-X
and B-X
Accelerates B-X
Proliferation B-X
of B-X
Colon B-X
Cancer B-X
Cells B-X
| B-X
Cancer B-X
Research B-X
Abstract B-X
. B-X
Defects B-X
in B-X
sulfate B-X
transport B-X
in B-X
chondrocytes B-X
lead B-X
to B-X
undersulfation B-X
of B-X
the B-X
cartilage B-X
extracellular B-X
matrix B-X
proteoglycans B-X
. B-X
Mutations B-X
in B-X
the B-X
diastrophic B-X
Abstract B-X
. B-X
Defects B-X
in B-X
sulfate B-X
transport B-X
in B-X
chondrocytes B-X
lead B-X
to B-X
undersulfation B-X
of B-X
the B-X
cartilage B-X
extracellular B-X
matrix B-X
proteoglycans B-X
. B-X
Mutations B-X
in B-X
the B-X
diastrophic B-X
Regulated B-X
transport B-X
of B-X
sulfate B-X
and B-X
oxalate B-X
by B-X
SLC26A2/DTDST B-X
Vitamin B-X
D-dependent B-X
rickets B-X
type B-X
II B-X
is B-X
a B-X
hereditary B-X
disease B-X
resulting B-X
from B-X
a B-X
defective B-X
vitamin B-X
D B-X
receptor B-X
. B-X
In B-X
three B-X
Japanese B-X
patients B-X
with B-X
vitamin B-X
D-dependent B-X
rickets B-X
type B-X
II B-X
whose B-X
fibroblasts B-X
displayed B-X

The	O
third	O
patient	O
(	O
with	O
AO2	B-Disease
)	O
had	O
the	O
R279W	O
mutation	O
compounded	O
with	O
a	O
novel	O
mutation	O
,	O
the	O
deletion	O
of	O
cytosine	O
418	O
(	O
delta	O
c418	O
)	O
,	O
predicting	O
a	O
frameshift	O
with	O
premature	O
termination	O
.	O
<EOS> B-X
We B-X
have B-X
identified B-X
three B-X
new B-X
frameshift B-X
mutations B-X
in B-X
the B-X
CFTR B-X
gene B-X
in B-X
patients B-X
with B-X
cystic B-X
fibrosis B-X
( B-X
CF B-X
) B-X
. B-X
The B-X
first B-X
one B-X
involves B-X
the B-X
deletion B-X
of B-X
an B-X
adenine B-X
nucleotide B-X
Report B-X
of B-X
a B-X
novel B-X
mutation B-X
in B-X
the B-X
SLC26A2 B-X
gene B-X
found B-X
in B-X
a B-X
Colombian B-X
adult B-X
patient B-X
with B-X
diastrophic B-X
dysplasia B-X
We B-X
report B-X
here B-X
two B-X
unrelated B-X
families B-X
in B-X
Japan B-X
and B-X
Korea B-X
having B-X
patients B-X
with B-X
a B-X
unique B-X
type B-X
of B-X
epidermolysis B-X
bullosa B-X
simplex B-X
and B-X
a B-X
novel B-X
mutation B-X
in B-X
the B-X
keratin B-X
gene B-X
KRT5 B-X
, B-X
A B-X
novel B-X
mutation B-X
in B-X
the B-X
sulfate B-X
transporter B-X
gene B-X
SLC26A2 B-X
( B-X
DTDST B-X
) B-X
specific B-X
to B-X
the B-X
Finnish B-X
population B-X
causes B-X
de B-X
la B-X
Chapelle B-X
dysplasia B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Mutations B-X
of B-X
the B-X
gene B-X
encoding B-X
the B-X
alpha-subunit B-X
of B-X
the B-X
lysosomal B-X
enzyme B-X
, B-X
beta-hexosaminidase B-X
, B-X
are B-X
the B-X
cause B-X
of B-X
Tay-Sachs B-X
disease B-X
. B-X
We B-X
previously B-X
showed B-X
that B-X
fibroblasts B-X
from B-X
one B-X
patient B-X
( B-X
We B-X
demonstrate B-X
in B-X
a B-X
large-scale B-X
evaluation B-X
that B-X
the B-X
accuracy B-X
of B-X
KD4i B-X
is B-X
comparable B-X
to B-X
existing B-X
state-of-the-art B-X
methods B-X
. B-X
However B-X
, B-X
a B-X
major B-X
advantage B-X
of B-X
our B-X
approach B-X
is B-X
that B-X
we B-X
also B-X
Mutations B-X
in B-X
the B-X
DTDST B-X
gene B-X
can B-X
result B-X
in B-X
a B-X
family B-X
of B-X
skeletal B-X
dysplasia B-X
conditions B-X
which B-X
comprise B-X
two B-X
lethal B-X
disorders B-X
, B-X
achondrogenesis B-X
type B-X
1B B-X
( B-X
ACG1B B-X
) B-X
and B-X
atelosteogenesis B-X
type B-X
2 B-X

Also	O
the	O
delta	O
c418	O
allele	O
was	O
underrepresented	O
in	O
the	O
cDNA	O
,	O
in	O
accordance	O
with	O
previous	O
observations	O
that	O
premature	O
stop	O
codons	O
reduce	O
mRNA	O
levels	O
.	O
<EOS> B-X
Sandhoff B-X
disease B-X
is B-X
an B-X
autosomal B-X
recessive B-X
lysosomal B-X
storage B-X
disease B-X
resulting B-X
from B-X
mutations B-X
of B-X
the B-X
HEXB B-X
gene B-X
encoding B-X
the B-X
beta B-X
subunit B-X
of B-X
beta-hexosaminidase B-X
A. B-X
Fibroblast B-X
lines B-X
from B-X
four B-X
patients B-X
with B-X
the B-X
Prevalence B-X
and B-X
Distribution B-X
of B-X
Listeria B-X
monocytogenes B-X
inlA B-X
Alleles B-X
Prone B-X
to B-X
Phase B-X
Variation B-X
and B-X
inlA B-X
Alleles B-X
with B-X
Premature B-X
Stop B-X
Codon B-X
Mutations B-X
among B-X
Human B-X
, B-X
Food B-X
, B-X
Animal B-X
, B-X
and B-X
Environmental B-X
Isolates B-X

The	O
presence	O
of	O
the	O
DTDST	O
R279W	O
mutation	O
in	O
a	O
total	O
of	O
11	O
patients	O
with	O
AO2	B-Disease
or	O
DTD	B-Disease
emphasizes	O
the	O
overlap	O
between	O
these	O
conditions	O
.	O
<EOS> B-X
RePub B-X
, B-X
Erasmus B-X
University B-X
Repository B-X
: B-X
Phenotypic B-X
and B-X
genotypic B-X
overlap B-X
between B-X
atelosteogenesis B-X
type B-X
2 B-X
and B-X
diastrophic B-X
dysplasia B-X
Mutations B-X
in B-X
diastrophic B-X
dysplasia B-X
sulfate B-X
transporter B-X
( B-X
DTDST B-X
) B-X
cause B-X
a B-X
spectrum B-X
of B-X
autosomal B-X
recessive B-X
chondrodysplasias B-X
. B-X
In B-X
decreasing B-X
order B-X
of B-X
severity B-X
, B-X
they B-X
include B-X
processes B-X
designated B-X
as B-X
achondrogenesis B-X
type B-X
Protein B-X
Page B-X
: B-X
NP_000103 B-X

This	O
mutation	O
has	O
not	O
been	O
found	O
so	O
far	O
in	O
8	O
analyzed	O
ACG1B	B-Disease
patients	O
,	O
suggesting	O
that	O
it	O
allows	O
some	O
residual	O
activity	O
of	O
the	O
sulfate	O
transporter	O
.	O
.	O
<EOS> B-X
PDF B-X
| B-X
( B-X
Article B-X
was B-X
originally B-X
published B-X
in B-X
Human B-X
Mutation B-X
17:159‚Äì171 B-X
, B-X
2001 B-X
) B-X
1 B-X
. B-X
Figure B-X
2 B-X
reports B-X
a B-X
deletion B-X
933 B-X
del B-X
T. B-X
This B-X
should B-X
be B-X
corrected B-X
to B-X
... B-X

Identification	O
of	O
WASP	O
mutations	O
,	O
mutation	O
hotspots	O
and	O
genotype	O
-	O
phenotype	O
disparities	O
in	O
24	O
patients	O
with	O
the	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
Identification B-X
of B-X
WASP B-X
mutations B-X
in B-X
10 B-X
Australian B-X
families B-X
with B-X
Wiskott‚ÄìAldrich B-X
syndrome B-X
and B-X
X-linked B-X
thrombocytopenia B-X
- B-X
ScienceDirect B-X
Wiskott-Aldrich B-X
syndrome B-X
protein B-X
Phenotypic B-X
and B-X
Genotypic B-X
Correction B-X
of B-X
WASP B-X
Gene B-X
Mutation B-X
in B-X
Wiskott-Aldrich B-X
Syndrome B-X
by B-X
Unrelated B-X
Cord B-X
Blood B-X
Stem B-X
Cell B-X
Transplantation B-X
Unique B-X
and B-X
Recurrent B-X
WAS B-X
Gene B-X
Mutations B-X
in B-X
Wiskott-Aldrich B-X
Syndrome B-X
and B-X
X-Linked B-X
Thrombocytopenia B-X
- B-X
ScienceDirect B-X
Abstract B-X
The B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
, B-X
an B-X
X-linked B-X
immunodeficiency B-X
disease B-X
caused B-X
by B-X
mutation B-X
in B-X
the B-X
recently B-X
isolated B-X
gene B-X
encoding B-X
WAS B-X
protein B-X
( B-X
WASP B-X
) B-X
, B-X
is B-X
known B-X
to B-X
Since B-X
the B-X
full B-X
functionality B-X
of B-X
any B-X
given B-X
protein B-X
can B-X
only B-X
be B-X
understood B-X
in B-X
terms B-X
of B-X
its B-X
interaction B-X
with B-X
other B-X
, B-X
often B-X
regulatory B-X
proteins B-X
, B-X
this B-X
unique B-X
reference B-X
source B-X
covers B-X
all B-X

The	O
Wiskott	B-Disease
-	I-Disease
Aldrich	I-Disease
syndrome	I-Disease
(	O
WAS	B-Disease
)	O
,	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
immunodeficiency	I-Disease
disease	I-Disease
caused	O
by	O
mutation	O
in	O
the	O
recently	O
isolated	O
gene	O
encoding	O
WAS	B-Disease
protein	O
(	O
WASP	O
)	O
,	O
is	O
known	O
to	O
be	O
associated	O
with	O
extensive	O
clinical	O
heterogeneity	O
.	O
<EOS> B-X
Wiskott B-X
Aldrich B-X
Syndrome B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Cancer B-X
heterogeneity B-X
, B-X
long B-X
recognized B-X
as B-X
an B-X
important B-X
clinical B-X
determinant B-X
of B-X
patient B-X
outcomes B-X
, B-X
was B-X
poorly B-X
understood B-X
at B-X
a B-X
molecular B-X
level B-X
. B-X
Genomic B-X
studies B-X
have B-X
significantly B-X
improved B-X
our B-X
understanding B-X
of B-X
Canine B-X
hemangiosarcoma B-X
is B-X
a B-X
highly B-X
aggressive B-X
vascular B-X
neoplasm B-X
associated B-X
with B-X
extensive B-X
clinical B-X
and B-X
anatomical B-X
heterogeneity B-X
and B-X
a B-X
grave B-X
prognosis B-X
. B-X
Comprehensive B-X
molecular B-X
characterization B-X
of B-X
hemangiosarcoma B-X
may B-X
identify B-X
novel B-X
therapeutic B-X
targets B-X
Dissecting B-X
the B-X
Clinical B-X
Heterogeneity B-X
of B-X
Autism B-X
Spectrum B-X
Disorders B-X
through B-X
Defined B-X
Genotypes B-X
Consensus-based B-X
recommendations B-X
for B-X
investigating B-X
clinical B-X
heterogeneity B-X
in B-X
systematic B-X
reviews B-X
Although B-X
the B-X
notion B-X
that B-X
tumors B-X
are B-X
heterogeneous B-X
is B-X
well B-X
rooted B-X
in B-X
diagnostic B-X
pathology B-X
, B-X
the B-X
extent B-X
of B-X
this B-X
heterogeneity B-X
at B-X
the B-X
molecular B-X
level B-X
and B-X
its B-X
impact B-X
on B-X
( B-X
targeted B-X
) B-X
Although B-X
meta-analysis B-X
is B-X
now B-X
well B-X
established B-X
as B-X
a B-X
method B-X
of B-X
reviewing B-X
evidence B-X
, B-X
an B-X
uncritical B-X
use B-X
of B-X
the B-X
technique B-X
can B-X
be B-X
very B-X
misleading B-X
. B-X
One B-X
common B-X
problem B-X
... B-X

Cumulative	O
mutation	O
data	O
have	O
revealed	O
that	O
WASP	O
genotypes	O
are	O
also	O
highly	O
variable	O
among	O
WAS	B-Disease
patients	O
,	O
but	O
the	O
relationship	O
of	O
phenotype	O
with	O
genotype	O
in	O
this	O
disease	O
remains	O
unclear	O
.	O
<EOS> B-X
Cystic B-X
fibrosis B-X
( B-X
CF B-X
) B-X
is B-X
a B-X
monogenic B-X
disease B-X
caused B-X
by B-X
mutations B-X
of B-X
the B-X
cystic B-X
fibrosis B-X
transmembrane B-X
conductance B-X
regulator B-X
( B-X
CFTR B-X
) B-X
gene B-X
. B-X
The B-X
genotype-phenotype B-X
relationship B-X
in B-X
this B-X
disease B-X
Genotype-phenotype B-X
correlation B-X
in B-X
cystic B-X
fibrosis B-X
patients B-X
bearing B-X
[ B-X
H939R B-X
; B-X
H949L B-X
] B-X
allele B-X
Understanding B-X
Genotype-Phenotype B-X
Effects B-X
in B-X
Cancer B-X
via B-X
Network B-X
Approaches B-X
< B-X
i B-X
> B-X
Purpose B-X
< B-X
/i B-X
> B-X
. B-X
Mutations B-X
and B-X
phenotypic B-X
characteristics B-X
remain B-X
unclear B-X
in B-X
patients B-X
with B-X
congenital B-X
hypothyroidism B-X
( B-X
CH B-X
) B-X
, B-X
and B-X
no B-X
study B-X
concerning B-X
whether B-X
the B-X
outcome B-X
MIGRATE-N B-X
citations B-X
-- B-X
January B-X
2011 B-X

To	O
address	O
this	O
issue	O
we	O
characterized	O
WASP	O
mutations	O
in	O
24	O
unrelated	O
WAS	B-Disease
patients	O
,	O
including	O
18	O
boys	O
with	O
severe	O
classical	O
WAS	B-Disease
and	O
6	O
boys	O
expressing	O
mild	O
forms	O
of	O
the	O
disease	O
,	O
and	O
then	O
examined	O
the	O
degree	O
of	O
correlation	O
of	O
these	O
as	O
well	O
as	O
all	O
previously	O
published	O
WASP	O
mutations	O
with	O
disease	O
severity	O
.	O
<EOS> B-X
Clinical B-X
course B-X
of B-X
patients B-X
with B-X
WASP B-X
gene B-X
mutations B-X
- B-X
ScienceDirect B-X
The B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
, B-X
an B-X
X-linked B-X
immunodeficiency B-X
disease B-X
caused B-X
by B-X
mutation B-X
in B-X
the B-X
recently B-X
isolated B-X
gene B-X
encoding B-X
WAS B-X
protein B-X
( B-X
WASP B-X
) B-X
, B-X
is B-X
known B-X
to B-X
be B-X
Background B-X
: B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
a B-X
rare B-X
and B-X
severe B-X
X-linked B-X
disorder B-X
with B-X
variable B-X
clinical B-X
phenotypes B-X
correlating B-X
with B-X
the B-X
type B-X
of B-X
mutations B-X
in B-X
the B-X
WAS B-X
gene B-X
. B-X
The B-X
Nuclear B-X
Role B-X
of B-X
WASp B-X
in B-X
the B-X
Pathogenesis B-X
of B-X
Dysregulated B-X
TH1 B-X
Immunity B-X
in B-X
Human B-X
Wiskott-Aldrich B-X
Syndrome B-X
High B-X
Prevalence B-X
of B-X
Nonsense B-X
, B-X
Frame B-X
Shift B-X
, B-X
and B-X
Splice-Site B-X
Mutations B-X
in B-X
16 B-X
Patients B-X
With B-X
Full-Blown B-X
Wiskott-Aldrich B-X
Syndrome B-X
- B-X
ScienceDirect B-X
Boys B-X
affected B-X
with B-X
Wiskott‚ÄìAldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
present B-X
with B-X
variable B-X
association B-X
of B-X
thrombocytopenia B-X
, B-X
eczema B-X
and B-X
immune B-X
deficiency B-X
. B-X
If B-X
untreated B-X
, B-X
WAS B-X
patients B-X
may B-X
succumb B-X
to B-X
intracerebral B-X
hemorrhages B-X
Mutations B-X
of B-X
the B-X
Wiskott-Aldrich B-X
Syndrome B-X
Protein B-X
( B-X
WASP B-X
) B-X
: B-X
hotspots B-X
, B-X
effect B-X
on B-X
transcription B-X
, B-X
and B-X
translation B-X
and B-X
phenotype/genotype B-X
correlation B-X
- B-X
ScienceDirect B-X

By	O
analysis	O
of	O
these	O
compiled	O
mutation	O
data	O
,	O
we	O
demonstrated	O
clustering	O
of	O
WASP	O
mutations	O
within	O
the	O
four	O
most	O
N	O
-	O
terminal	O
exons	O
of	O
the	O
gene	O
and	O
also	O
identified	O
several	O
sites	O
within	O
this	O
region	O
as	O
hotspots	O
for	O
WASP	O
mutation	O
.	O

These	O
characteristics	O
were	O
observed	O
,	O
however	O
,	O
in	O
both	O
severe	O
and	O
mild	O
cases	O
of	O
the	O
disease	O
.	O
<EOS> B-X
AbstractBackground B-X
. B-X
The B-X
course B-X
of B-X
disease B-X
in B-X
mild B-X
and B-X
moderate B-X
COVID-19 B-X
has B-X
many B-X
implications B-X
for B-X
mobile B-X
patients B-X
, B-X
such B-X
as B-X
the B-X
risk B-X
of B-X
spread B-X
of B-X
the B-X
infection B-X
, B-X
COVID-19 B-X
patients B-X
experience B-X
a B-X
wide B-X
range B-X
of B-X
disease B-X
severity B-X
. B-X
Why B-X
do B-X
some B-X
people B-X
get B-X
severe B-X
and B-X
life-threatening B-X
illness B-X
, B-X
while B-X
others B-X
suffer B-X
no B-X
symptoms B-X
or B-X
just B-X
mild B-X
ones B-X
? B-X
Symptoms B-X
and B-X
signs B-X
, B-X
severity B-X
, B-X
complications B-X
of B-X
COVID-19 B-X
infection B-X
Improving B-X
surveillance B-X
through B-X
routine B-X
reporting B-X
of B-X
occupation B-X
and B-X
industry B-X
not B-X
only B-X
benefits B-X
health B-X
care B-X
personnel B-X
, B-X
but B-X
all B-X
workers B-X
during B-X
the B-X
coronavirus B-X
disease B-X
2019 B-X
pandemic B-X
. B-X
Digestive B-X
Symptoms B-X
in B-X
COVID-19 B-X
Patients B-X
With B-X
Mild B-X
Disease B-X
Severity B-X
: B-X
Clinical B-X
Presentation B-X
, B-X
Stool B-X
Viral B-X
RNA B-X
Testing B-X
, B-X
and B-X
Outcomes B-X
WHO B-X
fact B-X
sheet B-X
dengue B-X
and B-X
severe B-X
dengue B-X
provides B-X
key B-X
facts B-X
, B-X
definition B-X
, B-X
provides B-X
information B-X
on B-X
global B-X
burden B-X
, B-X
transmission B-X
, B-X
characteristics B-X
, B-X
treatment B-X
, B-X
prevention B-X
and B-X
control B-X
and B-X
WHO B-X
Clinicians B-X
, B-X
discover B-X
how B-X
you B-X
can B-X
best B-X
care B-X
for B-X
your B-X
hospitalized B-X
patients B-X
with B-X
a B-X
confirmed B-X
infection B-X
caused B-X
by B-X
novel B-X
coronavirus B-X
2019 B-X
( B-X
COVID-19 B-X
) B-X
. B-X

Similarly	O
,	O
while	O
the	O
cumulative	O
data	O
revealed	O
a	O
predominance	O
of	O
missense	O
mutations	O
among	O
the	O
WASP	O
gene	O
lesions	O
observed	O
in	O
boys	O
with	O
isolated	B-Disease
thrombocytopenia	I-Disease
,	O
missense	O
mutations	O
were	O
not	O
exclusively	O
associated	O
with	O
milder	O
WAS	B-Disease
phenotypes	O
,	O
but	O
also	O
comprised	O
a	O
substantial	O
portion	O
(	O
38	O
%	O
)	O
of	O
the	O
WASP	O
gene	O
defects	O
found	O
in	O
patients	O
with	O
severe	O
disease	O
.	O
<EOS> B-X
Inherited B-X
platelet B-X
disorders B-X
: B-X
thrombocytopenias B-X
and B-X
thrombocytopathies B-X
Abstract B-X
. B-X
Congenital B-X
thrombocytopenias B-X
, B-X
once B-X
considered B-X
rare B-X
and B-X
obscure B-X
conditions B-X
, B-X
are B-X
today B-X
recognized B-X
with B-X
increasing B-X
frequency B-X
, B-X
especially B-X
due B-X
to B-X
the B-X
measu B-X
Abstract B-X
. B-X
The B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
an B-X
X-linked B-X
immunodeficiency B-X
disease B-X
with B-X
a B-X
characteristic B-X
clinical B-X
phenotype B-X
that B-X
includes B-X
thrombocytopenia B-X
wit B-X
Human B-X
Phenotypes B-X
Associated B-X
with B-X
GATA-1 B-X
Mutations B-X
Download B-X
Citation B-X
| B-X
Two B-X
novel B-X
mutations B-X
of B-X
Wiskott B-X
- B-X
Aldrich B-X
syndrome B-X
: B-X
The B-X
molecular B-X
prediction B-X
of B-X
interaction B-X
between B-X
the B-X
mutated B-X
WASP B-X
L101P B-X
with B-X
WASP-interacting B-X
protein B-X
by B-X
molecular B-X
modeling B-X
| B-X
Wiskott-Aldrich B-X
Unregulated B-X
actin B-X
polymerization B-X
by B-X
WASp B-X
causes B-X
defects B-X
of B-X
mitosis B-X
and B-X
cytokinesis B-X
in B-X
X-linked B-X
neutropenia B-X
Download B-X
Citation B-X
| B-X
Outcomes B-X
Following B-X
Gene B-X
Therapy B-X
in B-X
Patients B-X
With B-X
Severe B-X
Wiskott-Aldrich B-X
Syndrome B-X
| B-X
Wiskott-Aldrich B-X
syndrome B-X
is B-X
a B-X
rare B-X
primary B-X
immunodeficiency B-X
associated B-X
with B-X
severe B-X
microthrombocytopenia B-X
. B-X
Partially B-X
HLA B-X
antigen-matched B-X
allogeneic B-X

These	O
findings	O
,	O
as	O
well	O
as	O
the	O
detection	O
of	O
identical	O
WASP	O
mutations	O
in	O
patients	O
with	O
disparate	O
phenotypes	O
,	O
reveal	O
a	O
lack	O
of	O
phenotype	O
concordance	O
with	O
genotype	O
in	O
WAS	B-Disease
and	O
thus	O
imply	O
that	O
phenotypic	O
outcome	O
in	O
this	O
disease	O
cannot	O
be	O
reliably	O
predicted	O
solely	O
on	O
the	O
basis	O
of	O
WASP	O
genotypes	O
.	O
.	O
<EOS> B-X
JCI B-X
- B-X
Second-site B-X
mutation B-X
in B-X
the B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
protein B-X
gene B-X
causes B-X
somatic B-X
mosaicism B-X
in B-X
two B-X
WAS B-X
siblings B-X
Whole-Genome B-X
Sequencing B-X
and B-X
Concordance B-X
Between B-X
Antimicrobial B-X
Susceptibility B-X
Genotypes B-X
and B-X
Phenotypes B-X
of B-X
Bacterial B-X
Isolates B-X
Associated B-X
with B-X
Bovine B-X
Respiratory B-X
Disease B-X
Genetic B-X
variations B-X
within B-X
the B-X
cytochrome B-X
P450 B-X
( B-X
CYP450 B-X
) B-X
superfamily B-X
of B-X
drug B-X
metabolizing B-X
enzymes B-X
confer B-X
substantial B-X
person-to-person B-X
and B-X
between-population B-X
differences B-X
in B-X
pharmacokinetics B-X
, B-X
and B-X
by B-X
extension B-X
, B-X
highly B-X
variable B-X
clinical B-X
Request B-X
PDF B-X
| B-X
Structural B-X
basis B-X
of B-X
Wiscott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
causing B-X
mutations B-X
in B-X
the B-X
WH1 B-X
domain B-X
| B-X
Wiskott-Aldrich B-X
syndrome B-X
( B-X
WAS B-X
) B-X
is B-X
an B-X
X-linked B-X
recessive B-X
immunodeficiency B-X
disease B-X
associated B-X
PDF B-X
| B-X
It B-X
is B-X
worthy B-X
to B-X
supplement B-X
Charney B-X
with B-X
two B-X
historical B-X
issues B-X
: B-X
( B-X
1 B-X
) B-X
There B-X
were B-X
two B-X
rival B-X
trends B-X
in B-X
the B-X
rebirth B-X
of B-X
genetic B-X
thought B-X
in B-X
the B-X
1960s B-X

Germline	O
mutations	O
in	O
the	O
3	O
'	O
part	O
of	O
APC	B-Disease
exon	O
15	O
do	O
not	O
result	O
in	O
truncated	O
proteins	O
and	O
are	O
associated	O
with	O
attenuated	O
adenomatous	B-Disease
polyposis	I-Disease
coli	I-Disease
.	O
<EOS> B-X
Abstract B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
is B-X
an B-X
inherited B-X
predisposition B-X
to B-X
colorectal B-X
cancer B-X
characterized B-X
by B-X
the B-X
development B-X
of B-X
numerous B-X
adenomatous B-X
polyps B-X
predominantly B-X
in B-X
the B-X
colorectal B-X
region B-X
. B-X
Germline B-X
mutations B-X
Large B-X
submicroscopic B-X
genomic B-X
APC B-X
deletions B-X
are B-X
a B-X
common B-X
cause B-X
of B-X
typical B-X
familial B-X
adenomatous B-X
polyposis B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
APC B-X
gene B-X
: B-X
database B-X
of B-X
germline B-X
and B-X
somatic B-X
mutations B-X
in B-X
human B-X
tumors B-X
and B-X
cell B-X
lines B-X
. B-X

Familial	B-Disease
adenomatous	I-Disease
polyposis	I-Disease
(	O
FAP	B-Disease
)	O
is	O
an	O
inherited	O
predisposition	O
to	O
colorectal	B-Disease
cancer	I-Disease
characterized	O
by	O
the	O
development	O
of	O
numerous	O
adenomatous	B-Disease
polyps	I-Disease
predominantly	O
in	O
the	O
colorectal	O
region	O
.	O
<EOS> B-X
Familial B-X
adenomatous B-X
polyposis B-X
in B-X
China B-X
( B-X
Review B-X
) B-X

Germline	O
mutations	O
in	O
the	O
adenomatous	B-Disease
polyposis	I-Disease
coli	I-Disease
(	O
APC	B-Disease
)	O
gene	O
are	O
responsible	O
for	O
most	O
cases	O
of	O
FAP	B-Disease
.	O
<EOS> B-X
APC B-X
germline B-X
mutations B-X
in B-X
families B-X
with B-X
familial B-X
adenomatous B-X
polyposis B-X
A B-X
small B-X
fraction B-X
of B-X
families B-X
with B-X
familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
display B-X
an B-X
attenuated B-X
form B-X
of B-X
FAP B-X
( B-X
AFAP B-X
) B-X
. B-X
We B-X
aimed B-X
to B-X
assess B-X
the B-X
presence B-X
of B-X
germline B-X
A B-X
novel B-X
APC B-X
mutation B-X
identified B-X
in B-X
a B-X
large B-X
Chinese B-X
family B-X
with B-X
familial B-X
adenomatous B-X
polyposis B-X
and B-X
a B-X
brief B-X
literature B-X
review B-X
Desmoids B-X
are B-X
locally B-X
aggressive B-X
, B-X
non-metastasizing B-X
soft-tissue B-X
tumours B-X
, B-X
whose B-X
aetiology B-X
is B-X
still B-X
unclear B-X
. B-X
In B-X
patients B-X
affected B-X
with B-X
familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
, B-X
the B-X
incidence B-X
of B-X
desmoids B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
characterized B-X
by B-X
the B-X
development B-X
of B-X
hundreds B-X
to B-X
thousands B-X
of B-X
colonic B-X
adenomas B-X
and B-X
an B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
patients B-X
develop B-X
various B-X
extracolonic B-X
lesions B-X
, B-X
among B-X
which B-X
functional B-X
adrenocortical B-X
neoplasms B-X
are B-X
infrequent B-X
. B-X
A B-X
44-year-old B-X
woman B-X
was B-X
hospitalized B-X
because B-X
of B-X
pseudo-Meigs B-X
' B-X
syndrome B-X

Mutations	O
at	O
the	O
5	O
end	O
of	O
APC	B-Disease
are	O
known	O
to	O
be	O
associated	O
with	O
a	O
relatively	O
mild	O
form	O
of	O
the	O
disease	O
,	O
called	O
attenuated	B-Disease
adenomatous	I-Disease
polyposis	I-Disease
coli	I-Disease
(	O
AAPC	B-Disease
)	O
.	O
<EOS> B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
is B-X
an B-X
inherited B-X
predisposition B-X
to B-X
colorectal B-X
cancer B-X
characterized B-X
by B-X
the B-X
development B-X
of B-X
numerous B-X
adenomatous B-X
polyps B-X
p B-X
Request B-X
PDF B-X
| B-X
The B-X
mutation B-X
spectrum B-X
of B-X
the B-X
APC B-X
gene B-X
in B-X
FAP B-X
patients B-X
from B-X
southern B-X
Italy B-X
: B-X
Detection B-X
of B-X
known B-X
and B-X
four B-X
novel B-X
mutations B-X
| B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X

We	O
identified	O
a	O
frameshift	O
mutation	O
in	O
the	O
3	O
part	O
of	O
exon	O
15	O
,	O
resulting	O
in	O
a	O
stop	O
codon	O
at	O
1862	O
,	O
in	O
a	O
large	O
Dutch	O
kindred	O
with	O
AAPC	B-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Eleven B-X
novel B-X
APC B-X
mutations B-X
identified B-X
in B-X
Portuguese B-X
FAP B-X
families B-X
| B-X
Germline B-X
mutations B-X
of B-X
the B-X
adenomatous B-X
polyposis B-X
coli B-X
( B-X
APC B-X
) B-X
gene B-X
are B-X
responsible B-X
for B-X
familial B-X
adenomatous B-X
polyposis B-X
Request B-X
PDF B-X
| B-X
On B-X
Apr B-X
1 B-X
, B-X
2017 B-X
, B-X
Revital B-X
Kariv B-X
and B-X
others B-X
published B-X
Treatment B-X
of B-X
Familial B-X
Adenomatous B-X
Polyposis B-X
Patients B-X
with B-X
APC B-X
Stop B-X
Codon B-X
Mutation B-X
by B-X
Read-Through B-X
| B-X
Find B-X
, B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X
) B-X
is B-X
an B-X
inherited B-X
predisposition B-X
to B-X
colorectal B-X
cancer B-X
characterized B-X
by B-X
the B-X
development B-X
of B-X
numerous B-X
adenomatous B-X
polyps B-X
p B-X

Western	O
blot	O
analysis	O
of	O
lymphoblastoid	O
cell	O
lines	O
derived	O
from	O
affected	O
family	O
members	O
from	O
this	O
kindred	O
,	O
as	O
well	O
as	O
from	O
a	O
previously	O
reported	O
Swiss	O
family	O
carrying	O
a	O
frameshift	O
mutation	O
at	O
codon	O
1987	O
and	O
displaying	O
a	O
similar	O
attenuated	O
phenotype	O
,	O
showed	O
only	O
the	O
wild	O
-	O
type	O
APC	B-Disease
protein	O
.	O
<EOS> B-X
This B-X
study B-X
evaluated B-X
the B-X
potential B-X
contribution B-X
of B-X
the B-X
APC B-X
gene B-X
to B-X
malignant B-X
transformation B-X
in B-X
patients B-X
with B-X
renal B-X
cell B-X
carcinoma B-X
. B-X
We B-X
tested B-X
36 B-X
human B-X
renal B-X
cell B-X
carcinoma B-X
samples B-X
and B-X
18 B-X
Abstract B-X
. B-X
To B-X
date B-X
, B-X
two B-X
point B-X
mutations B-X
, B-X
G209A B-X
and B-X
G88C B-X
, B-X
have B-X
been B-X
reported B-X
in B-X
the B-X
coding B-X
region B-X
of B-X
the B-X
Œ±‚Äêsynuclein B-X
gene B-X
in B-X
autosomal B-X
dominant B-X
familial B-X
Parkinson B-X
FULL B-X
TEXT B-X
Abstract B-X
: B-X
Several B-X
mitochondrial B-X
tRNA B-X
mutations B-X
have B-X
been B-X
associated B-X
with B-X
hypertension B-X
, B-X
but B-X
their B-X
pathophysiology B-X
remains B-X
poorly B-X
understood B-X
. B-X
In B-X
this B-X
report B-X
, B-X
... B-X
A B-X
deafness-associated B-X
tRNAHis B-X
mutation B-X
alters B-X
the B-X
mitochondrial B-X
function B-X
, B-X
ROS B-X
production B-X
and B-X
membrane B-X
potential B-X
A B-X
deafness-associated B-X
tRNAAsp B-X
mutation B-X
alters B-X
the B-X
m1G37 B-X
modification B-X
, B-X
aminoacylation B-X
and B-X
stability B-X
of B-X
tRNAAsp B-X
and B-X
mitochondrial B-X
function B-X
PDF B-X
| B-X
The B-X
authors B-X
of B-X
the B-X
above B-X
paper B-X
wish B-X
to B-X
note B-X
that B-X
the B-X
codon B-X
corresponding B-X
to B-X
the B-X
mutation B-X
at B-X
the B-X
nucleotide B-X
4921 B-X
is B-X
given B-X
incorrectly B-X
in B-X
the B-X
text B-X
... B-X
| B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
Analysis B-X
of B-X
the B-X
APC B-X
and B-X
MYH B-X
Genes B-X
in B-X
Czech B-X
Families B-X
Affected B-X
by B-X
FAP B-X
or B-X
Multiple B-X
Adenomas B-X
: B-X
13 B-X
Novel B-X
Mutations B-X
| B-X
Familial B-X
adenomatous B-X
polyposis B-X
( B-X
FAP B-X

Our	O
study	O
indicates	O
that	O
chain	O
-	O
terminating	O
mutations	O
located	O
in	O
the	O
3	O
part	O
of	O
APC	B-Disease
do	O
not	O
result	O
in	O
detectable	O
truncated	O
polypeptides	O
and	O
we	O
hypothesize	O
that	O
this	O
is	O
likely	O
to	O
be	O
the	O
basis	O
for	O
the	O
observed	O
AAPC	B-Disease
phenotype	O
.	O
.	O
<EOS> B-X
APC B-X
mutations B-X
introduce B-X
premature B-X
stop B-X
codons B-X
into B-X
the B-X
open B-X
reading B-X
frame B-X
of B-X
the B-X
gene B-X
, B-X
leading B-X
to B-X
the B-X
formation B-X
of B-X
truncated B-X
tumor B-X
suppressor B-X
proteins B-X
. B-X
Both B-X
RNA B-X
and B-X
protein B-X
levels B-X
Request B-X
PDF B-X
| B-X
Somatic B-X
Apc B-X
mutations B-X
are B-X
selected B-X
upon B-X
their B-X
capacity B-X
to B-X
inactivate B-X
the B-X
beta-catenin B-X
downregulating B-X
activity B-X
| B-X
The B-X
APC B-X
gene B-X
, B-X
originally B-X
identified B-X
as B-X
the B-X
gene B-X
for B-X
familial B-X
adenomatous B-X
Attenuated B-X
APC B-X
alleles B-X
produce B-X
functional B-X
protein B-X
from B-X
internal B-X
translation B-X
initiation B-X
Request B-X
PDF B-X
| B-X
Genetic B-X
alterations B-X
of B-X
the B-X
APC B-X
gene B-X
in B-X
familial B-X
adenomatous B-X
polyposis B-X
patients B-X
of B-X
the B-X
hellenic B-X
group B-X
for B-X
the B-X
study B-X
of B-X
colorectal B-X
cancer B-X
| B-X
Familial B-X
Adenomatous B-X
Polyposis B-X
( B-X
FAP B-X
Request B-X
PDF B-X
| B-X
APC B-X
Haploinsufficiency B-X
, B-X
but B-X
Not B-X
CTNNB1 B-X
or B-X
CDH1 B-X
Gene B-X
Mutations B-X
, B-X
Accounts B-X
for B-X
a B-X
Fraction B-X
of B-X
Familial B-X
Adenomatous B-X
Polyposis B-X
Patients B-X
Without B-X
APC B-X
Truncating B-X
Mutations B-X
| B-X
Familial B-X
adenomatous B-X

Complete	O
genomic	O
sequence	O
and	O
analysis	O
of	O
117	O
kb	O
of	O
human	O
DNA	O
containing	O
the	O
gene	O
BRCA1	O
.	O
<EOS> B-X
Table B-X
4 B-X
. B-X
Positions B-X
of B-X
Exons B-X
for B-X
Genes B-X
in B-X
the B-X
BRCA1 B-X
Contig B-X
- B-X
`` B-X
Complete B-X
Genomic B-X
Sequence B-X
and B-X
Analysis B-X
of B-X
117 B-X
kb B-X
of B-X
Human B-X
DNA B-X
Containing B-X
the B-X
Gene B-X
BRCAI B-X
'' B-X
Over B-X
100 B-X
distinct B-X
disease-associated B-X
mutations B-X
have B-X
been B-X
identified B-X
in B-X
the B-X
breast-ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
BRCA1 B-X
. B-X
Loss B-X
of B-X
the B-X
wild-type B-X
allele B-X
in B-X
> B-X
90 B-X
% B-X
of B-X
tumors B-X
from B-X
patients B-X
with B-X
To B-X
date B-X
, B-X
more B-X
than B-X
300 B-X
distinct B-X
small B-X
deletions B-X
, B-X
insertions B-X
and B-X
point B-X
mutations B-X
, B-X
mostly B-X
leading B-X
to B-X
premature B-X
termination B-X
of B-X
translation1 B-X
, B-X
have B-X
been B-X
reported B-X
in B-X
the B-X
breast/ovarian-cancer B-X
susceptibility B-X
Germ-line B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
cause B-X
hereditary B-X
predisposition B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
account B-X
for B-X
about B-X
40 B-X
% B-X
of B-X
high-risk B-X
families B-X
. B-X
Mutation-screening B-X
methods B-X
An B-X
international B-X
, B-X
peer-reviewed B-X
genome B-X
sciences B-X
journal B-X
featuring B-X
outstanding B-X
original B-X
research B-X
that B-X
offers B-X
novel B-X
insights B-X
into B-X
the B-X
biology B-X
of B-X
all B-X
organisms B-X
scientific B-X
article B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Over	O
100	O
distinct	O
disease	O
-	O
associated	O
mutations	O
have	O
been	O
identified	O
in	O
the	O
breast	B-Disease
-	I-Disease
ovarian	I-Disease
cancer	I-Disease
susceptibility	O
gene	O
BRCA1	O
.	O
<EOS> B-X
Mutations B-X
in B-X
BRCA1 B-X
, B-X
BRCA2 B-X
and B-X
other B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
genes B-X
in B-X
Central B-X
and B-X
South B-X
American B-X
populations B-X

Loss	O
of	O
the	O
wild	O
-	O
type	O
allele	O
in	O
>	O
90	O
%	O
of	O
tumors	B-Disease
from	O
patients	O
with	O
inherited	O
BRCA1	O
mutations	O
indicates	O
tumor	B-Disease
suppressive	O
function	O
.	O

The	O
low	O
incidence	O
of	O
somatic	O
mutations	O
suggests	O
that	O
BRCA1	O
inactivation	O
in	O
sporadic	O
tumors	B-Disease
occurs	O
by	O
alternative	O
mechanisms	O
,	O
such	O
as	O
interstitial	O
chromosomal	O
deletion	O
or	O
reduced	O
transcription	O
.	O
<EOS> B-X
Genomic B-X
structure B-X
of B-X
chromosome B-X
17 B-X
deletions B-X
in B-X
BRCA1 B-X
associated B-X
ovarian B-X
cancers B-X
Request B-X
PDF B-X
| B-X
A B-X
sporadic B-X
breast B-X
tumor B-X
with B-X
a B-X
somatically B-X
acquired B-X
complex B-X
genomic B-X
rearrangement B-X
in B-X
BRCA1 B-X
| B-X
Germ-line B-X
mutations B-X
in B-X
BRCA1 B-X
cause B-X
a B-X
substantial B-X
proportion B-X
of B-X
inherited B-X
breast B-X
cancer B-X
, B-X
Abstract B-X
. B-X
Mutations B-X
of B-X
the B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
1 B-X
( B-X
BRCA1 B-X
) B-X
account B-X
for B-X
about B-X
40-45 B-X
% B-X
of B-X
hereditary B-X
breast B-X
cancer B-X
cases B-X
. B-X
Moreover B-X
, B-X
a B-X
significant B-X
Pancreatic B-X
Cancer B-X
: B-X
Molecular B-X
Characterization B-X
, B-X
Clonal B-X
Evolution B-X
and B-X
Cancer B-X
Stem B-X
Cells B-X
Loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
) B-X
involving B-X
several B-X
chromosome B-X
3p B-X
regions B-X
accompanied B-X
by B-X
chromosome B-X
3p B-X
deletions B-X
are B-X
detected B-X
in B-X
almost B-X
100 B-X
% B-X
of B-X
small B-X
( B-X
SCLCs B-X
) B-X
and B-X
more B-X
than B-X
NBR1 B-X
| B-X
Cancer B-X
Genetics B-X
Web B-X

To	O
identify	O
possible	O
features	O
of	O
the	O
BRCA1	O
genomic	O
region	O
that	O
may	O
contribute	O
to	O
chromosomal	O
instability	O
as	O
well	O
as	O
potential	O
transcriptional	O
regulatory	O
elements	O
,	O
a	O
117	O
,	O
143	O
-	O
bp	O
DNA	O
sequence	O
encompassing	O
BRCA1	O
was	O
obtained	O
by	O
random	O
sequencing	O
of	O
four	O
cosmids	O
identified	O
from	O
a	O
human	O
chromosome	O
17	O
specific	O
library	O
.	O
<EOS> B-X
Complete B-X
genomic B-X
sequence B-X
and B-X
analysis B-X
of B-X
117 B-X
kb B-X
of B-X
human B-X
DNA B-X
containing B-X
the B-X
gene B-X
BRCA1 B-X
. B-X
Reviewing B-X
the B-X
characteristics B-X
of B-X
BRCA B-X
and B-X
PALB2-related B-X
cancers B-X
in B-X
the B-X
precision B-X
medicine B-X
era B-X
Non-Coding B-X
Variants B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Genes B-X
: B-X
Potential B-X
Impact B-X
on B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
Predisposition B-X
BRCA1 B-X
Recruitment B-X
to B-X
Transcriptional B-X
Pause B-X
Sites B-X
Is B-X
Required B-X
for B-X
R-Loop-Driven B-X
DNA B-X
Damage B-X
Repair B-X
Over B-X
100 B-X
distinct B-X
disease-associated B-X
mutations B-X
have B-X
been B-X
identified B-X
in B-X
the B-X
breast-ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
BRCA1 B-X
. B-X
Loss B-X
of B-X
the B-X
wild-type B-X
allele B-X
in B-X
> B-X
90 B-X
% B-X
of B-X
tumors B-X
from B-X
patients B-X
with B-X
The B-X
prima B-X
donna B-X
of B-X
epigenetics B-X
: B-X
the B-X
regulation B-X
of B-X
gene B-X
expression B-X
by B-X
DNA B-X
methylation B-X
The B-X
present B-X
invention B-X
relates B-X
generally B-X
to B-X
the B-X
field B-X
of B-X
human B-X
genetics B-X
. B-X
Specifically B-X
, B-X
the B-X
present B-X
invention B-X
relates B-X
to B-X
methods B-X
and B-X
materials B-X
used B-X
to B-X
isolate B-X
and B-X
detect B-X
a B-X
human B-X
breast B-X

The	O
24	O
exons	O
of	O
BRCA1	O
span	O
an	O
81	O
-	O
kb	O
region	O
that	O
has	O
an	O
unusually	O
high	O
density	O
of	O
Alu	O
repetitive	O
DNA	O
(	O
41	O
.	O
5	O
%	O
)	O
,	O
but	O
relatively	O
low	O
density	O
(	O
4	O
.	O
8	O
%	O
)	O
of	O
other	O
repetitive	O
sequences	O
.	O
<EOS> B-X
Polyploid B-X
formation B-X
has B-X
played B-X
a B-X
major B-X
role B-X
in B-X
the B-X
evolution B-X
of B-X
many B-X
plant B-X
and B-X
animal B-X
genomes B-X
; B-X
however B-X
, B-X
surprisingly B-X
little B-X
is B-X
known B-X
regarding B-X
the B-X
subsequent B-X
evolution B-X
of B-X
DNA B-X
sequences B-X
Bat B-X
genomes B-X
are B-X
characterised B-X
by B-X
an B-X
A-T B-X
richness B-X
and B-X
by B-X
a B-X
small B-X
C-value B-X
compared B-X
with B-X
other B-X
mammalian B-X
groups B-X
. B-X
It B-X
has B-X
been B-X
suggested B-X
that B-X
the B-X
small B-X
C-value B-X
is B-X
mainly B-X
due B-X
Download B-X
Citation B-X
| B-X
Genomic B-X
rearrangements B-X
in B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
| B-X
Mutations B-X
in B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
predispose B-X
women B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
. B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Repetitive B-X
Sequences B-X
in B-X
Plant B-X
Nuclear B-X
DNA B-X
: B-X
Types B-X
, B-X
Distribution B-X
, B-X
Evolution B-X
and B-X
Function B-X
Large B-X
contrasts B-X
are B-X
observed B-X
between B-X
the B-X
messenger B-X
RNA B-X
populations B-X
of B-X
different B-X
tissues B-X
and B-X
of B-X
embryos B-X
at B-X
different B-X
stages B-X
of B-X
development B-X
. B-X
Nevertheless B-X
, B-X
coding B-X
sequences B-X
for B-X
genes B-X
not B-X
expressed B-X
in B-X
Six B-X
R B-X
sequences B-X
have B-X
been B-X
described B-X
as B-X
members B-X
of B-X
a B-X
new B-X
family B-X
of B-X
dispersed B-X
repetitive B-X
DNA B-X
in B-X
the B-X
mouse B-X
genome B-X
( B-X
Gebhard B-X
et B-X
al. B-X
, B-X
1982 B-X
) B-X
. B-X
Several B-X
sequenced B-X
PDF B-X
| B-X
Genetic B-X
linkage B-X
data B-X
have B-X
shown B-X
that B-X
alterations B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
are B-X
responsible B-X
for B-X
the B-X
majority B-X
of B-X
hereditary B-X
breast-ovarian B-X
cancers B-X
. B-X
However B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X

BRCA1	O
intron	O
lengths	O
range	O
in	O
size	O
from	O
403	O
bp	O
to	O
9	O
.	O
<EOS> B-X
Evaluation B-X
of B-X
a B-X
Next-Generation B-X
Sequencing B-X
Assay B-X
for B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Mutation B-X
Detection B-X
- B-X
ScienceDirect B-X
PDF B-X
| B-X
BRCA1 B-X
( B-X
breast B-X
cancer B-X
1 B-X
, B-X
early B-X
onset B-X
) B-X
, B-X
a B-X
well-known B-X
breast B-X
cancer B-X
susceptibility B-X
gene B-X
, B-X
is B-X
a B-X
highly B-X
alternatively B-X
spliced B-X
gene B-X
. B-X
BRCA1 B-X
alternative B-X
... B-X
| B-X
Long-Range B-X
PCR B-X
and B-X
Next-Generation B-X
Sequencing B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
in B-X
Breast B-X
Cancer B-X
- B-X
ScienceDirect B-X
Download B-X
Citation B-X
| B-X
Gross B-X
rearrangements B-X
in B-X
BRCA1 B-X
but B-X
not B-X
BRCA2 B-X
play B-X
a B-X
notable B-X
role B-X
in B-X
predisposition B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
in B-X
high-risk B-X
families B-X
of B-X
German B-X
origin B-X
| B-X
A B-X
total B-X
Download B-X
scientific B-X
diagram B-X
| B-X
BRCA1 B-X
( B-X
9,10 B-X
) B-X
and B-X
( B-X
9,10,11B B-X
) B-X
normalized B-X
signal B-X
ratios B-X
increase B-X
in B-X
c.591C B-X
> B-X
T B-X
carriers B-X
. B-X
Shown B-X
are B-X
representative B-X
examples B-X
of B-X
cDNA B-X
amplification B-X
with B-X
The B-X
detection B-X
of B-X
short B-X
exons B-X
is B-X
a B-X
challenging B-X
open B-X
problem B-X
in B-X
the B-X
field B-X
of B-X
bioinformatics B-X
. B-X
Due B-X
to B-X
the B-X
fact B-X
that B-X
the B-X
weakness B-X
of B-X
existing B-X
model-independent B-X
methods B-X
lies B-X
in B-X
their B-X

2	O
kb	O
and	O
contain	O
the	O
intragenic	O
microsatellite	O
markers	O
D17S1323	O
,	O
D17S1322	O
,	O
and	O
D17S855	O
,	O
which	O
localize	O
to	O
introns	O
12	O
,	O
19	O
,	O
and	O
20	O
,	O
respectively	O
.	O
<EOS> B-X
Haplotype B-X
analysis B-X
of B-X
BRCA1 B-X
intragenic B-X
markers B-X
in B-X
Iranian B-X
patients B-X
with B-X
familial B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
The B-X
present B-X
invention B-X
relates B-X
generally B-X
to B-X
the B-X
field B-X
of B-X
human B-X
genetics B-X
, B-X
and B-X
more B-X
specifically B-X
to B-X
the B-X
detection B-X
of B-X
a B-X
specific B-X
type B-X
of B-X
germline B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
, B-X
The B-X
present B-X
invention B-X
relates B-X
generally B-X
to B-X
the B-X
field B-X
of B-X
human B-X
genetics B-X
, B-X
and B-X
more B-X
specifically B-X
to B-X
the B-X
detection B-X
of B-X
a B-X
specific B-X
type B-X
of B-X
germline B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
, B-X

In	O
addition	O
to	O
BRCA1	O
,	O
the	O
contig	O
contains	O
two	O
complete	O
genes	O
Rho7	O
,	O
a	O
member	O
of	O
the	O
rho	O
family	O
of	O
GTP	O
binding	O
proteins	O
,	O
and	O
VAT1	O
,	O
an	O
abundant	O
membrane	O
protein	O
of	O
cholinergic	O
synaptic	O
vesicles	O
.	O
<EOS> B-X
VAT B-X
1 B-X
: B-X
An B-X
abundant B-X
membrane B-X
protein B-X
from B-X
torpedo B-X
cholinergic B-X
synaptic B-X
vesicles B-X
- B-X
ScienceDirect B-X
1 B-X
. B-X
Calcium B-X
binding B-X
properties B-X
were B-X
examined B-X
in B-X
VAT-1 B-X
, B-X
an B-X
abundant B-X
41-kDa B-X
membrane B-X
protein B-X
expressed B-X
in B-X
the B-X
cholinergic B-X
cynaptic B-X
vesicles B-X
of B-X
Torpedo B-X
. B-X
2 B-X
. B-X
An B-X
overlay B-X
assay B-X
, B-X
The B-X
Rho-family B-X
proteins B-X
make B-X
up B-X
a B-X
major B-X
branch B-X
of B-X
the B-X
Ras B-X
superfamily B-X
of B-X
small B-X
GTPases B-X
. B-X
To B-X
date B-X
, B-X
22 B-X
human B-X
genes B-X
encoding B-X
at B-X
least B-X
25 B-X
proteins B-X
have B-X
been B-X
described B-X
Synaptic B-X
vesicle B-X
membrane B-X
proteins B-X
interact B-X
to B-X
form B-X
a B-X
multimeric B-X
complex B-X
VAT-1 B-X
is B-X
an B-X
abundant B-X
41-kDa B-X
protein B-X
from B-X
Torpedo B-X
cholinergic B-X
synaptic B-X
vesicles B-X
. B-X
Most B-X
of B-X
VAT-1 B-X
immunoreactivity B-X
( B-X
70 B-X
% B-X
) B-X
is B-X
localized B-X
to B-X
the B-X
synaptic B-X
vesicle B-X
membrane B-X
while B-X
the B-X
rest B-X
Evolution B-X
of B-X
the B-X
Rho B-X
family B-X
of B-X
ras-like B-X
GTPases B-X
in B-X
eukaryotes B-X
Dynamics B-X
of B-X
the B-X
Rho-family B-X
small B-X
GTPases B-X
in B-X
actin B-X
regulation B-X
and B-X
motility B-X

Partial	O
sequences	O
of	O
the	O
1A1	O
-	O
3B	O
B	O
-	O
box	O
protein	O
pseudogene	O
and	O
IFP	O
35	O
,	O
an	O
interferon	O
induced	O
leucine	O
zipper	O
protein	O
,	O
reside	O
within	O
the	O
contig	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
IFI35 B-X
- B-X
interferon-induced B-X
protein B-X
35 B-X
PDF B-X
| B-X
The B-X
methyl-CpG B-X
binding B-X
domain B-X
( B-X
MBD B-X
) B-X
proteins B-X
are B-X
key B-X
molecules B-X
in B-X
the B-X
interpretation B-X
of B-X
DNA B-X
methylation B-X
signals B-X
leading B-X
to B-X
gene B-X
silencing B-X
. B-X
We B-X
... B-X
| B-X
Find B-X
, B-X
Interferons B-X
play B-X
a B-X
critical B-X
role B-X
in B-X
the B-X
innate B-X
immune B-X
response B-X
against B-X
a B-X
variety B-X
of B-X
pathogens B-X
, B-X
such B-X
as B-X
HIV-1 B-X
. B-X
Recent B-X
studies B-X
have B-X
shown B-X
that B-X
long B-X
non-coding B-X
genes B-X
are B-X
part B-X

An	O
L21	O
ribosomal	O
protein	O
pseudogene	O
is	O
embedded	O
in	O
BRCA1	O
intron	O
13	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
RPL21 B-X
- B-X
ribosomal B-X
protein B-X
L21 B-X
Identification B-X
and B-X
Analysis B-X
of B-X
Over B-X
2000 B-X
Ribosomal B-X
Protein B-X
Pseudogenes B-X
in B-X
the B-X
Human B-X
Genome B-X
Request B-X
PDF B-X
| B-X
Identification B-X
of B-X
the B-X
first B-X
case B-X
of B-X
germline B-X
duplication B-X
of B-X
BRCA1 B-X
exon B-X
13 B-X
in B-X
an B-X
Italian B-X
family B-X
| B-X
In B-X
this B-X
work B-X
we B-X
report B-X
for B-X
the B-X
first B-X
time B-X
a B-X
Re-recognition B-X
of B-X
pseudogenes B-X
: B-X
From B-X
molecular B-X
to B-X
clinical B-X
applications B-X
Request B-X
PDF B-X
| B-X
Genomic B-X
rearrangements B-X
of B-X
the B-X
BRCA1 B-X
gene B-X
in B-X
Chilean B-X
breast B-X
cancer B-X
families B-X
: B-X
An B-X
MLPA B-X
analysis B-X
| B-X
Point B-X
mutations B-X
and B-X
small B-X
deletions B-X
and B-X
insertions B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Pseudogenes B-X
transcribed B-X
in B-X
breast B-X
invasive B-X
carcinoma B-X
show B-X
subtype-specific B-X
expression B-X
and B-X
ceRNA B-X
potential B-X

The	O
order	O
of	O
genes	O
on	O
the	O
chromosome	O
is	O
centromere	O
-	O
1FP	O
35	O
-	O
VAT1	O
-	O
Rho7	O
-	O
BRCA1	O
-	O
1A1	O
-	O
3B	O
-	O
telomere	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Low B-X
contribution B-X
of B-X
BRCA1/2 B-X
genomic B-X
rearrangement B-X
to B-X
high-risk B-X
breast B-X
cancer B-X
in B-X
the B-X
Korean B-X
population B-X
| B-X
Genomic B-X
rearrangement B-X
occasionally B-X
affects B-X
the B-X
BRCA1/2 B-X
genes B-X
in B-X
Caucasian B-X
breast B-X
cancer B-X
patients B-X
By B-X
definition B-X
, B-X
telomeric B-X
sequences B-X
are B-X
located B-X
at B-X
the B-X
very B-X
ends B-X
or B-X
terminal B-X
regions B-X
of B-X
chromosomes B-X
. B-X
However B-X
, B-X
several B-X
vertebrate B-X
species B-X
show B-X
blocks B-X
of B-X
( B-X
TTAGGG B-X
) B-X
n B-X
repeats B-X
BRCA1 B-X
, B-X
which B-X
functions B-X
as B-X
a B-X
tumor B-X
suppressor B-X
in B-X
human B-X
breast B-X
cancer B-X
cells B-X
, B-X
is B-X
a B-X
nuclear B-X
phosphoprotein B-X
which B-X
associates B-X
with B-X
RNA B-X
polymerase B-X
II B-X
holoenzyme B-X
. B-X
Mutations B-X
in B-X
BRCA1 B-X
are B-X
BEST B-X
: B-X
Biomedical B-X
Entity B-X
Search B-X
Tool B-X
BEST B-X
: B-X
Biomedical B-X
Entity B-X
Search B-X
Tool B-X
113705 B-X
- B-X
BREAST B-X
CANCER B-X
1 B-X
GENE B-X
; B-X
BRCA1 B-X
- B-X
BRCA1 B-X
113705 B-X
- B-X
BREAST B-X
CANCER B-X
1 B-X
GENE B-X
; B-X
BRCA1 B-X
- B-X
BRCA1 B-X

Identification	O
of	O
a	O
RING	O
protein	O
that	O
can	O
interact	O
in	O
vivo	O
with	O
the	O
BRCA1	O
gene	O
product	O
.	O
<EOS> B-X
Identification B-X
and B-X
characterization B-X
of B-X
missense B-X
alterations B-X
in B-X
the B-X
BRCA1 B-X
associated B-X
RING B-X
domain B-X
( B-X
BARD1 B-X
) B-X
gene B-X
in B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
BARD1 B-X
( B-X
BRCA1 B-X
associated B-X
RING B-X
domain B-X
1 B-X
) B-X
The B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
encodes B-X
a B-X
large B-X
polypeptide B-X
that B-X
contains B-X
the B-X
cysteine‚Äìrich B-X
RING B-X
motif B-X
, B-X
a B-X
zinc‚Äìbinding B-X
domain B-X
found B-X
in B-X
a B-X
variety B-X
of B-X
regulatory B-X
The B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
encodes B-X
a B-X
large B-X
polypeptide B-X
that B-X
contains B-X
the B-X
cysteine‚Äìrich B-X
RING B-X
motif B-X
, B-X
a B-X
zinc‚Äìbinding B-X
domain B-X
found B-X
in B-X
a B-X
variety B-X
of B-X
regulatory B-X
The B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
encodes B-X
a B-X
large B-X
polypeptide B-X
that B-X
contains B-X
the B-X
cysteine‚Äìrich B-X
RING B-X
motif B-X
, B-X
a B-X
zinc‚Äìbinding B-X
domain B-X
found B-X
in B-X
a B-X
variety B-X
of B-X
regulatory B-X
BRCA1 B-X
Associated B-X
RING B-X
Domain B-X
1 B-X
( B-X
BARD1 B-X
) B-X
encodes B-X
a B-X
protein B-X
which B-X
interacts B-X
with B-X
the B-X
N-terminal B-X
region B-X
of B-X
BRCA1 B-X
in B-X
vivo B-X
and B-X
in B-X
vitro B-X
. B-X
The B-X
full B-X
length B-X
( B-X
FL B-X

The	O
hereditary	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
gene	O
,	O
BRCA1	O
,	O
encodes	O
a	O
large	O
polypeptide	O
that	O
contains	O
the	O
cysteine	O
-	O
rich	O
RING	O
motif	O
,	O
a	O
zinc	O
-	O
binding	O
domain	O
found	O
in	O
a	O
variety	O
of	O
regulatory	O
proteins	O
.	O
<EOS> B-X
The B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
encodes B-X
a B-X
large B-X
polypeptide B-X
that B-X
contains B-X
the B-X
cysteine-rich B-X
RING B-X
motif B-X
, B-X
a B-X
zinc-binding B-X
domain B-X
found B-X
in B-X
a B-X
variety B-X
of B-X
The B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
encodes B-X
a B-X
large B-X
polypeptide B-X
that B-X
contains B-X
the B-X
cysteine-rich B-X
RING B-X
motif B-X
, B-X
a B-X
zinc-binding B-X
domain B-X
found B-X
in B-X
a B-X
variety B-X
of B-X
regulatory B-X
The B-X
four B-X
ligand B-X
cysteine B-X
residues B-X
form B-X
a B-X
Cys-X2-Cys-X17-Cys-X2-Cys B-X
motif B-X
, B-X
which B-X
is B-X
reminiscent B-X
of B-X
the B-X
( B-X
Cys B-X
) B-X
4 B-X
type B-X
zinc-finger B-X
motif B-X
found B-X
in B-X
numerous B-X
transcriptional B-X
regulatory B-X
proteins B-X
. B-X
However B-X
Download B-X
Citation B-X
| B-X
New B-X
complexities B-X
for B-X
BRCA1 B-X
and B-X
BRCA2 B-X
| B-X
A B-X
large B-X
number B-X
of B-X
diverse B-X
functions B-X
have B-X
been B-X
attributed B-X
to B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
breast B-X
cancer B-X
susceptibility B-X
genes B-X
. B-X
Here B-X
Zinc B-X
fingers B-X
: B-X
DNA B-X
binding B-X
and B-X
protein-protein B-X
interactions B-X
The B-X
best-understood B-X
protein B-X
structure B-X
involved B-X
in B-X
DNA B-X
binding B-X
is B-X
the B-X
helix-turn-helix B-X
motif B-X
. B-X
A B-X
second B-X
DNA-binding B-X
domain B-X
, B-X
the B-X
finger B-X
structure B-X
, B-X
has B-X
been B-X
proposed B-X
on B-X
the B-X
basis B-X
of B-X
sequence B-X
Complete B-X
information B-X
for B-X
BARD1 B-X
gene B-X
( B-X
Protein B-X
Coding B-X
) B-X
, B-X
BRCA1 B-X
Associated B-X
RING B-X
Domain B-X
1 B-X
, B-X
including B-X
: B-X
function B-X
, B-X
proteins B-X
, B-X
disorders B-X
, B-X
pathways B-X
, B-X
orthologs B-X
, B-X
and B-X
expression B-X

Here	O
we	O
describe	O
a	O
novel	O
protein	O
that	O
interacts	O
in	O
vivo	O
with	O
the	O
N	O
-	O
terminal	O
region	O
of	O
BRCA1	O
.	O
<EOS> B-X
MERIT40 B-X
facilitates B-X
BRCA1 B-X
localization B-X
and B-X
DNA B-X
damage B-X
repair B-X

This	O
BRCA1	O
-	O
associated	O
RING	O
domain	O
(	O
BARD1	O
)	O
protein	O
contains	O
an	O
N	O
-	O
terminal	O
RING	O
motif	O
,	O
three	O
tandem	O
ankyrin	O
repeats	O
,	O
and	O
a	O
C	O
-	O
terminal	O
sequence	O
with	O
significant	O
homology	O
to	O
the	O
phylogenetically	O
conserved	O
BRCT	O
domains	O
that	O
lie	O
near	O
the	O
C	O
terminus	O
of	O
BRCA1	O
.	O
<EOS> B-X
Breast B-X
cancer B-X
1 B-X
( B-X
BRCA1 B-X
) B-X
and B-X
BRCA1-associated B-X
RING B-X
domain B-X
1 B-X
( B-X
BARD1 B-X
) B-X
are B-X
multidomain B-X
proteins B-X
that B-X
interact B-X
in B-X
vivo B-X
via B-X
their B-X
N-terminal B-X
RING B-X
finger B-X
motif B-X
regions B-X
. B-X
To B-X
BARD1 B-X
( B-X
BRCA1 B-X
associated B-X
RING B-X
domain B-X
1 B-X
) B-X
Identification B-X
of B-X
a B-X
RING B-X
protein B-X
that B-X
can B-X
interact B-X
in B-X
vivo B-X
with B-X
the B-X
BRCA1 B-X
gene B-X
product B-X
. B-X
Crystal B-X
Structure B-X
of B-X
the B-X
BARD1 B-X
Ankyrin B-X
Repeat B-X
Domain B-X
and B-X
Its B-X
Functional B-X
Consequences B-X
The B-X
BARD1 B-X
C-Terminal B-X
Domain B-X
Structure B-X
and B-X
Interactions B-X
with B-X
Polyadenylation B-X
Factor B-X
CstF-50 B-X
E3 B-X
ubiquitin-protein B-X
ligase B-X
. B-X
The B-X
BRCA1-BARD1 B-X
heterodimer B-X
specifically B-X
mediates B-X
the B-X
formation B-X
of B-X
'Lys-6'-linked B-X
polyubiquitin B-X
chains B-X
and B-X
coordinates B-X
a B-X
diverse B-X
range B-X
of B-X
cellular B-X
pathways B-X
such B-X
as B-X
DNA B-X
damage B-X
repair B-X
, B-X
ubiquitination B-X
BARD1 B-X
- B-X
Wikipedia B-X

The	O
BARD1	O
/	O
BRCA1	O
interaction	O
is	O
disrupted	O
by	O
BRCA1	O
missense	O
mutations	O
that	O
segregate	O
with	O
breast	B-Disease
cancer	I-Disease
susceptibility	O
,	O
indicating	O
that	O
BARD1	O
may	O
be	O
involved	O
in	O
mediating	O
tumour	B-Disease
suppression	O
by	O
BRCA1	O
.	O
.	O
<EOS> B-X
The B-X
basal-like B-X
mammary B-X
carcinomas B-X
induced B-X
by B-X
Brca1 B-X
or B-X
Bard1 B-X
inactivation B-X
implicate B-X
the B-X
BRCA1/BARD1 B-X
heterodimer B-X
in B-X
tumor B-X
suppression B-X
| B-X
PNAS B-X
Mechanisms B-X
of B-X
BRCA1 B-X
Tumor B-X
Suppression B-X
| B-X
Cancer B-X
Discovery B-X
Deciphering B-X
the B-X
BRCA1 B-X
Tumor B-X
Suppressor B-X
Network B-X
Dualistic B-X
Role B-X
of B-X
BARD1 B-X
in B-X
Cancer B-X
Functional B-X
analysis B-X
of B-X
BARD1 B-X
missense B-X
variants B-X
in B-X
homology B-X
directed B-X
repair B-X
of B-X
DNA B-X
double B-X
strand B-X
breaks B-X
Mutation B-X
screening B-X
of B-X
the B-X
BARD1 B-X
gene B-X
: B-X
evidence B-X
for B-X
involvement B-X
of B-X
the B-X
Cys557Ser B-X
allele B-X
in B-X
hereditary B-X
susceptibility B-X
to B-X
breast B-X
cancer B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Cancer B-X
predisposing B-X
missense B-X
and B-X
protein B-X
truncating B-X
BARD1 B-X
mutations B-X
in B-X
non‚ÄêBRCA1 B-X
or B-X
BRCA2 B-X
breast B-X
cancer B-X
families B-X
- B-X
De B-X
Brakeleer B-X
- B-X
2010 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X

Detection	O
of	O
heterozygous	O
mutations	O
in	O
BRCA1	O
using	O
high	O
density	O
oligonucleotide	O
arrays	O
and	O
two	O
-	O
colour	O
fluorescence	O
analysis	O
.	O
<EOS> B-X
Semantic B-X
Scholar B-X
extracted B-X
view B-X
of B-X
`` B-X
Detection B-X
of B-X
heterozygous B-X
mutations B-X
in B-X
brca1 B-X
using B-X
high B-X
density B-X
oligonucleotide B-X
arrays B-X
and B-X
two-color B-X
fluorescence B-X
analysis B-X
'' B-X
by B-X
J. B-X
Hacia B-X
et B-X
al B-X
. B-X
Two B-X
color B-X
hybridization B-X
analysis B-X
using B-X
high B-X
density B-X
oligonucleotide B-X
arrays B-X
and B-X
energy B-X
transfer B-X
dyes B-X
. B-X
The B-X
ability B-X
to B-X
scan B-X
a B-X
large B-X
gene B-X
rapidly B-X
and B-X
accurately B-X
for B-X
all B-X
possible B-X
heterozygous B-X
mutations B-X
in B-X
large B-X
numbers B-X
of B-X
patient B-X
samples B-X
will B-X
be B-X
critical B-X
for B-X
the B-X
future B-X
of B-X
medicine B-X
. B-X
Written B-X
by B-X
experts B-X
from B-X
Washington B-X
University B-X
School B-X
of B-X
Medicine B-X
, B-X
this B-X
text B-X
is B-X
a B-X
thorough B-X
review B-X
of B-X
the B-X
specific B-X
molecular B-X
genetic B-X
techniques B-X
that B-X
can B-X
provide B-X
diagnostically B-X
useful B-X
molecular B-X
genetic B-X
information B-X
PDF B-X
| B-X
Breast B-X
cancer B-X
is B-X
the B-X
most B-X
frequent B-X
form B-X
of B-X
carcinoma B-X
in B-X
European B-X
females B-X
( B-X
incidence B-X
65 B-X
per B-X
100,000 B-X
) B-X
. B-X
In B-X
about B-X
10 B-X
% B-X
of B-X
all B-X
cases B-X
, B-X
pedigree B-X
scientific B-X
article B-X

The	O
ability	O
to	O
scan	O
a	O
large	O
gene	O
rapidly	O
and	O
accurately	O
for	O
all	O
possible	O
heterozygous	O
mutations	O
in	O
large	O
numbers	O
of	O
patient	O
samples	O
will	O
be	O
critical	O
for	O
the	O
future	O
of	O
medicine	O
.	O
<EOS> B-X
Next B-X
Generation B-X
Sequencing B-X
and B-X
the B-X
Future B-X
of B-X
Genetic B-X
Diagnosis B-X
Genome-wide B-X
association B-X
studies B-X
and B-X
genetic B-X
testing B-X
: B-X
understanding B-X
the B-X
science B-X
, B-X
success B-X
, B-X
and B-X
future B-X
of B-X
a B-X
rapidly B-X
developing B-X
field B-X
Genomic B-X
translational B-X
research B-X
: B-X
Paving B-X
the B-X
way B-X
to B-X
individualized B-X
cardiac B-X
functional B-X
analyses B-X
and B-X
personalized B-X
cardiology B-X
Next-generation B-X
sequencing B-X
technologies B-X
have B-X
been B-X
and B-X
continue B-X
to B-X
be B-X
deployed B-X
in B-X
clinical B-X
laboratories B-X
, B-X
enabling B-X
rapid B-X
transformations B-X
in B-X
genomic B-X
medicine B-X
. B-X
These B-X
technologies B-X
have B-X
reduced B-X
the B-X
cost B-X
of B-X
large-scale B-X
sequencing B-X
ACMG B-X
clinical B-X
laboratory B-X
standards B-X
for B-X
next-generation B-X
sequencing B-X
Big B-X
Data B-X
Analytics B-X
for B-X
Genomic B-X
Medicine B-X
A B-X
wide B-X
variety B-X
of B-X
biomedical B-X
photonic B-X
technologies B-X
have B-X
been B-X
developed B-X
recently B-X
for B-X
clinical B-X
monitoring B-X
of B-X
early B-X
disease B-X
states B-X
; B-X
molecular B-X
diagnostics B-X
and B-X
imaging B-X
of B-X
physiological B-X
parameters B-X
; B-X
molecular B-X
and B-X
genetic B-X

We	O
have	O
designed	O
high	O
-	O
density	O
arrays	O
consisting	O
of	O
over	O
96	O
,	O
600	O
oligonucleotides	O
20	O
-	O
nucleotides	O
(	O
nt	O
)	O
in	O
length	O
to	O
screen	O
for	O
a	O
wide	O
range	O
of	O
heterozygous	O
mutations	O
in	O
the	O
3	O
.	O
<EOS> B-X
High B-X
density B-X
DNA B-X
methylation B-X
array B-X
with B-X
single B-X
CpG B-X
site B-X
resolution B-X
- B-X
ScienceDirect B-X
To B-X
date B-X
, B-X
genome-scale B-X
analyses B-X
in B-X
the B-X
domestic B-X
horse B-X
have B-X
been B-X
limited B-X
by B-X
suboptimal B-X
single B-X
nucleotide B-X
polymorphism B-X
( B-X
SNP B-X
) B-X
density B-X
and B-X
uneven B-X
genomic B-X
coverage B-X
of B-X
the B-X
current B-X
SNP B-X
genotyping B-X
We B-X
report B-X
a B-X
device B-X
to B-X
fill B-X
an B-X
array B-X
of B-X
small B-X
chemical B-X
reaction B-X
chambers B-X
( B-X
microreactors B-X
) B-X
with B-X
reagent B-X
and B-X
then B-X
seal B-X
them B-X
using B-X
pressurized B-X
viscous B-X
liquid B-X
acting B-X
through B-X
a B-X
flexible B-X
While B-X
one B-X
marvels B-X
at B-X
the B-X
DNA B-X
generated B-X
by B-X
the B-X
Human B-X
Genome B-X
Project B-X
, B-X
perhaps B-X
just B-X
as B-X
significant B-X
and B-X
fascinating B-X
is B-X
the B-X
development B-X
of B-X
the B-X
amazing B-X
analytical B-X
technology B-X
that B-X
has B-X
permitted B-X
Motility B-X
and B-X
invasion B-X
are B-X
key B-X
steps B-X
in B-X
the B-X
metastatic B-X
cascade B-X
, B-X
enabling B-X
cells B-X
to B-X
move B-X
through B-X
normal B-X
tissue B-X
borders B-X
into B-X
the B-X
surrounding B-X
stroma B-X
. B-X
Most B-X
available B-X
in B-X
vitro B-X
assays B-X
track B-X
Low-density B-X
( B-X
LD B-X
) B-X
single B-X
nucleotide B-X
polymorphism B-X
( B-X
SNP B-X
) B-X
arrays B-X
provide B-X
a B-X
cost-effective B-X
solution B-X
for B-X
genomic B-X
prediction B-X
and B-X
selection B-X
, B-X
but B-X
algorithms B-X
and B-X
computational B-X
tools B-X
are B-X
needed B-X
for B-X
the B-X
A B-X
high-throughput B-X
genotyping B-X
platform B-X
is B-X
needed B-X
to B-X
enable B-X
marker-assisted B-X
breeding B-X
in B-X
the B-X
allo-octoploid B-X
cultivated B-X
strawberry B-X
Fragaria B-X
√ó B-X
ananassa B-X
. B-X
Short-read B-X
sequences B-X
from B-X
one B-X
diploid B-X
and B-X
19 B-X
octoploid B-X
accessions B-X
were B-X
aligned B-X

45	O
-	O
kilobases	O
(	O
kb	O
)	O
exon	O
11	O
of	O
the	O
hereditary	B-Disease
breast	I-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
gene	O
BRCA1	O
.	O
<EOS> B-X
BRCA1 B-X
is B-X
a B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
. B-X
An B-X
inferred B-X
germline B-X
regulatory B-X
mutation B-X
was B-X
previously B-X
reported B-X
in B-X
the B-X
BRCA1-linked B-X
kindred B-X
K2035 B-X
, B-X
ba B-X
Rapid B-X
evolution B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
in B-X
humans B-X
and B-X
other B-X
primates B-X
The B-X
maintenance B-X
of B-X
chromosomal B-X
integrity B-X
is B-X
an B-X
essential B-X
task B-X
of B-X
every B-X
living B-X
organism B-X
and B-X
cellular B-X
repair B-X
mechanisms B-X
exist B-X
to B-X
guard B-X
against B-X
insults B-X
to B-X
DNA B-X
. B-X
Given B-X
the B-X
importance B-X
of B-X
this B-X
Checkpoint B-X
kinase B-X
2 B-X
( B-X
CHEK2 B-X
, B-X
Chk2 B-X
) B-X
emerges B-X
as B-X
an B-X
important B-X
signal B-X
transducer B-X
of B-X
cellular B-X
responses B-X
to B-X
DNA B-X
damage B-X
and B-X
a B-X
candidate B-X
tumor B-X
suppressor B-X
whose B-X
defects B-X
contribute B-X
to B-X
molecular B-X

Reference	O
and	O
test	O
samples	O
were	O
co	O
-	O
hybridized	O
to	O
these	O
arrays	O
and	O
differences	O
in	O
hybridization	O
patterns	O
quantitated	O
by	O
two	O
-	O
colour	O
analysis	O
.	O
<EOS> B-X
The B-X
invention B-X
provides B-X
methods B-X
of B-X
analyzing B-X
a B-X
nucleic B-X
acid B-X
in B-X
a B-X
target B-X
sample B-X
for B-X
variant B-X
alleles B-X
. B-X
In B-X
such B-X
methods B-X
, B-X
a B-X
first-labelled B-X
control B-X
sample B-X
and B-X
a B-X
second-labelled B-X
target B-X
sample B-X
PDF B-X
| B-X
Array-based B-X
comparative B-X
genomic B-X
hybridization B-X
( B-X
CGH B-X
) B-X
measures B-X
copy-number B-X
variations B-X
at B-X
multiple B-X
loci B-X
simultaneously B-X
, B-X
providing B-X
an B-X
important B-X
tool B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
The B-X
OGT B-X
team B-X
of B-X
in-house B-X
experts B-X
provides B-X
answers B-X
to B-X
frequently B-X
asked B-X
questions B-X
about B-X
aCGH B-X
for B-X
CNV B-X
analysis B-X
. B-X
Read B-X
now B-X
. B-X
The B-X
ability B-X
to B-X
scan B-X
a B-X
large B-X
gene B-X
rapidly B-X
and B-X
accurately B-X
for B-X
all B-X
possible B-X
heterozygous B-X
mutations B-X
in B-X
large B-X
numbers B-X
of B-X
patient B-X
samples B-X
will B-X
be B-X
critical B-X
for B-X
the B-X
future B-X
of B-X
medicine B-X
. B-X
PDF B-X
| B-X
DNA B-X
Microarray B-X
is B-X
one B-X
such B-X
technology B-X
which B-X
enables B-X
the B-X
researchers B-X
to B-X
investigate B-X
and B-X
address B-X
issues B-X
which B-X
were B-X
once B-X
thought B-X
to B-X
be B-X
non B-X
traceable B-X
.... B-X
| B-X
Find B-X
, B-X
read B-X
PDF B-X
| B-X
Although B-X
oligonucleotide B-X
probes B-X
complementary B-X
to B-X
single B-X
nucleotide B-X
substitutions B-X
are B-X
commonly B-X
used B-X
in B-X
microarray-based B-X
screens B-X
for B-X
genetic B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
Download B-X
Citation B-X
| B-X
Overview B-X
of B-X
Nucleic B-X
Acid B-X
Arrays B-X
| B-X
Nucleic B-X
acid B-X
array B-X
technology B-X
refers B-X
to B-X
the B-X
use B-X
and B-X
fabrication B-X
of B-X
arrays B-X
containing B-X
thousands B-X
of B-X
nucleic B-X
acid B-X
samples B-X
bound B-X
to B-X
solid B-X

Fourteen	O
of	O
fifteen	O
patient	O
samples	O
with	O
known	O
mutations	O
were	O
accurately	O
diagnosed	O
,	O
and	O
no	O
false	O
positive	O
mutations	O
were	O
identified	O
in	O
20	O
control	O
samples	O
.	O
<EOS> B-X
Abstract B-X
. B-X
As B-X
more B-X
mutations B-X
are B-X
identified B-X
in B-X
genes B-X
of B-X
known B-X
sequence B-X
, B-X
there B-X
is B-X
a B-X
crucial B-X
need B-X
in B-X
the B-X
areas B-X
of B-X
medical B-X
genetics B-X
and B-X
genome B-X
analysis B-X
for B-X
rapid B-X
, B-X
Personalized B-X
genomic B-X
analyses B-X
for B-X
cancer B-X
mutation B-X
discovery B-X
and B-X
interpretation B-X
Comparison B-X
of B-X
Sanger B-X
Sequencing B-X
, B-X
Pyrosequencing B-X
, B-X
and B-X
Melting B-X
Curve B-X
Analysis B-X
for B-X
the B-X
Detection B-X
of B-X
KRAS B-X
Mutations B-X
A B-X
highly B-X
accurate B-X
, B-X
low B-X
cost B-X
test B-X
forBRCA1 B-X
mutations B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Accurate B-X
genome-wide B-X
detection B-X
of B-X
somatic B-X
mutations B-X
with B-X
low B-X
variant B-X
allele B-X
frequency B-X
( B-X
VAF B-X
, B-X
< B-X
1 B-X
% B-X
) B-X
has B-X
proven B-X
difficult B-X
, B-X
for B-X
which B-X
generalized B-X
, B-X
scalable B-X
methods B-X
are B-X
lacking B-X
Rapid B-X
Genotyping B-X
of B-X
Common B-X
MeCP2 B-X
Mutations B-X
with B-X
an B-X
Electronic B-X
DNA B-X
Microchip B-X
Using B-X
Serial B-X
Differential B-X
Hybridization B-X
We B-X
describe B-X
Exome B-X
Cancer B-X
Test B-X
v1.0 B-X
( B-X
EXaCT-1 B-X
) B-X
, B-X
the B-X
first B-X
New B-X
York B-X
State-Department B-X
of B-X
Health-approved B-X
whole-exome B-X
sequencing B-X
( B-X
WES B-X
) B-X
-based B-X
test B-X
for B-X
precision B-X
cancer B-X
care B-X
. B-X
EXaCT-1 B-X

Eight	O
single	O
nucleotide	O
polymorphisms	O
were	O
also	O
readily	O
detected	O
.	O
<EOS> B-X
Single B-X
nucleotide B-X
polymorphisms B-X
and B-X
disease B-X
gene B-X
mapping B-X
Efficient B-X
Approach B-X
to B-X
Unique B-X
Single-Nucleotide B-X
Polymorphism B-X
Discovery B-X
Determination B-X
of B-X
Single-Nucleotide B-X
Polymorphisms B-X
by B-X
Real-time B-X
Pyrophosphate B-X
DNA B-X
Sequencing B-X
Single-Nucleotide B-X
Polymorphism B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Lesson B-X
12 B-X
: B-X
Single B-X
Nucleotide B-X
Polymorphisms B-X
| B-X
STAT B-X
555 B-X
The B-X
increasing B-X
interest B-X
in B-X
the B-X
discovery B-X
and B-X
characterization B-X
of B-X
single B-X
nucleotide B-X
polymorphisms B-X
( B-X
SNPs B-X
) B-X
emphasis B-X
the B-X
need B-X
for B-X
high-throughput B-X
and B-X
cost B-X
effective B-X
scoring B-X
methods B-X
. B-X
Pyrosequencing B-X
is B-X
a B-X
novel B-X
Post-translational B-X
modification B-X
( B-X
PTM B-X
) B-X
plays B-X
a B-X
crucial B-X
role B-X
in B-X
biological B-X
functions B-X
and B-X
corresponding B-X
disease B-X
developments B-X
. B-X
Discovering B-X
disease-associated B-X
non-synonymous B-X
SNPs B-X
( B-X
nsSNPs B-X
) B-X
altering B-X
PTM B-X
sites B-X
can B-X
help B-X
to B-X

DNA	O
chip	O
-	O
based	O
assays	O
may	O
provide	O
a	O
valuable	O
new	O
technology	O
for	O
high	O
-	O
throughput	O
cost	O
-	O
efficient	O
detection	O
of	O
genetic	O
alterations	O
.	O
<EOS> B-X
Revisiting B-X
lab-on-a-chip B-X
technology B-X
for B-X
drug B-X
discovery B-X
Molecular B-X
Approaches B-X
for B-X
High B-X
Throughput B-X
Detection B-X
and B-X
Quantification B-X
of B-X
Genetically B-X
Modified B-X
Crops B-X
: B-X
A B-X
Review B-X
Request B-X
PDF B-X
| B-X
Fluorescence-based B-X
assay B-X
formats B-X
and B-X
signal B-X
amplification B-X
strategies B-X
for B-X
DNA B-X
microarray B-X
analysis B-X
| B-X
DNA B-X
microarrays B-X
are B-X
powerful B-X
tools B-X
for B-X
the B-X
high B-X
throughput B-X
analysis B-X
of B-X
nucleic B-X
acids B-X
due B-X
to B-X
High-Throughput B-X
Sequencing B-X
Technologies B-X
Genetic B-X
testing B-X
and B-X
genomic B-X
studies B-X
are B-X
helping B-X
people B-X
around B-X
the B-X
world B-X
lead B-X
healthier B-X
lives B-X
and B-X
fight B-X
disease B-X
and B-X
infection B-X
on B-X
a B-X
global B-X
scale B-X
. B-X
Breakthrough B-X
technologies B-X
in B-X
genomic B-X
analysis B-X
are B-X
Overview B-X
of B-X
High B-X
Throughput B-X
Sequencing B-X
Technologies B-X
to B-X
Elucidate B-X
Molecular B-X
Pathways B-X
in B-X
Cardiovascular B-X
Diseases B-X
Assay B-X
Techniques B-X
and B-X
Test B-X
Development B-X
for B-X
COVID-19 B-X
Diagnosis B-X

Autosomal	O
dominant	O
primary	O
hyperparathyroidism	B-Disease
and	I-Disease
jaw	I-Disease
tumor	I-Disease
syndrome	I-Disease
associated	O
with	O
renal	B-Disease
hamartomas	I-Disease
and	O
cystic	B-Disease
kidney	I-Disease
disease	I-Disease
:	O
linkage	O
to	O
1q21	O
-	O
q32	O
and	O
loss	O
of	O
the	O
wild	O
type	O
allele	O
in	O
renal	B-Disease
hamartomas	I-Disease
.	O
<EOS> B-X
Abstract B-X
. B-X
The B-X
hyperparathyroidism‚Äêjaw B-X
tumour B-X
( B-X
HPT‚ÄêJT B-X
) B-X
syndrome B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disease B-X
characterized B-X
by B-X
the B-X
occurrence B-X
of B-X
parathyroid B-X
tumours B-X
and B-X
fibro B-X
Abstract B-X
. B-X
The B-X
hyperparathyroidism-jaw B-X
tumor B-X
( B-X
HPT-JT B-X
) B-X
syndrome B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
characterized B-X
by B-X
the B-X
occurrence B-X
of B-X
parathyroid B-X
tumors B-X
and B-X
ossify B-X
Multiple B-X
Endocrine B-X
Neoplasia B-X
and B-X
Hyperparathyroid-Jaw B-X
Tumor B-X
Syndromes B-X
: B-X
Clinical B-X
Features B-X
, B-X
Genetics B-X
, B-X
and B-X
Surveillance B-X
Recommendations B-X
in B-X
Childhood B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Familial B-X
primary B-X
hyperparathyroidism B-X
is B-X
the B-X
main B-X
feature B-X
of B-X
2 B-X
familial B-X
endocrine B-X
neoplasia B-X
syndromes B-X
: B-X
multiple B-X
endocrine B-X
neoplasia B-X
type B-X
1 B-X
( B-X
MEN B-X
1 B-X
) B-X
and B-X
hyperparat B-X
Hyperparathyroidism-Jaw B-X
tumor B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X

Hereditary	B-Disease
hyperparathyroidism	I-Disease
-	I-Disease
jaw	I-Disease
tumor	I-Disease
syndrome	I-Disease
(	O
HPT	B-Disease
-	I-Disease
JT	I-Disease
)	O
is	O
an	O
autosomal	B-Disease
dominant	I-Disease
disease	I-Disease
(	O
OMIM	O
145001	O
)	O
that	O
has	O
recently	O
been	O
mapped	O
to	O
chromosomal	O
region	O
1q21	O
-	O
q32	O
(	O
HRPT2	O
)	O
.	O
<EOS> B-X
HRPT2 B-X
, B-X
the B-X
gene B-X
associated B-X
with B-X
hyperparathyroidism-jaw B-X
tumor B-X
( B-X
HPT-JT B-X
) B-X
syndrome B-X
, B-X
was B-X
previously B-X
mapped B-X
to B-X
1q24-q32 B-X
. B-X
It B-X
was B-X
recently B-X
cloned B-X
, B-X
and B-X
several B-X
germline B-X
Hyperparathyroidism‚Äìjaw B-X
tumour B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X
is B-X
a B-X
rare B-X
variant B-X
of B-X
familial B-X
hyperparathyroidism B-X
, B-X
characterized B-X
by B-X
primary B-X
hyperparathyroidism B-X
( B-X
PHP B-X
The B-X
syndrome B-X
of B-X
hereditary B-X
hyperparathyroidism B-X
and B-X
jaw B-X
tumors B-X
( B-X
HPT-JT B-X
) B-X
is B-X
characterized B-X
by B-X
inheritance B-X
, B-X
in B-X
an B-X
autosomal B-X
dominant B-X
pattern B-X
, B-X
of B-X
recurrent B-X
parathyroid B-X
adenomas B-X
, B-X
fibro-osseous B-X
tumors B-X
of B-X
Request B-X
PDF B-X
| B-X
Revised B-X
14.7-cM B-X
Locus B-X
for B-X
the B-X
Hyperparathyroidism‚ÄìJaw B-X
Tumor B-X
Syndrome B-X
Gene B-X
, B-X
HRPT2 B-X
| B-X
To B-X
the B-X
Editor B-X
: B-X
We B-X
reported B-X
previously B-X
that B-X
the B-X
locus B-X
for B-X
hyperparathyroidism‚Äìjaw B-X
tumor B-X
syndrome B-X
( B-X
PDF B-X
| B-X
Approximately B-X
70 B-X
families B-X
with B-X
familial B-X
isolated B-X
hyperparathyroidism B-X
( B-X
FIHP B-X
) B-X
have B-X
been B-X
reported B-X
. B-X
Whether B-X
it B-X
is B-X
a B-X
separate B-X
entity B-X
or B-X
a B-X
variant B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
145001 B-X
- B-X
HYPERPARATHYROIDISM B-X
2 B-X
WITH B-X
JAW B-X
TUMORS B-X
; B-X
HRPT2 B-X
- B-X
HYPERPARATHYROIDISM B-X
, B-X
FAMILIAL B-X
PRIMARY B-X
, B-X
WITH B-X
MULTIPLE B-X
OSSIFYING B-X
JAW B-X
FIBROMAS B-X
; B-X
; B-X
HYPERPARATHYROIDISM-JAW B-X
TUMOR B-X
SYNDROME B-X
, B-X
HEREDITARY B-X
; B-X
HPT-JT B-X
- B-X

Here	O
we	O
report	O
two	O
families	O
with	O
HPT	B-Disease
-	I-Disease
JT	I-Disease
syndrome	I-Disease
in	O
which	O
adult	B-Disease
renal	I-Disease
hamartomas	I-Disease
or	O
cystic	B-Disease
kidney	I-Disease
disease	I-Disease
were	O
prominent	O
associated	O
features	O
,	O
possibly	O
representing	O
a	O
new	O
phenotypic	O
variant	O
of	O
the	O
HPT	B-Disease
-	I-Disease
JT	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
The B-X
spectrum B-X
of B-X
CDC73-related B-X
disorders B-X
includes B-X
the B-X
following B-X
phenotypes B-X
: B-X
Request B-X
PDF B-X
| B-X
Uterine B-X
tumors B-X
are B-X
a B-X
phenotypic B-X
manifestation B-X
of B-X
the B-X
hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
| B-X
The B-X
hyperparathyroidism-jaw B-X
tumour B-X
( B-X
HPT-JT B-X
) B-X
syndrome B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
characterized B-X
by B-X
parathyroid B-X
Request B-X
PDF B-X
| B-X
HRPT2 B-X
, B-X
encoding B-X
parafibromin B-X
, B-X
is B-X
mutated B-X
in B-X
hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
| B-X
We B-X
report B-X
here B-X
the B-X
identification B-X
of B-X
a B-X
gene B-X
associated B-X
with B-X
the B-X
hyperparathyroidism-jaw B-X
tumor B-X
( B-X
HPT-JT B-X
Autosomal B-X
dominant B-X
polycystic B-X
kidney B-X
disease B-X
( B-X
ADPKD B-X
) B-X
, B-X
also B-X
sometimes B-X
more B-X
vaguely B-X
referred B-X
to B-X
as B-X
`` B-X
adult B-X
polycystic B-X
kidney B-X
disease B-X
'' B-X
, B-X
is B-X
as B-X
the B-X
name B-X
would B-X
suggest B-X
, B-X
Request B-X
PDF B-X
| B-X
Dental B-X
findings B-X
in B-X
a B-X
family B-X
with B-X
hyperparathyroidism B-X
- B-X
Jaw B-X
tumor B-X
syndrome B-X
and B-X
a B-X
novel B-X
HRPT2 B-X
gene B-X
mutation B-X
| B-X
Hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X
is B-X
an B-X
important B-X
Large B-X
intragenic B-X
deletion B-X
of B-X
CDC73 B-X
( B-X
exons B-X
4‚Äì10 B-X
) B-X
in B-X
a B-X
three-generation B-X
hyperparathyroidism-jaw B-X
tumor B-X
( B-X
HPT-JT B-X
) B-X
syndrome B-X
family B-X
Diagnosis B-X
and B-X
Screening B-X
of B-X
Autosomal B-X
Dominant B-X
Polycystic B-X
Kidney B-X
Disease B-X

In	O
the	O
first	O
family	O
,	O
renal	B-Disease
lesions	I-Disease
were	O
present	O
in	O
five	O
out	O
of	O
six	O
affected	O
individuals	O
,	O
whereas	O
HPT	B-Disease
and	O
JT	B-Disease
were	O
seen	O
in	O
four	O
and	O
two	O
cases	O
,	O
respectively	O
.	O
<EOS> B-X
Kidney B-X
cancer B-X
is B-X
one B-X
of B-X
the B-X
top B-X
ten B-X
most B-X
common B-X
cancers B-X
. B-X
Learn B-X
more B-X
about B-X
common B-X
symptoms B-X
and B-X
why B-X
they B-X
happen B-X
. B-X
ON B-X
THIS B-X
PAGE B-X
: B-X
You B-X
will B-X
find B-X
information B-X
about B-X
the B-X
number B-X
of B-X
adults B-X
who B-X
are B-X
diagnosed B-X
with B-X
kidney B-X
cancer B-X
each B-X
year B-X
. B-X
You B-X
will B-X
also B-X
read B-X
general B-X
information B-X
on B-X
surviving B-X
Respect B-X
the B-X
differences B-X
between B-X
these B-X
two B-X
commonly B-X
confused B-X
words B-X
. B-X
Respectfully B-X
is B-X
related B-X
to B-X
something B-X
being B-X
important B-X
while B-X
respectively B-X
is B-X
related B-X
to B-X
the B-X
order B-X
of B-X
things B-X
. B-X
Abstract B-X
. B-X
Hereditary B-X
hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disease B-X
( B-X
OMIM B-X
145001 B-X
) B-X
that B-X
has B-X
recently B-X
been B-X
mapped B-X
to B-X
chromosomal B-X
Abstract B-X
. B-X
Hereditary B-X
hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disease B-X
( B-X
OMIM B-X
145001 B-X
) B-X
that B-X
has B-X
recently B-X
been B-X
mapped B-X
to B-X
chromosomal B-X
This B-X
writing B-X
convention B-X
tells B-X
the B-X
reader B-X
that B-X
the B-X
relationship B-X
between B-X
two B-X
sets B-X
of B-X
words B-X
or B-X
phrases B-X
in B-X
a B-X
sentence B-X
is B-X
the B-X
same B-X
as B-X
the B-X
order B-X
in B-X
which B-X
they B-X
appear B-X
. B-X
Kidney B-X
Cancer B-X
( B-X
Renal B-X
cell B-X
carcinoma B-X
) B-X
- B-X
Renal B-X
and B-X
Urology B-X
News B-X

In	O
the	O
second	O
family	O
,	O
JT	B-Disease
was	O
found	O
in	O
three	O
of	O
the	O
five	O
affected	O
individuals	O
and	O
two	O
affected	O
members	O
also	O
exhibited	O
polycystic	B-Disease
kidney	I-Disease
disease	I-Disease
.	O
<EOS> B-X
Identification B-X
of B-X
a B-X
pathogenic B-X
mutation B-X
in B-X
a B-X
Chinese B-X
pedigree B-X
with B-X
polycystic B-X
kidney B-X
disease B-X
Polycystic B-X
kidney B-X
disease B-X
( B-X
PKD B-X
) B-X
is B-X
a B-X
heritable B-X
disorder B-X
with B-X
diffuse B-X
cystic B-X
involvement B-X
of B-X
both B-X
kidneys B-X
without B-X
dysplasia B-X
( B-X
1 B-X
) B-X
. B-X
All B-X
forms B-X
of B-X
PKD B-X
can B-X
have B-X
clinical B-X
Polycystic B-X
Kidney B-X
Disease B-X
without B-X
an B-X
Apparent B-X
Family B-X
History B-X
Polycystic B-X
Kidney B-X
Disease B-X
without B-X
an B-X
Apparent B-X
Family B-X
History B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X
Evidence B-X
of B-X
a B-X
third B-X
ADPKD B-X
locus B-X
is B-X
not B-X
supported B-X
by B-X
re-analysis B-X
of B-X
designated B-X
PKD3 B-X
families B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
Background B-X
. B-X
Ultrasound B-X
, B-X
genetic B-X
and B-X
clinical B-X
correlations B-X
are B-X
available B-X
for B-X
ADPKD-1 B-X
, B-X
but B-X
lacking B-X
for B-X
ADPKD-2 B-X
. B-X
The B-X
present B-X
study B-X
was B-X
carried B-X
out B-X
to B-X
add B-X
Monoallelic B-X
Mutations B-X
to B-X
DNAJB11 B-X
Cause B-X
Atypical B-X
Autosomal-Dominant B-X
Polycystic B-X
Kidney B-X
Disease B-X
- B-X
ScienceDirect B-X

The	O
possibility	O
of	O
the	O
latter	O
cosegregating	O
as	O
a	O
separate	O
autosomal	O
dominant	O
gene	O
can	O
not	O
be	O
ruled	O
out	O
.	O
<EOS> B-X
It B-X
is B-X
hard B-X
to B-X
predict B-X
if B-X
your B-X
children B-X
will B-X
inherit B-X
a B-X
genetic B-X
disorder B-X
. B-X
Learn B-X
about B-X
the B-X
factors B-X
that B-X
impact B-X
the B-X
chances B-X
of B-X
developing B-X
a B-X
genetic B-X
condition B-X
. B-X
Genetic B-X
linkage B-X
analysis B-X
is B-X
a B-X
powerful B-X
tool B-X
to B-X
detect B-X
the B-X
chromosomal B-X
location B-X
of B-X
disease B-X
genes B-X
. B-X
It B-X
is B-X
based B-X
on B-X
the B-X
observation B-X
that B-X
genes B-X
that B-X
reside B-X
physicall B-X
Brody B-X
disease B-X
is B-X
a B-X
rare B-X
muscle B-X
disorder B-X
characterized B-X
by B-X
exercise-induced B-X
impairment B-X
in B-X
muscle B-X
relaxation B-X
, B-X
due B-X
to B-X
a B-X
markedly B-X
reduced B-X
influx B-X
of B-X
calcium B-X
ions B-X
in B-X
the B-X
sarcoplasmic B-X
reticulum B-X
. B-X
A B-X
Many B-X
of B-X
the B-X
genetic B-X
childhood B-X
disorders B-X
leading B-X
to B-X
death B-X
in B-X
the B-X
pre- B-X
or B-X
neonatal B-X
period B-X
or B-X
during B-X
early B-X
childhood B-X
follow B-X
autosomal B-X
recessive B-X
modes B-X
of B-X
inheritance B-X
and B-X
bear B-X
specific B-X
challenges B-X
for B-X
Combined B-X
Genetic B-X
and B-X
High-Throughput B-X
Strategies B-X
for B-X
Molecular B-X
Diagnosis B-X
of B-X
Inherited B-X
Retinal B-X
Dystrophies B-X
Hereditary B-X
hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disease B-X
( B-X
OMIM B-X
145001 B-X
) B-X
that B-X
has B-X
recently B-X
been B-X
mapped B-X
to B-X
chromosomal B-X
region B-X
1q21-q32 B-X
( B-X
HRPT2 B-X
) B-X
. B-X
Here B-X
Genome-wide B-X
linkage B-X
analysis B-X
, B-X
followed B-X
by B-X
targeted B-X
deep B-X
sequencing B-X
, B-X
in B-X
a B-X
Danish B-X
multigeneration B-X
family B-X
with B-X
juvenile B-X
cataract B-X
revealed B-X
a B-X
region B-X
of B-X
chromosome B-X
17 B-X
co-segregating B-X
with B-X
the B-X
disease B-X
trait B-X
. B-X

A	O
sex	O
-	O
dependent	O
penetrance	O
of	O
primary	B-Disease
HPT	I-Disease
,	O
resulting	O
in	O
predominantly	O
male	O
-	O
affected	O
cases	O
was	O
evident	O
in	O
the	O
two	O
families	O
.	O
<EOS> B-X
Genotype-phenotype B-X
correlation B-X
in B-X
multiple B-X
endocrine B-X
neoplasia B-X
type B-X
2 B-X
Hereditary B-X
hyperparathyroidism B-X
has B-X
been B-X
reported B-X
to B-X
occur B-X
in B-X
5‚Äì10 B-X
% B-X
of B-X
cases B-X
of B-X
primary B-X
hyperparathyroidism B-X
in B-X
the B-X
context B-X
of B-X
multiple B-X
endocrine B-X
Total B-X
parathyroidectomy B-X
in B-X
a B-X
large B-X
cohort B-X
of B-X
cases B-X
with B-X
hyperparathyroidism B-X
associated B-X
with B-X
multiple B-X
endocrine B-X
neoplasia B-X
type B-X
1 B-X
: B-X
experience B-X
from B-X
a B-X
single B-X
academic B-X
center B-X
PDF B-X
| B-X
Context B-X
The B-X
clinical B-X
phenotype B-X
of B-X
multiple B-X
endocrine B-X
neoplasia B-X
type B-X
4 B-X
( B-X
MEN4 B-X
) B-X
is B-X
undefined B-X
due B-X
to B-X
a B-X
limited B-X
number B-X
of B-X
published B-X
cases B-X
. B-X
Knowledge B-X
on B-X
... B-X
| B-X
Biochemical B-X
, B-X
bone B-X
and B-X
renal B-X
patterns B-X
in B-X
hyperparathyroidism B-X
associated B-X
with B-X
multiple B-X
endocrine B-X
neoplasia B-X
type B-X
1 B-X
Clinical B-X
Case B-X
Seminar B-X
: B-X
CDC73 B-X
Intragenic B-X
Deletion B-X
in B-X
Familial B-X
Primary B-X
Hyperparathyroidism B-X
Associated B-X
With B-X
Parathyroid B-X
Carcinoma B-X
Multiple B-X
endocrine B-X
neoplasia B-X
type B-X
1 B-X
( B-X
MEN1 B-X
) B-X
syndrome B-X
includes B-X
varying B-X
combinations B-X
of B-X
more B-X
than B-X
20 B-X
endocrine B-X
and B-X
non-endocrine B-X
tumors B-X
. B-X

Twenty	O
microsatellite	O
markers	O
in	O
the	O
HRPT2	O
region	O
were	O
typed	O
,	O
in	O
addition	O
to	O
markers	O
in	O
the	O
multiple	B-Disease
endocrine	I-Disease
neoplasia	I-Disease
(	I-Disease
MEN	I-Disease
)	I-Disease
types	I-Disease
1	I-Disease
and	I-Disease
2	I-Disease
regions	O
at	O
11q13	O
and	O
10q11	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Rare B-X
somatic B-X
inactivation B-X
of B-X
the B-X
multiple B-X
endocrine B-X
neoplasia B-X
type B-X
1 B-X
gene B-X
in B-X
secondary B-X
hyperparathyroidism B-X
of B-X
uremia B-X
| B-X
The B-X
molecular B-X
pathway B-X
of B-X
autonomous B-X
growth B-X
of B-X
the B-X
parathyroid B-X
glands B-X
Request B-X
PDF B-X
| B-X
Genetic B-X
and B-X
clinical B-X
characterization B-X
of B-X
sporadic B-X
cystic B-X
parathyroid B-X
tumours B-X
| B-X
The B-X
hyperparathyroidism B-X
-- B-X
jaw B-X
tumour B-X
( B-X
HPT B-X
-- B-X
JT B-X
) B-X
syndrome B-X
is B-X
one B-X
of B-X
the B-X
familial B-X
disorders B-X

The	O
disease	O
in	O
these	O
two	O
kindreds	O
was	O
linked	O
to	O
five	O
markers	O
in	O
the	O
1q21	O
-	O
q32	O
region	O
(	O
logarithm	O
-	O
of	O
-	O
odds	O
scores	O
3	O
.	O
2	O
-	O
4	O
2	O
-	O
4	O
.	O
2	O
)	O
,	O
whereas	O
linkage	O
to	O
the	O
MEN1	B-Disease
and	O
MEN2	B-Disease
regions	O
was	O
excluded	O
.	O
<EOS> B-X
Multiple B-X
endocrine B-X
neoplasia B-X
type B-X
1 B-X
( B-X
MEN1 B-X
) B-X
and B-X
type B-X
4 B-X
( B-X
MEN4 B-X
) B-X
Genetic B-X
and B-X
Clinical B-X
Features B-X
of B-X
Multiple B-X
Endocrine B-X
Neoplasia B-X
Types B-X
1 B-X
and B-X
2 B-X
Request B-X
PDF B-X
| B-X
Distinct B-X
loci B-X
on B-X
chromosome B-X
1q21 B-X
and B-X
6q22 B-X
predispose B-X
to B-X
familial B-X
nonmedullary B-X
thyroid B-X
cancer B-X
: B-X
A B-X
SNP B-X
array-based B-X
linkage B-X
analysis B-X
of B-X
38 B-X
families B-X
| B-X
Familial B-X
nonmedullary B-X
thyroid B-X
cancer B-X
Request B-X
PDF B-X
| B-X
Familial B-X
nephrotic B-X
syndrome B-X
: B-X
Clinical B-X
spectrum B-X
and B-X
linkage B-X
to B-X
chromosome B-X
19q13 B-X
| B-X
Familial B-X
nephrotic B-X
syndrome B-X
( B-X
NS B-X
) B-X
has B-X
both B-X
autosomal B-X
dominant B-X
and B-X
recessive B-X
forms B-X
of B-X
inheritance B-X
Localization B-X
of B-X
genes B-X
modulating B-X
the B-X
predisposition B-X
to B-X
schizophrenia B-X
: B-X
a B-X
revision B-X
Approximately B-X
70 B-X
families B-X
with B-X
familial B-X
isolated B-X
hyperparathyroidism B-X
( B-X
FIHP B-X
) B-X
have B-X
been B-X
reported B-X
. B-X
Whether B-X
it B-X
is B-X
a B-X
separate B-X
entity B-X
or B-X
a B-X
variant B-X
of B-X
multiple B-X
endocri B-X
We B-X
sought B-X
to B-X
map B-X
the B-X
disease-causing B-X
gene B-X
in B-X
a B-X
large B-X
Spanish B-X
kindred B-X
with B-X
familial B-X
hemiplegic B-X
migraine B-X
( B-X
FHM B-X
) B-X
. B-X
Patients B-X
were B-X
classified B-X
according B-X
to B-X
the B-X
ICH B-X

Meiotic	O
recombinations	O
detected	O
in	O
affected	O
individuals	O
placed	O
the	O
locus	O
telomeric	O
of	O
D1S215	O
,	O
thus	O
narrowing	O
the	O
HRPT2	O
region	O
from	O
>	O
60	O
to	O
approximately	O
34	O
centimorgans	O
.	O
<EOS> B-X
Hyperparathyroidism‚ÄìJaw B-X
Tumor B-X
Syndrome B-X
: B-X
The B-X
HRPT2 B-X
Locus B-X
Is B-X
within B-X
a B-X
0.7-cM B-X
Region B-X
on B-X
Chromosome B-X
1q B-X
- B-X
ScienceDirect B-X
Request B-X
PDF B-X
| B-X
The B-X
hyperparathyroidism-jaw B-X
tumour B-X
syndrome B-X
in B-X
a B-X
Portuguese B-X
kindred B-X
| B-X
The B-X
hyperparathyroidism-jaw B-X
tumour B-X
( B-X
HPT-JT B-X
) B-X
syndrome B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disease B-X
characterized B-X
by B-X
the B-X
occurrence B-X
of B-X
parathyroid B-X
Request B-X
PDF B-X
| B-X
Cell B-X
Division B-X
Cycle B-X
Protein B-X
73 B-X
Homolog B-X
( B-X
CDC73 B-X
) B-X
Mutations B-X
in B-X
the B-X
Hyperparathyroidism-Jaw B-X
Tumor B-X
Syndrome B-X
( B-X
HPT-JT B-X
) B-X
and B-X
Parathyroid B-X
Tumors B-X
| B-X
The B-X
hyperparathyroidism-jaw B-X
tumor B-X
( B-X
HPT-JT B-X
Request B-X
PDF B-X
| B-X
A B-X
Genotypic B-X
and B-X
Histopathological B-X
Study B-X
of B-X
a B-X
Large B-X
Dutch B-X
Kindred B-X
with B-X
Hyperparathyroidism-Jaw B-X
Tumor B-X
Syndrome B-X
1 B-X
| B-X
Familial B-X
primary B-X
hyperparathyroidism B-X
is B-X
the B-X
main B-X
feature B-X
of B-X
2 B-X
familial B-X
endocrine B-X

Loss	O
of	O
heterozygosity	O
was	O
studied	O
in	O
seven	O
renal	B-Disease
hamartomas	I-Disease
from	O
two	O
affected	O
individuals	O
in	O
the	O
first	O
family	O
,	O
as	O
well	O
as	O
in	O
a	O
jaw	B-Disease
tumor	I-Disease
and	O
a	O
parathyroid	B-Disease
tumor	I-Disease
from	O
the	O
second	O
family	O
.	O
<EOS> B-X
Jaw B-X
tumor B-X
in B-X
recurrent B-X
primary B-X
hyperparathyroidism B-X
: B-X
A B-X
case B-X
report B-X
CDC73 B-X
germline B-X
mutation B-X
in B-X
a B-X
family B-X
with B-X
mixed B-X
epithelial B-X
and B-X
stromal B-X
tumors B-X
The B-X
hyperparathyroidism-jaw B-X
tumour B-X
( B-X
HPT-JT B-X
) B-X
syndrome B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
characterized B-X
by B-X
parathyroid B-X
tumours B-X
, B-X
which B-X
are B-X
frequently B-X
carcinomas B-X
, B-X
and B-X
ossifying B-X
jaw B-X
fibromas B-X
. B-X
In B-X
addition B-X
, B-X
Families B-X
with B-X
hereditary B-X
predispositions B-X
to B-X
cancer B-X
continue B-X
to B-X
provide B-X
a B-X
unique B-X
opportunity B-X
for B-X
the B-X
identification B-X
and B-X
characterization B-X
of B-X
genes B-X
involved B-X
in B-X
carcinogenesis B-X
. B-X
A B-X
surprising B-X
number B-X
of B-X
genetic B-X
syndromes B-X
predispose B-X
The B-X
hyperparathyroidism-jaw B-X
tumor B-X
syndrome B-X
( B-X
HPT-JT B-X
) B-X
is B-X
an B-X
autosomal B-X
dominantly B-X
inherited B-X
disorder B-X
whose B-X
principal B-X
features B-X
are B-X
neoplastic B-X
and/or B-X
cystic B-X
lesions B-X
in B-X
three B-X
main B-X
organs B-X
: B-X
the B-X
parathyroid B-X
glands B-X
, B-X
Parathyroid B-X
Cancer B-X
CDC73 B-X
Germline B-X
Mutation B-X
in B-X
a B-X
Family B-X
With B-X
Mixed B-X
Epithelial B-X
and B-X
Stromal B-X
Tumors B-X
- B-X
ScienceDirect B-X

All	O
renal	B-Disease
hamartomas	I-Disease
showed	O
loss	O
of	O
heterozygosity	O
at	O
the	O
1q21	O
-	O
q32	O
region	O
.	O

The	O
losses	O
invariably	O
involved	O
the	O
wild	O
type	O
allele	O
derived	O
from	O
the	O
unaffected	O
parent	O
,	O
suggesting	O
the	O
inactivation	O
of	O
a	O
tumor	B-Disease
suppressor	O
gene	O
in	O
this	O
region	O
<EOS> B-X
Recent B-X
insights B-X
into B-X
the B-X
function B-X
of B-X
autophagy B-X
in B-X
cancer B-X
Abstract B-X
. B-X
Oncogenesis B-X
results B-X
from B-X
an B-X
accumulation B-X
of B-X
genetic B-X
mutations B-X
in B-X
a B-X
single B-X
cell B-X
. B-X
Mutations B-X
may B-X
result B-X
in B-X
the B-X
cell B-X
acquiring B-X
new B-X
functions B-X
or B-X
losing B-X
spe B-X
Studies B-X
of B-X
allelic B-X
imbalance B-X
and B-X
suppression B-X
of B-X
tumourigenicity B-X
have B-X
consistently B-X
suggested B-X
that B-X
the B-X
short B-X
arm B-X
of B-X
chromosome B-X
three B-X
( B-X
3p B-X
) B-X
harbours B-X
tumour B-X
suppressor B-X
genes B-X
( B-X
TSGs B-X
) B-X
whose B-X
inactivation B-X
Allele-Specific B-X
Wild-Type B-X
TP53 B-X
Expression B-X
in B-X
the B-X
Unaffected B-X
Carrier B-X
Parent B-X
of B-X
Children B-X
with B-X
Li-Fraumeni B-X
Syndrome B-X
Abstract B-X
: B-X
MEN B-X
1 B-X
is B-X
a B-X
rare B-X
hereditary B-X
cancer B-X
syndrome B-X
which B-X
manifests B-X
a B-X
variety B-X
of B-X
endocrine B-X
and B-X
non-endocrine B-X
neoplasms B-X
and B-X
lesions B-X
. B-X
Growing B-X
knowledge B-X
of B-X
this B-X
condition B-X
in B-X
both B-X
its B-X

Independent	O
origin	O
of	O
single	O
and	O
double	O
mutations	O
in	O
the	O
human	O
glucose	O
6	O
-	O
phosphate	O
dehydrogenase	O
gene	O
.	O
<EOS> B-X
Molecular B-X
characterization B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
in B-X
patients B-X
from B-X
the B-X
southern B-X
Brazilian B-X
city B-X
of B-X
Porto B-X
Alegre B-X
, B-X
RS B-X
We B-X
report B-X
results B-X
from B-X
a B-X
systematic B-X
study B-X
to B-X
identify B-X
the B-X
molecular B-X
basis B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
on B-X
a B-X
sample B-X
of B-X
299 B-X
male B-X
subjects B-X
from B-X
the B-X
Hellenic B-X
population B-X
Glucose-6-phosphate B-X
Dehydrogenase B-X
Mutations B-X
and B-X
Haplotypes B-X
in B-X
Mexican B-X
Mestizos B-X
- B-X
ScienceDirect B-X
G6PD B-X
Mutations B-X

The	O
vast	O
majority	O
of	O
both	O
polymorphic	O
and	O
sporadic	O
G6PD	O
variants	O
are	O
due	O
to	O
single	O
missense	O
mutations	O
.	O

In	O
the	O
four	O
polymorphic	O
variants	O
that	O
have	O
two	O
point	O
mutations	O
,	O
one	O
of	O
the	O
mutations	O
is	O
always	O
376	O
A	O
-	O
-	O
>	O
G	O
(	O
126	O
Asn	O
-	O
-	O
>	O
Asp	O
)	O
,	O
which	O
on	O
its	O
own	O
gives	O
rise	O
to	O
the	O
nondeficient	O
polymorphic	O
variant	O
,	O
G6PD	O
A	O
.	O
<EOS> B-X
Defining B-X
‚Äú B-X
mutation B-X
‚Äù B-X
and B-X
‚Äú B-X
polymorphism B-X
‚Äù B-X
in B-X
the B-X
era B-X
of B-X
personal B-X
genomics B-X
CYP2A6 B-X
is B-X
a B-X
major B-X
hepatic B-X
member B-X
of B-X
the B-X
cytochrome B-X
P450 B-X
family B-X
in B-X
humans B-X
. B-X
Much B-X
variation B-X
in B-X
CYP2A6 B-X
levels B-X
and B-X
activity B-X
can B-X
be B-X
attributed B-X
to B-X
genetic B-X
polymorphisms B-X
of B-X
this B-X
gene B-X
The B-X
G6PD B-X
gene B-X
provides B-X
instructions B-X
for B-X
making B-X
an B-X
enzyme B-X
called B-X
glucose-6-phosphate B-X
dehydrogenase B-X
. B-X
Learn B-X
about B-X
this B-X
gene B-X
and B-X
related B-X
health B-X
conditions B-X
. B-X
The B-X
gene B-X
that B-X
codes B-X
for B-X
G6PD B-X
is B-X
located B-X
in B-X
the B-X
distal B-X
long B-X
arm B-X
of B-X
the B-X
X B-X
chromosome B-X
at B-X
the B-X
Xq28 B-X
locus B-X
. B-X
The B-X
G6PD B-X
gene B-X
is B-X
18 B-X
kilobases B-X
( B-X
kb B-X
Context B-X
: B-X
Ketosis-prone B-X
diabetes B-X
( B-X
KPD B-X
) B-X
is B-X
mostly B-X
observed B-X
in B-X
males B-X
of B-X
West B-X
African B-X
descent B-X
and B-X
is B-X
characterized B-X
by B-X
phasic B-X
or B-X
permanent B-X
insulin B-X
dependence B-X
without B-X
G6PD B-X
A- B-X
occurs B-X
in B-X
high B-X
frequency B-X
in B-X
Africa B-X
, B-X
Southern B-X
Europe B-X
, B-X
and B-X
North B-X
and B-X
South B-X
America B-X
. B-X
It B-X
is B-X
associated B-X
with B-X
lower B-X
enzyme B-X
levels B-X
and B-X
acute B-X
intermittent B-X
hemolysis B-X
. B-X
Human B-X
Metabolic B-X
Enzymes B-X
Deficiency B-X
: B-X
A B-X
Genetic B-X
Mutation B-X
Based B-X
Approach B-X

In	O
a	O
study	O
of	O
G6PD	B-Disease
deficient	I-Disease
patients	O
who	O
presented	O
with	O
clinical	O
favism	B-Disease
in	O
Spain	O
,	O
we	O
have	O
found	O
a	O
new	O
polymorphic	O
variant	O
that	O
we	O
have	O
called	O
G6PD	O
Malaga	O
,	O
whose	O
only	O
abnormality	O
is	O
a	O
542	O
A	O
-	O
-	O
>	O
T	O
(	O
181	O
Asp	O
-	O
-	O
>	O
Val	O
)	O
mutation	O
.	O
<EOS> B-X
The B-X
present B-X
study B-X
confirms B-X
the B-X
marked B-X
genetic B-X
heterogeneity B-X
of B-X
G6PD B-X
deficiency B-X
in B-X
Spain B-X
and B-X
demonstrate B-X
that B-X
the B-X
PCR-RE B-X
analysis B-X
is B-X
an B-X
easy B-X
tool B-X
for B-X
rapid B-X
diagnosis B-X
of B-X
the B-X
molecular B-X
defect B-X
Clinical B-X
complications B-X
of B-X
G6PD B-X
deficiency B-X
in B-X
Latin B-X
American B-X
and B-X
Caribbean B-X
populations B-X
: B-X
systematic B-X
review B-X
and B-X
implications B-X
for B-X
malaria B-X
elimination B-X
programmes B-X
In B-X
order B-X
to B-X
explore B-X
the B-X
nature B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
in B-X
Spain B-X
, B-X
we B-X
have B-X
analysed B-X
the B-X
G6PD B-X
gene B-X
in B-X
11 B-X
unrelated B-X
Spanish B-X
G6PD-deficient B-X
males B-X
and B-X
their B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
characterization B-X
of B-X
erythrocyte B-X
glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
in B-X
Tunisia B-X
| B-X
Screening B-X
of B-X
G6PD B-X
deficiency B-X
was B-X
carried B-X
out B-X
on B-X
79 B-X
unrelated B-X
subjects B-X
( B-X
32 B-X
females B-X
and B-X
47 B-X
males B-X
Functional B-X
characterization B-X
of B-X
the B-X
thylakoid B-X
Ndh B-X
complex B-X
phosphorylation B-X
by B-X
site-directed B-X
mutations B-X
in B-X
the B-X
ndhF B-X
gene B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
The B-X
recent B-X
unraveling B-X
of B-X
structures B-X
of B-X
genes B-X
for B-X
the B-X
gonadotropin B-X
subunits B-X
and B-X
gonadotropin B-X
receptors B-X
has B-X
provided B-X
reproductive B-X
endocrinologists B-X
with B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
; B-X
EC B-X
1.1.1.49 B-X
from B-X
thirty-six B-X
unrelated B-X
Spanish B-X
males B-X
was B-X
partially B-X
purified B-X
from B-X
blood B-X
, B-X
and B-X
the B-X
variants B-X
were B-X
characterized B-X
biochemically B-X
and B-X
electrophoretically B-X
according B-X
to B-X
the B-X

This	O
is	O
the	O
same	O
mutation	O
as	O
previously	O
found	O
in	O
association	O
with	O
the	O
mutation	O
of	O
G6PD	O
A	O
in	O
the	O
double	O
mutant	O
,	O
G6PD	O
Santamaria	O
.	O
<EOS> B-X
Biochemical B-X
Analysis B-X
of B-X
Two B-X
Single B-X
Mutants B-X
that B-X
Give B-X
Rise B-X
to B-X
a B-X
Polymorphic B-X
G6PD B-X
A-Double B-X
Mutant B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
has B-X
previously B-X
been B-X
reported B-X
among B-X
both B-X
the B-X
black B-X
and B-X
white B-X
populations B-X
of B-X
Costa B-X
Rica B-X
. B-X
All B-X
28 B-X
G6PD B-X
A- B-X
samples B-X
were B-X
found B-X
to B-X
be B-X
PDF B-X
| B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
the B-X
most B-X
frequent B-X
human B-X
enzymopathy B-X
, B-X
affecting B-X
over B-X
400 B-X
million B-X
people B-X
globally B-X
. B-X
Worldwide B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
A B-X
population B-X
sample B-X
from B-X
S√£o B-X
Tom√© B-X
e B-X
Pr√≠ncipe B-X
( B-X
West B-X
Africa B-X
) B-X
was B-X
screened B-X
for B-X
the B-X
G6PD-deficient B-X
variants B-X
A- B-X
( B-X
376G/202A B-X
) B-X
, B-X
Betica B-X
( B-X
376G/968C B-X
) B-X
, B-X
and B-X
Santa B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
the B-X
most B-X
common B-X
enzymopathy B-X
in B-X
the B-X
world B-X
. B-X
More B-X
than B-X
160 B-X
mutations B-X
causing B-X
the B-X
disease B-X
have B-X
been B-X
identified B-X
, B-X
but B-X
only B-X
10 B-X
% B-X

G6PD	O
Malaga	O
is	O
associated	O
with	O
enzyme	B-Disease
deficiency	I-Disease
(	O
class	O
III	O
)	O
,	O
and	O
the	O
enzymic	O
properties	O
of	O
G6PD	O
Malaga	O
and	O
G6PD	O
Santamaria	O
are	O
quite	O
similar	O
,	O
indicating	O
that	O
in	O
this	O
case	O
the	O
effects	O
of	O
the	O
two	O
mutations	O
are	O
additive	O
rather	O
than	O
synergistic	O
.	O
<EOS> B-X
DNA B-X
sequencing B-X
revealed B-X
seven B-X
different B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
mutations B-X
in B-X
G6PD B-X
deficient B-X
subjects B-X
from B-X
10 B-X
Polish B-X
families B-X
. B-X
Among B-X
them B-X
we B-X
found B-X
two B-X
novel B-X
mutations B-X
: B-X
679C B-X
-- B-X
Request B-X
PDF B-X
| B-X
On B-X
Sep B-X
7 B-X
, B-X
2012 B-X
, B-X
Ikbel B-X
Benmansour B-X
and B-X
others B-X
published B-X
Two B-X
new B-X
class B-X
III B-X
G6PD B-X
variants B-X
[ B-X
G6PD B-X
Tunis B-X
( B-X
c.920A B-X
> B-X
C B-X
: B-X
p.307Gln B-X
> B-X
Stacking B-X
of B-X
a B-X
low-lignin B-X
trait B-X
with B-X
an B-X
increased B-X
guaiacyl B-X
and B-X
5-hydroxyguaiacyl B-X
unit B-X
trait B-X
leads B-X
to B-X
additive B-X
and B-X
synergistic B-X
effects B-X
on B-X
saccharification B-X
efficiency B-X
in B-X
Arabidopsis B-X
thaliana B-X
Additive B-X
Phenotypes B-X
Underlie B-X
Epistasis B-X
of B-X
Fitness B-X
Effects B-X
| B-X
Genetics B-X
Mutation B-X
load B-X
under B-X
additive B-X
fitness B-X
effects B-X
Epistasis B-X
and B-X
Quantitative B-X
Traits B-X
: B-X
Using B-X
Model B-X
Organisms B-X
to B-X
Study B-X
Gene-Gene B-X
Interactions B-X
Author B-X
Summary B-X
Epistasis B-X
, B-X
the B-X
extent B-X
to B-X
which B-X
the B-X
effects B-X
of B-X
a B-X
mutation B-X
depend B-X
on B-X
its B-X
genetic B-X
context B-X
, B-X
can B-X
have B-X
profound B-X
effects B-X
on B-X
the B-X
evolutionary B-X
process B-X
and B-X
strongly B-X
affects B-X

G6PD	O
Santamaria	O
might	O
have	O
been	O
produced	O
by	O
recombination	O
between	O
G6PD	O
A	O
and	O
G6PD	O
Malaga	O
;	O
however	O
haplotype	O
analysis	O
,	O
including	O
the	O
use	O
of	O
a	O
new	O
silent	O
polymorphism	O
,	O
suggests	O
that	O
the	O
same	O
542	O
A	O
-	O
-	O
>	O
T	O
mutation	O
has	O
taken	O
place	O
independently	O
in	O
a	O
G6PD	O
B	O
gene	O
to	O
give	O
G6PD	O
Malaga	O
and	O
in	O
a	O
G6PD	O
A	O
gene	O
to	O
give	O
G6PD	O
Santamaria	O
.	O
<EOS> B-X
The B-X
most B-X
telomeric B-X
region B-X
of B-X
the B-X
human B-X
X B-X
chromosome B-X
within B-X
band B-X
Xq28 B-X
consists B-X
of B-X
a B-X
gene-rich B-X
region B-X
of B-X
about B-X
3 B-X
Mb B-X
which B-X
contains B-X
the B-X
genes B-X
for B-X
coagulation B-X
factor B-X
VIIIc B-X
, B-X
Abstract B-X
. B-X
Background B-X
. B-X
Diabetic B-X
nephropathy B-X
( B-X
DN B-X
) B-X
represents B-X
a B-X
devastating B-X
complication B-X
of B-X
diabetes B-X
. B-X
Family B-X
clustering B-X
, B-X
heterogeneity B-X
in B-X
the B-X
onset B-X
and B-X
progression B-X
PDF B-X
| B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
in B-X
Africa B-X
is B-X
of B-X
high B-X
prevalence B-X
, B-X
although B-X
precise B-X
data B-X
are B-X
lacking B-X
in B-X
many B-X
individual B-X
nations B-X
.... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Many B-X
mutations B-X
of B-X
the B-X
housekeeping B-X
gene B-X
encoding B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
cause B-X
G6PD B-X
deficiency B-X
in B-X
humans B-X
. B-X
Some B-X
underlie B-X
severe B-X
forms B-X
of B-X
chronic B-X
nonspherocytic B-X
hemolytic B-X
anemia B-X
( B-X
CNSHA B-X
) B-X
Download B-X
Citation B-X
| B-X
Severe B-X
G6PD B-X
Deficiency B-X
Due B-X
to B-X
a B-X
New B-X
Missense B-X
Mutation B-X
in B-X
an B-X
Infant B-X
of B-X
Northern B-X
European B-X
Descent B-X
| B-X
We B-X
report B-X
a B-X
term B-X
male B-X
infant B-X
born B-X
to B-X
parents B-X
of B-X
PDF B-X
| B-X
Background/aims B-X
: B-X
In B-X
Jordan B-X
, B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
is B-X
a B-X
significant B-X
health B-X
problem B-X
, B-X
and B-X
the B-X
incidence B-X
was B-X
reported B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

These	O
findings	O
help	O
to	O
outline	O
the	O
relationship	O
and	O
evolution	O
of	O
mutations	O
in	O
the	O
human	O
G6PD	O
locus	O
.	O
.	O
<EOS> B-X
Evidence B-X
for B-X
Balancing B-X
Selection B-X
from B-X
Nucleotide B-X
Sequence B-X
Analyses B-X
of B-X
Human B-X
G6PD B-X
We B-X
report B-X
results B-X
from B-X
a B-X
systematic B-X
study B-X
to B-X
identify B-X
the B-X
molecular B-X
basis B-X
of B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
deficiency B-X
on B-X
a B-X
sample B-X
of B-X
299 B-X
male B-X
subjects B-X
from B-X
the B-X
Hellenic B-X
population B-X
Abstract B-X
. B-X
Although B-X
mutations B-X
in B-X
the B-X
glucose-6-phosphate B-X
dehydrogenase B-X
( B-X
G6PD B-X
) B-X
gene B-X
result B-X
in B-X
several B-X
blood-related B-X
diseases B-X
in B-X
humans B-X
, B-X
they B-X
also B-X
confer B-X
resistanc B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
and B-X
the B-X
risk B-X
of B-X
malaria B-X
and B-X
other B-X
diseases B-X
in B-X
children B-X
in B-X
Kenya B-X
: B-X
a B-X
case-control B-X
and B-X
a B-X
cohort B-X
study B-X
- B-X
ScienceDirect B-X
Glucose-6-phosphate B-X
dehydrogenase B-X
deficiency B-X
and B-X
the B-X
risk B-X
of B-X
malaria B-X
and B-X
other B-X
diseases B-X
in B-X
children B-X
in B-X
Kenya B-X
: B-X
a B-X
case-control B-X
and B-X
a B-X
cohort B-X
study B-X
- B-X
The B-X
Lancet B-X
Haematology B-X

BRCA1	O
R841W	O
:	O
a	O
strong	O
candidate	O
for	O
a	O
common	O
mutation	O
with	O
moderate	O
phenotype	O
.	O
<EOS> B-X
BRCA1 B-X
mutations B-X
in B-X
southern B-X
England B-X
. B-X
BRCA1 B-X
mutations B-X
cause B-X
increased B-X
risk B-X
for B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
, B-X
frequently B-X
of B-X
early B-X
onset B-X
. B-X
Many B-X
different B-X
mutations B-X
occur B-X
in B-X
BRCA1 B-X
, B-X
including B-X
several B-X
examples B-X
of B-X
recurrent B-X
mutations B-X
, B-X
VCV000054591.7 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X
UniProtKB/SwissProt B-X
variant B-X
VAR_007773 B-X
VCV000017681.11 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
description B-X

BRCA1	O
mutations	O
cause	O
increased	O
risk	O
for	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
,	O
frequently	O
of	O
early	O
onset	O
.	O
<EOS> B-X
Women B-X
who B-X
carry B-X
a B-X
BRCA1 B-X
or B-X
BRCA2 B-X
mutation B-X
are B-X
at B-X
high B-X
risk B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
, B-X
and B-X
may B-X
be B-X
at B-X
moderately B-X
increased B-X
risk B-X
of B-X
other B-X
cancer B-X
types B-X
. B-X

Many	O
different	O
mutations	O
occur	O
in	O
BRCA1	O
,	O
including	O
several	O
examples	O
of	O
recurrent	O
mutations	O
,	O
each	O
of	O
which	O
accounts	O
for	O
a	O
significant	O
number	O
of	O
families	O
with	O
heritable	O
cancer	B-Disease
predisposition	O
.	O

These	O
common	O
mutations	O
have	O
an	O
etiological	O
role	O
in	O
many	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
cases	O
and	O
provide	O
the	O
opportunity	O
to	O
examine	O
genotype	O
-	O
phenotype	O
correlations	O
and	O
genotype	O
-	O
environment	O
interactions	O
in	O
individuals	O
with	O
the	O
identical	O
BRCA1	O
lesion	O
.	O
<EOS> B-X
Ovarian B-X
cancer B-X
is B-X
the B-X
most B-X
common B-X
cause B-X
of B-X
death B-X
from B-X
gynecological B-X
cancers B-X
in B-X
the B-X
Western B-X
world B-X
. B-X
There B-X
are B-X
many B-X
genetic B-X
and B-X
environmental B-X
factors B-X
which B-X
can B-X
influence B-X
a B-X
woman B-X
's B-X
Ovarian B-X
surface B-X
epithelium B-X
: B-X
family B-X
history B-X
and B-X
early B-X
events B-X
in B-X
ovarian B-X
cancer B-X

We	O
report	O
a	O
novel	O
missense	O
change	O
in	O
BRCA1	O
,	O
2640	O
C	O
-	O
-	O
>	O
T	O
(	O
R841W	O
)	O
,	O
found	O
in	O
3	O
cases	O
from	O
a	O
subject	O
group	O
of	O
305	O
breast	B-Disease
and	I-Disease
79	I-Disease
ovarian	I-Disease
cancer	I-Disease
cases	O
from	O
Orange	O
County	O
,	O
CA	O
.	O
<EOS> B-X
Mutational B-X
analysis B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
in B-X
Peruvian B-X
families B-X
with B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
Request B-X
PDF B-X
| B-X
Characteristics B-X
of B-X
BRCA1 B-X
mutations B-X
in B-X
a B-X
population-based B-X
case B-X
series B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
| B-X
Breast B-X
and B-X
ovarian B-X
cancers B-X
account B-X
for B-X
approximately B-X
210000 B-X
newly B-X
diagnosed B-X
cases B-X
per B-X
Protein B-X
biomarkers B-X
of B-X
ovarian B-X
cancer B-X
: B-X
the B-X
forest B-X
and B-X
the B-X
trees B-X
Abstract B-X
. B-X
Previously B-X
developed B-X
models B-X
for B-X
predicting B-X
absolute B-X
risk B-X
of B-X
invasive B-X
epithelial B-X
ovarian B-X
cancer B-X
have B-X
included B-X
a B-X
limited B-X
number B-X
of B-X
risk B-X
factors B-X
and B-X
have B-X
PDF B-X
| B-X
A B-X
total B-X
of B-X
264 B-X
unrelated B-X
breast/ovarian B-X
cancer B-X
patients B-X
and B-X
45 B-X
healthy B-X
individuals B-X
with B-X
familial B-X
antecedents B-X
referred B-X
for B-X
genetic B-X
testing B-X
were B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
www.ca.gov B-X
| B-X
California B-X
State B-X
Portal B-X
Ovarian B-X
cancer B-X
in B-X
the B-X
world B-X
: B-X
epidemiology B-X
and B-X
risk B-X
factors B-X

These	O
are	O
consecutive	O
,	O
population	O
-	O
based	O
cases	O
not	O
selected	O
for	O
age	O
or	O
family	O
history	O
.	O
<EOS> B-X
Association B-X
of B-X
Consecutive B-X
Influenza B-X
Vaccinations B-X
and B-X
Pneumonia B-X
: B-X
A B-X
Population-Based B-X
Case-Control B-X
Study B-X
Methodology B-X
Series B-X
Module B-X
3 B-X
: B-X
Cross-sectional B-X
Studies B-X
Monogenic B-X
Diabetes B-X
: B-X
From B-X
Genetic B-X
Insights B-X
to B-X
Population-Based B-X
Precision B-X
in B-X
Care B-X
. B-X
Reflections B-X
From B-X
a B-X
Diabetes B-X
Care B-X
Editors B-X
‚Äô B-X
Expert B-X
Forum B-X
| B-X
Diabetes B-X
Care B-X
Cervical B-X
Screening B-X
at B-X
Age B-X
50‚Äì64 B-X
Years B-X
and B-X
the B-X
Risk B-X
of B-X
Cervical B-X
Cancer B-X
at B-X
Age B-X
65 B-X
Years B-X
and B-X
Older B-X
: B-X
Population-Based B-X
Case B-X
Control B-X
Study B-X
Prevalence B-X
of B-X
incidental B-X
prostate B-X
cancer B-X
: B-X
A B-X
systematic B-X
review B-X
of B-X
autopsy B-X
studies B-X
Familial B-X
cancer B-X
among B-X
consecutive B-X
uterine B-X
cancer B-X
patients B-X
in B-X
Sweden B-X
Author B-X
summary B-X
Traditionally B-X
pediatric B-X
cancer B-X
have B-X
been B-X
thought B-X
to B-X
be‚Äìmostly‚Äìcaused B-X
by B-X
pure B-X
bad B-X
luck B-X
. B-X
In B-X
recent B-X
years B-X
, B-X
however B-X
, B-X
this B-X
notion B-X
has B-X
been B-X
challenged B-X
by B-X
novel B-X
findings B-X
as B-X

In	O
all	O
three	O
cases	O
,	O
there	O
is	O
a	O
strong	O
family	O
history	O
of	O
breast	B-Disease
,	I-Disease
ovarian	I-Disease
,	I-Disease
or	I-Disease
other	I-Disease
cancers	I-Disease
possibly	O
related	O
to	O
a	O
BRCA1	O
defect	O
and	O
family	O
members	O
showed	O
a	O
high	O
concordance	O
of	O
cancer	B-Disease
incidence	O
with	O
the	O
presence	O
of	O
R841W	O
.	O
<EOS> B-X
BRCA1 B-X
R841W B-X
: B-X
a B-X
strong B-X
candidate B-X
for B-X
a B-X
common B-X
mutation B-X
with B-X
moderate B-X
phenotype B-X
. B-X
Some B-X
types B-X
of B-X
cancer B-X
can B-X
run B-X
in B-X
families B-X
. B-X
For B-X
example B-X
, B-X
your B-X
risks B-X
of B-X
developing B-X
certain B-X
types B-X
of B-X
breast B-X
cancer B-X
, B-X
bowel B-X
cancer B-X
or B-X
ovarian B-X
cancer B-X
are B-X
higher B-X
if B-X
BRCA1 B-X
R841W B-X
: B-X
A B-X
strong B-X
candidate B-X
for B-X
a B-X
common B-X
mutation B-X
with B-X
moderate B-X
phenotype B-X
- B-X
Barker B-X
- B-X
1996 B-X
- B-X
Genetic B-X
Epidemiology B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Purpose B-X
: B-X
To B-X
summarize B-X
the B-X
impact B-X
of B-X
a B-X
family B-X
history B-X
of B-X
breast B-X
cancer B-X
on B-X
mammography B-X
practices B-X
and B-X
beliefs B-X
. B-X
Method B-X
: B-X
Survey B-X
data B-X
concerning B-X
breast B-X
health B-X
practices B-X
and B-X
beliefs B-X
were B-X
Familial B-X
cancer B-X
includes B-X
some B-X
types B-X
of B-X
cancer B-X
aggregation B-X
without B-X
a B-X
well-defined B-X
inheritance B-X
pattern B-X
. B-X
Cancer B-X
genetics B-X
is B-X
an B-X
essential B-X
component B-X
of B-X
clinical B-X
practice B-X
in B-X
oncology B-X
. B-X
In B-X
Brazil B-X
, B-X
breast B-X
Purpose B-X
: B-X
To B-X
assess B-X
primary B-X
care B-X
providers B-X
' B-X
communication B-X
about B-X
breast B-X
cancer B-X
risk B-X
. B-X
Methods B-X
: B-X
We B-X
evaluated B-X
86 B-X
primary B-X
care B-X
providers B-X
' B-X
communication B-X
of B-X
risk B-X
using B-X
unannounced B-X
standardized B-X
( B-X

The	O
age	O
of	O
cancer	B-Disease
onset	O
was	O
not	O
always	O
distinct	O
from	O
typical	O
sporadic	O
cases	O
.	O
<EOS> B-X
Age-specific B-X
incidence B-X
of B-X
inherited B-X
versus B-X
sporadic B-X
cancers B-X
: B-X
A B-X
test B-X
of B-X
the B-X
multistage B-X
theory B-X
of B-X
carcinogenesis B-X
Early-onset B-X
colorectal B-X
cancer B-X
: B-X
A B-X
separate B-X
subset B-X
of B-X
colorectal B-X
cancer B-X
Age-specific B-X
incidence B-X
of B-X
inherited B-X
versus B-X
sporadic B-X
cancers B-X
: B-X
A B-X
test B-X
of B-X
the B-X
multistage B-X
theory B-X
of B-X
carcinogenesis B-X
| B-X
PNAS B-X
Breast B-X
cancer B-X
development B-X
and B-X
progression B-X
: B-X
Risk B-X
factors B-X
, B-X
cancer B-X
stem B-X
cells B-X
, B-X
signaling B-X
pathways B-X
, B-X
genomics B-X
, B-X
and B-X
molecular B-X
pathogenesis B-X
BRCA1 B-X
mutations B-X
cause B-X
increased B-X
risk B-X
for B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
, B-X
frequently B-X
of B-X
early B-X
onset B-X
. B-X
Many B-X
different B-X
mutations B-X
occur B-X
in B-X
BRCA1 B-X
, B-X
including B-X
several B-X
examples B-X
of B-X
recurrent B-X
mutations B-X
, B-X
Several B-X
checks B-X
prevent B-X
uncontrolled B-X
proliferation B-X
of B-X
cells B-X
. B-X
Normal B-X
cells B-X
commit B-X
suicide B-X
when B-X
they B-X
can B-X
not B-X
pass B-X
various B-X
quality B-X
control B-X
tests B-X
; B-X
a B-X
built-in B-X
counting B-X
mechanism B-X
limits B-X
the B-X
number B-X
of B-X
Epidemiology B-X
of B-X
Pancreatic B-X
Cancer B-X
: B-X
Global B-X
Trends B-X
, B-X
Etiology B-X
and B-X
Risk B-X
Factors B-X

Testing	O
of	O
a	O
sample	O
of	O
413	O
unrelated	O
individuals	O
to	O
examine	O
the	O
hypothesis	O
that	O
R841W	O
might	O
be	O
a	O
rare	O
polymorphism	O
detected	O
one	O
additional	O
instance	O
in	O
a	O
woman	O
with	O
breast	B-Disease
cancer	I-Disease
diagnosed	O
at	O
age	O
77	O
years	O
,	O
and	O
cancer	B-Disease
in	O
one	O
parent	O
.	O
<EOS> B-X
The B-X
Family-Cancer B-X
Database B-X
was B-X
constructed B-X
from B-X
the B-X
nationwide B-X
Swedish B-X
registries B-X
to B-X
include B-X
more B-X
than B-X
30,000 B-X
cancers B-X
in B-X
offspring B-X
diagnosed B-X
at B-X
ages B-X
15-51 B-X
years B-X
and B-X
their B-X
parents B-X
. B-X
Cancer B-X
risk B-X
in B-X
Lung B-X
cancer B-X
can B-X
run B-X
in B-X
families B-X
. B-X
Learn B-X
about B-X
what B-X
a B-X
hereditary B-X
predisposition B-X
means B-X
, B-X
specific B-X
gene B-X
mutations B-X
associated B-X
with B-X
the B-X
disease B-X
, B-X
and B-X
more B-X
. B-X
This B-X
series B-X
of B-X
guides B-X
offers B-X
extensive B-X
information B-X
on B-X
helping B-X
children B-X
understand B-X
and B-X
deal B-X
with B-X
cancer B-X
in B-X
another B-X
family B-X
member B-X
. B-X
Parental B-X
cancer B-X
and B-X
the B-X
family B-X
: B-X
A B-X
population-based B-X
estimate B-X
of B-X
the B-X
number B-X
of B-X
US B-X
cancer B-X
survivors B-X
residing B-X
with B-X
their B-X
minor B-X
children B-X
Some B-X
types B-X
of B-X
cancer B-X
run B-X
in B-X
certain B-X
families B-X
, B-X
but B-X
most B-X
cancers B-X
are B-X
not B-X
clearly B-X
linked B-X
to B-X
the B-X
genes B-X
we B-X
inherit B-X
from B-X
our B-X
parents B-X
. B-X
Gene B-X
changes B-X
that B-X
start B-X
in B-X
If B-X
you B-X
have B-X
cancer B-X
, B-X
will B-X
your B-X
kids B-X
get B-X
cancer B-X
too B-X
? B-X
The B-X
role B-X
genes B-X
play B-X
in B-X
cancer B-X
is B-X
n't B-X
always B-X
simple B-X
. B-X
Hear B-X
our B-X
providers B-X
discuss B-X
cancer B-X
and B-X
genetics B-X
Cancer B-X
can B-X
seem B-X
to B-X
run B-X
in B-X
some B-X
families B-X
, B-X
but B-X
most B-X
cancer B-X
is B-X
not B-X
inherited B-X
. B-X
Check B-X
your B-X
knowledge B-X
about B-X
common B-X
myths B-X
concerning B-X
cancer B-X
and B-X
family B-X
history B-X
. B-X

R841W	O
is	O
likely	O
to	O
be	O
an	O
etiologically	O
significant	O
lesion	O
with	O
involvement	O
in	O
close	O
to	O
1	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
of	O
0	O
-	O
1	O
.	O
7	O
%	O
)	O
of	O
all	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancers	I-Disease
in	O
this	O
population	O
.	O
<EOS> B-X
Understanding B-X
the B-X
spectrum B-X
and B-X
frequency B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
a B-X
Hakka B-X
population B-X
will B-X
assist B-X
in B-X
the B-X
prevention B-X
and B-X
control B-X
of B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
in B-X
this B-X
population B-X
Gene-panel B-X
sequencing B-X
allows B-X
comprehensive B-X
analysis B-X
of B-X
multiple B-X
genes B-X
simultaneously B-X
and B-X
is B-X
now B-X
routinely B-X
used B-X
in B-X
clinical B-X
mutation B-X
testing B-X
of B-X
high-risk B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
patients B-X
. B-X
However B-X
, B-X
only B-X
BRCA1 B-X
Worldwide B-X
variation B-X
in B-X
the B-X
distribution B-X
of B-X
BRCA B-X
mutations B-X
is B-X
well B-X
recognised B-X
, B-X
and B-X
for B-X
the B-X
Moroccan B-X
population B-X
no B-X
comprehensive B-X
studies B-X
about B-X
BRCA B-X
mutation B-X
spectra B-X
or B-X
frequencies B-X
have B-X
been B-X
published B-X
. B-X
The B-X
objective B-X
of B-X
this B-X
population-based B-X
study B-X
is B-X
to B-X
describe B-X
epidemiological B-X
and B-X
genetic B-X
features B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
in B-X
North B-X
Sardinia B-X
, B-X
Italy B-X
. B-X
Patients B-X
who B-X
carry B-X
a B-X
high-risk B-X
mutation B-X
To B-X
systematically B-X
assess B-X
the B-X
prevalence B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
gene B-X
mutations B-X
in B-X
women B-X
with B-X
Hereditary B-X
Breast B-X
and/or B-X
Ovarian B-X
Cancer B-X
( B-X
HBOC B-X
) B-X
in B-X
Arab B-X
countries B-X
and B-X
to B-X
describe B-X
the B-X
variability B-X
Confidence B-X
Intervals B-X
- B-X
Statistics B-X
Teaching B-X
Tools B-X
< B-X
em B-X
> B-X
BRCA1 B-X
< B-X
/em B-X
> B-X
R841W B-X
: B-X
A B-X
strong B-X
candidate B-X
for B-X
a B-X
common B-X
mutation B-X
with B-X
moderate B-X
phenotype B-X
| B-X
David B-X
F. B-X
Barker B-X
; B-X
Eduardo B-X
R.A. B-X
Almeida B-X
; B-X
Graham B-X
Casey B-X

Ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
:	O
founder	O
effect	O
among	O
north	O
African	O
Jews	O
.	O
<EOS> B-X
Altmetric B-X
‚Äì B-X
Ataxia-telangiectasia B-X
: B-X
founder B-X
effect B-X
among B-X
north B-X
African B-X
Jews B-X
A B-X
publicly B-X
available B-X
article B-X
also B-X
appearing B-X
in B-X
PubMed B-X
about B-X
Ataxia B-X
Telangiectasia B-X
Founder B-X
Effects B-X
for B-X
ATM B-X
Gene B-X
Mutations B-X
in B-X
Italian B-X
Ataxia B-X
Telangiectasia B-X
Families B-X
- B-X
Chessa B-X
- B-X
2009 B-X
- B-X
Annals B-X
of B-X
Human B-X
Genetics B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Focusing B-X
New B-X
Ataxia B-X
Telangiectasia B-X
Therapeutic B-X
Approaches B-X
, B-X
Luciana B-X
Chessa B-X
, B-X
Roberto B-X
Micheli B-X
and B-X
Anna B-X
Molinaro B-X
To B-X
gain B-X
insight B-X
into B-X
the B-X
molecular B-X
mechanisms B-X
underlying B-X
the B-X
inherited B-X
predisposition B-X
to B-X
breast B-X
cancer B-X
in B-X
non-Ashkenazi B-X
Jews B-X
, B-X
we B-X
genotyped B-X
54 B-X
Jewish B-X
Moroccan B-X
women B-X
with B-X
breast B-X
cancer B-X
, B-X
unselected B-X
for B-X

The	O
ATM	O
gene	O
is	O
responsible	O
for	O
the	O
autosomal	B-Disease
recessive	I-Disease
disorder	I-Disease
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
characterized	O
by	O
cerebellar	B-Disease
degeneration	I-Disease
,	O
immunodeficiency	B-Disease
and	O
cancer	B-Disease
predisposition	I-Disease
.	O
<EOS> B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
characterized B-X
by B-X
cerebellar B-X
degeneration B-X
, B-X
immunodeficiency B-X
, B-X
chromosomal B-X
instability B-X
, B-X
radiosensitivity B-X
, B-X
and B-X
cancer B-X
predisposition B-X
. B-X
A-T B-X
cells B-X
are B-X
sensitive B-X
to B-X
Ataxia B-X
Telangiectasia B-X
- B-X
NORD B-X
( B-X
National B-X
Organization B-X
for B-X
Rare B-X
Disorders B-X
) B-X

A	B-Disease
-	I-Disease
T	I-Disease
carriers	O
were	O
reported	O
to	O
be	O
moderately	O
cancer	B-Disease
-	I-Disease
prone	I-Disease
.	O
<EOS> B-X
Alcohol B-X
Intake B-X
and B-X
Breast B-X
Cancer B-X
Risk B-X
: B-X
Weighing B-X
the B-X
Overall B-X
Evidence B-X
NBS1 B-X
Heterozygosity B-X
and B-X
Cancer B-X
Risk B-X
Cancer B-X
risk B-X
in B-X
patients B-X
with B-X
Noonan B-X
syndrome B-X
carrying B-X
a B-X
PTPN11 B-X
mutation B-X
Risk B-X
of B-X
extracolonic B-X
cancers B-X
for B-X
people B-X
with B-X
biallelic B-X
and B-X
monoallelic B-X
mutations B-X
in B-X
MUTYH B-X
The B-X
spectrum B-X
and B-X
frequency B-X
of B-X
cancers B-X
associated B-X
with B-X
germline B-X
TP53 B-X
mutations B-X
are B-X
uncertain B-X
. B-X
To B-X
address B-X
this B-X
issue B-X
a B-X
cohort B-X
of B-X
individuals B-X
from B-X
28 B-X
families B-X
with B-X
Li-Fraumeni B-X
syndrome B-X
, B-X
segregating B-X

A	O
wide	O
variety	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
mutations	O
,	O
most	O
of	O
which	O
are	O
unique	O
to	O
single	O
families	O
,	O
were	O
identified	O
in	O
various	O
ethnic	O
groups	O
,	O
precluding	O
carrier	O
screening	O
with	O
mutation	O
-	O
specific	O
assays	O
.	O
<EOS> B-X
Diagnostic B-X
Testing B-X
by B-X
CFTR B-X
Gene B-X
Mutation B-X
Analysis B-X
in B-X
a B-X
Large B-X
Group B-X
of B-X
Hispanics B-X
As B-X
the B-X
most B-X
common B-X
lethal B-X
autosomal B-X
recessive B-X
disorder B-X
in B-X
North B-X
America B-X
, B-X
cystic B-X
fibrosis B-X
( B-X
CF B-X
) B-X
is B-X
an B-X
obvious B-X
candidate B-X
for B-X
general B-X
population B-X
carrier B-X
screening B-X
. B-X
Although B-X
the B-X
identification B-X
Mutation B-X
is B-X
the B-X
only B-X
way B-X
that B-X
new B-X
alleles B-X
can B-X
be B-X
created B-X
within B-X
a B-X
population B-X
. B-X
Mutations B-X
generate B-X
the B-X
variation B-X
on B-X
which B-X
natural B-X
selection B-X
acts B-X
. B-X
A B-X
gene B-X
mutation B-X
changes B-X
the B-X
DNA B-X
sequence B-X
of B-X
a B-X
gene B-X
in B-X
a B-X
way B-X
that B-X
makes B-X
it B-X
different B-X
from B-X
most B-X
people B-X
's B-X
. B-X
The B-X
change B-X
can B-X
be B-X
inherited B-X
or B-X
acquired B-X
. B-X
Carrier B-X
screening B-X
by B-X
next‚Äêgeneration B-X
sequencing B-X
: B-X
health B-X
benefits B-X
and B-X
cost B-X
effectiveness B-X
Sodium B-X
channel B-X
SCN1A B-X
and B-X
epilepsy B-X
: B-X
mutations B-X
and B-X
mechanisms B-X
Carrier B-X
Screening B-X
in B-X
the B-X
Age B-X
of B-X
Genomic B-X
Medicine B-X
| B-X
ACOG B-X

However	O
,	O
a	O
single	O
mutation	O
was	O
observed	O
in	O
32	O
/	O
33	O
defective	O
ATM	O
alleles	O
in	O
Jewish	O
A	B-Disease
-	I-Disease
T	I-Disease
families	O
of	O
North	O
African	O
origin	O
,	O
coming	O
from	O
various	O
regions	O
of	O
Morocco	O
and	O
Tunisia	O
.	O
<EOS> B-X
There B-X
is B-X
so B-X
much B-X
to B-X
discover B-X
in B-X
Morocco B-X
and B-X
Tunisia B-X
, B-X
making B-X
them B-X
ideal B-X
travel B-X
destinations B-X
for B-X
the B-X
savvy B-X
globetrotter B-X
on B-X
a B-X
North B-X
Africa B-X
vacation B-X
. B-X
The B-X
ATM B-X
gene B-X
is B-X
responsible B-X
for B-X
the B-X
autosomal B-X
recessive B-X
disorder B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
characterized B-X
by B-X
cerebellar B-X
degeneration B-X
, B-X
immunodeficiency B-X
and B-X
cancer B-X
predisposition B-X
. B-X
A-T B-X
carriers B-X
were B-X
reported B-X
to B-X
Culture B-X
of B-X
North B-X
Africa B-X
- B-X
Wikipedia B-X
History B-X
of B-X
North B-X
Africa B-X
- B-X
Wikipedia B-X
Atlas B-X
Mountains B-X
, B-X
series B-X
of B-X
mountain B-X
ranges B-X
in B-X
northwestern B-X
Africa B-X
, B-X
running B-X
generally B-X
southwest B-X
to B-X
northeast B-X
to B-X
form B-X
the B-X
geologic B-X
backbone B-X
of B-X
the B-X
countries B-X
of B-X
the B-X
Maghrib B-X
( B-X
the B-X
western B-X
Other B-X
articles B-X
where B-X
History B-X
of B-X
Morocco B-X
is B-X
discussed B-X
: B-X
Morocco B-X
: B-X
History B-X
: B-X
This B-X
discussion B-X
focuses B-X
on B-X
Morocco B-X
since B-X
the B-X
16th B-X
century B-X
. B-X
For B-X
a B-X
more-detailed B-X
treatment B-X
of B-X
earlier B-X
periods B-X
Abstract B-X
. B-X
The B-X
ATM B-X
gene B-X
is B-X
responsible B-X
for B-X
the B-X
autosomal B-X
recessive B-X
disorder B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
characterized B-X
by B-X
cerebellar B-X
degeneration B-X
, B-X
immunodeficien B-X

This	O
mutation	O
,	O
103C	O
-	O
-	O
>	O
T	O
,	O
results	O
in	O
a	O
stop	O
codon	O
at	O
position	O
35	O
of	O
the	O
ATM	O
protein	O
.	O
<EOS> B-X
ATM-dependent B-X
DNA B-X
damage B-X
checkpoint B-X
functions B-X
regulate B-X
gene B-X
expression B-X
in B-X
human B-X
fibroblasts B-X
ClinVar B-X
archives B-X
and B-X
aggregates B-X
information B-X
about B-X
relationships B-X
among B-X
variation B-X
and B-X
human B-X
health B-X
. B-X
ClinVar B-X
archives B-X
and B-X
aggregates B-X
information B-X
about B-X
relationships B-X
among B-X
variation B-X
and B-X
human B-X
health B-X
. B-X
ClinVar B-X
archives B-X
and B-X
aggregates B-X
information B-X
about B-X
relationships B-X
among B-X
variation B-X
and B-X
human B-X
health B-X
. B-X
VCV000003025.10 B-X
- B-X
ClinVar B-X
- B-X
NCBI B-X
NA02052 B-X
GM01588 B-X

In	O
keeping	O
with	O
the	O
nature	O
of	O
this	O
mutation	O
,	O
various	O
antibodies	O
directed	O
against	O
the	O
ATM	O
protein	O
failed	O
to	O
defect	O
this	O
protein	O
in	O
patient	O
cells	O
.	O
<EOS> B-X
Heterozygous B-X
carriers B-X
of B-X
germ-line B-X
loss-of-function B-X
variants B-X
in B-X
the B-X
DNA B-X
repair B-X
gene B-X
PALB2 B-X
are B-X
at B-X
a B-X
highly B-X
increased B-X
lifetime B-X
risk B-X
for B-X
developing B-X
breast B-X
cancer B-X
. B-X
While B-X
truncating B-X
variants B-X
in B-X
PALB2 B-X
are B-X
Lung B-X
cancer B-X
is B-X
the B-X
leading B-X
cause B-X
of B-X
cancer B-X
deaths B-X
, B-X
and B-X
effective B-X
treatments B-X
are B-X
urgently B-X
needed B-X
. B-X
Loss-of-function B-X
mutations B-X
in B-X
the B-X
DNA B-X
damage B-X
response B-X
kinase B-X
ATM B-X
are B-X
common B-X
in B-X
lung B-X
Severe B-X
early B-X
and B-X
late B-X
radiation B-X
reaction B-X
to B-X
radiotherapy B-X
is B-X
extremely B-X
rare B-X
in B-X
breast B-X
cancer B-X
patients B-X
. B-X
Such B-X
a B-X
reaction B-X
prompted B-X
an B-X
investigation B-X
into B-X
a B-X
44-year-old B-X
mother B-X
( B-X
patient B-X
A-T213 B-X
) B-X
DNA B-X
double-strand B-X
break B-X
( B-X
DSB B-X
) B-X
signaling B-X
and B-X
repair B-X
are B-X
critical B-X
for B-X
genome B-X
integrity B-X
. B-X
They B-X
rely B-X
on B-X
highly B-X
coordinated B-X
processes B-X
including B-X
posttranslational B-X
modifications B-X
of B-X
proteins B-X
. B-X
Here B-X
we B-X
show B-X
Hereditary B-X
heterozygous B-X
mutations B-X
in B-X
a B-X
variety B-X
of B-X
DNA B-X
double-strand B-X
break B-X
( B-X
DSB B-X
) B-X
repair B-X
genes B-X
have B-X
been B-X
associated B-X
with B-X
increased B-X
breast B-X
cancer B-X
risk B-X
. B-X
In B-X
the B-X
Finnish B-X
population B-X
, B-X
PALB2 B-X
Ataxia-telangiectasia B-X
mutated B-X
and B-X
Rad3 B-X
related B-X
( B-X
ATR B-X
) B-X
‚ÄìSeckel B-X
syndrome B-X
and B-X
autosomal B-X
recessive B-X
primary B-X
microcephaly B-X
( B-X
MCPH B-X
) B-X
syndrome B-X
share B-X
clinical B-X
features B-X
. B-X
RNA B-X
interference B-X
( B-X
RNAi B-X
) B-X
of B-X
MCPH1 B-X
DNA B-X
damage B-X
response B-X
mediator B-X
protein B-X
53BP1 B-X
is B-X
a B-X
key B-X
regulator B-X
of B-X
non-homologous B-X
end-joining B-X
( B-X
NHEJ B-X
) B-X
repair B-X
. B-X
53BP1 B-X
protects B-X
DNA B-X
broken B-X
ends B-X
from B-X
resection B-X
by B-X
recruiting B-X
two B-X
downstream B-X
factors B-X

A	O
rapid	O
carrier	O
detection	O
assay	O
detected	O
this	O
mutation	O
in	O
three	O
out	O
of	O
488	O
ATM	O
alleles	O
of	O
Jewish	O
Moroccan	O
or	O
Tunisian	O
origin	O
.	O
<EOS> B-X
Two B-X
mutations B-X
in B-X
the B-X
MCOLN1 B-X
mucolipidosis B-X
IV B-X
( B-X
ML B-X
IV B-X
) B-X
gene B-X
represent B-X
approximately B-X
95 B-X
% B-X
of B-X
the B-X
mutations B-X
in B-X
Ashkenazi-Jewish B-X
patients B-X
with B-X
ML B-X
IV B-X
. B-X
The B-X
mutations B-X
, B-X
a B-X
Request B-X
PDF B-X
| B-X
ATM B-X
haplotypes B-X
and B-X
associated B-X
mutations B-X
in B-X
Iranian B-X
patients B-X
with B-X
ataxia-telangiectasia B-X
: B-X
Recurring B-X
homozygosity B-X
without B-X
a B-X
founder B-X
haplotype B-X
| B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
north B-X
african B-X
jews B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
Request B-X
PDF B-X
| B-X
Ataxia-Telangiectasia B-X
: B-X
Phenotype/Genotype B-X
Studies B-X
of B-X
ATM B-X
Protein B-X
Expression B-X
, B-X
Mutations B-X
, B-X
and B-X
Radiosensitivity B-X
| B-X
Previous B-X
studies B-X
on B-X
a B-X
limited B-X
number B-X
of B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
patients B-X
with B-X

This	O
founder	O
effect	O
provides	O
a	O
unique	O
opportunity	O
for	O
population	O
-	O
based	O
screening	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
carriers	O
in	O
a	O
large	O
Jewish	O
community	O
.	O
.	O
<EOS> B-X
Founder B-X
Effect B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Founder B-X
Effect B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Randomised B-X
trial B-X
of B-X
population‚Äêbased B-X
BRCA B-X
testing B-X
in B-X
Ashkenazi B-X
Jews B-X
: B-X
long‚Äêterm B-X
outcomes B-X
- B-X
Manchanda B-X
- B-X
2020 B-X
- B-X
BJOG B-X
: B-X
An B-X
International B-X
Journal B-X
of B-X
Obstetrics B-X
& B-X
amp B-X
; B-X
Gynaecology B-X
- B-X
Wiley B-X

Mutation	O
analysis	O
of	O
BRCA1	O
and	O
BRCA2	O
in	O
a	O
male	B-Disease
breast	I-Disease
cancer	I-Disease
population	O
.	O
<EOS> B-X
Prevalence B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Mutations B-X
in B-X
Male B-X
Breast B-X
Cancer B-X
Patients B-X
in B-X
Canada B-X
- B-X
ScienceDirect B-X
Male B-X
breast B-X
cancer B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutation B-X
carriers B-X
: B-X
pathology B-X
data B-X
from B-X
the B-X
Consortium B-X
of B-X
Investigators B-X
of B-X
Modifiers B-X
of B-X
BRCA1/2 B-X
Men B-X
who B-X
inherit B-X
a B-X
mutation B-X
in B-X
the B-X
BRCA2 B-X
gene B-X
carry B-X
a B-X
6 B-X
% B-X
risk B-X
of B-X
developing B-X
breast B-X
cancer B-X
by B-X
the B-X
age B-X
of B-X
70 B-X
. B-X
The B-X
proportion B-X
of B-X
male B-X
breast B-X
cancers B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

A	O
population	O
-	O
based	O
series	O
of	O
54	O
male	B-Disease
breast	I-Disease
cancer	I-Disease
cases	O
from	O
Southern	O
California	O
were	O
analyzed	O
for	O
germ	O
-	O
line	O
mutations	O
in	O
the	O
inherited	B-Disease
breast	I-Disease
/	I-Disease
ovarian	I-Disease
cancer	I-Disease
genes	O
,	O
BRCA1	O
and	O
BRCA2	O
.	O
<EOS> B-X
The B-X
heritable B-X
defects B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
have B-X
been B-X
shown B-X
to B-X
predispose B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
In B-X
a B-X
previous B-X
report B-X
, B-X
we B-X
analyzed B-X
46 B-X
Italian B-X
families B-X
with B-X
BRCA1 B-X
and B-X
BRCA2 B-X
are B-X
genetic B-X
mutations B-X
that B-X
increase B-X
the B-X
risk B-X
of B-X
developing B-X
breast B-X
cancer B-X
in B-X
a B-X
woman B-X
's B-X
lifetime B-X
. B-X
Learn B-X
the B-X
difference B-X
between B-X
BRCA1 B-X
and B-X
BRCA2 B-X
. B-X
Several B-X
medical B-X
options B-X
are B-X
available B-X
for B-X
managing B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
risk B-X
in B-X
women B-X
who B-X
have B-X
BRCA1 B-X
or B-X
BRCA2 B-X
mutations B-X
, B-X
but B-X
who B-X
have B-X
not B-X
yet B-X
had B-X
breast B-X
or B-X
ovarian B-X
BRCA1 B-X
and B-X
BRCA2 B-X
are B-X
the B-X
best-known B-X
genes B-X
linked B-X
to B-X
breast B-X
cancer B-X
. B-X
Learn B-X
how B-X
they B-X
impact B-X
cancer B-X
risk B-X
here B-X
. B-X
Germline B-X
mutations B-X
in B-X
the B-X
tumor B-X
suppressor B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
predispose B-X
individuals B-X
to B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
. B-X
Progress B-X
in B-X
determining B-X
the B-X
function B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
suggests B-X
that B-X
they B-X
Almost B-X
half B-X
( B-X
48 B-X
% B-X
) B-X
of B-X
women B-X
in B-X
southern B-X
Sweden B-X
with B-X
early-onset B-X
breast B-X
cancer B-X
have B-X
some B-X
family B-X
history B-X
of B-X
breast B-X
or B-X
ovarian B-X
cancer B-X
, B-X
and B-X
9.0 B-X
% B-X
of B-X
early-onset B-X
The B-X
clinical B-X
classification B-X
of B-X
rare B-X
sequence B-X
variants B-X
identified B-X
in B-X
the B-X
high-risk B-X
breast B-X
cancer B-X
susceptibility B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
is B-X
essential B-X
for B-X
appropriate B-X
genetic B-X
counselling B-X
. B-X
Here B-X
we B-X
present B-X
an B-X
overview B-X

Nine	O
(	O
17	O
%	O
)	O
of	O
the	O
patients	O
had	O
a	O
family	O
history	O
of	O
breast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
in	O
at	O
least	O
one	O
first	O
-	O
degree	O
relative	O
.	O
<EOS> B-X
Contribution B-X
of B-X
extended B-X
family B-X
history B-X
in B-X
assessment B-X
of B-X
risk B-X
for B-X
breast B-X
and B-X
colon B-X
cancer B-X
Family B-X
history B-X
of B-X
breast B-X
cancer B-X
and B-X
all-cause B-X
mortality B-X
after B-X
breast B-X
cancer B-X
diagnosis B-X
in B-X
the B-X
Breast B-X
Cancer B-X
Family B-X
Registry B-X
Elevated B-X
Cancer B-X
Mortality B-X
in B-X
the B-X
Relatives B-X
of B-X
Patients B-X
with B-X
Pancreatic B-X
Cancer B-X
Validation B-X
of B-X
Family B-X
Cancer B-X
History B-X
Data B-X
in B-X
High-Risk B-X
Families B-X
: B-X
The B-X
Influence B-X
of B-X
Cancer B-X
Site B-X
, B-X
Ethnicity B-X
, B-X
Kinship B-X
Degree B-X
, B-X
and B-X
Multiple B-X
Family B-X
Reporters B-X
Family B-X
history B-X
is B-X
important B-X
for B-X
identifying B-X
candidates B-X
for B-X
high B-X
risk B-X
cancer B-X
screening B-X
and B-X
referral B-X
for B-X
genetic B-X
counseling B-X
. B-X
We B-X
sought B-X
to B-X
determine B-X
the B-X
percentage B-X
of B-X
individuals B-X
who B-X
would B-X
be B-X
eligible B-X

A	O
further	O
seven	O
(	O
13	O
%	O
)	O
of	O
the	O
patients	O
reported	O
breast	B-Disease
/	I-Disease
ovarian	I-Disease
cancer	I-Disease
in	O
at	O
least	O
one	O
second	O
-	O
degree	O
relative	O
and	O
in	O
no	O
first	O
-	O
degree	O
relatives	O
.	O
<EOS> B-X
This B-X
cohort B-X
study B-X
estimates B-X
age-specific B-X
risks B-X
of B-X
breast B-X
, B-X
ovarian B-X
, B-X
and B-X
contralateral B-X
breast B-X
cancer B-X
among B-X
carriers B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
and B-X
evaluates B-X
ris B-X
Cancer B-X
Risk B-X
Estimates B-X
for B-X
Family B-X
Members B-X
of B-X
a B-X
Population-based B-X
Family B-X
Registry B-X
for B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
| B-X
Cancer B-X
Epidemiology B-X
, B-X
Biomarkers B-X
& B-X
Prevention B-X
We B-X
reviewed B-X
5,268 B-X
references B-X
from B-X
electronic B-X
searches B-X
, B-X
reference B-X
lists B-X
, B-X
and B-X
manual B-X
searches B-X
of B-X
recently B-X
published B-X
studies B-X
. B-X
After B-X
applying B-X
inclusion B-X
and B-X
exclusion B-X
criteria B-X
, B-X
we B-X
reviewed B-X
1,600 B-X
full-text B-X
Carolyn B-X
D. B-X
Farrell B-X
, B-X
MS B-X
, B-X
CNP B-X
, B-X
CGC B-X

No	O
germ	O
-	O
line	O
BRCA1	O
mutations	O
were	O
found	O
.	O
<EOS> B-X
BRCA1 B-X
germline B-X
mutations B-X
dominate B-X
familial B-X
breast B-X
cancer B-X
patients B-X
in B-X
Henan B-X
China B-X
Germline B-X
mutation B-X
analysis B-X
of B-X
BRCA1 B-X
gene B-X
has B-X
demonstrated B-X
significant B-X
allelic B-X
heterogeneity B-X
. B-X
These B-X
differences B-X
represent B-X
historical B-X
influences B-X
of B-X
migration B-X
, B-X
population B-X
structure B-X
and B-X
geographic B-X
or B-X
cultural B-X
isolation B-X
. B-X
To B-X
date B-X
Germline B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
tumor B-X
suppressor B-X
gene B-X
are B-X
thought B-X
to B-X
be B-X
the B-X
most B-X
common B-X
cause B-X
of B-X
hereditary B-X
ovarian B-X
cancer B-X
. B-X
The B-X
aim B-X
of B-X
this B-X
study B-X
was B-X
to B-X
explore B-X
further B-X
A B-X
patient B-X
with B-X
breast B-X
carcinoma B-X
diagnosed B-X
at B-X
the B-X
age B-X
of B-X
30 B-X
years B-X
and B-X
ovarian B-X
carcinoma B-X
diagnosed B-X
at B-X
the B-X
age B-X
of B-X
41 B-X
years B-X
was B-X
found B-X
to B-X
have B-X
germline B-X
mutations B-X
in B-X
both B-X
A B-X
population-based B-X
series B-X
of B-X
649 B-X
unselected B-X
incident B-X
cases B-X
of B-X
ovarian B-X
cancer B-X
diagnosed B-X
in B-X
Ontario B-X
, B-X
Canada B-X
, B-X
during B-X
1995-96 B-X
was B-X
screened B-X
for B-X
germline B-X
mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
. B-X
We B-X
Predisposition B-X
to B-X
prostate B-X
cancer B-X
has B-X
a B-X
genetic B-X
component B-X
, B-X
and B-X
there B-X
are B-X
reports B-X
of B-X
familial B-X
clustering B-X
of B-X
breast B-X
and B-X
prostate B-X
cancer B-X
. B-X
Two B-X
highly B-X
penetrant B-X
genes B-X
that B-X
predispose B-X
individuals B-X
to B-X

Two	O
male	B-Disease
breast	I-Disease
cancer	I-Disease
patients	O
(	O
4	O
%	O
of	O
the	O
total	O
)	O
were	O
found	O
to	O
carry	O
novel	O
truncating	O
mutations	O
in	O
the	O
BRCA2	O
gene	O
.	O
<EOS> B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
a B-X
population-based B-X
study B-X
of B-X
male B-X
breast B-X
cancer B-X
PDF B-X
| B-X
Mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
account B-X
for B-X
approximately B-X
5 B-X
% B-X
of B-X
the B-X
overall B-X
familial B-X
risk B-X
of B-X
breast B-X
cancer B-X
. B-X
We B-X
have B-X
carried B-X
out B-X
a B-X
mutational B-X
analysis B-X
... B-X
| B-X
Request B-X
PDF B-X
| B-X
BRCA2 B-X
germline B-X
mutations B-X
in B-X
male B-X
breast B-X
cancer B-X
patients B-X
in B-X
the B-X
Polish B-X
population B-X
| B-X
Breast B-X
cancer B-X
is B-X
a B-X
rare B-X
disease B-X
in B-X
men B-X
. B-X
Germ-line B-X
mutations B-X
in B-X
BRCA2 B-X
and B-X
Mutational B-X
analysis B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
in B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
families B-X
from B-X
Asturias B-X
( B-X
Northern B-X
Spain B-X
) B-X
The B-X
etiology B-X
of B-X
breast B-X
cancer B-X
in B-X
Africa B-X
is B-X
scarcely B-X
investigated B-X
. B-X
Breast B-X
cancer B-X
was B-X
responsible B-X
for B-X
456/2,233 B-X
cancer B-X
patients B-X
( B-X
20.4 B-X
% B-X
) B-X
ascertained B-X
between B-X
1999 B-X
and B-X
2004 B-X
at B-X
Gezira B-X

Only	O
one	O
of	O
the	O
two	O
male	B-Disease
breast	I-Disease
cancer	I-Disease
patients	O
carrying	O
a	O
BRCA2	O
mutation	O
had	O
a	O
family	O
history	O
of	O
cancer	B-Disease
,	O
with	O
one	O
case	O
of	O
ovarian	B-Disease
cancer	I-Disease
in	O
a	O
first	O
-	O
degree	O
relative	O
.	O
<EOS> B-X
Men B-X
With B-X
BRCA B-X
Mutations B-X
Have B-X
Much B-X
Higher B-X
Risk B-X
of B-X
Cancer B-X
Faults B-X
in B-X
the B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
are B-X
most B-X
commonly B-X
associated B-X
with B-X
breast B-X
cancer B-X
in B-X
women B-X
, B-X
but B-X
they B-X
bring B-X
other B-X
risks B-X
to B-X
men B-X
too B-X
. B-X
Long-term B-X
survival B-X
and B-X
BRCA B-X
status B-X
in B-X
male B-X
breast B-X
cancer B-X
: B-X
a B-X
retrospective B-X
single-center B-X
analysis B-X
Recent B-X
linkage B-X
analyses B-X
demonstrate B-X
the B-X
strength B-X
of B-X
the B-X
genetic B-X
association B-X
between B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
in B-X
some B-X
families B-X
. B-X
These B-X
findings B-X
highlight B-X
th B-X
Recent B-X
linkage B-X
analyses B-X
demonstrate B-X
the B-X
strength B-X
of B-X
the B-X
genetic B-X
association B-X
between B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
in B-X
some B-X
families B-X
. B-X
These B-X
findings B-X
highlight B-X
the B-X
importance B-X
of B-X
considering B-X
a B-X
woman B-X
's B-X
family B-X
Women B-X
who B-X
have B-X
one B-X
first-degree B-X
relative B-X
affected B-X
by B-X
ovarian B-X
cancer B-X
are B-X
at B-X
greater B-X
risk B-X
for B-X
ovarian B-X
cancer B-X
but B-X
not B-X
at B-X
an B-X
age B-X
earlier B-X
than B-X
the B-X
general B-X
population B-X
. B-X
The B-X
small B-X
Ovarian B-X
cancer B-X
in B-X
a B-X
first-degree B-X
relative B-X
is B-X
a B-X
very B-X
strong B-X
predictor B-X
of B-X
epithelial B-X
ovarian B-X
cancer B-X
, B-X
especially B-X
early-onset B-X
ovarian B-X
cancer B-X
. B-X
Ovarian B-X
cancer B-X
in B-X
first-degree B-X
relatives B-X
seems B-X
to B-X
be B-X
positively B-X

The	O
remaining	O
eight	O
cases	O
(	O
89	O
%	O
)	O
of	O
male	B-Disease
breast	I-Disease
cancer	I-Disease
with	O
a	O
family	O
history	O
of	O
breast	B-Disease
/	I-Disease
ovarian	I-Disease
cancer	I-Disease
in	O
first	O
-	O
degree	O
relatives	O
remain	O
unaccounted	O
for	O
by	O
mutations	O
in	O
either	O
the	O
BRCA1	O
gene	O
or	O
the	O
BRCA2	O
gene	O
.	O
.	O
<EOS> B-X
A B-X
population-based B-X
series B-X
of B-X
54 B-X
male B-X
breast B-X
cancer B-X
cases B-X
from B-X
Southern B-X
California B-X
were B-X
analyzed B-X
for B-X
germ-line B-X
mutations B-X
in B-X
the B-X
inherited B-X
breast/ovarian B-X
cancer B-X
genes B-X
, B-X
BRCA1 B-X
and B-X
BRCA2 B-X
. B-X
Nine B-X
( B-X
Mutation B-X
analysis B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
in B-X
a B-X
male B-X
breast B-X
cancer B-X
population B-X
| B-X
Meta B-X

Molecular	O
basis	O
for	O
Duarte	B-Disease
and	I-Disease
Los	I-Disease
Angeles	I-Disease
variant	I-Disease
galactosemia	I-Disease
.	O

Human	O
orythrocytes	O
that	O
are	O
homozygous	O
for	O
the	O
Duarte	B-Disease
enzyme	I-Disease
variant	I-Disease
of	I-Disease
galactosemia	I-Disease
(	O
D	O
/	O
D	O
)	O
have	O
a	O
characteristic	O
isoform	O
on	O
isoelectric	O
focusing	O
and	O
50	O
%	O
reduction	O
in	O
galactose	O
-	O
1	O
-	O
phosphate	O
uridyltransferase	O
(	O
GALT	O
)	O
enzyme	O
activity	O
.	O
<EOS> B-X
Human B-X
orythrocytes B-X
that B-X
are B-X
homozygous B-X
for B-X
the B-X
Duarte B-X
enzyme B-X
variant B-X
of B-X
galactosemia B-X
( B-X
D/D B-X
) B-X
have B-X
a B-X
characteristic B-X
isoform B-X
on B-X
isoelectric B-X
focusing B-X
and B-X
50 B-X
% B-X
reduction B-X
in B-X
galactose-1-phosphate B-X
uridyltransferase B-X
( B-X
WikiGenes B-X
- B-X
galactose-1P B-X
- B-X
[ B-X
( B-X
2R,3R,4S,5R,6R B-X
) B-X
-3,4,5-trihydroxy-6 B-X
... B-X

The	O
Duarte	O
biochemical	O
phenotype	O
has	O
a	O
molecular	O
genotype	O
of	O
N314D	O
/	O
N314D	O
.	O
<EOS> B-X
Phenotype‚ÄìGenotype B-X
Discrepancy B-X
Due B-X
to B-X
a B-X
5.5-kb B-X
Deletion B-X
in B-X
the B-X
GALT B-X
Gene B-X
The B-X
N314D B-X
Polymorphism B-X
of B-X
Galactose-1-Phosphate B-X
Uridyl B-X
Transferase B-X
Does B-X
Not B-X
Modify B-X
the B-X
Risk B-X
of B-X
Ovarian B-X
Cancer B-X
| B-X
Cancer B-X
Epidemiology B-X
, B-X
Biomarkers B-X
& B-X
Prevention B-X
Distribution B-X
of B-X
Q188R B-X
and B-X
N314D B-X
mutations B-X
in B-X
the B-X
Hungarian B-X
galactosemic B-X
population B-X
- B-X
Horv√°th B-X
- B-X
2000 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Simultaneous B-X
Amplification B-X
, B-X
Detection B-X
, B-X
and B-X
Analysis B-X
of B-X
Common B-X
Mutations B-X
in B-X
the B-X
Galactose-1-Phosphate B-X
Uridyl B-X
Transferase B-X
Gene B-X
Purpose B-X
: B-X
We B-X
previously B-X
reported B-X
a B-X
deletion B-X
of B-X
the B-X
Galactose-1-Phosphate B-X
Uridyl B-X
Transferase B-X
( B-X
GALT B-X
) B-X
gene B-X
. B-X
This B-X
deletion B-X
can B-X
cause B-X
apparent B-X
homozygosity B-X
for B-X
variants B-X
located B-X
on B-X
the B-X
opposite B-X
allele B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
We B-X
identified B-X
14 B-X
mutations B-X
in B-X
15 B-X
Japanese B-X
subjects B-X
from B-X
13 B-X
families B-X
with B-X
galactose-1-phosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
deficiency B-X
using B-X
denaturing B-X
gradient B-X
gel B-X
electrophoresis B-X
( B-X
DGGE B-X
) B-X
and B-X
direct B-X
sequence B-X
analysis B-X

The	O
characteristic	O
Duarte	O
isoform	O
is	O
also	O
associated	O
with	O
a	O
variant	O
called	O
the	O
"	O
Los	O
Angeles	O
(	O
LA	O
)	O
phenotype	O
,	O
"	O
which	O
has	O
increased	O
GALT	O
enzyme	O
activity	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
GALT B-X
Protein B-X
Database B-X
: B-X
Querying B-X
Structural B-X
and B-X
Functional B-X
Features B-X
of B-X
GALT B-X
Enzyme B-X
| B-X
Knowledge B-X
of B-X
the B-X
impact B-X
of B-X
variations B-X
on B-X
protein B-X
structure B-X
can B-X
enhance B-X
the B-X
comprehension B-X
of B-X
Request B-X
PDF B-X
| B-X
Frequency B-X
Distribution B-X
of B-X
Q188R B-X
, B-X
N314D B-X
, B-X
Duarte B-X
1 B-X
, B-X
and B-X
Duarte B-X
2 B-X
GALT B-X
Variant B-X
Alleles B-X
in B-X
an B-X
Indian B-X
Galactosemia B-X
Population B-X
| B-X
Classical B-X
galactosemia B-X
is B-X
a B-X
genetic B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
and B-X
biochemical B-X
characterization B-X
of B-X
the B-X
GALT B-X
gene B-X
in B-X
Korean B-X
patients B-X
with B-X
galactose-1-phosphate B-X
uridyltransferase B-X
deficiency B-X
| B-X
Three B-X
different B-X
types B-X
of B-X
galactosemia B-X
have B-X
been B-X
described B-X
, B-X
and B-X
the B-X
WikiGenes B-X
- B-X
GALT B-X
- B-X
galactose-1-phosphate B-X
uridylyltransferase B-X
606999 B-X
- B-X
GALACTOSE-1-PHOSPHATE B-X
URIDYLYLTRANSFERASE B-X
; B-X
GALT B-X
- B-X
GALT/IL11RA B-X
SPLICED B-X
READ-THROUGH B-X
TRANSCRIPT B-X
, B-X
INCLUDED B-X
- B-X
GALT B-X

We	O
evaluated	O
GALT	O
enzyme	O
activity	O
and	O
screened	O
the	O
GALT	O
genes	O
of	O
145	O
patients	O
with	O
one	O
or	O
more	O
N314D	O
-	O
containing	O
alleles	O
.	O

We	O
found	O
seven	O
with	O
the	O
LA	O
biochemical	O
phenotype	O
,	O
and	O
all	O
had	O
a	O
1721C	O
-	O
-	O
>	O
T	O
transition	O
in	O
exon	O
7	O
in	O
cis	O
with	O
the	O
N314D	O
missense	O
mutation	O
.	O
<EOS> B-X
PDF B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
2010 B-X
, B-X
Ramandeep B-X
Singh B-X
published B-X
Coexistence B-X
of B-X
Duarte B-X
1 B-X
and B-X
Duarte B-X
2 B-X
variants B-X
of B-X
galactosemia B-X
with B-X
extrahepatic B-X
biliary B-X
atresia B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X

The	O
1721C	O
-	O
-	O
>	O
T	O
transition	O
is	O
a	O
neutral	O
polymorphism	O
for	O
leucine	O
at	O
amino	O
acid	O
218	O
(	O
L218L	O
)	O
.	O
<EOS> B-X
LAT1 B-X
is B-X
expressed B-X
at B-X
the B-X
inner B-X
BRB B-X
and B-X
mediates B-X
blood-to-retina B-X
L-leucine B-X
transport B-X
. B-X
This B-X
transport B-X
system B-X
plays B-X
a B-X
key B-X
role B-X
in B-X
maintaining B-X
large B-X
neutral B-X
amino B-X
acids B-X
as B-X
well B-X
as B-X
neurotransmitters B-X
Strong B-X
Purifying B-X
Selection B-X
at B-X
Synonymous B-X
Sites B-X
in B-X
D. B-X
melanogaster B-X
The B-X
permease-like B-X
amino B-X
acid B-X
sensor B-X
Ssy1p B-X
of B-X
Saccharomyces B-X
cerevisiae B-X
is B-X
required B-X
for B-X
transcriptional B-X
induction B-X
, B-X
in B-X
response B-X
to B-X
external B-X
amino B-X
acids B-X
, B-X
of B-X
several B-X
genes B-X
encoding B-X
peptide B-X
and B-X
amino B-X
acid B-X
Neutral B-X
mutation B-X
- B-X
Wikipedia B-X
BIOL B-X
B242 B-X
- B-X
MOLECULAR B-X
EVOLUTION B-X
The B-X
U.S. B-X
Department B-X
of B-X
Energy B-X
's B-X
Office B-X
of B-X
Scientific B-X
and B-X
Technical B-X
Information B-X

In	O
pedigree	O
analyses	O
,	O
this	O
1721C	O
-	O
-	O
>	O
T	O
transition	O
segregated	O
with	O
the	O
LA	O
phenotype	O
of	O
increased	O
GALT	O
activity	O
in	O
three	O
different	O
biochemical	O
phenotypes	O
(	O
LA	O
/	O
N	O
,	O
LA	O
/	O
G	O
,	O
and	O
LA	O
/	O
D	O
)	O
.	O
<EOS> B-X
We B-X
describe B-X
a B-X
stratagem B-X
for B-X
identifying B-X
new B-X
mutations B-X
in B-X
the B-X
galactose-1-phosphate B-X
uridyl B-X
transferase B-X
( B-X
GALT B-X
) B-X
gene B-X
. B-X
GALT B-X
enzyme B-X
activity B-X
and B-X
isoforms B-X
were B-X
defined B-X
in B-X
erythrocytes B-X
from B-X
probands B-X
and B-X
PDF B-X
| B-X
Many B-X
genetic B-X
variations B-X
of B-X
GALK1 B-X
have B-X
been B-X
identified B-X
in B-X
the B-X
patients B-X
with B-X
galactokinase B-X
( B-X
GALK1 B-X
) B-X
deficiency B-X
. B-X
However B-X
, B-X
the B-X
molecular B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Request B-X
PDF B-X
| B-X
Frequencies B-X
of B-X
the B-X
Los B-X
Angeles B-X
and B-X
Duarte B-X
galactose-1-phosphate B-X
uridyltransferase B-X
variant B-X
alleles B-X
in B-X
the B-X
Hungarian B-X
population B-X
| B-X
Unlabelled B-X
: B-X
Classical B-X
galactosaemia B-X
is B-X
an B-X
autosomal B-X
recessively B-X
inherited B-X
disorder B-X
caused B-X
Becky B-X
G B-X
- B-X
Wikipedia B-X
Tour B-X
de B-X
France B-X
2021 B-X
- B-X
Official B-X
site B-X
of B-X
the B-X
famed B-X
race B-X
from B-X
the B-X
Tour B-X
de B-X
France B-X
. B-X
Includes B-X
route B-X
, B-X
riders B-X
, B-X
teams B-X
, B-X
and B-X
coverage B-X
of B-X
past B-X
Tours B-X
Frases B-X
con B-X
vocabulario B-X
HSK B-X
4 B-X
de B-X
la B-X
D B-X
a B-X
la B-X
G B-X
- B-X
hablochino.com B-X
Composed B-X
in B-X
Naples B-X
in B-X
the B-X
1530s B-X
, B-X
Juan B-X
de B-X
Vald√©s B-X
& B-X
# B-X
39 B-X
; B-X
s B-X
Di√°logo B-X
de B-X
la B-X
lengua B-X
occupies B-X
a B-X
special B-X
place B-X
in B-X
Spanish B-X
humanism B-X
, B-X
just B-X
as B-X
its B-X

To	O
determine	O
the	O
mechanism	O
for	O
increased	O
activity	O
of	O
the	O
LA	O
variant	O
,	O
we	O
compared	O
GALT	O
mRNA	O
,	O
protein	O
abundance	O
,	O
and	O
enzyme	O
thermal	O
stability	O
in	O
lymphoblast	O
cell	O
lines	O
of	O
D	O
and	O
LA	O
phenotypes	O
with	O
comparable	O
genotypes	O
.	O
<EOS> B-X
Current B-X
strategies B-X
for B-X
targeting B-X
the B-X
activity B-X
of B-X
androgen B-X
receptor B-X
variants B-X
Coupling B-X
between B-X
protein B-X
stability B-X
and B-X
catalytic B-X
activity B-X
determines B-X
pathogenicity B-X
of B-X
G6PD B-X
variants B-X
Enhanced B-X
activity B-X
of B-X
human B-X
serotonin B-X
transporter B-X
variants B-X
associated B-X
with B-X
autism B-X
Use B-X
of B-X
Cells B-X
Expressing B-X
Œ≥ B-X
Subunit B-X
Variants B-X
to B-X
Identify B-X
Diverse B-X
Mechanisms B-X
of B-X
AMPK B-X
Activation B-X
Protein B-X
kinase B-X
CŒ± B-X
gain-of-function B-X
variant B-X
in B-X
Alzheimer B-X
‚Äô B-X
s B-X
disease B-X
displays B-X
enhanced B-X
catalysis B-X
by B-X
a B-X
mechanism B-X
that B-X
evades B-X
down-regulation B-X
| B-X
PNAS B-X
Abstract B-X
. B-X
Lactase B-X
persistence B-X
is B-X
a B-X
heritable B-X
, B-X
autosomal B-X
dominant B-X
, B-X
condition B-X
that B-X
results B-X
in B-X
a B-X
sustained B-X
ability B-X
to B-X
digest B-X
the B-X
milk B-X
sugar B-X
lactose B-X
throughout B-X
adul B-X
Hemophilia B-X
B B-X
Gene B-X
Therapy B-X
with B-X
a B-X
High-Specific-Activity B-X
Factor B-X
IX B-X
Variant B-X

GALT	O
protein	O
abundance	O
was	O
increased	O
in	O
LA	O
compared	O
to	O
D	O
alleles	O
,	O
but	O
mRNA	O
was	O
similar	O
among	O
all	O
genotypes	O
.	O
<EOS> B-X
The B-X
Duarte B-X
allele B-X
impairs B-X
biostability B-X
of B-X
galactose‚Äê1‚Äêphosphate B-X
uridyltransferase B-X
in B-X
human B-X
lymphoblasts B-X
- B-X
Lai B-X
- B-X
1998 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X

When	O
LA	O
/	O
D	O
and	O
D	O
/	O
D	O
GALT	O
biochemical	O
phenotypes	O
were	O
compared	O
to	O
N	O
/	O
N	O
GALT	O
phenotypes	O
,	O
both	O
had	O
50	O
%	O
,	O
as	O
compared	O
to	O
21	O
%	O
,	O
reduction	O
in	O
GALT	O
activity	O
in	O
the	O
wild	O
type	O
(	O
N	O
/	O
N	O
)	O
after	O
exposure	O
at	O
identical	O
initial	O
enzyme	O
activity	O
to	O
50	O
degrees	O
C	O
for	O
15	O
min	O
.	O
<EOS> B-X
The B-X
overview B-X
of B-X
our B-X
research B-X
on B-X
global B-X
education B-X
. B-X
The B-X
two B-X
primary B-X
sources B-X
of B-X
government B-X
crime B-X
statistics B-X
both B-X
paint B-X
an B-X
incomplete B-X
picture B-X
, B-X
though B-X
efforts B-X
at B-X
improvement B-X
are B-X
underway B-X
. B-X
We B-X
previously B-X
identified B-X
a B-X
missense B-X
mutation B-X
at B-X
amino B-X
acid B-X
135 B-X
of B-X
human B-X
galactose B-X
1-phosphate B-X
uridyltransferase B-X
( B-X
hGALT B-X
) B-X
in B-X
which B-X
a B-X
leucine B-X
( B-X
TTG B-X
) B-X
was B-X
substituted B-X
for B-X
a B-X
serine B-X
The B-X
past B-X
five B-X
decades B-X
have B-X
seen B-X
large B-X
shifts B-X
in B-X
U.S. B-X
society B-X
and B-X
culture B-X
. B-X
See B-X
how B-X
Millennials B-X
today B-X
compare B-X
with B-X
their B-X
grandparents B-X
50 B-X
years B-X
ago B-X
. B-X
`` B-X
Both B-X
teams B-X
have B-X
wanted B-X
to B-X
play B-X
the B-X
schedule B-X
as B-X
we B-X
've B-X
set B-X
out B-X
'' B-X
The B-X
share B-X
of B-X
18- B-X
to B-X
29-year-olds B-X
living B-X
with B-X
their B-X
parents B-X
has B-X
become B-X
a B-X
majority B-X
since B-X
U.S. B-X
coronavirus B-X
cases B-X
began B-X
spreading B-X
early B-X
this B-X
year B-X
. B-X
Facebook B-X
and B-X
YouTube B-X
dominate B-X
the B-X
social B-X
media B-X
landscape B-X
. B-X
But B-X
younger B-X
Americans B-X
, B-X
especially B-X
those B-X
ages B-X
18 B-X
to B-X
24 B-X
, B-X
stand B-X
out B-X
in B-X
using B-X
a B-X
variety B-X
of B-X
platforms B-X
like B-X
Snapchat B-X

We	O
conclude	O
that	O
the	O
codon	O
change	O
N314D	O
in	O
cis	O
with	O
the	O
base	O
-	O
pair	O
transition	O
1721C	O
-	O
-	O
>	O
T	O
produces	O
the	O
LA	B-Disease
variant	I-Disease
of	I-Disease
galactosemia	I-Disease
and	O
that	O
this	O
nucleotide	O
change	O
increases	O
GALT	O
activity	O
by	O
increasing	O
GALT	O
protein	O
abundance	O
without	O
increasing	O
transcription	O
or	O
decreasing	O
thermal	O
lability	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
Galactosemias B-X

A	O
favorable	O
codon	O
bias	O
for	O
the	O
mutated	O
codon	O
with	O
consequently	O
increased	O
translation	O
rates	O
is	O
postulated	O
as	O
the	O
mechanism	O
.	O
.	O
<EOS> B-X
A B-X
critical B-X
analysis B-X
of B-X
codon B-X
optimization B-X
in B-X
human B-X
therapeutics B-X
The B-X
Impact B-X
of B-X
Selection B-X
at B-X
the B-X
Amino B-X
Acid B-X
Level B-X
on B-X
the B-X
Usage B-X
of B-X
Synonymous B-X
Codons B-X
Codon B-X
optimality B-X
, B-X
bias B-X
and B-X
usage B-X
in B-X
translation B-X
and B-X
mRNA B-X
decay B-X
Codon B-X
optimality B-X
controls B-X
differential B-X
mRNA B-X
translation B-X
during B-X
amino B-X
acid B-X
starvation B-X
Fine-Tuning B-X
Translation B-X
Kinetics B-X
Selection B-X
as B-X
the B-X
Driving B-X
Force B-X
of B-X
Codon B-X
Usage B-X
Bias B-X
in B-X
the B-X
Hepatitis B-X
A B-X
Virus B-X
Capsid B-X
Codon B-X
Bias B-X
as B-X
a B-X
Means B-X
to B-X
Fine-Tune B-X
Gene B-X
Expression B-X
PDF B-X
| B-X
In B-X
a B-X
wide B-X
variety B-X
of B-X
organisms B-X
, B-X
synonymous B-X
codons B-X
are B-X
used B-X
with B-X
different B-X
frequencies B-X
, B-X
a B-X
phenomenon B-X
known B-X
as B-X
codon B-X
bias B-X
. B-X
Population B-X
genetic B-X
... B-X
| B-X
Find B-X
, B-X

The	O
TSG101	O
tumor	B-Disease
susceptibility	O
gene	O
is	O
located	O
in	O
chromosome	O
11	O
band	O
p15	O
and	O
is	O
mutated	O
in	O
human	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
The B-X
TSG101 B-X
tumor B-X
susceptibility B-X
gene B-X
is B-X
located B-X
in B-X
chromosome B-X
11 B-X
band B-X
p15 B-X
and B-X
is B-X
mutated B-X
in B-X
human B-X
breast B-X
cancer B-X
. B-X
Retraction B-X
. B-X
The B-X
TSG101 B-X
tumor B-X
susceptibility B-X
gene B-X
is B-X
located B-X
in B-X
chromosome B-X
11 B-X
band B-X
p15 B-X
and B-X
is B-X
mutated B-X
in B-X
human B-X
breast B-X
cancer B-X
The B-X
TSG101 B-X
Tumor B-X
Susceptibility B-X
Gene B-X
Is B-X
Located B-X
in B-X
Chromosome B-X
11 B-X
Band B-X
p15 B-X
and B-X
Is B-X
Mutated B-X
in B-X
Human B-X
Breast B-X
Cancer B-X
: B-X
Cell B-X
RETRACTED B-X
: B-X
The B-X
TSG101 B-X
Tumor B-X
Susceptibility B-X
Gene B-X
Is B-X
Located B-X
in B-X
Chromosome B-X
11 B-X
Band B-X
p15 B-X
and B-X
Is B-X
Mutated B-X
in B-X
Human B-X
Breast B-X
Cancer B-X
: B-X
Cell B-X
RETRACTED B-X
: B-X
The B-X
TSG101 B-X
Tumor B-X
Susceptibility B-X
Gene B-X
Is B-X
Located B-X
in B-X
Chromosome B-X
11 B-X
Band B-X
p15 B-X
and B-X
Is B-X
Mutated B-X
in B-X
Human B-X
Breast B-X
Cancer B-X
- B-X
ScienceDirect B-X
WikiGenes B-X
- B-X
TSG101 B-X
- B-X
tumor B-X
susceptibility B-X
101 B-X
The B-X
Multifaceted B-X
Roles B-X
of B-X
the B-X
Tumor B-X
Susceptibility B-X
Gene B-X
101 B-X
( B-X
TSG101 B-X
) B-X
in B-X
Normal B-X
Development B-X
and B-X
Disease B-X

Recent	O
work	O
has	O
identified	O
a	O
mouse	O
gene	O
(	O
tsg101	O
)	O
whose	O
inactivation	O
in	O
fibroblasts	O
results	O
in	O
cellular	O
transformation	O
and	O
the	O
ability	O
to	O
produce	O
metastatic	B-Disease
tumors	I-Disease
in	O
nude	O
mice	O
.	O
<EOS> B-X
Limin B-X
Li B-X
's B-X
4 B-X
research B-X
works B-X
with B-X
576 B-X
citations B-X
and B-X
164 B-X
reads B-X
, B-X
including B-X
: B-X
Reversible B-X
Tumorigenesis B-X
Induced B-X
by B-X
Deficiency B-X
of B-X
Vasodilator-Stimulated B-X
Phosphoprotein B-X

Here	O
,	O
we	O
report	O
that	O
the	O
human	O
homolog	O
,	O
TSG101	O
,	O
which	O
we	O
isolated	O
and	O
mapped	O
to	O
chromosome	O
11	O
,	O
bands	O
15	O
.	O
<EOS> B-X
The B-X
products B-X
of B-X
the B-X
yeast B-X
MMS2 B-X
and B-X
two B-X
human B-X
homologs B-X
( B-X
hMMS2 B-X
and B-X
CROC-1 B-X
) B-X
define B-X
a B-X
structurally B-X
and B-X
functionally B-X
conserved B-X
Ubc-like B-X
protein B-X
family B-X
. B-X
We B-X
isolated B-X
and B-X
characterized B-X
the B-X
gene B-X
encoding B-X
human B-X
transglutaminase B-X
( B-X
TG B-X
) B-X
( B-X
X B-X
) B-X
( B-X
TGM5 B-X
) B-X
and B-X
mapped B-X
it B-X
to B-X
the B-X
15q15.2 B-X
region B-X
of B-X
chromosome B-X
15 B-X
by B-X
fluorescence B-X
References B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

1	O
-	O
15	O
1	O
-	O
15	O
.	O
<EOS> B-X
1/15 B-X
plus B-X
1/10 B-X
is B-X
1/6 B-X
. B-X
Get B-X
stepwise B-X
instruction B-X
to B-X
add B-X
fractional B-X
numbers B-X
. B-X
Equations B-X
: B-X
Tiger B-X
Algebra B-X
gives B-X
you B-X
not B-X
only B-X
the B-X
answers B-X
, B-X
but B-X
also B-X
the B-X
complete B-X
step B-X
by B-X
step B-X
method B-X
for B-X
solving B-X
your B-X
equations B-X
1/15-1/25 B-X
so B-X
that B-X
you B-X
understand B-X
better B-X
Kingdom B-X
of B-X
Heroes-Tower B-X
hard B-X
75 B-X
-1/01‚àº1/15 B-X
‰∏çÊªÖÁµÇÁÑâSeraph B-X
- B-X
YouTube B-X
The B-X
Resurrection B-X
of B-X
Christ B-X
- B-X
Now B-X
, B-X
brothers B-X
and B-X
sisters B-X
, B-X
I B-X
want B-X
to B-X
remind B-X
you B-X
of B-X
the B-X
gospel B-X
I B-X
preached B-X
to B-X
you B-X
, B-X
which B-X
you B-X
received B-X
and B-X
on B-X
which B-X
The B-X
Vine B-X
and B-X
the B-X
Branches B-X
- B-X
‚Äú B-X
I B-X
am B-X
the B-X
true B-X
vine B-X
, B-X
and B-X
my B-X
Father B-X
is B-X
the B-X
gardener B-X
. B-X
He B-X
cuts B-X
off B-X
every B-X
branch B-X
in B-X
me B-X
that B-X
bears B-X
no B-X
Asa B-X
‚Äô B-X
s B-X
Reform B-X
- B-X
The B-X
Spirit B-X
of B-X
God B-X
came B-X
on B-X
Azariah B-X
son B-X
of B-X
Oded B-X
. B-X
He B-X
went B-X
out B-X
to B-X
meet B-X
Asa B-X
and B-X
said B-X
to B-X
him B-X
, B-X
‚Äú B-X
Listen B-X
to B-X
Read B-X
a B-X
Simplified B-X
Version B-X
of B-X
The B-X
United B-X
Nations B-X
Universal B-X
Declaration B-X
of B-X
Human B-X
Rights B-X
for B-X
Teens B-X
and B-X
Young B-X
Adults B-X
. B-X
Watch B-X
Videos B-X
and B-X
Learn B-X
More B-X
About B-X
the B-X
Fundamental B-X
Rights B-X
and B-X
Privileges B-X

2	O
,	O
a	O
region	O
proposed	O
to	O
contain	O
tumor	B-Disease
suppressor	O
gene	O
(	O
s	O
)	O
,	O
is	O
mutated	O
at	O
high	O
frequency	O
in	O
human	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Abstract B-X
. B-X
Chromosome B-X
11p15 B-X
has B-X
attracted B-X
considerable B-X
attention B-X
because B-X
of B-X
the B-X
biological B-X
importance B-X
of B-X
this B-X
region B-X
to B-X
human B-X
disease B-X
. B-X
Apart B-X
from B-X
being B-X
an B-X
import B-X
A B-X
cluster B-X
of B-X
cooperating B-X
tumor-suppressor B-X
gene B-X
candidates B-X
in B-X
chromosomal B-X
deletions B-X
| B-X
PNAS B-X
Recent B-X
work B-X
has B-X
identified B-X
a B-X
mouse B-X
gene B-X
( B-X
tsg101 B-X
) B-X
whose B-X
inactivation B-X
in B-X
fibroblasts B-X
results B-X
in B-X
cellular B-X
transformation B-X
and B-X
the B-X
ability B-X
to B-X
produce B-X
metastatic B-X
tumors B-X
in B-X
nude B-X
mice B-X
. B-X
Here B-X
Abstract B-X
. B-X
Copy B-X
number B-X
variants B-X
( B-X
CNVs B-X
) B-X
, B-X
insertions B-X
, B-X
deletions B-X
and B-X
duplications B-X
, B-X
contribute B-X
considerably B-X
to B-X
human B-X
genetic B-X
variation B-X
and B-X
disease B-X
development B-X
. B-X
A B-X
rec B-X
Tumor B-X
Suppressor B-X
Genes B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
) B-X
and B-X
in B-X
silico B-X
expression B-X
analysis B-X
were B-X
applied B-X
to B-X
identify B-X
genes B-X
significantly B-X
downregulated B-X
in B-X
breast B-X
cancer B-X
within B-X
the B-X
genomic B-X
interval B-X
6q23‚Äì25 B-X
. B-X
Systematic B-X
comparison B-X
of B-X
The B-X
deleted B-X
in B-X
liver B-X
cancer B-X
( B-X
DLC-1 B-X
) B-X
gene B-X
at B-X
chromosome B-X
8p21‚Äì22 B-X
is B-X
altered B-X
mainly B-X
by B-X
genomic B-X
deletion B-X
or B-X
aberrant B-X
promoter B-X
methylation B-X
in B-X
a B-X
large B-X
number B-X
of B-X
human B-X
cancers B-X
such B-X

In	O
7	O
of	O
15	O
uncultured	O
primary	O
human	O
breast	B-Disease
carcinomas	I-Disease
,	O
intragenic	O
deletions	O
were	O
shown	O
in	O
TSG101	O
genomic	O
DNA	O
and	O
transcripts	O
by	O
gel	O
and	O
sequence	O
analysis	O
,	O
and	O
mutations	O
affecting	O
two	O
TSG101	O
alleles	O
were	O
identified	O
in	O
four	O
of	O
these	O
cancers	B-Disease
.	O
<EOS> B-X
Intragenic B-X
deletions B-X
of B-X
TSG101 B-X
, B-X
the B-X
human B-X
homolog B-X
of B-X
a B-X
mouse B-X
gene B-X
( B-X
tsg101 B-X
) B-X
that B-X
acts B-X
to B-X
suppress B-X
malignant B-X
cell B-X
growth B-X
, B-X
were B-X
reported B-X
in B-X
human B-X
breast B-X
tumours B-X
. B-X
PDF B-X
| B-X
TSG101 B-X
is B-X
a B-X
candidate B-X
tumor B-X
suppressor B-X
gene B-X
whose B-X
deletion B-X
in B-X
NIH3T3 B-X
cells B-X
leads B-X
to B-X
spontaneous B-X
lung B-X
metastases B-X
in B-X
nude B-X
mice B-X
. B-X
Aberrant B-X
transcripts B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
Reduction B-X
of B-X
TSG101 B-X
protein B-X
has B-X
a B-X
negative B-X
impact B-X
on B-X
tumor B-X
cell B-X
growth B-X
| B-X
TSG101 B-X
was B-X
defined B-X
originally B-X
as B-X
a B-X
tumor-suppressor B-X
gene B-X
, B-X
raising B-X
the B-X
expectation B-X
that B-X
absence B-X
Somatic B-X
mutations B-X
affect B-X
key B-X
pathways B-X
in B-X
lung B-X
adenocarcinoma B-X
WikiGenes B-X
- B-X
Sequence B-X
Analysis B-X
Genetics B-X
of B-X
Prostate B-X
Cancer B-X

No	O
TSG101	O
defects	O
were	O
found	O
in	O
matched	O
normal	O
breast	O
tissue	O
from	O
the	O
breast	B-Disease
cancer	I-Disease
patients	O
.	O
<EOS> B-X
Genomic B-X
Changes B-X
in B-X
Normal B-X
Breast B-X
Tissue B-X
in B-X
Women B-X
at B-X
Normal B-X
Risk B-X
or B-X
at B-X
High B-X
Risk B-X
for B-X
Breast B-X
Cancer B-X
The B-X
TSG101 B-X
gene B-X
, B-X
identified B-X
through B-X
insertional B-X
mutagenesis B-X
, B-X
is B-X
localized B-X
in B-X
a B-X
region B-X
that B-X
exhibits B-X
LOH B-X
in B-X
human B-X
cancers B-X
, B-X
suggesting B-X
that B-X
TSG101 B-X
might B-X
be B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
Comparison B-X
of B-X
Breast B-X
Cancer B-X
to B-X
Healthy B-X
Control B-X
Tissue B-X
Discovers B-X
Novel B-X
Markers B-X
with B-X
Potential B-X
for B-X
Prognosis B-X
and B-X
Early B-X
Detection B-X
TSG101 B-X
| B-X
Cancer B-X
Genetics B-X
Web B-X
Request B-X
PDF B-X
| B-X
Up-regulation B-X
of B-X
Tumor B-X
Susceptibility B-X
Gene B-X
101 B-X
Conveys B-X
Poor B-X
Prognosis B-X
through B-X
Suppression B-X
of B-X
p21 B-X
Expression B-X
in B-X
Ovarian B-X
Cancer B-X
| B-X
The B-X
function B-X
of B-X
tumor B-X
susceptibility B-X
gene B-X
101 B-X
( B-X
TSG101 B-X
The B-X
multidomain B-X
protein B-X
encoded B-X
by B-X
the B-X
Tumor B-X
Susceptibility B-X
Gene B-X
101 B-X
( B-X
TSG101 B-X
) B-X
is B-X
ubiquitously B-X
expressed B-X
and B-X
is B-X
suggested B-X
to B-X
function B-X
in B-X
diverse B-X
intracellular B-X
processes B-X
. B-X
In B-X
this B-X
review B-X
, B-X

These	O
findings	O
strongly	O
implicate	O
TSG101	O
mutations	O
in	O
human	O
breast	B-Disease
cancer	I-Disease
<EOS> B-X
Identification B-X
of B-X
TSG101 B-X
Functional B-X
Domains B-X
and B-X
p21 B-X
Loci B-X
Required B-X
for B-X
TSG101-Mediated B-X
p21 B-X
Gene B-X
Regulation B-X
PDF B-X
| B-X
Previous B-X
studies B-X
reported B-X
that B-X
the B-X
Tumor B-X
Susceptibility B-X
Gene B-X
101 B-X
( B-X
TSG101 B-X
) B-X
is B-X
upregulated B-X
in B-X
selected B-X
human B-X
malignancies B-X
, B-X
and B-X
the B-X
expression B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Up-regulation B-X
of B-X
Tumor B-X
Susceptibility B-X
Gene B-X
101 B-X
Conveys B-X
Poor B-X
Prognosis B-X
through B-X
Suppression B-X
of B-X
p21 B-X
Expression B-X
in B-X
Ovarian B-X
Cancer B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Request B-X
PDF B-X
| B-X
Role B-X
of B-X
TSG101 B-X
in B-X
cancer B-X
| B-X
The B-X
tumor B-X
susceptibility B-X
gene B-X
101 B-X
( B-X
TSG101 B-X
) B-X
encodes B-X
a B-X
multidomain B-X
protein B-X
that B-X
contains B-X
a B-X
UEV B-X
( B-X
ubiquitin B-X
e2 B-X
variant B-X
) B-X
TSG101 B-X
tumor B-X
susceptibility B-X
101 B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Functional B-X
inactivation B-X
of B-X
tumor B-X
susceptibility B-X
gene B-X
tsg101 B-X
leads B-X
to B-X
cellular B-X
transformation B-X
and B-X
tumorigenesis B-X
in B-X
mice B-X
. B-X
While B-X
human B-X
TSG101 B-X
is B-X
located B-X
in B-X
a B-X
region B-X
where B-X
frequent B-X
loss B-X
of B-X
heterozygosity B-X
can B-X
BRCA2 B-X
localization B-X
to B-X
the B-X
midbody B-X
by B-X
Filamin B-X
A B-X
regulates B-X
CEP55 B-X
signaling B-X
and B-X
completion B-X
of B-X
cytokinesis B-X

Moderate	O
intergenerational	O
and	O
somatic	O
instability	O
of	O
a	O
55	O
-	O
CTG	O
repeat	O
in	O
transgenic	O
mice	O
.	O
<EOS> B-X
Trinucleotide B-X
Repeats B-X
in B-X
Transgenic B-X
Mice B-X
: B-X
New B-X
Insights B-X
- B-X
Frank B-X
M. B-X
Longo B-X
, B-X
Stephen B-X
M. B-X
Massa B-X
, B-X
1997 B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
SCOPUS B-X
Ï†ïÎ≥¥ B-X
Í≤ÄÏÉâ B-X
ÌîåÎû´Ìèº B-X
- B-X
ÎÖºÎ¨∏ B-X
Î≥¥Í∏∞ B-X

Myotonic	B-Disease
dystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
associated	O
with	O
the	O
expansion	O
of	O
a	O
(	O
CTG	O
)	O
n	O
trinucleotide	O
repeat	O
in	O
the	O
3	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
the	O
DM	B-Disease
protein	O
kinase	O
gene	O
(	O
DMPK	O
)	O
.	O
<EOS> B-X
Results B-X
suggest B-X
a B-X
role B-X
of B-X
( B-X
CTG B-X
) B-X
n B-X
expansion B-X
at B-X
the B-X
DMPK B-X
locus B-X
in B-X
unexplained B-X
hypotonias B-X
and B-X
muscular B-X
myopathies B-X
other B-X
than B-X
DM B-X
. B-X
This B-X
calls B-X
for B-X
screening B-X
of B-X
the B-X

The	O
(	O
CTG	O
)	O
n	O
repeat	O
is	O
polymorphic	O
and	O
varies	O
in	O
size	O
between	O
5	O
and	O
37	O
repeats	O
in	O
unaffected	O
individuals	O
whereas	O
in	O
affected	O
patients	O
there	O
are	O
between	O
50	O
and	O
4	O
,	O
000	O
CTGs	O
.	O
<EOS> B-X
Recent B-X
advances B-X
in B-X
the B-X
detection B-X
of B-X
repeat B-X
expansions B-X
with B-X
short-read B-X
next-generation B-X
sequencing B-X
Genes B-X
with B-X
triplet B-X
repeats B-X
: B-X
candidate B-X
mediators B-X
of B-X
neuropsychiatric B-X
disorders B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
Autosomal B-X
dominant B-X
familial B-X
spastic B-X
paraplegia B-X
( B-X
FSP B-X
) B-X
is B-X
a B-X
genetically B-X
heterogeneous B-X
neurodegenerative B-X
disorder B-X
displaying B-X
anticipation B-X
for B-X
which B-X
three B-X
Amazon.com B-X
: B-X
Risograph B-X
RP3700UI B-X
Black B-X
Ink B-X
( B-X
2-1 B-X
000 B-X
cc B-X
. B-X
Ctgs/Ctn B-X
) B-X
- B-X
Genuine B-X
OEM B-X
toner B-X
: B-X
Office B-X
Products B-X
A B-X
Pentanucleotide B-X
ATTTC B-X
Repeat B-X
Insertion B-X
in B-X
the B-X
Non-coding B-X
Region B-X
of B-X
DAB1 B-X
, B-X
Mapping B-X
to B-X
SCA37 B-X
, B-X
Causes B-X
Spinocerebellar B-X
Ataxia B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Amazon.com B-X
: B-X
SHARP B-X
BR B-X
MX-2300 B-X
STAPLES B-X
3-5 B-X
, B-X
000 B-X
STAPLE B-X
CTGS B-X
, B-X
5kEA B-X
yield B-X
: B-X
Office B-X
Products B-X

The	O
size	O
of	O
the	O
(	O
CTG	O
)	O
n	O
repeat	O
,	O
which	O
increases	O
through	O
generations	O
,	O
generally	O
correlates	O
with	O
clinical	O
severity	O
and	O
age	O
of	O
onset	O
.	O
<EOS> B-X
The B-X
C9orf72 B-X
repeat B-X
size B-X
correlates B-X
with B-X
onset B-X
age B-X
of B-X
disease B-X
, B-X
DNA B-X
methylation B-X
and B-X
transcriptional B-X
downregulation B-X
of B-X
the B-X
promoter B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
an B-X
underlying B-X
CTG B-X
trinucleotide B-X
repeat B-X
expansion B-X
at B-X
a B-X
locus B-X
on B-X
chromosome B-X
19q13.3 B-X
. B-X
We B-X
have B-X
determined B-X
the B-X
repeat B-X
length B-X
in B-X
23 B-X
DM B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
was B-X
the B-X
first B-X
of B-X
a B-X
group B-X
of B-X
diseases B-X
to B-X
be B-X
identified B-X
for B-X
which B-X
the B-X
genetic B-X
basis B-X
is B-X
the B-X
expansion B-X
of B-X
a B-X
triplet B-X
repeat B-X
. B-X
Myotonic B-X

The	O
instability	O
of	O
the	O
CTG	O
repeat	O
appears	O
to	O
depend	O
on	O
its	O
size	O
as	O
well	O
as	O
on	O
the	O
sex	O
of	O
the	O
transmitting	O
parent	O
.	O
<EOS> B-X
The B-X
most B-X
common B-X
form B-X
of B-X
adult B-X
muscular B-X
dystrophy B-X
, B-X
myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
, B-X
is B-X
caused B-X
by B-X
the B-X
abnormal B-X
expansion B-X
of B-X
the B-X
CTG B-X
repeat B-X
, B-X
located B-X
in B-X
the B-X
3 B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Moreover	O
,	O
mitotic	O
instability	O
analysis	O
of	O
different	O
human	O
DM	B-Disease
tissues	O
shows	O
length	O
mosaicism	O
between	O
different	O
cell	O
lineages	O
.	O
<EOS> B-X
PDF B-X
| B-X
BACKGROUND B-X
Chromosomal B-X
mosaicism B-X
, B-X
the B-X
presence B-X
of B-X
two B-X
or B-X
more B-X
distinct B-X
cell B-X
lines B-X
, B-X
is B-X
prevalent B-X
throughout B-X
human B-X
pre- B-X
and B-X
post-implantation B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
Republished B-X
: B-X
Non-heritable B-X
genetics B-X
of B-X
human B-X
disease B-X
: B-X
spotlight B-X
on B-X
post-zygotic B-X
genetic B-X
variation B-X
acquired B-X
during B-X
lifetime B-X
Mosaic B-X
Analysis B-X
in B-X
Drosophila B-X
WikiGenes B-X
- B-X
Mosaicism B-X
WikiGenes B-X
- B-X
Dmpk B-X
- B-X
dystrophia B-X
myotonica-protein B-X
kinase B-X

The	O
molecular	O
mechanisms	O
of	O
triplet	O
instability	O
remain	O
elusive	O
.	O
<EOS> B-X
Advances B-X
in B-X
mechanisms B-X
of B-X
genetic B-X
instability B-X
related B-X
to B-X
hereditary B-X
neurological B-X
diseases B-X
Abstract B-X
. B-X
Substantial B-X
progress B-X
has B-X
been B-X
realized B-X
in B-X
the B-X
past B-X
several B-X
years B-X
in B-X
our B-X
understanding B-X
of B-X
the B-X
molecular B-X
mechanisms B-X
responsible B-X
for B-X
the B-X
expansions B-X
and B-X
d B-X
Molecular B-X
tandem B-X
repeat B-X
strategy B-X
for B-X
elucidating B-X
mechanical B-X
properties B-X
of B-X
high-strength B-X
proteins B-X
The B-X
disulfide B-X
bond B-X
is B-X
prone B-X
to B-X
ultraviolet B-X
light-induced B-X
cleavage B-X
, B-X
but B-X
the B-X
microscopic B-X
details B-X
of B-X
the B-X
light-activated B-X
bond B-X
breakage B-X
remain B-X
elusive B-X
. B-X
Here B-X
, B-X
we B-X
carry B-X
out B-X
quantum B-X
chemical B-X
calculations B-X
Checkpoint B-X
Responses B-X
to B-X
Unusual B-X
Structures B-X
Formed B-X
by B-X
DNA B-X
Repeats B-X
Unveiling B-X
sequence-stability B-X
and B-X
structure-stability B-X
relationships B-X
is B-X
a B-X
major B-X
goal B-X
of B-X
protein B-X
chemistry B-X
and B-X
structural B-X
biology B-X
. B-X
Despite B-X
the B-X
enormous B-X
efforts B-X
devoted B-X
, B-X
answers B-X
to B-X
these B-X
issues B-X
remain B-X
elusive B-X
. B-X
In B-X
Anisotropic B-X
Singlet B-X
Fission B-X
in B-X
Single B-X
Crystalline B-X
Hexacene B-X

To	O
investigate	O
the	O
role	O
of	O
genomic	O
sequences	O
in	O
instability	O
,	O
we	O
produced	O
transgenic	O
mice	O
containing	O
a	O
45	O
-	O
kb	O
genomic	O
segment	O
with	O
a	O
55	O
-	O
CTG	O
repeat	O
cloned	O
from	O
a	O
mildly	O
affected	O
patient	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
the B-X
expansion B-X
of B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
in B-X
the B-X
3‚Ä≤ B-X
untranslated B-X
region B-X
( B-X
UTR B-X
) B-X
of B-X
the B-X
DM B-X
protein B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
associated B-X
with B-X
the B-X
expansion B-X
of B-X
a B-X
( B-X
CTG B-X
) B-X
n B-X
trinucleotide B-X
repeat B-X
in B-X
the B-X
3‚Ä≤ B-X
untranslated B-X
region B-X
( B-X
UTR B-X
) B-X
of B-X
the B-X
DM B-X
protein B-X
On B-X
the B-X
wrong B-X
DNA B-X
track B-X
: B-X
Molecular B-X
mechanisms B-X
of B-X
repeat-mediated B-X
genome B-X
instability B-X
Request B-X
PDF B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
2003 B-X
, B-X
R. B-X
T. B-X
Libby B-X
published B-X
Genomic B-X
context B-X
drives B-X
SCA7 B-X
CAG B-X
repeat B-X
instability B-X
, B-X
while B-X
expressed B-X
SCA7 B-X
cDNAs B-X
are B-X
intergenerationally B-X
and B-X
somatically B-X
stable B-X
To B-X
better B-X
understand B-X
human B-X
health B-X
and B-X
disease B-X
, B-X
researchers B-X
create B-X
a B-X
wide B-X
variety B-X
of B-X
mouse B-X
models B-X
that B-X
carry B-X
human B-X
DNA B-X
. B-X
With B-X
recent B-X
advances B-X
in B-X
genome B-X
engineering B-X
, B-X
the B-X
targeted B-X
PDF B-X
| B-X
The B-X
CAG B-X
repeats B-X
in B-X
the B-X
human B-X
Huntington B-X
's B-X
disease B-X
( B-X
HD B-X
) B-X
gene B-X
exhibit B-X
striking B-X
length-dependent B-X
intergenerational B-X
instability B-X
, B-X
typically B-X
small B-X
size B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
Request B-X
PDF B-X
| B-X
Progressive B-X
skeletal B-X
muscle B-X
weakness B-X
in B-X
transgenic B-X
mice B-X
expressing B-X
CTG B-X
expansions B-X
is B-X
associated B-X
with B-X
the B-X
activation B-X
of B-X
the B-X
ubiquitin-proteasome B-X
pathway B-X
| B-X
Myotonic B-X
dystrophy B-X
type B-X
1 B-X
( B-X
DM1 B-X
) B-X

In	O
contrast	O
to	O
other	O
mouse	O
models	O
containing	O
CAG	O
repeats	O
within	O
cDNAs	O
,	O
these	O
mice	O
showed	O
both	O
intergenerational	O
and	O
somatic	O
repeat	O
instability	O
.	O
.	O
<EOS> B-X
Somatic B-X
CTG‚Ä¢CAG B-X
repeat B-X
instability B-X
in B-X
a B-X
mouse B-X
model B-X
for B-X
myotonic B-X
dystrophy B-X
type B-X
1 B-X
is B-X
associated B-X
with B-X
changes B-X
in B-X
cell B-X
nuclearity B-X
and B-X
DNA B-X
ploidy B-X
Abstract B-X
. B-X
Expression B-X
of B-X
unstable B-X
translated B-X
CAG B-X
repeats B-X
is B-X
the B-X
mutational B-X
mechanism B-X
in B-X
nine B-X
different B-X
neurodegenerative B-X
disorders B-X
. B-X
Although B-X
the B-X
products B-X
of B-X
gene B-X
PDF B-X
| B-X
Expression B-X
of B-X
unstable B-X
translated B-X
CAG B-X
repeats B-X
is B-X
the B-X
mutational B-X
mechanism B-X
in B-X
nine B-X
different B-X
neurodegenerative B-X
disorders B-X
. B-X
Although B-X
the B-X
products B-X
of B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Abstract B-X
. B-X
To B-X
elucidate B-X
the B-X
pathophysiology B-X
of B-X
spinocerebellar B-X
ataxia B-X
type B-X
1 B-X
( B-X
SCA1 B-X
) B-X
and B-X
to B-X
evaluate B-X
repeat B-X
length B-X
instability B-X
in B-X
the B-X
context B-X
of B-X
the B-X
mouse B-X
Sca1 B-X
ge B-X
PDF B-X
| B-X
CAG/polyglutamine B-X
expansion B-X
has B-X
been B-X
shown B-X
to B-X
form B-X
the B-X
molecular B-X
basis B-X
of B-X
an B-X
increasing B-X
number B-X
of B-X
inherited B-X
neurodegenerative B-X
diseases B-X
. B-X
The B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Abstract B-X
. B-X
Spinocerebellar B-X
ataxia B-X
type B-X
7 B-X
( B-X
SCA7 B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
cerebellar B-X
ataxia B-X
caused B-X
by B-X
a B-X
CAG B-X
repeat B-X
expansion B-X
in B-X
the B-X
ataxin-7 B-X
gene B-X
. B-X
In B-X
humans B-X
, B-X
SCA7 B-X

Missense	O
mutations	O
in	O
the	O
Fas	O
gene	O
resulting	O
in	O
autoimmune	B-Disease
lymphoproliferative	I-Disease
syndrome	I-Disease
:	O
a	O
molecular	O
and	O
immunological	O
analysis	O
.	O
<EOS> B-X
Missense B-X
Mutations B-X
in B-X
the B-X
Fas B-X
Gene B-X
Resulting B-X
in B-X
Autoimmune B-X
Lymphoproliferative B-X
Syndrome B-X
: B-X
A B-X
Molecular B-X
and B-X
Immunological B-X
Analysis B-X
- B-X
ScienceDirect B-X
Mutations B-X
in B-X
the B-X
Fas B-X
( B-X
apo-1 B-X
, B-X
CD95 B-X
) B-X
gene B-X
result B-X
in B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
. B-X
These B-X
mutations B-X
are B-X
dominated B-X
by B-X
small B-X
deletions B-X
and B-X
point B-X
mutations B-X
that B-X
Lymphoproliferative B-X
Syndrome B-X
With B-X
Autoimmunity B-X
: B-X
A B-X
Possible B-X
Genetic B-X
Basis B-X
for B-X
Dominant B-X
Expression B-X
of B-X
the B-X
Clinical B-X
Manifestations B-X
- B-X
ScienceDirect B-X
Abstract B-X
. B-X
Programmed B-X
cell B-X
death B-X
( B-X
or B-X
apoptosis B-X
) B-X
is B-X
a B-X
physiological B-X
process B-X
essential B-X
to B-X
the B-X
normal B-X
development B-X
and B-X
homeostatic B-X
maintenance B-X
of B-X
the B-X
immune B-X
system B-X
. B-X
Programmed B-X
cell B-X
death B-X
( B-X
or B-X
apoptosis B-X
) B-X
is B-X
a B-X
physiological B-X
process B-X
essential B-X
to B-X
the B-X
normal B-X
development B-X
and B-X
homeostatic B-X
maintenance B-X
of B-X
the B-X
immune B-X
system B-X
. B-X
The B-X
Fas/Apo-1 B-X
receptor B-X
plays B-X
a B-X
crucial B-X

Programmed	O
cell	O
death	O
(	O
or	O
apoptosis	O
)	O
is	O
a	O
physiological	O
process	O
essential	O
to	O
the	O
normal	O
development	O
and	O
homeostatic	O
maintenance	O
of	O
the	O
immune	O
system	O
.	O
<EOS> B-X
Programmed B-X
Cell B-X
Death B-X
in B-X
Animal B-X
Development B-X
and B-X
Disease B-X
Programmed B-X
Cell B-X
Death B-X
in B-X
Animal B-X
Development B-X
and B-X
Disease B-X
: B-X
Cell B-X
Programmed B-X
Cell B-X
Death B-X
and B-X
Inflammation B-X
: B-X
Winter B-X
is B-X
Coming B-X
Programmed B-X
Cell B-X
Death B-X
in B-X
Animal B-X
Development B-X
and B-X
Disease B-X
- B-X
ScienceDirect B-X
PDF B-X
| B-X
The B-X
process B-X
of B-X
programmed B-X
cell B-X
death B-X
, B-X
or B-X
apoptosis B-X
, B-X
is B-X
generally B-X
characterized B-X
by B-X
distinct B-X
morphological B-X
characteristics B-X
and B-X
energy-dependent B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
What B-X
is B-X
apoptosis B-X
, B-X
and B-X
why B-X
is B-X
it B-X
important B-X
? B-X
Intertwined B-X
pathways B-X
of B-X
programmed B-X
cell B-X
death B-X
in B-X
immunity B-X

The	O
Fas	O
/	O
Apo	O
-	O
1	O
receptor	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
regulation	O
of	O
apoptosis	O
,	O
as	O
demonstrated	O
by	O
lymphoproliferation	O
in	O
MRL	O
-	O
lpr	O
/	O
lpr	O
mice	O
and	O
by	O
the	O
recently	O
described	O
autoimmune	B-Disease
lymphoproliferative	I-Disease
syndrome	I-Disease
(	O
ALPS	B-Disease
)	O
in	O
humans	O
,	O
both	O
of	O
which	O
are	O
due	O
to	O
mutations	O
in	O
the	O
Fas	O
gene	O
.	O
<EOS> B-X
Most B-X
humans B-X
with B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
carry B-X
heterozygous B-X
dominant B-X
mutations B-X
in B-X
one B-X
allele B-X
of B-X
the B-X
gene B-X
encoding B-X
Fas/APO-1/CD95 B-X
. B-X
ALPS B-X
patients B-X
, B-X
like B-X
Fas-deficient B-X
MRL B-X
lpr/lpr B-X
mice B-X
Fas/Apo-1 B-X
( B-X
CD95 B-X
) B-X
triggers B-X
programmed B-X
cell B-X
death B-X
( B-X
PCD B-X
) B-X
and B-X
is B-X
involved B-X
in B-X
immune B-X
response B-X
control B-X
and B-X
cell-mediated B-X
cytotoxicity B-X
. B-X
In B-X
the B-X
autoimmune/lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
, B-X
Advances B-X
in B-X
the B-X
management B-X
and B-X
understanding B-X
of B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
Rapamycin B-X
improves B-X
lymphoproliferative B-X
disease B-X
in B-X
murine B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
Deregulation B-X
of B-X
Fas B-X
ligand B-X
expression B-X
as B-X
a B-X
novel B-X
cause B-X
of B-X
autoimmune B-X
lymphoproliferative B-X
syndrome-like B-X
disease B-X
Abstract B-X
. B-X
Autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
is B-X
characterized B-X
by B-X
lymphoproliferation B-X
and B-X
autoimmune B-X
clinical B-X
manifestations B-X
and B-X
is B-X
generally B-X
caused B-X
Apoptosis B-X
or B-X
programmed B-X
cell B-X
death B-X
plays B-X
an B-X
essential B-X
role B-X
during B-X
development B-X
of B-X
the B-X
immune B-X
system B-X
, B-X
in B-X
immune B-X
responses B-X
, B-X
and B-X
in B-X
the B-X
control B-X
of B-X
tissue B-X
homeostasis B-X
in B-X
the B-X
adult B-X

We	O
describe	O
a	O
novel	O
family	O
with	O
ALPS	B-Disease
in	O
which	O
three	O
affected	O
siblings	O
carry	O
two	O
distinct	O
missense	O
mutations	O
on	O
both	O
the	O
Fas	O
gene	O
alleles	O
and	O
show	O
lack	O
of	O
Fas	O
-	O
induced	O
apoptosis	O
.	O
<EOS> B-X
Missense B-X
mutations B-X
in B-X
the B-X
Fas B-X
gene B-X
resulting B-X
in B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
: B-X
a B-X
molecular B-X
and B-X
immunological B-X
analysis B-X
. B-X
Request B-X
PDF B-X
| B-X
Deficiency B-X
of B-X
the B-X
Fas B-X
apoptosis B-X
pathway B-X
without B-X
Fas B-X
gene B-X
mutations B-X
is B-X
a B-X
familial B-X
trait B-X
predisposing B-X
to B-X
development B-X
of B-X
autoimmune B-X
diseases B-X
and B-X
cancer B-X
| B-X
Fas/Apo-1 B-X
( B-X
CD95 B-X
) B-X
Haploinsufficiency B-X
, B-X
rather B-X
than B-X
the B-X
effect B-X
of B-X
an B-X
excessive B-X
production B-X
of B-X
soluble B-X
CD95 B-X
( B-X
CD95ŒîTM B-X
) B-X
, B-X
is B-X
the B-X
basis B-X
for B-X
ALPS B-X
Ia B-X
in B-X
a B-X
family B-X
with B-X
duplicated B-X
3‚Ä≤ B-X
splice B-X
Onset B-X
of B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
in B-X
humans B-X
as B-X
a B-X
consequence B-X
of B-X
genetic B-X
defect B-X
accumulation B-X
PDF B-X
| B-X
The B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
is B-X
characterized B-X
by B-X
early-onset B-X
lymphadenopathy B-X
, B-X
splenomegaly B-X
, B-X
immune B-X
cytopenias B-X
, B-X
and B-X
an B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X

The	O
children	O
share	O
common	O
clinical	O
features	O
including	O
splenomegaly	B-Disease
and	O
lymphadenopathy	B-Disease
,	O
but	O
only	O
one	O
developed	O
severe	O
autoimmune	B-Disease
manifestations	I-Disease
.	O
<EOS> B-X
A B-X
Girl B-X
with B-X
Autoimmune B-X
Cytopenias B-X
, B-X
Nonmalignant B-X
Lymphadenopathy B-X
, B-X
and B-X
Recurrent B-X
Infections B-X
Autoimmune B-X
lymphoproliferative B-X
syndrome B-X
( B-X
ALPS B-X
) B-X
is B-X
characterized B-X
by B-X
nonmalignant B-X
lymphadenopathy B-X
, B-X
splenomegaly B-X
, B-X
and B-X
autoimmune B-X
cytopenias B-X
. B-X
In B-X
1995 B-X
, B-X
defective B-X
lymphocyte B-X
apoptosis B-X
secondary B-X
to B-X
mutations B-X
in B-X
the B-X
FAS B-X
How B-X
I B-X
treat B-X
autoimmune B-X
lymphoproliferative B-X
syndrome B-X
Cervical B-X
lymph B-X
node B-X
diseases B-X
in B-X
children B-X
Diagnosis B-X
and B-X
Management B-X
of B-X
Autoimmune B-X
Cytopenias B-X
in B-X
Childhood B-X
Symptoms B-X
The B-X
major B-X
clinical B-X
symptoms B-X
of B-X
ALPS B-X
result B-X
from B-X
lymphoproliferation B-X
, B-X
or B-X
the B-X
excessive B-X
production B-X
of B-X
a B-X
type B-X
of B-X
white B-X
blood B-X
cell B-X
called B-X
a B-X
lymphocyte B-X
, B-X
and B-X
autoimmune B-X
destruction B-X
of B-X
Autoimmune B-X
Lymphoproliferative B-X
Syndrome B-X
: B-X
an B-X
update B-X
and B-X
review B-X
of B-X
the B-X
literature B-X

In	O
all	O
three	O
siblings	O
,	O
we	O
demonstrated	O
the	O
presence	O
of	O
anergic	O
CD3	O
+	O
CD4	O
-	O
CD8	O
-	O
(	O
double	O
negative	O
,	O
[	O
DN	O
]	O
)	O
T	O
cells	O
;	O
moreover	O
,	O
a	O
chronic	O
lymphocyte	O
activation	O
was	O
found	O
,	O
as	O
demonstrated	O
by	O
the	O
presence	O
of	O
high	O
levels	O
of	O
HLA	O
-	O
DR	O
expression	O
on	O
peripheral	O
CD3	O
+	O
cells	O
and	O
by	O
the	O
presence	O
of	O
high	O
levels	O
of	O
serum	O
activation	O
markers	O
such	O
as	O
soluble	O
interleukin	O
-	O
2	O
receptor	O
(	O
slL	O
-	O
2R	O
)	O
and	O
soluble	O
CD30	O
(	O
sCD30	O
)	O
.	O
.	O
<EOS> B-X
The B-X
recently B-X
discovered B-X
population B-X
of B-X
TCRŒ±Œ≤+ B-X
CD4-/CD8- B-X
( B-X
double-negative B-X
, B-X
DN B-X
) B-X
T-cells B-X
are B-X
highly B-X
potent B-X
suppressor B-X
cells B-X
in B-X
mice B-X
and B-X
humans B-X
. B-X
In B-X
preclinical B-X
transplantation B-X
models B-X
, B-X
adoptive B-X
transfer B-X
Request B-X
PDF B-X
| B-X
Plasma B-X
levels B-X
of B-X
soluble B-X
interleukin B-X
2 B-X
receptor B-X
, B-X
soluble B-X
CD30 B-X
, B-X
interleukin B-X
10 B-X
and B-X
B B-X
cell B-X
activator B-X
of B-X
the B-X
tumour B-X
necrosis B-X
factor B-X
family B-X
during B-X
follow-up B-X
in B-X
vasculitis B-X
Helper B-X
T B-X
cells B-X
down-regulate B-X
CD4 B-X
expression B-X
upon B-X
chronic B-X
stimulation B-X
giving B-X
rise B-X
to B-X
double-negative B-X
T B-X
cells B-X
The B-X
establishment B-X
of B-X
reservoirs B-X
of B-X
latently B-X
infected B-X
cells B-X
is B-X
thought B-X
to B-X
contribute B-X
to B-X
the B-X
persistence B-X
of B-X
HIV-1 B-X
infection B-X
in B-X
the B-X
host B-X
. B-X
Studies B-X
so B-X
far B-X
have B-X
mainly B-X
focused B-X
on B-X
the B-X
Programmed B-X
cell B-X
death B-X
1 B-X
and B-X
Helios B-X
distinguish B-X
TCR-Œ±Œ≤+ B-X
double B-X
negative B-X
( B-X
CD4-CD8- B-X
) B-X
T B-X
cells B-X
that B-X
derive B-X
from B-X
self-reactive B-X
CD8 B-X
T B-X
cells B-X
Induction B-X
of B-X
a B-X
Regulatory B-X
Phenotype B-X
in B-X
CD3+ B-X
CD4+ B-X
HLA-DR+ B-X
T B-X
Cells B-X
after B-X
Allogeneic B-X
Mixed B-X
Lymphocyte B-X
Culture B-X
; B-X
Indications B-X
of B-X
Both B-X
Contact-Dependent B-X
and B-X
-Independent B-X
Activation B-X

The	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
gene	O
product	O
,	O
a	O
constitutively	O
expressed	O
nuclear	O
protein	O
that	O
is	O
not	O
up	O
-	O
regulated	O
following	O
genome	O
damage	O
.	O
<EOS> B-X
The B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
, B-X
a B-X
constitutively B-X
expressed B-X
nuclear B-X
protein B-X
that B-X
is B-X
not B-X
up-regulated B-X
following B-X
genome B-X
damage B-X
| B-X
PNAS B-X
The B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
, B-X
a B-X
constitutively B-X
expressed B-X
nuclear B-X
protein B-X
that B-X
is B-X
not B-X
up-regulated B-X
following B-X
genome B-X
damage B-X
| B-X
PNAS B-X
The B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
, B-X
a B-X
constitutively B-X
expressed B-X
nuclear B-X
protein B-X
that B-X
is B-X
not B-X
up-regulated B-X
following B-X
genome B-X
damage B-X
| B-X
PNAS B-X
Purification B-X
and B-X
DNA B-X
binding B-X
properties B-X
of B-X
the B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
ATM B-X
| B-X
PNAS B-X
The B-X
product B-X
of B-X
the B-X
ataxia-telangiectasia B-X
gene B-X
( B-X
ATM B-X
) B-X
was B-X
identified B-X
by B-X
using B-X
an B-X
antiserum B-X
developed B-X
to B-X
a B-X
peptide B-X
corresponding B-X
to B-X
the B-X
deduced B-X
amino B-X
acid B-X
sequence B-X
. B-X
The B-X
ATM B-X
protein B-X
DNA B-X
Repair B-X
and B-X
Human B-X
Disease B-X
highlights B-X
the B-X
molecular B-X
complexities B-X
of B-X
a B-X
few B-X
well-known B-X
human B-X
hereditary B-X
disorders B-X
that B-X
arise B-X
due B-X
to B-X
perturbations B-X
in B-X
the B-X
fidelity B-X
of B-X
diverse B-X
DNA B-X
repair B-X
machineries B-X
. B-X
The B-X
role B-X
of B-X
ATM B-X
and B-X
DNA B-X
damage B-X
in B-X
neurons B-X
: B-X
upstream B-X
and B-X
downstream B-X
connections B-X

The	O
product	O
of	O
the	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
gene	O
(	O
ATM	O
)	O
was	O
identified	O
by	O
using	O
an	O
antiserum	O
developed	O
to	O
a	O
peptide	O
corresponding	O
to	O
the	O
deduced	O
amino	O
acid	O
sequence	O
.	O
<EOS> B-X
Stable B-X
Brain B-X
ATM B-X
Message B-X
and B-X
Residual B-X
Kinase-Active B-X
ATM B-X
Protein B-X
in B-X
Ataxia-Telangiectasia B-X
Ataxia-telangiectasia B-X
mutated B-X
( B-X
ATM B-X
) B-X
is B-X
the B-X
gene B-X
product B-X
mutated B-X
in B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
which B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
with B-X
symptoms B-X
including B-X
neurodegeneration B-X
, B-X
cancer B-X
predisposition B-X
and B-X
A B-X
biweekly B-X
scientific B-X
journal B-X
publishing B-X
high-quality B-X
research B-X
in B-X
molecular B-X
biology B-X
and B-X
genetics B-X
, B-X
cancer B-X
biology B-X
, B-X
biochemistry B-X
, B-X
and B-X
related B-X
fields B-X

The	O
ATM	O
protein	O
is	O
a	O
single	O
,	O
high	O
-	O
molecular	O
weight	O
protein	O
predominantly	O
confined	O
to	O
the	O
nucleus	O
of	O
human	O
fibroblasts	O
,	O
but	O
is	O
present	O
in	O
both	O
nuclear	O
and	O
microsomal	O
fractions	O
from	O
human	O
lymphoblast	O
cells	O
and	O
peripheral	O
blood	O
lymphocytes	O
.	O
<EOS> B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Analysis B-X
of B-X
ATM B-X
protein B-X
in B-X
fractionated B-X
human B-X
lymphoblasts B-X
and B-X
peripheral B-X
blood B-X
lymphocytes B-X
. B-X
( B-X
A B-X
) B-X
B-310 B-X
lymphoblasts B-X
( B-X
1 B-X
10 B-X
7 B-X
) B-X
were B-X
fractionated B-X
. B-X
Request B-X
PDF B-X
| B-X
Characterization B-X
of B-X
microsomal B-X
fraction B-X
proteome B-X
in B-X
human B-X
lymphoblasts B-X
reveals B-X
the B-X
down-regulation B-X
of B-X
galectin-1 B-X
by B-X
interleukin-12 B-X
| B-X
T B-X
helper B-X
cells B-X
( B-X
Th B-X
) B-X
are B-X
divided B-X
into B-X
Th1 B-X
and B-X
We B-X
have B-X
curated B-X
an B-X
in-depth B-X
subcellular B-X
proteomic B-X
map B-X
of B-X
primary B-X
human B-X
CD4+ B-X
T B-X
cells B-X
, B-X
divided B-X
into B-X
cytosolic B-X
, B-X
nuclear B-X
and B-X
membrane B-X
fractions B-X
generated B-X
by B-X
an B-X
optimized B-X
fractionation B-X
and B-X
HiRIEF-LC-MS/MS B-X
Loss B-X
of B-X
the B-X
tumor B-X
suppressor B-X
BIN1 B-X
enables B-X
ATM B-X
Ser/Thr B-X
kinase B-X
activation B-X
by B-X
the B-X
nuclear B-X
protein B-X
E2F1 B-X
and B-X
renders B-X
cancer B-X
cells B-X
resistant B-X
to B-X
cisplatin B-X
TcellSubC B-X
: B-X
An B-X
Atlas B-X
of B-X
the B-X
Subcellular B-X
Proteome B-X
of B-X
Human B-X
T B-X
Cells B-X
This B-X
highly B-X
specific B-X
ATM B-X
antibody B-X
is B-X
suitable B-X
for B-X
use B-X
in B-X
WB B-X
and B-X
is B-X
guaranteed B-X
to B-X
work B-X
as B-X
stated B-X
on B-X
the B-X
product B-X
data B-X
sheet B-X
. B-X
| B-X
R30879 B-X
DNA B-X
Polymerases B-X
in B-X
Normal B-X
and B-X
Leukemic B-X
Human B-X
Hematopoietic B-X
Cells B-X
- B-X
ScienceDirect B-X

ATM	O
protein	O
levels	O
and	O
localization	O
remain	O
constant	O
throughout	O
all	O
stages	O
of	O
the	O
cell	O
cycle	O
.	O
<EOS> B-X
PDF B-X
| B-X
Ataxia B-X
telangiectasia‚Äìmutated B-X
gene B-X
( B-X
ATM B-X
) B-X
is B-X
a B-X
350-kDa B-X
protein B-X
whose B-X
function B-X
is B-X
defective B-X
in B-X
the B-X
autosomal B-X
recessive B-X
disorder B-X
ataxia B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X

Truncated	O
ATM	O
protein	O
was	O
not	O
detected	O
in	O
lymphoblasts	O
from	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
patients	O
homozygous	O
for	O
mutations	O
leading	O
to	O
premature	O
protein	O
termination	O
.	O
<EOS> B-X
The B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
, B-X
a B-X
constitutively B-X
expressed B-X
nuclear B-X
protein B-X
that B-X
is B-X
not B-X
up-regulated B-X
following B-X
genome B-X
damage B-X
. B-X
The B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
, B-X
a B-X
constitutively B-X
expressed B-X
nuclear B-X
protein B-X
that B-X
is B-X
not B-X
up-regulated B-X
following B-X
genome B-X
damage B-X
| B-X
PNAS B-X
The B-X
ataxia-telangiectasia B-X
gene B-X
product B-X
, B-X
a B-X
constitutively B-X
expressed B-X
nuclear B-X
protein B-X
that B-X
is B-X
not B-X
up-regulated B-X
following B-X
genome B-X
damage B-X
| B-X
PNAS B-X
Request B-X
PDF B-X
| B-X
ATM B-X
mutations B-X
in B-X
Italian B-X
families B-X
with B-X
ataxia B-X
telangiectasia B-X
include B-X
two B-X
distinct B-X
large B-X
genomic B-X
deletions B-X
| B-X
In B-X
patients B-X
affected B-X
by B-X
Ataxia-Telangiectasia B-X
( B-X
A-T B-X
) B-X
, B-X
mutations B-X
in B-X
the B-X
The B-X
product B-X
of B-X
the B-X
gene B-X
( B-X
ATM B-X
) B-X
mutated B-X
in B-X
the B-X
human B-X
genetic B-X
disorder B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
a B-X
high B-X
molecular B-X
weight B-X
, B-X
protein B-X
( B-X
approximately B-X
350kDa B-X
) B-X
containing B-X
PDF B-X
| B-X
The B-X
product B-X
of B-X
the B-X
ataxia-telangiectasia B-X
gene B-X
( B-X
ATM B-X
) B-X
was B-X
identified B-X
by B-X
using B-X
an B-X
antiserum B-X
developed B-X
to B-X
a B-X
peptide B-X
corresponding B-X
to B-X
the B-X
deduced B-X
amino B-X
... B-X
| B-X
Find B-X
, B-X
Request B-X
PDF B-X
| B-X
Improved B-X
diagnostic B-X
testing B-X
for B-X
ataxia-telangiectasia B-X
by B-X
immunoblotting B-X
of B-X
nuclear B-X
lysates B-X
for B-X
ATM B-X
protein B-X
expression B-X
and B-X
PI-3 B-X
kinase B-X
activity B-X
| B-X
The B-X
laboratory B-X
diagnosis B-X
of B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X

Exposure	O
of	O
normal	O
human	O
cells	O
to	O
gamma	O
-	O
irradiation	O
and	O
the	O
radiomimetic	O
drug	O
neocarzinostatin	O
had	O
no	O
effect	O
on	O
ATM	O
protein	O
levels	O
,	O
in	O
contrast	O
to	O
a	O
noted	O
rise	O
in	O
p53	O
levels	O
over	O
the	O
same	O
time	O
interval	O
.	O
<EOS> B-X
Effects B-X
of B-X
prostaglandin B-X
E2 B-X
on B-X
p53 B-X
mRNA B-X
transcription B-X
and B-X
p53 B-X
mutagenesis B-X
during B-X
T-cell-independent B-X
human B-X
B-cell B-X
clonal B-X
expansion B-X
INT6/EIF3E B-X
interacts B-X
with B-X
ATM B-X
and B-X
is B-X
required B-X
for B-X
proper B-X
execution B-X
of B-X
the B-X
DNA B-X
damage B-X
response B-X
in B-X
human B-X
cells B-X
The B-X
human B-X
genetic B-X
disorder B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
due B-X
to B-X
lack B-X
of B-X
functional B-X
ATM B-X
, B-X
a B-X
protein B-X
kinase B-X
which B-X
is B-X
involved B-X
in B-X
cellular B-X
responses B-X
to B-X
DNA B-X
double B-X
strand B-X
breaks B-X
Protein B-X
Phosphatase B-X
5 B-X
Regulates B-X
the B-X
Function B-X
of B-X
53BP1 B-X
after B-X
Neocarzinostatin-induced B-X
DNA B-X
Damage B-X
A B-X
Switch B-X
in B-X
p53 B-X
Dynamics B-X
Marks B-X
Cells B-X
That B-X
Escape B-X
from B-X
DSB-Induced B-X
Cell B-X
Cycle B-X
Arrest B-X
Long B-X
Term B-X
Aggresome B-X
Accumulation B-X
Leads B-X
to B-X
DNA B-X
Damage B-X
, B-X
p53-dependent B-X
Cell B-X
Cycle B-X
Arrest B-X
, B-X
and B-X
Steric B-X
Interference B-X
in B-X
Mitosis B-X
Neocarzinostatin B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

These	O
findings	O
are	O
consistent	O
with	O
a	O
role	O
for	O
the	O
ATM	O
protein	O
in	O
ensuring	O
the	O
fidelity	O
of	O
DNA	O
repair	O
and	O
cell	O
cycle	O
regulation	O
following	O
genome	O
damage	O
.	O
.	O
<EOS> B-X
Mechanisms B-X
of B-X
DNA B-X
damage B-X
, B-X
repair B-X
and B-X
mutagenesis B-X
DNA B-X
Damage B-X
Response B-X
Mutations B-X
in B-X
the B-X
ATM B-X
tumor B-X
suppressor B-X
gene B-X
confer B-X
hypersensitivity B-X
to B-X
DNA-damaging B-X
chemotherapeutic B-X
agents B-X
. B-X
To B-X
explore B-X
genetic B-X
resistance B-X
mechanisms B-X
, B-X
we B-X
performed B-X
genome-wide B-X
CRISPR-Cas9 B-X
screens B-X
in B-X
cells B-X
treated B-X
with B-X
the B-X

Type	O
III	O
collagen	O
is	O
crucial	O
for	O
collagen	O
I	O
fibrillogenesis	O
and	O
for	O
normal	O
cardiovascular	O
development	O
.	O
<EOS> B-X
Type B-X
III B-X
collagen B-X
is B-X
important B-X
for B-X
type B-X
I B-X
collagen B-X
fibrillogenesis B-X
and B-X
for B-X
dermal B-X
and B-X
cardiovascular B-X
development B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
. B-X
| B-X
Harvard B-X
Catalyst B-X
Profiles B-X
| B-X
Harvard B-X
Catalyst B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
| B-X
PNAS B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
| B-X
PNAS B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
| B-X
PNAS B-X
Type B-X
III B-X
collagen B-X
is B-X
a B-X
fibrillar B-X
forming B-X
collagen B-X
comprising B-X
three B-X
alpha1 B-X
( B-X
III B-X
) B-X
chains B-X
and B-X
is B-X
expressed B-X
in B-X
early B-X
embryos B-X
and B-X
throughout B-X
embryogenesis B-X
. B-X
In B-X
the B-X
adult B-X
, B-X
type B-X
Vascular B-X
Ehlers-Danlos B-X
Syndrome B-X
Mutations B-X
in B-X
Type B-X
III B-X
Collagen B-X
Differently B-X
Stall B-X
the B-X
Triple B-X
Helical B-X
Folding B-X

Type	O
III	O
collagen	O
is	O
a	O
fibrillar	O
forming	O
collagen	O
comprising	O
three	O
alpha1	O
(	O
III	O
)	O
chains	O
and	O
is	O
expressed	O
in	O
early	O
embryos	O
and	O
throughout	O
embryogenesis	O
.	O
<EOS> B-X
The B-X
collŒ±gen B-X
III B-X
fibril B-X
has B-X
a B-X
‚Äú B-X
flexi-rod B-X
‚Äù B-X
structure B-X
of B-X
flexible B-X
sequences B-X
interspersed B-X
with B-X
rigid B-X
bioactive B-X
domains B-X
including B-X
two B-X
with B-X
hemostatic B-X
roles B-X
Collagen B-X
, B-X
type B-X
III B-X
, B-X
alpha B-X
1 B-X
- B-X
Wikipedia B-X

In	O
the	O
adult	O
,	O
type	O
III	O
collagen	O
is	O
a	O
major	O
component	O
of	O
the	O
extracellular	O
matrix	O
in	O
a	O
variety	O
of	O
internal	O
organs	O
and	O
skin	O
.	O
<EOS> B-X
Type B-X
III B-X
collagen B-X
( B-X
Col3 B-X
) B-X
, B-X
a B-X
fibril-forming B-X
collagen B-X
, B-X
is B-X
a B-X
major B-X
extracellular B-X
matrix B-X
component B-X
in B-X
a B-X
variety B-X
of B-X
internal B-X
organs B-X
and B-X
skin B-X
. B-X
It B-X
is B-X
also B-X
expressed B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
. B-X
Extracellular B-X
Matrix B-X
Reorganization B-X
During B-X
Wound B-X
Healing B-X
and B-X
Its B-X
Impact B-X
on B-X
Abnormal B-X
Scarring B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
Collagen B-X
Type B-X
3 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Collagen B-X
Type B-X
3 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Anti-Collagen B-X
Type B-X
III B-X
and B-X
other B-X
cell B-X
signaling B-X
antibodies B-X
at B-X
Cell B-X
Applications B-X
, B-X
your B-X
worldwide B-X
provider B-X
of B-X
human B-X
& B-X
animal B-X
cells B-X
, B-X
antibodies B-X
, B-X
& B-X
cell B-X
culture B-X
& B-X
molecular B-X
biology B-X
tools B-X

Mutations	O
in	O
the	O
COL3A1	O
gene	O
have	O
been	O
implicated	O
as	O
a	O
cause	O
of	O
type	B-Disease
IV	I-Disease
Ehlers	I-Disease
-	I-Disease
Danlos	I-Disease
syndrome	I-Disease
,	O
a	O
disease	O
leading	O
to	O
aortic	B-Disease
rupture	I-Disease
in	O
early	O
adult	O
life	O
.	O
<EOS> B-X
The B-X
type B-X
of B-X
variants B-X
at B-X
the B-X
COL3A1 B-X
gene B-X
associates B-X
with B-X
the B-X
phenotype B-X
and B-X
severity B-X
of B-X
vascular B-X
Ehlers‚ÄìDanlos B-X
syndrome B-X
Haploinsufficiency B-X
of B-X
the B-X
murine B-X
Col3a1 B-X
locus B-X
causes B-X
aortic B-X
dissection B-X
: B-X
a B-X
novel B-X
model B-X
of B-X
the B-X
vascular B-X
type B-X
of B-X
Ehlers‚ÄìDanlos B-X
syndrome B-X
Request B-X
PDF B-X
| B-X
COL3A1 B-X
haploinsufficiency B-X
results B-X
in B-X
a B-X
variety B-X
of B-X
Ehlers-Danlos B-X
syndrome B-X
type B-X
IV B-X
with B-X
delayed B-X
onset B-X
of B-X
complications B-X
and B-X
longer B-X
life B-X
expectancy B-X
| B-X
To B-X
characterize B-X
the B-X
clinical B-X
outcome B-X
of B-X
Vascular B-X
Ehlers-Danlos B-X
syndrome B-X
( B-X
vEDS B-X
) B-X
is B-X
characterized B-X
by B-X
arterial B-X
, B-X
intestinal B-X
, B-X
and/or B-X
uterine B-X
fragility B-X
; B-X
thin B-X
, B-X
translucent B-X
skin B-X
; B-X
easy B-X
bruising B-X
; B-X
characteristic B-X
facial B-X
appearance B-X
( B-X
thin B-X

To	O
directly	O
study	O
the	O
role	O
of	O
Col3a1	O
in	O
development	O
and	O
disease	O
,	O
we	O
have	O
inactivated	O
the	O
Col3a1	O
gene	O
in	O
embryonic	O
stem	O
cells	O
by	O
homologous	O
recombination	O
.	O
<EOS> B-X
Type B-X
III B-X
collagen B-X
is B-X
a B-X
fibrillar B-X
forming B-X
collagen B-X
comprising B-X
three B-X
Œ± B-X
1 B-X
( B-X
III B-X
) B-X
chains B-X
and B-X
is B-X
expressed B-X
in B-X
early B-X
embryos B-X
and B-X
throughout B-X
embryogenesis B-X
. B-X
In B-X
the B-X
adult B-X
, B-X
Collagen B-X
alpha-1 B-X
( B-X
III B-X
) B-X
chain B-X
, B-X
also B-X
known B-X
as B-X
the B-X
alpha B-X
1 B-X
chain B-X
of B-X
type B-X
III B-X
collagen B-X
, B-X
is B-X
a B-X
protein B-X
that B-X
in B-X
humans B-X
is B-X
encoded B-X
by B-X
the B-X
COL3A1 B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
120180 B-X
- B-X
COLLAGEN B-X
, B-X
TYPE B-X
III B-X
, B-X
ALPHA-1 B-X
; B-X
COL3A1 B-X
- B-X
COLLAGEN B-X
, B-X
FETAL B-X
; B-X
; B-X
COLLAGEN B-X
, B-X
BLOOD B-X
VESSEL B-X
- B-X
COL3A1 B-X
120180 B-X
- B-X
COLLAGEN B-X
, B-X
TYPE B-X
III B-X
, B-X
ALPHA-1 B-X
; B-X
COL3A1 B-X
- B-X
COLLAGEN B-X
, B-X
FETAL B-X
; B-X
; B-X
COLLAGEN B-X
, B-X
BLOOD B-X
VESSEL B-X
- B-X
COL3A1 B-X

The	O
mutated	O
allele	O
was	O
transmitted	O
through	O
the	O
mouse	O
germ	O
line	O
and	O
homozygous	O
mutant	O
animals	O
were	O
derived	O
from	O
heterozygous	O
intercrosses	O
.	O
<EOS> B-X
Exclusive B-X
transmission B-X
of B-X
the B-X
embryonic B-X
stem B-X
cell‚Äêderived B-X
genome B-X
through B-X
the B-X
mouse B-X
germline B-X
Technical B-X
approaches B-X
for B-X
mouse B-X
models B-X
of B-X
human B-X
disease B-X
Genetic B-X
manipulations B-X
in B-X
the B-X
rat B-X
: B-X
progress B-X
and B-X
prospects B-X
MutS B-X
homolog B-X
4 B-X
localization B-X
to B-X
meiotic B-X
chromosomes B-X
is B-X
required B-X
for B-X
chromosome B-X
pairing B-X
during B-X
meiosis B-X
in B-X
male B-X
and B-X
female B-X
mice B-X
Characterization B-X
of B-X
Two B-X
Mst1-Deficient B-X
Mouse B-X
Models B-X
Knockout B-X
mice B-X
: B-X
simple B-X
solutions B-X
to B-X
the B-X
problems B-X
of B-X
genetic B-X
background B-X
and B-X
flanking B-X
genes B-X
: B-X
Trends B-X
in B-X
Neurosciences B-X
An B-X
Unstable B-X
Targeted B-X
Allele B-X
of B-X
the B-X
Mouse B-X
Mitf B-X
Gene B-X
With B-X
a B-X
High B-X
Somatic B-X
and B-X
Germline B-X
Reversion B-X
Rate B-X

About	O
10	O
%	O
of	O
the	O
homozygous	O
mutant	O
animals	O
survived	O
to	O
adulthood	O
but	O
have	O
a	O
much	O
shorter	O
life	O
span	O
compared	O
with	O
wild	O
-	O
type	O
mice	O
.	O
<EOS> B-X
< B-X
p B-X
> B-X
Type B-X
III B-X
collagen B-X
is B-X
a B-X
fibrillar B-X
forming B-X
collagen B-X
comprising B-X
three B-X
alpha1 B-X
( B-X
III B-X
) B-X
chains B-X
and B-X
is B-X
expressed B-X
in B-X
early B-X
embryos B-X
and B-X
throughout B-X
embryogenesis B-X
. B-X
In B-X
the B-X
Type B-X
III B-X
collagen B-X
is B-X
a B-X
fibrillar B-X
forming B-X
collagen B-X
comprising B-X
three B-X
Œ±1 B-X
( B-X
III B-X
) B-X
chains B-X
and B-X
is B-X
expressed B-X
in B-X
early B-X
embryos B-X
and B-X
throughout B-X
embryogenesis B-X
. B-X
In B-X
the B-X
adult B-X
, B-X
type B-X
Lifespan B-X
extension B-X
and B-X
delayed B-X
immune B-X
and B-X
collagen B-X
aging B-X
in B-X
mutant B-X
mice B-X
with B-X
defects B-X
in B-X
growth B-X
hormone B-X
production B-X
| B-X
PNAS B-X
The B-X
first B-X
long-lived B-X
mutants B-X
: B-X
discovery B-X
of B-X
the B-X
insulin/IGF-1 B-X
pathway B-X
for B-X
ageing B-X
Human B-X
SOD1 B-X
ALS B-X
Mutations B-X
in B-X
a B-X
Drosophila B-X
Knock-In B-X
Model B-X
Cause B-X
Severe B-X
Phenotypes B-X
and B-X
Reveal B-X
Dosage-Sensitive B-X
Gain- B-X
and B-X
Loss-of-Function B-X
Components B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
| B-X
PNAS B-X

The	O
major	O
cause	O
of	O
death	O
of	O
mutant	O
mice	O
was	O
rupture	O
of	O
the	O
major	O
blood	O
vessels	O
,	O
similar	O
to	O
patients	O
with	O
type	B-Disease
IV	I-Disease
Ehlers	I-Disease
-	I-Disease
Danlos	I-Disease
syndrome	I-Disease
.	O
<EOS> B-X
Targetable B-X
cellular B-X
signaling B-X
events B-X
mediate B-X
vascular B-X
pathology B-X
in B-X
vascular B-X
Ehlers-Danlos B-X
syndrome B-X
Original B-X
Article B-X
from B-X
The B-X
New B-X
England B-X
Journal B-X
of B-X
Medicine B-X
‚Äî B-X
Clinical B-X
and B-X
Genetic B-X
Features B-X
of B-X
Ehlers‚ÄìDanlos B-X
Syndrome B-X
Type B-X
IV B-X
, B-X
the B-X
Vascular B-X
Type B-X
Purpose B-X
: B-X
To B-X
characterize B-X
the B-X
clinical B-X
outcome B-X
of B-X
heterozygosity B-X
for B-X
COL3A1 B-X
null B-X
mutations B-X
in B-X
Ehlers-Danlos B-X
syndrome B-X
type B-X
IV B-X
, B-X
the B-X
vascular B-X
type B-X
. B-X
Methods B-X
: B-X
We B-X
identified B-X
mutations B-X
that B-X
produced B-X
The B-X
FactsBooks B-X
Series B-X
has B-X
established B-X
itself B-X
as B-X
the B-X
best B-X
source B-X
of B-X
easily-accessible B-X
and B-X
accurate B-X
facts B-X
about B-X
protein B-X
groups B-X
. B-X
Described B-X
as B-X
`` B-X
a B-X
growing B-X
series B-X
of B-X
excellent B-X
manuals B-X
'' B-X
by B-X
The B-X
FactsBooks B-X
Series B-X
has B-X
established B-X
itself B-X
as B-X
the B-X
best B-X
source B-X
of B-X
easily-accessible B-X
and B-X
accurate B-X
facts B-X
about B-X
protein B-X
groups B-X
. B-X
Described B-X
as B-X
`` B-X
a B-X
growing B-X
series B-X
of B-X
excellent B-X
manuals B-X
'' B-X
by B-X

Ultrastructural	O
analysis	O
of	O
tissues	O
from	O
mutant	O
mice	O
revealed	O
that	O
type	O
III	O
collagen	O
is	O
essential	O
for	O
normal	O
collagen	O
I	O
fibrillogenesis	O
in	O
the	O
cardiovascular	O
system	O
and	O
other	O
organs	O
.	O
.	O
<EOS> B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
| B-X
PNAS B-X
Type B-X
III B-X
collagen B-X
is B-X
crucial B-X
for B-X
collagen B-X
I B-X
fibrillogenesis B-X
and B-X
for B-X
normal B-X
cardiovascular B-X
development B-X
| B-X
PNAS B-X
In B-X
vitro B-X
fibrillogenesis B-X
of B-X
tropocollagen B-X
type B-X
III B-X
in B-X
collagen B-X
type B-X
I B-X
affects B-X
its B-X
relative B-X
fibrillar B-X
topology B-X
and B-X
mechanics B-X
Type B-X
III B-X
collagen B-X
is B-X
a B-X
fibrillar B-X
forming B-X
collagen B-X
comprising B-X
three B-X
alpha1 B-X
( B-X
III B-X
) B-X
chains B-X
and B-X
is B-X
expressed B-X
in B-X
early B-X
embryos B-X
and B-X
throughout B-X
embryogenesis B-X
. B-X
In B-X
the B-X
adult B-X
, B-X
type B-X
Request B-X
PDF B-X
| B-X
Type B-X
III B-X
collagen B-X
affects B-X
dermal B-X
and B-X
vascular B-X
collagen B-X
fibrillogenesis B-X
and B-X
tissue B-X
integrity B-X
in B-X
a B-X
mutant B-X
Col3a1 B-X
transgenic B-X
mouse B-X
model B-X
| B-X
Type B-X
III B-X
collagen B-X
is B-X
a B-X
major B-X
fibrillar B-X
Type B-X
III B-X
collagen B-X
( B-X
COL3A1 B-X
) B-X
: B-X
Gene B-X
and B-X
protein B-X
structure B-X
, B-X
tissue B-X
distribution B-X
, B-X
and B-X
associated B-X
diseases B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Nonsense	O
mutation	O
in	O
exon	O
3	O
of	O
the	O
proteolipid	O
protein	O
gene	O
(	O
PLP	O
)	O
in	O
a	O
family	O
with	O
an	O
unusual	O
form	O
of	O
Pelizaeus	B-Disease
-	I-Disease
Merzbacher	I-Disease
disease	I-Disease
.	O
<EOS> B-X
NAA B-X
and B-X
Pelizaeus-Merzbacher B-X
disease B-X
| B-X
Neurology B-X
Pelizaeus-Merzbacher B-X
Disease B-X
and B-X
Spastic B-X
Paraplegia B-X
Type B-X
2 B-X
: B-X
Two B-X
Faces B-X
of B-X
Myelin B-X
Loss B-X
From B-X
Mutations B-X
in B-X
the B-X
Same B-X
Gene B-X
- B-X
Lynn B-X
D. B-X
Hudson B-X
, B-X
2003 B-X
Novel B-X
exon B-X
3B B-X
proteolipid B-X
protein B-X
gene B-X
mutation B-X
causing B-X
late‚Äêonset B-X
spastic B-X
paraplegia B-X
type B-X
2 B-X
with B-X
variable B-X
penetrance B-X
in B-X
female B-X
family B-X
members B-X
- B-X
Sivakumar B-X
- B-X
1999 B-X
- B-X
Annals B-X
of B-X
Neurology B-X
- B-X
Wiley B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X
A B-X
definitive B-X
, B-X
clinically B-X
oriented B-X
guide B-X
to B-X
the B-X
pathology B-X
of B-X
genetics B-X
of B-X
developmental B-X
neuropathology B-X
Developmental B-X
neuropathology B-X
relates B-X
to B-X
the B-X
wide B-X
range B-X
of B-X
disorders B-X
affecting B-X
the B-X
developing B-X
brain B-X
or B-X
pre- B-X
and B-X

We	O
report	O
a	O
G	O
-	O
-	O
>	O
A	O
transition	O
at	O
nucleotide	O
431	O
of	O
the	O
proteolipid	O
protein	O
gene	O
(	O
PLP	O
)	O
results	O
in	O
a	O
nonsense	O
codon	O
in	O
a	O
family	O
with	O
an	O
unusual	O
form	O
of	O
Pelizaeus	B-Disease
-	I-Disease
Merzbacher	I-Disease
disease	I-Disease
(	O
PMD	B-Disease
)	O
.	O
<EOS> B-X
Download B-X
Citation B-X
| B-X
Pelizaeus‚ÄìMerzbacher B-X
Disease B-X
| B-X
Pelizaeus-Merzbacher B-X
disease B-X
( B-X
PMD B-X
) B-X
is B-X
an B-X
X-linked B-X
dysmyeli-nating B-X
disorder B-X
of B-X
the B-X
central B-X
nervous B-X
system B-X
( B-X
CNS B-X
) B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
... B-X
Request B-X
PDF B-X
| B-X
Preimplantation B-X
genetic B-X
diagnosis B-X
for B-X
Pelizaeus-Merzbacher B-X
disease B-X
with B-X
testing B-X
for B-X
age-related B-X
aneuploidies B-X
| B-X
Pelizaeus-Merzbacher B-X
disease B-X
( B-X
PMD B-X
) B-X
is B-X
an B-X
X-linked B-X
recessive B-X
demyelinating B-X
disorder B-X
of B-X
the B-X
central B-X
nervous B-X

The	O
mutation	O
,	O
which	O
creates	O
a	O
second	O
AluI	O
restriction	O
site	O
,	O
results	O
in	O
a	O
nonsense	O
mutation	O
in	O
PLP	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Differences B-X
in B-X
endoplasmic-reticulum B-X
quality B-X
control B-X
determine B-X
the B-X
cellular B-X
response B-X
to B-X
disease-associated B-X
mutants B-X
of B-X
proteolipid B-X
protein B-X
| B-X
Missense B-X
mutations B-X
in B-X
human B-X
PLP1 B-X
, B-X
the B-X
gene B-X
encoding B-X
myelin B-X
proteolipid B-X

The	O
clinical	O
picture	O
resembles	O
somewhat	O
that	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
spastic	I-Disease
paraplegia	I-Disease
(	O
SPG	B-Disease
)	O
.	O
<EOS> B-X
The B-X
purpose B-X
of B-X
this B-X
overview B-X
is B-X
to B-X
increase B-X
the B-X
awareness B-X
of B-X
clinicians B-X
regarding B-X
hereditary B-X
spastic B-X
paraplegia B-X
. B-X
Hereditary B-X
spastic B-X
paraplegia B-X
: B-X
a B-X
clinical B-X
and B-X
epidemiological B-X
study B-X
of B-X
a B-X
Brazilian B-X
pediatric B-X
population B-X
X B-X
linked B-X
hereditary B-X
spastic B-X
paraplegia B-X
is B-X
a B-X
rare B-X
condition B-X
that B-X
has B-X
been B-X
divided B-X
into B-X
two B-X
forms B-X
( B-X
the B-X
pure B-X
spastic B-X
form B-X
and B-X
the B-X
complicated B-X
form B-X
) B-X
as B-X
a B-X
function B-X
of B-X
Spastic B-X
Paraplegia B-X
is B-X
a B-X
group B-X
of B-X
inherited B-X
neurological B-X
diseases B-X
whose B-X
main B-X
feature B-X
is B-X
progressive B-X
spasticity B-X
in B-X
the B-X
lower B-X
limbs B-X
as B-X
a B-X
result B-X
of B-X
neuronal B-X
dysfunction B-X
. B-X
Read B-X
more B-X
about B-X
diagnostics B-X

It	O
differs	O
from	O
this	O
and	O
both	O
the	O
classical	O
and	O
connatal	O
forms	O
of	O
PMD	B-Disease
in	O
that	O
it	O
is	O
relatively	O
mild	O
in	O
form	O
,	O
onset	O
is	O
delayed	O
beyond	O
age	O
2	O
years	O
,	O
nystagmus	B-Disease
is	O
absent	O
,	O
tremors	B-Disease
are	O
prominent	O
,	O
mental	B-Disease
retardation	I-Disease
is	O
not	O
severe	O
,	O
some	O
patients	O
show	O
dementia	B-Disease
or	O
personality	B-Disease
disorders	I-Disease
,	O
the	O
disease	O
is	O
progressive	O
rather	O
than	O
static	O
in	O
some	O
,	O
and	O
several	O
females	O
show	O
signs	O
of	O
disease	O
.	O
<EOS> B-X
Evaluation B-X
of B-X
the B-X
infant B-X
or B-X
child B-X
with B-X
infantile B-X
nystagmus B-X
syndrome B-X
( B-X
INS B-X
) B-X
is B-X
very B-X
challenging B-X
because B-X
INS B-X
can B-X
be B-X
an B-X
isolated B-X
abnormality B-X
or B-X
appear B-X
in B-X
associatio B-X
Congenital B-X
or B-X
infantile B-X
nystagmus B-X
is B-X
a B-X
clinical B-X
sign B-X
that B-X
may B-X
take B-X
many B-X
different B-X
forms B-X
. B-X
Involuntary B-X
, B-X
rhythmic B-X
eye B-X
movements B-X
are B-X
characteristic B-X
, B-X
as B-X
they B-X
are B-X
in B-X
acquired B-X
nystagmus B-X
. B-X
Nystagmus B-X
in B-X
pediatric B-X
patients B-X
: B-X
interventions B-X
and B-X
patient-focused B-X
perspectives B-X
Nystagmus B-X
is B-X
clinically B-X
described B-X
based B-X
on B-X
amplitude B-X
, B-X
frequency B-X
, B-X
and B-X
direction B-X
of B-X
oscillations B-X
. B-X
It B-X
can B-X
be B-X
broadly B-X
classified B-X
as B-X
physiologic B-X
or B-X
pathologic B-X
. B-X
Excep B-X
People B-X
can B-X
sometimes B-X
miss B-X
the B-X
early B-X
signs B-X
and B-X
symptoms B-X
of B-X
Parkinson B-X
's B-X
disease B-X
, B-X
as B-X
they B-X
can B-X
be B-X
subtle B-X
and B-X
sporadic B-X
. B-X
In B-X
this B-X
article B-X
, B-X
we B-X
look B-X
at B-X
13 B-X
Read B-X
about B-X
motor B-X
neurone B-X
disease B-X
( B-X
MND B-X
) B-X
, B-X
a B-X
rare B-X
condition B-X
where B-X
parts B-X
of B-X
the B-X
nervous B-X
system B-X
become B-X
damaged B-X
. B-X
This B-X
causes B-X
progressive B-X
weakness B-X
, B-X
usually B-X
with B-X
muscle B-X
wasting B-X
Nystagmus B-X
can B-X
be B-X
difficult B-X
to B-X
categorize B-X
, B-X
especially B-X
since B-X
the B-X
spectrum B-X
of B-X
this B-X
eye B-X
movement B-X
encompasses B-X
both B-X
normal B-X
physiology B-X
and B-X
serious B-X
( B-X
sometimes B-X
rare B-X
) B-X
und B-X

The	O
nonsense	O
mutation	O
,	O
which	O
is	O
in	O
exon	O
3B	O
,	O
should	O
block	O
the	O
synthesis	O
of	O
normal	O
PLP	O
but	O
spare	O
DM20	O
,	O
the	O
isoform	O
whose	O
persistence	O
has	O
been	O
associated	O
with	O
mild	O
forms	O
of	O
PLP	B-Disease
-	I-Disease
associated	I-Disease
disease	I-Disease
in	O
both	O
humans	O
and	O
mice	O
.	O
.	O
<EOS> B-X
The B-X
mdx B-X
mouse B-X
, B-X
which B-X
carries B-X
a B-X
nonsense B-X
mutation B-X
in B-X
exon B-X
23 B-X
of B-X
the B-X
dystrophin B-X
gene B-X
, B-X
has B-X
been B-X
used B-X
as B-X
an B-X
animal B-X
model B-X
of B-X
Duchenne B-X
muscular B-X
dystrophy B-X
to B-X
evaluate B-X
We B-X
report B-X
a B-X
G B-X
-- B-X
> B-X
A B-X
transition B-X
at B-X
nucleotide B-X
431 B-X
of B-X
the B-X
proteolipid B-X
protein B-X
gene B-X
( B-X
PLP B-X
) B-X
results B-X
in B-X
a B-X
nonsense B-X
codon B-X
in B-X
a B-X
family B-X
with B-X
an B-X
unusual B-X
An B-X
exonic B-X
missense B-X
mutation B-X
, B-X
c.436C B-X
> B-X
G B-X
, B-X
in B-X
the B-X
PLP1 B-X
gene B-X
of B-X
a B-X
patient B-X
affected B-X
by B-X
the B-X
hypomyelinating B-X
leukodystrophy B-X
, B-X
Pelizaeus‚ÄìMerzbacher B-X
disease B-X
, B-X
has B-X
previously B-X
been B-X
found B-X
to B-X
Request B-X
PDF B-X
| B-X
A B-X
PLP B-X
splicing B-X
abnormality B-X
is B-X
associated B-X
with B-X
an B-X
unusual B-X
presentation B-X
of B-X
PMD B-X
| B-X
We B-X
report B-X
that B-X
a B-X
deletion B-X
of B-X
19 B-X
base B-X
pairs B-X
( B-X
bp B-X
) B-X
in B-X
intron B-X
Restoration B-X
of B-X
the B-X
Normal B-X
Splicing B-X
Pattern B-X
of B-X
the B-X
PLP1 B-X
Gene B-X
by B-X
Means B-X
of B-X
an B-X
Antisense B-X
Oligonucleotide B-X
Directed B-X
against B-X
an B-X
Exonic B-X
Mutation B-X
Nonsense B-X
mutation B-X
in B-X
exon B-X
3 B-X
of B-X
the B-X
proteolipid B-X
protein B-X
gene B-X
( B-X
PLP B-X
) B-X
in B-X
a B-X
family B-X
with B-X
an B-X
unusual B-X
form B-X
of B-X
Pelizaeus‚ÄêMerzbacher B-X
disease B-X
- B-X
Hodes B-X
- B-X
1997 B-X
- B-X
American B-X
Journal B-X
Request B-X
PDF B-X
| B-X
Myelin B-X
defects B-X
in B-X
PLP-null B-X
mice B-X
| B-X
This B-X
study B-X
explores B-X
subtle B-X
defects B-X
in B-X
the B-X
myelin B-X
of B-X
proteolipid B-X
protein B-X
( B-X
PLP B-X
) B-X
-null B-X
mice B-X
that B-X
could B-X
potentially B-X
underlie B-X
the B-X

Common	O
BRCA1	O
variants	O
and	O
susceptibility	O
to	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
in	O
the	O
general	O
population	O
.	O
<EOS> B-X
Prevalence B-X
and B-X
spectrum B-X
of B-X
BRCA B-X
germline B-X
variants B-X
in B-X
mainland B-X
Chinese B-X
familial B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
patients B-X
Classification B-X
of B-X
BRCA1 B-X
missense B-X
variants B-X
of B-X
unknown B-X
clinical B-X
significance B-X

Most	O
multiple	O
case	O
families	O
of	O
young	O
onset	O
breast	B-Disease
cancer	I-Disease
and	O
ovarian	B-Disease
cancer	I-Disease
are	O
thought	O
to	O
be	O
due	O
to	O
highly	O
penetrant	O
mutations	O
in	O
the	O
predisposing	O
genes	O
BRCA1	O
and	O
BRCA2	O
.	O
<EOS> B-X
Breast B-X
cancer B-X
results B-X
from B-X
genetic B-X
and B-X
environmental B-X
factors B-X
leading B-X
to B-X
the B-X
accumulation B-X
of B-X
mutations B-X
in B-X
essential B-X
genes B-X
. B-X
Genetic B-X
predisposition B-X
may B-X
have B-X
a B-X
strong B-X
, B-X
almost B-X
singular B-X
effect B-X
, B-X
as B-X

However	O
,	O
these	O
mutations	O
are	O
uncommon	O
in	O
the	O
population	O
and	O
they	O
probably	O
account	O
for	O
only	O
a	O
few	O
percent	O
of	O
all	O
breast	B-Disease
cancer	I-Disease
incidence	O
.	O
<EOS> B-X
What B-X
role B-X
do B-X
inherited B-X
mutations B-X
, B-X
such B-X
as B-X
the B-X
BRCA B-X
mutation B-X
, B-X
play B-X
in B-X
breast B-X
cancer B-X
? B-X
This B-X
post B-X
explores B-X
testing B-X
for B-X
genetic B-X
mutations B-X
. B-X
Since B-X
the B-X
advent B-X
of B-X
high-throughput B-X
sequencing B-X
technologies B-X
, B-X
organised B-X
germline B-X
screening B-X
, B-X
independent B-X
of B-X
personal B-X
and B-X
family B-X
cancer B-X
history B-X
, B-X
has B-X
been B-X
frequently B-X
proposed B-X
. B-X
A B-X
critical B-X
prerequisite B-X
is B-X
knowledge B-X

A	O
much	O
larger	O
fraction	O
of	O
breast	B-Disease
cancer	I-Disease
might	O
,	O
in	O
principle	O
,	O
be	O
due	O
to	O
common	O
variants	O
which	O
confer	O
more	O
modest	O
individual	O
risks	O
.	O
<EOS> B-X
Polygenic B-X
susceptibility B-X
to B-X
breast B-X
cancer B-X
: B-X
current B-X
state-of-the-art B-X
One B-X
of B-X
the B-X
most B-X
important B-X
risk B-X
factors B-X
for B-X
breast B-X
cancer B-X
is B-X
family B-X
history B-X
of B-X
the B-X
disease B-X
, B-X
indicating B-X
that B-X
genetic B-X
factors B-X
are B-X
important B-X
determinants B-X
of B-X
breast B-X
cancer B-X
risk B-X
. B-X
A B-X
Despite B-X
thousands B-X
of B-X
genetic B-X
loci B-X
identified B-X
to B-X
date B-X
, B-X
a B-X
large B-X
proportion B-X
of B-X
genetic B-X
variation B-X
predisposing B-X
to B-X
complex B-X
disease B-X
and B-X
traits B-X
remains B-X
unaccounted B-X
for B-X
. B-X
Advances B-X
in B-X
sequencing B-X
technology B-X
enable B-X
The B-X
Genetics B-X
of B-X
Cancer B-X
Risk B-X
Common B-X
and B-X
rare B-X
variants B-X
in B-X
multifactorial B-X
susceptibility B-X
to B-X
common B-X
diseases B-X
Genetic B-X
Variation B-X
and B-X
its B-X
Role B-X
in B-X
Malignancy B-X
Genome-Wide B-X
Association B-X
Studies B-X
of B-X
Cancer B-X

There	O
are	O
several	O
common	O
polymorphisms	O
in	O
the	O
BRCA1	O
gene	O
which	O
generate	O
amino	O
acid	O
substitutions	O
.	O
<EOS> B-X
Next-generation B-X
sequencing B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
in B-X
breast B-X
cancer B-X
patients B-X
and B-X
control B-X
subjects B-X
Common B-X
variants B-X
in B-X
the B-X
ATM B-X
, B-X
BRCA1 B-X
, B-X
BRCA2 B-X
, B-X
CHEK2 B-X
and B-X
TP53 B-X
cancer B-X
susceptibility B-X
genes B-X
are B-X
unlikely B-X
to B-X
increase B-X
breast B-X
cancer B-X
risk B-X
Determination B-X
of B-X
Cancer B-X
Risk B-X
Associated B-X
with B-X
Germ B-X
Line B-X
BRCA1 B-X
Missense B-X
Variants B-X
by B-X
Functional B-X
Analysis B-X

We	O
have	O
examined	O
the	O
frequency	O
of	O
four	O
of	O
these	O
polymorphisms	O
Gln356Arg	O
,	O
Pro871Leu	O
,	O
Glu1038Gly	O
and	O
Ser1613Gly	O
in	O
large	O
series	O
of	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
cases	O
and	O
matched	O
controls	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Most B-X
multiple B-X
case B-X
families B-X
of B-X
young B-X
onset B-X
breast B-X
cancer B-X
and B-X
ovarian B-X
cancer B-X
are B-X
thought B-X
to B-X
be B-X
due B-X
to B-X
highly B-X
penetrant B-X
mutations B-X
in B-X
the B-X
predisposing B-X
ge B-X
Missense B-X
Polymorphisms B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
and B-X
Risk B-X
of B-X
Breast B-X
and B-X
Ovarian B-X
Cancer B-X
| B-X
Cancer B-X
Epidemiology B-X
, B-X
Biomarkers B-X
& B-X
Prevention B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Gene B-X
Mutations B-X
Screening B-X
In B-X
Sporadic B-X
Breast B-X
Cancer B-X
Patients B-X
In B-X
Kazakhstan B-X
PDF B-X
| B-X
Background B-X
: B-X
BRCA1 B-X
and B-X
BRCA2 B-X
germline B-X
mutations B-X
predispose B-X
heterozygous B-X
carriers B-X
to B-X
hereditary B-X
breast/ovarian B-X
cancer B-X
. B-X
However B-X
, B-X
unclassified B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X

Due	O
to	O
strong	O
linkage	O
disequilibrium	O
,	O
these	O
four	O
sites	O
generate	O
only	O
three	O
haplotypes	O
with	O
a	O
frequency	O
>	O
1	O
.	O
<EOS> B-X
Gene B-X
Linkage B-X
Disequilibrium B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Linkage B-X
Disequilibrium B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Linkage B-X
Disequilibrium B-X
and B-X
Recent B-X
Selection B-X
at B-X
Three B-X
Immunity B-X
Receptor B-X
Loci B-X
in B-X
Drosophila B-X
simulans B-X
Many B-X
genetic B-X
studies B-X
of B-X
disease B-X
association B-X
rely B-X
heavily B-X
on B-X
linkage B-X
disequilibrium B-X
( B-X
LD B-X
) B-X
patterns B-X
between B-X
pairs B-X
of B-X
markers B-X
to B-X
detect B-X
susceptibility B-X
markers B-X
. B-X
This B-X
is B-X
true B-X
of B-X
large-scale B-X
positional B-X

3	O
%	O
.	O
<EOS> B-X
Log B-X
in B-X
to B-X
My3 B-X
The B-X
world B-X
‚Äô B-X
s B-X
most B-X
sustainable B-X
smartphones B-X
, B-X
made B-X
with B-X
care B-X
for B-X
people B-X
and B-X
planet B-X
. B-X
Discover B-X
the B-X
right B-X
phone B-X
for B-X
you B-X
. B-X
Smarandache B-X
Function B-X
, B-X
Vol B-X
. B-X
2-3 B-X
- B-X
Google B-X
Âõæ‰π¶ B-X
three.com.mo B-X
3GÊæ≥ÈñÄ B-X
Kelley B-X
Wingate B-X
's B-X
Math B-X
Practice B-X
for B-X
third B-X
grade B-X
is B-X
designed B-X
to B-X
help B-X
students B-X
master B-X
basic B-X
math B-X
skills B-X
through B-X
focused B-X
math B-X
practice B-X
. B-X
Practice B-X
pages B-X
will B-X
be B-X
leveled B-X
in B-X
order B-X
to B-X
3HK B-X
. B-X
144,421 B-X
Ê¨°Ëµû B-X
. B-X
3 B-X
È¶ôÊ∏ØÊòØÔ¶¥ÂÖàÁöÑÔßäÂãïÈÄöË®äÊúçÂãôÁáüËæ¶ÂïÜ B-X
3 B-X
( B-X
ÈõªË®ä B-X
) B-X
- B-X
Áª¥Âü∫ÁôæÁßëÔºåËá™Áî±ÁöÑÁôæÁßëÂÖ®‰π¶ B-X

The	O
most	O
common	O
haplotypes	O
,	O
defined	O
by	O
the	O
alleles	O
Gln356Pro871Glu1038Ser1613	O
and	O
Gln356Leu871Gly1038Gly1613	O
,	O
have	O
frequencies	O
of	O
0	O
.	O
<EOS> B-X
Twenty B-X
alleles B-X
for B-X
the B-X
locus B-X
human B-X
leukocyte B-X
antigen B-X
( B-X
HLA-A B-X
) B-X
and B-X
46 B-X
for B-X
the B-X
HLA-B B-X
locus B-X
were B-X
detected B-X
in B-X
Jordanians B-X
. B-X
This B-X
indicates B-X
the B-X
existence B-X
of B-X
high B-X
polymorphism B-X
in B-X
A B-X
PCR-based B-X
SSO-assay B-X
has B-X
been B-X
developed B-X
to B-X
characterize B-X
the B-X
allelic B-X
polymorphism B-X
at B-X
the B-X
HLA-DPA1 B-X
locus B-X
. B-X
To B-X
validate B-X
the B-X
performance B-X
of B-X
this B-X
assay B-X
, B-X
77 B-X
samples B-X
were B-X
typed B-X
side B-X
by B-X
Understanding B-X
population-wide B-X
haplotype B-X
frequencies B-X
of B-X
human B-X
leukocyte B-X
antigen B-X
( B-X
HLA B-X
) B-X
alleles B-X
in B-X
linkage B-X
disequilibrium B-X
is B-X
important B-X
for B-X
hematopoietic B-X
stem B-X
cell B-X
transplantation B-X
The B-X
immune B-X
responses B-X
of B-X
natural B-X
killer B-X
cells B-X
are B-X
regulated B-X
, B-X
in B-X
part B-X
, B-X
by B-X
killer B-X
cell B-X
immunoglobulin-like B-X
receptors B-X
( B-X
KIR B-X
) B-X
. B-X
The B-X
16 B-X
closely-related B-X
genes B-X
in B-X
the B-X
KIR B-X
gene B-X

57	O
and	O
0	O
.	O
<EOS> B-X
Piperonal B-X
Functional B-X
use B-X
( B-X
s B-X
) B-X
- B-X
cosmetic B-X
, B-X
flavor B-X
and B-X
fragrance B-X
agents B-X
. B-X
Has B-X
a B-X
floral B-X
type B-X
odor B-X
and B-X
an B-X
cherry B-X
type B-X
flavor B-X
. B-X
Cysteamine B-X
Hydrochloride B-X
, B-X
CAS B-X
: B-X
156-57-0 B-X
, B-X
is B-X
an B-X
antioxidant B-X
and B-X
an B-X
inhibitor B-X
of B-X
DMBA-induced B-X
tumors B-X
. B-X
Cited B-X
in B-X
2 B-X
publications B-X
Buy B-X
Tetramethylammonium B-X
chloride B-X
( B-X
CAS B-X
75-57-0 B-X
) B-X
, B-X
a B-X
biochemical B-X
for B-X
proteomics B-X
research B-X
, B-X
from B-X
Santa B-X
Cruz B-X
. B-X
Purity B-X
: B-X
‚â•99 B-X
% B-X
, B-X
MF B-X
: B-X
C4H12ClN B-X
, B-X
MW B-X
: B-X
109.60 B-X
- B-X
The B-X
Washington B-X
Post B-X
Cysteamine B-X
hydrochloride B-X
( B-X
2-Amino¬≠ethane¬≠thiol B-X
) B-X
; B-X
> B-X
= B-X
98 B-X
% B-X
titration B-X
; B-X
Cysteamine B-X
derived B-X
from B-X
cysteine B-X
degradation B-X
is B-X
the B-X
simplest B-X
stable B-X
aminothiol B-X
; B-X
This B-X
compound B-X
is B-X
also B-X
offered B-X
as B-X
part B-X

32	O
respectively	O
,	O
and	O
these	O
frequencies	O
do	O
not	O
differ	O
significantly	O
between	O
patient	O
and	O
control	O
groups	O
.	O
<EOS> B-X
Estimating B-X
the B-X
Size B-X
of B-X
Treatment B-X
Effects B-X
Efficacy B-X
of B-X
faecal B-X
microbiota B-X
transplantation B-X
for B-X
patients B-X
with B-X
irritable B-X
bowel B-X
syndrome B-X
in B-X
a B-X
randomised B-X
, B-X
double-blind B-X
, B-X
placebo-controlled B-X
study B-X
| B-X
Gut B-X
Tight B-X
Glycemic B-X
Control B-X
in B-X
Critically B-X
Ill B-X
Children B-X
The B-X
Benefits B-X
of B-X
Exercise B-X
for B-X
the B-X
Clinically B-X
Depressed B-X
Pharmacotherapy B-X
for B-X
Post-traumatic B-X
Stress B-X
Disorder B-X
In B-X
Combat B-X
Veterans B-X
This B-X
study B-X
analyzed B-X
morphometric B-X
and B-X
hemodynamic B-X
parameters B-X
of B-X
aneurysmal B-X
and B-X
non-aneurysmal B-X
middle B-X
cerebral B-X
artery B-X
( B-X
MCA B-X
) B-X
bifurcations B-X
and B-X
their B-X
relationship B-X
with B-X
optimal B-X
values B-X
derived B-X
from B-X
the B-X
principle B-X
of B-X
minimum B-X
Frequency B-X
of B-X
Binge B-X
Eating B-X
Episodes B-X
in B-X
Bulimia B-X
Nervosa B-X
and B-X
Binge B-X
Eating B-X
Disorder B-X
: B-X
Diagnostic B-X
Considerations B-X

Thus	O
the	O
most	O
common	O
polymorphisms	O
of	O
the	O
BRCA1	O
gene	O
do	O
not	O
make	O
a	O
significant	O
contribution	O
to	O
breast	B-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
risk	O
.	O
<EOS> B-X
The B-X
association B-X
between B-X
BRCA1 B-X
gene B-X
polymorphism B-X
and B-X
cancer B-X
risk B-X
: B-X
a B-X
meta-analysis B-X
Most B-X
multiple B-X
case B-X
families B-X
of B-X
young B-X
onset B-X
breast B-X
cancer B-X
and B-X
ovarian B-X
cancer B-X
are B-X
thought B-X
to B-X
be B-X
due B-X
to B-X
highly B-X
penetrant B-X
mutations B-X
in B-X
the B-X
predisposing B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
. B-X
However B-X
PDF B-X
| B-X
Most B-X
multiple B-X
case B-X
families B-X
of B-X
young B-X
onset B-X
breast B-X
cancer B-X
and B-X
ovarian B-X
cancer B-X
are B-X
thought B-X
to B-X
be B-X
due B-X
to B-X
highly B-X
penetrant B-X
mutations B-X
in B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X

However	O
,	O
our	O
data	O
suggest	O
that	O
the	O
Arg356	O
allele	O
may	O
have	O
a	O
different	O
genotype	O
distribution	O
in	O
breast	B-Disease
cancer	I-Disease
patients	O
from	O
that	O
in	O
controls	O
(	O
Arg356	O
homozygotes	O
are	O
more	O
frequent	O
in	O
the	O
control	O
groups	O
,	O
P	O
=	O
0	O
.	O
01	O
)	O
,	O
indicating	O
that	O
it	O
may	O
be	O
protective	O
against	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
The B-X
present B-X
meta-analysis B-X
indicates B-X
that B-X
consumption B-X
of B-X
apples B-X
is B-X
associated B-X
with B-X
a B-X
reduced B-X
risk B-X
of B-X
cancer B-X
in B-X
different B-X
anatomical B-X
sites B-X
. B-X
To B-X
date B-X
, B-X
the B-X
epidemiological B-X
data B-X
indicates B-X
that B-X
consumption B-X
of B-X
5 B-X
or B-X
more B-X
cups B-X
of B-X
green B-X
tea B-X
a B-X
day B-X
shows B-X
a B-X
non-statistically B-X
significant B-X
trend B-X
towards B-X
the B-X
prevention B-X
of B-X
breast B-X
cancer B-X
Vegetarian B-X
dietary B-X
patterns B-X
and B-X
the B-X
risk B-X
of B-X
breast B-X
cancer B-X
in B-X
a B-X
low-risk B-X
population B-X
Dietary B-X
Mushroom B-X
Intake B-X
May B-X
Reduce B-X
the B-X
Risk B-X
of B-X
Breast B-X
Cancer B-X
: B-X
Evidence B-X
from B-X
a B-X
Meta-Analysis B-X
of B-X
Observational B-X
Studies B-X
Request B-X
PDF B-X
| B-X
Haplotype B-X
analysis B-X
of B-X
common B-X
variants B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
and B-X
risk B-X
of B-X
sporadic B-X
breast B-X
cancer B-X
| B-X
Truncation B-X
mutations B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
cause B-X
a B-X
substantial B-X
increase B-X
in B-X
Strong B-X
epidemiologic B-X
evidence B-X
documents B-X
the B-X
protective B-X
effect B-X
of B-X
physical B-X
activity B-X
on B-X
breast B-X
cancer B-X
risk B-X
, B-X
recurrence B-X
, B-X
and B-X
mortality B-X
, B-X
but B-X
the B-X
underlying B-X
mechanisms B-X
remain B-X
to B-X
be B-X
identified B-X
. B-X
Using B-X
Green B-X
tea B-X
compounds B-X
in B-X
breast B-X
cancer B-X
prevention B-X
and B-X
treatment B-X

If	O
this	O
finding	O
can	O
be	O
confirmed	O
,	O
it	O
may	O
provide	O
an	O
insight	O
into	O
the	O
structural	O
features	O
of	O
the	O
BRCA1	O
protein	O
that	O
are	O
important	O
for	O
its	O
function	O
.	O
<EOS> B-X
Structural B-X
analysis B-X
of B-X
BRCA1 B-X
reveals B-X
modification B-X
hotspot B-X
Mechanisms B-X
of B-X
BRCA1 B-X
Tumor B-X
Suppression B-X
BRCA1 B-X
and B-X
BRCA2 B-X
are B-X
breast B-X
cancer B-X
susceptibility B-X
genes B-X
. B-X
Mutations B-X
within B-X
BRCA1 B-X
and B-X
BRCA1 B-X
are B-X
responsible B-X
for B-X
most B-X
familial B-X
breast B-X
cancer B-X
cases B-X
. B-X
Targeted B-X
deletion B-X
of B-X
Brca1 B-X
or B-X
Brca2 B-X
in B-X
FUNCTIONAL B-X
ANALYSIS B-X
OF B-X
BRCA1 B-X
C-TERMINAL B-X
MISSENSE B-X
MUTATIONS B-X
IDENTIFIED B-X
IN B-X
BREAST B-X
AND B-X
OVARIAN B-X
CANCER B-X
FAMILIES B-X

Kniest	B-Disease
dysplasia	I-Disease
:	O
Dr	O
.	O
W	O
.	O
<EOS> B-X
Kniest B-X
dysplasia B-X
: B-X
Dr. B-X
W. B-X
Kniest B-X
, B-X
his B-X
patient B-X
, B-X
the B-X
molecular B-X
defect B-X
- B-X
Spranger B-X
- B-X
1997 B-X
- B-X
American B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Kniest B-X
dysplasia B-X
is B-X
an B-X
extremely B-X
rare B-X
disorder B-X
of B-X
bone B-X
growth B-X
that B-X
leads B-X
to B-X
short B-X
stature B-X
, B-X
malformed B-X
bones B-X
and B-X
joints B-X
, B-X
and B-X
skeletal B-X
abnormalities B-X
. B-X
Megalophthalmos B-X
, B-X
cleft B-X
plate B-X
and B-X
midfacial B-X
hypoplasia B-X
in B-X
a B-X
4 B-X
months B-X
old B-X
female B-X
with B-X
short-trunk B-X
dwarfism B-X
, B-X
consistent B-X
with B-X
Kniest B-X
dysplasia B-X
( B-X
a B-X
rare B-X
type B-X
of B-X
skeletal B-X
dysplasia B-X
) B-X
. B-X
Kniest B-X
dysplasia B-X
is B-X
rare B-X
type B-X
of B-X
short B-X
limbed B-X
skeletal B-X
dysplasia B-X
. B-X
Pathology B-X
Genetics B-X
It B-X
is B-X
thought B-X
to B-X
carry B-X
an B-X
autosomal B-X
dominant B-X
inheritance B-X
. B-X
Kniest B-X
dysplasia B-X
is B-X
one B-X
of B-X
a B-X
spectrum B-X
Kniest B-X
Dysplasia B-X
in B-X
a B-X
Girl B-X
Aged B-X
6 B-X
Years B-X
, B-X
Petrasova B-X
Sarka B-X
, B-X
Zemkova B-X
Daniela B-X
, B-X
Marik B-X
Ivo B-X
, B-X
Mortier B-X
Geert B-X
R B-X
and B-X
Kozlowski B-X
Kazimierz B-X
In B-X
1952 B-X
, B-X
Kniest B-X
( B-X
1952 B-X
) B-X
described B-X
an B-X
unusual B-X
form B-X
of B-X
disproportional B-X
dwarfism B-X
, B-X
called B-X
‚Äú B-X
atypical B-X
chondrodystrophy. B-X
‚Äù B-X
Kniest B-X
dysplasia B-X
is B-X
a B-X
type B-X
II B-X
collagenopathy B-X
with B-X
characteristic B-X
clinical B-X
The B-X
portal B-X
for B-X
rare B-X
diseases B-X
and B-X
orphan B-X
drugs B-X

Kniest	O
,	O
his	O
patient	O
,	O
the	O
molecular	O
defect	O
.	O
<EOS> B-X
Kniest B-X
dysplasia B-X
Dr. B-X
W. B-X
Kniest B-X
his B-X
patient B-X
the B-X
molecular B-X
defect B-X
Kniest B-X
Dysplasia B-X
disease B-X
: B-X
Malacards B-X
- B-X
Research B-X
Articles B-X
, B-X
Drugs B-X
, B-X
Genes B-X
, B-X
Clinical B-X
Trials B-X
Kniest B-X
Dysplasia B-X
- B-X
NORD B-X
( B-X
National B-X
Organization B-X
for B-X
Rare B-X
Disorders B-X
) B-X
Kniest B-X
and B-X
Stickler B-X
dysplasia B-X
are B-X
two B-X
chondrodysplasias B-X
characterized B-X
by B-X
specific B-X
phenotypes B-X
. B-X
No B-X
basic B-X
defect B-X
has B-X
been B-X
found B-X
in B-X
patients B-X
with B-X
Kniest B-X
dysplasia B-X
, B-X
whereas B-X
Stickler B-X
dysplasia B-X
is B-X
one B-X
of B-X
Orthodontic B-X
Treatment B-X
in B-X
a B-X
Patient B-X
With B-X
Kniest B-X
Dysplasia B-X
: B-X
A B-X
Case B-X
Study B-X
and B-X
Review B-X
of B-X
Literature B-X
- B-X
Tania B-X
Jhamb B-X
, B-X
Hayat B-X
Masood B-X
, B-X
Jeffrey B-X
Arigo B-X
, B-X
P. B-X
Emile B-X
Rossouw B-X
, B-X
Kniest B-X
dysplasia B-X
is B-X
a B-X
type B-X
of B-X
chondrodysplasia B-X
characterized B-X
by B-X
severe B-X
craniofacial B-X
abnormalities B-X
including B-X
tracheomalacia B-X
, B-X
midface B-X
hypoplasia B-X
, B-X
and B-X
cleft B-X
palate B-X
. B-X
We B-X
previously B-X
described B-X
a B-X
6-year-old B-X
girl B-X
with B-X
Kniest B-X
To B-X
study B-X
the B-X
variability B-X
of B-X
the B-X
ophthalmic B-X
phenotype B-X
in B-X
Kniest B-X
dysplasia B-X
. B-X
Kniest B-X
dysplasia B-X
is B-X
an B-X
inherited B-X
disorder B-X
associated B-X
with B-X
defects B-X
in B-X
type B-X
II B-X
collagen B-X
and B-X
characterised B-X
by B-X
short-trunked B-X
dwarfism B-X

Kniest	B-Disease
dysplasia	I-Disease
is	O
a	O
severe	O
chondrodysplasia	B-Disease
caused	O
by	O
the	O
defective	B-Disease
formation	I-Disease
of	I-Disease
type	I-Disease
II	I-Disease
collagen	I-Disease
.	O
<EOS> B-X
Kniest B-X
Syndrome B-X
| B-X
Syndromes B-X
: B-X
Rapid B-X
Recognition B-X
and B-X
Perioperative B-X
Implications B-X
| B-X
AccessAnesthesiology B-X
| B-X
McGraw-Hill B-X
Medical B-X

We	O
report	O
about	O
Dr	O
.	O
Kniest	O
,	O
who	O
first	O
described	O
the	O
condition	O
in	O
1952	O
,	O
and	O
his	O
patient	O
,	O
who	O
,	O
at	O
the	O
age	O
of	O
50	O
years	O
is	O
severely	B-Disease
handicapped	I-Disease
with	O
short	B-Disease
stature	I-Disease
,	O
restricted	B-Disease
joint	I-Disease
mobility	I-Disease
,	O
and	O
blindness	B-Disease
but	O
is	O
mentally	O
alert	O
and	O
leads	O
an	O
active	O
life	O
.	O
<EOS> B-X
Kniest B-X
dysplasia B-X
is B-X
a B-X
severe B-X
chondrodysplasia B-X
caused B-X
by B-X
the B-X
defective B-X
formation B-X
of B-X
type B-X
II B-X
collagen B-X
. B-X
We B-X
report B-X
about B-X
Dr. B-X
Kniest B-X
, B-X
who B-X
first B-X
described B-X
the B-X
condition B-X
in B-X
1952 B-X
, B-X
Information B-X
for B-X
people B-X
with B-X
vision B-X
loss B-X
including B-X
details B-X
of B-X
support B-X
organisations B-X
, B-X
plus B-X
advice B-X
about B-X
specialist B-X
equipment B-X
, B-X
home B-X
modifications B-X
and B-X
mobility B-X
. B-X
Even B-X
if B-X
you B-X
‚Äô B-X
re B-X
busy B-X
, B-X
you B-X
still B-X
need B-X
to B-X
find B-X
a B-X
way B-X
to B-X
be B-X
physically B-X
active B-X
. B-X
Short B-X
stature B-X
can B-X
happen B-X
because B-X
of B-X
a B-X
family B-X
trait B-X
, B-X
a B-X
genetic B-X
condition B-X
, B-X
or B-X
a B-X
growth B-X
hormone B-X
deficiency B-X
. B-X
Treatment B-X
may B-X
be B-X
available B-X
. B-X
Learn B-X
more B-X
about B-X
the B-X
causes B-X
, B-X
physical B-X
characteristics B-X
and B-X
other B-X
detailed B-X
information B-X
about B-X
Kneist B-X
dysplasia B-X
, B-X
a B-X
form B-X
of B-X
skeletal B-X
dysplasia B-X
. B-X
There B-X
are B-X
many B-X
government B-X
services B-X
and B-X
for B-X
people B-X
living B-X
with B-X
or B-X
caring B-X
for B-X
someone B-X
with B-X
vision B-X
or B-X
hearing B-X
impairments B-X
. B-X
Classification B-X
provides B-X
a B-X
structure B-X
for B-X
Paralympic B-X
competition B-X
. B-X
Athletes B-X
competing B-X
in B-X
Para B-X
sports B-X
have B-X
an B-X
impairment B-X
that B-X
leads B-X
to B-X
a B-X
competitive B-X

Molecular	O
analysis	O
of	O
the	O
patients	O
DNA	O
showed	O
a	O
single	O
base	O
(	O
G	O
)	O
deletion	O
involving	O
the	O
GT	O
dinucleotide	O
at	O
the	O
start	O
of	O
intron	O
18	O
destroying	O
a	O
splice	O
site	O
of	O
the	O
COL2A1	O
gene	O
.	O

This	O
is	O
in	O
accordance	O
with	O
molecular	O
findings	O
in	O
other	O
patients	O
with	O
Kniest	B-Disease
dysplasia	I-Disease
and	O
confirms	O
,	O
in	O
the	O
original	O
patient	O
,	O
that	O
the	O
disorder	O
is	O
caused	O
by	O
small	O
inframe	O
deletions	O
often	O
due	O
to	O
exon	O
skipping	O
as	O
a	O
result	O
of	O
COL2A1	O
splice	O
site	O
mutations	O
.	O
.	O
<EOS> B-X
Stickler B-X
syndrome B-X
caused B-X
by B-X
COL2A1 B-X
mutations B-X
: B-X
genotype‚Äìphenotype B-X
correlation B-X
in B-X
a B-X
series B-X
of B-X
100 B-X
patients B-X
Original B-X
article B-X
: B-X
Alternative B-X
splicing B-X
modifies B-X
the B-X
effect B-X
of B-X
mutations B-X
in B-X
COL11A1 B-X
and B-X
results B-X
in B-X
recessive B-X
type B-X
2 B-X
Stickler B-X
syndrome B-X
with B-X
profound B-X
hearing B-X
loss B-X
The B-X
ophthalmic B-X
features B-X
in B-X
Kniest B-X
dysplasia B-X
are B-X
very B-X
similar B-X
to B-X
those B-X
in B-X
other B-X
disorders B-X
of B-X
type B-X
II B-X
collagen B-X
such B-X
as B-X
Stickler B-X
syndrome B-X
. B-X
It B-X
is B-X
likely B-X
that B-X
different B-X
type B-X
II B-X
Request B-X
PDF B-X
| B-X
Spondyloperipheral B-X
dysplasia B-X
is B-X
caused B-X
by B-X
truncating B-X
mutations B-X
in B-X
the B-X
C-propeptide B-X
of B-X
COL2A1 B-X
| B-X
The B-X
term B-X
`` B-X
spondyloperipheral B-X
dysplasia B-X
'' B-X
( B-X
SPD B-X
) B-X
has B-X
been B-X
applied B-X
to B-X
the B-X
Stickler B-X
syndrome B-X
is B-X
an B-X
autosomal B-X
dominant B-X
connective B-X
tissue B-X
disorder B-X
caused B-X
by B-X
mutations B-X
in B-X
different B-X
collagen B-X
genes B-X
. B-X
The B-X
aim B-X
of B-X
our B-X
study B-X
was B-X
to B-X
define B-X
more B-X
precisely B-X
the B-X
phenotype B-X
and B-X

Cloning	O
of	O
the	O
homogentisate	O
1	O
,	O
2	O
-	O
dioxygenase	O
gene	O
,	O
the	O
key	O
enzyme	O
of	O
alkaptonuria	B-Disease
in	O
mouse	O
.	O
<EOS> B-X
EC B-X
number B-X
1.13.11.5 B-X
EC B-X
number B-X
1.13.11.5 B-X

We	O
determined	O
48	O
amino	O
acid	O
residues	O
from	O
five	O
peptides	O
from	O
the	O
homogeneous	O
monomer	O
of	O
homogentisate	O
1	O
,	O
2	O
-	O
dioxygenase	O
(	O
HGO	O
;	O
E	O
.	O
C	O
.	O
1	O
.	O
13	O
.	O
11	O
.	O
15	O
)	O
of	O
mouse	O
liver	O
.	O
<EOS> B-X
We B-X
determined B-X
48 B-X
amino B-X
acid B-X
residues B-X
from B-X
five B-X
pep-tides B-X
from B-X
the B-X
homogeneous B-X
monomer B-X
of B-X
homogentisate B-X
1,2-dioxygenase B-X
( B-X
HGO B-X
; B-X
E.C B-X
. B-X
1.13.11.15 B-X
) B-X
of B-X
mouse B-X
liver B-X
. B-X
After B-X
digestion B-X
with B-X
Information B-X
on B-X
EC B-X
1.13.11.5 B-X
- B-X
homogentisate B-X
1,2-dioxygenase B-X
Steady-state B-X
kinetics B-X
and B-X
inhibition B-X
of B-X
anaerobically B-X
purified B-X
human B-X
homogentisate B-X
1,2-dioxygenase B-X
cytoplasm B-X
, B-X
homogentisate B-X
1,2-dioxygenase B-X
activity B-X
, B-X
cellular B-X
amino B-X
acid B-X
metabolic B-X
process B-X
, B-X
L-phenylalanine B-X
catabolic B-X
process B-X
Complete B-X
information B-X
for B-X
HGD B-X
gene B-X
( B-X
Protein B-X
Coding B-X
) B-X
, B-X
Homogentisate B-X
1,2-Dioxygenase B-X
, B-X
including B-X
: B-X
function B-X
, B-X
proteins B-X
, B-X
disorders B-X
, B-X
pathways B-X
, B-X
orthologs B-X
, B-X
and B-X
expression B-X
. B-X
GeneCards B-X
- B-X
Chronic B-X
alcohol B-X
feeding B-X
causes B-X
lipid B-X
accumulation B-X
and B-X
apoptosis B-X
in B-X
the B-X
liver B-X
. B-X
This B-X
study B-X
investigated B-X
the B-X
role B-X
of B-X
bioactive B-X
lipid B-X
metabolites B-X
in B-X
alcohol-induced B-X
liver B-X
damage B-X
and B-X
tested B-X
the B-X
potential B-X
of B-X
Homogentisate B-X
dioxygenase B-X
( B-X
HGO B-X
) B-X
cleaves B-X
the B-X
aromatic B-X
ring B-X
during B-X
the B-X
metabolic B-X
degradation B-X
of B-X
Phe B-X
and B-X
Tyr B-X
. B-X
HGO B-X
deficiency B-X
causes B-X
alkaptonuria B-X
( B-X
AKU B-X
) B-X
, B-X
the B-X
first B-X
human B-X
disease B-X

After	O
digestion	O
with	O
trypsin	O
,	O
peptides	O
were	O
separated	O
by	O
reversed	O
phase	O
chromatography	O
and	O
amino	O
acid	O
sequenced	O
.	O
<EOS> B-X
A B-X
Systematical B-X
Analysis B-X
of B-X
Tryptic B-X
Peptide B-X
Identification B-X
with B-X
Reverse B-X
Phase B-X
Liquid B-X
Chromatography B-X
and B-X
Electrospray B-X
Ion B-X
Trap B-X
Mass B-X
Spectrometry B-X
- B-X
ScienceDirect B-X
Liquid B-X
Chromatography B-X
Mass B-X
Spectrometry-Based B-X
Proteomics B-X
: B-X
Biological B-X
and B-X
Technological B-X
Aspects B-X
Improved B-X
peptide B-X
elution B-X
time B-X
prediction B-X
for B-X
reversed-phase B-X
liquid B-X
chromatography-MS B-X
by B-X
incorporating B-X
peptide B-X
sequence B-X
information B-X

The	O
deduced	O
codon	O
sequence	O
of	O
three	O
peptides	O
was	O
used	O
to	O
derive	O
degenerated	O
oligomeres	O
.	O
<EOS> B-X
Biomathematical B-X
Description B-X
of B-X
Synthetic B-X
Peptide B-X
Libraries B-X
Evolving B-X
a B-X
Peptide B-X
: B-X
Library B-X
Platforms B-X
and B-X
Diversification B-X
Strategies B-X
Molecular B-X
Cloning B-X
, B-X
Sequencing B-X
, B-X
and B-X
Expression B-X
of B-X
omp-40 B-X
, B-X
the B-X
Gene B-X
Coding B-X
for B-X
the B-X
Major B-X
Outer B-X
Membrane B-X
Protein B-X
from B-X
the B-X
Acidophilic B-X
Bacterium B-X
Thiobacillus B-X
ferrooxidans B-X
Defensins B-X
are B-X
cysteine-rich B-X
cationic B-X
antimicrobial B-X
peptides B-X
contributing B-X
to B-X
the B-X
innate B-X
immunity B-X
in B-X
plants B-X
. B-X
A B-X
unique B-X
gene B-X
encoding B-X
a B-X
highly B-X
cationic B-X
bi-domain B-X
defensin B-X
MtDef5 B-X
has B-X
been B-X
identified B-X
in B-X
a B-X
model B-X

By	O
combining	O
these	O
oligos	O
,	O
we	O
were	O
able	O
to	O
amplify	O
fragments	O
from	O
100	O
to	O
300	O
bases	O
(	O
b	O
)	O
from	O
mouse	O
liver	O
cDNA	O
by	O
polymerase	O
chain	O
reaction	O
after	O
reverse	O
transcription	O
(	O
RT	O
-	O
PCR	O
)	O
.	O
<EOS> B-X
A B-X
method B-X
to B-X
amplify B-X
long B-X
genomic B-X
regions B-X
( B-X
up B-X
to B-X
approximately B-X
12.3 B-X
kb B-X
) B-X
from B-X
pestiviruses B-X
in B-X
one B-X
RT-PCR B-X
is B-X
described B-X
. B-X
The B-X
difficulty B-X
in B-X
designing B-X
conserved B-X
Pestivirus B-X
primers B-X
for B-X
With B-X
the B-X
decoding B-X
of B-X
the B-X
human B-X
genome B-X
and B-X
the B-X
potential B-X
application B-X
of B-X
its B-X
information B-X
to B-X
gene B-X
chips B-X
, B-X
the B-X
ability B-X
to B-X
generate B-X
cDNA B-X
libraries B-X
for B-X
functional B-X
assays B-X
of B-X
specific B-X
gene B-X
Gene B-X
Quantification B-X
& B-X
optimisation B-X
real-time B-X
/ B-X
kinetic B-X
PCR B-X
/ B-X
RT-PCR B-X
reactions B-X
An B-X
Improved B-X
Method B-X
for B-X
Absolute B-X
Quantification B-X
of B-X
mRNA B-X
Using B-X
Multiplex B-X
Polymerase B-X
Chain B-X
Reaction B-X
: B-X
Determination B-X
of B-X
Renin B-X
and B-X
Angiotensinogen B-X
mRNA B-X
Levels B-X
in B-X
Various B-X
Tissues B-X
- B-X
ScienceDirect B-X

A	O
fragment	O
of	O
200	O
b	O
was	O
cloned	O
and	O
used	O
as	O
a	O
probe	O
to	O
screen	O
a	O
mouse	O
liver	O
cDNA	O
library	O
.	O
<EOS> B-X
Cloning B-X
of B-X
Œ±2u B-X
globulin B-X
cDNA B-X
using B-X
a B-X
high B-X
efficiency B-X
technique B-X
for B-X
the B-X
cloning B-X
of B-X
trace B-X
messenger B-X
RNAs B-X
- B-X
ScienceDirect B-X
Molecular B-X
cloning B-X
, B-X
genomic B-X
organization B-X
and B-X
cell‚Äêbinding B-X
characteristics B-X
of B-X
mouse B-X
SpŒ± B-X
Molecular B-X
cloning B-X
, B-X
gene B-X
structure B-X
and B-X
expression B-X
profile B-X
of B-X
two B-X
mouse B-X
peroxisomal B-X
3-ketoacyl-CoA B-X
thiolase B-X
genes B-X
Œ≤-spectrins B-X
are B-X
crucial B-X
for B-X
the B-X
maintenance B-X
of B-X
cell B-X
shape B-X
, B-X
the B-X
establishment B-X
of B-X
cell B-X
polarity B-X
, B-X
and B-X
the B-X
formation B-X
of B-X
distinct B-X
membrane B-X
domains B-X
. B-X
Our B-X
strategy B-X
for B-X
identifying B-X
genes B-X
important B-X
PDF B-X
| B-X
The B-X
main B-X
ethanol-active B-X
alcohol B-X
dehydrogenase B-X
( B-X
ADH B-X
; B-X
alcohol B-X
: B-X
NAD+ B-X
oxidoreductase B-X
, B-X
EC B-X
1.1.1.1 B-X
) B-X
in B-X
mouse B-X
liver B-X
( B-X
ADH-AA B-X
) B-X
is B-X
similar B-X
in B-X
catalytic B-X
and B-X
... B-X
Molecular B-X
characterization B-X
of B-X
TUB B-X
, B-X
TULP1 B-X
, B-X
and B-X
TULP2 B-X
, B-X
members B-X
of B-X
the B-X
novel B-X
tubby B-X
gene B-X
family B-X
and B-X
their B-X
possible B-X
relation B-X
to B-X
ocular B-X
diseases B-X
The B-X
main B-X
ethanol-active B-X
alcohol B-X
dehydrogenase B-X
( B-X
ADH B-X
; B-X
alcohol B-X
: B-X
NAD+ B-X
oxidoreductase B-X
, B-X
EC B-X
1.1.1.1 B-X
) B-X
in B-X
mouse B-X
liver B-X
( B-X
ADH-AA B-X
) B-X
is B-X
similar B-X
in B-X
catalytic B-X
and B-X
molecular B-X
prope B-X
... B-X

One	O
clone	O
from	O
this	O
library	O
contained	O
the	O
complete	O
cDNA	O
-	O
insert	O
for	O
HGO	O
as	O
determined	O
by	O
sequencing	O
.	O
<EOS> B-X
PDF B-X
| B-X
Collections B-X
of B-X
full-length B-X
nonredundant B-X
cDNA B-X
clones B-X
are B-X
critical B-X
reagents B-X
for B-X
functional B-X
genomics B-X
. B-X
The B-X
first B-X
step B-X
toward B-X
these B-X
resources B-X
is B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
A B-X
Gene-enriched B-X
BAC B-X
Library B-X
for B-X
Cloning B-X
Large B-X
Allele-specific B-X
Fragments B-X
from B-X
Maize B-X
: B-X
Isolation B-X
of B-X
a B-X
240-kb B-X
Contig B-X
of B-X
the B-X
bronze B-X
Region B-X
Gene B-X
Tagging B-X
Strategies B-X
To B-X
Assess B-X
Protein B-X
Expression B-X
, B-X
Localization B-X
, B-X
and B-X
Function B-X
in B-X
Drosophila B-X
Phosphoglycerate B-X
kinase B-X
( B-X
PGK B-X
) B-X
, B-X
a B-X
major B-X
enzyme B-X
in B-X
glycolysis B-X
, B-X
is B-X
encoded B-X
by B-X
the B-X
X B-X
chromosome B-X
in B-X
mammals B-X
. B-X
We B-X
have B-X
initiated B-X
molecular B-X
analysis B-X
of B-X
the B-X
PGK B-X
structur B-X
Interpretation B-X
of B-X
ever-increasing B-X
raw B-X
sequence B-X
information B-X
generated B-X
by B-X
modern B-X
genome B-X
sequencing B-X
technologies B-X
faces B-X
multiple B-X
challenges B-X
, B-X
such B-X
as B-X
gene B-X
function B-X
analysis B-X
and B-X
genome B-X
annotation B-X
. B-X
Indeed B-X
, B-X
nearly B-X
40 B-X
% B-X
Interpretation B-X
of B-X
ever-increasing B-X
raw B-X
sequence B-X
information B-X
generated B-X
by B-X
modern B-X
genome B-X
sequencing B-X
technologies B-X
faces B-X
multiple B-X
challenges B-X
, B-X
such B-X
as B-X
gene B-X
function B-X
analysis B-X
and B-X
genome B-X
annotation B-X
. B-X
Indeed B-X
, B-X
nearly B-X
40 B-X
% B-X
Finding B-X
and B-X
Mapping B-X
New B-X
Genes B-X
Faster B-X
than B-X
Ever B-X
: B-X
Revisited B-X
| B-X
Genetics B-X

The	O
cDNA	O
encodes	O
for	O
a	O
protein	O
of	O
50	O
kDa	O
,	O
as	O
predicted	O
.	O

The	O
cDNA	O
of	O
mouse	O
HGO	O
has	O
an	O
overall	O
identity	O
of	O
41	O
%	O
to	O
the	O
corresponding	O
gene	O
hmgA	O
from	O
Aspergillus	O
.	O
<EOS> B-X
The B-X
2008 B-X
update B-X
of B-X
the B-X
Aspergillus B-X
nidulans B-X
genome B-X
annotation B-X
: B-X
a B-X
community B-X
effort B-X
PDF B-X
| B-X
We B-X
report B-X
here B-X
the B-X
first B-X
characterization B-X
of B-X
a B-X
gene B-X
encoding B-X
a B-X
homogentisate B-X
dioxygenase B-X
, B-X
the B-X
Aspergillus B-X
nidulans B-X
hmgA B-X
gene B-X
. B-X
The B-X
HmgA B-X
protein B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
A B-X
large B-X
set B-X
of B-X
mRNA B-X
and B-X
encoded B-X
protein B-X
sequences B-X
, B-X
from B-X
orthologous B-X
murine B-X
and B-X
human B-X
genes B-X
, B-X
was B-X
compiled B-X
to B-X
analyze B-X
statistical B-X
, B-X
biological B-X
, B-X
and B-X
evolutionary B-X
properties B-X
of B-X
coding B-X
We B-X
determined B-X
48 B-X
amino B-X
acid B-X
residues B-X
from B-X
five B-X
pep-tides B-X
from B-X
the B-X
homogeneous B-X
monomer B-X
of B-X
homogentisate B-X
1,2-dioxygenase B-X
( B-X
HGO B-X
; B-X
E.C B-X
. B-X
1.13.11.15 B-X
) B-X
of B-X
mouse B-X
live B-X
Aspergilli B-X
have B-X
been B-X
widely B-X
used B-X
in B-X
the B-X
production B-X
of B-X
organic B-X
acids B-X
, B-X
enzymes B-X
, B-X
and B-X
secondary B-X
metabolites B-X
for B-X
almost B-X
a B-X
century B-X
. B-X
Today B-X
, B-X
several B-X
GRAS B-X
( B-X
generally B-X
recognized B-X
as B-X
The B-X
Silver B-X
locus B-X
product B-X
Pmel17/gp100/Silv/ME20 B-X
: B-X
controversial B-X
in B-X
name B-X
and B-X
in B-X
function B-X
PDF B-X
| B-X
Type B-X
I B-X
hereditary B-X
tyrosinaemia B-X
( B-X
HT1 B-X
) B-X
is B-X
a B-X
severe B-X
human B-X
inborn B-X
disease B-X
resulting B-X
from B-X
loss B-X
of B-X
fumaryl-acetoacetate B-X
hydrolase B-X
( B-X
Fah B-X
) B-X
. B-X
Homozygous B-X
... B-X
| B-X
Find B-X
, B-X

Sequence	O
similarities	O
to	O
human	O
expressed	O
sequence	O
tags	O
(	O
EST	O
)	O
clones	O
ranged	O
from	O
70	O
%	O
to	O
20	O
%	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Expressed B-X
sequence B-X
tag B-X
( B-X
EST B-X
) B-X
sequencing B-X
projects B-X
are B-X
underway B-X
for B-X
numerous B-X
organisms B-X
, B-X
generating B-X
millions B-X
of B-X
short B-X
, B-X
single-pass B-X
nucleotide B-X
sequence B-X
re B-X
We B-X
have B-X
performed B-X
a B-X
systematic B-X
analysis B-X
of B-X
gene B-X
identification B-X
in B-X
genomic B-X
sequence B-X
by B-X
similarity B-X
search B-X
against B-X
expressed B-X
sequence B-X
tags B-X
( B-X
ESTs B-X
) B-X
to B-X
assess B-X
the B-X
suitability B-X
of B-X
this B-X
method B-X
for B-X
Analyses B-X
of B-X
Expressed B-X
Sequence B-X
Tags B-X
from B-X
Apple B-X
| B-X
Plant B-X
Physiology B-X
An B-X
Oligonucleotide B-X
Fingerprint B-X
Normalized B-X
and B-X
Expressed B-X
Sequence B-X
Tag B-X
Characterized B-X
Zebrafish B-X
cDNA B-X
Library B-X

The	O
positions	O
of	O
122	O
conserved	O
amino	O
acids	O
could	O
be	O
determined	O
by	O
multiple	O
sequence	O
alignment	O
.	O
<EOS> B-X
Abstract B-X
. B-X
A B-X
general B-X
searching B-X
method B-X
for B-X
comparing B-X
multiple B-X
sequence B-X
alignments B-X
was B-X
developed B-X
to B-X
detect B-X
sequence B-X
relationships B-X
between B-X
conserved B-X
protein B-X
regions B-X
A B-X
statistical B-X
score B-X
for B-X
assessing B-X
the B-X
quality B-X
of B-X
multiple B-X
sequence B-X
alignments B-X
Variation B-X
in B-X
structural B-X
location B-X
and B-X
amino B-X
acid B-X
conservation B-X
of B-X
functional B-X
sites B-X
in B-X
protein B-X
domain B-X
families B-X
Abstract B-X
. B-X
The B-X
use B-X
of B-X
some B-X
multiple-sequence B-X
alignments B-X
in B-X
phylogenetic B-X
analysis B-X
, B-X
particularly B-X
those B-X
that B-X
are B-X
not B-X
very B-X
well B-X
conserved B-X
, B-X
requires B-X
the B-X
elimination B-X
o B-X
Persistently B-X
conserved B-X
positions B-X
in B-X
structurally B-X
similar B-X
, B-X
sequence B-X
dissimilar B-X
proteins B-X
: B-X
Roles B-X
in B-X
preserving B-X
protein B-X
fold B-X
and B-X
function B-X
This B-X
review B-X
provides B-X
an B-X
overview B-X
on B-X
the B-X
development B-X
of B-X
Multiple B-X
sequence B-X
alignment B-X
( B-X
MSA B-X
) B-X
methods B-X
and B-X
their B-X
main B-X
applications B-X
. B-X
It B-X
is B-X
focused B-X
on B-X
progress B-X
made B-X
ove B-X
Alignments B-X
are B-X
a B-X
powerful B-X
way B-X
to B-X
compare B-X
related B-X
DNA B-X
or B-X
protein B-X
sequences B-X
. B-X
They B-X
can B-X
be B-X
used B-X
to B-X
capture B-X
various B-X
facts B-X
about B-X
the B-X
sequences B-X
aligned B-X
, B-X
such B-X
as B-X
common B-X
evolutionary B-X

We	O
identified	O
one	O
first	O
intron	O
of	O
928	O
b	O
in	O
the	O
mouse	O
gene	O
.	O
<EOS> B-X
Gene-breaking B-X
: B-X
A B-X
new B-X
paradigm B-X
for B-X
human B-X
retrotransposon-mediated B-X
gene B-X
evolution B-X
Genes B-X
encoding B-X
cell-surface B-X
proteins B-X
control B-X
nervous B-X
system B-X
development B-X
and B-X
are B-X
implicated B-X
in B-X
neurological B-X
disorders B-X
. B-X
These B-X
genes B-X
produce B-X
alternative B-X
mRNA B-X
isoforms B-X
which B-X
remain B-X
poorly B-X
characterized B-X
, B-X
impeding B-X
understanding B-X
of B-X
how B-X
Gene B-X
annotation B-X
is B-X
a B-X
critical B-X
resource B-X
in B-X
genomics B-X
research B-X
. B-X
Many B-X
computational B-X
approaches B-X
have B-X
been B-X
developed B-X
to B-X
assemble B-X
transcriptomes B-X
based B-X
on B-X
high-throughput B-X
short-read B-X
sequencing B-X
, B-X
however B-X
, B-X
only B-X
with B-X
limited B-X
Eukaryotic B-X
gene B-X
expression B-X
relies B-X
on B-X
extensive B-X
crosstalk B-X
between B-X
transcription B-X
and B-X
RNA B-X
processing B-X
. B-X
Changes B-X
in B-X
this B-X
composite B-X
regulation B-X
network B-X
may B-X
provide B-X
an B-X
important B-X
means B-X
for B-X
shaping B-X
cell B-X
type-specific B-X
transcriptomes B-X
. B-X

The	O
gene	O
for	O
HGO	O
seems	O
to	O
be	O
expressed	O
in	O
various	O
tissues	O
,	O
as	O
shown	O
by	O
RT	O
-	O
PCR	O
on	O
different	O
cDNAs	O
.	O
<EOS> B-X
Improved B-X
quantitative B-X
real-time B-X
RT‚ÄìPCR B-X
for B-X
expression B-X
profiling B-X
of B-X
individual B-X
cells B-X
Two-step B-X
quantitative B-X
real-time B-X
RT-PCR B-X
( B-X
RT-qPCR B-X
) B-X
, B-X
also B-X
known B-X
as B-X
real-time B-X
RT-PCR B-X
, B-X
kinetic B-X
RT-PCR B-X
, B-X
or B-X
quantitative B-X
fluorescent B-X
RT-PCR B-X
, B-X
has B-X
become B-X
the B-X
method B-X
of B-X
choice B-X
for B-X
gene B-X
We B-X
have B-X
evaluated B-X
suitable B-X
reference B-X
genes B-X
for B-X
real B-X
time B-X
( B-X
RT B-X
) B-X
-quantitative B-X
PCR B-X
( B-X
qPCR B-X
) B-X
analysis B-X
in B-X
Japanese B-X
pear B-X
( B-X
Pyrus B-X
pyrifolia B-X
) B-X
. B-X
We B-X
tested B-X
most B-X
frequently B-X

FISH	O
experiments	O
with	O
the	O
whole	O
murine	O
cDNA	O
as	O
probe	O
clearly	O
revealed	O
signals	O
at	O
the	O
human	O
chromosomal	O
band	O
3q13	O
.	O
<EOS> B-X
PDF B-X
| B-X
ERV9 B-X
is B-X
a B-X
low B-X
repeated B-X
family B-X
of B-X
human B-X
endogenous B-X
retroviral B-X
elements B-X
, B-X
which B-X
has B-X
close B-X
to B-X
50 B-X
members B-X
, B-X
in B-X
addition B-X
to B-X
at B-X
least B-X
4000 B-X
solitary B-X
LTRs B-X
.... B-X
An B-X
international B-X
, B-X
peer-reviewed B-X
genome B-X
sciences B-X
journal B-X
featuring B-X
outstanding B-X
original B-X
research B-X
that B-X
offers B-X
novel B-X
insights B-X
into B-X
the B-X
biology B-X
of B-X
all B-X
organisms B-X
Abstracts B-X
of B-X
the B-X
12 B-X
th B-X
European B-X
Cytogenomics B-X
Conference B-X
2019 B-X
| B-X
Molecular B-X
Cytogenetics B-X
| B-X
Full B-X
Text B-X

3	O
-	O
q21	O
.	O
<EOS> B-X
t B-X
( B-X
3 B-X
; B-X
5 B-X
) B-X
( B-X
q21 B-X
; B-X
q31 B-X
) B-X
t B-X
( B-X
1 B-X
; B-X
1 B-X
) B-X
( B-X
p36 B-X
; B-X
q21 B-X
) B-X
in B-X
Non B-X
Hodgkin B-X
Lymphoma B-X
Close B-X
phenotypic B-X
similarity B-X
between B-X
two B-X
cases B-X
carrying B-X
a B-X
rec B-X
( B-X
3 B-X
) B-X
dup B-X
q B-X
, B-X
inv B-X
( B-X
3 B-X
) B-X
( B-X
p25q21 B-X
) B-X
, B-X
12 B-X
additional B-X
infants B-X
from B-X
the B-X
same B-X
inv B-X
Chromosome B-X
3 B-X
Pure B-X
interstitial B-X
deletions B-X
of B-X
the B-X
long B-X
arm B-X
of B-X
chromosome B-X
13 B-X
are B-X
correlated B-X
with B-X
variable B-X
phenotypes B-X
according B-X
to B-X
the B-X
size B-X
and B-X
the B-X
location B-X
of B-X
the B-X
deleted B-X
region B-X
. B-X
Deletions B-X
involving B-X
the B-X
Chromosome B-X
3 B-X
duplication B-X
q21 B-X
leads B-X
to B-X
qter B-X
deletion B-X
p25 B-X
leads B-X
to B-X
pter B-X
syndrome B-X
in B-X
children B-X
of B-X
carriers B-X
of B-X
a B-X
pericentric B-X
inversion B-X
inv B-X
( B-X
3 B-X
) B-X
( B-X
p25q21 B-X
) B-X
. B-X
The B-X
t B-X
( B-X
3 B-X
; B-X
3 B-X
) B-X
( B-X
q21 B-X
; B-X
q26.2 B-X
) B-X
is B-X
known B-X
to B-X
be B-X
mainly B-X
observed B-X
in B-X
hematologic B-X
myeloid B-X
malignancies B-X
, B-X
as B-X
a B-X
form B-X
of B-X
3q21q26 B-X
syndrome B-X
. B-X

This	O
corresponds	O
well	O
to	O
the	O
previous	O
assignment	O
of	O
the	O
locus	O
for	O
the	O
human	O
alkaptonuria	B-Disease
gene	O
(	O
AKU	O
)	O
to	O
the	O
same	O
chromosomal	O
region	O
by	O
multipoint	O
linkage	O
analysis	O
.	O
<EOS> B-X
human B-X
gene B-X
map B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
PDF B-X
| B-X
On B-X
Sep B-X
1 B-X
, B-X
1999 B-X
, B-X
C B-X
F B-X
Inglehearn B-X
and B-X
others B-X
published B-X
A B-X
new B-X
family B-X
linked B-X
to B-X
the B-X
RP1 B-X
dominant B-X
retinitis B-X
pigmentosa B-X
locus B-X
on B-X
chromosome B-X
8q B-X
| B-X
Find B-X
A B-X
260,000 B-X
Mr B-X
protein B-X
complex B-X
containing B-X
the B-X
subunits B-X
coded B-X
for B-X
by B-X
the B-X
uvrA B-X
, B-X
uvrB B-X
and B-X
uvrC B-X
genes B-X
of B-X
E. B-X
coli B-X
. B-X
UvrA B-X
is B-X
an B-X
adenosine B-X
triphosphatase B-X
and B-X
brings B-X
into B-X
locus B-X
rps1-k B-X
encompasses B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X

We	O
therefore	O
conclude	O
that	O
the	O
HGO	O
cDNA	O
encodes	O
the	O
gene	O
responsible	O
for	O
alkaptonuria	B-Disease
.	O
<EOS> B-X
Cloned B-X
DNA B-X
can B-X
be B-X
used B-X
in B-X
numerous B-X
ways B-X
dictated B-X
by B-X
the B-X
needs B-X
of B-X
the B-X
experiment B-X
. B-X
In B-X
this B-X
section B-X
, B-X
we B-X
consider B-X
some B-X
of B-X
the B-X
basic B-X
uses B-X
that B-X
are B-X
applicable B-X
Alkaptonuria B-X
( B-X
AKU B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
caused B-X
by B-X
the B-X
deficiency B-X
of B-X
homogentisate B-X
1,2 B-X
dioxygenase B-X
( B-X
HGO B-X
) B-X
activity B-X
. B-X
The B-X
disease B-X
is B-X
characterized B-X
by B-X
homogentisic B-X
aciduria B-X
, B-X
Identification B-X
of B-X
Homogentisate B-X
Dioxygenase B-X
as B-X
a B-X
Target B-X
for B-X
Vitamin B-X
E B-X
Biofortification B-X
in B-X
Oilseeds B-X
Request B-X
PDF B-X
| B-X
Allele B-X
heterogeneity B-X
of B-X
alkaptonuria B-X
causing B-X
mutations B-X
and B-X
possible B-X
reasons B-X
for B-X
high B-X
incidence B-X
of B-X
this B-X
disease B-X
in B-X
Slovakia B-X
| B-X
Background B-X
: B-X
Alkaptonuria B-X
( B-X
AKU B-X
) B-X
is B-X
a B-X
rare B-X
Identification B-X
of B-X
Homogentisate B-X
Dioxygenase B-X
as B-X
a B-X
Target B-X
for B-X
Vitamin B-X
E B-X
Biofortification B-X
in B-X
Oilseeds B-X
| B-X
Plant B-X
Physiology B-X

PTEN	O
,	O
a	O
putative	O
protein	O
tyrosine	O
phosphatase	O
gene	O
mutated	O
in	O
human	O
brain	B-Disease
,	I-Disease
breast	I-Disease
,	I-Disease
and	I-Disease
prostate	I-Disease
cancer	I-Disease
.	O
<EOS> B-X
PTEN B-X
, B-X
a B-X
putative B-X
protein B-X
tyrosine B-X
phosphatase B-X
gene B-X
mutated B-X
in B-X
human B-X
brain B-X
, B-X
breast B-X
, B-X
and B-X
prostate B-X
cancer B-X
| B-X
Meta B-X
PTEN B-X
, B-X
a B-X
putative B-X
protein B-X
tyrosine B-X
phosphatase B-X
gene B-X
mutated B-X
in B-X
human B-X
brain B-X
, B-X
breast B-X
, B-X
and B-X
prostate B-X
cancer B-X
- B-X
CSHL B-X
Scientific B-X
Digital B-X
Repository B-X
PTEN B-X
, B-X
a B-X
Putative B-X
Protein B-X
Tyrosine B-X
Phosphatase B-X
Gene B-X
Mutated B-X
in B-X
Human B-X
Brain B-X
, B-X
Breast B-X
, B-X
and B-X
Prostate B-X
Cancer B-X
| B-X
Science B-X
PTEN B-X
, B-X
a B-X
Putative B-X
Protein B-X
Tyrosine B-X
Phosphatase B-X
Gene B-X
Mutated B-X
in B-X
Human B-X
Brain B-X
, B-X
Breast B-X
, B-X
and B-X
Prostate B-X
Cancer B-X
| B-X
Science B-X
PTEN B-X
, B-X
a B-X
Putative B-X
Protein B-X
Tyrosine B-X
Phosphatase B-X
Gene B-X
Mutated B-X
in B-X
Human B-X
Brain B-X
, B-X
Breast B-X
, B-X
and B-X
Prostate B-X
Cancer B-X
| B-X
Science B-X
PTEN B-X
, B-X
a B-X
Putative B-X
Protein B-X
Tyrosine B-X
Phosphatase B-X
Gene B-X
Mutated B-X
in B-X
Human B-X
Brain B-X
, B-X
Breast B-X
, B-X
and B-X
Prostate B-X
Cancer B-X
| B-X
Science B-X
Mapping B-X
of B-X
homozygous B-X
deletions B-X
on B-X
human B-X
chromosome B-X
10q23 B-X
has B-X
led B-X
to B-X
the B-X
isolation B-X
of B-X
a B-X
candidate B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
PTEN B-X
, B-X
that B-X
appears B-X
to B-X
be B-X
mutated B-X
at B-X
considerable B-X
frequency B-X

Mapping	O
of	O
homozygous	O
deletions	O
on	O
human	O
chromosome	O
10q23	O
has	O
led	O
to	O
the	O
isolation	O
of	O
a	O
candidate	O
tumor	B-Disease
suppressor	O
gene	O
,	O
PTEN	O
,	O
that	O
appears	O
to	O
be	O
mutated	O
at	O
considerable	O
frequency	O
in	O
human	O
cancers	B-Disease
.	O
<EOS> B-X
Mapping B-X
of B-X
homozygous B-X
deletions B-X
on B-X
human B-X
chromosome B-X
10q23 B-X
has B-X
led B-X
to B-X
the B-X
isolation B-X
of B-X
a B-X
candidate B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
PTEN B-X
, B-X
that B-X
appears B-X
to B-X
be B-X
mutated B-X
at B-X
considerable B-X
frequency B-X
To B-X
date B-X
, B-X
only B-X
a B-X
limited B-X
number B-X
of B-X
tumor B-X
suppressor B-X
genes B-X
have B-X
been B-X
identified B-X
as B-X
being B-X
inactivated B-X
in B-X
lung B-X
cancer B-X
. B-X
The B-X
p53 B-X
and B-X
RB B-X
genes B-X
are B-X
frequently B-X
inactivat B-X
We B-X
used B-X
overlapping B-X
and B-X
nested B-X
homozygous B-X
deletions B-X
, B-X
contig B-X
building B-X
, B-X
genomic B-X
sequencing B-X
, B-X
and B-X
physical B-X
and B-X
transcript B-X
mapping B-X
to B-X
further B-X
define B-X
a B-X
approximately B-X
630-kb B-X
lung B-X
cancer B-X
homozygous B-X
deletion B-X
region B-X
Localization B-X
of B-X
Multiple B-X
Melanoma B-X
Tumor‚ÄìSuppressor B-X
Genes B-X
on B-X
Chromosome B-X
11 B-X
by B-X
Use B-X
of B-X
Homozygosity B-X
Mapping-of-Deletions B-X
Analysis B-X
Localization B-X
of B-X
Multiple B-X
Melanoma B-X
Tumor‚ÄìSuppressor B-X
Genes B-X
on B-X
Chromosome B-X
11 B-X
by B-X
Use B-X
of B-X
Homozygosity B-X
Mapping-of-Deletions B-X
Analysis B-X
- B-X
ScienceDirect B-X
Homozygous B-X
Deletions B-X
and B-X
Recurrent B-X
Amplifications B-X
Implicate B-X
New B-X
Genes B-X
Involved B-X
in B-X
Prostate B-X
Cancer B-X
PTEN B-X
, B-X
a B-X
putative B-X
protein B-X
tyrosine B-X
phosphatase B-X
gene B-X
mutated B-X
in B-X
human B-X
brain B-X
, B-X
breast B-X
, B-X
and B-X
prostate B-X
cancer B-X
. B-X
| B-X
College B-X
of B-X
Medicine B-X

In	O
preliminary	O
screens	O
,	O
mutations	O
of	O
PTEN	O
were	O
detected	O
in	O
31	O
%	O
(	O
13	O
/	O
42	O
)	O
of	O
glioblastoma	B-Disease
cell	O
lines	O
and	O
xenografts	O
,	O
100	O
%	O
(	O
4	O
/	O
4	O
)	O
of	O
prostate	B-Disease
cancer	I-Disease
cell	O
lines	O
,	O
6	O
%	O
(	O
4	O
/	O
65	O
)	O
of	O
breast	B-Disease
cancer	I-Disease
cell	O
lines	O
and	O
xenografts	O
,	O
and	O
17	O
%	O
(	O
3	O
/	O
18	O
)	O
of	O
primary	B-Disease
glioblastomas	I-Disease
.	O
<EOS> B-X
Correction B-X
of B-X
PTEN B-X
mutations B-X
in B-X
glioblastoma B-X
cell B-X
lines B-X
via B-X
AAV-mediated B-X
gene B-X
editing B-X
Comprehensive B-X
genomic B-X
profiling B-X
of B-X
glioblastoma B-X
tumors B-X
, B-X
BTICs B-X
, B-X
and B-X
xenografts B-X
reveals B-X
stability B-X
and B-X
adaptation B-X
to B-X
growth B-X
environments B-X
| B-X
PNAS B-X
Analysis B-X
of B-X
cell-free B-X
circulating B-X
tumor B-X
DNA B-X
in B-X
419 B-X
patients B-X
with B-X
glioblastoma B-X
and B-X
other B-X
primary B-X
brain B-X
tumors B-X
A B-X
collection B-X
of B-X
breast B-X
cancer B-X
cell B-X
lines B-X
for B-X
the B-X
study B-X
of B-X
functionally B-X
distinct B-X
cancer B-X
subtypes B-X
Mutational B-X
profiling B-X
of B-X
kinases B-X
in B-X
glioblastoma B-X
Choosing B-X
the B-X
right B-X
cell B-X
line B-X
for B-X
breast B-X
cancer B-X
research B-X
Molecular B-X
characterization B-X
of B-X
breast B-X
cancer B-X
cell B-X
lines B-X
through B-X
multiple B-X
omic B-X
approaches B-X

The	O
predicted	O
PTEN	O
product	O
has	O
a	O
protein	O
tyrosine	O
phosphatase	O
domain	O
and	O
extensive	O
homology	O
to	O
tensin	O
,	O
a	O
protein	O
that	O
interacts	O
with	O
actin	O
filaments	O
at	O
focal	O
adhesions	O
.	O
<EOS> B-X
Molecular B-X
characterization B-X
of B-X
human B-X
tensin B-X
. B-X
Growth B-X
suppression B-X
of B-X
glioma B-X
cells B-X
by B-X
PTEN B-X
requires B-X
a B-X
functional B-X
phosphatase B-X
catalytic B-X
domain B-X
Growth B-X
suppression B-X
of B-X
glioma B-X
cells B-X
by B-X
PTEN B-X
requires B-X
a B-X
functional B-X
phosphatase B-X
catalytic B-X
domain B-X
| B-X
PNAS B-X
Deletions B-X
of B-X
all B-X
or B-X
part B-X
of B-X
chromosome B-X
10 B-X
are B-X
the B-X
most B-X
common B-X
genetic B-X
alterations B-X
in B-X
high-grade B-X
gliomas B-X
. B-X
The B-X
PTEN B-X
gene B-X
( B-X
also B-X
called B-X
MMAC1 B-X
and B-X
TEP1 B-X
) B-X
maps B-X
to B-X
The B-X
rapid B-X
developments B-X
in B-X
molecular B-X
genetics B-X
have B-X
clarified B-X
many B-X
of B-X
the B-X
muta B-X
tions B-X
in B-X
monogenic B-X
thyroid B-X
diseases B-X
over B-X
the B-X
last B-X
two B-X
decades B-X
; B-X
now B-X
the B-X
target B-X
of B-X
molecular B-X
thyroid B-X
genetics B-X

These	O
homologies	O
suggest	O
that	O
PTEN	O
may	O
suppress	O
tumor	B-Disease
cell	O
growth	O
by	O
antagonizing	O
protein	O
tyrosine	O
kinases	O
and	O
may	O
regulate	O
tumor	B-Disease
cell	O
invasion	O
and	O
metastasis	B-Disease
through	O
interactions	O
at	O
focal	O
adhesions	O
.	O
.	O
<EOS> B-X
The B-X
role B-X
of B-X
focal B-X
adhesion B-X
kinase B-X
in B-X
tumor B-X
initiation B-X
and B-X
progression B-X
PTEN/MMAC1 B-X
is B-X
a B-X
major B-X
new B-X
tumor B-X
suppressor B-X
gene B-X
that B-X
encodes B-X
a B-X
dual-specificity B-X
phosphatase B-X
with B-X
sequence B-X
similarity B-X
to B-X
the B-X
cytoskeletal B-X
protein B-X
tensin B-X
. B-X
Recently B-X
, B-X
we B-X
reported B-X
that B-X
PTEN B-X
dephosphorylates B-X
focal B-X
Tumor B-X
Suppressor B-X
PTEN B-X
Inhibition B-X
of B-X
Cell B-X
Invasion B-X
, B-X
Migration B-X
, B-X
and B-X
Growth B-X
: B-X
Differential B-X
Involvement B-X
of B-X
Focal B-X
Adhesion B-X
Kinase B-X
and B-X
p130Cas B-X
| B-X
Cancer B-X
Research B-X
The B-X
Protein B-X
Phosphatase B-X
Activity B-X
of B-X
PTEN B-X
Regulates B-X
Src B-X
Family B-X
Kinases B-X
and B-X
Controls B-X
Glioma B-X
Migration B-X
| B-X
Cancer B-X
Research B-X
The B-X
tumor B-X
suppressor B-X
PTEN B-X
is B-X
a B-X
phosphatase B-X
with B-X
sequence B-X
similarity B-X
to B-X
the B-X
cytoskeletal B-X
protein B-X
tensin B-X
. B-X
Here B-X
the B-X
cellular B-X
roles B-X
of B-X
PTEN B-X
were B-X
investigated B-X
. B-X
Overexpression B-X
of B-X
PTEN B-X
inhibited B-X
cell B-X
Abstract B-X
. B-X
Integrins B-X
are B-X
major B-X
adhesion- B-X
and B-X
signaling-receptor B-X
proteins B-X
that B-X
mediate B-X
cell B-X
migration B-X
and B-X
invasion B-X
. B-X
They B-X
also B-X
trigger B-X
a B-X
variety B-X
of B-X
signal B-X
transduc B-X
Integrins B-X
are B-X
major B-X
adhesion- B-X
and B-X
signaling-receptor B-X
proteins B-X
that B-X
mediate B-X
cell B-X
migration B-X
and B-X
invasion B-X
. B-X
They B-X
also B-X
trigger B-X
a B-X
variety B-X
of B-X
signal B-X
transduction B-X
pathways B-X
and B-X
regulate B-X
cytoskeletal B-X
organization B-X
, B-X
specific B-X
gene B-X

Heterogeneity	O
in	O
Schwartz	B-Disease
-	I-Disease
Jampel	I-Disease
chondrodystrophic	I-Disease
myotonia	I-Disease
.	O
<EOS> B-X
Chondrodystrophic B-X
myotonia B-X
or B-X
Schwartz-Jampel B-X
syndrome B-X
is B-X
a B-X
rare B-X
genetic B-X
disorder B-X
characterized B-X
by B-X
myotonia B-X
and B-X
skeletal B-X
dysplasia B-X
. B-X
It B-X
may B-X
be B-X
progressive B-X
in B-X
nature B-X
. B-X
Recently B-X
, B-X
the B-X
gene B-X
responsible B-X
for B-X

The	O
Schwartz	B-Disease
-	I-Disease
Jampel	I-Disease
syndrome	I-Disease
(	O
SJS	B-Disease
;	O
chondrodystrophic	B-Disease
myotonia	I-Disease
;	O
McK	O
255	O
,	O
800	O
)	O
is	O
a	O
recessively	B-Disease
inherited	I-Disease
condition	I-Disease
defined	O
by	O
myotonia	B-Disease
,	O
short	B-Disease
stature	I-Disease
,	O
and	O
bone	B-Disease
dysplasia	I-Disease
.	O
<EOS> B-X
Clinico-pathogenetic B-X
findings B-X
and B-X
management B-X
of B-X
chondrodystrophic B-X
myotonia B-X
( B-X
Schwartz-Jampel B-X
syndrome B-X
) B-X
: B-X
a B-X
case B-X
report B-X
Chondrodystrophic B-X
myotonia B-X
or B-X
Schwartz-Jampel B-X
syndrome B-X
is B-X
a B-X
rare B-X
genetic B-X
disorder B-X
characterized B-X
by B-X
myotonia B-X
and B-X
skeletal B-X
dysplasia B-X
. B-X
It B-X
may B-X
be B-X
progressive B-X
in B-X
nature B-X
. B-X
Recently B-X
, B-X
the B-X
gene B-X
responsible B-X
for B-X
Skeletal B-X
dysplasia B-X
describes B-X
a B-X
range B-X
of B-X
disorders B-X
that B-X
are B-X
present B-X
at B-X
birth B-X
and B-X
affect B-X
bone B-X
growth B-X
. B-X
Skeletal B-X
dysplasias B-X
, B-X
like B-X
achondroplasia B-X
, B-X
the B-X
most B-X
common B-X
type B-X
of B-X
dwarfism B-X
, B-X
affect B-X
the B-X
way B-X
bones B-X
grow B-X
. B-X
A B-X
genetic B-X
or B-X
pathological B-X
condition B-X
that B-X
is B-X
characterized B-X
by B-X
short B-X
stature B-X
and B-X
undersize B-X
. B-X
Abnormal B-X
skeletal B-X
growth B-X
usually B-X
results B-X
in B-X
an B-X
adult B-X
who B-X
is B-X
significantly B-X
below B-X
the B-X
average B-X
height B-X
. B-X
What B-X
is B-X
myotonia B-X
congenita B-X
? B-X
Myotonia B-X
congenita B-X
is B-X
an B-X
inherited B-X
myopathy B-X
, B-X
a B-X
disease B-X
that B-X
causes B-X
problems B-X
with B-X
the B-X
tone B-X
and B-X
contraction B-X
of B-X
skeletal B-X
muscles B-X
. B-X
It B-X
doesn B-X
‚Äô B-X
t B-X
Learn B-X
about B-X
skeletal B-X
dysplasia B-X
( B-X
dwarfism B-X
) B-X
from B-X
Cleveland B-X
Clinic B-X
. B-X
Read B-X
about B-X
the B-X
many B-X
causes B-X
of B-X
this B-X
set B-X
of B-X
conditions B-X
that B-X
can B-X
cause B-X
short B-X
stature B-X
in B-X
some B-X
people B-X
. B-X

Genetic	O
linkage	O
between	O
SJS	B-Disease
and	O
chromosomal	O
region	O
1q36	O
-	O
34	O
has	O
been	O
observed	O
in	O
several	O
families	O
,	O
but	O
the	O
gene	O
has	O
not	O
yet	O
been	O
identified	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
PP05.6 B-X
‚Äì B-X
2896 B-X
: B-X
Genotype-phenotype B-X
correlations B-X
and B-X
counseling B-X
in B-X
carriers B-X
of B-X
Filamin B-X
A B-X
gene B-X
mutations B-X
| B-X
Objective B-X
Mutations B-X
in B-X
the B-X
X-linked B-X
gene B-X
Filamin B-X
A B-X
( B-X
FLNA B-X
) B-X
HLA B-X
Association B-X
with B-X
Drug-Induced B-X
Adverse B-X
Reactions B-X
Genome-wide B-X
association B-X
study B-X
of B-X
Stevens-Johnson B-X
Syndrome B-X
and B-X
Toxic B-X
Epidermal B-X
Necrolysis B-X
in B-X
Europe B-X
PharmGKB B-X
Summary B-X
: B-X
Very B-X
Important B-X
Pharmacogene B-X
Information B-X
for B-X
Human B-X
Leukocyte B-X
Antigen B-X
B B-X
( B-X
HLA-B B-X
) B-X
Stevens-Johnson B-X
syndrome B-X
( B-X
SJS B-X
) B-X
and B-X
Toxic B-X
Epidermal B-X
Necrolysis B-X
( B-X
TEN B-X
) B-X
are B-X
rare B-X
but B-X
extremely B-X
severe B-X
cutaneous B-X
adverse B-X
drug B-X
reactions B-X
in B-X
which B-X
drug-specific B-X
associations B-X
with B-X
HLA-B B-X
alleles B-X
were B-X
described B-X
PDF B-X
| B-X
Chondrodystrophic B-X
myotonia B-X
or B-X
Schwartz-Jampel B-X
syndrome B-X
is B-X
a B-X
rare B-X
genetic B-X
disorder B-X
characterized B-X
by B-X
myotonia B-X
and B-X
skeletal B-X
dysplasia B-X
. B-X
It B-X
may B-X
be B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Request B-X
PDF B-X
| B-X
Structural B-X
and B-X
Functional B-X
Mutations B-X
of B-X
the B-X
Perlecan B-X
Gene B-X
Cause B-X
Schwartz-Jampel B-X
Syndrome B-X
, B-X
with B-X
Myotonic B-X
Myopathy B-X
and B-X
Chondrodysplasia B-X
| B-X
Perlecan B-X
, B-X
a B-X
large B-X
heparan B-X
sulfate B-X
proteoglycan B-X
, B-X
is B-X

We	O
studied	O
the	O
clinical	O
and	O
radiological	O
features	O
in	O
81	O
patients	O
from	O
the	O
literature	O
and	O
5	O
own	O
patients	O
trying	O
to	O
identify	O
distinct	O
subgroups	O
.	O
<EOS> B-X
Identification B-X
of B-X
subgroups B-X
of B-X
inflammatory B-X
and B-X
degenerative B-X
MRI B-X
findings B-X
in B-X
the B-X
spine B-X
and B-X
sacroiliac B-X
joints B-X
: B-X
a B-X
latent B-X
class B-X
analysis B-X
of B-X
1037 B-X
patients B-X
with B-X
persistent B-X
low B-X
back B-X
pain B-X
Identifying B-X
Multiple B-X
Myeloma B-X
Prognostic B-X
Subgroups B-X
With B-X
Distinct B-X
Genetic B-X
and B-X
Clinical B-X
Features B-X
- B-X
The B-X
ASCO B-X
Post B-X
Download B-X
Citation B-X
| B-X
The B-X
use B-X
of B-X
a B-X
classification B-X
approach B-X
to B-X
identify B-X
subgroups B-X
of B-X
patients B-X
with B-X
acute B-X
low B-X
back B-X
pain B-X
. B-X
Interrater B-X
reliability B-X
and B-X
short-term B-X
treatment B-X
outcomes B-X
| B-X
A B-X
prospective B-X
, B-X
Defining B-X
distinct B-X
features B-X
of B-X
anti-MOG B-X
antibody B-X
associated B-X
central B-X
nervous B-X
system B-X
demyelination B-X
The B-X
population B-X
of B-X
adults B-X
with B-X
Alzheimer B-X
‚Äô B-X
s B-X
disease B-X
( B-X
AD B-X
) B-X
varies B-X
in B-X
needs B-X
and B-X
outcomes B-X
. B-X
The B-X
heterogeneity B-X
of B-X
current B-X
AD B-X
diagnostic B-X
subgroups B-X
impedes B-X
the B-X
use B-X
of B-X
data B-X
Request B-X
PDF B-X
| B-X
Anti-MOG B-X
antibodies B-X
are B-X
present B-X
in B-X
a B-X
subgroup B-X
of B-X
patients B-X
with B-X
a B-X
neuromyelitis B-X
optica B-X
phenotype B-X
| B-X
Background B-X
: B-X
Antibodies B-X
against B-X
myelin B-X
oligodendrocyte B-X
glycoprotein B-X
( B-X
MOG B-X
) B-X
have B-X
been B-X
COVID-19 B-X
pneumonia B-X
: B-X
what B-X
has B-X
CT B-X
taught B-X
us B-X
? B-X
- B-X
The B-X
Lancet B-X
Infectious B-X
Diseases B-X

In	O
addition	O
,	O
we	O
tested	O
genetic	O
linkage	O
to	O
the	O
SJS	B-Disease
locus	O
on	O
chromosome	O
1	O
in	O
one	O
family	O
with	O
two	O
affected	O
sibs	O
.	O
<EOS> B-X
Mapping B-X
autism B-X
risk B-X
loci B-X
using B-X
genetic B-X
linkage B-X
and B-X
chromosomal B-X
rearrangements B-X
Chromosome B-X
1 B-X
is B-X
the B-X
largest B-X
human B-X
chromosome B-X
, B-X
spanning B-X
about B-X
249 B-X
million B-X
DNA B-X
building B-X
blocks B-X
( B-X
base B-X
pairs B-X
) B-X
and B-X
representing B-X
approximately B-X
8 B-X
percent B-X
of B-X
the B-X
total B-X
DNA B-X
in B-X
cells B-X
Linkage B-X
Analysis B-X
in B-X
the B-X
Next-Generation B-X
Sequencing B-X
Era B-X
Identification B-X
of B-X
a B-X
New B-X
Locus B-X
for B-X
a B-X
Peculiar B-X
Form B-X
of B-X
Congenital B-X
Muscular B-X
Dystrophy B-X
with B-X
Early B-X
Rigidity B-X
of B-X
the B-X
Spine B-X
, B-X
on B-X
Chromosome B-X
1p35-36 B-X
- B-X
ScienceDirect B-X
All B-X
FOXP2-related B-X
speech B-X
and B-X
language B-X
disorders B-X
, B-X
regardless B-X
of B-X
the B-X
underlying B-X
genetic B-X
alteration B-X
, B-X
have B-X
a B-X
core B-X
phenotype B-X
: B-X
childhood B-X
apraxia B-X
of B-X
speech B-X
( B-X
CAS B-X
) B-X
, B-X
a B-X
disorder B-X
of B-X

We	O
found	O
that	O
a	O
group	O
of	O
patients	O
have	O
mild	O
skeletal	O
changes	O
which	O
may	O
be	O
secondary	O
consequences	O
of	O
myotonia	B-Disease
,	O
while	O
another	O
group	O
of	O
patients	O
appear	O
to	O
have	O
primary	O
bone	B-Disease
dysplasia	I-Disease
with	O
myotonia	B-Disease
.	O
<EOS> B-X
Measuring B-X
quality B-X
of B-X
life B-X
impairment B-X
in B-X
skeletal B-X
muscle B-X
channelopathies B-X
Potassium-Aggravated B-X
Myotonia B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
The B-X
nondystrophic B-X
myotonias B-X
are B-X
an B-X
important B-X
group B-X
of B-X
skeletal B-X
muscle B-X
channelopathies B-X
electrophysiologically B-X
characterized B-X
by B-X
altered B-X
membrane B-X
excitability B-X
. B-X
Learn B-X
more B-X
about B-X
how B-X
to B-X
diagnosis B-X
and B-X
treat B-X
this B-X
condition B-X
. B-X
X-Linked B-X
Myotubular B-X
Myopathy B-X
- B-X
NORD B-X
( B-X
National B-X
Organization B-X
for B-X
Rare B-X
Disorders B-X
) B-X
Myotonic B-X
dystrophy B-X
type B-X
1 B-X
( B-X
DM1 B-X
) B-X
and B-X
type B-X
2 B-X
( B-X
DM2 B-X
) B-X
represent B-X
the B-X
most B-X
frequent B-X
multisystemic B-X
muscular B-X
dystrophies B-X
in B-X
adulthood B-X
. B-X
They B-X
are B-X
progressive B-X
, B-X
autosomal B-X
dominant B-X
diseases B-X
Myotonic B-X
dystrophies B-X
( B-X
DM B-X
) B-X
are B-X
slowly B-X
progressing B-X
multisystemic B-X
disorders B-X
caused B-X
by B-X
repeat B-X
expansions B-X
in B-X
the B-X
DMPK B-X
or B-X
CNBP B-X
genes B-X
. B-X
The B-X
multisystemic B-X
involvement B-X
in B-X
DM B-X
patients B-X
often B-X
reflects B-X
the B-X
Myotonia B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Within	O
this	O
latter	O
group	O
,	O
there	O
are	O
differences	O
in	O
age	O
of	O
manifestation	O
,	O
clinical	O
course	O
and	O
pattern	O
of	O
bone	O
changes	O
.	O
<EOS> B-X
Pediatric B-X
Lupus B-X
‚Äì B-X
Are B-X
There B-X
Differences B-X
in B-X
Presentation B-X
, B-X
Genetics B-X
, B-X
Response B-X
to B-X
Therapy B-X
, B-X
Damage B-X
Accrual B-X
Compared B-X
to B-X
Adult B-X
Lupus B-X
? B-X
Update B-X
on B-X
Bone B-X
Forming B-X
Tumors B-X
of B-X
the B-X
Head B-X
and B-X
Neck B-X
Abstract B-X
. B-X
Psoriasis B-X
and B-X
PsA B-X
are B-X
immune-mediated B-X
diseases B-X
with B-X
a B-X
strong B-X
genetic B-X
component B-X
. B-X
More B-X
than B-X
20 B-X
new B-X
loci B-X
have B-X
been B-X
recently B-X
linked B-X
to B-X
these B-X
diseases B-X
. B-X
How B-X
Fabry B-X
disease B-X
revisited B-X
: B-X
Management B-X
and B-X
treatment B-X
recommendations B-X
for B-X
adult B-X
patients B-X
- B-X
ScienceDirect B-X
Rheumatoid B-X
Arthritis B-X
: B-X
Early B-X
diagnosis B-X
and B-X
treatment B-X
outcomes B-X
Neoplasm B-X
or B-X
not B-X
? B-X
General B-X
principles B-X
of B-X
morphologic B-X
analysis B-X
of B-X
dry B-X
bone B-X
specimens B-X
- B-X
ScienceDirect B-X
Most B-X
people B-X
will B-X
live B-X
to B-X
experience B-X
aging B-X
. B-X
Age-related B-X
deterioration B-X
is B-X
affecting B-X
an B-X
ever-growing B-X
number B-X
of B-X
people B-X
. B-X
Although B-X
the B-X
process B-X
is B-X
unavoidable B-X
, B-X
it B-X
is B-X
important B-X
to B-X
understand B-X
the B-X

We	O
tentatively	O
isolate	O
three	O
different	O
types	O
of	O
SJS	B-Disease
type	I-Disease
1A	I-Disease
,	O
usually	O
recognized	O
in	O
childhood	O
,	O
with	O
moderate	O
bone	B-Disease
dysplasia	I-Disease
,	O
corresponding	O
to	O
the	O
original	O
descriptions	O
of	O
Schwartz	O
,	O
Jampel	O
and	O
Aberfeld	O
;	O
type	O
1B	O
,	O
similar	O
to	O
type	O
1A	O
but	O
recognizable	O
at	O
birth	O
,	O
with	O
more	O
pronounced	O
bone	B-Disease
dysplasia	I-Disease
resembling	O
Kniest	B-Disease
dysplasia	I-Disease
;	O
and	O
type	O
2	O
,	O
manifest	O
at	O
birth	O
,	O
with	O
increased	O
mortality	O
and	O
bone	B-Disease
dysplasia	I-Disease
resembling	O
Pyle	B-Disease
disease	I-Disease
.	O
<EOS> B-X
Skeletal B-X
dysplasia B-X
describes B-X
a B-X
category B-X
of B-X
rare B-X
genetic B-X
disorders B-X
that B-X
affect B-X
bones B-X
and B-X
joints B-X
and B-X
hinder B-X
children B-X
‚Äô B-X
s B-X
growth B-X
and B-X
development B-X
. B-X
The B-X
disorder B-X
causes B-X
abnormally B-X
shaped B-X
bones B-X
. B-X
Request B-X
PDF B-X
| B-X
Schwartz-Jampel B-X
Syndrome B-X
: B-X
three B-X
pediatric B-X
case B-X
reports B-X
| B-X
Schwartz-Jampel B-X
syndrome B-X
is B-X
a B-X
heterogeneous B-X
autosomal B-X
recessive B-X
syndrome B-X
defined B-X
by B-X
myotonia B-X
, B-X
short B-X
stature B-X
, B-X
bone B-X
dysplasia B-X
and B-X
growth B-X
PDF B-X
| B-X
Schwartz-Jampel B-X
syndrome B-X
is B-X
a B-X
rare B-X
autosomal B-X
recessive B-X
disorder B-X
characterized B-X
by B-X
myotonia B-X
and B-X
skeletal B-X
dysplasia B-X
. B-X
Botulinum B-X
toxin B-X
A B-X
is B-X
emerging B-X
as B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
The B-X
radiologic B-X
diagnosis B-X
of B-X
skeletal B-X
dysplasias B-X
: B-X
past B-X
, B-X
present B-X
and B-X
future B-X
Download B-X
Table B-X
| B-X
Two B-X
point B-X
lod B-X
scores B-X
for B-X
a B-X
microsatellite B-X
at B-X
the B-X
locus B-X
APOC B-X
II B-X
from B-X
publication B-X
: B-X
Genetic B-X
heterogeneity B-X
in B-X
Schwartz-Jampel B-X
syndrome B-X
: B-X
Two B-X
families B-X
with B-X
neonatal B-X
Schwartz-Jampel B-X
syndrome B-X
Kniest B-X
dysplasia B-X
is B-X
a B-X
variant B-X
of B-X
the B-X
spondyloepiphyseal B-X
dysplasias B-X
causedby B-X
an B-X
abnormal B-X
synthesis B-X
of B-X
collagen B-X
type B-X
II B-X
. B-X
In B-X
1952 B-X
, B-X
Kniest B-X
reportedthe B-X
first B-X
specifi B-X
Kniest B-X
dysplasia B-X
- B-X
Wikipedia B-X

Genetic	O
analysis	O
of	O
the	O
family	O
with	O
two	O
sibs	O
affected	O
by	O
SJS	B-Disease
type	I-Disease
2	I-Disease
showed	O
evidence	O
against	O
linkage	O
to	O
chromosome	O
1p36	O
-	O
34	O
.	O
<EOS> B-X
Download B-X
Citation B-X
| B-X
Schwartz-Jampel B-X
Syndrome B-X
| B-X
In B-X
1962 B-X
, B-X
Schwartz B-X
and B-X
Jampel B-X
described B-X
the B-X
first B-X
case B-X
of B-X
Schwartz-Jampel B-X
syndrome B-X
( B-X
SJS B-X
) B-X
or B-X
chondrodystrophic B-X
myotonia B-X
. B-X
| B-X
Find B-X
, B-X
read B-X
Request B-X
PDF B-X
| B-X
Schwartz-Jampel B-X
Syndrome B-X
| B-X
In B-X
1962 B-X
, B-X
Schwartz B-X
and B-X
Jampel B-X
described B-X
the B-X
first B-X
case B-X
of B-X
Schwartz-Jampel B-X
syndrome B-X
( B-X
SJS B-X
) B-X
or B-X
chondrodystrophic B-X
myotonia B-X
. B-X
| B-X
Find B-X
, B-X
read B-X
Issue B-X
: B-X
The B-X
American B-X
Journal B-X
of B-X
Human B-X
Genetics B-X

CONCLUSIONS	O
SJS	B-Disease
is	O
clinically	O
and	O
radiologically	O
heterogeneous	O
.	O
<EOS> B-X
Chronic B-X
pulmonary B-X
complications B-X
associated B-X
with B-X
toxic B-X
epidermal B-X
necrolysis B-X
: B-X
A B-X
case B-X
report B-X
and B-X
literature B-X
review B-X
PDF B-X
| B-X
Schwartz-Jampel B-X
syndrome B-X
( B-X
SJS B-X
) B-X
, B-X
first B-X
described B-X
in B-X
the B-X
United B-X
States B-X
in B-X
1962 B-X
, B-X
is B-X
a B-X
hereditary B-X
disorder B-X
characterized B-X
by B-X
facial B-X
dysmorphism B-X
and B-X
... B-X
| B-X
Find B-X
, B-X
Stevens-Johnson B-X
syndrome B-X
( B-X
SJS B-X
) B-X
is B-X
an B-X
acute B-X
inflammatory B-X
skin B-X
condition B-X
. B-X
Terminology B-X
SJS B-X
is B-X
on B-X
a B-X
spectrum B-X
of B-X
disease B-X
with B-X
toxic B-X
epidermal B-X
necrolysis B-X
syndrome B-X
( B-X
TENS B-X
) B-X
at B-X
the B-X
Request B-X
PDF B-X
| B-X
Dental B-X
findings B-X
and B-X
muscular-skeletal B-X
features B-X
in B-X
Schwartz-Jampel B-X
syndrome B-X
: B-X
case B-X
report B-X
of B-X
two B-X
affected B-X
siblings B-X
| B-X
Schwartz-Jampel B-X
syndrome B-X
( B-X
SJS B-X
) B-X
is B-X
a B-X
rare B-X
, B-X
inherited B-X
disorder B-X
Schwartz‚ÄìJampel B-X
syndrome B-X
( B-X
SJS B-X
) B-X
is B-X
a B-X
very B-X
rare B-X
inherited B-X
disorder B-X
characterized B-X
by B-X
multiple B-X
skeletal B-X
deformities B-X
, B-X
limited B-X
joint B-X
mobility B-X
, B-X
micrognathia B-X
, B-X
blepharophimosis B-X
, B-X
myotonia B-X
, B-X
and B-X
growth B-X
retardation B-X
Toxic B-X
epidermal B-X
necrolysis B-X
( B-X
TEN B-X
) B-X
and B-X
Stevens B-X
Johnson B-X
Syndrome B-X
( B-X
SJS B-X
) B-X
are B-X
severe B-X
adverse B-X
cutaneous B-X
drug B-X
reactions B-X
that B-X
predominantly B-X
involve B-X
the B-X
skin B-X
and B-X
mucous B-X
membranes B-X
. B-X
Both B-X
are B-X

The	O
causes	O
of	O
heterogeneity	O
are	O
not	O
known	O
yet	O
but	O
are	O
likely	O
to	O
include	O
both	O
different	O
mutations	O
at	O
the	O
SJS	B-Disease
locus	O
on	O
chromosome	O
1	O
and	O
the	O
presence	O
of	O
a	O
second	O
SJS	B-Disease
locus	O
.	O
<EOS> B-X
Challenges B-X
and B-X
solutions B-X
for B-X
gene B-X
identification B-X
in B-X
the B-X
presence B-X
of B-X
familial B-X
locus B-X
heterogeneity B-X
Using B-X
whole B-X
exome B-X
sequencing B-X
to B-X
identify B-X
inherited B-X
causes B-X
of B-X
autism B-X
A B-X
novel B-X
locus B-X
for B-X
episodic B-X
ataxia B-X
: B-X
UBR4 B-X
the B-X
likely B-X
candidate B-X
Ion B-X
channels B-X
and B-X
neurological B-X
disease B-X
: B-X
DNA B-X
based B-X
diagnosis B-X
is B-X
now B-X
possible B-X
, B-X
and B-X
ion B-X
channels B-X
may B-X
be B-X
important B-X
in B-X
common B-X
paroxysmal B-X
disorders B-X
| B-X
Journal B-X
of B-X
Neurology B-X
, B-X
Neurosurgery B-X
& B-X
Episodic B-X
ataxias B-X
( B-X
EAs B-X
) B-X
are B-X
rare B-X
neurological B-X
channelopathies B-X
that B-X
are B-X
characterized B-X
by B-X
spells B-X
of B-X
imbalance B-X
and B-X
a B-X
lack B-X
of B-X
co-ordination B-X
. B-X
There B-X
are B-X
seven B-X
clinically B-X
recognized B-X
EAs B-X
and B-X
multiple B-X
Request B-X
PDF B-X
| B-X
Spectrum B-X
of B-X
HSPG2 B-X
( B-X
Perlecan B-X
) B-X
mutations B-X
in B-X
patients B-X
with B-X
Schwartz-Jampel B-X
syndrome B-X
| B-X
Schwartz-Jampel B-X
syndrome B-X
( B-X
SJS B-X
) B-X
is B-X
a B-X
rare B-X
autosomal B-X
recessive B-X
condition B-X
defined B-X
by B-X
the B-X
PDF B-X
| B-X
To B-X
interpret B-X
genetic B-X
variants B-X
discovered B-X
from B-X
next-generation B-X
sequencing B-X
( B-X
NGS B-X
) B-X
, B-X
integration B-X
of B-X
heterogeneous B-X
information B-X
is B-X
vital B-X
for B-X
success B-X
.... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X

A	O
tentative	O
clinico	O
-	O
radiological	O
classification	O
can	O
be	O
useful	O
for	O
the	O
characterization	O
of	O
patients	O
and	O
the	O
development	O
of	O
genotype	O
-	O
phenotype	O
correlations	O
.	O
.	O
<EOS> B-X
We B-X
developed B-X
a B-X
comprehensive B-X
mutation B-X
detection B-X
system B-X
with B-X
a B-X
detection B-X
rate B-X
of B-X
almost B-X
20 B-X
% B-X
in B-X
unselected B-X
patients B-X
and B-X
up B-X
to B-X
85 B-X
% B-X
in B-X
a B-X
selected B-X
group B-X
. B-X
Using B-X
the B-X
Genotype-phenotype B-X
correlation B-X
in B-X
Brazillian B-X
Rett B-X
syndrome B-X
patients B-X
Request B-X
PDF B-X
| B-X
Investigating B-X
genotype-phenotype B-X
relationships B-X
in B-X
Rett B-X
syndrome B-X
using B-X
an B-X
international B-X
data B-X
set B-X
| B-X
Rett B-X
syndrome B-X
is B-X
an B-X
uncommon B-X
neurodevelopmental B-X
disorder B-X
with B-X
an B-X
incidence B-X
of B-X
1:9,000 B-X
live B-X
female B-X
births B-X
Rubinstein-Taybi B-X
syndrome B-X
( B-X
RSTS B-X
) B-X
is B-X
an B-X
extremely B-X
rare B-X
autosomal B-X
dominant B-X
genetic B-X
disease B-X
, B-X
with B-X
an B-X
estimated B-X
prevalence B-X
of B-X
one B-X
case B-X
per B-X
125,000 B-X
live B-X
births B-X
. B-X
RSTS B-X
is B-X
characterized B-X
by B-X

A	O
clinical	O
overview	O
of	O
WT1	O
gene	O
mutations	O
.	O
<EOS> B-X
A B-X
clinical B-X
overview B-X
of B-X
WT1 B-X
gene B-X
mutations B-X
- B-X
Little B-X
- B-X
1997 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Mutation B-X
Analysis B-X
of B-X
the B-X
WT1 B-X
Gene B-X
in B-X
Myelodysplastic B-X
Syndromes B-X
Abstract B-X
. B-X
To B-X
evaluate B-X
the B-X
incidence B-X
and B-X
clinical B-X
impact B-X
of B-X
WT1 B-X
gene B-X
mutations B-X
in B-X
younger B-X
adult B-X
patients B-X
with B-X
cytogenetically B-X
normal B-X
acute B-X
myeloid B-X
leukemia B-X
( B-X
CN-A B-X
Abstract B-X
. B-X
Recent B-X
studies B-X
of B-X
WT1 B-X
mutations B-X
in B-X
acute B-X
myeloid B-X
leukemia B-X
( B-X
AML B-X
) B-X
mostly B-X
report B-X
an B-X
association B-X
with B-X
unfavorable B-X
clinical B-X
outcome B-X
. B-X
We B-X
screened B-X
842 B-X
patien B-X
Clinical B-X
Trials B-X
and B-X
Observations B-X
: B-X
Prevalence B-X
and B-X
prognostic B-X
implications B-X
of B-X
WT1 B-X
mutations B-X
in B-X
pediatric B-X
acute B-X
myeloid B-X
leukemia B-X
( B-X
AML B-X
) B-X
: B-X
a B-X
report B-X
from B-X
the B-X
Children B-X
's B-X
Oncology B-X
Group B-X
Prognostic B-X
implications B-X
of B-X
mutations B-X
and B-X
expression B-X
of B-X
the B-X
Wilms B-X
tumor B-X
1 B-X
( B-X
WT1 B-X
) B-X
gene B-X
in B-X
adult B-X
acute B-X
T-lymphoblastic B-X
leukemia B-X
Mutations B-X
in B-X
the B-X
WT1 B-X
gene B-X
were B-X
anticipated B-X
to B-X
explain B-X
the B-X
genetic B-X
basis B-X
of B-X
the B-X
childhood B-X
kidney B-X
cancer B-X
, B-X
Wilms B-X
tumour B-X
( B-X
WT B-X
) B-X
. B-X
Six B-X
years B-X
on B-X
, B-X
we B-X
review B-X

Mutations	O
in	O
the	O
WT1	O
gene	O
were	O
anticipated	O
to	O
explain	O
the	O
genetic	O
basis	O
of	O
the	O
childhood	O
kidney	B-Disease
cancer	I-Disease
,	O
Wilms	B-Disease
tumour	I-Disease
(	O
WT	B-Disease
)	O
.	O
<EOS> B-X
PDF B-X
| B-X
Wilms B-X
tumour B-X
( B-X
WT B-X
) B-X
is B-X
the B-X
most B-X
common B-X
malignant B-X
neoplasm B-X
of B-X
the B-X
kidney B-X
in B-X
childhood B-X
and B-X
accounts B-X
for B-X
approximately B-X
8 B-X
% B-X
of B-X
all B-X
childhood B-X
solid B-X
... B-X
| B-X
The B-X
WT1 B-X
Wilms B-X
tumor B-X
gene B-X
product B-X
: B-X
a B-X
developmentally B-X
regulated B-X
transcription B-X
factor B-X
in B-X
the B-X
kidney B-X
that B-X
functions B-X
as B-X
a B-X
tumor B-X
suppressor B-X
- B-X
III B-X
- B-X
1993 B-X
- B-X
The B-X
FASEB B-X
Journal B-X
- B-X
Wilms B-X
‚Äô B-X
tumours B-X
: B-X
about B-X
tumour B-X
suppressor B-X
genes B-X
, B-X
an B-X
oncogene B-X
and B-X
a B-X
chameleon B-X
gene B-X
Wilms B-X
' B-X
Tumor B-X
Suppressor B-X
Gene B-X
WT1 B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X
Wilms B-X
' B-X
Tumor B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Six	O
years	O
on	O
,	O
we	O
review	O
100	O
reports	O
of	O
intragenic	O
WT1	O
mutations	O
and	O
examine	O
the	O
accompanying	O
clinical	O
phenotypes	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
The B-X
Mutational B-X
Spectrum B-X
of B-X
WT1 B-X
in B-X
Male B-X
Infertility B-X
| B-X
To B-X
evaluate B-X
the B-X
impact B-X
of B-X
WT1 B-X
mutations B-X
in B-X
isolated B-X
severe B-X
spermatogenic B-X
impairment B-X
in B-X
a B-X
population B-X
of B-X
European B-X
ancestry B-X
PDF B-X
| B-X
WT1 B-X
gene B-X
mutations B-X
have B-X
been B-X
described B-X
in B-X
46 B-X
, B-X
XY B-X
patients B-X
with B-X
ambiguous B-X
genitalia B-X
or B-X
complete B-X
gonadal B-X
dysgenesis B-X
with B-X
or B-X
without B-X
Wilms B-X
' B-X
tumor B-X
, B-X
... B-X
| B-X
Find B-X
PDF B-X
| B-X
To B-X
analyze B-X
the B-X
prognostic B-X
impact B-X
of B-X
Wilms B-X
' B-X
tumor B-X
1 B-X
( B-X
WT1 B-X
) B-X
gene B-X
mutations B-X
in B-X
cytogenetically B-X
normal B-X
acute B-X
myeloid B-X
leukemia B-X
( B-X
CN-AML B-X
) B-X
. B-X
PATIENTS B-X
AND B-X
... B-X
PDF B-X
| B-X
Denys-Drash B-X
syndrome B-X
( B-X
DDS B-X
) B-X
and B-X
Frasier B-X
syndrome B-X
( B-X
FS B-X
) B-X
are B-X
caused B-X
by B-X
mutations B-X
of B-X
the B-X
WT1 B-X
gene B-X
. B-X
These B-X
disorders B-X
are B-X
characterized B-X
by B-X
renal B-X
disease B-X
, B-X
Papers B-X
with B-X
the B-X
keyword B-X
WAGR B-X
syndrome B-X
( B-X
Page B-X
7 B-X
) B-X
| B-X
Read B-X
by B-X
QxMD B-X

While	O
only	O
5	O
%	O
of	O
sporadic	B-Disease
Wilms	I-Disease
tumours	I-Disease
have	O
intragenic	O
WT1	O
mutations	O
,	O
>	O
90	O
%	O
of	O
patients	O
with	O
the	O
Denys	B-Disease
-	I-Disease
Drash	I-Disease
syndrome	I-Disease
(	O
renal	B-Disease
nephropathy	I-Disease
,	O
gonadal	B-Disease
anomaly	I-Disease
,	O
predisposition	B-Disease
to	I-Disease
WT	I-Disease
)	O
carry	O
constitutional	O
intragenic	O
WT1	O
mutations	O
.	O
<EOS> B-X
Mutations B-X
in B-X
the B-X
WT1 B-X
gene B-X
were B-X
anticipated B-X
to B-X
explain B-X
the B-X
genetic B-X
basis B-X
of B-X
the B-X
childhood B-X
kidney B-X
cancer B-X
, B-X
Wilms B-X
tumour B-X
( B-X
WT B-X
) B-X
. B-X
Six B-X
years B-X
on B-X
, B-X
we B-X
review B-X
Denys-Drash B-X
syndrome B-X
( B-X
DDS B-X
) B-X
is B-X
characterized B-X
by B-X
nephropathy B-X
, B-X
genital B-X
abnormalities B-X
, B-X
and B-X
predisposition B-X
to B-X
Wilms B-X
' B-X
tumor B-X
. B-X
DDS B-X
patients B-X
usually B-X
present B-X
heterozygous B-X
de B-X
novo B-X
germline B-X
< B-X
i B-X
Denys-Drash B-X
syndrome B-X
( B-X
DDS B-X
) B-X
is B-X
a B-X
rare B-X
disorder B-X
consisting B-X
of B-X
the B-X
triad B-X
of B-X
congenital B-X
nephropathy B-X
, B-X
Wilms B-X
tumor B-X
, B-X
and B-X
intersex B-X
disorders B-X
resulting B-X
from B-X
mutations B-X
in B-X
the B-X
Wilms B-X
tumor B-X
Raised B-X
risk B-X
of B-X
Wilms B-X
tumour B-X
in B-X
patients B-X
with B-X
aniridia B-X
and B-X
submicroscopic B-X
WT1 B-X
deletion B-X
The B-X
risk B-X
of B-X
ESRD B-X
is B-X
remarkably B-X
low B-X
for B-X
the B-X
majority B-X
of B-X
patients B-X
with B-X
Wilms B-X
tumor B-X
. B-X
However B-X
, B-X
those B-X
with B-X
WAGR B-X
or B-X
associated B-X
GU B-X
anomalies B-X
are B-X
at B-X
higher B-X
risk B-X
and B-X
Familial B-X
Wilms B-X
tumour B-X
resulting B-X
from B-X
WT1 B-X
mutation B-X
: B-X
intronic B-X
polymorphism B-X
causing B-X
artefactual B-X
constitutional B-X
homozygosity B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Renal B-X
Failure B-X
in B-X
the B-X
Denys-Drash B-X
and B-X
Wilms B-X
‚Äô B-X
Tumor-Aniridia B-X
Syndromes B-X
| B-X
Cancer B-X
Research B-X

WT1	O
mutations	O
have	O
also	O
been	O
reported	O
in	O
juvenile	B-Disease
granulosa	I-Disease
cell	I-Disease
tumour	I-Disease
,	O
non	B-Disease
-	I-Disease
asbestos	I-Disease
related	I-Disease
mesothelioma	I-Disease
,	O
desmoplastic	B-Disease
small	I-Disease
round	I-Disease
cell	I-Disease
tumour	I-Disease
and	O
,	O
most	O
recently	O
,	O
acute	B-Disease
myeloid	I-Disease
leukemia	I-Disease
.	O
.	O
<EOS> B-X
Desmoplastic B-X
small B-X
round B-X
cell B-X
tumors B-X
of B-X
the B-X
pleura B-X
: B-X
a B-X
review B-X
of B-X
the B-X
clinical B-X
literature B-X
Small B-X
cell B-X
mesothelioma B-X
is B-X
an B-X
extremely B-X
rare B-X
subtype B-X
that B-X
can B-X
be B-X
mistaken B-X
for B-X
small B-X
cell B-X
lung B-X
cancer B-X
. B-X
Learn B-X
about B-X
diagnosis B-X
and B-X
treatment B-X
. B-X
The B-X
new B-X
molecular B-X
biology B-X
of B-X
granulosa B-X
cell B-X
tumors B-X
of B-X
the B-X
ovary B-X
Ovary B-X
tumor B-X
- B-X
Granulosa B-X
cell B-X
tumor B-X
- B-X
adult B-X
The B-X
American B-X
Cancer B-X
Society B-X
's B-X
most B-X
recent B-X
estimates B-X
and B-X
statistics B-X
for B-X
acute B-X
myeloid B-X
leukemia B-X
in B-X
the B-X
United B-X
States B-X
are B-X
located B-X
here B-X
. B-X
‚Äò B-X
Acute B-X
myeloid B-X
leukemia B-X
: B-X
a B-X
comprehensive B-X
review B-X
and B-X
2016 B-X
update B-X
' B-X
Acute B-X
myeloid B-X
leukemia B-X
is B-X
also B-X
called B-X
acute B-X
myelocytic B-X
leukemia B-X
, B-X
acute B-X
myelogenous B-X
leukemia B-X
, B-X
acute B-X
granulocytic B-X
leukemia B-X
, B-X
acute B-X
non-lymphocytic B-X
leukemia B-X
, B-X
or B-X
sometimes B-X
just B-X
AML B-X
. B-X
It B-X
is B-X
most B-X

A	O
mutation	O
in	O
autosomal	B-Disease
dominant	I-Disease
myotonia	I-Disease
congenita	I-Disease
affects	O
pore	O
properties	O
of	O
the	O
muscle	O
chloride	O
channel	O
.	O
<EOS> B-X
A B-X
mutation B-X
in B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
affects B-X
pore B-X
properties B-X
of B-X
the B-X
muscle B-X
chloride B-X
channel B-X
| B-X
PNAS B-X
A B-X
mutation B-X
in B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
affects B-X
pore B-X
properties B-X
of B-X
the B-X
muscle B-X
chloride B-X
channel B-X
| B-X
PNAS B-X
A B-X
mutation B-X
in B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
affects B-X
pore B-X
properties B-X
of B-X
the B-X
muscle B-X
chloride B-X
channel B-X
| B-X
PNAS B-X
The B-X
Myotonia B-X
Congenita B-X
Mutation B-X
A331T B-X
Confers B-X
a B-X
Novel B-X
Hyperpolarization-Activated B-X
Gate B-X
to B-X
the B-X
Muscle B-X
Chloride B-X
Channel B-X
ClC-1 B-X
The B-X
Myotonia B-X
Congenita B-X
Mutation B-X
A331T B-X
Confers B-X
a B-X
Novel B-X
Hyperpolarization-Activated B-X
Gate B-X
to B-X
the B-X
Muscle B-X
Chloride B-X
Channel B-X
ClC-1 B-X
| B-X
Journal B-X
of B-X
Neuroscience B-X
Myotonia B-X
congenita B-X
( B-X
MC B-X
) B-X
is B-X
a B-X
genetic B-X
disease B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
skeletal B-X
muscle B-X
chloride B-X
channel B-X
gene B-X
( B-X
CLCN1 B-X
) B-X
encoding B-X
the B-X
skeletal B-X
muscle B-X
chloride B-X
channel B-X
( B-X
ClC-1 B-X

Autosomal	B-Disease
dominant	I-Disease
myotonia	I-Disease
congenita	I-Disease
is	O
an	O
inherited	B-Disease
disorder	I-Disease
of	I-Disease
skeletal	I-Disease
muscle	I-Disease
caused	O
by	O
mutations	O
in	O
a	O
voltage	O
-	O
gated	O
Cl	O
-	O
channel	O
gene	O
(	O
CLCN1	O
,	O
7q35	O
)	O
.	O
<EOS> B-X
Spectrum B-X
of B-X
mutations B-X
in B-X
the B-X
major B-X
human B-X
skeletal B-X
muscle B-X
chloride B-X
channel B-X
gene B-X
( B-X
CLCN1 B-X
) B-X
leading B-X
to B-X
myotonia B-X
. B-X
Recessive B-X
congenital B-X
myotonia B-X
resulting B-X
from B-X
maternal B-X
isodisomy B-X
of B-X
chromosome B-X
7 B-X
: B-X
a B-X
case B-X
report B-X
Myotonia B-X
, B-X
defined B-X
as B-X
delayed B-X
relaxation B-X
of B-X
muscle B-X
after B-X
contraction B-X
, B-X
is B-X
seen B-X
in B-X
a B-X
group B-X
of B-X
genetic B-X
disorders B-X
that B-X
includes B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
( B-X
Thomsen B-X
's B-X
disease B-X
) B-X
CLCN1 B-X
chloride B-X
voltage-gated B-X
channel B-X
1 B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
CLCN1 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Here	O
,	O
we	O
report	O
that	O
a	O
mutation	O
predicting	O
the	O
substitution	O
of	O
Gly	O
230	O
by	O
glutamic	O
acid	O
(	O
G230E	O
)	O
between	O
segments	O
D3	O
and	O
D4	O
dramatically	O
alters	O
the	O
pore	O
properties	O
of	O
a	O
recombinant	O
human	O
muscle	O
Cl	O
-	O
channel	O
(	O
hCIC	O
-	O
1	O
)	O
expressed	O
in	O
a	O
mammalian	O
cell	O
line	O
(	O
tsA201	O
)	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Characterization B-X
of B-X
two B-X
new B-X
dominant B-X
CIC-1 B-X
channel B-X
mutations B-X
associated B-X
with B-X
myotonia B-X
| B-X
Voltage-gated B-X
ClC-1 B-X
chloride B-X
channels B-X
encoded B-X
by B-X
the B-X
CLCN1 B-X
gene B-X
have B-X
a B-X
major B-X
role B-X
in B-X
setting B-X
Request B-X
PDF B-X
| B-X
Topology B-X
of B-X
the B-X
human B-X
skeletal B-X
muscle B-X
chloride B-X
channel B-X
hCIC-1 B-X
probed B-X
with B-X
hydrophilic B-X
epitope B-X
insertion B-X
| B-X
To B-X
investigate B-X
the B-X
membrane B-X
topology B-X
of B-X
the B-X
skeletal B-X
muscle B-X
chloride B-X
channel B-X
ClC-1 B-X
Request B-X
PDF B-X
| B-X
Mechanism B-X
of B-X
Inverted B-X
Activation B-X
of B-X
ClC-1 B-X
Channels B-X
Caused B-X
by B-X
a B-X
Novel B-X
Myotonia B-X
Congenita B-X
Mutation B-X
| B-X
The B-X
voltage-gated B-X
chloride B-X
channel B-X
ClC-1 B-X
is B-X
the B-X
major B-X
contributor B-X
of B-X
membrane B-X
conductance B-X
Request B-X
PDF B-X
| B-X
The B-X
Anion-Selective B-X
Pore B-X
of B-X
the B-X
Bestrophins B-X
, B-X
a B-X
Family B-X
of B-X
Chloride B-X
Channels B-X
Associated B-X
with B-X
Retinal B-X
Degeneration B-X
| B-X
Mutations B-X
in B-X
human B-X
bestrophin-1 B-X
( B-X
VMD2 B-X
) B-X
are B-X
genetically B-X
linked B-X
Request B-X
PDF B-X
| B-X
Carboxy-Terminal B-X
Truncations B-X
Modify B-X
the B-X
Outer B-X
Pore B-X
Vestibule B-X
of B-X
Muscle B-X
Chloride B-X
Channels B-X
| B-X
Mammalian B-X
ClC-type B-X
chloride B-X
channels B-X
have B-X
large B-X
cytoplasmic B-X
carboxy-terminal B-X
domains B-X
whose B-X
function B-X
is B-X
still B-X
insufficiently B-X
understood B-X
Download B-X
Citation B-X
| B-X
Novel B-X
CLCN1 B-X
mutations B-X
with B-X
unique B-X
clinical B-X
and B-X
electrophysiological B-X
consequences B-X
| B-X
Myotonia B-X
is B-X
a B-X
condition B-X
characterized B-X
by B-X
impaired B-X
relaxation B-X
of B-X
muscle B-X
following B-X
sudden B-X
forceful B-X
contraction B-X
. B-X
We B-X
systematically B-X

The	O
G230E	O
mutation	O
causes	O
substantial	O
changes	O
in	O
anion	O
and	O
cation	O
selectivity	O
as	O
well	O
as	O
a	O
fundamental	O
change	O
in	O
rectification	O
of	O
the	O
current	O
-	O
voltage	O
relationship	O
.	O

Whereas	O
wild	O
-	O
type	O
channels	O
are	O
characterized	O
by	O
pronounced	O
inward	O
rectification	O
and	O
a	O
Cl	O
>	O
thiocyanate	O
>	O
Br	O
>	O
NO	O
(	O
3	O
)	O
>	O
I	O
>	O
CH	O
(	O
3	O
)	O
SO	O
(	O
3	O
)	O
selectivity	O
,	O
G230E	O
exhibits	O
outward	O
rectification	O
at	O
positive	O
potentials	O
and	O
a	O
thiocyanate	O
>	O
NO	O
(	O
3	O
)	O
>	O
I	O
>	O
Br	O
>	O
Cl	O
>	O
CH	O
(	O
3	O
)	O
SO	O
(	O
3	O
)	O
selectivity	O
.	O
<EOS> B-X
Mechanism B-X
of B-X
Ba2+ B-X
block B-X
of B-X
a B-X
mouse B-X
inwardly B-X
rectifying B-X
K+ B-X
channel B-X
: B-X
differential B-X
contribution B-X
by B-X
two B-X
discrete B-X
residues B-X
1 B-X
. B-X
Depolarizing B-X
pulses B-X
positive B-X
to B-X
0 B-X
mV B-X
elicit B-X
a B-X
transient B-X
outward B-X
current B-X
( B-X
Ito B-X
) B-X
and B-X
a B-X
sustained B-X
'pedestal B-X
' B-X
current B-X
in B-X
canine B-X
atrial B-X
myocytes B-X
. B-X
The B-X
pedestal B-X
current B-X
Anion B-X
Permeation B-X
in B-X
Ca2+-Activated B-X
Cl‚àí B-X
Channels B-X
The B-X
Anion-Selective B-X
Pore B-X
of B-X
the B-X
Bestrophins B-X
, B-X
a B-X
Family B-X
of B-X
Chloride B-X
Channels B-X
Associated B-X
with B-X
Retinal B-X
Degeneration B-X
Request B-X
PDF B-X
| B-X
Myotonia B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
muscle B-X
chloride B-X
channel B-X
geneCLCN1 B-X
| B-X
Pure B-X
non-syndromic B-X
, B-X
non-dystrophic B-X
myotonia B-X
in B-X
humans B-X
is B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
genes B-X
coding B-X
for B-X
Identification B-X
of B-X
a B-X
region B-X
of B-X
strong B-X
discrimination B-X
in B-X
the B-X
pore B-X
of B-X
CFTR B-X
| B-X
American B-X
Journal B-X
of B-X
Physiology-Lung B-X
Cellular B-X
and B-X
Molecular B-X
Physiology B-X
PDF B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
1997 B-X
, B-X
Christoph B-X
Fahlke B-X
and B-X
others B-X
published B-X
Poreforming B-X
segments B-X
in B-X
voltage-gated B-X
chloride B-X
channels B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X

Furthermore	O
,	O
the	O
cation	O
-	O
to	O
-	O
anion	O
permeability	O
ratio	O
of	O
the	O
mutant	O
is	O
much	O
greater	O
than	O
that	O
of	O
the	O
wild	O
-	O
type	O
channel	O
.	O
<EOS> B-X
Cation B-X
Permeability B-X
and B-X
Cation-Anion B-X
Interactions B-X
in B-X
a B-X
Mutant B-X
GABA-Gated B-X
Chloride B-X
Channel B-X
from B-X
Drosophila B-X
: B-X
Biophysical B-X
Journal B-X
Cation B-X
Permeability B-X
and B-X
Cation-Anion B-X
Interactions B-X
in B-X
a B-X
Mutant B-X
GABA-Gated B-X
Chloride B-X
Channel B-X
from B-X
Drosophila B-X
: B-X
Biophysical B-X
Journal B-X
Relationship B-X
between B-X
anion B-X
binding B-X
and B-X
anion B-X
permeability B-X
revealed B-X
by B-X
mutagenesis B-X
within B-X
the B-X
cystic B-X
fibrosis B-X
transmembrane B-X
conductance B-X
regulator B-X
chloride B-X
channel B-X
pore B-X
A B-X
mutation B-X
in B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
affects B-X
pore B-X
properties B-X
of B-X
the B-X
muscle B-X
chloride B-X
channel B-X
. B-X
Determinants B-X
of B-X
Anion B-X
Permeation B-X
in B-X
the B-X
Second B-X
Transmembrane B-X
Domain B-X
of B-X
the B-X
Mouse B-X
Bestrophin-2 B-X
Chloride B-X
Channel B-X
A B-X
mutation B-X
in B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
affects B-X
pore B-X
properties B-X
of B-X
the B-X
muscle B-X
chloride B-X
channel B-X
Halide B-X
Permeation B-X
in B-X
Wild-Type B-X
and B-X
Mutant B-X
Cystic B-X
Fibrosis B-X
Transmembrane B-X
Conductance B-X
Regulator B-X
Chloride B-X
Channels B-X

Voltage	O
-	O
dependent	O
blocks	O
by	O
intracellular	O
and	O
extracellular	O
iodide	O
help	O
to	O
distinguish	O
two	O
distinct	O
ion	O
binding	O
sites	O
within	O
the	O
hClC	O
-	O
1	O
conduction	O
pathway	O
.	O
<EOS> B-X
Molecular B-X
mechanisms B-X
of B-X
ion B-X
conduction B-X
in B-X
ClC-type B-X
chloride B-X
channels B-X
: B-X
Lessons B-X
from B-X
disease-causing B-X
mutations B-X
- B-X
ScienceDirect B-X
PDF B-X
| B-X
Voltage-gated B-X
Cl- B-X
channels B-X
belonging B-X
to B-X
the B-X
ClC B-X
family B-X
exhibit B-X
unique B-X
properties B-X
of B-X
ion B-X
permeation B-X
and B-X
gating B-X
. B-X
We B-X
functionally B-X
probed B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X

Both	O
binding	O
sites	O
are	O
preserved	O
in	O
the	O
mutant	O
but	O
have	O
decreased	O
affinities	O
for	O
iodide	O
.	O
<EOS> B-X
A B-X
single B-X
active B-X
catalytic B-X
site B-X
is B-X
sufficient B-X
to B-X
promote B-X
transport B-X
in B-X
P-glycoprotein B-X
Mutations B-X
in B-X
factor B-X
H B-X
reduce B-X
binding B-X
affinity B-X
to B-X
C3b B-X
and B-X
heparin B-X
and B-X
surface B-X
attachment B-X
to B-X
endothelial B-X
cells B-X
in B-X
hemolytic B-X
uremic B-X
syndrome B-X
Inhibitor B-X
binding B-X
mode B-X
and B-X
allosteric B-X
regulation B-X
of B-X
Na+-glucose B-X
symporters B-X
Conformational B-X
diversity B-X
facilitates B-X
antibody B-X
mutation B-X
trajectories B-X
and B-X
discrimination B-X
between B-X
foreign B-X
and B-X
self-antigens B-X
| B-X
PNAS B-X
The B-X
Effect B-X
of B-X
Iodide B-X
and B-X
Chloride B-X
on B-X
Transthyretin B-X
Structure B-X
and B-X
Stability B-X
, B-X
| B-X
Biochemistry B-X

These	O
findings	O
suggest	O
that	O
Gly	O
230	O
is	O
critical	O
for	O
normal	O
ion	O
conductance	O
in	O
hClC	O
-	O
1	O
and	O
that	O
this	O
residue	O
resides	O
within	O
the	O
channel	O
pore	O
.	O
.	O
<EOS> B-X
A B-X
mutation B-X
in B-X
autosomal B-X
dominant B-X
myotonia B-X
congenita B-X
affects B-X
pore B-X
properties B-X
of B-X
the B-X
muscle B-X
chloride B-X
channel B-X
‚Äî B-X
Northwestern B-X
Scholars B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

The	O
incidence	O
of	O
PAX6	O
mutation	O
in	O
patients	O
with	O
simple	O
aniridia	B-Disease
:	O
an	O
evaluation	O
of	O
mutation	O
detection	O
in	O
12	O
cases	O
.	O
<EOS> B-X
The B-X
incidence B-X
of B-X
PAX6 B-X
mutation B-X
in B-X
patients B-X
with B-X
simple B-X
aniridia B-X
: B-X
an B-X
evaluation B-X
of B-X
mutation B-X
detection B-X
in B-X
12 B-X
cases B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
The B-X
incidence B-X
of B-X
PAX6 B-X
mutation B-X
in B-X
patients B-X
with B-X
simple B-X
aniridia B-X
: B-X
an B-X
evaluation B-X
of B-X
mutation B-X
detection B-X
in B-X
12 B-X
cases B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
Molecular B-X
analysis B-X
of B-X
the B-X
PAX6 B-X
gene B-X
for B-X
aniridia B-X
and B-X
congenital B-X
cataracts B-X
in B-X
Tunisian B-X
families B-X
Impaired B-X
DNA-binding B-X
affinity B-X
of B-X
novel B-X
PAX6 B-X
mutations B-X

Twelve	O
aniridia	B-Disease
patients	O
,	O
five	O
with	O
a	O
family	O
history	O
and	O
seven	O
presumed	O
to	O
be	O
sporadic	O
,	O
were	O
exhaustively	O
screened	O
in	O
order	O
to	O
test	O
what	O
proportion	O
of	O
people	O
with	O
aniridia	B-Disease
,	O
uncomplicated	O
by	O
associated	O
anomalies	O
,	O
carry	O
mutations	O
in	O
the	O
human	O
PAX6	O
gene	O
.	O
<EOS> B-X
Download B-X
Table B-X
| B-X
Primers B-X
for B-X
RT-PCR B-X
( B-X
numbering B-X
according B-X
to B-X
Ton B-X
et B-X
al B-X
' B-X
) B-X
from B-X
publication B-X
: B-X
The B-X
incidence B-X
of B-X
PAX6 B-X
mutation B-X
in B-X
patients B-X
with B-X
simple B-X
aniridia B-X
: B-X
An B-X
Request B-X
PDF B-X
| B-X
Novel B-X
mutations B-X
of B-X
the B-X
PAX6 B-X
gene B-X
identified B-X
in B-X
Chinese B-X
patients B-X
with B-X
aniridia B-X
| B-X
Mutations B-X
in B-X
PAX6 B-X
are B-X
the B-X
major B-X
cause B-X
of B-X
aniridia B-X
. B-X
Only B-X
a B-X
few B-X
PAX6 B-X
Chromosomal B-X
deletions B-X
at B-X
11p13 B-X
are B-X
a B-X
frequent B-X
cause B-X
of B-X
congenital B-X
Aniridia B-X
, B-X
a B-X
rare B-X
pan-ocular B-X
genetic B-X
disease B-X
, B-X
and B-X
of B-X
WAGR B-X
syndrome B-X
, B-X
accounting B-X
up B-X
to B-X
30 B-X
% B-X
of B-X
cases B-X
Parental B-X
Mosaicism B-X
in B-X
PAX6 B-X
Causes B-X
Intra-Familial B-X
Variability B-X
: B-X
Implications B-X
for B-X
Genetic B-X
Counseling B-X
of B-X
Congenital B-X
Aniridia B-X
and B-X
Microphthalmia B-X
Download B-X
Citation B-X
| B-X
A B-X
Review B-X
of B-X
the B-X
Clinical B-X
and B-X
Genetic B-X
Aspects B-X
of B-X
Aniridia B-X
| B-X
Abstract B-X
Aniridia B-X
classically B-X
presents B-X
with B-X
a B-X
bilateral B-X
congenital B-X
absence B-X
or B-X
malformation B-X
of B-X
the B-X
irides B-X
, B-X
foveal B-X
R B-X
Axton B-X
's B-X
8 B-X
research B-X
works B-X
with B-X
425 B-X
citations B-X
and B-X
360 B-X
reads B-X
, B-X
including B-X
: B-X
Hemolytic B-X
uremic B-X
syndrome B-X
associated B-X
with B-X
Denys-Drash B-X
syndrome B-X
Presented B-X
Abstracts B-X
from B-X
the B-X
Thirty B-X
Fourth B-X
Annual B-X
Education B-X
Conference B-X
of B-X
the B-X
National B-X
Society B-X
of B-X
Genetic B-X
Counselors B-X
( B-X
Pittsburgh B-X
, B-X
PA B-X
, B-X
October B-X
2015 B-X
) B-X
| B-X
SpringerLink B-X

Mutations	O
were	O
detected	O
in	O
90	O
%	O
of	O
the	O
cases	O
.	O
<EOS> B-X
By B-X
studying B-X
the B-X
protein B-X
C B-X
gene B-X
of B-X
121 B-X
consecutive B-X
patients B-X
with B-X
symptomatic B-X
type B-X
I B-X
protein B-X
C B-X
deficiency B-X
, B-X
we B-X
detected B-X
55 B-X
different B-X
candidate B-X
mutations B-X
in B-X
90 B-X
cases B-X
. B-X
The B-X
mutations B-X
This B-X
assay B-X
provides B-X
improved B-X
breadth B-X
and B-X
sensitivity B-X
for B-X
profiling B-X
clinically B-X
relevant B-X
genes B-X
in B-X
these B-X
prevalent B-X
solid B-X
tumor B-X
types B-X
. B-X
Activating B-X
mutations B-X
in B-X
the B-X
BRAF B-X
kinase B-X
have B-X
been B-X
reported B-X
in B-X
a B-X
large B-X
number B-X
of B-X
cases B-X
of B-X
malignant B-X
melanoma B-X
. B-X
This B-X
suggests B-X
that B-X
therapy B-X
with B-X
specific B-X
RAF B-X
kinase B-X
inhibitors B-X
may B-X
find B-X
The B-X
idiopathic B-X
CHD B-X
has B-X
a B-X
marked B-X
heterogeneity B-X
and B-X
the B-X
mutated B-X
GATA4 B-X
gene B-X
may B-X
be B-X
responsible B-X
for B-X
CHD B-X
in B-X
a B-X
subset B-X
of B-X
patients B-X
. B-X
The B-X
LungCarta B-X
panel B-X
is B-X
a B-X
sensitive B-X
method B-X
of B-X
screening B-X
for B-X
multiple B-X
alterations B-X
( B-X
214 B-X
mutations B-X
across B-X
26 B-X
genes B-X
) B-X
and B-X
which B-X
optimizes B-X
the B-X
use B-X
of B-X
limited B-X
amounts B-X
of B-X
tumor B-X
DNA B-X
The B-X
authors B-X
identified B-X
WNT10A B-X
as B-X
a B-X
major B-X
gene B-X
in B-X
the B-X
aetiology B-X
of B-X
isolated B-X
hypodontia B-X
. B-X
By B-X
including B-X
WNT10A B-X
in B-X
the B-X
DNA B-X
diagnostics B-X
of B-X
isolated B-X
tooth B-X
agenesis B-X
, B-X
the B-X
yield B-X
of B-X
To B-X
clarify B-X
the B-X
clinical B-X
significance B-X
of B-X
the B-X
mutation B-X
of B-X
p53 B-X
gene B-X
in B-X
hepatocellular B-X
carcinoma B-X
( B-X
HCC B-X
) B-X
, B-X
90 B-X
resected B-X
specimens B-X
from B-X
Japanese B-X
patients B-X
were B-X
assayed B-X
using B-X
a B-X
polymerase B-X
chain B-X

Three	O
mutation	O
detection	O
techniques	O
were	O
used	O
to	O
determine	O
if	O
one	O
method	O
was	O
superior	O
for	O
this	O
gene	O
.	O
<EOS> B-X
Computational B-X
approaches B-X
to B-X
identify B-X
functional B-X
genetic B-X
variants B-X
in B-X
cancer B-X
genomes B-X
Genomic B-X
mutation B-X
rates B-X
: B-X
What B-X
high-throughput B-X
methods B-X
can B-X
tell B-X
us B-X
Methods B-X
of B-X
molecular B-X
analysis B-X
: B-X
mutation B-X
detection B-X
in B-X
solid B-X
tumours B-X
| B-X
Molecular B-X
Pathology B-X
Many B-X
different B-X
methods B-X
were B-X
developed B-X
to B-X
detect B-X
commonly B-X
known B-X
mutations B-X
and B-X
to B-X
screen B-X
new B-X
mutations B-X
of B-X
the B-X
epidermal B-X
growth B-X
factor B-X
receptor B-X
in B-X
non-small B-X
cell B-X
lung B-X
cancer B-X
patients B-X
. B-X
Some B-X
of B-X

The	O
protein	O
truncation	O
test	O
(	O
PTT	O
)	O
was	O
used	O
on	O
RT	O
-	O
PCR	O
products	O
,	O
SSCP	O
on	O
genomic	O
PCR	O
amplifications	O
,	O
and	O
chemical	O
cleavage	O
of	O
mismatch	O
on	O
both	O
RT	O
-	O
PCR	O
and	O
genomic	O
amplifications	O
.	O
<EOS> B-X
Protein B-X
Truncation B-X
Test B-X
( B-X
PTT B-X
) B-X
for B-X
dystrophin B-X
The B-X
protein B-X
truncation B-X
test B-X
( B-X
PTT B-X
) B-X
is B-X
a B-X
mutation-detection B-X
method B-X
used B-X
to B-X
scan B-X
for B-X
premature B-X
termination B-X
( B-X
nonsense B-X
) B-X
mutations B-X
. B-X
PCR B-X
amplification B-X
of B-X
the B-X
DNA B-X
or B-X
mRNA B-X
source B-X
The B-X
predominance B-X
of B-X
truncative B-X
mutations B-X
responsible B-X
for B-X
choroideremia B-X
( B-X
CHM B-X
) B-X
led B-X
us B-X
to B-X
investigate B-X
the B-X
use B-X
of B-X
the B-X
protein B-X
truncation B-X
test B-X
( B-X
PTT B-X
) B-X
applied B-X
to B-X
lymphocyte B-X
RNA B-X
derived B-X
PCR B-X
candidate B-X
region B-X
mismatch B-X
scanning B-X
: B-X
adaptation B-X
to B-X
quantitative B-X
, B-X
high-throughput B-X
genotyping B-X
Comparison B-X
of B-X
the B-X
mismatch-specific B-X
endonuclease B-X
method B-X
and B-X
denaturing B-X
high-performance B-X
liquid B-X
chromatography B-X
for B-X
the B-X
identification B-X
of B-X
HBB B-X
gene B-X
mutations B-X
An B-X
Overview B-X
of B-X
Mutation B-X
Detection B-X
Methods B-X
in B-X
Genetic B-X
Disorders B-X
PCR-Based B-X
Methods B-X
for B-X
the B-X
Enrichment B-X
of B-X
Minority B-X
Alleles B-X
and B-X
Mutations B-X

For	O
RT	O
-	O
PCR	O
products	O
,	O
only	O
the	O
translated	O
portion	O
of	O
the	O
gene	O
was	O
screened	O
.	O
<EOS> B-X
Rapid B-X
and B-X
efficient B-X
cDNA B-X
library B-X
screening B-X
by B-X
self-ligation B-X
of B-X
inverse B-X
PCR B-X
products B-X
( B-X
SLIP B-X
) B-X
Automated B-X
selection B-X
of B-X
aptamers B-X
against B-X
protein B-X
targets B-X
translated B-X
in B-X
vitro B-X
: B-X
from B-X
gene B-X
to B-X
aptamer B-X
Identification B-X
of B-X
Novel B-X
Imprinted B-X
Genes B-X
in B-X
a B-X
Genome-Wide B-X
Screen B-X
for B-X
Maternal B-X
Methylation B-X
RT-PCR B-X
( B-X
reverse B-X
transcription-polymerase B-X
chain B-X
reaction B-X
) B-X
is B-X
the B-X
most B-X
sensitive B-X
technique B-X
for B-X
mRNA B-X
detection B-X
and B-X
quantitation B-X
currently B-X
available B-X
. B-X
Compared B-X
to B-X
the B-X
two B-X
other B-X
commonly B-X
used B-X
techniques B-X
for B-X
quantifying B-X
The B-X
characterization B-X
of B-X
the B-X
diversity B-X
of B-X
species B-X
living B-X
within B-X
ecosystems B-X
is B-X
of B-X
major B-X
scientific B-X
interest B-X
to B-X
understand B-X
the B-X
functioning B-X
of B-X
these B-X
ecosystems B-X
. B-X
It B-X
is B-X
also B-X
becoming B-X
a B-X
societal B-X
issue B-X
The B-X
process B-X
of B-X
making B-X
a B-X
ribonucleic B-X
acid B-X
( B-X
RNA B-X
) B-X
copy B-X
of B-X
a B-X
DNA B-X
( B-X
deoxyribonucleic B-X
acid B-X
) B-X
molecule B-X
, B-X
called B-X
transcription B-X
, B-X
is B-X
necessary B-X
for B-X
all B-X
forms B-X
of B-X
life B-X
Fragmented B-X
RNA B-X
from B-X
formalin-fixed B-X
paraffin-embedded B-X
( B-X
FFPE B-X
) B-X
tissue B-X
is B-X
a B-X
known B-X
obstacle B-X
to B-X
gene B-X
expression B-X
analysis B-X
. B-X
In B-X
this B-X
study B-X
, B-X
the B-X
impact B-X
of B-X
RNA B-X
integrity B-X
, B-X
gene-specific B-X
reverse B-X

On	O
genomic	O
products	O
exons	O
1	O
to	O
13	O
(	O
including	O
740	O
bp	O
of	O
the	O
3	O
untranslated	O
sequence	O
and	O
all	O
intron	O
/	O
exon	O
boundaries	O
)	O
were	O
screened	O
,	O
as	O
was	O
a	O
neuroretina	O
specific	O
enhancer	O
in	O
intron	O
4	O
.	O
<EOS> B-X
Identification B-X
and B-X
characterization B-X
of B-X
a B-X
neuroretina-specific B-X
enhancer B-X
element B-X
in B-X
the B-X
quail B-X
Pax-6 B-X
( B-X
Pax-QNR B-X
) B-X
gene B-X
. B-X
Conserved B-X
elements B-X
in B-X
Pax6 B-X
intron B-X
7 B-X
involved B-X
in B-X
( B-X
auto B-X
) B-X
regulation B-X
and B-X
alternative B-X
transcription B-X
- B-X
ScienceDirect B-X
The B-X
incidence B-X
of B-X
PAX6 B-X
mutation B-X
in B-X
patients B-X
with B-X
simple B-X
aniridia B-X
: B-X
an B-X
evaluation B-X
of B-X
mutation B-X
detection B-X
in B-X
12 B-X
cases B-X
. B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
GeneBase B-X
1.1 B-X
: B-X
a B-X
tool B-X
to B-X
summarize B-X
data B-X
from B-X
NCBI B-X
gene B-X
datasets B-X
and B-X
its B-X
application B-X
to B-X
an B-X
update B-X
of B-X
human B-X
gene B-X
statistics B-X
The B-X
Human B-X
Nramp2 B-X
Gene B-X
: B-X
Characterization B-X
of B-X
the B-X
Gene B-X
Structure B-X
, B-X
Alternative B-X
Splicing B-X
, B-X
Promoter B-X
Region B-X
and B-X
Polymorphisms B-X
- B-X
ScienceDirect B-X
Disruption B-X
of B-X
Autoregulatory B-X
Feedback B-X
by B-X
a B-X
Mutation B-X
in B-X
a B-X
Remote B-X
, B-X
Ultraconserved B-X
PAX6 B-X
Enhancer B-X
Causes B-X
Aniridia B-X
Cis-regulatory B-X
organization B-X
of B-X
the B-X
Pax6 B-X
gene B-X
in B-X
the B-X
ascidian B-X
Ciona B-X
intestinalis B-X

Ten	O
of	O
the	O
possible	O
12	O
mutations	O
in	O
the	O
five	O
familial	O
cases	O
and	O
five	O
of	O
the	O
sporadic	O
patients	O
were	O
found	O
,	O
all	O
of	O
which	O
conformed	O
to	O
a	O
functional	O
outcome	O
of	O
haploinsufficiency	O
.	O
<EOS> B-X
Why B-X
haploinsufficiency B-X
persists B-X
Evidence B-X
for B-X
a B-X
critical B-X
contribution B-X
of B-X
haploinsufficiency B-X
in B-X
the B-X
complex B-X
pathogenesis B-X
of B-X
Marfan B-X
syndrome B-X
Loss-of-function B-X
mutations B-X
in B-X
TNFAIP3 B-X
leading B-X
to B-X
A20 B-X
haploinsufficiency B-X
cause B-X
an B-X
early B-X
onset B-X
autoinflammatory B-X
syndrome B-X
Why B-X
haploinsufficiency B-X
persists B-X
| B-X
PNAS B-X
Mechanisms B-X
of B-X
Haploinsufficiency B-X
Revealed B-X
by B-X
Genome-Wide B-X
Profiling B-X
in B-X
Yeast B-X
Characterising B-X
and B-X
Predicting B-X
Haploinsufficiency B-X
in B-X
the B-X
Human B-X
Genome B-X
Clinical B-X
and B-X
genetic B-X
characteristics B-X
of B-X
Chinese B-X
patients B-X
with B-X
familial B-X
or B-X
sporadic B-X
pediatric B-X
cataract B-X

Five	O
were	O
splice	O
site	O
mutations	O
(	O
one	O
in	O
the	O
donor	O
site	O
of	O
intron	O
4	O
,	O
two	O
in	O
the	O
donor	O
site	O
of	O
intron	O
6	O
,	O
one	O
in	O
each	O
of	O
the	O
acceptor	O
sites	O
of	O
introns	O
8	O
and	O
9	O
)	O
and	O
five	O
were	O
nonsense	O
mutations	O
in	O
exons	O
8	O
,	O
9	O
,	O
10	O
,	O
11	O
,	O
and	O
12	O
.	O
<EOS> B-X
Common B-X
Multiples B-X
of B-X
9 B-X
, B-X
10 B-X
, B-X
11 B-X
, B-X
and B-X
12 B-X
? B-X
( B-X
Page B-X
1 B-X
) B-X
/ B-X
Help B-X
Me B-X
! B-X
/ B-X
Math B-X
Is B-X
Fun B-X
Forum B-X
The B-X
human B-X
HPRT B-X
gene B-X
contains B-X
spans B-X
approximately B-X
42,000 B-X
base B-X
pairs B-X
in B-X
genomic B-X
DNA B-X
, B-X
has B-X
a B-X
mRNA B-X
of B-X
approximately B-X
900 B-X
bases B-X
and B-X
a B-X
protein B-X
coding B-X
sequence B-X
of B-X
657 B-X
bases B-X
( B-X
NCERT B-X
Exemplar B-X
Problems B-X
Solutions B-X
for B-X
Class B-X
6 B-X
, B-X
7 B-X
, B-X
8 B-X
, B-X
9 B-X
, B-X
10 B-X
, B-X
11 B-X
, B-X
12 B-X
all B-X
subjects B-X
like B-X
Maths B-X
, B-X
Science B-X
, B-X
Physics B-X
, B-X
Chemistry B-X
, B-X
Unraveling B-X
the B-X
effect B-X
of B-X
silent B-X
, B-X
intronic B-X
and B-X
missense B-X
mutations B-X
on B-X
VWF B-X
splicing B-X
: B-X
contribution B-X
of B-X
next B-X
generation B-X
sequencing B-X
in B-X
the B-X
study B-X
of B-X
mRNA B-X
| B-X
Haematologica B-X
Validation B-X
and B-X
Classification B-X
of B-X
Atypical B-X
Splicing B-X
Variants B-X
Associated B-X
With B-X
Osteogenesis B-X
Imperfecta B-X
NCERT B-X
Solutions B-X
for B-X
Class B-X
6 B-X
to B-X
12 B-X
are B-X
available B-X
in B-X
PDF B-X
format B-X
free B-X
download B-X
NCERT B-X
Solutions B-X
are B-X
solved B-X
by B-X
expert B-X
teachers B-X
session B-X
2020-2021 B-X
Novel B-X
intronic B-X
RHD B-X
variants B-X
identified B-X
in B-X
serologically B-X
D‚Äênegative B-X
blood B-X
donors B-X
- B-X
El B-X
Wafi B-X
- B-X
2017 B-X
- B-X
Vox B-X
Sanguinis B-X
- B-X
Wiley B-X
Online B-X
Library B-X

SSCP	O
analysis	O
of	O
individually	O
amplified	O
exons	O
,	O
with	O
which	O
nine	O
of	O
the	O
10	O
mutations	O
were	O
seen	O
,	O
was	O
the	O
most	O
useful	O
detection	O
method	O
for	O
PAX6	O
.	O
.	O
<EOS> B-X
Identification B-X
of B-X
novel B-X
mutant B-X
PAX6 B-X
alleles B-X
in B-X
Indian B-X
cases B-X
of B-X
familial B-X
aniridia B-X
Run-on B-X
mutation B-X
in B-X
the B-X
PAX6 B-X
gene B-X
and B-X
chorioretinal B-X
degeneration B-X
in B-X
autosomal B-X
dominant B-X
aniridia B-X
Haploinsufficiency B-X
at B-X
the B-X
PAX6 B-X
locus B-X
causes B-X
aniridia B-X
, B-X
a B-X
panocular B-X
eye B-X
condition B-X
characterized B-X
by B-X
iris B-X
hypoplasia B-X
and B-X
a B-X
variety B-X
of B-X
other B-X
anterior B-X
and B-X
posterior B-X
eye B-X
defects B-X
leading B-X
to B-X
poor B-X
vision B-X
Neethirajan B-X
, B-X
Mol B-X
Vis B-X
2003 B-X
; B-X
9:205-209 B-X
. B-X

Insulin	O
gene	O
region	O
contributes	O
to	O
genetic	O
susceptibility	O
to	O
,	O
but	O
may	O
not	O
to	O
low	O
incidence	O
of	O
,	O
insulin	B-Disease
-	I-Disease
dependent	I-Disease
diabetes	I-Disease
mellitus	I-Disease
in	O
Japanese	O
.	O
<EOS> B-X
Insulin B-X
Gene B-X
Region B-X
Contributes B-X
to B-X
Genetic B-X
Susceptibility B-X
to B-X
, B-X
but B-X
May B-X
Not B-X
to B-X
Low B-X
Incidence B-X
of B-X
, B-X
Insulin-Dependent B-X
Diabetes B-X
Mellitus B-X
in B-X
Japanese B-X
- B-X
ÁôæÂ∫¶Â≠¶ÊúØ B-X
A B-X
major B-X
component B-X
of B-X
inherited B-X
susceptibility B-X
to B-X
Type B-X
1 B-X
( B-X
insulin-dependent B-X
) B-X
diabetes B-X
mellitus B-X
has B-X
been B-X
mapped B-X
to B-X
the B-X
major B-X
histocompatibility B-X
complex B-X
. B-X
Cert B-X
In B-X
the B-X
Caucasian B-X
population B-X
, B-X
it B-X
has B-X
been B-X
demonstrated B-X
that B-X
the B-X
insulin B-X
gene B-X
( B-X
INS B-X
) B-X
region B-X
contains B-X
the B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
locus B-X
( B-X
IDDM2 B-X
) B-X
. B-X
In B-X
the B-X
Japanese B-X
The B-X
insulin B-X
gene B-X
region B-X
contributes B-X
to B-X
IDDM B-X
susceptibility B-X
independently B-X
of B-X
HLA B-X
class B-X
II B-X
genes B-X
in B-X
Polish B-X
diabetic B-X
patients B-X
- B-X
ÁôæÂ∫¶Â≠¶ÊúØ B-X
The B-X
aetiology B-X
of B-X
insulin-dependent B-X
diabetes B-X
( B-X
IDDM B-X
) B-X
involves B-X
genetic B-X
predisposition B-X
, B-X
a B-X
major B-X
component B-X
of B-X
which B-X
has B-X
been B-X
mapped B-X
in B-X
the B-X
HLA B-X
complex B-X
, B-X
near B-X
to B-X
or B-X
identical B-X
with B-X
Diabetes B-X
mellitus B-X
is B-X
the B-X
second B-X
most B-X
common B-X
chronic B-X
disease B-X
in B-X
childhood B-X
in B-X
the B-X
Western B-X
world B-X
, B-X
after B-X
childhood B-X
asthma B-X
. B-X
For B-X
reasons B-X
that B-X
are B-X
not B-X
entirely B-X
clear B-X
, B-X
childhood B-X
type B-X
Genetics B-X
and B-X
pathogenesis B-X
of B-X
type B-X
1 B-X
diabetes B-X
: B-X
prospects B-X
for B-X
prevention B-X
and B-X
intervention B-X

In	O
the	O
Caucasian	O
population	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
the	O
insulin	O
gene	O
(	O
INS	O
)	O
region	O
contains	O
the	O
insulin	B-Disease
-	I-Disease
dependent	I-Disease
diabetes	I-Disease
mellitus	I-Disease
locus	O
(	O
IDDM2	O
)	O
.	O
<EOS> B-X
PDF B-X
| B-X
The B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
2 B-X
gene B-X
( B-X
IDDM2 B-X
) B-X
is B-X
a B-X
type B-X
1 B-X
diabetes B-X
susceptibility B-X
locus B-X
contributed B-X
to B-X
by B-X
the B-X
variable B-X
number B-X
of B-X
tandem B-X
... B-X
| B-X
Find B-X
, B-X
Remapping B-X
the B-X
Insulin B-X
Gene/IDDM2 B-X
Locus B-X
in B-X
Type B-X
1 B-X
Diabetes B-X
| B-X
Diabetes B-X
Abstract B-X
. B-X
Context B-X
: B-X
It B-X
is B-X
suggested B-X
that B-X
insulin B-X
autoimmunity B-X
plays B-X
an B-X
important B-X
role B-X
in B-X
the B-X
development B-X
of B-X
type B-X
1 B-X
diabetes B-X
in B-X
humans B-X
. B-X
However B-X
, B-X
the B-X
association B-X
b B-X
Non B-X
HLA B-X
genetic B-X
markers B-X
association B-X
with B-X
type-1 B-X
diabetes B-X
mellitus B-X
- B-X
ScienceDirect B-X
Download B-X
Citation B-X
| B-X
The B-X
insulin B-X
gene B-X
in B-X
diabetes B-X
| B-X
Lack B-X
of B-X
insulin B-X
production B-X
or B-X
abnormalities B-X
affecting B-X
insulin B-X
secretion B-X
are B-X
key B-X
to B-X
the B-X
development B-X
of B-X
almost B-X
all B-X
forms B-X
of B-X
diabetes B-X
, B-X
PDF B-X
| B-X
There B-X
is B-X
still B-X
uncertainty B-X
concerning B-X
the B-X
joint B-X
action B-X
of B-X
the B-X
two B-X
established B-X
type B-X
1 B-X
diabetes B-X
susceptibility B-X
loci B-X
, B-X
the B-X
HLA B-X
class B-X
II B-X
DQB1 B-X
and B-X
DRB1 B-X
... B-X
| B-X
Find B-X
IUBMB B-X
Life B-X
is B-X
the B-X
flagship B-X
journal B-X
of B-X
the B-X
International B-X
Union B-X
of B-X
Biochemistry B-X
and B-X
Molecular B-X
Biology B-X
and B-X
is B-X
devoted B-X
to B-X
the B-X
rapid B-X
publication B-X
of B-X
the B-X
most B-X
novel B-X
and B-X
significant B-X
short B-X
articles B-X

In	O
the	O
Japanese	O
population	O
,	O
however	O
,	O
there	O
has	O
been	O
no	O
report	O
demonstrating	O
the	O
contribution	O
of	O
IDDM2	O
to	O
the	O
pathogenesis	O
of	O
IDDM	B-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Genetics B-X
of B-X
Type B-X
1 B-X
diabetes B-X
in B-X
Asian B-X
and B-X
Caucasian B-X
populations B-X
| B-X
Among B-X
candidate B-X
genes B-X
for B-X
type B-X
1 B-X
diabetes B-X
, B-X
HLA B-X
, B-X
INS B-X
, B-X
CTLA4 B-X
, B-X
PTPN22 B-X
and B-X
Approaches B-X
in B-X
type B-X
1 B-X
diabetes B-X
research B-X
: B-X
A B-X
status B-X
report B-X
Insulin B-X
Gene B-X
Region B-X
Contributes B-X
to B-X
Genetic B-X
Susceptibility B-X
to B-X
, B-X
but B-X
May B-X
Not B-X
to B-X
Low B-X
Incidence B-X
of B-X
, B-X
Insulin-Dependent B-X
Diabetes B-X
Mellitus B-X
in B-X
Japanese B-X
- B-X
ScienceDirect B-X
Download B-X
Citation B-X
| B-X
Genetics B-X
and B-X
pathogenesis B-X
of B-X
type B-X
1 B-X
diabetes B-X
: B-X
Prospects B-X
for B-X
prevention B-X
and B-X
intervention B-X
| B-X
Type B-X
1 B-X
diabetes B-X
is B-X
etiologically B-X
a B-X
multifactorial B-X
disease B-X
caused B-X
by B-X
a B-X
complex B-X
interaction B-X
Request B-X
PDF B-X
| B-X
On B-X
Oct B-X
1 B-X
, B-X
2013 B-X
, B-X
A. B-X
Safari B-X
and B-X
others B-X
published B-X
Incidence B-X
of B-X
potential B-X
drug‚Äì/INS B-X
; B-X
drug B-X
interactions B-X
and B-X
its B-X
associated B-X
factors B-X
in B-X
neurology B-X
wards B-X
of B-X
two B-X
Yasuko B-X
Uchigata B-X
's B-X
334 B-X
research B-X
works B-X
with B-X
4,754 B-X
citations B-X
and B-X
3,851 B-X
reads B-X
, B-X
including B-X
: B-X
Usefulness B-X
of B-X
glycated B-X
albumin B-X
as B-X
a B-X
predictor B-X
of B-X
mortality B-X
in B-X
chronic B-X
hemodialysis B-X
patients B-X
with B-X
diabetes B-X
socolar B-X

We	O
conducted	O
an	O
association	O
study	O
of	O
IDDM	B-Disease
in	O
a	O
large	O
number	O
of	O
Japanese	O
subjects	O
with	O
multiple	O
polymorphisms	O
in	O
INS	O
region	O
.	O
<EOS> B-X
In B-X
the B-X
Caucasian B-X
population B-X
, B-X
it B-X
has B-X
been B-X
demonstrated B-X
that B-X
the B-X
insulin B-X
gene B-X
( B-X
< B-X
i B-X
> B-X
INS B-X
< B-X
/i B-X
> B-X
) B-X
region B-X
contains B-X
the B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
locus B-X
( B-X
Use B-X
of B-X
DNA B-X
polymorphisms B-X
for B-X
genetic B-X
analysis B-X
of B-X
non-insulin B-X
dependent B-X
diabetes B-X
mellitus B-X
- B-X
ScienceDirect B-X
Insulin B-X
gene B-X
region B-X
contributes B-X
to B-X
genetic B-X
susceptibility B-X
to B-X
, B-X
but B-X
may B-X
not B-X
to B-X
low B-X
incidence B-X
of B-X
, B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
in B-X
Japanese B-X
Genetic B-X
epidemiology B-X
of B-X
diabetes B-X
Request B-X
PDF B-X
| B-X
No B-X
Association B-X
of B-X
Type B-X
1 B-X
Diabetes B-X
with B-X
a B-X
Microsatellite B-X
Marker B-X
for B-X
CTLA-4 B-X
in B-X
a B-X
Japanese B-X
Population B-X
| B-X
Susceptibility B-X
to B-X
insulin-dependent B-X
( B-X
type B-X
1 B-X
) B-X
diabetes B-X
mellitus B-X
is B-X
Request B-X
PDF B-X
| B-X
Global B-X
Haplotype B-X
Diversity B-X
in B-X
the B-X
Human B-X
Insulin B-X
Gene B-X
Region B-X
| B-X
The B-X
insulin B-X
minisatellite B-X
( B-X
INS B-X
VNTR B-X
) B-X
has B-X
been B-X
intensively B-X
analyzed B-X
due B-X
to B-X
its B-X
associations B-X
with B-X
diseases B-X
Request B-X
PDF B-X
| B-X
The B-X
Insulin B-X
Gene B-X
Variable B-X
Number B-X
Tandem B-X
Repeat B-X
and B-X
Risk B-X
of B-X
Type B-X
2 B-X
Diabetes B-X
in B-X
a B-X
Population-Based B-X
Sample B-X
of B-X
Families B-X
and B-X
Unrelated B-X
Men B-X
and B-X
Women B-X
| B-X
Abnormalities B-X
in B-X

We	O
found	O
a	O
significant	O
association	O
of	O
the	O
INS	O
region	O
with	O
IDDM	B-Disease
.	O
<EOS> B-X
Transmission B-X
test B-X
for B-X
linkage B-X
disequilibrium B-X
: B-X
the B-X
insulin B-X
gene B-X
region B-X
and B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
( B-X
IDDM B-X
) B-X
. B-X
Previous B-X
studies B-X
have B-X
suggested B-X
an B-X
association B-X
between B-X
polymorphisms B-X
in B-X
the B-X
insulin B-X
gene B-X
region B-X
and B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
( B-X
IDDM B-X
) B-X
. B-X
Most B-X
of B-X
the B-X
studies B-X
so B-X
far B-X
have B-X
been B-X
performed B-X
The B-X
Effect B-X
of B-X
Parental B-X
Imprinting B-X
on B-X
the B-X
INS-IGF2 B-X
Locus B-X
of B-X
Korean B-X
Type B-X
I B-X
Diabetic B-X
Patients B-X
PDF B-X
| B-X
Insulin B-X
dependent B-X
diabetes B-X
mellitus B-X
( B-X
IDDM B-X
) B-X
is B-X
an B-X
autoimmune B-X
disease B-X
with B-X
a B-X
strong B-X
association B-X
between B-X
disease B-X
and B-X
the B-X
HLA B-X
class B-X
II B-X
region B-X
. B-X
Because B-X
... B-X
| B-X
Find B-X
Some B-X
environmental B-X
and B-X
genetic B-X
factors B-X
play B-X
important B-X
roles B-X
in B-X
etiopathogenesis B-X
of B-X
type B-X
1 B-X
or B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
( B-X
IDDM B-X
) B-X
. B-X
HLA B-X
genes B-X
, B-X
the B-X
IDDM1 B-X
locus B-X
located B-X
the B-X
human B-X
From B-X
Markers B-X
to B-X
Molecular B-X
Mechanisms B-X
: B-X
Type B-X
1 B-X
Diabetes B-X
in B-X
the B-X
Post-GWAS B-X
Era B-X
Linkage B-X
disequilibrium B-X
( B-X
association B-X
) B-X
analysis B-X
was B-X
used B-X
to B-X
evaluate B-X
a B-X
candidate B-X
region B-X
near B-X
the B-X
CTLA4/CD28 B-X
genes B-X
using B-X
a B-X
multi-ethnic B-X
collection B-X
of B-X
families B-X
with B-X

Alleles	O
positively	O
associated	O
with	O
IDDM	B-Disease
in	O
INS	O
region	O
were	O
the	O
same	O
as	O
those	O
positively	O
-	O
associated	O
with	O
IDDM	B-Disease
in	O
Caucasian	O
population	O
,	O
although	O
positively	O
-	O
associated	O
alleles	O
are	O
very	O
common	O
(	O
allele	O
frequencies	O
>	O
0	O
.	O
9	O
)	O
in	O
the	O
Japanese	O
general	O
population	O
.	O
<EOS> B-X
The B-X
prevalence B-X
rates B-X
of B-X
MetS B-X
and B-X
knee B-X
OA B-X
tended B-X
to B-X
increase B-X
with B-X
age B-X
in B-X
males B-X
; B-X
however B-X
, B-X
there B-X
was B-X
no B-X
association B-X
between B-X
MetS B-X
and B-X
knee B-X
OA B-X
. B-X
On B-X
the B-X
Among B-X
an B-X
essentially B-X
healthy B-X
population B-X
, B-X
coffee B-X
intake B-X
was B-X
negatively B-X
associated B-X
with B-X
d-ROMs B-X
in B-X
men B-X
, B-X
but B-X
not B-X
in B-X
women B-X
. B-X
Whether B-X
the B-X
favorable B-X
effect B-X
of B-X
coffee B-X
, B-X
if B-X
present B-X
Our B-X
findings B-X
indicate B-X
that B-X
functional B-X
disability B-X
is B-X
common B-X
among B-X
Japanese B-X
elderly B-X
adults B-X
and B-X
that B-X
its B-X
major B-X
cause B-X
is B-X
stroke B-X
in B-X
men B-X
and B-X
dementia B-X
in B-X
women B-X
. B-X
Our B-X
results B-X
showed B-X
that B-X
FLI B-X
is B-X
associated B-X
with B-X
the B-X
development B-X
of B-X
diabetes B-X
regardless B-X
of B-X
sex B-X
and B-X
the B-X
presence B-X
or B-X
absence B-X
of B-X
IFG B-X
, B-X
and B-X
that B-X
it B-X
may B-X
be B-X
a B-X
useful B-X
The B-X
prevalence B-X
of B-X
LS B-X
in B-X
the B-X
general B-X
population B-X
was B-X
higher B-X
in B-X
females B-X
than B-X
in B-X
males B-X
. B-X
A B-X
strong B-X
risk B-X
factor B-X
for B-X
LS B-X
was B-X
radiographic B-X
knee B-X
OA B-X
. B-X
Also B-X
, B-X
those B-X
We B-X
used B-X
a B-X
general B-X
concept B-X
of B-X
NSP B-X
, B-X
which B-X
allowed B-X
us B-X
to B-X
collect B-X
the B-X
unified B-X
data B-X
about B-X
this B-X
condition B-X
among B-X
the B-X
participants B-X
. B-X
NSP B-X
was B-X
a B-X
prevalent B-X
health B-X
problem B-X
that B-X
Mapping B-X
rare B-X
and B-X
common B-X
causal B-X
alleles B-X
for B-X
complex B-X
human B-X
diseases B-X

These	O
data	O
suggest	O
that	O
IDDM2	O
is	O
involved	O
in	O
the	O
genetic	O
susceptibility	O
to	O
IDDM	B-Disease
in	O
Japanese	O
.	O
<EOS> B-X
The B-X
IDDM2 B-X
component B-X
of B-X
the B-X
genetic B-X
susceptibility B-X
to B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
( B-X
IDDM B-X
) B-X
has B-X
been B-X
mapped B-X
to B-X
chromosome B-X
11p15.5 B-X
. B-X
The B-X
exact B-X
identity B-X
of B-X
IDDM2 B-X
remains B-X
uncertain B-X
. B-X
It B-X
WikiGenes B-X
- B-X
IDDM2 B-X
- B-X
insulin-dependent B-X
diabetes B-X
mellitus B-X
2 B-X
The B-X
IDDM2 B-X
locus B-X
encoding B-X
susceptibility B-X
to B-X
type B-X
1 B-X
diabetes B-X
was B-X
mapped B-X
previously B-X
to B-X
a B-X
4.1‚Äìkb B-X
region B-X
spanning B-X
the B-X
insulin B-X
gene B-X
and B-X
a B-X
minisatellite B-X
or B-X
variable B-X
number B-X
of B-X
tandem B-X
repeats B-X
( B-X
Insulin B-X
Transactivator B-X
MafA B-X
Regulates B-X
Intrathymic B-X
Expression B-X
of B-X
Insulin B-X
and B-X
Affects B-X
Susceptibility B-X
to B-X
Type B-X
1 B-X
Diabetes B-X

The	O
high	O
frequencies	O
of	O
disease	O
-	O
associated	O
alleles	O
in	O
the	O
general	O
population	O
suggest	O
that	O
IDDM2	O
locus	O
is	O
not	O
responsible	O
for	O
the	O
low	O
incidence	O
of	O
IDDM	B-Disease
in	O
Japanese	O
.	O
<EOS> B-X
Molecular B-X
aspects B-X
of B-X
type B-X
1 B-X
diabetes B-X
Current B-X
knowledge B-X
of B-X
Japanese B-X
type B-X
1 B-X
diabetic B-X
syndrome B-X
- B-X
Abiru B-X
- B-X
2002 B-X
- B-X
Diabetes/Metabolism B-X
Research B-X
and B-X
Reviews B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Type B-X
1 B-X
diabetes B-X
is B-X
a B-X
multifactorial B-X
disease B-X
which B-X
results B-X
from B-X
a B-X
T-cell-mediated B-X
autoimmune B-X
destruction B-X
of B-X
the B-X
pancreatic B-X
beta B-X
cells B-X
in B-X
genetically B-X
predisp B-X
Genetic B-X
susceptibility B-X
factors B-X
of B-X
Type B-X
1 B-X
diabetes B-X
in B-X
Asians B-X
- B-X
Park B-X
- B-X
2001 B-X
- B-X
Diabetes/Metabolism B-X
Research B-X
and B-X
Reviews B-X
- B-X
Wiley B-X
Online B-X
Library B-X

The	O
human	O
complement	O
C9	O
gene	O
:	O
identification	O
of	O
two	O
mutations	O
causing	O
deficiency	O
and	O
revision	O
of	O
the	O
gene	O
structure	O
.	O
<EOS> B-X
The B-X
human B-X
complement B-X
C9 B-X
gene B-X
: B-X
identification B-X
of B-X
two B-X
mutations B-X
causing B-X
deficiency B-X
and B-X
revision B-X
of B-X
the B-X
gene B-X
structure B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
The B-X
human B-X
complement B-X
C9 B-X
gene B-X
: B-X
identification B-X
of B-X
two B-X
mutations B-X
causing B-X
deficiency B-X
and B-X
revision B-X
of B-X
the B-X
gene B-X
structure B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Genetic B-X
basis B-X
of B-X
human B-X
complement B-X
C8 B-X
beta B-X
deficiency B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Genetic B-X
Basis B-X
of B-X
Human B-X
Complement B-X
C8Œ±-Œ≥ B-X
Deficiency B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
PDF B-X
| B-X
On B-X
Oct B-X
1 B-X
, B-X
1990 B-X
, B-X
Eliecer B-X
Coto B-X
and B-X
others B-X
published B-X
TaqI B-X
polymorphism B-X
at B-X
the B-X
human B-X
complement B-X
component B-X
C9 B-X
gene B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
The B-X
ninth B-X
component B-X
of B-X
human B-X
complement B-X
( B-X
C9 B-X
) B-X
is B-X
the B-X
last B-X
of B-X
the B-X
terminal B-X
complement B-X
components B-X
creating B-X
the B-X
membrane B-X
attack B-X
complex B-X
. B-X
C9 B-X
is B-X
a B-X
single-chain B-X
serum B-X
protein B-X
that B-X
The B-X
ninth B-X
component B-X
of B-X
human B-X
complement B-X
( B-X
C9 B-X
) B-X
is B-X
the B-X
last B-X
of B-X
the B-X
terminal B-X
complement B-X
components B-X
creating B-X
the B-X
membrane B-X
attack B-X
complex B-X
. B-X
C9 B-X
is B-X
a B-X
single-chain B-X
serum B-X
protein B-X
that B-X

The	O
ninth	O
component	O
of	O
human	O
complement	O
(	O
C9	O
)	O
is	O
the	O
last	O
of	O
the	O
terminal	O
complement	O
components	O
creating	O
the	O
membrane	O
attack	O
complex	O
.	O
<EOS> B-X
The B-X
mystery B-X
behind B-X
membrane B-X
insertion B-X
: B-X
a B-X
review B-X
of B-X
the B-X
complement B-X
membrane B-X
attack B-X
complex B-X
CryoEM B-X
reveals B-X
how B-X
the B-X
complement B-X
membrane B-X
attack B-X
complex B-X
ruptures B-X
lipid B-X
bilayers B-X
Molecular B-X
cell B-X
biology B-X
of B-X
complement B-X
membrane B-X
attack B-X
- B-X
ScienceDirect B-X
Structure B-X
of B-X
Complement B-X
C6 B-X
Suggests B-X
a B-X
Mechanism B-X
for B-X
Initiation B-X
and B-X
Unidirectional B-X
, B-X
Sequential B-X
Assembly B-X
of B-X
Membrane B-X
Attack B-X
Complex B-X
( B-X
MAC B-X
) B-X
The B-X
membrane B-X
attack B-X
complex B-X
( B-X
MAC B-X
) B-X
/perforin-like B-X
protein B-X
complement B-X
component B-X
9 B-X
( B-X
C9 B-X
) B-X
is B-X
the B-X
major B-X
component B-X
of B-X
the B-X
MAC B-X
, B-X
a B-X
multi-protein B-X
complex B-X
that B-X
forms B-X
pores B-X
in B-X
The B-X
membrane B-X
attack B-X
complex B-X
( B-X
MAC B-X
) B-X
/perforin-like B-X
protein B-X
complement B-X
component B-X
9 B-X
( B-X
C9 B-X
) B-X
is B-X
the B-X
major B-X
component B-X
of B-X
the B-X
MAC B-X
, B-X
a B-X
multi-protein B-X
complex B-X
that B-X
forms B-X
pores B-X
in B-X
Complement B-X
component B-X
9 B-X
- B-X
Wikipedia B-X

C9	O
is	O
a	O
single	O
-	O
chain	O
serum	O
protein	O
that	O
is	O
encoded	O
by	O
a	O
gene	O
located	O
on	O
chromosome	O
5p	O
.	O
<EOS> B-X
Chromosomal B-X
assignment B-X
of B-X
genes B-X
encoding B-X
the B-X
Œ± B-X
, B-X
Œ≤ B-X
, B-X
and B-X
Œ≥ B-X
subunits B-X
of B-X
human B-X
complement B-X
protein B-X
C8 B-X
: B-X
Identification B-X
of B-X
a B-X
close B-X
physical B-X
linkage B-X
between B-X
the B-X
Œ± B-X
and B-X
the B-X
Genetic B-X
Association B-X
of B-X
the B-X
Porcine B-X
C9 B-X
Complement B-X
Component B-X
with B-X
Hemolytic B-X
Complement B-X
Activity B-X

Deficiency	B-Disease
of	I-Disease
terminal	I-Disease
complement	I-Disease
components	I-Disease
is	O
generally	O
associated	O
with	O
recurrent	O
neisseria	B-Disease
infections	I-Disease
.	O
<EOS> B-X
Deficiency B-X
of B-X
the B-X
eighth B-X
component B-X
of B-X
complement B-X
associated B-X
with B-X
recurrent B-X
meningococcal B-X
meningitis B-X
: B-X
case B-X
report B-X
and B-X
literature B-X
review B-X
Infections B-X
Revealing B-X
Complement B-X
Deficiency B-X
in B-X
Adults B-X
The B-X
immune B-X
system B-X
is B-X
the B-X
body B-X
‚Äô B-X
s B-X
defense B-X
mechanism B-X
against B-X
infections B-X
and B-X
is B-X
made B-X
of B-X
two B-X
pathways B-X
- B-X
the B-X
innate B-X
and B-X
adaptive B-X
pathway B-X
. B-X
[ B-X
1 B-X
] B-X
The B-X
innate B-X

We	O
studied	O
a	O
previously	O
described	O
Swiss	O
family	O
with	O
inherited	B-Disease
C9	I-Disease
deficiency	I-Disease
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Hereditary B-X
complement B-X
( B-X
C9 B-X
) B-X
deficiency B-X
associated B-X
with B-X
dermatomyositis B-X
| B-X
A B-X
28-year-old B-X
Japanese B-X
woman B-X
with B-X
hereditary B-X
complement B-X
( B-X
C9 B-X
) B-X
deficiency B-X
and B-X
dermatomyositis B-X
is B-X
reported B-X
. B-X
She B-X
Isolated B-X
genetic B-X
deficiencies B-X
of B-X
individual B-X
components B-X
of B-X
the B-X
complement B-X
system B-X
have B-X
been B-X
described B-X
in B-X
man B-X
for B-X
all B-X
the B-X
components B-X
of B-X
the B-X
classical B-X
pathway B-X
and B-X
t B-X
... B-X
PDF B-X
| B-X
Deficiency B-X
of B-X
the B-X
ninth B-X
component B-X
of B-X
human B-X
complement B-X
( B-X
C9 B-X
) B-X
is B-X
the B-X
most B-X
common B-X
complement B-X
deficiency B-X
in B-X
Japan B-X
, B-X
with B-X
an B-X
incidence B-X
of B-X
approximately B-X
... B-X
| B-X
Find B-X
Properdin B-X
deficiency B-X
in B-X
a B-X
large B-X
Swiss B-X
family B-X
: B-X
identification B-X
of B-X
a B-X
stop B-X
codon B-X
in B-X
the B-X
properdin B-X
gene B-X
, B-X
and B-X
association B-X
of B-X
meningococcal B-X
disease B-X
with B-X
lack B-X
of B-X
the B-X
IgG2 B-X
allotype B-X
marker B-X
Request B-X
PDF B-X
| B-X
Inherited B-X
complement B-X
deficiencies B-X
and B-X
bacterial B-X
infections B-X
| B-X
A B-X
wide B-X
variety B-X
of B-X
bacteria B-X
are B-X
recognized B-X
by B-X
the B-X
complement B-X
system B-X
through B-X
the B-X
early B-X
components B-X
that B-X
trigger B-X
the B-X
three B-X
pathways B-X
Complement B-X
activation B-X
associated B-X
with B-X
ADAMTS13 B-X
deficiency B-X
in B-X
human B-X
and B-X
murine B-X
thrombotic B-X
microangiopathy B-X
Nongroupable B-X
meningococci B-X
or B-X
bacteria B-X
related B-X
to B-X
the B-X
genus B-X
Neisseria B-X
rarely B-X
cause B-X
meningitis B-X
. B-X
Complement B-X
deficiency B-X
has B-X
been B-X
identified B-X
as B-X
a B-X
major B-X
predisposing B-X
... B-X

To	O
identify	O
the	O
genetic	O
basis	O
of	O
C9	B-Disease
deficiency	I-Disease
,	O
we	O
developed	O
an	O
approach	O
using	O
exon	O
-	O
specific	O
PCR	O
and	O
direct	O
DNA	O
sequencing	O
.	O
<EOS> B-X
Deficiency B-X
of B-X
the B-X
ninth B-X
component B-X
of B-X
human B-X
complement B-X
( B-X
C9 B-X
) B-X
is B-X
the B-X
most B-X
common B-X
complement B-X
deficiency B-X
in B-X
Japan B-X
but B-X
is B-X
rare B-X
in B-X
other B-X
countries B-X
. B-X
We B-X
studied B-X
the B-X
molecular B-X
Novel B-X
Sequencing-based B-X
Strategies B-X
for B-X
High-Throughput B-X
Discovery B-X
of B-X
Genetic B-X
Mutations B-X
Underlying B-X
Inherited B-X
Antibody B-X
Deficiency B-X
Disorders B-X
Total B-X
C4B B-X
Deficiency B-X
Due B-X
to B-X
Gene B-X
Deletion B-X
and B-X
Gene B-X
Conversion B-X
in B-X
a B-X
Patient B-X
with B-X
Severe B-X
Infections B-X
Clinical B-X
and B-X
Molecular B-X
Characterization B-X
of B-X
NF1 B-X
Patients B-X
In B-X
vitro B-X
DNA B-X
amplification B-X
by B-X
means B-X
of B-X
the B-X
polymerase B-X
chain B-X
reaction B-X
is B-X
currently B-X
revolutionizing B-X
human B-X
molecular B-X
genetics B-X
. B-X
Since B-X
its B-X
inception B-X
in B-X
1985 B-X
, B-X
a B-X
Total B-X
C4B B-X
Deficiency B-X
Due B-X
to B-X
Gene B-X
Deletion B-X
and B-X
Gene B-X
Conversion B-X
in B-X
a B-X
Patient B-X
with B-X
Severe B-X
Infections B-X
| B-X
Clinical B-X
and B-X
Vaccine B-X
Immunology B-X
The B-X
complement B-X
system B-X
is B-X
crucial B-X
for B-X
defense B-X
against B-X
pathogens B-X
and B-X
removal B-X
of B-X
dying B-X
cells B-X
or B-X
immune B-X
complexes B-X
. B-X
Thus B-X
, B-X
clinical B-X
indications B-X
for B-X
possible B-X
complete B-X
complement B-X
deficiencies B-X
include B-X
among B-X
others B-X

As	O
a	O
cause	O
of	O
C9	B-Disease
deficiency	I-Disease
,	O
we	O
found	O
two	O
different	O
point	O
mutations	O
,	O
both	O
generating	O
TGA	O
stop	O
codons	O
in	O
the	O
coding	O
sequence	O
.	O
<EOS> B-X
Five B-X
TGA B-X
‚Äú B-X
stop B-X
‚Äù B-X
codons B-X
occur B-X
within B-X
the B-X
translated B-X
sequence B-X
of B-X
the B-X
yeast B-X
mitochondrial B-X
gene B-X
for B-X
cytochrome B-X
c B-X
oxidase B-X
subunit B-X
II B-X
Request B-X
PDF B-X
| B-X
An B-X
abnormal B-X
but B-X
functionally B-X
active B-X
complement B-X
component B-X
C9 B-X
protein B-X
found B-X
in B-X
an B-X
Irish B-X
family B-X
with B-X
subtotal B-X
C9 B-X
deficiency B-X
| B-X
Two B-X
independently B-X
segregating B-X
C9 B-X
genetic B-X
defects B-X
have B-X
previously B-X
Stops B-X
making B-X
sense B-X
: B-X
translational B-X
trade-offs B-X
and B-X
stop B-X
codon B-X
reassignment B-X
A B-X
Peptide B-X
Chain B-X
Release B-X
Factor B-X
2 B-X
Affects B-X
the B-X
Stability B-X
of B-X
UGA-Containing B-X
Transcripts B-X
in B-X
Arabidopsis B-X
Chloroplasts B-X
Author B-X
summary B-X
The B-X
stop B-X
codon B-X
gives B-X
the B-X
translating B-X
ribosome B-X
the B-X
signal B-X
for B-X
the B-X
termination B-X
of B-X
peptide B-X
synthesis B-X
, B-X
but B-X
occasionally B-X
the B-X
ribosome B-X
goes B-X
past B-X
the B-X
stop B-X
codon B-X
and B-X
continues B-X
translating B-X

One	O
mutation	O
,	O
a	O
C	O
to	O
A	O
exchange	O
,	O
was	O
detected	O
in	O
exon	O
2	O
at	O
cDNA	O
position	O
166	O
,	O
the	O
other	O
,	O
a	O
C	O
to	O
T	O
exchange	O
,	O
was	O
located	O
in	O
exon	O
4	O
(	O
cDNA	O
position	O
464	O
)	O
.	O
<EOS> B-X
Ahi-1 B-X
, B-X
a B-X
Novel B-X
Gene B-X
Encoding B-X
a B-X
Modular B-X
Protein B-X
with B-X
WD40-Repeat B-X
and B-X
SH3 B-X
Domains B-X
, B-X
Is B-X
Targeted B-X
by B-X
the B-X
Ahi-1 B-X
and B-X
Mis-2 B-X
Provirus B-X
Integrations B-X
DJ-1 B-X
was B-X
recently B-X
identified B-X
as B-X
a B-X
gene B-X
product B-X
responsible B-X
for B-X
a B-X
subset B-X
of B-X
familial B-X
Parkinson B-X
's B-X
disease B-X
( B-X
PD B-X
) B-X
. B-X
The B-X
mechanisms B-X
by B-X
which B-X
mutations B-X
in B-X
DJ-1 B-X
alter B-X
its B-X
Wilson B-X
‚Äô B-X
s B-X
disease B-X
( B-X
WD B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
condition B-X
caused B-X
by B-X
an B-X
impaired B-X
copper B-X
metabolism B-X
due B-X
to B-X
hereditary B-X
mutations B-X
in B-X
the B-X
ATP7B B-X
gene B-X
; B-X
the B-X
Rare B-X
sequence B-X
variants B-X
in B-X
the B-X
non-coding B-X
part B-X
of B-X
the B-X
BRCA B-X
genes B-X
are B-X
often B-X
reported B-X
as B-X
variants B-X
of B-X
uncertain B-X
significance B-X
( B-X
VUS B-X
) B-X
, B-X
which B-X
leave B-X
patients B-X
and B-X
doctors B-X
in B-X
a B-X
Mutations B-X
in B-X
SLC26A1 B-X
Cause B-X
Nephrolithiasis B-X
- B-X
ScienceDirect B-X
Usher B-X
syndrome B-X
type B-X
I B-X
( B-X
USH1 B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
characterized B-X
by B-X
congenital B-X
sensorineural B-X
hearing B-X
loss B-X
, B-X
vestibular B-X
dysfunction B-X
and B-X
visual B-X
impairment B-X
due B-X
to B-X
early B-X
onset B-X
retinitis B-X
pigmentosa1 B-X
Mutations B-X
in B-X
the B-X
Œî7-sterol B-X
reductase B-X
gene B-X
in B-X
patients B-X
with B-X
the B-X
Smith‚ÄìLemli‚ÄìOpitz B-X
syndrome B-X

In	O
family	O
studies	O
of	O
three	O
first	O
-	O
degree	O
relatives	O
with	O
heterozygous	O
C9	B-Disease
deficiency	I-Disease
,	O
we	O
demonstrated	O
that	O
the	O
two	O
mutations	O
are	O
segregating	O
independently	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
High B-X
prevalence B-X
of B-X
complement B-X
component B-X
C6 B-X
deficiency B-X
among B-X
African-Americans B-X
in B-X
the B-X
South-eastern B-X
USA B-X
| B-X
Complement B-X
component B-X
C6 B-X
is B-X
a B-X
part B-X
of B-X
the B-X
membrane B-X
attack B-X
complex B-X
that B-X
forms B-X
Request B-X
PDF B-X
| B-X
Typing B-X
of B-X
the B-X
nt343C B-X
> B-X
T B-X
( B-X
R95X B-X
) B-X
allele B-X
of B-X
the B-X
C9 B-X
gene B-X
by B-X
PCR-SSP B-X
and B-X
the B-X
allele B-X
frequency B-X
of B-X
R95X B-X
in B-X
five B-X
ethnic B-X
populations B-X
| B-X
Request B-X
PDF B-X
| B-X
Deficiencies B-X
of B-X
the B-X
components B-X
of B-X
the B-X
classic B-X
and B-X
alternative B-X
activation B-X
pathways B-X
of B-X
the B-X
complement B-X
system B-X
| B-X
The B-X
congenital B-X
deficiencies B-X
of B-X
the B-X
individual B-X
components B-X
of B-X
the B-X
classic B-X
and B-X
Autosomal-Dominant B-X
Corneal B-X
Endothelial B-X
Dystrophies B-X
CHED1 B-X
and B-X
PPCD1 B-X
Are B-X
Allelic B-X
Disorders B-X
Caused B-X
by B-X
Non-coding B-X
Mutations B-X
in B-X
the B-X
Promoter B-X
of B-X
OVOL2 B-X

Therefore	O
,	O
these	O
mutations	O
are	O
sufficient	O
to	O
explain	O
the	O
complete	O
deficiency	O
of	O
both	O
the	O
probands	O
studied	O
.	O
<EOS> B-X
Gross B-X
deletions/duplications B-X
in B-X
PROS1 B-X
are B-X
relatively B-X
common B-X
in B-X
point B-X
mutation-negative B-X
hereditary B-X
protein B-X
S B-X
deficiency B-X
Identification B-X
of B-X
a B-X
novel B-X
compound B-X
heterozygous B-X
mutation B-X
of B-X
the B-X
CYP21A2 B-X
gene B-X
causing B-X
21‚Äëhydroxylase B-X
deficiency B-X
in B-X
a B-X
Chinese B-X
pedigree B-X
Expanding B-X
the B-X
Spectrum B-X
of B-X
Founder B-X
Mutations B-X
Causing B-X
Isolated B-X
Gonadotropin-Releasing B-X
Hormone B-X
Deficiency B-X
Request B-X
PDF B-X
| B-X
Further B-X
study B-X
on B-X
heterogeneic B-X
basis B-X
of B-X
complement B-X
C8Œ≤ B-X
deficiency B-X
| B-X
In B-X
Caucasian B-X
population B-X
, B-X
the B-X
most B-X
common B-X
molecular B-X
basis B-X
for B-X
C8 B-X
beta B-X
deficiency B-X
s B-X
a B-X
single B-X
C B-X
Defects B-X
of B-X
the B-X
mitochondrial B-X
respiratory B-X
chain B-X
are B-X
associated B-X
with B-X
a B-X
diverse B-X
spectrum B-X
of B-X
clinical B-X
phenotypes B-X
, B-X
and B-X
may B-X
be B-X
caused B-X
by B-X
mutations B-X
in B-X
either B-X
the B-X
nuclear B-X
or B-X
the B-X
mitochondrial B-X
genome B-X
Whole-exome B-X
sequencing B-X
( B-X
WES B-X
) B-X
, B-X
one B-X
of B-X
the B-X
next-generation B-X
sequencing B-X
( B-X
NGS B-X
) B-X
, B-X
has B-X
become B-X
a B-X
powerful B-X
tool B-X
to B-X
identify B-X
exonic B-X
variants B-X
. B-X
Investigating B-X
causality B-X
of B-X
the B-X
sequence B-X
Background B-X
Protein B-X
C B-X
( B-X
PC B-X
) B-X
is B-X
one B-X
of B-X
the B-X
most B-X
important B-X
physiological B-X
inhibitors B-X
of B-X
coagulation B-X
proteases B-X
. B-X
Hereditary B-X
PC B-X
deficiency B-X
causes B-X
a B-X
predisposition B-X
to B-X
venous B-X
thrombosis B-X
( B-X
VT B-X
) B-X

DNA	O
sequencing	O
of	O
the	O
exon	O
-	O
intron	O
junctions	O
revealed	O
a	O
number	O
of	O
revisions	O
regarding	O
the	O
boundaries	O
between	O
exons	O
4	O
,	O
5	O
,	O
and	O
6	O
as	O
well	O
as	O
between	O
exons	O
10	O
and	O
11	O
.	O
<EOS> B-X
Changes B-X
in B-X
exon‚Äìintron B-X
structure B-X
during B-X
vertebrate B-X
evolution B-X
affect B-X
the B-X
splicing B-X
pattern B-X
of B-X
exons B-X
Conserved B-X
sequence B-X
elements B-X
associated B-X
with B-X
exon B-X
skipping B-X
Assembly B-X
of B-X
splicing B-X
complexes B-X
on B-X
exon B-X
11 B-X
of B-X
the B-X
human B-X
insulin B-X
receptor B-X
gene B-X
does B-X
not B-X
correlate B-X
with B-X
splicing B-X
efficiency B-X
in-vitro B-X
Regulation B-X
of B-X
alternative B-X
RNA B-X
splicing B-X
by B-X
exon B-X
definition B-X
and B-X
exon B-X
sequences B-X
in B-X
viral B-X
and B-X
mammalian B-X
gene B-X
expression B-X
A B-X
diverse B-X
epigenetic B-X
landscape B-X
at B-X
human B-X
exons B-X
with B-X
implication B-X
for B-X
expression B-X
Exon B-X
11 B-X
homozygous B-X
mutations B-X
and B-X
intron B-X
10/exon B-X
11 B-X
junction B-X
deletions B-X
in B-X
the B-X
KIT B-X
gene B-X
are B-X
associated B-X
with B-X
poor B-X
prognosis B-X
of B-X
patients B-X
with B-X
gastrointestinal B-X
stromal B-X
tumors B-X
Predominant B-X
RET B-X
Germline B-X
Mutations B-X
in B-X
Exons B-X
10 B-X
, B-X
11 B-X
, B-X
and B-X
16 B-X
in B-X
Iranian B-X
Patients B-X
with B-X
Hereditary B-X
Medullary B-X
Thyroid B-X
Carcinoma B-X

No	O
additional	O
introns	O
were	O
detected	O
in	O
exons	O
6	O
and	O
10	O
.	O
<EOS> B-X
Interspecies B-X
conservation B-X
of B-X
gene B-X
order B-X
and B-X
intron‚Äìexon B-X
structure B-X
in B-X
a B-X
genomic B-X
locus B-X
of B-X
high B-X
gene B-X
density B-X
and B-X
complexity B-X
in B-X
Plasmodium B-X
Huntington B-X
‚Äô B-X
s B-X
disease B-X
is B-X
caused B-X
by B-X
a B-X
CAG B-X
repeat B-X
expansion B-X
in B-X
exon B-X
1 B-X
of B-X
the B-X
HTT B-X
gene B-X
. B-X
We B-X
have B-X
previously B-X
shown B-X
that B-X
exon B-X
1 B-X
HTT B-X
does B-X
not B-X
always B-X

Furthermore	O
,	O
DNA	O
marker	O
studies	O
were	O
conducted	O
using	O
known	O
polymorphisms	O
of	O
the	O
C6	O
,	O
C7	O
,	O
and	O
C9	O
genes	O
,	O
confirming	O
the	O
linkage	O
of	O
the	O
observed	O
C9	O
mutations	O
with	O
defined	O
haplotypes	O
.	O
.	O
<EOS> B-X
DNApod B-X
: B-X
DNA B-X
polymorphism B-X
annotation B-X
database B-X
from B-X
next-generation B-X
sequence B-X
read B-X
archives B-X
With B-X
the B-X
aim B-X
of B-X
understanding B-X
relationship B-X
between B-X
genetic B-X
and B-X
phenotypic B-X
variations B-X
in B-X
cultivated B-X
tomato B-X
, B-X
single B-X
nucleotide B-X
polymorphism B-X
( B-X
SNP B-X
) B-X
markers B-X
covering B-X
the B-X
whole B-X
genome B-X
of B-X
cultivated B-X
tomato B-X
were B-X
Importance B-X
of B-X
genetic B-X
polymorphisms B-X
in B-X
liver B-X
transplantation B-X
outcomes B-X
Intron B-X
length B-X
polymorphisms B-X
( B-X
ILPs B-X
) B-X
, B-X
a B-X
type B-X
of B-X
gene-based B-X
functional B-X
marker B-X
, B-X
could B-X
themselves B-X
be B-X
related B-X
to B-X
the B-X
particular B-X
traits B-X
. B-X
Here B-X
, B-X
we B-X
developed B-X
a B-X
genome-wide B-X
cotton B-X
Intron B-X
length B-X
polymorphisms B-X
( B-X
ILPs B-X
) B-X
, B-X
a B-X
type B-X
of B-X
gene-based B-X
functional B-X
marker B-X
, B-X
could B-X
themselves B-X
be B-X
related B-X
to B-X
the B-X
particular B-X
traits B-X
. B-X
Here B-X
, B-X
we B-X
developed B-X
a B-X
genome-wide B-X
cotton B-X
Our B-X
initial B-X
genome-wide B-X
association B-X
study B-X
( B-X
GWAS B-X
) B-X
identified B-X
20 B-X
promising B-X
candidate B-X
genes B-X
for B-X
milk B-X
fatty B-X
acid B-X
( B-X
FA B-X
) B-X
traits B-X
in B-X
a B-X
Chinese B-X
Holstein B-X
population B-X
, B-X
including B-X
PRLR B-X
, B-X
As B-X
an B-X
important B-X
component B-X
of B-X
miRNA B-X
processing B-X
genes B-X
, B-X
RAN B-X
gene B-X
encodes B-X
the B-X
ras-related B-X
nuclear B-X
protein B-X
, B-X
which B-X
is B-X
a B-X
unique B-X
member B-X
of B-X
the B-X
Ras B-X
superfamily B-X
of B-X
GTPases B-X
. B-X
The B-X

BRCA1	O
mutations	O
in	O
women	O
attending	O
clinics	O
that	O
evaluate	O
the	O
risk	O
of	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Pre-test B-X
prediction B-X
models B-X
of B-X
BRCA1 B-X
or B-X
BRCA2 B-X
mutation B-X
in B-X
breast/ovarian B-X
families B-X
attending B-X
familial B-X
cancer B-X
clinics B-X
Among B-X
women B-X
with B-X
breast B-X
cancer B-X
and B-X
a B-X
family B-X
history B-X
of B-X
the B-X
disease B-X
, B-X
the B-X
percentage B-X
with B-X
BRCA1 B-X
coding-region B-X
mutations B-X
is B-X
less B-X
than B-X
the B-X
45 B-X
percent B-X
predicted B-X
by B-X
genetic-linkage B-X
analysis B-X
. B-X
BRCA1 B-X
and B-X
BRCA2 B-X
testing B-X
: B-X
weighing B-X
the B-X
demand B-X
against B-X
the B-X
benefits B-X
. B-X
Evaluating B-X
Women B-X
With B-X
Ovarian B-X
Cancer B-X
for B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Mutations B-X
: B-X
Missed B-X
Opportunities B-X
Evaluation B-X
of B-X
models B-X
to B-X
predict B-X
BRCA B-X
germline B-X
mutations B-X
Context.‚ÄîStudies B-X
of B-X
high-risk B-X
families B-X
with B-X
multiple B-X
early-onset B-X
cases B-X
of B-X
breast B-X
cancer B-X
have B-X
been B-X
useful B-X
for B-X
assessing B-X
the B-X
type B-X
and B-X
spectrum B-X
of B-X
germline B-X
mutati B-X
Home B-X
Page B-X
: B-X
Annals B-X
of B-X
Oncology B-X

BACKGROUND	O
To	O
define	O
the	O
incidence	O
of	O
BRCA1	O
mutations	O
among	O
patients	O
seen	O
in	O
clinics	O
that	O
evaluate	O
the	O
risk	O
of	O
breast	B-Disease
cancer	I-Disease
,	O
we	O
analyzed	O
DNA	O
samples	O
from	O
women	O
seen	O
in	O
this	O
setting	O
and	O
constructed	O
probability	O
tables	O
to	O
provide	O
estimates	O
of	O
the	O
likelihood	O
of	O
finding	O
a	O
BRCA1	O
mutation	O
in	O
individual	O
families	O
.	O
<EOS> B-X
BRCA1 B-X
mutations B-X
in B-X
women B-X
attending B-X
clinics B-X
that B-X
evaluate B-X
the B-X
risk B-X
of B-X
breast B-X
cancer B-X
‚Äî B-X
Mayo B-X
Clinic B-X
Prevalence B-X
and B-X
phenotype B-X
of B-X
BRCA B-X
mutation B-X
can B-X
vary B-X
by B-X
race B-X
. B-X
The B-X
purpose B-X
of B-X
this B-X
study B-X
is B-X
to B-X
evaluate B-X
the B-X
prevalence B-X
of B-X
BRCA1/2 B-X
mutations B-X
in B-X
non-familial B-X
br B-X
Home B-X
Page B-X
: B-X
Annals B-X
of B-X
Oncology B-X
WikiGenes B-X
- B-X

METHODS	O
Clinical	O
information	O
,	O
family	O
histories	O
,	O
and	O
blood	O
for	O
DNA	O
analysis	O
were	O
obtained	O
from	O
263	O
women	O
with	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Purpose B-X
: B-X
This B-X
study B-X
is B-X
part B-X
of B-X
an B-X
ongoing B-X
National B-X
Cancer B-X
Institute B-X
multidisciplinary B-X
, B-X
etiologically-focused B-X
, B-X
cross-sectional B-X
study B-X
of B-X
Familial B-X
Testicular B-X
Cancer B-X
( B-X
FTC B-X
) B-X
. B-X
The B-X
current B-X
report B-X
targets B-X
Cancer B-X
risks B-X
in B-X
first B-X
degree B-X
relatives B-X
of B-X
BRCA1 B-X
mutation B-X
carriers B-X
: B-X
effects B-X
of B-X
mutation B-X
and B-X
proband B-X
disease B-X
status B-X

Conformation	O
-	O
sensitive	O
gel	O
electrophoresis	O
and	O
DNA	O
sequencing	O
were	O
used	O
to	O
identify	O
BRCA1	O
mutations	O
.	O
<EOS> B-X
PDF B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
1998 B-X
, B-X
Jarmo B-X
K√∂rkk√∂ B-X
and B-X
others B-X
published B-X
Use B-X
of B-X
conformation B-X
sensitive B-X
gel B-X
electrophoresis B-X
to B-X
detect B-X
single-base B-X
changes B-X
in B-X
the B-X
gene B-X
for B-X
COL10A1 B-X
| B-X
Find B-X
PDF B-X
| B-X
Conformation-sensitive B-X
gel B-X
electrophoresis B-X
( B-X
CSGE B-X
) B-X
has B-X
been B-X
introduced B-X
as B-X
the B-X
most B-X
reliable B-X
method B-X
for B-X
the B-X
screening B-X
of B-X
large B-X
and B-X
multi-exon B-X
genes B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
An B-X
update B-X
on B-X
conformation B-X
sensitive B-X
gel B-X
electrophoresis B-X
- B-X
Ganguly B-X
- B-X
2002 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Download B-X
Citation B-X
| B-X
Conformation B-X
Sensitive B-X
Gel B-X
Electrophoresis B-X
| B-X
Conformation B-X
sensitive B-X
gel B-X
electrophoresis B-X
( B-X
CSGE B-X
) B-X
is B-X
a B-X
rapid B-X
screening B-X
method B-X
for B-X
the B-X
detection B-X
of B-X
DNA B-X
sequence B-X
variation B-X
, B-X
specifically B-X
... B-X
The B-X
frequency B-X
of B-X
genomic B-X
rearrangements B-X
in B-X
BRCA1 B-X
was B-X
assessed B-X
in B-X
42 B-X
American B-X
families B-X
with B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
who B-X
were B-X
seeking B-X
genetic B-X
testing B-X
and B-X
who B-X
were B-X
subsequently B-X
found B-X
to B-X
be B-X
PDF B-X
| B-X
Detection B-X
of B-X
mutations B-X
is B-X
of B-X
central B-X
importance B-X
in B-X
the B-X
study B-X
of B-X
genetic B-X
and B-X
malignant B-X
diseases B-X
. B-X
Mutation B-X
detection B-X
helps B-X
us B-X
in B-X
understanding B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
The B-X
British B-X
Journal B-X
of B-X
Haematology B-X
publishes B-X
original B-X
research B-X
papers B-X
in B-X
clinical B-X
, B-X
laboratory B-X
and B-X
experimental B-X
haematology B-X
. B-X
The B-X
Journal B-X
also B-X
features B-X
annotations B-X
, B-X
reviews B-X
, B-X
short B-X
reports B-X
, B-X
images B-X
in B-X

RESULTS	O
BRCA1	O
mutations	O
were	O
identified	O
in	O
16	O
percent	O
of	O
women	O
with	O
a	O
family	O
history	O
of	O
breast	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Analysis B-X
of B-X
5382insC B-X
( B-X
BRCA1 B-X
) B-X
and B-X
6174delT B-X
( B-X
BRCA2 B-X
) B-X
mutations B-X
in B-X
382 B-X
healthy B-X
Chilean B-X
women B-X
with B-X
a B-X
family B-X
history B-X
of B-X
breast B-X
cancer B-X
Effects B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
on B-X
female B-X
fertility B-X

Only	O
7	O
percent	O
of	O
women	O
from	O
families	O
with	O
a	O
history	O
of	O
breast	B-Disease
cancer	I-Disease
but	O
not	O
ovarian	B-Disease
cancer	I-Disease
had	O
BRCA1	O
mutations	O
.	O
<EOS> B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
in B-X
women B-X
of B-X
different B-X
ethnicities B-X
undergoing B-X
testing B-X
for B-X
hereditary B-X
breast-ovarian B-X
cancer B-X

The	O
rates	O
were	O
higher	O
among	O
women	O
from	O
families	O
with	O
a	O
history	O
of	O
both	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
.	O
<EOS> B-X
The B-X
average B-X
woman B-X
has B-X
a B-X
small B-X
chance B-X
of B-X
getting B-X
breast B-X
cancer B-X
and B-X
an B-X
even B-X
smaller B-X
chance B-X
of B-X
getting B-X
ovarian B-X
cancer B-X
. B-X
But B-X
if B-X
someone B-X
in B-X
your B-X
family B-X
has B-X
had B-X
breast B-X
Prevalence B-X
of B-X
family B-X
histories B-X
of B-X
breast B-X
cancer B-X
in B-X
the B-X
general B-X
population B-X
and B-X
the B-X
incidence B-X
of B-X
related B-X
seeking B-X
of B-X
health B-X
care B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
This B-X
study B-X
showed B-X
no B-X
increased B-X
risk B-X
of B-X
ovarian B-X
cancer B-X
in B-X
families B-X
that B-X
tested B-X
negative B-X
for B-X
BRCA1/2 B-X
or B-X
were B-X
untested B-X
. B-X
These B-X
data B-X
help B-X
counselling B-X
women B-X
from B-X
BRCA1/2 B-X
negative B-X
families B-X
with B-X
Request B-X
PDF B-X
| B-X
Risk B-X
of B-X
ovarian B-X
cancer B-X
in B-X
breast-cancer B-X
patients B-X
with B-X
a B-X
family B-X
history B-X
of B-X
breast B-X
or B-X
ovarian B-X
cancer B-X
: B-X
A B-X
population-based B-X
cohort B-X
study B-X
| B-X
Patients B-X
with B-X
breast B-X
cancer B-X
who B-X
PDF B-X
| B-X
Background B-X
: B-X
Mutations B-X
in B-X
BRCA1/2 B-X
genes B-X
confer B-X
ovarian B-X
, B-X
alongside B-X
breast B-X
, B-X
cancer B-X
risk B-X
. B-X
We B-X
examined B-X
the B-X
risk B-X
of B-X
developing B-X
ovarian B-X
cancer B-X
in B-X
... B-X
| B-X
Find B-X
, B-X
To B-X
define B-X
the B-X
prevalence B-X
and B-X
relative B-X
contributions B-X
of B-X
BRCA1 B-X
and B-X
BRCA2 B-X
mutations B-X
among B-X
African B-X
American B-X
families B-X
with B-X
breast B-X
cancer B-X
, B-X
we B-X
analyzed B-X
28 B-X
DNA B-X
samples B-X
from B-X
patients B-X
identified B-X
through B-X
two B-X

Among	O
family	O
members	O
,	O
an	O
average	O
age	O
of	O
less	O
than	O
55	O
years	O
at	O
the	O
diagnosis	O
of	O
breast	B-Disease
cancer	I-Disease
,	O
the	O
presence	O
of	O
ovarian	B-Disease
cancer	I-Disease
,	O
the	O
presence	O
of	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
in	O
the	O
same	O
woman	O
,	O
and	O
Ashkenazi	O
Jewish	O
ancestry	O
were	O
all	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
detecting	O
a	O
BRCA1	O
mutation	O
.	O
<EOS> B-X
Co-existence B-X
of B-X
breast B-X
and B-X
ovarian B-X
cancers B-X
in B-X
BRCA B-X
germ-line B-X
mutation B-X
carriers B-X
Three B-X
founder B-X
mutations B-X
in B-X
the B-X
cancer-associated B-X
genes B-X
BRCA1 B-X
and B-X
BRCA2 B-X
occur B-X
frequently B-X
enough B-X
among B-X
Ashkenazi B-X
Jews B-X
to B-X
warrant B-X
consideration B-X
of B-X
genetic B-X
testing B-X
outside B-X
the B-X
setting B-X
of B-X
high-risk B-X
families B-X
with B-X
multiple B-X
This B-X
data B-X
shows B-X
that B-X
the B-X
presence B-X
of B-X
the B-X
5382insC B-X
mutation B-X
in B-X
the B-X
BRCA1 B-X
gene B-X
is B-X
not B-X
always B-X
associated B-X
with B-X
the B-X
development B-X
of B-X
ovarian B-X
cancer B-X
. B-X
It B-X
is B-X
very B-X
likely B-X
that B-X
BRCA B-X
Mutations B-X
and B-X
Risk B-X
of B-X
Prostate B-X
Cancer B-X
in B-X
Ashkenazi B-X
Jews B-X
| B-X
Clinical B-X
Cancer B-X
Research B-X
Family B-X
history B-X
of B-X
breast B-X
cancer B-X
as B-X
a B-X
determinant B-X
of B-X
the B-X
risk B-X
of B-X
developing B-X
endometrial B-X
cancer B-X
: B-X
a B-X
nationwide B-X
cohort B-X
study B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
See B-X
the B-X
American B-X
Cancer B-X
Society B-X
's B-X
screening B-X
guidelines B-X
for B-X
women B-X
at B-X
average B-X
risk B-X
of B-X
breast B-X
cancer B-X
and B-X
for B-X
those B-X
at B-X
higher B-X
risk B-X
for B-X
breast B-X
cancer B-X
. B-X
Family B-X
History B-X
of B-X
Breast B-X
Cancer B-X
in B-X
First-Degree B-X
Relatives B-X
and B-X
Triple-Negative B-X
Breast B-X
Cancer B-X
Risk B-X

No	O
association	O
was	O
found	O
between	O
the	O
presence	O
of	O
bilateral	O
breast	B-Disease
cancer	I-Disease
or	O
the	O
number	O
of	O
breast	B-Disease
cancers	I-Disease
in	O
a	O
family	O
and	O
the	O
detection	O
of	O
a	O
BRCA1	O
mutation	O
,	O
or	O
between	O
the	O
position	O
of	O
the	O
mutation	O
in	O
the	O
BRCA1	O
gene	O
and	O
the	O
presence	O
of	O
ovarian	B-Disease
cancer	I-Disease
in	O
a	O
family	O
.	O
<EOS> B-X
Association B-X
between B-X
family B-X
history B-X
, B-X
mutation B-X
locations B-X
, B-X
and B-X
prevalence B-X
of B-X
BRCA1 B-X
or B-X
2 B-X
mutations B-X
in B-X
ovarian B-X
cancer B-X
patients B-X
The B-X
association B-X
between B-X
cancer B-X
family B-X
history B-X
and B-X
ovarian B-X
cancer B-X
risk B-X
in B-X
BRCA1/2 B-X
mutation B-X
carriers B-X
: B-X
can B-X
it B-X
be B-X
explained B-X
by B-X
the B-X
mutation B-X
position B-X
? B-X
Abstract B-X
. B-X
Individuals B-X
carrying B-X
germline B-X
mutations B-X
in B-X
one B-X
allele B-X
of B-X
the B-X
BRCA1 B-X
or B-X
BRCA2 B-X
genes B-X
are B-X
at B-X
significantly B-X
increased B-X
risk B-X
of B-X
developing B-X
cancer B-X
. B-X
Although B-X
t B-X
Breast B-X
and B-X
ovarian B-X
cancer B-X
risk B-X
evaluation B-X
in B-X
families B-X
with B-X
a B-X
disease-causing B-X
mutation B-X
in B-X
BRCA1/2 B-X
Clinical B-X
Evaluation B-X
of B-X
BRCA1/2 B-X
Mutation B-X
in B-X
Mexican B-X
Ovarian B-X
Cancer B-X
Patients B-X
Clinical B-X
Evaluation B-X
of B-X
BRCA1/2 B-X
Mutation B-X
in B-X
Mexican B-X
Ovarian B-X
Cancer B-X
Patients B-X
- B-X
ScienceDirect B-X
Ovarian B-X
cancer B-X
( B-X
OC B-X
) B-X
mostly B-X
arises B-X
sporadically B-X
, B-X
but B-X
a B-X
fraction B-X
of B-X
cases B-X
are B-X
associated B-X
with B-X
mutations B-X
in B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genes B-X
. B-X
The B-X
presence B-X
of B-X
a B-X
BRCA B-X
mutation B-X

CONCLUSIONS	O
Among	O
women	O
with	O
breast	B-Disease
cancer	I-Disease
and	O
a	O
family	O
history	O
of	O
the	O
disease	O
,	O
the	O
percentage	O
with	O
BRCA1	O
coding	O
-	O
region	O
mutations	O
is	O
less	O
than	O
the	O
45	O
percent	O
predicted	O
by	O
genetic	O
-	O
linkage	O
analysis	O
.	O
<EOS> B-X
These B-X
findings B-X
indicate B-X
a B-X
strong B-X
familial B-X
relationship B-X
for B-X
breast B-X
cancer B-X
in B-X
African B-X
American B-X
women B-X
. B-X
The B-X
associations B-X
with B-X
family B-X
history B-X
of B-X
colon B-X
cancer B-X
and B-X
leukemia B-X
warrant B-X
further B-X
investigation B-X
. B-X
First-degree B-X
family B-X
history B-X
was B-X
associated B-X
with B-X
increased B-X
risk B-X
of B-X
invasive B-X
breast B-X
cancer B-X
in B-X
all B-X
subgroups B-X
of B-X
older B-X
women B-X
irrespective B-X
of B-X
a B-X
relative B-X
's B-X
age B-X
at B-X
diagnosis B-X
. B-X
Family B-X
history B-X
and B-X
risk B-X
of B-X
breast B-X
cancer B-X
: B-X
an B-X
analysis B-X
accounting B-X
for B-X
family B-X
structure B-X
Adolescents B-X
with B-X
family B-X
history B-X
may B-X
reduce B-X
their B-X
risk B-X
by B-X
avoiding B-X
alcohol B-X
. B-X
Separate B-X
risk B-X
factors B-X
were B-X
observed B-X
among B-X
girls B-X
with B-X
family B-X
history B-X
versus B-X
girls B-X
with B-X
no B-X
family B-X
history B-X
, B-X
possibly B-X
Mutation B-X
Screening B-X
of B-X
the B-X
BRCA1 B-X
Gene B-X
in B-X
Early B-X
Onset B-X
and B-X
Familial B-X
Breast/Ovarian B-X
Cancer B-X
in B-X
Moroccan B-X
Population B-X
A B-X
major B-X
risk B-X
factor B-X
for B-X
breast B-X
cancer B-X
is B-X
having B-X
a B-X
first-degree B-X
family B-X
history B-X
of B-X
the B-X
disease B-X
. B-X
Benign B-X
breast B-X
disease B-X
( B-X
BBD B-X
) B-X
, B-X
particularly B-X
atypical B-X
hyperplasia B-X
, B-X
is B-X
also B-X
Awareness B-X
of B-X
hereditary B-X
breast B-X
cancer B-X
genetic B-X
testing B-X
, B-X
of B-X
breast B-X
cancer B-X
risk B-X
factors B-X
, B-X
and B-X
of B-X
increased B-X
level B-X
of B-X
risk B-X
based B-X
on B-X
family B-X
history B-X
are B-X
necessary B-X
before B-X
women B-X
can B-X
seek B-X

These	O
results	O
suggest	O
that	O
even	O
in	O
a	O
referral	O
clinic	O
specializing	O
in	O
screening	O
women	O
from	O
high	O
-	O
risk	O
families	O
,	O
the	O
majority	O
of	O
tests	O
for	O
BRCA1	O
mutations	O
will	O
be	O
negative	O
and	O
therefore	O
uninformative	O
.	O
.	O
<EOS> B-X
The B-X
Role B-X
of B-X
Testing B-X
for B-X
BRCA1 B-X
and B-X
BRCA2 B-X
Mutations B-X
in B-X
Cancer B-X
Prevention B-X
Too B-X
Many B-X
Referrals B-X
of B-X
Low-risk B-X
Women B-X
for B-X
BRCA1/2 B-X
Genetic B-X
Services B-X
by B-X
Family B-X
Physicians B-X
Learn B-X
about B-X
BRCA B-X
testing B-X
for B-X
breast B-X
cancer B-X
screening B-X
. B-X
Who B-X
should B-X
consider B-X
testing B-X
? B-X
What B-X
are B-X
the B-X
risks B-X
and B-X
benefits B-X
of B-X
testing B-X
? B-X
BRCA B-X
mutation‚Äênegative B-X
women B-X
from B-X
hereditary B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
families B-X
: B-X
a B-X
qualitative B-X
study B-X
of B-X
the B-X
BRCA‚Äênegative B-X
experience B-X
For B-X
women B-X
with B-X
a B-X
hereditary B-X
risk B-X
of B-X
breast B-X
cancer B-X
, B-X
the B-X
Johns B-X
Hopkins B-X
Breast B-X
Center B-X
in B-X
Baltimore B-X
, B-X
MD B-X
, B-X
offers B-X
guidance B-X
on B-X
genetic B-X
testing B-X
, B-X
screenings B-X
and B-X
preventive B-X
mastectomy B-X
BRCA1 B-X
and B-X
BRCA2 B-X
genetic B-X
testing‚Äîpitfalls B-X
and B-X
recommendations B-X
for B-X
managing B-X
variants B-X
of B-X
uncertain B-X
clinical B-X
significance B-X
Find B-X
out B-X
who B-X
‚Äô B-X
s B-X
at B-X
higher B-X
risk B-X
of B-X
developing B-X
breast B-X
cancer B-X
and B-X
learn B-X
about B-X
special B-X
breast B-X
cancer B-X
screening B-X
recommendations B-X
for B-X
women B-X
at B-X
higher B-X
risk B-X
. B-X

Mutations	O
in	O
the	O
arginine	O
-	O
rich	O
protein	O
gene	O
(	O
ARP	O
)	O
in	O
pancreatic	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
‚Äì B-X
Fingerprint B-X
‚Äî B-X
Mayo B-X
Clinic B-X
EBSCOhost B-X
| B-X
8911405 B-X
| B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
. B-X
EBSCOhost B-X
| B-X
8911405 B-X
| B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
. B-X
Table B-X
2 B-X
Clinicopathological B-X
data B-X
of B-X
the B-X
pancreatic B-X
ductal B-X
adenocarcinomas B-X
- B-X
`` B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
'' B-X
( B-X
PDF B-X
) B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
| B-X
laura B-X
christa B-X
- B-X
Academia.edu B-X
S B-X
Rivard B-X
's B-X
4 B-X
research B-X
works B-X
with B-X
96 B-X
citations B-X
and B-X
142 B-X
reads B-X
, B-X
including B-X
: B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
Table B-X
1 B-X
List B-X
of B-X
all B-X
mutations B-X
in B-X
sub-clones B-X
of B-X
PCR B-X
products B-X
of B-X
the B-X
ARP B-X
gene B-X
in B-X
15 B-X
pancreatic B-X
adenocarcinomas B-X
that B-X
had B-X
mutations B-X
in B-X
one B-X
, B-X
or B-X
more B-X
, B-X
subclones B-X
- B-X

The	O
ARP	O
gene	O
encodes	O
a	O
highly	O
conserved	O
arginine	O
-	O
rich	O
protein	O
from	O
chromosomal	O
band	O
3p21	O
.	O
<EOS> B-X
L B-X
BOSTICK B-X
's B-X
4 B-X
research B-X
works B-X
with B-X
37 B-X
citations B-X
and B-X
25 B-X
reads B-X
, B-X
including B-X
: B-X
A B-X
gene B-X
from B-X
human B-X
chromosomal B-X
band B-X
3p21.1 B-X
encodes B-X
a B-X
highly B-X
conserved B-X
arginine-rich B-X
protein B-X
and B-X
is B-X
We B-X
have B-X
identified B-X
a B-X
gene B-X
, B-X
called B-X
ARP B-X
for B-X
Arginine-rich B-X
protein B-X
, B-X
in B-X
human B-X
chromosomal B-X
band B-X
3p21 B-X
. B-X
It B-X
is B-X
approximately B-X
600 B-X
Kb B-X
telomeric B-X
to B-X
the B-X
ACY1 B-X
locus B-X
( B-X
Miller B-X
Mutations B-X
in B-X
the B-X
Arginine-rich B-X
Protein B-X
Gene B-X
, B-X
in B-X
Lung B-X
, B-X
Breast B-X
, B-X
and B-X
Prostate B-X
Cancers B-X
, B-X
and B-X
in B-X
Squamous B-X
Cell B-X
Carcinoma B-X
of B-X
the B-X
Head B-X
and B-X
Neck B-X
| B-X
Cancer B-X
Research B-X
Abstract B-X
. B-X
Epithelial B-X
cancers B-X
inflict B-X
a B-X
heavy B-X
human B-X
and B-X
social B-X
burden B-X
. B-X
It B-X
was B-X
estimated B-X
[ B-X
Tyczynski B-X
JE B-X
, B-X
Bray B-X
F B-X
, B-X
Parkin B-X
DM B-X
. B-X
Lung B-X
cancer B-X
in B-X
Europe B-X
in B-X

1	O
1	O
.	O
<EOS> B-X
1-1 B-X
- B-X
Wikipedia B-X
1-1 B-X
- B-X
Wikipedia B-X
1-1 B-X
- B-X
Wikipedia B-X
1+1 B-X
- B-X
Wikipedia B-X
1+1 B-X
- B-X
Wikipedia B-X
1+1 B-X
- B-X
Wikipedia B-X
1+1 B-X
( B-X
song B-X
) B-X
- B-X
Wikipedia B-X

At	O
the	O
cytogenetic	O
level	O
this	O
region	O
is	O
frequently	O
deleted	O
in	O
a	O
variety	O
of	O
different	O
solid	B-Disease
tumors	I-Disease
,	O
although	O
not	O
in	O
pancreatic	B-Disease
cancer	I-Disease
.	O
<EOS> B-X
Causes B-X
and B-X
consequences B-X
of B-X
microRNA B-X
dysregulation B-X
in B-X
cancer B-X
The B-X
Role B-X
of B-X
Chromosomal B-X
Instability B-X
in B-X
Cancer B-X
and B-X
Therapeutic B-X
Responses B-X
DLC1 B-X
( B-X
deleted B-X
in B-X
liver B-X
cancer B-X
1 B-X
) B-X
Pathology B-X
and B-X
Molecular B-X
Genetics B-X
of B-X
Pancreatic B-X
Neoplasms B-X
< B-X
i B-X
> B-X
FHIT B-X
< B-X
/i B-X
> B-X
, B-X
located B-X
at B-X
FRA3B B-X
, B-X
is B-X
one B-X
of B-X
the B-X
most B-X
commonly B-X
deleted B-X
genes B-X
in B-X
human B-X
cancers B-X
, B-X
and B-X
loss B-X
of B-X
FHIT B-X
protein B-X
is B-X
Neuroblastoma B-X
tumour B-X
genetics B-X
: B-X
clinical B-X
and B-X
biological B-X
aspects B-X
| B-X
Journal B-X
of B-X
Clinical B-X
Pathology B-X
Chromosomes B-X
and B-X
cancer B-X
cells B-X

We	O
have	O
reported	O
the	O
presence	O
of	O
a	O
specific	O
mutation	O
(	O
ATG50	O
-	O
-	O
>	O
AGG	O
)	O
or	O
deletion	O
of	O
codon	O
50	O
of	O
the	O
ARP	O
gene	O
in	O
different	O
tumor	B-Disease
types	I-Disease
(	O
Shridhar	O
et	O
al	O
.	O
,	O
1996	O
,	O
1996a	O
)	O
.	O
<EOS> B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
. B-X
Neoplasia B-X
: B-X
Mutations B-X
in B-X
the B-X
DNA-binding B-X
codons B-X
of B-X
TP53 B-X
, B-X
which B-X
are B-X
associated B-X
with B-X
decreased B-X
expression B-X
of B-X
TRAILreceptor-2 B-X
, B-X
predict B-X
for B-X
poor B-X
survival B-X
in B-X
diffuse B-X
large B-X
B-cell B-X
lymphoma B-X
Download B-X
Table B-X
| B-X
Clinicopathological B-X
data B-X
of B-X
the B-X
pancreatic B-X
ductal B-X
adeno- B-X
carcinomas B-X
from B-X
publication B-X
: B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
| B-X
The B-X
ARP B-X
gene B-X
Mutations B-X
of B-X
the B-X
K-ras B-X
gene B-X
have B-X
been B-X
implicated B-X
in B-X
the B-X
pathogenesis B-X
of B-X
human B-X
lung B-X
adenocarcinomas B-X
. B-X
In B-X
most B-X
studies B-X
published B-X
so B-X
far B-X
, B-X
squamous B-X
cell B-X
lung B-X
cancers B-X
harbored B-X
ras B-X
mutations B-X
Polyomaviruses B-X
( B-X
PyVs B-X
) B-X
have B-X
a B-X
wide B-X
range B-X
of B-X
hosts B-X
, B-X
from B-X
humans B-X
to B-X
fish B-X
, B-X
and B-X
their B-X
effects B-X
on B-X
hosts B-X
vary B-X
. B-X
The B-X
differences B-X
in B-X
the B-X
infection B-X
characteristics B-X
of B-X
[ B-X
USC02 B-X
] B-X
42 B-X
USC B-X
1996 B-X
: B-X
Protection B-X
and B-X
preservation B-X
of B-X
traditional B-X
religions B-X
of B-X
Native B-X
Americans B-X
Virus B-X
Taxonomy B-X
1996 B-X
‚Äî B-X
A B-X
Bulletin B-X
from B-X
the B-X
Xth B-X
International B-X
Congress B-X
of B-X
Virology B-X
in B-X
Jerusalem B-X
| B-X
SpringerLink B-X

In	O
the	O
present	O
study	O
,	O
we	O
have	O
observed	O
mutations	O
involving	O
codon	O
50	O
in	O
11	O
of	O
37	O
pancreatic	B-Disease
tumors	I-Disease
.	O
<EOS> B-X
The B-X
mutational B-X
landscapes B-X
of B-X
pancreatic B-X
and B-X
liver B-X
cancer B-X
share B-X
many B-X
common B-X
genetic B-X
alterations B-X
which B-X
drive B-X
cancer B-X
progression B-X
. B-X
However B-X
, B-X
these B-X
mutations B-X
do B-X
not B-X
occur B-X
in B-X
all B-X
cases B-X
of B-X
these B-X
Pancreatic B-X
ductal B-X
adenocarcinoma B-X
( B-X
PDA B-X
) B-X
has B-X
a B-X
dismal B-X
prognosis B-X
and B-X
insights B-X
into B-X
both B-X
disease B-X
etiology B-X
and B-X
targeted B-X
intervention B-X
are B-X
needed B-X
. B-X
A B-X
total B-X
of B-X
109 B-X
micro-dissected B-X
PDA B-X
cases B-X
were B-X
Inorganic B-X
arsenic B-X
is B-X
an B-X
environmental B-X
human B-X
carcinogen B-X
of B-X
several B-X
organs B-X
including B-X
the B-X
urinary B-X
tract B-X
. B-X
RWPE-1 B-X
cells B-X
are B-X
immortalized B-X
, B-X
non-tumorigenic B-X
, B-X
human B-X
prostate B-X
epithelia B-X
that B-X
become B-X
malignantly B-X
transformed B-X
into B-X

The	O
frequency	O
of	O
codon	O
50	O
mutation	O
is	O
roughly	O
the	O
same	O
in	O
pancreatic	B-Disease
tumors	I-Disease
as	O
in	O
the	O
other	O
types	O
of	O
tumors	B-Disease
previously	O
examined	O
.	O
<EOS> B-X
Comprehensive B-X
Analysis B-X
of B-X
Hypermutation B-X
in B-X
Human B-X
Cancer B-X
The B-X
purpose B-X
of B-X
this B-X
review B-X
is B-X
to B-X
summarize B-X
the B-X
evidence B-X
that B-X
can B-X
be B-X
used B-X
to B-X
reconstruct B-X
the B-X
etiology B-X
of B-X
human B-X
cancers B-X
from B-X
mutations B-X
found B-X
in B-X
tumors B-X
. B-X
Mutat B-X
Genome-wide B-X
mutational B-X
spectra B-X
analysis B-X
reveals B-X
significant B-X
cancer-specific B-X
heterogeneity B-X
Mutations B-X
in B-X
the B-X
arginine-rich B-X
protein B-X
gene B-X
( B-X
ARP B-X
) B-X
in B-X
pancreatic B-X
cancer B-X
‚Äî B-X
Mayo B-X
Clinic B-X
Request B-X
PDF B-X
| B-X
Polymorphic B-X
variation B-X
of B-X
the B-X
ARP B-X
gene B-X
on B-X
3p21 B-X
in B-X
Japanese B-X
esophageal B-X
cancer B-X
patients B-X
| B-X
Allelic B-X
loss B-X
of B-X
the B-X
short B-X
arm B-X
of B-X
chromosome B-X
3 B-X
is B-X
common B-X
in B-X
esophageal B-X
Chromosome B-X
17p B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

In	O
addition	O
,	O
we	O
have	O
detected	O
mutations	O
at	O
codon	O
51	O
in	O
multiple	O
PCR	O
subclones	O
in	O
two	O
other	O
pancreatic	B-Disease
tumors	I-Disease
.	O
<EOS> B-X
Values B-X
of B-X
mutations B-X
of B-X
K-ras B-X
oncogene B-X
at B-X
codon B-X
12 B-X
in B-X
detection B-X
of B-X
pancreatic B-X
cancer B-X
: B-X
15-year B-X
experience B-X
Comprehensive B-X
Validation B-X
of B-X
Snapback B-X
Primer-Based B-X
Melting B-X
Curve B-X
Analysis B-X
to B-X
Detect B-X
Nucleotide B-X
Variation B-X
in B-X
the B-X
Codon B-X
12 B-X
and B-X
13 B-X
of B-X
KRAS B-X
Gene B-X
Novel B-X
mutant-enriched B-X
Sequencing B-X
Identified B-X
High B-X
Frequency B-X
of B-X
PIK3CA B-X
Mutations B-X
in B-X
Pharyngeal B-X
Cancer B-X
KRAS B-X
mutant B-X
tumor B-X
subpopulations B-X
can B-X
subvert B-X
durable B-X
responses B-X
to B-X
personalized B-X
cancer B-X
treatments B-X
Pancreatic B-X
cancer B-X
: B-X
Circulating B-X
Tumor B-X
Cells B-X
and B-X
Primary B-X
Tumors B-X
show B-X
Heterogeneous B-X
KRAS B-X
Mutations B-X
Liquid B-X
biopsy B-X
in B-X
pancreatic B-X
ductal B-X
adenocarcinoma B-X
: B-X
current B-X
status B-X
of B-X
circulating B-X
tumor B-X
cells B-X
and B-X
circulating B-X
tumor B-X
DNA B-X
Pancreatic B-X
ductal B-X
adenocarcinoma B-X
( B-X
PDAC B-X
) B-X
is B-X
a B-X
devastating B-X
disease B-X
. B-X
Circulating B-X
tumor B-X
cells B-X
( B-X
CTC B-X
) B-X
in B-X
the B-X
blood B-X
are B-X
hypothesized B-X
as B-X
the B-X
means B-X
of B-X
systemic B-X
tumor B-X
spread B-X
. B-X

Mutations	O
in	O
the	O
ARP	O
gene	O
are	O
thus	O
commonly	O
observed	O
in	O
pancreatic	B-Disease
cancer	I-Disease
,	O
as	O
well	O
as	O
many	O
other	O
cancers	B-Disease
.	O
<EOS> B-X
Genetic B-X
evolution B-X
of B-X
pancreatic B-X
cancer B-X
: B-X
lessons B-X
learnt B-X
from B-X
the B-X
pancreatic B-X
cancer B-X
genome B-X
sequencing B-X
project B-X
Genetics B-X
and B-X
pathology B-X
of B-X
pancreatic B-X
cancer B-X
Lack B-X
of B-X
association B-X
between B-X
UGT1A7 B-X
, B-X
UGT1A9 B-X
, B-X
ARP B-X
, B-X
SPINK1 B-X
and B-X
CFTR B-X
gene B-X
polymorphisms B-X
and B-X
pancreatic B-X
cancer B-X
in B-X
Italian B-X
patients B-X
Lack B-X
of B-X
association B-X
between B-X
UGT1A7 B-X
, B-X
UGT1A9 B-X
, B-X
ARP B-X
, B-X
SPINK1 B-X
and B-X
CFTR B-X
gene B-X
polymorphisms B-X
and B-X
pancreatic B-X
cancer B-X
in B-X
Italian B-X
patients B-X
Molecular B-X
Pathogenesis B-X
of B-X
Pancreatic B-X
Cancer B-X
Genetic B-X
Susceptibility B-X
to B-X
Pancreatic B-X
Cancer B-X
Inherited B-X
Pancreatic B-X
Cancer B-X
Syndromes B-X

Difficulties	O
in	O
the	O
ascertainment	O
of	O
C9	B-Disease
deficiency	I-Disease
:	O
lessons	O
to	O
be	O
drawn	O
from	O
a	O
compound	O
heterozygote	O
C9	B-Disease
-	I-Disease
deficient	I-Disease
subject	O
.	O
<EOS> B-X
Difficulties B-X
in B-X
the B-X
ascertainment B-X
of B-X
C9 B-X
deficiency B-X
: B-X
lessons B-X
to B-X
be B-X
drawn B-X
from B-X
a B-X
compound B-X
heterozygote B-X
C9‚Äêdeficient B-X
subject B-X
- B-X
HOBART B-X
- B-X
1997 B-X
- B-X
Clinical B-X
& B-X
amp B-X
; B-X
Experimental B-X
Immunology B-X
- B-X
V B-X
C B-X
Joysey B-X
's B-X
10 B-X
research B-X
works B-X
with B-X
316 B-X
citations B-X
and B-X
100 B-X
reads B-X
, B-X
including B-X
: B-X
Difficulties B-X
in B-X
the B-X
ascertainment B-X
of B-X
C9 B-X
deficiency B-X
: B-X
Lessons B-X
to B-X
be B-X
drawn B-X
from B-X
a B-X
An B-X
abnormal B-X
but B-X
functionally B-X
active B-X
complement B-X
component B-X
C9 B-X
protein B-X
found B-X
in B-X
an B-X
Irish B-X
family B-X
with B-X
subtotal B-X
C9 B-X
deficiency B-X
Complement B-X
( B-X
C B-X
) B-X
deficiencies B-X
are B-X
not B-X
common B-X
and B-X
laboratory B-X
screening B-X
for B-X
clinical B-X
reasons B-X
generally B-X
involves B-X
examining B-X
relatively B-X
few B-X
samples B-X
. B-X
Nevertheless B-X
, B-X
because B-X
of B-X
the B-X
range B-X
of B-X
tests B-X
, B-X
Komplement B-X
C9-Mangel B-X
The B-X
results B-X
of B-X
the B-X
present B-X
( B-X
VIIth B-X
Complement B-X
Genetics B-X
Workshop B-X
and B-X
Conference B-X
, B-X
Mainz B-X
, B-X
May B-X
1998 B-X
) B-X
and B-X
past B-X
reference B-X
typing B-X
workshops B-X
for B-X
the B-X
terminal B-X
complement B-X
components B-X
C6 B-X
, B-X
A B-X
group B-X
of B-X
patients B-X
with B-X
long-surviving B-X
mismatched B-X
kidney B-X
allografts B-X
were B-X
investigated B-X
for B-X
complement B-X
function B-X
using B-X
haemolytic B-X
assays B-X
in B-X
agarose B-X
gels B-X
. B-X
One B-X
patient B-X
was B-X
found B-X
to B-X
have B-X
no B-X
alternative B-X
pathway B-X

A	O
group	O
of	O
patients	O
with	O
long	O
-	O
surviving	O
mismatched	O
kidney	O
allografts	O
were	O
investigated	O
for	O
complement	O
function	O
using	O
haemolytic	O
assays	O
in	O
agarose	O
gels	O
.	O
<EOS> B-X
A B-X
group B-X
of B-X
patients B-X
with B-X
long‚Äêsurviving B-X
mismatched B-X
kidney B-X
allografts B-X
were B-X
investigated B-X
for B-X
complement B-X
function B-X
using B-X
haemolytic B-X
assays B-X
in B-X
agarose B-X
gels B-X
. B-X
One B-X
patient B-X
was B-X
found B-X
to B-X
have B-X
no B-X
alternative B-X
pathway B-X
A B-X
method B-X
of B-X
prolonging B-X
the B-X
survival B-X
of B-X
a B-X
homologous B-X
transplanted B-X
cell B-X
, B-X
tissue B-X
or B-X
organ B-X
is B-X
presented B-X
. B-X
These B-X
methods B-X
comprise B-X
the B-X
step B-X
of B-X
administering B-X
an B-X
inhibitor B-X
of B-X
complement B-X
activity B-X
Impact B-X
of B-X
complement B-X
component B-X
3/4/5 B-X
single B-X
nucleotide B-X
polymorphisms B-X
on B-X
renal B-X
transplant B-X
recipients B-X
with B-X
antibody-mediated B-X
rejection B-X
Request B-X
PDF B-X
| B-X
Non-Complement- B-X
and B-X
Complement-Activating B-X
Antibodies B-X
Synergize B-X
to B-X
Cause B-X
Rejection B-X
of B-X
Cardiac B-X
Allografts B-X
| B-X
Alloantibodies B-X
( B-X
AlloAbs B-X
) B-X
are B-X
a B-X
clinically B-X
significant B-X
component B-X
of B-X
the B-X
immune B-X
response B-X
to B-X
organ B-X
Abstract B-X
- B-X
2019 B-X
- B-X
Xenotransplantation B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Heterogeneity B-X
in B-X
the B-X
genetic B-X
basis B-X
of B-X
human B-X
complement B-X
C9 B-X
deficiency B-X
- B-X
ÁôæÂ∫¶Â≠¶ÊúØ B-X
POSTER B-X
PRESENTATIONS B-X

One	O
patient	O
was	O
found	O
to	O
have	O
no	O
alternative	O
pathway	O
activity	O
but	O
a	O
low	O
normal	O
classical	O
pathway	O
.	O
<EOS> B-X
Diagnosis B-X
of B-X
complement B-X
alternative B-X
pathway B-X
disorders B-X
- B-X
ScienceDirect B-X
Overactivity B-X
of B-X
Alternative B-X
Pathway B-X
Convertases B-X
in B-X
Patients B-X
With B-X
Complement-Mediated B-X
Renal B-X
Diseases B-X
Editorial B-X
: B-X
The B-X
Role B-X
of B-X
Complement B-X
in B-X
Health B-X
and B-X
Disease B-X
Decreased B-X
Ficolin-3-mediated B-X
Complement B-X
Lectin B-X
Pathway B-X
Activation B-X
and B-X
Alternative B-X
Pathway B-X
Amplification B-X
During B-X
Bacterial B-X
Infections B-X
in B-X
Patients B-X
With B-X
Type B-X
2 B-X
Diabetes B-X
Mellitus B-X
The B-X
term B-X
complement B-X
references B-X
a B-X
set B-X
of B-X
serum B-X
proteins B-X
that B-X
cooperates B-X
with B-X
both B-X
the B-X
innate B-X
and B-X
the B-X
adaptive B-X
immune B-X
systems B-X
to B-X
eliminate B-X
the B-X
bold B-X
and B-X
tissue B-X
pathogens B-X
. B-X
Like B-X
the B-X
Complement B-X
disorders B-X
and B-X
hereditary B-X
angioedema B-X
- B-X
Journal B-X
of B-X
Allergy B-X
and B-X
Clinical B-X
Immunology B-X

Surprisingly	O
,	O
investigation	O
revealed	O
that	O
the	O
patients	O
complement	O
was	O
normal	O
for	O
all	O
components	O
except	O
C9	O
,	O
which	O
was	O
functionally	O
absent	O
.	O
<EOS> B-X
PDF B-X
| B-X
On B-X
Oct B-X
1 B-X
, B-X
1995 B-X
, B-X
A.E.E B-X
. B-X
Ahmed B-X
and B-X
others B-X
published B-X
Clinical B-X
utility B-X
of B-X
complement B-X
assessment B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
Abstract B-X
. B-X
Age-related B-X
macular B-X
degeneration B-X
( B-X
AMD B-X
) B-X
is B-X
a B-X
progressive B-X
disease B-X
of B-X
the B-X
central B-X
retina B-X
and B-X
the B-X
leading B-X
cause B-X
of B-X
irreversible B-X
vision B-X
loss B-X
in B-X
the B-X
western B-X
The B-X
Alternative B-X
and B-X
Terminal B-X
Pathways B-X
of B-X
Complement B-X
Mediate B-X
Post-Traumatic B-X
Spinal B-X
Cord B-X
Inflammation B-X
and B-X
Injury B-X
AH50 B-X
: B-X
Complement B-X
proteins B-X
are B-X
components B-X
of B-X
the B-X
innate B-X
immune B-X
system B-X
. B-X
There B-X
are B-X
3 B-X
pathways B-X
to B-X
complement B-X
activation B-X
: B-X
( B-X
1 B-X
) B-X
the B-X
classical B-X
pathway B-X
, B-X
( B-X
2 B-X
) B-X

The	O
patient	O
was	O
shown	O
to	O
be	O
heterozygous	O
for	O
DNA	O
markers	O
in	O
the	O
C6	O
,	O
C7	O
and	O
C9	O
region	O
of	O
chromosome	O
5	O
and	O
therefore	O
appears	O
to	O
be	O
a	O
compound	O
heterozygote	O
for	O
two	O
uncharacterized	O
C9	B-Disease
deficiency	I-Disease
genes	O
.	O
<EOS> B-X
Difficulties B-X
in B-X
the B-X
ascertainment B-X
of B-X
C9 B-X
deficiency B-X
: B-X
lessons B-X
to B-X
be B-X
drawn B-X
from B-X
a B-X
compound B-X
heterozygote B-X
C9-deficient B-X
subject B-X
Region-specific B-X
detection B-X
of B-X
neuroblastoma B-X
loss B-X
of B-X
heterozygosity B-X
at B-X
multiple B-X
loci B-X
simultaneously B-X
using B-X
a B-X
SNP-based B-X
tag-array B-X
platform B-X
Complement B-X
component B-X
C7 B-X
deficiency B-X
in B-X
two B-X
Spanish B-X
families B-X
Request B-X
PDF B-X
| B-X
On B-X
Sep B-X
1 B-X
, B-X
2003 B-X
, B-X
R B-X
W√ºrzner B-X
published B-X
Deficiencies B-X
of B-X
the B-X
complement B-X
MAC B-X
II B-X
gene B-X
cluster B-X
( B-X
C6 B-X
, B-X
C7 B-X
, B-X
C9 B-X
) B-X
: B-X
Is B-X
subtotal B-X
Experimental B-X
Generation B-X
of B-X
SNP B-X
Haplotype B-X
Signatures B-X
in B-X
Patients B-X
with B-X
Sickle B-X
Cell B-X
Anaemia B-X
Microsatellite B-X
analysis B-X
of B-X
genetic B-X
diversity B-X
among B-X
clinical B-X
and B-X
nonclinical B-X
Saccharomyces B-X
cerevisiae B-X
isolates B-X
suggests B-X
heterozygote B-X
advantage B-X
in B-X
clinical B-X
environments B-X
Background B-X
Sickle B-X
cell B-X
anemia B-X
is B-X
caused B-X
by B-X
a B-X
single B-X
type B-X
of B-X
mutation B-X
, B-X
a B-X
homozygous B-X
A‚ÜíT B-X
substitution B-X
in B-X
the B-X
√ü B-X
globin B-X
gene B-X
. B-X
Clinical B-X
severity B-X
is B-X
diverse B-X
, B-X
partially B-X
due B-X

Serological	O
analysis	O
by	O
ELISA	O
revealed	O
that	O
he	O
has	O
trace	O
concentrations	O
of	O
a	O
non	O
-	O
functional	O
C9	O
molecule	O
.	O
<EOS> B-X
The B-X
union B-X
of B-X
antibody B-X
and B-X
antigen B-X
gives B-X
rise B-X
to B-X
a B-X
series B-X
of B-X
reactions B-X
, B-X
the B-X
qualitative B-X
or B-X
semiquantitative B-X
study B-X
of B-X
which B-X
is B-X
the B-X
domain B-X
of B-X
serology B-X
. B-X
In B-X
order B-X
to B-X
get B-X
monoclonal B-X
antibodies B-X
( B-X
MoAbs B-X
) B-X
against B-X
neoantigens B-X
of B-X
terminal B-X
complement B-X
complex B-X
. B-X
MoAbs B-X
after B-X
immunization B-X
of B-X
mice B-X
with B-X
polymerized B-X
human B-X
C9 B-X
were B-X
screened B-X
for B-X
reactivities B-X
against B-X
positive B-X
serum B-X
antibodies B-X
: B-X
Topics B-X
by B-X
WorldWideScience.org B-X
Complement-mediated B-X
lipopolysaccharide B-X
release B-X
and B-X
outer B-X
membrane B-X
damage B-X
in B-X
Escherichia B-X
coli B-X
J5 B-X
: B-X
requirement B-X
for B-X
C9 B-X
igg B-X
antibodies B-X
reactive B-X
: B-X
Topics B-X
by B-X
Science.gov B-X
Investigation B-X
and B-X
Exploitation B-X
of B-X
Antibody B-X
Combining B-X
Sites B-X
| B-X
SpringerLink B-X
The B-X
pentraxins B-X
are B-X
an B-X
ancient B-X
family B-X
of B-X
proteins B-X
with B-X
a B-X
unique B-X
architecture B-X
found B-X
as B-X
far B-X
back B-X
in B-X
evolution B-X
as B-X
the B-X
Horseshoe B-X
crab B-X
. B-X
In B-X
humans B-X
the B-X
two B-X
members B-X
of B-X
this B-X

Western	O
blot	O
analysis	O
was	O
not	O
sufficiently	O
sensitive	O
to	O
permit	O
detection	O
of	O
this	O
molecule	O
.	O
<EOS> B-X
Combined B-X
use B-X
of B-X
Western B-X
blot/ELISA B-X
to B-X
improve B-X
the B-X
serological B-X
diagnosis B-X
of B-X
human B-X
tuberculosis B-X
Important B-X
considerations B-X
for B-X
protein B-X
analyses B-X
using B-X
antibody B-X
based B-X
techniques B-X
: B-X
down-sizing B-X
Western B-X
blotting B-X
up-sizes B-X
outcomes B-X
The B-X
necessity B-X
of B-X
and B-X
strategies B-X
for B-X
improving B-X
confidence B-X
in B-X
the B-X
accuracy B-X
of B-X
western B-X
blots B-X
Western B-X
or B-X
immunoblotting B-X
analysis B-X
of B-X
protein B-X
expression B-X
in B-X
cells B-X
and B-X
tissues B-X
has B-X
been B-X
the B-X
major B-X
analytical B-X
tool B-X
for B-X
assessing B-X
molecular B-X
biological B-X
functions B-X
in B-X
basic B-X
cell B-X
biological B-X
research B-X
, B-X
pathology B-X
and B-X
Western B-X
Blot B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Western B-X
Blot B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Western B-X
Blot B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

We	O
hypothesize	O
that	O
the	O
patient	O
is	O
heterozygous	O
for	O
a	O
complete	B-Disease
deficiency	I-Disease
of	I-Disease
C9	I-Disease
and	O
for	O
a	O
gene	O
directing	O
hyposynthesis	O
of	O
a	O
defective	O
C9	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
On B-X
Jun B-X
8 B-X
, B-X
2007 B-X
, B-X
K. B-X
E. B-X
Sullivan B-X
and B-X
others B-X
published B-X
Genetically B-X
determined B-X
deficiences B-X
of B-X
the B-X
complement B-X
system B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
C9 B-X
complement B-X
C9 B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
Complement B-X
Component B-X
C1r B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

We	O
also	O
suggest	O
that	O
C9	B-Disease
deficiency	I-Disease
may	O
be	O
more	O
common	O
among	O
Caucasians	O
than	O
has	O
been	O
reported	O
.	O
.	O
<EOS> B-X
This B-X
guideline B-X
aims B-X
to B-X
describe B-X
the B-X
complement B-X
system B-X
and B-X
the B-X
functions B-X
of B-X
the B-X
constituent B-X
pathways B-X
, B-X
with B-X
particular B-X
focus B-X
on B-X
primary B-X
immunodeficienci B-X

Screening	O
for	O
ESR	O
mutations	O
in	O
breast	B-Disease
and	I-Disease
ovarian	I-Disease
cancer	I-Disease
patients	O
.	O
<EOS> B-X
Analysis B-X
of B-X
ESR1 B-X
mutation B-X
in B-X
circulating B-X
tumor B-X
DNA B-X
demonstrates B-X
evolution B-X
during B-X
therapy B-X
for B-X
metastatic B-X
breast B-X
cancer B-X
Comparison B-X
of B-X
ESR1 B-X
Mutations B-X
in B-X
Tumor B-X
Tissue B-X
and B-X
Matched B-X
Plasma B-X
Samples B-X
from B-X
Metastatic B-X
Breast B-X
Cancer B-X
Patients B-X
- B-X
ScienceDirect B-X
ESR1 B-X
alterations B-X
and B-X
metastasis B-X
in B-X
estrogen B-X
receptor B-X
positive B-X
breast B-X
cancer B-X
In B-X
the B-X
present B-X
study B-X
, B-X
leukocyte B-X
DNA B-X
from B-X
143 B-X
patients B-X
with B-X
familial B-X
clustering B-X
of B-X
breast B-X
and/or B-X
ovarian B-X
cancer B-X
and B-X
tumour B-X
DNA B-X
from B-X
96 B-X
breast B-X
carcinomas B-X
were B-X
screened B-X
for B-X
base B-X
mutations B-X

In	O
the	O
present	O
study	O
,	O
leukocyte	O
DNA	O
from	O
143	O
patients	O
with	O
familial	O
clustering	O
of	O
breast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarian	I-Disease
cancer	I-Disease
and	O
tumour	B-Disease
DNA	O
from	O
96	O
breast	B-Disease
carcinomas	I-Disease
were	O
screened	O
for	O
base	O
mutations	O
in	O
the	O
estrogen	O
receptor	O
gene	O
(	O
ESR	O
)	O
.	O
<EOS> B-X
Liquid B-X
biopsy B-X
of B-X
cancer B-X
: B-X
a B-X
multimodal B-X
diagnostic B-X
tool B-X
in B-X
clinical B-X
oncology B-X
Download B-X
Citation B-X
| B-X
On B-X
Jan B-X
1 B-X
, B-X
2001 B-X
, B-X
George B-X
F. B-X
Allan B-X
published B-X
Estrogen B-X
and B-X
Progesterone B-X
Receptors B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X
need B-X
on B-X
ResearchGate B-X
133430 B-X
- B-X
ESTROGEN B-X
RECEPTOR B-X
1 B-X
; B-X
ESR1 B-X
- B-X
ESTROGEN B-X
RECEPTOR B-X
; B-X
ESR B-X
; B-X
ER B-X
; B-X
; B-X
ESTROGEN B-X
RECEPTOR B-X
, B-X
ALPHA B-X
; B-X
ESRA B-X
- B-X
ESR1 B-X

Three	O
patients	O
with	O
a	O
family	O
history	O
of	O
cancer	B-Disease
were	O
carrying	O
a	O
Gly160Cys	O
germline	O
substitution	O
.	O
<EOS> B-X
Identification B-X
of B-X
a B-X
novel B-X
germline B-X
BRCA2 B-X
variant B-X
in B-X
a B-X
Chinese B-X
breast B-X
cancer B-X
family B-X
High B-X
frequency B-X
of B-X
pathogenic B-X
germline B-X
variants B-X
within B-X
homologous B-X
recombination B-X
repair B-X
in B-X
patients B-X
with B-X
advanced B-X
cancer B-X
The B-X
cloning B-X
of B-X
the B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
susceptibility B-X
gene B-X
, B-X
BRCA1 B-X
, B-X
allows B-X
direct B-X
estimation B-X
of B-X
the B-X
proportion B-X
of B-X
these B-X
cancers B-X
in B-X
the B-X
general B-X
population B-X
which B-X
can B-X
be B-X
attributed B-X

This	O
alteration	O
was	O
also	O
detected	O
in	O
eight	O
(	O
four	O
females	O
and	O
four	O
males	O
)	O
of	O
729	O
controls	O
(	O
366	O
female	O
,	O
363	O
males	O
)	O
,	O
indicating	O
that	O
the	O
substitution	O
probably	O
represents	O
a	O
polymorphism	O
.	O
<EOS> B-X
Screening B-X
for B-X
ESR B-X
mutations B-X
in B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
patients B-X
. B-X
These B-X
substances B-X
were B-X
considered B-X
by B-X
a B-X
previous B-X
Working B-X
Group B-X
, B-X
in B-X
June B-X
1998 B-X
( B-X
IARC B-X
, B-X
1999 B-X
) B-X
, B-X
under B-X
the B-X
title B-X
‚Äò B-X
Oral B-X
contraceptives B-X
, B-X
combined B-X
‚Äô B-X
. B-X
Since B-X
Recent B-X
Male-Mediated B-X
Gene B-X
Flow B-X
over B-X
a B-X
Linguistic B-X
Barrier B-X
in B-X
Iberia B-X
, B-X
Suggested B-X
by B-X
Analysis B-X
of B-X
a B-X
Y-Chromosomal B-X
DNA B-X
Polymorphism B-X
Abstract B-X
. B-X
In B-X
recent B-X
years B-X
, B-X
human B-X
and B-X
wildlife B-X
monitoring B-X
studies B-X
have B-X
identified B-X
perfluoroalkyl B-X
acids B-X
( B-X
PFAA B-X
) B-X
worldwide B-X
. B-X
This B-X
has B-X
led B-X
to B-X
efforts B-X
to B-X
better B-X
unders B-X
In B-X
the B-X
present B-X
study B-X
, B-X
leukocyte B-X
DNA B-X
from B-X
143 B-X
patients B-X
with B-X
familial B-X
clustering B-X
of B-X
breast B-X
and/or B-X
ovarian B-X
cancer B-X
and B-X
tumour B-X
DNA B-X
from B-X
96 B-X
breast B-X
carcinomas B-X
were B-X
screened B-X
for B-X
base B-X
mutations B-X
Recent B-X
Male-Mediated B-X
Gene B-X
Flow B-X
over B-X
a B-X
Linguistic B-X
Barrier B-X
in B-X
Iberia B-X
, B-X
Suggested B-X
by B-X
Analysis B-X
of B-X
a B-X
Y-Chromosomal B-X
DNA B-X
Polymorphism B-X
- B-X
ScienceDirect B-X
Screening B-X
for B-X
ESR B-X
mutations B-X
in B-X
breast B-X
and B-X
ovarian B-X
cancer B-X
patients B-X
- B-X
Andersen B-X
- B-X
1997 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X

However	O
,	O
in	O
the	O
229	O
female	O
controls	O
in	O
whom	O
family	O
history	O
of	O
cancer	B-Disease
was	O
known	O
,	O
one	O
of	O
two	O
who	O
had	O
a	O
sister	O
with	O
breast	B-Disease
cancer	I-Disease
was	O
carrying	O
the	O
variant	O
allele	O
.	O
<EOS> B-X
Family B-X
history B-X
of B-X
cancer B-X
and B-X
risk B-X
of B-X
breast B-X
cancer B-X
in B-X
the B-X
Black B-X
Women B-X
's B-X
Health B-X
Study B-X
The B-X
relation B-X
between B-X
family B-X
history B-X
of B-X
ovarian B-X
, B-X
breast B-X
, B-X
and B-X
endometrial B-X
cancer B-X
and B-X
risk B-X
of B-X
epithelial B-X
ovarian B-X
carcinoma B-X
was B-X
analyzed B-X
within B-X
the B-X
framework B-X
of B-X
a B-X
case-control B-X
study B-X
conducted B-X
from B-X
Whole-exome B-X
sequencing B-X
of B-X
Finnish B-X
hereditary B-X
breast B-X
cancer B-X
families B-X
We B-X
examined B-X
effects B-X
of B-X
obesity B-X
and B-X
lifetime B-X
exercise B-X
patterns B-X
on B-X
postmenopausal B-X
breast B-X
cancer B-X
risk B-X
according B-X
to B-X
family B-X
history B-X
in B-X
a B-X
large B-X
population-based B-X
case B-X
control B-X
study B-X
conducted B-X
in B-X
Los B-X
Angeles B-X
County B-X
How B-X
do B-X
women B-X
at B-X
increased B-X
, B-X
but B-X
unexplained B-X
, B-X
familial B-X
risk B-X
of B-X
breast B-X
cancer B-X
perceive B-X
and B-X
manage B-X
their B-X
risk B-X
? B-X
A B-X
qualitative B-X
interview B-X
study B-X
In B-X
a B-X
population-based B-X
cohort B-X
of B-X
1090 B-X
Icelandic B-X
patients B-X
, B-X
a B-X
Cys557Ser B-X
missense B-X
variant B-X
of B-X
the B-X
BARD1 B-X
gene B-X
, B-X
which B-X
interacts B-X
with B-X
BRCA1 B-X
, B-X
increased B-X
the B-X
risk B-X
of B-X
single B-X
and B-X
multiple B-X
The B-X
WHO B-X
estimates B-X
that B-X
lung B-X
cancer B-X
is B-X
the B-X
most B-X
frequent B-X
cancer B-X
in B-X
the B-X
world B-X
today B-X
and B-X
the B-X
global B-X
incidence B-X
of B-X
lung B-X
cancer B-X
is B-X
increasing B-X
at B-X
0.5 B-X
% B-X
per B-X
year B-X
due B-X

Hence	O
,	O
a	O
possible	O
clinical	O
significance	O
of	O
the	O
glycine	O
into	O
cysteine	O
cannot	O
be	O
completely	O
ruled	O
out	O
and	O
should	O
be	O
further	O
investigated	O
.	O
<EOS> B-X
Abstract B-X
. B-X
The B-X
occurrence B-X
and B-X
relative B-X
positions B-X
of B-X
cysteine B-X
residues B-X
were B-X
investigated B-X
in B-X
proteins B-X
of B-X
various B-X
species B-X
. B-X
Considering B-X
random B-X
mathematical B-X
occurrenc B-X
Bile B-X
acids B-X
regulate B-X
cysteine B-X
catabolism B-X
and B-X
glutathione B-X
regeneration B-X
to B-X
modulate B-X
hepatic B-X
sensitivity B-X
to B-X
oxidative B-X
injury B-X
Thermal B-X
decomposition B-X
of B-X
the B-X
amino B-X
acids B-X
glycine B-X
, B-X
cysteine B-X
, B-X
aspartic B-X
acid B-X
, B-X
asparagine B-X
, B-X
glutamic B-X
acid B-X
, B-X
glutamine B-X
, B-X
arginine B-X
and B-X
histidine B-X
A B-X
new B-X
mechanism B-X
for B-X
cannabidiol B-X
in B-X
regulating B-X
the B-X
one‚Äêcarbon B-X
cycle B-X
and B-X
methionine B-X
levels B-X
in B-X
Dictyostelium B-X
and B-X
in B-X
mammalian B-X
epilepsy B-X
models B-X
Preparation B-X
of B-X
Proteins B-X
and B-X
Peptides B-X
for B-X
Mass B-X
Spectrometry B-X
Analysis B-X
in B-X
a B-X
Bottom-Up B-X
Proteomics B-X
Workflow B-X
Amino B-X
acids B-X
and B-X
asthma B-X
: B-X
a B-X
case-control B-X
study B-X
| B-X
European B-X
Respiratory B-X
Society B-X
Insights B-X
into B-X
the B-X
Chemistry B-X
of B-X
Non-Enzymatic B-X
Browning B-X
Reactions B-X
in B-X
Different B-X
Ribose-Amino B-X
Acid B-X
Model B-X
Systems B-X

Somatic	O
mutations	O
were	O
not	O
detected	O
in	O
any	O
of	O
the	O
tumours	B-Disease
studied	O
,	O
and	O
the	O
present	O
data	O
do	O
not	O
provide	O
support	O
for	O
somatic	O
ESR	O
base	O
mutations	O
as	O
an	O
important	O
mechanism	O
for	O
hormonal	O
therapy	O
resistance	O
in	O
estrogen	B-Disease
receptor	I-Disease
-	I-Disease
positive	I-Disease
breast	I-Disease
carcinomas	I-Disease
.	O
.	O
<EOS> B-X
Clinical B-X
Implications B-X
of B-X
ESR1 B-X
Mutations B-X
in B-X
Hormone B-X
Receptor-Positive B-X
Advanced B-X
Breast B-X
Cancer B-X
Landscape B-X
of B-X
somatic B-X
mutations B-X
in B-X
gastric B-X
cancer B-X
assessed B-X
using B-X
next‚Äëgeneration B-X
sequencing B-X
analysis B-X
Association B-X
of B-X
ESR1 B-X
Mutations B-X
and B-X
Visceral B-X
Metastasis B-X
in B-X
Patients B-X
with B-X
Estrogen B-X
Receptor-Positive B-X
Advanced B-X
Breast B-X
Cancer B-X
from B-X
Brazil B-X
The B-X
Emerging B-X
Role B-X
of B-X
ESR1 B-X
Mutations B-X
in B-X
Luminal B-X
Breast B-X
Cancer B-X
as B-X
a B-X
Prognostic B-X
and B-X
Predictive B-X
Biomarker B-X
of B-X
Response B-X
to B-X
Endocrine B-X
Therapy B-X
Approximately B-X
70 B-X
% B-X
of B-X
breast B-X
cancers B-X
are B-X
oestrogen B-X
receptor B-X
Œ± B-X
( B-X
ER B-X
) B-X
positive B-X
, B-X
and B-X
are B-X
, B-X
therefore B-X
, B-X
treated B-X
with B-X
endocrine B-X
therapies B-X
. B-X
However B-X
, B-X
about B-X
25 B-X
% B-X
ESR1 B-X
Mutations B-X
Are B-X
Not B-X
a B-X
Common B-X
Mechanism B-X
of B-X
Endocrine B-X
Resistance B-X
in B-X
Patients B-X
With B-X
Estrogen B-X
Receptor‚ÄìPositive B-X
Breast B-X
Cancer B-X
Treated B-X
With B-X
Neoadjuvant B-X
Aromatase B-X
Inhibitor B-X
Therapy B-X
Estrogen B-X
Receptor B-X
( B-X
ER B-X
) B-X
Mutations B-X
in B-X
Breast B-X
Cancer B-X
: B-X
Hidden B-X
in B-X
Plain B-X
Sight B-X

Molecular	O
bases	O
of	O
C7	B-Disease
deficiency	I-Disease
:	O
three	O
different	O
defects	O
.	O

The	O
molecular	O
basis	O
of	O
C7	B-Disease
deficiency	I-Disease
has	O
been	O
investigated	O
in	O
two	O
Irish	O
families	O
and	O
a	O
number	O
of	O
Israeli	O
families	O
of	O
Moroccan	O
Sephardic	O
Jewish	O
origin	O
.	O
<EOS> B-X
The B-X
molecular B-X
basis B-X
of B-X
C7 B-X
deficiency B-X
has B-X
been B-X
investigated B-X
in B-X
two B-X
Irish B-X
families B-X
and B-X
a B-X
number B-X
of B-X
Israeli B-X
families B-X
of B-X
Moroccan B-X
Sephardic B-X
Jewish B-X
origin B-X
. B-X
Exon B-X
PCR B-X
and B-X
sequencing B-X
revealed B-X
Ethnic B-X
Sephardic B-X
Jews B-X
in B-X
the B-X
Medical B-X
Literature B-X
: B-X
A B-X
Comprehensive B-X
Collection B-X
... B-X
- B-X
Google B-X
Âõæ‰π¶ B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

Exon	O
PCR	O
and	O
sequencing	O
revealed	O
a	O
heterozygous	O
point	O
mutation	O
at	O
the	O
3	O
splice	O
acceptor	O
site	O
of	O
intron	O
1	O
in	O
one	O
Irish	O
family	O
.	O
<EOS> B-X
Gene-breaking B-X
transposon B-X
mutagenesis B-X
reveals B-X
an B-X
essential B-X
role B-X
for B-X
histone B-X
H2afza B-X
in B-X
zebrafish B-X
larval B-X
development B-X
- B-X
ScienceDirect B-X
Identification B-X
of B-X
novel B-X
mutations B-X
in B-X
the B-X
Œ±-galactosidase B-X
A B-X
gene B-X
in B-X
patients B-X
with B-X
Fabry B-X
disease B-X
: B-X
Pitfalls B-X
of B-X
mutation B-X
analyses B-X
in B-X
patients B-X
with B-X
low B-X
Œ±-galactosidase B-X
A B-X
activity B-X
- B-X
ScienceDirect B-X
Pre-mRNA B-X
trans-splicing B-X
: B-X
from B-X
kinetoplastids B-X
to B-X
mammals B-X
, B-X
an B-X
easy B-X
language B-X
for B-X
life B-X
diversity B-X
PDF B-X
| B-X
The B-X
cloned B-X
argininosuccinate B-X
synthetase B-X
gene B-X
from B-X
a B-X
citrullinemia B-X
patient B-X
's B-X
fibroblast B-X
cell B-X
line B-X
revealed B-X
a B-X
single B-X
base B-X
substitution B-X
( B-X
G B-X
to B-X
C B-X
) B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
The B-X
dermal B-X
type B-X
I B-X
collagen B-X
of B-X
a B-X
patient B-X
with B-X
Ehlers-Danlos B-X
type B-X
VIIB B-X
( B-X
EDS-VIIB B-X
) B-X
contained B-X
normal B-X
alpha B-X
2 B-X
( B-X
I B-X
) B-X
chains B-X
and B-X
mutant B-X
pN-alpha B-X
2 B-X
( B-X
I B-X
) B-X
Genetic B-X
deficiency B-X
of B-X
the B-X
glycogen-debranching B-X
enzyme B-X
( B-X
debrancher B-X
) B-X
causes B-X
glycogen B-X
storage B-X
disease B-X
type B-X
III B-X
( B-X
GSD B-X
III B-X
) B-X
, B-X
which B-X
is B-X
divided B-X
into B-X
two B-X
subtypes B-X
: B-X
IIIa B-X
and B-X
IIIb B-X
Ethnic B-X
Sephardic B-X
Jews B-X
in B-X
the B-X
Medical B-X
Literature B-X
: B-X
A B-X
Comprehensive B-X
Collection B-X
... B-X
- B-X
Google B-X
Âõæ‰π¶ B-X

In	O
the	O
other	O
Irish	O
family	O
,	O
exons	O
7	O
and	O
8	O
failed	O
to	O
amplify	O
and	O
they	O
were	O
shown	O
to	O
be	O
deleted	O
.	O
<EOS> B-X
Large B-X
Deletions B-X
and B-X
Point B-X
Mutations B-X
Involving B-X
DOCK8 B-X
in B-X
the B-X
Autosomal B-X
Recessive B-X
Form B-X
of B-X
the B-X
Hyper-IgE B-X
Syndrome B-X
Characterization B-X
of B-X
a B-X
Putative B-X
Founder B-X
Mutation B-X
that B-X
Accounts B-X
for B-X
the B-X
High B-X
Incidence B-X
of B-X
Cystinosis B-X
in B-X
Brittany B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X
Ethnic B-X
Sephardic B-X
Jews B-X
in B-X
the B-X
Medical B-X
Literature B-X
: B-X
A B-X
Comprehensive B-X
Collection B-X
... B-X
- B-X
Google B-X
Âõæ‰π¶ B-X
Mutation B-X
Detection B-X
of B-X
PKD1 B-X
Identifies B-X
a B-X
Novel B-X
Mutation B-X
Common B-X
to B-X
Three B-X
Families B-X
with B-X
Aneurysms B-X
and/or B-X
Very-Early-Onset B-X
Disease B-X
- B-X
ScienceDirect B-X
Analysis B-X
of B-X
the B-X
CTNS B-X
gene B-X
in B-X
patients B-X
of B-X
German B-X
and B-X
Swiss B-X
origin B-X
with B-X
nephropathic B-X
cystinosis B-X
- B-X
Kiehntopf B-X
- B-X
2002 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X

Marker	O
haplotype	O
studies	O
of	O
the	O
C6	O
and	O
C7	O
gene	O
region	O
and	O
Southern	O
blots	O
show	O
that	O
the	O
Irish	O
family	O
with	O
the	O
splice	O
defect	O
also	O
segregate	O
for	O
the	O
deletion	O
,	O
which	O
is	O
not	O
easily	O
detected	O
in	O
heterozygotes	O
.	O
<EOS> B-X
The B-X
molecular B-X
basis B-X
of B-X
C7 B-X
deficiency B-X
has B-X
been B-X
investigated B-X
in B-X
two B-X
Irish B-X
families B-X
and B-X
a B-X
number B-X
of B-X
Israeli B-X
families B-X
of B-X
Moroccan B-X
Sephardic B-X
Jewish B-X
origin B-X
. B-X
Exon B-X
PCR B-X
and B-X
sequencing B-X
revealed B-X
Lect B-X
4 B-X
. B-X
Heterozygosity B-X
Request B-X
PDF B-X
| B-X
Two B-X
mutations B-X
of B-X
the B-X
C7 B-X
gene B-X
, B-X
c.1424G B-X
> B-X
A B-X
and B-X
c.281-1G B-X
> B-X
T B-X
, B-X
in B-X
two B-X
Korean B-X
families B-X
| B-X
Complement B-X
C7 B-X
deficiency B-X
is B-X
associated B-X
with B-X
increased B-X
CollapsABEL B-X
: B-X
an B-X
R B-X
library B-X
for B-X
detecting B-X
compound B-X
heterozygote B-X
alleles B-X
in B-X
genome-wide B-X
association B-X
studies B-X
Request B-X
PDF B-X
| B-X
Molecular B-X
defects B-X
of B-X
the B-X
C7 B-X
gene B-X
in B-X
two B-X
patients B-X
with B-X
complement B-X
C7 B-X
deficiency B-X
| B-X
Different B-X
genetic B-X
mutations B-X
have B-X
been B-X
described B-X
in B-X
complement B-X
components B-X
resulting B-X
in B-X
total B-X
or B-X
Detection B-X
of B-X
Heterozygous B-X
Mutations B-X
in B-X
the B-X
Genome B-X
of B-X
Mismatch B-X
Repair B-X
Defective B-X
Diploid B-X
Yeast B-X
Using B-X
a B-X
Bayesian B-X
Approach B-X
| B-X
Genetics B-X
Request B-X
PDF B-X
| B-X
Characterization B-X
of B-X
a B-X
large B-X
genomic B-X
deletion B-X
in B-X
four B-X
Irish B-X
families B-X
with B-X
C7 B-X
deficiency B-X
| B-X
Inherited B-X
deficiency B-X
of B-X
the B-X
seventh B-X
complement B-X
component B-X
( B-X
C7 B-X
) B-X
is B-X
associated B-X
with B-X

The	O
Israeli	O
C7	B-Disease
-	I-Disease
deficient	I-Disease
cases	O
all	O
share	O
a	O
C7	O
haplotype	O
and	O
are	O
homozygous	O
for	O
a	O
mis	O
-	O
sense	O
mutation	O
in	O
exon	O
9	O
.	O
<EOS> B-X
Ethnic B-X
Sephardic B-X
Jews B-X
in B-X
the B-X
Medical B-X
Literature B-X
: B-X
A B-X
Comprehensive B-X
Collection B-X
... B-X
- B-X
Google B-X
Âõæ‰π¶ B-X

However	O
,	O
one	O
individual	O
is	O
heterozygous	O
for	O
markers	O
at	O
adjacent	O
C6	O
loci	O
,	O
showing	O
that	O
there	O
has	O
been	O
an	O
intergenic	O
recombination	O
and	O
suggesting	O
that	O
the	O
deficiency	O
mutation	O
is	O
of	O
appreciable	O
antiquity	O
.	O
.	O
<EOS> B-X
Molecular B-X
bases B-X
of B-X
C7 B-X
deficiency B-X
: B-X
three B-X
different B-X
defects B-X
. B-X
Molecular B-X
bases B-X
of B-X
C7 B-X
deficiency B-X
: B-X
three B-X
different B-X
defects B-X
. B-X
| B-X
The B-X
Journal B-X
of B-X
Immunology B-X
Recent B-X
studies B-X
of B-X
extra-pair B-X
paternity B-X
have B-X
found B-X
support B-X
for B-X
the B-X
idea B-X
that B-X
heterozygous B-X
males B-X
have B-X
an B-X
advantage B-X
in B-X
siring B-X
offspring B-X
. B-X
Most B-X
studies B-X
use B-X
DNA B-X
microsatellite B-X
loci B-X
to B-X
determine B-X
paternity B-X
We B-X
have B-X
analyzed B-X
43 B-X
recessive B-X
mutations B-X
reducing B-X
meiotic B-X
intragenic B-X
recombination B-X
in B-X
Schizosaccharomyces B-X
pombe B-X
. B-X
These B-X
mutations B-X
were B-X
isolated B-X
by B-X
a B-X
screen B-X
for B-X
reduced B-X
plasmid-by-chromosome B-X
recombination B-X
at B-X
the B-X
ade6 B-X
locus B-X
. B-X
Request B-X
PDF B-X
| B-X
C7 B-X
Deficiency B-X
and B-X
Meningococcal B-X
Infection B-X
Susceptibility B-X
in B-X
Two B-X
Spanish B-X
Families B-X
| B-X
In B-X
this B-X
work B-X
, B-X
we B-X
report B-X
the B-X
genetic B-X
basis B-X
of B-X
C7 B-X
deficiency B-X
in B-X
two B-X
different B-X
Spanish B-X
Request B-X
PDF B-X
| B-X
Linkage B-X
disequilibrium B-X
analysis B-X
of B-X
the B-X
human B-X
adenosine B-X
deaminase B-X
( B-X
ADA B-X
) B-X
gene B-X
provides B-X
evidence B-X
for B-X
a B-X
lack B-X
of B-X
correlation B-X
between B-X
hot B-X
spots B-X
of B-X
equal B-X
and B-X
unequal B-X
homologous B-X
Edward B-X
B. B-X
Lewis B-X
' B-X
science B-X
is B-X
the B-X
bridge B-X
linking B-X
experimental B-X
genetics B-X
as B-X
conducted B-X
in B-X
the B-X
first B-X
half B-X
of B-X
the B-X
twentieth B-X
century B-X
, B-X
and B-X
the B-X
powerful B-X
molecular B-X
genetic B-X
approaches B-X
that B-X
revolutionized B-X

Molecular	O
heterogeneity	O
of	O
classical	B-Disease
and	I-Disease
Duarte	I-Disease
galactosemia	I-Disease
:	O
mutation	O
analysis	O
by	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
.	O
<EOS> B-X
Molecular B-X
heterogeneity B-X
of B-X
classical B-X
and B-X
Duarte B-X
galactosemia B-X
: B-X
mutation B-X
analysis B-X
by B-X
denaturing B-X
gradient B-X
gel B-X
electrophoresis B-X
. B-X
Molecular B-X
heterogeneity B-X
of B-X
classical B-X
and B-X
Duarte B-X
galactosemia B-X
: B-X
mutation B-X
analysis B-X
by B-X
denaturing B-X
gradient B-X
gel B-X
electrophoresis B-X
| B-X
Meta B-X
HUMAN B-X
MUTATION B-X
10:49‚Äì57 B-X
( B-X
1997 B-X
) B-X
¬© B-X
1997 B-X
WILEY-LISS B-X
, B-X
INC. B-X
HUMU B-X
762 B-X
RESEARCH B-X
ARTICLE B-X
Molecular B-X
Heterogeneity B-X
of B-X
Classical B-X
and B-X
Duarte B-X
Galactosemia B-X
: B-X
Mutation B-X
Analysis B-X
by B-X
Denaturing‚Ä¶ B-X
Molecular B-X
characterization B-X
of B-X
Polish B-X
patients B-X
with B-X
classical B-X
galactosaemia B-X
| B-X
SpringerLink B-X
Classical B-X
galactosemia B-X
is B-X
caused B-X
by B-X
one B-X
common B-X
missense B-X
mutation B-X
( B-X
Q188R B-X
) B-X
and B-X
by B-X
several B-X
rare B-X
mutations B-X
in B-X
the B-X
galactose‚Äê1‚Äêphosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
gene B-X
. B-X
The B-X
most B-X
common B-X
variant B-X
Identification B-X
of B-X
mutations B-X
in B-X
the B-X
galactose‚Äê1‚Äêphosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
gene B-X
in B-X
16 B-X
Turkish B-X
patients B-X
with B-X
galactosemia B-X
, B-X
including B-X
a B-X
novel B-X
mutation B-X
of B-X
F294Y B-X
- B-X
Seyrantepe B-X
- B-X
1999 B-X
- B-X
Human B-X
gene2phenotype B-X

Classical	B-Disease
galactosemia	I-Disease
is	O
caused	O
by	O
one	O
common	O
missense	O
mutation	O
(	O
Q188R	O
)	O
and	O
by	O
several	O
rare	O
mutations	O
in	O
the	O
galactose	O
-	O
1	O
-	O
phosphate	O
uridyltransferase	O
(	O
GALT	O
)	O
gene	O
.	O
<EOS> B-X
Classic B-X
galactosemia B-X
is B-X
an B-X
inborn B-X
error B-X
of B-X
galactose B-X
metabolism B-X
and B-X
results B-X
from B-X
deficiency B-X
of B-X
the B-X
ubiquitously B-X
expressed B-X
enzyme B-X
galactose-1-phosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
. B-X
Nine B-X
missense B-X
mutations B-X
, B-X
three B-X
splicing B-X
The B-X
spectrum B-X
of B-X
mutations B-X
in B-X
the B-X
Galactose-1-phosphate B-X
uridyl B-X
transferase B-X
( B-X
GALT B-X
) B-X
gene B-X
is B-X
described B-X
in B-X
11 B-X
cases B-X
of B-X
classic B-X
galactosemia B-X
and B-X
38 B-X
of B-X
Duarte-2 B-X
type B-X
identified B-X
by B-X
the B-X
Texas B-X
Classical B-X
galactosaemia B-X
, B-X
deficiency B-X
of B-X
galactose-1-phosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
, B-X
is B-X
characterized B-X
by B-X
acute B-X
symptoms B-X
of B-X
hepatomegaly B-X
, B-X
jaundice B-X
, B-X
sepsis B-X
, B-X
cataracts B-X
and B-X
growth B-X
retardation B-X
. B-X
Treatment B-X
with B-X
Classic B-X
galactosemia B-X
is B-X
a B-X
rare B-X
genetic B-X
metabolic B-X
disease B-X
with B-X
an B-X
unmet B-X
treatment B-X
need B-X
. B-X
Current B-X
standard B-X
of B-X
care B-X
fails B-X
to B-X
prevent B-X
chronically-debilitating B-X
brain B-X
and B-X
gonadal B-X
complications B-X
. B-X
Many B-X
mutations B-X
in B-X

The	O
most	O
common	O
variant	O
of	O
GALT	O
,	O
the	O
Duarte	O
variant	O
,	O
occurs	O
as	O
two	O
types	O
,	O
Duarte	O
-	O
1	O
(	O
D	O
-	O
1	O
)	O
and	O
Duarte	O
-	O
2	O
(	O
D	O
-	O
2	O
)	O
,	O
both	O
of	O
which	O
carry	O
the	O
sequence	O
change	O
N314D	O
.	O
<EOS> B-X
Presence B-X
of B-X
a B-X
deletion B-X
in B-X
the B-X
5‚Ä≤ B-X
upstream B-X
region B-X
of B-X
the B-X
GALT B-X
gene B-X
in B-X
Duarte B-X
( B-X
D2 B-X
) B-X
alleles B-X
| B-X
Journal B-X
of B-X
Medical B-X
Genetics B-X
A B-X
common B-X
mutation B-X
associated B-X
with B-X
the B-X
Duarte B-X
galactosemia B-X
allele B-X
. B-X
Classical B-X
galactosemia B-X
( B-X
G/G B-X
) B-X
is B-X
caused B-X
by B-X
the B-X
lack B-X
of B-X
galactose-1-phosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
activity B-X
. B-X
A B-X
more B-X
common B-X
clinical B-X
variant B-X
, B-X
Duarte/Classical B-X
( B-X
D/G B-X
) B-X
produces B-X
partial B-X
Duarte B-X
variant B-X
galactosemia B-X
is B-X
inherited B-X
in B-X
an B-X
autosomal B-X
recessive B-X
manner B-X
. B-X
When B-X
one B-X
parent B-X
is B-X
heterozygous B-X
for B-X
the B-X
< B-X
i B-X
> B-X
GALT B-X
< B-X
/i B-X
> B-X
D B-X
< B-X
sub B-X
> B-X
2 B-X
The B-X
human B-X
cDNA B-X
and B-X
gene B-X
for B-X
galactose-1-phosphate B-X
uridyl B-X
transferase B-X
( B-X
GALT B-X
) B-X
have B-X
been B-X
cloned B-X
and B-X
sequenced B-X
. B-X
A B-X
prevalent B-X
mutation B-X
( B-X
Q188R B-X
) B-X
is B-X
known B-X
to B-X
cause B-X
classic B-X
galactosemia B-X
The B-X
term B-X
`` B-X
galactosemia B-X
'' B-X
refers B-X
to B-X
disorders B-X
of B-X
galactose B-X
metabolism B-X
that B-X
include B-X
classic B-X
galactosemia B-X
, B-X
clinical B-X
variant B-X
galactosemia B-X
, B-X
and B-X
biochemical B-X
variant B-X
galactosemia B-X
. B-X
This B-X
GeneReview B-X
focuses B-X
on B-X
: B-X
Infants B-X
with B-X
Duarte B-X
variant B-X
galactosemia B-X
who B-X
receive B-X
breast B-X
milk B-X
or B-X
a B-X
high B-X
galactose-containing B-X
formula B-X
( B-X
dairy B-X
milk-based B-X
formula B-X
) B-X
are B-X
typically B-X
asymptomatic B-X
and B-X
show B-X
the B-X
same B-X
prevalence B-X
of B-X
acute B-X
issues B-X

D	O
-	O
1	O
increases	O
,	O
whereas	O
D	O
-	O
2	O
decreases	O
GALT	O
activity	O
.	O
<EOS> B-X
Molecular B-X
analysis B-X
of B-X
GALT B-X
gene B-X
in B-X
Argentinian B-X
population B-X
: B-X
Correlation B-X
with B-X
enzyme B-X
activity B-X
and B-X
characterization B-X
of B-X
a B-X
novel B-X
Duarte-like B-X
allele B-X
Request B-X
PDF B-X
| B-X
Duarte B-X
( B-X
DG B-X
) B-X
galactosemia B-X
: B-X
A B-X
pilot B-X
study B-X
of B-X
biochemical B-X
and B-X
neurodevelopmental B-X
assessment B-X
in B-X
children B-X
detected B-X
by B-X
newborn B-X
screening B-X
| B-X
Newborn B-X
screening B-X
for B-X
galactosemia B-X
has B-X
shown B-X
Although B-X
numerous B-X
reports B-X
have B-X
appeared B-X
showing B-X
high B-X
levels B-X
of B-X
galactitol B-X
in B-X
the B-X
urine B-X
of B-X
patients B-X
with B-X
galactose-1-phosphate B-X
uridylyltransferase B-X
deficiency B-X
, B-X
little B-X
attention B-X
has B-X
been B-X
paid B-X
to B-X
measurement B-X
of B-X
urinary B-X
galactonate B-X

To	O
study	O
the	O
molecular	O
genetics	O
of	O
classical	B-Disease
and	I-Disease
Duarte	I-Disease
galactosemia	I-Disease
,	O
we	O
analyzed	O
the	O
GALT	O
mutations	O
in	O
30	O
families	O
with	O
classical	B-Disease
galactosemia	I-Disease
,	O
in	O
10	O
families	O
with	O
the	O
D	O
-	O
2	O
variant	O
and	O
in	O
3	O
individuals	O
carrying	O
the	O
D	O
-	O
1	O
allele	O
by	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
.	O
<EOS> B-X
PubMed B-X
journal B-X
article B-X
: B-X
Molecular B-X
heterogeneity B-X
of B-X
classical B-X
and B-X
Duarte B-X
galactosemia B-X
: B-X
mutation B-X
analysis B-X
by B-X
denaturing B-X
gradient B-X
gel B-X
electrophoresis B-X
. B-X
Download B-X
Prime B-X
PubMed B-X
App B-X
to B-X
iPhone B-X
, B-X
iPad B-X
, B-X
or B-X
A B-X
novel B-X
BRCA2 B-X
mutation B-X
in B-X
an B-X
Indonesian B-X
family B-X
found B-X
with B-X
a B-X
new B-X
, B-X
rapid B-X
, B-X
and B-X
sensitive B-X
mutation B-X
detection B-X
method B-X
based B-X
on B-X
pooled B-X
denaturing B-X
gradient B-X
gel B-X
electrophoresis B-X
and B-X
targeted B-X
sequencing B-X
Background B-X
: B-X
Classical B-X
Galactosemia B-X
( B-X
CG B-X
) B-X
is B-X
a B-X
rare B-X
autosomal B-X
recessive B-X
metabolic B-X
disease B-X
caused B-X
by B-X
mutations B-X
in B-X
the B-X
galactose-1-phosphate B-X
uridyl B-X
transferase B-X
( B-X
GALT B-X
) B-X
gene B-X
. B-X
This B-X
study B-X
aim B-X
Abstract B-X
. B-X
We B-X
describe B-X
the B-X
prediction B-X
of B-X
the B-X
structural B-X
and B-X
functional B-X
effects B-X
of B-X
mutations B-X
on B-X
the B-X
enzyme B-X
galactose-1-phosphate B-X
uridyltransferase B-X
related B-X
to B-X
the B-X
Classic B-X
galactosemia B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
caused B-X
by B-X
the B-X
deficiency B-X
of B-X
galactose B-X
1-phosphate B-X
uridyltransferase B-X
( B-X
GALT B-X
) B-X
. B-X
Although B-X
the B-X
potentially B-X
lethal B-X
, B-X
neonatal B-X
hepatotoxic B-X
syndrome B-X
is B-X
prevented B-X
by B-X
Infants B-X
with B-X
Duarte B-X
variant B-X
galactosemia B-X
who B-X
receive B-X
breast B-X
milk B-X
or B-X
a B-X
high B-X
galactose-containing B-X
formula B-X
( B-X
dairy B-X
milk-based B-X
formula B-X
) B-X
are B-X
typically B-X
asymptomatic B-X
and B-X
show B-X
the B-X
same B-X
prevalence B-X
of B-X
acute B-X
issues B-X
Galactosemia B-X
: B-X
a B-X
strategy B-X
to B-X
identify B-X
new B-X
biochemical B-X
phenotypes B-X
and B-X
molecular B-X
genotypes B-X
. B-X

DGGE	O
detected	O
59	O
of	O
the	O
60	O
classical	O
galactosemia	B-Disease
alleles	O
.	O
<EOS> B-X
Newborn B-X
screening B-X
for B-X
galactosemia B-X
yields B-X
a B-X
high B-X
number B-X
of B-X
false-positive B-X
results B-X
. B-X
Confirmatory B-X
DNA B-X
testing B-X
for B-X
unknown B-X
galactosemia B-X
mutations B-X
on B-X
the B-X
initial B-X
positive B-X
sample B-X
using B-X
novel B-X
techniques B-X
of B-X
mutation B-X
detection B-X

Q188R	O
accounted	O
for	O
60	O
%	O
,	O
K285N	O
accounted	O
for	O
28	O
%	O
of	O
these	O
alleles	O
.	O
<EOS> B-X
Molecular B-X
heterogeneity B-X
of B-X
classical B-X
and B-X
duarte B-X
galactosemia B-X
: B-X
Mutation B-X
analysis B-X
by B-X
denaturing B-X
gradient B-X
gel B-X
electrophoresis B-X
- B-X
Greber‚ÄêPlatzer B-X
- B-X
1997 B-X
- B-X
Human B-X
Mutation B-X
- B-X
Wiley B-X
Online B-X
Library B-X

Eight	O
novel	O
candidate	O
galactosemia	B-Disease
mutations	O
were	O
found	O
.	O

On	O
all	O
D	O
-	O
2	O
alleles	O
N314D	O
occurred	O
in	O
cis	O
with	O
two	O
intronic	O
sequence	O
changes	O
,	O
on	O
the	O
D	O
-	O
1	O
alleles	O
in	O
cis	O
with	O
a	O
neutral	O
mutation	O
in	O
exon	O
7	O
.	O
<EOS> B-X
Intron B-X
7 B-X
conserved B-X
sequence B-X
elements B-X
regulate B-X
the B-X
splicing B-X
of B-X
the B-X
SMN B-X
genes B-X
The B-X
DAU B-X
cluster B-X
: B-X
a B-X
comparative B-X
analysis B-X
of B-X
18 B-X
RHD B-X
alleles B-X
, B-X
some B-X
forming B-X
partial B-X
D B-X
antigens B-X
Exon B-X
identity B-X
crisis B-X
: B-X
disease-causing B-X
mutations B-X
that B-X
disrupt B-X
the B-X
splicing B-X
code B-X
Identification B-X
of B-X
cis-suppression B-X
of B-X
human B-X
disease B-X
mutations B-X
by B-X
comparative B-X
genomics B-X
Determinants B-X
of B-X
Exon B-X
7 B-X
Splicing B-X
in B-X
the B-X
Spinal B-X
Muscular B-X
Atrophy B-X
Genes B-X
, B-X
SMN1 B-X
and B-X
SMN2 B-X
Seemingly B-X
Neutral B-X
Polymorphic B-X
Variants B-X
May B-X
Confer B-X
Immunity B-X
to B-X
Splicing-Inactivating B-X
Mutations B-X
: B-X
A B-X
Synonymous B-X
SNP B-X
in B-X
Exon B-X
5 B-X
of B-X
MCAD B-X
Protects B-X
from B-X
Deleterious B-X
Mutations B-X
in B-X
a B-X
Flanking B-X
Exonic B-X
Splicing B-X
Enhancer B-X
- B-X
Consensus B-X
on B-X
the B-X
use B-X
and B-X
interpretation B-X
of B-X
cystic B-X
fibrosis B-X
mutation B-X
analysis B-X
in B-X
clinical B-X
practice B-X

We	O
conclude	O
that	O
the	O
mutations	O
causing	O
galactosemia	B-Disease
are	O
highly	O
heterogeneous	O
and	O
that	O
K285N	O
is	O
a	O
second	O
common	O
galactosemia	B-Disease
mutation	O
in	O
our	O
population	O
.	O
.	O

Isolation	O
of	O
full	O
-	O
length	O
ATM	O
cDNA	O
and	O
correction	O
of	O
the	O
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
cellular	O
phenotype	O
.	O
<EOS> B-X
Isolation B-X
of B-X
full-length B-X
ATM B-X
cDNA B-X
and B-X
correction B-X
of B-X
the B-X
ataxia-telangiectasia B-X
cellular B-X
phenotype B-X
| B-X
PNAS B-X
Isolation B-X
of B-X
full-length B-X
ATM B-X
cDNA B-X
and B-X
correction B-X
of B-X
the B-X
ataxia-telangiectasia B-X
cellular B-X
phenotype B-X
| B-X
PNAS B-X
Reconstitution B-X
of B-X
the B-X
Ataxia-Telangiectasia B-X
Cellular B-X
Phenotype B-X
With B-X
Lentiviral B-X
Vectors B-X

A	O
gene	O
mutated	O
in	O
the	O
human	O
genetic	B-Disease
disorder	I-Disease
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
ATM	O
,	O
was	O
recently	O
identified	O
by	O
positional	O
cloning	O
.	O
<EOS> B-X
A B-X
gene B-X
, B-X
ATM B-X
, B-X
that B-X
is B-X
mutated B-X
in B-X
the B-X
autosomal B-X
recessive B-X
disorder B-X
ataxia B-X
telangiectasia B-X
( B-X
AT B-X
) B-X
was B-X
identified B-X
by B-X
positional B-X
cloning B-X
on B-X
chromosome B-X
11q22-23 B-X
. B-X
AT B-X
is B-X
characterized B-X
Gene B-X
Found B-X
for B-X
Fatal B-X
Childhood B-X
Disease B-X
, B-X
Ataxia-Telangiectasia B-X
ATM B-X
was B-X
originally B-X
identified B-X
by B-X
positional B-X
cloning B-X
as B-X
the B-X
gene B-X
that B-X
underlies B-X
the B-X
autosomal B-X
recessive B-X
condition B-X
ataxia-telangiectasia B-X
. B-X
The B-X
encoded B-X
protein B-X
plays B-X
a B-X
central B-X
role B-X
in B-X
the B-X
complex B-X
processes B-X
that B-X
A B-X
single B-X
ataxia B-X
telangiectasia B-X
gene B-X
with B-X
a B-X
product B-X
similar B-X
to B-X
PI-3 B-X
kinase B-X
| B-X
Science B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
involving B-X
cerebellar B-X
degeneration B-X
, B-X
immunodeficiency B-X
radiation B-X
sensitivity B-X
, B-X
and B-X
cancer B-X
predisposition B-X
. B-X
A-T B-X
heterozygotes B-X
are B-X
moderately B-X
cancer B-X
prone B-X
. B-X
The B-X
A-T B-X
Ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
is B-X
an B-X
autosomal B-X
recessively B-X
inherited B-X
disease B-X
( B-X
one B-X
case B-X
in B-X
40,000 B-X
to B-X
one B-X
case B-X
in B-X
100,000 B-X
live B-X
births B-X
) B-X
whose B-X
principal B-X
features B-X
are B-X
oculocutaneous B-X
telangiectasia B-X
, B-X
The B-X
A‚ÄêT B-X
gene B-X
hunt B-X

ATM	O
is	O
a	O
member	O
of	O
the	O
phosphatidylinositol	O
-	O
3	O
-	O
kinase	O
superfamily	O
,	O
some	O
of	O
which	O
are	O
protein	O
kinases	O
and	O
appear	O
to	O
have	O
important	O
roles	O
in	O
cell	O
cycle	O
control	O
and	O
radiation	O
signal	O
transduction	O
.	O
<EOS> B-X
Phosphatidylinositol B-X
3-kinase-related B-X
kinase B-X
- B-X
Wikipedia B-X
ATM B-X
is B-X
involved B-X
in B-X
DNA B-X
damage B-X
recognition B-X
and B-X
cell B-X
cycle B-X
control B-X
in B-X
response B-X
to B-X
ionizing B-X
radiation B-X
damage B-X
. B-X
There B-X
is B-X
evidence B-X
that B-X
ATM B-X
may B-X
also B-X
have B-X
a B-X
more B-X
general B-X
signalling B-X
Phosphatidylinositol B-X
3-kinase B-X
mediates B-X
activation B-X
of B-X
ATM B-X
by B-X
high B-X
NaCl B-X
and B-X
by B-X
ionizing B-X
radiation B-X
: B-X
Role B-X
in B-X
osmoprotective B-X
transcriptional B-X
regulation B-X
Diversity B-X
, B-X
classification B-X
and B-X
function B-X
of B-X
the B-X
plant B-X
protein B-X
kinase B-X
superfamily B-X
Phosphatidylinositol B-X
3-Kinase-Related B-X
Kinase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Phosphatidylinositol B-X
3-Kinase-Related B-X
Kinase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X
Phosphoinositide B-X
3-kinase B-X
- B-X
Wikipedia B-X

We	O
describe	O
herein	O
,	O
to	O
our	O
knowledge	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
cloning	O
of	O
a	O
full	O
-	O
length	O
cDNA	O
for	O
ATM	O
and	O
correction	O
of	O
multiple	O
aspects	O
of	O
the	O
radio	O
-	O
sensitive	O
phenotype	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
cells	O
by	O
transfection	O
with	O
this	O
cDNA	O
.	O
<EOS> B-X
Isolation B-X
of B-X
full-length B-X
ATM B-X
cDNA B-X
and B-X
correction B-X
of B-X
the B-X
ataxia-telangiectasia B-X
cellular B-X
phenotype B-X
| B-X
PNAS B-X
Isolation B-X
of B-X
full-length B-X
ATM B-X
cDNA B-X
and B-X
correction B-X
of B-X
the B-X
ataxia-telangiectasia B-X
cellular B-X
phenotype B-X
| B-X
PNAS B-X
Ataxia‚Äìtelangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
characterized B-X
by B-X
neurodegeneration B-X
, B-X
immunodeficiency B-X
, B-X
cancer B-X
predisposition B-X
, B-X
genome B-X
instability B-X
, B-X
and B-X
radiation B-X
sensitivity B-X
. B-X
Previous B-X
research B-X
has B-X
shown B-X
that B-X
Herein B-X
definition B-X
is B-X
- B-X
in B-X
this B-X
. B-X
How B-X
to B-X
use B-X
herein B-X
in B-X
a B-X
sentence B-X
. B-X
People B-X
Use B-X
their B-X
Knowledge B-X
of B-X
Common B-X
Events B-X
to B-X
Understand B-X
Language B-X
, B-X
and B-X
Do B-X
So B-X
as B-X
Quickly B-X
as B-X
Possible B-X
The B-X
Yeast B-X
TEL1 B-X
Gene B-X
Partially B-X
Substitutes B-X
for B-X
Human B-X
ATM B-X
in B-X
Suppressing B-X
Hyperrecombination B-X
, B-X
Radiation-Induced B-X
Apoptosis B-X
and B-X
Telomere B-X
Shortening B-X
in B-X
A-T B-X
Cells B-X
How B-X
to B-X
use B-X
herein B-X
in B-X
a B-X
sentence B-X
. B-X
Example B-X
sentences B-X
with B-X
the B-X
word B-X
herein B-X
. B-X
herein B-X
example B-X
sentences B-X
. B-X

Overexpression	O
of	O
ATM	O
cDNA	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
cells	O
enhanced	O
the	O
survival	O
of	O
these	O
cells	O
in	O
response	O
to	O
radiation	O
exposure	O
,	O
decreased	O
radiation	O
-	O
induced	O
chromosome	O
aberrations	O
,	O
reduced	O
radio	O
-	O
resistant	O
DNA	O
synthesis	O
,	O
and	O
partially	O
corrected	O
defective	O
cell	O
cycle	O
checkpoints	O
and	O
induction	O
of	O
stress	O
-	O
activated	O
protein	O
kinase	O
.	O
<EOS> B-X
Effect B-X
of B-X
irradiation B-X
on B-X
DNA B-X
synthesis B-X
, B-X
NBN B-X
gene B-X
expression B-X
and B-X
chromosomal B-X
stability B-X
in B-X
cells B-X
with B-X
NBN B-X
mutations B-X
Disruption B-X
of B-X
the B-X
checkpoint B-X
kinase B-X
1/cell B-X
division B-X
cycle B-X
25A B-X
pathway B-X
abrogates B-X
ionizing B-X
radiation-induced B-X
S B-X
and B-X
G2 B-X
checkpoints B-X
Protein B-X
kinase B-X
C B-X
controls B-X
activation B-X
of B-X
the B-X
DNA B-X
integrity B-X
checkpoint B-X
Checkpoint B-X
kinase B-X
1 B-X
in B-X
DNA B-X
damage B-X
response B-X
and B-X
cell B-X
cycle B-X
regulation B-X
Radioresistant B-X
DNA B-X
synthesis B-X
in B-X
cells B-X
of B-X
patients B-X
showing B-X
increased B-X
chromosomal B-X
sensitivity B-X
to B-X
ionizing B-X
radiation B-X
- B-X
ScienceDirect B-X
Disruption B-X
of B-X
the B-X
checkpoint B-X
kinase B-X
1/cell B-X
division B-X
cycle B-X
25A B-X
pathway B-X
abrogates B-X
ionizing B-X
radiation-induced B-X
S B-X
and B-X
G2 B-X
checkpoints B-X
| B-X
PNAS B-X
Suppression B-X
of B-X
X-ray-induced B-X
chromosome B-X
aberrations B-X
in B-X
ataxia B-X
telangiectasia B-X
cells B-X
by B-X
introduction B-X
of B-X
a B-X
normal B-X
human B-X
chromosome B-X
11 B-X
- B-X
ScienceDirect B-X

This	O
correction	O
of	O
the	O
defects	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
cells	O
provides	O
further	O
evidence	O
of	O
the	O
multiplicity	O
of	O
effector	O
functions	O
of	O
the	O
ATM	O
protein	O
and	O
suggests	O
possible	O
approaches	O
to	O
gene	O
therapy	O
.	O
.	O
<EOS> B-X
PDF B-X
| B-X
ATM B-X
kinase B-X
plays B-X
a B-X
central B-X
role B-X
in B-X
signaling B-X
DNA B-X
double-strand B-X
breaks B-X
to B-X
cell B-X
cycle B-X
checkpoints B-X
and B-X
to B-X
the B-X
DNA B-X
repair B-X
machinery B-X
. B-X
Although B-X
the B-X
... B-X
| B-X
Find B-X
, B-X
PDF B-X
| B-X
The B-X
cloning B-X
of B-X
a B-X
full-length B-X
cDNA B-X
for B-X
the B-X
gene B-X
( B-X
ATM B-X
) B-X
mutated B-X
in B-X
the B-X
human B-X
genetic B-X
disorder B-X
ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
has B-X
been B-X
described B-X
... B-X
| B-X
Find B-X
Request B-X
PDF B-X
| B-X
Functional B-X
and B-X
Computational B-X
Assessment B-X
of B-X
Missense B-X
Variants B-X
in B-X
the B-X
Ataxia-Telangiectasia B-X
Mutated B-X
( B-X
ATM B-X
) B-X
Gene B-X
: B-X
Mutations B-X
With B-X
Increased B-X
Cancer B-X
Risk B-X
| B-X
The B-X
functional B-X
consequences B-X
of B-X
missense B-X
PDF B-X
| B-X
Ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
is B-X
a B-X
complex B-X
, B-X
autosomal B-X
recessive B-X
disorder B-X
characterized B-X
by B-X
cerebellar B-X
ataxia B-X
, B-X
believed B-X
to B-X
result B-X
from B-X
progressive B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
PDF B-X
| B-X
The B-X
human B-X
genetic B-X
disorder B-X
ataxia-telangiectasia B-X
( B-X
AT B-X
) B-X
is B-X
characterized B-X
by B-X
immunodeficiency B-X
, B-X
progressive B-X
cerebellar B-X
ataxia B-X
, B-X
radiosensitivity B-X
, B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
Ataxia-telangiectasia B-X
: B-X
future B-X
prospects B-X

Fusion	O
genes	O
resulting	O
from	O
alternative	O
chromosomal	O
translocations	O
are	O
overexpressed	O
by	O
gene	O
-	O
specific	O
mechanisms	O
in	O
alveolar	B-Disease
rhabdomyosarcoma	I-Disease
.	O
<EOS> B-X
Fusion B-X
genes B-X
resulting B-X
from B-X
alternative B-X
chromosomal B-X
translocations B-X
are B-X
overexpressed B-X
by B-X
gene-specific B-X
mechanisms B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
| B-X
PNAS B-X
Mechanism B-X
for B-X
transcriptional B-X
gain B-X
of B-X
function B-X
resulting B-X
from B-X
chromosomal B-X
translocation B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
| B-X
PNAS B-X
Mechanisms B-X
of B-X
Impaired B-X
Differentiation B-X
in B-X
Rhabdomyosarcoma B-X
PAX3-FOXO1 B-X
Fusion B-X
Gene B-X
in B-X
Rhabdomyosarcoma B-X
Chromosomal B-X
translocations B-X
identified B-X
in B-X
hematopoietic B-X
and B-X
solid B-X
tumors B-X
result B-X
in B-X
deregulated B-X
expression B-X
of B-X
protooncogenes B-X
or B-X
creation B-X
of B-X
chimeric B-X
proteins B-X
with B-X
tumorigenic B-X
potential B-X
. B-X
In B-X
the B-X
pediatric B-X
solid B-X
tumor B-X
alveolar B-X
rhabdomyosarcoma B-X
In B-X
the B-X
pediatric B-X
cancer B-X
alveolar B-X
rhabdomyosarcoma B-X
, B-X
characteristic B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
or B-X
variant B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X
p36 B-X
; B-X
A B-X
CALL B-X
TO B-X
ARMS B-X
: B-X
TARGETING B-X
THE B-X
PAX3-FOXO1 B-X
GENE B-X
IN B-X
ALVEOLAR B-X
RHABDOMYOSARCOMA B-X

Chromosomal	O
translocations	O
identified	O
in	O
hematopoietic	B-Disease
and	I-Disease
solid	I-Disease
tumors	I-Disease
result	O
in	O
deregulated	O
expression	O
of	O
protooncogenes	O
or	O
creation	O
of	O
chimeric	O
proteins	O
with	O
tumorigenic	O
potential	O
.	O
<EOS> B-X
Chromosomal B-X
abnormalities B-X
in B-X
tumours B-X
were B-X
recognized B-X
at B-X
the B-X
end B-X
of B-X
the B-X
last B-X
century B-X
but B-X
their B-X
significance B-X
has B-X
only B-X
recently B-X
become B-X
clear B-X
. B-X
Distinct B-X
translocations B-X
in B-X
leukaemias B-X
and B-X
in B-X
solid B-X
tumours B-X
Oncogenic B-X
chromosomal B-X
translocations B-X
and B-X
human B-X
cancer B-X
( B-X
Review B-X
) B-X
Causes B-X
of B-X
oncogenic B-X
chromosomal B-X
translocation B-X
Adenoid B-X
cystic B-X
carcinoma B-X
: B-X
emerging B-X
role B-X
of B-X
translocations B-X
and B-X
gene B-X
fusions B-X
Targeted B-X
Cancer B-X
Therapy B-X
: B-X
Vital B-X
Oncogenes B-X
and B-X
a B-X
New B-X
Molecular B-X
Genetic B-X
Paradigm B-X
for B-X
Cancer B-X
Initiation B-X
Progression B-X
and B-X
Treatment B-X
The B-X
activation B-X
of B-X
oncogenes B-X
involves B-X
genetic B-X
changes B-X
to B-X
cellular B-X
protooncogenes B-X
. B-X
The B-X
consequence B-X
of B-X
these B-X
genetic B-X
alterations B-X
is B-X
to B-X
confer B-X
a B-X
growth B-X
advantage B-X
to B-X
the B-X
cell B-X
. B-X
Three B-X
genetic B-X
mechanisms B-X
Signal B-X
Transduction B-X
in B-X
Cancer B-X

In	O
the	O
pediatric	O
solid	B-Disease
tumor	I-Disease
alveolar	B-Disease
rhabdomyosarcoma	I-Disease
,	O
a	O
consistent	O
t	O
(	O
2	O
;	O
13	O
)	O
(	O
q35	O
;	O
q14	O
)	O
or	O
variant	O
t	O
(	O
1	O
;	O
13	O
)	O
(	O
p36	O
;	O
q14	O
)	O
translocation	O
generates	O
PAX3	O
-	O
FKHR	O
or	O
PAX7	O
-	O
FKHR	O
fusion	O
proteins	O
,	O
respectively	O
.	O
<EOS> B-X
Although B-X
the B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
translocation B-X
has B-X
been B-X
found B-X
in B-X
most B-X
cases B-X
of B-X
the B-X
pediatric B-X
cancer B-X
alveolar B-X
rhabdomyosarcoma B-X
, B-X
several B-X
cases B-X
have B-X
Chromosomal B-X
translocations B-X
identified B-X
in B-X
hematopoietic B-X
and B-X
solid B-X
tumors B-X
result B-X
in B-X
deregulated B-X
expression B-X
of B-X
protooncogenes B-X
or B-X
creation B-X
of B-X
chimeric B-X
proteins B-X
with B-X
tumorigenic B-X
potential B-X
. B-X
In B-X
the B-X
pediatric B-X
solid B-X
tumor B-X
alveolar B-X
rhabdomyosarcoma B-X
The B-X
chromosomal B-X
translocations B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
and B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X
p36 B-X
; B-X
q14 B-X
) B-X
are B-X
characteristic B-X
of B-X
alveolar B-X
The B-X
most B-X
common B-X
types B-X
of B-X
rhabdomyosarcoma B-X
( B-X
RMS B-X
) B-X
are B-X
alveolar B-X
RMS B-X
( B-X
ARMS B-X
) B-X
, B-X
which B-X
are B-X
characterized B-X
by B-X
the B-X
specific B-X
translocation B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
Cytogenetic B-X
studies B-X
of B-X
the B-X
pediatric B-X
solid B-X
tumor B-X
alveolar B-X
rhabdomyosarcoma B-X
have B-X
demonstrated B-X
the B-X
presence B-X
of B-X
a B-X
consistent B-X
chromosomal B-X
translocation B-X
, B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
Fusion B-X
of B-X
PAX7 B-X
to B-X
FKHR B-X
by B-X
the B-X
Variant B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X
p36 B-X
; B-X
q14 B-X
) B-X
Translocation B-X
in B-X
Alveolar B-X
Rhabdomyosarcoma B-X
| B-X
Cancer B-X
Research B-X
Soft B-X
Tissues B-X
: B-X
Alveolar B-X
rhabdomyosarcoma B-X
with B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
PAX3/FOXO1 B-X

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
in	O
addition	O
to	O
functional	O
alterations	O
these	O
translocations	O
are	O
associated	O
with	O
fusion	O
product	O
overexpression	O
.	O
<EOS> B-X
c-MYC B-X
is B-X
the B-X
prototype B-X
for B-X
oncogene B-X
activation B-X
by B-X
chromosomal B-X
translocation B-X
. B-X
In B-X
contrast B-X
to B-X
the B-X
tightly B-X
regulated B-X
expression B-X
of B-X
c-myc B-X
in B-X
normal B-X
cells B-X
, B-X
c-myc B-X
is B-X
frequently B-X
deregulated B-X
in B-X
human B-X
Identification B-X
of B-X
novel B-X
cancer B-X
fusion B-X
genes B-X
using B-X
chromosome B-X
breakpoint B-X
screening B-X
Genomic B-X
rearrangements B-X
are B-X
a B-X
hallmark B-X
of B-X
cancer B-X
biology B-X
and B-X
progression B-X
, B-X
allowing B-X
cells B-X
to B-X
rapidly B-X
transform B-X
through B-X
alterations B-X
in B-X
regulatory B-X
structures B-X
, B-X
changes B-X
in B-X
expression B-X
patterns B-X
, B-X
reprogramming B-X
of B-X
signaling B-X
N-Myc B-X
is B-X
a B-X
global B-X
transcription B-X
factor B-X
that B-X
regulates B-X
the B-X
expression B-X
of B-X
genes B-X
involved B-X
in B-X
a B-X
number B-X
of B-X
essential B-X
cellular B-X
processes B-X
including B-X
: B-X
ribosome B-X
biogenesis B-X
, B-X
cell B-X
cycle B-X
and B-X
apoptosis B-X
. B-X
Chromosomal B-X
rearrangements B-X
including B-X
translocations B-X
, B-X
deletions B-X
, B-X
inversions B-X
, B-X
and B-X
insertions B-X
are B-X
common B-X
genetic B-X
alterations B-X
in B-X
cancer B-X
. B-X
Over B-X
1,000 B-X
recurrent B-X
c B-X
Non-coding B-X
RNAs B-X
in B-X
cancers B-X
with B-X
chromosomal B-X
rearrangements B-X
: B-X
the B-X
signatures B-X
, B-X
causes B-X
, B-X
functions B-X
and B-X
implications B-X
ETS B-X
rearrangements B-X
in B-X
prostate B-X
cancer B-X

Furthermore	O
,	O
PAX3	O
-	O
FKHR	O
and	O
PAX7	O
-	O
FKHR	O
overexpression	O
occurs	O
by	O
distinct	O
mechanisms	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
PAX3-FKHR B-X
and B-X
PAX7-FKHR B-X
gene B-X
fusions B-X
are B-X
prognostic B-X
indicators B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
: B-X
a B-X
report B-X
from B-X
the B-X
children B-X
‚Äô B-X
s B-X
oncology B-X
group B-X
| B-X
Alveolar B-X
rhabdomyosarcoma B-X
( B-X
ARMS B-X
) B-X
PDF B-X
| B-X
In B-X
the B-X
pediatric B-X
cancer B-X
alveolar B-X
rhabdomyosarcoma B-X
, B-X
characteristic B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
or B-X
variant B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X

Transcription	O
of	O
PAX3	O
-	O
FKHR	O
is	O
increased	O
relative	O
to	O
wild	O
-	O
type	O
PAX3	O
by	O
a	O
copy	O
number	O
-	O
independent	O
process	O
.	O
<EOS> B-X
High B-X
Expression B-X
of B-X
the B-X
PAX3-FKHR B-X
Oncoprotein B-X
Is B-X
Required B-X
to B-X
Promote B-X
Tumorigenesis B-X
of B-X
Human B-X
Myoblasts B-X
Request B-X
PDF B-X
| B-X
Transcriptional B-X
regulation B-X
of B-X
IGF-I B-X
receptor B-X
gene B-X
expression B-X
by B-X
the B-X
PAX3-FKHR B-X
oncoprotein B-X
| B-X
Chromosomal B-X
translocations B-X
that B-X
disrupt B-X
the B-X
molecular B-X
organization B-X
of B-X
transcription B-X
factors B-X
are B-X
typical B-X
of B-X
a B-X
variety B-X
Inhibiting B-X
phosphorylation B-X
of B-X
the B-X
oncogenic B-X
PAX3-FOXO1 B-X
reduces B-X
alveolar B-X
rhabdomyosarcoma B-X
phenotypes B-X
identifying B-X
novel B-X
therapy B-X
options B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Stability B-X
analysis B-X
of B-X
PAX3 B-X
and B-X
PAX3-FKHR B-X
transcripts B-X
. B-X
SJRH28 B-X
cells B-X
were B-X
treated B-X
with B-X
10 B-X
gml B-X
actinomycin B-X
D B-X
for B-X
the B-X
indicated B-X
times B-X
. B-X
RNA B-X
was B-X
isolated B-X
, B-X

In	O
contrast	O
,	O
PAX7	O
-	O
FKHR	O
overexpression	O
results	O
from	O
fusion	O
gene	O
amplification	O
.	O
<EOS> B-X
Fusion B-X
genes B-X
resulting B-X
from B-X
alternative B-X
chromosomal B-X
translocations B-X
are B-X
overexpressed B-X
by B-X
gene-specific B-X
mechanisms B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
| B-X
PNAS B-X
Fusion B-X
genes B-X
resulting B-X
from B-X
alternative B-X
chromosomal B-X
translocations B-X
are B-X
overexpressed B-X
by B-X
gene-specific B-X
mechanisms B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
| B-X
PNAS B-X
Fusion B-X
genes B-X
resulting B-X
from B-X
alternative B-X
chromosomal B-X
translocations B-X
are B-X
overexpressed B-X
by B-X
gene-specific B-X
mechanisms B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
| B-X
PNAS B-X
Genomic B-X
and B-X
clinical B-X
analysis B-X
of B-X
amplification B-X
of B-X
the B-X
13q31 B-X
chromosomal B-X
region B-X
in B-X
alveolar B-X
rhabdomyosarcoma B-X
: B-X
a B-X
report B-X
from B-X
the B-X
Children B-X
‚Äô B-X
s B-X
Oncology B-X
Group B-X
The B-X
chromosomal B-X
translocations B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
and B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X
p36 B-X
; B-X
q14 B-X
) B-X
are B-X
characteristic B-X
of B-X
alveolar B-X
The B-X
chromosomal B-X
translocations B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
and B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X
p36 B-X
; B-X
q14 B-X
) B-X
are B-X
characteristic B-X
of B-X
alveolar B-X

Thus	O
,	O
gene	O
-	O
specific	O
mechanisms	O
were	O
selected	O
to	O
overexpress	O
PAX3	O
-	O
FKHR	O
and	O
PAX7	O
-	O
FKHR	O
in	O
alveolar	B-Disease
rhabdomyosarcoma	I-Disease
,	O
presumably	O
due	O
to	O
differences	O
in	O
regulation	O
between	O
the	O
wild	O
-	O
type	O
loci	O
.	O
<EOS> B-X
Pax3 B-X
: B-X
Fkhr B-X
interferes B-X
with B-X
embryonic B-X
Pax3 B-X
and B-X
Pax7 B-X
function B-X
: B-X
implications B-X
for B-X
alveolar B-X
rhabdomyosarcoma B-X
cell B-X
of B-X
origin B-X
Request B-X
PDF B-X
| B-X
Structural B-X
Analysis B-X
of B-X
PAX7 B-X
Rearrangements B-X
in B-X
Alveolar B-X
Rhabdomyosarcoma B-X
| B-X
In B-X
the B-X
pediatric B-X
cancer B-X
alveolar B-X
rhabdomyosarcoma B-X
, B-X
the B-X
common B-X
2 B-X
; B-X
13 B-X
and B-X
less B-X
frequent B-X
1 B-X
; B-X
13 B-X
Genetic B-X
regulation B-X
of B-X
the B-X
intercellular B-X
adhesion B-X
locus B-X
in B-X
staphylococci B-X
Multiple B-X
interactions B-X
between B-X
regulatory B-X
regions B-X
are B-X
required B-X
to B-X
stabilize B-X
an B-X
active B-X
chromatin B-X
hub B-X
The B-X
genetic B-X
basis B-X
of B-X
pigmentation B-X
differences B-X
within B-X
and B-X
between B-X
Drosophila B-X
species B-X
Cross-Regulation B-X
among B-X
the B-X
Polycomb B-X
Group B-X
Genes B-X
in B-X
Drosophila B-X
melanogaster B-X
Circadian B-X
Clock-Specific B-X
Roles B-X
for B-X
the B-X
Light B-X
Response B-X
Protein B-X
WHITE B-X
COLLAR-2 B-X

We	O
postulate	O
that	O
these	O
overexpression	O
mechanisms	O
ensure	O
a	O
critical	O
level	O
of	O
gene	O
product	O
for	O
the	O
oncogenic	O
effects	O
of	O
these	O
fusions	O
.	O
.	O
<EOS> B-X
Chromosomal B-X
translocations B-X
identified B-X
in B-X
hematopoietic B-X
and B-X
solid B-X
tumors B-X
result B-X
in B-X
deregulated B-X
expression B-X
of B-X
protooncogenes B-X
or B-X
creation B-X
of B-X
chimeric B-X
proteins B-X
with B-X
tumorigenic B-X
potential B-X
. B-X
In B-X
the B-X
pediatric B-X
solid B-X
tumor B-X
alveolar B-X
rhabdomyosarcoma B-X
MYC B-X
MYC B-X
proto-oncogene B-X
, B-X
bHLH B-X
transcription B-X
factor B-X
[ B-X
Homo B-X
sapiens B-X
( B-X
human B-X
) B-X
] B-X
- B-X
Gene B-X
- B-X
NCBI B-X
The B-X
t B-X
( B-X
2 B-X
; B-X
13 B-X
) B-X
( B-X
q35 B-X
; B-X
q14 B-X
) B-X
and B-X
t B-X
( B-X
1 B-X
; B-X
13 B-X
) B-X
( B-X
p36 B-X
; B-X
q14 B-X
) B-X
chromosomal B-X
translocations B-X
are B-X
specifically B-X
associated B-X
with B-X

atm	O
and	O
p53	O
cooperate	O
in	O
apoptosis	O
and	O
suppression	O
of	O
tumorigenesis	O
,	O
but	O
not	O
in	O
resistance	O
to	O
acute	B-Disease
radiation	I-Disease
toxicity	I-Disease
.	O
<EOS> B-X
Tumor B-X
suppression B-X
by B-X
p53 B-X
in B-X
the B-X
absence B-X
of B-X
Atm B-X
Functional B-X
Interaction B-X
of B-X
H2AX B-X
, B-X
NBS1 B-X
, B-X
and B-X
p53 B-X
in B-X
ATM-Dependent B-X
DNA B-X
Damage B-X
Responses B-X
and B-X
Tumor B-X
Suppression B-X
Apoptosis B-X
, B-X
p53 B-X
, B-X
and B-X
Tumor B-X
Cell B-X
Sensitivity B-X
to B-X
Anticancer B-X
Agents B-X
| B-X
Cancer B-X
Research B-X
Mutations B-X
in B-X
atm B-X
and B-X
p53 B-X
cause B-X
the B-X
human B-X
cancer-associated B-X
diseases B-X
ataxia-telangiectasia B-X
and B-X
Li-Fraumeni B-X
syndrome B-X
, B-X
respectively B-X
. B-X
The B-X
two B-X
genes B-X
are B-X
believed B-X
to B-X
interact B-X
in B-X
a B-X
number B-X
of B-X
pathways B-X
, B-X
Mutations B-X
in B-X
atm B-X
and B-X
p53 B-X
cause B-X
the B-X
human B-X
cancer-associated B-X
diseases B-X
ataxia-telangiectasia1 B-X
and B-X
Li-Fraumeni B-X
syndrome2,3 B-X
, B-X
respectively B-X
. B-X
The B-X
two B-X
genes B-X
are B-X
believed B-X
to B-X
interact B-X
in B-X
a B-X
number B-X
of B-X
pathways4‚Äì6 B-X
, B-X
Chk2 B-X
Is B-X
a B-X
Tumor B-X
Suppressor B-X
That B-X
Regulates B-X
Apoptosis B-X
in B-X
both B-X
an B-X
Ataxia B-X
Telangiectasia B-X
Mutated B-X
( B-X
ATM B-X
) B-X
-Dependent B-X
and B-X
an B-X
ATM-Independent B-X
Manner B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
The B-X
past B-X
few B-X
years B-X
have B-X
witnessed B-X
an B-X
astonishing B-X
international B-X
effort B-X
that B-X
established B-X
the B-X
role B-X
of B-X
some B-X
20 B-X
new B-X
molecules B-X
in B-X
apoptosis B-X
and B-X
added B-X
activation B-X
or B-X
suppression B-X
of B-X
apoptosis B-X
to B-X
the B-X

Mutations	O
in	O
atm	O
and	O
p53	O
cause	O
the	O
human	O
cancer	B-Disease
-	I-Disease
associated	I-Disease
diseases	I-Disease
ataxia	B-Disease
-	I-Disease
telangiectasia	I-Disease
and	O
Li	B-Disease
-	I-Disease
Fraumeni	I-Disease
syndrome	I-Disease
,	O
respectively	O
.	O
<EOS> B-X
p53 B-X
centrosomal B-X
localization B-X
diagnoses B-X
ataxia-telangiectasia B-X
homozygotes B-X
and B-X
heterozygotes B-X
Ataxia-telangiectasia B-X
( B-X
A-T B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
neurodegenerative B-X
disorder B-X
characterized B-X
by B-X
radiosensitivity B-X
, B-X
genomic B-X
instability B-X
, B-X
and B-X
predisposition B-X
to B-X
cancer B-X
. B-X
A-T B-X
is B-X
caused B-X
by B-X
biallelic B-X
mutations B-X
in B-X
the B-X
The B-X
p53 B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
TP53 B-X
) B-X
is B-X
mutated B-X
more B-X
often B-X
in B-X
human B-X
cancers B-X
than B-X
any B-X
other B-X
gene B-X
yet B-X
reported B-X
. B-X
Of B-X
importance B-X
, B-X
it B-X
is B-X
mutated B-X
frequently B-X
in B-X
Ataxia B-X
telangiectasia B-X
mutated‚Äìdeficient B-X
B-cell B-X
chronic B-X
lymphocytic B-X
leukemia B-X
occurs B-X
in B-X
pregerminal B-X
center B-X
cells B-X
and B-X
results B-X
in B-X
defective B-X
damage B-X
response B-X
and B-X
unrepaired B-X
chromosome B-X
damage B-X
- B-X
ScienceDirect B-X
The B-X
Role B-X
of B-X
Tumor B-X
Protein B-X
53 B-X
Mutations B-X
in B-X
Common B-X
Human B-X
Cancers B-X
and B-X
Targeting B-X
the B-X
Murine B-X
Double B-X
Minute B-X
2‚ÄìP53 B-X
Interaction B-X
for B-X
Cancer B-X
Therapy B-X
< B-X
b B-X
> B-X
< B-X
i B-X
> B-X
Objectives B-X
: B-X
< B-X
/i B-X
> B-X
< B-X
/b B-X
> B-X
The B-X
aims B-X
of B-X
this B-X
study B-X
were B-X
to B-X
assess B-X
expressions B-X
of B-X
the B-X
DNA B-X
damage B-X
response B-X
( B-X
DDR B-X
Breast B-X
cancer B-X
is B-X
the B-X
most B-X
prevalent B-X
tumor B-X
entity B-X
in B-X
Li-Fraumeni B-X
syndrome B-X
. B-X
Up B-X
to B-X
80 B-X
% B-X
of B-X
individuals B-X
with B-X
a B-X
Li-Fraumeni-like B-X
phenotype B-X
do B-X
not B-X
harbor B-X
detectable B-X
causative B-X
germline B-X
TP53 B-X
variants B-X

The	O
two	O
genes	O
are	O
believed	O
to	O
interact	O
in	O
a	O
number	O
of	O
pathways	O
,	O
including	O
regulation	O
of	O
DNA	O
damage	O
-	O
induced	O
cell	O
-	O
cycle	O
checkpoints	O
,	O
apoptosis	O
and	O
radiation	O
sensitivity	O
,	O
and	O
cellular	O
proliferation	O
.	O
<EOS> B-X
Understanding B-X
the B-X
limitations B-X
of B-X
radiation-induced B-X
cell B-X
cycle B-X
checkpoints B-X
Effects B-X
of B-X
different B-X
doses B-X
of B-X
X‚Äëray B-X
irradiation B-X
on B-X
cell B-X
apoptosis B-X
, B-X
cell B-X
cycle B-X
, B-X
DNA B-X
damage B-X
repair B-X
and B-X
glycolysis B-X
in B-X
HeLa B-X
cells B-X
Effects B-X
of B-X
different B-X
doses B-X
of B-X
X‚Äëray B-X
irradiation B-X
on B-X
cell B-X
apoptosis B-X
, B-X
cell B-X
cycle B-X
, B-X
DNA B-X
damage B-X
repair B-X
and B-X
glycolysis B-X
in B-X
HeLa B-X
cells B-X
Time-resolved B-X
mapping B-X
of B-X
genetic B-X
interactions B-X
to B-X
model B-X
rewiring B-X
of B-X
signaling B-X
pathways B-X
p53 B-X
and B-X
Cell B-X
Cycle B-X
Effects B-X
After B-X
DNA B-X
Damage B-X
Cell B-X
death-stimulated B-X
cell B-X
proliferation B-X
: B-X
A B-X
tissue B-X
regeneration B-X
mechanism B-X
usurped B-X
by B-X
tumors B-X
during B-X
radiotherapy B-X
Naphthazarin B-X
enhances B-X
ionizing B-X
radiation-induced B-X
cell B-X
cycle B-X
arrest B-X
and B-X
apoptosis B-X
in B-X
human B-X
breast B-X
cancer B-X
cells B-X

Atm	O
-	O
null	O
mice	O
,	O
as	O
well	O
as	O
those	O
null	O
for	O
p53	O
,	O
develop	O
mainly	O
T	B-Disease
-	I-Disease
cell	I-Disease
lymphomas	I-Disease
,	O
supporting	O
the	O
view	O
that	O
these	O
genes	O
have	O
similar	O
roles	O
in	O
thymocyte	O
development	O
.	O
<EOS> B-X
Block B-X
of B-X
T B-X
cell B-X
development B-X
in B-X
P53-deficient B-X
mice B-X
accelerates B-X
development B-X
of B-X
lymphomas B-X
with B-X
characteristic B-X
RAG-dependent B-X
cytogenetic B-X
alterations B-X
- B-X
ScienceDirect B-X
The B-X
development B-X
of B-X
T B-X
cells B-X
from B-X
stem B-X
cells B-X
in B-X
mice B-X
and B-X
humans B-X
Challenging B-X
perspectives B-X
on B-X
the B-X
cellular B-X
origins B-X
of B-X
lymphoma B-X
Lymphomas B-X
can B-X
develop B-X
from B-X
B B-X
cells B-X
chronically B-X
helped B-X
by B-X
idiotype-specific B-X
T B-X
cells B-X
Human B-X
T B-X
cell B-X
development B-X
, B-X
localization B-X
, B-X
and B-X
function B-X
throughout B-X
life B-X
Transcriptional B-X
silencing B-X
of B-X
the B-X
p73 B-X
gene B-X
through B-X
methylation B-X
has B-X
been B-X
demonstrated B-X
in B-X
human B-X
leukemias B-X
and B-X
lymphomas B-X
. B-X
However B-X
, B-X
the B-X
role B-X
of B-X
p73 B-X
in B-X
the B-X
malignant B-X
process B-X
remains B-X
to B-X
be B-X
Peripheral B-X
T B-X
cell B-X
lymphoma B-X
: B-X
new B-X
model B-X
+ B-X
new B-X
insight B-X

To	O
study	O
the	O
interactions	O
of	O
these	O
two	O
genes	O
on	O
an	O
organismal	O
level	O
,	O
we	O
bred	O
mice	O
heterozygous	O
for	O
null	O
alleles	O
of	O
both	O
atm	O
and	O
p53	O
to	O
produce	O
all	O
genotypic	O
combinations	O
.	O
<EOS> B-X
‚Äò B-X
Super B-X
p53 B-X
‚Äô B-X
mice B-X
exhibit B-X
enhanced B-X
DNA B-X
damage B-X
response B-X
, B-X
are B-X
tumor B-X
resistant B-X
and B-X
age B-X
normally B-X
Knockout B-X
and B-X
transgenic B-X
mice B-X
of B-X
Trp53 B-X
: B-X
what B-X
have B-X
we B-X
learned B-X
about B-X
p53 B-X
in B-X
breast B-X
cancer B-X
? B-X
Two B-X
hot B-X
spot B-X
mutant B-X
p53 B-X
mouse B-X
models B-X
display B-X
differential B-X
gain B-X
of B-X
function B-X
in B-X
tumorigenesis B-X
Using B-X
Mouse B-X
Models B-X
to B-X
Explore B-X
MDM-p53 B-X
Signaling B-X
in B-X
Development B-X
, B-X
Cell B-X
Growth B-X
, B-X
and B-X
Tumorigenesis B-X
Œî122p53 B-X
, B-X
a B-X
mouse B-X
model B-X
of B-X
Œî133p53Œ± B-X
, B-X
enhances B-X
the B-X
tumor-suppressor B-X
activities B-X
of B-X
an B-X
attenuated B-X
p53 B-X
mutant B-X
Loss B-X
of B-X
p21 B-X
increases B-X
sensitivity B-X
to B-X
ionizing B-X
radiation B-X
and B-X
delays B-X
the B-X
onset B-X
of B-X
lymphoma B-X
in B-X
atm-deficient B-X
mice B-X
Declining B-X
p53 B-X
function B-X
in B-X
the B-X
aging B-X
process B-X
: B-X
A B-X
possible B-X
mechanism B-X
for B-X
the B-X
increased B-X
tumor B-X
incidence B-X
in B-X
older B-X
populations B-X
| B-X
PNAS B-X

Mice	O
doubly	O
null	O
for	O
atm	O
and	O
p53	O
exhibited	O
a	O
dramatic	O
acceleration	O
of	O
tumour	B-Disease
formation	O
relative	O
to	O
singly	O
null	O
mice	O
,	O
indicating	O
that	O
both	O
genes	O
collaborate	O
in	O
a	O
significant	O
manner	O
to	O
prevent	O
tumorigenesis	O
.	O
<EOS> B-X
Mutations B-X
in B-X
atm B-X
and B-X
p53 B-X
cause B-X
the B-X
human B-X
cancer-associated B-X
diseases B-X
ataxia-telangiectasia1 B-X
and B-X
Li-Fraumeni B-X
syndrome2,3 B-X
, B-X
respectively B-X
. B-X
The B-X
two B-X
genes B-X
are B-X
believed B-X
to B-X
interact B-X
in B-X
a B-X
number B-X
of B-X
pathways4‚Äì6 B-X
, B-X
Two B-X
faces B-X
of B-X
p53 B-X
: B-X
aging B-X
and B-X
tumor B-X
suppression B-X
Atm B-X
heterozygous B-X
deficiency B-X
enhances B-X
development B-X
of B-X
mammary B-X
carcinomas B-X
in B-X
p53 B-X
heterozygous B-X
knockout B-X
mice B-X
The B-X
combined B-X
status B-X
of B-X
ATM B-X
and B-X
p53 B-X
link B-X
tumor B-X
development B-X
with B-X
therapeutic B-X
response B-X
Transgenic B-X
and B-X
Knockout B-X
Mice B-X
Models B-X
to B-X
Reveal B-X
the B-X
Functions B-X
of B-X
Tumor B-X
Suppressor B-X
Genes B-X
Using B-X
Mice B-X
to B-X
Examine B-X
p53 B-X
Functions B-X
in B-X
Cancer B-X
, B-X
Aging B-X
, B-X
and B-X
Longevity B-X
Bmi-1 B-X
collaborates B-X
with B-X
c-Myc B-X
in B-X
tumorigenesis B-X
by B-X
inhibiting B-X
c-Myc-induced B-X
apoptosis B-X
via B-X
INK4a/ARF B-X

With	O
respect	O
to	O
their	O
roles	O
in	O
apoptosis	O
,	O
loss	O
of	O
atm	O
rendered	O
thymocytes	O
only	O
partly	O
resistant	O
to	O
irradiation	O
-	O
induced	O
apoptosis	O
,	O
whereas	O
additional	O
loss	O
of	O
p53	O
engendered	O
complete	O
resistance	O
.	O
<EOS> B-X
The B-X
role B-X
of B-X
p53 B-X
in B-X
cancer B-X
drug B-X
resistance B-X
and B-X
targeted B-X
chemotherapy B-X
DNA B-X
damage B-X
can B-X
induce B-X
apoptosis B-X
in B-X
proliferating B-X
lymphoid B-X
cells B-X
via B-X
p53-independent B-X
mechanisms B-X
inhibitable B-X
by B-X
Bcl-2 B-X
- B-X
ScienceDirect B-X
P53 B-X
status B-X
may B-X
be B-X
a B-X
determinant B-X
of B-X
chemosensitivity B-X
of B-X
tumor B-X
cells B-X
; B-X
however B-X
, B-X
its B-X
involvement B-X
in B-X
cellular B-X
resistance B-X
to B-X
cisplatin B-X
remains B-X
uncertain B-X
. B-X
To B-X
investigate B-X
the B-X
relationships B-X
between B-X
p53 B-X
Hemizygosity B-X
for B-X
Atm B-X
and B-X
Brca1 B-X
influence B-X
the B-X
balance B-X
between B-X
cell B-X
transformation B-X
and B-X
apoptosis B-X
The B-X
involvement B-X
of B-X
the B-X
tumor B-X
suppressor B-X
protein B-X
, B-X
p53 B-X
, B-X
in B-X
thymic B-X
epithelial B-X
cell-induced B-X
apoptosis B-X
of B-X
CD4+8+ B-X
( B-X
double B-X
positive B-X
) B-X
thymocytes B-X
, B-X
was B-X
studied B-X
in B-X
an B-X
in B-X
vitro B-X
model B-X
Both B-X
inactivation B-X
of B-X
p53 B-X
function B-X
and B-X
loss B-X
of B-X
sensitivity B-X
to B-X
Fas B-X
contribute B-X
to B-X
a B-X
malignant B-X
phenotype B-X
and B-X
frequently B-X
occur B-X
during B-X
tumor B-X
progression B-X
. B-X
Although B-X
in B-X
the B-X
majority B-X
of B-X
cases B-X
only B-X
In B-X
vivo B-X
analysis B-X
of B-X
p53 B-X
tumor B-X
suppressor B-X
function B-X
using B-X
genetically B-X
engineered B-X
mouse B-X
models B-X

This	O
implies	O
that	O
the	O
irradiation	O
-	O
induced	O
atm	O
and	O
p53	O
apoptotic	O
pathways	O
are	O
not	O
completely	O
congruent	O
.	O
<EOS> B-X
How B-X
does B-X
p53 B-X
induce B-X
apoptosis B-X
and B-X
how B-X
does B-X
this B-X
relate B-X
to B-X
p53-mediated B-X
tumour B-X
suppression B-X
? B-X
Atm B-X
is B-X
part B-X
of B-X
a B-X
pathway B-X
that B-X
responds B-X
to B-X
DNA B-X
damage B-X
from B-X
ionizing B-X
radiation B-X
( B-X
IR B-X
) B-X
. B-X
This B-X
pathway B-X
involves B-X
p53 B-X
, B-X
as B-X
Atm-deficient B-X
cell B-X
lines B-X
and B-X
mice B-X
are B-X
p53 B-X
deficient B-X
cells B-X
rely B-X
on B-X
ATM B-X
and B-X
ATR-mediated B-X
checkpoint B-X
signaling B-X
through B-X
the B-X
p38 B-X
MAPK/MK2pathway B-X
for B-X
survival B-X
after B-X
DNA B-X
damage B-X
Apoptosis B-X
- B-X
the B-X
p53 B-X
network B-X
| B-X
Journal B-X
of B-X
Cell B-X
Science B-X
Chk1 B-X
Suppresses B-X
a B-X
Caspase-2 B-X
Apoptotic B-X
Response B-X
to B-X
DNA B-X
Damage B-X
that B-X
Bypasses B-X
p53 B-X
, B-X
Bcl-2 B-X
, B-X
and B-X
Caspase-3 B-X
p53-Independent B-X
Apoptosis B-X
Limits B-X
DNA B-X
Damage-Induced B-X
Aneuploidy B-X
Cellular B-X
Pathways B-X
in B-X
Response B-X
to B-X
Ionizing B-X
Radiation B-X
and B-X
Their B-X
Targetability B-X
for B-X
Tumor B-X
Radiosensitization B-X

Finally	O
-	O
and	O
in	O
contrast	O
to	O
prior	O
predictions	O
-	O
atm	O
and	O
p53	O
do	O
not	O
appear	O
to	O
interact	O
in	O
acute	B-Disease
radiation	I-Disease
toxicity	I-Disease
,	O
suggesting	O
a	O
separate	O
atm	O
effector	O
pathway	O
for	O
this	O
DNA	O
damage	O
response	O
and	O
having	O
implications	O
for	O
the	O
prognosis	O
and	O
treatment	O
of	O
human	O
tumours	B-Disease
.	O
.	O
<EOS> B-X
Role B-X
of B-X
AKT B-X
signaling B-X
in B-X
DNA B-X
repair B-X
and B-X
clinical B-X
response B-X
to B-X
cancer B-X
therapy B-X
Role B-X
of B-X
p53 B-X
in B-X
regulating B-X
tissue B-X
response B-X
to B-X
radiation B-X
by B-X
mechanisms B-X
independent B-X
of B-X
apoptosis B-X
ROS B-X
and B-X
the B-X
DNA B-X
damage B-X
response B-X
in B-X
cancer B-X
- B-X
ScienceDirect B-X
Strategies B-X
for B-X
optimizing B-X
the B-X
response B-X
of B-X
cancer B-X
and B-X
normal B-X
tissues B-X
to B-X
radiation B-X
Tumor B-X
Suppression B-X
by B-X
p53 B-X
in B-X
the B-X
Absence B-X
of B-X
Atm B-X
| B-X
Molecular B-X
Cancer B-X
Research B-X
In B-X
mammalian B-X
cells B-X
, B-X
the B-X
DNA B-X
damage B-X
response B-X
( B-X
DDR B-X
) B-X
prevents B-X
the B-X
replication B-X
and B-X
propagation B-X
of B-X
DNA B-X
errors B-X
to B-X
the B-X
next B-X
generation B-X
, B-X
thus B-X
maintaining B-X
genomic B-X
s B-X
DNA B-X
damage B-X
repair B-X
as B-X
a B-X
target B-X
in B-X
pancreatic B-X
cancer B-X
: B-X
state-of-the-art B-X
and B-X
future B-X
perspectives B-X
| B-X
Gut B-X

Trinucleotide	O
repeat	O
expansion	O
at	O
the	O
myotonic	B-Disease
dystrophy	I-Disease
locus	O
reduces	O
expression	O
of	O
DMAHP	O
.	O
<EOS> B-X
Abstract B-X
. B-X
The B-X
causative B-X
mutation B-X
in B-X
the B-X
majority B-X
of B-X
cases B-X
of B-X
myotonic B-X
dystrophy B-X
has B-X
been B-X
shown B-X
to B-X
be B-X
the B-X
expansion B-X
of B-X
a B-X
CTG B-X
trinucleotide B-X
repeat B-X
, B-X
but B-X
the B-X
mechan B-X
Caught B-X
in B-X
the B-X
middle B-X
: B-X
two B-X
genes B-X
troubled B-X
by B-X
trinucleotide B-X
expansion B-X
in B-X
myotonic B-X
dystrophy B-X
- B-X
1998 B-X
- B-X
Clinical B-X
Genetics B-X
- B-X
Wiley B-X
Online B-X
Library B-X
Myotonic B-X
dystrophy B-X
, B-X
or B-X
dystrophia B-X
myotonica B-X
( B-X
DM B-X
) B-X
, B-X
is B-X
an B-X
autosomal B-X
dominant B-X
multisystem B-X
disorder B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
CTG B-X
trinucleotide B-X
repeat B-X
in B-X
the B-X
3‚Ä≤ B-X
untranslated B-X
region B-X
Myotonic B-X
dystrophy B-X
1 B-X
( B-X
DM1 B-X
) B-X
is B-X
a B-X
dominant B-X
, B-X
neuromuscular B-X
disease B-X
which B-X
represents B-X
the B-X
most B-X
common B-X
form B-X
of B-X
muscular B-X
dystrophy B-X
with B-X
a B-X
frequency B-X
of B-X
1 B-X
in B-X
8,000 B-X
. B-X
Today B-X
ALZFORUM B-X
| B-X
NETWORKING B-X
FOR B-X
A B-X
CURE B-X

Myotonic	B-Disease
dystrophy	I-Disease
,	O
or	O
dystrophia	B-Disease
myotonica	I-Disease
(	O
DM	B-Disease
)	O
,	O
is	O
an	O
autosomal	B-Disease
dominant	I-Disease
multisystem	I-Disease
disorder	I-Disease
caused	O
by	O
the	O
expansion	O
of	O
a	O
CTG	O
trinucleotide	O
repeat	O
in	O
the	O
3	O
untranslated	O
region	O
of	O
the	O
DMPK	O
protein	O
kinase	O
gene	O
on	O
chromosome	O
19q13	O
.	O
<EOS> B-X
MYOTONIC B-X
DYSTROPHY B-X
AND B-X
THE B-X
HEART B-X

3	O
(	O
refs	O
1	O
-	O
3	O
)	O
.	O
<EOS> B-X
javascript B-X
- B-X
Vue B-X
3 B-X
refs B-X
is B-X
undefined B-X
in B-X
render B-X
function B-X
- B-X
Stack B-X
Overflow B-X
Forum B-X
enforcement B-X
projects B-X
- B-X
ECHA B-X
focus B-X
- B-X
Vue.js B-X
3 B-X
use B-X
autofocus B-X
on B-X
input B-X
with B-X
ref B-X
inside B-X
a B-X
method B-X
- B-X
Stack B-X
Overflow B-X
Personal B-X
blog B-X
of B-X
Dan B-X
Vega B-X
vuejs3 B-X
- B-X
How B-X
to B-X
access B-X
dynamic B-X
ref-tagged B-X
html B-X
elements B-X
in B-X
Vue.js B-X
3 B-X
? B-X
- B-X
Stack B-X
Overflow B-X
Edited B-X
to B-X
make B-X
that B-X
question B-X
more B-X
understandable B-X
for B-X
future B-X
readers B-X
I B-X
‚Äô B-X
ve B-X
been B-X
trying B-X
out B-X
the B-X
composition B-X
API B-X
of B-X
Vue B-X
3 B-X
lately B-X
and B-X
had B-X
a B-X
hard B-X
time B-X
understanding B-X
the B-X
Ref B-X
( B-X
) B-X
and B-X
Reactive B-X
( B-X
) B-X
are B-X
the B-X
new B-X
ways B-X
of B-X
creating B-X
reactive B-X
property B-X
introduced B-X
in B-X
Composition B-X
API B-X
Vue B-X
3 B-X
. B-X
We B-X
could B-X
create B-X
a B-X
variable B-X
as B-X
we B-X
normally B-X

Although	O
the	O
DM	B-Disease
mutation	O
was	O
identified	O
more	O
than	O
five	O
years	O
ago	O
,	O
the	O
pathogenic	O
mechanisms	O
underlying	O
this	O
most	O
prevalent	O
form	O
of	O
hereditary	O
adult	O
neuromuscular	B-Disease
disease	I-Disease
remain	O
elusive	O
.	O
<EOS> B-X
Mitochondria B-X
in B-X
neuromuscular B-X
disorders B-X
- B-X
ScienceDirect B-X
WikiGenes B-X
- B-X
Neuromuscular B-X
Diseases B-X
Neuromuscular B-X
disorders B-X
: B-X
genes B-X
, B-X
genetic B-X
counseling B-X
and B-X
therapeutic B-X
trials B-X
Download B-X
Citation B-X
| B-X
Myotonic B-X
dystrophy B-X
type B-X
2 B-X
caused B-X
by B-X
a B-X
CCTG B-X
expansion B-X
in B-X
intron B-X
I B-X
of B-X
ZNF9 B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
, B-X
the B-X
most B-X
common B-X
form B-X
of B-X
muscular B-X
15th B-X
International B-X
Congress B-X
on B-X
Neuromuscular B-X
Diseases B-X
, B-X
July B-X
6 B-X
- B-X
10 B-X
, B-X
2018 B-X
Vienna B-X
, B-X
Austria B-X
Request B-X
PDF B-X
| B-X
Shieh B-X
, B-X
PB B-X
. B-X
Muscular B-X
dystrophies B-X
and B-X
other B-X
genetic B-X
myopathies B-X
. B-X
Neurol B-X
Clin B-X
31 B-X
: B-X
1009-1029 B-X
| B-X
With B-X
advances B-X
in B-X
the B-X
genetics B-X
of B-X
muscle B-X
disease B-X
, B-X
the B-X
PDF B-X
| B-X
This B-X
review B-X
demonstrates B-X
genetic B-X
and B-X
phenotypic B-X
heterogeneity B-X
in B-X
all B-X
of B-X
the B-X
multisystemic B-X
myotonic B-X
disorders B-X
collectively B-X
called B-X
'myotonic B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
the B-X
research B-X
you B-X

Previous	O
work	O
from	O
our	O
laboratory	O
demonstrated	O
that	O
a	O
DNase	O
l	O
-	O
hypersensitive	O
site	O
located	O
adjacent	O
to	O
the	O
repeats	O
on	O
the	O
wild	O
-	O
type	O
allele	O
is	O
eliminated	O
by	O
repeat	O
expansion	O
,	O
indicating	O
that	O
large	O
CTG	O
-	O
repeat	O
arrays	O
may	O
be	O
associated	O
with	O
a	O
local	O
chromatin	O
environment	O
that	O
represses	O
gene	O
expression	O
.	O
<EOS> B-X
Myotonic B-X
dystrophy B-X
, B-X
or B-X
dystrophia B-X
myotonica B-X
( B-X
DM B-X
) B-X
, B-X
is B-X
an B-X
autosomal B-X
dominant B-X
multisystem B-X
disorder B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
CTG B-X
trinucleotide B-X
repeat B-X
in B-X
the B-X
3‚Ä≤ B-X
untranslated B-X
region B-X
Abstract B-X
. B-X
Expanded B-X
CAG B-X
repeat B-X
tracts B-X
are B-X
the B-X
cause B-X
of B-X
at B-X
least B-X
a B-X
dozen B-X
neurodegenerative B-X
disorders B-X
. B-X
In B-X
humans B-X
, B-X
long B-X
CAG B-X
repeats B-X
tend B-X
to B-X
expand B-X
during B-X
transmissi B-X
Request B-X
PDF B-X
| B-X
Antisense B-X
Transcription B-X
and B-X
Heterochromatin B-X
at B-X
the B-X
DM1 B-X
CTG B-X
Repeats B-X
Are B-X
Constrained B-X
by B-X
CTCF B-X
| B-X
Prior B-X
studies B-X
of B-X
the B-X
DM1 B-X
locus B-X
have B-X
shown B-X
that B-X
the B-X
CTG B-X
repeats B-X
are B-X
Mechanism B-X
of B-X
allele-selective B-X
inhibition B-X
of B-X
huntingtin B-X
expression B-X
by B-X
duplex B-X
RNAs B-X
that B-X
target B-X
CAG B-X
repeats B-X
: B-X
function B-X
through B-X
the B-X
RNAi B-X
pathway B-X
Abstract B-X
. B-X
Myotonic B-X
dystrophy B-X
is B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
CTG B-X
repeat B-X
sequence B-X
. B-X
The B-X
mechanism B-X
by B-X
which B-X
this B-X
expanded B-X
repeat B-X
produces B-X
the B-X
pathophysiology B-X
of B-X
my B-X
Download B-X
Citation B-X
| B-X
Chromatin B-X
structure B-X
of B-X
repeating B-X
CTG/CAG B-X
and B-X
CGG/CCG B-X
sequences B-X
in B-X
human B-X
disease B-X
| B-X
In B-X
eukaryotic B-X
cells B-X
, B-X
chromatin B-X
structure B-X
organizes B-X
genomic B-X
DNA B-X
in B-X
a B-X
dynamic B-X
fashion B-X
, B-X
and B-X
After B-X
reverse B-X
transcription B-X
and B-X
integration B-X
of B-X
the B-X
genome B-X
of B-X
human B-X
immunodeficiency B-X
virus B-X
( B-X
HIV B-X
) B-X
in B-X
a B-X
target B-X
cell B-X
, B-X
the B-X
viral B-X
DNA B-X
becomes B-X
packaged B-X
into B-X
chromatin B-X
. B-X
Regions B-X
of B-X

Here	O
we	O
report	O
that	O
the	O
hypersensitive	O
site	O
contains	O
an	O
enhancer	O
element	O
that	O
regulates	O
transcription	O
of	O
the	O
adjacent	O
DMAHP	O
homeobox	O
gene	O
.	O
<EOS> B-X
Unveiling B-X
the B-X
gene B-X
regulatory B-X
landscape B-X
in B-X
diseases B-X
through B-X
the B-X
identification B-X
of B-X
DNase B-X
I-hypersensitive B-X
sites B-X
Homeobox B-X
genes B-X
encode B-X
transcription B-X
factors B-X
that B-X
dictate B-X
developmental B-X
identity B-X
, B-X
including B-X
that B-X
of B-X
the B-X
Mullerian B-X
tract B-X
. B-X
These B-X
genes B-X
also B-X
direct B-X
differential B-X
Mullerian B-X
transformation B-X
of B-X
the B-X
ovarian B-X
cancer B-X
cells B-X
. B-X
Hypersensitive B-X
Site B-X
2 B-X
Specifies B-X
a B-X
Unique B-X
Function B-X
within B-X
the B-X
Human B-X
Œ≤-Globin B-X
Locus B-X
Control B-X
Region B-X
To B-X
Stimulate B-X
Globin B-X
Gene B-X
Transcription B-X
Request B-X
PDF B-X
| B-X
The B-X
Six B-X
Family B-X
of B-X
Homeobox B-X
Genes B-X
in B-X
Development B-X
and B-X
Cancer B-X
| B-X
The B-X
homeobox B-X
gene B-X
superfamily B-X
encodes B-X
transcription B-X
factors B-X
that B-X
act B-X
as B-X
master B-X
regulators B-X
of B-X
development B-X
through B-X
their B-X
Download B-X
Citation B-X
| B-X
Distribution B-X
and B-X
Characterization B-X
of B-X
Regulatory B-X
Elements B-X
in B-X
the B-X
Human B-X
Genome B-X
| B-X
The B-X
regulation B-X
of B-X
transcription B-X
and B-X
subsequent B-X
gene B-X
splicing B-X
are B-X
crucial B-X
to B-X
correct B-X
gene B-X
expression B-X
. B-X
Although B-X
Request B-X
PDF B-X
| B-X
Six B-X
family B-X
genes B-X
- B-X
Structure B-X
and B-X
function B-X
as B-X
transcription B-X
factors B-X
and B-X
their B-X
roles B-X
in B-X
development B-X
| B-X
The B-X
members B-X
of B-X
the B-X
Six B-X
gene B-X
family B-X
were B-X
identified B-X
as B-X
homologues B-X
PDF B-X
| B-X
SIX5 B-X
( B-X
previously B-X
known B-X
as B-X
myotonic B-X
dystrophy B-X
associated B-X
homeodomain B-X
protein-DMAHP B-X
) B-X
is B-X
a B-X
member B-X
of B-X
the B-X
SIX B-X
[ B-X
sine B-X
oculis B-X
homeobox B-X
( B-X
Drosophila B-X
) B-X
... B-X
| B-X
Find B-X
, B-X

Analysis	O
of	O
DMAHP	O
expression	O
in	O
the	O
cells	O
of	O
DM	B-Disease
patients	O
with	O
loss	O
of	O
the	O
hypersensitive	O
site	O
revealed	O
a	O
two	O
-	O
to	O
fourfold	O
reduction	O
in	O
steady	O
-	O
state	O
DMAHP	O
transcript	O
levels	O
relative	O
to	O
wild	O
-	O
type	O
controls	O
.	O
<EOS> B-X
beta B-X
cell B-X
dysfunction B-X
is B-X
a B-X
central B-X
component B-X
of B-X
the B-X
pathogenesis B-X
of B-X
type B-X
2 B-X
diabetes B-X
. B-X
Using B-X
oligonucleotide B-X
microarrays B-X
and B-X
real-time B-X
PCR B-X
of B-X
pancreatic B-X
islets B-X
isolated B-X
from B-X
humans B-X
with B-X
type B-X
2 B-X
Transcriptional B-X
Regulation B-X
of B-X
INSR B-X
, B-X
the B-X
Insulin B-X
Receptor B-X
Gene B-X

Allele	O
-	O
specific	O
analysis	O
of	O
DMAHP	O
expression	O
showed	O
that	O
steady	O
-	O
state	O
transcript	O
levels	O
from	O
the	O
expanded	O
allele	O
were	O
greatly	O
reduced	O
in	O
comparison	O
to	O
those	O
from	O
the	O
wild	O
-	O
type	O
allele	O
.	O
<EOS> B-X
Visualizing B-X
allele-specific B-X
expression B-X
in B-X
single B-X
cells B-X
reveals B-X
epigenetic B-X
mosaicism B-X
in B-X
an B-X
H19 B-X
loss-of-imprinting B-X
mutant B-X
Request B-X
PDF B-X
| B-X
Increase B-X
of B-X
DMPK B-X
and B-X
decrease B-X
of B-X
DMAHP B-X
gene B-X
expression B-X
in B-X
muscle B-X
and B-X
blood B-X
of B-X
myotonic B-X
dystrophy B-X
patients B-X
compared B-X
to B-X
normal B-X
subjects B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
Abstract B-X
. B-X
The B-X
mutation B-X
underlying B-X
myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
was B-X
identified B-X
at B-X
the B-X
end B-X
of B-X
1991 B-X
amidst B-X
great B-X
rejoicing B-X
from B-X
the B-X
patients B-X
supporting B-X
the B-X
research B-X
and B-X
PDF B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
caused B-X
by B-X
the B-X
expansion B-X
of B-X
a B-X
trinucleotide B-X
repeat B-X
, B-X
CTG B-X
, B-X
in B-X
the B-X
3 B-X
' B-X
untranslated B-X
region B-X
of B-X
a B-X
protein B-X
kinase B-X
gene B-X
SIX5 B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Together	O
,	O
these	O
results	O
demonstrate	O
that	O
CTG	O
-	O
repeat	O
expansions	O
can	O
suppress	O
local	O
gene	O
expression	O
and	O
implicate	O
DMAHP	O
in	O
DM	B-Disease
pathogenesis	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Several B-X
examples B-X
have B-X
come B-X
to B-X
light B-X
in B-X
which B-X
mutations B-X
in B-X
non-protein-coding B-X
regions B-X
give B-X
rise B-X
to B-X
a B-X
deleterious B-X
gain-of-function B-X
by B-X
non-coding B-X
RNA B-X
. B-X
Ex B-X
Request B-X
PDF B-X
| B-X
On B-X
Apr B-X
1 B-X
, B-X
2001 B-X
, B-X
R.P B-X
. B-X
Junghans B-X
and B-X
others B-X
published B-X
Does B-X
( B-X
CUG B-X
) B-X
n B-X
repeat B-X
in B-X
DMPK B-X
mRNA B-X
‚Äò B-X
paint B-X
‚Äô B-X
chromosome B-X
19 B-X
to B-X
RNA B-X
toxicity B-X
in B-X
human B-X
disease B-X
and B-X
animal B-X
models B-X
: B-X
From B-X
the B-X
uncovering B-X
of B-X
a B-X
new B-X
mechanism B-X
to B-X
the B-X
development B-X
of B-X
promising B-X
therapies B-X
- B-X
ScienceDirect B-X
Request B-X
PDF B-X
| B-X
CTG B-X
Expansion B-X
in B-X
the B-X
DMPK B-X
Gene B-X
: B-X
Semen B-X
Quality B-X
Assessment B-X
and B-X
Outcome B-X
of B-X
Preimplantation B-X
Genetic B-X
Diagnosis B-X
| B-X
Context B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
Antisense B-X
Oligonucleotides B-X
: B-X
Rising B-X
Stars B-X
in B-X
Eliminating B-X
RNA B-X
Toxicity B-X
in B-X
Myotonic B-X
Dystrophy B-X
Request B-X
PDF B-X
| B-X
Heterozygous B-X
loss B-X
of B-X
Six5 B-X
in B-X
mice B-X
is B-X
sufficient B-X
to B-X
cause B-X
ocular B-X
cataracts B-X
| B-X
Myotonic B-X
dystrophy B-X
( B-X
DM B-X
) B-X
is B-X
an B-X
autosomal B-X
dominant B-X
disorder B-X
characterized B-X
by B-X
skeletal B-X
muscle B-X
WikiGenes B-X
- B-X
SIX5 B-X
- B-X
SIX B-X
homeobox B-X
5 B-X

Constitutively	O
methylated	O
CpG	O
dinucleotides	O
as	O
mutation	O
hot	O
spots	O
in	O
the	O
retinoblastoma	B-Disease
gene	O
(	O
RB1	O
)	O
.	O
<EOS> B-X
( B-X
PDF B-X
) B-X
Constitutively B-X
Methylated B-X
Cp B-X
G B-X
Dinucleotides B-X
as B-X
Mutation B-X
Hot B-X
Spots B-X
in B-X
the B-X
Retinoblastoma B-X
Gene B-X
( B-X
RB1 B-X
| B-X
Shiva B-X
Singh B-X
- B-X
Academia.edu B-X
Methylation B-X
levels B-X
at B-X
selected B-X
CpG B-X
sites B-X
in B-X
the B-X
factor B-X
VIII B-X
and B-X
FGFR3 B-X
genes B-X
, B-X
in B-X
mature B-X
female B-X
and B-X
male B-X
germ B-X
cells B-X
: B-X
implications B-X
for B-X
male-driven B-X
evolution B-X
. B-X
Clinical B-X
Implications B-X
of B-X
Promoter B-X
Hypermethylation B-X
in B-X
RASSF1A B-X
and B-X
MGMT B-X
in B-X
Retinoblastoma B-X
Cytosine B-X
Methylation B-X
Affects B-X
the B-X
Mutability B-X
of B-X
Neighboring B-X
Nucleotides B-X
in B-X
Germline B-X
and B-X
Soma B-X
| B-X
Genetics B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

A	O
wide	O
spectrum	O
of	O
mutations	O
,	O
ranging	O
from	O
point	O
mutations	O
to	O
large	O
deletions	O
,	O
have	O
been	O
described	O
in	O
the	O
retinoblastoma	B-Disease
gene	O
(	O
RB1	O
)	O
.	O
<EOS> B-X
Screening B-X
of B-X
RB1 B-X
gene B-X
mutations B-X
in B-X
Chinese B-X
patients B-X
with B-X
retinoblastoma B-X
and B-X
preliminary B-X
exploration B-X
of B-X
genotype‚Äìphenotype B-X
correlations B-X
RB1 B-X
gene B-X
inactivation B-X
by B-X
chromothripsis B-X
in B-X
human B-X
retinoblastoma B-X
PDF B-X
| B-X
Retinoblastoma B-X
( B-X
RB B-X
) B-X
is B-X
a B-X
malignant B-X
, B-X
childhood B-X
tumour B-X
of B-X
the B-X
developing B-X
retina B-X
that B-X
occurs B-X
with B-X
an B-X
estimated B-X
frequency B-X
of B-X
1 B-X
in B-X
20 B-X
000 B-X
.... B-X
| B-X
Find B-X

Mutations	O
have	O
been	O
found	O
throughout	O
the	O
gene	O
;	O
however	O
,	O
these	O
genetic	O
alterations	O
do	O
not	O
appear	O
to	O
be	O
homogeneously	O
distributed	O
.	O
<EOS> B-X
Author B-X
summary B-X
Mutations B-X
that B-X
alter B-X
the B-X
function B-X
of B-X
driver B-X
genes B-X
by B-X
changing B-X
DNA B-X
nucleotides B-X
have B-X
been B-X
recognized B-X
as B-X
key B-X
players B-X
in B-X
cancer B-X
progression B-X
. B-X
However B-X
, B-X
recent B-X
evidence B-X
has B-X
shown B-X
High B-X
Frequency B-X
and B-X
Heterogeneous B-X
Distribution B-X
of B-X
p53 B-X
Mutations B-X
in B-X
Aflatoxin B-X
B1-induced B-X
Mouse B-X
Lung B-X
Tumors B-X
| B-X
Cancer B-X
Research B-X
The B-X
occurrence B-X
of B-X
repetitive B-X
genomic B-X
changes B-X
that B-X
provide B-X
a B-X
selective B-X
growth B-X
advantage B-X
in B-X
pluripotent B-X
stem B-X
cells B-X
is B-X
of B-X
concern B-X
for B-X
their B-X
clinical B-X
application B-X
. B-X
However B-X
, B-X
the B-X
effect B-X
of B-X
different B-X
The B-X
population B-X
genetics B-X
of B-X
mutations B-X
: B-X
good B-X
, B-X
bad B-X
and B-X
indifferent B-X
Constitutively B-X
methylated B-X
CpG B-X
dinucleotides B-X
as B-X
mutation B-X
hot B-X
spots B-X
in B-X
the B-X
retinoblastoma B-X
gene B-X
( B-X
RB1 B-X
) B-X
. B-X
Copy B-X
number B-X
alterations B-X
( B-X
CNAs B-X
) B-X
comprise B-X
deletions B-X
or B-X
amplifications B-X
of B-X
fragments B-X
of B-X
genomic B-X
material B-X
that B-X
are B-X
particularly B-X
common B-X
in B-X
cancer B-X
and B-X
play B-X
a B-X
major B-X
contribution B-X
in B-X
its B-X
development B-X
and B-X
ScienceDirect.com B-X
| B-X
Science B-X
, B-X
health B-X
and B-X
medical B-X
journals B-X
, B-X
full B-X
text B-X
articles B-X
and B-X
books B-X
. B-X

In	O
particular	O
,	O
a	O
significant	O
proportion	O
of	O
disease	O
-	O
causing	O
mutations	O
results	O
in	O
the	O
premature	O
termination	O
of	O
protein	O
synthesis	O
,	O
and	O
the	O
majority	O
of	O
these	O
mutations	O
occur	O
as	O
C	O
-	O
-	O
>	O
T	O
transitions	O
at	O
CpG	O
dinucleotides	O
(	O
CpGs	O
)	O
.	O
<EOS> B-X
A B-X
large B-X
fraction B-X
of B-X
the B-X
p53 B-X
mutations B-X
in B-X
lung B-X
cancers B-X
from B-X
smokers B-X
are B-X
G-to-T B-X
transversions B-X
, B-X
a B-X
type B-X
of B-X
mutation B-X
that B-X
is B-X
infrequent B-X
in B-X
lung B-X
cancers B-X
from B-X
nonsmokers B-X
and B-X
in B-X
Oxidative B-X
DNA B-X
damage B-X
may B-X
play B-X
an B-X
important B-X
role B-X
in B-X
human B-X
disease B-X
including B-X
cancer B-X
. B-X
Previously B-X
, B-X
mutational B-X
spectra B-X
have B-X
been B-X
determined B-X
using B-X
systems B-X
that B-X
include B-X
transition B-X
metal B-X
ions B-X
and B-X
hydrogen B-X
A B-X
large B-X
number B-X
of B-X
diseases B-X
are B-X
caused B-X
by B-X
premature B-X
stop B-X
mutations B-X
that B-X
often B-X
lead B-X
to B-X
a B-X
complete B-X
loss B-X
of B-X
protein B-X
function B-X
and B-X
a B-X
severe B-X
reduction B-X
in B-X
mRNA B-X
levels B-X
due B-X
to B-X
Suppression B-X
of B-X
Nonsense B-X
Mutations B-X
in B-X
Cell B-X
Culture B-X
and B-X
Mice B-X
by B-X
Multimerized B-X
Suppressor B-X
tRNA B-X
Genes B-X
mRNA B-X
Translation B-X
Gone B-X
Awry B-X
: B-X
Translation B-X
Fidelity B-X
and B-X
Neurological B-X
Disease B-X
Translational B-X
readthrough B-X
potential B-X
of B-X
natural B-X
termination B-X
codons B-X
in B-X
eucaryotes B-X
‚Äì B-X
The B-X
impact B-X
of B-X
RNA B-X
sequence B-X

Such	O
recurrent	O
CpG	O
mutations	O
,	O
including	O
those	O
found	O
in	O
RB1	O
,	O
are	O
likely	O
the	O
result	O
of	O
the	O
deamination	O
of	O
5	O
-	O
methylcytosine	O
within	O
these	O
CpGs	O
.	O
<EOS> B-X
Abstract B-X
. B-X
Methylated B-X
cytosines B-X
( B-X
5mCs B-X
) B-X
are B-X
frequently B-X
mutated B-X
in B-X
the B-X
genome B-X
. B-X
However B-X
, B-X
no B-X
studies B-X
have B-X
yet B-X
comprehensively B-X
analysed B-X
mutation‚Äìmethylation B-X
associati B-X
The B-X
interaction B-X
between B-X
cytosine B-X
methylation B-X
and B-X
processes B-X
of B-X
DNA B-X
replication B-X
and B-X
repair B-X
shape B-X
the B-X
mutational B-X
landscape B-X
of B-X
cancer B-X
genomes B-X
Cytosine B-X
methylation B-X
is B-X
a B-X
common B-X
form B-X
of B-X
post-replicative B-X
DNA B-X
modification B-X
seen B-X
in B-X
both B-X
bacteria B-X
and B-X
eukaryotes B-X
. B-X
Modified B-X
cytosines B-X
have B-X
long B-X
been B-X
known B-X
to B-X
act B-X
as B-X
hotspots B-X
for B-X
mutations B-X
due B-X
PDF B-X
| B-X
CpG B-X
dinucleotides B-X
provide B-X
hotspots B-X
for B-X
transitional B-X
mutations B-X
in B-X
a B-X
variety B-X
of B-X
genes B-X
, B-X
some B-X
leading B-X
to B-X
genetic B-X
diseases B-X
in B-X
humans B-X
. B-X
Although B-X
this B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
Cytosine B-X
Methylation B-X
Affects B-X
the B-X
Mutability B-X
of B-X
Neighboring B-X
Nucleotides B-X
in B-X
Germline B-X
and B-X
Soma B-X
| B-X
Genetics B-X
Request B-X
PDF B-X
| B-X
Cytosine B-X
methylation B-X
and B-X
DNA B-X
repair B-X
| B-X
Cytosine B-X
methylation B-X
is B-X
a B-X
common B-X
form B-X
of B-X
post-replicative B-X
DNA B-X
modification B-X
seen B-X
in B-X
both B-X
bacteria B-X
and B-X
eukaryotes B-X
. B-X
Modified B-X
cytosines B-X
have B-X
long B-X
Genomic B-X
and B-X
Epigenomic B-X
Aberrations B-X
in B-X
Esophageal B-X
Squamous B-X
Cell B-X
Carcinoma B-X
and B-X
Implications B-X
for B-X
Patients B-X

In	O
the	O
present	O
study	O
,	O
we	O
used	O
the	O
sodiumbisulfite	O
conversion	O
method	O
to	O
detect	O
cytosine	O
methylation	O
in	O
representative	O
exons	O
of	O
RB1	O
.	O

We	O
analyzed	O
DNA	O
from	O
a	O
variety	O
of	O
tissues	O
and	O
specifically	O
targeted	O
CGA	O
codons	O
in	O
RB1	O
,	O
where	O
recurrent	O
premature	O
termination	O
mutations	O
have	O
been	O
reported	O
.	O
<EOS> B-X
Sensitive B-X
and B-X
Efficient B-X
Detection B-X
of B-X
RB1 B-X
Gene B-X
Mutations B-X
Enhances B-X
Care B-X
for B-X
Families B-X
with B-X
Retinoblastoma B-X
- B-X
ScienceDirect B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Details B-X
of B-X
typical B-X
2-D B-X
DNA B-X
electrophoresis B-X
patterns B-X
of B-X
the B-X
RB1 B-X
gene B-X
in B-X
DNA B-X
samples B-X
from B-X
retinoblastoma B-X
patients B-X
RB-5 B-X
, B-X
RB-23 B-X
, B-X
RB-17 B-X
, B-X
RB-31 B-X
, B-X
RB-7 B-X
Constitutively B-X
Methylated B-X
Cp B-X
G B-X
Dinucleotides B-X
as B-X
Mutation B-X
Hot B-X
Spots B-X
in B-X
the B-X
Retinoblastoma B-X
Gene B-X
( B-X
RB1 B-X
) B-X
: B-X
The B-X
American B-X
Journal B-X
of B-X
Human B-X
Genetics B-X
Constitutively B-X
Methylated B-X
Cp B-X
G B-X
Dinucleotides B-X
as B-X
Mutation B-X
Hot B-X
Spots B-X
in B-X
the B-X
Retinoblastoma B-X
Gene B-X
( B-X
RB1 B-X
) B-X
: B-X
The B-X
American B-X
Journal B-X
of B-X
Human B-X
Genetics B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Deletion B-X
of B-X
exon B-X
24 B-X
of B-X
the B-X
RB B-X
gene B-X
in B-X
a B-X
patient B-X
with B-X
family B-X
history B-X
( B-X
RB134 B-X
) B-X
. B-X
( B-X
A B-X
) B-X
Example B-X
of B-X
Southern B-X
blot B-X
analysis B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

We	O
found	O
that	O
DNA	O
methylation	O
within	O
RB1	O
exons	O
8	O
,	O
14	O
,	O
25	O
,	O
and	O
27	O
appeared	O
to	O
be	O
restricted	O
to	O
CpGs	O
,	O
including	O
six	O
CGA	O
codons	O
.	O
<EOS> B-X
We B-X
have B-X
shown B-X
previously B-X
that B-X
the B-X
most B-X
common B-X
point B-X
mutation B-X
in B-X
the B-X
RB1 B-X
gene B-X
in B-X
retinoblastoma B-X
tumours B-X
is B-X
a B-X
C B-X
-- B-X
> B-X
T B-X
transition B-X
and B-X
that B-X
the B-X
majority B-X
of B-X
these B-X
De B-X
novo B-X
mutational B-X
profile B-X
in B-X
RB1 B-X
clarified B-X
using B-X
a B-X
mutation B-X
rate B-X
modeling B-X
algorithm B-X
Studies B-X
of B-X
de B-X
novo B-X
mutations B-X
offer B-X
great B-X
promise B-X
to B-X
improve B-X
our B-X
understanding B-X
of B-X
human B-X
disease B-X
. B-X
After B-X
a B-X
causal B-X
gene B-X
has B-X
been B-X
identified B-X
, B-X
it B-X
is B-X
natural B-X
to B-X
hypothesize B-X
that B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Schematic B-X
depiction B-X
of B-X
the B-X
multiplex B-X
PCR/2-D B-X
DNA B-X
electrophoresis B-X
system B-X
. B-X
from B-X
publication B-X
: B-X
Mutational B-X
scanning B-X
of B-X
large B-X
genes B-X
by B-X
extensive B-X
PCR B-X
multiplexing B-X
and B-X
two-dimensional B-X
electrophoresis B-X
: B-X

Other	O
codons	O
containing	O
methylated	O
cytosines	O
have	O
not	O
been	O
reported	O
to	O
be	O
mutated	O
.	O

Therefore	O
,	O
disease	O
-	O
causing	O
mutations	O
at	O
CpGs	O
in	O
RB1	O
appear	O
to	O
be	O
determined	O
by	O
several	O
factors	O
,	O
including	O
the	O
constitutive	O
presence	O
of	O
DNA	O
methylation	O
at	O
cytosines	O
within	O
CpGs	O
,	O
the	O
specific	O
codon	O
within	O
which	O
the	O
methylated	O
cytosine	O
is	O
located	O
,	O
and	O
the	O
particular	O
region	O
of	O
the	O
gene	O
within	O
which	O
that	O
codon	O
resides	O
.	O
.	O
<EOS> B-X
Characterization B-X
of B-X
CpG B-X
island B-X
DNA B-X
methylation B-X
of B-X
impairment-related B-X
genes B-X
in B-X
a B-X
rat B-X
model B-X
of B-X
cognitive B-X
aging B-X
The B-X
Role B-X
of B-X
DNA B-X
Methylation B-X
in B-X
Aging B-X
, B-X
Rejuvenation B-X
, B-X
and B-X
Age-Related B-X
Disease B-X
Sensitivity B-X
of B-X
transcription B-X
factors B-X
to B-X
DNA B-X
methylation B-X
CpG B-X
island B-X
methylation B-X
status B-X
and B-X
mutation B-X
analysis B-X
of B-X
the B-X
RB1 B-X
gene B-X
essential B-X
promoter B-X
region B-X
and B-X
protein-binding B-X
pocket B-X
domain B-X
in B-X
nervous B-X
system B-X
tumours B-X
A B-X
wide B-X
spectrum B-X
of B-X
mutations B-X
, B-X
ranging B-X
from B-X
point B-X
mutations B-X
to B-X
large B-X
deletions B-X
, B-X
have B-X
been B-X
described B-X
in B-X
the B-X
retinoblastoma B-X
gene B-X
( B-X
RB1 B-X
) B-X
. B-X
Mutations B-X
have B-X
been B-X
found B-X
throughout B-X
Abstract B-X
. B-X
First B-X
triplets B-X
of B-X
mRNA B-X
coding B-X
region B-X
affect B-X
the B-X
yield B-X
of B-X
translation B-X
. B-X
We B-X
have B-X
applied B-X
the B-X
flowseq B-X
method B-X
to B-X
analyze B-X
> B-X
30 B-X
000 B-X
variants B-X
of B-X
the B-X
codons B-X
ENCODE B-X
analysis B-X
identifies B-X
dynamic B-X
DNA B-X
methylation B-X
patterns B-X
and B-X
relationships B-X
to B-X
regulatory B-X
elements B-X

The	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
tumor	I-Disease
suppressor	O
gene	O
product	O
interacts	O
with	O
Sp1	O
to	O
repress	O
vascular	O
endothelial	O
growth	O
factor	O
promoter	O
activity	O
.	O
<EOS> B-X
Alterations B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
, B-X
which B-X
is B-X
supposed B-X
to B-X
act B-X
as B-X
a B-X
tumor B-X
suppressor B-X
gene B-X
, B-X
can B-X
cause B-X
hereditary B-X
tumors B-X
associated B-X
with B-X
the B-X
VHL B-X
s B-X
Loss B-X
of B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
function B-X
occurs B-X
in B-X
familial B-X
and B-X
most B-X
sporadic B-X
clear B-X
cell B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
RCC B-X
) B-X
, B-X
resulting B-X
in B-X
the B-X
aberrant B-X
VHL B-X
is B-X
the B-X
causative B-X
gene B-X
for B-X
von B-X
Hippel-Lindau B-X
disease B-X
and B-X
sporadic B-X
clear B-X
cell B-X
renal B-X
cancer B-X
. B-X
It B-X
has B-X
been B-X
shown B-X
that B-X
pVHL B-X
can B-X
suppress B-X
the B-X
expression B-X
of B-X
certain B-X
genes B-X
that B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
VHL B-X
) B-X
has B-X
a B-X
critical B-X
role B-X
in B-X
the B-X
pathogenesis B-X
of B-X
clear-cell B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
RCC B-X
) B-X
, B-X
as B-X
VHL B-X
mutations B-X
have B-X
been B-X
Deregulation B-X
of B-X
hypoxia-inducible B-X
factor B-X
( B-X
HIF B-X
) B-X
is B-X
an B-X
established B-X
feature B-X
of B-X
tumours B-X
that B-X
develop B-X
in B-X
patients B-X
with B-X
von B-X
Hippel‚ÄìLindau B-X
disease B-X
, B-X
caused B-X
by B-X
inactivating B-X
germline B-X
mutations B-X
of B-X
theVHLtumour B-X
suppressor B-X
Our B-X
understanding B-X
of B-X
the B-X
scientific B-X
basis B-X
for B-X
urothelial B-X
malignancy B-X
has B-X
advanced B-X
significantly B-X
. B-X
Studies B-X
in B-X
prostate B-X
cancer B-X
, B-X
few B-X
and B-X
far B-X
between B-X
20 B-X
years B-X
ago B-X
, B-X
have B-X
increased B-X
and B-X
the B-X
Nucleic B-X
acids B-X
are B-X
the B-X
fundamental B-X
building B-X
blocks B-X
of B-X
DNA B-X
and B-X
RNA B-X
and B-X
are B-X
found B-X
in B-X
virtually B-X
every B-X
living B-X
cell B-X
. B-X
Molecular B-X
biology B-X
is B-X
a B-X
branch B-X
of B-X
science B-X
that B-X
studies B-X
the B-X

The	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
tumor	I-Disease
suppressor	O
gene	O
(	O
VHL	O
)	O
has	O
a	O
critical	O
role	O
in	O
the	O
pathogenesis	O
of	O
clear	B-Disease
-	I-Disease
cell	I-Disease
renal	I-Disease
cell	I-Disease
carcinoma	I-Disease
(	O
RCC	B-Disease
)	O
,	O
as	O
VHL	O
mutations	O
have	O
been	O
found	O
in	O
both	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
disease	I-Disease
-	I-Disease
associated	I-Disease
and	I-Disease
sporadic	I-Disease
RCCs	I-Disease
.	O
<EOS> B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
VHL B-X
) B-X
, B-X
which B-X
resides B-X
on B-X
chromosome B-X
3p25 B-X
, B-X
is B-X
mutated B-X
or B-X
silenced B-X
in B-X
> B-X
50 B-X
% B-X
of B-X
sporadic B-X
clear B-X
cell B-X
renal B-X
cell B-X
Abstract B-X
. B-X
Background B-X
: B-X
Somatic B-X
alteration B-X
of B-X
the B-X
von B-X
Hippel‚ÄìLindau B-X
disease B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
VHL B-X
) B-X
is B-X
one B-X
of B-X
the B-X
most B-X
common B-X
genetic B-X
changes B-X
observed B-X
in B-X
the B-X
Loss B-X
of B-X
heterozygosity B-X
( B-X
LOH B-X
) B-X
studies B-X
have B-X
suggested B-X
that B-X
somatic B-X
mutations B-X
of B-X
a B-X
tumour B-X
suppressor B-X
gene B-X
or B-X
genes B-X
on B-X
chromosome B-X
3p B-X
are B-X
a B-X
critical B-X
event B-X
in B-X
the B-X
pathogenesis B-X
of B-X
Inactivation B-X
of B-X
tumour B-X
suppressor B-X
gene B-X
( B-X
s B-X
) B-X
( B-X
TSGs B-X
) B-X
on B-X
3p B-X
appears B-X
to B-X
be B-X
a B-X
critical B-X
event B-X
in B-X
the B-X
pathogenesis B-X
of B-X
clear B-X
cell B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
CC-RCC B-X
Germ B-X
line B-X
VHL B-X
tumor B-X
suppressor B-X
gene B-X
loss-of-function B-X
mutations B-X
cause B-X
von B-X
Hippel-Lindau B-X
disease B-X
, B-X
which B-X
is B-X
associated B-X
with B-X
an B-X
increased B-X
risk B-X
of B-X
central B-X
nervous B-X
system B-X
hemangioblastomas B-X
, B-X
clear B-X
cell B-X
renal B-X
carcinomas B-X
The B-X
von B-X
Hippel‚ÄìLindau B-X
tumor B-X
suppressor B-X
gene B-X
product B-X
, B-X
pVHL B-X
, B-X
functions B-X
as B-X
the B-X
substrate B-X
recognition B-X
component B-X
of B-X
an B-X
E3-ubiquitin B-X
ligase B-X
, B-X
which B-X
targets B-X
the B-X
oxygen-sensitive B-X
Œ±-subunit B-X
of B-X
hypoxia-inducible B-X
factor B-X
( B-X
VHL B-X
( B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
) B-X

Recent	O
studies	O
suggest	O
that	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
mRNA	O
is	O
upregulated	O
in	O
RCC	B-Disease
-	I-Disease
and	I-Disease
von	I-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
disease	I-Disease
-	I-Disease
associated	I-Disease
tumors	I-Disease
.	O
<EOS> B-X
Up-Regulation B-X
of B-X
Vascular B-X
Endothelial B-X
Growth B-X
Factor B-X
and B-X
Its B-X
Receptors B-X
in B-X
von B-X
Hippel-Lindau B-X
Disease-associated B-X
and B-X
Sporadic B-X
Hemangioblastomas B-X
| B-X
Cancer B-X
Research B-X
Our B-X
findings B-X
indicate B-X
that B-X
VHL B-X
gene B-X
alterations B-X
and B-X
HIF-1 B-X
alpha B-X
protein B-X
expression B-X
correlate B-X
with B-X
a B-X
significant B-X
increase B-X
in B-X
VEGF B-X
production B-X
by B-X
RCC B-X
. B-X
In B-X
turn B-X
it B-X
is B-X
associated B-X
with B-X
a B-X
Vascular B-X
endothelial B-X
growth B-X
factor B-X
overexpression B-X
is B-X
correlated B-X
with B-X
von B-X
Hippel‚ÄêLindau B-X
tumor B-X
suppressor B-X
gene B-X
inactivation B-X
in B-X
patients B-X
with B-X
sporadic B-X
renal B-X
cell B-X
carcinoma B-X
- B-X
Igarashi B-X
- B-X
2002 B-X
- B-X
Cancer B-X
- B-X
Wiley B-X
Online B-X
ObjectivesRetinal B-X
angioma B-X
frequently B-X
occurs B-X
in B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
. B-X
However B-X
, B-X
VHL B-X
gene B-X
alterations B-X
have B-X
not B-X
been B-X
documented B-X
in B-X
retinal B-X
angiomas.Metho B-X
Vascular B-X
tumors B-X
in B-X
livers B-X
with B-X
targeted B-X
inactivation B-X
of B-X
the B-X
von B-X
Hippel‚ÄìLindau B-X
tumor B-X
suppressor B-X
Vascular B-X
Endothelial B-X
Growth B-X
Factor-B B-X
and B-X
Vascular B-X
Endothelial B-X
Growth B-X
Factor-C B-X
Expression B-X
in B-X
Renal B-X
Cell B-X
Carcinomas B-X
| B-X
Cancer B-X
Research B-X
The B-X
von B-X
Hippel-Lindau B-X
Gene B-X
, B-X
Kidney B-X
Cancer B-X
, B-X
and B-X
Oxygen B-X
Sensing B-X
| B-X
American B-X
Society B-X
of B-X
Nephrology B-X

We	O
have	O
therefore	O
assessed	O
the	O
effect	O
of	O
the	O
VHL	O
gene	O
product	O
on	O
VEGF	O
expression	O
.	O
<EOS> B-X
Abstract B-X
. B-X
The B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumour B-X
suppressor B-X
gene B-X
product B-X
is B-X
believed B-X
to B-X
be B-X
involved B-X
in B-X
the B-X
down-regulation B-X
of B-X
transcriptional B-X
elongation B-X
by B-X
preventi B-X
Loss B-X
of B-X
pVHL B-X
is B-X
sufficient B-X
to B-X
cause B-X
HIF B-X
dysregulation B-X
in B-X
primary B-X
cells B-X
but B-X
does B-X
not B-X
promote B-X
tumor B-X
growth B-X
The B-X
VHL B-X
tumor B-X
suppressor B-X
gene B-X
is B-X
inactivated B-X
in B-X
patients B-X
with B-X
von B-X
Hippel B-X
-- B-X
Lindau B-X
disease B-X
and B-X
in B-X
most B-X
sporadic B-X
clear B-X
cell B-X
renal B-X
carcinomas B-X
. B-X
Although B-X
VHL B-X
protein B-X
... B-X
von B-X
Hippel-Lindau B-X
Protein-Mediated B-X
Repression B-X
of B-X
Tumor B-X
Necrosis B-X
Factor B-X
Alpha B-X
Translation B-X
Revealed B-X
through B-X
Use B-X
of B-X
cDNA B-X
Arrays B-X
Request B-X
PDF B-X
| B-X
Expression B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Gene B-X
in B-X
Nonneoplastic B-X
and B-X
Neoplastic B-X
Lesions B-X
of B-X
the B-X
Thyroid B-X
| B-X
Alterations B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
, B-X
Inhibition B-X
of B-X
Ocular B-X
Angiogenesis B-X
by B-X
an B-X
Adenovirus B-X
Carrying B-X
the B-X
Human B-X
von B-X
Hippel-Lindau B-X
Tumor-Suppressor B-X
Gene B-X
In B-X
Vivo B-X
| B-X
IOVS B-X
| B-X
ARVO B-X
Journals B-X
OVEREXPRESSION B-X
OF B-X
VASCULAR B-X
ENDOTHELIAL B-X
GROWTH B-X
FACTOR B-X
AND B-X
THE B-X
DEVELOPMENT B-X
OF B-X
POST-TRANSPLANTATION B-X
CANCER B-X

VEGF	O
promoter	O
-	O
luciferase	O
constructs	O
were	O
transiently	O
cotransfected	O
with	O
a	O
wild	O
-	O
type	O
VHL	O
(	O
wt	O
-	O
VHL	O
)	O
vector	O
in	O
several	O
cell	O
lines	O
,	O
including	O
293	O
embryonic	O
kidney	O
and	O
RCC	B-Disease
cell	O
lines	O
.	O
<EOS> B-X
Effects B-X
of B-X
PAX2 B-X
expression B-X
in B-X
a B-X
human B-X
fetal B-X
kidney B-X
( B-X
HEK293 B-X
) B-X
cell B-X
line B-X
- B-X
ScienceDirect B-X
Three B-X
putative B-X
FABP7 B-X
promoter B-X
regions B-X
drive B-X
reporter B-X
gene B-X
expression B-X
in B-X
RCC B-X
cell B-X
lines B-X
, B-X
but B-X
not B-X
in B-X
the B-X
HEK293 B-X
cell B-X
line B-X
. B-X
BRN2 B-X
and B-X
NFI B-X
may B-X
be B-X
key B-X
factors B-X
regulating B-X
We B-X
conclude B-X
that B-X
the B-X
HEK-293 B-X
cell B-X
line B-X
is B-X
as B-X
sensitive B-X
as B-X
the B-X
Neuro-2a B-X
cell B-X
line B-X
for B-X
the B-X
rapid B-X
isolation B-X
of B-X
rabies B-X
virus B-X
and B-X
may B-X
serve B-X
as B-X
an B-X
alternative B-X
cell B-X
line B-X
The B-X
overall B-X
incidence B-X
and B-X
mortality B-X
of B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
RCC B-X
) B-X
, B-X
the B-X
most B-X
common B-X
kidney B-X
cancer B-X
, B-X
are B-X
steadily B-X
increasing B-X
for B-X
reasons B-X
that B-X
are B-X
not B-X
fully B-X
explained B-X
. B-X
Choosing B-X
the B-X
right B-X
cell B-X
line B-X
for B-X
renal B-X
cell B-X
cancer B-X
research B-X
PAX2 B-X
inactivation B-X
enhances B-X
cisplatin-induced B-X
apoptosis B-X
in B-X
renal B-X
carcinoma B-X
cells B-X
- B-X
ScienceDirect B-X
Culture B-X
in B-X
embryonic B-X
kidney B-X
serum B-X
and B-X
xeno-free B-X
media B-X
as B-X
renal B-X
cell B-X
carcinoma B-X
and B-X
renal B-X
cell B-X
carcinoma B-X
cancer B-X
stem B-X
cells B-X
research B-X
model B-X

wt	O
-	O
VHL	O
protein	O
inhibited	O
VEGF	O
promoter	O
activity	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
up	O
to	O
5	O
-	O
to	O
10	O
-	O
fold	O
.	O
<EOS> B-X
Role B-X
of B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
in B-X
the B-X
regulation B-X
of B-X
angiogenesis B-X
- B-X
ScienceDirect B-X
Overexpression B-X
of B-X
Vascular B-X
Endothelial B-X
Growth B-X
Factor B-X
and B-X
the B-X
Development B-X
of B-X
Post-Transplantation B-X
Cancer B-X
| B-X
Cancer B-X
Research B-X
PDF B-X
| B-X
Here B-X
, B-X
we B-X
report B-X
that B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
( B-X
VEGF B-X
) B-X
-A B-X
secretion B-X
by B-X
human B-X
airway B-X
smooth B-X
muscle B-X
cells B-X
was B-X
increased B-X
by B-X
interleukin B-X
1 B-X
beta B-X
... B-X
| B-X
Clear B-X
cell B-X
renal B-X
cell B-X
cancer B-X
( B-X
CC-RCC B-X
) B-X
is B-X
a B-X
highly B-X
chemoresistant B-X
tumor B-X
characterized B-X
by B-X
frequent B-X
inactivation B-X
of B-X
the B-X
von B-X
Hippel‚ÄìLindau B-X
( B-X
VHL B-X
) B-X
gene B-X
. B-X
The B-X
prognosis B-X
is B-X
reportedly B-X

Deletion	O
analysis	O
defined	O
a	O
144	O
-	O
bp	O
region	O
of	O
the	O
VEGF	O
promoter	O
necessary	O
for	O
VHL	O
repression	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Transcriptional B-X
regulation B-X
of B-X
the B-X
Vascular B-X
Endothelial B-X
Growth B-X
Factor B-X
gene B-X
- B-X
A B-X
concert B-X
of B-X
activating B-X
factors B-X
| B-X
The B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
A B-X
( B-X
VEGF-A B-X
) B-X
is B-X
essential B-X
Download B-X
Citation B-X
| B-X
Downregulation B-X
of B-X
CAP4 B-X
gene B-X
by B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
protein B-X
in B-X
human B-X
renal B-X
cancer B-X
cells B-X
| B-X
We B-X
previously B-X
identified B-X
9 B-X
genes B-X
( B-X
i.e. B-X
, B-X
thymosin B-X
beta4 B-X
, B-X
Home B-X
Page B-X
: B-X
Kidney B-X
International B-X
Entrez B-X
Gene B-X

This	O
VHL	O
-	O
responsive	O
element	O
is	O
GC	O
rich	O
and	O
specifically	O
binds	O
the	O
transcription	O
factor	O
Sp1	O
in	O
crude	O
nuclear	O
extracts	O
.	O
<EOS> B-X
WikiGenes B-X
- B-X
SP1 B-X
- B-X
Sp1 B-X
transcription B-X
factor B-X
Request B-X
PDF B-X
| B-X
Transcription B-X
Factor B-X
Sp1 B-X
Expression B-X
Is B-X
a B-X
Significant B-X
Predictor B-X
of B-X
Survival B-X
in B-X
Human B-X
Gastric B-X
Cancer B-X
| B-X
The B-X
transcription B-X
factor B-X
Sp1 B-X
regulates B-X
the B-X
expression B-X
of B-X
multiple B-X
genes B-X
. B-X
However B-X
Request B-X
PDF B-X
| B-X
Involvement B-X
of B-X
transcription B-X
factor B-X
Sp1 B-X
in B-X
quercetin-mediated B-X
inhibitory B-X
effect B-X
on B-X
the B-X
androgen B-X
receptor B-X
in B-X
human B-X
prostate B-X
cancer B-X
cells B-X
| B-X
The B-X
transactivation B-X
function B-X
of B-X
the B-X
human B-X
androgen B-X
receptor B-X
LEDGF/p75 B-X
interacts B-X
with B-X
DNA/protein B-X
to B-X
regulate B-X
gene B-X
expression B-X
and B-X
function B-X
. B-X
Despite B-X
the B-X
recognized B-X
diversity B-X
of B-X
function B-X
of B-X
LEDGF/p75 B-X
, B-X
knowledge B-X
of B-X
its B-X
transregulation B-X
is B-X
in B-X
its B-X
infancy B-X
. B-X
Here B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

In	O
Drosophila	O
cells	O
,	O
cotransfected	O
VHL	O
represses	O
Sp1	O
-	O
mediated	O
activation	O
but	O
not	O
basal	O
activity	O
of	O
the	O
VEGF	O
promoter	O
.	O
<EOS> B-X
The B-X
Promyelocytic B-X
Leukemia B-X
Protein B-X
Interacts B-X
with B-X
Sp1 B-X
and B-X
Inhibits B-X
Its B-X
Transactivation B-X
of B-X
the B-X
Epidermal B-X
Growth B-X
Factor B-X
Receptor B-X
Promoter B-X
Download B-X
scientific B-X
diagram B-X
| B-X
Transfection B-X
experiments B-X
in B-X
Drosophila B-X
S2 B-X
cells B-X
. B-X
( B-X
a B-X
) B-X
The B-X
VHL-responsive B-X
cis B-X
element B-X
, B-X
which B-X
binds B-X
Sp1 B-X
, B-X
is B-X
also B-X
potently B-X
transactivated B-X
by B-X
Sp1 B-X
. B-X
Request B-X
PDF B-X
| B-X
Von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
protein B-X
represses B-X
platelet-derived B-X
growth B-X
factor B-X
B-chain B-X
gene B-X
expression B-X
via B-X
the B-X
Sp1 B-X
binding B-X
element B-X
in B-X
the B-X
proximal B-X
PDGF-B B-X
promoter B-X
| B-X
VHL B-X
is B-X
the B-X
causative B-X
Increased B-X
Sp1 B-X
phosphorylation B-X
as B-X
a B-X
mechanism B-X
of B-X
hepatocyte B-X
growth B-X
factor B-X
( B-X
HGF/SF B-X
) B-X
-induced B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
( B-X
VEGF/VPF B-X
) B-X
transcription B-X
| B-X
Journal B-X
of B-X
Cell B-X
Science B-X
Request B-X
PDF B-X
| B-X
Association B-X
between B-X
Expression B-X
of B-X
Transcription B-X
Factor B-X
Sp1 B-X
and B-X
Increased B-X
Vascular B-X
Endothelial B-X
Growth B-X
Factor B-X
Expression B-X
, B-X
Advanced B-X
Stage B-X
, B-X
and B-X
Poor B-X
Survival B-X
in B-X
Patients B-X
with B-X
Resected B-X
Gastric B-X
Cancer B-X
PDF B-X
| B-X
The B-X
promyelocytic B-X
leukemia B-X
protein B-X
( B-X
PML B-X
) B-X
is B-X
a B-X
nuclear B-X
phosphoprotein B-X
with B-X
growth- B-X
and B-X
transformation-suppressing B-X
ability B-X
. B-X
Having B-X
previously B-X
shown B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

We	O
next	O
demonstrated	O
in	O
coimmunoprecipitates	O
that	O
VHL	O
and	O
Sp1	O
were	O
part	O
of	O
the	O
same	O
complex	O
and	O
,	O
by	O
using	O
a	O
glutathione	O
-	O
S	O
-	O
transferase	O
-	O
VHL	O
fusion	O
protein	O
and	O
purified	O
Sp1	O
,	O
that	O
VHL	O
and	O
Sp1	O
directly	O
interact	O
.	O
<EOS> B-X
We B-X
established B-X
a B-X
purification B-X
system B-X
for B-X
glutathione-S-transferase B-X
( B-X
GST B-X
) B-X
fusion B-X
protein B-X
using B-X
glutathione B-X
coupled B-X
magnetic B-X
particle B-X
. B-X
Glutathione B-X
was B-X
coupled B-X
covalently B-X
to B-X
the B-X
surface B-X
of B-X
magnetic B-X
particles B-X
with B-X
isothiocyanate B-X
This B-X
chapter B-X
describes B-X
the B-X
use B-X
of B-X
glutathione B-X
S-transferase B-X
( B-X
GST B-X
) B-X
gene B-X
fusion B-X
proteins B-X
as B-X
a B-X
method B-X
for B-X
inducible B-X
, B-X
high-level B-X
protein B-X
expression B-X
and B-X
purification B-X
from B-X
bacterial B-X
cell B-X
lysates B-X
. B-X
HitPredict B-X
- B-X
High B-X
confidence B-X
protein-protein B-X
interactions B-X
Activation B-X
of B-X
Sp1-mediated B-X
Vascular B-X
Permeability B-X
Factor/Vascular B-X
Endothelial B-X
Growth B-X
Factor B-X
Transcription B-X
Requires B-X
Specific B-X
Interaction B-X
with B-X
Protein B-X
Kinase B-X
C B-X
Œ∂ B-X
- B-X
ScienceDirect B-X
The B-X
Promyelocytic B-X
Leukemia B-X
Protein B-X
Interacts B-X
with B-X
Sp1 B-X
and B-X
Inhibits B-X
Its B-X
Transactivation B-X
of B-X
the B-X
Epidermal B-X
Growth B-X
Factor B-X
Receptor B-X
Promoter B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
An B-X
Important B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Domain B-X
Mediates B-X
Sp1-Binding B-X
and B-X
Self-Association B-X
- B-X
ScienceDirect B-X
BioKDE B-X

Furthermore	O
,	O
endogenous	O
VEGF	O
mRNA	O
levels	O
were	O
suppressed	O
in	O
permanent	O
RCC	B-Disease
cell	O
lines	O
expressing	O
wt	O
-	O
VHL	O
,	O
and	O
nuclear	O
run	O
-	O
on	O
studies	O
indicated	O
that	O
VHL	O
regulation	O
of	O
VEGF	O
occurs	O
at	O
least	O
partly	O
at	O
the	O
transcriptional	O
level	O
.	O
<EOS> B-X
Estrogen B-X
receptor B-X
Œ± B-X
is B-X
a B-X
novel B-X
target B-X
of B-X
the B-X
Von B-X
Hippel-Lindau B-X
protein B-X
and B-X
is B-X
responsible B-X
for B-X
the B-X
proliferation B-X
of B-X
VHL-deficient B-X
cells B-X
under B-X
hypoxic B-X
conditions B-X
VEGF B-X
exerts B-X
an B-X
angiogenesis-independent B-X
function B-X
in B-X
cancer B-X
cells B-X
to B-X
promote B-X
their B-X
malignant B-X
progression B-X
Differential B-X
Regulation B-X
of B-X
the B-X
Transcriptional B-X
Activities B-X
of B-X
Hypoxia-Inducible B-X
Factor B-X
1 B-X
Alpha B-X
( B-X
HIF-1Œ± B-X
) B-X
and B-X
HIF-2Œ± B-X
in B-X
Stem B-X
Cells B-X
Download B-X
Citation B-X
| B-X
Endogenous B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
protein B-X
regulates B-X
catecholaminergic B-X
phenotype B-X
in B-X
PC12 B-X
cells B-X
| B-X
Loss B-X
of B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
gene B-X
function B-X
leads B-X
to B-X
VHL B-X
disease B-X
, B-X
Transcription-Dependent B-X
Nuclear-Cytoplasmic B-X
Trafficking B-X
Is B-X
Required B-X
for B-X
the B-X
Function B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Protein B-X
Endothelial B-X
Function B-X
of B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Gene B-X
: B-X
Control B-X
of B-X
Fibroblast B-X
Growth B-X
Factor B-X
Receptor B-X
Signaling B-X
Download B-X
Citation B-X
| B-X
Regulation B-X
of B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
transcription B-X
by B-X
endothelial B-X
PAS B-X
domain B-X
protein B-X
1 B-X
( B-X
EPAS1 B-X
) B-X
and B-X
possible B-X
involvement B-X
of B-X
EPAS1 B-X
in B-X
the B-X
angiogenesis B-X
of B-X
renal B-X
cell B-X

These	O
observations	O
support	O
a	O
new	O
mechanism	O
for	O
VHL	O
-	O
mediated	O
transcriptional	O
repression	O
via	O
a	O
direct	O
inhibitory	O
action	O
on	O
Sp1	O
and	O
suggest	O
that	O
loss	O
of	O
Sp1	O
inhibition	O
may	O
be	O
important	O
in	O
the	O
pathogenesis	O
of	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
disease	I-Disease
and	O
RCC	B-Disease
.	O
.	O
<EOS> B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
product B-X
interacts B-X
with B-X
Sp1 B-X
to B-X
repress B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
promoter B-X
activity B-X
. B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
VHL B-X
) B-X
has B-X
a B-X
critical B-X
role B-X
in B-X
the B-X
pathogenesis B-X
of B-X
clear-cell B-X
renal B-X
cell B-X
carcinoma B-X
( B-X
RCC B-X
) B-X
, B-X
as B-X
VHL B-X
mutations B-X
have B-X
been B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
product B-X
interacts B-X
with B-X
Sp1 B-X
to B-X
repress B-X
vascular B-X
endothelial B-X
growth B-X
factor B-X
promoter B-X
activity B-X
. B-X
| B-X
Molecular B-X
and B-X
Cellular B-X
Biology B-X
Mechanism B-X
of B-X
von B-X
Hippel-Lindau B-X
Protein-Mediated B-X
Suppression B-X
of B-X
Nuclear B-X
Factor B-X
kappa B-X
B B-X
Activity B-X
Request B-X
PDF B-X
| B-X
An B-X
Important B-X
von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Domain B-X
Mediates B-X
Sp1-Binding B-X
and B-X
Self-Association B-X
| B-X
VHL B-X
is B-X
the B-X
causative B-X
gene B-X
for B-X
both B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
disease B-X
and B-X
sporadic B-X
PDF B-X
| B-X
Mutation B-X
or B-X
loss B-X
of B-X
function B-X
of B-X
the B-X
von B-X
Hippel-Lindau B-X
( B-X
VHL B-X
) B-X
tumor B-X
suppressor B-X
gene B-X
is B-X
regularly B-X
found B-X
in B-X
sporadic B-X
renal B-X
cell B-X
carcinomas B-X
( B-X
RCC B-X
) B-X
, B-X
well B-X
Download B-X
Citation B-X
| B-X
The B-X
Von B-X
Hippel-Lindau B-X
Tumor B-X
Suppressor B-X
Gene B-X
and B-X
Kidney B-X
Cancer B-X
| B-X
The B-X
von B-X
Hippel-Lindau B-X
tumor B-X
suppressor B-X
gene B-X
( B-X
VHL B-X
) B-X
, B-X
which B-X
resides B-X
on B-X
chromosome B-X
3p25 B-X
, B-X
is B-X

Adult	B-Disease
onset	I-Disease
globoid	I-Disease
cell	I-Disease
leukodystrophy	I-Disease
(	O
Krabbe	B-Disease
disease	I-Disease
)	O
:	O
analysis	O
of	O
galactosylceramidase	O
cDNA	O
from	O
four	O
Japanese	O
patients	O
.	O
<EOS> B-X
Table B-X
1 B-X
Oligonucleotide B-X
primers B-X
used B-X
to B-X
amplify B-X
the B-X
GALC B-X
cDNA B-X
and B-X
genomic B-X
DNA B-X
( B-X
R B-X
antisense B-X
primer B-X
, B-X
underlining B-X
artificial B-X
restriction B-X
enzyme B-X
recognition B-X
site B-X
for B-X
subcloning B-X
, B-X
small B-X
letter B-X
in B-X
Adult-onset B-X
Krabbe B-X
disease B-X
in B-X
two B-X
generations B-X
of B-X
a B-X
Chinese B-X
family B-X
Clinical B-X
and B-X
molecular B-X
report B-X
of B-X
novel B-X
GALC B-X
mutations B-X
in B-X
Moroccan B-X
patient B-X
with B-X
Krabbe B-X
disease B-X
: B-X
case B-X
report B-X
Abstract B-X
We B-X
examined B-X
galactosylceramidase B-X
( B-X
GALC B-X
) B-X
cDNA B-X
in B-X
four B-X
Japanese B-X
patients B-X
with B-X
adult B-X
onset B-X
globoid B-X
cell B-X
leukodystrophy B-X
( B-X
Krabbe B-X
disease B-X
; B-X
AO-GLD B-X
) B-X
by B-X
polymerase B-X
chain B-X
reaction/single-strand B-X
conformation B-X
polymorphism B-X
Krabbe B-X
disease B-X
( B-X
globoid B-X
cell B-X
leukodystrophy B-X
) B-X
is B-X
an B-X
autosomal B-X
recessive B-X
neurodegenerative B-X
disorder B-X
that B-X
affects B-X
both B-X
the B-X
central B-X
and B-X
peripheral B-X
nervous B-X
syst B-X
Altered B-X
Trafficking B-X
and B-X
Processing B-X
of B-X
GALC B-X
Mutants B-X
Correlates B-X
with B-X
Globoid B-X
Cell B-X
Leukodystrophy B-X
Severity B-X
| B-X
Journal B-X
of B-X
Neuroscience B-X
Europe B-X
PMC B-X
is B-X
an B-X
archive B-X
of B-X
life B-X
sciences B-X
journal B-X
literature B-X
. B-X

We	O
examined	O
galactosylceramidase	O
(	O
GALC	O
)	O
cDNA	O
in	O
four	O
Japanese	O
patients	O
with	O
adult	B-Disease
onset	I-Disease
globoid	I-Disease
cell	I-Disease
leukodystrophy	I-Disease
(	O
Krabbe	B-Disease
disease	I-Disease
;	O
AO	B-Disease
-	I-Disease
GLD	I-Disease
)	O
by	O
polymerase	O
chain	O
reaction	O
/	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
(	O
PCR	O
-	O
SSCP	O
)	O
analysis	O
,	O
subsequent	O
sequence	O
determination	O
,	O
and	O
restriction	O
enzyme	O
digestion	O
of	O
PCR	O
products	O
,	O
initial	O
symptoms	O
were	O
the	O
onset	O
of	O
slowly	O
progressive	O
spastic	B-Disease
paraplegia	I-Disease
from	O
the	O
middle	O
of	O
the	O
second	O
decade	O
,	O
and	O
all	O
patients	O
had	O
diminished	B-Disease
GALC	I-Disease
activity	I-Disease
in	O
their	O
leukocytes	O
.	O
<EOS> B-X
BackgroundKrabbe B-X
disease B-X
, B-X
or B-X
globoid B-X
cell B-X
leukodystrophy B-X
, B-X
is B-X
an B-X
autosomal B-X
recessive B-X
disorder B-X
caused B-X
by B-X
the B-X
deficiency B-X
of B-X
galactocerebrosidase B-X
( B-X
GALC B-X
) B-X
activity B-X
. B-X
A B-X
Krabbe B-X
disease B-X
( B-X
also B-X
known B-X
as B-X
globoid B-X
cell B-X
leukodystrophy B-X
) B-X
cause B-X
by B-X
a B-X
deficiency B-X
of B-X
the B-X
enzyme B-X
Œ≤-galactocerebrosidase B-X
( B-X
galactosylceramidase B-X
, B-X
GALC B-X
) B-X
. B-X
The B-X
deficiency B-X
of B-X
GALC B-X
leads B-X
to B-X
PDF B-X
| B-X
Krabbe B-X
disease B-X
( B-X
KD B-X
) B-X
( B-X
globoid B-X
cell B-X
leukodystrophy B-X
) B-X
is B-X
a B-X
degenerative B-X
, B-X
lysosomal B-X
storage B-X
disease B-X
, B-X
caused B-X
by B-X
a B-X
severe B-X
loss B-X
of B-X
galactocerebrosidase B-X
... B-X
| B-X
Find B-X
The B-X
present B-X
study B-X
aimed B-X
to B-X
establish B-X
a B-X
fluorescence-based B-X
polymerase B-X
chain B-X
reaction-linked B-X
single-strand B-X
conformation B-X
polymorphism B-X
( B-X
F-PCR-SSCP B-X
) B-X
assay B-X
for B-X
the B-X
identification B-X
of B-X
Fasciola B-X
spp B-X
. B-X
Based B-X
on B-X
the B-X
sequences B-X
of B-X
Adult-onset B-X
Krabbe B-X
disease B-X
in B-X
two B-X
generations B-X
of B-X
a B-X
Chinese B-X
family B-X
Genotype B-X
and B-X
phenotype B-X
classification B-X
of B-X
29 B-X
patients B-X
affected B-X
by B-X
Krabbe B-X
disease B-X
Krabbe B-X
disease B-X
is B-X
an B-X
autosomal B-X
recessive B-X
leukodystrophy B-X
. B-X
It B-X
is B-X
pathologically B-X
characterized B-X
by B-X
demyelination B-X
of B-X
the B-X
central B-X
and B-X
peripheral B-X
nervous B-X
systems B-X
and B-X
the B-X
accumulation B-X
of B-X
globoid B-X
cells B-X
in B-X
brain B-X
white B-X

We	O
identified	O
three	O
missense	O
mutations	O
(	O
I66M	O
,	O
G270D	O
,	O
L618S	O
)	O
and	O
one	O
exon	O
-	O
6	O
skipping	O
(	O
535	O
-	O
573del	O
)	O
.	O
<EOS> B-X
Missense B-X
, B-X
nonsense B-X
, B-X
and B-X
translationally B-X
silent B-X
mutations B-X
can B-X
inactivate B-X
genes B-X
by B-X
altering B-X
the B-X
inclusion B-X
of B-X
mutant B-X
exons B-X
in B-X
mRNA B-X
, B-X
but B-X
their B-X
overall B-X
frequency B-X
among B-X
disease-causing B-X
exonic B-X
substitutions B-X
is B-X
Our B-X
results B-X
suggest B-X
that B-X
aberrant B-X
exon B-X
skipping B-X
associated B-X
to B-X
putative B-X
splicing B-X
enhancer B-X
disruption B-X
and B-X
silencer B-X
creation B-X
is B-X
one B-X
previously B-X
unrecognized B-X
mechanism B-X
in B-X
Wilson B-X
disease B-X
. B-X
What B-X
is B-X
more B-X
, B-X
the B-X
A B-X
variety B-X
of B-X
genetic B-X
backgrounds B-X
cause B-X
the B-X
loss B-X
of B-X
function B-X
of B-X
thiazide-sensitive B-X
sodium B-X
chloride B-X
cotransporter B-X
, B-X
encoded B-X
by B-X
SLC12A3 B-X
, B-X
responsible B-X
for B-X
the B-X
phenotypes B-X
in B-X
Gitelman B-X
syndrome B-X
. B-X
Recently B-X
, B-X
Spinal B-X
muscular B-X
atrophy B-X
( B-X
SMA B-X
) B-X
is B-X
a B-X
frequent B-X
autosomal B-X
recessive B-X
neurodegenerative B-X
disorder B-X
leading B-X
to B-X
weakness B-X
and B-X
atrophy B-X
of B-X
voluntary B-X
muscles B-X
. B-X
The B-X
survival B-X
motor B-X
neuron B-X
gene B-X
( B-X
SMN B-X
) B-X
Exon B-X
skipping B-X
, B-X
as B-X
a B-X
therapy B-X
to B-X
restore B-X
a B-X
reading B-X
frame B-X
or B-X
switch B-X
protein B-X
isoforms B-X
, B-X
is B-X
under B-X
clinical B-X
trial B-X
. B-X
We B-X
hypothesised B-X
that B-X
removing B-X
an B-X
in-frame B-X
exon B-X
containing B-X
a B-X
bioRxiv B-X
- B-X
the B-X
preprint B-X
server B-X
for B-X
biology B-X
, B-X
operated B-X
by B-X
Cold B-X
Spring B-X
Harbor B-X
Laboratory B-X
, B-X
a B-X
research B-X
and B-X
educational B-X
institution B-X

Two	O
of	O
the	O
patients	O
had	O
only	O
the	O
I66M	O
mutant	O
mRNA	O
,	O
and	O
one	O
only	O
the	O
G27OD	O
mutant	O
mRNA	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Clone B-X
and B-X
expression B-X
of B-X
mutant B-X
M-CSF B-X
and B-X
its B-X
receptor B-X
from B-X
human B-X
leukemic B-X
cell B-X
line B-X
J6-1 B-X
| B-X
Macrophage B-X
colony-stimulating B-X
factor B-X
( B-X
M-CSF B-X
) B-X
plays B-X
important B-X
roles B-X
in B-X
hematopoietic B-X
Problems B-X
- B-X
Biochemistry B-X
- B-X
NCBI B-X
Bookshelf B-X

The	O
fourth	O
patient	O
carried	O
a	O
compound	O
heterozygous	O
mutation	O
of	O
535	O
-	O
573del	O
and	O
L618S	O
.	O

To	O
determine	O
the	O
enzymatic	O
activities	O
produced	O
by	O
these	O
mutations	O
,	O
we	O
constructed	O
mutated	O
GALC	O
cDNAs	O
and	O
expressed	O
them	O
in	O
COS	O
-	O
1	O
cells	O
.	O
<EOS> B-X
Missense B-X
mutation B-X
in B-X
mouse B-X
GALC B-X
mimics B-X
human B-X
gene B-X
defect B-X
and B-X
offers B-X
new B-X
insights B-X
into B-X
Krabbe B-X
disease B-X
Krabbe B-X
disease B-X
, B-X
one B-X
of B-X
the B-X
autosomal-recessive B-X
lysosomal B-X
storage B-X
disorders B-X
( B-X
LSDs B-X
) B-X
, B-X
is B-X
caused B-X
by B-X
a B-X
deficiency B-X
of B-X
galactocerebrosidase B-X
( B-X
GALC B-X
) B-X
activity B-X
, B-X
resulting B-X
in B-X
the B-X
intracellular B-X
Molecular B-X
Characterization B-X
of B-X
Mutations B-X
That B-X
Cause B-X
Globoid B-X
Cell B-X
Leukodystrophy B-X
and B-X
Pharmacological B-X
Rescue B-X
Using B-X
Small B-X
Molecule B-X
Chemical B-X
Chaperones B-X
| B-X
Journal B-X
of B-X
Neuroscience B-X
Galactosylceramidase B-X
- B-X
an B-X
overview B-X
| B-X
ScienceDirect B-X
Topics B-X

Three	O
mutations	O
,	O
viz	O
.	O
,	O
G270D	O
,	O
L618S	O
,	O
and	O
exon	O
-	O
6	O
skipping	O
(	O
535	O
-	O
573del	O
)	O
,	O
produced	O
diminished	B-Disease
GALC	I-Disease
activity	I-Disease
as	O
expected	O
.	O
<EOS> B-X
{ B-X
{ B-X
nm.description B-X
} B-X
} B-X
We B-X
examined B-X
galactosylceramidase B-X
( B-X
GALC B-X
) B-X
cDNA B-X
in B-X
four B-X
Japanese B-X
patients B-X
with B-X
adult B-X
onset B-X
globoid B-X
cell B-X
leukodystrophy B-X
( B-X
Krabbe B-X
disease B-X
; B-X
AO-GLD B-X
) B-X
by B-X
polymerase B-X
Download B-X
Citation B-X
| B-X
On B-X
Mar B-X
1 B-X
, B-X
2018 B-X
, B-X
Ïù¥ÏÉÅÌùî B-X
and B-X
others B-X
published B-X
Late B-X
Infantile-Onset B-X
Globoid B-X
Cell B-X
Leukodystrophy B-X
: B-X
Treatment B-X
using B-X
Hematopoietic B-X
Stem B-X
Cell B-X
Transplantation B-X
| B-X
Find B-X
, B-X
read B-X
and B-X

The	O
I66M	O
mutation	O
in	O
the	O
wild	O
-	O
type	O
GALC	O
cDNA	O
(	O
I289	O
)	O
had	O
normal	O
activity	O
,	O
but	O
when	O
this	O
mutation	O
and	O
the	O
V289	O
polymorphism	O
were	O
introduced	O
into	O
the	O
same	O
allele	O
,	O
it	O
had	O
decreased	O
activity	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
Krabbe B-X
disease B-X
: B-X
Are B-X
certain B-X
mutations B-X
disease-causing B-X
only B-X
when B-X
specific B-X
polymorphisms B-X
are B-X
present B-X
or B-X
when B-X
inherited B-X
in B-X
trans B-X
with B-X
specific B-X
second B-X
mutations B-X
? B-X
| B-X
‚Ä¢Newborn B-X
screening B-X
for B-X
Challenges B-X
in B-X
the B-X
association B-X
of B-X
human B-X
single B-X
nucleotide B-X
polymorphism B-X
mentions B-X
with B-X
unique B-X
database B-X
identifiers B-X
The B-X
declaration B-X
of B-X
COVID-19 B-X
as B-X
a B-X
global B-X
pandemic B-X
in B-X
March B-X
resulted B-X
in B-X
a B-X
rapid B-X
decrease B-X
in B-X
step B-X
counts B-X
worldwide B-X
. B-X
BackgroundMutations B-X
in B-X
the B-X
parkin B-X
gene B-X
, B-X
an B-X
E3 B-X
protein-ubiquitin B-X
ligase B-X
, B-X
cause B-X
autosomal B-X
recessive B-X
early-onset B-X
Parkinson B-X
disease B-X
( B-X
PD B-X
) B-X
. B-X
The B-X
role B-X
of B-X
polymorphisms B-X
Research B-X
on B-X
why B-X
psychologists B-X
should B-X
use B-X
exercise B-X
as B-X
part B-X
of B-X
their B-X
treatment B-X
. B-X
Parenting B-X
and B-X
the B-X
decline B-X
of B-X
physical B-X
activity B-X
from B-X
age B-X
9 B-X
to B-X
15 B-X
Decreased B-X
activity B-X
is B-X
when B-X
you B-X
move B-X
around B-X
or B-X
talk B-X
slowly B-X
or B-X
feel B-X
weak B-X
or B-X
tired B-X
all B-X
the B-X
time B-X
. B-X
People B-X
with B-X
dementia B-X
can B-X
be B-X
less B-X
active B-X
for B-X
many B-X
reasons B-X
. B-X

Thus	O
,	O
the	O
combination	O
of	O
a	O
unique	O
mutation	O
and	O
polymorphism	O
causes	O
conformational	O
change	O
in	O
the	O
GALC	O
enzyme	O
,	O
resulting	O
in	O
low	O
enzymatic	O
activity	O
.	O
<EOS> B-X
Request B-X
PDF B-X
| B-X
A B-X
single B-X
mutation B-X
in B-X
the B-X
GALC B-X
gene B-X
is B-X
responsible B-X
for B-X
the B-X
majority B-X
of B-X
late B-X
onset B-X
Krabbe B-X
disease B-X
patients B-X
in B-X
the B-X
Catania B-X
( B-X
Sicily B-X
, B-X
Italy B-X
) B-X
region B-X
Structural B-X
snapshots B-X
illustrate B-X
the B-X
catalytic B-X
cycle B-X
of B-X
Œ≤-galactocerebrosidase B-X
, B-X
the B-X
defective B-X
enzyme B-X
in B-X
Krabbe B-X
disease B-X
New B-X
therapeutic B-X
approaches B-X
for B-X
Krabbe B-X
disease B-X
: B-X
The B-X
potential B-X
of B-X
pharmacological B-X
chaperones B-X
PDF B-X
| B-X
Glycosphingolipids B-X
are B-X
ubiquitous B-X
components B-X
of B-X
mammalian B-X
cell B-X
membranes B-X
, B-X
and B-X
defects B-X
in B-X
their B-X
catabolism B-X
by B-X
lysosomal B-X
enzymes B-X
cause B-X
a B-X
diverse B-X
... B-X
| B-X
Find B-X
, B-X
read B-X
and B-X
cite B-X
all B-X
Request B-X
PDF B-X
| B-X
Krabbe B-X
Disease B-X
: B-X
Genetic B-X
Aspects B-X
and B-X
Progress B-X
toward B-X
Therapy B-X
| B-X
Krabbe B-X
disease B-X
or B-X
globoid B-X
cell B-X
leukodystrophy B-X
is B-X
a B-X
disorder B-X
involving B-X
the B-X
white B-X
matter B-X
of B-X
the B-X
peripheral B-X
and B-X
Request B-X
PDF B-X
| B-X
Krabbe B-X
disease B-X
: B-X
Clinical B-X
, B-X
biochemical B-X
and B-X
molecular B-X
information B-X
on B-X
six B-X
new B-X
patients B-X
and B-X
successful B-X
retrospective B-X
diagnosis B-X
using B-X
stored B-X
newborn B-X
screening B-X
cards B-X
| B-X
To B-X
present B-X
clinical B-X
, B-X

AO	B-Disease
-	I-Disease
GLD	I-Disease
mutations	O
,	O
including	O
those	O
found	O
here	O
,	O
are	O
located	O
in	O
the	O
N	O
-	O
terminus	O
(	O
I66M	O
,	O
G270D	O
,	O
535	O
-	O
573del	O
)	O
or	O
C	O
-	O
terminus	O
(	O
L618S	O
)	O
of	O
the	O
GALC	O
enzyme	O
,	O
whereas	O
the	O
reported	O
mutations	O
in	O
the	O
infantile	O
form	O
(	O
IF	B-Disease
-	I-Disease
GLD	I-Disease
)	O
are	O
in	O
the	O
central	O
domain	O
.	O
<EOS> B-X
The B-X
BEN B-X
domain B-X
is B-X
a B-X
novel B-X
sequence-specific B-X
DNA-binding B-X
domain B-X
conserved B-X
in B-X
neural B-X
transcriptional B-X
repressors B-X
Abstract B-X
. B-X
Primary B-X
lateral B-X
sclerosis B-X
( B-X
PLS B-X
) B-X
is B-X
a B-X
rare B-X
progressive B-X
paralytic B-X
disorder B-X
that B-X
results B-X
from B-X
dysfunction B-X
of B-X
the B-X
upper B-X
motoneurons B-X
. B-X
Although B-X
PLS B-X
is B-X
a B-X
spo B-X
Tyrosine B-X
kinase B-X
domains B-X
dynamically B-X
fluctuate B-X
between B-X
two B-X
main B-X
structural B-X
forms B-X
that B-X
are B-X
referred B-X
to B-X
as B-X
type B-X
I B-X
( B-X
DFG-in B-X
) B-X
or B-X
type B-X
II B-X
( B-X
DFG-out B-X
) B-X
conformations B-X
. B-X
Comprehensive B-X
data B-X
Delivering B-X
CRISPR B-X
: B-X
a B-X
review B-X
of B-X
the B-X
challenges B-X
and B-X
approaches B-X
The B-X
receptors B-X
for B-X
follitropin B-X
( B-X
FSHR B-X
) B-X
, B-X
thyrotropin B-X
( B-X
TSHR B-X
) B-X
, B-X
and B-X
lutropin/chorionic B-X
gonadotropin B-X
( B-X
LHCGR B-X
) B-X
are B-X
the B-X
members B-X
of B-X
the B-X
glycoprotein B-X
hormone B-X
( B-X
GPH B-X
) B-X
receptors B-X
Mutations B-X
in B-X
Tetratricopeptide B-X
Repeat B-X
Domain B-X
7A B-X
Result B-X
in B-X
a B-X
Severe B-X
Form B-X
of B-X
Very B-X
Early B-X
Onset B-X
Inflammatory B-X
Bowel B-X
Disease B-X
Request B-X
PDF B-X
| B-X
Adult-onset B-X
Krabbe B-X
disease B-X
in B-X
two B-X
generations B-X
of B-X
a B-X
Chinese B-X
family B-X
| B-X
Background B-X
: B-X
Krabbe B-X
disease B-X
( B-X
KD B-X
) B-X
is B-X
a B-X
rare B-X
autosomal B-X
recessive B-X
lysosomal B-X
storage B-X
disorder B-X
caused B-X

This	O
difference	O
in	O
mutation	O
sites	O
may	O
affect	O
the	O
clinical	O
features	O
of	O
GLD	B-Disease
.	O
<EOS> B-X
Clinical B-X
Outcomes B-X
of B-X
TP53 B-X
Mutations B-X
in B-X
Cancers B-X
Novel B-X
mutations B-X
in B-X
PIEZO1 B-X
cause B-X
an B-X
autosomal B-X
recessive B-X
generalized B-X
lymphatic B-X
dysplasia B-X
with B-X
non-immune B-X
hydrops B-X
fetalis B-X
THOC2 B-X
Mutations B-X
Implicate B-X
mRNA-Export B-X
Pathway B-X
in B-X
X-Linked B-X
Intellectual B-X
Disability B-X
Abstract B-X
. B-X
The B-X
Fas B-X
pathway B-X
and B-X
regulatory B-X
T B-X
( B-X
TR B-X
) B-X
cells B-X
play B-X
intertwining B-X
roles B-X
in B-X
controlling B-X
T B-X
cell B-X
tolerance B-X
through B-X
deletion B-X
and B-X
suppression B-X
of B-X
autoreactive B-X
T B-X
Altered B-X
Trafficking B-X
and B-X
Processing B-X
of B-X
GALC B-X
Mutants B-X
Correlates B-X
with B-X
Globoid B-X
Cell B-X
Leukodystrophy B-X
Severity B-X
Mutations B-X
of B-X
the B-X
FHL1 B-X
Gene B-X
Cause B-X
Emery-Dreifuss B-X
Muscular B-X
Dystrophy B-X
Molecular B-X
Characterization B-X
of B-X
Mutations B-X
That B-X
Cause B-X
Globoid B-X
Cell B-X
Leukodystrophy B-X
and B-X
Pharmacological B-X
Rescue B-X
Using B-X
Small B-X
Molecule B-X
Chemical B-X
Chaperones B-X

